PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lu, ZG; Xu, J; Wang, Q; Pan, YX				Lu, Zhigang; Xu, Jin; Wang, Qian; Pan, Ying-Xian			Morphine modulates the expression of mu-opioid receptor exon 5-associated full-length C-terminal splice variants by upregulating miR-378a-3p	FASEB JOURNAL			English	Article						microRNA; morphine; opioid; OPRM1; splicing	MESSENGER-RNA; GENE; TOLERANCE; MICRORNAS; IDENTIFICATION; ASSOCIATION; REGION; MOR1	The mu-opioid receptor gene, OPRM1, undergoes extensive alternative splicing, creating an array of splice variants that are conserved from rodent to human. Both mouse and human OPRM1 have five exon 5-associated seven transmembrane full-length carboxyl terminal variants, MOR-1B1, MOR-1B2, MOR-1B3, MOR-1B4, and MOR-1B5, all of which are derived from alternative 3 ' splicing from exon 3 to alternative sites within exon 5. The functional relevance of these exon 5-associated MOR-1Bs has been demonstrated in mu agonist-induced G protein coupling, adenylyl cyclase activity, receptor internalization and desensitization, and post-endocytic sorting, as well as region-specific expression at the mRNA level. In the present study, we mapped a polyadenylation site for both mouse and human MOR-1Bs that defines the 3 '-untranslated regions (3 '-UTR) of MOR-1Bs and stabilizes mMOR-1Bs mRNAs. We identified a conserved miR378a-3p sequence in the 3 '-UTR of both mouse and human MOR-1B(S) transcripts through which miR-378a-3p can regulate the expression of MOR-1Bs at the mRNA level. Chronic morphine treatment significantly increased the miR-378-3p level in Be(2)C cells and the brainstem of the morphine tolerant mice, contributing to the decreased expression of the mouse and human MOR-1B3 and MOR-1B4. Our study provides new insights into the role of miRNAs and Oprm1 splice variants in morphine tolerance.	[Lu, Zhigang] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Peoples R China; [Lu, Zhigang] Nanjing Univ Chinese Med, Affiliated Hosp, Coll Clin Med 1, Nanjing, Peoples R China; [Lu, Zhigang] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Peoples R China; [Xu, Jin; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA; [Xu, Jin; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA; [Wang, Qian] Nanjing Univ Chinese Med, Int Educ Coll, Nanjing, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Nanjing University of Chinese Medicine	Lu, ZG (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Peoples R China.; Pan, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA.	luzg@njucm.edu.cn; pany@mskcc.org			HHS \ NIH \ National Institute on Drug Abuse (NIDA) [DA042888, DA046714, DA007242]; Mayday Foundation; Peter F. McManus Charitable Trust; NSFC \ National Natural Science Foundation of China [81673412]; HHS \ NIH \ National Cancer Institute (NCI) [CA08748]	HHS \ NIH \ National Institute on Drug Abuse (NIDA); Mayday Foundation; Peter F. McManus Charitable Trust; NSFC \ National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Institute on Drug Abuse (NIDA), Grant/Award Number: DA042888, DA046714 and DA007242; The Mayday Foundation; The Peter F. McManus Charitable Trust; NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81673412; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA08748	Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Barbierato M, 2015, CNS NEUROL DISORD-DR, V14, P239, DOI 10.2174/1871527314666150116123932; Ding NX, 2018, INT J MOL MED, V42, P381, DOI 10.3892/ijmm.2018.3639; Dreyer JL, 2010, GENOME MED, V2, DOI 10.1186/gm213; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Havens MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004312; He Ying, 2012, Frontiers in Genetics, V3, P110, DOI 10.3389/fgene.2012.00110; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Hu XM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916666283; Hwang CK, 2012, J NEUROIMMUNE PHARM, V7, P808, DOI 10.1007/s11481-011-9323-2; Hyun J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10993; Ide S, 2005, GENE, V364, P139, DOI 10.1016/j.gene.2005.05.040; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; KOLESNIKOV YA, 1993, P NATL ACAD SCI USA, V90, P5162, DOI 10.1073/pnas.90.11.5162; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Kucherenko MM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.202002; Li H, 2014, EUR J CANCER, V50, P1207, DOI 10.1016/j.ejca.2013.12.010; Lu ZG, 2015, J CLIN INVEST, V125, P2626, DOI 10.1172/JCI81070; Lu ZG, 2014, MOL PHARMACOL, V85, P368, DOI 10.1124/mol.113.089292; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pan YX, 2005, MOL PHARMACOL, V68, P866, DOI 10.1124/mol.105.011858; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Rodriguez Raquel E., 2012, Frontiers in Genetics, V3, P223, DOI 10.3389/fgene.2012.00223; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Tapocik JD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00020; Tapocik JD, 2013, ADDICT BIOL, V18, P480, DOI 10.1111/j.1369-1600.2012.00470.x; Wei XF, 2016, RNA BIOL, V13, P1300, DOI 10.1080/15476286.2016.1239008; Wu QF, 2005, MOL PHARMACOL, V68, P279, DOI 10.1124/mol.105.012567; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Wu QF, 2009, MOL PHARMACOL, V75, P744, DOI 10.1124/mol.108.053462; Wu QF, 2008, FASEB J, V22, P4085, DOI 10.1096/fj.08-108175; Xu JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087078; Xu J, 2015, P NATL ACAD SCI USA, V112, P279, DOI 10.1073/pnas.1419183112; Zhang YH, 2006, BRAIN RES, V1099, P33, DOI 10.1016/j.brainres.2006.04.133	37	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4540	4556		10.1096/fj.201901879RR	http://dx.doi.org/10.1096/fj.201901879RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31999011	Green Accepted			2022-12-26	WOS:000510165500001
J	Landa-Galvan, HV; Rios-Castro, E; Romero-Garcia, T; Rueda, A; Olivares-Reyes, JA				Landa-Galvan, Huguet, V; Rios-Castro, Emmanuel; Romero-Garcia, Tatiana; Rueda, Angelica; Alberto Olivares-Reyes, Jesus			Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes	PLOS ONE			English	Article							GLUCOSE-TRANSPORT; DIABETIC CARDIOMYOPATHY; CARDIAC METABOLISM; DYSFUNCTION ROLE; RESISTANCE; KINASE; HEAT-SHOCK-PROTEIN-60; PHOSPHORYLATION; UBIQUITINATION; DYSREGULATION	Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors, with insulin resistance as a critical component for its development. Insulin signaling in the heart leads to Akt (also known as PKB) activation, a serine/threonine protein kinase, which regulates cardiac glucose metabolism and growth. Cardiac metabolic inflexibility, characterized by impaired insulin-induced glucose uptake and oxidation, has been reported as an early and consistent change in the heart of different models of MetS and diabetes; however, the evaluation of Akt activation has yielded variable results. Here we report in cardiomyocytes of MetS rats, diminished insulin-induced glucose uptake and Akt activation, evaluated by its impaired mobilization towards the plasma membrane and phosphorylation, and reflected in a re-distribution of its interacting proteins, assessed by label-free mass spectrometry (data are available via ProteomeXchange with identifier PXD013260). We report 45 proteins with diminished abundance in Akt complex of MetS cardiomyocytes, mainly represented by energy metabolism-related proteins, and also, 31 Akt-interacting proteins with increased abundance, which were mainly related to contraction, endoplasmic reticulum stress, and Akt negative regulation. These results emphasize the relevance of Akt in the regulation of energy metabolism in the heart and highlight Akt-interacting proteins that could be involved in the detrimental effects of MetS in the heart.	[Landa-Galvan, Huguet, V; Romero-Garcia, Tatiana; Rueda, Angelica; Alberto Olivares-Reyes, Jesus] IPN, CINVESTAV, Dept Bioquim, Mexico City, DF, Mexico; [Rios-Castro, Emmanuel] IPN, CINVESTAV, LaNSE, Unidad Genom Prote & Metabolom UGPM, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Rueda, A; Olivares-Reyes, JA (corresponding author), IPN, CINVESTAV, Dept Bioquim, Mexico City, DF, Mexico.	arueda@cinvestav.mx; jolivare@cinvestav.mx	Rueda, Angelica/G-4055-2012; Rueda, Angelica/AAW-4621-2020; Olivares-Reyes, Jesus Alberto/G-3180-2018	Rueda, Angelica/0000-0001-8749-8494; Rueda, Angelica/0000-0001-8749-8494; Romero-Garcia, Tatiana/0000-0003-4316-2248; Rios-Castro, Emmanuel/0000-0002-7671-7943; Olivares-Reyes, Jesus Alberto/0000-0001-8389-9274	Cinvestav-IPN; CONACYT/SEP Research Grant [A1-S-9082, 167673]; PRODEP-SEP grant [Cinvestav-CA-10, 28915/2018]; SEP-CINVESTAV 2018 grant [2]; Estimulo a la Investigacion Medica "Miguel Aleman Valdes" 2018; CONACYT scholarship grant [278067, 295776]	Cinvestav-IPN; CONACYT/SEP Research Grant; PRODEP-SEP grant; SEP-CINVESTAV 2018 grant; Estimulo a la Investigacion Medica "Miguel Aleman Valdes" 2018; CONACYT scholarship grant	This work was supported by Cinvestav-IPN and partially by CONACYT/SEP Research Grant 167673 (to J.A.O-R.); CONACYT/SEP Research Grant A1-S-9082 (to A.R.); PRODEP-SEP grant to the Academic Group Cinvestav-CA-10, ID 28915/2018 (to A.R. and J.A.O-R.); SEP-CINVESTAV 2018 grant #2 (to A.R.); Estimulo a la Investigacion Medica "Miguel Aleman Valdes" 2018 (to J.A.O-R.) and by a CONACYT scholarship grant, No. 278067 (to H.V.L-G.) and No. 295776 (to T.R-G.).	Abel ED, 2012, ARTERIOSCL THROM VAS, V32, P2068, DOI 10.1161/ATVBAHA.111.241984; Ali AY, 2015, MOL CARCINOGEN, V54, P1301, DOI 10.1002/mc.22205; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Baba T, 2010, FEBS LETT, V584, P2796, DOI 10.1016/j.febslet.2010.05.015; Balderas-Villalobos J, 2013, AM J PHYSIOL-HEART C, V305, pH1344, DOI 10.1152/ajpheart.00211.2013; Berti L, 1997, DIABETOLOGIA, V40, P606, DOI 10.1007/s001250050722; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Carvajal K, 2005, BBA-BIOENERGETICS, V1709, P231, DOI 10.1016/j.bbabio.2005.08.001; Carvajal K, 2003, MOL CELL BIOCHEM, V249, P157, DOI 10.1023/A:1024799025126; Carvajal-Zarrabal O, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/386425; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Cerniglia GJ, 2015, MOL CANCER THER, V14, P1928, DOI 10.1158/1535-7163.MCT-14-0888; Chen HS, 2005, DIABETES, V54, P175, DOI 10.2337/diabetes.54.1.175; Chen HY, 2009, IEEE MTT S INTERNATIONAL MICROWAVE WORKSHOP SERIES ON WIRELESS SENSING, LOCAL POSITIONING, AND RFID (IMWS 2009-CROATIA), P151; Chen S, 2011, TRENDS ENDOCRIN MET, V22, P429, DOI 10.1016/j.tem.2011.07.005; Davidoff AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE718, DOI 10.1152/ajpendo.00358.2003; de Alba-Aguayo DR, 2017, CELL CALCIUM, V62, P29, DOI 10.1016/j.ceca.2017.01.009; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Deng W, 2014, ENDOCRINOLOGY, V155, P1618, DOI 10.1210/en.2013-1817; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; El Hafidi M, 2004, AM J PHYSIOL-REG I, V287, pR1387, DOI 10.1152/ajpregu.00159.2004; Fang CX, 2005, DIABETOLOGIA, V48, P2412, DOI 10.1007/s00125-005-1940-y; Fernandez-Miranda G, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00520; Gomez-Suarez M, 2016, CELL DEATH DIFFER, V23, P1060, DOI 10.1038/cdd.2015.163; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Gray S, 2011, TRENDS ENDOCRIN MET, V22, P394, DOI 10.1016/j.tem.2011.05.001; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE19, DOI 10.1161/01.ATV.0000112379.88385.67; Gu JL, 2018, DIABETES, V67, P507, DOI 10.2337/db17-0219; Vazquez-Jimenez JG, 2016, CELL SIGNAL, V28, P53, DOI 10.1016/j.cellsig.2015.10.001; Gutierrez-Rodelo C, 2017, GAC MED MEX, V153, P214; Hagiwara Y, 2002, CELL STRUCT FUNCT, V27, P375, DOI 10.1247/csf.27.375; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harmancey R, 2012, FASEB J, V26, P3118, DOI 10.1096/fj.12-208991; Huang BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061430; Huisamen B, 2001, MOL CELL BIOCHEM, V223, P15, DOI 10.1023/A:1017528402205; Jacquin MA, 2013, CELL DEATH DIFFER, V20, P1043, DOI 10.1038/cdd.2013.32; Ji HT, 2012, EMBO REP, V13, P554, DOI 10.1038/embor.2012.53; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069910; Jia GH, 2018, DIABETOLOGIA, V61, P21, DOI 10.1007/s00125-017-4390-4; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Marker T, 2012, DIABETES, V61, P615, DOI 10.2337/db10-1574; Mahmoud AM, 2017, ADV EXP MED BIOL, V999, P207, DOI 10.1007/978-981-10-4307-9_12; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Souza GHMF, 2017, METHODS MOL BIOL, V1546, P57, DOI 10.1007/978-1-4939-6730-8_4; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Montes M, 2000, J NUTR BIOCHEM, V11, P30, DOI 10.1016/S0955-2863(99)00068-6; Montessuit C, 2013, BBA-MOL CELL RES, V1833, P848, DOI 10.1016/j.bbamcr.2012.08.009; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Punthakee Z, 2018, CAN J DIABETES, V42, pS10, DOI 10.1016/j.jcjd.2017.10.003; Riehle C, 2016, CIRC RES, V118, P1151, DOI 10.1161/CIRCRESAHA.116.306206; Shan YX, 2003, J BIOL CHEM, V278, P45492, DOI 10.1074/jbc.M304498200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh S, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0516-4; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Y, 2013, GEOCHEM-EXPLOR ENV A, V13, P3, DOI 10.1144/geochem2012-139; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vasanji Z, 2006, AM J PHYSIOL-CELL PH, V291, pC772, DOI 10.1152/ajpcell.00086.2005; Vital P, 2006, J ENDOCRINOL, V190, P425, DOI 10.1677/joe.1.06596; Wang Q, 2012, ENDOCRINOLOGY, V153, P5600, DOI 10.1210/en.2012-1424; Wang SY, 2019, BBA-MOL BASIS DIS, V1865, P1865, DOI 10.1016/j.bbadis.2018.08.011; Wang SY, 2017, TOXICOL LETT, V269, P1, DOI 10.1016/j.toxlet.2017.01.009; Wende AR, 2015, MOL CELL BIOL, V35, P831, DOI 10.1128/MCB.01109-14; Wong SK, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0123-9; Xu XH, 2013, J MOL CELL BIOL, V5, P61, DOI 10.1093/jmcb/mjs055; Yang JY, 2009, J MOL CELL CARDIOL, V46, P919, DOI 10.1016/j.yjmcc.2009.02.015; Yao H, 2014, AM J CARDIOVASC DRUG, V14, P433, DOI 10.1007/s40256-014-0089-9; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8152, DOI 10.1002/jcp.27603; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; ZANINETTI D, 1983, DIABETOLOGIA, V25, P525; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhang YM, 2014, J MOL CELL CARDIOL, V74, P76, DOI 10.1016/j.yjmcc.2014.04.020; Zhang YM, 2011, ANTIOXID REDOX SIGN, V15, P2407, DOI 10.1089/ars.2010.3751; Zhang ZY, 2019, DIABETES RES CLIN PR, V156, DOI 10.1016/j.diabres.2017.10.004; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	87	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228115	10.1371/journal.pone.0228115	http://dx.doi.org/10.1371/journal.pone.0228115			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995605	Green Published, gold			2022-12-26	WOS:000534609400047
J	Chia, J; Scott, K				Chia, Justine; Scott, Kristin			Activation of specific mushroom body output neurons inhibits proboscis extension and sucrose consumption	PLOS ONE			English	Article							OLFACTORY MEMORY FORMATION; EFFERENT NEURONS; TASTE MEMORY; DROSOPHILA; DOPAMINE; EXPRESSION; BEHAVIOR; OCTOPAMINE; RETRIEVAL; CIRCUIT	The ability to modify behavior based on prior experience is essential to an animal's survival. For example, animals may become attracted to a previously neutral odor or reject a previously appetitive food source based on previous encounters. In Drosophila, the mushroom bodies (MBs) are critical for olfactory associative learning and conditioned taste aversion, but how the output of the MBs affects specific behavioral responses is unresolved. In conditioned taste aversion, Drosophila shows a specific behavioral change upon learning: proboscis extension to sugar is reduced after a sugar stimulus is paired with an aversive stimulus. While studies have identified MB output neurons (MBONs) that drive approach or avoidance behavior, whether the same MBONs impact innate proboscis extension behavior is unknown. Here, we tested the role of MB pathways in altering proboscis extension and identified MBONs that synapse onto multiple MB compartments that upon activation significantly decreased proboscis extension to sugar. Activating several of these lines also decreased sugar consumption, revealing that these MBONs have a general role in modifying feeding behavior beyond proboscis extension. The MBONs that decreased proboscis extension and ingestion are different from those that drive avoidance behavior in another context. These studies provide insight into how activation of MB output neurons decreases proboscis extension to taste compounds.	[Chia, Justine; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chia, Justine; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NIH NIDCD [1R01DC013280]; NSF predoctoral fellowship	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NSF predoctoral fellowship(National Science Foundation (NSF))	KS received 1R01DC013280 from NIH NIDCD. JC received an NSF predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2016, ELIFE, V5, DOI [DOI 10.7554/ELIFE.16135, 10.7554/eLife.16135]; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cohn R, 2015, CELL, V163, P1742, DOI 10.1016/j.cell.2015.11.019; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Handler A, 2019, CELL, V178, P60, DOI 10.1016/j.cell.2019.05.040; Hattori D, 2017, CELL, V169, P956, DOI 10.1016/j.cell.2017.04.028; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hige T, 2015, NEURON, V88, P985, DOI 10.1016/j.neuron.2015.11.003; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim H, 2017, ELIFE, V6, DOI 10.7554/eLife.23386; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kirkhart C, 2015, J NEUROSCI, V35, P5950, DOI 10.1523/JNEUROSCI.3930-14.2015; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Lewis LPC, 2015, CURR BIOL, V25, P2203, DOI 10.1016/j.cub.2015.07.015; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Masek P, 2016, J NEUROGENET, V30, P112, DOI 10.1080/01677063.2016.1185104; Masek P, 2015, CURR BIOL, V25, P1535, DOI 10.1016/j.cub.2015.04.027; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Mohamed GA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0430-2; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; Pai TP, 2013, P NATL ACAD SCI USA, V110, P7898, DOI 10.1073/pnas.1216336110; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Placais PY, 2013, CELL REP, V5, P769, DOI 10.1016/j.celrep.2013.09.032; Pool AH, 2014, CURR OPIN NEUROBIOL, V29, P57, DOI 10.1016/j.conb.2014.05.008; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Simpson JH, 2016, J NEUROGENET, V30, P185, DOI 10.1080/01677063.2016.1248761; Tsao CH, 2018, ELIFE, V7, DOI 10.7554/eLife.35264; Wong MY, 2015, MOL BIOL CELL, V26, P2466, DOI 10.1091/mbc.E15-01-0002; Wu M, 2016, ELIFE, V5, DOI 10.7554/eLife.21022	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0223034	10.1371/journal.pone.0223034	http://dx.doi.org/10.1371/journal.pone.0223034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990947	gold, Green Published, Green Submitted			2022-12-26	WOS:000534605400006
J	Szlosek, D; Robertson, J; Quimby, J; Mack, R; Ogeer, J; Clements, C; McCrann, DJ; Coyne, MJ				Szlosek, Donald; Robertson, Jane; Quimby, Jessica; Mack, Rebekah; Ogeer, Jennifer; Clements, Celeste; McCrann, Donald J.; Coyne, Michael J.			A retrospective evaluation of the relationship between symmetric dimethylarginine, creatinine and body weight in hyperthyroid cats	PLOS ONE			English	Article							RENAL-FUNCTION; FELINE HYPERTHYROIDISM; SERUM CONCENTRATIONS; KIDNEY-FUNCTION; METHIMAZOLE; VALIDATION; BIOMARKERS; DISEASE; MASS	Hyperthyroidism in cats can mask changes in renal function, including chronic kidney disease (CKD), because of hyperfiltration and muscle loss. Symmetric dimethylarginine (SDMA) has been shown to increase earlier than creatinine in cats with renal dysfunction, and, unlike creatinine, SDMA is not impacted by lean muscle mass. The aim of this study was to describe the relationship between SDMA, creatinine, body weight and TT4 over time during treatment of hyperthyroidism. Cats were retrospectively identified from the US IDEXX Reference Laboratories database where TT4, SDMA and creatinine were measured on the same cat at multiple time points. A hyperthyroid treated group was identified (TT4 <= 4.7 mu g/dL and decreased by a minimum of 2.5 mu g/dL) that had body weight and laboratory results available from more than one visit, and was used to evaluate body weight, creatinine, SDMA and TT4 pre-treatment and at 1-30, 31-60, 61-90, 91-120 days post-treatment. Creatinine significantly decreased with increasing concentrations of TT4 (Spearman's rho = -0.37, P < 0.001), whereas SDMA did not. Body weight, SDMA and creatinine concentrations significantly increased during the immediate 1-30 day post-treatment period (P < 0.012, P < 0.001, P < 0.001, respectively). During treatment creatinine continued to increase as cats gained weight. In contrast, SDMA remained stable during treatment and was comparable to age-matched control cats. Therefore, SDMA may be a more reliable biomarker of renal function than creatinine in hyperthyroid cats before and during treatment.	[Szlosek, Donald; Robertson, Jane; Mack, Rebekah; Ogeer, Jennifer; Clements, Celeste; McCrann, Donald J.; Coyne, Michael J.] IDEXX Labs Inc, Westbrook, ME 04092 USA; [Quimby, Jessica] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Ogeer, Jennifer] Antech Diagnost, Fountain Valley, CA USA	University System of Ohio; Ohio State University	Coyne, MJ (corresponding author), IDEXX Labs Inc, Westbrook, ME 04092 USA.	michael-coyne@idexx.com		Coyne, Michael/0000-0003-4107-2353	IDEXX Laboratories, Inc. Westbrook, ME, USA	IDEXX Laboratories, Inc. Westbrook, ME, USA	The work presented in this study was funded by IDEXX Laboratories, Inc. Westbrook, ME, USA (https://www.idexx.com/en/about-idexx/).IDEXX Laboratories provided support in the form of salaries for authors (DS, JR, RM, JO, CC, DJM, MJC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adams WH, 1997, VET RADIOL ULTRASOUN, V38, P231, DOI 10.1111/j.1740-8261.1997.tb00846.x; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Becker TJ, 2000, J AM ANIM HOSP ASSOC, V36, P215, DOI 10.5326/15473317-36-3-215; Boag AK, 2007, VET REC, V161, P711, DOI 10.1136/vr.161.21.711; Covey HL, 2019, J VET INTERN MED, V33, P508, DOI 10.1111/jvim.15450; GRAVES TK, 1994, AM J VET RES, V55, P1745; Hall JA, 2016, J VET INTERN MED, V30, P794, DOI 10.1111/jvim.13942; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; HOLZWORTH J, 1980, J AM VET MED ASSOC, V176, P345; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Milner RJ, 2006, JAVMA-J AM VET MED A, V228, P559, DOI 10.2460/javma.228.4.559; Nabity MB, 2015, J VET INTERN MED, V29, P1036, DOI 10.1111/jvim.12835; NCLSI, 2008, CLIN LAB STAND I MAN; Peterson ME, 2016, J VET INTERN MED, V30, P1780, DOI 10.1111/jvim.14591; Peterson M, 2012, J FELINE MED SURG, V14, P804, DOI 10.1177/1098612X12464462; PETERSON ME, 1983, J AM VET MED ASSOC, V183, P103; R Core Team, 2020, R LANG ENV STAT COMP; Riensche MR, 2008, J FELINE MED SURG, V10, P160, DOI 10.1016/j.jfms.2007.10.005; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; THODAY KL, 1992, VET REC, V131, P257, DOI 10.1136/vr.131.12.257; van Hoek I, 2008, J VET INTERN MED, V22, P879, DOI 10.1111/j.1939-1676.2008.0110.x; Vaske HH, 2016, J FELINE MED SURG, V18, P55, DOI 10.1177/1098612X15575385; Wakeling J, 2008, J SMALL ANIM PRACT, V49, P287, DOI 10.1111/j.1748-5827.2008.00544.x; Wakeling J, 2011, J VET INTERN MED, V25, P1057, DOI 10.1111/j.1939-1676.2011.00790.x; Williams TL, 2010, J VET INTERN MED, V24, P1086, DOI 10.1111/j.1939-1676.2010.0566.x; Williams TL, 2016, VET CLIN PATH, V45, P148, DOI 10.1111/vcp.12324	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227964	10.1371/journal.pone.0227964	http://dx.doi.org/10.1371/journal.pone.0227964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990929	Green Published, gold			2022-12-26	WOS:000534605400029
J	Wang, LQ; Zhang, H; Wu, X; Wang, ZY; Fang, WW; Jiang, M; Chen, HM; Huang, LF; Liu, C				Wang, Liqiang; Zhang, Hui; Wu, Xi; Wang, Ziyue; Fang, Weiwei; Jiang, Mei; Chen, Haimei; Huang, Linfang; Liu, Chang			Phylogenetic relationships of Atractylodes lancea, A. chinensis and A. macrocephala, revealed by complete plastome and nuclear gene sequences	PLOS ONE			English	Article							CHLOROPLAST GENOMES; IDENTIFICATION; GENERATION; SOFTWARE; SPACER; TOOL	Atractylodes lancea, A. chinensis, and A. macrocephala are the three most widely used medicinal species of the Atractylodes genus. Their similar morphological features cause disagreement as whether they are three unique species, leading to their frequent misuses in medical products. Our study aimed to understand their relationships through both the complete plastome sequences and nuclear sequences, to identify molecular markers for their differentiation and explore the evolutionary relationships among three species. We sequenced, annotated, and analyzed the plastomes of these three species. The plastomes are 153,201, 153,258, and 153,265 bps in length for A. lancea, A. chinensis, and A. macrocephaly, respectively. Similar to other Asteraceae species, their plastomes exhibit typical quadripartite structures. Each plastome consists of 119 distinct genes, including 78 protein-coding, 37 tRNA, and 4 rRNA genes. Analyses of indels, single-nucleotide polymorphisms and simple sequence repeats, and comparison of plastomes showed high degree of conservation, leading to difficulty in the discovery of differentiating markers. We identified eleven potential molecular markers using an algorithm based on interspecific and intraspecific nucleotide diversity gaps. Validation experiments with fifty-five individuals from the three species collected from the botanical garden and fields confirmed that the marker cz11 could effectively distinguish samples from the three different species. Analysis of the several nuclear sequences suggests that the species of A. macrocephala may be a hybrid of A. lancea and A. chinensis. In summary, the results from this study highlight the complex relationships among of these three medicinal plants.	[Wang, Liqiang; Zhang, Hui; Wu, Xi; Jiang, Mei; Chen, Haimei; Huang, Linfang; Liu, Chang] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, Key Lab Bioact Subst & Resource Utilizat Chinese, Minist Educ, Beijing, Peoples R China; [Wang, Ziyue; Fang, Weiwei] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Beijing Jiaotong University	Huang, LF; Liu, C (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, Key Lab Bioact Subst & Resource Utilizat Chinese, Minist Educ, Beijing, Peoples R China.	lfhuang@implad.ac.cn; cliu6688@yahoo.com	xi, wu/AAI-7373-2021	liu, chang/0000-0003-3879-7302	National Projects for the Standardization of Traditional Chinese Medicines [2017-110108-83-03-001423]; Innovation Funds for Medical Sciences of Chinese Academy of Medical Sciences [2016-I2M-3-016, 2017-I2M-1-013]; National Science Foundation of China [81872966]; National Science & Technology Fundamental Resources Investigation Program of China [2018FY100705]; National Mega-Project for Innovative Drugs [2019ZX09735-002]	National Projects for the Standardization of Traditional Chinese Medicines; Innovation Funds for Medical Sciences of Chinese Academy of Medical Sciences; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Fundamental Resources Investigation Program of China; National Mega-Project for Innovative Drugs	This work was supported by National Projects for the Standardization of Traditional Chinese Medicines (2017-110108-83-03-001423), Innovation Funds for Medical Sciences [2016-I2M-3-016, 2017-I2M-1-013] of Chinese Academy of Medical Sciences, funds from National Science Foundation of China [81872966], National Science & Technology Fundamental Resources Investigation Program of China [2018FY100705] and The National Mega-Project for Innovative Drugs [2019ZX09735-002]. The funders were not involved in the study design, data collection, and analysis, decision to publish, or manuscript preparation.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Burland T G, 2000, Methods Mol Biol, V132, P71; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Dong WP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01148; Dubchak Inna, 2007, V395, P3; He L, 2017, MOLECULES, V22, DOI 10.3390/molecules22020249; Huang YL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01797; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jo YD, 2011, PLANT CELL REP, V30, P217, DOI 10.1007/s00299-010-0929-2; Kim JH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4028353; Kress WJ, 2017, J SYST EVOL, V55, P291, DOI 10.1111/jse.12254; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lei WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21669; Lewis S, 2002, APOLLO SEQUENCE ANNO, V3, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li ZZ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010319; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Ma XQ, 2000, PHYTOCHEMISTRY, V54, P363, DOI 10.1016/S0031-9422(00)00111-4; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mizukami H, 1998, BIOL PHARM BULL, V21, P474, DOI 10.1248/bpb.21.474; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Nie XJ, 2014, PLANT MOL BIOL REP, V32, P828, DOI 10.1007/s11105-013-0691-z; Park I, 2017, MOLECULES, V22, DOI 10.3390/molecules22112012; Peng HS, 2012, INT J MOL SCI, V13, P14623, DOI 10.3390/ijms131114623; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shiba M, 2006, BIOL PHARM BULL, V29, P315, DOI 10.1248/bpb.29.315; Shimato Y, 2018, J NAT MED-TOKYO, V72, P192, DOI 10.1007/s11418-017-1131-4; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wang HY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020409; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073946; Yuan Ju-Hong, 2008, Zhongguo Zhong Yao Za Zhi, V33, P1523; Zou Xiao-xing, 2009, Yaoxue Xuebao, V44, P680	45	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227610	10.1371/journal.pone.0227610	http://dx.doi.org/10.1371/journal.pone.0227610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990944	gold, Green Published			2022-12-26	WOS:000534605400020
J	Bo, QK; Zheng, XD; Chen, ZW				Bo, Qi-Kang; Zheng, Xiao-Dong; Chen, Zhi-Wei			Feeding intensity and molecular prey identification of the common long-armed octopus, Octopus minor (Mollusca: Octopodidae) in the wild	PLOS ONE			English	Article							DIET ANALYSIS; VULGARIS; DNA; CEPHALOPODA; BEHAVIOR; PRIMERS; FISH	The common long-armed octopus, Octopus minor, is an important component of systems and supports the local fisheries in the coastal areas of northern China. For the fishery management and artificial breeding, especially for the management of exclusive conservation reserves, its role in the ecosystem requires assessment. Therefore, the feeding intensity of O. minor was studied from April to July 2014 when females reaching ovary maturation, and prey composition was identified from stomach contents using a DNA barcoding method. Of the 172 sampled octopuses, 66 had stomach contents that were nearly digested into pulp. On the whole, the feeding intensity of octopus remained more or less the same during the first three months and significantly decreased in July. The changes of feeding intensity were different between females and males; in females, the intensity of feeding decreased from April to July; in case of males, however, the feeding activity increased from April to June and decreased thereafter. The feeding intensity of the females was extremely greater than that of the males. O. minor was a generalist predator and based on homology searches and phylogenetic analysis, a total of 10 different taxa were identified in the stomach contents. In terms of percent composition by frequency of occurrences (%N), fishes accounted for the most of the octopuses diet (50%), followed by cephalopod (25%), crustaceans (21.7%), annelid (1.7%) and nematode (1.7%). The families of Gobiidae and Octopodidae appeared in all months and Protunidae appeared in three months. The results confirmed that Gobiidae family (45.8%, by frequency of occurrences) was an important source of food during the time when females reaching ovarian maturation. From April to July, the observed cannibalism showed an increasing trend. Controlling and reducing fishing production of Gobiidae fishes in conservation area are recommended from April to June when female octopuses are actively feeding.	[Bo, Qi-Kang; Zheng, Xiao-Dong] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Bo, Qi-Kang] Tianjin Fisheries Res Inst, Breeding Stn Bohai Sea Aquat Resources, Tianjin, Peoples R China; [Zheng, Xiao-Dong; Chen, Zhi-Wei] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China	Ocean University of China; Ocean University of China	Zheng, XD (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China.; Zheng, XD (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China.	xdzheng@mail.ouc.edu.cn			National Natural Science Foundation of China [31672257, 31172058]; Fundamental Research Funds for the Central Universities [201822022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by research grants from National Natural Science Foundation of China (Nos. 31672257; 31172058) and Fundamental Research Funds for the Central Universities(No.201822022).	AMBROSE R F, 1983, Marine Ecology, V4, P251, DOI 10.1111/j.1439-0485.1983.tb00299.x; AMBROSE RF, 1984, J EXP MAR BIOL ECOL, V77, P29, DOI 10.1016/0022-0981(84)90049-2; ANDREWS PLR, 1983, J MAR BIOL ASSOC UK, V63, P109, DOI 10.1017/S0025315400049845; Biandolino F, 2010, AQUACULT INT, V18, P1163, DOI 10.1007/s10499-010-9331-x; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Bo QK, 2016, MAR ECOL-EVOL PERSP, V37, P1073, DOI 10.1111/maec.12364; [薄其康 Bo Qikang], 2014, [海洋与湖沼, Oceanologia et Limnologia Sinica], V45, P583; Braley M, 2010, MOL ECOL RESOUR, V10, P466, DOI 10.1111/j.1755-0998.2009.02767.x; Carreon-Martinez L, 2010, MOL ECOL, V19, P25, DOI 10.1111/j.1365-294X.2009.04412.x; CASTRO B G, 1990, Scientia Marina, V54, P375; Colwell RK, 2009, ESTIMATES STAT ESTIM; CORTEZ T, 1995, MAR BIOL, V123, P497, DOI 10.1007/BF00349228; Domingues P, 2004, AQUACULTURE, V229, P239, DOI 10.1016/S0044-8486(03)00351-X; Dong ZZ, 1988, FAUNA SINICA; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Grubert MA, 1999, B MAR SCI, V65, P441; GUERRA A, 1994, ANTARCT SCI, V6, P175, DOI 10.1017/S0954102094000271; Kim DH, 2008, FISHERIES SCI, V74, P1215, DOI 10.1111/j.1444-2906.2008.01645.x; Liu Jian-ying, 2017, Marine Sciences (Beijing), V41, P113; MATHER JA, 1991, J ZOOL, V224, P27, DOI 10.1111/j.1469-7998.1991.tb04786.x; Meheust E, 2015, MAR BIOL RES, V11, P385, DOI 10.1080/17451000.2014.943240; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Nixon M., 1985, CAPTURE PREY DIET FE; Paquin MM, 2014, DEEP-SEA RES PT I, V85, P110, DOI 10.1016/j.dsr.2013.12.002; Phillips BF, 2006, COMP BIOCHEM PHYS B, V143, P219, DOI 10.1016/j.cbpb.2005.11.009; Pillay T V R, 1952, J ZOOL SOC INDIA, V4, P185; Promboon P, 2011, SCI MAR, V75, P811, DOI 10.3989/scimar.2011.75n4811; Riccialdelli L, 2010, MAR ECOL PROG SER, V418, P235, DOI 10.3354/meps08826; Ritchie L., 1970, OCTOPUS PREDATION PO; Rosa R, 2004, MAR BIOL, V145, P563, DOI 10.1007/s00227-004-1340-8; Rosas-Luis R, 2019, MAR ECOL-EVOL PERSP, V40, DOI 10.1111/maec.12535; Roura A, 2012, MAR BIOL, V159, P1335, DOI 10.1007/s00227-012-1914-9; Scheel D, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P434, DOI 10.1007/978-1-4020-6806-5_20; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Smith CD, 2003, MAR BIOL, V143, P1127, DOI 10.1007/s00227-003-1144-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Vincent TLS, 1998, MAR ECOL-P S Z N I, V19, P13; Voight JR, 2004, J MOLLUS STUD, V70, P400, DOI 10.1093/mollus/70.4.400; Yamamoto T., 1942, JAP J MALACOL, V12, P9	43	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0220482	10.1371/journal.pone.0220482	http://dx.doi.org/10.1371/journal.pone.0220482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986139	gold, Green Submitted, Green Published			2022-12-26	WOS:000534603400004
J	Mekie, M; Mekonnen, W; Assegid, M				Mekie, Maru; Mekonnen, Wubegzier; Assegid, Meselech			Cohabitation duration, obstetric, behavioral and nutritional factors predict preeclampsia among nulliparous women in West Amhara Zones of Ethiopia: Age matched case control study	PLOS ONE			English	Article							RISK; HYPERTENSION; DISEASE	Background Preeclampsia is a major cause of maternal and perinatal mortality in developing countries. Identifying its risk factors is essential for early diagnosis and management. However, there has been a paucity of information on predictors of preeclampsia among nulliparous women in a resource limited setting. This study bridges the gap in this regard by examining the association of cohabitation duration, obstetric, behavioral and nutrition factors with preeclampsia among nulliparous women in West Amhara Zones of Ethiopia. Methods Age matched case-control study design was employed among 110 preeclamptic and 220 non-preeclamptic women who came for delivery services at Felege Hiwot, Addis Alem, and Debre Tabor hospitals. Double population proportion formula with an assumption of 95% confidence interval, 80% power and a 2:1 control to case ratio was used to calculate sample size. Epi data 3.1 and SPSS 20 were used for data entry and analysis, respectively. Magnitudes of cohabitation duration, obstetric, behavioral and nutritional factors among nulliparous women with preeclampsia and their controls were calculated and the differences were tested with a Chi-square test. Conditional bivariable and multivariable logistic regression analysis were fitted to identify predictors of preeclampsia. Odds ratio along with their 95% confidence interval were used to identify the strength, direction and significance of association. Ethical clearance was secured from the research ethics committee of the School of Public Health in Addis Ababa University. Results A total of 107 cases and 214 controls completed the interview giving a response rate of 97.27% for both cases and controls. Short cohabitation duration (AOR = 2.13, 95% CI (1.10, 4.1)), unplanned pregnancy (AOR = 2.35, 95% CI (1.01, 5.52)), and high body weight (AOR = 2.00, 95% CI (1.10, 3.63)) were found to be significant risk factors for preeclampsia. Whereas, antenatal advice about nutrition (AOR = 0.52, 95% CI (0.29, 0.96)), vegetable intake (AOR = 0.42, 95% CI (0.22, 0.82)) and fruit intake during pregnancy (AOR = 0.45, 95% CI (0.24, 0.87)) were protective factors for preeclampsia. Conclusion Special attention should be given to nulliparous women with short cohabitation duration, unplanned pregnancy, and high body weight to minimize the effect of preeclampsia. Nutritional counseling shall be stressed during antenatal care follow ups.	[Mekie, Maru] Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre Tabor, Ethiopia; [Mekonnen, Wubegzier; Assegid, Meselech] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Mekie, M (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre Tabor, Ethiopia.	maru.mekie1@gmail.com		Mekie, Maru/0000-0001-6022-4717	College of Health Science of Addis Ababa University	College of Health Science of Addis Ababa University	The data collection fee of this study has been funded by the College of Health Science of Addis Ababa University. The funding body has no any role in the design, data collection, analysis and interpretation, and write-up apart from funding the data collection process.	American College of Obstetrics and Gynecology, 2002, DIAGN MAN PREECL ECL, V77, P67; [Anonymous], 2017, ETH DEM HLTH SURV; Bej Punyatoya, 2013, J Family Med Prim Care, V2, P371, DOI 10.4103/2249-4863.123924; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P15, DOI 10.4314/ejhs.v24i0.3S; Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198; Bruce C., 2003, ANTHROPOMETRIC INDIC ANTHROPOMETRIC INDIC; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; El-Moselhy E. A., 2011, The Journal of American Science, V7, P311; Endeshaw M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1029-2; Endeshaw M, 2015, MIDWIFERY, V31, P617, DOI 10.1016/j.midw.2015.03.003; Esposito G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145873; Federal Ministry of Health, 2016, NAT STRAT NEWB CHILD; Gaym A, 2011, INT J GYNECOL OBSTET, V115, P112, DOI 10.1016/j.ijgo.2011.07.012; Grum T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1507-1; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Mahomed N, 2000, J Obstet Gynaecol, V20, P472; Meltzer HM, 2011, AM J CLIN NUTR, V94, p1970S, DOI 10.3945/ajcn.110.001248; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Olayemi O, 2010, AUST NZ J OBSTET GYN, V50, P40, DOI 10.1111/j.1479-828X.2009.01115.x; Palei AC, 2013, ACTA PHYSIOL, V208, P224, DOI 10.1111/apha.12106; Parker SE, 2016, BJOG-INT J OBSTET GY, V123, P788, DOI 10.1111/1471-0528.13413; Ramesh K, 2014, J CLIN DIAGN RES, V8, pJC01, DOI 10.7860/JCDR/2014/10255.4802; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Sadat Z, 2012, IRAN RED CRESCENT ME, V14, P20; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Torjusen H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006143; Townsend R, 2016, INTEGR BLOOD PRESS C, V9, P79, DOI 10.2147/IBPC.S77344; Wagnew M, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.9716; WHO, 2011, REC PREV TREATM PREE	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228127	10.1371/journal.pone.0228127	http://dx.doi.org/10.1371/journal.pone.0228127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986179	Green Published, gold			2022-12-26	WOS:000534603400037
J	Wu, XQ; Zhang, X; Yu, L; Zhang, C; Ye, LP; Ren, D; Li, Y; Sun, XQ; Yu, LF; Ouyang, Y; Chen, XF; Song, LB; Liu, P; Lin, X				Wu, Xianqiu; Zhang, Xin; Yu, Liang; Zhang, Chen; Ye, Liping; Ren, Dong; Li, Yue; Sun, Xiaoqing; Yu, Lefan; Ouyang, Ying; Chen, Xiangfu; Song, Libing; Liu, Pian; Lin, Xi			Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer	ONCOGENE			English	Article							CIRCULATING TUMOR-CELLS; YES-ASSOCIATED PROTEIN; YAP; ANOIKIS; MECHANISMS; SUPPRESSOR; DORMANCY	Circulating tumor cells (CTC) disseminating is an important cause of distant metastasis. However, the mechanism involved in increasing the numbers of CTCs in breast cancer is unclear. Herein, Zinc finger protein 367 (ZNF367) was identified as a potential prometastatic gene in an integrative breast cancer datasets. ZNF367 was upregulated in breast cancer tissues and cell lines, and significantly correlated with poorer metastasis-free and overall survivals in patients. ZNF367 promoted tumor metastasis accompanied with increase of CTC numbers. Mechanistically, ZNF367 interacted with chromatin remodeling protein BRG1 and transcriptionally activated CIT and TP53BP2, leading to the inhibition of the Hippo pathway and activation of YAP1, which gave rise to the resistance of anoikis and increased CTCs in the blood circulation. More importantly, administration of a YAP1 inhibitor Verteporfin resensitized ZNF367-overexpressing breast cancer cells to anoikis and abrogated metastasis. Our findings addressed the importance of ZNF367 in breast cancer as a prognostic biomarker and offered a potential therapeutic strategy for the treatment of a subset of metastatic breast cancer with ZNF367 overexpression.	[Wu, Xianqiu; Zhang, Xin; Ye, Liping; Li, Yue; Sun, Xiaoqing; Ouyang, Ying; Chen, Xiangfu; Song, Libing; Lin, Xi] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Expt Res,State Key Lab Oncol Southern China, Guangzhou 510060, Peoples R China; [Wu, Xianqiu] Sun Yat Sen Univ, Affiliated Jiangmen Hosp, Jiangmen Cent Hosp, Dept Gastrointestinal Surg, Jiangmen 529030, Peoples R China; [Zhang, Xin; Ren, Dong] Sun Yat Sen Univ, Affiliated Jiangmen Hosp, Jiangmen Cent Hosp, Clin Expt Ctr, Jiangmen 529030, Peoples R China; [Yu, Liang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc & Breast Surg, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Chen] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hepatobiliary Surg, Wuhan 430022, Peoples R China; [Yu, Lefan] UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Liu, Pian] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China; [Lin, Xi] Sun Yat Sen Univ, Canc Ctr, Ultrason Dept, Guangzhou 510060, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Huazhong University of Science & Technology; University of London; Birkbeck University London; University College London; Huazhong University of Science & Technology; Sun Yat Sen University	Lin, X (corresponding author), Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Expt Res,State Key Lab Oncol Southern China, Guangzhou 510060, Peoples R China.; Liu, P (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China.; Lin, X (corresponding author), Sun Yat Sen Univ, Canc Ctr, Ultrason Dept, Guangzhou 510060, Peoples R China.	liupianamazing@126.com; linxi@sysucc.org.cn	Zhang, Xin/C-2464-2017; Song, LB/AAL-1968-2020	Zhang, Xin/0000-0001-6036-2685; Ye, Liping/0000-0002-2263-0631	National Natural Science Foundation of China [81772800]; Fundamental Research Funds for the Central Universities [2017KFYXJJ258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 81772800); Fundamental Research Funds for the Central Universities (No. 2017KFYXJJ258).	Asano H, 2004, BIOCHEM J, V384, P647, DOI 10.1042/BJ20040394; Aslan B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8351; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Groot AF, 2017, CANCER TREAT REV, V60, P130, DOI 10.1016/j.ctrv.2017.09.003; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Gao Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0340-0; Gibault F, 2017, CHEMMEDCHEM, V12, P954, DOI 10.1002/cmdc.201700063; Giuliano M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0440-8; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Jain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101423; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lin E, 2018, ANNU REV BIOMED ENG, V20, P329, DOI 10.1146/annurev-bioeng-062117-120947; Lu C, 2017, NAT GENET, V49, P178, DOI 10.1038/ng.3779; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; McCarthy N, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3746; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Rack B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju066; Ren CL, 2016, INT J CANCER, V138, P1586, DOI 10.1002/ijc.29679; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sinn HP, 2010, PATHOLOGE, V31, P361, DOI 10.1007/s00292-010-1307-0; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Tseng LM, 2013, NEOPLASMA, V60, P290, DOI 10.4149/neo_2013_038; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wong CW, 2001, CANCER RES, V61, P333; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang X, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0717-5; Zhang XP, 2017, ONCOTARGET, V8, P38863, DOI 10.18632/oncotarget.16408; Zhang ZL, 2009, CANCER EPIDEM BIOMAR, V18, P2685, DOI 10.1158/1055-9965.EPI-09-0097	39	22	23	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2568	2582		10.1038/s41388-020-1166-y	http://dx.doi.org/10.1038/s41388-020-1166-y		JAN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31988454				2022-12-26	WOS:000509655100001
J	Grosser, M; Gellissen, S; Borchert, P; Sedlacik, J; Nawabi, J; Fiehler, J; Forkert, ND				Grosser, Malte; Gellissen, Susanne; Borchert, Patrick; Sedlacik, Jan; Nawabi, Jawed; Fiehler, Jens; Forkert, Nils Daniel			Improved multi-parametric prediction of tissue outcome in acute ischemic stroke patients using spatial features	PLOS ONE			English	Article							PERFUSION; PERFORMANCE; THRESHOLDS; DIFFUSION; TIME	Introduction In recent years, numerous methods have been proposed to predict tissue outcome in acute stroke patients using machine learning methods incorporating multiparametric imaging data. Most methods include diffusion and perfusion parameters as image-based parameters but do not include any spatial information although these parameters are spatially dependent, e.g. different perfusion properties in white and gray brain matter. This study aims to investigate if including spatial features improves the accuracy of multi-parametric tissue outcome prediction. Materials and methods Acute and follow-up multi-center MRI datasets of 99 patients were available for this study. Logistic regression, random forest, and XGBoost machine learning models were trained and tested using acute MR diffusion and perfusion features and known follow-up lesions. Different combinations of atlas coordinates and lesion probability maps were included as spatial information. The stroke lesion predictions were compared to the true tissue outcomes using the area under the receiver operating characteristic curve (ROC AUC) and the Dice metric. Results The statistical analysis revealed that including spatial features significantly improves the tissue outcome prediction. Overall, the XGBoost and random forest models performed best in every setting and achieved state-of-the-art results regarding both metrics with similar improvements achieved including Montreal Neurological Institute (MNI) reference space coordinates or voxel-wise lesion probabilities. Conclusion Spatial features should be integrated to improve lesion outcome prediction using machine learning models.	[Grosser, Malte; Gellissen, Susanne; Borchert, Patrick; Sedlacik, Jan; Nawabi, Jawed; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary; University of Calgary	Grosser, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	malte.grosser@gmail.com	; Forkert, Nils Daniel/K-6273-2012	Nawabi, Jawed/0000-0002-1137-0643; Forkert, Nils Daniel/0000-0003-2556-3224	Heart and Stroke Foundation of Canada [G-17-0018368]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work is supported by the Heart and Stroke Foundation of Canada Grant in aid (G-17-0018368).	Arakawa S, 2006, STROKE, V37, P1211, DOI 10.1161/01.STR.0000217258.63925.6b; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; d'Esterre CD, 2015, STROKE, V46, P3390, DOI 10.1161/STROKEAHA.115.009250; Faraway JJ, 2010, GEN LINEAR MODELS; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Forkert ND, 2014, METHOD INFORM MED, V53, P469, DOI 10.3414/ME14-01-0007; Forkert ND, 2013, METHOD INFORM MED, V52, P467, DOI 10.3414/ME13-02-0001; Jonsdottir KY, 2009, STROKE, V40, P3006, DOI 10.1161/STROKEAHA.109.552216; Kemmling A, 2015, J CEREBR BLOOD F MET, V35, P1397, DOI 10.1038/jcbfm.2015.144; Kidwell CS, 2013, STROKE, V44, P73, DOI 10.1161/STROKEAHA.112.670034; Livne M, 2018, STROKE, V49, P912, DOI 10.1161/STROKEAHA.117.019440; Lundberg S, 2017, ABS17050 CORR; Maier O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145118; Mckinley R, BRAINLESION GLIOMA M, P275; McKinley R, 2017, J CEREBR BLOOD F MET, V37, P2728, DOI 10.1177/0271678X16674221; Nielsen A, 2018, STROKE, V49, P1394, DOI 10.1161/STROKEAHA.117.019740; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; R Core Team, 2021, R LANGUAGE ENV STAT; Robben D, BRAINLESION GLIOMA M, P254; Shapley Lloyd S., 1953, CONTRIBUTIONS THEORY, P307, DOI [10.3390/atmos10110723, DOI 10.1515/9781400881970-018]; Siemonsen S, 2014, J CEREBR BLOOD F MET, V34, P813, DOI 10.1038/jcbfm.2014.13; Subbanna NK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00541; Winzeck S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00679; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	28	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228113	10.1371/journal.pone.0228113	http://dx.doi.org/10.1371/journal.pone.0228113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978179	Green Published, gold			2022-12-26	WOS:000534599100113
J	Moon, BY; Kim, SY; Yu, DS				Moon, Byeong-Yeon; Kim, Sang-Yeob; Yu, Dong-Sik			Receiver operating characteristic curve analysis of clinical signs for screening of convergence insufficiency in young adults	PLOS ONE			English	Article							BINOCULAR DYSFUNCTIONS; SYMPTOMS; VERGENCE; TRIAL	Convergence insufficiency (CI) is a dysfunction of binocular vision that is associated with various signs and symptoms in near work. However, CI screening is performed less frequently in adults than in children. We aimed to evaluate the ability of screening tests to discriminate CI from other binocular vision anomalies and normal binocular vision in young adults. One hundred eighty-four university students (age, 18-28 years) who underwent an eye examination due to ocular discomfort were included. Near point of convergence (NPC), phoria, accommodative amplitude, fusional vergence, the ratio of accommodative convergence to accommodation, relative accommodation, binocular accommodative facility, vergence facility, and the values corresponding to Sheard's and Percival's criteria were evaluated. Receiver operating characteristic (ROC) curve analysis for each test was also performed. The prevalence of CI ranged from 10.3% to 21.2%, depending on the signs and the presence of CI associated with accommodative disorders. Assessments based on NPC, Sheard's criterion, and Percival's criterion showed high discriminative ability, with the ability being higher between the CI and normal binocular vision groups than between the CI and non-CI groups. Sheard's criterion showed the highest diagnostic performance in discriminating CI with three signs from the non-CI group. The cut-off values were 7.2 cm for NPC, -0.23 to 1.00 for Sheard's criterion, and -4.00 to -2.33 for Percival's criterion. Our results suggest that the use of Sheard's criterion with NPC shows high performance for screening of CI.	[Moon, Byeong-Yeon; Kim, Sang-Yeob; Yu, Dong-Sik] Kangwon Natl Univ, Dept Optometry, Samcheok, South Korea	Kangwon National University	Yu, DS (corresponding author), Kangwon Natl Univ, Dept Optometry, Samcheok, South Korea.	yds@kangwon.ac.kr		Yu, Dong-Sik/0000-0002-4387-4408				Bade A, 2013, OPTOMETRY VISION SCI, V90, P988, DOI 10.1097/OPX.0000000000000012; Benjamin WJ, 2006, BORISHS CLIN REFRACT, P968; Borsting Eric, 2003, Optometry, V74, P25; Martinez PC, 2009, OPTOMETRY, V80, P702, DOI 10.1016/j.optm.2009.06.011; Cacho-Mart inez P, 2010, J OPTOM, V3, P185, DOI [DOI 10.1016/S1888-4296(10)70028-5, 10.1016/s1888-4296(10)70028-5]; Cacho-Martinez P, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/549435; COOPER J, 1978, J AM OPTOM ASSOC, V49, P673; Cooper Jeffrey, 2012, Optometry, V83, P137; Darko-Takyi C., 2016, OPTOM REP, V5, P5626, DOI DOI 10.4081/OPTOMETRY.2016.5626; Davis AL, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6963976; Dwyer P, 1992, CLIN EXP OPTOM, V75, P10, DOI DOI 10.1111/J.1444-0938.1992.TB01010.X; Gall R, 1998, OPTOMETRY VISION SCI, V75, P731, DOI 10.1097/00006324-199810000-00018; Gallaway M, 2002, OPTOMETRY VISION SCI, V79, P265, DOI 10.1097/00006324-200204000-00013; Garcia A, 2002, OPTOMETRY VISION SCI, V79, P779, DOI 10.1097/00006324-200212000-00010; Gupta R, 2013, INT J MED RES REV, V1, P222; Horwood AM, 2014, BRIT J OPHTHALMOL, V98, P679, DOI 10.1136/bjophthalmol-2013-304533; Kim Y, 2018, CORP COMMUN, V23, P117, DOI 10.1108/CCIJ-05-2017-0047; Liaptsis D, 2010, NON-DESTRUCTIVE TESTING CONFERENCE 2010 (NDT 2010), P4; MaplesWC SavoyRS, 2009, OVD, V40, P100; Menjivar AM, 2018, CLIN EXP OPTOM, V101, P578, DOI 10.1111/cxo.12661; O'Leary CI, 2006, OPHTHAL PHYSL OPT, V26, P555, DOI 10.1111/j.1475-1313.2006.00400.x; Paniccia SM, 2015, OPTOMETRY VISUAL PER, V3, P158; Percival A., 1928, PRESCRIBING SPECTACL, V3rd, P102; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2014, CLIN MANAGEMENT BINO, P36; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; SCHOR CM, 1992, OPTOMETRY VISION SCI, V69, P258, DOI 10.1097/00006324-199204000-00002; SHEEDY JE, 1978, AM J OPTOM PHYS OPT, V55, P670; SHEEDY JE, 1977, AM J OPTOM PHYS OPT, V54, P474; Tsai LH, 2012, CHUNG SHAN MED J, V23, P87, DOI [10.30096/CSMJ.201212.0003, DOI 10.30096/CSMJ.201212.0003]; Wajuihian S. O., 2015, AFRICAN VISION EYE H, V74, P1, DOI DOI 10.HTTPS://D0I.0RG/10; Wajuihian SO, 2017, AFR VIS EYE HLTH, V76, P1, DOI DOI 10.4102/aveh.v76i1.363; Weissberg EM, 2004, ESSENTIAL CLIN BINOC, P158; Wick BC, 1987, DIAGNOSIS MANAGEMENT, P461; WORRELL BE, 1971, AMER J OPT ARCH AM A, V48, P373; Yu Dongsik, 2016, [Journal of Korean Ophthalmic Optics Society, 한국안광학회지], V21, P235, DOI 10.14479/jkoos.2016.21.3.235	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228313	10.1371/journal.pone.0228313	http://dx.doi.org/10.1371/journal.pone.0228313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978203	Green Published, gold			2022-12-26	WOS:000534599100140
J	Menz, I; Lakhwani, D; Clotault, J; Linde, M; Foucher, F; Debener, T				Menz, Ina; Lakhwani, Deepika; Clotault, Jeremy; Linde, Marcus; Foucher, Fabrice; Debener, Thomas			Analysis of the Rdr1 gene family in different Rosaceae genomes reveals an origin of an R-gene cluster after the split of Rubeae within the Rosoideae subfamily	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; NBS; EVOLUTION; MULTIPLE; DIVERSITY; PROTEINS; PATTERNS; NUMBERS; ROSE	The Rdr1 gene confers resistance to black spot in roses and belongs to a large TNL gene family, which is organized in two major clusters at the distal end of chromosome 1. We used the recently available chromosome scale assemblies for the R. chinensis `Old Blush' genome, re-sequencing data for nine rose species and genome data for Fragaria, Rubus, Malus and Prunus to identify Rdr1 homologs from different taxa within Rosaceae. Members of the Rdr1 gene family are organized into two major clusters in R. chinensis and at a syntenic location in the Fragaria genome. Phylogenetic analysis indicates that the two clusters existed prior to the split of Rosa and Fragaria and that one cluster has a more recent origin than the other. Genes belonging to cluster 2, such as the functional Rdr1 gene muRdr1A, were subject to a faster evolution than genes from cluster 1. As no Rdr1 homologs were found in syntenic positions for Prunus persica, Malus x domestica and Rubus occidentalis, a translocation of the Rdr1 clusters to the current positions probably happened after the Rubeae split from other groups within the Rosoideae approximately 70-80 million years ago during the Cretaceous period.	[Menz, Ina; Linde, Marcus; Debener, Thomas] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany; [Lakhwani, Deepika; Clotault, Jeremy; Foucher, Fabrice] Univ Angers, Agrocampus Ouest, INRA, IRHS, Beaucouze, France	Leibniz University Hannover; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers	Debener, T (corresponding author), Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany.	debener@genetik.uni-hannover.de	Debener, Thomas/AAJ-9056-2020; Foucher, Fabrice/AAJ-5069-2021	Foucher, Fabrice/0000-0002-3693-7183; Clotault, Jeremy/0000-0002-7678-1929; Debener, Thomas/0000-0002-2012-2246	Open Access fund of Leibniz Universitat Hannover	Open Access fund of Leibniz Universitat Hannover	The authors received no specific funding for this work. The publication of this article was funded by the Open Access fund of Leibniz Universitat Hannover.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Brands SJ, 2000, SYSTEMA NATURAE 2000; Buti M, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy010; Chavan S, 2015, THEOR APPL GENET, V128, P985, DOI 10.1007/s00122-015-2484-2; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edger PP, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix124; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jia YX, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0208-x; Jones DA, 1997, ADV BOT RES, V24, P89; Jung S, 2019, NUCLEIC ACIDS RES, V47, pD1137, DOI 10.1093/nar/gky1000; Koopman WJM, 2008, AM J BOT, V95, P353, DOI 10.3732/ajb.95.3.353; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li YP, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0142-6; Ma FF, 2018, THEOR APPL GENET, V131, P253, DOI 10.1007/s00122-017-2999-9; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Menz I, 2018, MOL PLANT PATHOL, V19, P1104, DOI 10.1111/mpp.12589; Mistry J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-298; Nakamura N, 2018, DNA RES, V25, P113, DOI 10.1093/dnares/dsx042; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Nieri D, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1982-5; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Perazzolli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083844; Raymond O, 2018, NAT GENET, V50, P772, DOI 10.1038/s41588-018-0110-3; Saint-Oyant LH, 2018, NAT PLANTS, V4, P473, DOI 10.1038/s41477-018-0166-1; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; Terefe D, 2011, PLANT BREEDING, V130, P291, DOI 10.1111/j.1439-0523.2010.01780.x; Terefe-Ayana D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-409; Terefe-Ayana D, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00035; van Eck L, 2018, COMPEND PL GENOME, P63, DOI 10.1007/978-3-319-76020-9_6; VanBuren R, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy094; VanBuren R, 2016, PLANT J, V87, P535, DOI 10.1111/tpj.13215; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wissemann V, 2005, BOT J LINN SOC, V147, P275, DOI 10.1111/j.1095-8339.2005.00368.x; WISSEMANN V, 2003, ENCY ROSE SCI, P111; Xiang YZ, 2017, MOL BIOL EVOL, V34, P262, DOI 10.1093/molbev/msw242; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524	45	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227428	10.1371/journal.pone.0227428	http://dx.doi.org/10.1371/journal.pone.0227428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971947	Green Published, gold			2022-12-26	WOS:000534374400012
J	Torok, G; Erdei, Z; Lilienberg, J; Apati, A; Homolya, L				Torok, Gyorgy; Erdei, Zsuzsa; Lilienberg, Julianna; Apati, Agota; Homolya, Laszlo			The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells	PLOS ONE			English	Article							RAT-LIVER; HUMAN HEPATOCYTES; EXPRESSION; DIFFERENTIATION; LOCALIZATION; COTRANSPORT; MODEL; GLUTATHIONE; PATHWAY; FAMILY	One of the most promising applications of human pluripotent stem cells is their utilization for human-based pharmacological models. Despite the fact that membrane transporters expressed in the liver play pivotal role in various hepatic functions, thus far only little attention was devoted to the membrane transporter composition of the stem cell-derived liver models. In the present work, we have differentiated HUES9, a human embryonic stem cell line, toward the hepatic lineage, and monitored the expression levels of numerous differentiation marker and liver transporter genes with special focus on ABC transporters. In addition, the effect of bile acid treatment and polarizing culturing conditions on hepatic maturation has been assessed. We found that most transporter genes crucial for hepatic functions are markedly induced during hepatic differentiation; however, as regards the transporter composition the end-stage cells still exhibited dual, hepatocyte and cholangiocyte character. Although the bile acid treatment and sandwich culturing only slightly influenced the gene expressions, the stimulated cell polarization resulted in formation of bile canaliculi and proper localization of transporters. Our results point to the importance of membrane transporters in human stem cell-derived hepatic models and demonstrate the relevance of cell polarization in generation of applicable cellular models with correctly localized transporters. On the basis of our observations we suggest that conventional criteria for the evaluation of the quality of stem cell-derived hepatocyte-like cells ought to be augmented with additional elements, such as polarized and functional expression of hepatic transporters.	[Torok, Gyorgy; Erdei, Zsuzsa; Lilienberg, Julianna; Apati, Agota; Homolya, Laszlo] Hungarian Acad Sci Ctr Excellence, Res Ctr Nat Sci, Inst Enzymol, Mol Cell Biol Res Grp, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Homolya, L (corresponding author), Hungarian Acad Sci Ctr Excellence, Res Ctr Nat Sci, Inst Enzymol, Mol Cell Biol Res Grp, Budapest, Hungary.	homolya@biomembrane.hu	Homolya, Laszlo/N-1154-2016	Homolya, Laszlo/0000-0003-1639-8140	National Research, Development and Innovation Fund (Hungary) [OTKA_K 128123, FIEK_16-1-2016-0005, OTKA_PD 128830]	National Research, Development and Innovation Fund (Hungary)	This research has been supported by the National Research, Development and Innovation Fund (Hungary, https://nkfih.gov.hu) (grant numbers to LH: OTKA_K 128123 and FIEK_16-1-2016-0005, grant number to EZ: OTKA_PD 128830). The funder had no role in study design, data collection and analysis,	Al-Qubaisi M, 2011, MOLECULES, V16, P2944, DOI 10.3390/molecules16042944; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ansede JH, 2010, DRUG METAB DISPOS, V38, P276, DOI 10.1124/dmd.109.028407; Anwer MS, 2014, PFLUG ARCH EUR J PHY, V466, P77, DOI 10.1007/s00424-013-1367-0; Apati A, 2019, EXPERT OPIN DRUG MET, V15, P61, DOI 10.1080/17425255.2019.1558207; Apati A, 2016, EXPERT OPIN DRUG MET, V12, P77, DOI 10.1517/17425255.2016.1121382; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Briz O, 2003, BIOCHEM J, V371, P897, DOI 10.1042/BJ20030034; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Donner MG, 2004, BIOL CHEM, V385, P331, DOI 10.1515/BC.2004.029; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Erdei Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194925; Erdelyi-Belle B, 2015, PATHOL ONCOL RES, V21, P1059, DOI 10.1007/s12253-015-9936-5; Farzaneh Z, 2010, STEM CELL REV REP, V6, P601, DOI 10.1007/s12015-010-9179-5; Faulkner-Jones A, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/044102; Fickert P, 2001, GASTROENTEROLOGY, V121, P170, DOI 10.1053/gast.2001.25542; Freyer N, 2016, BIORESEARCH OPEN ACC, V5, P235, DOI 10.1089/biores.2016.0027; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hoffmaster KA, 2004, PHARM RES-DORDR, V21, P1294, DOI 10.1023/B:PHAM.0000033018.97745.0d; Hurrell T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39400-1; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Kovacs T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18309-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JT, 2015, TOXICOL SCI, V147, P39, DOI 10.1093/toxsci/kfv117; Meier F, 2017, INT J MOL MED, V40, P1759, DOI 10.3892/ijmm.2017.3190; Meseguer-Ripolles J, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0171-8; Miki T, 2011, TISSUE ENG PART C-ME, V17, P557, DOI [10.1089/ten.tec.2010.0437, 10.1089/ten.TEC.2010.0437]; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Pettinato G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32888; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Ros JE, 2003, J PATHOL, V200, P553, DOI 10.1002/path.1379; Ros JE, 2003, GUT, V52, P1060, DOI 10.1136/gut.52.7.1060; Rose KA, 2016, J PHARM SCI-US, V105, P950, DOI 10.1016/S0022-3549(15)00192-6; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sarkadi B, 2010, STEM CELLS, V28, P174, DOI 10.1002/stem.262; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siller R, 2015, STEM CELL REP, V4, P939, DOI 10.1016/j.stemcr.2015.04.001; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Sommerfeld A, 2015, J BIOL CHEM, V290, P24237, DOI 10.1074/jbc.M115.666883; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Swift B, 2010, MOL PHARMACEUT, V7, P491, DOI 10.1021/mp900227a; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Telbisz A, 2016, EXPERT OPIN THER TAR, V20, P501, DOI 10.1517/14728222.2016.1102889; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; van de Steeg E, 2010, J CLIN INVEST, V120, P2942, DOI 10.1172/JCI42168; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2005, J BIOL CHEM, V280, P8742, DOI 10.1074/jbc.M411080200	56	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227751	10.1371/journal.pone.0227751	http://dx.doi.org/10.1371/journal.pone.0227751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971960	Green Published, gold			2022-12-26	WOS:000534374400017
J	Schedwill, P; Paschkewitz, S; Teubner, H; Steinmetz, N; Nehring, V				Schedwill, Petra; Paschkewitz, Sophia; Teubner, Heide; Steinmetz, Nadine; Nehring, Volker			From the host's point of view: Effects of variation in burying beetle brood care and brood size on the interaction with parasitic mites	PLOS ONE			English	Article							NICROPHORUS-VESPILLOIDES COLEOPTERA; MALE PARENTAL CARE; POECILOCHIRUS-CARABI MESOSTIGMATA; REPRODUCTIVE SUCCESS; PATERNAL CARE; SEXUAL CONFLICT; NECROPHORUS; DISPERSAL; EVOLUTION; VIRULENCE	The fitness and virulence of parasites is often determined by how many resources they can wrangle out of their hosts. Host defenses that help to keep resources from the parasites will then reduce virulence and parasite fitness. Here, we study whether host brood care and brood size regulation can protect host fitness and harm a parasite. We use the biparental brood-caring burying beetle Nicrophorus vespilloides and its phoretic Poecilochirus carabi mites as a model. Since paternal brood care does not seem to benefit the offspring in a clean laboratory setting, the male presence has been suggested to strengthen the defense against parasites. We manipulated male presence and found no effect on the fitness of the parasitic mites or the beetle offspring. We further manipulated beetle brood size and found larger broods to reduce parasite fitness. The specific pattern we observed suggests that beetle larvae are strong competitors and consume the carrion resource before all parasites develop. They thus starve the parasites. These results shed new light on the observation that the parasites appear to reduce host brood size early on-potentially to avert later competition their offspring might have to face.	[Schedwill, Petra; Paschkewitz, Sophia; Teubner, Heide; Steinmetz, Nadine; Nehring, Volker] Univ Freiburg, Inst Biol 1, Evolutionary Biol & Ecol, Freiburg, Germany	University of Freiburg	Nehring, V (corresponding author), Univ Freiburg, Inst Biol 1, Evolutionary Biol & Ecol, Freiburg, Germany.	volker.nehring@biologie.uni-freiburg.de	Nehring, Volker/H-1908-2012	Nehring, Volker/0000-0002-0494-1428	German Research Foundation (DFG); University of Freiburg; Internationale Graduiertenakademie of the Freiburg Research Services; German Research Foundation (DFG) [Ne1969/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg; Internationale Graduiertenakademie of the Freiburg Research Services; German Research Foundation (DFG)(German Research Foundation (DFG))	The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. PS - Internationale Graduiertenakademie of the Freiburg Research Services and VN - German Research Foundation (DFG) Ne1969/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BART J, 1989, BEHAV ECOL SOCIOBIOL, V24, P109, DOI 10.1007/BF00299642; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V22, P429, DOI 10.1007/BF00294981; BARTLETT J, 1987, BEHAV ECOL SOCIOBIOL, V21, P179, DOI 10.1007/BF00303208; BENINGER CW, 1993, ENVIRON ENTOMOL, V22, P766, DOI 10.1093/ee/22.4.766; BLACKMAN SW, 1994, J ZOOL, V234, P217, DOI 10.1111/j.1469-7998.1994.tb06070.x; Blackman SW, 1995, THESIS; Boncoraglio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031713; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Connelly M, 2019, INT LIB TWENT C HIST, P1; Davies NB, 2012, INTRO BEHAV ECOLOGY; De Gasperin O, 2016, INTERSPECIFIC INTERA, P1, DOI [10.1371/journal.pone.0150969, DOI 10.1371/JOURNAL.PONE.0150969]; De Gasperin O, 2015, ECOL EVOL, V5, P5552, DOI 10.1002/ece3.1795; De Gasperin O, 2015, ECOL ENTOMOL, V40, P787, DOI 10.1111/een.12259; De Gasperin O, 2015, ANIM BEHAV, V109, P199, DOI 10.1016/j.anbehav.2015.08.014; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Eggert AK, 1998, ANIM BEHAV, V55, P97, DOI 10.1006/anbe.1997.0588; Eggert Anne-Katrin, 1997, P216; FORBES MRL, 1993, OIKOS, V67, P444, DOI 10.2307/3545356; Hall SR, 2009, AM NAT, V174, P149, DOI 10.1086/600086; Keppner EM, 2018, J EVOLUTION BIOL, V31, P822, DOI 10.1111/jeb.13266; KORN W, 1983, Spixiana, V6, P251; LYON BE, 1987, BEHAV ECOL SOCIOBIOL, V20, P377, DOI 10.1007/BF00300684; Maynard-Smith J, 1977, ANIM BEHAV, V25, P1, DOI [10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8)]; Moreno J, 1999, BEHAV ECOL SOCIOBIOL, V47, P47, DOI 10.1007/s002650050648; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; MULLER JK, 1990, J INSECT BEHAV, V3, P265, DOI 10.1007/BF01417917; Nehring V, 2019, INT J PARASITOL, V49, P759, DOI 10.1016/j.ijpara.2019.05.011; Nehring V, 2017, ECOL EVOL, V7, P10743, DOI 10.1002/ece3.3591; OTRONEN M, 1988, ANN ZOOL FENN, V25, P191; Parker DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9449; Pike VL, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1220; Pilakouta N, 2015, J EVOLUTION BIOL, V28, P1965, DOI 10.1111/jeb.12712; Pilakouta N, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0875; Pilakouta N, 2016, ANIM BEHAV, V111, P175, DOI 10.1016/j.anbehav.2015.10.016; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; SCHWARZ HH, 1992, OECOLOGIA, V89, P487, DOI 10.1007/BF00317154; Schwarz HH, 1998, EXP APPL ACAROL, V22, P621, DOI 10.1023/A:1006054604520; Schwarz HH, 1998, J NAT HIST, V32, P159, DOI 10.1080/00222939800770101; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Smiseth PT, 2007, EVOLUTION, V61, P2331, DOI 10.1111/j.1558-5646.2007.00192.x; SPRINGETT BP, 1968, J ANIM ECOL, V37, P417, DOI 10.2307/2957; Sun S, 2019, MUTUALISTIC INTERACT, DOI [10.1101/590125, DOI 10.1101/590125]; TRIVERS RL, 1974, AM ZOOL, V14, P249; Ward RJS, 2009, BEHAV ECOL, V20, P1274, DOI 10.1093/beheco/arp132; Wilson DS, 1987, EVOL ECOL, V1, P139, DOI 10.1007/BF02067397; Wilson EO, 2000, SOCIOBIOLOGY, P336	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0228047	10.1371/journal.pone.0228047	http://dx.doi.org/10.1371/journal.pone.0228047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961905	Green Published, Green Submitted, gold			2022-12-26	WOS:000534372000024
J	Sliwinska-Kowalska, M; Fuente, A; Zamyslowska-Szmytke, E				Sliwinska-Kowalska, Mariola; Fuente, Adrian; Zamyslowska-Szmytke, Ewa			Cochlear dysfunction is associated with styrene exposure in humans	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; INDUCED HEARING-LOSS; OCCUPATIONAL-EXPOSURE; NOISE; NEUROTOXICITY; SENSITIVITY; AGE	Aim Occupational exposure to styrene has been shown to be associated with an increased probability of developing hearing loss. However, the sites of lesions in the auditory system in humans remain unknown. The aim of this study was to investigate the possible adverse effects of styrene exposure on the cochlea of human subjects. Design The hearing function of 98 styrene-exposed male workers from the glass fibre-reinforced plastics industry (mean concentration of 55 mg/m(3)) was evaluated bilaterally using puretone audiometry (1000-16000 Hz), distortion product otoacoustic emissions (DPOAEs), and auditory brainstem response (ABR). The results were compared to a group of 111 male workers exposed to noise (above 85 dBA) and 70 male white-collar workers exposed to neither noise nor solvents. Age and noise exposure levels were accounted for as confounding variables in all statistical models. Results Styrene exposure was significantly associated with poorer pure-tone thresholds (1-8 kHz), lower DPOAE amplitudes (5-6 kHz), and shorter wave V latencies in both ears compared to control-group subjects. Similar results were found among noise-exposed subjects. A further analysis with wave V latency showed that styrene-exposed subjects showed significantly shorter latencies than expected according to normative data. These results suggest that occupational exposure to styrene at moderate concentrations is associated with cochlear dysfunction, at least at high frequencies. DPOAEs may be considered a valuable diagnostic tool in hearing conservation programs in workers exposed to styrene.	[Sliwinska-Kowalska, Mariola; Zamyslowska-Szmytke, Ewa] Nofer Inst Occupat Med, Dept Audiol & Phoniatr, Lodz, Poland; [Fuente, Adrian] Ctr Rech Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Fuente, Adrian] Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, Montreal, PQ, Canada	Nofer Institute of Occupational Medicine; Universite de Montreal; Universite de Montreal	Fuente, A (corresponding author), Ctr Rech Inst Univ Geriatrie Montreal, Montreal, PQ, Canada.; Fuente, A (corresponding author), Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, Montreal, PQ, Canada.	adrian.fuente@umontreal.ca		Fuente, Adrian/0000-0003-3736-5057; Zamyslowska-Szmytke, Ewa/0000-0003-2516-3327; Sliwinska-Kowalska, Mariola/0000-0001-7569-3882	6th European Framework Project under the Marie Curie Host Fellowship for the Transfer of Knowledge 'NOISEHEAR' [MTKD-CT-2004-003137]	6th European Framework Project under the Marie Curie Host Fellowship for the Transfer of Knowledge 'NOISEHEAR'	MSK received funding from the 6th European Framework Project under the Marie Curie Host Fellowship for the Transfer of Knowledge 'NOISEHEAR' (Contract No. MTKD-CT-2004-003137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Attias J, 1998, BRIT J AUDIOL, V32, P39, DOI 10.3109/03005364000000049; Bergamaschi E, 1997, INT ARCH OCC ENV HEA, V69, P209, DOI 10.1007/s004200050138; Bonfiglioli R, 2014, AM J IND MED, V57, P254, DOI 10.1002/ajim.22257; Brodkin CA, 2001, OCCUP ENVIRON MED, V58, P95, DOI 10.1136/oem.58.2.95; Butlin RK., 1997, CAMBRIDGE SERIES STA, V671998; Calabrese G, 1996, INT ARCH OCC ENV HEA, V68, P219; Campo P, 2001, HEARING RES, V154, P170, DOI 10.1016/S0378-5955(01)00218-0; Canty A., 2015, BOOT BOOTSTRAP R S P; Christensen MS, 2018, EPIDEMIOLOGY, V29, P342, DOI 10.1097/EDE.0000000000000819; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Fuente A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-39; Fuente A, 2011, INT J AUDIOL, V50, P857, DOI 10.3109/14992027.2011.605805; ISO, 1989, 82531 ISO; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; Johnson Ann-Christin, 2006, Noise Health, V8, P45; Johnson Ann-Christin, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P315, DOI 10.2478/v10001-007-0040-2; LONSBURYMARTIN BL, 1991, J ACOUST SOC AM, V89, P1749, DOI 10.1121/1.401009; Lopez-Escamez J, 1999, ACTA OTO-LARYNGOL, V53; Loquet G, 1999, NEUROTOXICOL TERATOL, V21, P689, DOI 10.1016/S0892-0362(99)00030-6; Luderer U, 2004, OCCUP ENVIRON MED, V61, P325, DOI 10.1136/oem.2002.005561; Makitie AA, 2003, HEARING RES, V179, P9, DOI 10.1016/S0378-5955(03)00066-2; MOLLER C, 1990, SCAND J WORK ENV HEA, V16, P189, DOI 10.5271/sjweh.1795; Morata TC, 2002, J OCCUP ENVIRON MED, V44, P806, DOI 10.1097/00043764-200209000-00002; Morata Thais C., 2002, Noise Health, V4, P73; Morioka I, 1999, ARCH ENVIRON HEALTH, V54, P341, DOI 10.1080/00039899909602498; Morioka I, 1999, ARCH ENVIRON HEALTH, V38, P252; MUIJSER H, 1988, TOXICOLOGY, V49, P331, DOI 10.1016/0300-483X(88)90016-9; Musiek Frank E, 2015, Handb Clin Neurol, V129, P313, DOI 10.1016/B978-0-444-62630-1.00018-4; MUTTI A, 1984, SCAND J WORK ENV HEA, V10, P225, DOI 10.5271/sjweh.2340; OUCHI T, 1994, ACTA OTO-LARYNGOL, P89; PAHWA R, 1993, VET HUM TOXICOL, V35, P516; PROSSER S, 1987, AUDIOLOGY, V26, P179; Pryor G, 1995, HDB NEUROTOXICOLOGY, P377; PRYOR GT, 1987, J APPL TOXICOL, V7, P55, DOI 10.1002/jat.2550070110; R Core Team, 2018, R LANG ENV STAT COMP; Sass-Kortsak Andrea M., 1995, Annals of Epidemiology, V5, P15, DOI 10.1016/1047-2797(94)00036-S; Sharpe D., 2015, PRACTICAL ASSESSMENT, V20, DOI DOI 10.7275/TBFA-X148; Shupak A, 2007, OTOL NEUROTOL, V28, P745, DOI 10.1097/MAO.0b013e3180a726c9; Sisto R, 2013, J ACOUST SOC AM, V134, P3739, DOI 10.1121/1.4824618; Sliwinska-Kowalska M, 2003, J OCCUP ENVIRON MED, V45, P15, DOI 10.1097/01.jom.0000048169.87707.c2; Uchida Y, 2008, EAR HEARING, V29, P176, DOI 10.1097/AUD.0b013e3181634eb8; Venet T, 2015, NEUROTOXICOL TERATOL, V48, P56, DOI 10.1016/j.ntt.2015.02.003; Verplanke AJW, 1998, INT ARCH OCC ENV HEA, V71, P47, DOI 10.1007/s004200050249; Vinck BM, 1999, AUDIOLOGY, V38, P44; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zamyslowska-Szmytke E, 2011, INT J AUDIOL, V50, P815, DOI 10.3109/14992027.2011.599872; Zamyslowska-Szmytke E, 2009, AUDIOL NEURO-OTOL, V14, P296, DOI 10.1159/000212108	48	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227978	10.1371/journal.pone.0227978	http://dx.doi.org/10.1371/journal.pone.0227978			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961907	Green Published, gold			2022-12-26	WOS:000534372000022
J	Tefera, GM; Megersa, WA; Gadisa, DA				Tefera, Gosaye Mekonen; Megersa, Worku Asefa; Gadisa, Diriba Alemayehu			Health-related quality of life and its determinants among ambulatory patients with epilepsy at Ambo General Hospital, Ethiopia: Using WHOQOL-BREF	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; TREATMENT OUTCOMES; PEOPLE; ADHERENCE; BURDEN; ADULTS	Background Health-related quality of life (HRQOL) is used as a measure of treatment outcomes, in addition to seizure control. Hence, the study was aimed to assess HRQOL and its determinants among adult patients with epilepsy (PWE). Method A hospital-based cross-sectional study was conducted from April 20 to June 27/2019, through patient interviews and patient's chart review (medication and clinical information). Data were analyzed using SPSS version 20. The psychometric property was done using Cronbach's alpha test value of >0.7 as accepted internal consistency and Kaiser-Meyer-Olkin (KMO) measure of sample size adequacy value of >= 0.5 as acceptable construct validity, for Afaan Oromo version questionnaire. Multivariate linear logistic regression analysis was done to find predictors for the HRQOL score. Results Of 121 PWE included in the study, 24.4% had overall poor HRQOL with the overall mean +/- SD score of 56.42 +/- 10.96. The predictors for low overall HRQOL score were: presence of co-morbidity (B = -5.620, SE = 1.531, p<0.0001, 95% C.I = -8.656 to -2.584), uncontrolled seizure for at least 2 years (B = -4.239, SE = 1.296, p = 0.001, 95% C.I = -6.809 to -1.670), divorced (B = -8.423, SE = 2.241, p<0.0001, 95%C.I = -12.867 to -3.978) relative to married, and no education (B = -8.715, SE = -8.15, SE = 2.604, p = 0.001, 95%C.I = -9.648 to -1.316) relative to who had level of education above tertiary. In addition, uncontrolled seizure (irrespective of time since seizure-free) (B = -10.083, SE = 2.104, p<0.0001, 95%C.I = -14.256 to -5.910), being widowed (B = -9.300, SE = 3.594, p = 0.011, 95%C.I = -16.429-2.170) relative to married and being illiterate/no education (B = -13.004, SE = 3.910, p = 0.001, 95%C.I = -20.760 to -5.248) relative to educational level of tertiary and above were found to be the strongest negative predictors of HRQOL of physical health. Moreover, uncontrolled seizure (irrespective of time since seizure-free) (B = -12.668, SE = 2.019, p<0.0001, 95%C.I = -16.671 to -8.664) and being divorced (B = -10.153, SE = 3.228, p = 0.002, 95%C. I = -16.556 to -3.751) compared to married were strong predictors for low HRQOL score of psychological health. Absence of Poly-pharmacy (B = 9.050, SE = 3.027, P = 0.003, 95%C.I = 3.047 to 15.054), being single (B = -9.551, SE = 2.095, p<0.0001, 95%C.I = -14.419 to -4.683), and divorced (B = -11.022, SE = 3.351, P = 0.001, 95%C.I = -17.668 to -4.376) relative to married were found to be strong predictors for HRQOL score of social health. Moreover, low HRQOL score of environmental health was predicted by rural residence (B = -5.795, SE = 2.101, p = 0.007, 95%C.I = -9.962 to -1.628), co-morbidity (B+ -4.230, SE = 2.125, p = 0.049, 95%C.I = -8.444 to -0.015) & uncontrolled seizure irrespective of time since seizure-free (B = -6.907, SE = 1.945, p = 0.001, 95%C.I = -10.765 to -3.049) and uncontrolled seizure of at least 2 years (B = -4.520, SE = 1.798, p = 0.014, 95% C.I = -8.088 to -0.953). Conclusions The majority of the study participants had a good overall HRQOL. In general, a low level of HRQOL score was significantly associated with the marital status of single/widowed/divorced, low level of education, low level of monthly income, co-morbidity, uncontrolled seizure, and poly-pharmacy; irrespective of HRQOL domains. Therefore, it is required to improve HRQOL, by avoiding modifiable factors for PWE to achieve the optimum HRQOL.	[Tefera, Gosaye Mekonen; Megersa, Worku Asefa] Ambo Univ, Dept Pharm, Clin Pharm Unit, Ambo, Ethiopia; [Gadisa, Diriba Alemayehu] Ambo Univ, Dept Pharm, Pharmacol Unit, Ambo, Ethiopia	Ambo University; Ambo University	Tefera, GM (corresponding author), Ambo Univ, Dept Pharm, Clin Pharm Unit, Ambo, Ethiopia.	Gosi2010pharma@gmail.com	Gadisa, Diriba/ABF-2838-2021; Mekonen, Gosaye/AAE-6667-2022; Mekonen, Gosaye/AAU-8435-2020	Gadisa, Diriba/0000-0002-3972-4175; Mekonen, Gosaye/0000-0002-7534-2828				Alexander HB, 2018, EPILEPSY BEHAV, V78, P96, DOI 10.1016/j.yebeh.2017.11.006; Alsaadi T, 2017, SEIZURE-EUR J EPILEP, V53, P13, DOI 10.1016/j.seizure.2017.10.017; Alsaadi T, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/196373; [Anonymous], EP AFR REG BRIDG GAP; [Anonymous], 2005, ATLAS EPILEPSY CARE; [Anonymous], 2003, ANN REPORT 2003 GLOB; Asadi-Pooya AA, 2011, IRAN RED CRESCENT ME, V13, P112; Ashwin M, 2013, J Neurosci Rural Pract, V4, pS62, DOI 10.4103/0976-3147.116467; Bautista RED, 2009, EPILEPSY BEHAV, V16, P325, DOI 10.1016/j.yebeh.2009.07.037; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Choi-Kwon S, 2003, ACTA NEUROL SCAND, V108, P428, DOI 10.1046/j.1600-0404.2003.00151.x; de Boer HM, 2013, CURR OPIN NEUROL, V26, P219, DOI 10.1097/WCO.0b013e32835f2037; Diop AG, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00405.x; Djibuti M, 2003, J NEUROL NEUROSUR PS, V74, P570, DOI 10.1136/jnnp.74.5.570; Espinosa-Jovel C, 2018, SEIZURE-EUR J EPILEP, V56, P67, DOI 10.1016/j.seizure.2018.02.002; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gurshaw M, 2014, J YOUNG PHARM, V6, P47, DOI 10.5530/jyp.2014.3.8; Hong Z, 2009, EPILEPSIA, V50, P2192, DOI 10.1111/j.1528-1167.2009.02185.x; Kinyanjui DWC, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-98; Lim YJ, 2009, EPILEPSY RES, V87, P107, DOI 10.1016/j.eplepsyres.2009.08.014; Lin CY, 2017, EPILEPSY BEHAV, V67, P60, DOI 10.1016/j.yebeh.2016.12.012; Lin CY, 2016, EPILEPSY BEHAV, V63, P103, DOI 10.1016/j.yebeh.2016.07.042; Mekonentefera G, 2015, EUR J THER, V21, P9, DOI 10.5455/GMJ-30-163442; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Niriayo YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35906-2; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Organization WH, 1996, WHOQOL BREF INTR ADM; Rakesh PS, 2012, NATL MED J INDIA, V25, P261; Reba K, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/3513159; Santos J.R.A., 1999, J EXT, V37, P1; Shakir Mohammed, 2012, Sultan Qaboos Univ Med J, V12, P449; Singh A, 2016, NEUROL CLIN, V34, P837, DOI 10.1016/j.ncl.2016.06.015; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x; Tegegne MT., 2014, SCI J PUBLIC HLTH, V2, P378; Thomas SV, 2005, NEUROL INDIA, V53, P46, DOI 10.4103/0028-3886.15054; Tiki T, 2018, J NEUROL NEUROBIOL, V4; Viteva E, 2013, Acta Neurol Taiwan, V22, P51; WHO, 2005, ATL EP CAR WORLD; Worku D, 2013, NEUROLOGY, V80; World Health Organization, 2018, EP KEY FACTS; Yousuf RM, 2017, BANGLADESH J MED SCI, V16, P545; Yue L, 2011, EPILEPSY BEHAV, V22, P692, DOI 10.1016/j.yebeh.2011.08.022	44	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227858	10.1371/journal.pone.0227858	http://dx.doi.org/10.1371/journal.pone.0227858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961886	gold, Green Published			2022-12-26	WOS:000534372000014
J	Fang, Y; Tschulakow, A; Taubitz, T; Illing, B; Biesemeier, A; Julien-Schraermeyer, S; Radu, RA; Jiang, ZC; Schraermeyer, U				Fang, Yuan; Tschulakow, Alexander; Taubitz, Tatjana; Illing, Barbara; Biesemeier, Antje; Julien-Schraermeyer, Sylvie; Radu, Roxana A.; Jiang, Zhichun; Schraermeyer, Ulrich			Fundus autofluorescence, spectral-domain optical coherence tomography, and histology correlations in a Stargardt disease mouse model	FASEB JOURNAL			English	Article						ABCA4; blue light damage; fundus autofluorescence; lipofuscin; mouse model; Stargardt disease	LIGHT-INDUCED RETINOPATHY; LIPOFUSCIN FLUOROPHORE; INDUCED DAMAGE; OCULAR FUNDUS; HUMAN RPE; PIGMENT; CELLS; ABCR; A2E; PHOTORECEPTORS	Stargardt disease (STGD1), known as inherited retinal dystrophy, is caused by ABCA4 mutations. The pigmented Abca4(-/-) mouse strain only reflects the early stage of STGD1 since it is devoid of retinal degeneration. This blue light-illuminated pigmented Abca4(-/-) mouse model presented retinal pigment epithelium (RPE) and photoreceptor degeneration which was similar to the advanced STGD1 phenotype. In contrast, wild-type mice showed no RPE degeneration after blue light illumination. In Abca4(-/-) mice, the acute blue light diminished the mean autofluorescence (AF) intensity in both fundus short-wavelength autofluorescence (SW-AF) and near-infrared autofluorescence (NIR-AF) modalities correlating with reduced levels of bisretinoid-fluorophores. Blue light-induced RPE cellular damage preceded the photoreceptors loss. In late-stage STGD1-like patient and blue light-illuminated Abca4(-/-) mice, lipofuscin and melanolipofuscin granules were found to contribute to NIR-AF, indicated by the colocalization of lipofuscin-AF and NIR-AF under the fluorescence microscope. In this mouse model, the correlation between in vivo and ex vivo assessments revealed histological characteristics of fundus AF abnormalities. The flecks which are hyper AF in both SW-AF and NIR-AF corresponded to the subretinal macrophages fully packed with pigment granules (lipofuscin, melanin, and melanolipofuscin). This mouse model, which has the phenotype of advanced STGD1, is important to understand the histopathology of Stargardt disease.	[Fang, Yuan; Tschulakow, Alexander; Taubitz, Tatjana; Illing, Barbara; Biesemeier, Antje; Julien-Schraermeyer, Sylvie; Schraermeyer, Ulrich] Univ Tubingen, Div Expt Vitreoretinal Surg, Inst Ophthalm Res, Ctr Ophthalmol, Schleichstr 12, D-72076 Tubingen, Germany; [Tschulakow, Alexander; Julien-Schraermeyer, Sylvie; Schraermeyer, Ulrich] STZ Ocutox, Preclin Drug Assessment, Hechingen, Germany; [Radu, Roxana A.; Jiang, Zhichun] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Stein Eye Inst, Los Angeles, CA 90095 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schraermeyer, U (corresponding author), Univ Tubingen, Div Expt Vitreoretinal Surg, Inst Ophthalm Res, Ctr Ophthalmol, Schleichstr 12, D-72076 Tubingen, Germany.	ulrich.schraermeyer@med.uni-tuebingen.de	Taubitz, Tatjana/AAA-2941-2021	Taubitz, Tatjana/0000-0002-6747-4484; Julien-Schraermeyer, Sylvie/0000-0002-2322-511X; Biesemeier, Antje/0000-0002-3462-8803; Radu, Roxana/0000-0002-5064-6403	NEI NIH HHS [P30 EY000331] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Blacharski P.A., 1988, RETINAL DYSTROPHY DE, P135; Bonilha VL, 2016, OPHTHALMIC GENET, V37, P150, DOI 10.3109/13816810.2014.958861; BOULTON M, 1990, VISION RES, V30, P1291, DOI 10.1016/0042-6989(90)90003-4; Ciccone L, 2018, RETINA-J RET VIT DIS, V38, P2214, DOI 10.1097/IAE.0000000000001841; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P5946, DOI 10.1167/iovs.15-17698; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Dontsov AE, 2017, BIOCHEMISTRY-MOSCOW+, V82, P916, DOI 10.1134/S0006297917080065; Duncker T, 2015, INVEST OPHTH VIS SCI, V56, P3159, DOI 10.1167/iovs.14-16343; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fujinami K, 2015, OPHTHALMOLOGY, V122, P326, DOI 10.1016/j.ophtha.2014.08.012; GELISKEN O, 1985, INT OPHTHALMOL, V8, P225, DOI 10.1007/BF00137651; Grey AC, 2011, INVEST OPHTH VIS SCI, V52, P3926, DOI 10.1167/iovs.10-7020; HAM WT, 1978, INVEST OPHTH VIS SCI, V17, P1029; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Issa PC, 2013, INVEST OPHTH VIS SCI, V54, P5602, DOI 10.1167/iovs.13-11688; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Katz ML, 2005, MECH AGEING DEV, V126, P513, DOI 10.1016/j.mad.2004.11.004; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Kellner S, 2009, AM J OPHTHALMOL, V147, P895, DOI 10.1016/j.ajo.2008.12.023; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Kumar V, 2017, GRAEF ARCH CLIN EXP, V255, P1917, DOI 10.1007/s00417-017-3736-4; Lambertus S, 2015, OPHTHALMOLOGY, V122, P335, DOI 10.1016/j.ophtha.2014.08.032; Lei L, 2012, MOL VIS, V18, P103; Lenis TL, 2018, P NATL ACAD SCI USA, V115, pE11120, DOI 10.1073/pnas.1802519115; Lenis TL, 2017, P NATL ACAD SCI USA, V114, P3987, DOI 10.1073/pnas.1620299114; Lin CH, 2017, TOXICOL SCI, V157, P196, DOI 10.1093/toxsci/kfx030; Lu B, 2017, OPHTHALMIC RES, V57, P252, DOI 10.1159/000452282; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Marie M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0331-5; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Nakamura M, 2018, EXP EYE RES, V177, P1, DOI 10.1016/j.exer.2018.07.022; Oguchi Y, 2018, JPN J OPHTHALMOL, V62, P605, DOI 10.1007/s10384-018-0614-5; Paavo M, 2018, J NEUROSCI RES, V97, P1; Parodi MB, 2019, GRAEF ARCH CLIN EXP, V257, P41, DOI 10.1007/s00417-018-4167-6; Parodi MB, 2015, BRIT J OPHTHALMOL, V99, P1354, DOI 10.1136/bjophthalmol-2014-306237; Polosa A, 2017, CURR EYE RES, V42, P924, DOI 10.1080/02713683.2016.1255336; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Rapp LM, 1980, EFFECTS CONSTANT LIG, P133; Rotenstreich Y, 2003, OPHTHALMOLOGY, V110, P1151, DOI 10.1016/S0161-6420(03)00333-6; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Rudolf M, 2013, OPHTHALMOLOGY, V120, P821, DOI 10.1016/j.ophtha.2012.10.007; Sarna T, 2003, EXP EYE RES, V76, P89, DOI 10.1016/S0014-4835(02)00247-6; Sears AE, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.5.6; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strauss RW, 2017, JAMA OPHTHALMOL, V135, P1232, DOI 10.1001/jamaophthalmol.2017.4152; Taubit T, 2018, PEERJ, V6, DOI 10.7717/peerj.5215; Taubitz T, 2019, EBIOMEDICINE, V48, P592, DOI 10.1016/j.ebiom.2019.09.048; Teussink MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172635; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; van der Burght Barbro W, 2013, Acta Ophthalmol, V91, pe537, DOI 10.1111/aos.12146; Voigt M, 2010, AM J OPHTHALMOL, V150, P330, DOI 10.1016/j.ajo.2010.04.001; Wajer SD, 2000, MICROVASC RES, V60, P281, DOI 10.1006/mvre.2000.2270; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P474, DOI 10.1562/2005-10-21-RA-725; Warburton S, 2007, MOL VIS, V13, P318; Wassell J, 1999, J BIOL CHEM, V274, P23828, DOI 10.1074/jbc.274.34.23828; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wolock CJ, 2019, GENET MED, V21, P2336, DOI 10.1038/s41436-019-0495-0; Wu L, 2014, INVEST OPHTH VIS SCI, V55, P1910, DOI 10.1167/iovs.14-13867; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	71	8	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3693	3714		10.1096/fj.201901784RR	http://dx.doi.org/10.1096/fj.201901784RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31989709	hybrid			2022-12-26	WOS:000519218400018
J	Zhang, JQ; Han, C; Song, K; Chen, WN; Ungerleider, N; Yao, L; Ma, WB; Wu, T				Zhang, Jinqiang; Han, Chang; Song, Kyoungsub; Chen, Weina; Ungerleider, Nathan; Yao, Lu; Ma, Wenbo; Wu, Tong			The long-noncoding RNA MALAT1 regulates TGF-beta/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; IDENTIFICATION; TRANSCRIPTION; ACTIVATION; METHYLATION; PHOSPHATASE; RECEPTOR; ACTIVIN; BIND	Recent studies have demonstrated the implication of long noncoding RNAs (lncRNAs) in a variety of physiological and pathological processes. However, the majority of lncRNAs are functionally unknown. The current study describes that the lncRNA MALAT1 regulates TGF-beta/Smad signaling pathway through formation of a lncRNA-protein complex containing Smads, SETD2 and PPM1A. Our data show that this lncRNA-proteins complex facilitates the dephosphorylation of pSmad2/3 by providing the interaction niche for pSmad2/3 and their specific phosphatase PPM1A, thus terminating TGF-beta/Smad signaling in hepatic cells. Based on these mechanistic studies, we performed further experiments to determine whether depletion of MALAT1 would augment cellular TGF-beta/Smad signaling. We observed that MALAT1 depletion enhanced TGF-beta/Smad signaling response, as reflect by amplification of Smad-mediated differentiation of induced pluripotent stem (iPS) cells to hepatocytes. Our experimental results demonstrate an important role of MALAT1 for regulation of TGF-beta/Smad signaling in hepatic cells. Given the diverse functions of TGF-beta/Smad pathway in various physiological and pathogenic processes, our results described in the current study will have broad implications for further understanding the role of MALAT1 in TGF-beta/Smad pathway in human biology and disease.	[Zhang, Jinqiang; Han, Chang; Song, Kyoungsub; Chen, Weina; Ungerleider, Nathan; Yao, Lu; Ma, Wenbo; Wu, Tong] Wenbo Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA		Wu, T (corresponding author), Wenbo Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA.	twu@tulane.edu	yao, lu/AAC-4304-2022		National Institutes of Health [CA226281, CA219541, CA102325]; Department of Defense grant [CA180361]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense grant(United States Department of Defense)	The work in the authors' laboratory is supported by National Institutes of Health grants CA226281, CA219541 and CA102325 and Department of Defense grant CA180361. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Caja L, 2011, J HEPATOL, V55, P351, DOI 10.1016/j.jhep.2010.10.041; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Christmann RB, 2014, ARTHRITIS RHEUMATOL, V66, P714, DOI 10.1002/art.38288; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dzieran J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072252; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lu X, 2014, ONCOGENE, V33, P2918, DOI 10.1038/onc.2013.246; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watts R, 2013, AM J PHYSIOL-CELL PH, V304, pC995, DOI 10.1152/ajpcell.00392.2012; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wu SS, 2019, CANCER RES, V79, P5432, DOI 10.1158/0008-5472.CAN-19-0773; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003	41	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228160	10.1371/journal.pone.0228160	http://dx.doi.org/10.1371/journal.pone.0228160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995604	Green Published, gold, Green Submitted			2022-12-26	WOS:000534609400050
J	Chauhan, SS; Toth, RK; Jensen, CC; Casillas, AL; Kashatus, DF; Warfel, NA				Chauhan, Shailender S.; Toth, Rachel K.; Jensen, Corbin C.; Casillas, Andrea L.; Kashatus, David F.; Warfel, Noel A.			PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer	ONCOGENE			English	Article							DEPENDENT PROTEIN-KINASE; CYTOCHROME-C; SMALL-CELL; FISSION; DRP1; PHOSPHORYLATION; FUSION; RESISTANCE; REGULATORS; SURVIVAL	Resistance to chemotherapy represents a major obstacle to the successful treatment of non-small-cell lung cancer (NSCLC). The goal of this study was to determine how PIM kinases impact mitochondrial dynamics, ROS production, and response to chemotherapy in lung cancer. Live-cell imaging and microscopy were used to determine the effect of PIM loss or inhibition on mitochondrial phenotype and ROS. Inhibition of PIM kinases caused excessive mitochondrial fission and significant upregulation of mitochondrial superoxide, increasing intracellular ROS. Mechanistically, we define a signaling axis linking PIM1 to Drp1 and mitochondrial fission in lung cancer. PIM inhibition significantly increased the protein levels and mitochondrial localization of Drp1, causing marked fragmentation of mitochondria. An inverse correlation between PIM1 and Drp1 was confirmed in NSCLC patient samples. Inhibition of PIM sensitized NSCLC cells to chemotherapy and produced a synergistic antitumor response in vitro and in vivo. Immunohistochemistry and transmission electron microscopy verified that PIM inhibitors promote mitochondrial fission and apoptosis in vivo. These data improve our knowledge about how PIM1 regulates mitochondria and provide justification for combining PIM inhibition with chemotherapy in NSCLC.	[Chauhan, Shailender S.; Warfel, Noel A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Toth, Rachel K.; Warfel, Noel A.] Univ Arizona, Canc Ctr, Tucson, AZ 85721 USA; [Jensen, Corbin C.; Casillas, Andrea L.] Univ Arizona, Dept Canc Biol, Tucson, AZ USA; [Kashatus, David F.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Warfel, Noel A.] Levy Canc Ctr, Rm 0977,1515 N Campbell Ave, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; University of Arizona; University of Virginia	Warfel, NA (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.; Warfel, NA (corresponding author), Univ Arizona, Canc Ctr, Tucson, AZ 85721 USA.; Warfel, NA (corresponding author), Levy Canc Ctr, Rm 0977,1515 N Campbell Ave, Tucson, AZ 85724 USA.	warfelna@email.arizona.edu	Chauhan, Shailender Singh/AAM-5269-2020; Kashatus, David/D-8299-2012	Chauhan, Shailender Singh/0000-0002-1975-2734; Casillas, Andrea L/0000-0002-2059-3048; Kashatus, David/0000-0001-8007-0612	American Cancer Society [RSG-16-159-01-CDD]; American Lung Association [LCD-504131]; Department of Defense PCRP Award [W81XWH-19-1-0455]; Cancer Center Support Grant [P30CA023074]	American Cancer Society(American Cancer Society); American Lung Association; Department of Defense PCRP Award(United States Department of Defense); Cancer Center Support Grant	We would like to thank Donna Zhang (University of Arizona) for providing the H1299 Keap1<SUP>-/-</SUP>cell line and assistance with the acquisition and analysis of EPR results. We thank Adam R. Kohr for his assistance with graphic design. The research was supported by American Cancer Society grant RSG-16-159-01-CDD, American Lung Association grant LCD-504131, and Department of Defense PCRP Award (W81XWH-19-1-0455) to NAW. Cancer Center Support Grant P30CA023074 also provided support for this research.	Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Cao LJ, 2019, CANCER LETT, V444, P116, DOI 10.1016/j.canlet.2018.12.015; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cristofani R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0866-5; Din S, 2013, P NATL ACAD SCI USA, V110, P5969, DOI 10.1073/pnas.1213294110; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Joseph B, 1999, BIOCHEM BIOPH RES CO, V262, P381, DOI 10.1006/bbrc.1999.1191; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kong B, 2014, J BIOL CHEM, V289, P27134, DOI 10.1074/jbc.M114.594812; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/srep42748; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lin JJ, 2016, TRENDS CANCER, V2, P350, DOI 10.1016/j.trecan.2016.05.010; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Nagdas S, 2019, CELL REP, V28, P1845, DOI 10.1016/j.celrep.2019.07.031; Qian W, 2014, ONCOTARGET, V5, P4180, DOI 10.18632/oncotarget.1944; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Roberts ER, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303019; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Song JH, 2015, ONCOGENE, V34, P3728, DOI 10.1038/onc.2014.306; Song Jin H, 2018, Mol Cancer Ther, V17, P2710, DOI 10.1158/1535-7163.MCT-18-0374; Song JH, 2016, ONCOTARGET, V7, P20152, DOI 10.18632/oncotarget.7918; Thomas KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045319; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Tu ML, 2011, LIFE SCI, V88, P233, DOI 10.1016/j.lfs.2010.12.001; von Eyss B, 2015, CANCER CELL, V28, P743, DOI 10.1016/j.ccell.2015.10.013; Wan J, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0665-1; Warfel NA, 2016, MOL CANCER THER, V15, P1637, DOI 10.1158/1535-7163.MCT-15-1018; Warfel NA, 2015, PHARMACOL THERAPEUT, V151, P41, DOI 10.1016/j.pharmthera.2015.03.001; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	42	21	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2597	2611		10.1038/s41388-020-1168-9	http://dx.doi.org/10.1038/s41388-020-1168-9		JAN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31992853	Green Submitted, Green Accepted			2022-12-26	WOS:000509838800001
J	Rana, J; Ahmmad, Z; Sen, KK; Bista, S; Islam, RM				Rana, Juwel; Ahmmad, Zobayer; Sen, Kanchan Kumar; Bista, Sanjeev; Islam, Rakibul M.			Socioeconomic differentials in hypertension based on JNC7 and ACC/AHA 2017 guidelines mediated by body mass index: Evidence from Nepal demographic and health survey	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; RISK-FACTORS; ASSOCIATION; DISPARITIES; PREVENTION; PREVALENCE; GRADIENTS; DISEASE	Background Unlike developed countries, higher socioeconomic status (SES-education, and wealth) is associated with hypertension in low and middle-income countries (LMICs) with limited evidence. We examined the associations between SES and hypertension in Nepal and the extent to which these associations vary by sex and urbanity. The body mass index (BMI) was examined as a secondary outcome and assessed as a potential mediator. Materials and methods We analyzed the latest Nepal Demographic and Health Survey data (N = 13,436) collected between June 2016 and January 2017, using a multistage stratified sampling technique. Participants aged 15 years or older from selected households were interviewed with an overall response rate of 97%. Primary outcomes were hypertension and normal blood pressure defined by the widely used Seventh Report of the Joint National Committee (JNC7) and the American College of Cardiology/American Heart Association (ACC/AHA) 2017. Results The prevalence of hypertension was higher in Nepalese men than women. The likelihood of being hypertensive was significantly higher in the higher education group compared with the lowest or no education group for men (OR 1.89 95% CI: 1.36, 2.61) and for women (OR 1.20 95% CI: 0.79, 1.83). People in the richest group were more likely to be hypertensive compared with people in the poorest group for men (OR 1.66 95% CI: 1.26, 2.19) and for women (OR 1.60 95% CI: 1.20, 2.12). The associations between SES (education) and hypertension were partially modified by sex and fully modified by urbanity. BMI mediated these associations. Conclusions The higher SES was positively associated with the higher likelihood of having hypertension in Nepal according to both JNC7 and ACC/AHA 2017 guidelines. These associations were mediated by BMI, which may help to explain broader socioeconomic differentials in cardiovascular disease (CVD) and related risk factors, particularly in terms of education and wealth. Our study suggests that the mediating factor of BMI should be tackled to diminish the risk of CVD in people with higher SES in LMICs.	[Rana, Juwel] South Asia Inst Social Transformat SAIST, Res & Innovat Dept, Dhaka, Bangladesh; [Rana, Juwel] North South Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Rana, Juwel] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Ahmmad, Zobayer] Univ Utah, Dept Sociol, Salt Lake City, UT USA; [Sen, Kanchan Kumar] Univ Dhaka, Dept Stat, Dhaka, Bangladesh; [Bista, Sanjeev] Ecole Hautes Etud Sante Publ, Adv Biostat & Epidemiol, Rennes, France; [Islam, Rakibul M.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia	North South University (NSU); University of Massachusetts System; University of Massachusetts Amherst; Utah System of Higher Education; University of Utah; University of Dhaka; Monash University	Rana, J (corresponding author), South Asia Inst Social Transformat SAIST, Res & Innovat Dept, Dhaka, Bangladesh.; Rana, J (corresponding author), North South Univ, Dept Publ Hlth, Dhaka, Bangladesh.; Rana, J (corresponding author), Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA.	juwelranasoc@gmail.com	; Rana, Md Juwel/E-4696-2018	Sen, Kanchan Kumar/0000-0001-7410-7490; Rana, Md Juwel/0000-0001-5597-664X				Al Kibria GM, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0606; Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI 10.1016/s2214-109x(17)30058-x; Amugsi DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017344; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Aryal N, 2019, HYPERTENS RES, V42, P284, DOI 10.1038/s41440-018-0138-x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bhurosy Trishnee, 2014, ScientificWorldJournal, V2014, P964236, DOI 10.1155/2014/964236; Busingye D, 2014, INT J EPIDEMIOL, V43, P1581, DOI 10.1093/ije/dyu171; Busingye D, 2014, INT J EPIDEMIOL, V43, P1563, DOI 10.1093/ije/dyu112; Cha SH, 2012, J EPIDEMIOL, V22, P425, DOI 10.2188/jea.JE20110132; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Degano IR, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Harshfield E, 2015, INT J EPIDEMIOL, V44, P1625, DOI 10.1093/ije/dyv087; He YH, 2009, NUTRITION, V25, P1143, DOI 10.1016/j.nut.2009.04.003; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Karki KB, 2008, WHO STEPS SURVEILLAN; Karmacharya BM, 2017, HEART ASIA, V9, P1, DOI 10.1136/heartasia-2016-010766; Kreatsoulas C, 2015, INT J EPIDEMIOL, V44, P1636, DOI 10.1093/ije/dyv182; Krishnan A, 2013, REG HLTH FORUM, V17, P1; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Ministry of Health and Population (MoHP) NNEaIII ICF., 2017, NEP DEM HLTH SURV; Neupane D, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000074; Pelletier David L., 1998, Food and Nutrition Bulletin, V19, P223; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Razak F, 2014, INT J EPIDEMIOL, V43, P1577, DOI 10.1093/ije/dyu159; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Sadowsky Jonathan, 2017, ROUTLEDGE HIST MADNE, P350, DOI [10.4324/9781351328081, DOI 10.4324/9781351328081]; Stroope S, 2015, SOC SCI RES, V53, P288, DOI 10.1016/j.ssresearch.2015.05.013; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Tripathy JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188619; Van Minh H, 2006, J HUM HYPERTENS, V20, P109, DOI 10.1038/sj.jhh.1001942; Westreich Daniel, 2013, Am J Epidemiol, V177, P292, DOI 10.1093/aje/kws412; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0218767	10.1371/journal.pone.0218767	http://dx.doi.org/10.1371/journal.pone.0218767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986173	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400002
J	Abbott, BN; Wallace, J; Nicholas, DM; Karim, F; Waltham, NJ				Abbott, Brett N.; Wallace, Jim; Nicholas, David M.; Karim, Fazlul; Waltham, Nathan J.			Bund removal to re-establish tidal flow, remove aquatic weeds and restore coastal wetland services-North Queensland, Australia	PLOS ONE			English	Article							GREAT-BARRIER-REEF; FRESH-WATER; SALT-MARSH; HYMENACHNE-AMPLEXICAULIS; ECOSYSTEM SERVICES; MANAGEMENT; BIODIVERSITY; FLOODPLAIN; ESTUARINE; QUALITY	The shallow tidal and freshwater coastal wetlands adjacent to the Great Barrier Reef lagoon provide a vital nursery and feeding complex that supports the life cycles of marine and freshwater fish, important native vegetation and vital bird habitat. Urban and agricultural development threaten these wetlands, with many of the coastal wetlands becoming lost or changed due to the construction of artificial barriers (e.g. bunds, roads, culverts and floodgates). Infestation by weeds has become a major issue within many of the wetlands modified (bunded) for ponded pasture growth last century. A range of expensive chemical and mechanical control methods have been used in an attempt to restore some of these coastal wetlands, with limited success. This study describes an alternative approach to those methods, investigating the impact of tidal reinstatement after bund removal on weed infestation, associated changes in water quality, and fish biodiversity, in the Boolgooroo lagoon region of the Mungalla wetlands, East of Ingham in North Queensland. High resolution remote sensing, electrofishing and in-water logging was used to track changes over time- 1 year before and 4 years after removal of an earth bund. With tides only penetrating the wetland a few times yearly, gross changes towards a more natural system occurred within a relatively short timeframe, leading to a major reduction in infestation of olive hymenachne, water hyacinth and salvina, reappearance of native vegetation, improvements in water quality, and a tripling of fish diversity. Weed abundance and water quality does appear to oscillate however, dependent on summer rainfall, as changes in hydraulic pressure stops or allows tidal ingress (fresh/saline cycling). With an estimated 30% of coastal wetlands bunded in the Great Barrier Reef region, a passive remediation method such as reintroduction of tidal flow by removal of an earth bund or levee could provide a more cost effective and sustainable means of controlling freshwater weeds and improving coastal water quality into the future.	[Abbott, Brett N.; Wallace, Jim; Nicholas, David M.] CSIRO Land & Water, Australian Trop Sci & Innovat Precinct, Townsville, Qld, Australia; [Wallace, Jim; Waltham, Nathan J.] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res TropWATER, Townsville, Qld, Australia; [Karim, Fazlul] CSIRO Land & Water, Black Mt Labs, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Abbott, BN (corresponding author), CSIRO Land & Water, Australian Trop Sci & Innovat Precinct, Townsville, Qld, Australia.	brett.abbott@csiro.au		Karim, Fazlul/0000-0002-6369-7410	Australian government through the Department of Sustainability, Environment, Water, Population and Communities (SEWPaC) [1173.2]	Australian government through the Department of Sustainability, Environment, Water, Population and Communities (SEWPaC)	This research was funded by the Australian government as part of national biodiversity funding through the Department of Sustainability, Environment, Water, Population and Communities (SEWPaC) - Project: 1173.2 Mungalla: Revegetation & restoration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJSaL R, 1982, WATER QUALITY CRITER; [Anonymous], 2014, GREAT BARRIER REEF R; [Anonymous], 2003, GLOBAL BIOGEOCHEM CY, DOI DOI 10.1029/2002GB001917; Anuja Sharma, 2016, Journal of Environmental Science and Technology, V9, P26; Arthington AH, 2015, AQUAT CONSERV, V25, P336, DOI 10.1002/aqc.2489; Australian and New Zealand Environment and Conservation Council and Agriculture and Resource Management Council of Australia and New Zealand, 2000, AUSTR NZ GUID FRESH, V2; Authority GBRMP, 2014, GREAT BARR REEF REG; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bell-James J., 2019, AUSTR PROPERTY LAW J, V27, P114; BISHOP KA, 1995, AUST J ECOL, V20, P81, DOI 10.1111/j.1442-9993.1995.tb00524.x; Blackman J.G., 1999, CHARACTERISTICS IMPO, P329; Boon PI, 2016, MAR FRESHWATER RES, V67, P721, DOI 10.1071/MF14222; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Burrows D, 2012, 1201 AUSTR CTR TROP; Butler B, 2009, AQUATI EOLOGY ASSESS; Butler B., 2007, DISSOLVED OXYGEN GUI; Butler B, 2009, AQUATIC ECOLOGY ASSE; Chisholm WP, 2006, P 15 AUSTR WEEDS C W; Cook FJ, 2000, MAR POLLUT BULL, V41, P319, DOI 10.1016/S0025-326X(00)00138-7; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Creighton C, 2016, ECOSYSTEMS, V19, P187, DOI 10.1007/s10021-015-9925-2; Crooks S., 2011, ENV DEP PAPERS, V121; Csurhes S., 1999, HYMENACHNE HYMENACHN; Csurhes S., 1998, POTENTIAL ENV WEEDS; Dobbs RJ, 2016, REV FISH BIOL FISHER, V26, P711, DOI 10.1007/s11160-015-9401-2; Ferreira JG, 2005, ECOL MODEL, V187, P513, DOI 10.1016/j.ecolmodel.2005.03.013; Flint N, 2015, MAR FRESHWATER RES, V66, P293, DOI 10.1071/MF14120; Gannon M, 2018, SCI AM; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gillanders BM, 2002, OCEANOGR MAR BIOL, V40, P233; Great Barrier Reef Marine Park Authority, 2018, REEF 2050 LONG TERM; Great Barrier Reef Marine Park Authority (GBRMPA), 2013, COAST EC MAN CAS STU; Grice AC, 2008, STRATEGY MANAGEMENT; Grice Anthony C., 2012, Ecological Management & Restoration, V13, P93, DOI 10.1111/j.1442-8903.2011.00621.x; Herbert ER, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00534.1; Houston WA, 2002, MAR FRESHWATER RES, V53, P1235, DOI 10.1071/MF01042; Howe AJ, 2010, MAR FRESHWATER RES, V61, P702, DOI 10.1071/MF09171; Hurst T, 2016, AUST J BOT, V64, P308, DOI 10.1071/BT16027; Hussner A, 2017, AQUAT BOT, V136, P112, DOI 10.1016/j.aquabot.2016.08.002; Karim F, 2014, HYDROLOGY WATER RESO, V2014, P645; Karim F, 2014, HYDR WAT RES S 2014; Knight J, 2015, WOR GEOMORPHOL LANDS, P57, DOI 10.1007/978-3-319-03560-4_7; LANDERS JC, 1991, ENVIRON MANAGE, V15, P151, DOI 10.1007/BF02393847; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Lemcke B, 2019, ALEMAN GRASS HIGH VA; Li FF, 2018, EXPERT REV MED DEVIC, V15, P445, DOI 10.1080/17434440.2018.1473031; Luke H, 2017, ECOL MANAG RESTOR, V18, P103, DOI 10.1111/emr.12264; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Middleton CH, 1991, PROB POND PAST WORKS; Mitsch W. J., 1993, WETLANDS; MURPHY KJ, 1988, CROP PROT, V7, P232, DOI 10.1016/0261-2194(88)90044-0; Murray NJ, 2019, NATURE, V565, P222, DOI 10.1038/s41586-018-0805-8; Newton A, 2005, ESTUAR COAST SHELF S, V62, P405, DOI 10.1016/j.ecss.2004.09.005; Oosterlee L, 2018, ESTUAR COAST, V41, P613, DOI 10.1007/s12237-017-0314-2; Pearson RG, 2013, MAR FRESHWATER RES, V64, P208, DOI 10.1071/MF12251; Perna CN, 2012, RIVER RES APPL, V28, P1093, DOI 10.1002/rra.1505; Portnoy JW, 1999, ENVIRON MANAGE, V24, P111, DOI 10.1007/s002679900219; Poulakis Gregg R., 2002, Wetlands Ecology and Management, V10, P51, DOI 10.1023/A:1014305310291; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Register of Australian Herbage Plant Cultivars, 1989, AUSTR J EXPT AGR, V29, P293; Reid B, 2018, ASSESSING POTENTIAL; ROZAS LP, 1994, WETLANDS, V14, P262, DOI 10.1007/BF03160632; Rozas LP, 1999, WETLANDS ECOLOGY MAN, V7; Sheaves M, 2014, MAR POLICY, V47, P23, DOI 10.1016/j.marpol.2014.01.024; Smith SM, 2009, RESTOR ECOL, V17, P606, DOI 10.1111/j.1526-100X.2008.00426.x; Staines S., 1990, HIST 1 OCCUPATION MU; Stewart BA, 2013, HYDROBIOLOGIA, V718, P131, DOI 10.1007/s10750-013-1611-9; Stumpf RP, 1998, ESTUAR COAST SHELF S, V46, P165, DOI 10.1006/ecss.1997.0276; Tempest JA, 2015, HYDROL PROCESS, V29, P2346, DOI 10.1002/hyp.10368; Van Coppenolle R, 2019, ESTUARINE COASTAL SH; Veitch V, 2005, FRESHWATER WETLANDS; Veitch V, 2007, 0715 AUSTR CTR TROP; Veitch V, 2008, 0802 J COOK U AUSTR; Villamagna AM, 2010, FRESHWATER BIOL, V55, P282, DOI 10.1111/j.1365-2427.2009.02294.x; Wallace J, 2017, MAR FRESHWATER RES, V68, P650, DOI 10.1071/MF15468; Waltham N, 2017, TROPICAL CONSERVATIO, V10; Waltham N, 2016, FISH SURVEY LILLIESM; Waltham NJ, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00071; Waltham NJ, 2018, J CRUSTACEAN BIOL, V38, P497, DOI 10.1093/jcbiol/ruy051; Waltham NJ, 2015, MAR POLICY, V57, P78, DOI 10.1016/j.marpol.2015.03.030; Wang Z, 2012, CHEMOSPHERE, V89, P1255, DOI 10.1016/j.chemosphere.2012.08.001; Wearne Lynise J., 2010, Plant Protection Quarterly, V25, P146; Weinstein MP, 2016, ECOL RESTOR, V34, P27, DOI 10.3368/er.34.1.27; Wildin JH, 1991, PROB POND PAST WORKS; Winn KO, 2006, J COASTAL RES, V22, P137, DOI 10.2112/05A-0011.1; Yan S-H, 2016, CRIT REV BIOTECHNOL, P1, DOI [10.3109/07388551.2013.811636, DOI 10.3109/07388551.2013.811636]	86	19	19	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0217531	10.1371/journal.pone.0217531	http://dx.doi.org/10.1371/journal.pone.0217531			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978046	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000534599100002
J	Chan, LLY; Rice, WL; Qiu, J				Chan, Leo Li-Ying; Rice, William L.; Qiu, Jean			Observation and quantification of the morphological effect of trypan blue rupturing dead or dying cells	PLOS ONE			English	Article							DYE EXCLUSION; IMAGE CYTOMETRY; VIABILITY	Trypan blue has long been the gold standard for staining dead cell to determine cell viability. The dye is excluded from membrane-intact live cells, but can enter and concentrate in membrane-compromised dead cells, rendering the cells dark blue. Over the years, there has been an understanding that trypan blue is inaccurate for cell viability under 80% without scientific support. We previously showed that trypan blue can alter the morphology of dead cells to a diffuse shape, which can lead to over-estimation of viability. Here, we investigate the origin of the dim and diffuse objects after trypan blue staining. Utilizing image and video acquisition, we show real-time transformation of cells into diffuse objects when stained with trypan blue. The same phenomenon was not observed when staining cells with propidium iodide. We also demonstrate the co-localization of trypan blue and propidium iodide, confirming these diffuse objects as cells that contain nuclei. The videos clearly show immediate cell rupturing after trypan blue contact. The formation of these diffuse objects was monitored and counted over time as cells die outside of the incubator. We hypothesize and demonstrate that rapid water influx may have caused the cells to rupture and disappear. Since some dead cells disappear after trypan blue staining, the total can be under-counted, leading to over-estimation of cell viability. This inaccuracy could affect the outcomes of cellular therapies, which require accurate measurements of immune cells that will be infused back into patients.	[Chan, Leo Li-Ying; Rice, William L.; Qiu, Jean] Nexcelom Biosci LLC, Dept Adv Technol R&D, Lawrence, MA 01843 USA		Chan, LLY (corresponding author), Nexcelom Biosci LLC, Dept Adv Technol R&D, Lawrence, MA 01843 USA.	lchan@nexcelom.com			Nexcelom Bioscience LLC	Nexcelom Bioscience LLC	The funder Nexcelom Bioscience LLC. provided support in the form of salaries for authors LLC, WLR, and JQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; Arcidiacono JA, 2018, CYTOTHERAPY, V20, P779, DOI 10.1016/j.jcyt.2018.03.039; BEAUDOIN AR, 1963, ANAT REC, V147, P387, DOI 10.1002/ar.1091470310; BISCHOF JC, 1995, BIOPHYS J, V68, P2608, DOI 10.1016/S0006-3495(95)80445-5; BLACK L, 1964, EXP CELL RES, V35, P9, DOI 10.1016/0014-4827(64)90066-7; Bursch W, 2000, J CELL SCI, V113, P1189; Cannon J, 2012, J PHYS CHEM B, V116, P4206, DOI 10.1021/jp2113363; Chan LL, 2012, J FLUORESC, V22, P1301, DOI 10.1007/s10895-012-1072-y; Chan LLY, 2017, METHODS MOL BIOL, V1601, P27, DOI 10.1007/978-1-4939-6960-9_3; Chan LLY, 2015, CYTOTECHNOLOGY, V67, P461, DOI 10.1007/s10616-014-9704-5; Chan LLY, 2013, J IMMUNOL METHODS, V388, P25, DOI 10.1016/j.jim.2012.11.010; FDA (Food and Drug Administration) . US Department of Health and Human Services Center for Biologics Evaluation and Research (CBER) Pharmacology and Toxicology, 2008, GUID FDA REV SPONS C; Costa EDF, 2009, INVEST OPHTH VIS SCI, V50, P385, DOI 10.1167/iovs.08-2285; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gao HW, 2003, J CHIN CHEM SOC-TAIP, V50, P329, DOI 10.1002/jccs.200300049; Hasegawa K, 2019, INFLAMM REGEN, V39, DOI 10.1186/s41232-019-0100-6; Kofanova OA, 2014, BIOPRESERV BIOBANK, V12, P206, DOI 10.1089/bio.2013.0090; Kwok AKH, 2004, BRIT J OPHTHALMOL, V88, P1590, DOI 10.1136/bjo.2004.044537; Lodish H, 2000, MOL CELL BIOL; MACKEY BM, 1991, J GEN MICROBIOL, V137, P2361, DOI 10.1099/00221287-137-10-2361; Mascotti K, 2000, TRANSFUSION, V40, P693, DOI 10.1046/j.1537-2995.2000.40060693.x; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Owen J, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0001; Page S.W., 2008, SMALL ANIMAL CLIN PH, P198; Piccinini F, 2017, BIOL PROCED ONLINE, V19, DOI 10.1186/s12575-017-0056-3; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sarma KD, 2000, CYTOTECHNOLOGY, V32, P93, DOI 10.1023/A:1008144527206; Solomon M, 2010, TRANSFUSION, V50, P820, DOI 10.1111/j.1537-2995.2009.02491.x; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Wainwright M, 2010, BIOTECH HISTOCHEM, V85, P341, DOI 10.3109/10520290903297528; Yip A, 2018, NAT REV DRUG DISCOV, V17, P161, DOI 10.1038/nrd.2017.266; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133	33	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227950	10.1371/journal.pone.0227950	http://dx.doi.org/10.1371/journal.pone.0227950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978129	Green Published, gold			2022-12-26	WOS:000534599100083
J	Kim, KH; Kim, JY; Lim, WJ; Jeong, S; Lee, HY; Cho, Y; Moon, JK; Kim, N				Kim, Kyoung Hyoun; Kim, Jae-Yoon; Lim, Won-Jun; Jeong, Seongmun; Lee, Ho-Yeon; Cho, Youngbum; Moon, Jung-Kyung; Kim, Namshin			Genome-wide association and epistatic interactions of flowering time in soybean cultivar	PLOS ONE			English	Article							MAP-BASED CLONING; MATURITY LOCUS; GENETIC ARCHITECTURE; TRANSCRIPTION FACTOR; GROWTH HABIT; E1; ADAPTATION; EXPRESSION; DIVERSITY; PROTEINS	Genome-wide association studies (GWAS) have enabled the discovery of candidate markers that play significant roles in various complex traits in plants. Recently, with increased interest in the search for candidate markers, studies on epistatic interactions between single nucleotide polymorphism (SNP) markers have also increased, thus enabling the identification of more candidate markers along with GWAS on single-variant-additive-effect. Here, we focused on the identification of candidate markers associated with flowering time in soybean (Glycine max). A large population of 2,662 cultivated soybean accessions was genotyped using the 180k Axiom (R) SoyaSNP array, and the genomic architecture of these accessions was investigated to confirm the population structure. Then, GWAS was conducted to evaluate the association between SNP markers and flowering time. A total of 93 significant SNP markers were detected within 59 significant genes, including E1 and E3, which are the main determinants of flowering time. Based on the GWAS results, multilocus epistatic interactions were examined between the significant and non-significant SNP markers. Two significant and 16 non-significant SNP markers were discovered as candidate markers affecting flowering time via interactions with each other. These 18 candidate SNP markers mapped to 18 candidate genes including E1 and E3, and the 18 candidate genes were involved in six major flowering pathways. Although further biological validation is needed, our results provide additional information on the existing flowering time markers and present another option to marker-assisted breeding programs for regulating flowering time of soybean.	[Kim, Kyoung Hyoun; Kim, Jae-Yoon; Lim, Won-Jun; Jeong, Seongmun; Lee, Ho-Yeon; Cho, Youngbum; Kim, Namshin] Korea Res Inst Biosci & Biotechnol KRIBB, Genome Editing Res Ctr, Daejeon, South Korea; [Kim, Kyoung Hyoun; Kim, Jae-Yoon; Lim, Won-Jun; Lee, Ho-Yeon; Cho, Youngbum; Kim, Namshin] Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Bioinformat, Daejeon, South Korea; [Moon, Jung-Kyung] Rural Dev Adm, Natl Inst Agr Sci, Jeonju, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); National Institute of Agricultural Sciences; Rural Development Administration (RDA)	Kim, N (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Genome Editing Res Ctr, Daejeon, South Korea.; Kim, N (corresponding author), Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Bioinformat, Daejeon, South Korea.	deepreds@kribb.re.kr		Jeong, Seongmun/0000-0002-0038-461X; Kim, Jae-Yoon/0000-0002-8557-0998; Kim, Kyoung Hyoun/0000-0002-7652-1879	National Research Foundation of Korea [NRF-2014M3C9A3064552]; Rural Development Administration, Republic of Korea [PJ01313201]; KRIBB Initiative program	National Research Foundation of Korea(National Research Foundation of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); KRIBB Initiative program	This work is supported by grants from the National Research Foundation of Korea (NRF-2014M3C9A3064552), Rural Development Administration, Republic of Korea (Project No. PJ01313201) and the KRIBB Initiative program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliassa C, 2018, BIOELECTROMAGNETICS, V39, P361, DOI 10.1002/bem.22123; Ahsan MA, 2019, DNA RES, V26, P119, DOI 10.1093/dnares/dsy043; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Assefa T, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5907-7; Battenfield SD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204757; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capovilla G, 2015, J EXP BOT, V66, P59, DOI 10.1093/jxb/eru416; Chen GS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142001; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Cheng JZ, 2017, PHYSIOL MOL BIOL PLA, V23, P477, DOI 10.1007/s12298-017-0458-3; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Contreras-Soto RI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171105; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Fan Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00946; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Hoang GT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219274; He TH, 2019, J EXP BOT, V70, P5603, DOI 10.1093/jxb/erz332; Helliwell CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021513; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Hohenstatt ML, 2018, PLANT CELL, V30, P117, DOI 10.1105/tpc.17.00117; Hu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130854; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jaudal M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00050; Jeong SC, 2019, THEOR APPL GENET, V132, P1179, DOI 10.1007/s00122-018-3271-7; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Kang HJ, 2019, NEW PHYTOL, V223, P336, DOI 10.1111/nph.15780; Kim MY, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0008; Kim SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211775; Kim Sung-D, 2012, IT CONVERGENCE SOC S, V2, P1, DOI DOI 10.1371/J0URNAL.PGEN.1002512; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Koo CL, 2015, BIOTECHNOL BIOPROC E, V20, P662, DOI 10.1007/s12257-015-0064-6; Langer SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00537; Lee GiAn, 2014, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V59, P492, DOI 10.7740/kjcs.2014.59.4.492; Lee SJ, 2018, PLANT PHYSIOL, V176, P717, DOI 10.1104/pp.17.00960; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; Li ZL, 2001, CROP SCI, V41, P1337, DOI 10.2135/cropsci2001.4141337x; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Liu Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15234; Liu W, 2018, NEW PHYTOL, V217, P1335, DOI 10.1111/nph.14884; Lu S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208386; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; Mazaheri M, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1653-x; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Moellers TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03695-9; Nascimento M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190303; Navarro JAR, 2017, NAT GENET, V49, P476, DOI 10.1038/ng.3784; Niel Clement, 2015, Front Genet, V6, P285, DOI 10.3389/fgene.2015.00285; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Preston JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00080; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Ren C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2989-3; Ritchie MD, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.05; Rouse DT, 2002, PLANT J, V29, P183, DOI 10.1046/j.0960-7412.2001.01210.x; SAINDON G, 1989, CROP SCI, V29, P1436, DOI 10.2135/cropsci1989.0011183X002900060021x; Sales E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183416; Samanfar B, 2017, THEOR APPL GENET, V130, P377, DOI 10.1007/s00122-016-2819-7; Sanchez R, 2009, MOL PLANT, V2, P643, DOI 10.1093/mp/ssp004; Seaton DD, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145766; Sedivy EJ, 2017, NEW PHYTOL, V214, P539, DOI 10.1111/nph.14418; Sehgal D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01189; Song YH, 2014, P NATL ACAD SCI USA, V111, P17672, DOI 10.1073/pnas.1415375111; Stewart DW, 2003, AGRON J, V95, P65, DOI 10.2134/agronj2003.0065; Sun XQ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00106; Thabet SG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206682; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Tsubokura Y, 2013, AGRONOMY-BASEL, V3, P117, DOI 10.3390/agronomy3010117; Wan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090048; Wang B, 2019, PLANT CELL, V31, P1416, DOI 10.1105/tpc.19.00343; Wang JX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2217-6; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu Dongqing, 2016, F1000Res, V5, DOI 10.12688/f1000research.7346.1; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Yi NJ, 2010, GENET RES, V92, P443, DOI 10.1017/S0016672310000595; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135; Zeng XR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4402-2; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089030; Zhang C, 2019, BIOINFORMATICS, V35, P1786, DOI 10.1093/bioinformatics/bty875; Zhang JP, 2015, PLANT J, V84, P1124, DOI 10.1111/tpj.13069; Zhang JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1441-4; Zhang J, 2010, P NATL ACAD SCI USA, V107, P1321, DOI 10.1073/pnas.0907304107; Zhang XZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29548; Zhao C, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0704-9; Zhao X, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6009-2	109	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0228114	10.1371/journal.pone.0228114	http://dx.doi.org/10.1371/journal.pone.0228114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968016	Green Published, gold			2022-12-26	WOS:000534373000026
J	Taniguchi, M; Ueda, Y; Matsushita, M; Nagaya, S; Hashizume, C; Arai, K; Kabayama, K; Fukase, K; Watanabe, K; Wardhani, LO; Hayashi, K; Okazaki, T				Taniguchi, Makoto; Ueda, Yoshibumi; Matsushita, Michiko; Nagaya, Shingo; Hashizume, Chieko; Arai, Kenta; Kabayama, Kazuya; Fukase, Koichi; Watanabe, Ken; Wardhani, Lusi Oka; Hayashi, Kazuhiko; Okazaki, Toshiro			Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction	FASEB JOURNAL			English	Article						ICAM-1; infiltration; malignant lymphoma; SMS2; sphingomyelin	LUNG EPITHELIAL-CELLS; TUMOR MICROENVIRONMENT; CIRCULATING MARKERS; SMS2 DEFICIENCY; FATTY LIVER; EXPRESSION; METASTASIS; ADHESION; SPHINGOLIPIDS; INFLAMMATION	The tumor microenvironment (TME) formation involving host cells and cancer cells through cell adhesion molecules (CAMs) is essential for the multiple steps of cancer metastasis and growth. Sphingomyelin synthase 2 (SMS2) is involved in inflammatory diseases such as obesity and diabetes mellitus by regulation of the SM/ceramide balance. However, the involvement of SMS2 in TME formation and metastasis is largely unknown. Here, we report that SMS2-deficient (SMS2-KO) mice show suppressed the EL4 cell infiltration to liver and prolonged survival time. ICAM-1 was identified as a candidate for the inhibition of TME formation in immortalized mouse embryonic fibroblasts (tMEFs) from mRNA array analysis for CAMs. Reduced SM/ceramide balance in SMS2-KO tMEFs suppressed the attachment of EL4 cells through transcriptional reduction of ICAM-1 by the inhibition of NF-kappa B activation. TNF-alpha-induced NF-kappa B activation and subsequent induction of ICAM-1 were suppressed in SMS2-KO tMEFs but restored by SMS2 re-introduction. In the EL4 cell infiltration mouse model, EL4 injection increased ICAM-1 expression in WT liver but not in SMS2-KO mouse liver. Therefore, inhibition of SMS2 may be a therapeutic target to suppress the infiltration of malignant lymphoma.	[Taniguchi, Makoto] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Kahoku, Ishikawa, Japan; [Ueda, Yoshibumi; Nagaya, Shingo; Hashizume, Chieko; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Fac Med, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan; [Ueda, Yoshibumi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Matsushita, Michiko] Univ Tottori, Sch Hlth Sci, Dept Pathobiol Sci & Technol, Tottori, Japan; [Arai, Kenta; Kabayama, Kazuya; Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka, Japan; [Kabayama, Kazuya; Fukase, Koichi] Osaka Univ, Grad Sch Sci, Project Res Ctr, Osaka, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Japan; [Wardhani, Lusi Oka; Hayashi, Kazuhiko] Tottori Univ, Dept Pathol & Microbiol, Fac Med, Div Mol Pathol, Tottori, Japan; [Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Kahoku, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University; University of Tokyo; Tottori University; Osaka University; Osaka University; National Center for Geriatrics & Gerontology; Tottori University; Kanazawa Medical University	Okazaki, T (corresponding author), Kanazawa Med Univ, Dept Hematol & Immunol, Fac Med, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan.	toshiroo@mbox.kyoto-inet.or.jp	Ueda, Yoshibumi/AHA-4956-2022; Watanabe, Ken/I-3960-2013; Kabayama, Kazuya/ABD-5748-2020; Taniguchi, Makoto/L-5757-2019	Ueda, Yoshibumi/0000-0003-1500-3469; Watanabe, Ken/0000-0003-0664-3915; Kabayama, Kazuya/0000-0002-7583-5454; Taniguchi, Makoto/0000-0001-5920-8285; Hashizume, Chieko/0000-0002-5937-3915; Wardhani, Lusi Oka/0000-0002-9895-9038	Kanazawa Medical University; JSPS KAKENHI [17K18205, 18H02697]; Takeda Science Foundation; Shalome Co., Ltd; ONO Pharmaceutical Co., Ltd; Strategic Research Foundation [S1201004, H2012-16]	Kanazawa Medical University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Shalome Co., Ltd; ONO Pharmaceutical Co., Ltd(Ono Pharmaceutical Co Ltd); Strategic Research Foundation	Kanazawa Medical University; JSPS KAKENHI, Grant/Award Number: 17K18205 and 18H02697; Takeda Science Foundation; Shalome Co., Ltd; ONO Pharmaceutical Co., Ltd; Strategic Research Foundation, Grant/Award Number: S1201004 and H2012-16	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Aoudjit F, 1998, J IMMUNOL, V161, P2333; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Benedicto A, 2017, ONCOL LETT, V14, P3883, DOI 10.3892/ol.2017.6700; Bertolino P, 2005, HEPATOLOGY, V42, P1063, DOI 10.1002/hep.20885; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BurkeGaffney A, 1996, BRIT J PHARMACOL, V119, P1149, DOI 10.1111/j.1476-5381.1996.tb16017.x; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Ding L, 2001, BRIT J CANCER, V85, P431, DOI 10.1054/bjoc.2001.1911; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Fernandez-Garcia P, 2019, CANCERS, V11, DOI 10.3390/cancers11010088; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harjunpaa H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01078; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Iyengar NM, 2016, J CLIN ONCOL, V34, P4270, DOI 10.1200/JCO.2016.67.4283; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanwar JR, 2003, CANCER GENE THER, V10, P468, DOI 10.1038/sj.cgt.7700590; Kitatani K, 2015, MOL CELLS, V38, P482, DOI 10.14348/molcells.2015.0118; Kotteas EA, 2014, ANTICANCER RES, V34, P4665; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Lind L, 2003, ATHEROSCLEROSIS, V169, P203, DOI 10.1016/S0021-9150(03)00012-1; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Matsumoto T, 2016, ANTICANCER RES, V36, P1473; Matsumoto T, 2015, ANTICANCER RES, V35, P4647; Matsuura K, 2019, ANTICANCER RES, V39, P4061, DOI 10.21873/anticanres.13562; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nakamura M, 2017, ANTICANCER RES, V37, P3429, DOI 10.21873/anticanres.11710; Ogiso H, 2015, J LIPID RES, V56, P1594, DOI 10.1194/jlr.M059972; Ohnishi T, 2017, FASEB J, V31, P3816, DOI 10.1096/fj.201601225RR; Roma-Rodrigues C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040840; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sakamoto H, 2017, BIOCHEM BIOPH RES CO, V482, P202, DOI 10.1016/j.bbrc.2016.11.041; Shakor ABA, 2011, J BIOL CHEM, V286, P36053, DOI 10.1074/jbc.M111.228593; Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Trayssac M, 2018, J CLIN INVEST, V128, P2702, DOI 10.1172/JCI97949; Ueda Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22399-2; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Zhang Y, 2011, BIOCHEM PHARMACOL, V82, P287, DOI 10.1016/j.bcp.2011.04.009; Zhang ZH, 2011, CLIN EXP METASTAS, V28, P551, DOI 10.1007/s10585-011-9391-y	49	9	9	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3838	3854		10.1096/fj.201901783RR	http://dx.doi.org/10.1096/fj.201901783RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31970839	Bronze			2022-12-26	WOS:000508877000001
J	Wergin, VV; Juergen,; Gropel, P; Mesagno, C				Wergin, V. Vanessa; Beckmann, Juergen; Groepel, Peter; Mesagno, Christopher			Investigating cumulative effects of pre-performance routine interventions in beach volleyball serving	PLOS ONE			English	Article							SELF-FOCUSED ATTENTION; MOTOR SKILL FAILURE; CHOKING; ACCURACY; PRESSURE; ANXIETY	Pre-performance routines (PPRs) can be used in certain sports to minimize the effects of choking under pressure. This study aimed to investigate the cumulative effectiveness of PPR interventions on the accuracy of beach volleyball serves. Fifty-four beach volleyball players were randomly assigned to one of three PPR intervention groups or a control group. Participants performed 10 serves at a target on the opposite side of the beach volleyball court (pretest), were educated on a PPR intervention, and then completed 10 serves at the target under pressure that was induced through videotaping and ego-relevant instructions (posttest). The results indicated no difference in post-test serving accuracy among the intervention groups and the wait-list control group and no difference in effectiveness between cumulative and isolated PPR use. A possible explanation may be the inefficiency of the pressure manipulation. However, the null results related to isolated and cumulative PPR use under general (i.e., no pressure) conditions are still an important research finding. Future research should investigate the effectiveness of cumulative and other PPRs in other sports in general and under pressure.	[Wergin, V. Vanessa; Beckmann, Juergen] Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany; [Beckmann, Juergen] Univ Queensland, Sch Movement & Nutr Sci, Brisbane, Qld, Australia; [Groepel, Peter] Univ Vienna, Dept Sport Sci, Div Sport Psychol, Vienna, Austria; [Mesagno, Christopher] Federat Univ Australia, Sch Hlth & Life Sci, Ballarat, Vic, Australia	Technical University of Munich; University of Queensland; University of Vienna; Federation University Australia	Wergin, VV (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany.	vanessa.wergin@tum.de	Mesagno, Christopher/AAX-5247-2020; Beckmann, Juergen/G-7271-2011; Wergin, Vivian Vanessa/AAX-5878-2020; Wergin, Vanessa/AAE-5232-2021	Mesagno, Christopher/0000-0001-9417-4359; Beckmann, Juergen/0000-0001-7238-4646; Wergin, Vivian Vanessa/0000-0002-3091-153X; Gropel, Peter/0000-0001-8765-176X	German Research Foundation (DFG); Technical University of Munich (TUM); Universities Australia; German Academic Exchange Service (DAAD) as a part of the Australia-Germany research cooperation scheme	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM); Universities Australia; German Academic Exchange Service (DAAD) as a part of the Australia-Germany research cooperation scheme(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. Further support was granted by Universities Australia and the German Academic Exchange Service (DAAD) as a part of the Australia-Germany research cooperation scheme.	Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Beauchamp PH, 1996, SPORT PSYCHOL, V10, P157, DOI 10.1123/tsp.10.2.157; Beckmann J, 2013, J EXP PSYCHOL GEN, V142, P679, DOI 10.1037/a0029852; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; BOUTCHER SH, 1987, INT J SPORT PSYCHOL, V18, P30; Cohn P.J., 1990, SPORT PSYCHOL, V4, P33, DOI [https://doi.org/10.1123/tsp.4.1.33, DOI 10.1123/TSP.4.1.33]; Cotterill S., 2010, INT REV SPORT EXER P, V3, P132, DOI [10.1080/1750984X.2010.488269, DOI 10.1080/1750984X.2010.488269]; Crews D. J., 2004, GOLF DIGEST, V1, P100, DOI DOI 10.1249/00005768-199301000-00016; Cross-Villasana F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145867; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallicchio G, 2016, SPORT EXERC PERFORM, V5, P14, DOI 10.1037/spy0000055; Gropel P, 2019, INT REV SPORT EXER P, V12, P176, DOI 10.1080/1750984X.2017.1408134; Gropel P, 2017, SPORT PSYCHOL, V31, P199, DOI 10.1123/tsp.2016-0054; Gropel P, 2016, SPORT EXERC PERFORM, V5, P206, DOI 10.1037/spy0000059; Harle SK, 2001, SPORT PSYCHOL, V15, P289, DOI 10.1123/tsp.15.3.289; Harmon-Jones E, 2006, PSYCHOPHYSIOLOGY, V43, P598, DOI 10.1111/j.1469-8986.2006.00465.x; Hatfield BD, 2004, J CLIN NEUROPHYSIOL, V21, P144, DOI 10.1097/00004691-200405000-00003; Hazell J, 2014, EUR J SPORT SCI, V14, P603, DOI 10.1080/17461391.2014.888484; Kais K, 2004, PERCEPT MOTOR SKILL, V98, P439; Koch C, 2009, KINESIOLOGY, V41, P52; KRANE V, 1994, SPORT PSYCHOL, V8, P189, DOI 10.1123/tsp.8.2.189; Lautenbach F, 2015, J APPL SPORT PSYCHOL, V27, P123, DOI 10.1080/10413200.2014.957364; Liao CM, 2002, J SPORT EXERCISE PSY, V24, P289, DOI 10.1123/jsep.24.3.289; Lidor R, 2005, SPORT PSYCHOL, V19, P343, DOI 10.1123/tsp.19.4.343; Marlow C, 1998, J Sci Med Sport, V1, P143, DOI 10.1016/S1440-2440(98)80010-8; Masters R., 2008, INT REV SPORT EXER P, V1, P160, DOI [10.1080/17509840802287218, DOI 10.1080/17509840802287218]; *McCann P., 2001, EUR J SPORT SCI, V1, P1, DOI [10.1080/17461390100071503, DOI 10.1080/17461390100071503, https://doi.org/10.1080/17461390100071503]; Mesagno C, 2008, SPORT PSYCHOL, V22, P439, DOI 10.1123/tsp.22.4.439; Mesagno C, 2019, PSYCHOL SPORT EXERC, V43, P73, DOI 10.1016/j.psychsport.2019.01.001; Mesagno C, 2017, CURR OPIN PSYCHOL, V16, P170, DOI 10.1016/j.copsyc.2017.05.015; Mesagno C, 2015, PSYCHOL SPORT EXERC, V19, P85, DOI 10.1016/j.psychsport.2015.03.005; Mesagno C, 2012, PSYCHOL SPORT EXERC, V13, P60, DOI 10.1016/j.psychsport.2011.07.007; Mesagno C, 2010, J APPL SPORT PSYCHOL, V22, P343, DOI 10.1080/10413200.2010.491780; Michalopoulou M., 2005, INT J PERF ANAL SPOR, V5, P41, DOI [10.1080/24748668.2005.11868314, DOI 10.1080/24748668.2005.11868314]; Oudejans RRD, 2011, ANXIETY STRESS COPIN, V24, P59, DOI 10.1080/10615806.2010.481331; Peterson CK, 2008, PSYCHOPHYSIOLOGY, V45, P86, DOI 10.1111/j.1469-8986.2007.00597.x; Raudsepp, 2005, KINESIOLOGY, V37, P13; Singer RN, 2000, ERGONOMICS, V43, P1661, DOI 10.1080/001401300750004078	41	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0228012	10.1371/journal.pone.0228012	http://dx.doi.org/10.1371/journal.pone.0228012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5QT	31968003	Green Published, gold			2022-12-26	WOS:000534373000024
J	Kim, BS; Tilstam, PV; Arnke, K; Leng, L; Ruhl, T; Piecychna, M; Schulte, W; Sauler, M; Frueh, FS; Storti, G; Lindenblatt, N; Giovanoli, P; Pallua, N; Bernhagen, J; Bucala, R				Kim, Bong-Sung; Tilstam, Pathricia V.; Arnke, Kevin; Leng, Lin; Ruhl, Tim; Piecychna, Marta; Schulte, Wibke; Sauler, Maor; Frueh, Florian S.; Storti, Gabriele; Lindenblatt, Nicole; Giovanoli, Pietro; Pallua, Norbert; Bernhagen, Juergen; Bucala, Richard			Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia	FASEB JOURNAL			English	Article						adipose tissue; D-DT; inflammation; macrophage; macrophage polarization; MIF; MIF-2; sepsis; wound healing	MIGRATION INHIBITORY FACTOR; D-DOPACHROME TAUTOMERASE; INSULIN-RESISTANCE; SEPTIC SHOCK; T-CELLS; INFLAMMATION; SEPSIS; EXPRESSION; HOMOLOG	Sepsis is a leading cause of death worldwide and recent studies have shown white adipose tissue (WAT) to be an important regulator in septic conditions. In the present study, the role of the inflammatory cytokine macrophage migration inhibitory factor (MIF) and its structural homolog D-dopachrome tautomerase (D-DT/MIF-2) were investigated in WAT in a murine endotoxemia model. Both MIF and MIF-2 levels were increased in the peritoneal fluid of LPS-challenged wild-type mice, yet, in visceral WAT, the proteins were differentially regulated, with elevated MIF but downregulated MIF-2 expression in adipocytes. Mif gene deletion polarized adipose tissue macrophages (ATM) toward an anti-inflammatory phenotype while Mif-2 gene knockout drove ATMs toward a pro-inflammatory phenotype and Mif-deficiency was found to increase fibroblast viability. Additionally, we observed the same differential regulation of these two MIF family proteins in human adipose tissue in septic vs healthy patients. Taken together, these data suggest an inverse relationship between adipocyte MIF and MIF-2 expression during systemic inflammation, with the downregulation of MIF-2 in fat tissue potentially increasing pro-inflammatory macrophage polarization to further drive adipose inflammation.	[Kim, Bong-Sung; Tilstam, Pathricia V.; Leng, Lin; Piecychna, Marta; Schulte, Wibke; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, POB 208031,300 Cedar St, New Haven, CT 06510 USA; [Kim, Bong-Sung; Ruhl, Tim; Pallua, Norbert] Rhein Westfal TH Aachen, Dept Plast Reconstruct & Hand Surg, Aachen, Germany; [Arnke, Kevin; Lindenblatt, Nicole; Giovanoli, Pietro] Univ Hosp Zurich, Dept Plast Surg & Hand Surg, Zurich, Switzerland; [Schulte, Wibke] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Schulte, Wibke] Charite Univ Med Berlin, Campus Charite Mitte I, Campus Virchow Klinikum, Dept Surg, Berlin, Germany; [Schulte, Wibke] BIH, Berlin, Germany; [Sauler, Maor] Yale Univ, Sch Med, Dept Pulm Crit Care & Sleep Med, New Haven, CT USA; [Storti, Gabriele] Univ Roma Tor Vergata, Unit Plast & Reconstruct Surg, Rome, Italy; [Bernhagen, Juergen] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res, Dept Vasc Biol, Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol, Munich, Germany	Yale University; RWTH Aachen University; University of Zurich; University Zurich Hospital; Yale University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Yale University; University of Rome Tor Vergata; University of Munich	Tilstam, PV (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208031,300 Cedar St, New Haven, CT 06510 USA.; Kim, BS (corresponding author), Univ Spital Zurich, Klin Plast Chirurg & Handchirurg, Ramistr 100, CH-8091 Zurich, Switzerland.	bong-sung.kim@usz.ch; pathricia.tilstam@yale.edu	Kim, Bong-Sung/AAR-3802-2021; Lindenblatt, Nicole/O-6708-2016; Frueh, Florian S./R-5012-2019; Storti, Gabriele/AAA-6683-2022	Lindenblatt, Nicole/0000-0003-0293-1004; Frueh, Florian S./0000-0003-0904-9591; Storti, Gabriele/0000-0001-7147-9854; Leng, Lin/0000-0002-0605-358X; Kim, Bong-Sung/0000-0002-0493-3196	Deutsche Forschungsgemeinschaft [SCHU2851/1-1, KI1973/1-1, KI1973/2-1, SFB 1123/A03, BE1977/7-1, BE1977/11-1]; START program [AR049610, HL130669]; Arthritis Foundation [548970]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START program(Austrian Science Fund (FWF)); Arthritis Foundation	Deutsche Forschungsgemeinschaft, Grant/Award Number: SCHU2851/1-1, KI1973/1-1, KI1973/2-1, SFB 1123/A03, BE1977/7-1 and BE1977/11-1; START program, Grant/Award Number: AR049610 and HL130669; Arthritis Foundation, Grant/Award Number: 548970	Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; Bainbridge P, 2013, J WOUND CARE, V22, P407; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164; Cassado AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00225; Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1; Dickerson RN, 2013, CRIT CARE, V17, DOI 10.1186/cc12715; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Finucane OM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113369; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gabhann JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085834; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Hecker A, 2019, LANGENBECK ARCH SURG, V404, P257, DOI 10.1007/s00423-019-01752-7; Heinrichs D, 2014, FASEB J, V28, P5136, DOI 10.1096/fj.14-256776; Hillenbrand A, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-26; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Ishimoto K, 2012, CYTOKINE, V60, P772, DOI 10.1016/j.cyto.2012.07.037; Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Kim BS, 2017, J CELL MOL MED, V21, P35, DOI 10.1111/jcmm.12936; Kim BS, 2016, BURNS, V42, P1265, DOI 10.1016/j.burns.2016.02.005; Kim BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137366; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Kolyva AS, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.34; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Moustaid N, 1996, J NUTR, V126, P865, DOI 10.1093/jn/126.4.865; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pepper DJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1360-z; Pierpont Yvonne N, 2014, ISRN Obes, V2014, P638936, DOI 10.1155/2014/638936; Qi DK, 2014, J CLIN INVEST, V124, P3540, DOI 10.1172/JCI73061; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; Roger T, 2001, J ENDOTOXIN RES, V7, P456, DOI 10.1177/09680519010070061101; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Sommer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073992; Van Cromphaut SJ, 2008, CURR PHARM DESIGN, V14, P1887, DOI 10.2174/138161208784980563; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wang SC, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0405-4; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080	57	14	14	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4219	4233		10.1096/fj.201901511R	http://dx.doi.org/10.1096/fj.201901511R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961019	Bronze, Green Accepted			2022-12-26	WOS:000508663100001
J	Miki, T; Kondol, Y; Takebayashi, T; Takasaki, H				Miki, Takahiro; Kondol, Yu; Takebayashi, Tsuneo; Takasaki, Hiroshi			Difference between physical therapist estimation and psychological patient-reported outcome measures in patients with low back pain	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; PSYCHOMETRIC PROPERTIES; MUSCULOSKELETAL PAIN; JAPANESE VERSION; TAMPA SCALE; DISABILITY; QUESTIONNAIRE; KINESIOPHOBIA; ASSOCIATION; DEPRESSION	Minimizing the number of patient-reported outcome measures (PROMs) can reduce patient burden. The primary aim of the present study was to investigate whether physical therapists (PTs) can estimate psychological PROM scores in patients with low back pain (LBP) through physical therapy evaluation. The secondary aims were; 1) to investigate whether the clinical experiences of PTs influence correlations between PT estimates and psychological PROM scores, and 2) to investigate the sensitivity and specificity of PT estimates for the psychological features detected by the PROMs. We recruited hospitalized patients owing to LBP, who underwent evaluation by PTs on the initial day of hospitalization. Patients completed PROMs, including the Pain Catastrophizing Scale (PCS), Tampa Scale for Kinesiophobia, and Hospital Anxiety and Depression Scale immediately before the initial physical therapy session. PTs rated the magnitude of patient kinesiophobia, pain catastrophizing, anxiety, and depression using an 11-point numerical rating scale (NRS; 0 = not detected at all, 10 = very highly detected) through physical therapy evaluation immediately after the initial session. The PTs were blinded to the PROM results. We categorized PTs into two subgroups (PTs with >= 4 years and those with < 4 years of clinical experience). Data from 78 patients (mean [SD] age = 60.5 [16.3] years) and 21 PTs were analyzed. A statistically significant but weak correlation (P =.04, Spearman's rho =.24) was detected only in the total PCS scores and PT NRS scores in a dataset of all patients and PTs. Further, there were no statistically significant differences in correlations (all P >. 05) between the two subgroups of PTs in all measures. Low sensitivity and high specificity of PT estimates for psychological features through physical therapy evaluation were identified in all PROMs when PT NRS scores were categorized into the binary score by 5 (negative: < 5; positive:>= 5).	[Miki, Takahiro; Kondol, Yu] Sapporo Maruyama Orthoped Hosp, Dept Rehabil, Sapporo, Hokkaido, Japan; [Takebayashi, Tsuneo] Sapporo Maruyama Orthoped Hosp, Dept Orthoped, Sapporo, Hokkaido, Japan; [Takasaki, Hiroshi] Saitama Prefectural Univ, Dept Phys Therapy, Koshigaya, Saitama, Japan		Takasaki, H (corresponding author), Saitama Prefectural Univ, Dept Phys Therapy, Koshigaya, Saitama, Japan.	physical.therapy.takasaki@gmail.com		Miki, Takahiro/0000-0002-0648-2675				Al-Obaidi SM, 2003, INT J REHABIL RES, V26, P101, DOI 10.1097/00004356-200306000-00004; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Beales D, 2016, MANUAL THER, V23, P48, DOI 10.1016/j.math.2016.03.010; Calley D, 2010, J ORTHOP SPORT PHYS, V40, P774, DOI 10.2519/jospt.2010.3381; Daykin AR, 2004, SPINE, V29, P783, DOI 10.1097/01.BRS.0000115135.19082.97; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; Gardner T, 2017, J PHYSIOTHER, V63, P132, DOI 10.1016/j.jphys.2017.05.017; Haggman S, 2004, PHYS THER, V84, P1157, DOI 10.1093/ptj/84.12.1157; Janssen MF, 2008, QUAL LIFE RES, V17, P463, DOI 10.1007/s11136-008-9318-5; Jellema P, 2005, PAIN, V118, P350, DOI 10.1016/j.pain.2005.09.002; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Kikuchi N, 2015, J ORTHOP SCI, V20, P985, DOI 10.1007/s00776-015-0751-3; Latimer J, 2004, CLIN J PAIN, V20, P45, DOI 10.1097/00002508-200401000-00009; Learman KE, 2014, PHYS THER, V94, P934, DOI 10.2522/ptj.20130567; Matsudaira K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152019; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; Matsuoka H., 2007, SHINSHIN IGAKU, V47, P95, DOI DOI 10.15064/jjpm.47.2_95; Melloh M, 2011, OCCUP MED-OXFORD, V61, P127, DOI 10.1093/occmed/kqq194; Nishigami T, 2017, J ORTHOP SCI, V22, P351, DOI 10.1016/j.jos.2016.11.015; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Reme SE, 2011, EUR J PAIN, V15, P1075, DOI 10.1016/j.ejpain.2011.04.012; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Shiroiwa T, 2016, VALUE HEALTH, V19, P648, DOI 10.1016/j.jval.2016.03.1834; Springer S, 2018, ISR J HEALTH POLICY, V7, DOI 10.1186/s13584-018-0266-4; Sullivan MJL, 2009, PHRONEMA, P1; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Takasaki H., 2014, OPEN J THERAPY REHAB, V02, P173, DOI [10.4236/ojtr.2014.24023, DOI 10.4236/OJTR.2014.24023]; Takasaki Hiroshi, 2017, J Phys Ther Sci, V29, P1409, DOI 10.1589/jpts.29.1409; Takasaki Hiroshi PhD, 2016, Phys Ther Res, V19, P58; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WCPT.org, 2019, JAP PROF PROF 2019; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227999	10.1371/journal.pone.0227999	http://dx.doi.org/10.1371/journal.pone.0227999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5QJ	31961900	Green Published, gold			2022-12-26	WOS:000534372000023
J	Winker, C; Rehbein, MA; Sabatinelli, D; Junghofer, M				Winker, Constantin; Rehbein, Maimu A.; Sabatinelli, Dean; Junghofer, Markus			Repeated noninvasive stimulation of the ventromedial prefrontal cortex reveals cumulative amplification of pleasant compared to unpleasant scene processing: A single subject pilot study	PLOS ONE			English	Article							SELECTIVE VISUAL-ATTENTION; BRAIN; PLEASURE	The ventromedial prefrontal cortex (vmPFC) is a major hub of the reward system and has been shown to activate specifically in response to pleasant / rewarding stimuli. Previous studies demonstrate enhanced pleasant cue reactivity after single applications of transcranial direct current stimulation (tDCS) to the vmPFC. Here we present a pilot case study in which we assess the cumulative impact of multiple consecutive vmPFC-tDCS sessions on the processing of visual emotional stimuli in an event-related MEG recording design. The results point to stable modulation of increased positivity biases (pleasant > unpleasant stimulus signal strength) after excitatory vmPFC stimulation and a reversed pattern (pleasant < unpleasant) after inhibitory stimulation across five consecutive tDCS sessions. Moreover, cumulative effects of these emotional bias modulations were observable for several sourcelocalized spatio-temporal clusters, suggesting an increase in modulatory efficiency by repeated tDCS sessions. This pilot study provides evidence for improvements in the effectiveness and utility of a novel tDCS paradigm in the context of emotional processing.	[Winker, Constantin; Rehbein, Maimu A.; Junghofer, Markus] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Winker, Constantin; Rehbein, Maimu A.; Junghofer, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany; [Sabatinelli, Dean] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Sabatinelli, Dean] Univ Georgia, BioImaging Res Ctr, Athens, GA 30602 USA	University of Munster; University of Munster; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Junghofer, M (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.; Junghofer, M (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany.	markus.junghoefer@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986; sabatinelli, dean/0000-0001-7409-8504	Interdisciplinary Center for Clinical Research of the University of Muenster [Ju2/024/15]; Collaborative Research Center [SFB-TRR58/C08]	Interdisciplinary Center for Clinical Research of the University of Muenster; Collaborative Research Center	This work was funded by the Interdisciplinary Center for Clinical Research of the University of Muenster (Ju2/024/15) and the Collaborative Research Center (SFB-TRR58/C08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend R, 2019, NEUROMODULATION, V22, P884, DOI 10.1111/ner.12787; Alonzo A, 2012, BRAIN STIMUL, V5, P208, DOI 10.1016/j.brs.2011.04.006; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Chib VS, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.44; Costa VD, 2010, HUM BRAIN MAPP, V31, P1446, DOI 10.1002/hbm.20948; Denny BT, 2014, EMOTION, V14, P425, DOI 10.1037/a0035276; Dittert N, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00076; Greenberg T, 2013, DEPRESS ANXIETY, V30, P242, DOI 10.1002/da.22016; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Junghofer M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00179; Junghofer M, 2017, CEREB CORTEX, V27, P3449, DOI 10.1093/cercor/bhx073; Keuper K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070788; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Laeger I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109949; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Li FH, 2018, BIOL PSYCHOL, V136, P57, DOI 10.1016/j.biopsycho.2018.05.013; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Monte-Silva K, 2010, J NEUROPHYSIOL, V103, P1735, DOI 10.1152/jn.00924.2009; Mungee A, 2014, NEUROREPORT, V25, P480, DOI 10.1097/WNR.0000000000000119; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Sabatinelli D, 2015, BRAIN CONNECT, V5, P1, DOI 10.1089/brain.2013.0186; Schindler S, 2016, HUM BRAIN MAPP, V37, P3575, DOI 10.1002/hbm.23261; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Steinberg C, 2012, J COGNITIVE NEUROSCI, V24, P17, DOI 10.1162/jocn_a_00067; van 't Wout M, 2016, BRAIN STIMUL, V9, P531, DOI 10.1016/j.brs.2016.03.004; Winker C, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00083; Winker C, 2018, NEUROIMAGE, V175, P388, DOI 10.1016/j.neuroimage.2018.03.067	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0222057	10.1371/journal.pone.0222057	http://dx.doi.org/10.1371/journal.pone.0222057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961881	Green Published, gold, Green Submitted			2022-12-26	WOS:000534372000003
J	De-Souza, EA; Pimentel, FSA; De-Queiroz, ALFV; Camara, H; Felix-Formiga, ML; Machado, CM; Pinto, S; Galina, A; Mori, MA; Montero-Lomeli, M; Masuda, CA				De-Souza, Evandro A.; Pimentel, Felipe S. A.; De-Queiroz, Ana Luiza F. V.; Camara, Henrique; Felix-Formiga, Mikaella L.; Machado, Caio M.; Pinto, Silas; Galina, Antonio; Mori, Marcelo A.; Montero-Lomeli, Monica; Masuda, Claudio A.			The yeast protein Ubx4p contributes to mitochondrial respiration and lithium?galactose?mediated activation of the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; galactose; mitochondria; endoplasmic reticulum stress (ER stress); endoplasmic reticulum?associated protein degradation (ERAD); Caenorhabditis elegans (C; elegans); ASPS-1; ASPSCR1; galactosemia; lithium	ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CALCIUM HOMEOSTASIS; ELECTRON-TRANSPORT; CA2+ HOMEOSTASIS; GENE-EXPRESSION; ER STRESS; LIFE-SPAN; LITHIUM	In the presence of galactose, lithium ions activate the unfolded protein response (UPR) by inhibiting phosphoglucomutase activity and causing the accumulation of galactose-related metabolites, including galactose-1-phosphate. These metabolites also accumulate in humans who have the disease classic galactosemia. Here, we demonstrate that Saccharomyces cerevisiae yeast strains harboring a deletion of UBX4, a gene encoding a partner of Cdc48p in the endoplasmic reticulum?associated degradation (ERAD) pathway, exhibit delayed UPR activation after lithium and galactose exposure because the deletion decreases galactose-1-phosphate levels. The delay in UPR activation did not occur in yeast strains in which key ERAD or proteasomal pathway genes had been disrupted, indicating that the ubx4? phenotype is ERAD-independent. We also observed that the ubx4? strain displays decreased oxygen consumption. The inhibition of mitochondrial respiration was sufficient to diminish galactose-1-phosphate levels and, consequently, affects UPR activation. Finally, we show that the deletion of the AMP-activated protein kinase ortholog?encoding gene SNF1 can restore the oxygen consumption rate in ubx4? strain, thereby reestablishing galactose metabolism, UPR activation, and cellular adaption to lithium?galactose challenge. Our results indicate a role for Ubx4p in yeast mitochondrial function and highlight that mitochondrial and endoplasmic reticulum functions are intertwined through galactose metabolism. These findings also shed new light on the mechanisms of lithium action and on the pathophysiology of galactosemia.	[De-Souza, Evandro A.; Pimentel, Felipe S. A.; De-Queiroz, Ana Luiza F. V.; Felix-Formiga, Mikaella L.; Machado, Caio M.; Montero-Lomeli, Monica; Masuda, Claudio A.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Galina, Antonio] Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Camara, Henrique; Pinto, Silas; Mori, Marcelo A.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Inst Biol, BR-13083970 Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual de Campinas	Masuda, CA (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.	cmasuda@bioqmed.ufrj.br	de Souza, Evandro Araujo/G-3696-2014; Masuda, Claudio Akio/F-7214-2014	de Souza, Evandro Araujo/0000-0002-9080-3864; Masuda, Claudio Akio/0000-0002-0310-7108; Seixas, Felipe/0000-0002-4753-8612; Camara, Henrique/0000-0001-7300-1416; Pinto, Silas/0000-0003-0894-8915	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants [E-26/203.203/2015, E-26/010.000837/2016]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2017/01184-9, 17/04377-2, 17/01339-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro fellowship [E-26/200.790/2019]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro fellowship	This work was supported by research grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants E-26/203.203/2015 (to M. M.-L.) and E-26/010.000837/2016 (to C. A. M.); and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2017/01184-9 (to M. A. M.). This work was also supported in part by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico fellowships (to E. A. D.-S., F. S. A. P., A. L. F. V. D.-Q., C. M. M., and M. L. F.-F.), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro fellowship E-26/200.790/2019 (to E. A. D.-S.), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo fellowships 17/04377-2 (to S. P.) and 17/01339-2 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aiello DP, 2004, J BIOL CHEM, V279, P38495, DOI 10.1074/jbc.M400833200; Aiello DP, 2002, J BIOL CHEM, V277, P45751, DOI 10.1074/jbc.M208748200; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Balakrishnan B, 2016, BIOCHEM BIOPH RES CO, V470, P205, DOI 10.1016/j.bbrc.2016.01.036; Berry G. T., 2017, CLASSIC GALACTOSEMIA; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Bozaquel-Morais BL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169682; Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; BRENNER S, 1974, GENETICS, V77, P71; Bro C, 2003, J BIOL CHEM, V278, P32141, DOI 10.1074/jbc.M304478200; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chien CY, 2013, J BIOL CHEM, V288, P37180, DOI 10.1074/jbc.M113.513598; CLARKE CF, 1991, J BIOL CHEM, V266, P16636; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Csutora P, 2005, AM J PHYSIOL-CELL PH, V289, pC58, DOI 10.1152/ajpcell.00464.2004; De-Souza EA, 2014, DIS MODEL MECH, V7, P55, DOI 10.1242/dmm.012641; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Ferreira JR, 2006, BIOCHEM BIOPH RES CO, V339, P30, DOI 10.1016/j.bbrc.2005.11.003; Fridovich-Keil JL, 2006, J CELL PHYSIOL, V209, P701, DOI 10.1002/jcp.20820; Fu LW, 2000, J BIOL CHEM, V275, P5431, DOI 10.1074/jbc.275.8.5431; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Habtemichael E. N., 2019, INSULIN STIMULATED P, DOI [10.1101/817049, DOI 10.1101/817049]; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Izawa T, 2017, CELL, V171, P890, DOI 10.1016/j.cell.2017.10.002; Jelicic B, 2005, FEMS MICROBIOL LETT, V253, P207, DOI 10.1016/j.femsle.2005.09.033; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Knupp J, 2019, CELL DEATH DIFFER, V26, P487, DOI 10.1038/s41418-018-0133-4; Lai K, 2014, FUTURE MED CHEM, V6, P1003, DOI [10.4155/fmc.14.43, 10.4155/FMC.14.43]; Li Y, 2010, MOL MICROBIOL, V78, P414, DOI 10.1111/j.1365-2958.2010.07343.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado CM, 2017, BBA-MOL BASIS DIS, V1863, P1403, DOI 10.1016/j.bbadis.2017.02.014; Madsen L, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-31; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Martensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y; Masuda CA, 2001, J BIOL CHEM, V276, P37794; Masuda CA, 2008, FEMS YEAST RES, V8, P1245, DOI 10.1111/j.1567-1364.2008.00440.x; Mizuno T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005491; Nagy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070410; Nicastro R, 2015, BBA-MOL CELL RES, V1853, P1615, DOI 10.1016/j.bbamcr.2015.03.014; NORAIS N, 1991, J BIOL CHEM, V266, P16541; Osman C, 2015, P NATL ACAD SCI USA, V112, pE947, DOI 10.1073/pnas.1501737112; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pinto S, 2018, REDOX BIOL, V18, P84, DOI 10.1016/j.redox.2018.06.006; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rendon OZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04564-3; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Simoes T, 2018, ELIFE, V7, DOI 10.7554/eLife.30015; Slepak TI, 2007, MOL GENET METAB, V92, P78, DOI 10.1016/j.ymgme.2007.06.005; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Torelli NQ, 2015, FREE RADICAL BIO MED, V81, P30, DOI 10.1016/j.freeradbiomed.2014.12.025; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Wu ZY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0615-3; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200	69	1	1	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3773	3782		10.1074/jbc.RA119.011271	http://dx.doi.org/10.1074/jbc.RA119.011271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	31996377	Green Published, hybrid			2022-12-26	WOS:000527704400005
J	Baek, Y; Kim, J; Ahn, J; Jo, I; Hong, S; Ryu, S; Ha, NC				Baek, Yeongjin; Kim, Jinwoo; Ahn, Jinsook; Jo, Inseong; Hong, Seokho; Ryu, Sangryeol; Ha, Nam-Chul			Structure and function of the hypochlorous acid?induced flavoprotein RclA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavoprotein; copper; crystal structure; nicotinamide adenine dinucleotide (NADH); disulfide; oxidative stress; macrophage; flavoprotein disulfide reductase; hypochlorous acid; innate immune response; oxygen; RclA	X-RAY; TRANSCRIPTION FACTOR; REDUCTASE; PROTEIN; MECHANISMS; OXIDATION; OXIDASE; HG2+	In response to microbial invasion, the animal immune system generates hypochlorous acid (HOCl) that kills microorganisms in the oxidative burst. HOCl toxicity is amplified in the phagosome through import of the copper cation (Cu2+). In Escherichia coli and Salmonella, the transcriptional regulator RclR senses HOCl stress and induces expression of the RclA, -B, and -C proteins involved in bacterial defenses against oxidative stress. However, the structures and biochemical roles of the Rcl proteins remain to be elucidated. In this study, we first examined the role of the flavoprotein disulfide reductase (FDR) RclA in the survival of Salmonella in macrophage phagosomes, finding that RclA promotes Salmonella survival in macrophage vacuoles containing sublethal HOCl levels. To clarify the molecular mechanism, we determined the crystal structure of RclA from E. coli at 2.9 ? resolution. This analysis revealed that the structure of homodimeric RclA is similar to those of typical FDRs, exhibiting two conserved cysteine residues near the flavin ring of the cofactor flavin adenine dinucleotide (FAD). Of note, we observed that Cu2+ accelerated RclA-mediated oxidation of NADH, leading to a lowering of oxygen levels in vitro. Compared with the RclA WT enzyme, substitution of the conserved cysteine residues lowered the specificity to Cu2+ or substantially increased the production of superoxide anion in the absence of Cu2+. We conclude that RclA-mediated lowering of oxygen levels could contribute to the inhibition of oxidative bursts in phagosomes. Our study sheds light on the molecular basis for how bacteria can survive HOCl stress in macrophages.	[Baek, Yeongjin; Kim, Jinwoo; Ahn, Jinsook; Jo, Inseong; Hong, Seokho; Ryu, Sangryeol; Ha, Nam-Chul] Seoul Natl Univ, Ctr Food Safety & Toxicol, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul 08826, South Korea; [Baek, Yeongjin; Kim, Jinwoo; Ahn, Jinsook; Jo, Inseong; Hong, Seokho; Ryu, Sangryeol; Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, CALS, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ha, NC (corresponding author), Seoul Natl Univ, Ctr Food Safety & Toxicol, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul 08826, South Korea.	hanc210@snu.ac.kr	Hong, Seokho/AGZ-9428-2022; Jo, Inseong/AGY-9957-2022; Ahn, Jinsook/AAE-5827-2022	Hong, Seokho/0000-0003-4603-8445; Jo, Inseong/0000-0002-7964-4751; Kim, Jinwoo/0000-0002-3397-1247	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) [710012-03-1HD120]; National Research Foundation of Korea [NRF-2017R1A2B2003992]; Korean Government (MSIT) [NRF-2019M3E5D6063871]; ARC Program - Ministry of Agriculture, Food, and Rural Affairs	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET); National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MSIT)(Korean Government); ARC Program - Ministry of Agriculture, Food, and Rural Affairs	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) Grant 710012-03-1HD120, the ARC Program (to N. C. H.) funded by the Ministry of Agriculture, Food, and Rural Affairs, National Research Foundation of Korea Grant NRF-2017R1A2B2003992 (to N. C. H.), and by Korean Government (MSIT) Grant NRF-2019M3E5D6063871.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Angiulli G, 2015, BBA-GEN SUBJECTS, V1850, P1891, DOI 10.1016/j.bbagen.2015.05.022; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Derke RM., 2019, MICROBIOLOGY, DOI [10.1101/690669, DOI 10.1101/690669]; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jo I, 2019, P NATL ACAD SCI USA, V116, P3740, DOI 10.1073/pnas.1811509116; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Ledwidge R, 2005, BIOCHEMISTRY-US, V44, P11402, DOI 10.1021/bi050519d; 신웅희, 2014, Biodesign, V2, P1; Lian P, 2014, BIOCHEMISTRY-US, V53, P7211, DOI 10.1021/bi500608u; LIOCHEV SI, 1992, ARCH BIOCHEM BIOPHYS, V294, P403, DOI 10.1016/0003-9861(92)90703-Y; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; Murakami K, 2014, BIOMETALS, V27, P551, DOI 10.1007/s10534-014-9731-x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park Suk-Youl, 2017, Biodesign, V5, P30; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; RAY S, 1989, J BIOSCIENCE, V14, P173, DOI 10.1007/BF02703169; RENNEX D, 1994, FEBS LETT, V355, P220, DOI 10.1016/0014-5793(94)01180-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; WEISS SJ, 1982, LAB INVEST, V47, P5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827	36	9	9	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3202	3212		10.1074/jbc.RA119.011530	http://dx.doi.org/10.1074/jbc.RA119.011530			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988242	hybrid, Green Published			2022-12-26	WOS:000519597300025
J	Bogenhagen, DF; Haley, JD				Bogenhagen, Daniel F.; Haley, John D.			Pulse-chase SILAC?based analyses reveal selective oversynthesis and rapid turnover of mitochondrial protein components of respiratory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial respiratory chain complex; protein assembly; proteomics; protein synthesis; protein dynamics; NADH dehydrogenase; oxidative phosphorylation system; stable isotope labeling with amino acids in cell culture (SILAC); mitochondrial biogenesis; respiratory complex assembly; protein turnover	ACYL-CARRIER PROTEIN; SUBUNIT; ARCHITECTURE; TRANSLATION; BIOGENESIS; SYNTHASE	Mammalian mitochondria assemble four complexes of the respiratory chain (RCI, RCIII, RCIV, and RCV) by combining 13 polypeptides synthesized within mitochondria on mitochondrial ribosomes (mitoribosomes) with over 70 polypeptides encoded in nuclear DNA, translated on cytoplasmic ribosomes, and imported into mitochondria. We have previously observed that mitoribosome assembly is inefficient because some mitoribosomal proteins are produced in excess, but whether this is the case for other mitochondrial assemblies such as the RCs is unclear. We report here that pulse-chase stable isotope labeling with amino acids in cell culture (SILAC) is a valuable technique to study RC assembly because it can reveal considerable differences in the assembly rates and efficiencies of the different complexes. The SILAC analyses of HeLa cells indicated that assembly of RCV, comprising F-1/F-o-ATPase, is rapid with little excess subunit synthesis, but that assembly of RCI (i.e. NADH dehydrogenase) is far less efficient, with dramatic oversynthesis of numerous proteins, particularly in the matrix-exposed N and Q domains. Unassembled subunits were generally degraded within 3 h. We also observed differential assembly kinetics for individual complexes that were immunoprecipitated with complex-specific antibodies. Immunoprecipitation with an antibody that recognizes the ND1 subunit of RCI co-precipitated a number of proteins implicated in FeS cluster assembly and newly synthesized ubiquinol-cytochrome c reductase Rieske iron-sulfur polypeptide 1 (UQCRFS1), the Rieske FeS protein in RCIII, reflecting some coordination between RCI and RCIII assemblies. We propose that pulse-chase SILAC labeling is a useful tool for studying rates of protein complex assembly and degradation.	[Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Haley, John D.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Haley, John D.] SUNY Stony Brook, Prote Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu		Haley, John/0000-0002-0283-6413; Bogenhagen, Daniel/0000-0002-9993-2574	National Institutes of Health [1R01 GM112790, PI-15-151]; United Mitochondrial Disease Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation	This work was supported by National Institutes of Health Grant 1R01 GM112790 and by Research Grant PI-15-151 (to D. F. B.) from the United Mitochondrial Disease Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bogenhagen DF, 2018, CELL REP, V22, P1935, DOI 10.1016/j.celrep.2018.01.066; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Boniecki MT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01497-1; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Dibley MG, 2020, MOL CELL PROTEOMICS, V19, P65, DOI 10.1074/mcp.RA119.001784; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; HUBER PJ, 1973, ANN STAT, V1, P799, DOI 10.1214/aos/1176342503; Isaac RS, 2018, ANNU REV GENET, V52, P511, DOI 10.1146/annurev-genet-120417-031709; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036; Nowinski SM, 2018, CURR BIOL, V28, pR1212, DOI 10.1016/j.cub.2018.08.022; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Snider J, 2019, ADV EXP MED BIOL, V1140, P575, DOI 10.1007/978-3-030-15950-4_34; Stoldt S, 2018, NAT CELL BIOL, V20, P528, DOI 10.1038/s41556-018-0090-7; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zong S, 2018, CELL RES, V28, P1026, DOI 10.1038/s41422-018-0071-1	37	24	24	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2544	2554		10.1074/jbc.RA119.011791	http://dx.doi.org/10.1074/jbc.RA119.011791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31974161	hybrid, Green Published			2022-12-26	WOS:000519969100001
J	Hartel, JA; Herberg, U; Jung, T; Winkler, C; Breuer, J; Muller, N				Haertel, Julian Alexander; Herberg, Ulrike; Jung, Thomas; Winkler, Christian; Breuer, Johannes; Mueller, Nicole			Physical activity and heart rate monitoring in Fontan patients - Should we recommend activities in higher intensities?	PLOS ONE			English	Article							QUALITY-OF-LIFE; EXERCISE CAPACITY; CIRCULATION; TOLERANCE; CHILDREN; ADULTS	Objective Exercise capacity is impaired in Fontan palliated patients. The change in daily activity behaviour with an increase in sedentary lifestyle results in low physical activity levels. This might have a greater impact on patients with chronic heart disease in contrast to healthy controls. For a better understanding, we compared data from cardiopulmonary exercise testing (CPET) with heart rates and physical activity in daily life. Methods 21 Fontan patients and 20 age, sex and BMI matched controls underwent CPET and 5 days of daily life activity tracking with a triaxial accelerometer (wGT3x-BT, Actigraph) including heart rate monitoring with an optical heart rate sensor. Results 27% of our Fontan teenagers and 71% of the Fontan adults reached the specific WHO recommendations for moderate to vigorous physical activity (MVPA) during everyday life (EDL), without differences to controls. There was a strong correlation between MVPA and (C)overdot(2peak) for all Fontan patients (p = 0.0035, Pearson r = 0.788). Daily MVPA correlated to peak oxygen uptake and lactate production. Up to workloads of 2 W/kg and in daily life heart rates in Fontan patients were similar to controls. Conclusions Daily MVPA is alarmingly low without any differences between Fontan patients and controls. Heart rate behaviour was similar and does not seem to be a limiting factor for physical activity in daily life. Higher intensity activities should be implemented regularly in EDL for Fontan patients. Proof is needed as to whether sports in moderate or possibly even in vigorous activity (e.g. high-intensity interval training) improve exercise capacity the most.	[Haertel, Julian Alexander; Herberg, Ulrike; Jung, Thomas; Winkler, Christian; Breuer, Johannes; Mueller, Nicole] Univ Hosp Bonn, Dept Paediat Cardiol, Bonn, Germany	University of Bonn	Hartel, JA (corresponding author), Univ Hosp Bonn, Dept Paediat Cardiol, Bonn, Germany.	Julian.Haertel@ukbonn.de	Herberg, Ulrike/AAY-2952-2021	Herberg, Ulrike/0000-0002-9386-0258; Hartel, Julian Alexander/0000-0003-0852-2850; Mueller, Nicole/0000-0001-9211-9209; Jung, Thomas/0000-0002-9971-9212	KinderHerzInnovationspreis NRW 2016	KinderHerzInnovationspreis NRW 2016	The study was funded by "KinderHerzInnovationspreis NRW 2016." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134606; Brassard P, 2006, CAN J CARDIOL, V22, P489, DOI 10.1016/S0828-282X(06)70266-5; Chu AHY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172535; Cordina R, 2013, HEART, V99, P1788, DOI 10.1136/heartjnl-2013-304249corr1; Cordina R, 2019, CURR OPIN CARDIOL, V34, P79, DOI 10.1097/HCO.0000000000000582; Cordina RL, 2013, INT J CARDIOL, V168, P780, DOI 10.1016/j.ijcard.2012.10.012; DRISCOLL DJ, 1986, J AM COLL CARDIOL, V7, P1087, DOI 10.1016/S0735-1097(86)80227-3; Duppen N, 2015, AM HEART J, V170, P606, DOI 10.1016/j.ahj.2015.06.018; Finger Jonas D, 2018, J Health Monit, V3, P23, DOI 10.17886/RKI-GBE-2018-023.2; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Goldberg DJ, 2013, CARDIOL YOUNG, V23, P824, DOI 10.1017/S1047951113001649; Greutmann M, 2011, HEART, V97, P1164, DOI 10.1136/hrt.2010.213579; Hager A, 2011, LEITLINIE PADIATRISC; Hedlund ER, 2018, CARDIOL YOUNG, V28, P438, DOI 10.1017/S1047951117002360; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hollmann W, 2009, SPORTMEDIZIN GRUNDLA, P320; Joshi VM, 1997, PEDIATR CARDIOL, V18, P357, DOI 10.1007/s002469900199; Lee JA, 2015, J SPORT SCI, V33, P991, DOI 10.1080/02640414.2014.981848; Lindinger A, 2010, KLIN PADIATR, V222, P321, DOI 10.1055/s-0030-1254155; McCrindle BW, 2007, ARCH DIS CHILD, V92, P509, DOI 10.1136/adc.2006.105239; Muller J, 2012, CLIN RES CARDIOL, V101, P55, DOI 10.1007/s00392-011-0364-6; Muller J, 2009, EUR HEART J, V30, P2915, DOI 10.1093/eurheartj/ehp305; Ohuchi H, 2015, CONGENIT HEART DIS, V10, P105, DOI 10.1111/chd.12222; Shafer KM, 2012, J AM COLL CARDIOL, V60, P2115, DOI 10.1016/j.jacc.2012.08.970; Such U., 2010, DTSCH Z F UR SPORTME, V61, P310; Sutherland N, 2015, HEART LUNG CIRC, V24, P753, DOI 10.1016/j.hlc.2015.03.005; Takken T, 2007, J CARDIOVASC MED, V8, P775, DOI 10.2459/JCM.0b013e328011c999; Troutman WB, 1998, J AM COLL CARDIOL, V31, P668, DOI 10.1016/S0735-1097(97)00545-7; Turquetto ALR, 2017, PEDIATR CARDIOL, V38, P981, DOI 10.1007/s00246-017-1606-9; World Health Organization, 2011, GLOB REC PHYS ACT HL	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0228255	10.1371/journal.pone.0228255	http://dx.doi.org/10.1371/journal.pone.0228255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999694	Green Published, gold			2022-12-26	WOS:000534612400059
J	Hadj-Abo, A; Enge, S; Rose, J; Kunte, H; Fleischhauer, M				Hadj-Abo, Alexander; Enge, Soeren; Rose, Joern; Kunte, Hagen; Fleischhauer, Monika			Individual differences in impulsivity and need for cognition as potential risk or resilience factors of diabetes self-management and glycemic control	PLOS ONE			English	Article							EFFICACY MEDIATE; DISPOSITIONAL DIFFERENCES; PERSONALITY-TRAITS; HEALTH LITERACY; CARE BEHAVIORS; MELLITUS; ADULTS; TYPE-1; COMPLICATIONS; ASSOCIATION	Objective Impulsivity is marked by insufficient reflection and forethought, whereas Need for Cognition (NFC) also referred to as cognitive motivation or intellectual engagement is marked by elaborated thinking. The aim of this study was to investigate the potential role of these personality traits as resilience or risk factors, respectively, in diabetes self-management and glycaemic control. Further, it was examined whether diabetes-specific self-efficacy could serve as a mediator of these relationships. Design/Measures Data of 77 participants with type 2 diabetes was ascertained, using self-report instruments for NFC, impulsivity, diabetes-specific self-efficacy, and diabetes self-management. Glycemic control was assessed by the biomarker HbA(1c). Results While NFC was strongly positively associated with diabetes self-management and glycemic control, impulsivity showed a reverse pattern. Results of simple and serial mediation models showed that the effects on diabetes self-management and HbA(1c) of both, impulsivity and NFC, were mediated by self-efficacy. Conclusion The moderate to high standardized coefficients suggests that NFC might be an important protective factor and impulsivity a possible risk factor for effective diabetes self-management and glycemic control. These traits could be applied for an easy-to-use questionnaire-based patient screening, enabling trait-tailored treatments and programs which in turn may lower economic and health costs associated with poor diabetes-care.	[Hadj-Abo, Alexander; Enge, Soeren; Kunte, Hagen; Fleischhauer, Monika] Med Sch Berlin, Fac Nat Sci, Dept Psychol, Berlin, Germany; [Rose, Joern] Diabet Ctr Berlin, Berlin, Germany		Hadj-Abo, A; Fleischhauer, M (corresponding author), Med Sch Berlin, Fac Nat Sci, Dept Psychol, Berlin, Germany.	alexander.hadj-abo@shk.medicalschool-berlin.de; monika.fleischhauer@medicalschool-berlin.de		, Alexander/0000-0002-5258-7320				Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; Al-Khawaldeh OA, 2012, J DIABETES COMPLICAT, V26, P10, DOI 10.1016/j.jdiacomp.2011.11.002; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], PRIM HLTH CARE RES D, DOI DOI 10.1017/S1463423610000101; Bandura A., 1978, ADV BEHAV RES THER, V1, P139, DOI [10.1016/0146-6402(78)90002-4, DOI 10.1016/0146-6402(78)90002-4]; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Beissert H., 2014, DEUTSCHSPRACHIGE KUR, V2014/32; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bottiroli S, 2014, CLIN GERONTOLOGIST, V37, P91, DOI 10.1080/07317115.2013.868846; Bruno G, 2005, DIABETES CARE, V28, P2613, DOI 10.2337/diacare.28.11.2613; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Celik S, 2015, GEN HOSP PSYCHIAT, V37, P116, DOI 10.1016/j.genhosppsych.2014.11.012; Chen PC, 2013, DIABETES CARE, V36, P376, DOI 10.2337/dc12-0473; Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Costa P. T., 1992, PSYCHOL ASSESSMENT R; Cozma AI, 2012, DIABETES CARE, V35, P1611, DOI 10.2337/dc12-0073; Crow S, 2001, INT J EAT DISORDER, V30, P222, DOI 10.1002/eat.1077; Cukic I, 2016, PERS INDIV DIFFER, V94, P377, DOI 10.1016/j.paid.2016.01.052; de Jonge P, 2014, DIABETOLOGIA, V57, P699, DOI 10.1007/s00125-013-3157-9; Dutton GR, 2009, J BEHAV MED, V32, P270, DOI 10.1007/s10865-009-9200-0; Eckstrand KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189113; Eisenstein SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133621; Enge S, 2008, PERS SOC PSYCHOL B, V34, P862, DOI 10.1177/0146167208315556; Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Field A., 2013, DISCOVERING STAT USI; Fleischhauer M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00420; Fleischhauer M, 2010, PERS SOC PSYCHOL B, V36, P82, DOI 10.1177/0146167209351886; Fransen MP, 2012, PATIENT EDUC COUNS, V88, P44, DOI 10.1016/j.pec.2011.11.015; Goodwin RD, 2006, J BEHAV MED, V29, P229, DOI 10.1007/s10865-006-9048-5; Gullo MJ, 2010, ALCOHOL CLIN EXP RES, V34, P1386, DOI 10.1111/j.1530-0277.2010.01222.x; Hayaki J, 2011, ADDICT BEHAV, V36, P389, DOI 10.1016/j.addbeh.2010.12.018; Holman N, 2014, DIABETIC MED, V31, P510, DOI 10.1111/dme.12397; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jacobs E, 2020, DIABETIC MED, V37, P1723, DOI 10.1111/dme.14100; Jacobs E, 2017, DIABETIC MED, V34, P855, DOI 10.1111/dme.13336; Jarvis J, 2010, DIABETES OBES METAB, V12, P12, DOI 10.1111/j.1463-1326.2009.01098.x; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Kamradt M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0185-1; Kenardy J, 2001, Eat Behav, V2, P183, DOI 10.1016/S1471-0153(01)00028-9; Keweloh WC, 2013, DIABETOL STOFFWECHS, V8, pFV49, DOI [10.1055/s-0033-1341709, DOI 10.1055/S-0033-1341709]; Lee YJ, 2016, PATIENT EDUC COUNS, V99, P287, DOI 10.1016/j.pec.2015.08.021; Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002; Nikoloudakis IA, 2018, HEALTH PSYCHOL REV, V12, P437, DOI 10.1080/17437199.2018.1525571; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370; Preuss UW, 2008, NERVENARZT, V79, P305, DOI 10.1007/s00115-007-2360-7; Rammstedt B., 2012, KURZE SKALA MESSUNG, V2012|23; REID JC, 1995, PATIENT EDUC COUNS, V25, P31, DOI 10.1016/0738-3991(94)00688-I; Richard AA, 2011, J NURS SCHOLARSHIP, V43, P255, DOI 10.1111/j.1547-5069.2011.01404.x; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Semenkovich K, 2015, DRUGS, V75, P577, DOI 10.1007/s40265-015-0347-4; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Shim U, 2014, ACTA DIABETOL, V51, P421, DOI 10.1007/s00592-013-0529-z; Skinner TC, 2014, DIABETIC MED, V31, P487, DOI 10.1111/dme.12339; Smith MA, 2014, J AGING HEALTH, V26, P841, DOI 10.1177/0898264314534896; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; Stupiansky NW, 2013, J PEDIATR PSYCHOL, V38, P247, DOI 10.1093/jpepsy/jss110; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Tregea H, 2016, PSYCHOL HEALTH, V31, P592, DOI 10.1080/08870446.2015.1128543; Tsenkova VK, 2012, PSYCHOTHER PSYCHOSOM, V81, P327, DOI 10.1159/000337413; Tuomilehto J, 1996, STROKE, V27, P210, DOI 10.1161/01.STR.27.2.210; Ulrich S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012527; Venkataraman K, 2012, J COMMUN HEALTH, V37, P653, DOI 10.1007/s10900-011-9496-x; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; World Health Organisation, 2017, FACT SHEET DIAB WORL	72	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227995	10.1371/journal.pone.0227995	http://dx.doi.org/10.1371/journal.pone.0227995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995586	gold, Green Published			2022-12-26	WOS:000534609400036
J	Kim, T; Kim, KS; Suh, GJ; Kwon, WY; Jung, YS; Ko, JI; Shin, SM				Kim, Taegyun; Kim, Kyung Su; Suh, Gil Joon; Kwon, Woon Yong; Jung, Yoon Sun; Ko, Jung-In; Shin, So Mi			Duty cycle of 33% increases cardiac output during cardiopulmonary resuscitation	PLOS ONE			English	Article							ASSOCIATION GUIDELINES UPDATE; BASIC LIFE-SUPPORT; BLOOD-FLOW; SPONTANEOUS CIRCULATION; CHEST COMPRESSIONS; PORCINE MODEL; CORONARY; ARREST; DECOMPRESSION; PRESSURE	Background The aim of this study was to investigate whether 33% duty cycle increases end-tidal carbon dioxide (ETCO2) level, a surrogate measurement for cardiac output during cardiopulmonary resuscitation (CPR), compared with 50% duty cycle. Methods Six pigs were randomly assigned to the DC33 or DC50 group. After 3 min of induced ventricular fibrillation (VF), CPR was performed for 5 min with 33% duty cycle (DC33 group) or with 50% duty cycle (DC50 group) (phase I). Defibrillation was delivered until return of spontaneous circulation (ROSC) thereafter. After 30 min of stabilization, the animals were reassigned to the opposite groups. VF was induced again, and CPR was performed (phase II). The primary outcome was ETCO2 during CPR, and the secondary outcomes were coronary perfusion pressure (CPP), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and right atrial pressure (RAP). Results Mean ETCO2 was higher in the DC33 group compared with the DC50 group (22.5 mmHg vs 21.5 mmHg, P = 0.018). In a linear mixed model, 33% duty cycle increased ETCO2 by 1.0 mmHg compared with 50% duty cycle (P < 0.001). ETCO2 increased over time in the DC33 group [0.6 mmHg/min] while ETCO2 decreased in the DC50 group [-0.6 mmHg/min] (P < 0.001). Duty cycle of 33% increased SAP (6.0 mmHg, P < 0.001), DAP (8.9 mmHg, P < 0.001) RAP (2.6 mmHg, P < 0.001) and CPP (4.7 mmHg, P < 0.001) compared with the duty cycle of 50%. Conclusion Duty cycle of 33% increased ETCO2, a surrogate measurement for cardiac output during CPR, compared with duty cycle of 50%. Moreover, ETCO2 increased over time during CPR with 33% duty cycle while ETCO2 decreased with 50% duty cycle.	[Kim, Taegyun; Kim, Kyung Su; Suh, Gil Joon; Kwon, Woon Yong; Shin, So Mi] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Suh, Gil Joon; Kwon, Woon Yong] Seoul Natl Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Jung, Yoon Sun] Seoul Natl Univ Hosp, Div Crit Care Med, Seoul, South Korea; [Ko, Jung-In] Natl Med Ctr, Dept Emergency Med, Seoul, South Korea; [Ko, Jung-In] Kangwon Natl Univ, Coll Med, Dept Emergency Med, Chuncheon Si, Gangwon Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Kangwon National University	Kim, KS (corresponding author), Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea.	kanesu@gmail.com	Kim, Taegyun/A-8426-2017; Kim, Kyung Su/F-3470-2010	Kim, Taegyun/0000-0002-3770-3944; Kim, Kyung Su/0000-0002-3897-0278; Kwon, Woon Yong/0000-0002-3343-5030	Seoul National University Hospital [0420170380]	Seoul National University Hospital	This work was supported by Seoul National University Hospital (grant number 0420170380), and the grant was given to Gil Joon Suh.	Chalkias A, 2015, SHOCK, V43, P285, DOI 10.1097/SHK.0000000000000285; Cherry Brandon H, 2015, World J Crit Care Med, V4, P1, DOI 10.5492/wjccm.v4.i1.1; DEAN JM, 1991, CIRCULATION, V84, P896, DOI 10.1161/01.CIR.84.2.896; Hartmann C, 2017, CRIT CARE MED, V45, pe1270, DOI 10.1097/CCM.0000000000002767; Jung J, 2017, SPR PROC ADV ROBOT, V1, P266, DOI 10.1007/978-3-319-50115-4_24; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kronick SL, 2015, CIRCULATION, V132, pS397, DOI 10.1161/CIR.0000000000000258; Lampe JW, 2018, RESUSCITATION, V131, P55, DOI 10.1016/j.resuscitation.2018.08.005; Lee HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20062-4; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Niles Dana E, 2011, Resuscitation, V82 Suppl 2, pS23, DOI 10.1016/S0300-9572(11)70147-2; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; SHIBUTANI K, 1994, ANESTH ANALG, V79, P829; Suh GJ, 2018, RESUSCITATION, V127, P119, DOI 10.1016/j.resuscitation.2018.04.011; Sunde K, 1998, RESUSCITATION, V36, P123, DOI 10.1016/S0300-9572(97)00098-1; von Seth M, 2017, SHOCK, V47, P514, DOI 10.1097/SHK.0000000000000761; Wang S, 2013, CRIT CARE MED, V41, P102, DOI 10.1097/CCM.0b013e318265792b; Yannopoulos D, 2005, RESUSCITATION, V64, P363, DOI 10.1016/j.resuscitation.2004.10.009; Zuercher M, 2010, CRIT CARE MED, V38, P1141, DOI 10.1097/CCM.0b013e3181ce1fe2	22	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228111	10.1371/journal.pone.0228111	http://dx.doi.org/10.1371/journal.pone.0228111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990926	Green Published, gold, Green Submitted			2022-12-26	WOS:000534605400041
J	Asadi, S; Wexler, AS; Cappa, CD; Barreda, S; Bouvier, NM; Ristenpart, WD				Asadi, Sima; Wexler, Anthony S.; Cappa, Christopher D.; Barreda, Santiago; Bouvier, Nicole M.; Ristenpart, William D.			Effect of voicing and articulation manner on aerosol particle emission during human speech	PLOS ONE			English	Article							SIZE DISTRIBUTION; AIR-FLOW; TRANSMISSION; INFORMATION; QUANTITY; LANGUAGE; VIRUS	Previously, we demonstrated a strong correlation between the amplitude of human speech and the emission rate of micron-scale expiratory aerosol particles, which are believed to play a role in respiratory disease transmission. To further those findings, here we systematically investigate the effect of different 'phones' (the basic sound units of speech) on the emission of particles from the human respiratory tract during speech. We measured the respiratory particle emission rates of 56 healthy human volunteers voicing specific phones, both in isolation and in the context of a standard spoken text. We found that certain phones are associated with significantly higher particle production; for example, the vowel /i/ ("need," "sea") produces more particles than /a/ ("saw," "hot") or /u/ ("blue," "mood"), while disyllabic words including voiced plosive consonants (e.g., /d/, /b/, /g/) yield more particles than words with voiceless fricatives (e.g., /s/, /h/, /f/). These trends for discrete phones and words were corroborated by the time-resolved particle emission rates as volunteers read aloud from a standard text passage that incorporates a broad range of the phones present in spoken English. Our measurements showed that particle emission rates were positively correlated with the vowel content of a phrase; conversely, particle emission decreased during phrases with a high fraction of voiceless fricatives. Our particle emission data is broadly consistent with prior measurements of the egressive airflow rate associated with the vocalization of various phones that differ in voicing and articulation. These results suggest that airborne transmission of respiratory pathogens via speech aerosol particles could be modulated by specific phonetic characteristics of the language spoken by a given human population, along with other, more frequently considered epidemiological variables.	[Asadi, Sima; Ristenpart, William D.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Air Qual Res Ctr, Davis, CA 95616 USA; [Wexler, Anthony S.; Cappa, Christopher D.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Barreda, Santiago] Univ Calif Davis, Dept Linguist, Davis, CA 95616 USA; [Bouvier, Nicole M.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Bouvier, Nicole M.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ristenpart, WD (corresponding author), Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Ristenpart, William/AAG-4462-2021	Cappa, Christopher/0000-0002-3528-3368; Asadi, Sima/0000-0001-8380-1564	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID/NIH) [R01 AI110703]; National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH) [P30-ES023513]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID/NIH); National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH)	WDR, ASW, and NMB received funding from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID/NIH, https://www.niaid.nih.gov), grant R01 AI110703. ASW received funding from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH, https://www.niehs.nih.gov) for the UC Davis Core Center, grant P30-ES023513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fairbanks G, 1960, VOICE ARTICULATION D; Fairbanks G, 1950, SPEECH MONOGR, V17, P390, DOI 10.1080/03637755009375019; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Inouye S, 2003, LANCET, V362, P170, DOI 10.1016/S0140-6736(03)13874-3; Jennison MW, 1942, AEROBIOLOGY, V17, P106, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1]; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Kaminota M, 2004, LANCET, V363, P571, DOI 10.1016/S0140-6736(04)15557-8; Lee J, 2019, AEROSOL AIR QUAL RES, V19, P840, DOI 10.4209/aaqr.2018.01.0031; Lindsley WG, 2016, INFLUENZA OTHER RESP, V10, P404, DOI 10.1111/irv.12390; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; Maddieson PLaI, 1996, SOUNDS WORLDS LANGUA; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Oldham MJ, 2019, J BREATH RES, V13, DOI 10.1088/1752-7163/ab0524; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Pellegrino F, 2011, LANGUAGE, V87, P539; Reetz H., 2009, PHONETICS TRANSCRIPT; STATHOPOULOS ET, 1985, FOLIA PHONIATR, V37, P152, DOI 10.1159/000265794; Sugihara, 2015, J PHONETIC SOC JAPAN, V19, P43, DOI DOI 10.24467/ONSEIKENKYU.19.3_43; Tang JW, 2015, INDOOR AIR, V25, P119, DOI 10.1111/ina.12175; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wei JJ, 2016, AM J INFECT CONTROL, V44, pS102, DOI 10.1016/j.ajic.2016.06.003; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115	32	86	86	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227699	10.1371/journal.pone.0227699	http://dx.doi.org/10.1371/journal.pone.0227699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986165	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400026
J	Laranjeira, PR; Bronzatti, JAG; Bruna, CQD; de Souza, RQ; Graziano, KU; Lusignan, V				Laranjeira, Paulo Roberto; Gonzalez Bronzatti, Jeane Aparecida; de Moraes Bruna, Camila Quartim; de Souza, Rafael Queiroz; Graziano, Kazuko Uchikawa; Lusignan, Viktoriya			False positive results of Bowie and Dick type test used for hospital steam sterilizer with slower come-up ramps: A case study	PLOS ONE			English	Article								Objective To determine if the standardized B&D type test for hospital steam sterilizer is correctly indicating cycle failures in slower come-up ramps cycles. Methods Two commercially available B&D type test were challenged in a quality control sterilizer. A common failure was simulated in triplicate cycles, using a standardized cycle configuration, and then compared to triplicate cycles of a common cycle configuration. Tests procedures were conducted according to B&D manufacturer test standard and results were compared to standardized endpoint specifications. Results We found that B&D type tests are only capable of detecting the presence of non-condensable gases if the sterilization equipment is adjusted to meet all the cycle requirements of the test. False positive results were obtained with come-up ramp time of 3 min. Correct results were only obtained with come-up ramp of 1.7-1.9 min. Conclusions Until the ISO 17665 and AAMI ST-79 standards are revised, equipment qualification experts should observe come-up time duration criterion for B&D type test cycles according to ISO 11140-4. Sterile Processing Department professionals must add the come-up ramp criterion to cycle evaluation before clearing the equipment for routine use. This will allow B&D correct performance, reducing the infection risk from unsterilized medical device.	[Laranjeira, Paulo Roberto] Cardinal Hlth, Miami Lakes, FL 33014 USA; [Gonzalez Bronzatti, Jeane Aparecida; de Moraes Bruna, Camila Quartim; de Souza, Rafael Queiroz; Graziano, Kazuko Uchikawa] Univ Sao Paulo, Nursing Sch Sao Paulo, Sao Paulo, SP, Brazil; [Lusignan, Viktoriya] Getinge, Englewood, CO USA	Cardinal Health Inc; Universidade de Sao Paulo	Laranjeira, PR (corresponding author), Cardinal Hlth, Miami Lakes, FL 33014 USA.	prlaranjeira@usp.br	Bruna, Camila/D-3515-2012; Laranjeira, Paulo Roberto/ABD-1307-2020	Bruna, Camila/0000-0002-7161-6035; Laranjeira, Paulo Roberto/0000-0003-1252-6344; Graziano, Kazuko/0000-0001-6899-082X				Allison DG, 1999, J APPL MICROBIOL, V87, P789, DOI 10.1046/j.1365-2672.1999.00948.x; [Anonymous], 2006, 176651 ISO; [Anonymous], 2015, 285 EN EUR COMM STAN; [Anonymous], 2009, 176652 ISO; [Anonymous], 2017, 111381 ISO; [Anonymous], 2013, ST79 AAMI AM NAT STA; AORN, 2017, GUID STER; British Standards Institute, 2007, 111404 ISO; British Standards Institute, 2014, 111401 ISO; Dennhofer E., 2015, CTR SERV, V6, P398; Dion M., 2013, PHARM ENG, V33, P1; Esen S, 2011, CTR SERV, V5, P365; Kaiser U., 2005, ZENTR STERIL, V13, P395; Kirk B., 2012, MED DEVICE DECONTAMI, V17, P1; Mosley G., 2008, PHARM MICROBIOL FORU, V14, P1; Seavey R, 2016, AM J INFECT CONTROL, V44, pE29, DOI 10.1016/j.ajic.2016.03.001; Spry Cynthia, 2008, AORN J, V88, P537, DOI 10.1016/j.aorn.2008.06.016; van Doornmalen J, 2008, AM J INFECT CONTROL, V36, P86, DOI 10.1016/j.ajic.2007.02.002; van Doornmalen JPCM, 2014, CENTRAL SERVICE, V4, P250	19	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227943	10.1371/journal.pone.0227943	http://dx.doi.org/10.1371/journal.pone.0227943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986177	Green Published, gold			2022-12-26	WOS:000534603400035
J	Nunes, A; Trappenberg, T; Alda, M				Nunes, Abraham; Trappenberg, Thomas; Alda, Martin		Int Consortium Lithium Genetics Co	Asymmetrical reliability of the Alda score favours a dichotomous representation of lithium responsiveness	PLOS ONE			English	Article							BIPOLAR DISORDER; DICHOTOMIZATION; VARIANCE; COST; HARD	The Alda score is commonly used to quantify lithium responsiveness in bipolar disorder. Most often, this score is dichotomized into "responder" and "non-responder" categories, respectively. This practice is often criticized as inappropriate, since continuous variables are thought to invariably be "more informative" than their dichotomizations. We therefore investigated the degree of informativeness across raw and dichotomized versions of the Alda score, using data from a published study of the scale's inter-rater reliability (n = 59 raters of 12 standardized vignettes each). After learning a generative model for the relationship between observed and ground truth scores (the latter defined by a consensus rating of the 12 vignettes), we show that the dichotomized scale is more robust to inter-rater disagreement than the raw 0-10 scale. Further theoretical analysis shows that when a measure's reliability is stronger at one extreme of the continuum-a scenario which has received little-to-no statistical attention, but which likely occurs for the Alda score >= 7-dichotomization of a continuous variable may be more informative concerning its ground truth value, particularly in the presence of noise. Our study suggests that research employing the Alda score of lithium responsiveness should continue using the dichotomous definition, particularly when data are sampled across multiple raters.	[Nunes, Abraham; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Nunes, Abraham; Trappenberg, Thomas] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada; [Alda, Martin] QEII Hlth Sci Ctr, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Alda, M (corresponding author), Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada.; Alda, M (corresponding author), QEII Hlth Sci Ctr, Halifax, NS, Canada.	malda@dal.ca	Nunes, Abraham/T-7723-2019; Alda, Martin/F-5812-2010	Nunes, Abraham/0000-0002-4955-9150; Alda, Martin/0000-0001-9544-3944; Trappenberg, Thomas/0000-0002-6144-8963	Genome Canada; Dalhousie Department of Psychiatry Research Fund; Canadian Institutes of Health Research [64410]; Natural Science and Engineering Research Council of Canada; Nova Scotia Health Research Foundation Scotia Scholars Graduate Scholarship; Killam Postgraduate Scholarship; Dalhousie Medical Research Foundation; Lindsay family	Genome Canada(Genome Canada); Dalhousie Department of Psychiatry Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Health Research Foundation Scotia Scholars Graduate Scholarship; Killam Postgraduate Scholarship; Dalhousie Medical Research Foundation; Lindsay family	Genome Canada (MA, AN; https://www.genomecanada.ca), Dalhousie Department of Psychiatry Research Fund (MA, AN; https://medicine.dal.ca/departments/department-sites/psychiatry.html), Canadian Institutes of Health Research #64410 (MA; http://www.cihr-irsc.gc.ca), Natural Science and Engineering Research Council of Canada (TT; https://www.nserc-crsng.gc.ca), Nova Scotia Health Research Foundation Scotia Scholars Graduate Scholarship (AN; https://nshrf.ca), Killam Postgraduate Scholarship (AN; http://www.killamlaureates.ca) and Dalhousie Medical Research Foundation and the Lindsay family (AN and MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2015, MOL PSYCHIATR, V20, P661, DOI 10.1038/mp.2015.4; Alda M, 2017, WORLD PSYCHIATRY, V16, P319, DOI 10.1002/wps.20462; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Bauer M., 2006, LITHIUM NEUROPSYCHIA, P157; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; DeCoster J, 2009, PSYCHOL METHODS, V14, P349, DOI 10.1037/a0016956; Fitzsimons GJ, 2008, J CONSUM RES, V35, P5, DOI 10.1086/589561; Gershon S, 2009, BIPOLAR DISORD, V11, P34, DOI 10.1111/j.1399-5618.2009.00709.x; Hou LP, 2016, LANCET, V387, P1085, DOI 10.1016/S0140-6736(16)00143-4; HUMPHREYS LG, 1974, J EDUC PSYCHOL, V66, P464, DOI 10.1037/h0036539; HUMPHREYS LG, 1978, J EDUC PSYCHOL, V70, P873, DOI 10.1037/0022-0663.70.6.873; Humphreys LG., 1978, INTELLIGENCE, V2, P1, DOI [10.1016/0160-2896(78)90010-7, DOI 10.1016/0160-2896(78)90010-7]; HUNTER JE, 1990, J APPL PSYCHOL, V75, P334, DOI 10.1037/0021-9010.75.3.334; Irwin JR, 2003, J MARKETING RES, V40, P366, DOI 10.1509/jmkr.40.3.366.19237; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Manchia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065636; Nunes A, ACTA PSYCHIAT SCANDI; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rucker DD, 2015, J CONSUM PSYCHOL, V25, P666, DOI 10.1016/j.jcps.2015.04.004; Streiner DL, 2002, CAN J PSYCHIAT, V47, P262, DOI 10.1177/070674370204700307	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0225353	10.1371/journal.pone.0225353	http://dx.doi.org/10.1371/journal.pone.0225353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986152	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400011
J	Beckwith, T; Cecil, K; Altaye, M; Severs, R; Wolfe, C; Percy, Z; Maloney, T; Yolton, K; LeMasters, G; Brunst, K; Ryan, P				Beckwith, Travis; Cecil, Kim; Altaye, Mekibib; Severs, Rachel; Wolfe, Christopher; Percy, Zana; Maloney, Thomas; Yolton, Kimberly; LeMasters, Grace; Brunst, Kelly; Ryan, Patrick			Reduced gray matter volume and cortical thickness associated with traffic-related air pollution in a longitudinally studied pediatric cohort	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POLYCYCLIC AROMATIC-HYDROCARBONS; SUPERIOR PARIETAL LOBULE; HUMAN PREFRONTAL CORTEX; PARTICULATE MATTER; PRENATAL EXPOSURE; BRAIN-DEVELOPMENT; FUNCTIONAL CONNECTIVITY; POSTNATAL MATURATION; MOTOR-PERFORMANCE	Early life exposure to air pollution poses a significant risk to brain development from direct exposure to toxicants or via indirect mechanisms involving the circulatory, pulmonary or gastrointestinal systems. In children, exposure to traffic related air pollution has been associated with adverse effects on cognitive, behavioral and psychomotor development. We aimed to determine whether childhood exposure to traffic related air pollution is associated with regional differences in brain volume and cortical thickness among children enrolled in a longitudinal cohort study of traffic related air pollution and child health. We used magnetic resonance imaging to obtain anatomical brain images from a nested subset of 12 year old participants characterized with either high or low levels of traffic related air pollution exposure during their first year of life. We employed voxel-based morphometry to examine group differences in regional brain volume, and with separate analyses, changes in cortical thickness. Smaller regional gray matter volumes were determined in the left pre- and post-central gyri, the cerebellum, and inferior parietal lobe of participants in the high traffic related air pollution exposure group relative to participants with low exposure. Reduced cortical thickness was observed in participants with high exposure relative to those with low exposure, primarily in sensorimotor regions of the brain including the pre- and post-central gyri and the paracentral lobule, but also within the frontal and limbic regions. These results suggest that significant childhood exposure to traffic related air pollution is associated with structural alterations in brain.	[Beckwith, Travis] Univ Cincinnati, Coll Med, Dept Environm Hlth, Mol Epidemiol Childrens Environm Hlth Training Pr, Cincinnati, OH 45267 USA; [Beckwith, Travis; Cecil, Kim; Maloney, Thomas] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Imaging Res Ctr, Cincinnati, OH 45229 USA; [Beckwith, Travis; Cecil, Kim; Altaye, Mekibib; Wolfe, Christopher; Maloney, Thomas; Yolton, Kimberly; Ryan, Patrick] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Altaye, Mekibib; Wolfe, Christopher; Ryan, Patrick] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Severs, Rachel] Western Kentucky Univ, Dept Psychol, Bowling Green, KY 42101 USA; [Percy, Zana; LeMasters, Grace; Brunst, Kelly] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Yolton, Kimberly] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gen & Community Pediat, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Western Kentucky University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Beckwith, T (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Mol Epidemiol Childrens Environm Hlth Training Pr, Cincinnati, OH 45267 USA.; Beckwith, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Imaging Res Ctr, Cincinnati, OH 45229 USA.; Beckwith, T (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.	Travis.Beckwith@cchmc.org	Yunkunis, Kimberly/AAO-5605-2021; Ryan, Patrick/HDO-1133-2022; Percy, Zana/L-7973-2019	Percy, Zana/0000-0002-2314-8118; Beckwith, Travis/0000-0001-6128-8464; Maloney, Thomas/0000-0002-2643-9009; Cecil, Kim/0000-0001-8233-5485; Severs, Rachel/0000-0002-8801-8621	National Institute for Environmental Health Sciences (NIEHS) [R01 ES019890, R01 ES027224, R01 ES026446]; National Center for Advancing Translational Sciences of the National Institutes of Health (NCATS) [UL1 TR001425]; National Institutes of Health (NIH) [T32-ES10957]	National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Advancing Translational Sciences of the National Institutes of Health (NCATS); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute for Environmental Health Sciences (NIEHS; https://www.niehs.nih.gov/), award numbers R01 ES019890 (P.R), R01 ES027224 (K. Y.), and R01 ES026446 (K.C.); the National Center for Advancing Translational Sciences of the National Institutes of Health (NCATS; https://ncats.nih.gov/), award number UL1 TR001425; and a National Institutes of Health (NIH; https://www.nih.gov/; https://researchtraining.nih.gov/programs/training-grants/T32) training grant awarded to the Molecular Epidemiology in Children's Environmental Health Training Program (MECEH), award number T32-ES10957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JL, 2017, NEUROTOXICOLOGY, V59, P140, DOI 10.1016/j.neuro.2015.12.014; Montes LGA, 2013, J ATTEN DISORD, V17, P641, DOI 10.1177/1087054711434351; Amlien IK, 2016, CEREB CORTEX, V26, P257, DOI 10.1093/cercor/bhu214; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baumann O, 2012, NEUROIMAGE, V61, P805, DOI 10.1016/j.neuroimage.2012.03.044; Beckwith TJ, 2018, NEUROTOXICOLOGY, V67, P1, DOI 10.1016/j.neuro.2018.04.004; Benes FM, 2003, CURR OPIN PSYCHIATR, V16, P317, DOI 10.1097/00001504-200305000-00007; Bjuland KJ, 2013, EARLY HUM DEV, V89, P371, DOI 10.1016/j.earlhumdev.2012.12.003; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Brokamp C, 2019, ANN EPIDEMIOL, V30, P37, DOI 10.1016/j.annepidem.2018.11.008; Brunst KJ, 2019, ENVIRON RES, V175, P71, DOI 10.1016/j.envres.2019.05.009; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2012, J ALZHEIMERS DIS, V28, P93, DOI 10.3233/JAD-2011-110722; Cassee FR, 2013, INHAL TOXICOL, V25, P802, DOI 10.3109/08958378.2013.850127; Caulfield M.D., 2013, FOCUSING POSSIBLE RO, P41, DOI [10.5772/52954, DOI 10.5772/52954]; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Chen H, 2017, LANCET, V389, P718, DOI 10.1016/S0140-6736(16)32399-6; Clifford A, 2016, ENVIRON RES, V147, P383, DOI 10.1016/j.envres.2016.01.018; Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x; Coombes SA, 2009, J ANXIETY DISORD, V23, P1072, DOI 10.1016/j.janxdis.2009.07.009; CORKIN S, 1970, ARCH NEUROL-CHICAGO, V23, P41, DOI 10.1001/archneur.1970.00480250045007; Costa LG, 2017, NEUROTOXICOLOGY, V59, P133, DOI 10.1016/j.neuro.2015.11.008; Costa LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/736385; D'Agostino E, 2006, LECT NOTES COMPUT SC, V4057, P136; Dahnke R, 2012, 18 ANN M ORG HUM BRA; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Davis DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064128; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Ejaz S, 2014, ENVIRON SCI POLLUT R, V21, P3351, DOI 10.1007/s11356-013-2294-5; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Flores-Pajot MC, 2016, ENVIRON RES, V151, P763, DOI 10.1016/j.envres.2016.07.030; Gaser C, THRESHOLD FREE CLUST; Gaser C., 2016, HBM, V2016, P336; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greenstein D, 2006, J CHILD PSYCHOL PSYC, V47, P1003, DOI 10.1111/j.1469-7610.2006.01658.x; Grootoonk S, 2000, NEUROIMAGE, V11, P49, DOI 10.1006/nimg.1999.0515; Guxens M, 2018, BIOL PSYCHIAT, V84, P295, DOI 10.1016/j.biopsych.2018.01.016; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Haukvik UK, 2014, SCHIZOPHRENIA BULL, V40, P410, DOI 10.1093/schbul/sbt005; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; HO KC, 1980, ARCH PATHOL LAB MED, V104, P635; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Hu SH, 2006, ATMOS ENVIRON, V40, pS378, DOI 10.1016/j.atmosenv.2006.02.038; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Joshi AA, 2011, NEUROREPORT, V22, P101, DOI 10.1097/WNR.0b013e3283424c84; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kamali A, 2014, NEUROSCIENCE, V277, P577, DOI 10.1016/j.neuroscience.2014.07.035; Kanold PO, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.016.2009; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; KOENDERINK MJT, 1994, BRAIN RES, V653, P173, DOI 10.1016/0006-8993(94)90387-5; KOENDERINK MJT, 1995, BRAIN RES, V678, P233, DOI 10.1016/0006-8993(95)00206-6; LeMasters GK, 2006, J PEDIATR-US, V149, P505, DOI 10.1016/j.jpeds.2006.06.035; Li G, 2013, CEREB CORTEX, V23, P2724, DOI 10.1093/cercor/bhs265; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; Lyall AE, 2015, CEREB CORTEX, V25, P2204, DOI 10.1093/cercor/bhu027; Marcos-Vidal L, 2018, HUM BRAIN MAPP, V39, P2442, DOI 10.1002/hbm.24013; Miller MI, 2000, NEUROIMAGE, V12, P676, DOI 10.1006/nimg.2000.0666; Molenberghs P, 2007, CEREB CORTEX, V17, P2703, DOI 10.1093/cercor/bhl179; Moreno-Rius J, 2018, PROG NEURO-PSYCHOPH, V85, P23, DOI 10.1016/j.pnpbp.2018.04.002; Mullen R, 2005, J SPORT EXERCISE PSY, V27, P212, DOI 10.1123/jsep.27.2.212; Newman NC, 2013, ENVIRON HEALTH PERSP, V121, P731, DOI 10.1289/ehp.1205555; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Park BY, 2016, NEURAL REGEN RES, V11, P119, DOI 10.4103/1673-5374.175056; Pedersen CB, 2004, SCHIZOPHR RES, V66, P83, DOI 10.1016/S0920-9964(03)00062-8; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Poissant H, 2014, PSYCHIAT RES-NEUROIM, V224, P242, DOI 10.1016/j.pscychresns.2014.08.011; Porro CA, 1996, J NEUROSCI, V16, P7688; Power MC, 2016, NEUROTOXICOLOGY, V56, P235, DOI 10.1016/j.neuro.2016.06.004; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Pun VC, 2017, ENVIRON HEALTH PERSP, V125, P342, DOI 10.1289/EHP494; RAKIC P, 1994, PROG BRAIN RES, V102, P227; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; RODIER PM, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432351; RUSHTON JP, 1990, PSYCHOL REP, V66, P659, DOI 10.2466/PR0.66.2.659-666; Ryan PH, 2008, SCI TOTAL ENVIRON, V404, P139, DOI 10.1016/j.scitotenv.2008.05.051; Ryan PH, 2007, ENVIRON HEALTH PERSP, V115, P278, DOI 10.1289/ehp.9480; Ryan PH, 2005, J ALLERGY CLIN IMMUN, V116, P279, DOI 10.1016/j.jaci.2005.05.014; Saenen ND, 2015, ENVIRON HEALTH PERSP, V123, P834, DOI 10.1289/ehp.1408549; Sahu M, 2011, SCI TOTAL ENVIRON, V409, P2642, DOI 10.1016/j.scitotenv.2011.03.032; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schutter DJLG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037252; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Shang CY, 2018, BRAIN IMAGING BEHAV, V12, P882, DOI 10.1007/s11682-017-9749-0; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Strawn JR, 2015, J ANXIETY DISORD, V32, P81, DOI 10.1016/j.janxdis.2015.03.004; Suades-Gonzalez E, 2015, ENDOCRINOLOGY, V156, P3473, DOI 10.1210/en.2015-1403; Sunyer J, 2019, BASIC CLIN PHARM TOX; Sunyer J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001792; Tang DL, 2008, ENVIRON HEALTH PERSP, V116, P674, DOI 10.1289/ehp.10471; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Uylings HBM, 1991, PROG BRAIN RES, V85, P185, DOI 10.1016/s0079-6123(08)62681-3; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Vanasse TJ, 2018, HUM BRAIN MAPP, V39, P3308, DOI 10.1002/hbm.24078; Vert C, 2017, INT J HYG ENVIR HEAL, V220, P1074, DOI 10.1016/j.ijheh.2017.06.009; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Walhovd KB, 2016, CEREB CORTEX, V27; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Weiss B, 2000, ENVIRON HEALTH PERSP, V108, P375, DOI 10.2307/3454523; Wolf RC, 2009, HUM BRAIN MAPP, V30, P2252, DOI 10.1002/hbm.20665; Woodward N, 2015, AIMS ENVIRON SCI, V2, P353, DOI 10.3934/environsci.2015.2.353; Yolton K, 2019, ENVIRON RES, V173, P199, DOI 10.1016/j.envres.2019.03.005; Yotter RA, 2011, 17 ANN M ORG HUM BRA; Yotter RA, 2011, J NEUROIMAGING, V21, pe134, DOI 10.1111/j.1552-6569.2010.00484.x; Yotter RA, 2011, HUM BRAIN MAPP, V32, P1109, DOI 10.1002/hbm.21095	127	25	25	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228092	10.1371/journal.pone.0228092	http://dx.doi.org/10.1371/journal.pone.0228092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978108	Green Published, gold			2022-12-26	WOS:000534599100110
J	Burgess, JL; Case, HB; Burgesscurrency, RA; Dickenson, NE				Burgess, Jamie L.; Case, Heather B.; Burgesscurrency, R. Alan; Dickenson, Nicholas E.			Dominant negative effects by inactive Spa47 mutants inhibit T3SS function and Shigella virulence	PLOS ONE			English	Article							SECRETION SYSTEM ATPASE; PROTON MOTIVE FORCE; III SECRETION; MOLECULAR ARCHITECTURE; INVASION; FLEXNERI; VISUALIZATION; CHAPERONE; PROTEINS; CELLS	Type three secretion systems (T3SS) are complex nano-machines that evolved to inject bacterial effector proteins directly into the cytoplasm of eukaryotic cells. Many high-priority human pathogens rely on one or more T3SSs to cause disease and evade host immune responses, underscoring the need to better understand the mechanisms through which T3SSs function and their role(s) in supporting pathogen virulence. We recently identified the Shigella protein Spa47 as an oligomerization-activated T3SS ATPase that fuels the T3SS and supports overall Shigella virulence. Here, we provide both in vitro and in vivo characterization of Spa47 oligomerization and activation in the presence and absence of engineered ATPase-inactive Spa47 mutants. The findings describe mechanistic details of Spa47-catalyzed ATP hydrolysis and uncover critical distinctions between oligomerization mechanisms capable of supporting ATP hydrolysis in vitro and those that support T3SS function in vivo. Concentration-dependent ATPase kinetics and experiments combining wild-type and engineered ATPase inactive Spa47 mutants found that monomeric Spa47 species isolated from recombinant preparations exhibit low-level ATPase activity by forming short-lived oligomers with active site contributions from at least two protomers. In contrast, isolated Spa47 oligomers exhibit enhanced ATP hydrolysis rates that likely result from multiple preformed active sites within the oligomeric complex, as is predicted to occur within the context of the type three secretion system injectisome. High-resolution fluorescence microscopy, T3SS activity, and virulence phenotype analyses of Shigella strains co-expressing wild-type Spa47 and the ATPase inactive Spa47 mutants demonstrate that the N-terminus of Spa47, not ATPase activity, is responsible for incorporation into the injectisome where the mutant strains exhibit a dominant negative effect on T3SS function and Shigella virulence. Together, the findings presented here help to close a significant gap in our understanding of how T3SS ATPases are activated and define restraints with respect to how ATP hydrolysis is ultimately coupled to T3SS function in vivo.	[Burgess, Jamie L.; Case, Heather B.; Burgesscurrency, R. Alan; Dickenson, Nicholas E.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Burgess, Jamie L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Burgesscurrency, R. Alan] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA	Utah System of Higher Education; Utah State University; University of Miami; University of Miami	Dickenson, NE (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	nick.dickenson@usu.edu		Dickenson, Nicholas/0000-0003-1572-6077; Burgess, Robert/0000-0003-4487-0959	National Institutes of Health [1R15AI124108-01A1]; R. Gaurth Hansen endowment funds; National Science Foundation Graduate Research Fellowships Program [120214]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); R. Gaurth Hansen endowment funds; National Science Foundation Graduate Research Fellowships Program	This work was supported in part by a National Institutes of Health Grant 1R15AI124108-01A1 and R. Gaurth Hansen endowment funds to N.E.D. J.L.B. received support from the National Science Foundation Graduate Research Fellowships Program, award 120214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PR, 2014, PROTEINS, V82, P3013, DOI 10.1002/prot.24662; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Ashida H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00219; Bemard AR, 2017, BIOCHEMISTRY-US, V56, P6503, DOI 10.1021/acs.biochem.7b00836; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Burgess JL, 2016, J BIOL CHEM, V291, P25837, DOI 10.1074/jbc.M116.755256; Burgess JL, 2016, PROTEIN SCI, V25, P1037, DOI 10.1002/pro.2917; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Carayol N, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a016717; Case HB, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3074; Case HB, 2018, BIOCHEMISTRY-US, V57, P6906, DOI 10.1021/acs.biochem.8b01077; Case HB, 2018, BIOCHEMISTRY-US, V57, P2266, DOI 10.1021/acs.biochem.8b00070; Chatterjee R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075028; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Demler HJ, 2019, PROTEINS, V87, P931, DOI 10.1002/prot.25754; Dickenson NE, 2012, INT J MOL SCI, V13, P15137, DOI 10.3390/ijms131115137; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Erhardt M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004800; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Majewski DD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08477-7; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino Tohru, 2016, PLoS Pathog, V12, pe1005495, DOI 10.1371/journal.ppat.1005495; NIESEL DW, 1985, J CLIN MICROBIOL, V22, P897, DOI 10.1128/JCM.22.6.897-902.1985; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Puhar A, 2014, CURR BIOL, V24, pR784, DOI 10.1016/j.cub.2014.07.016; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schroeder GN, 2007, MICROBIOL-SGM, V153, P2862, DOI 10.1099/mic.0.2007/007427-0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Zhang YD, 2017, P NATL ACAD SCI USA, V114, P6098, DOI 10.1073/pnas.1705823114	45	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228227	10.1371/journal.pone.0228227	http://dx.doi.org/10.1371/journal.pone.0228227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978132	Green Published, gold			2022-12-26	WOS:000534599100129
J	da Costa, LA; Andreoli, MCC; Carvalho, AB; Draibe, SA; Pestana, JOM; Canziani, MEF				da Costa, Laurisson Albuquerque; Cruz Andreoli, Maria Claudia; Carvalho, Aluizio Barbosa; Draibe, Sergio Antonio; Medina Pestana, Jose Osmar; Fernandes Canziani, Maria Eugenia			Clinical outcomes of incident peritoneal dialysis patients coming from kidney transplantation program: A case-control study	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; ALLOGRAFT FAILURE; INTRAVENOUS IRON; MORTALITY; SURVIVAL; RETURN; RECIPIENTS; ALBUMIN; IMPACT	Introduction Brazil ranks second in the absolute number of transplantations in the world. Despite improvements in graft survival, many patients will progress to graft loss and return to dialysis. Concerns exist regarding adverse clinical outcomes in this population when undergone peritoneal dialysis (PD). Objective To compare the occurrence of mortality, technique failure, and peritonitis among incident patients in PD coming from either Tx or pre-dialysis treatment. Methodology A retrospective study in which 47 adult patients with Tx failure (Tx group) were matched for age, gender, diabetes mellitus (DM), modality and start year of PD, with 1:1 predialysis patient (nTx group). The Fine-Gray competing risk model was used to analyze mortality and technique failure. Results Compared to nTx, the Tx group had a lower body mass index, serum potassium, and albumin concentrations. A higher ferritin level, transferrin saturation and the number of patients with positive serology for viral hepatitis were also observed in the Tx group. In the multivariate analysis, patients of the Tx group had 4.4-times higher risk of death (p = 0.007), with infection as the main cause. Technique failure and peritonitis were similar in both groups. Conclusion Previous Tx is a risk factor for mortality but not for technique failure or peritonitis in incident patients on a PD program.	[da Costa, Laurisson Albuquerque; Cruz Andreoli, Maria Claudia; Carvalho, Aluizio Barbosa; Draibe, Sergio Antonio; Medina Pestana, Jose Osmar; Fernandes Canziani, Maria Eugenia] Univ Fed Sao Paulo, Div Nephrol, Dept Internal Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Canziani, MEF (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Dept Internal Med, Sao Paulo, Brazil.	mecanziani1@gmail.com	Canziani, Maria E F/AGI-3240-2022; draibe, sergio antonio/D-9426-2015					[Anonymous], 2018, 2018 USRDS ANN DAT R; Ansell D, 2007, AM J TRANSPLANT, V7, P1167, DOI 10.1111/j.1600-6143.2007.01745.x; Badve SV, 2006, NEPHROL DIAL TRANSPL, V21, P776, DOI 10.1093/ndt/gfi248; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Benomar M, 2018, NEPHROL DIAL TRANSPL; Brar A, 2017, AM J NEPHROL, V45, P180, DOI 10.1159/000455015; Brazil. Associaca o Brasileira de Transplantes. Registro Brasileiro de Transplantes, DIM TRANSPL BRAS CAD; Chaudhri S, 2016, NEPHROLOGY CARLTON; Chen A, 2012, CLIN J AM SOC NEPHRO, V7, P153, DOI 10.2215/CJN.03160411; Coronel F, 2010, NEFROLOGIA, V30, P626, DOI 10.3265/Nefrologia.pre2010.Jul.10553; Davies SJ, 2001, PERITON DIALYSIS INT, V21, pS280; de Castro Rodrigues Ferreira F, 2017, J NEPHROL; Duman S, 2004, INT UROL NEPHROL, V36, P249, DOI 10.1023/B:UROL.0000034678.84908.9b; Hu SL, 2017, PERITON DIALYSIS INT, V37, P477, DOI 10.3747/pdi.2016.00211; Ishida JH, 2015, CLIN J AM SOC NEPHRO, V10, P1799, DOI 10.2215/CJN.01090115; Joshi U, 2014, PERITON DIALYSIS INT, V34, P299, DOI 10.3747/pdi.2012.00209; Kaysi S, 2012, TRANSPL P, V44, P2997, DOI 10.1016/j.transproceed.2012.05.084; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Madar H, 2010, PERITON DIALYSIS INT, V30, P470, DOI 10.3747/pdi.2009.00168; Marcen R, 2009, TRANSPLANTATION, V87, P1340, DOI 10.1097/TP.0b013e3181a23837; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Miskulin DC, 2014, CLIN J AM SOC NEPHRO, V9, P1930, DOI 10.2215/CJN.03370414; Molnar MZ, 2013, SEMIN DIALYSIS, V26, P667, DOI 10.1111/sdi.12129; Mujais S, 2006, KIDNEY INT, V70, pS133, DOI 10.1038/sj.ki.5001930; Rao PS, 2005, NEPHROL DIAL TRANSPL, V20, P387, DOI 10.1093/ndt/gfh595; Sasal J, 2001, PERITON DIALYSIS INT, V21, P405; Wang Q, 2003, AM J KIDNEY DIS, V41, P664, DOI 10.1053/ajkd.2003.50128; Yang KS, 2013, TRANSPL P, V45, P2949, DOI 10.1016/j.transproceed.2013.08.080; Yelken BM, 2010, CLIN TRANSPLANT, V24, P481, DOI 10.1111/j.1399-0012.2009.01097.x; Zitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114144	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227870	10.1371/journal.pone.0227870	http://dx.doi.org/10.1371/journal.pone.0227870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978190	gold, Green Published			2022-12-26	WOS:000534599100070
J	Guo, YY; Werner, CF; Canales, A; Yu, L; Jia, XT; Anikeeva, P; Yoshinobu, T				Guo, Yuanyuan; Werner, Carl F.; Canales, Andres; Yu, Li; Jia, Xiaoting; Anikeeva, Polina; Yoshinobu, Tatsuo			Polymer-fiber-coupled field-effect sensors for label-free deep brain recordings	PLOS ONE			English	Article							ADDRESSABLE POTENTIOMETRIC SENSOR; CHEMICAL IMAGING SENSOR; MULTIFUNCTIONAL FIBERS; HIGH-SPEED; SIMULATION; MICROSCOPY	Electrical recording permits direct readout of neural activity but offers limited ability to correlate it to the network topography. On the other hand, optical imaging reveals the architecture of neural circuits, but relies on bulky optics and fluorescent reporters whose signals are attenuated by the brain tissue. Here we introduce implantable devices to record brain activities based on the field effect, which can be further extended with capability of label-free electrophysiological mapping. Such devices reply on light-addressable potentiometric sensors (LAPS) coupled to polymer fibers with integrated electrodes and optical waveguide bundles. The LAPS utilizes the field effect to convert electrophysiological activity into regional carrier redistribution, and the neural activity is read out in a spatially resolved manner as a photocurrent induced by a modulated light beam. Spatially resolved photocurrent recordings were achieved by illuminating different pixels within the fiber bundles. These devices were applied to record local field potentials in the mouse hippocampus. In conjunction with the raster-scanning via the single modulated beam, this technology may enable fast label-free imaging of neural activity in deep brain regions.	[Guo, Yuanyuan] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Grad Sch Biomed Engn, Grad Sch Med, Sendai, Miyagi 9800845, Japan; [Werner, Carl F.; Yoshinobu, Tatsuo] Tohoku Univ, Dept Biomed Engn, Dept Elect Engn, Sendai, Miyagi 9808579, Japan; [Canales, Andres; Jia, Xiaoting; Anikeeva, Polina] MIT, Dept Mat Sci & Engn, Res Lab Elect, Cambridge, MA 24139 USA; [Canales, Andres; Jia, Xiaoting; Anikeeva, Polina] MIT, McGovern Inst Brain Res, Cambridge, MA 24139 USA; [Yu, Li; Jia, Xiaoting] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Blacksburg, VA 24060 USA	Tohoku University; Tohoku University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Virginia Polytechnic Institute & State University	Guo, YY (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Grad Sch Biomed Engn, Grad Sch Med, Sendai, Miyagi 9800845, Japan.; Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn, Res Lab Elect, Cambridge, MA 24139 USA.; Anikeeva, P (corresponding author), MIT, McGovern Inst Brain Res, Cambridge, MA 24139 USA.	yyuanguo@fris.tohoku.ac.jp; anikeeva@mit.edu	Guo, Yuanyuan/AAT-8786-2020	Guo, Yuanyuan/0000-0002-9618-7919; Yu, Li/0000-0002-2970-6846	Japan Society for the Promotion of Science Fellowship (JSPS) for Young Scientist;  [15J02011]	Japan Society for the Promotion of Science Fellowship (JSPS) for Young Scientist(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was financially supported by Grant-in-Aid for JSPS research fellows (15J02011). Yuanyuan Guo was the recipient of the Japan Society for the Promotion of Science Fellowship (JSPS) for Young Scientist during the year of 2015-2017.; This work was financially supported by Grant-in-Aid for JSPS research fellows (15J02011). Yuanyuan Guo was the recipient of the Japan Society for the Promotion of Science Fellowship (JSPS) for Young Scientist during the year of 2015-2017.	Abouraddy AF, 2007, NAT MATER, V6, P336, DOI 10.1038/nmat1889; Bucher ES, 2015, ANNU REV ANAL CHEM, V8, P239, DOI 10.1146/annurev-anchem-071114-040426; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Canales A, 2018, ACCOUNTS CHEM RES, V51, P829, DOI 10.1021/acs.accounts.7b00558; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Flusberg BA, 2005, OPT LETT, V30, P2272, DOI 10.1364/OL.30.002272; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fromherz P, 2008, SOLID STATE ELECTRON, V52, P1364, DOI 10.1016/j.sse.2008.04.024; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Guo Y, 2014, SENSOR ACTUAT B-CHEM, V204, P659, DOI 10.1016/j.snb.2014.08.016; Guo YY, 2014, PHYS STATUS SOLIDI A, V211, P1467, DOI 10.1002/pssa.201330354; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; ichiro Miyamoto K, 2016, SENSORS ACTUATORS B; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2573; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Meng CB, 2018, NEURON, V98, P707, DOI 10.1016/j.neuron.2018.04.012; Miyamoto K, 2014, SENSOR ACTUAT B-CHEM, V194, P521, DOI 10.1016/j.snb.2013.12.090; Miyamoto K, 2012, SENSOR ACTUAT B-CHEM, V170, P82, DOI 10.1016/j.snb.2011.02.029; OWICKI JC, 1994, ANNU REV BIOPH BIOM, V23, P87, DOI 10.1146/annurev.bb.23.060194.000511; Parak WJ, 2000, IEEE T BIO-MED ENG, V47, P1106, DOI 10.1109/10.855939; Park S, 2017, NAT NEUROSCI, V20, P612, DOI 10.1038/nn.4510; Poghossian A, 2009, SEMIN CELL DEV BIOL, V20, P41, DOI 10.1016/j.semcdb.2009.01.014; Soref R, 2006, IEEE J SEL TOP QUANT, V12, P1678, DOI 10.1109/JSTQE.2006.883151; Stein B, 2004, SENSOR ACTUAT B-CHEM, V98, P299, DOI 10.1016/j.snb.2003.10.034; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Wagner T, 2011, SENSOR LETT, V9, P812, DOI 10.1166/sl.2011.1620; Wagner T, 2012, SENSOR ACTUAT B-CHEM, V170, P34, DOI 10.1016/j.snb.2010.12.003; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Yoshinobu T, 2005, METHODS, V37, P94, DOI 10.1016/j.ymeth.2005.05.020; Yoshinobu T, 2015, SENSOR ACTUAT B-CHEM, V207, P926, DOI 10.1016/j.snb.2014.09.002	34	17	17	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228076	10.1371/journal.pone.0228076	http://dx.doi.org/10.1371/journal.pone.0228076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978197	Green Published, gold			2022-12-26	WOS:000534599100108
J	Ivey, G; Youker, RT				Ivey, Gabrianne; Youker, Robert T.			Disease-relevant mutations alter amino acid co-evolution networks in the second nucleotide binding domain of CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ATP-BINDING; TRIOSEPHOSPHATE ISOMERASE; CONFORMATIONAL-CHANGE; SEQUENCE STATISTICS; CASSETTE; HYDROLYSIS; WALKER; PHENOTYPE	Cystic Fibrosis (CF) is an inherited disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel. Mutations in CFTR cause impaired chloride ion transport in the epithelial tissues of patients leading to cardiopulmonary decline and pancreatic insufficiency in the most severely affected patients. CFTR is composed of twelve membrane-spanning domains, two nucleotide-binding domains (NBDs), and a regulatory domain. The most common mutation in CFTR is a deletion of phenylalanine at position 508 (.F508) in NBD1. Previous research has primarily concentrated on the structure and dynamics of the NBD1 domain; However numerous pathological mutations have also been found in the lesser-studied NBD2 domain. We have investigated the amino acid co-evolved network of interactions in NBD2, and the changes that occur in that network upon the introduction of CF and CF-related mutations (S1251N(T), S1235R, D1270N, N1303K (T)). Extensive coupling between the alpha- and beta-subdomains were identified with residues in, or near Walker A, Walker B, H-loop and C-loop motifs. Alterations in the predicted residue network varied from moderate for the S1251T perturbation to more severe for N1303T. The S1235R and D1270N networks varied greatly compared to the wildtype, but these CF mutations only affect ion transport preference and do not severely disrupt CFTR function, suggesting dynamic flexibility in the network of interactions in NBD2. Our results also suggest that inappropriate interactions between the beta-subdomain and Q-loop could be detrimental. We also identified mutations predicted to stabilize the NBD2 residue network upon introduction of the CF and CF-related mutations, and these predicted mutations are scored as benign by the MUTPRED2 algorithm. Our results suggest the level of disruption of the co-evolution predictions of the amino acid networks in NBD2 does not have a straightforward correlation with the severity of the CF phenotypes observed.	[Ivey, Gabrianne] Kyder Christian Acad, Franklin, NC USA; [Ivey, Gabrianne] Southwestern Community Coll, Sylva, NC USA; [Youker, Robert T.] Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA; [Ivey, Gabrianne] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA	University of North Carolina; Western Carolina University; University of North Carolina; Appalachian State University	Youker, RT (corresponding author), Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA.	rtyouker@wcu.edu	Youker, Robert/AAP-8725-2021	Youker, Robert/0000-0002-3986-1655				Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; Banjar H, 1999, ANN TROP PAEDIATR, V19, P69, DOI 10.1080/02724939992671; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Champeimont R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26401; Cheng RR, 2016, PROTEIN SCI, V25, P111, DOI 10.1002/pro.2758; Chong PA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009522; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; DeStefano S, 2018, J CYST FIBROS, V17, P573, DOI 10.1016/j.jcf.2018.05.011; Dib L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048124; Dong Q, 2015, J BIOL CHEM, V290, P14140, DOI 10.1074/jbc.M114.611616; Douam F, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006908; Durani V, 2013, METHOD ENZYMOL, V523, P237, DOI 10.1016/B978-0-12-394292-0.00011-4; Farhat R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/138103; Federici S, 2001, ARCH PEDIATRIE, V8, P150, DOI 10.1016/S0929-693X(00)00177-9; Feldmann Delphine, 2003, Hum Mutat, V22, P340, DOI 10.1002/humu.9183; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; George A. M., 2016, ABC TRANSPORTERS 40; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gulyas-Kovacs A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036546; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hsu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009455; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Kloch M, 2010, CELL PHYSIOL BIOCHEM, V25, P169, DOI 10.1159/000276549; Kolaczkowski M, 2013, BBA-BIOMEMBRANES, V1828, P479, DOI 10.1016/j.bbamem.2012.10.024; LaRusch J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004376; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopes-Pacheco M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00275; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Moran O, 2017, CELL MOL LIFE SCI, V74, P85, DOI 10.1007/s00018-016-2390-z; Noordhoek-van der J.J, 2017, DUTCH CYSTIC FIBROSI; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; OSBORNE L, 1992, HUM GENET, V89, P653, DOI 10.1007/BF00221957; Oteri F, 2017, NUCLEIC ACIDS RES, V45, pW307, DOI 10.1093/nar/gkx336; Parente DJ, 2015, PROTEINS, V83, P2293, DOI 10.1002/prot.24948; Pejaver V, 2017, BIORXIV, DOI [10.1101/134981, DOI 10.1101/134981]; Pele J., 2017, ADV TECH BIOL MED, V5, P250, DOI [10.4172/2379-1764.1000250, DOI 10.4172/2379-1764.1000250]; Proctor EA, 2015, CHEM SCI, V6, P1237, DOI 10.1039/c4sc01320d; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Rapino D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119796; Rene C, 2011, EUR J HUM GENET, V19, P36, DOI 10.1038/ejhg.2010.137; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stone John Edward, 1998, TACHYON RAY TRACING; Sullivan BJ, 2012, J MOL BIOL, V420, P384, DOI 10.1016/j.jmb.2012.04.025; Sullivan BJ, 2011, J MOL BIOL, V413, P195, DOI 10.1016/j.jmb.2011.08.001; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; TARENTINO AL, 1975, BIOCHEM BIOPH RES CO, V67, P455, DOI 10.1016/0006-291X(75)90337-X; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Vernon RM, 2017, J BIOL CHEM, V292, P14147, DOI 10.1074/jbc.M116.772335; Wahab AA, 2001, J TROP PEDIATRICS, V47, P110, DOI 10.1093/tropej/47.2.110; Yang RY, 2008, BIOCHEMISTRY-US, V47, P8456, DOI 10.1021/bi8007643; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115	70	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227668	10.1371/journal.pone.0227668	http://dx.doi.org/10.1371/journal.pone.0227668			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978131	Green Published, gold			2022-12-26	WOS:000534599100050
J	Perry, D; Hammar, L; Linderholm, HW; Gullstrom, M				Perry, Diana; Hammar, Linus; Linderholm, Hans W.; Gullstrom, Martin			Spatial risk assessment of global change impacts on Swedish seagrass ecosystems	PLOS ONE			English	Article							ZOSTERA-MARINA L; OCEAN ACIDIFICATION; CLIMATE-CHANGE; BALTIC SEA; COMMUNITY STRUCTURE; FISH; RESPONSES; BIODIVERSITY; SIMULATIONS; ACCLIMATION	Improved knowledge on the risk in ecologically important habitats on a regional scale from multiple stressors is critical for managing functioning and resilient ecosystems. This risk assessment aimed to identify seagrass ecosystems in southern Sweden that will be exposed to a high degree of change from multiple global change stressors in mid- and end-of-century climate change conditions. Risk scores were calculated from the expected overlap of three stressors: sea surface temperature increases, ocean acidification and wind driven turbid conditions. Three high-risk regions were identified as areas likely to be exposed to a particularly high level of pressure from the global stressors by the end of the century. In these areas it can be expected that there will be a large degree of stressor change from the current conditions. Given the ecological importance of seagrass meadows for maintaining high biodiversity and a range of other ecosystem services, these risk zones should be given high priority for incorporation into management strategies, which can attempt to reduce controllable stressors in order to mitigate the consequences of some of the impending pressures and manage for maintained ecosystem resilience.	[Perry, Diana; Gullstrom, Martin] Stockholm Univ, Dept Ecol Environm & Plant Sci, Seagrass Ecol & Physiol Res Grp, Stockholm, Sweden; [Perry, Diana] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden; [Hammar, Linus] Octopus Ink Res & Anal, Gothenburg, Sweden; [Linderholm, Hans W.] Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden	Stockholm University; Swedish University of Agricultural Sciences; University of Gothenburg	Perry, D (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, Seagrass Ecol & Physiol Res Grp, Stockholm, Sweden.; Perry, D (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden.	diana.perry@su.se	Linderholm, Hans W/N-1020-2013	Linderholm, Hans W/0000-0002-1522-8919	Swedish Research Council Formas [2011-1640]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	DP and MG received funding from The Swedish Research Council Formas (grant number: 2011-1640) https://formas.se/en/start-page.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; [Anonymous], CUMULATIVE EFFECTS M; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; [Anonymous], 2015, P NATL ACAD SCI US; Baden S, 2003, AMBIO, V32, P374, DOI 10.1639/0044-7447(2003)032[0374:VSZMLI]2.0.CO;2; Baden SP, 2001, ECOL STU AN, V151, P213; BADEN SP, 1990, AMBIO, V19, P113; Baden S, 2012, MAR ECOL PROG SER, V451, P61, DOI 10.3354/meps09585; Bostrom C, 2003, WORLD ATLAS SEAGRASS; Bostrom C, 2014, AQUAT CONSERV, V24, P410, DOI 10.1002/aqc.2424; Boyd PW, 2018, GLOBAL CHANGE BIOL, V24, P2239, DOI 10.1111/gcb.14102; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Buapet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083804; Chan F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02777-y; Connell SD, 2018, ECOLOGY, V99, P1005, DOI 10.1002/ecy.2209; den Elzen M., 2017, EMISSIONS GAP REPORT; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Envall M, 2012, ALGRASUTBREDNING ZOS; EVANS AS, 1986, AQUAT BOT, V24, P185, DOI 10.1016/0304-3770(86)90095-1; George R, 2018, ECOL EVOL, V8, P4508, DOI 10.1002/ece3.3952; Green E.P., 2003, WORLD ATLAS SEAGRASS; Hammar J, 2018, HAVS VATTENMYNDIGHET, P37; Hammar L, 2011, 9 EUR WAV TID EN C S, P1; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Havenhand J, 2017, HAVSPLANERING MED HA; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; JOHANNESSON K, 1989, OIKOS, V54, P77, DOI 10.2307/3565899; Landis WG, 2003, HUM ECOL RISK ASSESS, V9, P1415, DOI 10.1080/10807030390250912; Lefcheck JS, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12645; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lunden B., 2013, NOR GEOGR TIDSSKR, V57, P121, DOI [10.1080/00291950310001379, DOI 10.1080/00291950310001379]; Meier HEM, 2012, CLIM DYNAM, V39, P2421, DOI 10.1007/s00382-012-1339-7; Meier HEM, 2011, CLIM RES, V48, P31, DOI 10.3354/cr00968; Meier HEM, 2011, OCEANOLOGIA, V53, P193, DOI 10.5697/oc.53-1-TI.193; Meier HEM, 2011, OCEANOGRAFI, V108; Moksnes PO, 2018, ESTUAR COAST, V41, P1712, DOI 10.1007/s12237-018-0382-y; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Nakicenovic N, 2000, SPECIAL REPORT WORKI; NORTON SB, 1992, ENVIRON TOXICOL CHEM, V11, P1663, DOI 10.1897/1552-8618(1992)11[1663:AFFERA]2.0.CO;2; Nyqvist A, 2009, AMBIO, V38, P85, DOI 10.1579/0044-7447-38.2.85; Pachauri R.K., 2014, CONTRIBUTION WORKING; Perry D, 2017, CAN J FISH AQUAT SCI, DOI [10.1139/cjfas-2016-0396, DOI 10.1139/CJFAS-2016-0396]; Perry D, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2986; Perry D, 2018, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00440; Pihl L, 1999, J SEA RES, V41, P281, DOI 10.1016/S1385-1101(99)00004-0; Pihl L, 2006, ESTUAR COAST SHELF S, V67, P123, DOI 10.1016/j.ecss.2005.10.016; Queiros AM, 2016, GLOBAL CHANGE BIOL, V22, P3927, DOI 10.1111/gcb.13423; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schulzweida U, 2017, CDO USERS GUIDE, P1; Sobocinski KL, 2013, ESTUAR COAST, V36, P775, DOI 10.1007/s12237-013-9586-3; Stal J, 2008, OCEAN COAST MANAGE, V51, P594, DOI 10.1016/j.ocecoaman.2008.06.006; Staveley TAB, 2019, ECOL EVOL, V9, P9076, DOI 10.1002/ece3.5453; Staveley TAB, 2017, ECOGRAPHY, V40, P936, DOI 10.1111/ecog.02745; SwAM, 2018, SYMPHONY INTEGRERAT; Takolander A, 2017, J SEA RES, V123, P16, DOI 10.1016/j.seares.2017.03.007; UCAR, UN NETCDF; Ventura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23728; Vinagre C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192700; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Vuorinen I, 2015, ECOL INDIC, V50, P196, DOI 10.1016/j.ecolind.2014.10.019; ZIMMERMAN RC, 1989, J EXP MAR BIOL ECOL, V130, P93, DOI 10.1016/0022-0981(89)90197-4; Zimmerman RC, 2017, MAR ECOL PROG SER, V566, P1, DOI 10.3354/meps12051; Zimmerman RC, 2015, LIMNOL OCEANOGR, V60, P1781, DOI 10.1002/lno.10139	63	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0225318	10.1371/journal.pone.0225318	http://dx.doi.org/10.1371/journal.pone.0225318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978099	Green Published, gold			2022-12-26	WOS:000534599100010
J	Ajepe, AA; Okunade, KS; Sekumade, AI; Daramola, ES; Beke, MO; Ijasan, O; Olowoselu, OF; Afolabi, BB				Ajepe, Adegbenga Adetona; Okunade, Kehinde Sharafadeen; Sekumade, Adebayo Isaiah; Daramola, Ebunoluwa Seun; Beke, Mary Olufunmilayo; Ijasan, Olaolopin; Olowoselu, Olusola Festus; Afolabi, Bosede Bosede			Prevalence and foetomaternal effects of iron deficiency anaemia among pregnant women in Lagos, Nigeria	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; MATERNAL MORBIDITY; HEALTH; OUTCOMES	Anaemia in pregnancy is a major health problem and an important cause of adverse foeto-maternal outcomes in developing countries. Iron deficiency is the cause of the overwhelming majority of the cases of anaemia in pregnancy. Iron deficiency anaemia (IDA) has been linked with adverse foetal and maternal outcomes. This study investigated the prevalence of IDA and evaluated its effects on foetomaternal outcomes among parturients in Lagos, Nigeria. This was a cross-sectional study that enrolled 220 women aged 15-49 years with singleton gestation at term, between May 1, 2016, and March 31, 2017. Participants were selected by systematic sampling and baseline data were collected through interviews. Venous blood samples were obtained to measure haemoglobin and serum ferritin concentrations, and the associations between IDA (defined as anaemia and iron deficiency) and pregnancy outcomes were examined. A P-value <0.05 was considered as statistically significant. The prevalence of IDA was 12.3%. Routine antenatal iron supplementation (adjusted odds ratio 0.18, 95% confidence interval 0.07-0.46; P = 0.001) and interpregnancy interval of at least 2 years (adjusted odds ratio 0.20, 95% confidence interval 0.05-0.97; P = 0.021) have significant association with IDA. Iron deficiency anaemia was not significantly associated with adverse perinatal outcomes but there were significant associations with increased risk of blood transfusion (P = 0.001) and maternal infectious morbidities such as puerperal pyrexia (P = 0.041) and wound infection (P = 0.020). IDA is still a fairly common condition among parturients in Lagos and it's mostly associated with maternal peripartum morbidities. Adequate pregnancy spacing through the use of effective contraception and routine antenatal iron supplementations in pregnancy is a recommended preventive measure against IDA and its adverse sequelae. Future studies should adopt the use of transferrin saturation (TSAT) in compliment with serum ferritin assay as a more sensitive marker of iron deficiency.	[Ajepe, Adegbenga Adetona; Okunade, Kehinde Sharafadeen; Sekumade, Adebayo Isaiah; Daramola, Ebunoluwa Seun; Beke, Mary Olufunmilayo; Ijasan, Olaolopin; Afolabi, Bosede Bosede] Lagos Univ Teaching Hosp, Dept Obstet & Gynaecol, Lagos, Nigeria; [Okunade, Kehinde Sharafadeen; Afolabi, Bosede Bosede] Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria; [Olowoselu, Olusola Festus] Univ Lagos, Coll Med, Dept Haematol & Blood Transfus, Lagos, Nigeria	University of Lagos; University of Lagos	Okunade, KS (corresponding author), Lagos Univ Teaching Hosp, Dept Obstet & Gynaecol, Lagos, Nigeria.; Okunade, KS (corresponding author), Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria.	sokunade@unilag.edu.ng	; OKUNADE, KEHINDE/A-8201-2017	Afolabi, Bosede/0000-0002-7511-7567; OKUNADE, KEHINDE/0000-0002-0957-7389	Fogarty International Center; National Institute of Mental Health of the National Institutes of Health [D43TW010543]; NIH	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	KSO was supported, in part, by the Fogarty International Center and National Institute of Mental Health of the National Institutes of Health (grant number D43TW010543). NIH played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adams PC, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2007.02.027; Afolabi BB, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316670444; Aimakhu C O, 2003, West Afr J Med, V22, P18; Alwan NA, 2015, BRIT J NUTR, V113, P1985, DOI 10.1017/S0007114515001166; [Anonymous], 2003, RES METHODOLOGY STAT; [Anonymous], 2016, PROTOCOL BOOKLET ABC; [Anonymous], 2012, GUID DAIL IR FOL AC; Anorlu R I, 2006, J Obstet Gynaecol, V26, P773, DOI 10.1080/01443610600963846; Audu B., 2009, NIGERIAN MED J, V50, P33; Auerbach M, 2021, J MATERN-FETAL NEO M, V34, P1002, DOI 10.1080/14767058.2019.1619690; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Dim Cyril C, 2007, MedGenMed, V9, P11; Drukker L, 2015, TRANSFUSION, V55, P2799, DOI 10.1111/trf.13252; Erhabor O, BRIT J MED HLTH SCI, V1, P47; Kilpatrick SJ, 2014, CREASY RESNIKS MATER, P918; Lawson RJ, 1983, OBSTET GYNAECOLOGY T, P73; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; MERCHANT K, 1988, PROG FOOD NUTR SCI, V12, P339; Miller JL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011866; Nair M, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000026; Nwizu E N, 2011, Afr J Reprod Health, V15, P33; Okunade K. S., 2014, International Journal of Medicine and Biomedical Research, V3, P114; Olusanya O., 1985, W AFR J MED, V4, P205; Owolabi AT, 2008, SINGAP MED J, V49, P526; Pena-Rosas JP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub5; Peyrin-Biroulet L, 2015, AM J CLIN NUTR, V102, P1585, DOI 10.3945/ajcn.114.103366; Razzaque A, 2005, INT J GYNECOL OBSTET, V89, pS41, DOI 10.1016/j.ijgo.2005.01.003; Reveiz L, 2011, COCHRANE DB SYST REV, V5; Shander A, 2014, TRANSFUS MED REV, V28, P156, DOI 10.1016/j.tmrv.2014.05.001; Skikne BS, 2008, AM J HEMATOL, V83, P872, DOI 10.1002/ajh.21279; Steer PJ, 2000, AM J CLIN NUTR, V71, p1285S, DOI 10.1093/ajcn/71.5.1285s; Stein J., 2018, INT J CHRONIC DIS, V2018, P1, DOI [10.1155/2018/9394060, DOI 10.1155/2018/9394060]; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Tiwari Manu, 2013, Med J Armed Forces India, V69, P31, DOI 10.1016/j.mjafi.2012.07.016; VanderJagt DJ, 2007, J HEALTH POPUL NUTR, V25, P75; Weiss G, 2002, WIEN KLIN WOCHENSCHR, V114, P357; World Health Organization, 2011, SER FERR CONC ASS IR	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227965	10.1371/journal.pone.0227965	http://dx.doi.org/10.1371/journal.pone.0227965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971986	Green Published, gold			2022-12-26	WOS:000534374400029
J	Gu, L; Zhu, YH; Lin, X; Tan, XY; Lu, BJ; Li, YJ				Gu, Li; Zhu, Yahui; Lin, Xi; Tan, Xingyu; Lu, Bingjun; Li, Youjun			Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis	ONCOGENE			English	Article							FATTY-ACID SYNTHASE; HEPATOCELLULAR-CARCINOMA; EXPRESSION; CELLS; AKT; PHOSPHORYLATION; PLASMALOGENS; INACTIVATION; RECRUITMENT; STABILITY	Metabolic alteration for adaptation of the local environment has been recognized as a hallmark of cancer. GNPAT dysregulation has been implicated in hepatocellular carcinoma (HCC). However, the precise posttranslational regulation of GNPAT is still undiscovered. Here we show that ACAT1 is upregulated in response to extra palmitic acid (PA). ACAT1 acetylates GNPAT at K128, which represses TRIM21-mediated GNPAT ubiquitination and degradation. Conversely, GNPAT deacetylation by SIRT4 antagonizes ACAT1's function. GNPAT represses TRIM21-mediated FASN degradation and promotes lipid metabolism. Furthermore, shRNA-mediated ACAT1 ablation and acetylation deficiency of GNPAT repress lipid metabolism and tumor progression in xenograft and DEN/CCl4-induced HCC. Otherwise, ACAT1 inhibitor combination with sorafenib enormously retards tumor formation in mice. Collectively, we demonstrate that stabilization of FASN by ACAT1-mediated GNPAT acetylation plays a critical role in hepatocarcinogenesis.	[Gu, Li; Zhu, Yahui; Lin, Xi; Tan, Xingyu; Lu, Bingjun; Li, Youjun] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Gu, Li; Zhu, Yahui; Lin, Xi; Tan, Xingyu; Lu, Bingjun; Li, Youjun] Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Gu, L; Li, YJ (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Gu, L; Li, YJ (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China.	gulicherry@whu.edu.cn; liy7@whu.edu.cn			National Nature Science Foundation of China [81772609, 81902843]; Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University [TFJC2018005]; China Postdoctoral Science Foundation [2019T120681, 2019M652702]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Profs Qunying Lei (Fudan University, Shanghai) for the SIRT family vectors and FASN plasmid, Yan Wang (Wuhan University, Wuhan, China) for the AAV8 vector, Ping Wang (East China Normal University, Shanghai, China) for pcDNA3.1(+)-5'flag Luc vector and Jinxiang Zhang (Wuhan Union Hospital, Wuahn, China) for providing the HCC samples. This work was supported by grants from the National Nature Science Foundation of China (81772609, 81902843), Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (TFJC2018005), and China Postdoctoral Science Foundation (2019T120681, 2019M652702).	Alo PL, 2007, ANTICANCER RES, V27, P2523; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Dorninger F, 2017, J NEUROCHEM, V143, P569, DOI 10.1111/jnc.14082; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Fan J, 2016, MOL CELL, V64, P859, DOI 10.1016/j.molcel.2016.10.014; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gingold JA, 2018, TRENDS MOL MED, V24, P395, DOI 10.1016/j.molmed.2018.02.006; Gong XL, 2016, WORLD J GASTROENTERO, V22, P6582, DOI 10.3748/wjg.v22.i29.6582; Gonzalez-Guerrico AM, 2016, ONCOTARGET, V7, P71151, DOI 10.18632/oncotarget.9463; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Gu L, 2018, CANCER RES, V78, P5808, DOI 10.1158/0008-5472.CAN-18-0340; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Han H, 2013, HEPATOLOGY, V57, P2378, DOI 10.1002/hep.26302; Hossain MS, 2017, J NEUROSCI, V37, P4074, DOI 10.1523/JNEUROSCI.3941-15.2017; Jin JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13594; Kim DW, 2017, J GASTROINTEST ONCOL, V8, P256, DOI 10.21037/jgo.2016.09.07; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Komljenovic D, 2009, CELL TISSUE RES, V337, P281, DOI 10.1007/s00441-009-0809-7; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Lee M, 2018, YONSEI MED J, V59, P1143, DOI 10.3349/ymj.2018.59.10.1143; Li L, 2016, J HEPATOL, V64, P333, DOI 10.1016/j.jhep.2015.10.004; Lin HP, 2016, CANCER RES, V76, P6924, DOI 10.1158/0008-5472.CAN-16-1597; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Malheiro AR, 2015, J INHERIT METAB DIS, V38, P111, DOI 10.1007/s10545-014-9795-3; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Souchek JJ, 2017, MOL CANCER THER, V16, P1819, DOI 10.1158/1535-7163.MCT-17-0013; Tesori V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09149; Wang B, 2017, NATURE, V545, P365, DOI 10.1038/nature22344; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06812-y; Zaytseva YY, 2015, ONCOTARGET, V6, P18891, DOI 10.18632/oncotarget.3783; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhu YH, 2017, CELL DEATH DIFFER, V24, P2199, DOI 10.1038/cdd.2017.151	40	26	31	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	11					2437	2449		10.1038/s41388-020-1156-0	http://dx.doi.org/10.1038/s41388-020-1156-0		JAN 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KU0ZS	31974474				2022-12-26	WOS:000509037000002
J	Vashist, P; Tandon, R; Murthy, GVS; Barua, CK; Deka, D; Singh, S; Gupta, V; Gupta, N; Wadhwani, M; Singh, R; Vishwanath, K				Vashist, Praveen; Tandon, Radhika; Murthy, G. V. S.; Barua, C. K.; Deka, Dipali; Singh, Sachchidanand; Gupta, Vivek; Gupta, Noopur; Wadhwani, Meenakshi; Singh, Rashmi; Vishwanath, K.		ICMR-EYE SEE Study Grp	Association of cataract and sun exposure in geographically diverse populations of India: The CASE study. First Report of the ICMR-EYE SEE Study Group	PLOS ONE			English	Article							AGE-RELATED CATARACT; LENS OPACITIES; RISK-FACTORS; SUNLIGHT EXPOSURE; RURAL-POPULATION; SOUTHERN INDIA; LIGHT EXPOSURE; UV-B; SMOKING; PREVALENCE	Purpose To determine the prevalence of cataract and its association with sun exposure and other environmental risk factors in three different geographically diverse populations of India. Design Population based cross sectional study during 2010-2016 Participants People aged. 40 years residing in randomly sampled villages were enumerated (12021) and 9735 (81%) underwent ophthalmic evaluation from plains, hilly and coastal regions (3595, 3231, 2909 respectively) Methods A detailed questionnaire-based interview about outdoor activity in present, past and remote past, usage of sun protective measures, exposure to smoke, and detailed ophthalmic examination including assessment of uncorrected and best corrected visual acuity, measurement of intraocular pressure, slit lamp examination, lens opacities categorization using LOCS III and posterior segment evaluation was done. Lifetime effective sun exposure was calculated using Melbourne formula and expressed as quintiles. These were supplemented with physical environmental measurements. Main outcome measures Lifetime sun exposure hours, smoking, indoor kitchen smoke exposure and their association with cataract and subtypes. Prevalence of cataract calculated based on lens opacities or evidence of cataract surgery. Results Cataract was identified in 3231 (33.3%) participants. Prevalence of cataract in males (32.3%) and females (34.1%) was similar. Nuclear cataract was the commonest sub-type identified in 94.7% of affected eyes. Sun exposure had a significant association with cataract with odds ratio (OR) increasing from 1.6 (95% Confidence Intervals [CI]: 1.4, 1.9) in 3rd quintile, to 2.6 (CI: 2.2, 3.1) in 4th quintile and 9.4 (CI: 7.9, 11.2) in 5th quintile (p<0.0001). Cataract also showed a significant association with smoking (OR: 1.4, CI: 1.2, 1.6) and indoor kitchen smoke exposure (OR: 1.2, CI: 1.0-1.4). Nuclear cataract showed a positive association with increasing sun exposure in 3rd (beta coefficient 0.5, CI:0.2-0.7), 4th beta: 0.9, CI: 0.7-1.1) and 5th (beta: 2.1, CI:1.8-2.4) quintiles of sun exposure, smoking (beta: 0.4, CI: 0.2-0.6) and indoor kitchen smoke exposure (beta: 0.3, CI: 01-0.5) while cortical cataract showed a positive association with sun exposure only in 5th quintile (beta: 2.6, CI:1.0-4.2). Posterior subcapsular cataract was not associated with any of the risk factors. Conclusion Cataract is associated with increasing level of sun exposure, smoking and exposure to indoor kitchen smoke.	[Vashist, Praveen; Tandon, Radhika; Gupta, Vivek; Gupta, Noopur; Wadhwani, Meenakshi; Singh, Rashmi] Community Ophthalmol, Dr RP Ctr Ophthalm Sci, New Delhi, India; [Murthy, G. V. S.] Publ Hlth Fdn India, Hyderabad, Telangana, India; [Barua, C. K.; Deka, Dipali] Reg Inst Ophthalmol, Gauhati, Assam, India; [Singh, Sachchidanand] Natl Phys Lab, New Delhi, India; [Vishwanath, K.] Pushpagiri Vitreo Retina Inst, Secunderabad, Telangana, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; Public Health Foundation of India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Physical Laboratory (NPL)	Tandon, R (corresponding author), Community Ophthalmol, Dr RP Ctr Ophthalm Sci, New Delhi, India.	radhika_tan@yahoo.com	GUPTA, NOOPUR/AAX-5043-2021; Singh, Sachchidanand/D-1537-2009	GUPTA, NOOPUR/0000-0001-8022-6656; Singh, Sachchidanand/0000-0003-0257-4705; Tandon, Radhika/0000-0001-9554-9933; Gupta, Vivek/0000-0002-6157-3705	Indian Council of Medical Research (ICMR) [68/4/2009NCD-1]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	Indian Council of Medical Research (ICMR) provided funding (Grant No 68/4/2009NCD-1) for this investigator-initiated project and had no direct role in the design and conduct of study. PV, RT, GVSM, DD, SS are Principal Investigators of respective sites.	Athanasiov PA, 2008, BRIT J OPHTHALMOL, V92, P1169, DOI 10.1136/bjo.2008.139725; Backes C, 2019, J EXPO SCI ENV EPID, V29, P753, DOI 10.1038/s41370-018-0087-0; Backes C, 2018, PHOTODERMATOL PHOTO, V34, P330, DOI 10.1111/phpp.12388; Beltran-Zambrano E, 2019, Arch Soc Esp Oftalmol (Engl Ed), V94, P60, DOI 10.1016/j.oftal.2018.10.020; CHATTERJEE A, 1982, BRIT J OPHTHALMOL, V66, P35, DOI 10.1136/bjo.66.1.35; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; COLLMAN GW, 1988, AM J PUBLIC HEALTH, V78, P1459, DOI 10.2105/AJPH.78.11.1459; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Delcourt C, 2000, ARCH OPHTHALMOL-CHIC, V118, P385, DOI 10.1001/archopht.118.3.385; HILLER R, 1986, AM J EPIDEMIOL, V124, P916, DOI 10.1093/oxfordjournals.aje.a114481; JAVITT JC, 1994, DOC OPHTHALMOL, V88, P307, DOI 10.1007/BF01203684; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; Lindblad BE, 2014, JAMA OPHTHALMOL, V132, P253, DOI 10.1001/jamaophthalmol.2013.6669; Lodhi NK, 2013, J GEOPHYS RES-ATMOS, V118, P1361, DOI 10.1002/jgrd.50165; McCarty CA, 1996, B WORLD HEALTH ORGAN, V74, P353; Neale RE, 2003, EPIDEMIOLOGY, V14, P707, DOI 10.1097/01.ede.0000086881.84657.98; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P989, DOI 10.1136/bjo.2003.038380; Nirmalan PK, 2003, INVEST OPHTH VIS SCI, V44, P4639, DOI 10.1167/iovs.03-0011; Pastor-Valero Maria, 2007, BMC Ophthalmol, V7, P18, DOI 10.1186/1471-2415-7-18; Pokhrel AK, 2005, INT J EPIDEMIOL, V34, P702, DOI 10.1093/ije/dyi015; Raju P, 2006, BRIT J OPHTHALMOL, V90, P1374, DOI 10.1136/bjo.2006.097295; Ravilla TD, 2016, ENVIRON HEALTH PERSP, V124, P1857, DOI 10.1289/EHP193; Sasaki H, 2011, EYE CONTACT LENS, V37, P191, DOI 10.1097/ICL.0b013e31821fbf29; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; Singh S, 2018, ATMOS ENVIRON, V188, P60, DOI 10.1016/j.atmosenv.2018.06.027; Sukhsohale Neelam D, 2013, Indian J Community Med, V38, P162, DOI 10.4103/0970-0218.116353; Tang Y, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0143743; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; West SK, 1998, JAMA-J AM MED ASSOC, V280, P714, DOI 10.1001/jama.280.8.714; WONG L, 1993, J EPIDEMIOL COMMUN H, V47, P46, DOI 10.1136/jech.47.1.46; Ye J, 2012, INVEST OPHTH VIS SCI, V53, P3885, DOI 10.1167/iovs.12-9820	33	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227868	10.1371/journal.pone.0227868	http://dx.doi.org/10.1371/journal.pone.0227868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5RH	31971985	Green Published, Green Submitted, gold			2022-12-26	WOS:000534374400024
J	Aplak, E; von Montfort, C; Haasler, L; Stucki, D; Steckel, B; Reichert, AS; Stahl, W; Brenneisen, P				Aplak, Elif; von Montfort, Claudia; Haasler, Lisa; Stucki, David; Steckel, Bodo; Reichert, Andreas S.; Stahl, Wilhelm; Brenneisen, Peter			CNP mediated selective toxicity on melanoma cells is accompanied by mitochondrial dysfunction	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; REDOX HOMEOSTASIS; QUALITY-CONTROL; CYTOTOXICITY; AUTOPHAGY; MEMBRANES; PROTEINS; ASSAY	Cerium (Ce) oxide nanoparticles (CNP; nanoceria) are reported to have cytotoxic effects on certain cancerous cell lines, while at the same concentration they show no cytotoxicity on normal (healthy) cells. Redox-active CNP exhibit both selective prooxidative as well as antioxidative properties. The former is proposed to be responsible for impairment of tumor growth and invasion and the latter for rescuing normal cells from reactive oxygen species (ROS)-induced damage. Here we address possible underlying mechanisms of prooxidative effects of CNP in a metastatic human melanoma cell line. Malignant melanoma is the most aggressive form of skin cancer, and once it becomes metastatic the prognosis is very poor. We have shown earlier that CNP selectively kill A375 melanoma cells by increasing intracellular ROS levels, whose basic amount is significantly higher than in the normal (healthy) counterpart, the melanocytes. Here we show that CNP initiate a mitochondrial increase of ROS levels accompanied by an increase in mitochondrial thiol oxidation. Furthermore, we observed CNP-induced changes in mitochondrial bioenergetics, dynamics, and cristae morphology demonstrating mitochondrial dysfunction which finally led to tumor cell death. CNP-induced cell death is abolished by administration of PEG-conjugated catalase. Overall, we propose that cerium oxide nanoparticles mediate cell death via hydrogen peroxide production linked to mitochondrial dysfunction.	[Aplak, Elif; von Montfort, Claudia; Haasler, Lisa; Stucki, David; Reichert, Andreas S.; Stahl, Wilhelm; Brenneisen, Peter] Heinrich Heine Univ Dusseldorf, Med Fac, Inst Biochem & Mol Biol 1, Dusseldorf, Germany; [Steckel, Bodo] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Mol Cardiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	von Montfort, C (corresponding author), Heinrich Heine Univ Dusseldorf, Med Fac, Inst Biochem & Mol Biol 1, Dusseldorf, Germany.	montfort@hhu.de	Wilhelm, Stahl/AHB-3164-2022	Stucki, David/0000-0002-0732-2761; Reichert, Andreas/0000-0001-9340-3113; Stahl, Wilhelm/0000-0001-8892-8345	DFG - Deutsche Forschungsgemeinschaft [BR1551/7-1]	DFG - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	P.B. grant BR1551/7-1 DFG - Deutsche Forschungsgemeinschaft https://www.dfg.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili L, 2014, BIOSCIENCE REP, V34, P7, DOI 10.1042/BSR20130091; Alili L, 2013, ANTIOXID REDOX SIGN, V19, P765, DOI 10.1089/ars.2012.4831; Alili L, 2011, BIOMATERIALS, V32, P2918, DOI 10.1016/j.biomaterials.2010.12.056; Ansenberger-Fricano K, 2013, FREE RADICAL BIO MED, V54, P116, DOI 10.1016/j.freeradbiomed.2012.08.573; Banasiak D, 1999, RADIAT ONCOL INVESTI, V7, P77, DOI 10.1002/(SICI)1520-6823(1999)7:2<77::AID-ROI3>3.0.CO;2-M; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Bindoli A, 2013, ANTIOXID REDOX SIGN, V18, P1557, DOI 10.1089/ars.2012.4655; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Brenneisen P, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020031; Chaiswing L, 2018, ANTIOXID REDOX SIGN, V29, P1237, DOI 10.1089/ars.2017.7485; Chen C, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020038; Chen XY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9817576; Cheng GL, 2013, TOXICOL IN VITRO, V27, P1082, DOI 10.1016/j.tiv.2013.02.005; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Creed S, 2019, METHODS MOL BIOL, V1928, P69, DOI 10.1007/978-1-4939-9027-6_5; Cui XJ, 2012, ANTIOXID REDOX SIGN, V16, P1212, DOI 10.1089/ars.2012.4532; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Fu Dong, 2018, Curr Protoc Cell Biol, V79, pe45, DOI 10.1002/cpcb.45; Gagnon J, 2015, EUR J INORG CHEM, P4510, DOI 10.1002/ejic.201500643; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; Hashimoto M, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14193; Heckert EG, 2008, BIOMATERIALS, V29, P2705, DOI 10.1016/j.biomaterials.2008.03.014; Ingawale DK, 2014, ENVIRON TOXICOL PHAR, V37, P118, DOI 10.1016/j.etap.2013.08.015; Jana SK, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2441-z; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Kiriyama Y, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7010001; Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBLANC OH, 1971, J MEMBRANE BIOL, V4, P227, DOI 10.1007/BF02431973; Liu ZR, 2017, J BUON, V22, P1582; Lyles RH, 2008, CONTEMP CLIN TRIALS, V29, P878, DOI 10.1016/j.cct.2008.05.009; Ma XQ, 2011, CHEM BIOL, V18, P1474, DOI 10.1016/j.chembiol.2011.08.009; Mahaseth T, 2017, MUTAT RES-REV MUTAT, V773, P274, DOI 10.1016/j.mrrev.2016.08.006; Maydt D, 2013, XENOBIOTICA, V43, P711, DOI 10.3109/00498254.2012.754112; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mittal S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/891934; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nebigil CG, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01262; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pal HC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01659-7; Pezzini I, 2017, NANOMEDICINE-UK, V12, P403, DOI 10.2217/nnm-2016-0342; Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Polster BM, 2014, METHOD ENZYMOL, V547, P225, DOI 10.1016/B978-0-12-801415-8.00013-8; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Reichert AS, 2004, TRENDS GENET, V20, P555, DOI 10.1016/j.tig.2004.08.012; Reisz JA, 2016, BLOOD, V128, pE32, DOI 10.1182/blood-2016-05-714816; Sack M, 2014, MOL CANCER THER, V13, P1740, DOI 10.1158/1535-7163.MCT-13-0950; Sack-Zschauer M, 2017, J BIOMED NANOTECHNOL, V13, P1735, DOI 10.1166/jbn.2017.2452; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Singh S, 2010, MOL BIOSYST, V6, P1813, DOI 10.1039/c0mb00014k; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Strom J, 2016, FASEB J, V30, P66, DOI 10.1096/fj.14-268904; Tetz LM, 2013, J PHARMACOL TOX MET, V67, P56, DOI 10.1016/j.vascn.2013.01.195; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Ursini F, 2016, REDOX BIOL, V8, P205, DOI 10.1016/j.redox.2016.01.010; von Montfort C, 2015, REDOX BIOL, V4, P1, DOI 10.1016/j.redox.2014.11.007; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang X, 2014, ANAL METHODS-UK, V6, P3019, DOI 10.1039/c4ay00288a; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Zhang Baohui, 2014, Electric Power Automation Equipment, V34, P1, DOI 10.3969/j.issn.1006-6047.2014.10.001; Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	87	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227926	10.1371/journal.pone.0227926	http://dx.doi.org/10.1371/journal.pone.0227926			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951630	Green Submitted, Green Published, gold			2022-12-26	WOS:000534370500036
J	Flores, KR; Viccaro, F; Aquilini, M; Scarpino, S; Ronchetti, F; Mancini, R; Di Napoli, A; Scozzi, D; Ricci, A				Flores, Krisstopher Richard; Viccaro, Fausta; Aquilini, Mauro; Scarpino, Stefania; Ronchetti, Francesco; Mancini, Rita; Di Napoli, Arianna; Scozzi, Davide; Ricci, Alberto			Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; OXIDATIVE STRESS; EXPRESSION; APOPTOSIS; RATS	Obstructive sleep apnea syndrome (OSAS) is a common disorder characterized by repeated episodes of upper airways collapse during the sleep. The following intermittent hypoxia triggers a state of chronic inflammation, which also interests the nervous system leading to neuronal damage and increased risk of cognitive impairment. Brain derived neurotrophic factor (BDNF) is a growth factor often associated with neuroplasticity and neuroprotection whose levels increase in several condition associated with neuronal damage. However, whether patients affected by OSAS have altered BDNF levels and whether such alteration may be reflective of their cognitive impairment is still controversial. Here we show that, when compared to healthy control volunteers, OSAS patients have increased serum levels of BDNF. Moreover, OSAS patients with the higher levels of BDNF also have reduced neurocognitive impairment as measured by The Montreal Cognitive Assessment (MoCA) questionnaire. Treatment with standard non-invasive mechanical ventilation (CPAP) also was able to ameliorate the level of cognitive impairment. Altogether our results indicate that BDNF levels represent a neuroprotective response to intermittent hypoxia in OSAS patients.	[Flores, Krisstopher Richard; Viccaro, Fausta; Aquilini, Mauro; Scarpino, Stefania; Ronchetti, Francesco; Mancini, Rita; Di Napoli, Arianna; Ricci, Alberto] Sapienza Univ, St Andrea Hosp, Div Resp Dis, Dept Clin & Mol Med, Rome, Italy; [Scozzi, Davide] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Washington University (WUSTL)	Ricci, A (corresponding author), Sapienza Univ, St Andrea Hosp, Div Resp Dis, Dept Clin & Mol Med, Rome, Italy.	alberto.ricci@uniroma1.it	Di Napoli, Arianna/AAB-3210-2022	Di Napoli, Arianna/0000-0002-3159-5380; Ricci, Alberto/0000-0002-1718-1587				Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Bergeron C, 2005, J ALLERGY CLIN IMMUN, V116, P1393, DOI 10.1016/j.jaci.2005.10.008; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Brzecka A, 2005, ACTA NEUROBIOL EXP, V65, P213; Emamian F, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00078; Fung SJ, 2007, BRAIN RES, V1179, P42, DOI 10.1016/j.brainres.2007.08.044; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gu XQ, 2001, J APPL PHYSIOL, V91, P1245, DOI 10.1152/jappl.2001.91.3.1245; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P2166, DOI 10.1164/ajrccm.162.6.2002126; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Lal C, 2012, CHEST, V141, P1601, DOI 10.1378/chest.11-2214; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Panaree B, 2011, SLEEP BREATH, V15, P649, DOI 10.1007/s11325-010-0415-7; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Satriotomo I, 2016, NEUROSCIENCE, V322, P479, DOI 10.1016/j.neuroscience.2016.02.060; Shiota S, 2013, J ALZHEIMERS DIS, V37, P325, DOI 10.3233/JAD-130419; Staats R, 2005, THORAX, V60, P688, DOI 10.1136/thx.2004.038208; Stanzani L, 2001, CEREBROVASC DIS, V12, P240, DOI 10.1159/000047710; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Vermehren-Schmaedick A, 2012, NEUROSCIENCE, V206, P1, DOI 10.1016/j.neuroscience.2012.01.017; Wang WH, 2012, ASIAN PAC J TROP MED, V5, P906, DOI 10.1016/S1995-7645(12)60169-2; Wang Y, 2010, J INT MED RES, V38, P1942, DOI 10.1177/147323001003800607; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Xie H, 2012, ACTA PHARMACOL SIN, V33, P5, DOI 10.1038/aps.2011.184; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055	28	10	13	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227834	10.1371/journal.pone.0227834	http://dx.doi.org/10.1371/journal.pone.0227834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951637	Green Published, gold			2022-12-26	WOS:000534370500032
J	Hwang, SH; Bang, S; Kim, W; Chung, J				Hwang, Sun-Hong; Bang, Sunhoe; Kim, Wonho; Chung, Jongkyeong			Von Hippel?Lindau tumor suppressor (VHL) stimulates TOR signaling by interacting with phosphoinositide 3-kinase (PI3K)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; target of rapamycin (TOR); metabolic regulation; S6 kinase; phosphatidylinositide 3-kinase (PI 3-kinase); cell size; nutrient sensing; p110; von Hippel?Lindau (VHL)	HYPOXIA-INDUCIBLE FACTORS; COMPLEX GENE-PRODUCTS; PROTEIN-KINASE B; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; CELL-GROWTH; MTOR; PHOSPHORYLATION; ACTIVATION; RAPAMYCIN	Cell growth is positively controlled by the phosphoinositide 3-kinase (PI3K)?target of rapamycin (TOR) signaling pathway under conditions of abundant growth factors and nutrients. To discover additional mechanisms that regulate cell growth, here we performed RNAi-based mosaic analyses in the Drosophila fat body, the primary metabolic organ in the fly. Unexpectedly, the knockdown of the Drosophila von Hippel?Lindau (VHL) gene markedly decreased cell size and body size. These cell growth phenotypes induced by VHL loss of function were recovered by activation of TOR signaling in Drosophila. Consistent with the genetic interactions between VHL and the signaling components of PI3K?TOR pathway in Drosophila, we observed that VHL loss of function in mammalian cells causes decreased phosphorylation of ribosomal protein S6 kinase and Akt, which represent the main activities of this pathway. We further demonstrate that VHL activates TOR signaling by directly interacting with the p110 catalytic subunit of PI3K. On the basis of the evolutionarily conserved regulation of PI3K?TOR signaling by VHL observed here, we propose that VHL plays an important role in the regulation and maintenance of proper cell growth in metazoans.	[Hwang, Sun-Hong; Bang, Sunhoe; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Hwang, Sun-Hong; Bang, Sunhoe; Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, 1 Gwanak Ro, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, 1 Gwanak Ro, Seoul 08826, South Korea.	jkc@snu.ac.kr			Korea Health Technology R&D project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HI17C0328]; BK21 Plus Program from the Ministry of Education of the Republic of Korea; Global Ph.D. Fellowship Program from National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of the Republic of Korea	Korea Health Technology R&D project through the Korea Health Industry Development Institute - Ministry of Health Welfare; BK21 Plus Program from the Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); Global Ph.D. Fellowship Program from National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of the Republic of Korea(National Research Foundation of Korea)	This work was supported by Grant HI17C0328 from the Korea Health Technology R&D project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (to J. C.); funds from the BK21 Plus Program from the Ministry of Education of the Republic of Korea (to S.-H. H., S. B., and J. C.); and by the Global Ph.D. Fellowship Program from National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning of the Republic of Korea (to S.-H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim E, 2017, MOL CELLS, V40, P315, DOI 10.14348/molcells.2017.0066; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim JA, 2018, MOL CELLS, V41, P264, DOI 10.14348/molcells.2018.0076; Kim W, 2017, DEV CELL, V42, P363, DOI 10.1016/j.devcel.2017.07.020; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Koh HY, 2018, MOL CELLS, V41, P881, DOI 10.14348/molcells.2018.0247; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Lolkema MP, 2004, EXP CELL RES, V301, P139, DOI 10.1016/j.yexcr.2004.07.016; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mans DA, 2008, EXP CELL RES, V314, P1229, DOI 10.1016/j.yexcr.2007.12.020; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pignoni F, 1997, DEVELOPMENT, V124, P271; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Thoma CR, 2007, CELL CYCLE, V6, P1809, DOI 10.4161/cc.6.15.4518; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; van den Heuvel CNAM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00117; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	76	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2336	2347		10.1074/jbc.RA119.011596	http://dx.doi.org/10.1074/jbc.RA119.011596			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31959630	hybrid, Green Published			2022-12-26	WOS:000517330200016
J	Kaneko, S; Noguchi, H; Fu, R; Kang, C; Kawamura, A; Amano, S; Miyawaki, A				Kaneko, Shuhei; Noguchi, Haruko; Fu, Rong; Kang, Cheolmin; Kawamura, Akira; Amano, Shinsuke; Miyawaki, Atsushi			Differences in cancer patients' work-cessation risk, based on gender and type of job: Examination of middle-aged and older adults in super-aged Japan	PLOS ONE			English	Article							DIAGNOSIS; EMPLOYMENT; SURVIVORS; REEMPLOYMENT; RETURN	Objectives In this paper, we aim to estimate the effect cancer diagnosis has on labour-force participation among middle-aged and older populations in Japan. We investigate the impact of cancer diagnosis on job cessation and the gap between gender or job types. Methods We sourced data from a nationwide, annual survey targeted population aged 51-70 featuring the same cohort throughout, and examined respondents' cancer diagnoses and whether they continued to work, while also considering differences between gender (observations: 53 373 for men and 44 027 for women) and occupation type (observations: 64 501 for cognitive worker and 20 921 for manual worker) in this regard. We also examined one-year lag effects, using propensity score matching to control for confounding characteristics. We also implement Logistic regression and derive the odds ratio to evaluate the relative risk of cancer diagnosis, which supplements the main result by propensity score matching. Results Overall, the diagnosis of cancer has a huge effect on labour-force participation among the population, but this effect varies across subpopulations. Male workers are more likely to quit their job in the year they are diagnosed with cancer (10.1 percentage points), and also in the following year (5.0 percentage points). Contrastingly, female workers are more likely to quit their job immediately after being diagnosed with cancer (18.6 percentage points); however, this effect totally disappears when considering likelihoods for the following year. Cognitive workers are more prone to quit their job in the year of diagnosis by 11.6 percentage points, and this effect remains significant, 3.8 percentage points, in the following year. On the other hand, for manual workers the effect during the year of diagnosis is huge. It amounts to 18.7 percentage points; however, the effect almost disappears in the following year. Conclusion Our results indicate the huge effect of cancer on job cessation, and that there might be a degree of discrimination in workplaces between gender and job types.	[Kaneko, Shuhei] Waseda Univ, Grad Sch Econ, Tokyo, Japan; [Noguchi, Haruko; Fu, Rong; Kang, Cheolmin; Kawamura, Akira] Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan; [Amano, Shinsuke] Japan Federat Canc Patient Grp, Yokohama, Kanagawa, Japan; [Miyawaki, Atsushi] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Waseda University; Waseda University; University of Tokyo	Kaneko, S (corresponding author), Waseda Univ, Grad Sch Econ, Tokyo, Japan.	shuhei7700@ruri.waseda.jp	Noguchi, Haruko/ABF-3059-2020; Kawamura, Akira/AAX-3214-2021; Miyawaki, Atsushi/GWR-2569-2022; FU, Rong/O-7293-2018	Noguchi, Haruko/0000-0002-4437-8238; Miyawaki, Atsushi/0000-0001-6126-1464; Kaneko, Shuhei/0000-0001-7093-2418; FU, Rong/0000-0002-2850-1697	Japanese Ministry of Health, Labour and Welfare [H29-Junkankitou-Ippan-002]; Organization for University Research Initiatives of Waseda University; Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [17H07182]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Organization for University Research Initiatives of Waseda University; Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HN is funded by funded by the Japanese Ministry of Health, Labour and Welfare (H29-Junkankitou-Ippan-002), and Organization for University Research Initiatives of Waseda University. RF is funded by Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 17H07182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabinet Office, WHIT PAP GEND EQ SOC; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cancer Research UK, CANC SURV COMM CANC; Choi KS, 2007, PSYCHO-ONCOL, V16, P205, DOI 10.1002/pon.1054; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Garcia-Gomez P, 2011, J HEALTH ECON, V30, P200, DOI 10.1016/j.jhealeco.2010.11.003; Gordon L, 2008, AUST NZ J PUBL HEAL, V32, P569, DOI 10.1111/j.1753-6405.2008.00312.x; Jensen LS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4839-x; Lindbohm ML, 2012, J CANCER SURVIV, V6, P72, DOI 10.1007/s11764-011-0200-z; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Main DS, 2005, PSYCHO-ONCOLOGY, V14, P992, DOI 10.1002/pon.913; Mehnert A, 2011, CRIT REV ONCOL HEMAT, V77, P109, DOI 10.1016/j.critrevonc.2010.01.004; Ministry of Health Labour and Welfare, GUID SUPP BAL MED TR; Ministry of Health Labour and Welfare, OV BAS SURV WAG STRU; Ministry of Health Labour and Welfare, 2015, ETH GUID MED HLTH RE; National Cancer Institute, CANC INC STAT; Paraponaris A, 2010, HEALTH POLICY, V98, P144, DOI 10.1016/j.healthpol.2010.06.013; Park JH, 2008, J CLIN ONCOL, V26, P1302, DOI 10.1200/JCO.2007.14.2984; Park JH, 2009, PSYCHO-ONCOLOGY, V18, P691, DOI 10.1002/pon.1452; Peteet JR, 2000, GEN HOSP PSYCHIAT, V22, P200, DOI 10.1016/S0163-8343(00)00076-1; Tamminga SJ, 2010, OCCUP ENVIRON MED, V67, P639, DOI 10.1136/oem.2009.050070; World Health Organization (WHO), WORLD CANC REPORT 20; Zajacova A, 2015, CANCER-AM CANCER SOC, V121, P4425, DOI 10.1002/cncr.29510	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227792	10.1371/journal.pone.0227792	http://dx.doi.org/10.1371/journal.pone.0227792			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995590	Green Submitted, Green Published, gold			2022-12-26	WOS:000534609400029
J	Lee, K; Kwon, JW; Jahng, WJ; Park, YH; Jee, D				Lee, Kook; Kwon, Jin-Woo; Jahng, Wan Jin; Park, Young-Hoon; Jee, Donghyun			Age- and sex-based evaluation of the association between refractive error and age-related macular degeneration in the Korean population	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; RISK-FACTORS; VITREOMACULAR ADHESION; SUNLIGHT EXPOSURE; PREVALENCE; MACULOPATHY; MYOPIA; CHORIOCAPILLARIS	Purpose The aim of this study was to investigate the association between refractive error and prevalence of age-related macular degeneration (AMD) in Korean adults, based on the sex and age group. Methods This was a nationwide population-based cross-sectional study that included 17,676 subjects aged over 40 years who participated in the 2008-2012 Korean National Health and Nutrition Examination Survey. Digital fundus images (45 degrees) were obtained for both eyes under physiologic mydriasis and were graded using the international classification and grading system for age-related macular degeneration. The spherical equivalents of refractive errors were calculated in diopters using auto-refraction data. Results After adjustment for potential confounders, myopia was associated with lower risk of any age-related macular degeneration [odds ratio (OR), 0.74; 95% Confidence Interval (CI), 0.61-0.91]. In particular, myopia was significantly associated with lower odds of age-related macular degeneration in female participants (any AMD: OR, 0.71; 95% CI, 0.54-0.93; early AMD: OR, 0.70; 95% CI, 0.53-0.93) and in participants younger than 50 years (any AMD: OR, 0.46; 95% CI, 0.24-0.90; early AMD: OR, 0.47; 95% CI, 0.24-0.93). There was no significant association between myopia and age-related macular degeneration in male participants and in participants older than 50 years. Conclusions In the Korean adult population, myopia was associated with significantly lower odds of any type of early age-related macular degeneration, particularly in females and in younger age groups.	[Lee, Kook; Park, Young-Hoon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Kwon, Jin-Woo; Jee, Donghyun] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Jahng, Wan Jin] Amer Univ Nigeria, Dept Petr Chem, Yola, Nigeria; [Park, Young-Hoon] Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; American University of Nigeria; Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Suwon, South Korea.	donghyunjee@catholic.ac.kr	Jahng, Wan Jin/C-1236-2018	Jahng, Wan Jin/0000-0001-8241-7739; Kwon, Jin-woo/0000-0003-2093-4284	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A03010528]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education [2016R1A6A1A03010528]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Boker T, 1993, Ger J Ophthalmol, V2, P10; Centofanti M, 2000, BRIT J OPHTHALMOL, V84, P786, DOI 10.1136/bjo.84.7.786; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cheung CMG, 2012, ARCH OPHTHALMOL-CHIC, V130, P480, DOI 10.1001/archophthalmol.2011.376; Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P1101, DOI 10.1167/iovs.13-13096; Fletcher AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1396, DOI 10.1001/archopht.126.10.1396; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; GROSSNIKLAUS HE, 1992, RETINA-J RET VIT DIS, V12, P127, DOI 10.1097/00006982-199212020-00009; Hayreh SS, 2004, OPHTHALMOLOGICA, V218, P333, DOI 10.1159/000079476; Hirata A, 1998, GRAEF ARCH CLIN EXP, V236, P132, DOI 10.1007/s004170050053; Hwang HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134338; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Hyman Leslie, 2002, Curr Opin Ophthalmol, V13, P171; Ikram MK, 2003, INVEST OPHTH VIS SCI, V44, P3778, DOI 10.1167/iovs.03-0120; Inhoffen W, 2012, OPHTHALMOLOGE, V109, P749, DOI 10.1007/s00347-011-2498-3; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe185, DOI 10.1111/j.1755-3768.2011.02316.x; Jonas JB, 2010, OPHTHALMOLOGY, V117, P2234, DOI 10.1016/j.ophtha.2009.12.006; Kavroulaki D, 2010, ACTA OPHTHALMOL, V88, P850, DOI 10.1111/j.1755-3768.2009.01607.x; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P5702, DOI 10.1167/iovs.14-14774; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Kim EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080361; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; La TY, 2014, CURR EYE RES, V39, P1232, DOI 10.3109/02713683.2014.907431; Lin SC, 2016, ASIA-PAC J OPHTHALMO, V5, P115, DOI 10.1097/APO.0000000000000169; Mojana F, 2008, AM J OPHTHALMOL, V146, P218, DOI 10.1016/j.ajo.2008.04.027; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Ondes F, 2000, JPN J OPHTHALMOL, V44, P91, DOI 10.1016/S0021-5155(99)00174-4; Owen CG, 2003, BRIT J OPHTHALMOL, V87, P312, DOI 10.1136/bjo.87.3.312; Pallikaris IG, 2006, AM J OPHTHALMOL, V141, P611, DOI 10.1016/j.ajo.2005.11.010; Pan CW, 2013, OPHTHALMOLOGY, V120, P284, DOI 10.1016/j.ophtha.2012.07.065; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park SJ, 2014, OPHTHALMOLOGY, V121, P1756, DOI 10.1016/j.ophtha.2014.03.022; Robison CD, 2009, AM J OPHTHALMOL, V148, P79, DOI 10.1016/j.ajo.2009.01.014; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shimada N, 2004, GRAEF ARCH CLIN EXP, V242, P284, DOI 10.1007/s00417-003-0836-0; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Tokoro T, 1988, Acta Ophthalmol Suppl, V185, P107; Uchino E, 2001, ARCH OPHTHALMOL-CHIC, V119, P1475; Wang JJ, 1998, INVEST OPHTH VIS SCI, V39, P2167; Weber-Krause B, 1997, OPHTHALMOLOGE, V94, P619, DOI 10.1007/s003470050170; Weikel KA, 2012, MOL ASPECTS MED, V33, P318, DOI 10.1016/j.mam.2012.03.005; West Emily S., 2005, International Ophthalmology Clinics, V45, P41; Wood A, 2019, AM J OPHTHALMOL, V206, P87, DOI 10.1016/j.ajo.2019.03.018	53	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228468	10.1371/journal.pone.0228468	http://dx.doi.org/10.1371/journal.pone.0228468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995613	gold, Green Published			2022-12-26	WOS:000534609400071
J	Huang, LP; Heuer, OD; Janssen, S; Hackl, D; Schmedt, N				Huang, Liping; Heuer, Olivia Denise; Janssen, Sabrina; Haeckl, Dennis; Schmedt, Niklas			Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database	PLOS ONE			English	Article							COMPLEMENT DEFICIENCY; HEALTH BURDEN; UNITED-STATES; COST; COMPLICATIONS; SEQUELAE; IMPACT	Background Limited data is available to describe clinical characteristics, long-term outcomes, healthcare resource use and the attributable costs of invasive meningococcal disease (IMD) in Germany. We aimed to examine demographic and clinical characteristics as well as healthcare resource use and related costs. Methods We conducted a retrospective cohort study based on the InGef database in patients with IMD between 2009 and 2015. Cases were identified based on hospital main discharge diagnoses of IMD. Demographics, clinical characteristics, 30-day and 1-year mortality as well as IMD-related complications and sequelae in IMD cases were examined. In addition, short and long-term costs and healthcare resource use in IMD cases were analyzed and compared to an age- and sex-matched control group without IMD. Results The study population comprised 164 IMD cases between 2009 and 2015. The mean length of the IMD-related hospitalization was 13 days and 38% of all cases presented with meningitis only, 35% with sepsis only, 16% with both and 11% with other IMD. The 30-day and oneyear mortality were 4.3% and 5.5%, respectively. Approximately 13% of IMD cases had documented IMD-related complications at hospital discharge and 24% suffered from sequelae during follow-up. The IMD-related hospitalization was associated with mean costs of _ 9,620 (standard deviation: _ 22,197). The difference of mean costs between IMD cases and matched non-IMD controls were _ 267 in the first month and _ 1,161 from one month to one year after discharged from IMD-related hospitalization. During the later follow-up period, the mean overall costs and costs associated with individual healthcare sectors were also higher for IMD cases without reaching statistical significance. Conclusions IMD resulted in severe complications and sequelae and was associated with extensive costs and increased healthcare resource use in Germany, especially in the first year after IMD diagnosis and due the IMD-related hospitalization.	[Huang, Liping] Pfizer Inc, Collegeville, PA USA; [Heuer, Olivia Denise; Schmedt, Niklas] Inst Appl Hlth Res Berlin, Berlin, Germany; [Janssen, Sabrina] Pfizer Deutschland GmbH, Berlin, Germany; [Haeckl, Dennis] WIG2 GmbH, Leipzig, Germany	Pfizer; Pfizer	Schmedt, N (corresponding author), Inst Appl Hlth Res Berlin, Berlin, Germany.	niklas.schmedt@ingef.de			Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was supported by Pfizer Inc. The funder provided support in the form of salaries for authors (LH, SJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; Anonychuk A, 2013, PHARMACOECONOMICS, V31, P563, DOI 10.1007/s40273-013-0057-2; Benard S, 2016, J INFECT PUBLIC HEAL, V9, P339, DOI 10.1016/j.jiph.2015.10.016; Borg J, 2009, PEDIATRICS, V123, pe502, DOI 10.1542/peds.2008-0581; Christensen H, 2016, VACCINE, V34, P3412, DOI 10.1016/j.vaccine.2016.04.004; Davis KL, 2011, HUM VACCINES, V7, P458, DOI 10.4161/hv.7.4.14434; Dell'Agnello G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019684; Erickson L, 1998, CLIN INFECT DIS, V26, P1159, DOI 10.1086/520303; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; European Centre for Disease Prevention and Control, 2018, SURV ATL INF DIS; Federal Ministry of Justice and Consumer Protection, 2019, SOC COD BOOK 5; Federal Ministry of Justice and Consumer Protection, 2019, SOC COD BOOK 10; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; Fijen CAP, 1999, CLIN INFECT DIS, V28, P98, DOI 10.1086/515075; German Institute of Medical Documentation and Information, 2018, GERM MOD 10 REV INT; Gustafsson N, 2018, CLINICOECONOMIC OUTC, V10, P563, DOI 10.2147/CEOR.S175835; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Kaplan SL, 2006, PEDIATRICS, V118, pE979, DOI 10.1542/peds.2006-0281; Karve S., 2011, HLTH OUTCOMES RES ME, V2, pe215, DOI DOI 10.1016/J.EHRM.2011.08.001; O'Brien JA, 2006, VALUE HEALTH, V9, P236, DOI 10.1111/j.1524-4733.2006.00113.x; Pelton SI, 2016, J ADOLESCENT HEALTH, V59, pS3, DOI 10.1016/j.jadohealth.2016.04.012; Rober Koch-Institut (RKI), 2016, SIT AUSG INF DEUTSCH; Robert Koch-Institut, 2017, EMPF STA SPAC DIAER; Robert Koch-Institut, 2015, FALLD R KOCH I ZURU; Robert Koch-Institute, 2017, INF JB MELD KRANKH 2; Scholz S, 2019, VACCINE, V37, P1692, DOI 10.1016/j.vaccine.2019.01.013; Stein-Zamir C, 2014, PEDIATR INFECT DIS J, V33, P777, DOI 10.1097/INF.0000000000000282; Stoof SP, 2015, CLIN INFECT DIS, V61, P1281, DOI 10.1093/cid/civ506; Strifler L, 2016, J PEDIAT INF DIS SOC, V5, P417, DOI 10.1093/jpids/piv065; Vazquez JA, 2016, EPIDEMIOL INFECT, V144, P3052, DOI 10.1017/S0950268816001308; Wang B, 2018, PHARMACOECONOMICS; Wang B, 2014, VACCINE, V32, P4791, DOI 10.1016/j.vaccine.2014.05.069	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228020	10.1371/journal.pone.0228020	http://dx.doi.org/10.1371/journal.pone.0228020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990941	gold, Green Published			2022-12-26	WOS:000534605400036
J	Waehrer, GM; Miller, TR; Marques, SCS; Oh, DL; Harris, NB				Waehrer, Geetha M.; Miller, Ted R.; Marques, Sara C. Silverio; Oh, Debora L.; Harris, Nadine Burke			Disease burden of adverse childhood experiences across 14 states	PLOS ONE			English	Article							HOUSEHOLD DYSFUNCTION; ADULT HEALTH; STRESS; RISK; VALIDITY; ABUSE; BEHAVIORS; IMPACT; COEFFICIENTS; SMOKING	Objective To examine whether the relationship between Adverse Childhood Experiences (ACEs) and health outcomes is similar across states and persists net of ACEs associations with smoking, heavy drinking, and obesity. Methods We use data from the Behavioral Risk Factor Surveillance System for 14 states. Logistic regressions yield estimates of the direct associations of ACEs exposure with health outcomes net of health risk factors, and indirect ACEs-health associations via health risk factors. Models were estimated for California (N = 22,475) and pooled data from 13 states (N = 110,076), and also separately by state. Results Exposure to ACEs is associated with significantly higher odds of smoking, heavy drinking, and obesity. Net of these health risk factors, there was a significant and graded relationship in California and the pooled 13-state data between greater ACEs exposure and odds of depression, asthma, COPD, arthritis, and cardiovascular disease. Four or more ACEs were less consistently associated across states with cancer and diabetes and a dose-response relationship was also not present. There was a wide range across individual states in the percentage change in health outcomes predicted for exposure to 4+ ACEs. ACEs-related smoking, heavy drinking, and obesity explain a large and significant proportion of 4+ ACEs associations with COPD and cardiovascular disease, however some effect, absent of risk behavior, remained. Conclusions ACE's associations with most of the health conditions persist independent of behavioral pathways but only asthma, arthritis, COPD, cardiovascular disease, and depression consistently exhibit a dose-response relationship. Our results suggest that attention to child maltreatment and household dysfunction, mental health treatment, substance abuse prevention and promotion of physical activity and healthy weight outcomes might mitigate some adverse health consequences of ACEs. Differences across states in the pattern of ACEs-health associations may also indicate fruitful areas for prevention.	[Waehrer, Geetha M.; Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA; [Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Marques, Sara C. Silverio; Oh, Debora L.; Harris, Nadine Burke] Ctr Youth Wellness, San Francisco, CA USA	Pacific Institute for Research & Evaluation (PIRE); Curtin University	Miller, TR (corresponding author), Pacific Inst Res & Evaluat, Calverton, MD 20705 USA.; Miller, TR (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.	miller@pire.org		Miller, Ted/0000-0002-0958-2639	JPB Foundation [542]	JPB Foundation	This research was funded by a grant from the JPB Foundation (Award #542) to TM.	ACEs Too High, 2017, ACES SCI, V101; Afifi TO, 2018, CHILD ABUSE NEGLECT, V83, pA1, DOI [10.1016/j.chiabu.2018.07.035, 10.1016/j.chiabu.2018.03.007]; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; Arnsten AFT, 2017, CELL, V171, P992, DOI 10.1016/j.cell.2017.11.004; Bair-Merritt MH, 2016, JAMA PEDIATR, V170, P313, DOI 10.1001/jamapediatrics.2015.4459; Bellis MA, 2014, J PUBLIC HEALTH-UK, V36, P81, DOI 10.1093/pubmed/fdt038; Bhan N, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2013-000016; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Bombard JM, 2005, AM J PREV MED, V28, P251, DOI 10.1016/j.amepre.2004.12.004; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; Breen R, 2013, SOCIOL METHOD RES, V42, P164, DOI 10.1177/0049124113494572; Bucci Monica, 2016, Adv Pediatr, V63, P403, DOI 10.1016/j.yapd.2016.04.002; Campbell JA, 2016, AM J PREV MED, V50, P344, DOI 10.1016/j.amepre.2015.07.022; Centers for Disease Control and Prevention, 2019, BRFSS DAT US GUID AT; Centers for Disease Control and Prevention, 2019, BRFSS ADV CHILDH EXP; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; CHROUSOS GP, 1997, GROWTH GENET HORM, V13, P1; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cossman Ronald E, 2008, J Health Hum Serv Adm, V30, P503; Cunningham TJ, 2014, INT J CHRONIC OBSTR, V9, P1033, DOI 10.2147/COPD.S68226; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dubowitz H, 2012, ACAD PEDIATR, V12, P259, DOI 10.1016/j.acap.2012.03.005; Ehring T, 2014, CLIN PSYCHOL REV, V34, P645, DOI 10.1016/j.cpr.2014.10.004; Felitti VJ, 2002, Z PSYCHOSOM MED PSYC, V48, P359; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Felitti VJ, 2014, CHADWICKS CHILD MALT, V2, P203; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; Finkelhor D, 2018, CHILD ABUSE NEGLECT, V85, P174, DOI 10.1016/j.chiabu.2017.07.016; Friedman A, 2017, CELL, V171, P1191, DOI 10.1016/j.cell.2017.10.017; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gilbert LK, 2015, AM J PREV MED, V48, P345, DOI 10.1016/j.amepre.2014.09.006; Gillespie RJ., 2017, JOURN CHILD ADOL TRA, V10, P249, DOI [DOI 10.1007/S40653-017-0138-Z, 10.1007/s40653-017-0138-z]; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Glaser R, 1999, JAMA-J AM MED ASSOC, V281, P2268, DOI 10.1001/jama.281.24.2268; Glowa PT, 2016, J AM BOARD FAM MED, V29, P303, DOI 10.3122/jabfm.2016.03.150310; Haggerty RJ., 1996, STRESS RISK RESILIEN; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; HERD JA, 1991, PHYSIOL REV, V71, P305, DOI 10.1152/physrev.1991.71.1.305; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; IOM NRC, 2014, NEW DIRECTIONS CHILD; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Klein JD, 2007, MED CARE, V45, P691, DOI 10.1097/MLR.0b013e3180326145; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lu Y, 2016, AM ECON J-APPL ECON, V8, P100, DOI 10.1257/app.20140405; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Oppenheimer R, 1986, ANOREXIA NERVOSA BUL, P357; Patten SB, 2015, EPIDEMIOL PSYCH SCI, V24, P158, DOI 10.1017/S2045796014000018; Pickens CM, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6709a1; Reuben A, 2016, J CHILD PSYCHOL PSYC, V57, P1103, DOI 10.1111/jcpp.12621; Ryan-Ibarra S, 2013, CALIFORNIA BEHAV RIS; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Sheikh MA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00727; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wen M, 2012, ETHNIC DIS, V22, P72; Williamson DF, 2002, INT J OBESITY, V26, P1075, DOI 10.1038/sj.ijo.0802038	65	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0226134	10.1371/journal.pone.0226134	http://dx.doi.org/10.1371/journal.pone.0226134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8ZJ	31990910	Green Submitted, gold, Green Published			2022-12-26	WOS:000534605400008
J	Coffey, DM; Royer, MA; Meyer, CG; Holland, KN				Coffey, Daniel M.; Royer, Mark A.; Meyer, Carl G.; Holland, Kim N.			Diel patterns in swimming behavior of a vertically migrating deepwater shark, the bluntnose sixgill (Hexanchus griseus)	PLOS ONE			English	Article							METABOLIC ENZYME-ACTIVITIES; POST-FEEDING THERMOTAXIS; HIDDEN MARKOV-MODELS; BODY ACCELERATION; TEMPERATURE-DEPENDENCE; HYPOXIA TOLERANCE; MOVEMENT BEHAVIOR; XIPHIAS-GLADIUS; OXYGEN LEVELS; BIGEYE TUNA	Diel vertical migration is a widespread behavioral phenomenon where organisms migrate through the water column and may modify behavior relative to changing environmental conditions based on physiological tolerances. Here, we combined a novel suite of biologging technologies to examine the thermal physiology (intramuscular temperature), fine-scale swimming behavior and activity (overall dynamic body acceleration as a proxy for energy expenditure) of bluntnose sixgill sharks (Hexanchus griseus) in response to environmental changes (depth, water temperature, dissolved oxygen) experienced during diel vertical migrations. In the subtropical waters off Hawai`i, sixgill sharks undertook pronounced diel vertical migrations and spent considerable amounts of time in cold (5-7 degrees C), low oxygen conditions (10-25% saturation) during their deeper daytime distribution. Further, sixgill sharks spent the majority of their deeper daytime distribution with intramuscular temperatures warmer than ambient water temperatures, thereby providing them with a significant thermal advantage over non-vertically migrating and smaller-sized prey. Sixgill sharks exhibited relatively high rates of activity during both shallow (night) and deep (day) phases and contrary to our predictions, did not reduce activity levels during their deeper daytime distribution while experiencing low temperature and dissolved oxygen levels. This demonstrates an ability to tolerate the low oxygen conditions occurring within the local oxygen minimum zone. The novel combination of biologging technologies used here enabled innovative in situ deep-sea natural experiments and provided significant insight into the behavioral and physiological ecology of an ecologically important deepwater species.	[Coffey, Daniel M.; Royer, Mark A.; Meyer, Carl G.; Holland, Kim N.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96822 USA; [Coffey, Daniel M.] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA	University of Hawaii System; University of Hawaii Manoa; Texas A&M University System	Coffey, DM (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96822 USA.; Coffey, DM (corresponding author), Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA.	daniel.coffey@tamucc.edu	Holland, Kim/ABH-1490-2021; Coffey, Daniel/K-7599-2019	Coffey, Daniel/0000-0001-5983-0146	PacIOOS, U.S. Integrated Ocean Observing System (IOOS(R)) - National Oceanic and Atmospheric Administration (NOAA) [NA11NOS0120039, NA16NOS0120024]	PacIOOS, U.S. Integrated Ocean Observing System (IOOS(R)) - National Oceanic and Atmospheric Administration (NOAA)	Funding support was provided by PacIOOS (http://www.pacioos.org), which is a part of the U.S. Integrated Ocean Observing System (IOOS (R)), funded in part by National Oceanic and Atmospheric Administration (NOAA) Awards #NA11NOS0120039 and #NA16NOS0120024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank L. Bennett-Jones, E. Cardona, and numerous Shark Lab interns for their invaluable assistance with this study. We also thank J. Muir and the local fishing community for their assistance with tag recovery. We thank J. Drazen, J. Polovina, and A. Wright for providing constructive comments during preparation of the manuscript. We also thank Wildlife Computers for providing the prototype oxygen-sensing tags utilized in this study and for technical advice. This is the Hawai'i Institute of Marine Biology (HIMB) contribution no. 1785 and the School of Ocean and Earth Science and Technology (SOEST) contribution no. 10891.	Almeida-Val VMF, 2000, COMP BIOCHEM PHYS B, V125, P219, DOI 10.1016/S0305-0491(99)00172-8; Andrews KS, 2007, CAN J ZOOL, V85, P1136, DOI 10.1139/Z07-088; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Bingham FM, 1996, DEEP-SEA RES PT II, V43, P199, DOI 10.1016/0967-0645(95)00090-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAREY FG, 1981, FISH B-NOAA, V79, P277; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; CAREY FG, 1995, ENVIRON BIOL FISH, V42, P7, DOI 10.1007/BF00002345; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Childress JJ, 1998, J EXP BIOL, V201, P1223; Coffey D.M., 2015, ANIM BIOTELEM, V3, P47, DOI DOI 10.1186/S40317-015-0088-X; Collins PM, 2015, ECOL EVOL, V5, P4642, DOI 10.1002/ece3.1660; Comfort CM, 2015, DEEP-SEA RES PT II, V115, P116, DOI 10.1016/j.dsr2.2014.04.005; Condon NE, 2012, MAR BIOL, V159, P1713, DOI 10.1007/s00227-012-1960-3; Crow Gerald L., 1996, Pacific Science, V50, P382; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Di Santo V, 2011, J FISH BIOL, V78, P195, DOI 10.1111/j.1095-8649.2010.02853.x; Drazen JC, 2007, LIMNOL OCEANOGR, V52, P2306, DOI 10.4319/lo.2007.52.5.2306; Ebert DA, 2002, S AFR J MARINE SCI, V24, P359, DOI 10.2989/025776102784528439; Ebert DA, 1986, 2 INT C IND FISH TOK; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Friedman JR, 2012, LIMNOL OCEANOGR, V57, P1701, DOI 10.4319/lo.2012.57.6.1701; Gilly WF, 2012, J EXP BIOL, V215, P3175, DOI 10.1242/jeb.072538; Gleiss AC, 2017, HYDROBIOLOGIA, V787, P181, DOI 10.1007/s10750-016-2957-6; Gleiss AC, 2013, MAR BIOL, V160, P2981, DOI 10.1007/s00227-013-2288-3; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2009, REV-METHODS TECHNOL, V9, P211, DOI 10.1007/978-1-4020-9640-2_13; Grassmann M, 2017, ADV MAR BIOL, V78, P89, DOI 10.1016/bs.amb.2017.08.002; Grubbs RD, 2014, 30 AN ELASM SOC S CH; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Herbert NA, 2017, POLAR BIOL, V40, P2297, DOI 10.1007/s00300-017-2142-z; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; HOLLAND KN, 1994, ENVIRON BIOL FISH, V40, P319, DOI 10.1007/BF00002520; HOLLAND KN, 1992, NATURE, V358, P410, DOI 10.1038/358410a0; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Hulbert LB, 2006, J FISH BIOL, V69, P406, DOI 10.1111/j.1095-8649.2006.01175.x; Jacoby DMP, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0781; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kawatsu S, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/732586; King JR, 2017, ENVIRON BIOL FISH, V100, P1543, DOI 10.1007/s10641-017-0664-4; Langrock R, 2015, BIOMETRICS, V71, P520, DOI 10.1111/biom.12282; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Leos-Barajas V, 2017, METHODS ECOL EVOL, V8, P161, DOI 10.1111/2041-210X.12657; Madigan DJ, 2015, P NATL ACAD SCI USA, V112, P8350, DOI 10.1073/pnas.1500524112; McClintock BT, 2018, METHODS ECOL EVOL, V9, P1518, DOI 10.1111/2041-210X.12995; Meekan MG, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00064; Mehner T, 2012, FRESHWATER BIOL, V57, P1342, DOI 10.1111/j.1365-2427.2012.02811.x; Meyer CG, 2012, J EXP BIOL, V215, P3681, DOI 10.1242/jeb.075432; Nakamura I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127667; Nakamura I, 2015, J ANIM ECOL, V84, P590, DOI 10.1111/1365-2656.12346; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; NEILL W H, 1976, Environmental Biology of Fishes, V1, P61, DOI 10.1007/BF00761729; NEILL WH, 1974, SCIENCE, V184, P1008, DOI 10.1126/science.184.4140.1008; NEILSON JD, 1990, ADV MAR BIOL, V26, P115, DOI 10.1016/S0065-2881(08)60200-X; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Nilsson GE, 2008, BIOL REV, V83, P173, DOI 10.1111/j.1469-185X.2008.00038.x; Papastamatiou YP, 2018, MOV ECOL, V6, DOI 10.1186/s40462-018-0127-3; Papastamatiou YP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18608-z; Papastamatiou YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127807; Papastamatiou YP., 2018, SHARK RES EMERG TECH, V3, P83; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Payne NL, 2016, FUNCT ECOL, V30, P903, DOI 10.1111/1365-2435.12618; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2018, R LANG ENV STAT COMP; Rodriguez-Cabello C, 2018, REG STUD MAR SCI, V23, P60, DOI 10.1016/j.rsma.2017.10.015; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Stoehr A, 2018, ICES J MAR SCI, V75, P858, DOI 10.1093/icesjms/fsx163; Urbina MA, 2013, PHYSIOL BIOCHEM ZOOL, V86, P740, DOI 10.1086/673727; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Watanabe YY, 2015, P NATL ACAD SCI USA, V112, P6104, DOI 10.1073/pnas.1500316112; Watanabe YY, 2012, J EXP MAR BIOL ECOL, V426, P5, DOI 10.1016/j.jembe.2012.04.021; WEIHS D, 1973, J MAR RES, V31, P194; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Whitney N.M., 2018, SHARK RES EMERGING T, P45; Whitney NM, 2016, FISH RES, V183, P210, DOI 10.1016/j.fishres.2016.06.003; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2013, STAT COMPUT, V23, P341, DOI 10.1007/s11222-012-9314-z; WURTSBAUGH WA, 1988, NATURE, V333, P846, DOI 10.1038/333846a0; Yeh J, 2009, DEEP-SEA RES PT I, V56, P251, DOI 10.1016/j.dsr.2008.08.005; Zucchini W, 2016, HIDDEN MARKOV MODELS; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	93	13	13	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228253	10.1371/journal.pone.0228253	http://dx.doi.org/10.1371/journal.pone.0228253			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978204	Green Published, Green Submitted, gold			2022-12-26	WOS:000534599100131
J	Min, B; Yoon, H; Park, J; Oh, YL; Kong, WS; Kim, JG; Choi, IG				Min, Byoungnam; Yoon, Hyeokjun; Park, Julius; Oh, Youn-Lee; Kong, Won-Sik; Kim, Jong-Guk; Choi, In-Geol			Unusual genome expansion and transcription suppression in ectomycorrhizal Tricholoma matsutake by insertions of transposable elements	PLOS ONE			English	Article							INDUCED POINT MUTATION; SCHIZOPHYLLUM-COMMUNE; SEQUENCE; ANNOTATION; MODEL; MECHANISMS; EXPRESSION; ALIGNMENT; PROVIDES; SIGNALP	Genome sequencing of Tricholoma matsutake revealed its unusually large size as 189.0 Mbp, which is a consequence of extraordinarily high transposable element (TE) content. We identified that 702 genes were surrounded by TEs, and 83.2% of these genes were not transcribed at any developmental stage. This observation indicated that the insertion of TEs alters the transcription of the genes neighboring these TEs. Repeat-induced point mutation, such as C to T hypermutation with a bias over "CpG" dinucleotides, was also recognized in this genome, representing a typical defense mechanism against TEs during evolution. Many transcription factor genes were activated in both the primordia and fruiting body stages, which indicates that many regulatory processes are shared during the developmental stages. Small secreted protein genes (<300 aa) were dominantly transcribed in the hyphae, where symbiotic interactions occur with the hosts. Comparative analysis with 37 Agaricomycetes genomes revealed that IstB-like domains (PF01695) were conserved across taxonomically diverse mycorrhizal genomes, where the T. matsutake genome contained four copies of this domain. Three of the IstB-like genes were overexpressed in the hyphae. Similar to other ectomycorrhizal genomes, the CAZyme gene set was reduced in T. matsutake, including losses in the glycoside hydrolase genes. The T. matsutake genome sequence provides insight into the causes and consequences of genome size inflation.	[Min, Byoungnam; Park, Julius; Choi, In-Geol] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea; [Yoon, Hyeokjun; Kim, Jong-Guk] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, Daegu, South Korea; [Oh, Youn-Lee; Kong, Won-Sik] RDA, NIHHS, Mushroom Res Div, Eumseong, South Korea; [Min, Byoungnam] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Korea University; Kyungpook National University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; University of California System; University of California Berkeley	Choi, IG (corresponding author), Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea.; Kim, JG (corresponding author), Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, Daegu, South Korea.; Kong, WS (corresponding author), RDA, NIHHS, Mushroom Res Div, Eumseong, South Korea.	wskong@korea.kr; kimjg@knu.ac.kr; igchoi@korea.ac.kr	Choi, In-Geol/F-3152-2013	Choi, In-Geol/0000-0001-7403-6274	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2019R1A2C1089704]; New and Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grants from the Ministry of Trade, Industry and Energy [20173010092460]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); New and Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grants from the Ministry of Trade, Industry and Energy	BM, JP, YO and IC were supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. NRF-2019R1A2C1089704) and New and Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grants from the Ministry of Trade, Industry and Energy (No. 20173010092460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1347-1; [Anonymous], 2004, MUSHROOMS CULTIVATIO; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Beck MR, 2009, MOL MICROBIOL, V72, P344, DOI 10.1111/j.1365-2958.2009.06647.x; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; Coste F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033416; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Garcia K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01734; Hane JK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-478; Hess J, 2014, GENOME BIOL EVOL, V6, P1564, DOI 10.1093/gbe/evu121; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Horns F, 2012, GENOME BIOL EVOL, V4, P240, DOI 10.1093/gbe/evs005; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kim KT, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpfs.2016.00186, 10.3389/fpls.2016.00186]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kumar Sujai, 2013, Frontiers in Genetics, V4, P237, DOI 10.3389/fgene.2013.00237; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Kuo A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00582; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Ludwig A, 2005, J MOL BIOL, V350, P200, DOI 10.1016/j.jmb.2005.03.058; Lum G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar001; Mandric I, 2017, BIOINFORMATICS, V33, P3302, DOI 10.1093/bioinformatics/btx365; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2016, NAT REV MICROBIOL, V14, P760, DOI 10.1038/nrmicro.2016.149; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Min B, 2017, BIOINFORMATICS, V33, P2936, DOI 10.1093/bioinformatics/btx353; Min XJ, 2010, J PROTEOM BIOINFORM, V3, P143, DOI DOI 10.4172/JPB.1000133; Molloy S, 2014, NAT REV MICROBIOL, V12, P458, DOI 10.1038/nrmicro3305; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Nowrousian M., 2014, MYCOTA 13 FUNGAL GEN, V2nd ed, P149; Ohm RA, 2013, ENVIRON MICROBIOL, V15, P943, DOI 10.1111/j.1462-2920.2012.02878.x; Ohm RA, 2011, MOL MICROBIOL, V81, P1433, DOI 10.1111/j.1365-2958.2011.07776.x; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park Hyun, 2010, Mycobiology, V38, P203, DOI 10.4489/MYCO.2010.38.3.203; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Peter M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12662; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Schradert CU, 2017, MOL CELL PROTEOMICS, V16, P1162, DOI 10.1074/mcp.M116.066803; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trudell SA, 2017, MYCOLOGIA, V109, P379, DOI 10.1080/00275514.2017.1326780; WESSELS JGH, 1991, PLANT CELL, V3, P793; Yeo CC, 1997, FEMS MICROBIOL LETT, V149, P257, DOI 10.1111/j.1574-6968.1997.tb10338.x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoon H, 2016, MITOCHONDRIAL DNA A, V27, P3855, DOI 10.3109/19401736.2014.958699; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274	62	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227923	10.1371/journal.pone.0227923	http://dx.doi.org/10.1371/journal.pone.0227923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978083	gold, Green Published, Green Submitted			2022-12-26	WOS:000534599100079
J	O'Brien, CA; Harris, TH				O'Brien, Carleigh A.; Harris, Tajie H.			ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain	PLOS ONE			English	Article							REGULATORY T-CELLS; COMMON VARIABLE IMMUNODEFICIENCY; INDUCIBLE COSTIMULATOR PROTEIN; MOLECULE ICOS; CHRONIC INFLAMMATION; FOXP3 EXPRESSION; IL-10 PRODUCTION; HELPER-CELLS; RECEPTOR; DIFFERENTIATION	Resistance to chronic Toxoplasma gondii infection requires ongoing recruitment of T cells to the brain. Thus, the factors that promote, sustain, and regulate the T cell response to the parasite in the brain are of great interest. The costimulatory molecule ICOS (inducible T cell costimulator) has been reported to act largely through the PI3K pathway in T cells, and can play pro-inflammatory or pro-regulatory roles depending on the inflammatory context and T cell type being studied. During infection with T. gondii, ICOS promotes early T cell responses, while in the chronic stage of infection ICOS plays a regulatory role by limiting T cell responses in the brain. We sought to characterize the role of ICOS signaling through PI3K during chronic infection using two models of ICOS deficiency: total ICOS knockout (KO) mice and ICOS YF mice that are unable to activate PI3K signaling. Overall, ICOS KO and ICOS YF mice had similar severe defects in parasite-specific IgG production and parasite control compared to WT mice. Additionally, we observed expanded effector T cell populations and a loss of Treg frequency in the brains of both ICOS KO and ICOS YF mice. When comparing the remaining Treg populations in infected mice, ICOS KO Tregs expressed WT levels of Foxp3 and CD25, while ICOS YF Tregs expressed significantly less Foxp3 and CD25 compared to both WT and ICOS KO mice. Together, these results suggest that PI3K-independent signaling downstream of ICOS plays an important role in Treg stability in the context of chronic inflammation.	[O'Brien, Carleigh A.; Harris, Tajie H.] Univ Virginia, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22901 USA; [O'Brien, Carleigh A.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 22904 USA	University of Virginia; University of Pennsylvania	Harris, TH (corresponding author), Univ Virginia, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22901 USA.	tajieharris@virginia.edu		O'Brien, Carleigh/0000-0003-4549-0640; Harris, Tajie/0000-0002-1355-2109	National Institutes of Health [R01NS091067, R56NS106028, T32AI007496, 5P30CA044579]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health grants R01NS091067 and R56NS106028 to T.H.H. and T32AI007496 to C.A. O. and National Cancer Institute 5P30CA044579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Eid R, 2014, CANCER IMMUNOL RES, V2, P1080, DOI 10.1158/2326-6066.CIR-14-0095; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Arandi N, 2013, SCAND J IMMUNOL, V77, P405, DOI 10.1111/sji.12040; Azizi G, 2017, CELL IMMUNOL, V315, P11, DOI 10.1016/j.cellimm.2016.12.007; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Clark LB, 1999, J IMMUNOL, V162, P2546; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Cunningham-Rundles C, 2008, J CLIN IMMUNOL, V28, pS42, DOI 10.1007/s10875-008-9182-7; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; Filisetti Denis, 2004, Ann Ist Super Sanita, V40, P71; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Harris T. KC, 2015, J IMMUNOLOGY UNPUB; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629; Landrith TA, 2015, SEMINARS IMMUNOPATHO; Li J, 2013, J IMMUNOL, V191, P200, DOI 10.4049/jimmunol.1203485; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mittrucker HW, 2002, J IMMUNOL, V169, P5813, DOI 10.4049/jimmunol.169.10.5813; Nouailles G, 2011, EUR J IMMUNOL, V41, P981, DOI 10.1002/eji.201040608; O'Brien CA, 2019, J IMMUNOL, V202, P1755, DOI 10.4049/jimmunol.1801229; O'Brien CA, 2017, J IMMUNOL, V198, P4054, DOI 10.4049/jimmunol.1601581; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oliva A, 1997, SCAND J IMMUNOL, V46, P86, DOI 10.1046/j.1365-3083.1997.d01-95.x; Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Roussel L, 2018, J EXP MED, V215, P3151, DOI 10.1084/jem.20180668; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Varzaneh FN, 2014, J CLIN IMMUNOL, V34, P524, DOI 10.1007/s10875-014-0053-0; Villegas EN, 2002, J IMMUNOL, V169, P937, DOI 10.4049/jimmunol.169.2.937; Villegas-Mendez A, 2016, INFECT IMMUN, V84, P34, DOI 10.1128/IAI.01100-15; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Wikenheiser DJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00304; Wikenheiser DJ, 2016, J IMMUNOL, V196, P778, DOI 10.4049/jimmunol.1403206; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wilson EH, 2006, J IMMUNOL, V177, P2365, DOI 10.4049/jimmunol.177.4.2365; Wong GK, 2016, J CLIN PATHOL, V69, P672, DOI 10.1136/jclinpath-2015-203351; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zaretsky AG, 2012, INFECT IMMUN, V80, P3602, DOI 10.1128/IAI.00333-12	67	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228251	10.1371/journal.pone.0228251	http://dx.doi.org/10.1371/journal.pone.0228251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978191	Green Published, gold			2022-12-26	WOS:000534599100130
J	Nakamura, C; Ishii, A; Matsuo, T; Ishida, R; Yamaguchi, T; Takada, K; Uji, M; Yoshikawa, T				Nakamura, Chika; Ishii, Akira; Matsuo, Takashi; Ishida, Rika; Yamaguchi, Takahiro; Takada, Katsuko; Uji, Masato; Yoshikawa, Takahiro			Neural effects of acute stress on appetite: A magnetoencephalography study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; FOOD CHOICE; MENTAL STRESS; FRONTAL POLE; SYNCHRONIZATION; OSCILLATIONS; ACTIVATION; SATIATION; ABSENCE; HUMANS	Stress is prevalent in modern society and can affect human health through its effects on appetite. Therefore, in the present study, we aimed to clarify the neural mechanisms by which acute stress affects appetite in healthy, non-obese males during fasting. In total, 22 volunteers participated in two experiments (stress and control conditions) on different days. The participants performed a stress-inducing speech-and-mental-arithmetic task under both conditions, and then viewed images of food, during which, their neural activity was recorded using magnetoencephalography (MEG). In the stress condition, the participants were told to perform the speech-and-mental-arithmetic task again subsequently to viewing the food images; however, another speech-and-mental-arithmetic task was not performed actually. Subjective levels of stress and appetite were then assessed using a visual analog scale. Electrocardiography was performed to assess the index of heart rate variability reflecting sympathetic nerve activity. The findings showed that subjective levels of stress and sympathetic nerve activity were increased in the MEG session in the stress condition, whereas appetite gradually increased in the MEG session only in the control condition. The decrease in alpha band power in the frontal pole caused by viewing the food images was greater in the stress condition than in the control condition. These findings suggest that acute stress can suppress the increase of appetite, and this suppression is associated with the frontal pole. The results of the present study may provide valuable clues to gain a further understanding of the neural mechanisms by which acute stress affects appetite. However, since the stress examined in the present study was related to the expectation of forthcoming stressful event, our present findings may not be generalized to the stress unrelated to the expectation of forthcoming stressful event.	[Nakamura, Chika; Ishii, Akira; Matsuo, Takashi; Ishida, Rika; Yamaguchi, Takahiro; Takada, Katsuko; Uji, Masato; Yoshikawa, Takahiro] Osaka City Univ, Dept Sports Med, Grad Sch Med, Abeno Ku, Osaka, Japan	Osaka Metropolitan University	Ishii, A (corresponding author), Osaka City Univ, Dept Sports Med, Grad Sch Med, Abeno Ku, Osaka, Japan.	a.ishii@med.osaka-cu.ac.jp		Matsuo, Takashi/0000-0002-7786-9375	JSPS KAKENHI [16H03248]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16H03248 (A.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Forte Science Communications for editorial help with the manuscript and Manryoukai Imaging Clinic for assistance with the MRI scans. This work was supported by JSPS KAKENHI Grant Number 16H03248.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Benelam B, 2009, NUTR BULL, V34, P126, DOI 10.1111/j.1467-3010.2009.01753.x; Berthoud HR, 2006, OBESITY, V14, P197; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; Born JM, 2010, INT J OBESITY, V34, P172, DOI 10.1038/ijo.2009.221; Calvez J, 2011, PHYSIOL BEHAV, V104, P675, DOI 10.1016/j.physbeh.2011.07.012; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Dess NK, 1998, J EXP PSYCHOL-ANIM B, V24, P60, DOI 10.1037/0097-7403.24.1.60; Gerstein DE, 2004, J AM DIET ASSOC, V104, P1151, DOI 10.1016/j.jada.2004.04.027; GRUNBERG NE, 1992, HEALTH PSYCHOL, V11, P97, DOI 10.1037/0278-6133.11.2.97; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Ishii A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16439-6; Kagawa Y, 2008, MAINICHI SHOKUJI KAR; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Khoury B, 2015, J PSYCHOSOM RES, V78, P519, DOI 10.1016/j.jpsychores.2015.03.009; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; McCann L, 2009, PHARM WORLD SCI, V31, P188, DOI 10.1007/s11096-008-9277-5; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Pursey Kirrilly M, 2014, Front Nutr, V1, P7, DOI 10.3389/fnut.2014.00007; Rutters F, 2009, OBESITY, V17, P72, DOI 10.1038/oby.2008.493; Scaife JC, 2016, PSYCHIAT RES-NEUROIM, V258, P44, DOI 10.1016/j.pscychresns.2016.10.004; Science and Technology Agency, 2005, STAND TABL FOOD COMP, V5th ed.; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Seong HM, 2004, P ANN INT IEEE EMBS, V26, P283; Steptoe A, 1998, BRIT J HEALTH PSYCH, V3, P51, DOI 10.1111/j.2044-8287.1998.tb00555.x; Suzuki K, 2012, EXP DIABETES RES, DOI 10.1155/2012/824305; Takada K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21383-0; Tanaka M, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-46; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Yoshikawa T, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0110-3; Yoshikawa T, 2014, BRAIN RES, V1543, P120, DOI 10.1016/j.brainres.2013.11.005; Yoshikawa T, 2013, MED SCI MONITOR, V19, P631, DOI 10.12659/MSM.889234	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0228039	10.1371/journal.pone.0228039	http://dx.doi.org/10.1371/journal.pone.0228039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968008	gold, Green Published			2022-12-26	WOS:000534373000025
J	Bratengeier, C; Liszka, A; Hoffman, J; Bakker, AD; Fahlgren, A				Bratengeier, Cornelia; Liszka, Aneta; Hoffman, Johan; Bakker, Astrid D.; Fahlgren, Anna			High shear stress amplitude in combination with prolonged stimulus duration determine induction of osteoclast formation by hematopoietic progenitor cells	FASEB JOURNAL			English	Article						aseptic loosening; bone marrow; Piezo1; SERCA2; viscoelastic	NITRIC-OXIDE; VISCOELASTIC PROPERTIES; LIPID-BILAYERS; CA2+ INFLUX; FLUID-FLOW; STEM-CELLS; BONE; PIEZO1; FREQUENCY; PRESSURE	To date, it is unclear how fluid dynamics stimulate mechanosensory cells to induce an osteoprotective or osteodestructive response. We investigated how murine hematopoietic progenitor cells respond to 2 minutes of dynamic fluid flow stimulation with a precisely controlled sequence of fluid shear stresses. The response was quantified by measuring extracellular adenosine triphosphate (ATP), immunocytochemistry of Piezo1, and sarcoplasmic/endoplasmic Ca2+ reticulum ATPase 2 (SERCA2), and by the ability of soluble factors produced by mechanically stimulated cells to modulate osteoclast differentiation. We rejected our initial hypothesis that peak wall shear stress rate determines the response of hematopoietic progenitor cells to dynamic fluid shear stress, as it had only a minor correlation with the abovementioned parameters. Low stimulus amplitudes corresponded to activation of Piezo1, SERCA2, low concentrations of extracellular ATP, and inhibition of osteoclastogenesis and resorption area, while high amplitudes generally corresponded to osteodestructive responses. At a given amplitude (3 Pa) and waveform (square), the duration of individual stimuli (duty cycle) showed a strong correlation with the release of ATP and osteoclast number and resorption area. Collectively, our data suggest that hematopoietic progenitor cells respond in a viscoelastic manner to loading, since a combination of high shear stress amplitude and prolonged duty cycle is needed to trigger an osteodestructive response. Plain Language Summary In case of painful joints or missing teeth, the current intervention is to replace them with an implant to keep a high-quality lifestyle. When exercising or chewing, the cells in the bone around the implant experience mechanical loading. This loading generally supports bone formation to strengthen the bone and prevent breaking, but can also stimulate bone loss when the mechanical loading becomes too high around orthopedic and dental implants. We still do not fully understand how cells in the bone can distinguish between mechanical loading that strengthens or weakens the bone. We cultured cells derived from the bone marrow in the laboratory to test whether the bone loss response depends on (i) how fast a mechanical load is applied (rate), (ii) how intense the mechanical load is (amplitude), or (iii) how long each individual loading stimulus is applied (duration). We mimicked mechanical loading as it occurs in the body, by applying very precisely controlled flow of fluid over the cells. We found that a mechanosensitive receptor Piezo1 was activated by a low amplitude stimulus, which usually strengthens the bone. The potential inhibitor of Piezo1, namely SERCA2, was only activated by a low amplitude stimulus. This happened regardless of the rate of application. At a constant high amplitude, a longer duration of the stimulus enhanced the bone-weakening response. Based on these results we deduce that a high loading amplitude tends to be bone weakening, and the longer this high amplitude persists, the worse it is for the bone.	[Bratengeier, Cornelia; Liszka, Aneta; Fahlgren, Anna] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, S-58185 Linkoping, Sweden; [Bakker, Astrid D.] Univ Amsterdam, ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Bakker, Astrid D.] Vrije Univ Amsterdam, Amsterdam Movement Sci, Amsterdam, Netherlands; [Hoffman, Johan] KTH Royal Inst Technol, Dept Computat Sci & Technol, Stockholm, Sweden	Linkoping University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Royal Institute of Technology	Bratengeier, C (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, S-58185 Linkoping, Sweden.	cornelia.bratengeier@liu.se	Bakker, Astrid Diana/AAD-1286-2019; Hoffman, Johan/F-6540-2014	Hoffman, Johan/0000-0003-4256-0463; Bratengeier, Cornelia/0000-0001-9302-0710; Liszka, Aneta/0000-0002-7252-6736	Vetenskapsradet (Swedish Research Council Formas) [2016-01822, 2016-06097, 521-20132593]; VINNOVA (Swedish Governmental Agency for Innovation Systems) [2012-04409]	Vetenskapsradet (Swedish Research Council Formas); VINNOVA (Swedish Governmental Agency for Innovation Systems)(Vinnova)	Vetenskapsradet (Swedish Research Council Formas), Grant/Award Number: 2016-01822, 2016-06097, 521-20132593; VINNOVA (Swedish Governmental Agency for Innovation Systems), Grant/Award Number: 2012-04409	Bacabac RG, 2005, ANN BIOMED ENG, V33, P104, DOI 10.1007/s10439-005-8968-5; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Balleza D, 2012, CHANNELS, V6, P220, DOI 10.4161/chan.21085; BANES AJ, 1990, AM BIOTECHNOL LAB, V8, P12; Bartlett GE, 2009, ACTA ORTHOP, V80, P139, DOI 10.3109/17453670902947382; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Bratengeier C, 2019, J CELL PHYSIOL, V234, P13057, DOI 10.1002/jcp.27976; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; Cinar E, 2015, P NATL ACAD SCI USA, V112, P11783, DOI 10.1073/pnas.1507309112; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; Delaunay C, 2013, CLIN ORTHOP RELAT R, V471, P3863, DOI 10.1007/s11999-013-2935-5; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Fahlgren A, 2018, J ORTHOP RES, V36, P1425, DOI 10.1002/jor.23780; Fahlgren A, 2010, ACTA ORTHOP, V81, P508, DOI 10.3109/17453674.2010.504610; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Frangos J. A., 1993, PHYS FORCES MAMMALIA; Fretwurst T, 2018, J DENT RES, V97, P259, DOI 10.1177/0022034517740560; Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gwam CU, 2017, J ARTHROPLASTY, V32, P2088, DOI 10.1016/j.arth.2017.02.046; Hatami J, 2013, EXP MECH, V53, P1291, DOI 10.1007/s11340-013-9744-3; Hoebertz A, 2000, BONE, V27, P503, DOI 10.1016/S8756-3282(00)00351-3; Hsieh YF, 2001, J BONE MINER RES, V16, P918, DOI 10.1359/jbmr.2001.16.5.918; Hu JJ, 2018, J MECH BEHAV BIOMED, V86, P1, DOI 10.1016/j.jmbbm.2018.05.038; Jafarabadi MR, 2016, LASER MED SCI, V31, P1827, DOI 10.1007/s10103-016-2058-9; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Jorgensen NR, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/673684; KARRHOLM J, 1994, J BONE JOINT SURG BR, V76B, P912, DOI 10.1302/0301-620X.76B6.7983118; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Kumar A, 2016, METHODS APPL FLUORES, V4, DOI [10.1088/2050-6120/4/4044008, 10.1088/2050-6120/4/4/044008]; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Lenneras M, 2018, J TISSUE ENG REGEN M, V12, P1728, DOI 10.1002/term.2700; Lewis AH, 2017, CELL REP, V19, P2572, DOI 10.1016/j.celrep.2017.05.079; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Lim CG, 2018, BMB REP, V51, P623, DOI 10.5483/BMBRep.2018.51.12.237; Lloyd SA, 2014, J BONE MINER RES, V29, P275, DOI 10.1002/jbmr.2165; Mahmmoud YA, 2008, J BIOL CHEM, V283, P21418, DOI 10.1074/jbc.M803654200; Maneshi MM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00069; Mann KA, 2014, COMPUT METHOD BIOMEC, V17, P1809, DOI 10.1080/10255842.2013.767336; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Morse A, 2014, J BONE MINER RES, V29, P2456, DOI 10.1002/jbmr.2278; Nagaraja Mamta Patel, 2014, Life-Basel, V4, P117, DOI 10.3390/life4020117; NAVAB M, 1991, J CLIN INVEST, V87, P1763, DOI 10.1172/JCI115195; Nilsson KG, 1996, J BONE JOINT SURG BR, V78B, P1; Praetorius HA, 2015, AM J PHYSIOL-CELL PH, V308, pC198, DOI 10.1152/ajpcell.00336.2014; Qiang YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28503-w; Roe AT, 2019, CARDIOVASC RES, V115, P752, DOI 10.1093/cvr/cvy257; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shibamoto A, 2018, INT J ORAL SCI, V10, DOI 10.1038/s41368-018-0009-y; Singh M, 2016, EXP HEMATOL, V44, P1181, DOI 10.1016/j.exphem.2016.08.009; Skripitz R, 2000, J ORTHOPAED RES, V18, P481, DOI 10.1002/jor.1100180322; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/NMETH.2647, 10.1038/nmeth.2647]; Tamai N, 2013, HIGH PRESSURE RES, V33, P271, DOI 10.1080/08957959.2013.767900; Teng JF, 2015, PFLUG ARCH EUR J PHY, V467, P27, DOI 10.1007/s00424-014-1530-2; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Uline MJ, 2012, BIOPHYS J, V102, P517, DOI 10.1016/j.bpj.2011.12.050; Vainionpaa A, 2006, OSTEOPOROSIS INT, V17, P455, DOI 10.1007/s00198-005-0005-x; van der Meer AD, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3366720; Vanleene M, 2013, BONE, V53, P507, DOI 10.1016/j.bone.2013.01.023; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wall M, 2018, J ORTHOP RES, V36, P605, DOI 10.1002/jor.23707; Wang YB, 2018, J PHYSIOL-LONDON, V596, P969, DOI 10.1113/JP274404; Watanabe N, 2006, BIOPHYS J, V91, P1984, DOI 10.1529/biophysj.105.060236; Wechalekar MD, 2014, WORLD J ORTHOP, V5, P566, DOI 10.5312/wjo.v5.i5.566; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Wu J, 2017, CELL REP, V21, P2357, DOI 10.1016/j.celrep.2017.10.120; Zhang TX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01712-z; Zheng WJ, 2017, PROTEINS, V85, P2198, DOI 10.1002/prot.25384	80	8	8	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3755	3772		10.1096/fj.201901458R	http://dx.doi.org/10.1096/fj.201901458R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957079	Green Published			2022-12-26	WOS:000508136200001
J	Clavel-Henry, M; Sole, J; Kristiansen, T; Bahamon, N; Rotllant, G; Company, JB				Clavel-Henry, Morane; Sole, Jordi; Kristiansen, Trond; Bahamon, Nixon; Rotllant, Guiomar; Company, Joan B.			Modeled buoyancy of eggs and larvae of the deep-sea shrimp Aristeus antennatus (Crustacea: Decapoda) in the northwestern Mediterranean Sea	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; WATER MASSES; TRANSPORT; BEHAVIOR; CATALAN; CONNECTIVITY; SURFACE; EDDY; CIRCULATION; ECOLOGY	Information on the buoyancy of eggs and larvae from deep-sea species is rare but necessary for explaining the position of non-swimming larvae in the water column. Due to embryonic morphology and ecology diversities, egg buoyancy has important variations within one species and among other ones. Nevertheless, it has hardly been explored if this buoyancy variability can be a strategy for deep-sea larvae to optimize their transport beyond their spawning areas. In the northwestern Mediterranean Sea, protozoea and mysis larvae of the commercial deep-sea shrimp Aristeus antennatus were recently found in upper layers, but to present, earlier stages like eggs and nauplii have not been collected. Using a Lagrangian transport model and larval characteristics, we evaluate the buoyancy and hydrodynamic effects on the transport of A. antennatus' larvae in the northwestern Mediterranean Sea. The transport models suggested that 75% of buoyant eggs released between 500 and 800 m depth (i.e., known spawning area), reached the upper water layers (0-75 m depth). Then, according to the modeled larval drifts, three spawning regions were defined in the studied area: 1) the northern part, along a continental margin crossed by large submarine canyons; 2) the central part, with two circular circulation structures (i.e., eddies); and 3) the southern part, with currents flowing through a channel. The number of larvae in the most upper layer (0-5 m depth) was higher if the larval transport model accounted for the ascent of eggs and nauplii (81%) instead of eggs reaching the surface before hatching (50%). The larvae reaching the most water upper layer (0-5 m depth) had higher rates of dispersal than the ones transported below the surface layer (deeper than 5 m depth). The results of larval dispersal simulations have implications for the understanding of A. antennatus larval ecology and for management decisions related to the shrimp fisheries in the northwestern Mediterranean Sea.	[Clavel-Henry, Morane; Bahamon, Nixon; Rotllant, Guiomar; Company, Joan B.] CSIC, Inst Ciencies Mar, Dept Renewable Marine Resources, Barcelona, Spain; [Sole, Jordi] CSIC, Inst Ciencies Mar, Dept Phys & Technol Oceanog, Barcelona, Spain; [Kristiansen, Trond] Norwegian Inst Water Res, Dept Marine Biogeochem & Oceanog, Oslo, Norway; [Bahamon, Nixon] CSIC, Ctr Estudios Avanzados Blanes, Blanes, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Norwegian Institute for Water Research (NIVA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Clavel-Henry, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Renewable Marine Resources, Barcelona, Spain.	morane@icm.csic.es	Bahamon, Nixon/O-2476-2019; Bahamon, Nixon/K-8922-2014; Rotllant, Guiomar/I-1838-2013; CLAVEL-HENRY, Morane/AAA-5019-2022; Solé, Jordi/T-3862-2019	Bahamon, Nixon/0000-0002-5802-7367; Bahamon, Nixon/0000-0002-5802-7367; Rotllant, Guiomar/0000-0002-6692-9678; CLAVEL-HENRY, Morane/0000-0002-2491-6203; Solé, Jordi/0000-0002-2371-1652; Kristiansen, Trond/0000-0001-6121-297X	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana within the CONECTA project [BES-2015-074126, CTM2014-54648-C2-1-R]; Spanish project CONECTA from the ICM-CSIC in Barcelona (ES) [CTM2014-54648-C2-1-R]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana within the CONECTA project; Spanish project CONECTA from the ICM-CSIC in Barcelona (ES)	This work was supported by the Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (BES-2015-074126) to support her PhD within the CONECTA project (CTM2014-54648-C2-1-R) to MC-H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The main author thanks all the Norwegian researchers from NIVA (Oslo, NO) who contributed to this paper: Johannes Rohrs, Knut-Frode Dagestad, Trine Bekkby and her family. The main author also thanks the editing from Hanna Morrissette and the advice from Elizabeth North from HPL-UMCES in Maryland (US). This study was possible thanks to the Spanish project CONECTA (CTM2014-54648-C2-1-R) lead from the ICM-CSIC in Barcelona (ES).	Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Carbonell A, 1999, FISH RES, V44, P1, DOI 10.1016/S0165-7836(99)00079-X; Carreton M, 2010, PEERJ, V7, pe6063; Chu KH, 1996, CRUSTACEANA, V69, P368, DOI 10.1163/156854096X00961; CHU KH, 1994, J EXP MAR BIOL ECOL, V183, P11, DOI 10.1016/0022-0981(94)90153-8; Clavel-Henry M, 2019, OCEAN SCI, V15, P1745, DOI 10.5194/os-15-1745-2019; Coll M, 2016, ECOL MODEL, V331, P100, DOI 10.1016/j.ecolmodel.2016.03.020; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Coombs SH, 2004, MAR BIOL, V145, P959, DOI 10.1007/s00227-004-1389-4; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Criales MM, 2015, MAR COAST FISH, V7, P148, DOI 10.1080/19425120.2014.1001541; Dagestad KF, 2018, GEOSCI MODEL DEV, V11, P1405, DOI 10.5194/gmd-11-1405-2018; DALL W, 1990, ADV MAR BIOL, V27, P1; Dallavalle JM, 1948, TECHNOLOGY FINE PART, P11; DEMESTRE M, 1992, MAR ECOL PROG SER, V84, P41, DOI 10.3354/meps084041; Dobkin S., 1960, P GULF CAR FISH I MI, V12; Escudier R, 2016, J GEOPHYS RES-OCEANS, V121, P3990, DOI 10.1002/2015JC011371; Fiedler PC, 2010, LIMNOL OCEANOGR-METH, V8, P313, DOI 10.4319/lom.2010.8.313; Fofonof NP, 1983, UNESCO TECHNICAL PAP, V44, Patent No. 53; GarciaLadona E, 1996, OCEANOL ACTA, V19, P489; Gorelli G., 2014, MAR STEWARD COUNC SC, V2, P116; GURNEY R, 1942, LARVAE DECAPOD CRUST; Heldt H., 1938, ANN I OCEANOGRAPHIQU, V18, P1; HERRING PJ, 1974, MAR BIOL, V25, P25, DOI 10.1007/BF00395105; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Hill AE, 1996, OCEANOL ACTA, V19, P357; Houpert L, 2015, PROG OCEANOGR, V132, P333, DOI 10.1016/j.pocean.2014.11.004; Karimova S., 2016, ESA LIV PLAN S NETH; Kristiansen T, 2009, BEHAV ECOL, V20, P490, DOI 10.1093/beheco/arp023; La Violette PE, 1995, SEASONAL INTERANNUAL, P1, DOI [10.1029/CE046p0001, DOI 10.1029/CE046P0001]; LAFUENTE JG, 1995, OCEANOL ACTA, V18, P245; Lindley JA, 1997, J CRUSTACEAN BIOL, V17, P569, DOI 10.2307/1549361; Lloyd MJ, 2012, MAR ECOL PROG SER, V469, P37, DOI 10.3354/meps09983; LOPEZ GARCIA MJ, 1994, J GEOPHYS RES-OCEANS, V99, P3285, DOI 10.1029/93JC02114; Macias D, 2014, ECOL MODEL, V281, P26, DOI 10.1016/j.ecolmodel.2014.03.002; Manca B, 2004, J MARINE SYST, V48, P83, DOI 10.1016/j.jmarsys.2003.11.025; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; Maynou F, 2008, J MARINE SYST, V71, P294, DOI 10.1016/j.jmarsys.2006.09.008; Nencioli F, 2010, J ATMOS OCEAN TECH, V27, P564, DOI 10.1175/2009JTECHO725.1; North EW, 2009, ICES INT COUNC EXPLO; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Palmas F, 2017, FISH OCEANOGR, V26, P364, DOI 10.1111/fog.12199; Pandian TJ, 2016, REPROD DEV AQUATIC I, P27; Parada C, 2003, FISH OCEANOGR, V12, P170, DOI 10.1046/j.1365-2419.2003.00235.x; Pinot JM, 2002, PROG OCEANOGR, V55, P335, DOI 10.1016/S0079-6611(02)00139-8; Pongtippatee-Taweepreda P, 2004, AQUACULTURE, V234, P183, DOI 10.1016/j.aquaculture.2003.10.036; PRICE ARG, 1982, J NAT HIST, V16, P745, DOI 10.1080/00222938200770571; Queiroga H, 2005, ADV MAR BIOL, V47, P107; Rosa R, 2007, MAR BIOL, V151, P935, DOI 10.1007/s00227-006-0535-6; Rossi V, 2014, GEOPHYS RES LETT, V41, P2883, DOI 10.1002/2014GL059540; Rothlisberg PC, 2013, BIOPHYSICS MARINE LA, P235, DOI [10.1029/CE045p0235, DOI 10.1029/CE045P0235]; Rubio A, 2005, PROG OCEANOGR, V66, P142, DOI 10.1016/j.pocean.2004.07.012; Rubio A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004245; Sabates A, 2013, J MARINE SYST, V111, P108, DOI 10.1016/j.jmarsys.2012.10.002; SALAT J, 1995, OCEANOL ACTA, V18, P227; Sarda F, 2003, J SHELLFISH RES, V22, P569; Sarda F, 2009, PROG OCEANOGR, V82, P227, DOI 10.1016/j.pocean.2009.07.001; Sayol JM, 2013, J GEOPHYS RES-OCEANS, V118, P6371, DOI 10.1002/2013JC009243; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; Subrahmanyam C. B., 1965, Journal of the Marine Biological Association of India, V7, P83; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Sundby S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138821; Tavares C, 2010, TREATISE ON ZOOLOGY-ANATOMY, TAXONOMY, BIOLOGY: THE CRUSTACEA, VOL 9, PT A, P99; Temple RF, 1967, US FISH WILDL SERV F, V66, P323; Thorpe SA, 2007, INTRODUCTION TO OCEAN TURBULENCE, P1; Torres AP, 2014, J MARINE SYST, V138, P112, DOI 10.1016/j.jmarsys.2013.11.017; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275; Warner JC, 2005, OCEAN MODEL, V8, P81, DOI 10.1016/j.ocemod.2003.12.003	74	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0223396	10.1371/journal.pone.0223396	http://dx.doi.org/10.1371/journal.pone.0223396			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995553	Green Published, gold, Green Submitted			2022-12-26	WOS:000534609400005
J	Brehm, AM; Tironi, S; Mortelliti, A				Brehm, Allison M.; Tironi, Sara; Mortelliti, Alessio			Effects of trap confinement on personality measurements in two terrestrial rodents	PLOS ONE			English	Article							ANIMAL PERSONALITY; INDIVIDUAL VARIATION; BEHAVIORAL SYNDROMES; NATURAL-SELECTION; EASTERN CHIPMUNKS; STRESS-RESPONSE; RISK-TAKING; FIELD-TEST; FEMALE; URBANIZATION	In recent years, consistent individual differences in behavior, or personalities, have been a topic of increasing interest as researchers strive to understand and predict the responses of individuals and populations to anthropogenic changes. Behavioral studies in wild populations often require that animals are live trapped before behavioral observation can occur, and this is especially true in studies investigating animal personalities. However, it is unknown whether the amount of time confined to a live trap may regulate the behavior of trapped individuals. Specifically, if the duration of trap confinement directly influences behavior, then by obtaining wild animals through live trapping we may be confounding the very measurements of greatest interest. To investigate whether the duration of trap confinement influences the behavior of trapped individuals, we performed a study on two small mammal species, focusing specifically on personality traits. We positioned high-definition trail cameras facing Longworth small mammal traps in the field to observe capture events and record the time of capture. We then measured personality in captured deer mice (Peromyscus maniculatus) and southern red-backed voles (Myodes gapperi) using three standardized tests, and through linear and generalized linear models we found that the time an animal had spent confined to a trap before testing did not affect 86% of behaviors exhibited. Our results showed two weak behavioral effects of confinement duration on boldness and docility resulting from an interaction between the duration of confinement and whether or not an individual was naive to trapping. Our results suggest that behavioral measurements of wild, trapped small mammals are not determined by the time spent confined to a trap. However, researchers should use caution and consider whether an animal is naive to trapping during analysis since habituation to the live trap may play a role in the effects of confinement duration on behavior.	[Brehm, Allison M.; Tironi, Sara; Mortelliti, Alessio] Univ Maine, Dept Wildlife Fisheries & Conservat Biol, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Mortelliti, A (corresponding author), Univ Maine, Dept Wildlife Fisheries & Conservat Biol, Orono, ME 04469 USA.	alessio.mortelliti@maine.edu			USDA National Institute of Food and Agriculture [ME041620, ME041913]; University of Maine; American Society of Mammalogists; Penobscot Experimental Forest Research Funds	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of Maine; American Society of Mammalogists; Penobscot Experimental Forest Research Funds	AM received funds for McIntire Stennis project numbers ME041620 and ME041913 through the Maine Agricultural & Forest Experiment Station supported by the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/program/mcintire-stennis-capacity-grant), AM received funding from the the University of Maine RRF Graduate Assistantship and RRF Undergraduate Assistantship, AMB received funds from the American Society of Mammalogists (Grants in aid of Research) and AM received funds from the Penobscot Experimental Forest Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett Samuel A., 1976, RAT STUDY BEHAV; Bates D., 2015, LME4 LINEAR MIXED EF; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Benevides FL, 2008, J WILDLIFE MANAGE, V72, P1434, DOI 10.2193/2006-519; Berger-Tal O, 2016, CONSERV BIOL, V30, P744, DOI 10.1111/cobi.12654; Bergvall UA, 2011, ANIM BEHAV, V81, P101, DOI 10.1016/j.anbehav.2010.09.018; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Boonstra R, 2009, REPROD ALL COSTS ADA, V82, P1930; Bosson CO, 2012, J ZOOL, V288, P159, DOI 10.1111/j.1469-7998.2012.00941.x; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Brehm AM, 2019, ECOL LETT, V22, P1387, DOI 10.1111/ele.13324; Brehm AM, 2018, ANIM BEHAV, V142, P101, DOI 10.1016/j.anbehav.2018.06.009; Brissette JC, 2014, GTRNRSP123 USDA, P1; Brown C, 2005, BEHAV ECOL, V16, P482, DOI 10.1093/beheco/ari016; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C., 2013, ANIMAL PERSONALITIES; Carter AJ, 2014, J EVOLUTION BIOL, V27, P815, DOI 10.1111/jeb.12358; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carter AJ, 2010, BEHAV ECOL, V21, P655, DOI 10.1093/beheco/arq036; Choleris E, DETAILED ETHOLOGICAL; Cleasby IR, 2015, METHODS ECOL EVOL, V6, P27, DOI 10.1111/2041-210X.12281; Dammhahn M, 2012, ANIM BEHAV, V84, P1131, DOI 10.1016/j.anbehav.2012.08.014; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Eccard J. A., 2013, BMC ECOLOGY, V13, P61, DOI [10.1016/j.anbehav.2015.02.007, DOI 10.1016/J.ANBEHAV.2015.02.007]; Fernandez-Teruel A, 2016, NAT REV NEUROSCI, V17, P591, DOI 10.1038/nrn.2016.102; Fletcher QE, 2006, J ZOOL, V270, P473, DOI 10.1111/j.1469-7998.2006.00153.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gracceva G, 2014, ETHOLOGY, V120, P753, DOI 10.1111/eth.12246; Haage M, 2017, OECOLOGIA, V183, P45, DOI 10.1007/s00442-016-3740-0; Harper JM, 2001, GEN COMP ENDOCR, V123, P337, DOI 10.1006/gcen.2001.7682; Kalueff AV, 2016, NAT REV NEUROSCI, V17, P45, DOI 10.1038/nrn.2015.8; Kenagy NJPGJ, 2000, SEASONAL CHANGES PLA, P245; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lapiedra O, 2018, SCIENCE, V360, P1017, DOI 10.1126/science.aap9289; Lapiedra O, 2017, GLOBAL CHANGE BIOL, V23, P592, DOI 10.1111/gcb.13395; Larkin RP, 2003, WILDLIFE SOC B, V31, P392; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Mazzamuto MV, 2019, ETHOL ECOL EVOL, V31, P38, DOI 10.1080/03949370.2018.1488768; Merrick MJ, 2017, BIOL CONSERV, V209, P34, DOI 10.1016/j.biocon.2017.01.021; Miranda AC, 2013, GLOBAL CHANGE BIOL, V19, P2634, DOI 10.1111/gcb.12258; Montiglio PO, 2012, ANIM BEHAV, V84, P1071, DOI 10.1016/j.anbehav.2012.08.010; Ortiz RM, 2000, COMP BIOCHEM PHYS A, V125, P317, DOI 10.1016/S1095-6433(00)00158-6; Pennisi E, 2016, SCIENCE, V352, P644, DOI 10.1126/science.352.6286.644; Perals D, 2017, ANIM BEHAV, V123, P69, DOI 10.1016/j.anbehav.2016.10.006; R Core Team, 2017, LANG ENV STAT COMP; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Reeder DM, 2004, GEN COMP ENDOCR, V136, P260, DOI 10.1016/j.ygcen.2003.12.020; Sapolsky RM, 2000, DO GLUCOCORTICOIDS I; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Taylor RW, 2014, J EVOLUTION BIOL, V27, P2308, DOI 10.1111/jeb.12495; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; Walsh RN, 1976, PSYCHOL B; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Wong BBM, 2015, BEHAV ECOL, V26, P665, DOI 10.1093/beheco/aru183; Zuur Alain F., 2009, P1	66	8	8	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0221136	10.1371/journal.pone.0221136	http://dx.doi.org/10.1371/journal.pone.0221136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986141	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400006
J	Caudell, MA; Dorado-Garcia, A; Eckford, S; Creese, C; Byarugaba, DK; Afakye, K; Chansa-Kabali, T; Fasina, FO; Kabali, E; Kiambi, S; Kimani, T; Mainda, G; Mangesho, PE; Chimpangu, F; Dube, K; Kikimoto, BB; Koka, E; Mugara, T; Rubegwa, B; Swiswa, S				Caudell, Mark A.; Dorado-Garcia, Alejandro; Eckford, Suzanne; Creese, Chris; Byarugaba, Denis K.; Afakye, Kofi; Chansa-Kabali, Tamara; Fasina, Folorunso O.; Kabali, Emmanuel; Kiambi, Stella; Kimani, Tabitha; Mainda, Geoffrey; Mangesho, Peter E.; Chimpangu, Francis; Dube, Kululeko; Kikimoto, Bashiru Boi; Koka, Eric; Mugara, Tendai; Rubegwa, Bachana; Swiswa, Samuel			Towards a bottom-up understanding of antimicrobial use and resistance on the farm: A knowledge, attitudes, and practices survey across livestock systems in five African countries	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC USE; ONE HEALTH; USAGE; FOOD; PROVINCE; ANIMALS; TRENDS	The nutritional and economic potentials of livestock systems are compromised by the emergence and spread of antimicrobial resistance. A major driver of resistance is the misuse and abuse of antimicrobial drugs. The likelihood of misuse may be elevated in low- and middle-income countries where limited professional veterinary services and inadequately controlled access to drugs are assumed to promote non-prudent practices (e.g., self-administration of drugs). The extent of these practices, as well as the knowledge and attitudes motivating them, are largely unknown within most agricultural communities in low- and middle-income countries. The main objective of this study was to document dimensions of knowledge, attitudes and practices related to antimicrobial use and antimicrobial resistance in livestock systems and identify the livelihood factors associated with these dimensions. A mixed-methods ethnographic approach was used to survey households keeping layers in Ghana (N = 110) and Kenya (N = 76), pastoralists keeping cattle, sheep, and goats in Tanzania (N = 195), and broiler farmers in Zambia (N = 198), and Zimbabwe (N = 298). Across countries, we find that it is individuals who live or work at the farm who draw upon their knowledge and experiences to make decisions regarding antimicrobial use and related practices. Input from animal health professionals is rare and antimicrobials are sourced at local, privately owned agrovet drug shops. We also find that knowledge, attitudes, and particularly practices significantly varied across countries, with poultry farmers holding more knowledge, desirable attitudes, and prudent practices compared to pastoralist households. Multivariate models showed that variation in knowledge, attitudes and practices is related to several factors, including gender, disease dynamics on the farm, and source of animal health information. Study results emphasize that interventions to limit antimicrobial resistance should be founded upon a bottom-up understanding of antimicrobial use at the farm-level given limited input from animal health professionals and under-resourced regulatory capacities within most low- and middle-income countries. Establishing this bottom-up understanding across cultures and production systems will inform the development and implementation of the behavioral change interventions to combat antimicrobial resistance globally.	[Caudell, Mark A.; Kiambi, Stella; Kimani, Tabitha] Food & Agr Org United Nations, Nairobi, Kenya; [Dorado-Garcia, Alejandro; Eckford, Suzanne; Creese, Chris] Food & Agr Org United Nations, Rome, Italy; [Byarugaba, Denis K.] Makerere Univ, Coll Vet Med, Kampala, Uganda; [Afakye, Kofi] Food & Agr Org United Nations, Accra, Ghana; [Chansa-Kabali, Tamara] Univ Zambia, Dept Psychol, Lusaka, Zambia; [Fasina, Folorunso O.; Rubegwa, Bachana] Food & Agr Org United Nat, Dar Es Salaam, Tanzania; [Kabali, Emmanuel; Dube, Kululeko; Mugara, Tendai] Food & Agr Org United Nat, Harare, Zimbabwe; [Mainda, Geoffrey] Minist Fisheries & Livestock, Dept Vet Serv, Lusaka, Zambia; [Mangesho, Peter E.] Natl Inst Med Res, Amani Med Res Ctr, Muheza, Tanzania; [Chimpangu, Francis] Food & Agr Org United Nations, Lusaka, Zambia; [Kikimoto, Bashiru Boi] Vet Serv, Publ Hlth & Food Safety Unit, Accra, Ghana; [Koka, Eric] Univ Cape Coast, Dept Sociol & Anthropol, Cape Coast, Ghana; [Swiswa, Samuel] Dept Livestock & Vet Serv, Div Vet Serv, Harare, Zimbabwe	Food & Agriculture Organization of the United Nations (FAO); Food & Agriculture Organization of the United Nations (FAO); Makerere University; Food & Agriculture Organization of the United Nations (FAO); University of Zambia; Food & Agriculture Organization of the United Nations (FAO); National Institute of Medical Research; University of Cape Coast	Caudell, MA (corresponding author), Food & Agr Org United Nations, Nairobi, Kenya.	mcaudell@wsu.edu	Kabali, Emmanuel/GSJ-3023-2022; eckford, suzanne/AAG-4116-2021; Fasina, Folorunso/B-6360-2015	Kabali, Emmanuel/0000-0003-3132-7789; Fasina, Folorunso/0000-0003-3088-8752; MANGESHO, PETER/0000-0003-0067-8375	Fleming Fund of the United Kingdom [GCP/GLO/710/UK]	Fleming Fund of the United Kingdom	This research was funded by a grant from the Fleming Fund of the United Kingdom (https://www.flemingfund.org/) to the Food and Agriculture Organization of the United Nations (GCP/GLO/710/UK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afema JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152130; Auta A, 2018, J INFECT; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Bett B, 2004, PREV VET MED, V63, P29, DOI 10.1016/j.prevetmed.2004.02.004; Boamah V.E., 2016, PRACTICES FACTORS IN; Caudell MA, 2019, PASTORALISM, V9, DOI 10.1186/s13570-019-0142-z; Caudell MA, 2018, LANCET PLANET HEALTH, V2, pE489, DOI [10.1016/S2542-5196(18)30225-0, 10.1016/s2542-5196(18)30225-0]; Caudell MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170328; Caudell MA, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0135-1; Cohen J., 2003, APPL MULTIPLE REGRES; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Cox JA, 2017, CLIN MICROBIOL INFEC, V23, P812, DOI 10.1016/j.cmi.2017.07.010; Creswell J.W., 2007, DESIGNING CONDUCTING; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Day MJ, 2019, LANCET INFECT DIS; Delespaux V, 2002, VET PARASITOL, V110, P117, DOI 10.1016/S0304-4017(02)00316-3; Dorado-Garcia A, 2018, J ANTIMICROB CHEMOTH, V73, P339, DOI 10.1093/jac/dkx397; Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706; Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881; Gauthier J., 1999, CITESEER, P133; Gehring R, 2002, J S AFR VET ASSOC, V73, P185; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Hendriksen RS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08853-3; Higham LE, 2016, TROP ANIM HEALTH PRO, V48, P1633, DOI 10.1007/s11250-016-1137-z; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Johnson S, 2019, ANIM PROD SCI, V59, P177, DOI 10.1071/AN16832; Katakweba AAS, 2015, J APPL MICROBIOL, V118, P966, DOI 10.1111/jam.12738; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Macaro G., 2018, INTERNAL REPORT; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; MATHER AE, 2011, P BIOL SCI, V279, P1630, DOI DOI 10.1098/rspb.2011.1975; Mbugua M.W., 2014, ANAL DEMAND ANTIBIOT; Mubito E.P., 2014, AM J RES COMM, V2, P51; Neter J., 1996, APPL LINEAR STAT MOD; Ngumbi AF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2544-3; Nonga HE, 2010, ZOONOSES PUBLIC HLTH, V57, P339, DOI 10.1111/j.1863-2378.2008.01226.x; O'Brien RM, 2017, SOC SCI QUART, V98, P360, DOI 10.1111/ssqu.12273; Ojo OE, 2016, TROP ANIM HEALTH PRO, V48, P189, DOI 10.1007/s11250-015-0939-8; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Palmer GH, 2013, ANTIMICROBIAL RESIST; Pearson M, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1599560; Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048; Roderick S, 2000, TROP ANIM HEALTH PRO, V32, P361, DOI 10.1023/A:1005277518352; Roope LSJ, 2019, SCIENCE, V364, P41, DOI 10.1126/science.aau4679; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sones KR, 2003, P INT C HELD MOMB KE; Turkson P, 2008, GHANA J AGR SCI, V41; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Health Organization Food and Agriculture Organization of the United Nations Health WOfA, 2016, ANT RES MAN DEV NAT; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	56	55	55	8	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0220274	10.1371/journal.pone.0220274	http://dx.doi.org/10.1371/journal.pone.0220274			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978098	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100005
J	Eves, FF				Eves, Frank F.			When weight is an encumbrance; avoidance of stairs by different demographic groups	PLOS ONE			English	Article							OF-DECISION PROMPTS; PHYSICAL-ACTIVITY; WORKPLACE INTERVENTION; CLIMBING INTERVENTION; HUMAN LOCOMOTION; ENERGETIC COST; PERCEPTION; CHOICE; ASSOCIATION; GLUCOSE	Background Locomotion is an energy costly behaviour, particularly when it entails raising weight against gravity. Minimization of locomotor costs appears a universal default. Avoidance of stair climbing helps humans minimise their energetic costs. In public access settings, demographic subgroups that raise more 'dead' weight than their comparison groups when climbing are more likely to avoid stairs by choosing the escalator. Individuals who minimise stair costs at work, however, can accumulate a deficit in energy expenditure in daily life with potential implications for weight gain. This paper tests the generality of avoidance of stairs in pedestrians encumbered by additional weight in three studies. Methods Pedestrian choices for stairs or the alternative were audited by trained observers who coded weight status, presence of large bags and sex for each pedestrian. Sex-specific silhouettes for BMIs of 25 facilitated coding of weight status. Choices between stairs and a lift to ascend and descend were coded in seven buildings (n = 26,981) and at an outdoor city centre site with the same alternatives (n = 7,433). A further study audited choices to ascend when the alternative to stairs was a sloped ramp in two locations (n = 16,297). Analyses employed bootstrapped logistic regression (1000 samples). Results At work and the city centre site, the overweight, those carrying a large bag and females avoided both stair climbing and descent more frequently than their comparison groups. The final study revealed greater avoidance of stairs in these demographic subgroups when the alternative means of ascent was a sloped ramp. Discussion Minimization of the physiological costs of transport-related walking biases behaviour towards avoidance of stair usage when an alternative is available. Weight carried is an encumbrance that can deter stair usage during daily life. This minimization of physical activity costs runs counter to public health initiatives to increase activity to improve population health.	[Eves, Frank F.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	University of Birmingham	Eves, FF (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	F.F.Eves@bham.ac.uk		Eves, Frank/0000-0002-4921-7169	Medical Research Council, UK [FFE G0802070/91321]; MRC [G0802070] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FFE G0802070/91321 Medical Research Council, UK The funders had no role in study design, data colection and analysis, decision to publish, or preparation of the manuscript.	Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Blake H, 2008, INT J WORKPLACE HEAL, V1, P162, DOI 10.1108/17538350810926525; BROWNELL KD, 1980, AM J PSYCHIAT, V137, P1540; CORLETT EN, 1972, APPL ERGON, V3, P195, DOI 10.1016/0003-6870(72)90100-7; Dishman RK, 1998, AM J PREV MED, V15, P344, DOI 10.1016/S0749-3797(98)00077-4; Durgin FH, 2012, J EXP PSYCHOL HUMAN, V38, P1582, DOI 10.1037/a0027805; Durgin FH, 2009, PSYCHON B REV, V16, P964, DOI 10.3758/PBR.16.5.964; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Eves FF, 2008, PREV MED, V47, P270, DOI 10.1016/j.ypmed.2007.12.008; Eves FF, 2008, OBES REV, V9, P83, DOI 10.1111/j.1467-789X.2007.00372.x; Eves FF, 2006, OBESITY, V14, P2210, DOI 10.1038/oby.2006.259; Eves FF, 2006, PREV MED, V43, P4, DOI 10.1016/j.ypmed.2006.03.011; Eves FF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220308; Eves FF, 2014, PSYCHON B REV, V21, P637, DOI 10.3758/s13423-013-0535-8; Eves FF, 2014, PSYCHON B REV, V21, P71, DOI 10.3758/s13423-013-0463-7; Eves FF, 2010, AM J PREV MED, V38, P573, DOI 10.1016/j.amepre.2010.02.004; Eves FF, 2009, J ENVIRON PSYCHOL, V29, P300, DOI 10.1016/j.jenvp.2008.10.002; Franchak JM, 2014, ATTEN PERCEPT PSYCHO, V76, P460, DOI 10.3758/s13414-013-0578-y; GARLING T, 1988, ENVIRON PLANN A, V20, P547, DOI 10.1068/a200547; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Jakicic JM, 2019, MED SCI SPORT EXER, V51, P1213, DOI 10.1249/MSS.0000000000001933; Kerr J, 2001, PREV MED, V33, P422, DOI 10.1006/pmed.2001.0908; Kerr J, 2001, J HEALTH PSYCHOL, V6, P495, DOI 10.1177/135910530100600503; Kerr J, 2001, J OCCUP HEALTH, V43, P205, DOI 10.1539/joh.43.205; KONCZAK J, 1992, J EXP PSYCHOL HUMAN, V18, P691, DOI 10.1037/0096-1523.18.3.691; Levine JA, 2005, ACTA PHYSIOL SCAND, V184, P309, DOI 10.1111/j.1365-201X.2005.01467.x; Levine JA, 2008, DIABETES, V57, P548, DOI 10.2337/db07-0815; Lewis A, 2012, BRIT J HEALTH PSYCH, V17, P631, DOI 10.1111/j.2044-8287.2011.02060.x; Lewis AL, 2011, ANN BEHAV MED, V42, P257, DOI 10.1007/s12160-011-9283-z; McCardle WD, 2007, EXERCISE PHYSL, DOI [10.1159/000097953, DOI 10.1159/000097953]; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; MEYERS AW, 1980, BEHAV MODIF, V4, P355, DOI 10.1177/014544558043005; National Health Service UK, 2018, PHYS ACT GUID AD; National Institute of Clinical Excellence, 2008, POSTTR STRESS DIS DI; Nishii J, 2000, BIOL CYBERN, V83, P435, DOI 10.1007/s004220000175; Olander EK, 2011, J ENVIRON PSYCHOL, V31, P200, DOI 10.1016/j.jenvp.2011.03.001; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Pedisic Z, 2014, OBESITY, V22, P2126, DOI 10.1002/oby.20817; Physical Activity Guidelines Advisory Committee, 2018, PHYS ACTIVITY GUIDEL, P1, DOI [10.1115/1.802878.ch1, DOI 10.1115/1.802878.CH1]; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Reeves ND, 2009, J ELECTROMYOGR KINES, V19, pE57, DOI 10.1016/j.jelekin.2007.09.009; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; RIESER JJ, 1995, J EXP PSYCHOL HUMAN, V21, P480, DOI 10.1037/0096-1523.21.3.480; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Soler RE, 2010, AM J PREV MED, V38, pS292, DOI 10.1016/j.amepre.2009.10.028; Srinivasan M, 2009, CHAOS, V19, DOI 10.1063/1.3141428; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Taylor-Covill GAH, 2016, J EXP PSYCHOL HUMAN, V42, P331, DOI 10.1037/xhp0000137; Taylor-Covill GAH, 2014, J EXP PSYCHOL HUMAN, V40, P915, DOI 10.1037/a0036071; Taylor-Covill GAH, 2013, PERCEPTION, V42, P459, DOI 10.1068/p7425; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; Verplanken B., 1999, EUR REV SOC PSYCHOL, V10, P101, DOI [10.1080/14792779943000035, DOI 10.1080/14792779943000035PLEASE, DOI 10.1080/14792779943000035]; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Webb OJ, 2007, AM J HEALTH PROMOT, V22, P38, DOI 10.4278/0890-1171-22.1.38; White E, 2013, PSYCHON B REV, V20, P1371, DOI 10.3758/s13423-013-0462-8; Zadra JR, 2016, PSYCHON B REV, V23, P1491, DOI 10.3758/s13423-016-1017-6	64	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228044	10.1371/journal.pone.0228044	http://dx.doi.org/10.1371/journal.pone.0228044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978202	gold, Green Published, Green Submitted			2022-12-26	WOS:000534599100101
J	Kim, S; Byun, JH; Park, A; Jung, IH				Kim, Sungchan; Byun, Jong Hyuk; Park, Anna; Jung, Il Hyo			A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea	PLOS ONE			English	Article							PREVENT RELAPSE; TRANSMISSION; TAFENOQUINE; MANAGEMENT; INCUBATION; DYNAMICS; DISEASES; PERIOD; IMPACT	Malaria has persisted as an endemic near the Demilitarized Zone in the Republic of Korea since the re-emergence of Plasmodium vivax malaria in 1993. The number of patients affected by malaria has increased recently despite many controls tools, one of the reasons behind which is the relapse of malaria via liver hypnozoites. Tafenoquine, a new drug approved by the United States Food and Drug Administration in 2018, is expected to reduce the rate of relapse of malaria hypnozoites and thereby decrease the prevalence of malaria among the population. In this work, we have developed a new transmission model for Plasmodium vivax that takes into account a more realistic intrinsic distribution from existing literature to quantify the current values of relapse parameters and to evaluate the effectiveness of the anti-relapse therapy. The model is especially suitable for estimating parameters near the Demilitarized Zone in Korea, in which the disease follows a distinguishable seasonality. Results were shown that radical cure could significantly reduce the prevalence level of malaria. However, eradication would still take a long time (over 10 years) even if the high-level treatment were to persist. In addition, considering that the vector's behavior is manipulated by the malaria parasite, relapse repression through vector control at the current level may result in a negative effect in containing the disease. We conclude that the use of effective drugs should be considered together with the increased level of the vector control to reduce malaria prevalence.	[Kim, Sungchan; Byun, Jong Hyuk; Park, Anna; Jung, Il Hyo] Pusan Natl Univ, Dept Math, Busan 46241, South Korea; [Park, Anna; Jung, Il Hyo] Pusan Natl Univ, Finance Fishery Manufacture Ind Math Ctr Big Data, Busan 46241, South Korea	Pusan National University; Pusan National University	Jung, IH (corresponding author), Pusan Natl Univ, Dept Math, Busan 46241, South Korea.; Jung, IH (corresponding author), Pusan Natl Univ, Finance Fishery Manufacture Ind Math Ctr Big Data, Busan 46241, South Korea.	ilhjung@pusan.ac.kr	byun, jong hyuk/AAG-8706-2019	byun, jong hyuk/0000-0001-6334-8176; JUNG, IL HYO/0000-0002-6086-5124; Kim, Sungchan/0000-0002-8384-7746	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [NRF-2017R1A5A1015722]; National Research Foundation of Korea(NRF) - Korean Government(MSIP) [NRF-2017R1A5A1015722]	National Research Foundation of Korea (NRF) - Korean Government (MSIP); National Research Foundation of Korea(NRF) - Korean Government(MSIP)	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP)(NRF-2017R1A5A1015722).; This work was supported by the National Research Foundation of Korea(NRF) Grant funded by the Korean Government(MSIP)(NRF-2017R1A5A1015722).	Agency CI, WORLD FACTBOOK; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2019, 2019 MAL CONTR MAN; Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; Beaulieu MRS, 2019, EVOL MED PUBLIC HLTH, P106, DOI 10.1093/emph/eoz019; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; Buchholz P, 2014, SPRINGERBRIEF MATH, P1, DOI 10.1007/978-3-319-06674-5; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cator LJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-164; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Chu CS, 2016, EXPERT REV ANTI-INFE, V14, P885, DOI 10.1080/14787210.2016.1220304; Churcher TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7054; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Feighner BH, 1998, EMERG INFECT DIS, V4, P295, DOI 10.3201/eid0402.980219; Feng XY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01473; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gilles HM, 2017, ESSENTIAL MALARIOLOG, VFourth; Im JH, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1684-4; Inaba H., 2019, J MATH BIOL, P1; Inaba H, 2012, J MATH BIOL, V65, P309, DOI 10.1007/s00285-011-0463-z; Ishikawa H, 2003, PARASITOL INT, V52, P81, DOI 10.1016/S1383-5769(02)00084-3; Kakizoe Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10371; Kim JE, 2019, APPL MATH COMPUT, V347, P616, DOI 10.1016/j.amc.2018.11.001; Kim SJ, 2013, INFECT CHEMOTHER, V45, P184, DOI 10.3947/ic.2013.45.2.184; Kim S, 2019, ADV DIFFER EQU-NY, V2019, DOI 10.1186/s13662-019-2405-9; Koole G, 2004, J APPL PROBAB, V41, P935, DOI 10.1239/jap/1091543436; Krylova O, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0098; Lacerda MVG, 2019, NEW ENGL J MED, V380, P215, DOI 10.1056/NEJMoa1710775; Llanos-Cuentas A, 2019, NEW ENGL J MED, V380, P229, DOI 10.1056/NEJMoa1802537; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lover AA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-539; Markus MB, 2011, J HIST BIOL, V44, P781, DOI 10.1007/s10739-010-9239-3; Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001; Nah K, 2014, COMPUT MATH APPL, V68, P915, DOI 10.1016/j.camwa.2014.05.001; Nah K, 2010, J THEOR BIOL, V266, P299, DOI 10.1016/j.jtbi.2010.06.032; Naing C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003071; Roy M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001979; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; Wearing H.J., 2005, PLOS MED, V2, DOI [10.1371/journal.pmed. 0020174, DOI 10.1371/journal.pmed.0020174]; Yeom JS, 2007, J KOREAN MED ASSOC, V50, P88, DOI 10.5124/jkma.2007.50.1.88; Yeom JS, 2008, INFECT CHEMOTHER, V40, P191, DOI 10.3947/ic.2008.40.4.191	43	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227919	10.1371/journal.pone.0227919	http://dx.doi.org/10.1371/journal.pone.0227919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978085	Green Published, Green Submitted, gold			2022-12-26	WOS:000534599100078
J	Ndebele-Murisa, MR; Mubaya, CP; Pretorius, L; Mamombe, R; Iipinge, K; Nchito, W; Mfune, JK; Siame, G; Mwalukanga, B				Ndebele-Murisa, Mzime R.; Mubaya, Chipo P.; Pretorius, Lulu; Mamombe, Rudo; Iipinge, Kornelia; Nchito, Wilma; Mfune, John K.; Siame, Gilbert; Mwalukanga, Brenda			City to city learning and knowledge exchange for climate resilience in southern Africa	PLOS ONE			English	Article							CHANGE ADAPTATION; WATER MANAGEMENT; CITIES; LESSONS; POLICY; HARARE; PERSPECTIVES; GOVERNANCE; CHALLENGES; NETWORKS	Southern African cities face several challenges including management of rapid urbanization, rising populations, expanding informal settlements; adequate water and other service provision, and a host of governance challenges. Climate change and variability add a compounding effect to this complex, multi stressor context. Addressing the complexity requires an understanding of urban ecosystems functioning and interactions amongst the built and natural environment (climate) and human systems. In this paper we argue that learning is essential for cities to be resilient to current and future challenges. We profile the Future Resilience for African CiTies And Lands (FRACTAL) project which contributed towards climate resilient development by providing relevant climate information for decision-making at the city regional scale in southern Africa. Following FRACTAL's city-to-city learning approach of sharing good practices, knowledge and experiences framed around transdisciplinary research, the study cities of Harare, Lusaka, Windhoek and Durban conducted city learning exchange visits between 2017 and 2018. We used a mixed methods approach to collect and analyze historical climate and hydrological data and current socio-economic and development data among the cities. A qualitative, in-depth, case study comparative analysis was used to identify similarities and differences as well as lessons drawn from the learning process during the city exchanges and these were complimented by desktop studies. Results showed water scarcity, large informal settlements, reliance on external water and energy sources, inadequate protection of ecologically sensitive resources and service provision as some of the common complications in the cities. Several lessons and transferable practices learnt from the cities included effective water conservation and waste management and the use of public-private partnerships in Windhoek, community engagements in Durban and Lusaka while lessons on decisive leadership in dealing with informal settlements emanated from Harare's limited informal settlements. Lastly, Durban's Adaptation Charter and integrated climate planning provided lessons for biodiversity protection and mainstreaming climate change at city governance level. While we recognize that cities are context-specific we consider these good practices as being broadly transferable to other southern African cities. We conclude that social, experiential and structured learning can be an innovative way of multi-stakeholder engagement and a useful approach to increase city resilience planning across southern Africa and cities that face similar developmental challenges.	[Ndebele-Murisa, Mzime R.; Mamombe, Rudo] Chinhoyi Univ Technol, Dept Freshwater & Fishery Sci, Chinhoyi, Zimbabwe; [Mubaya, Chipo P.] Chinhoyi Univ Technol, Int Collaborat Off, Chinhoyi, Zimbabwe; [Pretorius, Lulu] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa; [Iipinge, Kornelia; Mfune, John K.] Univ Namibia, Dept Biol Sci, Windhoek, Namibia; [Nchito, Wilma; Siame, Gilbert; Mwalukanga, Brenda] Univ Zambia, Dept Geog & Environm Studies, Lusaka, Zambia; [Ndebele-Murisa, Mzime R.] START Int, Washington, DC 20005 USA	University of Kwazulu Natal; University of Namibia; University of Zambia	Ndebele-Murisa, MR (corresponding author), Chinhoyi Univ Technol, Dept Freshwater & Fishery Sci, Chinhoyi, Zimbabwe.; Ndebele-Murisa, MR (corresponding author), START Int, Washington, DC 20005 USA.	murisa.mzime@gmail.com	Murisa, Mzime/AFS-0432-2022; Murisa, Mzime/H-8882-2019	Murisa, Mzime/0000-0001-8096-2979; Nchito, Wilma Sithabiso/0000-0001-7089-9777; Pretorius, Lulu/0000-0001-5064-9658	UK's Department for International Development (DFID); Natural Environment Research Council (NERC); START International's Global Environmental Change (GEC) grants (2016-2017); IDRC's African Climate Change Leadership Program (AfriCLP) (2018-2019); NERC [NE/M020118/1, NE/M020347/1] Funding Source: UKRI	UK's Department for International Development (DFID); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); START International's Global Environmental Change (GEC) grants (2016-2017); IDRC's African Climate Change Leadership Program (AfriCLP) (2018-2019); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the UK's Department for International Development (DFID) and the Natural Environment Research Council (NERC) (2015-2019). The Authors acknowledge funding from START International's Global Environmental Change (GEC) grants (2016-2017) also administered under FRACTAL while the data analyses and writing of this manuscript was funded under the IDRC's African Climate Change Leadership Program (AfriCLP) (2018-2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CIT RES FRAM; [Anonymous], 2018, FRACTAL WRIT SHOP CA; [Anonymous], 2009, OECD ENV WORKING PAP, DOI [10.1787/220062444715, DOI 10.1787/220062444715]; Araos M, 2016, ENVIRON SCI POLICY, V66, P375, DOI 10.1016/j.envsci.2016.06.009; Arrighi A, 2016, WORKING PAPER SERIES, V7; Bai X, 2018, FUTURE EARTH URBAN K; Bandura A., 1971, SOCIAL LEARNING THEO; Bigio A.G., 2003, BUILDING SAFER CITIE, P91; Blackmore C, 2010, SOCIAL LEARNING SYSTEMS AND COMMUNITIES OF PRACTICE, P1, DOI 10.1007/978-1-84996-133-2; Brandt P, 2013, ECOL ECON, V92, P1, DOI 10.1016/j.ecolecon.2013.04.008; Broto VC, 2015, CURR OPIN ENV SUST, V13, P11, DOI 10.1016/j.cosust.2014.12.005; Broto VC, 2013, GLOBAL ENVIRON CHANG, V23, P92, DOI 10.1016/j.gloenvcha.2012.07.005; Campbell L., 2016, STEPPING BACK UNDERS; Campbell T., 2012, SMART CITIES CITIES; Carmin J, 2012, J PLAN EDUC RES, V32, P18, DOI 10.1177/0739456X11430951; Childers DL, 2015, SUSTAINABILITY-BASEL, V7, P3774, DOI 10.3390/su7043774; Chirisa I, DECENTRALIZED DOMEST; Cundill G, 2018, GLOB CHALL, V3; Dian S, 2017, WHAT CAPE TOWN CAN L; Donkor FK, 2019, ENVIRON COMMUN, V13, P561, DOI 10.1080/17524032.2019.1596145; EThekwini Municipality, 2014, DURB CLIM CHANG STRA; Fauchereau N, 2003, NAT HAZARDS, V29, P139, DOI 10.1023/A:1023630924100; Goodrick D., 2014, COMP CASE STUDIES ME, V9; Government of the Republic of Zambia (GRZ) Ministry of Local Government M Lusaka City Council (LCC), 2013, ASS FLOOD RISK MAZ S; Haarhoff J, 1996, WATER SCI TECHNOL, V33, P25, DOI 10.1016/0273-1223(96)00403-9; Habitat UN, 2007, ZAMB LUS URB PROF; Howarth C, 2017, ENERGY RES SOC SCI, V31, P295, DOI 10.1016/j.erss.2017.06.011; Jabareen Y, 2013, CITIES, V31, P220, DOI 10.1016/j.cities.2012.05.004; Jasanoff S., 2009, 5 BRANCH SCI ADVISER; Jones L, 2018, REGIONAL ENV CHANGE, V18, P1553; Kayaga S, 2006, P I CIVIL ENG-WAT M, P3; Klenk N, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.475; Krause RM, 2012, REV POLICY RES, V29, P585, DOI 10.1111/j.1541-1338.2012.00582.x; Lafforgue M, 2015, ENVIRON SCI-WAT RES, V1, P622, DOI [10.1039/C5EW00056D, 10.1039/c5ew00056d]; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Lee T, 2012, POLICY SCI, V45, P199, DOI 10.1007/s11077-012-9159-5; Lykke AM, 2009, IOP C SER EARTH ENV, V8, DOI 10.1088/1755-1315/8/1/012004; Mapimhidze R, 2014, URBAN WETLANDS SIEGE; Mather A, 2011, LOCAL SUSTAIN, V1, P543, DOI 10.1007/978-94-007-0785-6_53; Maure G, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab190; Mauser W, 2013, CURRENT OPINION ENV, V5; Miller TR, 2014, SUSTAIN SCI, V9, P239, DOI 10.1007/s11625-013-0224-6; Moodley S, 2019, HABITAT INT, V85, P34, DOI 10.1016/j.habitatint.2019.02.004; Mubaya CP, 2015, UNTAMED URBANISMS, P134; Muchadenyika D, 2017, CITIES, V63, P33, DOI 10.1016/j.cities.2016.12.022; Muchadenyika D, 2015, HABITAT INT, V48, P1, DOI 10.1016/j.habitatint.2015.03.003; Mukheibir P, 2007, J ENERGY SOUTH AFR, V18, P4; Muller M, 2007, ENVIRON URBAN, V19, P99, DOI 10.1177/0956247807076726; Nchito WS, 2018, UNDERSTANDING INTERA; Ndebele-Murisa MR, 2019, POLICY BRIEF; Ndunguru MG, 2016, J WATER SANIT HYG DE, V6, P519, DOI 10.2166/washdev.2016.157; Nhapi I, 2008, WATER ENVIRON J, V22, P54, DOI 10.1111/j.1747-6593.2007.00084.x; Pelling M, 2015, CLIMATIC CHANGE, V133, P113, DOI 10.1007/s10584-014-1303-0; Phiri A., 2016, Environment and Pollution, V5, P1, DOI 10.5539/ep.v5n2p1; Pinto I, 2016, CLIMATIC CHANGE, V135, P655, DOI 10.1007/s10584-015-1573-1; Polk M, 2015, FUTURES, V65, P110, DOI 10.1016/j.futures.2014.11.001; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Roberts D, 2013, ENVIRON URBAN, V25, P299, DOI 10.1177/0956247813500904; Roberts D, 2012, ENVIRON URBAN, V24, P167, DOI 10.1177/0956247811431412; Scott D., 2018, TELLING STORIES MULT; Shepherd TG, 2018, CLIMATIC CHANGE, V151, P555, DOI 10.1007/s10584-018-2317-9; Simon D, 2015, CURR OPIN ENV SUST, V13, P109, DOI 10.1016/j.cosust.2015.03.003; Sithole A., 2013, INT J HUMANITIES SOC, V3, P193; Snyder WM, 2010, SOCIAL LEARNING SYSTEMS AND COMMUNITIES OF PRACTICE, P107, DOI 10.1007/978-1-84996-133-2_7; Sorensen Paul, 2017, International Journal of Environmental Studies, V74, P515, DOI 10.1080/00207233.2017.1335019; Stern E, 2012, BROADENING RANGE DES; Steyaert P, 2007, ENVIRON SCI POLICY, V10, P575, DOI 10.1016/j.envsci.2007.01.011; Steynor A, 2016, CLIM RISK MANAG, V13, P95, DOI 10.1016/j.crm.2016.03.001; Taylor A., 2016, TRANSDISCIPLINARITY; Tendaupenyu I, 2002, THESIS; Teye J.K, 2018, MIGRATION GLOBALIZIN, P97; Thompson MA, 2017, ENVIRON SCI POLICY, V74, P30, DOI 10.1016/j.envsci.2017.04.006; Tschakert P, 2010, ECOL SOC, V15; Urge-Vorsatz D, 2018, NAT CLIM CHANGE, V8, P174, DOI 10.1038/s41558-018-0100-6; von Wehrden H, 2019, SUSTAIN SCI, V14, P875, DOI 10.1007/s11625-018-0594-x; Weber B, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0164; Weissberg RP, 2013, PHI DELTA KAPPAN, V95, P8, DOI 10.1177/003172171309500203; Williams DS, 2018, INFORM SETTLEMENTS F; World Economic Forum, 2019, S AFR EN TRANS IND; Zeppel H, 2013, INT POLIT ECON SER, P217; Ziervogel G, 2008, ENV SCI POLICY SUSTA; Ziervogel G, 2019, AMBIO, V48, P494, DOI 10.1007/s13280-018-1141-9; Ziervogel G, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090955	83	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227915	10.1371/journal.pone.0227915	http://dx.doi.org/10.1371/journal.pone.0227915			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978090	Green Published, gold			2022-12-26	WOS:000534599100076
J	Xu, YY; Li, FF; Zhao, XJ; Tan, CK; Wang, BY; Chen, YY; Cao, J; Wu, DF; Yu, H				Xu, Yanyong; Li, Feifei; Zhao, Xiaojie; Tan, Chenkun; Wang, Binyi; Chen, Yiyong; Cao, Jia; Wu, Dongfang; Yu, Hong			Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice	FASEB JOURNAL			English	Article						atherosclerosis; high-density lipoprotein; inflammation; methionine sulfoxide reductase A; scavenger receptor class B type I	HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E; SR-BI; REDUCES ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; MITOCHONDRIAL-FUNCTION; METABOLISM; LIVER	High-density lipoprotein (HDL), a well-known atheroprotective factor, can be converted to proatherogenic particles in chronic inflammation. HDL-targeted therapeutic strategy for atherosclerotic cardiovascular disease (CVD) is currently under development. This study aims to assess the role of methionine sulfoxide reductase A (MsrA) in abnormal HDL and its related disorders in scavenger receptor class B type I deficient (SR-BI-/-) mice. First, we demonstrated that MsrA overexpression attenuated ROS level and inflammation in HepG2 cells. For the in vivo study, SR-BI-/- mice were intravenously injected with lentivirus to achieve hepatic MsrA overexpression. High-level hepatic MsrA significantly reduced the plasma free cholesterol contents, improved HDL functional proteins apolipoprotein A-I (apoAI), apoE, paraoxonase1 (PON1), and lecithin:cholesterol acyltransferase (LCAT), while decreased the pro-inflammatory property of dysfunctional HDL, contributing to reduced atherosclerosis and hepatic steatosis in Western diet-fed mice. Furthermore, the study revealed that hepatic MsrA altered the expression of several genes controlling HDL biogenesis, cholesterol esterification, cholesterol uptake mediated by low-density lipoprotein receptor (LDLR) and biliary excretion, as well as suppressed nuclear factor kappa B (NF-kappa B) signaling pathway, which largely relied on liver X receptor alpha (LXR alpha)-upregulation. These results provide original evidence that MsrA may be a promising target for the therapy of dysfunctional HDL-related CVD.	[Xu, Yanyong; Li, Feifei; Zhao, Xiaojie; Tan, Chenkun; Wang, Binyi; Chen, Yiyong; Cao, Jia; Yu, Hong] Wuhan Univ, Dept Biochem & Mol Biol, Hubei Prov Key Lab Dev Originated Dis, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Wu, Dongfang] Wuhan Univ, Dept Pharm, Zhongnan Hosp, Wuhan, Peoples R China	Wuhan University; Wuhan University	Yu, H (corresponding author), Wuhan Univ, Dept Biochem & Mol Biol, Hubei Prov Key Lab Dev Originated Dis, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	yu.hong@whu.edu.cn		xu, yanyong/0000-0002-2811-0725	National Natural Science Foundation of China (NSFC) [81270364]; Medical Science advancement Program of Wuhan University [TFJC2018001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Medical Science advancement Program of Wuhan University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670423; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570417; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81270364; Medical Science advancement Program of Wuhan University, Grant/Award Number: TFJC2018001	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Armitage J, 2019, J AM COLL CARDIOL, V73, P477, DOI 10.1016/j.jacc.2018.10.072; Beltowski J, 2008, CARDIOVASC THER, V26, P297, DOI 10.1111/j.1755-5922.2008.00062.x; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; Brites F, 2017, BBA CLIN, V8, P66, DOI 10.1016/j.bbacli.2017.07.002; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Cao J, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1502-y; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Fan H, 2015, ANTIOXID REDOX SIGN, V22, P832, DOI 10.1089/ars.2014.6022; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Hafiane A, 2017, ATHEROSCLEROSIS, V257, P90, DOI 10.1016/j.atherosclerosis.2017.01.013; Hafiane A, 2015, ANN CLIN LAB SCI, V45, P659; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Korber M, 2017, BBA-MOL CELL BIOL L, V1862, P1534, DOI 10.1016/j.bbalip.2017.09.002; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Linton MF, 2017, TRENDS ENDOCRIN MET, V28, P461, DOI 10.1016/j.tem.2017.02.001; Ljunggren SA, 2015, BBA-MOL CELL BIOL L, V1851, P1587, DOI 10.1016/j.bbalip.2015.09.006; Ma K, 2005, ARTERIOSCL THROM VAS, V25, P149, DOI 10.1161/01.ATV.0000150414.89591.6a; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Manichaikul A, 2012, ARTERIOSCL THROM VAS, V32, P1991, DOI 10.1161/ATVBAHA.112.249714; Mardones P, 2001, J LIPID RES, V42, P170; Masson D, 2004, J LIPID RES, V45, P543, DOI 10.1194/jlr.M300432-JLR200; Meilhac O, 2015, HANDB EXP PHARMACOL, V224, P509, DOI 10.1007/978-3-319-09665-0_16; Moskovitz J, 2016, AM J PHYSIOL-ENDOC M, V310, pE388, DOI 10.1152/ajpendo.00453.2015; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nan CL, 2010, BIOCHEM BIOPH RES CO, V402, P608, DOI 10.1016/j.bbrc.2010.10.064; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2019, PATHOLOGY, V51, P142, DOI 10.1016/j.pathol.2018.10.017; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Panzenbock U, 2005, BBA-PROTEINS PROTEOM, V1703, P171, DOI 10.1016/j.bbapap.2004.11.003; Qi Y, 2018, J CLIN LIPIDOL, V12, P89, DOI 10.1016/j.jacl.2017.11.003; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Schulman IG, 2017, FEBS LETT, V591, P2978, DOI 10.1002/1873-3468.12702; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Subedi BH, 2014, VASC HEALTH RISK MAN, V10, P205, DOI 10.2147/VHRM.S45648; Van Eck M, 2007, ARTERIOSCL THROM VAS, V27, P2413, DOI 10.1161/ATVBAHA.107.145474; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Witkowski A, 2018, FASEB J, V32, P3149, DOI 10.1096/fj.201701127R; Xu YY, 2015, J LIPID RES, V56, P1891, DOI 10.1194/jlr.M058776; Yu H, 2006, ARTERIOSCL THROM VAS, V26, P150, DOI 10.1161/01.ATV.0000194096.89476.73; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517; Zhang C, 2010, J CELL BIOCHEM, V111, P94, DOI 10.1002/jcb.22666; Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhou CY, 2013, DIS MARKERS, V2013, P97, DOI 10.1155/2013/816189	56	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3805	3819		10.1096/fj.201902429R	http://dx.doi.org/10.1096/fj.201902429R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31975555	hybrid			2022-12-26	WOS:000509219700001
J	Dingley, J; Okano, S; Lee-Kelland, R; Scull-Brown, E; Thoresen, M; Chakkarapani, E				Dingley, John; Okano, Satomi; Lee-Kelland, Richard; Scull-Brown, Emma; Thoresen, Marianne; Chakkarapani, Ela			Closed circuit xenon delivery for 72h in neonatal piglets following hypoxic insult using an ambient pressure automated control system: Development, technical evaluation and pulmonary effects	PLOS ONE			English	Article							COMPUTER-CONTROLLED INFUSION; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; INHALED XENON; DELAYED XENON; NEUROPROTECTION; ANESTHESIA; PROTECTS; INJURY; FEASIBILITY	Background Therapeutic hypothermia (TH) for 72h is the standard treatment following neonatal encephalopathy (NE). However, one-third do not benefit and adjunctive therapies are urgently needed. Xenon enhances neuroprotection with TH when administered at 50% concentration within 5hours of hypoxia in experimental studies. Delayed initiation (similar to 10 hours of age) of 30% xenon for 24 hours during TH did not improve early adverse biomarkers in a clinical trial of Xenon+TH vs TH. After hypoxia-ischemia, excitotoxic injury via N-methyl-D-aspartate receptor overactivation lasts days. Since xenon partially inhibits this receptor, we hypothesised that giving 50% xenon throughout the entire 72h TH and rewarming periods would enhance neuroprotection. Xenon costs $30/litre, so a closed-circuit breathing system is desirable with automated fresh gas delivery. Methods Seven mechanically ventilated newborn pigs were randomized to receive 50% inhaled xenon for 72h during hypothermia (rectal-temperature 35 degrees C) and subsequent rewarming following a global hypoxic-ischemic insult (XeHT, N = 4) or under normothermia for 72h (rectal-temperature 38.5 degrees C) following sham insult (XeNT, N = 3). An automated fresh gas delivery system injected oxygen/air/xenon boluses into a closed-circuit based on measured Results and discussion Median (IQR) xenon consumption was 0.31 L/h (0.18, 0.50) and 0.34L/h (0.32, 0.49) for hypothermic and normothermic groups respectively, 0.34L/h (0.25, 0.53) overall. 92% of 9626 xenon and 69% of 9635 oxygen measurements were within 20% variation from targets. For xenon concentration, the median absolute performance errors for the XeHT and XeNT groups were 6.14% and 3.84% respectively and 4.31% overall. For oxygen these values were 13.42%, 15.05% and 12.4% respectively. There were no adverse pulmonary pathophysiology findings. Clinical problems over the total period included three related to sensors, seven breathing system leaks, ten partial and one complete tracheal tube occlusion episodes. Conclusion The automated controller functioned as intended maintaining an inhaled xenon concentration close to the 50% target for 72-78h at a xenon cost of $11.1/h.	[Dingley, John] ABM Univ Hlth Board, Dept Anaesthet, Swansea, W Glam, Wales; [Dingley, John] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Okano, Satomi; Lee-Kelland, Richard; Scull-Brown, Emma; Thoresen, Marianne; Chakkarapani, Ela] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Bristol, Avon, England; [Thoresen, Marianne] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway	Swansea University; University of Bristol; University of Oslo	Dingley, J (corresponding author), ABM Univ Hlth Board, Dept Anaesthet, Swansea, W Glam, Wales.; Dingley, J (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	j.dingley@swan.ac.uk		Chakkarapani, Elavazhagan/0000-0003-3380-047X	Wellcome Trust TRACK award [WT14]; ROSETREES TRUST [A1017]; SPARKS [18BTL01]	Wellcome Trust TRACK award; ROSETREES TRUST(Rosetrees Trust); SPARKS	This work was supported by the Wellcome Trust TRACK award WT14, (https://wellcome.ac.uk/) and ROSETREES TRUST, A1017 (https://rosetreestrust.co.uk) to EC. MT received a grant from SPARKS 18BTL01 that supported the staff salaries for the project (https://www.sparks.org.uk/).The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Dr Xun Liu PhD, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS28EG, United Kingdom for assisting with the experiments and Dr Silvia Planas MD, Consultant Pathologist, North Bristol Hospital NHS Trust, Bristol, United Kingdom, for blind scoring of the lung sections into 4 categories.	Arola O, 2017, J AM COLL CARDIOL, V70, P2652, DOI 10.1016/j.jacc.2017.09.1088; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Baumert JH, 2007, ANESTH ANALG, V105, P1200, DOI 10.1213/01.ane.0000284697.73471.9c; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Campos-Pires R, 2018, J NEUROTRAUM, V35, P1037, DOI 10.1089/neu.2017.5360; Chakkarapani E., 2015, ANIMAL MODELS DEVELO; Chakkarapani E, 2009, ANESTH ANALG, V109, P451, DOI 10.1213/ane.0b013e3181aa9550; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dingley J, 2015, ANESTH ANALG, V120, P1331, DOI 10.1213/ANE.0000000000000693; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Hagberg H, 2016, NEUROBIOL DIS, V92, P102, DOI 10.1016/j.nbd.2015.09.011; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Jia P, 2015, CRIT CARE MED, V43, pE250, DOI 10.1097/CCM.0000000000001001; Jia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064329; Kee WDN, 2007, ANAESTHESIA, V62, P1251, DOI 10.1111/j.1365-2044.2007.05257.x; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Li Q, 2013, HEART LUNG CIRC, V22, P276, DOI 10.1016/j.hlc.2012.10.016; Liu X, 2017, EPILEPSIA, V58, P1902, DOI 10.1111/epi.13914; Liu X, 2015, PEDIATR RES, V77, P779, DOI 10.1038/pr.2015.49; Miao YF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18914-6; National Institute for Health and Care Excellence, 2010, THER HYP INTR TEMP M; Peng T, 2013, CNS NEUROSCI THER; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; Preckel B, 2006, ANESTHESIOLOGY, V105, P187, DOI 10.1097/00000542-200607000-00029; Rawat S, 2010, ANESTH ANALG, V110, P101, DOI 10.1213/ANE.0b013e3181be0e17; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Thoresen M, 1996, PEDIATR RES, V40, P738, DOI 10.1203/00006450-199611000-00014; Thoresen M, 2015, COOL XENON STUDY; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; VARVEL JR, 1992, J PHARMACOKINET BIOP, V20, P63, DOI 10.1007/BF01143186; Veldeman M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00511; Zhao HL, 2014, KIDNEY INT, V85, P112, DOI 10.1038/ki.2013.334	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0224447	10.1371/journal.pone.0224447	http://dx.doi.org/10.1371/journal.pone.0224447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961878	Green Published, gold			2022-12-26	WOS:000534372000004
J	Xu, R; Gopireddy, RR; Wu, YD; Wu, L; Tao, X; Shao, J; Wang, WX; Li, L; Jovanovic, A; Xu, B; Kenyon, NJ; Lu, Q; Xiang, YK; Fu, Q				Xu, Rui; Gopireddy, Raghavender Reddy; Wu, Yudi; Wu, Lei; Tao, Xiang; Shao, Ji; Wang, Wenxin; Li, Li; Jovanovic, Aleksandra; Xu, Bing; Kenyon, Nicolas J.; Lu, Quan; Xiang, Yang K.; Fu, Qin			Hyperinsulinemia promotes heterologous desensitization of beta(2) adrenergic receptor in airway smooth muscle in obesity	FASEB JOURNAL			English	Article						asthma; obesity; phosphodiesterase 4; beta-adrenergic receptor agonist	PROTEIN-COUPLED RECEPTORS; BRONCHODILATOR SUBSENSITIVITY; PHOSPHODIESTERASE-4 INHIBITOR; INSULIN-RESISTANCE; INCIDENT ASTHMA; ROFLUMILAST; HYPERRESPONSIVENESS; METAANALYSIS; ACTIVATION; RESPONSES	beta-Adrenergic receptor (beta-AR) agonists are the most common clinical bronchodilators for asthma. Obesity influences asthma severity and may impair response to beta-AR agonists. Previous studies show that in obese mice, hyperinsulinemia plays a crucial role in beta-AR desensitization in the heart. We therefore investigated whether insulin promotes beta-AR desensitization in airway smooth muscle (ASM) and compromises airway relaxation responsiveness to beta-AR agonists. We found that human ASM cells and mouse airway tissues exposed to insulin exhibit impaired beta(2)AR-induced cAMP accumulation and airway relaxation. This impaired relaxation is associated with insulin-induced phosphorylation and expression of phosphodiesterase 4D (PDE4D) through transactivation of a G protein-coupled receptor kinase 2 (GRK2)-dependent beta(2)AR-G(i)-ERK1/2 cascade. Both acute and chronic pharmacological inhibition of PDE4 effectively reversed impaired beta(2)AR-mediated ASM relaxation in an obesity mouse model induced by a high fat diet. Collectively, these findings reveal that cross talk between insulin and beta(2)AR signaling promotes ASM beta(2)AR desensitization in obesity through upregulation of PDE4D phosphorylation and expression. Our results identify a novel pathway of asthma pathogenesis in patients with obesity/metabolic syndrome, in which the GRK2-mediated signaling can be a potential therapeutic modality to prevent or treat beta(2)AR desensitization in ASM. Moreover, PDE4 inhibitors may be used as efficacious therapeutic agents for asthma in obese and diabetic subjects.	[Xu, Rui; Wu, Yudi; Wu, Lei; Tao, Xiang; Shao, Ji; Wang, Wenxin; Li, Li; Fu, Qin] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Xu, Rui; Li, Li; Fu, Qin] Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan, Peoples R China; [Gopireddy, Raghavender Reddy; Jovanovic, Aleksandra; Xu, Bing; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Xu, Bing; Xiang, Yang K.] VA Northern Calif Healthcare Syst, Mather, CA USA; [Kenyon, Nicolas J.] Univ Calif Davis, Dept Med, Davis, CA 95616 USA; [Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Huazhong University of Science & Technology; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health	Fu, Q (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Peoples R China.; Xiang, YK (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ykxiang@ucdavis.edu; fuqin@mails.tjmu.edu.cn	Fu, Qin/O-6960-2014	Fu, Qin/0000-0002-7954-7708	NSFC\ Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao [81729004]; National Natural Science Foundation of China (NSFC) [81773730, 81473212]; California Tobacco-Related Disease Research Program [TRDRP587390]	NSFC\ Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); California Tobacco-Related Disease Research Program(University of California System)	NSFC vertical bar Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao, Grant/Award Number: 81729004; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773730 and 81473212; California Tobacco-Related Disease Research Program, Grant/Award Number: TRDRP587390	Arshi M, 2010, RESPIROLOGY, V15, P779, DOI 10.1111/j.1440-1843.2010.01767.x; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Fu Q, 2015, CELL SIGNAL, V27, P707, DOI 10.1016/j.cellsig.2014.11.018; Fu Q, 2014, DIABETES, V63, P2676, DOI 10.2337/db13-1763; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Gosens R, 2003, EUR J PHARMACOL, V481, P125, DOI 10.1016/j.ejphar.2003.08.081; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Hu AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118712; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; Krymskaya VP, 2007, CURR TOP DEV BIOL, V79, P61, DOI 10.1016/S0070-2153(06)79003-2; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Mellbin LG, 2013, EUR HEART J, V34, P3137, DOI 10.1093/eurheartj/eht332; NEWNHAM DM, 1994, AM J MED, V97, P29, DOI 10.1016/0002-9343(94)90045-0; Nie ZY, 2014, AM J RESP CELL MOL, V51, P251, DOI 10.1165/rcmb.2013-0452OC; Park HJ, 2016, AM J RESP CELL MOL, V55, P82, DOI 10.1165/rcmb.2015-0345OC; Pera T, 2015, FASEB J, V29, P4227, DOI 10.1096/fj.15-273094; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Schaafsma D, 2007, BRIT J PHARMACOL, V150, P136, DOI 10.1038/sj.bjp.0706985; SETTE C, 1994, J BIOL CHEM, V269, P9245; Shi Q, 2017, CARDIOVASC RES, V113, P656, DOI 10.1093/cvr/cvx036; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; van Schalkwyk E, 2005, J ALLERGY CLIN IMMUN, V116, P292, DOI 10.1016/j.jaci.2005.04.023; Wang QT, 2017, CIRCULATION, V135, P73, DOI 10.1161/CIRCULATIONAHA.116.022281; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102	35	4	5	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3996	4008		10.1096/fj.201800688RR	http://dx.doi.org/10.1096/fj.201800688RR		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960515	Bronze			2022-12-26	WOS:000508662600001
J	Dache, ZA; Otandault, A; Tanos, R; Pastor, B; Meddeb, R; Sanchez, C; Arena, G; Lasorsa, L; Bennett, A; Grange, T; El Messaoudi, S; Mazard, T; Prevostel, C; Thierry, AR				Dache, Zahra Al Amir; Otandault, Amaelle; Tanos, Rita; Pastor, Brice; Meddeb, Romain; Sanchez, Cynthia; Arena, Giuseppe; Lasorsa, Laurence; Bennett, Andrew; Grange, Thierry; El Messaoudi, Safia; Mazard, Thibault; Prevostel, Corinne; Thierry, Alain R.			Blood contains circulating cell-free respiratory competent mitochondria	FASEB JOURNAL			English	Article						blood; circulating DNA; mitochondria; mitochondrial genome; respiratory competent	MESENCHYMAL STEM-CELLS; SINGLE-STRAND; DNA; BIOMARKER; DISEASE; SENSORS	Mitochondria are considered as the power-generating units of the cell due to their key role in energy metabolism and cell signaling. However, mitochondrial components could be found in the extracellular space, as fragments or encapsulated in vesicles. In addition, this intact organelle has been recently reported to be released by platelets exclusively in specific conditions. Here, we demonstrate for the first time, that blood preparation with resting platelets, contains whole functional mitochondria in normal physiological state. Likewise, we show, that normal and tumor cultured cells are able to secrete their mitochondria. Using serial centrifugation or filtration followed by polymerase chain reaction-based methods, and Whole Genome Sequencing, we detect extracellular full-length mitochondrial DNA in particles over 0.22 mu m holding specific mitochondrial membrane proteins. We identify these particles as intact cell-free mitochondria using fluorescence-activated cell sorting analysis, fluorescence microscopy, and transmission electron microscopy. Oxygen consumption analysis revealed that these mitochondria are respiratory competent. In view of previously described mitochondrial potential in intercellular transfer, this discovery could greatly widen the scope of cell-cell communication biology. Further steps should be developed to investigate the potential role of mitochondria as a signaling organelle outside the cell and to determine whether these circulating units could be relevant for early detection and prognosis of various diseases.	[Dache, Zahra Al Amir; Otandault, Amaelle; Tanos, Rita; Pastor, Brice; Meddeb, Romain; Sanchez, Cynthia; Lasorsa, Laurence; El Messaoudi, Safia; Mazard, Thibault; Prevostel, Corinne; Thierry, Alain R.] Univ Montpellier, Inst Reg Canc Montpellier, INSERM U1194, IRCM, Montpellier, France; [Arena, Giuseppe] INSERM U1030, Gustave Roussy Canc Campus, F-94805 Villejuif, France; [Bennett, Andrew; Grange, Thierry] Univ Paris Diderot, Inst Jacques Monod, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite	Thierry, AR (corresponding author), INSERM, IRCM, U1194, 208 Rue Apothicaires, F-34298 Montpellier 5, France.	alain.thierry@inserm.fr	MAZARD, Thibault/ABH-6334-2020; Prevostel, Corinne/AAO-1433-2020; Arena, Giuseppe/ABE-8093-2021	MAZARD, Thibault/0000-0002-5644-9603; Arena, Giuseppe/0000-0003-2398-5503; Al Amir Dache, Zahra/0000-0001-7415-4940; PREVOSTEL, Corinne/0000-0002-7553-087X; Grange, Thierry/0000-0001-8700-3092; pastor, brice/0000-0001-9096-3537	SIRIC Montpellier Grant [INCa-DGOS-Inserm 6045]; Institut National de la Sante et de la Recherche Medicale	SIRIC Montpellier Grant; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	SIRIC Montpellier Grant, Grant/Award Number: INCa-DGOS-Inserm 6045; Institut National de la Sante et de la Recherche Medicale	Bennett EA, 2014, BIOTECHNIQUES, V56, P289, DOI 10.2144/000114176; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Dames Shale, 2015, Methods Mol Biol, V1264, P77, DOI 10.1007/978-1-4939-2257-4_8; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mahrouf-Yorgov M, 2017, CELL DEATH DIFFER, V24, P1224, DOI 10.1038/cdd.2017.51; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meddeb R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41593-4; Meddeb R, 2019, CLIN CHEM, V65, P623, DOI 10.1373/clinchem.2018.298323; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104; Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Otandault A, 2019, ANN ONCOL, V30, P374, DOI 10.1093/annonc/mdz031; Patel D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13227-0; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601; Rigothier C, 2016, J CELL BIOCHEM, V117, P2737, DOI 10.1002/jcb.25571; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roberts RG, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002338; Rodriguez AM, 2018, CELL CYCLE, V17, P712, DOI 10.1080/15384101.2018.1445906; Rodriguez-Nuevo A, 2019, CELL STRESS, V3, P195, DOI 10.15698/cst2019.06.190; Sanchez C, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0069-0; Sansone P, 2017, P NATL ACAD SCI USA, V114, pE9066, DOI 10.1073/pnas.1704862114; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sudakov NP, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1387, DOI 10.1134/S000629791510020X; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107; Wang JY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0832-2; Wiemerslage L, 2016, MITOCHONDRION, V30, P138, DOI 10.1016/j.mito.2016.07.004; Yu M, 2012, MITOCHONDR DNA, V23, P329, DOI 10.3109/19401736.2012.696625; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang RY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36097	43	144	145	9	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3616	3630		10.1096/fj.201901917RR	http://dx.doi.org/10.1096/fj.201901917RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957088	Green Submitted, hybrid			2022-12-26	WOS:000508135400001
J	Sandoval, DR; Toledo, AG; Painter, CD; Tota, EM; Sheikh, MO; West, AMV; Frank, MM; Wells, L; Xu, D; Bicknell, R; Corbett, KD; Esko, JD				Sandoval, Daniel R.; Toledo, Alejandro Gomez; Painter, Chelsea D.; Tota, Ember M.; Sheikh, M. Osman; West, Alan M., V; Frank, Martin M.; Wells, Lance; Xu, Ding; Bicknell, Roy; Corbett, Kevin D.; Esko, Jeffrey D.			Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteomics; heparin-binding protein; heparin; heparan sulfate; endothelium; vascular biology; glycosaminoglycan; extracellular matrix; C-type lectin 14a (CLEC14A); LPHAMS	LAMININ ALPHA-4 CHAIN; GROWTH-FACTOR; MOLECULAR-CLONING; LYMPHOCYTE CHEMOATTRACTANT; SPROUTING ANGIOGENESIS; EPITHELIN PRECURSOR; TERMINAL DOMAIN; RECEPTOR; AFFINITY; GLYCOSAMINOGLYCANS	Animal cells express heparan sulfate proteoglycans that perform many important cellular functions by way of heparan sulfate?protein interactions. The identification of membrane heparan sulfate?binding proteins is challenging because of their low abundance and the need for extensive enrichment. Here, we report a proteomics workflow for the identification and characterization of membrane-anchored and extracellular proteins that bind heparan sulfate. The technique is based on limited proteolysis of live cells in the absence of denaturation and fixation, heparin-affinity chromatography, and high-resolution LC-MS/MS, and we designate it LPHAMS. Application of LPHAMS to U937 monocytic and primary murine and human endothelial cells identified 55 plasma membrane, extracellular matrix, and soluble secreted proteins, including many previously unidentified heparin-binding proteins. The method also facilitated the mapping of the heparin-binding domains, making it possible to predict the location of the heparin-binding site. To validate the discovery feature of LPHAMS, we characterized one of the newly-discovered heparin-binding proteins, C-type lectin 14a (CLEC14A), a member of the C-type lectin family that modulates angiogenesis. We found that the C-type lectin domain of CLEC14A binds one-to-one to heparin with nanomolar affinity, and using molecular modeling and mutagenesis, we mapped its heparin-binding site. CLEC14A physically interacted with other glycosaminoglycans, including endothelial heparan sulfate and chondroitin sulfate E, but not with neutral or sialylated oligosaccharides. The LPHAMS technique should be applicable to other cells and glycans and provides a way to expand the repertoire of glycan-binding proteins for further study.	[Sandoval, Daniel R.; Toledo, Alejandro Gomez; Painter, Chelsea D.; Corbett, Kevin D.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Sandoval, Daniel R.; Painter, Chelsea D.; West, Alan M., V] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Tota, Ember M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sheikh, M. Osman; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Frank, Martin M.] Biognos AB, S-41705 Gothenburg, Sweden; [Xu, Ding] Univ Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent, Birmingham B15 2TT, W Midlands, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Birmingham	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Esko, JD (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu		Bicknell, Roy/0000-0002-0941-8919; Frank, Martin/0000-0002-1006-6746; Sheikh, Mohammed/0000-0002-9481-8318; Corbett, Kevin/0000-0001-5854-2388; Wells, Lance/0000-0003-4956-5363	Program of Excellence in Glycoscience from the National Institutes of Health [P01 HL107150, P01 HL131474]; National Institutes of Health [R01 AR070179, R01 GM104141, P41 GM103490]	Program of Excellence in Glycoscience from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Program of Excellence in Glycoscience Grants P01 HL107150 and P01 HL131474 from the National Institutes of Health (to J. D. E.), a supplement to Grant P01 HL131474 (to D.R.S.), and National Institutes of Health Grants R01 AR070179 (to D. X.), R01 GM104141 (to K. D. C.), and P41 GM103490 (to L. W.). The University of California, San Diego, and J. D. E. have a financial interest in TEGA Therapeutics, Inc. J. D. E. and the University of California, San Diego, may financially benefit from this interest if the company is successful in marketing its products (recombinant heparan sulfate) that are related to this research. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angel PM, 2007, RAPID COMMUN MASS SP, V21, P674, DOI 10.1002/rcm.2874; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; Beckman M, 2009, FEBS J, V276, P7343, DOI 10.1111/j.1742-4658.2009.07444.x; BENECKY MJ, 1988, BIOCHEMISTRY-US, V27, P7565, DOI 10.1021/bi00419a058; BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cummings RD., 2017, ESSENTIALS GLYCOBIOL, Vpp, P435, DOI DOI 10.1101/GLYCOBIOLOGY.3E.034; DIXIT VM, 1984, J BIOL CHEM, V259, P100; EHRLICH HJ, 1991, BIOCHEMISTRY-US, V30, P1021, DOI 10.1021/bi00218a020; FLODGAARD H, 1991, EUR J BIOCHEM, V197, P535, DOI 10.1111/j.1432-1033.1991.tb15942.x; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Holtz AM, 2015, J CELL BIOL, V209, P739, DOI 10.1083/jcb.201411024; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11118-y; Joo EJ, 2005, GLYCOBIOLOGY, V15, P1, DOI 10.1093/glycob/cwh132; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan KA, 2017, ONCOGENE, V36, P6097, DOI 10.1038/onc.2017.214; Khan KA, 2019, FEBS J, V286, P3299, DOI 10.1111/febs.14985; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kim TK, 2018, MOL ONCOL, V12, P356, DOI 10.1002/1878-0261.12169; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Ledoux D, 2003, FEBS LETT, V537, P23, DOI 10.1016/S0014-5793(03)00064-4; Lee S, 2017, J CLIN INVEST, V127, P457, DOI 10.1172/JCI85145; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; Menoret A, 2000, J IMMUNOL METHODS, V237, P119, DOI 10.1016/S0022-1759(00)00137-X; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; NAKAMURA H, 1994, J BIOL CHEM, V269, P25143; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Noy PJ, 2016, FASEB J, V30, P2311, DOI 10.1096/fj.201500122R; Nunes QM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217633; Ohashi K, 2002, NEPHRON, V90, P158, DOI 10.1159/000049037; Olaya-Abril A, 2014, J PROTEOMICS, V97, P164, DOI 10.1016/j.jprot.2013.03.035; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Riera M, 1999, MOL CELL BIOCHEM, V191, P97, DOI 10.1023/A:1006810311743; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh A, 2019, GLYCOBIOLOGY, V29, P515, DOI 10.1093/glycob/cwz027; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; Sue SC, 2004, J MOL BIOL, V343, P1365, DOI 10.1016/j.jmb.2004.09.014; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van Wijk XMR, 2014, ANGIOGENESIS, V17, P443, DOI 10.1007/s10456-013-9401-6; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Xu D, 2011, J BIOL CHEM, V286, P41736, DOI 10.1074/jbc.M111.299685; YAMADA KM, 1980, J BIOL CHEM, V255, P6055; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Yamashita H, 2004, J MOL BIOL, V335, P1145, DOI 10.1016/j.jmb.2003.11.047; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351; Yip CW, 2014, CARCINOGENESIS, V35, P2485, DOI 10.1093/carcin/bgu164; Yu WH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006093; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang B, 2014, J CLIN INVEST, V124, P209, DOI 10.1172/JCI71090; Zhang X, 2018, P NATL ACAD SCI USA, V115, P3828, DOI 10.1073/pnas.1720859115; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746	98	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2804	2821		10.1074/jbc.RA119.011639	http://dx.doi.org/10.1074/jbc.RA119.011639			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31964714	Green Published, hybrid			2022-12-26	WOS:000519969100023
J	Song, XZ; Akasaka, H; Wang, H; Abbasgholizadeh, R; Shin, JH; Zang, FL; Chen, JY; Logsdon, CD; Maitra, A; Bean, AJ; Wang, HM				Song, Xianzhou; Akasaka, Hironari; Wang, Hua; Abbasgholizadeh, Reza; Shin, Ji-Hyun; Zang, Fenglin; Chen, Jiayi; Logsdon, Craig D.; Maitra, Anirban; Bean, Andrew J.; Wang, Huamin			Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic cancer; endocytosis; receptor tyrosine kinase; ubiquitylation (ubiquitination); protein degradation; tumor suppressor gene; Axl; c-Cbl; Gas6; HPK1; kinase signaling	CASPASE-MEDIATED CLEAVAGE; GENE-EXPRESSION; DEGRADATION; GROWTH; CELLS; ADENOCARCINOMA; OVEREXPRESSION; BAFILOMYCIN-A1; METASTASIS; ACTIVATION	The oncogenic receptor tyrosine kinase AXL is overexpressed in cancer and plays an important role in carcinomas of multiple organs. However, the mechanisms of AXL overexpression in cancer remain unclear. In this study, using HEK293T, Panc-1, and Panc-28 cells and samples of human pancreatic intraepithelial neoplasia (PanIN), along with several biochemical approaches and immunofluorescence microscopy analyses, we sought to investigate the mechanisms that regulate AXL over-expression in pancreatic ductal adenocarcinoma (PDAC). We found that AXL interacts with hematopoietic progenitor kinase 1 (HPK1) and demonstrate that HPK1 down-regulates AXL and decreases its half-life. The HPK1-mediated AXL degradation was inhibited by the endocytic pathway inhibitors leupeptin, bafilomycin A1, and monensin. HPK1 accelerated the movement of AXL from the plasma membrane to endosomes in pancreatic cancer cells treated with the AXL ligand growth arrest-specific 6 (GAS6). Moreover, HPK1 increased the binding of AXL to the Cbl proto-oncogene (c-Cbl); promoted AXL ubiquitination; decreased AXL-mediated signaling, including phospho-AKT and phospho-ERK signaling; and decreased the invasion capability of PDAC cells. Importantly, we show that AXL expression inversely correlates with HPK1 expression in human PanINs and that patients whose tumors have low HPK1 and high AXL expression levels have shorter survival than those with low AXL or high HPK1 expression (p < 0.001). Our results suggest that HPK1 is a tumor suppressor that targets AXL for degradation via the endocytic pathway. HPK1 loss of function may contribute to AXL overexpression and thereby enhance AXL-dependent downstream signaling and tumor invasion in PDAC.	[Song, Xianzhou; Akasaka, Hironari; Abbasgholizadeh, Reza; Shin, Ji-Hyun; Zang, Fenglin; Chen, Jiayi; Maitra, Anirban; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol, Houston, TX 77030 USA; [Wang, Hua] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Maitra, Anirban; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Bean, Andrew J.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol, Unit 085, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hmwang@mdanderson.org	Chen, Jiayi/GZM-5106-2022		National Institutes of Health [1R01 CA196941, 1R01CA195651]; Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at University of Texas M. D. Anderson Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at University of Texas M. D. Anderson Cancer Center	This work was supported by National Institutes of Health Grants 1R01 CA196941 and 1R01CA195651 and the Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at University of Texas M. D. Anderson Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745670; Are M, 2017, J SURG ONCOL, V115, P637, DOI 10.1002/jso.24585; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goyette MA, 2018, CELL REP, V23, P1476, DOI 10.1016/j.celrep.2018.04.019; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Hernandez S, 2018, CELL REP, V25, P80, DOI 10.1016/j.celrep.2018.09.012; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; HYMAN C, 1983, J CELL BIOL, V96, P1316, DOI 10.1083/jcb.96.5.1316; Kariolis MS, 2017, J CLIN INVEST, V127, P183, DOI 10.1172/JCI85610; Kirane A, 2015, CANCER RES, V75, P3699, DOI 10.1158/0008-5472.CAN-14-2887-T; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Leconet W, 2014, ONCOGENE, V33, P5405, DOI 10.1038/onc.2013.487; Leconet W, 2017, CLIN CANCER RES, V23, P2806, DOI 10.1158/1078-0432.CCR-16-1316; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Ludwig KF, 2018, CANCER RES, V78, P246, DOI 10.1158/0008-5472.CAN-17-1973; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Meric F, 2002, CLIN CANCER RES, V8, P361; Moody G, 2016, INT J CANCER, V139, P1340, DOI 10.1002/ijc.30180; Moore RH, 1999, J CELL SCI, V112, P329; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Skinner HD, 2017, CLIN CANCER RES, V23, P2713, DOI 10.1158/1078-0432.CCR-16-2586; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tsou AP, 1998, GENOMICS, V50, P331, DOI 10.1006/geno.1998.5338; Tveten K, 2009, ACTA BIOCH BIOPH SIN, V41, P246, DOI 10.1093/abbs/gmp008; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Wang H, 2016, SEMIN CANCER BIOL, V36, P88, DOI 10.1016/j.semcancer.2015.09.004; Wang H, 2014, J BIOL CHEM, V289, P4009, DOI 10.1074/jbc.M113.520106; Wang H, 2009, CANCER RES, V69, P1063, DOI 10.1158/0008-5472.CAN-08-1751; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Wimmel A, 2001, EUR J CANCER, V37, P2264, DOI 10.1016/S0959-8049(01)00271-4; Wu CW, 2002, ANTICANCER RES, V22, P1071; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang G, 2018, CLIN CANCER RES, V24, P4771, DOI 10.1158/1078-0432.CCR-17-2773; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	54	7	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2348	2358		10.1074/jbc.RA119.012186	http://dx.doi.org/10.1074/jbc.RA119.012186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31959629	Green Published, hybrid			2022-12-26	WOS:000517330200017
J	Xu, R; Ritz, BK; Wang, YK; Huang, JC; Zhao, C; Gong, KZ; Liu, XN; Du, JH				Xu, Rong; Ritz, Brianna K.; Wang, Yekai; Huang, Jiancheng; Zhao, Chen; Gong, Kaizheng; Liu, Xinnong; Du, Jianhai			The retina and retinal pigment epithelium differ in nitrogen metabolism and are metabolically connected	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; nitrogen metabolism; retinal metabolism; mitochondrial metabolism; amino acid	MITOCHONDRIAL PYRUVATE CARRIER; NERVOUS-TISSUE; GLIAL-CELLS; TCA CYCLE; GLUTAMATE; AMMONIA; TRANSPORT; NEURONS; PATHWAY; GLUCOSE	Defects in energy metabolism in either the retina or the immediately adjacent retinal pigment epithelium (RPE) underlie retinal degeneration, but the metabolic dependence between retina and RPE remains unclear. Nitrogen-containing metabolites such as amino acids are essential for energy metabolism. Here, we found that N-15-labeled ammonium is predominantly assimilated into glutamine in both the retina and RPE/choroid ex vivo. [N-15]Ammonium tracing in vivo show that, like the brain, the retina can synthesize asparagine from ammonium, but RPE/choroid and the liver cannot. However, unless present at toxic concentrations, ammonium cannot be recycled into glutamate in the retina and RPE/choroid. Tracing with N-15-labeled amino acids show that the retina predominantly uses aspartate transaminase for de novo synthesis of glutamate, glutamine, and aspartate, whereas RPE uses multiple transaminases to utilize and synthesize amino acids. Retina consumes more leucine than RPE, but little leucine is catabolized. The synthesis of serine and glycine is active in RPE but limited in the retina. RPE, but not the retina, uses alanine as mitochondrial substrates through mitochondrial pyruvate carrier. However, when the mitochondrial pyruvate carrier is inhibited, alanine may directly enter the retinal mitochondria but not those of RPE. In conclusion, our results demonstrate that the retina and RPE differ in nitrogen metabolism and highlight that the RPE supports retinal metabolism through active amino acid metabolism.	[Xu, Rong] Yangzhou Univ, Affiliated Hosp, Cent Lab, Yangzhou 225012, Jiangsu, Peoples R China; [Xu, Rong; Ritz, Brianna K.; Wang, Yekai; Huang, Jiancheng; Du, Jianhai] West Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA; [Xu, Rong; Ritz, Brianna K.; Wang, Yekai; Huang, Jiancheng; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Huang, Jiancheng; Zhao, Chen] Fudan Univ, Inst Eye, Eye & ENT Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Gong, Kaizheng; Liu, Xinnong] Yangzhou Univ, Affiliated Hosp, Dept Cardiol, Yangzhou 225012, Jiangsu, Peoples R China; [Liu, Xinnong] Yangzhou Univ, Affiliated Hosp, Dept Gen Surg, Yangzhou 225012, Jiangsu, Peoples R China	Yangzhou University; West Virginia University; West Virginia University; Fudan University; Yangzhou University; Yangzhou University	Liu, XN (corresponding author), 368 Hanjiang Middle Rd, Yangzhou 225012, Jiangsu, Peoples R China.; Du, JH (corresponding author), WVU Eye Inst, One Med Ctr Dr,POB 9193, Morgantown, WV 26505 USA.	yzyyxhk@163.com; jianhai.du@wvumedicine.org		Du, Jianhai/0000-0002-2019-8128	National Institutes of Health [EY026030]; Retina Research Foundation; Yanzhou University International Academic Exchange Fund Studentship; Yangzhou University International Academic Exchange Fund Grant [XKYCX18_130]; West Virginia University Summer Undergraduate Vision Research Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; Yanzhou University International Academic Exchange Fund Studentship; Yangzhou University International Academic Exchange Fund Grant; West Virginia University Summer Undergraduate Vision Research Fellowship	This work was supported by National Institutes of Health Grant EY026030 (to J. D.) and by the Retina Research Foundation (to J. D.). This work was also supported in part by a Yanzhou University International Academic Exchange Fund Studentship (to R. X.), the Yangzhou University International Academic Exchange Fund Grant XKYCX18_130 (to R. X.), and a West Virginia University Summer Undergraduate Vision Research Fellowship (to B. K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; AMES A, 1980, J NEUROCHEM, V35, P131; Ames A 3rd, 1980, Neurochem Int, V1C, P393, DOI 10.1016/0197-0186(80)90075-3; Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Bowman CE, 2016, MOL CELL BIOL, V36, P2089, DOI 10.1128/MCB.00166-16; Bringmann A, 1998, J BRAIN RES, V39, P193; Brown EE, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101201; Bui BV, 2009, J NEUROCHEM, V111, P589, DOI 10.1111/j.1471-4159.2009.06354.x; Chao JR, 2017, J BIOL CHEM, V292, P12895, DOI 10.1074/jbc.M117.788422; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Coles JA, 1996, J PHYSIOL-LONDON, V495, P305, DOI 10.1113/jphysiol.1996.sp021595; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Du JH, 2015, METHOD ENZYMOL, V561, P149, DOI 10.1016/bs.mie.2015.04.002; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; Felszeghy S, 2019, REDOX BIOL, V20, P1, DOI 10.1016/j.redox.2018.09.011; Fisher CR, 2018, INVEST OPHTH VIS SCI, V59, pAMD41, DOI 10.1167/iovs.18-24289; Franco TMA, 2017, ACS CHEM BIOL, V12, P1235, DOI 10.1021/acschembio.7b00142; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Grenell A, 2019, P NATL ACAD SCI USA, V116, P3530, DOI 10.1073/pnas.1812941116; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Huang JC, 2019, THERANOSTICS, V9, P1170, DOI 10.7150/thno.26281; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Lieth E, 2001, J NEUROCHEM, V76, P1712, DOI 10.1046/j.1471-4159.2001.00156.x; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Lomelino CL, 2017, J BIOL CHEM, V292, P19952, DOI 10.1074/jbc.R117.819060; Marcaggi P, 2001, PROG NEUROBIOL, V64, P157, DOI 10.1016/S0301-0082(00)00043-5; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Millard P, 2019, BIOINFORMATICS, V35, P4484, DOI 10.1093/bioinformatics/btz209; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; PARKS JM, 1976, J NEUROCHEM, V27, P987, DOI 10.1111/j.1471-4159.1976.tb00301.x; PEREZSALA D, 1986, J BIOL CHEM, V261, P13969; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Scerri TS, 2017, NAT GENET, V49, P559, DOI 10.1038/ng.3799; Singh C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129398; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Tompkins SC, 2019, CELL REP, V28, P2608, DOI 10.1016/j.celrep.2019.07.098; Uhlmann S, 2003, GRAEF ARCH CLIN EXP, V241, P451, DOI 10.1007/s00417-003-0639-3; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Venkatesh A, 2015, J CLIN INVEST, V125, P1446, DOI 10.1172/JCI79766; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Walker V, 2014, ADV CLIN CHEM, V67, P73, DOI 10.1016/bs.acc.2014.09.002; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; Yam M, 2019, J BIOL CHEM, V294, P10278, DOI 10.1074/jbc.RA119.007983; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zaganas I, 2013, METAB BRAIN DIS, V28, P127, DOI 10.1007/s11011-013-9382-6; Zhang LJ, 2016, HUM MOL GENET, V25, P4244, DOI 10.1093/hmg/ddw256; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhu SY, 2018, EXP EYE RES, V174, P113, DOI 10.1016/j.exer.2018.05.032	60	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2324	2335		10.1074/jbc.RA119.011727	http://dx.doi.org/10.1074/jbc.RA119.011727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953322	Green Published, hybrid			2022-12-26	WOS:000517330200015
J	Devlin, LA; Ramsbottom, SA; Overman, LM; Lisgo, SN; Clowry, G; Molinari, E; Powell, L; Miles, CG; Sayer, JA				Devlin, L. A.; Ramsbottom, S. A.; Overman, L. M.; Lisgo, S. N.; Clowry, G.; Molinari, E.; Powell, L.; Miles, C. G.; Sayer, J. A.			Embryonic and foetal expression patterns of the ciliopathy gene CEP164	PLOS ONE			English	Article							JOUBERT-SYNDROME; PRIMARY CILIA; RETINAL DEVELOPMENT; DNA-DAMAGE; LOCALIZATION; CENTRIOLE; REVEALS; MICROSCOPY; DOCKING; LIVER	Nephronophthisis-related ciliopathies (NPHP-RC) are a group of inherited genetic disorders that share a defect in the formation, maintenance or functioning of the primary cilium complex, causing progressive cystic kidney disease and other clinical manifestations. Mutations in centrosomal protein 164 kDa (CEP164), also known as NPHP15, have been identified as a cause of NPHP-RC. Here we have utilised the MRC-Wellcome Trust Human Developmental Biology Resource (HDBR) to perform immunohistochemistry studies on human embryonic and foetal tissues to determine the expression patterns of CEP164 during development. Notably expression is widespread, yet defined, in multiple organs including the kidney, retina and cerebellum. Murine studies demonstrated an almost identical Cep164 expression pattern. Taken together, these data support a conserved role for CEP164 throughout the development of numerous organs, which, we suggest, accounts for the multi-system disease phenotype of CEP164-mediated NPHP-RC.	[Devlin, L. A.; Ramsbottom, S. A.; Molinari, E.; Powell, L.; Miles, C. G.; Sayer, J. A.] Newcastle Univ, Inst Genet Med, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England; [Overman, L. M.; Lisgo, S. N.] Inst Genet Med, Int Ctr Life, MRC Wellcome Trust Human Dev Biol Resource, Newcastle Upon Tyne, Tyne & Wear, England; [Clowry, G.] Newcastle Univ, Med Sch, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England; [Sayer, J. A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Rd, Newcastle Upon Tyne, Tyne & Wear, England; [Sayer, J. A.] Natl Inst Hlth Res Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Sayer, JA (corresponding author), Newcastle Univ, Inst Genet Med, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, JA (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Rd, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, JA (corresponding author), Natl Inst Hlth Res Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	john.sayer@ncl.ac.uk	Clowry, Gavin John/A-4881-2009; Sayer, John A./AAN-2729-2020; Molinari, Elisa/GPC-5319-2022	Sayer, John A./0000-0003-1881-3782; Molinari, Elisa/0000-0002-1840-915X; Lisgo, Steven/0000-0001-5186-3971; Devlin, Laura/0000-0003-4251-9903; Rock, Simon/0000-0001-8531-1534; Clowry, Gavin/0000-0002-6489-8329	Medical Research Council Discovery Medicine North Doctoral Training Partnership; Northern Counties Kidney Research Fund; Kidney Research UK [PDF_003_20151124)]; MRC [MR/R006237/1, 1934315] Funding Source: UKRI	Medical Research Council Discovery Medicine North Doctoral Training Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Northern Counties Kidney Research Fund; Kidney Research UK(Kidney Research UK (KRUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	L.A.D is funded by the Medical Research Council Discovery Medicine North Doctoral Training Partnership (https://www.dimen.org.uk) and The Northern Counties Kidney Research Fund (http://www.nckrf.org.uk), S.A.R is supported by a Kidney Research UK Post-doctoral fellowship (PDF_003_20151124). JAS is funded by Kidney Research UK and The Northern Counties Kidney Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2001, INT J DEV NEUROSCI, V19, P53, DOI 10.1016/S0736-5748(00)00065-4; Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Airik R, 2019, KIDNEY INT, V96, P320, DOI 10.1016/j.kint.2019.04.014; Ajzenberg Henry, 2015, Cilia, V4, P8, DOI 10.1186/s13630-015-0017-x; Al-Jaberi N, 2015, CEREB CORTEX, V25, P631, DOI 10.1093/cercor/bht254; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Atlas THP, 2018, CEP164; Best J, 2015, HEPATOBIL SURG NUTR, V4, P48, DOI 10.3978/j.issn.2304-3881.2015.01.16; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Burke MC, 2014, J CELL BIOL, V207, P123, DOI 10.1083/jcb.201406140; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Cheng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032029; Cho KH, 2011, SURG RADIOL ANAT, V33, P523, DOI 10.1007/s00276-011-0796-8; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Clotman F, 2008, LIVER INT, V28, P377, DOI 10.1111/j.1478-3231.2007.01617.x; Daly OM, 2016, J CELL SCI, V129, P1769, DOI 10.1242/jcs.186221; Davidson A.J., 2008, STEMBOOK; Delaine-Smith RM, 2014, FASEB J, V28, P430, DOI 10.1096/fj.13-231894; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Ensembl, 2018, CEP164 MUR; Faa G, 2012, J CELL PHYSIOL, V227, P1257, DOI 10.1002/jcp.22985; Fishman EL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04678-8; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Hill MA, 2019, EMBRYOLOGY VISION RE; HOLLENBERG MJ, 1973, AM J ANAT, V137, P357, DOI 10.1002/aja.1001370402; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Hynes AM, 2014, P NATL ACAD SCI USA, V111, P9893, DOI 10.1073/pnas.1322373111; Ichimura K, 2010, CELL TISSUE RES, V341, P197, DOI 10.1007/s00441-010-0983-7; IMPC, 2018, CEP164; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Koefoed K, 2014, ORGANOGENESIS, V10, P108, DOI 10.4161/org.27483; Kong D, 2014, J CELL BIOL, V206, P855, DOI 10.1083/jcb.201407087; LAMBERT SR, 1989, ARCH OPHTHALMOL-CHIC, V107, P709, DOI 10.1001/archopht.1989.01070010727035; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; Lindstrom NO, 2018, J AM SOC NEPHROL, V29, P785, DOI 10.1681/ASN.2017080887; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Lynn RB, 1996, BIOCHEM BIOPH RES CO, V219, P884, DOI 10.1006/bbrc.1996.0328; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Maria M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34764; Martinez S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00018; Masyuk AI, 2008, DEV DYNAM, V237, P2007, DOI 10.1002/dvdy.21530; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; Oda T, 2014, GENES CELLS, V19, P927, DOI 10.1111/gtc.12191; Pan YR, 2009, CELL CYCLE, V8, P655, DOI 10.4161/cc.8.4.7844; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Ramsbottom SA, 2018, P NATL ACAD SCI USA, V115, P12489, DOI 10.1073/pnas.1809432115; Saqui-Salces M, 2012, FASEB J, V26, P3127, DOI 10.1096/fj.11-197426; Saraga-Babic M, 2012, PEDIATR NEPHROL, V27, P55, DOI 10.1007/s00467-011-1941-7; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Seely JC, 2017, J TOXICOL PATHOL, V30, P125, DOI 10.1293/tox.2017-0006; Shi XY, 2017, NAT CELL BIOL, V19, P1178, DOI 10.1038/ncb3599; Siller SS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007128; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; Slaats GG, 2015, J CLIN INVEST, V125, P3657, DOI 10.1172/JCI80657; Slaats GG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004594; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Srivastava S, 2017, HUM MOL GENET; Srivastava S, 2018, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00287; Sturm V, 2010, EYE, V24, P222, DOI 10.1038/eye.2009.116; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; UCSC, 2018, CEP164; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; VANDORP DB, 1991, AM J MED GENET, V40, P100, DOI 10.1002/ajmg.1320400121; White JJ, 2013, WIRES DEV BIOL, V2, P149, DOI 10.1002/wdev.65; Wu B, 2013, J UROLOGY, V189, P2385, DOI 10.1016/j.juro.2012.12.002; Yang, 2018, NATURE COMMUNICATION; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang X, 2011, BIOINFORM BIOL INSIG, V5, P99, DOI 10.4137/BBI.S6930	78	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0221914	10.1371/journal.pone.0221914	http://dx.doi.org/10.1371/journal.pone.0221914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990917	Green Published, gold, Green Submitted			2022-12-26	WOS:000534605400004
J	Herzberg, D; Strobel, P; Muller, H; Meneses, C; Werner, M; Bustamante, H				Herzberg, Daniel; Strobel, Pablo; Muller, Heine; Meneses, Constanza; Werner, Marianne; Bustamante, Hedie			Proteomic profiling of proteins in the dorsal horn of the spinal cord in dairy cows with chronic lameness	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROPATHIC PAIN; HEALTHY CONTROLS; ANIMAL-MODELS; HSP70; MECHANISMS; RECEPTORS; ENOLASE; ROLES; PEROXIREDOXIN	Chronic lameness affects bovine welfare and has a negative economic impact in dairy industry. Moreover, due to the translational gap between traditional pain models and new drugs development for treating chronic pain states, naturally occurring painful diseases could be a potential translational tool for chronic pain research. We therefore employed liquid chromatography tandem mass spectrometry (LC-MS/MS) to stablish the proteomic profile of the spinal cord samples from lumbar segments (L2-L4) of chronic lame dairy cows. Data were validated and quantified through software tool (Scaffold (R) v 4.0) using output data from two search engines (SEQUEST (R) and X-Tandem (R)). Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) analysis was performed to detect proteins interactions. LC-MS/MS identified a total amount of 177 proteins; of which 129 proteins were able to be quantified. Lame cows showed a strong upregulation of interacting proteins with chaperone and stress functions such as Hsp70 (p < 0.006), Hsc70 (p < 0.0079), Hsp90 (p < 0.015), STIP (p > 0.0018) and Grp78 (p <0.0068), and interacting proteins associated to glycolytic pathway such as; gamma-enolase (p < 0.0095), alpha-enolase (p < 0.013) and hexokinase-1 (p < 0.028). It was not possible to establish a clear network of interaction in several upregulated proteins in lame cows. Non-interacting proteins were mainly associated to redox process and cytoskeletal organization. The most relevant down regulated protein in lame cows was myelin basic protein (MBP) (p < 0.02). Chronic inflammatory lameness in cows is associated to increased expression of stress proteins with chaperone, metabolism, redox and structural functions. A state of endoplasmic reticulum stress and unfolded protein response (UPR) might explain the changes in protein expression in lame cows; however, further studies need to be performed in order to confirm these findings.	[Herzberg, Daniel; Muller, Heine; Bustamante, Hedie] Univ Austral Chile, Fac Vet Sci, Vet Clin Sci Dept, Valdivia, Chile; [Strobel, Pablo; Werner, Marianne] Univ Austral Chile, Fac Vet Sci, Anim Sci Dept, Valdivia, Chile; [Meneses, Constanza] North Caroline State Univ, Comparat Biomed Sci Grad Program, Coll Vet Med, Raleigh, NC USA	Universidad Austral de Chile; Universidad Austral de Chile; University of North Carolina; North Carolina State University	Herzberg, D; Bustamante, H (corresponding author), Univ Austral Chile, Fac Vet Sci, Vet Clin Sci Dept, Valdivia, Chile.	danielherzberg@gmail.com; hbustamante@uach.cl		Bustamante, Hedie/0000-0002-2276-9676; Herzberg, Daniel/0000-0002-4864-7626	Conicyt [21150613]	Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Conicyt/Scholarship No 21150613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backryd E, 2015, J PAIN RES, V8, P321, DOI 10.2147/JPR.S82970; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Bock A, 2015, SHOCK, V44, P137, DOI 10.1097/SHK.0000000000000394; Bohonowych JE, 2014, PROSTATE, V74, P395, DOI 10.1002/pros.22761; Booth CJ, 2004, J DAIRY SCI, V87, P4115, DOI 10.3168/jds.S0022-0302(04)73554-7; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Cao L, 2009, EUR J IMMUNOL, V39, P3562, DOI 10.1002/eji.200939657; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Cizkova D, 2005, PHYSIOL RES, V54, P349, DOI 10.33549/physiolres.930267; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Gao X, 2007, PAIN, V131, P262, DOI 10.1016/j.pain.2007.01.011; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Gomez-Varela D, 2019, J PROTEOMICS, V190, P1, DOI 10.1016/j.jprot.2018.04.004; Grandin T, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8070124; Griffiths BE, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00065; Guedes RP, 2006, NEUROCHEM RES, V31, P603, DOI 10.1007/s11064-006-9058-2; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hafner A, 2013, AGING CELL, V12, P604, DOI 10.1111/acel.12093; Haque A, 2016, METAB BRAIN DIS, V31, P487, DOI 10.1007/s11011-016-9801-6; Huang HL, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-33; Hutchinson MR, 2009, NEUROSCIENCE, V164, P1821, DOI 10.1016/j.neuroscience.2009.09.046; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kakimura J, 2001, BIOCHEM BIOPH RES CO, V281, P6, DOI 10.1006/bbrc.2001.4299; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Khoutorsky A, 2018, TRENDS NEUROSCI, V41, P100, DOI 10.1016/j.tins.2017.11.006; Kim JK, 2011, J IMMUNOL, V187, P6327, DOI 10.4049/jimmunol.1100612; Klinck MP, 2017, PAIN, V158, P1633, DOI 10.1097/j.pain.0000000000000978; Komori N, 2007, PHYSIOL GENOMICS, V29, P215, DOI 10.1152/physiolgenomics.00255.2006; Kossaibati MA, 1997, VET J, V154, P41, DOI 10.1016/S1090-0233(05)80007-3; Kuner R, 2015, PAIN, V156, pS11, DOI 10.1097/j.pain.0000000000000118; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Laudati E, 2017, NEUROCHEM INT, V108, P100, DOI 10.1016/j.neuint.2017.03.002; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Liu DQ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00072; Manivannan J, 2013, NEUROSCIENCE, V253, P40, DOI 10.1016/j.neuroscience.2013.08.023; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Nascimento DSM, 2018, MOL NEUROBIOL, V55, P3959, DOI 10.1007/s12035-017-0628-x; Mhaille AN, 2008, J NEUROPATH EXP NEUR, V67, P200, DOI 10.1097/NEN.0b013e318165b239; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mizumura K, 2015, HANDB EXP PHARMACOL, V227, P57, DOI 10.1007/978-3-662-46450-2_4; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mohan R, 2015, IUBMB LIFE, V67, P395, DOI 10.1002/iub.1384; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Netto LES, 2016, MOL CELLS, V39, P65, DOI 10.14348/molcells.2016.2349; Niederberger E, 2008, EXPERT REV PROTEOMIC, V5, P799, DOI 10.1586/14789450.5.6.799; Niforou K, 2014, REDOX BIOL, V2, P323, DOI 10.1016/j.redox.2014.01.017; Nishio N, 2013, NEUROSCIENCE, V247, P201, DOI 10.1016/j.neuroscience.2013.05.023; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Peracoli JC, 2013, J REPROD IMMUNOL, V100, P129, DOI 10.1016/j.jri.2013.08.003; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Polcyn Rachel, 2017, Neuroimmunol Neuroinflamm, V4, P254, DOI 10.20517/2347-8659.2017.59; Ranjbar S, 2016, J DAIRY SCI, V99, P7495, DOI 10.3168/jds.2016-11142; Reader JD, 2011, J DAIRY SCI, V94, P5045, DOI 10.3168/jds.2011-4415; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Sayas CL, 2014, J ALZHEIMERS DIS, V40, pS17, DOI 10.3233/JAD-132315; Sepulveda-Varas P, 2018, J DAIRY SCI, V101, P9439, DOI 10.3168/jds.2018-14674; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Sun WH, 2016, J DENT RES, V95, P135, DOI 10.1177/0022034515618382; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tadich N, 2013, VET J, V197, P401, DOI 10.1016/j.tvjl.2013.01.029; Tadich N, 2010, VET J, V184, P60, DOI 10.1016/j.tvjl.2009.01.005; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; Tukaj S, 2016, CELL STRESS CHAPERON, V21, P213, DOI 10.1007/s12192-016-0670-z; Tytell Michael, 2016, F1000Res, V5, DOI 10.12688/f1000research.7247.1; van Noort JM, 2008, J PATHOL, V214, P267, DOI 10.1002/path.2273; Villarroel-Campos D, 2014, DEV NEUROBIOL, V74, P953, DOI 10.1002/dneu.22178; Wahlen K, 2017, J PAIN RES, V10, P797, DOI 10.2147/JPR.S128597; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Yamashita N, 2012, MOL NEUROBIOL, V45, P234, DOI 10.1007/s12035-012-8242-4; Yang Eun Sun, 2014, Exp Neurobiol, V23, P372, DOI 10.5607/en.2014.23.4.372; Yon JM, 2002, J CELL MOL MED, V6, P307, DOI 10.1111/j.1582-4934.2002.tb00511.x; Yowtak J, 2011, PAIN, V152, P844, DOI 10.1016/j.pain.2010.12.034; Yu-Kemp HC, 2016, J BIOL CHEM, V291, P658, DOI 10.1074/jbc.C115.689265; Zhang EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11555; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Zhou F, 2017, J PAIN RES, V10, P653, DOI 10.2147/JPR.S125805	95	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228134	10.1371/journal.pone.0228134	http://dx.doi.org/10.1371/journal.pone.0228134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990932	gold, Green Published			2022-12-26	WOS:000534605400043
J	Baptista, JS; Traynelis, VC; Liberti, EA; Fontes, RBV				Baptista, Josemberg S.; Traynelis, Vincent C.; Liberti, Edson A.; Fontes, Ricardo B., V			Expression of degenerative markers in intervertebral discs of young and elderly asymptomatic individuals	PLOS ONE			English	Article							PRODUCE MATRIX METALLOPROTEINASES; NITRIC-OXIDE; INTERBODY FUSION; BASIC SCIENCE; INTERLEUKIN-6; DEGRADATION; SPINE	Intervertebral disc (IVD) degeneration is a remodeling process mediated by several growth factors and cytokines. This process has been extensively studied in vitro and with pathologic specimens obtained during surgery for scoliosis or back pain. However, the occurrence and temporal evolution of these molecules during normal aging, particularly in the cervical segment, is not known. Our objective was to study and compare the presence of putative mediators in the IVD of young (< 35 years, G1) and elderly (> 65 years, G2) presumably asymptomatic individuals. Thirty C4-5 and C5-6 discs and thirty L4-5 and L5-S1 discs per group were collected during the autopsy of individuals whose family members denied a history of neck or back pain. Discs were divided into anterior, central (lumbar only) and posterior sectors for analysis. Immunohistochemistry for TNF-alpha, IL-1 beta, VEGF, NGF-beta, BDNF, TIMP-1, MMP-1, -2 and -3 was performed and reactivity compared between groups and sectors. All of these molecules were detected in every disc sector of both G1 and G2. Most statistical comparisons (25/45, 55.6%) revealed an increase in mediator expression in G2 in relation to G1. Regional differences in the expression of remodeling enzymes were rare; NGF-beta and BDNF had slightly higher expression in the cervical segment of elderly individuals. A senescent profile with elevated VEGF, MMP-2 and MMP-3 was observed across most G2 disc regions and were generally elevated from G1. In conclusion, the mere presence of any of the studied molecules inside the IVD cannot be considered pathologic. Expression of remodeling enzymes and inflammatory mediators is relatively similar across different vertebral segments and disc regions leading to a common degenerated pattern, while neurotrophins have slightly higher expression in cervical discs. These findings support the concept that disc remodeling in different segments follows a similar pathway that can be potentially mediated to avoid structural failure.	[Baptista, Josemberg S.] Univ Fed Espirito Santo, Dept Morphol, Vitoria, ES, Brazil; [Baptista, Josemberg S.; Liberti, Edson A.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, Sao Paulo, Brazil; [Traynelis, Vincent C.; Fontes, Ricardo B., V] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA	Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Rush University	Baptista, JS (corresponding author), Univ Fed Espirito Santo, Dept Morphol, Vitoria, ES, Brazil.; Baptista, JS (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, Sao Paulo, Brazil.	josemberg.baptista@ufes.br	da Silva Baptista, Josemberg/D-7597-2013	da Silva Baptista, Josemberg/0000-0003-0514-8170				Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8; Fontes RBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139283; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; Fontes RBV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218121; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Furusawa N, 2001, SPINE, V26, P1110, DOI 10.1097/00007632-200105150-00004; Genevay S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2858; Gomez-Reino J, 2012, RHEUMATOLOGY, V51, pV31, DOI 10.1093/rheumatology/kes116; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P506, DOI 10.3109/10520295.2012.703692; Gruber HE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2456; Hasegawa A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4165; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Jacobs W, 2011, SPINE, V36, pE950, DOI 10.1097/BRS.0b013e31821cbba5; Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Kang JD, 1996, SPINE, V21, P271, DOI 10.1097/00007632-199602010-00003; Koike Y, 2003, SPINE, V28, P1928, DOI 10.1097/01.BRS.0000083324.65405.AE; Kokubo Y, 2008, J NEUROSURG-SPINE, V9, P285, DOI 10.3171/SPI/2008/9/9/285; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Lee JM, 2010, J ORTHOP RES OF 0805; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Purmessur D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2487; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schroeder M, 2013, J NEUROSURG-SPINE, V18, P496, DOI 10.3171/2013.1.SPINE12483; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; Weiler C, 2012, Eur Spine J, V21 Suppl 6, pS810, DOI 10.1007/s00586-011-1922-3; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Wijayathunga VN, 2019, SPINE, V44, P793, DOI 10.1097/BRS.0000000000002958; Zhou ZJ, 2011, J NEUROSURG-SPINE, V15, P295, DOI 10.3171/2011.4.SPINE10330; Zigouris A, 2011, J NEUROSURG-SPINE, V14, P268, DOI 10.3171/2010.9.SPINE09935	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228155	10.1371/journal.pone.0228155	http://dx.doi.org/10.1371/journal.pone.0228155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986181	Green Published, gold			2022-12-26	WOS:000534603400039
J	Rahman, N; Shamsuzzaman, M; Lindahl, L				Rahman, Nusrat; Shamsuzzaman, Md; Lindahl, Lasse			Interaction between the assembly of the ribosomal subunits: Disruption of 40S ribosomal assembly causes accumulation of extra-ribosomal 60S ribosomal protein uL18/L5	PLOS ONE			English	Article							RNA; YEAST; TURNOVER; REVEALS; EXCESS; P53	Inhibition of the synthesis of an essential ribosomal protein (r-protein) abrogates the assembly of its cognate subunit, while assembly of the other subunit continues. Ribosomal components that are not stably incorporated into ribosomal particles due to the disrupted assembly are rapidly degraded. The 60S protein uL18/L5 is an exception and this protein accumulates extra-ribosomally during inhibition of 60S assembly. Since the r-proteins in each ribosomal subunit are essential only for the formation of their cognate subunit, it would be predicted that accumulation of extra-ribosomal uL18/L5 is specific to restriction of 60S assembly and does not occur abolition of 40S assembly. Contrary to this prediction, we report here that repression of 40S r-protein genes does lead to accumulation of uL18/L5 outside of the ribosome. Furthermore, the effect varies depending on which 40S ribosomal protein is repressed. Our results also show extra-ribosomal uL18/L5 is formed during 60S assembly, not during degradation of mature cytoplasmic 60S subunits. Finally, we propose a model for the accumulation of extra-ribosomal uL18 in response to the abolition of 40S r-proteins.	[Rahman, Nusrat; Shamsuzzaman, Md; Lindahl, Lasse] Univ Maryland Baltimore Cty UMBC, Dept Biol Sci, Baltimore, MD 21250 USA; [Rahman, Nusrat] Bentley Univ, Bentley Hlth Thought Leadership Network, Waltham, MA 02452 USA; [Shamsuzzaman, Md] Verizon Innovat Ctr, Waltham, MA USA	University System of Maryland; University of Maryland Baltimore County; Bentley University	Lindahl, L (corresponding author), Univ Maryland Baltimore Cty UMBC, Dept Biol Sci, Baltimore, MD 21250 USA.	lindahl@umbc.edu		Lindahl, Lasse/0000-0001-8418-7885	National Science Foundation, USA [0920578]; University of Maryland, Baltimore County; Benelein Technologies, LLC	National Science Foundation, USA(National Science Foundation (NSF)); University of Maryland, Baltimore County; Benelein Technologies, LLC	This study was funded by grant number 0920578 from the National Science Foundation, USA to JM Zengel and LL, and a gift from The Benelein Technologies, LLC to LL (no grant number). Further funding was provided by an internal appropriation from the University of Maryland, Baltimore County to LL (no grant number). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Axt K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085703; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bassler J, 2019, ANNU REV BIOCHEM, V88, P281, DOI 10.1146/annurev-biochem-013118-110817; Bohnsack KE, 2019, EMBO J, V38, DOI 10.15252/embj.2018100278; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Cerezo E, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1516; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; DESHMUKH M, 1993, MOL CELL BIOL, V13, P2835, DOI 10.1128/MCB.13.5.2835; Fancello L, 2017, ONCOTARGET, V8, P14462, DOI 10.18632/oncotarget.14895; Fox JM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112806; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; Goldfarbi KC, 2017, GENE DEV, V31, P59, DOI 10.1101/gad.286963.116; Gomez-Herreros F, 2013, J BIOL CHEM, V288, P31689, DOI 10.1074/jbc.M113.500488; GORENSTEIN C, 1977, MOL GEN GENET, V157, P327, DOI 10.1007/BF00268670; Gregory B, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800150; Hagner PR, 2011, ONCOGENE, V30, P1531, DOI 10.1038/onc.2010.533; Heijnen HF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004371; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lawrence MG, 2016, NUCLEIC ACIDS RES, V44, P5798, DOI 10.1093/nar/gkw493; Liao JM, 2014, J MOL CELL BIOL, V6, P206, DOI 10.1093/jmcb/mju018; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pelava A, 2016, BIOCHEM SOC T, V44, P1086, DOI 10.1042/BST20160106; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Pestov DG, 2012, MOL CELL BIOL, V32, P2135, DOI 10.1128/MCB.06763-11; Piazzi M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112718; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Sung MK, 2016, MOL BIOL CELL, V27, P2642, DOI 10.1091/mbc.E16-05-0290; Talkish J, 2016, RNA, V22, P852, DOI 10.1261/rna.055780.115; Tomecki R, 2017, FEBS LETT, V591, P1801, DOI 10.1002/1873-3468.12682; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Woolford Jr JL, 1991, MOL CELLULAR BIOL YE, P587; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang R, 2016, IEEE INT SYMP CIRC S, P718, DOI 10.1109/ISCAS.2016.7527341; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	41	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0222479	10.1371/journal.pone.0222479	http://dx.doi.org/10.1371/journal.pone.0222479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986150	Green Submitted, gold, Green Published			2022-12-26	WOS:000534603400008
J	Roberts, BRT; Fernandes, MA; MacLeod, CM				Roberts, Brady R. T.; Fernandes, Myra A.; MacLeod, Colin M.			Re-evaluating whether bilateral eye movements influence memory retrieval	PLOS ONE			English	Article							INCREASED INTERHEMISPHERIC INTERACTION; EPISODIC MEMORY; SELECTIVE ATTENTION; DIVIDED ATTENTION; SACCADE EXECUTION; ENHANCE MEMORY; FALSE MEMORIES; EEG COHERENCE; EMDR; HANDEDNESS	Several recent studies have reported enhanced memory when retrieval is preceded by repetitive horizontal eye movements, relative to vertical or no eye movements. The reported memory boost has been referred to as the Saccade-Induced Retrieval Enhancement (SIRE) effect. Across two experiments, memory performance was compared following repetitive horizontal or vertical eye movements, as well as following a control condition of no eye movements. In Experiment 1, we conceptually replicated Christman and colleagues' seminal study, finding a statistically significant SIRE effect, albeit with weak Bayesian evidence. We therefore sought to conduct another close extension. In Experiment 2, horizontal and vertical eye movement conditions were manipulated separately, and sample size was increased. No evidence of a SIRE effect was found: Bayesian statistical analyses demonstrated significant evidence for a null effect. Taken together, these experiments suggest that the SIRE effect is inconsistent. The current experiments call into question the generalizability of the SIRE effect and suggest that its presence is very sensitive to experimental design. Future work should further assess the robustness of the effect before exploring related theories or underlying mechanisms.	[Roberts, Brady R. T.; Fernandes, Myra A.; MacLeod, Colin M.] Univ Waterloo, Dept Psychol, Waterloo, ON, Canada	University of Waterloo	Roberts, BRT (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON, Canada.	brady.roberts@uwaterloo.ca	MacLeod, Colin M/ABG-9527-2021; Roberts, Brady R.T./AAS-8736-2021	MacLeod, Colin M/0000-0002-8350-7362; Roberts, Brady R.T./0000-0002-2228-8805	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) awarded to MAF and CMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; BAKAN P, 1969, NATURE, V223, P975, DOI 10.1038/223975a0; Bartels RM, 2018, J BEHAV THER EXP PSY, V59, P107, DOI 10.1016/j.jbtep.2018.01.001; Brunye TT, 2009, BRAIN COGNITION, V70, P279, DOI 10.1016/j.bandc.2009.03.003; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Christman SD, 2004, BRAIN COGNITION, V56, P313, DOI 10.1016/j.bandc.2004.08.005; Christman SD, 2001, NEUROPSYCHOLOGY, V15, P607, DOI 10.1037//0894-4105.15.4.607; Christman SD, 2003, NEUROPSYCHOLOGY, V17, P221, DOI 10.1037/0894-4105.17.2.221; Christman SD, 2000, 41 PSYCH SOC C NEW O; Christman SD, 2006, NEUROPSYCHOLOGY, V20, P336, DOI 10.1037/0894-4105.20.3.336; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; de Haan B, 2008, BRAIN RES, V1204, P102, DOI 10.1016/j.brainres.2008.01.105; DESMEDT JE, 1989, ELECTROEN CLIN NEURO, V74, P321, DOI 10.1016/0168-5597(89)90001-4; Edlin JM, 2013, BRAIN COGNITION, V81, P345, DOI 10.1016/j.bandc.2012.12.006; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandes MA, 2000, J EXP PSYCHOL GEN, V129, P155, DOI 10.1037/0096-3445.129.2.155; Fernandes MA, 2018, CURR DIR PSYCHOL SCI, V27, P302, DOI 10.1177/0963721418755385; Fleck JI, 2019, BRAIN COGNITION, V132, P56, DOI 10.1016/j.bandc.2019.03.001; Fleck JI, 2018, BRAIN COGNITION, V123, P142, DOI 10.1016/j.bandc.2018.03.009; Greenwald R, 1996, PROF PSYCHOL-RES PR, V27, P67, DOI 10.1037/0735-7028.27.1.67; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; HANSOTIA P, 1990, ELECTROEN CLIN NEURO, V76, P388, DOI 10.1016/0013-4694(90)90093-Y; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Houben STL, 2019, CLIN PSYCHOL SCI, V7, P405, DOI 10.1177/2167702619830392; Houben STL, 2018, CLIN PSYCHOL SCI, V6, P610, DOI 10.1177/2167702618757658; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Lee CW, 2019, CLIN PSYCHOL SCI, V7, P403, DOI 10.1177/2167702619830395; LOFTUS GR, 1972, COGNITIVE PSYCHOL, V3, P525, DOI 10.1016/0010-0285(72)90021-7; Lyle KB, 2008, PSYCHON B REV, V15, P515, DOI 10.3758/PBR.15.3.515; Lyle KB, 2015, MEMORY, V23, P187, DOI 10.1080/09658211.2013.877487; Lyle KB, 2010, BRAIN COGNITION, V73, P128, DOI 10.1016/j.bandc.2010.04.004; MacLeod CM, 2010, J EXP PSYCHOL LEARN, V36, P671, DOI 10.1037/a0018785; MACMILLAN NA, 1985, PSYCHOL BULL, V98, P185, DOI 10.1037/0033-2909.98.1.185; Matzke D, 2015, J EXP PSYCHOL GEN, V144, pE1, DOI 10.1037/xge0000038; Meade ME, 2018, EXP AGING RES, V44, P369, DOI 10.1080/0361073X.2018.1521432; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Morey R. D., 2018, BAYESFACTOR; Morey RD, 2016, MULTIVAR BEHAV RES, V51, P11, DOI 10.1080/00273171.2015.1052710; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; NIELSEN T, 1990, BRAIN COGNITION, V14, P113, DOI 10.1016/0278-2626(90)90064-U; Nieuwenhuis S, 2013, BRAIN COGNITION, V81, P52, DOI 10.1016/j.bandc.2012.10.003; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Nyberg L, 1996, Psychon Bull Rev, V3, P135, DOI 10.3758/BF03212412; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parker A, 2007, BRAIN COGNITION, V63, P221, DOI 10.1016/j.bandc.2006.08.005; Parker A, 2017, BRAIN COGNITION, V114, P40, DOI 10.1016/j.bandc.2017.03.006; Parker A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00630; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pearson DG, 2014, COGNITION, V132, P416, DOI 10.1016/j.cognition.2014.05.006; POSTMAN L, 1965, Q J EXP PSYCHOL, V17, P132, DOI 10.1080/17470216508416422; Prichard E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00009; Propper RE, 2007, J NERV MENT DIS, V195, P785, DOI 10.1097/NMD.0b013e318142cf73; Propper RE, 2008, J EMDR PRACT RES, V2, P269, DOI 10.1891/1933-3196.2.4.269; Psychology Software Tools Inc., 2016, E PRIME; R Core Team, 2021, R LANGUAGE ENV STAT; Rosano C, 2002, CEREB CORTEX, V12, P107, DOI 10.1093/cercor/12.2.107; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Samara Z., 2011, FRONT PSYCHIATRY, V2, P4, DOI DOI 10.3389/FPSYT.2011.00004; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Shapiro F, 2002, J CLIN PSYCHOL, V58, P1, DOI 10.1002/jclp.1126; Shapiro F, 1989, J TRAUMA STRESS, P199, DOI DOI 10.1002/JTS.2490020207; Shen K, 2016, J COGNITIVE NEUROSCI, V28, P1772, DOI 10.1162/jocn_a_01007; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Stickgold R, 2002, J CLIN PSYCHOL, V58, P61, DOI 10.1002/jclp.1129; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; van Schie K, 2019, CLIN PSYCHOL SCI, V7, P1159, DOI 10.1177/2167702619859335; Wammes JD, 2016, Q J EXP PSYCHOL, V69, P1752, DOI 10.1080/17470218.2015.1094494	71	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227790	10.1371/journal.pone.0227790	http://dx.doi.org/10.1371/journal.pone.0227790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986171	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400030
J	Lazarevich, I; Stasenko, S; Rozhnova, M; Pankratova, E; Dityatev, A; Kazantsev, V				Lazarevich, Ivan; Stasenko, Sergey; Rozhnova, Maiya; Pankratova, Evgeniya; Dityatev, Alexander; Kazantsev, Victor			Activity-dependent switches between dynamic regimes of extracellular matrix expression	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; RECEPTORS	Experimental studies highlight the important role of the extracellular matrix (ECM) in the regulation of neuronal excitability and synaptic connectivity in the nervous system. In its turn, the neural ECM is formed in an activity-dependent manner. Its maturation closes the so-called critical period of neural development, stabilizing the efficient configurations of neural networks in the brain. ECM is locally remodeled by proteases secreted and activated in an activity-dependent manner into the extracellular space and this process is important for physiological synaptic plasticity. We ask if ECM remodeling may be exaggerated under pathological conditions and enable activity-dependent switches between different regimes of ECM expression. We consider an analytical model based on known mechanisms of interaction between neuronal activity and expression of ECM, ECM receptors and ECM degrading proteases. We demonstrate that either inhibitory or excitatory influence of ECM on neuronal activity may lead to the bistability of ECM expression, so two stable stationary states are observed. Noteworthy, only in the case when ECM has predominant inhibitory influence on neurons, the bistability is dependent on the activity of proteases. Excitatory ECM-neuron feedback influences may also result in spontaneous oscillations of ECM expression, which may coexist with a stable stationary state. Thus, ECM-neuronal interactions support switches between distinct dynamic regimes of ECM expression, possibly representing transitions into disease states associated with remodeling of brain ECM.	[Lazarevich, Ivan; Stasenko, Sergey; Rozhnova, Maiya; Pankratova, Evgeniya; Kazantsev, Victor] Lobachevsky State Univ Nizhni Novgorod, Nizhnii Novgorod, Russia; [Lazarevich, Ivan] Paris Sci & Lettres Univ, Lab Neurosci Cognit, Grp Neural Theory, Ecole Normale Super, Paris, France; [Dityatev, Alexander] German Ctr Neurodegenerat Dis, Mol Neuroplast Grp, Magdeburg, Germany; [Dityatev, Alexander] Otto von Guericke Univ, Med Fac, Magdeburg, Germany; [Dityatev, Alexander] CBBS, Magdeburg, Germany	Lobachevsky State University of Nizhni Novgorod; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University	Lazarevich, I; Stasenko, S (corresponding author), Lobachevsky State Univ Nizhni Novgorod, Nizhnii Novgorod, Russia.; Lazarevich, I (corresponding author), Paris Sci & Lettres Univ, Lab Neurosci Cognit, Grp Neural Theory, Ecole Normale Super, Paris, France.	vanya.lzr@gmail.com; stasenko@neuro.nnov.ru	Kazantsev, Victor B/L-1424-2013; Stasenko, Sergey Victorovich/J-4825-2013; Pankratova, Evgeniya V./M-2733-2016	Pankratova, Evgeniya V./0000-0003-4214-7230; Dityatev, Alexander/0000-0002-0472-0553; Kazantsev, Viktor/0000-0002-2881-6648	Ministry of Education and Science of Russian Federation [14, Y26.31.0022]	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Education and Science of Russian Federation under project 14.Y26.31.0022, IAL, SVS, MAR,EVP and VBK acknowledge individual support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezin V, 2014, PROG BRAIN RES, V214, P353, DOI 10.1016/B978-0-444-63486-3.00015-3; Bijata M, 2017, CELL REP, V19, P1767, DOI 10.1016/j.celrep.2017.05.023; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Favuzzi E, 2017, NEURON, V95, P639, DOI 10.1016/j.neuron.2017.06.028; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Hayani H, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00149; Hodgkin A. L., 1952, J PHYSL; Kazantsev V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041646; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; Larreta-Garde V, 2002, J THEOR BIOL, V217, P105, DOI 10.1006/jtbi.2002.3010; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Song I, 2019, NEUROSCIENCE M PLANN; Song I, 2018, BRAIN RES BULL, V136, P101, DOI 10.1016/j.brainresbull.2017.03.003; Sterratt D, 2011, PRINCIPLES COMPUTATI; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zeug A, 2014, PROG BRAIN RES, V214, P287, DOI 10.1016/B978-0-444-63486-3.00013-X	20	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227917	10.1371/journal.pone.0227917	http://dx.doi.org/10.1371/journal.pone.0227917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978183	Green Published, gold			2022-12-26	WOS:000534599100077
J	Lee, EG; Tulloch, J; Chen, S; Leong, L; Saxton, AD; Kraemer, B; Darvas, M; Keene, CD; Shutes-David, A; Todd, K; Millard, S; Yu, CE				Lee, Eun-Gyung; Tulloch, Jessica; Chen, Sunny; Leong, Lesley; Saxton, Aleen D.; Kraemer, Brian; Darvas, Martin; Keene, C. Dirk; Shutes-David, Andrew; Todd, Kaitlin; Millard, Steve; Yu, Chang-En			Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; CEREBROSPINAL-FLUID; ALLELIC EXPRESSION; MESSENGER-RNA; CIRCULAR RNAS; BRAIN; RISK; PROTEINS; PREDICTS; ABUNDANT	The apolipoprotein E gene (APOE) is the strongest genetic risk factor for late-onset Alzheimer's disease (AD), yet the expression of APOE is not clearly understood. For example, it is unclear whether AD patients have elevated or decreased APOE expression or why the correlation levels of APOE RNA and the ApoE protein differ across studies. Likewise, APOE has a single CpG island (CGI) that overlaps with its 3'-exon, and this CGI's effect is unknown. We previously reported that the APOE CGI is highly methylated in human postmortem brain (PMB) and that this methylation is altered in AD frontal lobe. In this study, we comprehensively characterized APOE RNA transcripts and correlated levels of RNA expression with DNA methylation levels across the APOE CGI. We discovered the presence of APOE circular RNA (circRNA) and found that circRNA and full-length mRNA each constitute approximately one third of the total APOE RNA, with truncated mRNAs likely constituting some of the missing fraction. All APOE RNA species demonstrated significantly higher expression in AD frontal lobe than in control frontal lobe. Furthermore, we observed a negative correlation between the levels of total APOE RNA and DNA methylation at the APOE CGI in the frontal lobe. When stratified by disease status, this correlation was strengthened in controls but not in AD. Our findings suggest a possible modified mechanism of gene action for APOE in AD that involves not only the protein isoforms but also an epigenetically regulated transcriptional program driven by DNA methylation in the APOE CGI.	[Lee, Eun-Gyung; Tulloch, Jessica; Chen, Sunny; Leong, Lesley; Saxton, Aleen D.; Kraemer, Brian; Shutes-David, Andrew; Todd, Kaitlin; Millard, Steve; Yu, Chang-En] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Kraemer, Brian; Yu, Chang-En] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Darvas, Martin; Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yu, CE (corresponding author), VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA.; Yu, CE (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	changeyu@uw.edu	; Darvas, Martin/E-2935-2015	Kraemer, Brian/0000-0002-2252-7634; Darvas, Martin/0000-0002-7942-2526	U.S. Department of Veterans Affairs Office of Research and Development Biomedical Laboratory Research Program; National Institute of Health/National Institute on Aging [I01BX000933, 1R01AG062514-01]	U.S. Department of Veterans Affairs Office of Research and Development Biomedical Laboratory Research Program; National Institute of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the U.S. Department of Veterans Affairs Office of Research and Development Biomedical Laboratory Research Program and National Institute of Health/National Institute on Aging grants (1) Grant number: I01BX000933 (VA Merit Review, PI: Chang-En Yu, PhD) and (2) Grant number: 1R01AG062514-01 (NIH/NIA, PI: Martin Darvas, PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akram A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.010; Alzheimer's association, 2019, 2019 AD FACTS FIG; Arendt T, 1997, J NEUROSCI, V17, P516; Baker-Nigh AT, 2016, J BIOL CHEM, V291, P27204, DOI 10.1074/jbc.M116.721779; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Beffert U, 1999, MOL BRAIN RES, V68, P181, DOI 10.1016/S0169-328X(99)00073-X; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fernandez CG, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00014; Foley P, 2010, BBA-MOL CELL BIOL L, V1801, P750, DOI 10.1016/j.bbalip.2010.05.004; Foraker J, 2015, J ALZHEIMERS DIS, V48, P745, DOI 10.3233/JAD-143060; Gottschalk William K, 2016, J Alzheimers Dis Parkinsonism, V6; Growdon WB, 1999, NEUROSCI LETT, V272, P83, DOI 10.1016/S0304-3940(99)00557-1; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Gupta VB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0105-6; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HOLM S, 1979, SCAND J STAT, V6, P65; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kruusvee V, 2017, P NATL ACAD SCI USA, V114, pE3243, DOI 10.1073/pnas.1700731114; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Linnertz C, 2014, ALZHEIMERS DEMENT, V10, P541, DOI 10.1016/j.jalz.2013.08.280; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Marais AD, 2019, PATHOLOGY, V51, P165, DOI 10.1016/j.pathol.2018.11.002; Martinez-Morillo E, 2014, ACTA NEUROPATHOL, V127, P633, DOI 10.1007/s00401-014-1266-2; Mathews DH, 2017, RNASTRUCTURE WEB SER; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Millard SP, 2013, ENVSTATS R PACKAGE E, DOI [10.1007/978-1-4614-8456-1, DOI 10.1007/978-1-4614-8456-1]; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Pasman Z, 1996, RNA, V2, P603; R Core Team, 2017, R PROJECT STAT COMPU; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Schmidt C, 2014, AM J ALZHEIMERS DIS, V29, P54, DOI 10.1177/1533317513505133; Seitz A, 2005, HUM MOL GENET, V14, P2661, DOI 10.1093/hmg/ddi296; Shinohara M, 2016, ANN NEUROL, V79, P758, DOI 10.1002/ana.24628; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Talwar P, 2016, J NEUROL SCI, V360, P179, DOI 10.1016/j.jns.2015.12.004; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; WICKHAM H, 2017, R PACKAGE VERSION, V1, P1, DOI DOI 10.1590/S0100-204X2017000300003; Wolters FJ, 2016, NEUROSCI LETT, V617, P139, DOI 10.1016/j.neulet.2016.02.018; YU CE, 1994, AM J HUM GENET, V54, P631; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zarow C, 1998, EXP NEUROL, V149, P79, DOI 10.1006/exnr.1997.6709; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001	66	16	16	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227667	10.1371/journal.pone.0227667	http://dx.doi.org/10.1371/journal.pone.0227667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978088	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100049
J	Volc, SM; Ramos, CRN; Galvao, HDR; Felicio, PS; Coelho, AS; Berardineli, GN; Campacci, N; Sabato, CD; Abrahao-Machado, LF; Santana, IVV; Campanella, N; Lengert, AV; Vidal, DO; Reis, RM; Dantas, CF; Coelho, RC; Boldrini, E; Serrano, SV; Palmero, EI				Volc, Sahlua Miguel; Niederauer Ramos, Cintia Regina; Reis Galvao, Henrique de Campos; Felicio, Paula Silva; Coelho, Aline Silva; Berardineli, Gustavo Noriz; Campacci, Natalia; Sabato, Cristina da Silva; Abrahao-Machado, Lucas Faria; Vidigal Santana, Iara Viana; Campanella, Nathalia; Lengert, Andre van Helvoort; Vidal, Daniel Onofre; Reis, Rui Manuel; Dantas, Caio F.; Coelho, Robson C.; Boldrini, Erica; Serrano, Sergio Vicente; Palmero, Edenir Inez			The Brazilian TP53 mutation (R337H) and sarcomas	PLOS ONE			English	Article							LI-FRAUMENI; SOFT-TISSUE; POPULATION; CARRIERS; CLASSIFICATION	Sarcomas represent less than 1% of all solid neoplasms in adults and over 20% in children. Their etiology is unclear, but genetic susceptibility plays an important role in this scenario. Sarcoma is central in Li-Fraumeni Syndrome (LFS), a familial predisposition cancer syndrome. In Brazil, the high prevalence of p.Arg337His mutations in the TP53 gene brings about a unique condition: a cluster of LFS. In the present work, we studied 502 sarcoma patients not selected by age or family history in an attempt to assess the impact of the so-called "Brazilian germline TP53 mutation" (p.Arg337His) on this tumor type. We found that 8% of patients are carriers, with leiomyosarcoma being the main histologic type of sarcoma, corresponding to 52.5% of the patients with the mutated TP53 gene. These findings emphasize the importance of genetic counseling and can better guide the management of sarcoma patients.	[Volc, Sahlua Miguel; Reis Galvao, Henrique de Campos] Barretos Canc Hosp, Oncogenet Dept, Sao Paulo, Brazil; [Niederauer Ramos, Cintia Regina; Felicio, Paula Silva; Coelho, Aline Silva; Campacci, Natalia; Campanella, Nathalia; Lengert, Andre van Helvoort; Vidal, Daniel Onofre; Reis, Rui Manuel; Palmero, Edenir Inez] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Berardineli, Gustavo Noriz; Sabato, Cristina da Silva; Reis, Rui Manuel; Palmero, Edenir Inez] Barretos Canc Hosp, Ctr Mol Diag, Sao Paulo, Brazil; [Abrahao-Machado, Lucas Faria; Vidigal Santana, Iara Viana] Barretos Canc Hosp, Pathol Dept, Sao Paulo, Brazil; [Lengert, Andre van Helvoort; Boldrini, Erica] Barretos Childrens Canc Hosp, Sao Paulo, Brazil; [Reis, Rui Manuel] Univ Minho, Life & Hlth Sci Res Inst ICVS, Hlth Sci Sch, Braga, Portugal; [Reis, Rui Manuel] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Dantas, Caio F.; Coelho, Robson C.; Serrano, Sergio Vicente] Barretos Canc Hosp, Clin Oncol Dept, Sao Paulo, Brazil; [Palmero, Edenir Inez] Dr Paulo Prata FACISB, Barretos Sch Hlth Sci, Sao Paulo, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade do Minho; Hospital de Cancer de Barretos	Palmero, EI (corresponding author), Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil.; Palmero, EI (corresponding author), Barretos Canc Hosp, Ctr Mol Diag, Sao Paulo, Brazil.; Palmero, EI (corresponding author), Dr Paulo Prata FACISB, Barretos Sch Hlth Sci, Sao Paulo, Brazil.	edenirip@yahoo.com.br	Palmero, Edenir/F-4341-2015; Vidal, Daniel O./C-7203-2012; Ramos, Cíntia Regina Niederauer/AAJ-5997-2020; Reis, Rui Manuel/B-1744-2018; van Helvoort Lengert, André/AAU-1140-2021	Palmero, Edenir/0000-0003-1904-2158; Ramos, Cíntia Regina Niederauer/0000-0003-3402-2948; Reis, Rui Manuel/0000-0002-9639-7940; van Helvoort Lengert, André/0000-0002-3632-343X; Volc, Sahlua/0000-0002-0577-6524	Barretos Cancer Hospital; CNPq Productivity Grants	Barretos Cancer Hospital; CNPq Productivity Grants	This work was supported by the Barretos Cancer Hospital. EIP and RMR are recipients of CNPq Productivity Grants. There was no additional external funding received for this study.	Achatz MI, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026195; Alaggio R, 2015, PEDIATR DEVEL PATHOL, V18, P481, DOI 10.2350/15-07-1666-MISC.1; Campanella NC, 2014, EUR J HUM GENET, V22, P875, DOI 10.1038/ejhg.2013.256; Casali P G, 2018, Ann Oncol, V29, piv268, DOI 10.1093/annonc/mdy321; Custodio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018015; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fletcher CDM, 2013, WHO CLASSIFICATION T; Garritano S, 2010, HUM MUTAT, V31, P143, DOI 10.1002/humu.21151; Giacomazzi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099893; Gomes MCB, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-3; Hui JYC, 2016, SURG CLIN N AM, V96, P901, DOI 10.1016/j.suc.2016.05.005; Karanian M, 2015, ANN PATHOL, V35, P71, DOI 10.1016/j.annpat.2014.11.003; Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112; LI FP, 1969, J NATL CANCER I, V43, P1365; Ognjanovic S, 2012, CANCER-AM CANCER SOC, V118, P1387, DOI 10.1002/cncr.26390; Palmero EI, 2008, CANCER LETT, V261, P21, DOI 10.1016/j.canlet.2007.10.044; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Schiavi A, 2015, CURR ONCOL, V22, P317, DOI 10.3747/co.22.2588; Seidinger AL, 2011, CANCER-AM CANCER SOC, V117, P2228, DOI 10.1002/cncr.25826; Serrano C, 2013, HEMATOL ONCOL CLIN N, V27, P957, DOI 10.1016/j.hoc.2013.07.002; Villani A, 2016, LANCET ONCOL, V17, P1295, DOI 10.1016/S1470-2045(16)30249-2; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227260	10.1371/journal.pone.0227260	http://dx.doi.org/10.1371/journal.pone.0227260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978118	gold, Green Published			2022-12-26	WOS:000534599100030
J	Yang, F; Yang, LL; Wataya-Kaneda, M; Teng, LT; Katayama, I				Yang, Fei; Yang, Lingli; Wataya-Kaneda, Mari; Teng, Lanting; Katayama, Ichiro			Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: A novel epilepsy model	PLOS ONE			English	Article							GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; PTEN DELETION; HIPPOCAMPAL; KV1.1; TSC1; DIFFERENTIATION; PROLIFERATION; STIMULATION	Objective To clarify the complex mechanism underlying epileptogeneis, a novel animal model was generated. Methods In our previous research, we have generated a melanocyte-lineage mTOR hyperactivation mouse model (Mitf-M-Cre Tsc2 KO mice; cKO mice) to investigate mTOR pathway in melanogenesis regulation, markedly reduced skin pigmentation was observed. Very unexpectedly, spontaneous recurrent epilepsy was also developed in this mouse model. Results Compared with control littermates, no change was found in either brain size or brain mass in cKO mice. Hematoxylin staining revealed no obvious aberrant histologic features in the whole brains of cKO mice. Histoimmunofluorescence staining and electron microscopy examination revealed markedly increased mTOR signaling and hyperproliferation of mitochondria in cKO mice, especially in the hippocampus. Furthermore, rapamycin treatment reversed these abnormalities. Conclusions This study suggests that our melanocyte-lineage mTOR hyperactivation mouse is a novel animal model of epilepsy, which may promote the progress of both epilepsy and neurophysiology research.	[Yang, Fei; Yang, Lingli; Wataya-Kaneda, Mari; Teng, Lanting; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Osaka, Japan	Osaka University	Wataya-Kaneda, M (corresponding author), Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Osaka, Japan.	mkaneda@derma.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [16k10155]; Practical Research Project for Rare and Intractable diseases from the Japan Agency for Medical Research and Development (AMED) [15ek0109082h0001, 16ek0109082h0002]; Clinical Research Project for Rare and Intractable Diseases from the Japan AMED [15Ik0103018h0002, 16Ik0103018h0003]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Practical Research Project for Rare and Intractable diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Clinical Research Project for Rare and Intractable Diseases from the Japan AMED	This work was supported from a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (16k10155), grant from the Practical Research Project for Rare and Intractable diseases from the Japan Agency for Medical Research and Development (AMED) (15ek0109082h0001, 16ek0109082h0002), and grant from the Clinical Research Project for Rare and Intractable Diseases from the Japan AMED (15Ik0103018h0002, 16Ik0103018h0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; BARDEN H, 1983, BRAIN RES BULL, V10, P847, DOI 10.1016/0361-9230(83)90218-6; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Becker AJ, 2018, NEUROPATH APPL NEURO, V44, P112, DOI 10.1111/nan.12451; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Cross JH, 2005, EPILEPSIA, V46, P17, DOI 10.1111/j.1528-1167.2005.00353.x; Cudmore RH, 2010, J NEUROSCI, V30, P12885, DOI 10.1523/JNEUROSCI.0740-10.2010; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; de Curtis M, 2016, EPILEPSIA, V57, P679, DOI 10.1111/epi.13370; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; GOLDGEIER MH, 1984, J INVEST DERMATOL, V82, P235, DOI 10.1111/1523-1747.ep12260111; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gudjohnsen SAH, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00149; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; Khoshkhoo S, 2017, NEURON, V93, P291, DOI 10.1016/j.neuron.2016.11.043; Kwiatkowski DJ, 2003, CANCER BIOL THER, V2, P471, DOI 10.4161/cbt.2.5.446; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lucchi C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00676; Marino S, 2002, DEVELOPMENT, V129, P3513; MARKERT CL, 1956, GENETICS, V41, P429; Metz AE, 2007, J PHYSIOL-LONDON, V581, P175, DOI 10.1113/jphysiol.2006.127068; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Opitz-Araya X, 2011, JOVE-J VIS EXP, DOI 10.3791/2462; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Rho JM, 1999, DEV NEUROSCI-BASEL, V21, P320, DOI 10.1159/000017381; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; SCHILD D, 1994, CELL CALCIUM, V15, P341, DOI 10.1016/0143-4160(94)90009-4; Singh A, 2016, NEUROL CLIN, V34, P837, DOI 10.1016/j.ncl.2016.06.015; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Yaar M, 2012, J INVEST DERMATOL, V132, P835, DOI 10.1038/jid.2011.386; Yang F, 2018, J INVEST DERMATOL, V138, P669, DOI 10.1016/j.jid.2017.10.007; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228204	10.1371/journal.pone.0228204	http://dx.doi.org/10.1371/journal.pone.0228204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978189	gold, Green Published			2022-12-26	WOS:000534599100125
J	Akatsuka, M; Masuda, Y; Tatsumi, H; Yamakage, M				Akatsuka, Masayuki; Masuda, Yoshiki; Tatsumi, Hiroomi; Yamakage, Michiaki			Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release	PLOS ONE			English	Article							GROUP BOX-1 PROTEIN; CLINICAL CHARACTERISTICS; ENDOTHELIAL INJURY; KIDNEY INJURY; INFLAMMATION; DYSFUNCTION; MEDIATORS; RECEPTOR; HMGB1	Multiple organ dysfunction induced by sepsis often involves kidney injury. Extracellular histones released in response to damage-associated molecular patterns are known to facilitate sepsis-induced organ dysfunction. Recombinant human soluble thrombomodulin (rhTM) and its lectin-like domain (D1) exert anti-inflammatory effects and neutralize damage-associated molecular patterns. However, the effects of rhTM and D1 on extracellular histone H3 levels and kidney injury remain poorly understood. Our purpose was to investigate the association between extracellular histone H3 levels and kidney injury, and to clarify the effects of rhTM and D1 on extracellular histone H3 levels, kidney injury, and survival in sepsis-induced rats. Rats in whom sepsis was induced via cecal ligation and puncture were used in this study. Histone H3 levels, histopathology of the kidneys, and the survival rate of rats at 24 h after cecal ligation and puncture were investigated. Histone H3 levels increased over time following cecal ligation and puncture. Histopathological analyses indicated that the distribution of degeneration foci among tubular epithelial cells of the kidney and levels of histone H3 increased simultaneously. Administration of rhTM and D1 significantly reduced histone H3 levels compared with that in the vehicle-treated group and improved kidney injury. The survival rates of rats in rhTM- and D1-treated groups were significantly higher than that in the vehicle-treated group. The results of this study indicated that rhTM and its D1 similarly reduce elevated histone H3 levels, thereby reducing acute kidney injury. Our findings also proposed that rhTM and D1 show potential as new treatment strategies for sepsis combined with acute kidney injury.	[Akatsuka, Masayuki; Yamakage, Michiaki] Sapporo Med Univ, Dept Anesthesiol, Sch Med, Sapporo, Hokkaido, Japan; [Akatsuka, Masayuki; Masuda, Yoshiki; Tatsumi, Hiroomi] Sapporo Med Univ, Dept Intens Care Med, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Akatsuka, M (corresponding author), Sapporo Med Univ, Dept Anesthesiol, Sch Med, Sapporo, Hokkaido, Japan.; Akatsuka, M (corresponding author), Sapporo Med Univ, Dept Intens Care Med, Sch Med, Sapporo, Hokkaido, Japan.	m.akatsuka@sapmed.ac.jp		Akatsuka, Masayuki/0000-0003-0065-9721	Japan Society for the Promotion of Science(JSPS), JSPS KAKENHI Grant [JP19K18331]	Japan Society for the Promotion of Science(JSPS), JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science(JSPS), JSPS KAKENHI Grant Number JP19K18331 (https://www.jsps.go.jp/english/index.html) to MA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Festing Michael F W, 2002, ILAR J, V43, P244; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; Ito T, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0348-y; Kawai C, 2016, AM J PATHOL, V186, P829, DOI 10.1016/j.ajpath.2015.11.025; Loghmani H, 2018, BLOOD, V132, P148, DOI 10.1182/blood-2017-12-768994; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Nagato M, 2009, CRIT CARE MED, V37, P2181, DOI 10.1097/CCM.0b013e3181a55184; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075961; Osumi W, 2015, J PHARMACOL SCI, V129, P233, DOI 10.1016/j.jphs.2015.11.007; ROSENBERG RD, 1984, J CLIN INVEST, V74, P1, DOI 10.1172/JCI111389; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Sharfuddin AA, 2009, J AM SOC NEPHROL, V20, P524, DOI 10.1681/ASN.2008060593; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yegenaga I, 2004, AM J KIDNEY DIS, V43, P817, DOI 10.1053/j.ajkd.2003.12.045	30	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228093	10.1371/journal.pone.0228093	http://dx.doi.org/10.1371/journal.pone.0228093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971961	Green Published, Green Submitted, gold			2022-12-26	WOS:000534374400039
J	Worku, MG; Enyew, EF; Desita, ZT; Moges, AM				Worku, Misganaw Gebrie; Enyew, Engdaw Fentahun; Desita, Zerubabel Tegegne; Moges, Abebe Muche			Sonographic measurement of normal common bile duct diameter and associated factors at the University of Gondar comprehensive specialized hospital and selected private imaging center in Gondar town, North West Ethiopia	PLOS ONE			English	Article							ULTRASOUND	Background The biliary tree is a three-dimensional system of channels that bile flows from the hepatocytes to the gallbladder and to the intestine. Size of the common bile duct (CBD) is a predictor of biliary obstruction and, therefore, its measurement is an important component of biliary system evaluation. Factors like age, height, weight, BMI, previous cholecystectomy, drugs, and type of imaging modality affect CBD diameter, but the duct significantly dilated due to obstructive biliary pathology. Objective To measure the normal CBD diameter and its association with age, sex, and anthropometric measurement at the University of Gondar Comprehensive Specialized Hospital and selected private imaging center, Gondar town, Northwest Ethiopia, 2019. Methods and materials Institutional based cross-sectional study was conducted on 206 subjects without any history of hepatobiliary abnormality. The CBD measured at the proximal part just caudal to the porta hepatis. Descriptive analysis, student t-test, one way ANOVA, correlation and both bivariable and multivariable linear regression analysis were implemented. In bivariable linear regression variables with p-value, less than 0.2 were selected for multivariable analysis and in multivariable linear regression analysis variables with P-Value less than 0.05 were considered as statistically significant. Results The mean age of the study participants was 39.4 (range 18-87). The mean diameter of the CBD was 3.64mm 95%CI (3.52, 3.77), which ranges from 1.8 to 5.9 mm, with 65% of the participant having CBD diameter less than 4mm. The diameter of CBD significantly associated with age with a linear trend. The mean diameter in a rural area was greater than subjects living in an urban area. Independent t-test showed no statistically significant difference in CBD diameter between male and female subjects. Conclusion The lower limit of the CBD diameter for this study was similar to most of the studies, but the upper limit was found to be slightly lower. The diameter was significantly associated with age along the linear trend and it was progressively increased from the lower age group onwards. The diameter of CBD did not show statistically significant association with any of the anthropometric measurement.	[Worku, Misganaw Gebrie; Enyew, Engdaw Fentahun; Moges, Abebe Muche] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia; [Desita, Zerubabel Tegegne] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Radiol, Gondar, Ethiopia	University of Gondar; University of Gondar	Worku, MG (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia.	misgeb2008@gmail.com		Fentahun, Engidaw/0000-0001-6873-1588; gebrie, misganaw/0000-0002-7647-6449	University of Gondar	University of Gondar	To conduct this study the author receive funding from University of Gondar, but the university had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adibi A, 2007, J RES MED SCI, V12, P121; Admassie Daniel, 2008, Ethiop Med J, V46, P391; [Anonymous], 2008, STANDING S GRAYS ANA, P1177; Bachar GN, 2003, J ULTRAS MED, V22, P879, DOI 10.7863/jum.2003.22.9.879; BEHAN M, 1978, AM J ROENTGENOL, V130, P701, DOI 10.2214/ajr.130.4.701; Bruno M, 2014, J CLIN GASTROENTEROL, V48, pE67, DOI 10.1097/MCG.0b013e3182a8848a; COOPERBERG PL, 1978, RADIOLOGY, V129, P477, DOI 10.1148/129.2.477; COOPERBERG PL, 1980, RADIOLOGY, V135, P141, DOI 10.1148/radiology.135.1.7360952; Keith L, 2014, CLIN ORIENTED ANATOM, P888; Khan LF, 2013, BANGLADESH J ANATOMY, V10, P23; Kratzer W, 2015, Z GASTROENTEROL, V53, P1161, DOI 10.1055/s-0034-1399476; Lal N, 2014, J CLIN DIAGNOSTIC RE, V8; MAHOUR GH, 1967, ANN SURG, V165, P415, DOI 10.1097/00000658-196703000-00011; Mohammad, 2013, IOSR J DENT MED SCI, V6, P32, DOI [10.9790/0853-0623234, DOI 10.9790/0853-0623234]; Mohammed Mazareq SH, 2018, MEASUREMENT NORMAL C; WACHSBERG RH, 1994, J ULTRAS MED, V13, P617; WU CC, 1984, J CLIN ULTRASOUND, V12, P473, DOI 10.1002/jcu.1870120804; Yeh BM, 2009, RADIOGRAPHICS, V29, P1669, DOI 10.1148/rg.296095514	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227135	10.1371/journal.pone.0227135	http://dx.doi.org/10.1371/journal.pone.0227135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971959	Green Published, gold			2022-12-26	WOS:000534374400009
J	Lopez, SM; Balog-Alvarez, C; Vitha, S; Bettis, AK; Canessa, EH; Kornegay, JN; Nghiem, PP				Lopez, Sara Mata; Balog-Alvarez, Cynthia; Vitha, Stanislav; Bettis, Amanda K.; Canessa, Emily H.; Kornegay, Joe N.; Nghiem, Peter P.			Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy	PLOS ONE			English	Article							MOUSE MODEL; STEM-CELLS; MUSCLE; EXPRESSION	Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the expression of dystrophin protein. Dogs with the genetic homologue, golden retriever muscular dystrophy dog (GRMD), have a splice site mutation that leads to skipping of exon 7 and a stop codon in the DMD transcript. Gene editing via homology-directed repair (HDR) has been used in the mdx mouse model of DMD but not in GRMD. In this study, we used clustered regularly interspaced short palindromic repeats (CRISPR) and transcription activator-like effector nucleases (TALEN) to restore dystrophin expression via HDR in myoblasts/myotubes and later via intramuscular injection of GRMD dogs. In vitro, DNA and RNA were successfully corrected but dystrophin protein was not translated. With intramuscular injection of two different guide arms, sgRNA A and B, there was mRNA expression and Sanger sequencing confirmed inclusion of exon 7 for all treatments. On Western blot analysis, protein expression of up to 6% of normal levels was seen in two dogs injected with sgRNA B and up to 16% of normal in one dog treated with sgRNA A. TALEN did not restore any dystrophin expression. While there were no adverse effects, clear benefits were not seen on histopathologic analysis, immunofluorescence microscopy, and force measurements. Based on these results, methods must be modified to increase the efficiency of HDR-mediated gene repair and protein expression.	[Lopez, Sara Mata; Balog-Alvarez, Cynthia; Bettis, Amanda K.; Kornegay, Joe N.; Nghiem, Peter P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Vitha, Stanislav] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA; [Canessa, Emily H.] Binghamton Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Johnson City, NY USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Nghiem, PP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	pnghiem@tamu.edu		Kornegay, Joe/0000-0002-5594-1882	Office of the Vice President of Research at Texas AM University; Proteomics core facility at Binghamton University NY; Decker Foundation; Department of Veterinary Integrative Biosciences; SOLID Biosciences; University Libraries; Office of the Vice President for Research	Office of the Vice President of Research at Texas AM University; Proteomics core facility at Binghamton University NY; Decker Foundation; Department of Veterinary Integrative Biosciences; SOLID Biosciences; University Libraries; Office of the Vice President for Research	The Olympus FV1000 confocal microscope acquisition was supported by the Office of the Vice President of Research at Texas A&M University. Mass spectrometry work was partially supported by Proteomics core facility at Binghamton University NY and The Decker Foundation. All studies performed at Texas A&M were fully funded by a start-up package to PPN from the Department of Veterinary Integrative Biosciences. SML's salary was funded by SOLID Biosciences. SOLID Biosciences provided support in the form of salaries for SML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.; We acknowledge the Microscopy and Imaging Center facility at Texas A&M University for imaging studies; Dr. Dana Gaddy for help preparing the manuscript; and Dr. Nancy Ing for assistance in the nested PCR process. The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research.	Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bartlett RJ, 1996, AM J VET RES, V57, P650; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16007; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cotten SW, 2014, AM J TRANSL RES, V6, P43; Devkota S, 2018, BMB REP, V51, P437, DOI 10.5483/BMBRep.2018.51.9.187; Doetschman T, 2017, CIRC RES, V120, P876, DOI 10.1161/CIRCRESAHA.116.309727; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; FDA, 2016, PER CENTR NERV SYST; He ZY, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2536-3; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jensen ON, 1999, METH MOL B, V112, P513; Klingler Werner, 2012, Acta Myol, V31, P184; Kornegay JN, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0124-z; Kornegay JN, 2014, ILAR J, V55, P119, DOI 10.1093/ilar/ilu011; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Li GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09306-x; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li Y, 2010, JOVE-J VIS EXP, DOI [10.3791/2011, DOI 10.3791/2011]; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lopez SM, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0162-1; Lukashev AN, 2016, BIOCHEMISTRY-MOSCOW+, V81, P700, DOI 10.1134/S0006297916070063; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Miki Y, 2012, J STEROID BIOCHEM, V131, P68, DOI 10.1016/j.jsbmb.2011.12.004; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nghiem PP, 2019, HUM GENET, V138, P483, DOI 10.1007/s00439-019-01976-z; Nishiyama J, 2017, NEURON, V96, P755, DOI 10.1016/j.neuron.2017.10.004; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Pawlikowski B, 2009, DEV DYNAM, V238, P138, DOI 10.1002/dvdy.21833; Schneider SM, 2018, MOL IMAGING BIOL, V20, P780, DOI 10.1007/s11307-018-1174-2; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Song YF, 2019, NAT MED, V25, P1505, DOI 10.1038/s41591-019-0594-0; Spitali P, 2013, FASEB J, V27, P4909, DOI 10.1096/fj.13-232025; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tang L, 2018, MOL REPROD DEV, V85, P250, DOI 10.1002/mrd.22961; van Putten M, 2013, FASEB J, V27, P2484, DOI 10.1096/fj.12-224170; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Yu HH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101668; Zhang YY, 2017, MATH PROBL ENG, V2017, P1, DOI 10.1155/2017/7696858	47	13	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0228072	10.1371/journal.pone.0228072	http://dx.doi.org/10.1371/journal.pone.0228072			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961902	Green Published, gold			2022-12-26	WOS:000534372000025
J	Lv, LL; Yu, KY; Lu, HY; Zhang, XQ; Liu, XQ; Sun, CY; Xu, HQ; Zhang, JY; He, XH; Zhang, D				Lv, Lingling; Yu, Kaiye; Lu, Haiyan; Zhang, Xiangqian; Liu, Xiaoqian; Sun, Chongyuan; Xu, Huanqing; Zhang, Jinyu; He, Xiaohui; Zhang, Dan			Transcriptome-wide identification of novel circular RNAs in soybean in response to low-phosphorus stress	PLOS ONE			English	Article							PHOSPHATE HOMEOSTASIS; ARABIDOPSIS; EXPRESSION; MICRORNA399; DEFICIENCY; CIRCRNAS; ROLES	Low-phosphorus (LP) stress is a major factor limiting the growth and yield of soybean. Circular RNAs (circRNAs) are novel noncoding RNAs that play a crucial role in plant responses to abiotic stress. However, how LP stress mediates the biogenesis of circRNAs in soybean remains unclear. Here, to explore the response mechanisms of circRNAs to LP stress, the roots of two representative soybean genotypes with different P-use efficiency, Bogao (a LP-sensitive genotype) and Nannong 94156 (a LP-tolerant genotype), were used for the construction of RNA sequencing (RNA-seq) libraries and circRNA identification. In total, 371 novel circRNA candidates, including 120 significantly differentially expressed (DE) circRNAs, were identified across different P levels and genotypes. More DE circRNAs were significantly regulated by LP stress in Bogao than in NN94156, suggesting that the tolerant genotype was less affected by LP stress than the sensitive genotype was; in other words, NN94156 may have a better ability to maintain P homeostasis under LP stress. Moreover, a positive correlation was observed between the expression patterns of P stress-induced circRNAs and their circRNA-host genes. Gene Ontology (GO) enrichment analysis of these circRNA-host genes and microRNA (miRNA)-targeted genes indicated that these DE circRNAs were involved mainly in defense responses, ADP binding, nucleoside binding, organic substance catabolic processes, oxidoreductase activity, and signal transduction. Together, our results revealed that LP stress can significantly alter the genome-wide profiles of circRNAs and indicated that the regulation of circRNAs was both genotype and environment specific in response to LP stress. LP-induced circRNAs might provide a rich resource for LP-responsive circRNA candidates for future studies.	[Lv, Lingling; Yu, Kaiye; Lu, Haiyan; Zhang, Xiangqian; Liu, Xiaoqian; Sun, Chongyuan; Xu, Huanqing; Zhang, Dan] Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China; [Zhang, Jinyu] Henan Inst Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China; [He, Xiaohui] Zhengzhou Univ, Smart City Inst, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Institute of Science & Technology; Zhengzhou University	Zhang, D (corresponding author), Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China.; He, XH (corresponding author), Zhengzhou Univ, Smart City Inst, Zhengzhou, Peoples R China.	hexh@zzu.edu.cn; zhangd@henau.edu.cn	Chongyuan, Sun/AAB-3226-2021; Zhang, Dan/AAX-1629-2020	Chongyuan, Sun/0000-0003-0022-1949; Zhang, Dan/0000-0001-6119-9533	key scientific and technological project of Henan Province [192102110023, 30601916]; Key Scientific Research Projects of Higher Education Institutions in Henan Province [20A210017]; Henan agricultural university science and technology innovation fund [KJCX2019C02]; Innovative Research Group Project of the National Natural Science Foundation of China (CN) [31701309]; Ministry of Science and Technology of China [2016YFD0100500]	key scientific and technological project of Henan Province; Key Scientific Research Projects of Higher Education Institutions in Henan Province; Henan agricultural university science and technology innovation fund; Innovative Research Group Project of the National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was funded by the key scientific and technological project of Henan Province (192102110023 and 30601916) to DZ, the Key Scientific Research Projects of Higher Education Institutions in Henan Province (20A210017) to DZ, the Henan agricultural university science and technology innovation fund (KJCX2019C02) to DZ, the Innovative Research Group Project of the National Natural Science Foundation of China (CN) (31701309) to HL, and the Ministry of Science and Technology of China (2016YFD0100500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bao H, 2019, FUNCT INTEGR GENOMIC, V19, P953, DOI 10.1007/s10142-019-00692-1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chao LI, 2016, CHINESE J OIL CROP S, DOI [10.7505/j.issn.1007-9084, DOI 10.7505/J.ISSN.1007-9084]; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Du QG, 2018, PLANT PHYSIOL, V177, P1743, DOI 10.1104/pp.18.00034; Gao Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12060; Garg A, 2018, J BIOL CHEM, V293, P4456, DOI 10.1074/jbc.RA117.001352; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Hackenberg M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-214; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Hsieh LC, 2010, PLANT SIGNAL BEHAV, V5, P537, DOI 10.4161/psb.11029; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Khaldun ABM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01475; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lei KJ, 2016, J PLANT RES, V129, P275, DOI 10.1007/s10265-015-0778-8; Li ZX, 2016, PLANT SCI, V252, P103, DOI 10.1016/j.plantsci.2016.07.009; Li ZY, 2018, PLANT MOL BIOL, V96, P473, DOI 10.1007/s11103-018-0711-3; Litholdo CG Jr., ADV EXPT MED BIOL, P345; Liu JQ, 2010, MOL PLANT, V3, P428, DOI 10.1093/mp/ssq008; Liu Q, 2004, ENVIRON GEOCHEM HLTH, V26, P325, DOI 10.1023/B:EGAH.0000039597.75201.57; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui A, 2013, INT J MOL SCI, V14, P22642, DOI 10.3390/ijms141122642; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Pan T, 2018, PLANT MOL BIOL, V96, P217, DOI 10.1007/s11103-017-0684-7; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Ren YZ, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0194-3; Sablok G, 2016, MOL PLANT, V9, P192, DOI 10.1016/j.molp.2015.12.021; Scheerer U, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00378; Shah S, 2014, GENE DEV, V28, P231, DOI 10.1101/gad.230177.113; Srivastava S, 2013, J EXP BOT, V64, P303, DOI 10.1093/jxb/ers333; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tian L, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1460-9; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Wang K, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz053; Wang TZ, 2017, J EXP BOT, V68, P5937, DOI 10.1093/jxb/erx384; Wang Y, 2019, PLANT SCI, V280, P258, DOI 10.1016/j.plantsci.2018.12.025; Wang YX, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02024; Wang ZP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00413; Warnes G.R., 2009, R PACKAGE VERSION, V2, P1; Xiang LX, 2018, PEERJ, V6, DOI 10.7717/peerj.4500; Ye CY, 2015, NEW PHYTOL, V208, P88, DOI 10.1111/nph.13585; Yin JL, 2018, POSTHARVEST BIOL TEC, V136, P90, DOI 10.1016/j.postharvbio.2017.10.013; Yuan JP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2929-2; Zhang D, 2017, PLANT MOL BIOL, V93, P137, DOI 10.1007/s11103-016-0552-x; Zhang D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004061; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhang ZL, 2019, J INTEGR PLANT BIOL, V61, P492, DOI 10.1111/jipb.12715; Zhao W, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00379; Zhao W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05922-9; [赵文龙 Zhao Wenlong], 2013, [农业环境科学学报, Journal of Agro-Environment Science], V32, P2331; Zhou R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010071; Zhu YX, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1712-3; Zuo JH, 2016, BIOCHEM BIOPH RES CO, V479, P132, DOI 10.1016/j.bbrc.2016.07.032	59	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227243	10.1371/journal.pone.0227243	http://dx.doi.org/10.1371/journal.pone.0227243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961887	Green Published, gold			2022-12-26	WOS:000534372000008
J	Naruse, C; Abe, K; Yoshihara, T; Kato, T; Nishiuchi, T; Asano, M				Naruse, Chie; Abe, Kanae; Yoshihara, Toru; Kato, Tomoaki; Nishiuchi, Takumi; Asano, Masahide			Heterochromatin protein 1 gamma deficiency decreases histone H3K27 methylation in mouse neurosphere neuronal genes	FASEB JOURNAL			English	Article						HP1 gamma; JMJD3; neurosphere; UTX	H3 LYSINE-9 METHYLATION; DNA METHYLATION; GENOME-WIDE; HP1; CELLS; CHROMODOMAIN; DOMAIN; MARKS; METHYLTRANSFERASE; DIFFERENTIATION	Heterochromatin protein (HP) 1 gamma, a component of heterochromatin in eukaryotes, is involved in H3K9 methylation. Although HP1 gamma is expressed strongly in neural tissues and neural stem cells, its functions are unclear. To elucidate the roles of HP1 gamma, we analyzed HP1 gamma -deficient (HP1 gamma KO) mouse embryonic neurospheres and determined that HP1 gamma KO neurospheres tended to differentiate after quaternary culture. Several genes normally expressed in neuronal cells were upregulated in HP1 gamma KO undifferentiated neurospheres, but not in the wild type (WT). Compared to that in the control neurospheres, the occupancy of H3K27me3 was lower around the transcription start sites (TSSs) of these genes in HP1 gamma KO neurospheres, while H3K9me2/3, H3K4me3, and H3K27ac amounts remained unchanged. Moreover, amounts of the H3K27me2/3 demethylases, UTX, and JMJD3, were increased around the TSSs of these genes. Treatment with GSK-J4, an inhibitor of H3K27 demethylases, decreased the expression of genes upregulated in HP1 gamma KO neurospheres, along with an increase of H3K27me3 amounts. Therefore, in murine neurospheres, HP1 gamma protected the promoter sites of differentiated cell-specific genes against H3K27 demethylases to repress the expression of these genes. A better understanding of central cellular processes such as histone methylation will help elucidate critical events such as cell-specific gene expression, epigenetics, and differentiation.	[Naruse, Chie; Yoshihara, Toru; Asano, Masahide] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan; [Abe, Kanae] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Kato, Tomoaki; Nishiuchi, Takumi] Kanazawa Univ, Div Funct Genom, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Kyoto University; Kanazawa University; Kanazawa University	Asano, M (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	asano@anim.med.kyoto-u.ac.jp		Nishiuchi, Takumi/0000-0001-9429-5396	MEXT | Japan Society for the Promotion of Science (JSPS) [25430085, 25290031]; Kyoto University Research Development Program ISHIZUE [FY2016]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University Research Development Program ISHIZUE	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 25430085 and 25290031; Kyoto University Research Development Program ISHIZUE, Grant/Award Number: FY2016	Abe K, 2011, BIOL REPROD, V85, P1013, DOI 10.1095/biolreprod.111.091512; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Aldiri I, 2012, DEV BIOL, V367, P91, DOI 10.1016/j.ydbio.2012.04.030; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Aydin E, 2015, J BIOSCIENCES, V40, P325, DOI 10.1007/s12038-015-9520-x; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Becker JS, 2017, MOL CELL, V68, P1023, DOI 10.1016/j.molcel.2017.11.030; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Juan AH, 2016, CELL REP, V17, P1369, DOI 10.1016/j.celrep.2016.09.087; Kim MY, 2010, NEUROSCIENCE, V170, P8, DOI 10.1016/j.neuroscience.2010.07.020; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2015, INT J MOL SCI, V16, P5125, DOI 10.3390/ijms16035125; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Naruse C, 2007, BIOCHEM BIOPH RES CO, V361, P109, DOI 10.1016/j.bbrc.2007.06.161; Naruse C, 2017, FASEB J, V31, P2252, DOI 10.1096/fj.201600642R; Ha N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00271; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Oshiro H, 2015, GENES CELLS, V20, P108, DOI 10.1111/gtc.12205; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Rube HT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11025; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sudo G, 2016, GENES CELLS, V21, P218, DOI 10.1111/gtc.12331; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	53	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3956	3968		10.1096/fj.201900139R	http://dx.doi.org/10.1096/fj.201900139R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961023	Bronze			2022-12-26	WOS:000508663800001
J	Rinkevich, FD				Rinkevich, Frank D.			Detection of amitraz resistance and reduced treatment efficacy in the Varroa Mite, Varroa destructor, within commercial beekeeping operations	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; JACOBSONI OUD.; HOUSE-FLY; COUMAPHOS; FLUVALINATE; POPULATIONS; MUTATIONS; ORGANOPHOSPHORUS; MECHANISMS; APIARIES	The parasitic mite Varroa destructor and the associated viruses it transmits are responsible for most instances of honey bee colony losses in the United States. As such, beekeepers utilize miticides to control Varroa populations. Widespread resistance has developed to the miticides fluvalinate and coumaphos. However, Varroa has largely maintained susceptibility to amitraz despite a long and extensive use history. Anecdotal reports of reduced amitraz effectiveness have been a widely discussed contemporary issue among commercial beekeepers. Amitraz resistance was measured by in vitro bioassays with technical amitraz as well as Apivar (R) efficacy tests. Amitraz resistance was evaluated in commercial beekeeping operations in Louisiana, New York, and South Dakota with a long history of amitraz use. This research shows that amitraz remains an effective Varroa control product in many operations. However, apiaries across operations displayed a wide range of amitraz resistance from no resistance to high resistance that resulted in Varroa control failure. The resistance ratios from in vitro amitraz bioassays were correlated with reduced Apivar (R) efficacy, demonstrating bona fide cases of Varroa control failures due to amitraz resistance. Therefore, amitraz resistance monitoring protocols need to be developed. A resistance monitoring network should be established to ensure the sustainability of miticide use for Varroa control.	[Rinkevich, Frank D.] USDA ARS, Honey Bee Breeding Genet & Physiol Res Lab, 1157 Ben Hur Rd, Baton Rouge, LA 70820 USA	United States Department of Agriculture (USDA)	Rinkevich, FD (corresponding author), USDA ARS, Honey Bee Breeding Genet & Physiol Res Lab, 1157 Ben Hur Rd, Baton Rouge, LA 70820 USA.	frank.rinkevich@usda.gov						Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Balabanidou V, 2018, CURR OPIN INSECT SCI, V27, P68, DOI 10.1016/j.cois.2018.03.001; BAXTER J, 1998, AM BEE J, V138, P291; Coats JR., 1982, INSECTICIDE MODE ACT, P198; Colin ME, 1997, APIDOLOGIE, V28, P375, DOI 10.1051/apido:19970605; Maggi MD, 2009, EXP APPL ACAROL, V47, P317, DOI 10.1007/s10493-008-9216-0; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.16; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Elzen PJ, 2002, AM BEE J, V142, P291; Elzen PJ, 1999, APIDOLOGIE, V30, P13, DOI 10.1051/apido:19990102; Field LM, 2001, BIOCHEMICAL SITES OF INSECTICIDE ACTION AND RESISTANCE, P209; FINNEY D J, 1971, P333; Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040; GEORGHIOU GP, 1994, PHYTOPROTECTION, V75, P51, DOI 10.7202/706071ar; Gonzalez-Cabrera J, 2018, J PEST SCI, V91, P1137, DOI 10.1007/s10340-018-0968-y; Gonzalez-Cabrera J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155332; Gonzalez-Cabrera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082941; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hamm RL, 2005, J ECON ENTOMOL, V98, P171, DOI 10.1603/0022-0493-98.1.171; Hardstone MC, 2007, PESTIC BIOCHEM PHYS, V89, P175, DOI 10.1016/j.pestbp.2007.06.006; Hillesheim E, 1996, EXP APPL ACAROL, V20, P283, DOI 10.1007/BF00052878; Johnson RM, 2010, INT J ACAROL, V36, P1, DOI 10.1080/01647950903468273; Kamler M, 2016, EXP APPL ACAROL, V69, P1, DOI 10.1007/s10493-016-0023-8; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Maggi MD, 2010, PARASITOL RES, V107, P1189, DOI 10.1007/s00436-010-1986-8; Martin SJ, 2004, BEE WORLD, V85, P67, DOI 10.1080/0005772X.2004.11099632; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Milani N, 1999, APIDOLOGIE, V30, P229, DOI 10.1051/apido:19990211; Morawetz L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219293; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Pettis J, 1998, AM BEE J US; Pettis JS, 2004, APIDOLOGIE, V35, P91, DOI 10.1051/apido:2003060; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Rinkevich FD, 2017, INSECTS, V8, DOI 10.3390/insects8010009; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; Rinkevich FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052761; Rinkevich FD, 2012, PESTIC BIOCHEM PHYS, V104, P192, DOI 10.1016/j.pestbp.2012.08.001; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SCOTT J G, 1989, Journal of Agricultural Entomology, V6, P53; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Shono T, 2004, PESTIC BIOCHEM PHYS, V80, P106, DOI 10.1016/j.pestbp.2004.06.004; Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x; Spreafico M, 2001, APIDOLOGIE, V32, P49, DOI 10.1051/apido:2001110; Thoms CA, 2018, AMBIO, P1; Traynor KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33207; Van Leeuwen T, 2016, ANNU REV ENTOMOL, V61, P475, DOI 10.1146/annurev-ento-010715-023907; Vu PD, 2016, TOXICOLOGICAL ANAL A; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	52	51	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227264	10.1371/journal.pone.0227264	http://dx.doi.org/10.1371/journal.pone.0227264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951619	Green Published, gold			2022-12-26	WOS:000534370500014
J	Richter, AA; Kobus, S; Czech, L; Hoeppner, A; Zarzycki, J; Erb, TJ; Lauterbach, L; Dickschat, JS; Bremer, E; Smits, SHJ				Richter, Alexandra A.; Kobus, Stefanie; Czech, Laura; Hoeppner, Astrid; Zarzycki, Jan; Erb, Tobias J.; Lauterbach, Lukas; Dickschat, Jeroen S.; Bremer, Erhard; Smits, Sander H. J.			The architecture of the diaminobutyrate acetyltransferase active site provides mechanistic insight into the biosynthesis of the chemical chaperone ectoine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetylation; crystal structure; enzyme; stress response; acetyltransferase; chemical chaperone; L-2; 4-diaminobutyrate; reaction mechanism; structural biology	COMPATIBLE SOLUTE HYDROXYECTOINE; ORGANIC OSMOLYTES; AMINO-ACID; IN-VITRO; PROTEIN; BACTERIA; STRESS; MUTANT; CRYSTALLIZATION; OSMOADAPTATION	Ectoine is a solute compatible with the physiologies of both prokaryotic and eukaryotic cells and is widely synthesized by bacteria as an osmotic stress protectant. Because it preserves functional attributes of proteins and macromolecular complexes, it is considered a chemical chaperone and has found numerous practical applications. However, the mechanism of its biosynthesis is incompletely understood. The second step in ectoine biosynthesis is catalyzed by l-2,4-diaminobutyrate acetyltransferase (EctA; EC 2.3.1.178), which transfers the acetyl group from acetyl-CoA to EctB-formed l-2,4-diaminobutyrate (DAB), yielding N-?-acetyl-l-2,4-diaminobutyrate (N-?-ADABA), the substrate of ectoine synthase (EctC). Here, we report the biochemical and structural characterization of the EctA enzyme from the thermotolerant bacterium Paenibacillus lautus (Pl). We found that (Pl)EctA forms a homodimer whose enzyme activity is highly regiospecific by producing N-?-ADABA but not the ectoine catabolic intermediate N-?-acetyl-l-2,4-diaminobutyric acid. High-resolution crystal structures of (Pl)EctA (at 1.2?2.2 ? resolution) (i) for its apo-form, (ii) in complex with CoA, (iii) in complex with DAB, (iv) in complex with both CoA and DAB, and (v) in the presence of the product N-?-ADABA were obtained. To pinpoint residues involved in DAB binding, we probed the structure-function relationship of (Pl)EctA by site-directed mutagenesis. Phylogenomics shows that EctA-type proteins from both Bacteria and Archaea are evolutionarily highly conserved, including catalytically important residues. Collectively, our biochemical and structural findings yielded detailed insights into the catalytic core of the EctA enzyme that laid the foundation for unraveling its reaction mechanism.	[Richter, Alexandra A.; Czech, Laura; Bremer, Erhard] Philipps Univ Marburg, Dept Biol, Lab Microbiol, Karl von Frisch Str 8, D-35043 Marburg, Germany; [Richter, Alexandra A.; Czech, Laura; Erb, Tobias J.; Bremer, Erhard] Philipps Univ Marburg, SYNMIKRO Res Ctr, D-35043 Marburg, Germany; [Kobus, Stefanie; Hoeppner, Astrid; Smits, Sander H. J.] Heinrich Heine Univ Dusseldorf, Ctr Struct Studies, Dusseldorf, Germany; [Smits, Sander H. J.] Heinrich Heine Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany; [Zarzycki, Jan; Erb, Tobias J.] Max Planck Inst Terr Microbiol, Dept Biochem & Synthet Metab, D-35043 Marburg, Germany; [Lauterbach, Lukas; Dickschat, Jeroen S.] Friedrich Wilhelms Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany	Philipps University Marburg; Philipps University Marburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Max Planck Society; University of Bonn	Bremer, E (corresponding author), Philipps Univ Marburg, Dept Biol, Lab Microbiol, Karl von Frisch Str 8, D-35043 Marburg, Germany.; Smits, SHJ (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	bremer@staff.uni-marburg.de; sander.smits@hhu.de	Czech, Laura/AAB-7425-2019	Zarzycki, Jan/0000-0002-6307-6497; Hoeppner, Astrid/0000-0002-7076-5936; Czech, Laura/0000-0001-7398-1186	Deutsche Forschungsgemeinschaft (DFG) [INST 160/621-1 FUGG]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We cordially acknowledge the staff of beamline P13 (DESY, EMBL, Hamburg, Germany) for kind and helpful support during crystal screening, and we are equally thankful to the staff of the ID23-1, ID29, ID30B, and ID30A-3 beamlines of the European Synchrotron Radiation Facility (Grenoble, France) for expertly providing synchrotron radiation facilities. We greatly appreciate the generous gift of ectoine by the bitop AG (Witten, Germany) for our study. We thank Jochen Sohn for excellent technical assistance during EctA protein overproduction and purification. We are thankful to Dr. Uwe Linne (Department of Chemistry, Philipps-University Marburg) for performing the MS analysis of recombinant (Pl)EctA proteins; access to the MS facilities of the Department of Chemistry of the PhilippsUniversity Marburg is gratefully acknowledged. We thank the Deutsche Forschungsgemeinschaft (DFG) for co-financing the SynaptG2Si mass spectrometer (Grant INST 160/621-1 FUGG to U. Linne and G. Bange). We appreciate the kind support of Lutz Schmitt (Institute of Biochemistry, University Dusseldorf) for this project. We are very grateful to Gert Bange for critical reading of the manuscript and many inspiring discussions. We particularly acknowledge and thank Alexander Lepak (SYNMIKRO Research Center, Philipps-University) for producing the video visualizing the predicted enzyme reaction mechanism of the L-2,4-diaminobutyrate acetyltransferase EctA.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], [No title captured]; Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; Booth IR, 2014, CURR OPIN MICROBIOL, V18, P16, DOI 10.1016/j.mib.2014.01.005; Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Bownik A, 2016, ARH HIG RADA TOKSIKO, V67, P260, DOI 10.1515/aiht-2016-67-2837; Brands S, 2019, ARCH BIOCHEM BIOPHYS, V674, DOI 10.1016/j.abb.2019.108097; Bremer E, 2019, ANNU REV MICROBIOL, V73, P313, DOI 10.1146/annurev-micro-020518-115504; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruce H, 2012, ACTA CRYSTALLOGR F, V68, P1175, DOI 10.1107/S1744309112030023; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Chattopadhyay MK, 2004, J BACTERIOL, V186, P8149, DOI 10.1128/JB.186.23.8149-8152.2004; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Czech L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36247-w; Czech L, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040177; Czech L, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005163; Czech L, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01772-17; da Costa M. S., 1998, V61, P117; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Gunde-Cimerman N, 2018, FEMS MICROBIOL REV, V42, P353, DOI 10.1093/femsre/fuy009; Hahn MB, 2017, PHYS CHEM CHEM PHYS, V19, P25717, DOI 10.1039/c7cp02860a; Harding T, 2016, GENOME BIOL EVOL, V8, P2241, DOI 10.1093/gbe/evw152; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; Herzog M, 2019, COLLOID SURFACE B, V178, P404, DOI 10.1016/j.colsurfb.2019.03.026; Hoppner A, 2014, J BIOL CHEM, V289, P29570, DOI 10.1074/jbc.M114.576769; Hoeppner A, 2014, ACTA CRYSTALLOGR F, V70, P493, DOI 10.1107/S2053230X14004798; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; INBAR L, 1988, J BIOL CHEM, V263, P16014; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Kobus S, 2015, ACTA CRYSTALLOGR F, V71, P1027, DOI 10.1107/S2053230X15011115; Kolp S, 2006, BBA-PROTEINS PROTEOM, V1764, P1234, DOI 10.1016/j.bbapap.2006.04.015; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; KUNTE HJ, 1993, J MICROBIOL METH, V17, P129; Kunte HJ, 2014, CURR BIOTECHNOL, V3, P10, DOI [10.2174/22115501113026660037, DOI 10.2174/22115501113026660037]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Manzanera M, 2004, FEMS MICROBIOL LETT, V233, P347, DOI 10.1016/j.femsle.2004.03.005; Mead DA, 2012, STAND GENOMIC SCI, V6, P366, DOI 10.4056/sigs.2605792; Meyer S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07441-z; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Peter DM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040517; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Reshetnikov AS, 2011, EXTREMOPHILES, V15, P653, DOI 10.1007/s00792-011-0396-x; Reshetnikov AS, 2011, METHOD ENZYMOL, P15, DOI 10.1016/B978-0-12-386905-0.00002-4; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; Richter AA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02811; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Sahin Erinc, 2012, Methods Mol Biol, V899, P403, DOI 10.1007/978-1-61779-921-1_25; Salvador M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01845; Schroter MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15512-4; Schulz A, 2017, ENVIRON MICROBIOL, V19, P4599, DOI 10.1111/1462-2920.13924; Schulz A, 2017, ENVIRON MICROBIOL, V19, P926, DOI 10.1111/1462-2920.13414; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Stadmiller SS, 2017, J MOL BIOL, V429, P1155, DOI 10.1016/j.jmb.2017.03.001; Stiller LM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040184; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Sun H, 2012, CRYOLETTERS, V33, P485; Tanne C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00150; Tramonti A, 2018, FEBS J, V285, P3925, DOI 10.1111/febs.14599; Ud-Din AIMS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071018; van den Berg J, 2017, NAT REV MICROBIOL, V15, P309, DOI 10.1038/nrmicro.2017.17; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wedeking A, 2014, CURR MED CHEM, V21, P2565, DOI 10.2174/0929867321666131228222730; Weinisch L, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003892; Widderich N, 2016, ENVIRON MICROBIOL, V18, P1227, DOI 10.1111/1462-2920.13156; Widderich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151285; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yanykin DV, 2019, PHOTOSYNTH RES, V141, P165, DOI 10.1007/s11120-019-00617-w; Zaccai G, 2016, SCI REP-UK, V6, DOI 10.1038/srep31434	97	10	12	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2822	2838		10.1074/jbc.RA119.011277	http://dx.doi.org/10.1074/jbc.RA119.011277			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31969391	Green Published, hybrid			2022-12-26	WOS:000519969100024
J	Valori, I; McKenna-Plumley, PE; Bayramova, R; Callegher, CZ; Altoe, G; Farroni, T				Valori, Irene; McKenna-Plumley, Phoebe E.; Bayramova, Rena; Callegher, Claudio Zandonella; Altoe, Gianmarco; Farroni, Teresa			Proprioceptive accuracy in Immersive Virtual Reality: A developmental perspective	PLOS ONE			English	Article							INTEGRATION; INFORMATION; CHILDREN; MODELS; ORIENTATION; MOVEMENTS; VISION; BODY; AGE	Proprioceptive development relies on a variety of sensory inputs, among which vision is hugely dominant. Focusing on the developmental trajectory underpinning the integration of vision and proprioception, the present research explores how this integration is involved in interactions with Immersive Virtual Reality (IVR) by examining how proprioceptive accuracy is affected by Age, Perception, and Environment. Individuals from 4 to 43 years old completed a self-turning task which asked them to manually return to a previous location with different sensory modalities available in both IVR and reality. Results were interpreted from an exploratory perspective using Bayesian model comparison analysis, which allows the phenomena to be described using probabilistic statements rather than simplified reject/notreject decisions. The most plausible model showed that 4-8-year-old children can generally be expected to make more proprioceptive errors than older children and adults. Across age groups, proprioceptive accuracy is higher when vision is available, and is disrupted in the visual environment provided by the IVR headset. We can conclude that proprioceptive accuracy mostly develops during the first eight years of life and that it relies largely on vision. Moreover, our findings indicate that this proprioceptive accuracy can be disrupted by the use of an IVR headset.	[Valori, Irene; McKenna-Plumley, Phoebe E.; Callegher, Claudio Zandonella; Altoe, Gianmarco; Farroni, Teresa] Univ Padua, Dept Dev Psychol & Socializat, Padua, Italy; [Bayramova, Rena] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua; University of Padua	Farroni, T (corresponding author), Univ Padua, Dept Dev Psychol & Socializat, Padua, Italy.	teresa.farroni@unipd.it	Valori, Irene/GQO-9731-2022; McKenna-Plumley, Phoebe/AFT-2755-2022	Valori, Irene/0000-0002-9560-2789; Altoe, Gianmarco/0000-0003-1154-9528; Bayramova, Rena/0000-0002-1562-7573; Zandonella Callegher, Claudio/0000-0001-7721-6318	Beneficentia Stiftung Foundation; Associazione Pro Musica Ruda-Scuola Comunale di Musica; Comune di Ruda (Udine, Italy)	Beneficentia Stiftung Foundation; Associazione Pro Musica Ruda-Scuola Comunale di Musica; Comune di Ruda (Udine, Italy)	Thanks to Beneficentia Stiftung Foundation for supporting our research.; Sincere thanks to Associazione Pro Musica Ruda-Scuola Comunale di Musica and the Comune di Ruda (Udine, Italy) for hosting our laboratory and supporting our work.	Adams H, 2018, IEEE T VIS COMPUT GR, V24, P1408, DOI 10.1109/TVCG.2018.2794072; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2013, TEXTS STAT SCI SERIE; Bailey JO, 2017, COGNITIVE DEVELOPMENT IN DIGITAL CONTEXTS, P181, DOI 10.1016/B978-0-12-809481-5.00009-2; Bakker NH, 1999, PRESENCE-TELEOP VIRT, V8, P36, DOI 10.1162/105474699566035; Bodenheimer B, 2017, P IEEE VIRT REAL ANN, P141, DOI 10.1109/VR.2017.7892241; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bremner A. J., 2012, MULTISENSORY DEV, P1, DOI DOI 10.1093/ACPROF:OSO/9780199586059.003.0001; Bremner A. J., 2012, MULTISENSORY DEV, P113; Bremner AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051887; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Delgado A, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2012)137; Etz A, 2018, PSYCHON B REV, V25, P5, DOI 10.3758/s13423-017-1262-3; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Fox J., 2016, APPL REGRESSION ANAL, V3rd; Gelman A, 2018, AM STAT, V1, P10; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Goble DJ, 2012, EXP BRAIN RES, V216, P35, DOI 10.1007/s00221-011-2904-8; Goble DJ, 2005, HUM MOVEMENT SCI, V24, P155, DOI 10.1016/j.humov.2005.05.004; Gromala D, 2009, AAAI FALL S SERIES, P71; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Haswell CC, 2009, NAT NEUROSCI, V12, P970, DOI 10.1038/nn.2356; HEARN M, 1989, PERCEPT MOTOR SKILL, V69, P811, DOI 10.2466/pms.1989.69.3.811; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Hurley MV, 1998, AGE AGEING, V27, P55, DOI 10.1093/ageing/27.1.55; Izawa J, 2012, AUTISM RES, V5, P124, DOI 10.1002/aur.1222; Jurgens R, 2006, EXP BRAIN RES, V174, P528, DOI 10.1007/s00221-006-0486-7; Kearns MJ, 2002, PERCEPTION, V31, P349, DOI 10.1068/p3311; Kruschke JK, 2018, PSYCHON B REV, V25, P178, DOI 10.3758/s13423-016-1221-4; Lathrop WB, 2002, PRESENCE-TELEOP VIRT, V11, P19, DOI 10.1162/105474602317343631; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; McElreath R., 2015, STAT RETHINKING BAYE; Meilinger T, 2015, 25 INT C ART REAL TE, P25; Mohler B.J., 2007, P IPT EGV S, P1; Mohler BJ, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134/1227138; Pereira EM, 2014, NEUROLOGIA, V29, P550, DOI 10.1016/j.nrl.2011.12.004; Morris SL, 2015, NEUROSCIENCE, V307, P273, DOI 10.1016/j.neuroscience.2015.08.040; Murray CD, 1999, ETHOS, V27, P315, DOI 10.1525/eth.1999.27.3.315; Neal RM, 2011, CH CRC HANDB MOD STA, P113; Nelson RJ, 2001, SOMATOSENSORY SYSTEM; Ng VK, 2017, CURR PSYCHOL, V36, P225, DOI 10.1007/s12144-015-9404-0; Petrini K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29163; Petrini K, 2015, CHILD DEV, V86, P1449, DOI 10.1111/cdev.12397; Pickering SJ, 2001, MEMORY, V9, P423, DOI 10.1080/09658210143000182; Pinheiro J., 2006, MIXED EFFECTS MODELS; Powell W. A., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P270, DOI 10.1109/ICVR.2013.6662085; Prothero JD, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P47; Quak M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00197; R Core Team, 2018, R LANG ENV STAT COMP; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Riecke BE, 2005, PROC SPIE, V5666, P344, DOI 10.1117/12.610846; Riecke BE, 2007, IEEE VIRTUAL REALITY 2007, PROCEEDINGS, P3; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Sigmundsson H, 2000, EXP BRAIN RES, V135, P348, DOI 10.1007/s002210000531; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Stan Development Team, 2018, STAN MOD LANG US GUI; Stan Development Team, 2017, STAN A C LIB PROB SA; Stillman BC., 2002, PHYSIOTHERAPY, V88, P667, DOI [10.1016/S0031-9406(05)60109-5, DOI 10.1016/S0031-9406(05)60109-5]; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; VONHOFSTEN C, 1988, NEUROPSYCHOLOGIA, V26, P805, DOI 10.1016/0028-3932(88)90051-6; Waddington G, 1999, AUST J PHYSIOTHER, V45, P7, DOI 10.1016/S0004-9514(14)60335-4; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Weerakkody NS, 2008, J PHYSIOL-LONDON, V586, P3183, DOI 10.1113/jphysiol.2008.152942; Wingert JR, 2014, ARCH PHYS MED REHAB, V95, P253, DOI 10.1016/j.apmr.2013.08.012	73	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0222253	10.1371/journal.pone.0222253	http://dx.doi.org/10.1371/journal.pone.0222253			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999710	Green Submitted, Green Published, gold			2022-12-26	WOS:000534612400003
J	Feldman, C; Dlamini, SK; Madhi, SA; Meiring, S; von Gottberg, A; de Beer, JC; de Necker, M; Stander, MP				Feldman, Charles; Dlamini, Sipho K.; Madhi, Shabir A.; Meiring, Susan; von Gottberg, Anne; de Beer, Janetta C.; de Necker, Margreet; Stander, Marthinus P.			The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; UGANDAN ADULTS; CHILDREN; DISEASE; TRIAL; HEALTH; AGE	Streptococcus pneumoniae (pneumococcus) remains an important cause of morbidity and mortality. Pneumococcal vaccination is part of the South African pediatric public immunization program but the potential cost-effectiveness of such an intervention for adults is unknown. This study aimed to compare the cost-effectiveness of two widely used pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) in South African adults, 18 years and older. Four analyses were carried out in a) both the private and public health care sectors; and b) for the HIV-infected population alone and for the total mixed population (all HIV-infected and -uninfected people). A previously published global pharmacoeconomic model was adapted and populated to represent the South African adult population. The model utilized a Markov-type process to depict the lifetime clinical and economic outcomes of patients who acquire pneumococcal disease in 2015, from a societal perspective. Costs were sourced in South African rand and converted to US dollar (USD). The incremental cost divided by the incremental effectiveness (expressed as quality-adjusted life years gained) represented the incremental cost-effectiveness ratio for PCV13 compared to PPSV23. Results indicated that the use of PCV13 compared to PPSV23 is highly cost-effective in the public sector cohorts with incremental cost-effectiveness ratios of $771 (R11,106)/quality-adjusted life year and $956 (R13,773)/quality-adjusted life year for the HIV-infected and mixed populations, respectively. The private sector cohort showed similar highly cost-effective results for the mixed population (incremental cost-effectiveness ratio $626 (R9,013)/quality-adjusted life year) and the HIVinfected cohort (dominant). In sensitivity analysis, the model was sensitive to vaccine price and effectiveness. Probabilistic sensitivity analyses found predominantly cost-effective ICERs. From a societal perspective, these findings provide some guidance to policy makers for consideration and implementation of an immunization strategy for both the public and private sector and amongst different adult patient pools in South Africa.	[Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Dlamini, Sipho K.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Fac Hlth Sci, Natl Res Fdn,Vaccine Preventable Dis Res Chair, Johannesburg, South Africa; [Meiring, Susan] Natl Inst Communicable Dis NICD, Div Publ Hlth Surveillance & Response, Cape Town, South Africa; [von Gottberg, Anne] Natl Inst Communicable Dis NICD, Ctr Resp Dis & Meningitis CRDM, Johannesburg, South Africa; [von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [de Beer, Janetta C.; de Necker, Margreet; Stander, Marthinus P.] TCD Global, TCD Outcomes Res, Centurion, South Africa	University of Witwatersrand; University of Cape Town; South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand	Feldman, C (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.	Charles.Feldman@wits.ac.za	Feldman, Charles/ABF-3315-2020	Feldman, Charles/0000-0002-6881-8314; von Gottberg, Anne/0000-0002-0243-7455; Madhi, Shabir/0000-0002-7629-0636	Pfizer	Pfizer(Pfizer)	Medical writing support was provided by TCD Outcomes Research and was funded by Pfizer. Editorial support was provided by TCD Outcomes Research. The funders had no role in study design, data collection and analysis, however they were involved in the decision to publish and reviewed the manuscript.	Actuarial Society of South Africa, AIDS MOD ASSA 2008; Al MJ, 2013, PHARMACOECONOMICS, V31, P93, DOI 10.1007/s40273-012-0011-8; [Anonymous], MAST PROC CAT; [Anonymous], 2015, WHO REP GLOB TOB EP; [Anonymous], 2017, PRESSREADER PRE 0630; Bamford A, 2014, AIDS, V28, P2033, DOI 10.1097/QAD.0000000000000385; Biagini Leandro, 2018, Value Health Reg Issues, V17, P194, DOI 10.1016/j.vhri.2018.09.005; Blommaert A, 2016, VACCINE, V34, P2106, DOI 10.1016/j.vaccine.2016.03.003; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Boyles T. H., 2013, Southern African Journal of Epidemiology & Infection, V28, P5; Boyles TH, 2017, J THORAC DIS, V9, P1469, DOI 10.21037/jtd.2017.05.31; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Centers for Disease Control and Prevention, PNEUM DIS TYP INF; Centers for Disease Control and Prevention. National Center for Health Statistics, 2009, MORT DAT NAT VIT STA; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140185; Cohen R, 2017, LANCET GLOB HEALTH, V5, pE244, DOI 10.1016/S2214-109X(17)30044-X; Council for Medical Schemes, ANN REP 2016 2016 AN; Council for Medical Schemes, ANN REP 2013 2014; Custer R, 1999, J VOCATIONAL TECHNIC, V15, P2; de Bruyn G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-277; Department of Health Republic of South Africa, 2 TRIENN REP COMM MO; Department of Health Republic of South Africa, 2013, GOVT GAZETTE, P36118; Department of Health Republic of South Africa, 2015, UN PAT FEE SCHED PAY; Department of Health Republic of South Africa, VACC MAN IMM WORKS E; Dirmesropian S, 2015, HUM VACC IMMUNOTHER, V11, P818, DOI 10.1080/21645515.2015.1011954; ENGLISH GM, 2000, TRANSPORT RES, V10, P1; Feldman Charles, 2016, F1000Res, V5, P2320; Filipovic I, 2011, RHEUMATOLOGY, V50, P1083, DOI 10.1093/rheumatology/keq399; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Fry AM, 2002, VACCINE, V21, P303, DOI 10.1016/S0264-410X(02)00451-6; Galante J, 2011, VALUE HEALTH, V14, pS60, DOI 10.1016/j.jval.2011.05.007; Health Policy Project, 2016, HLTH FIN PROF S AFR; Heijink R, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0694-9; Heo JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177342; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Levinsohn JA, 2011, 16901 NBER; Lin SH, 2011, EPIDEMIOL INFECT, V139, P1307, DOI 10.1017/S0950268810002402; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; Meiring S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149104; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Naidoo N., 2014, THESIS; National Institute for Communicable Diseases. National Cancer Registry, CANC S AFR FULL REP; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Organ Donor Foundation of South Africa, TRANSPL STAT S AFR 2; Patterson S., 2016, Trials in Vaccinology, V5, P92, DOI 10.1016/j.trivac.2016.04.004; Pfizer Laboratories, 2015, PREV 13; Gonzalez-Moro JMR, 2016, CLIN DRUG INVEST, V36, P41, DOI 10.1007/s40261-015-0345-z; SAMA-SA Pulmonology Society Working Group, 1999, SAMJ, V89; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sculpher M., USE PROBABILISTIC SE; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Shiri T, 2019, VALUE HLTH; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; Smith KJ, 2008, VACCINE, V26, P1420, DOI 10.1016/j.vaccine.2008.01.007; Smith KJ, 2013, VACCINE, V31, P3950, DOI 10.1016/j.vaccine.2013.06.037; Souter J, 2014, SA PHARM J, V81, P15; Statistics South Africa, MID POP EST 2019; Statistics South Africa, MID POP EST 2014 STA; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Treskova M, 2019, PHARMACOECONOMICS, V37, P1093, DOI 10.1007/s40273-019-00805-5; University of Pretoria, SPEECH LANG PATH AUD; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Watanabe A, 2015, RESP MED, V25, P444; Watera C, 2004, AIDS, V18, P1210, DOI 10.1097/00002030-200405210-00018; World Health Organization, 2014, AFR COST EFF RES MAL; World Health Organization, WORLD HLTH REP 2002; World Health Organization, 2014, GLOB HLTH OBS DAT S; World Health Organization (WHO), IMM VACC BIOL PNEUM; Wright C, 2011, COUNTING COST MENING	75	4	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227945	10.1371/journal.pone.0227945	http://dx.doi.org/10.1371/journal.pone.0227945			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995597	gold, Green Published			2022-12-26	WOS:000534609400032
J	Haubold, J; Ludwig, JM; Li, Y; Buechter, M; Wetter, A; Umutlu, L; Theysohn, JM				Haubold, Johannes; Ludwig, Johannes M.; Li, Yan; Buechter, Matthias; Wetter, Axel; Umutlu, Lale; Theysohn, Jens M.			Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization	PLOS ONE			English	Article							DRUG-ELUTING BEADS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; CT	Purpose The purpose of this study is to evaluate the use of density measurements in the diagnosis of an underlying residual tumor beyond iodine depositions after Lipiodol-based conventional transarterial chemoembolization (cTACE). Method and materials Thirty follow-up CT scans of 20 patients 6-12 weeks after Lipiodol-based cTACE, receiving a digital subtraction angiography at the same time, were analyzed. Reference for the detection of a residual tumor was the angiography, and a visible contrast enhancement was categorized as a residual tumor (n = 16 with residual tumor; n = 14 without residual tumor). The density of the iodine depositions was measured in all containing slices in non-contrast-, arterial- and portal venous-phase CT scans, with a slice thickness of 5.00 mm. The mean density of the iodine deposition during the portal venous phase was subtracted from the mean density of the arterial phase to calculate the density changes (a positive enhancement score represents washout in the portal venous phase). In addition, a quotient relating to the noncontrast measurement was evaluated. Results Patients with a residual tumor displayed significantly higher enhancement scores in favor of density reduction between the arterial and portal venous phases, compared to patients without a residual tumor (1.41 +/- 3.59, n = 14 vs.-13.97 +/- 2.88, n = 16; p-value < 0.01). Furthermore, 87.75% of patients with an enhancement score higher than -1.00 (n = 9) had a residual tumor, whereas 100.00% of patients with an enhancement score lower than-20.00 (n = 6) were shown to be tumor-free. The enhancement score quotient resulted in similar findings. Conclusion After cTACE in patients with hepatocellular carcinoma (HCC), the presence of a viable tumor correlated with enhancement scores based on the density measurements of iodine depositions in different phases of the CT scan. Low enhancement scores were associated with completely treated tumors and can aid the decision process to avoid possibly unnecessary angiographies.	[Haubold, Johannes; Ludwig, Johannes M.; Li, Yan; Wetter, Axel; Umutlu, Lale; Theysohn, Jens M.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Buechter, Matthias] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Haubold, J (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	johannes.haubold@uk-essen.de			Guerbet (Villepinte, France)	Guerbet (Villepinte, France)	The study was partially funded by Guerbet (Villepinte, France; http://www.guerbet.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi M, 2015, SAUDI J GASTROENTERO, V21, P175, DOI 10.4103/1319-3767.157571; Baur J, 2016, HEPATIC MED-EVID RES, V8, P69, DOI 10.2147/HMER.S105395; Bialecki Eldad S, 2005, HPB (Oxford), V7, P26, DOI 10.1080/13651820410024049; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen CS, 2016, ONCOTARGET, V7, P7241, DOI 10.18632/oncotarget.6892; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Gulani V, 2017, LANCET NEUROL, V16, P564, DOI 10.1016/S1474-4422(17)30158-8; HESSEL SJ, 1981, RADIOLOGY, V138, P273, DOI 10.1148/radiology.138.2.7455105; Kloeckner R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1480-x; Kubota K, 2001, ABDOM IMAGING, V26, P184, DOI 10.1007/s002610000139; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mazioti A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7070; Minami Y, 2015, LIVER CANCER, V4, P106, DOI 10.1159/000367733; Miyayama S, 2016, HEPATOL RES, V46, P890, DOI 10.1111/hepr.12632; Monier A, 2017, EUR RADIOL, V27, P1431, DOI 10.1007/s00330-016-4488-y; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9	16	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227972	10.1371/journal.pone.0227972	http://dx.doi.org/10.1371/journal.pone.0227972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995589	Green Published, gold			2022-12-26	WOS:000534609400033
J	Friedrich, F; Valadao, MC; Brum, M; Comaru, T; Pitrez, PM; Jones, MH; Pinto, LA; Scotta, MC				Friedrich, Frederico; Valadao, Maria Clara; Brum, Marcos; Comaru, Talitha; Pitrez, Paulo Marcio; Jones, Marcus Herbert; Pinto, Leonardo A.; Scotta, Marcelo C.			Impact of maternal dTpa vaccination on the incidence of pertussis in young infants	PLOS ONE			English	Article							ACELLULAR PERTUSSIS; HOSPITALIZATIONS; IMMUNIZATION; EPIDEMIOLOGY; DIPHTHERIA; TETANUS; FUTURE	Introduction Pertussis is an important public health problem worldwide, especially in infants. An increase in the incidence in many countries occurred after 2010, including Brazil. In 2013, dTpa vaccine was introduced in the Brazil national immunization schedule of pregnant women. The objective of this study was to evaluate the national trends in the incidence of pertussis in Brazil in children under 1 year old, and the impact of the introduction of dTpa vaccine during pregnancy. Methods The incidence of hospitalizations and non-hospitalized confirmed cases of pertussis in neonates (< 1 month age) and young infants (1 month-< 1 year age) were analyzed, comparing the incidence in pre maternal vaccination (2011-2013) with the post-vaccination (20152017). We used non-respiratory hospitalizations as comparison, during the same period. A database of the Brazilian Ministry of Health (DATASUS) was used to analyze cases from 2007 to 2017 and the subsets of 2011-2013 and 2015-2017, after Pertussis resurgence. The vaccination data was accessed through the link of the Information System of the National Immunization Program (pni.datasus.gov.br). Results Between 2007 and 2017, 17,818 children under one year of age were hospitalized due to pertussis in Brazil. In the pre maternal vaccination period 2011-2013, the mean annual incidence of non-hospitalized confirmed cases of pertussis in children under 1 month was 722.2 / 100,000 and in the period of 2015-2017 the average was 377.3 / 100,000, representing a decrease of 47.7% [IRR 0.52 (0.46-0.59)]. At those periods of time, the average incidence per year for children of one month-< 1 year aged was 64.9 / 100,000 (2011-2013) and 29.3 / 100,000 (2015-2017) [IRR 0.45 (CI 0.29-0.69)]. Conclusion Vaccination of pregnant woman coincides with the reduction in the number of cases of pertussis in children under 1 month of age from 2015. Immunization of pregnant woman seems to have an important impact on the prevention of the disease in young infants who have not yet received their own pertussis vaccine.	[Friedrich, Frederico; Valadao, Maria Clara; Brum, Marcos; Comaru, Talitha; Pitrez, Paulo Marcio; Jones, Marcus Herbert; Pinto, Leonardo A.; Scotta, Marcelo C.] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Sch Med, Dept Pediat, Ctr Infant, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Friedrich, F (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUCRS, Sch Med, Dept Pediat, Ctr Infant, Porto Alegre, RS, Brazil.	fredericofriedrich@gmail.com	comaru, Talitha/AGW-6946-2022; Pinto, Leonardo A./C-6866-2008; Pinto, Leonardo A./AAG-2800-2020; Friedrich, Frederico/ABF-8992-2021; Jones, Marcus Herbert/A-3580-2011; Pitrez, Paulo/A-3040-2011	Pinto, Leonardo A./0000-0002-3906-5456; Pinto, Leonardo A./0000-0002-3906-5456; Jones, Marcus Herbert/0000-0002-8263-1265; Friedrich, Frederico/0000-0001-6939-0340; Comaru, Talitha/0000-0002-3574-6318; Pitrez, Paulo/0000-0001-7319-1133	Coordination of Improvement of Personnel Higher Education - Brazil (CAPES) [001]	Coordination of Improvement of Personnel Higher Education - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present work was carried out with the support of the Coordination of Improvement of Personnel Higher Education - Brazil (CAPES) Financing Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; Brown K., 2005, Morbidity and Mortality Weekly Report, V54, P1283; Cherry JD, 2016, CLIN INFECT DIS, V63, pS119, DOI 10.1093/cid/ciw550; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Fabricius G, 2018, EPIDEMIOL INFECT, V146, P858, DOI 10.1017/S0950268818000808; Faucette AN, 2015, HUM VACC IMMUNOTHER, V11, P2549, DOI 10.1080/21645515.2015.1070984; Gentile A, 2018, VACCINE, V36, P1375, DOI [10.1016/j.vaccine.2018.01.091, 10.1016/j.vaccine.2018.01.0]; Guimaraes LM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1222-3; Hamborsky J., 2017, EPIDEMIOLOGY PREVENT; Hewlett EL, 2014, J INFECT DIS, V209, P982, DOI 10.1093/infdis/jit639; Hovingh ES, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0039-8; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2013, CENS POP; Ministerio da Saude-Brasil [Brazilian Ministry of Health], 2018, IM COV BRAZ; Ministerio da Saude-Brasil [Brazilian Ministry of Health], 2018, SIST INF IM SI PNI D; Ministerio da Saude-Brasil [Brazilian Ministry of Health], 2018, EP MORB; Ministerio da Saude-Brasil [Brazilian Ministry of Health]. Sistema de Informac (SINAN), 2018, SIST INF COQ; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nunes MC, 2016, CLIN INFECT DIS, V63, pS174, DOI 10.1093/cid/ciw527; Prata N, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1490-6; Scotta MC, 2018, VACCINE, V36, P280, DOI 10.1016/j.vaccine.2017.11.057; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Torres RSLA, 2015, J PEDIAT-BRAZIL, V91, P333, DOI [10.1016/j.jped.2014.09.004, 10.1016/j.jpedp.2015.04.006]; van Hoek AJ, 2013, EUROSURVEILLANCE, V18, P15; Winter K, 2017, CLIN INFECT DIS, V64, P9, DOI 10.1093/cid/ciw633; Winter K, 2017, CLIN INFECT DIS, V64, P3, DOI 10.1093/cid/ciw634; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010	29	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228022	10.1371/journal.pone.0228022	http://dx.doi.org/10.1371/journal.pone.0228022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990945	Green Published, gold			2022-12-26	WOS:000534605400037
J	Guerra-Correa, ES; Merino-Viteri, A; Andrango, MB; Torres-Carvajal, O				Guerra-Correa, Estefany S.; Merino-Viteri, Andres; Belen Andrango, Maria; Torres-Carvajal, Omar			Thermal biology of two tropical lizards from the Ecuadorian Andes and their vulnerability to climate change	PLOS ONE			English	Article							OPERATIVE TEMPERATURES; STENOCERCUS SQUAMATA; LIOLAEMUS; DIVERSITY; ECTOTHERMS; PHYSIOLOGY; TOLERANCE; EVOLUTION; ECOLOGY; HEAT	This study aims to analyze the thermal biology and climatic vulnerability of two closely related lizard species (Stenocercus festae and S. guentheri) inhabiting the Ecuadorian Andes at high altitudes. Four physiological parameters-body temperature (T-b), preferred temperature (T-pref), critical thermal maximum (CTmax), and critical thermal minimum (CTmin)-were evaluated to analyze the variation of thermophysiological traits among these populations that inhabit different environmental and altitudinal conditions. We also evaluate the availability of operative temperatures, warming tolerance, and thermal safety margin of each population to estimate their possible risks in the face of future raising temperatures. Similar to previous studies, our results suggest that some physiological traits (CTmax and T-b) are influenced by environmental heterogeneity, which brings changes on the thermoregulatory behavior. Other parameters (T-pref and CTmin), may be also influenced by phylogenetic constraints. Moreover, the fluctuating air temperature (T-air) as well as the operative temperatures (T-e) showed that these lizards exploit a variety of thermal microenvironments, which may facilitate behavioral thermoregulation. Warming tolerance and thermal safety margin analyses suggest that both species find thermal refugia and remain active without reducing their performance or undergoing thermal stress within their habitats. We suggest that studies on the thermal biology of tropical Andean lizards living at high altitudes are extremely important as these environments exhibit a unique diversity of microclimates, which consequently result on particular thermophysiological adaptations.	[Guerra-Correa, Estefany S.; Merino-Viteri, Andres; Belen Andrango, Maria; Torres-Carvajal, Omar] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Museo Zool, Quito, Pichincha, Ecuador; [Merino-Viteri, Andres] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Lab Ecofisiol, Quito, Pichincha, Ecuador	Pontificia Universidad Catolica del Ecuador; Pontificia Universidad Catolica del Ecuador	Guerra-Correa, ES (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Museo Zool, Quito, Pichincha, Ecuador.	estefy92guerra@gmail.com	Merino-Viteri, Andrés/AHB-0977-2022	Merino-Viteri, Andrés/0000-0003-1039-2645; Guerra-Correa, Estefany S./0000-0002-0011-6631	Pontificia Universidad Catolica del Ecuador [K13060]	Pontificia Universidad Catolica del Ecuador	This research was funded by Pontificia Universidad Catolica del Ecuador (Grant number: K13060). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Andrango MB, 2016, J THERM BIOL, V62, P30, DOI 10.1016/j.jtherbio.2016.09.012; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Stellatelli OA, 2018, J THERM BIOL, V73, P61, DOI 10.1016/j.jtherbio.2018.02.009; Ansaloni R, 2003, REV U AZUAY, V31-32, P166; BAKKEN GS, 1992, AM ZOOL, V32, P194; Brusch GA, 2016, OECOLOGIA, V180, P325, DOI 10.1007/s00442-015-3467-3; Buckley LB, 2013, INTEGR COMP BIOL, V53, P571, DOI 10.1093/icb/ict026; Camacho A, 2017, J THERM BIOL, V68, P63, DOI 10.1016/j.jtherbio.2017.03.010; Camacho A, 2015, J THERM BIOL, V49-50, P106, DOI 10.1016/j.jtherbio.2015.02.007; Carvajal-Campos A., 2009, THESIS; Cisneros-Heredia DF, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2017-2.RLTS.T178306A54446402.en, DOI 10.2305/IUCN.UK.2017-2.RLTS.T178306A54446402.EN]; Cisneros-Heredia DF, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2017-2.RLTS.T44579900A44579911.en, DOI 10.2305/IUCN.UK.2017-2.RLTS.T44579900A44579911.EN]; Corbalan V, 2013, J THERM BIOL, V38, P384, DOI 10.1016/j.jtherbio.2013.05.006; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Cabre MF, 2016, ATMOSFERA, V29, P35, DOI 10.20937/ATM.2016.29.01.04; Ales RG, 2017, J THERM BIOL, V68, P73, DOI 10.1016/j.jtherbio.2017.02.001; Grigg Joseph W., 2013, Biology Letters, V9, P1; Gunderson AR, 2015, AM NAT, V185, P653, DOI 10.1086/680849; Gutierrez JA, 2010, J THERM BIOL, V35, P332, DOI 10.1016/j.jtherbio.2010.07.001; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUEY RB, 1979, AM ZOOL, V19, P357; Ibarguengoytia NR, 2010, J THERM BIOL, V35, P21, DOI 10.1016/j.jtherbio.2009.10.003; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kubisch E., 2013, THESIS; La Torre-Cuadros MDLA, 2007, BIODIVERS CONSERV, V16, P2965, DOI 10.1007/s10531-007-9155-9; Labra A, 2009, AM NAT, V174, P204, DOI 10.1086/600088; Kubisch EL, 2016, J COMP PHYSIOL B, V186, P243, DOI 10.1007/s00360-015-0952-2; Lind AJ., 2008, AMPHIBIANS REPTILES; Maes D, 2010, J INSECT CONSERV, V14, P485, DOI 10.1007/s10841-010-9277-3; Maia-Carneiro T, 2013, BEHAV PROCESS, V100, P48, DOI 10.1016/j.beproc.2013.08.001; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Mazorra L, 2008, AMI EAR DATABASE; Medina M, 2012, J THERM BIOL, V37, P579, DOI 10.1016/j.jtherbio.2012.06.006; Merkel E, CLIMATE DATA CITIES; Azocar DLM, 2013, OECOLOGIA, V171, P773, DOI 10.1007/s00442-012-2447-0; Munoz MM, 2016, EVOLUTION, V70, P2537, DOI 10.1111/evo.13064; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; PEARSON OP, 1954, COPEIA, P111, DOI 10.2307/1440329; Pincheira-Donoso D., 2012, SELECCION EVOLUCION; Rodriguez-Serrano E, 2009, J THERM BIOL, V34, P306, DOI 10.1016/j.jtherbio.2009.04.002; Sears MW, 2005, OECOLOGIA, V143, P25, DOI 10.1007/s00442-004-1767-0; Simmons JE, 1987, HERPETOLOGICAL CIRCU; Sinervo B, 2011, SCIENCE, V332, DOI 10.1126/science.1195348; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Tiessen H, 2011, CLIMATE CHANGE BIODI; Torres-Carvajal O, 2007, ZOOL SCR, V36, P311, DOI 10.1111/j.1463-6409.2006.00284.x; Torres-Carvajal O, 2013, J HERPETOL, V47, P184, DOI 10.1670/11-211; Torres-Carvajal O, 2007, HERPETOL MONOGR, V21, P76, DOI 10.1655/06-001.1; Uetz P., 2021, REPTILE DATABASE; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Vazquez ML, 2007, THESIS	57	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228043	10.1371/journal.pone.0228043	http://dx.doi.org/10.1371/journal.pone.0228043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978205	Green Published, gold			2022-12-26	WOS:000534599100100
J	Haseda, Y; Munakata, L; Meng, J; Suzuki, R; Aoshi, T				Haseda, Yasunari; Munakata, Lisa; Meng, Jie; Suzuki, Ryo; Aoshi, Taiki			Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice	PLOS ONE			English	Article							ANTIGEN-SPECIFIC CD8(+); I INTERFERON; VACCINE; ADJUVANTS; COMBINATION; LIPOSOMES; IMMUNITY; CAF09	For the induction of antigen-specific T-cell responses by vaccination, an appropriate immune adjuvant is required. Vaccine adjuvants generally provide two functions, namely, immune potentiator and delivery, and many adjuvants that can efficiently induce T-cell responses are known to have the combination of these two functions. In this study, we explored a cationic lipid DOTAP-based adjuvant. We found that the microfluidic preparation of DOTAP nanoparticles induced stronger CD4(+) and CD8(+) T-cell responses than liposomal DOTAP. The further addition of Type-A CpG D35 in DOTAP nanoparticles increased the induction of T-cell responses, particularly in CD4(+) T cells. Further investigations revealed that the size of DOTAP nanoparticles, prepared buffer conditions, and physicochemical interaction with vaccine antigen are important factors for the efficient induction of T-cell responses with a relatively small antigen dose. These results suggested that microfluidic-prepared DOTAP nanoparticles plus D35 are a promising adjuvant for a vaccine that induces therapeutic T-cell responses for treating cancer and infectious diseases.	[Haseda, Yasunari; Meng, Jie; Aoshi, Taiki] Osaka Univ, Res Inst Microbial Dis, BIKEN Innovat Vaccine Res Alliance Labs, Vaccine Dynam Project, Suita, Osaka, Japan; [Munakata, Lisa; Suzuki, Ryo] Teikyo Univ, Fac Pharma Sci, Lab Drug & Gene Delivery Res, Itabashi Ku, Tokyo, Japan; [Aoshi, Taiki] Osaka Univ, Res Fdn Microbial Dis, BIKEN Ctr Innovat Vaccine Res & Dev, Vaccine Dynam Project, Suita, Osaka, Japan	Osaka University; Teikyo University; Osaka University	Aoshi, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, BIKEN Innovat Vaccine Res Alliance Labs, Vaccine Dynam Project, Suita, Osaka, Japan.; Aoshi, T (corresponding author), Osaka Univ, Res Fdn Microbial Dis, BIKEN Ctr Innovat Vaccine Res & Dev, Vaccine Dynam Project, Suita, Osaka, Japan.	aoshi@biken.osaka-u.ac.jp		Suzuki, Ryo/0000-0001-6614-4486	KAKENHI [16K01436]; Research Foundation for Microbial Diseases of Osaka University	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Foundation for Microbial Diseases of Osaka University	This research was supported by KAKENHI (16K01436) and Research Foundation for Microbial Diseases of Osaka University. The Research Foundation for Microbial Diseases of Osaka University had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Akkaya M, 2017, EUR J IMMUNOL, V47, P1890, DOI 10.1002/eji.201747113; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Belliveau NM, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.28; Brito LA, 2013, SEMIN IMMUNOL, V25, P130, DOI 10.1016/j.smim.2013.05.007; Chen WS, 2008, CANCER IMMUNOL IMMUN, V57, P517, DOI 10.1007/s00262-007-0390-4; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dupuis M, 1999, VACCINE, V18, P434, DOI 10.1016/S0264-410X(99)00263-7; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Foged C, 2012, EUR J PHARM SCI, V45, P482, DOI 10.1016/j.ejps.2011.08.016; Gandhapudi SK, 2019, J IMMUNOL, V202, P3524, DOI 10.4049/jimmunol.1801634; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V145, P102, DOI 10.1016/j.jconrel.2010.03.027; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hu Z, 2018, NAT REV IMMUNOL, V18, P168, DOI 10.1038/nri.2017.131; Kastner E, 2014, INT J PHARMACEUT, V477, P361, DOI 10.1016/j.ijpharm.2014.10.030; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Korsholm KS, 2014, VACCINE, V32, P3927, DOI 10.1016/j.vaccine.2014.05.050; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Ma JP, 2017, LAB CHIP, V17, P209, DOI 10.1039/c6lc01049k; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mount A, 2013, EXPERT REV VACCINES, V12, P733, DOI 10.1586/14760584.2013.811185; Mutwiri G, 2011, EXPERT REV VACCINES, V10, P95, DOI [10.1586/erv.10.154, 10.1586/ERV.10.154]; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Ott PA, 2019, CANCER DISCOV, V9, P476, DOI 10.1158/2159-8290.CD-18-1357; Panagioti E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00276; Pedersen GK, 2018, SEMIN IMMUNOL, V39, P4, DOI 10.1016/j.smim.2018.10.003; Puangpetch A, 2012, CLIN VACCINE IMMUNOL, V19, P675, DOI 10.1128/CVI.05545-11; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Saade F, 2013, VACCINE, V31, P1999, DOI 10.1016/j.vaccine.2012.12.077; Sahin U, 2018, SCIENCE, V359, P1355, DOI 10.1126/science.aar7112; Schmidt ST, 2016, J CONTROL RELEASE, V239, P107, DOI 10.1016/j.jconrel.2016.08.034; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; Vasievich EA, 2011, CANCER IMMUNOL IMMUN, V60, P629, DOI 10.1007/s00262-011-0970-1; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Walsh C, 2014, METHODS MOL BIOL, V1141, P109, DOI 10.1007/978-1-4939-0363-4_6; Yan WL, 2007, MOL IMMUNOL, V44, P3672, DOI 10.1016/j.molimm.2007.04.009; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Zhao CX, 2011, CHEM ENG SCI, V66, P1463, DOI 10.1016/j.ces.2010.08.039; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	42	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227891	10.1371/journal.pone.0227891	http://dx.doi.org/10.1371/journal.pone.0227891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978077	Green Published, gold			2022-12-26	WOS:000534599100074
J	Hsia, RY; Mannix, RC; Guo, J; Kornblith, AE; Lin, F; Sokolove, PE; Manley, GT				Hsia, Renee Y.; Mannix, Rebekah C.; Guo, Joanna; Kornblith, Aaron E.; Lin, Feng; Sokolove, Peter E.; Manley, Geoffrey T.			Revisits, readmissions, and outcomes for pediatric traumatic brain injury in California, 2005-2014	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; LONG-TERM; MILD; ADOLESCENTS; SERVICES; CHILDREN; VISITS; COSTS; CARE	Long-term outcomes related to emergency department revisit, hospital readmission, and all-cause mortality, have not been well characterized across the spectrum of pediatric traumatic brain injury (TBI). We evaluated emergency department visit outcomes up to 1 year after pediatric TBI, in comparison to a referent group of trauma patients without TBI. We performed a longitudinal, retrospective study of all pediatric trauma patients who presented to emergency departments and hospitals in California from 2005 to 2014. We compared emergency department visits, dispositions, revisits, readmissions, and mortality in pediatric trauma patients with a TBI diagnosis to those without TBI (Other Trauma patients). We identified 208,222 pediatric patients with an index diagnosis of TBI and 1,314,064 patients with an index diagnosis of Other Trauma. Population growth adjusted TBI visits increased by 5.6% while those for Other Trauma decreased by 40.7%. The majority of patients were discharged from the emergency department on their first visit (93.2% for traumatic brain injury vs. 96.5% for Other Trauma). A greater proportion of TBI patients revisited the emergency department (33.4% vs. 3.0%) or were readmitted to the hospital (0.9% vs. 0.04%) at least once within a year of discharge. The health burden within a year after a pediatric TBI visit is considerable and is greater than that of non-TBI trauma. These data suggest that outpatient strategies to monitor for short-term and longer-term sequelae after pediatric TBI are needed to improve patient outcomes, lessen the burden on families, and more appropriately allocate resources in the healthcare system.	[Hsia, Renee Y.; Guo, Joanna; Kornblith, Aaron E.; Sokolove, Peter E.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Mannix, Rebekah C.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah C.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Lin, Feng] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hsia, RY (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.; Hsia, RY (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	renee.hsia@ucsf.edu		Kornblith, Aaron/0000-0002-1344-575X; Mannix, Rebekah/0000-0003-3608-2792	NIH [1U01 NS086090-01]; One Mind	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); One Mind	This study was supported in part by NIH 1U01 NS086090-01 (GTM), One Mind (GTM), and a gift from the Fisher Family. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsors. There was no internal funding and no additional external funding received for this study.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Alpern ER, 2014, ACAD EMERG MED, V21, P365, DOI 10.1111/acem.12347; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Cho CS, 2012, PEDIATR EMERG CARE, V28, P606, DOI 10.1097/PEC.0b013e31825cf7cf; Duseja R, 2015, ANN INTERN MED, V162, P750, DOI 10.7326/M14-1616; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Geiger AA, 2011, J SURG RES, V170, P133, DOI 10.1016/j.jss.2011.03.026; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Huebner ARS, 2018, PM&R, V10, P462, DOI 10.1016/j.pmrj.2017.10.004; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Lumba-Brown A, 2018, JAMA PEDIAT; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McCrea M, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2846; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Center for Injury Prevention and Control, 2014, WISQARS COST INJ REP; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227981	10.1371/journal.pone.0227981	http://dx.doi.org/10.1371/journal.pone.0227981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978188	gold, Green Published			2022-12-26	WOS:000534599100090
J	Inzaghi, E; Kistner, A; Germani, D; Deodati, A; Vanpee, M; Legnevall, L; Berinder, K; Cianfarani, S				Inzaghi, Elena; Kistner, Anna; Germani, Daniela; Deodati, Annalisa; Vanpee, Mireille; Legnevall, Lena; Berinder, Katarina; Cianfarani, Stefano			A prospective case-control study on miRNA circulating levels in subjects born small for gestational age (SGA) evaluated from childhood into young adulthood	PLOS ONE			English	Article							INSULIN SENSITIVITY INDEXES; FATTY LIVER-DISEASE; GLUCOSE-TOLERANCE; METABOLIC SYNDROME; BODY-COMPOSITION; OBESE CHILDREN; MICRORNAS; GROWTH; WEIGHT; BIRTH	Objective microRNAs (miRNAs) associated with metabolic risk have never been extensively investigated in SGA subjects. The aim of the current study was to evaluate miRNAs in SGA and AGA subjects and their relationships with the metabolic status and growth. Design and methods A prospective longitudinal case-control study was performed in 23 SGA with postnatal catch-up growth and 27 AGA subjects evaluated at the age of 9 and 21 years. Circulating levels of miR-122-5p, miR-16-5p, miR-126-3p, and miR-486-5p were assessed by qPCR. Results SGA subjects were shorter both at 9 and at 21 years. No significant differences in insulin like growth factors and metabolic profile were found with the exception of basal glycemia at 9 years. miRNA levels did not differ between SGA and AGA subjects, at 9 and 21 years. miR16-5p and miR-126-3p levels were higher at 9 than at 21 years. In SGA subjects, miR-122-5p at 9 years was inversely related to adiponectin levels at 21 years and miR-486-5p at 9 years was inversely related to whole-body insulin sensitivity at 9 years and directly related to Hb1Ac at 21 years. Regression analyses showed no predictive value of miRNAs for growth parameters in neither SGA nor AGA subjects. Conclusions SGA with postnatal catch-up growth did not show any difference in metabolic risk markers or miRNA circulating levels compared to AGA controls in childhood and young adulthood. miR-122-5p during childhood could identify SGA subjects at higher risk of developing insulin resistance and, eventually, type 2 diabetes in adulthood but further studies are needed to confirm it.	[Inzaghi, Elena; Deodati, Annalisa; Cianfarani, Stefano] Tor Vergata Univ, Dipartimento Pediat Univ Osped, Bambino Gesu Childrens Hosp, Rome, Italy; [Kistner, Anna; Berinder, Katarina] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Kistner, Anna] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Imaging & Physiol, Stockholm, Sweden; [Germani, Daniela] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy; [Vanpee, Mireille; Legnevall, Lena; Cianfarani, Stefano] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Vanpee, Mireille; Legnevall, Lena; Cianfarani, Stefano] Univ Hosp, Stockholm, Sweden; [Berinder, Katarina] Karolinska Univ Hosp, Patient Area Endocrinol & Nephrol, Stockholm, Sweden	IRCCS Bambino Gesu; University of Rome Tor Vergata; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Rome Tor Vergata; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Inzaghi, E (corresponding author), Tor Vergata Univ, Dipartimento Pediat Univ Osped, Bambino Gesu Childrens Hosp, Rome, Italy.	elena.inzaghi@opbg.net	Kistner, Anna/AFL-7807-2022; Kistner, Anna/AAG-7740-2022; cianfarani, stefano/K-2079-2016	Kistner, Anna/0000-0002-7942-3211; Kistner, Anna/0000-0002-7942-3211; cianfarani, stefano/0000-0002-2580-8781; Vanpee, Mireille/0000-0003-0988-3818; Inzaghi, Elena/0000-0002-8315-5168	Swedish Society of Medicine; Berth von Kantzows foundation; Magnus Bergvalls foundation; Sigurd and Elsa Goljes memory foundation; Samariten foundation for paediatric reserch; Mjolkdroppen Foundation; Barnavard Society; Children Research Foundation at Astrid Lindgren Children's Hospital; Freemason Scholarship; Mayflower Annual Campaign for Children's Health; Ospedale Pediatrico Bambino Gesu	Swedish Society of Medicine; Berth von Kantzows foundation; Magnus Bergvalls foundation; Sigurd and Elsa Goljes memory foundation; Samariten foundation for paediatric reserch; Mjolkdroppen Foundation; Barnavard Society; Children Research Foundation at Astrid Lindgren Children's Hospital; Freemason Scholarship; Mayflower Annual Campaign for Children's Health; Ospedale Pediatrico Bambino Gesu	This work was supported by the Swedish Society of Medicine (AK), The Berth von Kantzows foundation (AK), The Magnus Bergvalls foundation (AK), The Sigurd and Elsa Goljes memory foundation (AK), The Samariten foundation for paediatric reserch (AK and MV),The Mjolkdroppen Foundation (MV), the Barnavard Society (MV), Children Research Foundation at Astrid Lindgren Children's Hospital (MV), a Freemason Scholarship (MV) and the Mayflower Annual Campaign for Children's Health (MV) and Clinical Research Funds (MV), Ospedale Pediatrico Bambino Gesu, Ricerca Corrente 2016 (AD, DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Bork-Jensen J, 2015, DIABETOLOGIA, V58, P363, DOI 10.1007/s00125-014-3434-2; Brandt S, 2018, PEDIATR OBES, V13, P175, DOI 10.1111/ijpo.12261; Cai M, 2017, J PREGNANCY, V2017, DOI 10.1155/2017/6972732; Carreras-Badosa G, 2017, J CLIN ENDOCR METAB, V102, P2584, DOI 10.1210/jc.2017-00089; Castano C, 2018, P NATL ACAD SCI USA, V115, P12158, DOI 10.1073/pnas.1808855115; Cianfarani S, 1999, ARCH DIS CHILD-FETAL, V81, pF71, DOI 10.1136/fn.81.1.F71; Cianfarani S, 2014, J PEDIATR-US, V165, P92, DOI 10.1016/j.jpeds.2014.01.052; Cianfarani Stefano, 2012, Front Endocrinol (Lausanne), V3, P118, DOI 10.3389/fendo.2012.00118; Clayton PE, 2007, J CLIN ENDOCR METAB, V92, P804, DOI 10.1210/jc.2006-2017; Cui XW, 2018, METABOLISM, V78, P95, DOI 10.1016/j.metabol.2017.09.006; Finken MJJ, 2018, ENDOCR REV, V39, P851, DOI 10.1210/er.2018-00083; Fischer-Posovszky P, 2016, HORM RES PAEDIAT, V86, P3, DOI 10.1159/000444677; Flowers E, 2015, METABOLISM, V64, P1051, DOI 10.1016/j.metabol.2015.05.013; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hromadnikova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138383; Huan TX, 2018, AGING CELL, V17, DOI 10.1111/acel.12687; Inzaghi E, 2017, HORM RES PAEDIAT, V87, P400, DOI 10.1159/000477241; Kistner A, 2012, ACTA PAEDIATR, V101, P1217, DOI 10.1111/apa.12005; Kitsiou-Tzeli S, 2017, CURR OPIN ENDOCRINOL, V24, P43, DOI 10.1097/MED.0000000000000305; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Mansego ML, 2017, PEDIATR OBES, V12, P19, DOI 10.1111/ijpo.12101; Marzano F, 2018, PEDIATR OBES, V13, P803, DOI 10.1111/ijpo.12439; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meas T, 2008, J CLIN ENDOCR METAB, V93, P3804, DOI 10.1210/jc.2008-0488; Mericq V, 2017, NAT REV ENDOCRINOL, V13, P50, DOI 10.1038/nrendo.2016.127; Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429; Parrizas M, 2016, BEST PRACT RES CL EN, V30, P591, DOI 10.1016/j.beem.2016.08.001; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Ramadhani MK, 2006, ATHEROSCLEROSIS, V184, P21, DOI 10.1016/j.atherosclerosis.2005.03.022; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Seyhan AA, 2015, MOL BIOSYST, V11, P1217, DOI 10.1039/c5mb00064e; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sookoian S, 2013, PEDIATR RES, V73, P531, DOI 10.1038/pr.2013.2; van der Steen M, 2016, ENDOCRIN METAB CLIN, V45, P283, DOI 10.1016/j.ecl.2016.01.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang R, 2015, EUR J ENDOCRINOL, V172, P291, DOI 10.1530/EJE-14-0867; Wang XY, 2017, AFR HEALTH SCI, V17, P474, DOI 10.4314/ahs.v17i2.22; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503	50	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228075	10.1371/journal.pone.0228075	http://dx.doi.org/10.1371/journal.pone.0228075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978117	Green Published, gold			2022-12-26	WOS:000534599100107
J	Ogawa-Akiyama, A; Sugiyama, H; Kitagawa, M; Tanaka, K; Kano, Y; Mise, K; Otaka, N; Tanabe, K; Morinaga, H; Kinomura, M; Uchida, HA; Wada, J				Ogawa-Akiyama, Ayu; Sugiyama, Hitoshi; Kitagawa, Masashi; Tanaka, Keiko; Kano, Yuzuki; Mise, Koki; Otaka, Nozomu; Tanabe, Katsuyuki; Morinaga, Hiroshi; Kinomura, Masaru; Uchida, Haruhito A.; Wada, Jun			Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome	PLOS ONE			English	Article							RENAL BIOPSY REGISTRY; PRORENIN RECEPTOR; PROXIMAL TUBULE; PROTECTIVE ROLE; KIDNEY-DISEASE; CELL BIOLOGY; INJURY; APOPTOSIS; PATHWAY; RITUXIMAB	Autophagy is a cellular mechanism involved in the bulk degradation of proteins and turnover of organelle. Several studies have shown the significance of autophagy of the renal tubular epithelium in rodent models of tubulointerstitial disorder. However, the role of autophagy in the regulation of human glomerular diseases is largely unknown. The current study aimed to demonstrate morphological evidence of autophagy and its association with the ultrastructural changes of podocytes and clinical data in patients with idiopathic nephrotic syndrome, a disease in which patients exhibit podocyte injury. The study population included 95 patients, including patients with glomerular disease (minimal change nephrotic syndrome [MCNS], n = 41; idiopathic membranous nephropathy [IMN], n = 37) and 17 control subjects who underwent percutaneous renal biopsy. The number of autophagic vacuoles and the grade of foot process effacement (FPE) in podocytes were examined by electron microscopy (EM). The relationships among the expression of autophagic vacuoles, the grade of FPE, and the clinical data were determined. Autophagic vacuoles were mainly detected in podocytes by EM. The microtubule-associated protein 1 light chain 3 (LC3)-positive area was co-localized with the Wilms tumor 1 (WT1)-positive area on immunofluorescence microscopy, which suggested that autophagy occurred in the podocytes of patients with MCNS. The number of autophagic vacuoles in the podocytes was significantly correlated with the podocyte FPE score (r = -0.443, p = 0.004), the amount of proteinuria (r = 0.334, p = 0.033), and the level of serum albumin (r = -0.317, p = 0.043) in patients with MCNS. The FPE score was a significant determinant for autophagy after adjusting for the age in a multiple regression analysis in MCNS patients (p = 0.0456). However, such correlations were not observed in patients with IMN or in control subjects. In conclusion, the results indicated that the autophagy of podocytes is associated with FPE and severe proteinuria in patients with MCNS. The mechanisms underlying the activation of autophagy in association with FPE in podocytes should be further investigated in order to elucidate the pathophysiology of MCNS.	[Ogawa-Akiyama, Ayu; Kitagawa, Masashi; Tanaka, Keiko; Kano, Yuzuki; Mise, Koki; Tanabe, Katsuyuki; Kinomura, Masaru; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Sugiyama, Hitoshi; Otaka, Nozomu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan; [Tanaka, Keiko] Tokai Univ, Sch Med, Dept Mol Life Sci, Hiratsuka, Kanagawa, Japan; [Morinaga, Hiroshi] Okayama Univ Hosp, Div Med Informat, Okayama, Japan; [Uchida, Haruhito A.] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama, Japan	Okayama University; Okayama University; Tokai University; Okayama University; Okayama University	Sugiyama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan.	hitoshis@okayama-u.ac.jp	WADA, Jun/B-2023-2011; Tanabe, Katsuyuki/J-1341-2019; Sugiyama, Hitoshi/B-2252-2011	WADA, Jun/0000-0003-1468-5170; Tanabe, Katsuyuki/0000-0003-4767-5892; Sugiyama, Hitoshi/0000-0002-4127-6471; Mise, Koki/0000-0003-0296-7429; Otaka, Nozomu/0000-0001-9705-0570	JSPS KAKENHI [24591200, 19K08679]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number (24591200 and 19K08679 to HS), https://www.jsps.go.jp/j-grantsinaid/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Beck LH, 2017, J AM SOC NEPHROL, V28, P2580, DOI 10.1681/ASN.2017020178; Bootman MD, 2018, CELL CALCIUM, V70, P32, DOI 10.1016/j.ceca.2017.08.005; Chen JC, 2013, J AM SOC NEPHROL, V24, P198, DOI 10.1681/ASN.2012010101; Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Condello M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030725; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Fang L, 2014, EXP CELL RES, V322, P290, DOI 10.1016/j.yexcr.2014.01.001; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Giannico G, 2009, CLIN J AM SOC NEPHRO, V4, P1747, DOI 10.2215/CJN.01510209; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grahammer F, 2014, P NATL ACAD SCI USA, V111, pE2817, DOI 10.1073/pnas.1402352111; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hayashi K, 2014, J CLIN INVEST, V124, P2523, DOI 10.1172/JCI69557; Hayek SS, 2017, NAT MED, V23, P945, DOI 10.1038/nm.4362; Hogan J, 2013, J AM SOC NEPHROL, V24, P702, DOI 10.1681/ASN.2012070734; Iijima K, 2014, LANCET, V384, P1273, DOI 10.1016/S0140-6736(14)60541-9; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Inoue T, 2010, CLIN IMMUNOL, V136, P447, DOI 10.1016/j.clim.2010.05.009; Isaka Y, 2011, AUTOPHAGY, V7, P1085, DOI 10.4161/auto.7.9.16465; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Kimura T, 2013, AUTOPHAGY, V9, P1876, DOI 10.4161/auto.25418; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kobayashi M, 2005, KIDNEY INT, V68, P1018, DOI 10.1111/j.1523-1755.2005.00494.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Li L, 2014, J AM SOC NEPHROL, V25, P305, DOI 10.1681/ASN.2013040374; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Liu WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07889-z; Liu WJ, 2014, AUTOPHAGY, V10, P243, DOI 10.4161/auto.27004; Maejima Y, 2016, J MOL CELL CARDIOL, V95, P19, DOI 10.1016/j.yjmcc.2015.10.032; Maruyama M, 2007, CLIN NEPHROL, V68, P73; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Sato S, 2009, PATHOBIOLOGY, V76, P221, DOI 10.1159/000228897; Sato S., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P167; Sato Shigeru, 2006, Journal of Nippon Medical School, V73, P52, DOI 10.1272/jnms.73.52; Sugiyama H, 1996, J AM SOC NEPHROL, V7, P2357; Sugiyama H, 1996, KIDNEY INT, V49, P103, DOI 10.1038/ki.1996.14; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Takei T, 2013, NEPHROL DIAL TRANSPL, V28, P1225, DOI 10.1093/ndt/gfs515; Takiue K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-14; Vivarelli M, 2017, CLIN J AM SOC NEPHRO, V12, P332, DOI 10.2215/CJN.05000516; Wang LL, 2018, CELL IMMUNOL, V328, P1, DOI 10.1016/j.cellimm.2018.02.013; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Yamamoto-Nonaka K, 2016, J AM SOC NEPHROL, V27, P2685, DOI 10.1681/ASN.2015040366; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8; Yu Q, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1803-9; Zapata-Benavides P, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9531074; Zeng CH, 2014, J PATHOL, V234, P203, DOI 10.1002/path.4382	68	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228337	10.1371/journal.pone.0228337	http://dx.doi.org/10.1371/journal.pone.0228337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978139	Green Published, gold			2022-12-26	WOS:000534599100142
J	Rheubert, JL; Meyer, MF; Strobel, RM; Pasternak, MA; Charvat, RA				Rheubert, Justin L.; Meyer, Michael F.; Strobel, Raeshelle M.; Pasternak, Megan A.; Charvat, Robert A.			Predicting antibacterial activity from snake venom proteomes	PLOS ONE			English	Article							AMINO-ACID OXIDASE; ANTIMICROBIAL ACTIVITY; VIPER VENOM; SAMPLE-SIZE; NAJA-ATRA; PURIFICATION; RATTLESNAKE; ANTIVENOM; EVOLUTION; PROTEINS	The continued evolution of antibiotic resistance has increased the urgency for new antibiotic development, leading to exploration of non-traditional sources. In particular, snake venom has garnered attention for its potent antibacterial properties. Numerous studies describing snake venom proteomic composition as well as antibiotic efficacy have created an opportunity to synthesize relationships between venom proteomes and their antibacterial properties. Using literature reported values from peer-reviewed studies, our study generated models to predict efficacy given venom protein family composition, snake taxonomic family, bacterial Gram stain, bacterial morphology, and bacterial respiration strategy. We then applied our predictive models to untested snake species with known venom proteomic compositions. Overall, our results provide potential protein families that serve as accurate predictors of efficacy as well as promising organisms in terms of antibacterial properties of venom. The results from this study suggest potential future research trajectories for antibacterial properties in snake venom by offering hypotheses for a variety of taxa.	[Rheubert, Justin L.; Strobel, Raeshelle M.; Pasternak, Megan A.; Charvat, Robert A.] Univ Findlay, Dept Biol, Findlay, OH 45840 USA; [Meyer, Michael F.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	University of Findlay; Washington State University	Rheubert, JL (corresponding author), Univ Findlay, Dept Biol, Findlay, OH 45840 USA.	rheubert@findlay.edu		Meyer, Michael/0000-0002-8034-9434	National Science Foundation Graduate Research Fellowship [NSFDGE-1347973]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by the National Science Foundation Graduate Research Fellowship, NSFDGE-1347973 (https://www.nsf.gov/) to MFM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi-Koubaa Z, 2016, INT J BIOL MACROMOL, V82, P757, DOI 10.1016/j.ijbiomac.2015.09.065; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Antao EM, 2018, BUNDESGESUNDHEITSBLA, V61, P499, DOI 10.1007/s00103-018-2726-y; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Boda FA, 2019, REV ROMANA MED LAB, V27, P305, DOI 10.2478/rrlm-2019-0015; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calvete JJ, 2012, J PROTEOME RES, V11, P1382, DOI 10.1021/pr201021d; Calvete JJ, 2010, J PROTEOME RES, V9, P528, DOI 10.1021/pr9008749; Calvete JJ, 2009, J PROTEOME RES, V8, P3055, DOI 10.1021/pr900249q; Campos PF, 2016, GENOME BIOL EVOL, V8, P2266, DOI 10.1093/gbe/evw149; Charvat RA, 2018, TOXICON, V150, P151, DOI 10.1016/j.toxicon.2018.05.016; Chen LW, 2011, TOXICON, V58, P46, DOI 10.1016/j.toxicon.2011.04.021; Ching ATC, 2012, J PROTEOME RES, V11, P1152, DOI 10.1021/pr200876c; de Lima DC, 2005, EVID-BASED COMPL ALT, V2, P39, DOI 10.1093/ecam/neh063; Del-Rei THM, 2019, TOXICON, V164, P61, DOI 10.1016/j.toxicon.2019.04.001; Fernandez J, 2015, TOXICON, V107, P217, DOI 10.1016/j.toxicon.2015.08.016; Ferreira BL, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen052; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; JANSEN DW, 1983, COPEIA, P262, DOI 10.2307/1444728; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Johnson RA., 2007, APPL MULTIVARIATE ST; Kalita B, 2017, J PROTEOME RES, V16, P583, DOI 10.1021/acs.jproteome.6b00693; Kao PH, 2012, TOXICON, V60, P367, DOI 10.1016/j.toxicon.2012.04.345; Kardong KV, 2002, J TOXICOL-TOXIN REV, V21, P1; Katz SL, 2015, LIMNOL OCEANOGR, V60, P1950, DOI 10.1002/lno.10143; Konshina AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019064; Korkmaz M., 2012, J FACULTY AGR HARRAN, V16, P25; Lee SC, 2014, J BIOL CHEM, V289, P20170, DOI 10.1074/jbc.M114.557157; Lomonte B, 2014, J PROTEOMICS, V105, P323, DOI 10.1016/j.jprot.2014.02.020; Mackessy SP, 2016, INTEGR COMP BIOL, V56, P1004, DOI 10.1093/icb/icw110; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Medina E, 2016, CURR TOP MICROBIOL, V398, P3, DOI 10.1007/82_2016_492; Meyer MF, 2018, PREDICTING ANTIBACTE; Modahl CM, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00279; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Ozverel CS, 2019, COMP BIOCHEM PHYS C, V220, P20, DOI 10.1016/j.cbpc.2019.02.013; Pahari S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-115; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Phua CS, 2012, J VENOM ANIM TOXINS, V18, P198, DOI 10.1590/S1678-91992012000200010; Pla D, 2017, BBA-GEN SUBJECTS, V1861, P814, DOI 10.1016/j.bbagen.2017.01.020; Pla D, 2017, J PROTEOMICS, V152, P1, DOI 10.1016/j.jprot.2016.10.006; Prabhakaran A. K., 2014, Asian Journal of Pharmaceutical Analysis, V4, P1; Rangsipanuratn W., 2019, PHARM SCI ASIA, V46, P80, DOI [10.29090/psa.2019.01.018.0003, DOI 10.29090/PSA.2019.01.018.0003]; Rey-Suarez P, 2019, TOXICON, V170, P85, DOI 10.1016/j.toxicon.2019.09.017; Samel M, 2008, COMP BIOCHEM PHYS B, V149, P572, DOI 10.1016/j.cbpb.2007.11.008; Samy RP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-100; Samy RP, 2007, J APPL MICROBIOL, V102, P650, DOI 10.1111/j.1365-2672.2006.03161.x; Samy RP, 2008, J CELL PHYSIOL, V216, P54, DOI 10.1002/jcp.21373; Samy RP, 2015, FEBS OPEN BIO, V5, P928, DOI 10.1016/j.fob.2015.10.004; San T. M., 2010, Journal of Applied Sciences, V10, P2328; Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500; Shan LL, 2016, J PROTEOMICS, V138, P83, DOI 10.1016/j.jprot.2016.02.028; Sokal R.R., 2012, BIOMETRY PRINCIPLES; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Tan CH, 2016, J PROTEOMICS, V132, P1, DOI 10.1016/j.jprot.2015.11.014; Tan CH, 2015, J PROTEOMICS, V126, P121, DOI 10.1016/j.jprot.2015.05.035; Tan CH, 2015, TOXICON, V93, P164, DOI 10.1016/j.toxicon.2014.11.231; Toyama MH, 2006, TOXICON, V47, P47, DOI 10.1016/j.toxicon.2005.09.008; Vonk FJ, 2011, BIOESSAYS, V33, P269, DOI 10.1002/bies.201000117; Winfree AT., 1980, GEOMETRY BIOL TIME; Xie JP, 2003, INT J ANTIMICROB AG, V22, P172, DOI 10.1016/S0924-8579(03)00110-9; Yan Xiao Mei, 2000, Acta Biologiae Experimentalis Sinica, V33, P309	64	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226807	10.1371/journal.pone.0226807	http://dx.doi.org/10.1371/journal.pone.0226807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978103	gold, Green Published			2022-12-26	WOS:000534599100020
J	Shaaban, B; Seeburger, V; Schroeder, A; Lohaus, G				Shaaban, Basel; Seeburger, Victoria; Schroeder, Annette; Lohaus, Gertrud			Sugar, amino acid and inorganic ion profiling of the honeydew from different hemipteran species feeding on Abies alba and Picea abies	PLOS ONE			English	Article							PEA APHID; PHLOEM-SAP; ACYRTHOSIPHON-PISUM; MULTIVARIATE-ANALYSIS; BOTANICAL ORIGIN; DIETARY SUCROSE; HOST-PLANT; INSECT; OSMOREGULATION; MELEZITOSE	Several hemipteran species feed on the phloem sap of plants and produce large amounts of honeydew that is collected by bees to produce honeydew honey. Therefore, it is important to know whether it is predominantly the hemipteran species or the host plant to influence the honeydew composition. This is particularly relevant for those botanical and zoological species from which the majority of honeydew honey originates. To investigate this issue, honeydew from two Cinara species located on Abies alba as well as from two Cinara and two Physokermes species located on Picea abies were collected. Phloem exudates of the host plants were also analyzed. Honeydew of all species contained different proportions of hexoses, sucrose, melezitose, erlose, and further di- and trisaccharides, whereas the phloem exudates of the host trees contained no trisaccharides. Moreover, the proportions of sugars differed significantly between hemipteran species feeding on the same tree species. Sucrose hydrolysis and oligosaccharide formation was shown in whole-body homogenates of aphids. The type of the produced oligosaccharides in the aphid-extracts correlated with the oligosaccharide composition in the honeydew of the different aphid species. The total contents of amino acids and inorganic ions in the honeydew were much lower than the sugar content. Glutamine and glutamate were predominant amino acids in the honeydew of all six hemipteran species and also in the phloem exudates of both tree species. Potassium was the dominant inorganic ion in all honeydew samples and also in the phloem exudate. Statistical analyses reveal that the sugar composition of honeydew is determined more by the hemipteran species than by the host plant. Consequently, it can be assumed that the sugar composition of honeydew honey is also more influenced by the hemipteran species than by the host tree.	[Shaaban, Basel; Lohaus, Gertrud] Univ Wuppertal, Mol Plant Sci Plant Biochem, Wuppertal, Germany; [Seeburger, Victoria; Schroeder, Annette] Univ Hohenheim, Apicultural State Inst, Stuttgart, Germany	University of Wuppertal; University Hohenheim	Lohaus, G (corresponding author), Univ Wuppertal, Mol Plant Sci Plant Biochem, Wuppertal, Germany.	lohaus@uni-wuppertal.de			Federal Ministry of Food and Agriculture (BMEL)	Federal Ministry of Food and Agriculture (BMEL)	The project is supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on the decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support program to G.L. and A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; BACON JSD, 1957, BIOCHEM J, V66, P289, DOI 10.1042/bj0660289; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; DOWNING N, 1980, J EXP BIOL, V87, P343; EHRHARDT P, 1965, EXPERIENTIA, V21, P472, DOI 10.1007/BF02150829; Febvay G, 1999, J EXP BIOL, V202, P2639; Fermo P, 2013, ENVIRON POLLUT, V178, P173, DOI 10.1016/j.envpol.2013.03.029; Findling S, 2015, PLANTA, V241, P229, DOI 10.1007/s00425-014-2183-2; Fink D, 2018, PLANTA, V248, P661, DOI 10.1007/s00425-018-2933-7; Fischer MK, 2002, J INSECT PHYSIOL, V48, P319, DOI 10.1016/S0022-1910(01)00179-2; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; FISHER DB, 1984, J INSECT PHYSIOL, V30, P387, DOI 10.1016/0022-1910(84)90096-9; Gottlinger T, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00205; GOLZ H, 1982, APIDOLOGIE, V13, P89; Haribal M, 2015, J EXP BIOL, V218, P3797, DOI 10.1242/jeb.129189; HENDRIX DL, 1992, COMP BIOCHEM PHYS B, V101, P23, DOI 10.1016/0305-0491(92)90153-I; Herve MR, 2018, J CHEM ECOL, V44, P215, DOI 10.1007/s10886-018-0932-6; Hijaz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101830; Hudson CS, 1920, J AM CHEM SOC, V42, P116, DOI 10.1021/ja01446a016; Imdorf A, 2002, SCHWEIZER ZENTRUM BI, V1, P1; Karley AJ, 2002, J EXP BIOL, V205, P3009; Kunkel H, 1985, WALDTRACHT WALDHONIG, P48; Leroy PD, 2011, ARTHROPOD-PLANT INTE, V5, P193, DOI 10.1007/s11829-011-9128-5; LIEBIG G, 1979, APIDOLOGIE, V10, P213, DOI 10.1051/apido:19790301; Lohaus G, 2000, PLANTA, V211, P833, DOI 10.1007/s004250000349; Lohaus G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087689; MITTLER TE, 1958, J EXP BIOL, V35, P74; Nadwodnik J, 2008, PLANTA, V227, P1079, DOI 10.1007/s00425-007-0682-0; Nottbohm FE, 1929, Z UNTERS LEBENSM, V57, P549; Oner-Sieben S, 2014, J EXP BOT, V65, P1905, DOI 10.1093/jxb/eru066; PROSSER WA, 1992, J INSECT PHYSIOL, V38, P93, DOI 10.1016/0022-1910(92)90037-E; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Ruoff K, 2007, APIDOLOGIE, V38, P438, DOI 10.1051/apido:2007027; Sabri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074656; Sandstrom JP, 2001, PHYSIOL ENTOMOL, V26, P202, DOI 10.1046/j.0307-6962.2001.00235.x; SASAKI T, 1993, ZOOL SCI, V10, P787; Sasaki T., 1995, J INSECT PHYSIOL, V37, P749; Schmelz H, 2002, ADIZ, V1, P23; Tiedge K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176865; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; WALTERS FS, 1988, ARCH INSECT BIOCHEM, V9, P35, DOI 10.1002/arch.940090103; WEIBULL J, 1990, PLANT PHYSIOL, V92, P222, DOI 10.1104/pp.92.1.222; West S. G., 1995, STRUCTURAL EQUATION, P56; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; Wilkinson TL, 2001, J EXP BIOL, V204, P3027; Woodring J, 2004, PHYSIOL ENTOMOL, V29, P311, DOI 10.1111/j.0307-6962.2004.00386.x; WYATT GR, 1961, ANNU REV ENTOMOL, V6, P75, DOI 10.1146/annurev.en.06.010161.000451; ZIEGLER H, 1959, Z NATURFORSCH PT B, V14, P278; Zoebelein G., 1957, Forstwissenschaftliches Zentralblatt, V76, P24, DOI 10.1007/BF01821463	56	19	19	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228171	10.1371/journal.pone.0228171	http://dx.doi.org/10.1371/journal.pone.0228171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978201	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100121
J	Yap, KL; Chong, YW; Liu, WX				Yap, Khong-Lim; Chong, Yung-Wey; Liu, Weixia			Enhanced handover mechanism using mobility prediction in wireless networks	PLOS ONE			English	Article								The rapid increase in the usage of the mobile internet has led to a great expansion of cellular data networks in order to provide better quality of service. However, the cost to expand the cellular network is high. One of the solutions to provide affordable wireless connectivity is the deployment of a WiFi access point to offload users' data usage. Nevertheless, the frequent and inefficient handover process between the WiFi AP and cellular network, especially when the mobile device is on the go, may degrade the network performance. Mobile devices do not have the intelligence to select the optimal network to enhance the quality of service (QoS). This paper presents an enhanced handover mechanism using mobility prediction (eHMP) to assist mobile devices in the handover process so that users can experience seamless connectivity. eHMP is tested in two wireless architectures, homogeneous and heterogeneous networks. The network performance significantly improved when eHMP is used in a homogeneous network, where the network throughput increases by 106% and the rate of retransmission decreases by 85%. When eHMP is used in a heterogeneous network, the network throughput increases by 55% and the retransmission rate decreases by 75%. The findings presented in this paper reveal that mobility prediction coupled with the multipath protocol can improve the QoS for mobile devices. These results will contribute to a better understanding of how the network service provider can offload traffic to the WiFi network without experiencing performance degradation.	[Yap, Khong-Lim; Chong, Yung-Wey] Univ Sains Malaysia, Natl Adv IPv6 Ctr, Usm, Penang, Malaysia; [Liu, Weixia] Minjiang Univ, Internet Innovat Res Ctr, Fuzhou, Peoples R China	Universiti Sains Malaysia; Minjiang University	Chong, YW (corresponding author), Univ Sains Malaysia, Natl Adv IPv6 Ctr, Usm, Penang, Malaysia.	chong@usm.my			Digi Telecommunications Sdn Bhd under grant [304/PNAV/650764/D113]	Digi Telecommunications Sdn Bhd under grant	This research has been supported by Digi Telecommunications Sdn Bhd under grant 304/PNAV/650764/D113 to Y-WC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Cheikh A, 2015, IEEE ICC, P3448, DOI 10.1109/ICC.2015.7248858; Cisco, 2019, CISCO VISUAL NETWORK; Ford A., 2013, INTERNET REQUESTS CO; Ford A, 2011, ARCHITECTURAL GUIDEL; Frommgen A, 2015, MOBICOM '15: PROCEEDINGS OF THE 21ST ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P248, DOI 10.1145/2789168.2795171; Hosny KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215334; Li XB, 2017, 2017 13TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (ICNC-FSKD), P2782; Lv QJ, 2017, IEEE T VEH TECHNOL, V66, P5204, DOI 10.1109/TVT.2016.2611654; Lv QJ, 2014, INT SYMP WIREL, P379, DOI 10.1109/WPMC.2014.7014848; Murad K, 2014, MATH PROBLEMS ENG; Paasch C., 2012, PROC ACM SIGCOMM WOR, P31, DOI [DOI 10.1145/2342468.2342476, 10.1145/2342468.2342476]; Perkins C, 2002, IP MOBILITY SUPPORT; Poosamani N, 2015, P 12 EAI INT C MOB U, P90; Pupatwibul P, 2013, PROCEEDINGS OF THE 2013 38TH ANNUAL IEEE CONFERENCE ON LOCAL COMPUTER NETWORKS WORKSHOPS (LCN WORKSHOPS), P936, DOI 10.1109/LCNW.2013.6758535; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18; Seong-Mun Kim, 2014, 2014 IEEE 11th Consumer Communications and Networking Conference (CCNC), P119, DOI 10.1109/CCNC.2014.6866558; Stynes D, 2016, INT WIREL COMMUN, P120, DOI 10.1109/IWCMC.2016.7577044; Sung NW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174220; Wang Y, 2014, PROCEEDINGS OF THE 2014 20TH INTERNATIONAL CONFERENCE ON AUTOMATION AND COMPUTING (ICAC'14), P3, DOI 10.1109/IConAC.2014.6935451; Yap K.L, 2018, P INT C GREEN HUM IN, P15	21	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227982	10.1371/journal.pone.0227982	http://dx.doi.org/10.1371/journal.pone.0227982			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978101	gold, Green Published			2022-12-26	WOS:000534599100091
J	Carvalho, AV; Hennequet-Antier, C; Crochet, S; Bordeau, T; Courousse, N; Cailleau-Audouin, E; Chartrin, P; Darras, VM; Zerjal, T; Collin, A; Coustham, V				Carvalho, Anais Vitorino; Hennequet-Antier, Christelle; Crochet, Sabine; Bordeau, Thierry; Courousse, Nathalie; Cailleau-Audouin, Estelle; Chartrin, Pascal; Darras, Veerle M.; Zerjal, Tatiana; Collin, Anne; Coustham, Vincent			Embryonic thermal manipulation has short and long-term effects on the development and the physiology of the Japanese quail	PLOS ONE			English	Article							BROILER CHICK EMBRYOGENESIS; HEAT-STRESS; COTURNIX-JAPONICA; BODY-TEMPERATURE; INCUBATION; RESPONSES; MUSCLE; PERFORMANCE; METABOLISM; THERMOREGULATION	In vertebrates, the embryonic environment is known to affect the development and the health of individuals. In broiler chickens, the thermal-manipulation (TM) of eggs during the incubation period was shown to improve heat tolerance at slaughter age (35 days of age) in association with several modifications at the molecular, metabolic and physiological levels. However, little is known about the Japanese quail (Coturnix japonica), a closely related avian species widely used as a laboratory animal model and farmed for its meat and eggs. Here we developed and characterized a TM procedure (39.5 degrees C and 65% relative humidity, 12 h/d, from days 0 to 13 of incubation) in quails by analyzing its short and long-term effects on zootechnical, physiological and metabolic parameters. Heat-tolerance was tested by a heat challenge (36 degrees C for 7h) at 35 days of age. TM significantly reduced the hatching rate of the animals and increased mortality during the first four weeks of life. At hatching, TM animals were heavier than controls, but lighter at 25 days of age for both sexes. Thirty-five days after hatching, TM decreased the surface temperature of the shank in females, suggesting a modulation of the blood flow to maintain the internal temperature. TM also increased blood partial pressure and oxygen saturation percentage at 35 days of age in females, suggesting a long-term modulation of the respiration physiology. Quails physiologically responded to the heat challenge, with a modification of several hematologic and metabolic parameters, including an increase in plasma corticosterone concentration. Several physiological parameters such as beak surface temperature and blood sodium concentration revealed that TM birds responded differently to the heat challenge compared to controls. Altogether, this first comprehensive characterization of TM in Japanese quail showed durable effects that may affect the response of TM quails to heat.	[Carvalho, Anais Vitorino; Hennequet-Antier, Christelle; Crochet, Sabine; Bordeau, Thierry; Courousse, Nathalie; Cailleau-Audouin, Estelle; Chartrin, Pascal; Collin, Anne; Coustham, Vincent] Univ Tours, INRAE, BOA, Nouzilly, France; [Darras, Veerle M.] Katholieke Univ Leuven, Lab Comparat Endocrinol, Dept Biol, Leuven, Belgium; [Zerjal, Tatiana] Univ Paris Saclay, AgroParisTech, INRAE, GABI, Jouy En Josas, France	INRAE; Universite de Tours; KU Leuven; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Coustham, V (corresponding author), Univ Tours, INRAE, BOA, Nouzilly, France.	vincent.coustham@inrae.fr	Coustham, Vincent/C-1836-2014; Coustham, Vincent/GON-4976-2022	Coustham, Vincent/0000-0002-5399-2723; Coustham, Vincent/0000-0002-5399-2723	ANR JCJC "QuailHeatE" Research Program [ANR-15-CE02-0009-01]	ANR JCJC "QuailHeatE" Research Program(French National Research Agency (ANR))	This study was supported by the ANR JCJC "QuailHeatE" Research Program [ANR-15-CE02-0009-01]	Ainsworth SJ, 2010, J ANAT, V216, P3, DOI 10.1111/j.1469-7580.2009.01173.x; Al-Zghoul MB, 2019, POULTRY SCI, V98, P991, DOI 10.3382/ps/pey379; Alagawany M, 2017, WORLD POULTRY SCI J, V73, P747, DOI 10.1017/S0043933917000782; Alkan S, 2013, ARCH TIERZUCHT, V56, P789, DOI 10.7482/0003-9438-56-078; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Archer GS, 2017, APPL ANIM BEHAV SCI, V186, P80, DOI 10.1016/j.applanim.2016.10.014; Baker LB, 2018, J APPL PHYSL; Bartholomew GA, 2012, AUK, V75, P150; Borges SA, 2004, POULTRY SCI, V83, P1551, DOI 10.1093/ps/83.9.1551; Burse RL, 1979, HUM FACTORS J HUM FA; Carvalho AV, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030197; COGBURN LA, 1987, GEN COMP ENDOCR, V68, P113, DOI 10.1016/0016-6480(87)90066-9; Collin A, 2007, POULTRY SCI, V86, P795, DOI 10.1093/ps/86.5.795; Collin A, 2005, ANIM RES, V54, P105, DOI 10.1051/animres:2005004; DACKE CG, 1993, J EXP BIOL, V184, P63; Darras VM, 1996, GEN COMP ENDOCR, V104, P203, DOI 10.1006/gcen.1996.0163; David S, FRONT GENET; DECUYPERE E, 1984, DOMEST ANIM ENDOCRIN, V1, P251, DOI 10.1016/0739-7240(84)90005-5; El-Daly EF, 2013, IRAN J APPL ANIM SCI, V3, P207; El-Gawad A. H. A., 2008, World Journal of Agricultural Sciences, V4, P605; Elahi S, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.4.046009; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hemid A. E. A., 2010, World Journal of Agricultural Sciences, V6, P517; Huang C, 2015, J ANIM SCI, V93, P2144, DOI 10.2527/jas.2014-8739; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Jose CP, 1994, AM STAT ASS 1994 P B, P1; Kawahara-Miki R, 2013, GENOMICS, V101, P345, DOI 10.1016/j.ygeno.2013.03.006; Kayang BB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-101; Khalil H. A, 2012, EGYPTIAN J ANIMAL PR, V47, P151; KOVACS K, 1983, GEN COMP ENDOCR, V50, P483, DOI 10.1016/0016-6480(83)90270-8; Lapenna D, 2001, FREE RADICAL BIO MED, V31, P331, DOI 10.1016/S0891-5849(01)00584-6; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Leroux S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0292-7; Li XX, 2017, J THERM BIOL, V70, P37, DOI 10.1016/j.jtherbio.2017.10.008; Liu HH, 2015, J THERM BIOL, V53, P80, DOI [10.1016/j.jtherbio.2015.08.013, 10.13413/j.cnki.jdxblxb.2015.01.19]; Loyau T, 2016, ANIMAL, V10, P1594, DOI 10.1017/S1751731116000616; Loyau T, 2015, ANIMAL, V9, P76, DOI 10.1017/S1751731114001931; Loyau T, 2014, POULTRY SCI, V93, P2078, DOI 10.3382/ps.2014-03881; Loyau T, 2013, J ANIM SCI, V91, P3674, DOI 10.2527/jas.2013-6445; Loyau T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2661-y; Loyau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105339; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MARDER J, 1983, COMP BIOCHEM PHYS A, V75, P425, DOI 10.1016/0300-9629(83)90105-6; Meillere A, 2015, BEHAV ECOL, V26, P569, DOI 10.1093/beheco/aru232; Minvielle F, 2004, WORLD POULTRY SCI J, V60, P500, DOI 10.1079/WPS200433; Moraes VMB, 2003, J THERM BIOL, V28, P133, DOI 10.1016/S0306-4565(02)00049-9; Nyuiadzi D, 2017, POULTRY SCI, V96, P4261, DOI 10.3382/ps/pex264; Ozbey O., 2004, International Journal of Poultry Science, V3, P485; Ozcelik M, 2004, ARCH TIERZUCHT, V47, P93, DOI 10.5194/aab-47-93-2004; Piepho HP, 2004, J COMPUT GRAPH STAT, V13, P456, DOI 10.1198/1061860043515; Piestun Y, 2008, J THERM BIOL, V33, P413, DOI 10.1016/j.jtherbio.2008.06.007; Piestun Y, 2008, POULTRY SCI, V87, P1516, DOI 10.3382/ps.2008-00030; Piestun Y, 2015, POULTRY SCI, V94, P273, DOI 10.3382/ps/peu047; Piestun Y, 2009, J APPL PHYSIOL, V106, P233, DOI 10.1152/japplphysiol.91090.2008; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Pinho J.P.A., 2013, J CHEM INF MODEL, V53, P1689, DOI [10.1021/ci400128m, DOI 10.1021/CI400128M]; Recoquillay J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1210-9; Sandra O, 2012, REPROD FERT DEVELOP, V24, P68, DOI 10.1071/RD11908; SCOTT TR, 1983, POULTRY SCI, V62, P290, DOI 10.3382/ps.0620290; Sellier N, 2006, J APPL POULTRY RES, V15, P219, DOI 10.1093/japr/15.2.219; Tzschentke B, 2008, COMPUT ELECTRON AGR, V64, P61, DOI 10.1016/j.compag.2008.05.003; Wang GS, 2014, J THERM BIOL, V43, P40, DOI 10.1016/j.jtherbio.2014.05.001; WEATHERS WW, 1976, J APPL PHYSIOL, V40, P521, DOI 10.1152/jappl.1976.40.4.521; Willemsen H, 2010, POULTRY SCI, V89, P2678, DOI 10.3382/ps.2010-00853; WOODARD AE, 1964, NATURE, V203, P422, DOI 10.1038/203422a0; Yahav S, 2004, POULTRY SCI, V83, P1959, DOI 10.1093/ps/83.12.1959; Yahav S, 1996, POULTRY SCI, V75, P402, DOI 10.3382/ps.0750402	68	9	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227700	10.1371/journal.pone.0227700	http://dx.doi.org/10.1371/journal.pone.0227700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971994	Green Published, gold			2022-12-26	WOS:000534374400015
J	Faigenbaum-Golovin, S; Shaus, A; Sober, B; Turkel, E; Piasetzky, E; Finkelstein, I				Faigenbaum-Golovin, Shira; Shaus, Arie; Sober, Barak; Turkel, Eli; Piasetzky, Eli; Finkelstein, Israel			Algorithmic handwriting analysis of the Samaria inscriptions illuminates bureaucratic apparatus in biblical Israel	PLOS ONE			English	Article							WRITER IDENTIFICATION; BINARIZATION; OSTRACA	Past excavations in Samaria, capital of biblical Israel, yielded a corpus of Hebrew ink on clay inscriptions (ostraca) that documents wine and oil shipments to the palace from surrounding localities. Many questions regarding these early 8th century BCE texts, in particular the location of their composition, have been debated. Authorship in countryside villages or estates would attest to widespread literacy in a relatively early phase of ancient Israel's history. Here we report an algorithmic investigation of 31 of the inscriptions. Our study establishes that they were most likely written by two scribes who recorded the shipments in Samaria. We achieved our results through a method comprised of image processing and newly developed statistical learning techniques. These outcomes contrast with our previous results, which indicated widespread literacy in the kingdom of Judah a century and half to two centuries later, ca. 600 BCE.	[Faigenbaum-Golovin, Shira; Shaus, Arie; Turkel, Eli] Tel Aviv Univ, Dept Appl Math, Tel Aviv, Israel; [Shaus, Arie; Finkelstein, Israel] Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, Tel Aviv, Israel; [Shaus, Arie] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Sober, Barak] Duke Univ, Dept Math, Durham, NC 27706 USA; [Piasetzky, Eli] Tel Aviv Univ, Sch Phys & Astron, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Harvard University; Harvard Medical School; Duke University; Tel Aviv University	Faigenbaum-Golovin, S; Shaus, A (corresponding author), Tel Aviv Univ, Dept Appl Math, Tel Aviv, Israel.; Shaus, A (corresponding author), Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, Tel Aviv, Israel.; Shaus, A (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Sober, B (corresponding author), Duke Univ, Dept Math, Durham, NC 27706 USA.	shirafaigen@gmail.com; ashaus@post.tau.ac.il; barakino@math.duke.edu		Sober, Barak/0000-0001-5090-5551; Shaus, Arie/0000-0003-3727-2774	European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement [229418]; Early Israel grant (New Horizons project), Tel Aviv University; ISF grant [2062/18]; Math+X grant from the Simons Foundation [400837]; Duke University	European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement; Early Israel grant (New Horizons project), Tel Aviv University; ISF grant; Math+X grant from the Simons Foundation; Duke University	The research reported here received initial funding from European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 229418, and by an Early Israel grant (New Horizons project), Tel Aviv University, as well as by ISF grant 2062/18. This study was supported by a generous donation from Mr. Jacques Chahine, made through the French Friends of Tel Aviv University. B. Sober is supported through Math+X grant 400837 from the Simons Foundation, as well as Duke University.	Aharoni Y., 1979, LAND BIBLE HIST GEOG, V2nd; Aharoni Y, 1981, ARAD INSCRIPTIONS; ahituv S, 2008, ECHOES HEBREW COGNAT; Bar-Yosef I, 2007, INT J DOC ANAL RECOG, V9, P89, DOI 10.1007/s10032-007-0041-5; Beit-Arieh I, 2007, TEL AVIV U MONOGRAPH, V25; Bulacu M, 2007, IEEE T PATTERN ANAL, V29, P701, DOI 10.1109/TPAMI.2007.1009; Dahllof M, 2018, DIGITAL MEDIEVALIST, V11, P1; Dhali MA, 2017, ICPRAM: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION APPLICATIONS AND METHODS, P693, DOI 10.5220/0006249706930702; Faigenbaum S, 2015, TEL MALHATA CENTRAL, P510; Faigenbaum S., 2014, AGYPTEN LEVANTE, V24, P349, DOI [DOI 10.1553/S349, 10.1553/s349]; Faigenbaum S, 2012, J ARCHAEOL SCI, V39, P3581, DOI 10.1016/j.jas.2012.06.013; Faigenbaum-Golovin S, 2015, SEMITICA, V57, P113, DOI DOI 10.2143/SE.57.0.3115458; Faigenbaum-Golovin S, P 19 ACM S DOC ENG D, V23, P1; Faigenbaum-Golovin S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178400; Faigenbaum-Golovin S, 2016, P NATL ACAD SCI USA, V113, P4664, DOI 10.1073/pnas.1522200113; Fecker D, 2014, INT C PATT RECOG, P3050, DOI 10.1109/ICPR.2014.526; Finkelstein I., 2013, FORGOTTEN KINGDOM AR; Finkelstein I, 2013, HEBR BIBLE ANC ISR, V2, P149, DOI 10.1628/219222713X13757034787838; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Goren Y, 2004, TEL AVIV U MONOGRAPH, V28; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kaufman I.T., 1992, ANCHOR BIBLE DICT, V5, P921; Lemaire A, 1977, LIT ANCIENNES PROCHE, V9; Lemaire A, 1973, OSTRACA HEBREUX EPOQ; Liphschitz N., 2015, MONOGRAPH SERIES I A, P709; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Markus D, P 10 INT C DOC AN RE, P221; Mazar A, 2006, BETH SHEAN VALLEY AR, V1; Mendel A, 2014, THESIS; Mendel-Geberovich A., 2017, B AM SCH ORIENTAL RE, V378, P113, DOI DOI 10.5615/bullamerschoorie.378.0113; Mendel-Geberovich A, 2019, VETUS TESTAMENTUM, V69, P682, DOI 10.1163/15685330-00001370; Meshel Z., 2012, KUNTILLET AJRUD HORV; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Naveh Joseph, 1960, IEJ, V10, P129; Niemann H.M., 2008, TEL AVIV, V35, P249; Panagopoulos M, 2009, IEEE T PATTERN ANAL, V31, P1404, DOI 10.1109/TPAMI.2008.201; RAINEY AF, 1988, B AM SCH ORIENTAL RE, P69, DOI 10.2307/1356786; Reisner G.A., 1924, HARVARD EXCAVATIONS; Rendsburg G, 1990, AM ORIENTAL SERIES, V72; Rollston CA, 1999, THESIS; Sass Benjamin, 2016, SEMITICA CLASSICA, V9, P19; Sexton A, P 3 INT C COMP VIS P, P212; Shaus A, 2019, ARCHAEOMETRY, V61, P459, DOI 10.1111/arcm.12419; Shaus A, P 10 IAPR INT WORKSH, P170, DOI [10.1109/DAS.2012.70, DOI 10.1109/DAS.2012.70]; Shaus A, 2017, P IM QUAL SYST PERF, P52, DOI [10.2352/ISSN.2470-1173.2017.12.IQSP-226, DOI 10.2352/ISSN.2470-1173.2017.12.IQSP-226]; Shaus A, P 16 INT GRAPH SOC C, P163; Shaus A, 2017, J IMAGING SCI TECHN, V61, DOI 10.2352/J.ImagingSci.Technol.2017.61.1.010404; Shaus A, 2012, INT CONF FRONT HAND, P645, DOI 10.1109/ICFHR.2012.187; Sober B, 2017, COMPUT AIDED DESIGN, V89, P12, DOI 10.1016/j.cad.2017.04.005; Sober B, 2014, PALEST EXPLOR Q, V146, P185, DOI 10.1179/0031032814Z.000000000101; Tahmasbi A, 2011, COMPUT BIOL MED, V41, P726, DOI 10.1016/j.compbiomed.2011.06.009; Tappy Ron E., 2016, ASOR, V70; Torczyner H, 1938, LACHISH I LACHISH LE; Trier OD, 1996, PATTERN RECOGN, V29, P641, DOI 10.1016/0031-3203(95)00118-2; Yadin Y, 1959, IEJ, V9, P184	55	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0227452	10.1371/journal.pone.0227452	http://dx.doi.org/10.1371/journal.pone.0227452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968002	Green Submitted, gold, Green Published			2022-12-26	WOS:000534373000017
J	Oliveira, HR; Jacocks, L; Czajkowska, BI; Kennedy, SL; Brown, TA				Oliveira, Hugo R.; Jacocks, Lauren; Czajkowska, Beata, I; Kennedy, Sandra L.; Brown, Terence A.			Multiregional origins of the domesticated tetraploid wheats	PLOS ONE			English	Article							WILD EMMER WHEAT; EVOLUTION; CULTIVATION; COMPLEX; AGRICULTURE; HYPOTHESIS; DIVERSITY; GEOGRAPHY; SOFTWARE; GENOMES	We used genotyping-by-sequencing (GBS) to investigate the evolutionary history of domesticated tetraploid wheats. With a panel of 189 wild and domesticated wheats, we identified 1,172,469 single nucleotide polymorphisms (SNPs) with a read depth >= 3. Principal component analyses (PCAs) separated the Triticum turgidum and Triticum timopheevii accessions, as well as wild T. turgidum from the domesticated emmers and the naked wheats, showing that SNP typing by GBS is capable of providing robust information on the genetic relationships between wheat species and subspecies. The PCAs and a neighbour-joining analysis suggested that domesticated tetraploid wheats have closest affinity with wild emmers from the northern Fertile Crescent, consistent with the results of previous genetic studies on the origins of domesticated wheat. However, a more detailed examination of admixture and allele sharing between domesticates and different wild populations, along with genome-wide association studies (GWAS), showed that the domesticated tetraploid wheats have also received a substantial genetic input from wild emmers from the southern Levant. Taking account of archaeological evidence that tetraploid wheats were first cultivated in the southern Levant, we suggest that a pre-domesticated crop spread from this region to southeast Turkey and became mixed with a wild emmer population from the northern Fertile Crescent. Fixation of the domestication traits in this mixed population would account for the allele sharing and GWAS results that we report. We also propose that feralization of the component of the pre-domesticated population that did not acquire domestication traits has resulted in the modern wild population from southeast Turkey displaying features of both the domesticates and wild emmer from the southern Levant, and hence appearing to be the sole progenitor of domesticated tetraploids when the phylogenetic relationships are studied by methods that assume a treelike pattern of evolution.	[Oliveira, Hugo R.; Jacocks, Lauren; Czajkowska, Beata, I; Kennedy, Sandra L.; Brown, Terence A.] Univ Manchester, Sch Earth & Environm Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Oliveira, Hugo R.] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal	University of Manchester; Universidade do Algarve	Brown, TA (corresponding author), Univ Manchester, Sch Earth & Environm Sci, Manchester Inst Biotechnol, Manchester, Lancs, England.	terry.brown@manchester.ac.uk		Jacocks, Lauren/0000-0003-2654-4009; Czajkowska, Dr Beata I./0000-0002-8596-9288; Oliveira, Hugo/0000-0002-5038-073X	European Research Council [339941]; Natural Environment Research Council [NE/M010805/1]; NERC [NE/M010805/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by: TAB, 339941, European Research Council, https://erc.europa.eu/, No involvement; TAB, NE/M010805/1, Natural Environment Research Council, https://nerc.ukri.org/, No involvement.	Allaby RC, 1999, GENOME, V42, P296, DOI 10.1139/gen-42-2-296; Allaby RG, 2003, GENOME, V46, P448, DOI [10.1139/g03-025, 10.1139/G03-025]; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Allaby RG, 2010, VEG HIST ARCHAEOBOT, V19, P151, DOI 10.1007/s00334-009-0232-8; [Anonymous], 2019, GPLOTS STAT PACKAGE; [Anonymous], 2018, J OPEN SOURCE SOFTW, DOI DOI 10.21105/JOSS.00731; Antolin F, 2015, J ARCHAEOL SCI, V61, P90, DOI 10.1016/j.jas.2015.05.007; Arranz-Otaegui A, 2016, P NATL ACAD SCI USA, V113, P14001, DOI 10.1073/pnas.1612797113; Arranz-Otaegui A, 2016, VEG HIST ARCHAEOBOT, V25, P629, DOI 10.1007/s00334-016-0564-0; Badaeva ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128556; Blumler MA., 1998, ORIGINS AGR CROP DOM, P252; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown TA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01287; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; BUSHUK W, 1978, CAN J PLANT SCI, V58, P1019, DOI 10.4141/cjps78-155; Civan P, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1180-7; Civan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081955; Clayton WD, 2009, GRASSBASE ONLINE WOR; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Czajkowska BI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215175; El Baidouri M, 2017, NEW PHYTOL, V213, P1477, DOI 10.1111/nph.14113; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; ESRI, 2011, ARCGIS DESKT REL 10; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gornicki P, 2014, NEW PHYTOL, V204, P704, DOI 10.1111/nph.12931; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Kari Bhagyalakshmi, 2008, Journal of Crop Science and Biotechnology, V11, P257; Khoshbakht K, 2009, J AGR RURAL DEV TROP, P189; Kim C, 2016, PLANT SCI, V242, P14, DOI 10.1016/j.plantsci.2015.04.016; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; MAAN SS, 1973, EUPHYTICA, V22, P287, DOI 10.1007/BF00022637; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Mori N., 2003, 10 INT WHEAT GEN S, P25; Mori N, 2009, BREEDING SCI, V59, P571, DOI 10.1270/jsbbs.59.571; Nave M, 2019, PLANT SCI, V285, P193, DOI 10.1016/j.plantsci.2019.05.012; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nevo E, 2014, J SYST EVOL, V52, P673, DOI 10.1111/jse.12124; Oladzad A, 2019, G3-GENES GENOM GENET, V9, P1881, DOI 10.1534/g3.119.400072; Oliveira HR, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-54; Ozkan H, 2005, THEOR APPL GENET, V110, P1052, DOI 10.1007/s00122-005-1925-8; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Pankin A, 2018, NEW PHYTOL, V218, P1247, DOI 10.1111/nph.15077; Poets AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0712-3; POYARKOVA H, 1988, EUPHYTICA, V38, P11, DOI 10.1007/BF00024806; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Sahri A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0264-2; Scheben A, 2017, PLANT BIOTECHNOL J, V15, P149, DOI 10.1111/pbi.12645; TAJIMA F, 1989, GENETICS, V123, P585; Weide A., 2015, ARCHAOLOGISCHE INFOR, V38, P381; Weide A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189811; Xue S, 2016, GENETICS, V204, P99, DOI 10.1534/genetics.116.191106; Zhang XG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01611; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	65	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0227148	10.1371/journal.pone.0227148	http://dx.doi.org/10.1371/journal.pone.0227148			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968001	Green Published, gold			2022-12-26	WOS:000534373000012
J	Bonzanni, M; Rouleau, N; Levin, M; Kaplan, DL				Bonzanni, Mattia; Rouleau, Nicolas; Levin, Michael; Kaplan, David L.			Optogenetically induced cellular habituation in non-neuronal cells	PLOS ONE			English	Article								Habituation, defined as the reversible decrement of a response during repetitive stimulation, is widely established as a form of non-associative learning. Though more commonly ascribed to neural cells and systems, habituation has also been observed in single aneural cells, although evidence is limited. Considering the generalizability of the habituation process, we tested the degree to which organism-level behavioral and single cell manifestations were similar. Human embryonic kidney (HEK) cells that overexpressed an optogenetic actuator were photostimulated to test the effect of different stimulation protocols on cell responses. Depolarization induced by the photocurrent decreased successively over the stimulation protocol and the effect was reversible upon withdrawal of the stimulus. In addition to frequency- and intensity-dependent effects, the history of stimulations on the cells impacted subsequent depolarization in response to further stimulation. We identified tetraethylammonium (TEA)-sensitive native K+ channels as one of the mediators of this habituation phenotype. Finally, we used a theoretical model of habituation to elucidate some mechanistic aspects of the habituation response. In conclusion, we affirm that habituation is a time- and state-dependent biological strategy that can be adopted also by individual nonneuronal cells in response to repetitive stimuli.	[Bonzanni, Mattia; Rouleau, Nicolas; Kaplan, David L.] Tufts Univ, Allen Discovery Ctr, Dept Biomed Engn, Medford, MA 02155 USA; [Levin, Michael] Tufts Univ, Allen Discovery Ctr, Dept Biol, Medford, MA 02155 USA	Tufts University; Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Allen Discovery Ctr, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084; BONZANNI, MATTIA/0000-0001-8506-4326	Paul G. Allen Frontiers Group [12171]; Templeton World Charity Foundation [TWCF0089/AB55]; National Institutes of Health [P41EB002520]	Paul G. Allen Frontiers Group; Templeton World Charity Foundation(Templeton World Charity Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by 1) ML and DK, No. 12171, Paul G. Allen Frontiers Group, https://alleninstitute. org/what-we-do/frontiers-group/. 2) M.L, No. TWCF0089/AB55, Templeton World Charity Foundation, https://www.templetonworldcharity.org/.3) D.K., P41EB002520, National Institutes of Health, https://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluska F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00902; Boisseau RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0446; Bonzanni M, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900028; EISENSTEIN EM, 1982, NEUROSCI BIOBEHAV R, V6, P183, DOI 10.1016/0149-7634(82)90054-9; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Katz Y, 2013, J NEUROSCI METH, V214, P113, DOI 10.1016/j.jneumeth.2013.01.017; Lyon Pamela, 2006, Cogn Process, V7, P11, DOI 10.1007/s10339-005-0016-8; MEINS F, 1979, DIFFERENTIATION, V15, P1, DOI 10.1111/j.1432-0436.1979.tb01029.x; Pischke MS, 2006, PLANT PHYSIOL, V140, P1255, DOI 10.1104/pp.105.076059; Ponce A, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13663; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681	14	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227230	10.1371/journal.pone.0227230	http://dx.doi.org/10.1371/journal.pone.0227230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951626	Green Published, gold			2022-12-26	WOS:000534370500013
J	Howard, IS; Franklin, S; Franklin, DW				Howard, Ian S.; Franklin, Sae; Franklin, David W.			Asymmetry in kinematic generalization between visual and passive lead-in movements are consistent with a forward model in the sensorimotor system	PLOS ONE			English	Article							CONTEXTUAL CUES; INTERNAL-MODEL; UNSTABLE DYNAMICS; IMPEDANCE CONTROL; MOTOR MEMORIES; ADAPTATION; CONSOLIDATION; EXPLICIT; IMPLICIT	In our daily life we often make complex actions comprised of linked movements, such as reaching for a cup of coffee and bringing it to our mouth to drink. Recent work has highlighted the role of such linked movements in the formation of independent motor memories, affecting the learning rate and ability to learn opposing force fields. In these studies, distinct prior movements (lead-in movements) allow adaptation of opposing dynamics on the following movement. Purely visual or purely passive lead-in movements exhibit different angular generalization functions of this motor memory as the lead-in movements are modified, suggesting different neural representations. However, we currently have no understanding of how different movement kinematics (distance, speed or duration) affect this recall process and the formation of independent motor memories. Here we investigate such kinematic generalization for both passive and visual lead-in movements to probe their individual characteristics. After participants adapted to opposing force fields using training lead-in movements, the lead-in kinematics were modified on random trials to test generalization. For both visual and passive modalities, recalled compensation was sensitive to lead-in duration and peak speed, falling off away from the training condition. However, little reduction in force was found with increasing lead-in distance. Interestingly, asymmetric transfer between lead-in movement modalities was also observed, with partial transfer from passive to visual, but very little vice versa. Overall these tuning effects were stronger for passive compared to visual lead-ins demonstrating the difference in these sensory inputs in regulating motor memories. Our results suggest these effects are a consequence of state estimation, with differences across modalities reflecting their different levels of sensory uncertainty arising as a consequence of dissimilar feedback delays.	[Howard, Ian S.] Univ Plymouth, Ctr Robot & Neural Syst, Sch Comp Elect & Math, Plymouth, Devon, England; [Franklin, Sae] Tech Univ Munich, Inst Cognit Syst, Dept Elect & Comp Engn, Munich, Germany; [Franklin, David W.] Tech Univ Munich, Dept Sport & Hlth Sci, Neuromuscular Diagnost, Munich, Germany	University of Plymouth; Technical University of Munich; Technical University of Munich	Howard, IS (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Sch Comp Elect & Math, Plymouth, Devon, England.	ian.howard@plymouth.ac.uk		Howard, Ian/0000-0002-6041-9669	Centre for Robotics and Neural Systems at the University of Plymouth; Bavarian State Ministry for Science, Research the Arts	Centre for Robotics and Neural Systems at the University of Plymouth; Bavarian State Ministry for Science, Research the Arts	Financial support for ISH was provided by the Centre for Robotics and Neural Systems at the University of Plymouth and by the Bavarian State Ministry for Science, Research & the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou T, 2011, J NEUROPHYSIOL, V106, P163, DOI 10.1152/jn.00869.2010; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Crevecoeur F, 2016, J NEUROSCI, V36, P8598, DOI 10.1523/JNEUROSCI.0184-16.2016; Donchin O, 2003, J NEUROSCI, V23, P9032; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05697-z; Howard IS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28416; Howard IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131268; Howard IS, 2015, CURR BIOL, V25, P397, DOI 10.1016/j.cub.2014.12.037; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Howard IS, 2012, J NEUROSCI, V32, P12756, DOI 10.1523/JNEUROSCI.5909-11.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Howard IS, 2018, CHARACTERIZATION NEU, P1030; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Hwang EJ, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S09; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Nozaki D, 2016, ELIFE, V5, DOI 10.7554/eLife.15378; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pandarinath C, 2015, ELIFE, V4, DOI 10.7554/eLife.07436; Reinkensmeyer DJ, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0148-3; Sarwary AME, 2015, J NEUROPHYSIOL, V114, P1565, DOI 10.1152/jn.00217.2015; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Schween R., 2019, EXPLICIT STRATEGIES, P694430, DOI [10.1101/694430, DOI 10.1101/694430]; Sheahan HR, 2016, NEURON, V92, P773, DOI 10.1016/j.neuron.2016.10.017; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Smith O. J., 1959, ISA J, V6, P28; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wainscott SK, 2005, J NEUROPHYSIOL, V93, P786, DOI 10.1152/jn.00240.2004; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yeo SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129388; Yokoi A, 2011, J NEUROSCI, V31, P17058, DOI 10.1523/JNEUROSCI.2982-11.2011	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228083	10.1371/journal.pone.0228083	http://dx.doi.org/10.1371/journal.pone.0228083			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995588	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400042
J	Kubo, Y; Sugiyama, S; Takachu, R; Tanaka, M; Ikeya, M; Sugiura, T; Kobori, K; Kobori, M				Kubo, Yusuke; Sugiyama, Shuhei; Takachu, Rie; Tanaka, Maki; Ikeya, Masae; Sugiura, Takeshi; Kobori, Kaori; Kobori, Makoto			Association between serum n-3 polyunsaturated fatty acids and quadriceps weakness immediately after total knee arthroplasty	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SIT-TO-STAND; MUSCLE STRENGTH; RELIABILITY; ATROPHY; PAIN	Objectives Quadriceps weakness (QW) following total knee arthroplasty (TKA) can be elicited by tourniquet-induced ischaemia reperfusion (IR), which causes a vigorous acute inflammatory response. Dietary n-3 polyunsaturated fatty acids (PUFA) are important determinants of organ and tissue protection from IR. This study aimed to examine the association between serum n-3 PUFA levels and QW, knee pain, and knee swelling immediately after TKA. Methods A total of 32 patients who underwent unilateral TKA participated in this prospective study. On Postoperative Day 1, serum n-3 PUFA (eicosapentaenoic acid and docosahexaenoic acid) levels were measured. Preoperatively and on Postoperative Day 4, quadriceps strength, knee pain during quadriceps testing, and knee circumference were measured. QW, knee pain, and knee swelling were defined as changes in quadriceps strength, knee pain during quadriceps testing, and knee circumference, respectively, between the preoperative to the postoperative measurement. Results Mean serum n-3 PUFA levels were 192 mu g/mL (standard deviation, 58 mu g/mL) on Postoperative Day 1. All measured variables changed significantly between the preoperative and the postoperative measurement time-points (P < 0.01). Quadriceps strength decreased from 1.2 to 0.4 Nm/kg (QW =-65%). Knee pain during quadriceps testing increased from 1.1 to 6.0 (knee pain = 4.0). Knee circumference increased from 40 to 44 cm (knee swelling = 10%). Multivariate analysis showed that lower serum n-3 PUFA levels were independently associated with an increased QW after adjusting for the Kellgren-Lawrence grade and the tourniquet time (P = 0.04). No significant relationship was observed between serum n-3 PUFA levels and knee pain or knee swelling. Conclusion Higher serum n-3 PUFA are independently associated with a lower increase in the QW immediately after TKA.	[Kubo, Yusuke; Sugiyama, Shuhei; Takachu, Rie; Sugiura, Takeshi; Kobori, Kaori; Kobori, Makoto] Hamamatsu City, Dept Rehabil, Kita Ku, Hamamatsu, Shizuoka, Japan; [Tanaka, Maki] Seirei Christopher Univ, Dept Rehabil Sci, Kita Ku, Hamamatsu, Shizuoka, Japan; [Ikeya, Masae] Tokoha Univ, Dept Hlth & Nutr Sci, Kita Ku, Hamamatsu, Shizuoka, Japan		Kubo, Y (corresponding author), Hamamatsu City, Dept Rehabil, Kita Ku, Hamamatsu, Shizuoka, Japan.	yusuke.kubo11@gmail.com			Seirei Christopher University	Seirei Christopher University	This work was supported by Seirei Christopher University Grants-in-Aid of Research. Yusuke Kubo and Maki Tanaka received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnahdi AH, 2016, KNEE SURG SPORT TR A, V24, P2587, DOI 10.1007/s00167-015-3827-x; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Brahmbhatt V, 2013, J NUTR BIOCHEM, V24, P104, DOI 10.1016/j.jnutbio.2012.02.014; Bu JY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6906712; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Castillo RL, 2014, CELL BIOCHEM FUNCT, V32, P274, DOI 10.1002/cbf.3012; de Souza MDC, 2015, LIPIDS, V50, P23, DOI 10.1007/s11745-014-3961-0; Dreyer HC, 2016, EXERC SPORT SCI REV, V44, P61, DOI 10.1249/JES.0000000000000076; Farias JG, 2017, EXP BIOL MED, V242, P1104, DOI 10.1177/1535370216649263; Gobbetti T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075581; Guler O, 2016, KNEE SURG SPORT TR A, V24, P2595, DOI 10.1007/s00167-015-3872-5; Holm B, 2010, ARCH PHYS MED REHAB, V91, P1770, DOI 10.1016/j.apmr.2010.07.229; Jakobsen TL, 2010, PHYSIOTHER RES INT, V15, P126, DOI 10.1002/pri.450; Jawhar A, 2016, KNEE SURG SPORT TR A, V24, P3313, DOI 10.1007/s00167-015-3859-2; Jing HR, 2014, J SURG RES, V187, P252, DOI 10.1016/j.jss.2013.10.009; Kittelson AJ, 2013, EUR J PHYS REHAB MED, V49, P909; Mizner RL, 2005, J ORTHOP RES, V23, P1083, DOI 10.1016/j.orthres.2005.01.021; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; Moreland JD, 2004, J AM GERIATR SOC, V52, P1121, DOI 10.1111/j.1532-5415.2004.52310.x; Muyskens JB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12671; Noble PC, 2005, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000150130.03519.fb; Prasad N, 2007, INT ORTHOP, V31, P39, DOI 10.1007/s00264-006-0096-9; Pua YH, 2017, SEMIN ARTHRITIS RHEU, V46, P544, DOI 10.1016/j.semarthrit.2016.10.012; Pua YH, 2015, J ARTHROPLASTY, V30, P1215, DOI 10.1016/j.arth.2015.02.010; Ross JL, 2016, J NEUROSCI, V36, P6857, DOI 10.1523/JNEUROSCI.4582-15.2016; Ross JL, 2014, J PAIN, V15, P1257, DOI 10.1016/j.jpain.2014.09.003; Roth ML, 2007, PAIN RES MANAG, V12, P185, DOI 10.1155/2007/394960; Scarborough DM, 1999, GAIT POSTURE, V10, P10; Shih YM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4929346; Silva M, 2003, J ARTHROPLASTY, V18, P605, DOI 10.1016/S0883-5403(03)00191-8; Suzuki T, 2015, J PHYS THER SCI, V27, P967, DOI 10.1589/jpts.27.967; Wang B, 2016, WORLD J GASTROENTERO, V22, P9784, DOI 10.3748/wjg.v22.i44.9784; Wang K, 2017, KNEE SURG SPORT TR A, V25, P2849, DOI 10.1007/s00167-015-3964-2; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Zeghichi-Hamri S, 2010, NUTR RES, V30, P849, DOI 10.1016/j.nutres.2010.10.010; Zendedel A, 2015, J NEUROIMMUNOL, V278, P200, DOI 10.1016/j.jneuroim.2014.11.007; Zhang R, 2015, NUTRITION, V31, P508, DOI 10.1016/j.nut.2014.10.015; Zuniga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028502	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228460	10.1371/journal.pone.0228460	http://dx.doi.org/10.1371/journal.pone.0228460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995616	Green Published, gold			2022-12-26	WOS:000534609400070
J	Sampaio, VD; Rodrigues, MGD; da Silva, LCF; de Castro, DB; Balieiro, PCD; Cabrinha, AA; Costa, AJL				Sampaio, Vanderson de Souza; de Almeida Rodrigues, Maria Gabriela; Ferreira da Silva, Leila Cristina; de Castro, Daniel Barros; da Silva Balieiro, Patricia Carvalho; Cabrinha, Ana Alzira; Leal Costa, Antonio Jose			Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach	PLOS ONE			English	Article							DETERMINANTS; EVOLUTION	Objectives Estimate TB mortality rates, catalogue multiple causes on death certificates in which TB was reported and identify predictors of TB from reporting on death certificates in the State of Amazonas, Brazil, based on a multiple cause of death approach. Methods The death records of residents in the Amazonas state between 2006-2014 were analyzed and separated into three categories: TB not reported on the death certificate (TBNoR), TB reported as the underlying cause of death (TBUC) and TB reported as an associated cause of death (TBAC). Age standardized annual mortality rates for TBUC, TBAC and with TB reported (TBUC plus TBAC) were estimated for the State of Amazonas using the direct standardization method and World Health Organization 2000-2025 standard population. Mortality odds ratios (OR) for reporting of TBUC and TBAC were estimated using multinomial logistic regression. Results Age standardized annual TBUC and TBAC mortality rates ranged between 5.9-7.8/105 and 2.7-4.0/105, respectively. TBUC was associated with being a resident in the State capital (OR = 0.66), of female gender (OR = 0.87), having an education level of 8 to 11, or 12 or more school years (OR = 0.67 and 0.50 respectively), non-white race/skin color (OR = 1.38) and place of death reported as in the State capital (OR = 1.69). TBAC was related to the triennium in which death occurred (OR = 1.21 and 1.22 for the years 2009-2011 and 2012-2014 respectively), age (OR = 36.1 and 16.5 for ages 15-39 and 40-64 years respectively) and when death occurred in the State capital (OR = 5.8). Conclusions TBUC was predominantly associated with predictors of unfavorable socioeconomic conditions and health care access constraints, whereas TBAC was mainly related to ages which were typical of high HIV disease incidence.	[Sampaio, Vanderson de Souza; de Castro, Daniel Barros] Fundacao Vigilancia Sande Amazonas, Sala Anal Situacao Saude, Manaus, Amazonas, Brazil; [Sampaio, Vanderson de Souza; de Almeida Rodrigues, Maria Gabriela] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil; [Sampaio, Vanderson de Souza; Ferreira da Silva, Leila Cristina] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Ferreira da Silva, Leila Cristina] Fundacao Vigilancia Saude Amazonas, Nucleo Ensino & Pesquisa, Manaus, Amazonas, Brazil; [da Silva Balieiro, Patricia Carvalho; Cabrinha, Ana Alzira] Fundacao Vigilancia Saude Amazonas, Nucleo Sistemas Informacoes, Manaus, Amazonas, Brazil; [Leal Costa, Antonio Jose] Univ Fed Rio de Janeiro, Inst Estudos Saude Colet, Area Epidemiol & Bioestat, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Amazonas; Universidade Federal do Rio de Janeiro	Costa, AJL (corresponding author), Univ Fed Rio de Janeiro, Inst Estudos Saude Colet, Area Epidemiol & Bioestat, Rio De Janeiro, RJ, Brazil.	ajcosta@iesc.ufrj.br	Sampaio, Vanderson/M-4337-2015	Sampaio, Vanderson/0000-0001-7307-8851; Costa, Antonio/0000-0002-0402-4865; Balieiro, Patricia/0000-0002-5221-6319	Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes de Saude - PECTI/AM/SAUDE, Carta Convite of Fundacao de Amparo a Pesquisa do Estado do Amazonas FAPEAM [001/2014]	Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes de Saude - PECTI/AM/SAUDE, Carta Convite of Fundacao de Amparo a Pesquisa do Estado do Amazonas FAPEAM	This work was supported by grant Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes de Saude - PECTI/AM/SAUDE, Carta Convite 001/2014 of Fundacao de Amparo a Pesquisa do Estado do Amazonas FAPEAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; [Anonymous], 2019, BRASIL LIVRE TUBERCU; Balieiro PC da S, 2017, CIEN SAUDE COLET; de Lima EEC, 2014, CAD SAUDE PUBLICA, V30, P1721, DOI 10.1590/0102-311X00131113; da Magno S, 2017, FATORES ASS COINFECC, P33; de Castro DB, 2018, INT J TUBERC LUNG D, V22, P171, DOI 10.5588/ijtld.17.0369; de Castro DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158574; Duarte R, 2018, PULMONOLOGY, V24, P115, DOI 10.1016/j.rppnen.2017.11.003; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Floe A, 2018, THORAX, V73, P70, DOI 10.1136/thoraxjnl-2016-209240; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2016, ATL NAC DIG BRAS; Kleinbaum D., 2013, APPL REGRESSION ANAL; Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28; Moriyama IMM, 2010, HIST STAT CLASSIFICA; Pacheco AG, 2014, INT J TUBERC LUNG D, V18, P1473, DOI 10.5588/ijtld.14.0181; Pinheiro C, 1998, REV SAUDE PUBLICA; Rocha MS, 2015, CAD SAUDE PUBLICA, V31, P709, DOI 10.1590/0102-311X00101214; Santo A, 2003, REV SAUDE; Santo Augusto Hasiak, 2006, J. bras. pneumol., V32, P544, DOI 10.1590/S1806-37132006000600012; Shilova MV, 2001, ANN NY ACAD SCI, V953, P124, DOI 10.1111/j.1749-6632.2001.tb11369.x; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; Vicentin G, 2002, CIENC SANDE COLETIVA; Wang WB, 2013, INT J TUBERC LUNG D, V17, P493, DOI 10.5588/ijtld.12.0400; Washko RM, 1992, PUBLIC HLTH REP, V111, P251; WHO, 2017, GLOB TUB REP 2017; World Health Organization (WHO), 2016, INT STAT CLASS DIS I; Yamamura M, 2015, REV LAT-AM ENFERM, V23, P910, DOI 10.1590/0104-1169.0450.2631	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0218359	10.1371/journal.pone.0218359	http://dx.doi.org/10.1371/journal.pone.0218359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995562	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400001
J	Xiao, Y; Liu, GD; Sun, Y; Gao, Y; Ouyang, XW; Chang, CS; Gong, LS; Yeh, SY				Xiao, Yao; Liu, Guodong; Sun, Yin; Gao, Yuan; Ouyang, Xiwu; Chang, Chawnshang; Gong, Liansheng; Yeh, Shuyuan			Targeting the estrogen receptor alpha (ER alpha)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; CIRCULAR RNA; GENDER DISPARITY; CANCER; PROLIFERATION; GELSOLIN; EXPRESSION; GROWTH; OVEREXPRESSION; MECHANISMS	Early studies indicated that estrogen receptor alpha (ER alpha) might impact the progression of hepatocellular carcinoma (HCC). However, the detailed mechanisms, especially its linkage to the gelsolin (GSN)-mediated cell invasion, remain unclear. Here we found that ER alpha could decrease HCC cell invasion via suppressing the circular RNA-SMG1.72 (circRNA-SMG1.72) expression via transcriptional regulation through directly binding to the 5 ' promoter region of its host gene SMG1, We showed that ER alpha-suppressed circ-SMG1.72 could sponge and inhibit the expression of the microRNA (miRNA, miR), miR-141-3p, which could then result in increasing the GSN messenger RNA translation via reduced miR binding to its 3 ' untranslated region (3 ' UTR). The preclinical study using an in vivo mouse model with orthotopic xenografts of HCC cells confirmed the in vitro data, and the human HCC clinical sample survey and tissue staining also confirmed the linkage of ER alpha/miR-141-3p/GSN signaling to the HCC progression. Together, our findings suggest that ER alpha can suppress HCC cell invasion via altering the ER alpha/circRNA-SMG1.72/miR-141-3p/GSN signaling, and targeting this newly identified signaling with small molecules may help in the development of novel therapies to better suppress the HCC progression.	[Xiao, Yao; Liu, Guodong; Gong, Liansheng] Cent South Univ, Xiangya Hosp, Dept Hepatobiliary & Pancreat Surg, Changsha 410008, Peoples R China; [Xiao, Yao; Liu, Guodong; Sun, Yin; Gao, Yuan; Ouyang, Xiwu; Chang, Chawnshang; Yeh, Shuyuan] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Xiao, Yao; Liu, Guodong; Sun, Yin; Gao, Yuan; Ouyang, Xiwu; Chang, Chawnshang; Yeh, Shuyuan] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Xiao, Yao; Liu, Guodong; Sun, Yin; Gao, Yuan; Ouyang, Xiwu; Chang, Chawnshang; Yeh, Shuyuan] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Xiao, Yao; Liu, Guodong; Sun, Yin; Gao, Yuan; Ouyang, Xiwu; Chang, Chawnshang; Yeh, Shuyuan] Univ Rochester, Med Ctr, Wilmot Canc Ctr Inst, Rochester, NY 14642 USA	Central South University; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Gong, LS (corresponding author), Cent South Univ, Xiangya Hosp, Dept Hepatobiliary & Pancreat Surg, Changsha 410008, Peoples R China.; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA.; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA.; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Ctr Inst, Rochester, NY 14642 USA.	gongliansheng8280@163.com; Shuyuan_Yeh@URMC.Rochester.edu	Xiao, Yao/AEX-1775-2022	Xiao, Yao/0000-0002-4638-4148; Liu, Guodong/0000-0003-1922-2538; Chang, Chawnshang/0000-0001-8510-3516	George Whipple Professorship Endowment; National Natural Science Foundation of China [81903004]; The 12th Five-year Key Discipline Construction in Hunan Province (Biomedical Engineering)	George Whipple Professorship Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The 12th Five-year Key Discipline Construction in Hunan Province (Biomedical Engineering)	This work was supported by George Whipple Professorship Endowment, National Natural Science Foundation of China (81903004) and The 12th Five-year Key Discipline Construction in Hunan Province (Biomedical Engineering). We thank Karen Wolf for help preparing the manuscript.	Ahlbory-Dieker DL, 2009, MOL ENDOCRINOL, V23, P1544, DOI 10.1210/me.2009-0045; Bai RX, 2018, CARBOHYD POLYM, V190, P255, DOI 10.1016/j.carbpol.2018.02.059; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Chen JJ, 2015, ONCOL REP, V33, P792, DOI 10.3892/or.2014.3647; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; Chen Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.142; Chow PKH, 2002, HEPATOLOGY, V36, P1221, DOI 10.1053/jhep.2002.36824; Deng BA, 2015, GENE, V571, P292, DOI 10.1016/j.gene.2015.06.083; Deng L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0248-0; Deng RZ, 2015, ONCOL LETT, V9, P2129, DOI 10.3892/ol.2015.3002; Ding M, 2018, J CELL BIOCHEM, V119, P9974, DOI 10.1002/jcb.27326; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Fu LY, 2017, ONCOTARGET, V8, P58405, DOI 10.18632/oncotarget.16881; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gu J, 2018, CELL PHYSIOL BIOCHEM, V48, P194, DOI 10.1159/000491718; Gu J, 2018, CANCER LETT, V434, P1, DOI 10.1016/j.canlet.2018.06.039; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang SY, 1995, J HEPATOL, V23, P712, DOI 10.1016/0168-8278(95)80038-7; Kavoosi Fraidoon, 2016, Adv Biomed Res, V5, P133, DOI 10.4103/2277-9175.187395; Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115; Lader AS, 2005, EXP CELL RES, V307, P153, DOI 10.1016/j.yexcr.2005.03.001; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liao CJ, 2011, GYNECOL ONCOL, V120, P135, DOI 10.1016/j.ygyno.2010.10.005; Liu CH, 2018, MOL THER, V26, P2267, DOI 10.1016/j.ymthe.2018.06.019; Liu CH, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0619-z; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Maynadier M, 2008, FASEB J, V22, P671, DOI 10.1096/fj.07-9322com; Megger DA, 2013, MOL CELL PROTEOMICS, V12, P2006, DOI 10.1074/mcp.M113.028027; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nathan S, 2017, BREAST CANCER RES TR, V166, P681, DOI 10.1007/s10549-017-4442-y; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Njei B, 2018, OBES SURG, V28, P3880, DOI 10.1007/s11695-018-3431-5; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Tang YY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0825-x; Tian MQ, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22281; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Villa E, 2002, MOL CELL ENDOCRINOL, V193, P65, DOI 10.1016/S0303-7207(02)00097-7; Wang SH, 2015, J GASTROEN HEPATOL, V30, P1237, DOI 10.1111/jgh.12934; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wu H, 2017, J HEPATOL, V66, P1193, DOI 10.1016/j.jhep.2017.01.030; Yang W, 2016, ONCOGENE, V35, P3919, DOI 10.1038/onc.2015.460; Yin WB, 2018, CLIN CHIM ACTA, V487, P363, DOI 10.1016/j.cca.2017.10.011; Yu MW, 2003, HEPATOLOGY, V38, P1393, DOI 10.1016/j.hep.2003.09.041; Zhou JC, 2013, ONCOL REP, V30, P1622, DOI 10.3892/or.2013.2610; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, DOI 10.1038/nrm4079; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.573	54	26	26	5	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2493	2508		10.1038/s41388-019-1150-6	http://dx.doi.org/10.1038/s41388-019-1150-6		JAN 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31996784				2022-12-26	WOS:000510136400001
J	Yi, XY; Liu, MX; Wang, JX; Luo, Q; Zhuo, HL; Yan, SD; Wang, DG; Han, Y				Yi, Xiaoyang; Liu, Minxia; Wang, Jiexi; Luo, Qun; Zhuo, Hailong; Yan, Shaoduo; Wang, Donggen; Han, Ying			Effect of phase-change material blood containers on the quality of red blood cells during transportation in environmentally-challenging conditions	PLOS ONE			English	Article								Background The effect of phase-change material blood containers on the quality of stored red blood cells (RBCs) transported in the Qinghai-Tibet Plateau remains to be studied. Study design and methods RBCs stored in a phase-change material blood container were transported from Chengdu to Tibet and then back to Chengdu. The detection time points were the 1st day of fresh-collected RBCs (group 1), the 14th day of resting refrigerated storage (group 2), and the 14th day of plateau transportation under refrigerated storage in the container (group 3). RBC counts, hemoglobin (HGB) content, free hemoglobin (FHb) content, blood biochemical indexes, hemorheologic indexes and 2,3-DPG content were detected. Results Compared with group 2, RBC counts and HGB were decreased, and the mean corpuscular volume (MCV), FHb and K+ content were increased in group 3. The glucose consumption and lactic acid production were significantly increased in groups 2 and 3. Compared with group 2, the 2,3-DPG content and whole blood viscosity were decreased in group 3. After resting refrigerated storage and plateau transportation, the RBC quality still met the national standard (GB18469-2012 whole blood and component blood quality requirements). Conclusion The phase-change material blood container can be maintained at a constant temperature under plateau environmental conditions, ensuring that the quality of the stored RBCs is compliant with GB18469-2012 whole blood and component blood quality requirements.	[Yi, Xiaoyang; Liu, Minxia; Wang, Jiexi; Yan, Shaoduo; Wang, Donggen; Han, Ying] Acad Mil Med Sci, Inst Transfus Med, Beijing Key Lab Blood Safety Supply Technol, Key Lab Blood Safety Supply Technol PLA, Beijing, Peoples R China; [Luo, Qun; Zhuo, Hailong] Transfus Dept, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Wang, DG; Han, Y (corresponding author), Acad Mil Med Sci, Inst Transfus Med, Beijing Key Lab Blood Safety Supply Technol, Key Lab Blood Safety Supply Technol PLA, Beijing, Peoples R China.	david_king@126.com; hanying_1001@126.com						[Anonymous], 184692012 GB; Chien, 1987, CLIN HEMORHEOLOGY; Dai X, 2007, MAT REV; Deng J, RES CIVILIAN HOSP MO; Gonzales R, 2016, TRANSFUSION, V56, pS85, DOI 10.1111/trf.13338; GORLIN JB, 2002, STANDARDS BLOOD BANK; Karkouti K, 2014, CAN J ANESTH, V61, P583, DOI 10.1007/s12630-013-0106-5; Kendrick DB, 1965, ANESTHESIOLOGY, V26, P584, DOI [10.1097/00000542-196507000-00039., DOI 10.1097/00000542-196507000-00039]; Orlov D, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12891; Peng B., 2018, MAT REP, V32, P248, DOI [DOI 10.1155/2018/9410560, 10.1155/2018/9410560]; Qin Penghua, 2003, Journal of Tsinghua University (Science and Technology), V43, P833; Qin R, 2003, CLIN HEMORHEOLOGY; Rentas FJ, 2004, TRANSFUSION, V44, P210, DOI 10.1111/j.1537-2995.2004.00642.x; Schimmer C, 2013, HEART LUNG VESSEL, V5, P148; Su Q, 2011, LAB MED CLIN, V8, P245; [王艳 Wang Yan], 2012, [军事医学, Military Medical Sciences], V36, P494; Zhong R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144201	17	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227862	10.1371/journal.pone.0227862	http://dx.doi.org/10.1371/journal.pone.0227862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995595	gold, Green Published			2022-12-26	WOS:000534609400030
J	Ericsson, AC; Personett, AR; Rindt, H; Grobman, ME; Reinero, CR				Ericsson, Aaron C.; Personett, Alexa R.; Rindt, Hansjorg; Grobman, Megan E.; Reinero, Carol R.			Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ONLINE RESOURCE; ASPIRATION; MICROBIOTA; BACTERIAL; COMMUNITIES; VARIABILITY; SEQUENCES; REVEALS; SEARCH	The lungs of people and companion animals are now recognized to harbor diverse, low biomass bacterial communities. While these communities are difficult to characterize using culture-based approaches, targeted molecular methods such as 16S rRNA amplicon sequencing can do so using DNA extracted from samples such as bronchoalveolar lavage fluid (BALF). Previous studies identified a surprisingly uniform composition of the microbiota in the lungs of healthy research dogs living in a controlled environment, however there are no reports of the lung microbiota of client-owned dogs. Moreover, compositional changes in the lung microbiota depending on disease status have been reported in people, suggesting that similar events may occur in dogs, a species subject to several respiratory disease mechanisms analogous to those seen in people. To address these knowledge gaps, BALF samples from client-owned dogs presenting to the University of Missouri Veterinary Health Center for respiratory signs between 2014 and 2017 were processed for and subjected to 16S rRNA sequencing. Based on specific diagnostic criteria, dogs were categorized as Chronic Bronchitis (CB, n = 53) or non-CB (n = 11). Community structure was compared between groups, as well as to historical data from healthy research dogs (n = 16) of a uniform breed and environment. The lung microbiota detected in all client-owned dogs was markedly different in composition from that previously detected in research dogs and contained increased relative abundance of multiple canine fecal and environmental bacteria, likely due to aspiration associated with their clinical signs. While inter-sample diversity differed significantly between samples from CB and non-CB dogs, the variability within both groups made it difficult to discern reproducible bacterial classifiers of disease. During subsequent analyses to identify other sources of variability within the data however, population wide temporal dynamics in community structure were observed, with substantial changes occurring in late 2015 and again in early 2017. A review of regional climate data indicated that the first change occurred during a historically warm and wet period, suggesting that changes in environmental conditions may be associated with changes in the respiratory microbiota in the context of respiratory disease. As the lung microbiota in humans and other animals is believed to result from repetitive micro-aspirations during health and in certain disease states associated with dyspnea and laryngeal dysfunction, these data support the increased colonization of the lower airways during compromised airway function, and the potential for temporal effects due to putative factors such as climate.	[Ericsson, Aaron C.; Personett, Alexa R.; Rindt, Hansjorg; Grobman, Megan E.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Rindt, Hansjorg; Grobman, Megan E.; Reinero, Carol R.] Univ Missouri, Comparat Internal Med Lab, Columbia, MO 65211 USA; [Grobman, Megan E.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Comparat Internal Med Lab, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.	ericssona@missouri.edu; reineroc@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269	NIH Office of the Director [OD019924-03]	NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Ericsson received funding from a K01 award (OD019924-03) from the NIH Office of the Director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bond SL, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1092-5; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Bustamante-Marin XM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028241; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chapman RW, 2008, PULM PHARMACOL THER, V21, P731, DOI 10.1016/j.pupt.2008.01.003; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Glendinning L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188455; Glendinning L, 2016, APPL ENVIRON MICROB, V82, P3225, DOI 10.1128/AEM.00540-16; Gollwitzer ES, 2014, PHARMACOL THERAPEUT, V141, P32, DOI 10.1016/j.pharmthera.2013.08.002; Hammer O., 2011, PALEONTOLOGY ELECT, V4, P1; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Maatta OLM, 2018, J VET INTERN MED, V32, P2074, DOI 10.1111/jvim.15321; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matthias-Maser S, 2000, ATMOS ENVIRON, V34, P3805, DOI 10.1016/S1352-2310(00)00139-4; McKiernan BC, 2000, VET CLIN N AM-SMALL, V30, P1267, DOI 10.1016/S0195-5616(00)06006-X; Nafe LA, 2018, JAVMA-J AM VET MED A, V253, P292, DOI 10.2460/javma.253.3.292; Pezzulo AA, 2013, APPL ENVIRON MICROB, V79, P5936, DOI 10.1128/AEM.01752-13; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramos FL, 2014, INT J CHRONIC OBSTR, V9, P139, DOI 10.2147/COPD.S38938; REBAR AH, 1980, VET PATHOL, V17, P294, DOI 10.1177/030098588001700303; Ren L, 2018, MSYSTEMS, P3; Rozanski E, 2014, VET CLIN N AM-SMALL, V44, P107, DOI 10.1016/j.cvsm.2013.09.005; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Terada K, 2008, THORAX, V63, P951, DOI 10.1136/thx.2007.092858; Timsit E, 2018, VET MICROBIOL, V221, P105, DOI 10.1016/j.vetmic.2018.06.007; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Vientos-Plotts AI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01287; Vientos-Plotts AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173818; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Weikl F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154131; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yun YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113466; Zakharkina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068302	49	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228085	10.1371/journal.pone.0228085	http://dx.doi.org/10.1371/journal.pone.0228085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990924	Green Published, gold			2022-12-26	WOS:000534605400039
J	Guillemette, R; Ushijima, B; Jalan, M; Hase, CC; Azam, F				Guillemette, Ryan; Ushijima, Blake; Jalan, Mihika; Hase, Claudia C.; Azam, Farooq			Insight into the resilience and susceptibility of marine bacteria to T6SS attack by Vibrio cholerae and Vibrio coralliilyticus	PLOS ONE			English	Article							VI-SECRETION-SYSTEM; EXTRACELLULAR METALLOPROTEASE; ANTAGONISTIC INTERACTIONS; ANTIMICROBIAL ACTIVITY; PROTEIN; PATHOGEN; IDENTIFICATION; TUBIASHII; INFECTION; EFFECTOR	The type VI secretion system (T6SS) is a nanomachine capable of killing adjacent microbial cells in a contact-dependent manner. Due to limited studies, relatively little is known about the range of marine bacteria that are susceptible to T6SS attack. Here, 15 diverse marine bacterial isolates from the phyla Bacteroidetes and (sic)-Proteobacteria were challenged against the marine bacterium and human pathogen, Vibrio cholerae, which has a well described T6SS. V. cholerae killed several of the tested (sic)-Proteobacteria, including members of the orders Vibrionales, Alteromonadales, Oceanospirillales, and Pseudomonadales. In contrast, V. cholerae co-existed with multiple Bacteroidetes and (sic)-Proteobacteria isolates, but was killed by Vibrio coralliilyticus. Follow-up experiments revealed that five V. coralliilyticus strains, including known coral and shellfish pathogens survived the T6SS challenge and killed V. cholerae. By using predicted protein comparisons and mutagenesis, we conclude that V. coralliilyticus protected itself in the challenge by using its own T6SS to kill V. cholerae. This study provides valuable insight into the resilience and susceptibility of marine bacteria to the V. cholerae T6SS, and provides the first evidence for a functional T6SS in V. coralliilyticus, both of which have implications for human and ocean health.	[Guillemette, Ryan; Jalan, Mihika; Azam, Farooq] Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, San Diego, CA 92103 USA; [Ushijima, Blake; Hase, Claudia C.] Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA; [Guillemette, Ryan] MIT, Civil & Environm Engn Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ushijima, Blake] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon State University; Massachusetts Institute of Technology (MIT); Smithsonian Institution; Smithsonian National Museum of Natural History	Guillemette, R (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, San Diego, CA 92103 USA.; Ushijima, B (corresponding author), Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA.; Guillemette, R (corresponding author), MIT, Civil & Environm Engn Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Ushijima, B (corresponding author), Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.	ryanpaul@mit.edu; UshijimaB@si.edu		Ushijima, Blake/0000-0002-1053-5207	Gordon & Betty Moore Foundation [4827]; Carlson College of Veterinary Medicine	Gordon & Betty Moore Foundation(Gordon and Betty Moore Foundation); Carlson College of Veterinary Medicine	This work was supported by the Gordon & Betty Moore Foundation Grant #4827 to (F.A.). B. U. and C.H. were supported by internal funds from the Carlson College of Veterinary Medicine to C.H. There was no additional external funding received for this study.	[Anonymous], 2018, APPL ENV MICROBIOL, V16; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; Bowman JP, 2007, MARINE DRUGS, P5; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brodmann M, 2017, NATURE COMMUNICATION; BYERS DM, 1985, P NATL ACAD SCI USA, V82, P6085, DOI 10.1073/pnas.82.18.6085; Campillo-Brocal JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1455-y; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Estes RM, 2004, DIS AQUAT ORGAN, V58, P223, DOI 10.3354/dao058223; Fuhrman JA, 2008, MICROBIAL ECOLOGY OC, P299; Gibbin E, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1173-0; GOLDBERG S, 1983, INFECT IMMUN, V42, P224, DOI 10.1128/IAI.42.1.224-230.1983; Hasegawa H, 2008, APPL ENVIRON MICROB, V74, P4101, DOI 10.1128/AEM.00061-08; Hasegawa H, 2009, APPL ENVIRON MICROB, V75, P7602, DOI 10.1128/AEM.01016-09; Hasegawa H, 2009, MICROBIOL-SGM, V155, P2296, DOI 10.1099/mic.0.028605-0; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Kirchberger PC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45133; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Lucas-Elio P, 2006, J BACTERIOL, V188, P2493, DOI 10.1128/JB.188.7.2493-2501.2006; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; McNally L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14371; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; NAIR S, 1987, APPL ENVIRON MICROB, V53, P2957, DOI 10.1128/AEM.53.12.2957-2962.1987; Nazarov S, 2018, EMBO J, V37, DOI 10.15252/embj.201797103; O'Toole G., 2011, J VISUALIZED EXPT; OKAMI Y, 1986, MICROBIAL ECOL, V12, P65, DOI 10.1007/BF02153223; Pedler BE, 2014, P NATL ACAD SCI USA, V111, P7202, DOI 10.1073/pnas.1401887111; Peoples LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195102; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00384; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; ROSENFELD WD, 1947, J BACTERIOL, V54, P393, DOI 10.1128/JB.54.3.393-398.1947; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Salomon D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005128; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Speare L, 2018, P NATL ACAD SCI US; Stutzmann S, 2016, MSPHERE, P1; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Toska J, 2018, P NATL ACAD SCI USA, V115, P7997, DOI 10.1073/pnas.1808469115; Townsley L, 2016, APPL ENVIRON MICROB, V82, P4441, DOI 10.1128/AEM.00807-16; Unterweger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048320; Ushijima B, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00791-17; Ushijima B, 2016, ENVIRON MICROBIOL, V18, P4055, DOI 10.1111/1462-2920.13428; Ushijima B, 2014, APPL ENVIRON MICROB, V80, P2102, DOI 10.1128/AEM.03463-13; Welsh RM, 2017, PEERJ, V5, DOI 10.7717/peerj.3315; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P1007, DOI 10.1099/ijs.0.63464-0; Yu M, 2012, MICROBIOL-SGM, V158, P835, DOI 10.1099/mic.0.055970-0; Zhao WJ, 2018, SCIENCE, V359, P210, DOI 10.1126/science.aap8775; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zobell CE, 1941, J MAR RES, V4, P42; Zoued A, 2016, NATURE, V531, P59, DOI 10.1038/nature17182	74	13	13	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227864	10.1371/journal.pone.0227864	http://dx.doi.org/10.1371/journal.pone.0227864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990915	Green Published, gold			2022-12-26	WOS:000534605400023
J	Schroder, A; Aitken, KJ; Jiang, JX; Sidler, M; Tolg, C; Siebenaller, A; Jeffrey, N; Kirwan, T; Leslie, B; Wu, CH; Weksberg, R; Delgado-Olguin, P; Bagli, DJ				Schroder, Annette; Aitken, Karen J.; Jiang, Jia-Xin; Sidler, Martin; Tolg, Cornelia; Siebenaller, Aliza; Jeffrey, Nefateri; Kirwan, Tyler; Leslie, Bruno; Wu, Changhao; Weksberg, Rosanna; Delgado-Olguin, Paul; Bagli, Darius J.			Persistent myopathy despite release of partial obstruction: in vivo reversal of dysfunction and transcriptional responses using rapamycin	FASEB JOURNAL			English	Article						bladder obstruction; core clock genes; drug therapy; rapamycin; smooth muscle	BLADDER-OUTLET-OBSTRUCTION; MUSCLE-CELL DIFFERENTIATION; URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; SMOOTH-MUSCLE; EXTRACELLULAR-MATRIX; DETRUSOR; GROWTH; RELIEF; HYPERTROPHY	Current and potential medical therapy for obstruction-induced myopathic bladder dysfunction (from benign prostatic hyperplasia or posterior urethral valves) focuses on symptoms. The persistent tissue pathology and dysfunction after release of obstruction is often deemed irreversible without any systematic therapeutic approaches. As rapamycin can attenuate bladder smooth muscle hypertrophy and dysfunction during the genesis of partial obstruction in vivo, we tested whether rapamycin could improve persistent function after release of obstruction (de-obstruction or REL). Female Sprague-Dawley rat bladders were partially obstructed (PBO) by suturing around both the urethra and a para-urethral steel rod, then removing the rod. One day prior to release of obstruction (preREL), voiding parameters and residual urine volume of preREL+future rapa, preREL+future veh groups were recorded. Release of obstruction (REL) was performed by suture removal following 6 weeks of PBO. For 4 more weeks after the de-obstruction, REL animals were randomized to rapamycin (REL+rapa) or vehicle (REL+veh). PBO for 6 weeks were used as positive controls. In shams, the urethra was exposed, but no suture tied. Voiding parameters and residual urine volume were measured prior to sacrifice of sham and REL+veh or REL+rapa, and PBO. Rapamycin efficacy was tested by pair-wise comparison of changes in individual voiding data from preREL+future veh or preREL+future rapa versus REL+veh or REL+rapa, respectively, as well as by comparisons of REL+veh to REL+rapa groups. Bladders were weighed and processed for a high-throughput QPCR array, and histopathology. Bladder/body mass ratios with PBO increased significantly and remained higher in the release phase in REL+veh animals. REL+rapa versus REL+veh improved residual volumes and micturition fractions toward sham levels. Three genes encoding extracellular proteins, BMP2, SOD3, and IGFBP7, correlated with functional improvement by Pearson's correlations. The promoters of these genes showed enrichment for several motifs including circadian E-boxes. While obstruction and REL augmented CLOCK and NPAS2 expression above sham levels, rapamycin treatment during release significantly blocked their expression. This experimental design of pharmaco-intervention during the de-obstruction phase revealed a novel pathway dysregulated during the clinically relevant treatment phase of obstructive bladder myopathy.	[Schroder, Annette; Sidler, Martin; Leslie, Bruno; Bagli, Darius J.] Hosp Sick Children, Dept Surg, Urol Div, Toronto, ON, Canada; [Schroder, Annette; Aitken, Karen J.; Jiang, Jia-Xin; Sidler, Martin; Tolg, Cornelia; Siebenaller, Aliza; Jeffrey, Nefateri; Kirwan, Tyler; Leslie, Bruno; Bagli, Darius J.] Hosp Sick Children, Dev & Stem Cell Biol Res Inst, Toronto, ON, Canada; [Jiang, Jia-Xin; Bagli, Darius J.] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON, Canada; [Sidler, Martin; Weksberg, Rosanna; Bagli, Darius J.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Wu, Changhao] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford, Surrey, England; [Weksberg, Rosanna] Hosp Sick Children, Genet & Genome Biol Res Inst, Toronto, ON, Canada; [Weksberg, Rosanna; Delgado-Olguin, Paul] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Delgado-Olguin, Paul] Hosp Sick Children, Translat Med, Toronto, ON, Canada; [Delgado-Olguin, Paul] Heart & Stroke Richard Lewar Ctr Excellence Card, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Surrey; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bagli, DJ (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Res Inst, 159420TUV PGCRL Bldg,686 Bay St, Toronto, ON M5G 0A4, Canada.	darius.bagli@sickkids.ca	Olguin, Paul Delgado/H-9293-2019	Olguin, Paul Delgado/0000-0002-5355-247X	CIHR; TPRM strategic training program in regenerative medicine; Deutsche Forschungsgemeinschaft; Department of Physiology, University of Toronto; Research Training competition, Sickkids Hospital Research Institute; Biotechnology and Biological Sciences Research Council [BB/P004695/1]; National Institute of Aging [1R01AG049321-01A1]; Heart and Stroke Foundation of Canada [G-17-0018613]; Natural Sciences and Engineering Research Council of Canada [500865]; Canadian Institutes of Health Research (CIHR) [162208, 149046]; Hospital for Sick Children; BBSRC [BB/P004695/1] Funding Source: UKRI	CIHR(Canadian Institutes of Health Research (CIHR)); TPRM strategic training program in regenerative medicine; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Physiology, University of Toronto(University of Toronto); Research Training competition, Sickkids Hospital Research Institute; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CIHR Operating Grant -DJB; TPRM strategic training program in regenerative medicine -KJA; Deutsche Forschungsgemeinschaft -AS; Department of Physiology, University of Toronto JX J; Research Training competition, Sickkids Hospital Research Institute -JXJ; Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/P004695/1 -CW; National Institute of Aging, Grant/Award Number: 1R01AG049321-01A1 -CW; Heart and Stroke Foundation of Canada, Grant/Award Number: G-17-0018613; Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: 500865; the Canadian Institutes of Health Research (CIHR), Grant/Award Number: 162208 and 149046; Hospital for Sick Children.	Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Aitken KJ, 2010, AM J PATHOL, V176, P304, DOI 10.2353/ajpath.2010.080834; Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201; Anea CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078626; Anumanthan G, 2009, J UROLOGY, V182, P1775, DOI 10.1016/j.juro.2009.05.126; Capolicchio G, 2001, J UROLOGY, V165, P2235, DOI 10.1016/S0022-5347(05)66173-3; Chai TC, 1999, J UROLOGY, V161, P1689, DOI 10.1016/S0022-5347(05)69006-4; Chalmers JA, 2008, AM J PHYSIOL-REG I, V295, pR1529, DOI 10.1152/ajpregu.90572.2008; Chang AY, 2011, AM J PHYSIOL-RENAL, V301, pF813, DOI 10.1152/ajprenal.00586.2010; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; de Jong BWD, 2008, NEUROUROL URODYNAM, V27, P454, DOI 10.1002/nau.20567; Denniff M, 2014, J MOL CELL CARDIOL, V66, P133, DOI 10.1016/j.yjmcc.2013.11.009; Duan LJ, 2015, CELL SIGNAL, V27, P215, DOI 10.1016/j.cellsig.2014.11.001; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Elkelini MS, 2009, BJU INT, V103, P537, DOI 10.1111/j.1464-410X.2008.08131.x; Elliott CS, 2014, NEUROUROL URODYNAM, V33, P1178, DOI 10.1002/nau.22480; Fusco F, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0329-4; GABELLA G, 1994, CELL TISSUE RES, V277, P333, DOI 10.1007/BF00327781; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; GUAN ZC, 1995, J UROLOGY, V154, P580, DOI 10.1016/S0022-5347(01)67115-5; Halachmi S, 2006, CELL TISSUE RES, V326, P149, DOI 10.1007/s00441-006-0204-6; Holmdahl G, 2005, J UROLOGY, V174, P1031, DOI 10.1097/01.ju.0000170233.87210.4f; Ihara T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46517-w; Ihare T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168234; Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007; Jin LH, 2011, AM J PHYSIOL-REG I, V301, pR896, DOI 10.1152/ajpregu.00046.2011; Jock M, 2014, BJU INT, V114, P946, DOI 10.1111/bju.12687; Kageyama S, 2000, NEUROUROL URODYNAM, V19, P233, DOI 10.1002/(SICI)1520-6777(2000)19:3<233::AID-NAU4>3.0.CO;2-M; Kanno Y, 2016, NEUROUROL URODYNAM, V35, P377, DOI 10.1002/nau.22721; Kim JC, 2001, UROLOGY, V57, P371, DOI 10.1016/S0090-4295(00)00886-4; Kim JC, 2000, NEUROUROL URODYNAM, V19, P29, DOI 10.1002/(SICI)1520-6777(2000)19:1<29::AID-NAU5>3.3.CO;2-R; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kiss Z, 2016, ENDOCR-RELAT CANCER, V23, pT123, DOI 10.1530/ERC-16-0366; Kojima M, 1997, J UROLOGY, V158, P89, DOI 10.1097/00005392-199707000-00024; Kudo T, 1999, Nihon Hinyokika Gakkai Zasshi, V90, P651; Kuo HC, 1996, J FORMOS MED ASSOC, V95, P469; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; Layne JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC611, DOI 10.1152/ajpcell.00435.2007; LEACH GE, 1987, J UROLOGY, V138, P574, DOI 10.1016/S0022-5347(17)43263-0; Lee KJ, 2009, CIRCULATION, V119, P2078, DOI 10.1161/CIRCULATIONAHA.107.737734; Lee SR, 2010, J UROLOGY, V183, P2440, DOI 10.1016/j.juro.2010.02.003; Lee T, 2007, J UROLOGY, V177, P1562, DOI 10.1016/j.juro.2006.11.070; Leng WW, 2003, J UROLOGY, V169, P563, DOI 10.1016/S0022-5347(05)63953-5; Levin RM, 1997, EUR UROL, V32, P15; Lin WY, 2012, BJU INT, V110, P1208, DOI 10.1111/j.1464-410X.2012.11185.x; Litlekalsoy J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2580-y; Makino J, 2016, J CELL BIOCHEM, V117, P2496, DOI 10.1002/jcb.25542; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Maselli G, 2011, INT J UROL, V18, P515, DOI 10.1111/j.1442-2042.2011.02772.x; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Negoro H, 2013, J UROLOGY, V190, P843, DOI 10.1016/j.juro.2013.02.024; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Nishino Y, 2006, BJU INT, V97, P747, DOI 10.1111/j.1464-410X.2006.06030.x; Noh JY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.153; O'Reilly PH., 2012, OBSTRUCTIVE UROPATHY; Parsons JK, 2008, UROLOGY, V72, P318, DOI 10.1016/j.urology.2008.03.057; Pen A, 2011, CANCER BIOL THER, V12, P634, DOI 10.4161/cbt.12.7.17171; Peters CA, 1997, AM J PHYSIOL-REG I, V272, pR1960, DOI 10.1152/ajpregu.1997.272.6.R1960; Rodrigo GC, 2018, FREE RADICAL BIO MED, V119, P115, DOI 10.1016/j.freeradbiomed.2017.10.381; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Saito Toshiro, 2015, J Smooth Muscle Res, V51, P95, DOI 10.1540/jsmr.51.95; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schroder A, 2013, J UROLOGY, V189, P2377, DOI 10.1016/j.juro.2012.12.110; SEKI N, 1992, J UROLOGY, V148, P1957, DOI 10.1016/S0022-5347(17)37092-1; Shi BK, 2009, UROL INT, V82, P43, DOI 10.1159/000176024; Sidler M, 2018, AM J PATHOL, V188, P2177, DOI 10.1016/j.ajpath.2018.06.024; Sidler M, 2017, UROLOGY, V105, DOI 10.1016/j.urology.2017.03.032; Sigurdardottir LG, 2012, CANCER EPIDEM BIOMAR, V21, P1002, DOI 10.1158/1055-9965.EPI-12-0116; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Song M, 2014, STEM CELLS DEV, V23, P654, DOI 10.1089/scd.2013.0277; Song YS, 2013, INT J UROL, V20, P116, DOI 10.1111/j.1442-2042.2012.03217.x; Streng T, 2012, BJU INT, V110, pE125, DOI 10.1111/j.1464-410X.2011.10838.x; Tolg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059413; Torihashi S, 2009, DIFFERENTIATION, V77, P277, DOI 10.1016/j.diff.2008.10.003; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141; White RS, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00293; Wolffenbuttel KP, 2008, NEUROUROL URODYNAM, V27, P782, DOI 10.1002/nau.20588; Wu C, 2012, J UROL, V187; Wu CH, 2014, FASEB J, V28, P4610, DOI 10.1096/fj.13-243295; Xie Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005482; Zhang EY, 2004, AM J PATHOL, V164, P601, DOI 10.1016/S0002-9440(10)63149-5; Zhu YF, 2008, UROL INT, V81, P222, DOI 10.1159/000144066	85	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3594	3615		10.1096/fj.201900547RR	http://dx.doi.org/10.1096/fj.201900547RR		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31984552	Green Submitted			2022-12-26	WOS:000509779800001
J	Ayensu, J; Annan, R; Lutterodt, H; Edusei, A; Peng, LS				Ayensu, Jessica; Annan, Reginald; Lutterodt, Herman; Edusei, Anthony; Peng, Loh Su			Prevalence of anaemia and low intake of dietary nutrients in pregnant women living in rural and urban areas in the Ashanti region of Ghana	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CHILD UNDERNUTRITION; MATERNAL ANEMIA; NUTRITION	Background Anaemia remains a major cause of morbidity and mortality among women and children worldwide. Because deficiencies in essential micronutrients such as iron, folate and vitamin B12 prior to and during gestation increase a woman's risk of being anaemic, adequate dietary intake of such nutrients is vital during this important phase in life. However, information on the dietary micronutrient intakes of pregnant women in Ghana, particularly of those resident in rural areas is scanty. Thus, this study aimed to assess anaemia prevalence and dietary micronutrient intakes in pregnant women in urban and rural areas in Ghana. Methods A comparative cross sectional study design involving 379 pregnant women was used to assess the prevalence of anaemia and low intake of dietary nutrients in pregnant women living in rural and urban areas in the Ashanti region of Ghana. Anaemia status and mid upper arm circumference (MUAC) were used as proxy for maternal nutritional status. Haemoglobin measurements were used to determine anaemia prevalence and the dietary diversity of the women were determined with a 24-hour dietary recall and a food frequency questionnaire. Results Overall, anaemia was present in 56.5% of the study population. Anaemia prevalence was higher among rural residents than urban dwellers. Majority of the respondents had inadequate intakes of iron, zinc, folate, calcium and vitamin A. The mean dietary diversity score (DDS) of the study population from the first 24-hour recall was 3.81 +/- 0.7. Of the 379 women, 28.8% met the minimum dietary diversity for women (MDD-W). The independent predictors of haemoglobin concentration were, gestational age, maternal age and dietary diversity score. Such that respondents with low DDS were more likely to be anaemic than those with high DDS (OR = 1.795, p = 0.022, 95% CI: 1.086 to 2.967). Conclusions A large percentage of pregnant women still have insufficient dietary intakes of essential nutrients required to support the nutritional demands during pregnancy. Particularly, pregnant women resident in rural areas require interventions such as nutrition education on the selection and preparation of diversified meals to mitigate the effects of undernutrition.	[Ayensu, Jessica; Annan, Reginald] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Ayensu, Jessica] Univ Cape Coast, Dept Clin Nutr & Dietet, Cape Coast, Ghana; [Lutterodt, Herman] Kwame Nkrumah Univ Sci & Technol, Dept Food Sci & Technol, Kumasi, Ghana; [Edusei, Anthony] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Peng, Loh Su] Univ Putra, Dept Nutr & Dietet, Seri Kembangan, Selangor, Malaysia	Kwame Nkrumah University Science & Technology; University of Cape Coast; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Universiti Putra Malaysia	Ayensu, J (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana.; Ayensu, J (corresponding author), Univ Cape Coast, Dept Clin Nutr & Dietet, Cape Coast, Ghana.	jessica.ayensu@ucc.edu.gh		Lutterodt, Herman/0000-0001-7015-7597; Annan, Reginald Adjetey/0000-0002-6559-1636; Ayensu, Jessica/0000-0002-0869-5703	Organization for Women in Science for the Developing World (OWSD); Swedish International Development Cooperation Agency (SIDA); World Academy of Sciences (TWAS)	Organization for Women in Science for the Developing World (OWSD); Swedish International Development Cooperation Agency (SIDA); World Academy of Sciences (TWAS)	This work was supported by a PhD Fellowship to JA from Organization for Women in Science for the Developing World (OWSD), Swedish International Development Cooperation Agency (SIDA), and The World Academy of Sciences (TWAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Afarwuah S, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12262; Aftab S., 2012, J MED RES, V51, P5; Ali Fatima, 2014, J Ayub Med Coll Abbottabad, V26, P506; Ayensu J, 2016, NUTR FOOD SCI, V46, P542, DOI 10.1108/NFS-11-2015-0146; Bhagowalia P., 2012, AGR INCOME NUTR LINK; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Boke Moges Muluneh, 2018, BMC Res Notes, V11, P892, DOI 10.1186/s13104-018-4001-6; Cochran WG., 1963, SAMPLING TECHNIQUES; Deeba F, 2012, PAK J MED RES, V51, P5; Ecker O., 2012, EC GROWTH AGR DIVERS; GSS GSS, 2015, GSS GHAN DEM HLTH SR; Khalafallah AA, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/630519; Khandelwal S, 2014, EUR J CLIN NUTR, V68, P539, DOI 10.1038/ejcn.2014.42; Kumar KJ, 2013, INT J PREVENTIVE MED, V4, P193; Little Matthew, 2016, BMC Obes, V3, P12, DOI 10.1186/s40608-016-0091-7; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Miller JL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011866; Ren A, 2007, INT J GYNECOL OBSTET, V98, P124, DOI 10.1016/j.ijgo.2007.05.011; Saaka M, 2015, ROLE DIETARY DIVERSI; Saaka M, 2017, J NUTR METAB, V2017, DOI 10.1155/2017/8497892; Schieve LA, 2000, OBSTET GYNECOL, V96, P194, DOI 10.1016/S0029-7844(00)00883-8; Stephen G, 2018, ANEMIA, V2018, DOI 10.1155/2018/1846280; Tatala S, 1998, AM J CLIN NUTR, V68, P171, DOI 10.1093/ajcn/68.1.171; Torlesse H, 2003, J NUTR, V133, P1320; University of Ghana, GHAN MICR SURV 2017; Varadharajan KS, 2013, ASIA PAC J CLIN NUTR, V22, P326, DOI 10.6133/apjcn.2013.22.3.19; WHO, 2001, PREV CONTR GUID PROG; World Health Organization, 2015, GLOB PREV AN 2011; Zerfu TA, 2016, AM J CLIN NUTR, V103, P1482, DOI 10.3945/ajcn.115.116798	30	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226026	10.1371/journal.pone.0226026	http://dx.doi.org/10.1371/journal.pone.0226026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978048	Green Published, gold			2022-12-26	WOS:000534599100012
J	Oeser, C; Pond, M; Butcher, P; Russell, AB; Henneke, P; Laing, K; Planche, T; Heath, PT; Harris, K				Oeser, Clarissa; Pond, Marcus; Butcher, Philip; Russell, Alison Bedford; Henneke, Philipp; Laing, Ken; Planche, Timothy; Heath, Paul T.; Harris, Kathryn			PCR for the detection of pathogens in neonatal early onset sepsis	PLOS ONE			English	Article							REAL-TIME PCR; INTENSIVE-CARE-UNIT; VANCOMYCIN-RESISTANT ENTEROCOCCI; BLOOD-STREAM INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; QUANTITATIVE DETECTION; GENE; DNA; IDENTIFICATION; DISEASE	Background A large proportion of neonates are treated for presumed bacterial sepsis with broad spectrum antibiotics even though their blood cultures subsequently show no growth. This study aimed to investigate PCR-based methods to identify pathogens not detected by conventional culture. Methods Whole blood samples of 208 neonates with suspected early onset sepsis were tested using a panel of multiplexed bacterial PCRs targeting Streptococcus pneumoniae, Streptococcus agalactiae (GBS), Staphylococcus aureus, Streptococcus pyogenes (GAS), Enterobacteriaceae, Enterococcus faecalis, Enterococcus faecium, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium, a 16S rRNA gene broad-range PCR and a multiplexed PCR for Candida spp. Results Two-hundred and eight samples were processed. In five of those samples, organisms were detected by conventional culture; all of those were also identified by PCR. PCR detected bacteria in 91 (45%) of the 203 samples that did not show bacterial growth in culture. S. aureus, Enterobacteriaceae and S. pneumoniae were the most frequently detected pathogens. A higher bacterial load detected by PCR was correlated positively with the number of clinical signs at presentation. Conclusion Real-time PCR has the potential to be a valuable additional tool for the diagnosis of neonatal sepsis.	[Oeser, Clarissa; Heath, Paul T.] St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis, London, England; [Pond, Marcus; Butcher, Philip; Laing, Ken; Planche, Timothy] St Georges Univ London, Inst Infect & Immun, Mol Microbiol, London, England; [Russell, Alison Bedford] Birmingham Womens NHS Fdn Trust, Neonatol, Birmingham, W Midlands, England; [Henneke, Philipp] Univ Med Ctr Freiburg, Pediat Infect Dis & Rheumatol, Freiburg, Germany; [Harris, Kathryn] Great Ormond St Hosp NHS Fdn Trust, Microbiol Virol & Infect Control, London, England; [Oeser, Clarissa] Publ Hlth England, Natl Infect Serv, London, England	St Georges University London; St Georges University London; University of Freiburg; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Public Health England	Oeser, C (corresponding author), St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis, London, England.; Oeser, C (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.	clarissa_oeser@yahoo.com		Planche, Timothy/0000-0002-0263-0888; Harris, Kathryn/0000-0003-3807-9749; Heath, Paul/0000-0002-7540-7433				Bergseng H, 2007, J MED MICROBIOL, V56, P223, DOI 10.1099/jmm.0.46731-0; Blackburn RM, 2012, ARCH DIS CHILD-FETAL, V97, pF487, DOI 10.1136/archdischild-2012-302261; Cao X, 2007, DIAGN MICR INFEC DIS, V57, P373, DOI 10.1016/j.diagmicrobio.2006.09.006; Chiesa C, 2004, CLIN CHEM, V50, P279, DOI 10.1373/clinchem.2003.025171; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Ferandon C, 2011, CLIN MICROBIOL INFEC, V17, P155, DOI 10.1111/j.1469-0691.2010.03217.x; Gomez M, 1999, PEDIATR INFECT DIS J, V18, P1014, DOI 10.1097/00006454-199911000-00016; Greenberg D, 1999, PEDIATR INFECT DIS J, V18, P479, DOI 10.1097/00006454-199905000-00021; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Harris KA, 2008, J CLIN MICROBIOL, V46, P2751, DOI 10.1128/JCM.02462-07; Hoffman JA, 2003, PEDIATRICS, V112, P1095, DOI 10.1542/peds.112.5.1095; Innings A, 2007, J CLIN MICROBIOL, V45, P874, DOI 10.1128/JCM.01556-06; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Jimenez-Truque N, 2012, PEDIATRICS, V129, pE1252, DOI 10.1542/peds.2011-2308; Macharashvili N, 2009, INT J INFECT DIS, V13, P499, DOI 10.1016/j.ijid.2008.08.020; McNeeley DF, 1996, PEDIATR INFECT DIS J, V15, P800, DOI 10.1097/00006454-199609000-00013; Meropol SB, 2015, BIRTH DEFECTS RES C, V105; Mohn SC, 2004, ANTIMICROB AGENTS CH, V48, P556, DOI 10.1128/AAC.48.2.556-560.2004; Muller-Pebody B, 2011, ARCH DIS CHILD-FETAL, V96, pF4, DOI 10.1136/adc.2009.178483; Olsen AL, 2009, ACTA PAEDIATR, V98, P1294, DOI 10.1111/j.1651-2227.2009.01322.x; Pammi M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007137.pub5; Pammi M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-390; Patel SJ, 2012, SEMIN PERINATOL, V36, P431, DOI 10.1053/j.semperi.2012.06.005; Patel SJ, 2010, CLIN PERINATOL, V37, P547, DOI 10.1016/j.clp.2010.06.004; Petti CA, 2005, J CLIN MICROBIOL, V43, P2510, DOI 10.1128/JCM.43.5.2510-2512.2005; RHODES PG, 1975, J PEDIATR-US, V86, P593, DOI 10.1016/S0022-3476(75)80159-4; Riemann K, 2007, J CLIN LAB ANAL, V21, P244, DOI 10.1002/jcla.20174; Roder B, 2010, J CLIN MICROBIOL, V48, P4260, DOI 10.1128/JCM.01230-10; Ronnestad A, 2005, PEDIATRICS, V115, pE262, DOI 10.1542/peds.2004-1834; ROSS KS, 1990, J MED GENET, V27, P569, DOI 10.1136/jmg.27.9.569; Sabet NS, 2006, DIAGN MICR INFEC DIS, V56, P13, DOI 10.1016/j.diagmicrobio.2006.02.013; Sallam A, 2004, AM J PERINAT, V21, P491, DOI 10.1055/s-2004-835967; Santo Domingo JW, 2003, BIOTECHNOL LETT, V25, P261, DOI 10.1023/A:1022303118122; Sherer CR, 2005, EMERG INFECT DIS, V11, P1470, DOI 10.3201/eid1109.050148; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; SIMPSON JM, 1995, EUR J PEDIATR, V154, P563, DOI 10.1007/s004310050343; Singh N, 2005, INFECT CONT HOSP EP, V26, P646, DOI 10.1086/502595; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; Tann CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097259; Tsai M-J, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083082; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Wirtschafter DD, 2011, J PERINATOL, V31, P514, DOI 10.1038/jp.2011.39; Wojkowska-Mach J, 2012, PEDIATR INFECT DIS J, V31, P691, DOI 10.1097/INF.0b013e3182567b74; Yapicioglu H, 2011, J TROP PEDIATRICS, V57, P157, DOI 10.1093/tropej/fmq060; Yilmaz NO, 2010, IRAN J PEDIATR, V20, P451	47	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226817	10.1371/journal.pone.0226817	http://dx.doi.org/10.1371/journal.pone.0226817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978082	Green Published, Green Accepted, gold			2022-12-26	WOS:000534599100021
J	Salari-Moghaddam, A; Keshteli, AH; Esmaillzadeh, A; Adibi, P				Salari-Moghaddam, Asma; Keshteli, Ammar Hassanzadeh; Esmaillzadeh, Ahmad; Adibi, Peyman			Water consumption and prevalence of irritable bowel syndrome among adults	PLOS ONE			English	Article							ASSOCIATION; HEALTH; FOODS; FIBER; DIET	Background and aim No previous study examined the association between whole-day water intake and odds of irritable bowel syndrome (IBS). We examined the association between whole-day water intake and odds of IBS in a large sample of Iranian adults. Methods This cross-sectional study was conducted among 4763 adults in Isfahan, Iran. Daily water intake was assessed using a pre-tested questionnaire by asking questions about the average number of glasses of water consumed in a day. IBS was assessed and defined using a modified Persian version of Rome III questionnaire. Results After taking potential confounders into account, no significant association between water consumption and odds of IBS was seen (OR: 1.14; 95% CI: 0.74-1.78). We observed that participants who were taking >8 glasses/d of water had greater odds of IBS-M in comparison to those who consumed < 2 glasses daily (OR: 2.07; 95% CI: 1.01-4.22). No significant association was observed between water intake and odds of IBS in either gender as well [for men: OR: 1.15; 95% CI: 0.59-2.24 and for women: OR: 1.15; 95% CI: 0.62-2.12]. By BMI status, no significant association was observed between whole day water intake and odds of IBS among normal weight (BMI<25 kg/m(2)) or overweight and obese people (BMI >= 25 kg/m(2)). Conclusion We found that whole-day water intake was not associated with odds of IBS. A significant association between consumption of > 8 glasses of water per day and odds of IBS-M was observed.	[Salari-Moghaddam, Asma] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Salari-Moghaddam, Asma; Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Keshteli, Ammar Hassanzadeh] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Keshteli, Ammar Hassanzadeh; Adibi, Peyman] Isfahan Univ Med Sci, Integrat Funct Gastroenterol Res Ctr, Esfahan, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Endocrinol & Metab Mol Cellular Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran; [Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Alberta; Isfahan University Medical Science; Tehran University of Medical Sciences; Isfahan University Medical Science	Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Mol Cellular Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran.	a-esmaillzadeh@tums.ac.ir	Sedeh, Peyman Adibi/AAJ-4582-2020	Sedeh, Peyman Adibi/0000-0001-6411-5235; Salari-Moghaddam, Asma/0000-0002-3999-8803				Adibi P, 2012, J RES MED SCI, V17, pS292; Anti M, 1998, HEPATO-GASTROENTEROL, V45, P727; Chatila R, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0698-2; Cozma-Petrut A, 2017, WORLD J GASTROENTERO, V23, P3771, DOI 10.3748/wjg.v23.i21.3771; Esmaillzadeh A, 2013, WORLD J GASTROENTERO, V19, P6465, DOI 10.3748/wjg.v19.i38.6465; Excellence NIfHaC, 2015, IRRITABLE BOWEL SYND; HOPE AK, 1986, MED J AUSTRALIA, V144, P306, DOI 10.5694/j.1326-5377.1986.tb128380.x; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Kant AK, 2009, AM J CLIN NUTR, V90, P655, DOI 10.3945/ajcn.2009.27749; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; McKenzie YA, 2016, J HUM NUTR DIET, V29, P549, DOI 10.1111/jhn.12385; Monnikes H, 2011, J CLIN GASTROENTEROL, V45, pS98, DOI 10.1097/MCG.0b013e31821fbf44; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; Nellesen D, 2013, J MANAGE CARE PHARM, V19, P755, DOI 10.18553/jmcp.2013.19.9.755; Ng QX, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100298; Ng QX, 2019, J GASTROEN HEPATOL, V34, P68, DOI 10.1111/jgh.14446; Rodrigues-Fisher L, 1993, Clin Nurs Res, V2, P464, DOI 10.1177/105477389300200408; Shin DH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8516785; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Sontrop JM, 2013, AM J NEPHROL, V37, P434, DOI 10.1159/000350377; Zaribaf F, 2018, EUR J CLIN NUTR, V72, P1537, DOI 10.1038/s41430-018-0109-y	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228205	10.1371/journal.pone.0228205	http://dx.doi.org/10.1371/journal.pone.0228205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978193	Green Published, gold			2022-12-26	WOS:000534599100126
J	Castrejon, M; Charles, A				Castrejon, Mauricio; Charles, Anthony			Human and climatic drivers affect spatial fishing patterns in a multiple-use marine protected area: The Galapagos Marine Reserve	PLOS ONE			English	Article							FISHERIES MANAGEMENT; REGRESSION TREES; LATIN-AMERICA; GOVERNANCE; COMANAGEMENT; PEOPLE; AUTOCORRELATION; LIVELIHOODS; IMPROVES	Assessments of the effectiveness of marine protected areas (MPAs) usually assume that fishing patterns change exclusively due to the implementation of an MPA. This assumption increases the risk of erroneous conclusions in assessing marine zoning, and consequently counter-productive management actions. Accordingly, it is important to understand how fishers respond to a combination of the implementation of no-take zones, and various climatic and human drivers of change. Those adaptive responses could influence the interpretation of assessment of no-take zone effectiveness, yet few studies have examined these aspects. Indeed, such analysis is often unfeasible in developing countries, due to the dominance of data-poor fisheries, which precludes full examination of the social-ecological outcomes of MPAs. In the Galapagos Marine Reserve (Ecuador), however, the availability of long-term spatially explicit fishery monitoring data (1997-2011) for the spiny lobster fishery allows such an analysis. Accordingly, we evaluated how the spatiotemporal allocation of fishing effort in this multiple-use MPA was affected by the interaction of diverse climatic and human drivers, before and after implementation of no-take zones. Geographic information system modelling techniques were used in combination with boosted regression models to identify how these drivers influenced fishers' behavior. Our results show that the boom-and-bust exploitation of the sea cucumber fishery and the global financial crisis 2007-09, rather than no-take zone implementation, were the most important drivers affecting the distribution of fishing effort across the archipelago. Both drivers triggered substantial macro-scale changes in fishing effort dynamics, which in turn altered the micro-scale dynamics of fishing patterns. Fishers' adaptive responses were identified, and their management implications analyzed. This leads to recommendations for more effective marine and fishery management in the Galapagos, based on improved assessment of the effectiveness of no-take zones.	[Castrejon, Mauricio] Dalhousie Univ, Interdisciplinary PhD Program, Halifax, NS, Canada; [Charles, Anthony] St Marys Univ, Management Sci & Environm Sci, Halifax, NS, Canada; [Castrejon, Mauricio] Univ Waterloo, Fac Environm, Waterloo, ON, Canada	Dalhousie University; Saint Marys University - Canada; University of Waterloo	Castrejon, M (corresponding author), Dalhousie Univ, Interdisciplinary PhD Program, Halifax, NS, Canada.; Castrejon, M (corresponding author), Univ Waterloo, Fac Environm, Waterloo, ON, Canada.	mauricio.castrejon@dal.ca		Castrejon, Mauricio/0000-0001-6942-386X	Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico); World Wildlife Fund's Russell E. Train Education for Nature Program; Natural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research Council of Canada (SSHRC)	Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); World Wildlife Fund's Russell E. Train Education for Nature Program; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR)	MC is grateful for the financial support provided by the Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico), and the World Wildlife Fund's Russell E. Train Education for Nature Program. AC acknowledges funding support from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Social Sciences and Humanities Research Council of Canada (SSHRC), through the Community Conservation Research Network (www.communityconservation.net).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto J, 2013, OCEAN COAST MANAGE, V71, P88, DOI 10.1016/j.ocecoaman.2012.10.013; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Bertelsen RD, 2009, NEW ZEAL J MAR FRESH, V43, P35, DOI 10.1080/00288330909509980; Bucaram SJ, 2014, MAR POLICY, V43, P80, DOI 10.1016/j.marpol.2013.05.005; Bucaram SJ, 2013, OCEAN COAST MANAGE, V78, P88, DOI 10.1016/j.ocecoaman.2013.03.001; Bustamante RH, 2000, SPINY LOBSTERS FISHE; Castrejon M., 2011, COMANEJO PESQUERO RE; Castrejon M, 2015, MARE PUBL SER, V13, P605, DOI 10.1007/978-3-319-17034-3_31; Castrejon M, 2013, MAR POLICY, V38, P235, DOI 10.1016/j.marpol.2012.05.040; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Charles A, 2016, AQUAT CONSERV, V26, P165, DOI 10.1002/aqc.2648; Charles A, 2012, CURR OPIN ENV SUST, V4, P351, DOI 10.1016/j.cosust.2012.05.011; Charles A, 2009, FISHERY MANAGERS GUIDEBOOK, 2ND EDITION, P253, DOI 10.1002/9781444316315.ch10; Charles AT, 2014, SEA, V16; Chasiluisa C, 2004, EVALUACION PESQUERIA, P130; Christie P, 2017, MAR POLICY, V84, P273, DOI 10.1016/j.marpol.2017.08.002; Defeo O, 2016, FISH FISH, V17, P176, DOI 10.1111/faf.12101; Defeo O, 2013, ECOL SOC, V18, DOI 10.5751/ES-05971-180430; Edgar GJ, 2004, ENVIRON CONSERV, V31, P212, DOI 10.1017/S0376892904001584; Edgar GJ, 2004, J BIOGEOGR, V31, P1107, DOI 10.1111/j.1365-2699.2004.01055.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Epler B, 2007, TOURISM EC POPULATIO; FOLKE C, 2003, NAVIGATING DYNAMICS, P325; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Guarderas AP, 2011, MAR ECOL PROG SER, V429, P219, DOI 10.3354/meps09103; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Hall SJ, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P132, DOI 10.1079/9781845936075.0132; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hearn A, 2008, OCEAN COAST MANAGE, V51, P567, DOI 10.1016/j.ocecoaman.2008.06.009; Heylings P, 2007, OCEAN COAST MANAGE, V50, P174, DOI 10.1016/j.ocecoaman.2006.09.003; Heylings P., 2002, RESERVA MARINA GAL P, P10; Costa BHE, 2013, FISH RES, V148, P27, DOI 10.1016/j.fishres.2013.08.001; Costa BHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065057; Izurieta A., 2014, PLAN MANEJO AREAS PR; Jones PJS, 2013, MAR POLICY, V41, P65, DOI 10.1016/j.marpol.2012.12.019; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Maestro M, 2019, OCEAN COAST MANAGE, V171, P28, DOI 10.1016/j.ocecoaman.2019.01.008; Martinez-Rincon RO, 2012, ECOL MODEL, V233, P20, DOI 10.1016/j.ecolmodel.2012.03.006; McCay BJ, 2014, MAR POLICY, V44, P49, DOI 10.1016/j.marpol.2013.08.001; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Moreno J, 2007, EVALUACION PESQUERIA; MORRISSEY JF, 1993, COPEIA, P425; OECD, 2017, MAR PROT AR EC MAN E; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ord JK, 2001, J REGIONAL SCI, V41, P411, DOI 10.1111/0022-4146.00224; Perez-Ramirez M, 2016, FISH RES, V182, P50, DOI 10.1016/j.fishres.2015.11.007; PNG, 2005, PLAN MAN PARQ NAC GA; Ramirez J, 2012, MEJORANDO PESQUERIA; Reck GK, 1983, THESIS; Reyes H, 2012, INFORM TECNICO PESQU; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Seijo JC, 2011, 544 FAO; Shepherd SA, 2004, ENVIRON CONSERV, V31, P102, DOI 10.1017/S0376892903001188; Soykan CU, 2014, ECOL APPL, V24, P71, DOI 10.1890/12-0826.1; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Szuwalski CS, 2016, FISH RES, V177, P82, DOI 10.1016/j.fishres.2016.01.002; Toral-Granda V., 2008, FAO Fisheries and Aquaculture Technical Paper, P231; Velazquez AV, 2003, FISH RES, V65, P123, DOI 10.1016/j.fishres.2003.09.011; Viteri C, 2014, ESTUDIO IMPACTOS SOC; Viteri C, 2007, OCEAN COAST MANAGE, V50, P253, DOI 10.1016/j.ocecoaman.2006.05.002; Westlund L, 2017, 603 FAO; White C, 2011, ECOL APPL, V21, P350, DOI 10.1890/09-1188.1; Wolff M, 2012, MAR ECOL PROG SER, V448, P7, DOI 10.3354/meps09542; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	68	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228094	10.1371/journal.pone.0228094	http://dx.doi.org/10.1371/journal.pone.0228094			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5RH	31971982	Green Published, gold			2022-12-26	WOS:000534374400040
J	Arafa, RA; Kamel, SM; Rakha, MT; Soliman, NEK; Moussa, OM; Shirasawa, K				Arafa, Ramadan A.; Kamel, Said M.; Rakha, Mohamed T.; Soliman, Nour Elden K.; Moussa, Olfat M.; Shirasawa, Kenta			Analysis of the lineage of Phytophthora infestans isolates using mating type assay, traditional markers, and next generation sequencing technologies	PLOS ONE			English	Article							POTATO FAMINE PATHOGEN; LATE BLIGHT; CLONAL LINEAGES; GENOME; POLYMORPHISMS; MITOCHONDRIAL; TOMATO; AMPLIFICATION; POPULATIONS; DIVERSITY	Phytophthora infestans (Mont.) de Bary, a hemibiotrophic oomycete, has caused severe epidemics of late blight in tomato and potato crops around the world since the Irish Potato Famine in the 1840s. Breeding of late blight resistant cultivars is one of the most effective strategies to overcome this disruptive disease. However, P. infestans is able to break down host resistance and acquire resistance to various fungicides, possibly because of the existence of high genetic variability among P. infestans isolates via sexual and asexual reproduction. Therefore, to manage this disease, it is important to understand the genetic divergence of P. infestans isolates. In this study, we analyzed the genomes of P. infestans isolates collected from Egypt and Japan using various molecular approaches including the mating type assay and genotyping simple sequence repeats, mitochondria DNA, and effector genes. We also analyzed genome-wide single nucleotide polymorphisms using doubledigest restriction-site associated DNA sequencing and whole genome resequencing (WGRS). The isolates were classified adequately using high-resolution genome-wide approaches. Moreover, these analyses revealed new clusters of P. infestans isolates in the Egyptian population. Monitoring the genetic divergence of P. infestans isolates as well as breeding of resistant cultivars would facilitate the elimination of the late blight disease.	[Arafa, Ramadan A.; Kamel, Said M.] Agr Res Ctr, Plant Pathol Res Inst, Giza, Egypt; [Arafa, Ramadan A.; Shirasawa, Kenta] Kazusa DNA Res Inst, Dept Frontier Res & Dev, Chiba, Japan; [Rakha, Mohamed T.] Univ Kafrelsheikh, Fac Agr, Dept Hort, Kafr Al Sheikh, Egypt; [Soliman, Nour Elden K.; Moussa, Olfat M.] Cairo Univ, Fac Agr, Dept Plant Pathol, Giza, Egypt	Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Kazusa DNA Research Institute; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Cairo University	Shirasawa, K (corresponding author), Kazusa DNA Res Inst, Dept Frontier Res & Dev, Chiba, Japan.	shirasaw@kazusa.or.jp	Arafa, Ramadan/AAE-7300-2021	ARAFA, RAMADAN/0000-0002-8655-4842; Shirasawa, Kenta/0000-0001-7880-6221	Ministry of Higher Education and Scientific Research (MHESR), Egypt [2013/2014-547]; Kazusa DNA Research Institute Foundation, Japan	Ministry of Higher Education and Scientific Research (MHESR), Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Kazusa DNA Research Institute Foundation, Japan	This work was supported by The Ministry of Higher Education and Scientific Research MHESR), Egypt (Grant Number: 2013/2014-547), and the Kazusa DNA Research Institute Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafa R. A., 2018, African Journal of Biotechnology, V17, P369, DOI 10.5897/ajb2017.16304; Arafa R. A., 2017, African Journal of Agricultural Research, V12, P2188, DOI 10.5897/ajar2017.12422; Arafa RA, 2018, J GEN PLANT PATHOL, V84, P104, DOI 10.1007/s10327-018-0763-x; Arafa RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189951; Avila-Adame C, 2006, CURR GENET, V49, P39, DOI 10.1007/s00294-005-0016-3; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chowdappa P, 2015, PLANT PATHOL, V64, P191, DOI 10.1111/ppa.12228; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Cooke L, 2017, EUROBLIGHT WORKSH, P14; Cooke LR, 2011, POTATO RES, V54, P183, DOI 10.1007/s11540-011-9187-0; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Day JP, 2004, PLANT PATHOL, V53, P303, DOI 10.1111/j.0032-0862.2004.01004.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Foolad MR, 2008, CRIT REV PLANT SCI, V27, P75, DOI 10.1080/07352680802147353; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; GOODWIN SB, 1992, PHYTOPATHOLOGY, V82, P955, DOI 10.1094/Phyto-82-955; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Grewe F, 2018, MYCOKEYS, P91, DOI 10.3897/mycokeys.43.29093; Grewe F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09906-7; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hansen ZR, 2016, J APPL MICROBIOL, V120, P1010, DOI 10.1111/jam.13079; Haverkort AJ, 2009, POTATO RES, V52, P249, DOI 10.1007/s11540-009-9136-3; HOHL HR, 1984, T BRIT MYCOL SOC, V83, P529, DOI 10.1016/S0007-1536(84)80057-1; Kato M, 1997, PHYTOPATHOLOGY, V87, P973, DOI 10.1094/PHYTO.1997.87.9.973; Kim MS, 2016, FOREST PATHOL, V46, P164, DOI 10.1111/efp.12263; Knapova G, 2002, PLANT PATHOL, V51, P698, DOI 10.1046/j.1365-3059.2002.00762.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lees AK, 2006, PLANT PATHOL, V55, P311, DOI 10.1111/j.1365-3059.2006.01359.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2012, G3-GENES GENOM GENET, V2, P1529, DOI 10.1534/g3.112.004150; Li Y, 2013, J MICROBIOL METH, V92, P316, DOI 10.1016/j.mimet.2012.11.021; Martin MD, 2016, MOL BIOL EVOL, V33, P478, DOI 10.1093/molbev/msv241; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rekad FZ, 2017, FUNGAL BIOL-UK, V121, P467, DOI 10.1016/j.funbio.2017.01.004; Runno-Paurson E, 2009, EUR J PLANT PATHOL, V124, P565, DOI 10.1007/s10658-009-9442-2; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shirasawa K, 2016, DNA RES, V23, P145, DOI 10.1093/dnares/dsw004; Shirasawa K, 2016, PLANT BIOTECHNOL J, V14, P51, DOI 10.1111/pbi.12348; Turkensteen LJ, 2000, PLANT PATHOL, V49, P688, DOI 10.1046/j.1365-3059.2000.00515.x; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Wang SM, 2017, NEW PHYTOL, V216, P205, DOI 10.1111/nph.14696; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yang L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01729; Yang X., 2013, Journal of Plant Pathology and Microbiology, V4, P180; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	51	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0221604	10.1371/journal.pone.0221604	http://dx.doi.org/10.1371/journal.pone.0221604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961875	Green Published, gold, Green Submitted			2022-12-26	WOS:000534372000001
J	Goetz, A; Mader, A; von Bronk, B; Weiss, AS; Opitz, M				Goetz, Alexandra; Mader, Andreas; von Bronk, Benedikt; Weiss, Anna S.; Opitz, Madeleine			Gene expression noise in a complex artificial toxin expression system	PLOS ONE			English	Article							BINDING PROTEIN CSRA; TRANSLATION INITIATION; FLUORESCENT PROTEINS; MECHANISMS; IDENTIFICATION; STOCHASTICITY; HETEROGENEITY; BIODIVERSITY; ARCHITECTURE; DEGRADATION	Gene expression is an intrinsically stochastic process. Fluctuations in transcription and translation lead to cell-to-cell variations in mRNA and protein levels affecting cellular function and cell fate. Here, using fluorescence time-lapse microscopy, we quantify noise dynamics in an artificial operon in Escherichia coli, which is based on the native operon of ColicinE2, a toxin. In the natural system, toxin expression is controlled by a complex regulatory network; upon induction of the bacterial SOS response, ColicinE2 is produced (cea gene) and released (cel gene) by cell lysis. Using this ColicinE2-based operon, we demonstrate that upon induction of the SOS response noise of cells expressing the operon is significantly lower for the (mainly) transcriptionally regulated gene cea compared to the additionally post-transcriptionally regulated gene cel. Likewise, we find that mutations affecting the transcriptional regulation by the repressor LexA do not significantly alter the population noise, whereas specific mutations to post-transcriptionally regulating units, strongly influence noise levels of both genes. Furthermore, our data indicate that global factors, such as the plasmid copy number of the operon encoding plasmid, affect gene expression noise of the entire operon. Taken together, our results provide insights on how noise in a native toxin-producing operon is controlled and underline the importance of post-transcriptional regulation for noise control in this system.	[Goetz, Alexandra; Mader, Andreas; von Bronk, Benedikt; Weiss, Anna S.; Opitz, Madeleine] Ludwig Maximilians Univ Munchen, Fac Phys, Geschwister Scholl Pl 1, Munich, Germany; [Goetz, Alexandra; Mader, Andreas; von Bronk, Benedikt; Weiss, Anna S.] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Geschwister Scholl Pl 1, Munich, Germany	University of Munich; University of Munich	Opitz, M (corresponding author), Ludwig Maximilians Univ Munchen, Fac Phys, Geschwister Scholl Pl 1, Munich, Germany.	opitz@physik.uni-muenchen.de		Weiss, Anna Sophie/0000-0001-8042-2411	DFG [OP252/9-1, SP1617, OP252/4-2]; Nano Systems Initiative Munich (NIM); Center for Nanoscience (CeNS); DFG through the Graduate School of Quantitative Biosciences Munich (QBM)	DFG(German Research Foundation (DFG)); Nano Systems Initiative Munich (NIM); Center for Nanoscience (CeNS); DFG through the Graduate School of Quantitative Biosciences Munich (QBM)	M.O.: supported by DFG grant OP252/4-2 part of the DFG Priority Program SP1617; M.O., A. S.W. and A.G.: supported by DFG grant OP252/9-1; M.O.: supported by the Nano Systems Initiative Munich (NIM); M.O.: supported by Center for Nanoscience (CeNS); B.v.B.: supported by DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2015, NAT REV MICROBIOL, V13, P497, DOI 10.1038/nrmicro3491; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Carey JN, 2019, CURR GENET, V65, P65, DOI 10.1007/s00294-018-0856-2; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; COLE ST, 1985, MOL GEN GENET, V198, P465, DOI 10.1007/BF00332940; Colin R, 2017, ELIFE, V6, DOI 10.7554/eLife.26796; Dacheux E, 2017, NUCLEIC ACIDS RES, V45, P6981, DOI 10.1093/nar/gkx430; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Edri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102308; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engl C, 2019, BIOCHEM SOC T, V47, P209, DOI 10.1042/BST20180500; Esquerre T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25057; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; Gotz A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24699-z; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; Hansen MMK, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900044; Hol FJH, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0068-2; Jones DL, 2014, SCIENCE, V346, P1533, DOI 10.1126/science.1255301; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kamensek S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-283; Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kleijn IT, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006386; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lechner M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005243; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mader A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119124; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mrak P, 2007, MOL GENET GENOMICS, V277, P391, DOI 10.1007/s00438-006-0185-x; Mundt M, 2018, ACS SYNTH BIOL, V7, P2618, DOI 10.1021/acssynbio.8b00279; Murphy KF, 2010, NUCLEIC ACIDS RES, V38, P2712, DOI 10.1093/nar/gkq091; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; OZEKI H, 1959, NATURE, V184, P337, DOI 10.1038/184337a0; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rasband WS, USNI H IMAGEJ; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Romeo T, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0009-2017; San Milian A, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0010; Sanchez A, 2013, ANNU REV BIOPHYS, V42, P469, DOI 10.1146/annurev-biophys-083012-130401; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; Silva JPN, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00340-19; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vakulskas CA, 2016, NUCLEIC ACIDS RES, V44, P7896, DOI 10.1093/nar/gkw484; Valentin-Hansen P, 2011, REGULATORY RNAS IN PROKARYOTES, P147; Vassilieva IM, 2002, MOL BIOL+, V36, P785, DOI 10.1023/A:1021621623503; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; von Bronk B, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/aae671; von Bronk B, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001457; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wu PJ, 1995, J ANTIMICROB CHEMOTH, V36, P927, DOI 10.1093/jac/36.6.927; Yang TY, 2010, NUCLEIC ACIDS RES, V38, P3936, DOI 10.1093/nar/gkq177; Youssef S, 2011, INTEGR BIOL-UK, V3, P1095, DOI 10.1039/c1ib00035g	69	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227249	10.1371/journal.pone.0227249	http://dx.doi.org/10.1371/journal.pone.0227249			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961890	Green Published, Green Submitted, gold			2022-12-26	WOS:000534372000009
J	Yu, AXD; Xu, ML; Yao, P; Kwan, KKL; Liu, YX; Duan, R; Dong, TTX; Ko, RKM; Tsim, KWK				Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Liu, Yong-Xiang; Duan, Ran; Dong, Tina Ting-Xia; Ko, Robert Kam-Ming; Tsim, Karl Wah-Keung			Corylin, a flavonoid derived from Psoralea Fructus, induces osteoblastic differentiation via estrogen and Wnt/beta-catenin signaling pathways	FASEB JOURNAL			English	Article						bioenergetics; estrogen signaling; micromass; natural product; osteoblast; Wnt; beta-catenin signaling	TRANSCRIPTION FACTOR; MICROMASS CULTURES; ENERGY-METABOLISM; BONE-DEVELOPMENT; CELL-LINE; OSTEOPROTEGERIN; EXPRESSION; WNT; INHIBITION; MECHANISM	Corylin is a naturally occurring flavonoid isolated from the fruit of Psoralea corylifolia L. (Fabaceae), which is a Chinese medicinal herb in treating osteoporosis. Although a variety of pharmacological activities of corylin have been reported, its osteogenic action and the underlying mechanism in bone development remain unclear. In the present study, the involvement of bone-specific genes in corylininduced differentiated osteoblasts was analyzed by RT-PCR, promoter-reporter assay, and Western blotting. In cultured osteoblasts, corylin-induced cell differentiation and mineralization, as well as increased the expressions of vital biological markers for osteogenesis, such as Runx2, Osterix, Col1, and ALP. Corylin was proposed to have dual pathways in triggering the osteoblastic differentiation. First, the osteogenic function of corylin acted through the activation of Wnt/beta-catenin signaling. The nuclear translocation of beta-catenin of cultured osteoblasts, as determined by flow cytometry and confocal microscopy, was triggered by applied corylin, and which was blocked by DKK-1, an inhibitor of Wnt/beta-catenin signaling. Second, the application of corylin-induced estrogenic response in a dose-dependent manner, and which was blocked by ICI 182 780, an antagonist of estrogen receptor. Furthermore, the activation of Runx2 promoter by corylin was abolished by both DKK-1 and ICI 182,780, indicating that the corylin exhibited its osteogenic effect via estrogen and Wnt/beta-catenin signaling pathways. In addition, corylin regulated the metabolic profiles, as well as the membrane potential of mitochondria, in cultured osteoblasts. Corylin also stimulated the osteogenesis in bone micromass derived from mesenchymal progenitor cells. This study demonstrated the osteogenic activities of corylin in osteoblasts and micromass, suggesting that corylin has the potential to be developed as a novel pro-osteogenic agent in targeting for the treatment of osteoblast-mediated osteoporosis.	[Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Duan, Ran; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung] HKUST Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen, Peoples R China; [Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Liu, Yong-Xiang; Duan, Ran; Dong, Tina Ting-Xia; Ko, Robert Kam-Ming; Tsim, Karl Wah-Keung] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Liu, Yong-Xiang; Duan, Ran; Dong, Tina Ting-Xia; Ko, Robert Kam-Ming; Tsim, Karl Wah-Keung] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), HKUST Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen, Peoples R China.	botsim@ust.hk			Shenzhen Science and Technology Innovation Committee [JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174]; China Postdoctoral Science Foundation [2019M653087]; Guangzhou Science and Technology Committee Research [GZSTI16SC02, GZSTI17SC02]; Hong Kong RGC Theme-based Research Scheme [T13-607/12R]; Hong Kong Innovation Technology Fund [UIM/340, UIM/385, ITS/500/18FP, TCPD/17-9]; Dr. Lau Wah Sham Foundation [PD18SC01, HMRF18SC06]	Shenzhen Science and Technology Innovation Committee; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangzhou Science and Technology Committee Research; Hong Kong RGC Theme-based Research Scheme; Hong Kong Innovation Technology Fund; Dr. Lau Wah Sham Foundation	Shenzhen Science and Technology Innovation Committee, Grant/Award Number: JCYJ20170413173747440, ZDSYS201707281432317 and JCYJ20180306174903174; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653087; Guangzhou Science and Technology Committee Research, Grant/Award Number: GZSTI16SC02 and GZSTI17SC02; Hong Kong RGC Theme-based Research Scheme, Grant/Award Number: T13-607/12R; Hong Kong Innovation Technology Fund, Grant/Award Number: UIM/340, UIM/385, ITS/500/18FP and TCPD/17-9; Dr. Lau Wah Sham Foundation, Grant/Award Number: PD18SC01 and HMRF18SC06	Almeida M, 2013, J GERONTOL A-BIOL, V68, P1197, DOI 10.1093/gerona/glt079; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bagan J, 2016, ORAL DIS, V22, P324, DOI 10.1111/odi.12447; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Boyce BF, 2005, CELL METAB, V2, P344, DOI 10.1016/j.cmet.2005.11.011; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot065490; Cong Q, 2016, STEM CELL REP, V6, P566, DOI 10.1016/j.stemcr.2016.02.001; Dai J, 2003, J BONE MINER RES, V18, pS312; Daniels K, 1996, METHOD CELL BIOL, V51, P237, DOI 10.1016/S0091-679X(08)60631-7; Drake MT, 2015, CLIN THER, V37, P1837, DOI 10.1016/j.clinthera.2015.06.006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eggerschwiler B, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1170-8; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Garnero P, 2014, BONE, V66, P46, DOI 10.1016/j.bone.2014.05.016; Greco KV, 2011, BIOCHEM PHARMACOL, V82, P1919, DOI 10.1016/j.bcp.2011.09.009; Guo JM, 2005, FOOD CHEM, V91, P287, DOI 10.1016/j.foodchem.2004.04.029; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Hung YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46299; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220, DOI 10.1152/ajpcell.2000.279.4.C1220; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Latha PG, 2000, FITOTERAPIA, V71, P223, DOI 10.1016/S0367-326X(99)00151-3; Lee SW, 2012, PLANTA MED, V78, P903, DOI 10.1055/s-0031-1298482; Li ZQ, 2018, INT J MED SCI, V15, P1415, DOI 10.7150/ijms.26741; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; RAMP WK, 1994, BONE MINER, V24, P59, DOI 10.1016/S0169-6009(08)80131-6; Riddle RC, 2014, J CLIN INVEST, V124, P1465, DOI 10.1172/JCI75554; Seo E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/897296; Seo E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/678028; Shen CY, 2017, BRIT J PHARMACOL, V174, P1395, DOI 10.1111/bph.13631; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thangaraj G, 2016, CHEM-BIOL INTERACT, V259, P313, DOI 10.1016/j.cbi.2016.03.027; Ucer S, 2017, J BONE MINER RES, V32, P560, DOI 10.1002/jbmr.3014; Wang DW, 2001, PLANTA MED, V67, P748, DOI 10.1055/s-2001-18343; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Xu ML, 2017, J BIOL CHEM, V292, P12667, DOI 10.1074/jbc.M117.777581; Yao QQ, 2017, BONE, V97, P175, DOI 10.1016/j.bone.2017.01.028; Zhang XN, 2016, AM J CHINESE MED, V44, P35, DOI 10.1142/S0192415X16500038; Zou P, 2012, FOOD CHEM TOXICOL, V50, P2831, DOI 10.1016/j.fct.2012.05.009	54	31	31	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4311	4328		10.1096/fj.201902319RRR	http://dx.doi.org/10.1096/fj.201902319RRR		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31965654				2022-12-26	WOS:000508585300001
J	Gasparutto, X; Wegrzyk, J; Rose-Dulcina, K; Hannouche, D; Armand, S				Gasparutto, Xavier; Wegrzyk, Jennifer; Rose-Dulcina, Kevin; Hannouche, Didier; Armand, Stephane			Can the fusion of motion capture and 3D medical imaging reduce the extrinsic variability due to marker misplacements?	PLOS ONE			English	Article							MEDIAL-LATERAL AXIS; STEREOPHOTOGRAMMETRY; RELIABILITY	In clinical gait analysis, measurement errors impede the reliability and repeatability of the measurements. This extrinsic variability can potentially mislead the clinical interpretation of the analysis and should thus be minimised. Skin marker misplacement has been identified as the largest source of extrinsic variability between measurements. The goal of this study was to test whether the fusion of motion capture and 3D medical imaging could reduce extrinsic variability due to skin marker misplacement. The fusion method consists in using anatomical landmarks identified with 3D medical imaging to correct marker misplacements. To assess the reduction of variability accountable to the fusion method, skin marker misplacements were voluntarily introduced in the measurement of the pelvis and hip kinematics during gait for two patients scheduled for unilateral hip arthroplasty and two patients that underwent unilateral hip arthroplasty. The root mean square deviation was reduced by -78 +/- 15% and the range of variability by -80 +/- 16% for the pelvis and hip kinematics in average. These results showed that the fusion method could significantly reduce the extrinsic variability due to skin marker misplacement and thus increase the reliability and repeatability of motion capture measurements. However, the identification of anatomical landmarks via medical imaging is a new source of extrinsic variability that should be assessed before considering the fusion method for clinical applications.	[Gasparutto, Xavier; Wegrzyk, Jennifer; Rose-Dulcina, Kevin; Armand, Stephane] Geneva Univ Hosp, Lab Kinesiol Willy Taillard, Geneva, Switzerland; [Gasparutto, Xavier; Wegrzyk, Jennifer; Rose-Dulcina, Kevin; Armand, Stephane] Univ Geneva, Geneva, Switzerland; [Hannouche, Didier] Geneva Univ Hosp, Div Orthopaed & Trauma Surg, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Gasparutto, X (corresponding author), Geneva Univ Hosp, Lab Kinesiol Willy Taillard, Geneva, Switzerland.; Gasparutto, X (corresponding author), Univ Geneva, Geneva, Switzerland.	xavier.gasparutto@hcuge.ch	; ARMAND, Stephane/Q-4395-2016	Gasparutto, Xavier/0000-0001-8617-6522; Hannouche, Didier/0000-0003-2060-2394; Rose-Dulcina, Kevin/0000-0002-8698-3268; ARMAND, Stephane/0000-0001-9144-4982; Wegrzyk, Jennifer/0000-0003-2140-6061	"Fondation pour la recherche osteo-articulaire" of Geneva	"Fondation pour la recherche osteo-articulaire" of Geneva	This project was funded by the "Fondation pour la recherche osteo-articulaire" of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar B, 2019, ORTHOP J SPORTS MED, V7, P1; Assi A, 2016, HDB HUMAN MOTION; Assi A, 2016, GAIT POSTURE, V48, P30, DOI 10.1016/j.gaitpost.2016.04.028; Baker R, HDB HUMAN MOTION, P1; Baker R, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-4; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Bittershol B, 2013, J BONE JT SURG, V95, P1; Chia K, 2017, GAIT POSTURE, V56, P68, DOI 10.1016/j.gaitpost.2017.04.040; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; D'Isidoro F, 2018, DOES HIP JOINT MOVE; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; Hara R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37707; Hausdorff J.M., 2005, J NEUROENG REHABIL, V9, P1; Hutchinson L, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038358; Macaulay CAJ, GAIT POSTURE, P440; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Noehren B, 2010, J ORTHOP RES, V28, P1405, DOI 10.1002/jor.21172; Osis ST, 2015, COMPUT METHOD BIOMEC, V18, P1108, DOI 10.1080/10255842.2013.873034; Passmore E, 2018, J BIOMECH, V69, P156, DOI 10.1016/j.jbiomech.2018.01.018; Passmore E, 2016, GAIT POSTURE, V45, P211, DOI 10.1016/j.gaitpost.2016.02.006; Rousseau MA, 2009, J ARTHROPLASTY, V24, P22, DOI 10.1016/j.arth.2007.12.015; Valente G, 2017, COMPUT METH PROG BIO, V152, P85, DOI 10.1016/j.cmpb.2017.09.012; Van Sint Jan S., 2007, COLOR ATLAS SKELETAL; Zheng LY, 2014, J BIOMECH, V47, P3217, DOI 10.1016/j.jbiomech.2014.08.009	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226648	10.1371/journal.pone.0226648	http://dx.doi.org/10.1371/journal.pone.0226648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995610	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400013
J	Mobark, NA; Alharbi, M; Alhabeeb, L; AlMubarak, L; Alaljelaify, R; AlSaeed, M; Almutairi, A; Alqubaishi, F; Ahmad, M; Al-Banyan, A; Alotabi, FE; Barakeh, D; AlZahrani, M; Al-Khalidi, H; Ajlan, A; Ramkissoon, LA; Ramkissoon, SH; Abedalthagafi, M				Mobark, Nahla A.; Alharbi, Musa; Alhabeeb, Lamees; AlMubarak, Latifa; Alaljelaify, Rasha; AlSaeed, Mariam; Almutairi, Amal; Alqubaishi, Fatmah; Ahmad, Maqsood; Al-Banyan, Ayman; Alotabi, Fahad E.; Barakeh, Duna; AlZahrani, Malak; Al-Khalidi, Hisham; Ajlan, Abdulrazag; Ramkissoon, Lori A.; Ramkissoon, Shakti H.; Abedalthagafi, Malak			Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADJUVANT THERAPY; GLIOBLASTOMA-MULTIFORME; PILOCYTIC ASTROCYTOMAS; MALIGNANT GLIOMA; REPEATED SURGERY; IDH1 MUTATION; CHEMOTHERAPY; COMBINATION; RECURRENT	Pediatric Low Grade Gliomas (PLGGs) display heterogeneity regarding morphology, genomic drivers and clinical outcomes. The treatment modality dictates the outcome and optimizing patient management can be challenging. In this study, we profiled a targeted panel of cancer-related genes in 37 Saudi Arabian patients with pLGGs to identify genetic abnormalities that can inform prognostic and therapeutic decision-making. We detected genetic alterations (GAs) in 97% (36/37) of cases, averaging 2.51 single nucleotide variations (SNVs) and 0.91 gene fusions per patient. The KIAA1549-BRAF fusion was the most common alteration (21/37 patients) followed by AFAP1-NTRK2 (2/37) and TBLXR-PI3KCA (2/37) fusions that were observed at much lower frequencies. The most frequently mutated) genes were NOTCH1-3 (7/37), ATM (4/37), RAD51C (3/37), RNF43 (3/37), SLX4 (3/37) and NF1 (3/ 37). Interestingly, we identified a GOPC-ROS1 fusion in an 8-year-old patient whose tumor lacked BRAF alterations and histologically classified as low grade glioma. The patient underwent gross total resection (GTR). The patient is currently disease free. To our knowledge this is the first report of GOPC-ROS1 fusion in PLGG. Taken together, we reveal the genetic characteristics of pLGG patients can enhance diagnostics and therapeutic decisions. In addition, we identified a GOPC-ROS1 fusion that may be a biomarker for pLGG.	[Mobark, Nahla A.; Alharbi, Musa] King Fahad Med City, Dept Paediat Oncol, Comprehens Canc Ctr, Riyadh, Saudi Arabia; [Alhabeeb, Lamees; AlMubarak, Latifa; Alaljelaify, Rasha; AlSaeed, Mariam; Almutairi, Amal; Alqubaishi, Fatmah; Abedalthagafi, Malak] King Fahad Med City, Genom Res Dept, Saudi Human Genome Project, Riyadh, Saudi Arabia; [Alhabeeb, Lamees; AlMubarak, Latifa; Alaljelaify, Rasha; AlSaeed, Mariam; Almutairi, Amal; Alqubaishi, Fatmah; Abedalthagafi, Malak] King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia; [Ahmad, Maqsood; Al-Banyan, Ayman; Alotabi, Fahad E.] King Fahad Med City, Dept Neurosci, Riyadh, Saudi Arabia; [Barakeh, Duna; AlZahrani, Malak; Al-Khalidi, Hisham; Ajlan, Abdulrazag] King Saud Univ, King Khalid Hosp, Dept Pathol, Riyadh, Saudi Arabia; [Ramkissoon, Lori A.] Univ N Carolina, Sch Med, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Ramkissoon, Shakti H.] Wake Forest Comprehens Canc Ctr, Winston Salem, NC USA; [Ramkissoon, Shakti H.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27101 USA; [Ramkissoon, Shakti H.] Fdn Med Inc, Morrisville, NC USA	King Fahad Medical City; King Fahad Medical City; King Abdulaziz City for Science & Technology; King Fahad Medical City; King Khalid Hospital; King Saud University; King Khalid University Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; Wake Forest University; Foundation Medicine	Abedalthagafi, M (corresponding author), King Fahad Med City, Genom Res Dept, Saudi Human Genome Project, Riyadh, Saudi Arabia.; Abedalthagafi, M (corresponding author), King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia.	malthagafi@kfmc.med.sa		ALzahrani, Malak/0000-0001-8537-0550; Aljelaify, Rasha/0000-0003-1923-1936; Barakeh, Duna/0000-0001-6395-7916	KFMC-IRF [1765]; Sanad Cancer research foundation [RGP 2017-1]	KFMC-IRF; Sanad Cancer research foundation	This Study was funded by KFMC-IRF 1765 (MA) and Sanad Cancer research foundation RGP 2017-1 (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thanks King Abdulaziz City for Science and Technology and the Saudi Human Genome Project for technical support. This Study was funded by KFMC-IRF 17-65 (MA) and Sanad Cancer research foundation RGP 2017-1 (MA)	Ater JL, 2016, CANCER-AM CANCER SOC, V122, P1928, DOI 10.1002/cncr.29987; Ater JL, 2012, J CLIN ONCOL, V30, P2641, DOI 10.1200/JCO.2011.36.6054; Babic I, 2018, FUTURE MED CHEM, V10, P1399, DOI 10.4155/fmc-2018-0084; Fernandez MB, 2016, CHILD NERV SYST, V32, P1939, DOI 10.1007/s00381-016-3132-0; Brzozowska A, 2015, ADV CLIN EXP MED, V24, P279, DOI 10.17219/acem/40456; Chhabda S, 2016, QUANT IMAGING MED SU, V6, P486, DOI 10.21037/qims.2016.10.01; Colin C, 2013, NEUROPATH APPL NEURO, V39, P693, DOI 10.1111/nan.12013; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P883, DOI 10.1016/j.clineuro.2012.08.030; Delgado-Lopez PD, 2017, CLIN TRANSL ONCOL, V19, P931, DOI 10.1007/s12094-017-1631-4; Farace P, 2013, J NEURO-ONCOL, V111, P177, DOI 10.1007/s11060-012-0997-y; Faulkner C, 2015, J NEUROPATH EXP NEUR, V74, P867, DOI 10.1097/NEN.0000000000000226; Freitag MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164679; GAJJAR A, 1993, PEDIATR NEUROSURG, V19, P113, DOI 10.1159/000120714; Johnson A, 2017, ONCOLOGIST, V22, P1478, DOI 10.1634/theoncologist.2017-0242; Jones DTW, 2018, NEURO-ONCOLOGY, V20, P160, DOI 10.1093/neuonc/nox141; Kiehna EN, 2017, J NEUROSURG-PEDIATR, V20, P51, DOI 10.3171/2017.2.PEDS16679; Lancaster DL, 2003, J NEURO-ONCOL, V63, P289, DOI 10.1023/A:1024278925822; Lassaletta A, 2017, J CLIN ONCOL, V35, P2934, DOI 10.1200/JCO.2016.71.8726; Leu S, 2016, J NEURO-ONCOL, V127, P363, DOI 10.1007/s11060-015-2048-y; Li YC, 2018, SEIZURE-EUR J EPILEP, V55, P76, DOI 10.1016/j.seizure.2018.01.011; Limentani SA, 2005, J NEURO-ONCOL, V72, P241, DOI 10.1007/s11060-004-2339-1; Lin A, 2012, J NEUROPATH EXP NEUR, V71, P66, DOI 10.1097/NEN.0b013e31823f2cb0; Lu B, 2016, CANCERS, V8, DOI 10.3390/cancers8090082; Lu RF, 2015, CELL TISSUE RES, V360, P321, DOI 10.1007/s00441-014-2088-1; Malmer BS, 2007, J NEURO-ONCOL, V82, P229, DOI 10.1007/s11060-006-9275-1; Mandl ES, 2008, SURG NEUROL, V69, P506, DOI 10.1016/j.surneu.2007.03.043; Molina ES, 2019, NEUROSURG REV, V42, P197, DOI 10.1007/s10143-017-0907-z; Mucha-Malecka A, 2012, REP PRACT ONCOL RADI, V17, P141, DOI 10.1016/j.rpor.2012.01.007; Okada H, 2015, CLIN CANCER RES, V21, P286, DOI 10.1158/1078-0432.CCR-14-1790; PACKER RJ, 1993, J CLIN ONCOL, V11, P850, DOI 10.1200/JCO.1993.11.5.850; Packer RJ, 2017, NEURO-ONCOLOGY, V19, P750, DOI 10.1093/neuonc/now209; Packer Roger J, 2010, Curr Neurol Neurosci Rep, V10, P10, DOI 10.1007/s11910-009-0084-8; Pirzkall A, 2009, NEURO-ONCOLOGY, V11, P842, DOI 10.1215/15228517-2009-005; Pollack IF, 2016, NEURO-ONCOLOGY, V18, P1157, DOI 10.1093/neuonc/now026; Prados MD, 1997, J NEURO-ONCOL, V32, P235, DOI 10.1023/A:1005736104205; Ramkissoon LA, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0559-4; Ratnam NM, 2019, NEURO-ONCOLOGY, V21, P37, DOI 10.1093/neuonc/noy084; Roberts M, 2018, CLIN NEUROL NEUROSUR, V175, P9, DOI 10.1016/j.clineuro.2018.10.001; Ryall S, 2017, BRAIN TUMOR PATHOL, V34, P51, DOI 10.1007/s10014-017-0282-z; Scheinemann K, 2011, PEDIATR BLOOD CANCER, V57, P84, DOI 10.1002/pbc.22917; Schiff D, 2016, NEURO-ONCOLOGY, V18, P1593, DOI 10.1093/neuonc/now262; Sehgal K, 2018, TRANSL CANCER RES, V7, pS779, DOI 10.21037/tcr.2018.08.11; Senders JT, 2017, ACTA NEUROCHIR, V159, P151, DOI 10.1007/s00701-016-3028-5; Tanaka K, 2015, CLIN NEUROL NEUROSUR, V138, P37, DOI 10.1016/j.clineuro.2015.07.019; Terasaki M, 2007, SURG NEUROL, V68, P250, DOI 10.1016/j.surneu.2006.11.042; Tsukiyama T, 2015, MOL CELL BIOL, V35, P2007, DOI 10.1128/MCB.00159-15; van der Vlis Tim A M Bouwens, 2017, Surg Neurol Int, V8, P223, DOI 10.4103/sni.sni_166_17; Wang W, 2017, TURK NEUROSURG, V27, P174, DOI 10.5137/1019-5149.JTN.15462-15.0; Winter SF, 2017, CRIT REV ONCOL HEMAT, V112, P41, DOI 10.1016/j.critrevonc.2017.02.016; Zeng L, 2018, J THORAC ONCOL, V13, pE114, DOI 10.1016/j.jtho.2018.02.005; Zhang XH, 2017, ONCOTARGET, V8, P7157, DOI 10.18632/oncotarget.12702; Zhong Z, 2015, EPILEPSY RES, V109, P100, DOI 10.1016/j.eplepsyres.2014.09.012	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228356	10.1371/journal.pone.0228356	http://dx.doi.org/10.1371/journal.pone.0228356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995621	gold, Green Published			2022-12-26	WOS:000534609400065
J	Thomsen, FB; Westerberg, M; Garmo, H; Robinson, D; Holmberg, L; Ulmert, HD; Stattin, P				Thomsen, Frederik B.; Westerberg, Marcus; Garmo, Hans; Robinson, David; Holmberg, Lars; Ulmert, Hans David; Stattin, Par			Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study	PLOS ONE			English	Article							SURVIVAL BENEFIT; BONE SCANS; RISK; MEN; MONOTHERAPY; CASTRATION; CARCINOMA; DIAGNOSIS; VALUES	The objective was to investigate the proportion of men with metastatic prostate cancer in groups defined by T stage, Gleason Grade Group (GGG) and serum levels of prostate-specific antigen (PSA) and if PSA can be used to rule in metastatic prostate cancer when combined with T stage and GGG. We identified 102,076 men in Prostate Cancer data Base Sweden 4.0 who were diagnosed with prostate cancer in 2006-2016. Risk of metastases was assessed for PSA stratified on T stage and five-tiered GGG. For men who had not undergone bone imaging, we used multiple imputation to classify metastatic prostate cancer. Advanced T stage, high GGG and high PSA were related to bone metastases. For example: only 79/38 190 (0.2%) of men with T1-2 and GGG 1 had PSA above 500 ng/mL, and 29/79 (44%) of these men had metastases; whereas 1 154/7 018 (16%) of men with T3-4 and GGG 5 had PSA above 500 ng/ml and 1 088/1 154 (94%) of these men had metastases. However, no PSA cut-off could accurately identify the majority of men with metastatic prostate cancer (i.e. high sensitivity) while also correctly classifying most men without metastasis (i.e. high specificity). In conclusion, these results support the use of imaging to confirm bone metastases in men with advanced prostate cancer as no PSA level in combination with T stage and GGG could accurately rule in metastatic prostate cancer and thereby safely omit bone imaging.	[Thomsen, Frederik B.] Univ Copenhagen, Rigshosp, Copenhagen Prostate Canc Ctr, Dept Urol, Copenhagen, Denmark; [Westerberg, Marcus; Garmo, Hans; Holmberg, Lars; Stattin, Par] Uppsala Univ Hosp, Dept Surg Sci, Uppsala, Sweden; [Westerberg, Marcus] Uppsala Univ, Dept Math, Uppsala, Sweden; [Garmo, Hans] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London, England; [Robinson, David] Ryhov Hosp, Dept Urol, Jonkoping, Sweden; [Ulmert, Hans David] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Ulmert, Hans David] David Geffen UCLA Sch Med, Ahmanson Translat Imaging Div, Los Angeles, CA USA; [Ulmert, Hans David] David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA	Rigshospitalet; University of Copenhagen; Uppsala University; Uppsala University Hospital; Uppsala University; University of London; King's College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thomsen, FB (corresponding author), Univ Copenhagen, Rigshosp, Copenhagen Prostate Canc Ctr, Dept Urol, Copenhagen, Denmark.	thomsen.frederik@gmail.com		Westerberg, Marcus/0000-0002-8906-6967; Robinson, David/0000-0002-3433-8873	Swedish Cancer Society [2016-464, 16 0700]; Swedish Research Council [2017-00847]; IMK Almene Fond	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); IMK Almene Fond	This project received research support from the Swedish Cancer Society (2016-464) and (16 0700) to PS and the Swedish Research Council (2017-00847) to PS. FBT is supported by research grant from IMK Almene Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project received research support from the Swedish Cancer Society (2016-464) and the Swedish Research Council (2017-00847). This project was made possible by the continuous work of the National Prostate Cancer Register of Sweden (NPCR) steering group: Par Stattin (chair), Ingela Franck Lissbrant (deputy chair), Johan Styrke, Camilla Thellenberg Karlsson, Lennart Astrom, Stefan Carlsson, Marie Hjalm-Eriksson, David Robinson, Mats Anden, OlaBratt, Magnus Tornblom, Johan Stranne, Jonas Hugosson, Maria Nyberg, Olof Akre, Per Fransson, Eva Johansson, Calle Waller, Gert Malmberg, Fredrik Sandin, and Karin Hellstrom.	Ang M, 2016, BJU INT, V117, P68, DOI 10.1111/bju.13411; Berglund A, 2011, J UROLOGY, V185, P833, DOI 10.1016/j.juro.2010.10.061; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Cornford P, 2016, EUR UROL, V71, P1, DOI DOI 10.1016/J.EURUR0.2016.07.021; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Engel J, 2010, EUR UROL, V57, P754, DOI 10.1016/j.eururo.2009.12.034; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Gleave ME, 1996, UROLOGY, V47, P708, DOI 10.1016/S0090-4295(96)80016-1; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; Lilleby W, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0540-3; Lorente JA, 1996, J UROLOGY, V155, P1348, DOI 10.1016/S0022-5347(01)66263-3; Makarov DV, 2013, JNCI-J NATL CANCER I, V105, P1306, DOI 10.1093/jnci/djt175; McGee S, 2002, J GEN INTERN MED, V17, P646; NPCR, 2016, ANN REPORT; ODONOGHUE JM, 1993, BRIT J RADIOL, V66, P672, DOI 10.1259/0007-1285-66-788-672; Pettersson A, 2018, ANN ONCOL, V29, P377, DOI 10.1093/annonc/mdx742; RANA A, 1992, BRIT J UROL, V69, P277, DOI 10.1111/j.1464-410X.1992.tb15528.x; Sooriakumaran P, 2017, EUR UROL, V72, P345, DOI 10.1016/j.eururo.2017.04.002; Stattin K, 2015, J UROLOGY, V194, P1594, DOI 10.1016/j.juro.2015.07.082; Stattin P, 2017, EUR UROL, V72, P125, DOI [10.1016/j.eururo.2016.07.023, 10.1016/j.eururo.2017.06.036]; Thomsen FB, 2015, EUR J CANCER, V51, P1283, DOI 10.1016/j.ejca.2015.03.021; Tomic K, 2015, ACTA ONCOL, V54, P158, DOI 10.3109/0284186X.2014.939299; Tomic K, 2015, EUR J CANCER, V51, P101, DOI 10.1016/j.ejca.2014.10.025; Tyrrell CJ, 1998, EUR UROL, V33, P447, DOI 10.1159/000019634; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Van Hemelrijck M, 2016, INT J EPIDEMIOL, V45, P73, DOI 10.1093/ije/dyv305; Westerberg M, 2020, ACTA ONCOL, V59, P106, DOI 10.1080/0284186X.2019.1662084	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228447	10.1371/journal.pone.0228447	http://dx.doi.org/10.1371/journal.pone.0228447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995611	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400069
J	Bergstrom, M; Hakansson, A; Blucher, A; Andersson, HS				Bergstrom, Maria; Hakansson, Andreas; Blucher, Anna; Andersson, Hakan S.			From carbohydrates to fat: Trends in food intake among Swedish nutrition students from 2002 to 2017	PLOS ONE			English	Article							LIFE-STYLE; ATTITUDES; OBESITY; HABITS; CONSUMPTION; PREVALENCE; MORTALITY; ONSET; DIETS; BMI	Earlier studies have implied a change in dietary habits of the Swedish population towards a low carbohydrate, high fat diet. Questions have been raised about the development in recent years and potential health effects. We have investigated the dietary intake of Swedish female students enrolled in a university nutrition course between 2002 and 2017. The students carried out self-reporting of all food and drink intake over one weekday and one weekend day. Intake of macronutrients (E%) and micronutrients were calculated for the whole period while statistical analysis was performed for changes between 2009 and 2017 (729 women). Results showed significant changes in carbohydrate intake (from 47.0 to 41.4 E%) and fat intake (from 31.7 to 37.5 E%). Carbohydrate intake was significantly lower than the Nordic Nutrition Recommendations (45-60 E%). However, daily fiber intake remains high (3.0 g/MJ) in a national context, and intake of vitamin D and folate appears to increase during the period. The results suggest that the observed national transition from carbohydrate to fat intake persists, and that it might be especially evident among individuals interested in food and nutrition. Considering the fiber and micronutrient intake, the change is not necessarily unfavorable for this particular group.	[Bergstrom, Maria; Blucher, Anna; Andersson, Hakan S.] Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden; [Hakansson, Andreas] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Andersson, Hakan S.] Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden	Linnaeus University; Lund University; Karolinska Institutet	Bergstrom, M; Andersson, HS (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden.; Andersson, HS (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden.	maria.bergstrom@lnu.se; hakan.andersson@ki.se		Bergstrom, Maria/0000-0001-7753-3823; Andersson, Hakan/0000-0003-1241-8888	Linnaeus University	Linnaeus University	This study received support from the Linnaeus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amcoff E, 2011, LIVSMEDELSOCH NARING; [Anonymous], 2014, NORDIC NUTR RECOMMEN; [Anonymous], 2005, SVENSK NANNGSR REK N; Becker W., 1990, Naringsforskning, V34, P70; Bjorck L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160474; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; de Munter JS, 2015, SCAND J PUBLIC HEALT, V43, P236, DOI 10.1177/1403494815569865; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/S0140-6736(17)32252-3, 10.1016/s0140-6736(17)32252-3]; Dickson-Spillmann M, 2011, J HUM NUTR DIET, V24, P54, DOI 10.1111/j.1365-277X.2010.01124.x; Edqvist J, 2018, DIABETES CARE, V41, P485, DOI 10.2337/dc17-1309; Eriksson L, 2008, SCAND J MED SCI SPOR, V18, P389, DOI 10.1111/j.1600-0838.2007.00723.x; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gavrieli A, 2019, NUTR METAB CARDIOVAS, V29, P127, DOI 10.1016/j.numecd.2018.10.011; Gose M, 2016, BRIT J NUTR, V115, P1498, DOI 10.1017/S0007114516000544; Groth MV, 2001, EUR J CLIN NUTR, V55, P959, DOI 10.1038/sj.ejcn.1601251; Gunnarsson A, 2012, SCI CULT-UK, V21, P315, DOI 10.1080/09505431.2011.632000; Hakansson A, 2015, FOOD NUTR RES, V59, DOI [10.3402/fnr.v59.26932, 10.3402/fnr.v59.27601]; Hall KD, 2019, CELL METAB, V30, P226, DOI 10.1016/j.cmet.2019.05.020; Hearty AP, 2007, APPETITE, V48, P1, DOI 10.1016/j.appet.2006.03.329; Jallinoja Piia, 2014, Food Nutr Res, V58, P23552, DOI 10.3402/fnr.v58.23552; James DCS, 2004, ETHNIC HEALTH, V9, P349, DOI 10.1080/1355785042000285375; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Kowalkowska J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020254; Loov H., 2015, LIVSMEDELSKONSUMTION; Mann J, 2009, LANCET, V374, P767, DOI 10.1016/S0140-6736(09)61575-0; Marconi S, 2018, FOODS, V7, DOI 10.3390/foods7010002; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mozaffarian D, 2015, JAMA-J AM MED ASSOC, V313, P2421, DOI 10.1001/jama.2015.5941; Muharemovic K, 2016, SCAND J PUBLIC HEALT, V44, P195, DOI 10.1177/1403494815617060; Neovius K, 2013, EUR J PUBLIC HEALTH, V23, P312, DOI 10.1093/eurpub/cks128; Norberg M., 2010, GLOB HLTH ACTION, V3; SCB (Statistics Sweden), FOLKM RIK LAN KOMM 3; Swedish Board of Agriculture, SVERIGES OFFICIELLA; Wadolowska L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3367-4; Wehling H, 2019, J HEALTH PSYCHOL, V24, P2042, DOI 10.1177/1359105317714318; Winkvist A, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0241-x; YouGov, 2017, FOOD HLTH	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228200	10.1371/journal.pone.0228200	http://dx.doi.org/10.1371/journal.pone.0228200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990946	Green Published, gold			2022-12-26	WOS:000534605400048
J	Mori, H; Yamashita, K; Saiki, ST; Matsumoto, A; Ujino-Ihara, T				Mori, Hideki; Yamashita, Kana; Saiki, Shin-Taro; Matsumoto, Asako; Ujino-Ihara, Tokuko			Climate sensitivity of Cryptomeria japonica in two contrasting environments: Perspectives from QTL mapping	PLOS ONE			English	Article							TREE-RING WIDTHS; WOOD PROPERTIES; RADIAL GROWTH; DENDROCHRONOLOGY; FOREST; DROUGHT; SUGI; CONDUCTANCE; RESPONSES; TRAITS	Long-lived forest tree species experience a wide range of environmental conditions throughout their lifespan. Evaluation of the underlying growth and development mechanisms of these species is essential to predict tree growth under climate change. This study investigated climate sensitivity to temperature, precipitation, dry periods, and the associated genomic regions in Cryptomeria japonica, Japan's most commercially important tree. We used tree rings and common garden experiments with three clonal replicates planted in two contrasting environments in Kyushu (Kumamoto site) and Honshu (Chiba site), Japan. Tree growth showed a significant negative correlation with the dry period (> 4 days) in March of the year of tree-ring formation at the Chiba site. In contrast, temperature and precipitation had little influence on tree growth. Quantitative trait locus (QTL) analysis was performed to investigate climate sensitivity to dry periods at the Chiba site, revealing 13 significant QTLs. One QTL showed a substantially large contribution to the overall climate sensitivity, accounting for 12.4% of the total phenotypic variation. The phenotypic variance explained (PVE) by other QTLs ranged from 0.9% to 2.9%, and the total PVE by all QTLs was 35.6%. These findings indicate that the tree population at the Chiba site could be vulnerable to drought in early spring and that the QTL showing the greatest impact on climate sensitivity may be closely related to genes associated with tolerance or adaptation to drought stress. The QTLs identified in this study could be useful for molecular breeding, forest management, and predicting the growth of C. japonica under a changing climate.	[Mori, Hideki; Yamashita, Kana; Saiki, Shin-Taro; Matsumoto, Asako; Ujino-Ihara, Tokuko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan	Mori, H (corresponding author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan.	morih@ffpri.affrc.go.jp	MORI, Hideki/AAB-4705-2020	MORI, Hideki/0000-0001-7496-5217; Saiki, Shin-Taro/0000-0002-3685-2665	Forestry and Forest Products Research Institute [201421]	Forestry and Forest Products Research Institute(Forestry & Forest Products Research Institute - Japan)	This study was supported by the Research Grant #201421 of the Forestry and Forest Products Research Institute to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, TREE PHYSIOL, V23, P859, DOI 10.1093/treephys/23.12.859; Abe H, 1999, TREES-STRUCT FUNCT, V14, P124; Abe H, 2011, SINGLE-POLLEN GENOTYPING, P47, DOI 10.1007/978-4-431-53901-8_5; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; [Anonymous], 2019, R LANG ENV STAT COMP; Batllori E, 2009, GLOBAL ECOL BIOGEOGR, V18, P460, DOI 10.1111/j.1466-8238.2009.00464.x; Berlin S, 2017, ANN BOT-LONDON, V120, P87, DOI 10.1093/aob/mcx029; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brookhouse M, 2006, AUST J BOT, V54, P435, DOI 10.1071/BT05039; Brown GR, 2003, GENETICS, V164, P1537; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; Carrer M, 2006, NEW PHYTOL, V170, P861, DOI 10.1111/j.1469-8137.2006.01703.x; Carrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022813; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Davis SD, 2002, AM J BOT, V89, P820, DOI 10.3732/ajb.89.5.820; de Villemereuil P, 2016, HEREDITY, V116, P249, DOI 10.1038/hdy.2015.93; DeSoto L, 2014, INT J BIOMETEOROL, V58, P2095, DOI 10.1007/s00484-014-0811-y; Downes G, 2014, AUST FORESTRY, V77, P179, DOI 10.1080/00049158.2014.970742; Fang KY, 2010, TREE-RING RES, V66, P51, DOI 10.3959/2008-18.1; Frank David, 2005, Dendrochronologia, V22, P107, DOI 10.1016/j.dendro.2005.02.004; Freeman JS, 2009, TREE GENET GENOMES, V5, P713, DOI 10.1007/s11295-009-0222-0; FUJINO Y, 1993, P SOC PHOTO-OPT INS, V2094, P2, DOI 10.1117/12.157854; FUJISAWA Y, 1995, MOKUZAI GAKKAISHI, V41, P249; Gaspar MJ, 2005, ANN FOREST SCI, V62, P837, DOI 10.1051/forest:2005090; Gebrekirstos A, 2014, CURR OPIN ENV SUST, V6, P48, DOI 10.1016/j.cosust.2013.10.011; Gray LK, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0983-1; Hayashi Y., 1960, TAXONOMICAL PHYTOGEO; Hiraoka Yuichiro, 2018, Front Plant Sci, V9, P1322, DOI 10.3389/fpls.2018.01322; Housset JM, 2018, NEW PHYTOL, V218, P630, DOI 10.1111/nph.14968; Huang AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087330; Huang MT, 2018, GLOBAL CHANGE BIOL, V24, P3546, DOI 10.1111/gcb.14294; Ishizuka W, 2012, EVOL APPL, V5, P229, DOI 10.1111/j.1752-4571.2011.00216.x; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jiang P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08229-z; Jyske T, 2014, TREE PHYSIOL, V34, P856, DOI 10.1093/treephys/tpu008; Kono Y, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0256-7; Lara W, 2015, DENDROCHRONOLOGIA, V34, P43, DOI 10.1016/j.dendro.2015.04.002; Leonelli G, 2009, CLIMATIC CHANGE, V96, P185, DOI 10.1007/s10584-009-9574-6; Leung E, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0887-y; Lu WJ, 2020, NEW PHYTOL, V225, P1218, DOI 10.1111/nph.16220; Ministry of the Environment and Ministry of Education, 2018, SYNTH REP OBS PROJ I; Montwe D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04039-5; Mori H, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1346-5; Moriguchi Y, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1011-1; NAKASHIZUKA T, 1995, ECOSCIENCE, V2, P245, DOI 10.1080/11956860.1995.11682290; Nanami S., 2010, APPL FOR SCI, V19, P27; Nardini A, 2003, TREES-STRUCT FUNCT, V17, P529, DOI 10.1007/s00468-003-0265-z; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Nishizono T, 2018, FORESTRY, V91, P206, DOI 10.1093/forestry/cpx055; Ohba K., 1993, CLONAL FORESTRY 2 CO, P66; Polle A, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01875; Pumijumnong N, 2013, TREES-STRUCT FUNCT, V27, P343, DOI 10.1007/s00468-012-0775-7; RAHMAN M, 2018, FORESTS, V9, DOI DOI 10.3390/F9010026; Rico L, 2014, PLANT BIOLOGY, V16, P419, DOI 10.1111/plb.12049; SAIKI ST, 2017, SCI REP, V7, DOI DOI 10.1038/S41598-017-02959-8; Saito T, 2017, HYDROL PROCESS, V31, P1952, DOI 10.1002/hyp.11162; Sixto H, 2011, NEW FOREST, V42, P163, DOI 10.1007/s11056-010-9244-6; Stocker T. F., 2013, CLIMATE CHANGE 2013; TANGE T, 1995, B TOKYO U FOR, V93, P65; Tani N, 2003, GENETICS, V165, P1551; Tei S, 2014, POLAR SCI, V8, P183, DOI 10.1016/j.polar.2013.12.002; Trujillo-Moya C, 2018, G3-GENES GENOM GENET, V8, P1225, DOI 10.1534/g3.117.300524; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Uchiyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079866; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Wils THG, 2011, TREES-STRUCT FUNCT, V25, P345, DOI 10.1007/s00468-010-0521-y; Yamashita K, 2006, MOKUZAI GAKKAISHI, V52, P8, DOI 10.2488/jwrs.52.8; Yoshimura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24513; Zhu K, 2014, GLOBAL CHANGE BIOL, V20, P251, DOI 10.1111/gcb.12382	70	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228278	10.1371/journal.pone.0228278	http://dx.doi.org/10.1371/journal.pone.0228278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990959	gold, Green Published, Green Submitted			2022-12-26	WOS:000534605400052
J	Borna, A; Carter, TR; Colombo, AP; Jau, YY; McKay, J; Weisend, M; Taulu, S; Stephen, JM; Schwindt, PDD				Borna, Amir; Carter, Tony R.; Colombo, Anthony P.; Jau, Yuan-Yu; McKay, Jim; Weisend, Michael; Taulu, Samu; Stephen, Julia M.; Schwindt, Peter D. D.			Non-Invasive Functional-Brain-Imaging with an OPM-based Magnetoencephalography System	PLOS ONE			English	Article							ATOMIC MAGNETOMETER; MEG; PERFORMANCE	A non-invasive functional-brain-imaging system based on optically-pumped-magnetometers (OPM) is presented. The OPM-based magnetoencephalography (MEG) system features 20 OPM channels conforming to the subject's scalp. We have conducted two MEG experiments on three subjects: assessment of somatosensory evoked magnetic field (SEF) and auditory evoked magnetic field (AEF) using our OPM-based MEG system and a commercial MEG system based on superconducting quantum interference devices (SQUIDs). We cross validated the robustness of our system by calculating the distance between the location of the equivalent current dipole (ECD) yielded by our OPM-based MEG system and the ECD location calculated by the commercial SQUID-based MEG system. We achieved sub-centimeter accuracy for both SEF and AEF responses in all three subjects. Due to the proximity (12 mm) of the OPM channels to the scalp, it is anticipated that future OPM-based MEG systems will offer enhanced spatial resolution as they will capture finer spatial features compared to traditional MEG systems employing SQUIDs.	[Borna, Amir; Carter, Tony R.; Colombo, Anthony P.; Jau, Yuan-Yu; Schwindt, Peter D. D.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA; [McKay, Jim] Candoo Syst Inc, Coquitlam, BC, Canada; [Weisend, Michael] StimSci Inc, Berkeley, CA USA; [Taulu, Samu] Univ Washington, Seattle, WA 98195 USA; [Stephen, Julia M.] Mind Res Network, Albuquerque, NM USA; [Stephen, Julia M.] Lovelace Biomed & Environm Res Inst, Albuquerque, NM USA	United States Department of Energy (DOE); Sandia National Laboratories; University of Washington; University of Washington Seattle; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute	Borna, A (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	aborna@sandia.gov		Stephen, Julia/0000-0003-2486-747X; Taulu, Samu/0000-0001-6164-3366	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01EB013302, R56EB013302]; U.S. Department of Energy National Nuclear Security Administration [DE-NA0003525]	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); U.S. Department of Energy National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE))	Authors AB, TC, AC, YJ, JM, MW, ST, JS, and PS were supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award numbers R01EB013302 and R56EB013302: https://www.nibib.nih.gov/The funder provided support in the form of salaries for authors AB, TC, AC, YJ, JM, MW, ST, JS, and PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Mr. James (Jim) McKay of Candoo System in British Columbia, Canada, has technical contribution to system simulation, sensor calibration, and localization algorithms. Dr. Michael Weisend, currently with StimScience, has decades of experience in electrophysiological data analysis and system design. For the presented work, Dr. Weisend has conducted MEG data analysis of SQUID-based MEG system.; The authors thank Dr. John Mosher for helpful discussion on operation of the OPM array and conducting MEG experiments; they also thank Kim Paulson for help in collecting the SQUID MEG data, Jeff Hunker for building the 18-coil system for the OPM MEG system, and QuSpin Inc. for building the multichannel transimpedance amplifier. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology & Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy National Nuclear Security Administration under contract DE-NA0003525. This paper describes objective technical results and analysis. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the U.S. Department of Energy or the United States Government.	Alem O, 2015, PHYS MED BIOL, V60, P4797, DOI 10.1088/0031-9155/60/12/4797; Alem O, 2014, J NEUROSCI, V34, P14324, DOI 10.1523/JNEUROSCI.3495-14.2014; Aydin U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118753; Borna A, 2017, PHYS MED BIOL, V62, P8909, DOI 10.1088/1361-6560/aa93d1; Boto E, 2018, NATURE, V555, P657, DOI 10.1038/nature26147; Boto E, 2017, NEUROIMAGE, V149, P404, DOI 10.1016/j.neuroimage.2017.01.034; Chella F, 2019, NEUROIMAGE, V197, P354, DOI 10.1016/j.neuroimage.2019.04.061; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; COHENTANNOUDJI C, 1972, PHYS REV A-GEN PHYS, V5, P968, DOI 10.1103/PhysRevA.5.968; Colombo AP, 2016, OPT EXPRESS, V24, P15403, DOI 10.1364/OE.24.015403; DUPONTRO.J, 1969, PHYS LETT A, VA 28, P638, DOI 10.1016/0375-9601(69)90480-0; Escudero J, 2007, IEEE T BIO-MED ENG, V54, P1965, DOI 10.1109/TBME.2007.894968; Forss N, 1999, BRAIN, V122, P1889, DOI 10.1093/brain/122.10.1889; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169; Hari R, 2007, MEG EEG PRIMER; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Iivanainen J, 2017, NEUROIMAGE, V147, P542, DOI 10.1016/j.neuroimage.2016.12.048; Johnson C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522648; Knappe S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491548; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Okada Y, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4962020; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Scherg M, 1990, ADV AUDIOL, P40, DOI DOI 10.1016/J.BSPC.2015.01.004; Seltzer SJ, 2004, APPL PHYS LETT, V85, P4804, DOI 10.1063/1.1814434; Shah VK, 2013, PHYS MED BIOL, V58, P8153, DOI 10.1088/0031-9155/58/22/8153; Taulu S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1935742; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Whalen C, 2008, HUM BRAIN MAPP, V29, P1288, DOI 10.1002/hbm.20465; Xia H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2392722; Zetter R, 2018, BRAIN TOPOGR, V31, P931, DOI 10.1007/s10548-018-0656-5	33	46	49	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227684	10.1371/journal.pone.0227684	http://dx.doi.org/10.1371/journal.pone.0227684			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978102	Green Published, Green Submitted, gold			2022-12-26	WOS:000534599100051
J	Bures, J; Kvetina, J; Radochova, V; Tacheci, I; Peterova, E; Herman, D; Dolezal, R; Kopacova, M; Rejchrt, S; Douda, T; Sestak, V; Douda, L; Karasova, JZ				Bures, Jan; Kvetina, Jaroslav; Radochova, Vera; Tacheci, Ilja; Peterova, Eva; Herman, David; Dolezal, Rafael; Kopacova, Marcela; Rejchrt, Stanislav; Douda, Tomas; Sestak, Vit; Douda, Ladislav; Karasova, Jana Zdarova			The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs	PLOS ONE			English	Article							HEALTHY; ELECTROGASTROGRAPHY; PROPOFOL; RECEPTORS; NUCLEUS; MODEL	Background Memantine, currently available for the treatment of Alzheimer's disease, is an uncompetitive antagonist of the N-methyl-D-aspartate type of glutamate receptors. Under normal physiologic conditions, these unstimulated receptor ion channels are blocked by magnesium ions, which are displaced after agonist-induced depolarization. In humans, memantine administration is associated with different gastrointestinal dysmotility side effects (vomiting, diarrhoea, constipation, motor-mediated abdominal pain), thus limiting its clinical use. Mechanism of these motility disorders has not been clarified yet. Pigs can be used in various preclinical experiments due to their relatively very similar gastrointestinal functions compared to humans. The aim of this study was to evaluate the impact of a single and repeated doses of memantine on porcine gastric myoelectric activity evaluated by means of electrogastrography (EGG). Methods Six adult female experimental pigs (Sus scrofa f. domestica, mean weight 41.7 +/- 5.0 kg) entered the study for two times. The first EGG was recorded after a single intragastric dose of memantine (20 mg). In the second part, EGG was accomplished after 7-day intragastric administration (20 mg per day). All EGG recordings were performed under general anaesthesia. Basal (15 minutes) and study recordings (120 minutes) were accomplished using an EGG stand (MMS, Enschede, the Netherlands). Running spectral analysis based on Fourier transform was used. Results were expressed as dominant frequency of gastric slow waves (DF) and power analysis (areas of amplitudes). Results Single dose of memantine significantly increased DF, from basic values (1.65 +/- 1.05 cycles per min.) to 2.86 cpm after 30 min. (p = 0.008), lasting till 75 min. (p = 0.014). Basal power (median 452; inter-quartile range 280-1312 mu V(boolean AND)2) raised after 15 min. (median 827; IQR 224-2769; p = 0.386; NS), lasting next 30 min. Repetitively administrated memantine caused important gastric arrhythmia. Basal DF after single and repeated administration was not different, however, a DF increase in the second part was more prominent (up to 3.18 +/- 2.16 after 15 and 30 min., p<0.001). In comparison with a single dose, basal power was significantly higher after repetitively administrated memantine (median 3940; IQR 69515023 mu V(boolean AND)2; p<0.001). Next dose of 20 mg memantine in the second part induced a prominent drop of power after 15 min. (median 541; IQR 328-2280 mu V(boolean AND)2; p<0.001), lasting till 120 min. (p<0.001). Conclusions Both single and repeated doses of memantine increased DF. Severe gastric arrhythmia and long-lasting low power after repeated administration might explain possible gastric dysmotility side effects in the chronic use of memantine.	[Bures, Jan; Kvetina, Jaroslav; Tacheci, Ilja; Peterova, Eva; Kopacova, Marcela; Rejchrt, Stanislav; Douda, Tomas; Douda, Ladislav] Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Gastroenterol 2, Hradec Kralove, Czech Republic; [Bures, Jan; Kvetina, Jaroslav; Tacheci, Ilja; Peterova, Eva; Kopacova, Marcela; Rejchrt, Stanislav; Douda, Tomas; Sestak, Vit; Douda, Ladislav] Univ Hosp, Hradec Kralove, Czech Republic; [Radochova, Vera] Univ Def, Fac Mil Hlth Sci, Anim Lab, Hradec Kralove, Czech Republic; [Herman, David; Karasova, Jana Zdarova] Univ Def, Fac Mil Hlth Sci, Dept Toxicol & Mil Pharm, Hradec Kralove, Czech Republic; [Herman, David; Dolezal, Rafael; Karasova, Jana Zdarova] Univ Hosp, Ctr Biomed Res, Hradec Kralove, Czech Republic; [Sestak, Vit] Charles Univ Prague, Inst Clin Biochem & Diagnost, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; University of Defence - Czech Republic; University of Defence - Czech Republic; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove	Bures, J (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Gastroenterol 2, Hradec Kralove, Czech Republic.; Bures, J (corresponding author), Univ Hosp, Hradec Kralove, Czech Republic.	bures@lfhk.cuni.cz	Dolezal, Rafael/B-3956-2017; Sestak, Vit/AAE-6304-2021; Douda, Ladislav/ABE-5291-2020; Herman, David/ABG-8341-2020; Rejchrt, Stanislav/W-3456-2017; Bures, Jan/E-5116-2017; Peterova, Eva/S-5665-2016; Tacheci, Ilja/N-3802-2016	Dolezal, Rafael/0000-0001-9495-3934; Douda, Ladislav/0000-0003-0131-6608; Herman, David/0000-0003-0784-4524; Zdarova Karasova, Jana/0000-0003-0891-9591; Sestak, Vit/0000-0002-4688-2577; Rejchrt, Stanislav/0000-0001-5166-9503; Bures, Jan/0000-0003-0326-117X; Peterova, Eva/0000-0001-7866-9722; Tacheci, Ilja/0000-0003-3583-2651	GACR (Grant Agency of Czech Republic) [18-13283S]	GACR (Grant Agency of Czech Republic)(Grant Agency of the Czech Republic)	JB and JZK: The study/research was funded by GACR (Grant Agency of Czech Republic), grant number 18-13283S. https://gacr.cz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AA, 2007, J CHROMATOGR B, V848, P311, DOI 10.1016/j.jchromb.2006.10.045; Ametamey SM, 2002, NUCL MED BIOL, V29, P227, DOI 10.1016/S0969-8051(01)00293-1; [Anonymous], 2009, EXPL REP EUR CONV PR; Bures J, 2011, HUM EXP TOXICOL, V30, P1955, DOI 10.1177/0960327111403174; Bures J, 2015, J APPL BIOMED, V13, P273, DOI 10.1016/j.jab.2015.04.004; Bures J, 2013, NEUROENDOCRINOL LETT, V34, P79; CHEN JDZ, 1994, ELECTROGASTROGRAPHY; Chen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183586; Clyburn C, 2018, AM J PHYSIOL-GASTR L, V314, pG623, DOI 10.1152/ajpgi.00395.2017; Cremonini F, 2004, BEST PRACT RES CL GA, V18, P717, DOI 10.1016/j.bpg.2004.04.003; Golovynska I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25753-6; Gong YL, 2017, BRAIN RES, V1659, P29, DOI 10.1016/j.brainres.2017.01.004; Hiemke C, 2018, PHARMACOPSYCHIATRY, V51, pE1, DOI [10.1055/s-0037-1600991, 10.1055/s-0043-116492]; HONEGGER UE, 1993, PHARMACOL TOXICOL, V73, P202, DOI 10.1111/j.1600-0773.1993.tb01564.x; Jocic M, 2001, PAIN, V89, P147, DOI 10.1016/S0304-3959(00)00357-2; Johnson JW, 2015, CURR OPIN PHARMACOL, V20, P54, DOI 10.1016/j.coph.2014.11.006; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Karasova JZ, 2018, J CHROMATOGR B, V1092, P350, DOI 10.1016/j.jchromb.2018.06.034; Karasova JZ, 2018, BASIC CLIN PHARMACOL, V122, P373, DOI 10.1111/bcpt.12922; Koch KL., 2004, HDB ELECTROGASTROGRA; Kohjitani A, 2005, ANESTH ANALG, V101, P1681, DOI 10.1213/01.ANE.0000184137.37687.B7; Kuiken SD, 2002, ALIMENT PHARM THER, V16, P1955, DOI 10.1046/j.1365-2036.2002.01358.x; Kvetina J, 2015, PHYSIOL RES, V64, pS647, DOI 10.33549/physiolres.933227; Landeira-Fernandez J, 2015, PHYSIOL BEHAV, V140, P209, DOI 10.1016/j.physbeh.2014.12.038; Lee TL, 1999, ANESTH ANALG, V89, P1246, DOI 10.1213/00000539-199911000-00031; Liu MY, 2008, CLIN THER, V30, P641, DOI 10.1016/j.clinthera.2008.04.005; Matsunaga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123289; Memis D, 2006, EUR J ANAESTH, V23, P700, DOI 10.1017/S0265021506000512; Micuda S, 2004, EUR J CLIN PHARMACOL, V60, P583, DOI 10.1007/s00228-004-0825-1; Parkman HP, 2003, NEUROGASTROENT MOTIL, V15, P89, DOI 10.1046/j.1365-2982.2003.00396.x; Periclou A, 2006, CLIN PHARMACOL THER, V79, P134, DOI 10.1016/j.clpt.2005.10.005; Schnoor J, 2005, CAN VET J, V46, P995; Schnoor J, 2003, LAB ANIM-UK, V37, P145, DOI 10.1258/00236770360563796; Seo JH, 2011, GASTROENTEROLOGY, V141, P2064, DOI 10.1053/j.gastro.2011.08.048; Suenderhauf C, 1995, PHARM RES, V30, P1; Tacheci I, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-48; Tacheci I, 2011, NEUROENDOCRINOL LETT, V32, P131; Tveden-Nyborg P, 2018, BASIC CLIN PHARMACOL, V123, P233, DOI 10.1111/bcpt.13059; Varayil J. E., 2009, FOLIA GASTROENTEROL, V7, P98; Victorino DB, 2017, BASIC CLIN PHARMACOL, V121, P382, DOI 10.1111/bcpt.12816; Wang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145441; WESEMANN W, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1243	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227781	10.1371/journal.pone.0227781	http://dx.doi.org/10.1371/journal.pone.0227781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978146	gold, Green Published			2022-12-26	WOS:000534599100060
J	Paulazo, MA; Sodero, AO				Paulazo, Maria A.; Sodero, Alejandro O.			Analysis of cholesterol in mouse brain by HPLC with UV detection	PLOS ONE			English	Article							ENZYMATIC DETERMINATION; HOMEOSTASIS	We describe a sensitive high performance liquid chromatography (HPLC)-based method for the determination of cholesterol in brain tissue. The method does not require the derivatization of the analyte and uses separation and quantification by reversed-phase HPLC coupled to UV detection. Lipids were methanol/chloroform extracted following the method of Bligh and Dyer, and separated using isopropanol/acetonitrile/water (60/30/10, v/v/v) as mobile phase. We observed lineal detection in a wide range of concentrations, from 62.5 to 2000 ng/mu L, and were able to detect a significant increase in the brain cholesterol levels between postnatal days 2 and 10 in C57BL6 mice. Based on our validation parameters, we consider this analytical method a useful tool to assess free cholesterol in rodent brain samples and cell cultures.	[Paulazo, Maria A.; Sodero, Alejandro O.] Pontifical Catholic Univ Argentina UCA, Inst Biomed Res BIOMED, C1107AFF, Buenos Aires, DF, Argentina; [Paulazo, Maria A.; Sodero, Alejandro O.] Natl Sci & Tech Res Council CONICET, C1107AFF, Buenos Aires, DF, Argentina	Pontifical Catholic University of Argentina; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Sodero, AO (corresponding author), Pontifical Catholic Univ Argentina UCA, Inst Biomed Res BIOMED, C1107AFF, Buenos Aires, DF, Argentina.	alejsodero@gmail.com		Paulazo, Maria Alejandra/0000-0002-0872-2994	Pontifical Catholic University of Argentina	Pontifical Catholic University of Argentina	This work was supported by the Pontifical Catholic University of Argentina. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; Arenas F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00382; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang TY, 2017, J LIPID RES, V58, P2239, DOI 10.1194/jlr.R075630; Czuba E, 2017, METAB BRAIN DIS, V32, P935, DOI 10.1007/s11011-017-0015-3; DEVRIES GH, 1974, J NEUROCHEM, V22, P259, DOI 10.1111/j.1471-4159.1974.tb11588.x; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DUNCAN IW, 1979, J CHROMATOGR, V162, P281, DOI 10.1016/S0378-4347(00)81515-7; Ghimenti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028182; Li LH, 2019, J FOOD DRUG ANAL, V27, P375, DOI 10.1016/j.jfda.2018.09.001; Lomonaco T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114430; Lomonaco T, 2013, J CHROMATOGR A, V1314, P54, DOI 10.1016/j.chroma.2013.08.091; Lu FX, 2018, PEDIATR RES, V83, P1218, DOI 10.1038/pr.2018.49; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Marcos J, 2007, STEROIDS, V72, P802, DOI 10.1016/j.steroids.2007.07.002; Martin MG, 2014, EMBO REP, V15, P1036, DOI 10.15252/embr.201439225; Meljon A, 2012, J LIPID RES, V53, P2469, DOI 10.1194/jlr.D028233; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Nunes VS, 2018, J BIOENERG BIOMEMBR, V50, P283, DOI 10.1007/s10863-018-9757-9; Saher G, 2015, BBA-MOL CELL BIOL L, V1851, P1083, DOI 10.1016/j.bbalip.2015.02.010; Saher G, 2011, NEUROSCIENTIST, V17, P79, DOI 10.1177/1073858410373835; Saher G, 2010, SUBCELL BIOCHEM, V51, P489, DOI 10.1007/978-90-481-8622-8_18; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Tint GS, 2006, J LIPID RES, V47, P1535, DOI 10.1194/jlr.M600141-JLR200; Valenza M, 2011, TRENDS NEUROSCI, V34, P474, DOI 10.1016/j.tins.2011.06.005	27	7	7	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228170	10.1371/journal.pone.0228170	http://dx.doi.org/10.1371/journal.pone.0228170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978159	Green Published, gold			2022-12-26	WOS:000534599100120
J	Powell, W; Frerichs, L; Townsley, R; Mayorga, M; Richmond, J; Corbie-Smith, G; Wheeler, S; Lich, KH				Powell, Wizdom; Frerichs, Leah; Townsley, Rachel; Mayorga, Maria; Richmond, Jennifer; Corbie-Smith, Giselle; Wheeler, Stephanie; Lich, Kristen Hassmiller			The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males	PLOS ONE			English	Article							INSURANCE-COVERAGE; HEALTH-INSURANCE; COLONOSCOPY; MICROSIMULATION; PREVALENCE; STATISTICS; NEOPLASIA; ADENOMAS; WHITE; RATES	Few investigations have explored the potential impact of the Affordable Care Act on health disparity outcomes in states that chose to forgo Medicaid expansion. Filling this evidence gap is pressing as Congress grapples with controversial healthcare legislation that could phase out Medicaid expansion. Colorectal cancer (CRC) is a commonly diagnosed, preventable cancer in the US that disproportionately burdens African American men and has substantial potential to be impacted by improved healthcare insurance coverage. Our objective was to estimate the impact of the Affordable Care Act (increasing insurance through health exchanges alone or with Medicaid expansion) on colorectal cancer outcomes and economic costs among African American and White males in North Carolina (NC), a state that did not expand Medicaid. We used an individual-based simulation model to estimate the impact of ACA (increasing insurance through health exchanges alone or with Medicaid expansion) on three CRC outcomes (screening, stage-specific incidence, and deaths) and economic costs among African American and White males in NC who were age-eligible for screening (between ages 50 and 75) during the study period, years of 2013-2023. Health exchanges and Medicaid expansion improved simulated CRC outcomes overall, though the impact was more substantial among AAs. Relative to health exchanges alone, Medicaid expansion would prevent between 7.1 to 25.5 CRC cases and 4.1 to 16.4 per 100,000 CRC cases among AA and White males, respectively. Our findings suggest policies that expanding affordable, quality healthcare coverage could have a demonstrable, cost-saving impact while reducing cancer disparities.	[Powell, Wizdom] Univ Connecticut, Hlth Dispar Inst, Farmington, CT USA; [Powell, Wizdom] Univ Connecticut, Dept Psychiat, Farmington, CT 06107 USA; [Frerichs, Leah; Wheeler, Stephanie; Lich, Kristen Hassmiller] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27515 USA; [Townsley, Rachel; Mayorga, Maria] North Carolina State Univ, Dept Ind & Syst Engn, Raleigh, NC USA; [Richmond, Jennifer] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Corbie-Smith, Giselle] Univ N Carolina, Ctr Hlth Equ Res, Chapel Hill, NC 27515 USA; [Corbie-Smith, Giselle] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Corbie-Smith, Giselle] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA	University of Connecticut; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Frerichs, L (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27515 USA.	leahf@unc.edu		Richmond, Jennifer/0000-0001-8660-4160; Frerichs, Leah/0000-0002-2507-3789; Mayorga, Maria/0000-0002-6399-2153	Cancer Prevention and Control Research Network (CPCRN) [3 U48 DP005017-01S8]; National Institutes of Drug Abuse [K01 DA032611]; National Heart, Lung, and Blood Institute [K01 HL138159]	Cancer Prevention and Control Research Network (CPCRN); National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: SW, 3 U48 DP005017-01S8, Cancer Prevention and Control Research Network (CPCRN); WP, K01 DA032611, National Institutes of Drug Abuse; LF, K01 HL138159, National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, COL CANC SCREEN INS; [Anonymous], 2017, COL CANC FACTS FIG 2; Antonisse L., 2017, EFFECTS MEDICAID EXP; Chubak J, 2016, CANCER EPIDEM BIOMAR, V25, P344, DOI 10.1158/1055-9965.EPI-15-0470; Clemans-Cope L, 2012, HEALTH AFFAIR, V31, P920, DOI 10.1377/hlthaff.2011.1086; Courtemanche C, 2017, J POLICY ANAL MANAG, V36, P178, DOI 10.1002/pam.21961; Davis MM, 2017, PREV MED, V101, P44, DOI 10.1016/j.ypmed.2017.05.001; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; Dorn S, 2015, EFFECTS MEDICAID EXP; Dworsky M, 2016, EFFECT 2014 MEDICAID; Eibner Christine, 2012, Rand Health Q, V2, P2; Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z; Greenspan M, 2015, DIGEST DIS SCI, V60, P2930, DOI 10.1007/s10620-015-3664-2; Haddix AC, 2003, PREVENTION EFFECTIVE; Hinton E., 2016, CHARACTERISTICS REMA; Kahn B, 2015, CANCER CAUSE CONTROL, V26, P1653, DOI 10.1007/s10552-015-0661-x; Kaiser Family Foundation, CUSS STAT STAT MED E; Lansdorp-Vogelaar I, 2009, GASTROINTEST ENDOSC, V70, P96, DOI 10.1016/j.gie.2008.08.040; Lebwohl B, 2012, ALIMENT PHARM THER, V35, P1467, DOI 10.1111/j.1365-2036.2012.05119.x; Lich KH, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160158; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Long S.K., 2014, TAKING STOCK HLTH IN; Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336; Office of the Assistant Secretary for Planning and Evaluation, 2017, MED EXP IMP INS COV; Parente ST, 2013, HEALTH SERV RES, V48, P826, DOI 10.1111/1475-6773.12036; Peterse EFP, 2017, HEALTH AFFAIR, V36, P2151, DOI 10.1377/hlthaff.2017.0228; Richman I, 2016, J GEN INTERN MED, V31, P315, DOI 10.1007/s11606-015-3504-2; Rudowitz R., 2014, UNDERSTANDING STATES; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Schroy PC, 2013, ANN INTERN MED, V159, P13, DOI 10.7326/0003-4819-159-1-201307020-00004; Scott JW, 2017, J TRAUMA ACUTE CARE, V82, P887, DOI 10.1097/TA.0000000000001400; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2014, HEALTH AFFAIR, V33, P78, DOI 10.1377/hlthaff.2013.1087; Sommers BD, 2013, NEW ENGL J MED, V368, P496, DOI 10.1056/NEJMp1215785; Subramanian S, 2009, CANCER EPIDEM BIOMAR, V18, P1971, DOI 10.1158/1055-9965.EPI-09-0083; Wheaton William D, 2009, Methods Rep RTI Press, V2009, P905; Wheeler Stephanie B, 2017, Prev Med Rep, V6, P9, DOI 10.1016/j.pmedr.2016.11.019; Wheeler SB, 2014, HEALTH PLACE, V29, P114, DOI 10.1016/j.healthplace.2014.07.001; Zauber AG, 2007, COST EFFECTIVENESS D	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226942	10.1371/journal.pone.0226942	http://dx.doi.org/10.1371/journal.pone.0226942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978084	Green Published, gold			2022-12-26	WOS:000534599100023
J	Yang, LT; Ma, F; Zeng, HT; Zhao, M; Zeng, XH; Liu, ZQ; Yang, PC				Yang, Li-Tao; Ma, Fei; Zeng, Hao-Tao; Zhao, Miao; Zeng, Xian-Hai; Liu, Zhi-Qiang; Yang, Ping-Chang			Restoration of Mal overcomes the defects of apoptosis in lung cancer cells	PLOS ONE			English	Article							RNA DECAY; EXPRESSION; RESISTANCE; FAS/FASL; INVASION; PATHWAY	Background and aims Cancer is one of the life-threatening diseases of human beings; the pathogenesis of cancer remains to be further investigated. Toll like receptor (TLR) activities are involved in the apoptosis regulation. This study aims to elucidate the role of Mal (MyD88-adapter-like) molecule in the apoptosis regulation of lung cancer (LC) cells. Methods The LC tissues were collected from LC patients. LC cells and normal control (NC) cells were isolated from the tissues and analyzed by pertinent biochemical and immunological approaches. Results We found that fewer apoptotic LC cells were induced by cisplatin in the culture as compared to NC cells. The expression of Fas ligand (FasL) was lower in LC cells than that in NC cells. FasL mRNA levels declined spontaneously in LC cells. A complex of FasL/TDP-43 was detected in LC cells. LC cells expressed less Mal than NC cells. Activation of Mal by lipopolysaccharide (LPS) increased TDP-43 expression in LC cells. TDP-43 formed a complex with FasL mRNA to prevent FasL mRNA from decay. Reconstitution of Mal or TDP-43 restored the sensitiveness of LC cells to apoptotic inducers. Conclusions LC cells express low Mal levels that contributes to FasL mRNA decay through impairing TDP-43 expression. Reconstitution of Mal restores sensitiveness of LC cells to apoptosis inducers that may be a novel therapeutic approach for LC treatment.	[Yang, Li-Tao; Ma, Fei; Zeng, Hao-Tao; Zhao, Miao; Zeng, Xian-Hai; Liu, Zhi-Qiang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Res Ctr Allergy & Immunol, ENT Inst, Shenzhen, Peoples R China; [Yang, Li-Tao; Ma, Fei; Zeng, Hao-Tao; Zhao, Miao; Zeng, Xian-Hai; Liu, Zhi-Qiang; Yang, Ping-Chang] Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China	Shenzhen University	Liu, ZQ; Yang, PC (corresponding author), Shenzhen Univ, Sch Med, Res Ctr Allergy & Immunol, ENT Inst, Shenzhen, Peoples R China.; Liu, ZQ; Yang, PC (corresponding author), Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China.	liuzhiqiang05312438@126.com; pcy2356@szu.edu.cn		Zeng, Xianhai/0000-0002-9519-0112	National Natural Science Foundation of China [31570932]; Shenzhen Science, Technology and Innovation Committee [KQJSCX20180328095619081, KQTD20170331145453160]; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases [2019B030301009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science, Technology and Innovation Committee; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases	This study was supported by grants of Dr. Ping-Chang Yang from National Natural Science Foundation of China (31570932), Shenzhen Science, Technology and Innovation Committee (KQJSCX20180328095619081, KQTD20170331145453160), and Guangdong Provincial Key Laboratory of Regional Immunity and Diseases (2019B030301009). The funders had no role in study design, data collection and analysis, decision to7 publish, or preparation of the manuscript.	An YF, 2018, TOXICOLOGY, V395, P9, DOI 10.1016/j.tox.2018.01.001; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Figgett WA, 2013, IMMUNITY, V39, P573, DOI 10.1016/j.immuni.2013.05.019; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Guo FJ, 2015, BIOCHEM BIOPH RES CO, V465, P293, DOI 10.1016/j.bbrc.2015.08.027; He WY, 2014, CYTOKINE, V68, P32, DOI 10.1016/j.cyto.2014.03.010; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Kadara H, 2016, CANCER PREV RES, V9, P518, DOI 10.1158/1940-6207.CAPR-15-0400; Labno A, 2016, BBA-MOL CELL RES, V1863, P3125, DOI 10.1016/j.bbamcr.2016.09.023; Lee S, 2015, BMB REP, V48, P239, DOI 10.5483/BMBRep.2015.48.5.060; Mashima T, 2005, DRUG RESIST UPDATE, V8, P339, DOI 10.1016/j.drup.2005.11.001; Mikulandra M, 2017, CURR MED CHEM, V24, P2011, DOI 10.2174/0929867324666170320114359; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Nanavaty P, 2014, CANCER CONTROL, V21, P9, DOI 10.1177/107327481402100102; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Popp MW, 2018, CURR OPIN GENET DEV, V48, P44, DOI 10.1016/j.gde.2017.10.007; Pore MM, 2013, CANCER LETT, V332, P359, DOI 10.1016/j.canlet.2010.09.012; Rathore R, 2017, APOPTOSIS, V22, P898, DOI 10.1007/s10495-017-1375-1; Sui YX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/598386; Suvarna V, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172655; Tian Y, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0416-y; Wang M, 2018, SYST BIOL REPROD MED, V64, P93, DOI 10.1080/19396368.2017.1422046; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Yang C, 2012, CELL BIOL INT, V36, P289, DOI 10.1042/CBI20100825; Yu LCH, 2005, FASEB J, V19, P1822, DOI 10.1096/fj.05-4226com; Zanoaga O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174291; Zhang L, 2013, CURR COLORECT CANC R, V9, P331, DOI 10.1007/s11888-013-0188-z; Zhang PP, 2016, CANCER SCI, V107, P1563, DOI 10.1111/cas.13072	29	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227634	10.1371/journal.pone.0227634	http://dx.doi.org/10.1371/journal.pone.0227634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978067	Green Published, gold			2022-12-26	WOS:000534599100048
J	Dieng, S; Cisse, D; Lombrail, P; Azogui-Levy, S				Dieng, Serigne; Cisse, Daouda; Lombrail, Pierre; Azogui-Levy, Sylvie			Mothers' oral health literacy and children's oral health status in Pikine, Senegal: A pilot study	PLOS ONE			English	Article							DENTAL-CARIES; DETERMINANTS; ASSOCIATION; DISPARITIES; DENTISTRY; FAMILY	Context and objective As elsewhere, disadvantaged children in Senegal are those most affected by dental diseases and difficulties in obtaining dental care. Studies conducted mainly in developed countries suggest that a low level of mothers' OHL is correlated with poor oral health of their children. The objective of this study is to estimate the level of mothers' OHL in Senegal and its relationto the dental health of their children. Methods This cross-sectional epidemiological survey took place among 315 children aged from 3 to 9 years old and their mothers. It estimated the children's dental health status by clinical examination which used a disposable examination kit and a headlamp, took place at the child's home, in the mother's presence. Examiners interviewing the mothers administered the Oral Health Literacy-Adult Questionnaire to determine their OHL and questioned them further about their social characteristics and their children's dental health behaviour. Logistic regression and correlations were used for the statistical analysis. Results The OHL score ranges from 0 to 17; mothers' mean score was 6.5 (+/- 3.1) and 56.5% had a low score (below the median). The prevalence of dental caries in children was 64.8%. Mothers' high OHL is associated with children caries free and low prevalence of dental caries. The logistic regression showed a significantly protective relation between children's dental caries and mothers' high OHL scores (mean score 12-17) (OR = 0.51, 95% CI: 0.29-0.88), high educational level (OR = 0.42, 95% CI: 0.23-0.76) and a high level of social contact (OR = 0.31, 95% CI: 0.15-0.63). The structural analysis showed that OHL was significantly correlated with both the mothers' social position (r = 0.61 and P<0.001) and the children's caries (r = -0.26 and P<0.001). Conclusion The OHL level of Senegalese mothers was significantly associated with their children's dental caries. Improving mothers' OHL might therefore help strengthen their capacities to promote oral health, thus helping to improve their children's dental health and reduce inequalities.	[Dieng, Serigne; Lombrail, Pierre; Azogui-Levy, Sylvie] Paris 13 Univ, Fac Med, Educ & Hlth Practices Lab LEPS EA 3412, Bobigny, Senegal; [Dieng, Serigne] Sanit Dist Koki, Louga, Senegal; [Cisse, Daouda] Univ Cheik Anta Diop, Publ Hlth Serv, Dept Dent, Fac Med Pharm & Dent, Dakar, Senegal; [Lombrail, Pierre] Paris 13 Univ, Fac Med, Publ Hlth Dept, Bobigny, France; [Azogui-Levy, Sylvie] Paris Diderot Univ, Dent Publ Hlth Dept, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Azogui-Levy, S (corresponding author), Paris 13 Univ, Fac Med, Educ & Hlth Practices Lab LEPS EA 3412, Bobigny, Senegal.; Azogui-Levy, S (corresponding author), Paris Diderot Univ, Dent Publ Hlth Dept, Paris, France.	sylvie.azogui-levy@univ-paris-diderot.fr		LOMBRAIL, Pierre/0000-0002-5436-2475				American Dental Association, 2006, HLTH LIT DENT; Arthi Veerasamy, 2013, Journal of Theory and Practice of Dental Public Health, V1, P20; Benadof D, 2017, INT J PAEDIATR DENT, V27, P326, DOI 10.1111/ipd.12265; Blizniuk A, 2015, COMMUNITY DENT HLTH, V32, P148, DOI 10.1922/CDH_3584-Blizniuk05; Brega AG, 2016, HEALTH EDUC RES, V31, P70, DOI 10.1093/her/cyv055; Bridges SM, 2014, PATIENT EDUC COUNS, V94, P411, DOI 10.1016/j.pec.2013.10.018; Broadbent JM, 2006, J DENT RES, V85, P339, DOI 10.1177/154405910608500411; Calvasina P, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0176-1; Cisse D, 2009, Odontostomatol Trop, V32, P25; Diagne Mamousse, 2005, CRITIQUE RAISON ORAL; Disser NP, 2020, J BONE JOINT SURG AM, V102, P1197, DOI 10.2106/JBJS.20.00847; Divaris K, 2012, ACTA ODONTOL SCAND, V70, P390, DOI 10.3109/00016357.2011.629627; Duijster D, 2014, EUR J ORAL SCI, V122, P125, DOI 10.1111/eos.12118; Edwards M, 2015, HEALTH EXPECT, V18, P1180, DOI 10.1111/hex.12093; Fisher-Owens SA, 2007, PEDIATRICS, V120, pE510, DOI 10.1542/peds.2006-3084; Gong DA, 2007, J PUBLIC HEALTH DENT, V67, P105, DOI 10.1111/j.1752-7325.2007.00023.x; Horowitz AM, 2012, J PUBLIC HEALTH DENT, V72, pS26, DOI 10.1111/j.1752-7325.2012.00316.x; Kranz Ashley M, 2013, Pediatr Dent, V35, pE68; Lee JY, 2007, J PUBLIC HEALTH DENT, V67, P94, DOI 10.1111/j.1752-7325.2007.00021.x; Lee JY, 2012, AM J PUBLIC HEALTH, V102, P923, DOI 10.2105/AJPH.2011.300291; Leye Benoist F, 2014, TROP DENT J, P58; Macek MD, 2010, J PUBLIC HEALTH DENT, V70, P197, DOI 10.1111/j.1752-7325.2010.00165.x; Martins MT, 2014, COMMUNITY DENT ORAL, V42, P289, DOI 10.1111/cdoe.12087; Nutbeam D, 2017, JAPANESE J HEAL ED P, V25, P210, DOI [DOI 10.11260/KENKOKYOIKU.25.210, 10.11260/kenkokyoiku.25.210]; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Olutola BG, 2012, INT J ENV RES PUB HE, V9, P3465, DOI 10.3390/ijerph9103465; Petersen PE, 2009, COMMUNITY DENT ORAL, V37, P1, DOI 10.1111/j.1600-0528.2008.00448.x; Shetty R.M., 2016, SAUDI J ORAL SCI, V3, P12, DOI [DOI 10.4103/1658-6816.174291, 10.4103/1658-6816.174291]; Sistani MMN, 2014, J INVESTIG CLIN DENT, V5, DOI 10.1111/jicd.12042; Van den Branden S, 2012, EUR J ORAL SCI, V120, P153, DOI 10.1111/j.1600-0722.2012.00951.x; Vann WF, 2010, J DENT RES, V89, P1395, DOI 10.1177/0022034510379601; Varenne B, 2011, REV EPIDEMIOL SANTE, V59, P385, DOI 10.1016/j.respe.2011.07.002; Vichayanrat T., 2014, M DENT J, V34, P243; Vyas Shaleen, 2016, J Adv Med Educ Prof, V4, P163; Warren JJ, 2016, COMMUNITY DENT ORAL, V44, P154, DOI 10.1111/cdoe.12200; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P289, DOI 10.1111/j.1600-0528.2012.00680.x	36	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0226876	10.1371/journal.pone.0226876	http://dx.doi.org/10.1371/journal.pone.0226876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5RH	31971936	gold, Green Published			2022-12-26	WOS:000534374400007
J	Szuwalski, C; Jin, XS; Shan, XJ; Clavelle, T				Szuwalski, Cody; Jin, Xianshi; Shan, Xiujuan; Clavelle, Tyler			Marine seafood production via intense exploitation and cultivation in China: Costs, benefits, and risks	PLOS ONE			English	Article							ENVIRONMENTAL-IMPACT; FISHERIES; AQUACULTURE; MANAGEMENT; SEA; VULNERABILITY; ANTIBIOTICS; POPULATION; ECOSYSTEMS; CULTURE	Identifying strategies to maintain seafood supply is central to global food supply. China is the world's largest producer of seafood and has used a variety of production methods in the ocean including domestic capture fisheries, aquaculture (both freshwater and marine), stock enhancement, artificial reef building, and distant water fisheries. Here we survey the outcomes of China's marine seafood production strategies, with particular attention paid to the associated costs, benefits, and risks. Benefits identified include high production, low management costs, and high employment, but significant costs and risks were also identified. For example, a majority of fish in China's catches are one year-old, ecosystem and catch composition has changed relative to the past, wild and farmed stocks can interact both negatively and positively, distant water fisheries are a potential source of conflict, and disease has caused crashes in mariculture farms. Reforming China's wild capture fisheries management toward strategies used by developed nations would continue to shift the burden of production to aquaculture and could have negative social impacts due to differences in fishing fleet size and behavior, ecosystem structure, and markets. Consequently, China may need to develop novel management methods in reform efforts, rather than rely on examples from other large seafood producing countries. Improved accounting of production from fisheries and aquaculture, harmonization and centralization of historical data sets and systematic scientific surveys would improve the knowledge base for planning and evaluating future reform.	[Szuwalski, Cody] NOAA, Alaska Fishery Sci Ctr, Seattle, WA 98115 USA; [Jin, Xianshi; Shan, Xiujuan] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Jin, Xianshi; Shan, Xiujuan] Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Clavelle, Tyler] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Qingdao National Laboratory for Marine Science & Technology; University of California System; University of California Santa Barbara	Szuwalski, C (corresponding author), NOAA, Alaska Fishery Sci Ctr, Seattle, WA 98115 USA.	cody.szuwalski@noaa.gov			Packard Foundation [2016-64741]; National Basic Research Program of China [2015CB453303]; National Key R&D Program of China [2017YFE0104400]	Packard Foundation(The David & Lucile Packard Foundation); National Basic Research Program of China(National Basic Research Program of China); National Key R&D Program of China	CS and TC were funded by the Packard Foundation (Grant #2016-64741). JX and SX were funded by the National Basic Research Program of China (2015CB453303) and National Key R&D Program of China (2017YFE0104400). Packard foundation website: https://www.packard.org/.China Basic Research Program description website: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Bao Zhiping and Iwen Su for help in data collection. We would like to thank Gregory Britten and an anonymous reviewer for comments that improved this manuscript. Supporting information is available online. The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the author(s) and do not necessarily reflect those of NOAA or the Department of Commerce. All data used in this analysis are publicly available in the annual publication of China Fishery Statistical Yearbooks and websites for the Sea Around Us, the Food and Agricultural Organization's, the Organisation for Economic Cooperation and Development, and the World Bank (cited above).	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Andersen KH, 2015, ECOL APPL, V25, P1390, DOI 10.1890/14-1209.1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barnett LAK, 2017, CURR BIOL, V27, P2843, DOI 10.1016/j.cub.2017.07.069; Bell JD, 2008, REV FISH SCI, V16, P1, DOI 10.1080/10641260701776951; Biao X, 2007, OCEAN COAST MANAGE, V50, P538, DOI 10.1016/j.ocecoaman.2007.02.006; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Breitburg DL, 2009, HYDROBIOLOGIA, V629, P31, DOI 10.1007/s10750-009-9762-4; Broughton EI, 2010, FOOD POLICY, V35, P471, DOI 10.1016/j.foodpol.2010.05.007; Brown CJ, 2014, CONSERV BIOL, V28, P677, DOI 10.1111/cobi.12267; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Callier M.D, 2017, REV AQUACULT, DOI [10.1111/raq.12193, DOI 10.1111/RAQ.12193]; Cao L, 2017, P NATL ACAD SCI USA, V114, P435, DOI 10.1073/pnas.1616583114; Cao L, 2015, SCIENCE, V347, P133, DOI 10.1126/science.1260149; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; China Agriculture Press, 1986, CHINA FISHERY STAT Y; Christensen V, 2004, B MAR SCI, V74, P549; Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946; Clavelle T, 2019, FISH FISH, DOI [10.1111/faf.12368, DOI 10.1111/FAF.12368]; Costello C, 2017, P NATL ACAD SCI USA, V114, P1442, DOI 10.1073/pnas.1620731114; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Fang JG, 2016, AQUACULT ENV INTERAC, V8, P201, DOI 10.3354/aei00179; FEIGON L, 2000, J CONTEMP CHINA, V9, P323; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Gibbs MT, 2004, AQUACULTURE, V240, P267, DOI 10.1016/j.aquaculture.2004.06.038; Guo Z, 2008, 1029 FAO; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hilborn R, P NATL ACAD SCI; Jennings S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133794; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Klinger DH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0834; Lin Long-Shan, 2006, Marine Sciences (Beijing), V30, P21; Lin YP, 2015, REV AQUACULT, V7, P28, DOI 10.1111/raq.12052; Link J, 2002, MAR ECOL PROG SER, V230, P1, DOI 10.3354/meps230001; Liu H, 2017, ENVIRON SCI POLLUT R, V24, P8957, DOI 10.1007/s11356-015-5239-3; Liu M, 2014, FISH FISH, V9, P219; Mallory TG, 2016, MAR POLICY, V68, P74, DOI 10.1016/j.marpol.2016.01.028; Mallory TG, 2013, MAR POLICY, V38, P99, DOI 10.1016/j.marpol.2012.05.024; Mangin T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204258; Matsuda H, 2006, ECOL APPL, V16, P225, DOI 10.1890/05-0346; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; Ministry of Agriculture (MOA), 2017, NOT STRENGTH CONTR D; Mo WY, 2017, ENVIRON SCI POLLUT R, V24, P8978, DOI 10.1007/s11356-015-5607-z; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; NOAA, 2021, CURR FISH STAT NO 20; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Pauly D., 2015, SEA US CONCEPTS DESI; Pauly D., 2015, WORKING PAPER SERIES; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Rudd MB, 2017, FISH FISH, V18, P313, DOI 10.1111/faf.12181; Sala E, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2504; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shen YB, 2018, NAT MICROBIOL, V3, P1054, DOI 10.1038/s41564-018-0205-8; Stern DI, 1996, WORLD DEV, V24, P1151, DOI 10.1016/0305-750X(96)00032-0; Sun P, 2017, ICES J MAR SCI, V74, P2239, DOI 10.1093/icesjms/fsx058; Szuwalski CS, 2017, P NATL ACAD SCI USA, V114, P717, DOI 10.1073/pnas.1612722114; Tang Q.S., 2017, DEV STRATEGY ENV FRI; Tang QS, 2016, ENVIRON DEV, V17, P175, DOI 10.1016/j.envdev.2015.06.012; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Troell M, 2009, AQUACULTURE, V297, P1, DOI 10.1016/j.aquaculture.2009.09.010; Venables WN., 2002, MODERN APPL STAT S 4; Wang QD, 2018, AMBIO, V47, P410, DOI 10.1007/s13280-017-0985-8; Wang S, 2009, CHINA SPECIES RED A, V2; Wang S, 2009, CHINA SPECIES RED B, V2; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Watson R, 2014, FISH FISH, V15, P231, DOI 10.1111/faf.12013; Wu RSS, 1995, MAR POLLUT BULL, V31, P159, DOI 10.1016/0025-326X(95)00100-2; Yang H, 2017, SCIENCE, V356, P1343, DOI 10.1126/science.aan8389; Ye YM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0179; Zhang B, 2007, J MARINE SYST, V67, P304, DOI 10.1016/j.jmarsys.2006.04.015; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1; Zou LL, 2015, AQUACULT REP, V2, P46, DOI 10.1016/j.aqrep.2015.07.001; Zou SC, 2011, ENVIRON POLLUT, V159, P2913, DOI 10.1016/j.envpol.2011.04.037	76	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227106	10.1371/journal.pone.0227106	http://dx.doi.org/10.1371/journal.pone.0227106			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951624	gold, Green Published			2022-12-26	WOS:000534370500009
J	Xie, JH; Zhao, Y; Yu, LQ; Liu, RJ; Dou, QW				Xie, Jihong; Zhao, Yan; Yu, Linqing; Liu, Ruijuan; Dou, Quanwen			Molecular karyotyping of Siberian wild rye (Elymus sibiricus L.) with oligonucleotide fluorescence in situ hybridization (FISH) probes	PLOS ONE			English	Article							GENETIC DIVERSITY; CHROMOSOMAL REARRANGEMENTS; REPETITIVE SEQUENCES; TRITICUM-ARARATICUM; GENOME ANALYSIS; MARKERS; WHEAT	Siberian wild rye (Elymus sibiricus L.), an allotetraploid species, is a potentially high-quality perennial forage crop native to temperate regions. We used fluorescently conjugated oligonucleotides, representing ten repetitive sequences, including 6 microsatellite repeats, two satellite repeats, and two ribosomal DNAs, to characterize E. sibiricus chromosomes, using sequential fluorescence in situ hybridization and genomic in situ hybridization assays. Our results showed that microsatellite repeats (AAG)(10) or (AGG)(10), satellite repeats pAs1 and pSc119.2, and ribosomal 5S rDNA and 45S rDNA are specific markers for unique chromosomes. A referable karyotype ideogram was suggested, by further polymorphism screening, across different E. sibiricus cultivars with a probe mixture of (AAG)(10), Oligo-pAs1, and OligopSc119.2. Chromosomal polymorphisms vary between different genomes and between different individual chromosomes. In particular, two distinct forms of chromosome E in H genome were identified in intra- and inter-populations. Here, the significance of these results, for E. sibiricus genome research and breeding, and novel approaches to improve fluorescence in situ hybridization-based karyotyping are discussed.	[Xie, Jihong; Yu, Linqing] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Zhao, Yan] Inner Mongolia Agr Univ, Coll Grassland Resource & Environm Sci, Hohhot, Peoples R China; [Liu, Ruijuan; Dou, Quanwen] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Crop Mol Breeding, Xining, Peoples R China; [Liu, Ruijuan; Dou, Quanwen] Chinese Acad Sci, Northwest Plateau Inst Biol, Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia Agricultural University; Chinese Academy of Sciences; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS	Dou, QW (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Crop Mol Breeding, Xining, Peoples R China.; Dou, QW (corresponding author), Chinese Acad Sci, Northwest Plateau Inst Biol, Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China.	douqw@nwipb.cas.cn			National Grass Variety Regional Trial Project [21301060001]; Central Public-interest Scientific Institution Basal Research Fund [Y2018LM05]	National Grass Variety Regional Trial Project; Central Public-interest Scientific Institution Basal Research Fund	This work was supported by National Grass Variety Regional Trial Project (21301060001) and Central Public-interest Scientific Institution Basal Research Fund (Y2018LM05) to QD.	BADAEVA ED, 1995, GENOME, V38, P976, DOI 10.1139/g95-128; BADAEVA ED, 1994, PLANT SYST EVOL, V192, P117, DOI 10.1007/BF00985912; Baum BR, 2012, BOTANY, V90, P407, DOI [10.1139/B2012-013, 10.1139/b2012-013]; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Cuadrado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081385; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Danilova TV, 2012, CHROMOSOMA, V121, P597, DOI 10.1007/s00412-012-0384-7; Dewey D.R., 1984, TAXON, V35, P202, DOI DOI 10.2307/1221077; Dou QW, 2011, J SYST EVOL, V49, P347, DOI 10.1111/j.1759-6831.2011.00138.x; Dou QW, 2016, COMP CYTOGENET, V10, P465, DOI 10.3897/CompCytogen.v10i4.9666; Giorgi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057994; Jiang JM, 2019, CHROMOSOME RES, V27, P153, DOI 10.1007/s10577-019-09607-z; Kato A, 2004, P NATL ACAD SCI USA, V101, P13554, DOI 10.1073/pnas.0403659101; Kato A, 1999, BIOTECH HISTOCHEM, V74, P160, DOI 10.3109/10520299909047968; KLEBESADEL LJ, 1969, AGRON J, V61, P855, DOI 10.2134/agronj1969.00021962006100060008x; Lei YT, 2014, CONSERV GENET RESOUR, V6, P861, DOI 10.1007/s12686-014-0225-5; Ma X, 2008, BIOCHEM SYST ECOL, V36, P514, DOI 10.1016/j.bse.2008.03.003; Ma X, 2012, MOLECULES, V17, P4424, DOI 10.3390/molecules17044424; [毛培胜 Mao Peisheng], 2003, [草地学报, Acta agrestia sinica], V11, P33; Rayburn A. L., 1986, PLANT MOL BIOL REP, V4, P102, DOI [10.1007/BF02732107, DOI 10.1007/BF02732107, /10.1007/BF02732107]; Said M, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2018.12.0096; Said M, 2018, THEOR APPL GENET, V131, P2213, DOI 10.1007/s00122-018-3148-9; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Xie WG, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1026-2; Xie WG, 2015, BIOCHEM SYST ECOL, V58, P211, DOI 10.1016/j.bse.2014.12.006; Yan JiaJun, 2010, Acta Prataculturae Sinica, V19, P173; Zhang JC, 2015, MOLECULES, V20, P5987, DOI 10.3390/molecules20045987; Zhao XH, 2017, HEREDITAS, V154, DOI 10.1186/s41065-017-0053-1; Zhou Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep20549	30	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227208	10.1371/journal.pone.0227208	http://dx.doi.org/10.1371/journal.pone.0227208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951623	gold, Green Published			2022-12-26	WOS:000534370500012
J	Wang, SH; Li, MX; Zhao, XJ; Wang, H; Zhu, J; Wang, C; Zhou, MS; Dong, HF; Zhou, R				Wang, Shuhong; Li, Mingxuan; Zhao, Xuejun; Wang, Huan; Zhu, Jie; Wang, Cheng; Zhou, Mengsi; Dong, Huifen; Zhou, Rui			Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-beta 1	FASEB JOURNAL			English	Article						KSRP; liver fibrosis; miR-27b; Schistosoma japonicum; TGF-beta	STELLATE CELLS; KUPFFER CELLS; PATHOGENESIS; ACTIVATION; MECHANISMS	Hepatic stellate cells (HSCs) are the main effectors for various types of hepatic fibrosis, including Schistosome-induced hepatic fibrosis. Multiple inflammatory cytokines/chemokines, such as transforming growth factor-beta 1 (TGF-beta 1), activate HSCs, and contribute to the development of hepatic fibrosis. MicroRNAs regulate gene expression at the posttranscriptional level and are involved in regulation of inflammatory cytokine/chemokine synthesis. In this study, we showed that soluble egg antigen (SEA) stimulation and Schistosoma japonicum infection downregulate miR-27b expression and increase KH-type splicing regulatory protein (KSRP) mRNA and protein levels in vitro and in vivo. miR-27b regulates the stabilization of TGF-beta 1 mRNA through targeting KSRP by interacting with their AU-rich elements in hepatocytes and non-parenchymal cells, which has an effect on the activation of HSCs. Importantly, our results have shown that either knockdown miR-27b or overexpression of KSRP attenuates S. japonicum-induced hepatic fibrosis in vivo. Therefore, our study highlights the crucial role of miR-27b and KSRP in the negative regulation of immune reactions in hepatocyte and non-parenchymal cells in response to SEA stimulation and S. japonicum infection. It reveals that manipulation of miR-27b or KSRP might be a useful strategy not only for treating Schistosome-induced hepatic fibrosis but also for curing hepatic fibrosis in general.	[Wang, Shuhong; Li, Mingxuan; Zhao, Xuejun; Zhu, Jie; Wang, Cheng; Zhou, Mengsi; Dong, Huifen; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, Wuhan, Hubei, Peoples R China; [Wang, Shuhong; Li, Mingxuan; Zhao, Xuejun; Wang, Huan; Zhu, Jie; Wang, Cheng; Zhou, Mengsi; Dong, Huifen; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Dong, HF; Zhou, R (corresponding author), Wuhan Univ, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	hfdong@whu.edu.cn; ruizhou@whu.edu.cn						Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Chen C, 2017, CELL BIOL INT, V41, P871, DOI 10.1002/cbin.10804; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Duan YN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005268; Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003; Hao CQ, 2014, CLIN EXP MED, V14, P141, DOI 10.1007/s10238-013-0229-6; He X, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006957; He X, 2018, P NATL ACAD SCI USA, V115, P180, DOI 10.1073/pnas.1715965115; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin CY, 2016, STEM CELLS, V34, P2707, DOI 10.1002/stem.2439; Khera TK, 2010, FEBS J, V277, P2754, DOI 10.1111/j.1742-4658.2010.07692.x; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lewis FA, 2014, ADV EXP MED BIOL, V766, P47, DOI 10.1007/978-1-4939-0915-5_3; Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x; Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; World Health Organization, 2019, SCHISTOSOMIASIS; Xia ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17590; Xidakis C, 2005, DIGEST DIS SCI, V50, P935, DOI 10.1007/s10620-005-2668-8; Yu Q, 2017, MOL BIOTECHNOL, V59, P365, DOI 10.1007/s12033-017-0025-8; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702; Zhu DD, 2018, FASEB J, V32, P4798, DOI 10.1096/fj.201700520RR; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044032	35	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4120	4133		10.1096/fj.201902438R	http://dx.doi.org/10.1096/fj.201902438R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31953889				2022-12-26	WOS:000519218400046
J	Kaestner, F; Seiler, F; Rapp, D; Eckert, E; Muller, J; Metz, C; Bals, R; Drexler, H; Lepper, PM; Goen, T				Kaestner, Franziska; Seiler, Frederik; Rapp, Daniel; Eckert, Elisabeth; Mueller, Johannes; Metz, Carlos; Bals, Robert; Drexler, Hans; Lepper, Philipp M.; Goeen, Thomas			Exposure of patients to di(2-ethylhexy) phthalate (DEHP) and its metabolite MEHP during extracorporeal membrane oxygenation (ECMO) therapy	PLOS ONE			English	Article							TRI(2-ETHYLHEXYL) TRIMELLITATE; BLOOD; HEMODIALYSIS; PLASTICIZER; RISK; CHOLESTASIS; PROGNOSIS; MORTALITY; MIGRATION; PRODUCTS	The plasticizer di(2-ethylhexyl)phthalate (DEHP) is often used for PVC medical devices, that are also largely used for intensive care medical treatments, like extracorporeal membrane oxygenation (ECMO) therapy. Due to the toxicological potential of DEHP, the inner exposure of patients with this plasticizer is a strong matter of concern as many studies have shown a high leaching potential of DEHP into blood. In this study, the inner DEHP exposure of patients undergoing ECMO treatment was investigated. The determined DEHP blood levels of ECMO patients and the patients of the control group ranged from 31.5 to 1009 mu g/L (median 156.0 mu g/L) and from 19.4 to 75.3 mu g/L (median 36.4 mu g/L), respectively. MEHP blood levels were determined to range from < LOD to 475 mu g/L (median 15.9 mu g/L) in ECMO patients and from < LOD to 9.9 mu g/L (median 3.7 mu g/L) in the control group patients, respectively. Increased DEHP exposure was associated with the number of cannulas and membranes of the ECMO setting, whereas residual diuresis decreased the exposure. Due to the suspected toxicological potential of DEHP, its use in medical devices should be further investigated, in particular for ICU patients with long-term exposure to PVC, like in ECMO therapy.	[Kaestner, Franziska; Seiler, Frederik; Metz, Carlos; Bals, Robert; Lepper, Philipp M.] Univ Hosp Saarland, Dept Internal Med 5, Homburg, Germany; [Rapp, Daniel] Saarland Univ, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Eckert, Elisabeth; Mueller, Johannes; Drexler, Hans; Goeen, Thomas] Friedrich Alexander Univ Erlangen Nurnberg, Inst & Outpatient Clin Occupat Social & Environm, Erlangen, Germany; [Kaestner, Franziska] Fachkliniken Wangen, Dept Resp Med, Wangen Im Allgau, Germany; [Rapp, Daniel] RKU Univ, Dept Neurol, Ulm, Germany; [Rapp, Daniel] Rehabil Clin Ulm, Ulm, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; University of Erlangen Nuremberg; Ulm University	Lepper, PM (corresponding author), Univ Hosp Saarland, Dept Internal Med 5, Homburg, Germany.	philipp.lepper@uks.eu						Almizraq RJ, 2018, TRANSFUSION, V58, P1089, DOI 10.1111/trf.14622; BAKER RWR, 1978, TOXICOLOGY, V9, P319, DOI 10.1016/0300-483X(78)90015-X; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Eckert E, 2016, CHEMOSPHERE, V145, P10, DOI 10.1016/j.chemosphere.2015.11.067; Eckert E, 2015, J CHROMATOGR A, V1410, P173, DOI 10.1016/j.chroma.2015.07.083; Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6; Genuis SJ, 2012, SCI WORLD J, V2012, DOI [DOI 10.1100/2012/615068, 10.1100/2012/615068]; Goen T, 2012, INT J HYG ENVIR HEAL, V215, P229, DOI 10.1016/j.ijheh.2011.08.012; Goen T, 2011, INT J HYG ENVIR HEAL, V215, P36, DOI 10.1016/j.ijheh.2011.07.011; Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/ehp.7932; Greiner TO, 2012, PERFUSION-UK, V27, P21, DOI 10.1177/0267659111419990; Haishima Y, 2004, INT J PHARMACEUT, V274, P119, DOI 10.1016/j.ijpharm.2004.01.009; Han JH, 2005, INT J PHARMACEUT, V294, P157, DOI 10.1016/j.ijpharm.2005.01.030; Hartwig A, 1743, MAK COLLECTION OCCUP, DOI [10.1002/3527600418.mb11781e6017, DOI 10.1002/3527600418.MB11781E6017]; Horvatits T, 2013, CURR OPIN CRIT CARE, V19, P128, DOI 10.1097/MCC.0b013e32835ec9e6; Hsiao CC, 2014, ANN THORAC SURG, V97, P1939, DOI 10.1016/j.athoracsur.2014.02.021; Huygh J, 2015, ENVIRON INT, V81, P64, DOI 10.1016/j.envint.2015.04.008; Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019; Kaestner F, 2018, ASAIO J, V64, P232, DOI 10.1097/MAT.0000000000000610; Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7; Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023; Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-5; Kramer L, 2007, CRIT CARE MED, V35, P1099, DOI 10.1097/01.CCM.0000259462.97164.A0; Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312; Muller T, 2009, CRIT CARE, V13, DOI 10.1186/cc8213; Munch F, 2018, CHEMOSPHERE, V202, P742, DOI 10.1016/j.chemosphere.2018.03.136; MUNCH J, 2019, PERFUSION, V34, DOI DOI 10.1177/0267659119851403; Pappalardo F, 2013, INTENS CARE MED, V39, P275, DOI 10.1007/s00134-012-2747-1; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 2002, LIVER, V22, P69, DOI 10.1034/j.1600-0676.2002.00014.x; ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609; SCENIHR- Scientific Committee on Emerging and Newly-Identified Health Risks, SAF MED DEV CONT DEH; Schmidt M, 2014, AM J RESP CRIT CARE, V189, P1374, DOI 10.1164/rccm.201311-2023OC; Schulz C, 2012, INT J HYG ENVIR HEAL, V215, P150, DOI 10.1016/j.ijheh.2012.01.003; SHNEIDER B, 1991, J PEDIATR GASTR NUTR, V13, P285, DOI 10.1097/00005176-199110000-00008; Sundaram V, 2017, HEPATOL COMMUN, V1, P726, DOI 10.1002/hep4.1088; Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H; von Rettberg H, 2009, PEDIATRICS, V124, P710, DOI 10.1542/peds.2008-1765	39	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0224931	10.1371/journal.pone.0224931	http://dx.doi.org/10.1371/journal.pone.0224931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999712	Green Published, gold			2022-12-26	WOS:000534612400006
J	Crespo-Lessmann, A; Curto, E; Mateus, E; Soto, L; Garcia-Moral, A; Torrejon, M; Belda, A; Giner, J; Ramos-Barbon, D; Plaza, V				Crespo-Lessmann, Astrid; Curto, Elena; Mateus, Eder; Soto, Lorena; Garcia-Moral, Alba; Torrejon, Montserrat; Belda, Alicia; Giner, Jordi; Ramos-Barbon, David; Plaza, Vicente			Total and specific immunoglobulin E in induced sputum in allergic and non-allergic asthma	PLOS ONE			English	Article							BRONCHIAL BIOPSIES; INTRINSIC ASTHMA; IGE; MUCOSA; VALIDATION; PHENOTYPES; RHINITIS; VALUES; CELL; RNA	Background Most patients with nonallergic asthma have normal serum immunoglobulin E (IgE) levels. Recent reports suggest that total and aeroallergen-specific IgE levels in induced sputum may be higher in nonallergic asthmatics than in healthy controls. Our objective is to compare total and dust-mite specific (Der p 1) IgE levels in induced sputum in allergic and nonallergic asthmatics and healthy controls. Methods Total and Der p 1-specific IgE were measured in induced sputum (ImmunoCAP immunoassay) from 56 age-and sex-matched asthmatics (21 allergic, 35 nonallergic) and 9 healthy controls. Allergic asthma was defined as asthma with a positive prick test and/or clinicallysignificant Der p 1-specific serum IgE levels. Results Patients with allergic asthma presented significantly higher total and Der p 1-specific serum IgE levels. There were no significant between-group differences in total sputum IgE. However, Der p 1-specific sputum IgE levels were significantly higher (p = 0.000) in the allergic asthmatics, but without differences between the controls and nonallergic asthmatics. Serum and sputum IgE levels were significantly correlated, both for total IgE (rho = 0.498; p = 0.000) and Der p 1-specific IgE (rho, 0.621; p = 0001). Conclusions Total IgE levels measured in serum and induced sputum are significantly correlated. No significant differences were found between the differents groups in total sputum IgE. Nevertheless, the levels of Der p 1-specific sputum IgE levels were significantly higher in the allergic asthmatics, but without differences between the controls and nonallergic asthmatics. Probably due to the lack of sensitivity of the test used, but with the growing evidence for local allergic reactions better methods are need to explore its presence.	[Crespo-Lessmann, Astrid; Curto, Elena; Mateus, Eder; Soto, Lorena; Garcia-Moral, Alba; Torrejon, Montserrat; Belda, Alicia; Giner, Jordi; Ramos-Barbon, David; Plaza, Vicente] Univ Autonoma Barcelona UAB, Dept Resp Med & Allergol, Hosp Santa Creu & St Pau, Inst St Pau Biomed Res,IBB St Pau,Dept Med,CIBER, Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; Hospital of Santa Creu i Sant Pau; Hospital Universitari Vall d'Hebron	Crespo-Lessmann, A (corresponding author), Univ Autonoma Barcelona UAB, Dept Resp Med & Allergol, Hosp Santa Creu & St Pau, Inst St Pau Biomed Res,IBB St Pau,Dept Med,CIBER, Barcelona, Spain.	acrespo@santpau.cat	RAMOS-BARBON, DAVID/C-6624-2009	RAMOS-BARBON, DAVID/0000-0002-9615-6557; Crespo Lessmann, Astrid/0000-0002-2238-6851	Fundacio Catalana de Pneumologia	Fundacio Catalana de Pneumologia	Funding sources: Leti Grant. Fundacio Catalana de Pneumologia, 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn JY, 2018, PEDIAT ALLER IMM PUL, V31, P73, DOI 10.1089/ped.2017.0864; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Arauujo L, 2013, J INVEST ALLERG CLIN, V23, P330; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Barnes PJ, 2009, CLIN EXP ALLERGY, V39, P1145, DOI 10.1111/j.1365-2222.2009.03298.x; Beeh KM, 2000, EUR RESPIR J, V16, P609, DOI 10.1034/j.1399-3003.2000.16d07.x; Belda J, 2000, AM J RESP CRIT CARE, V161, P475, DOI 10.1164/ajrccm.161.2.9903097; Borriello EM, 2013, SHORTNESS BREATH, V2, P55; Lessmann AC, 2015, RESPIRATION, V90, P111, DOI 10.1159/000431259; Dakhama A, 2004, AM J RESP CRIT CARE, V170, P952, DOI 10.1164/rccm.200311-1610oc; De Schryver E, 2015, ALLERGY ASTHMA IMMUN, V7, P321, DOI 10.4168/aair.2015.7.4.321; Vennera MD, 2014, INT J GEN MED, V7, P365, DOI 10.2147/IJGM.S45259; Froidure A, 2016, EUR RESPIR J, V47, P304, DOI 10.1183/13993003.01824-2014; Humbert M, 1996, AM J RESP CRIT CARE, V153, P1931, DOI 10.1164/ajrccm.153.6.8665058; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Lommatzsch M, 2016, ALLERGO J, V25, P27, DOI 10.1007/s15007-016-1002-4; Lommatzsch M, 2014, THORAX, V69, P94, DOI 10.1136/thoraxjnl-2013-203738; Manise M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058388; Margarit G, 2005, Allergol Immunopathol (Madr), V33, P48; MERRETT J, 1987, CLIN ALLERGY, V17, P409, DOI 10.1111/j.1365-2222.1987.tb02034.x; Mouthuy J, 2011, AM J RESP CRIT CARE, V184, P206, DOI 10.1164/rccm.201009-1434OC; de Llano LP, 2013, J ASTHMA, V50, P296, DOI 10.3109/02770903.2012.757780; Peters SP, 2014, J ALLER CL IMM-PRACT, V2, P650, DOI 10.1016/j.jaip.2014.09.006; Pillai P, 2014, J ALLERGY CLIN IMMUN, V133, P1770, DOI 10.1016/j.jaci.2014.03.027; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Rondon C, 2017, ALLERGY, V72, P24, DOI 10.1111/all.12988; Rondon C, 2012, ALLERGY, V67, P1282, DOI 10.1111/all.12002; Rondon C, 2014, J ALLERGY CLIN IMMUN, V133, P1026, DOI 10.1016/j.jaci.2013.10.034; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Valenta R, 2000, J ALLERGY CLIN IMMUN, V105, P432, DOI 10.1067/mai.2000.104783; Vega JM, 2007, J ASTHMA, V44, P867, DOI 10.1080/02770900701752615; Ying S, 2001, J ALLERGY CLIN IMMUN, V107, P686, DOI 10.1067/mai.2001.114339	35	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228045	10.1371/journal.pone.0228045	http://dx.doi.org/10.1371/journal.pone.0228045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995587	Green Published, gold			2022-12-26	WOS:000534609400040
J	Lee, SY; Kim, DY; Sohn, MK; Lee, J; Lee, SG; Shin, YI; Kim, SY; Oh, GJ; Lee, YH; Lee, YS; Joo, MC; Lee, SY; Ahn, J; Chang, WH; Choi, JY; Kang, SH; Kim, I; Han, J; Kim, YH				Lee, Seung Yeol; Kim, Deog Young; Sohn, Min Kyun; Lee, Jongmin; Lee, Sam-Gyu; Shin, Yong-Il; Kim, Soo-Yeon; Oh, Gyung-Jae; Lee, Young Hoon; Lee, Yang-Soo; Joo, Min Cheol; Lee, So Young; Ahn, Jeonghoon; Chang, Won Hyuk; Choi, Ji Yoo; Kang, Sung Hyun; Kim, Il Yoel; Han, Junhee; Kim, Yun-Hee			Determining the cut-off score for the Modified Barthel Index and the Modified Rankin Scale for assessment of functional independence and residual disability after stroke	PLOS ONE			English	Article							REHABILITATION; RELIABILITY; SENSITIVITY; HANDICAP; VALIDITY; VERSION; GRADES; TOOL	Assessment of functional independence and residual disability is very important for measuring treatment outcome after stroke. The modified Rankin Scale (mRS) and the modified Barthel Index (MBI) are commonly used scales to measure disability or dependence in activities of daily living (ADL) of stroke survivors. Lack of consensus regarding MBI score categories has caused confusion in interpreting stroke outcomes. The purpose of this study was to identify the optimal corresponding MBI and modified Rankin scale (mRS) grades for categorization of MBI. The Korean versions of the MBI (K-MBI) and mRS were collected from 5,759 stroke patients at 3 months after onset of stroke. The sensitivity and specificity were calculated at K-MBI score cutoffs for each mRS grade to obtain optimally corresponding K-MBI scores and mRS grades. We also plotted receiver operating characteristic (ROC) curves of sensitivity and specificity and determined the area under the curve (AUC). The K-MBI cutoff points with the highest sum of sensitivity and specificity were 100 (sensitivity 0.940; specificity 0.612), 98 (sensitivity 0.904; specificity 0.838), 94 (sensitivity 0.885; specificity 0.937), 78 (sensitivity 0.946; specificity, 0.973), and 55 (sensitivity 937; specificity 0.986) for mRS grades 0, 1, 2, 3, and 4, respectively. From this result, the K-MBI cutoff score range for each mRS grade can be obtained. For mRS grade 0, the K-MBI cutoff score is 100, indicating no associated score range. For mRS grades 1, 2, 3, 4, and 5, the K-MBI score ranges is from 99 to 98, 97 to 94, 93 to 78, 77 to 55, and under 54, respectively.The AUC for the ROC curve was 0.791 for mRS grade 0, 0.919 for mRS grade 1, 0.970 for mRS grade 2, 0.0 for mRS grade 3, and 0.991 for mRS grade 4. The K-MBI cutoff score ranges for representing mRS grades were variable; mRS grades 0, 1, and 2 had narrow K-MBI score ranges, while mRS grades 3, 4, and 5 exhibited broad K-MBI score ranges. mRS grade seemed to sensitively differentiate mild residual disability of stroke survivors, whereas K-MBI provided more specific information of the functional status of stroke survivors with moderate to severe residual impairment.	[Lee, Seung Yeol; Chang, Won Hyuk; Kim, Yun-Hee] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc & Stroke Inst, Dept Phys & Rehabil Med,Ctr Prevent & Rehabil,Sch, Seoul, South Korea; [Kim, Deog Young] Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul, South Korea; [Sohn, Min Kyun] Chungnam Natl Univ, Sch Med, Dept Rehabil Med, Daejeon, South Korea; [Lee, Jongmin] Konkuk Univ, Dept Rehabil Med, Sch Med, Seoul, South Korea; [Lee, Sam-Gyu] Chonnam Natl Univ, Dept Phys & Rehabil Med, Med Sch, Gwangju, South Korea; [Shin, Yong-Il; Kim, Soo-Yeon] Pusan Natl Univ, Dept Rehabil Med, Yangsan Hosp, Yangsan, South Korea; [Oh, Gyung-Jae; Lee, Young Hoon] Wonkwang Univ, Dept Prevent Med, Sch Med, Iksan, South Korea; [Lee, Yang-Soo] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Rehabil Med, Daegu, South Korea; [Joo, Min Cheol] Wonkwang Univ, Dept Rehabil Med, Sch Med, Iksan, South Korea; [Lee, So Young] Univ Jeju, Jeju Natl Univ Hosp, Dept Rehabil Med, Coll Med, Jeju, South Korea; [Ahn, Jeonghoon] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea; [Choi, Ji Yoo; Kang, Sung Hyun; Kim, Il Yoel] Korea Ctr Dis Control & Prevent, Div Chron Dis Prevent, Osong, South Korea; [Han, Junhee] Hallym Univ, Dept Stat, Chunchon, South Korea; [Han, Junhee] Hallym Univ, Inst Stat, Chunchon, South Korea; [Kim, Yun-Hee] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Dept Hlth Sci & Technol,Dept Med Device Managemen, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Chungnam National University; Konkuk University; Konkuk University Medical Center; Chonnam National University; Pusan National University; Pusan National University Hospital; Wonkwang University; Kyungpook National University; Kyungpook National University Hospital; Wonkwang University; Jeju National University; Ewha Womans University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Hallym University; Hallym University; Sungkyunkwan University (SKKU)	Kim, YH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc & Stroke Inst, Dept Phys & Rehabil Med,Ctr Prevent & Rehabil,Sch, Seoul, South Korea.; Han, J (corresponding author), Hallym Univ, Dept Stat, Chunchon, South Korea.; Han, J (corresponding author), Hallym Univ, Inst Stat, Chunchon, South Korea.; Kim, YH (corresponding author), Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Dept Hlth Sci & Technol,Dept Med Device Managemen, Seoul, South Korea.	hanjh@hallym.ac.kr; Yyun1225.kim@samsung.com	Kim, Yun-Hee/GVS-6426-2022; Kim, Yun Hee/F-4600-2014; Ahn, Jeonghoon/CAA-1956-2022	Ahn, Jeonghoon/0000-0002-0177-0192; Sohn, Min Kyun/0000-0002-2548-545X; kim, deog young/0000-0001-7622-6311	Korea Centers for Disease Control and Prevention [2016E-33003-02]; National Research Foundation of Korea by the Korean government (MSIP) [NRF-2017R1A2A1A05000730]	Korea Centers for Disease Control and Prevention; National Research Foundation of Korea by the Korean government (MSIP)	This work was supported by a grant from the Korea Centers for Disease Control and Prevention (2016E-33003-02; www.cdc.go.kr) and National Research Foundation of Korea by the Korean government (MSIP) (NRF-2017R1A2A1A05000730; www.nrf.re.kr) to YHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin A, 2013, CLIN NEUROL NEUROSUR, V115, P1003, DOI 10.1016/j.clineuro.2012.10.015; Chang WH, 2016, J NEUROL, V263, P1166, DOI 10.1007/s00415-016-8119-y; Chang WH, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0293-5; CONNELL FA, 1985, AM J EPIDEMIOL, V121, P744; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Franceschini M, 2010, EUR J PHYS REHAB MED, V46, P517; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Jung HY, 2007, ANN REHABIL MED-ARM, V31, P283; Kim DY, 2010, AM J PHYS MED REHAB, V89, P879, DOI 10.1097/PHM.0b013e3181f70aa7; Kong KH, 2010, J REHABIL MED, V42, P453, DOI 10.2340/16501977-0545; Kucukdeveci AA, 2000, SCAND J REHABIL MED, V32, P87; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Leung SOC, 2007, CLIN REHABIL, V21, P912, DOI 10.1177/0269215507077286; MAHONEY F I, 1965, Md State Med J, V14, P61; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; New PW, 2006, NEUROEPIDEMIOLOGY, V26, P4, DOI 10.1159/000089536; Ohura T, 2014, J PHYS THER SCI, V26, P1971, DOI 10.1589/jpts.26.1971; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2007, STROKE, V38, pE144, DOI 10.1161/STROKEAHA.107.490110; Quinn TJ, 2009, STROKE, V40, P762, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; RANKIN J, 1957, Scott Med J, V2, P200; Salgado AV, 1996, STROKE, V27, P661, DOI 10.1161/01.STR.27.4.661; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Shah S, 1992, Aust Occup Ther J, V39, P5, DOI 10.1111/j.1440-1630.1992.tb01729.x; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Uyttenboogaart M, 2007, J NEUROL, V254, P1113, DOI 10.1007/s00415-007-0646-0; Weimar C, 2002, STROKE, V33, P2053, DOI 10.1161/01.STR.0000022808.21776.BF; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; WOLFE CDA, 1991, STROKE, V22, P1242, DOI 10.1161/01.STR.22.10.1242	34	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226324	10.1371/journal.pone.0226324	http://dx.doi.org/10.1371/journal.pone.0226324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995563	Green Published, gold			2022-12-26	WOS:000534609400009
J	Zhang, W; Ham, J; Li, Q; Deyssenroth, MA; Lambertini, L; Huang, YL; Tsuchiya, KJ; Chen, J; Nomura, Y				Zhang, Wei; Ham, Jacob; Li, Qian; Deyssenroth, Maya A.; Lambertini, Luca; Huang, Yonglin; Tsuchiya, Kenji J.; Chen, Jia; Nomura, Yoko			Moderate prenatal stress may buffer the impact of Superstorm Sandy on placental genes: Stress in Pregnancy (SIP) Study	PLOS ONE			English	Article							POSTNATAL DEPRESSION SCALE; FALSE DISCOVERY RATE; MATERNAL STRESS; LIFE EVENTS; MONOAMINE-OXIDASE; CHILD-DEVELOPMENT; EARLY ADVERSITY; DOWN-REGULATION; MESSENGER-RNA; FETAL	The placenta plays a central role in the epigenetic programming of neurodevelopment by prenatal stress (PS), but this pathway is not fully understood. It difficult to study in humans because the conditions for intense, traumatic PS are almost impossible to create ethically. This study was able to capitalize on a 2012 disaster that hit New York, Superstorm Sandy, to examine the impact of traumatic stress on placental gene expression while also examining normative PS, and compare the two. Of the 303 expectant mothers participating in the Stress in Pregnancy Study, 95 women were pregnant when Superstorm Sandy struck. During their pregnancy, participants completed self-report measures of PS and distress that were combined, using latent profile analysis, into one global indicator of normative PS. Placental tissue was collected at delivery and frozen for storage. RNA expression was assessed for 40 placental genes known to associate with the stress response system and neurodevelopment in offspring. Results showed that normative PS increased expression of just MECP2, HSD11B2, and ZNF507, whereas Superstorm Sandy PS decreased expression of CDKL5, CFL1, DYRK1A, HSD11B2, MAOA, MAOB, NCOR1, and ZNF507. Interaction analyses indicated that Superstorm Sandy PS was associated with decreased gene expression for the low and high PS group for CFL1, DYRK1A, HSD11B2, MAOA, and NCOR1 and increased expression for the moderate PS group for FOXP1, NR3C1, and NR3C2. This study supports the idea that a moderate amount of normative PS may buffer the impact of traumatic PS, in this case caused by Superstorm Sandy, on placental gene expression, which suggests that the placenta itself mirrors the organism's ability to develop an epigenetic resilience to, and inoculation from, stress.	[Zhang, Wei; Huang, Yonglin; Nomura, Yoko] CUNY, Dept Psychol, Queens Coll, New York, NY 10021 USA; [Zhang, Wei] New Jersey City Univ, Dept Psychol, Jersey City, NJ USA; [Ham, Jacob; Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Li, Qian; Deyssenroth, Maya A.; Chen, Jia; Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Lambertini, Luca] Icahn Sch Med Mt Sinai, Dept Med Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Lambertini, Luca] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Huang, Yonglin; Nomura, Yoko] CUNY, Grad Ctr, Dept Psychol, New York, NY 10021 USA; [Tsuchiya, Kenji J.; Nomura, Yoko] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Shizuoka, Japan	City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Hamamatsu University School of Medicine	Nomura, Y (corresponding author), CUNY, Dept Psychol, Queens Coll, New York, NY 10021 USA.; Nomura, Y (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Nomura, Y (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.; Nomura, Y (corresponding author), CUNY, Grad Ctr, Dept Psychol, New York, NY 10021 USA.; Nomura, Y (corresponding author), Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Shizuoka, Japan.	yoko.nomura@qc.cuny.edu	Tsuchiya, Kenji J./I-9123-2019	Tsuchiya, Kenji J./0000-0002-1314-4199; Deyssenroth, Maya/0000-0003-2913-2392; Huang, Yong Lin/0000-0003-4186-7973; Zhang, Wei/0000-0002-9192-9549	NIMH [K01 MH080062]; ARRA [K01 MH080062S, R01MH102729]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ARRA	This work was supported by the NIMH grants K01 MH080062, ARRA supplement K01 MH080062S and R01MH102729 (to YN). https://www.nimh.nih.gov/index.shtml.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287; [Anonymous], 2015, PSYCHONEUROENDOCRINO, V56, P62, DOI [10.1016/j.psyneuen.2015.02.015, DOI 10.1016/J.PSYNEUEN.2015.02.015]; Babenko O, 2015, NEUROSCI BIOBEHAV R, V48, P70, DOI 10.1016/j.neubiorev.2014.11.013; Bacon C, 2015, MOL PSYCHIATR, V20, P632, DOI 10.1038/mp.2014.116; Baggio S, 2015, GYNECOL SURG, V12, P279, DOI 10.1007/s10397-015-0901-9; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Barrett ES, 2016, PAEDIATR PERINAT EP, V30, P105, DOI 10.1111/ppe.12264; Barrett ES, 2014, NEUROTOXICOLOGY, V41, P20, DOI 10.1016/j.neuro.2013.12.011; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Blake, 2013, AL182012 NAT HURR CT; Blakeley PM, 2013, J PSYCHOSOM RES, V75, P341, DOI 10.1016/j.jpsychores.2013.07.002; Bock J, 2015, BIOL PSYCHIAT, V78, P315, DOI 10.1016/j.biopsych.2015.02.036; Bock J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00011; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; Cao-Lei L., 2016, CURR MOL BIO REP, V2, P16, DOI DOI 10.1007/S40610-016-0030-X; Capron LE, 2018, PSYCHONEUROENDOCRINO, V87, P166, DOI 10.1016/j.psyneuen.2017.10.019; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; Chiofalo B, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6073167; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dancause KN, 2013, EARLY HUM DEV, V89, P773, DOI 10.1016/j.earlhumdev.2013.06.006; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008; Davis EP, 2014, PSYCHONEUROENDOCRINO, V49, P11, DOI 10.1016/j.psyneuen.2014.06.014; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; Dohrenwend BP, 2006, PSYCHOL BULL, V132, P477, DOI 10.1037/0033-2909.132.3.477; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Faa G, 2016, BIRTH DEFECTS RES C, V108, P207, DOI 10.1002/bdrc.21139; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Finik J, 2017, INT J EPIDEMIOL, V46, P1388, DOI 10.1093/ije/dyw264; Garbrecht Mark R, 2013, ISRN Oncol, V2013, P245246, DOI 10.1155/2013/245246; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ghaemmaghami P, 2014, DEV PSYCHOBIOL, V56, P734, DOI 10.1002/dev.21142; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Gluckman P, 2016, PRINCIPLES OF EVOLUTIONARY MEDICINE, 2ND EDITION, P1, DOI 10.1093/acprof:oso/9780199663927.001.0001; Goldenberg RL, 1997, ACTA OBSTET GYN SCAN, V76, P19; Graignic-Philippe R, 2014, NEUROSCI BIOBEHAV R, V43, P137, DOI 10.1016/j.neubiorev.2014.03.022; Hocher B., 2014, J REPROD IMMUNOL, V104-105, P8; Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535; Huizink A, 2016, PSYCTESTS DATASET; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Itoh M, 2012, J BIOL CHEM, V287, P13859, DOI 10.1074/jbc.M111.309864; Janssen AB, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12373; Jensen P. C., 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039791; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kappil MA, 2015, EPIGENETICS-US, V10, P842, DOI 10.1080/15592294.2015.1073881; Kertes DA, 2016, CHILD DEV, V87, P61, DOI 10.1111/cdev.12487; Ketchesin KD, 2017, STRESS, V20, P449, DOI 10.1080/10253890.2017.1322575; Kheirabadi GR, 2012, IRAN J MED SCI, V37, P32; King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Lagana AS, 2017, INT J WOMENS HEALTH, V9, P323, DOI 10.2147/IJWH.S119729; Laplante DP, 2007, INFANCY, V12, P69, DOI 10.1111/j.1532-7078.2007.tb00234.x; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Lei CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107653; Li J, 2012, NEUROSCI BIOBEHAV R, V36, P1085, DOI 10.1016/j.neubiorev.2011.12.006; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Mann P E, 2001, Prog Brain Res, V133, P251; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MMWR, 2013, DEATHS ASS HURR SAND, V62, P2010; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Monk D, 2015, AM J OBSTET GYNECOL, V213, pS152, DOI 10.1016/j.ajog.2015.06.032; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; O'Connor TG, 2002, BRIT J PSYCHIAT, V180; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Oberlander TF, 2012, J ADOLESCENT HEALTH, V51, pS9, DOI 10.1016/j.jadohealth.2012.04.009; Palma-Gudiel H, 2015, EPIGENETICS-US, V10, P893, DOI 10.1080/15592294.2015.1088630; Palma-Gudiel H, 2015, NEUROSCI BIOBEHAV R, V55, P520, DOI 10.1016/j.neubiorev.2015.05.016; Paquette AG, 2015, EPIGENOMICS-UK, V7, P767, DOI 10.2217/epi.15.28; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park S, 2015, PSYCHOL MED, V45, P3009, DOI 10.1017/S003329171500094X; Ping EY, 2015, PSYCHONEUROENDOCRINO, V56, P62, DOI 10.1016/j.psyneuen.2015.02.015; Ponder KL, 2011, DEV PSYCHOBIOL, V53, P711, DOI 10.1002/dev.20549; Qiu A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.3; Qiu A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.79; Raikkonen K, 2014, CLIN ENDOCRINOL, V81, P175, DOI 10.1111/cen.12412; Reynolds RM, 2015, PSYCHOL MED, V45, P2023, DOI 10.1017/S003329171400316X; Riley LA, 1989, MOL PHARM, V36; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seth S, 2015, INT J MOL SCI, V16, P27482, DOI 10.3390/ijms161126034; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Sjaarda CP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07405-3; Spielberger C. D., 1973, MANUAL STATE TRAIT I; St-Pierre J, 2016, PLACENTA, V48, pS66, DOI 10.1016/j.placenta.2015.11.013; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tees MT, 2010, MATERN CHILD HLTH J, V14, P511, DOI 10.1007/s10995-009-0486-x; Togher KL, 2014, EPIGENETICS-US, V9, P816, DOI 10.4161/epi.28703; Vachev TI, 2016, INT J CURR MICROBIOL, V5, P221, DOI DOI 10.20546/ijcmas.2016.501.020; Vaiman D, 2017, PLACENTA, V52, P127, DOI 10.1016/j.placenta.2016.12.026; Van den Bergh BRH, 2020, NEUROSCI BIOBEHAV R, V117, P26, DOI 10.1016/j.neubiorev.2017.07.003; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Vinkers CH, 2015, EPIGENOMICS-UK, V7, P593, DOI [10.2217/EPI.15.11, 10.2217/epi.15.11]; Vitale SG, 2016, J OBSTET GYNAECOL CA, V38, P1079, DOI 10.1016/j.jogc.2016.09.008; Vitale SG, 2017, J PSYCHOSOM OBST GYN, V38, P317, DOI 10.1080/0167482X.2016.1244185; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Weiss Daniel S., 1997, P399; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; Zhang W, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12581; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	115	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226605	10.1371/journal.pone.0226605	http://dx.doi.org/10.1371/journal.pone.0226605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995614	gold, Green Published			2022-12-26	WOS:000534609400012
J	Oulhaj, A; Bakir, S; Aziz, F; Suliman, A; Almahmeed, W; Sourij, H; Shehab, A				Oulhaj, Abderrahim; Bakir, Sherif; Aziz, Faisal; Suliman, Abubaker; Almahmeed, Wael; Sourij, Harald; Shehab, Abdulla			Agreement between cardiovascular disease risk assessment tools: An application to the United Arab Emirates population	PLOS ONE			English	Article							PREDICTION; SCORE; GUIDELINE	Introduction Evidence regarding the performance of cardiovascular disease (CVD) risk assessment tools is limited in the United Arab Emirates (UAE). Therefore, we assessed the agreement between various externally validated CVD risk assessment tools in the UAE. Methods A secondary analysis of the Abu Dhabi Screening Program for Cardiovascular Risk Markers (AD-SALAMA) data, a large population-based cross-sectional survey conducted in Abu Dhabi, UAE during the period 2009 until 2015, was performed in July 2019. The analysis included 2,621 participants without type 2 Diabetes and without history of cardiovascular diseases. The CVD risk assessment tools included in the analysis were the World Health Organization for Middle East and North Africa Region (WHO-MENA), the systematic coronary risk evaluation for high risk countries (SCORE-H), the pooled cohort risk equations for white (PCRE-W) and African Americans (PCRE-AA), the national cholesterol education program Framingham risk score (FRAM-ATP), and the laboratory Framingham risk score (FRAM-LAB). Results The overall concordance coefficient was 0.50. The agreement between SCORE-H and PCRE-W, PCRE-AA, FRAM-LAB, FRAM-ATP and WHO-MENA, were 0.47, 0.39, 0.0.25, 0.42 and 0.18, respectively. PCRE-AA classified the highest proportion of participants into high-risk category of CVD (16.4%), followed by PCRE-W (13.6%), FRAM-LAB (6.9%), SCORE-H (4.5%), FRAM-ATP (2.7%), and WHO-MENA (0.4%). Conclusions We found a poor agreement between various externally validated CVD risk assessment tools when applied to a large data collected in the UAE. This poses a challenge to choose any of these tools for clinical decision-making regarding the primary prevention of CVD in the country.	[Oulhaj, Abderrahim; Suliman, Abubaker] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Oulhaj, Abderrahim; Sourij, Harald] United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain, U Arab Emirates; [Bakir, Sherif] Sheikh Shakhbout Med City, Cardiol Dept, Abu Dhabi, U Arab Emirates; [Aziz, Faisal; Sourij, Harald] Med Univ Graz, Dept Internal Med, Cardiovasc Diabetol Res Grp, Div Endocrinol & Diabetol, Graz, Austria; [Aziz, Faisal] Ctr Biomarker Res Med CBmed, Graz, Austria; [Almahmeed, Wael] Cleveland Clin, Heart & Vasc Inst, Abu Dhabi, U Arab Emirates; [Shehab, Abdulla] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; Medical University of Graz; Cleveland Clinic Foundation; United Arab Emirates University	Oulhaj, A (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.; Oulhaj, A (corresponding author), United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain, U Arab Emirates.	aoulhaj@uaeu.ac.ae	Aziz, Faisal/O-3263-2016	Aziz, Faisal/0000-0002-0109-2969; Sourij, Harald/0000-0003-3510-9594; Suliman, Abubaker/0000-0001-8906-3590				Al-Rawahi Abdulhakeem, 2015, Oman Med J, V30, P315, DOI 10.5001/omj.2015.65; Allan GM, 2014, CURR OPIN LIPIDOL, V25, P254, DOI 10.1097/MOL.0000000000000095; Allan GM, 2013, CIRCULATION, V127, P1948, DOI 10.1161/CIRCULATIONAHA.112.000412; Bansal Manish, 2015, Indian Heart J, V67, P332, DOI 10.1016/j.ihj.2015.04.017; Barnhart HX, 2002, BIOMETRICS, V58, P1020, DOI 10.1111/j.0006-341X.2002.01020.x; Bazo-Alvarez Juan Carlos, 2015, Crit Pathw Cardiol, V14, P74, DOI 10.1097/HPC.0000000000000045; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Garg N, 2017, INDIAN HEART J, V69, P458, DOI 10.1016/j.ihj.2017.01.015; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; McBride G.B, 2005, PROPOSAL STRENGTH OF; Motamed N, 2017, INT J CARDIOL, V228, P52, DOI 10.1016/j.ijcard.2016.11.048; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Radaideh G, 2017, INT CARDIOVASC FORUM, V11; Selvarajah S, 2014, INT J CARDIOL, V176, P211, DOI 10.1016/j.ijcard.2014.07.066; Steichen TJ, 2002, STATA J, V2, P183, DOI 10.1177/1536867X0200200206; WHO, CARD DIS CVDS; World Health Organization, 2007, WHO ISH RISK PRED CH; World Health Organization, 2018, UN AR EM WHO NONC DI; World Health Organization, 2007, PREV CARD DIS POCK G	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228031	10.1371/journal.pone.0228031	http://dx.doi.org/10.1371/journal.pone.0228031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978187	Green Published, gold			2022-12-26	WOS:000534599100097
J	Romanchek, GR; Liu, Z; Abbaszadeh, S				Romanchek, Gregory R.; Liu, Zheng; Abbaszadeh, Shiva			Kernel-based Gaussian process for anomaly detection in sparse gamma-ray data	PLOS ONE			English	Article							BACKGROUND ESTIMATION; STATISTICAL-METHODS; ALGORITHMS	In radioactive source surveying protocols, a number of task-inherent features degrade the quality of collected gamma ray spectra, including: limited dwell times, a fluctuating background, a large distance to the source, weak source activity, and the low sensitivity of mobile detectors. Thus, collected gamma ray spectra are expected to be sparse and noise dominated. For extremely sparse spectra, direct background subtraction is infeasible and many background estimation techniques do not apply. In this paper, we present a statistical algorithm for source estimation and anomaly detection under such conditions. We employ a fixed-hyperparameter Gaussian processes regression methodology with a linear innovation sequence scheme in order to quickly update an ongoing source distribution estimate with no prior training required. We have evaluated the effectiveness of this approach for anomaly detection using background spectra collected with a Kromek D3S and simulated source spectrum and hyperparameters defined by detector characteristics and information derived from collected spectra. We attained an area under the ROC curve of 0.902 for identifying sparse source peaks within a sparse gamma ray spectrum and achieved a true positive rate of 93% when selecting the optimum thresholding value derived from the ROC curve.	[Romanchek, Gregory R.; Liu, Zheng; Abbaszadeh, Shiva] Univ Illinois, Grainger Coll Engn, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA; [Abbaszadeh, Shiva] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Santa Cruz	Romanchek, GR (corresponding author), Univ Illinois, Grainger Coll Engn, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA.	romanch2@illinois.edu		Romanchek, Gregory/0000-0002-4775-2176; Abbaszadeh, Shiva/0000-0001-6345-2408	Department of Energy National Nuclear Security Administration through the Consortium for Nonproliferation Enabling Capabilities [DE-NA0002576]; Defense Advanced Research Projects Agency (DARPA) Young Faculty Award [N66001-4170-5536P]	Department of Energy National Nuclear Security Administration through the Consortium for Nonproliferation Enabling Capabilities; Defense Advanced Research Projects Agency (DARPA) Young Faculty Award(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This material is based upon work supported by the Department of Energy National Nuclear Security Administration under Award Number(s) DE-NA0002576 through the Consortium for Nonproliferation Enabling Capabilities to GR (https://cnec.ncsu.edu/).This work was supported by the Defense Advanced Research Projects Agency (DARPA) Young Faculty Award under contract number N66001-4170-5536P to SA (https://www.darpa.mil/work-with-us/for-universities/young-faculty-award).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamaniotis M, 2013, IEEE T NUCL SCI, V60, P2209, DOI 10.1109/TNS.2013.2260868; [Anonymous], 2016, ADV RAD THREAT DET S; Ayat NE, 2005, PATTERN RECOGN, V38, P1733, DOI 10.1016/j.patcog.2005.03.011; Bishop C, 2016, PATTERN RECOGN, P291; BURGESS DD, 1983, NUCL INSTRUM METHODS, V214, P431, DOI 10.1016/0167-5087(83)90612-9; Csato L, 2002, NEURAL COMPUT, V14, P641, DOI 10.1162/089976602317250933; Duvenaud D., 2014, AUTOMATIC MODEL CONS; Ely JH, 2004, IEEE T NUCL SCI, V51, P1672, DOI 10.1109/TNS.2004.832286; Fagan DK, 2012, APPL RADIAT ISOTOPES, V70, P2428, DOI 10.1016/j.apradiso.2012.06.016; Fischer A, 2017, SENSING; Fischer R, 2000, PHYS REV E, V61, P1152, DOI 10.1103/PhysRevE.61.1152; Hajekm B, 2015, RANDOM PROCESSES ENG; Jarman KD, 2008, APPL RADIAT ISOTOPES, V66, P362, DOI 10.1016/j.apradiso.2007.09.010; Kirkpatrick JM, 2009, IEEE T NUCL SCI, V56, P1278, DOI 10.1109/TNS.2009.2020516; Kouzes R.T., 2003, P 2003 IEEE NUCL SCI, VVolume 2, P1448, DOI [10.1109/NSSMIC.2003.1351967, DOI 10.1109/NSSMIC.2003.1351967]; Krishnamoorthy A, 2013, SIG P ALGO ARCH ARR, P70; Kromek Group, D3S ID WEAR RIID GAM; Liu Z, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040960; Liu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205092; Philips GW, 2005, PRIMER DETECTION NUC; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ristic B, 2008, INFORM FUSION, V9, P317, DOI 10.1016/j.inffus.2007.06.004; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; TERVO RJ, 1983, NUCL INSTRUM METHODS, V216, P205, DOI 10.1016/0167-5087(83)90351-4; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Ziock KP, 2002, AIP CONF PROC, V632, P60, DOI 10.1063/1.1513955	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228048	10.1371/journal.pone.0228048	http://dx.doi.org/10.1371/journal.pone.0228048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971971	Green Published, gold			2022-12-26	WOS:000534374400036
J	Chen, SM; Lin, CE; Chen, HH; Cheng, YF; Cheng, HW; Imai, K				Chen, Shih-Ming; Lin, Chia-En; Chen, Hung-Hsiang; Cheng, Yu-Fan; Cheng, Hui-Wen; Imai, Kazuhiro			Effect of prednisolone on glyoxalase 1 in an inbred mouse model of aristolochic acid nephropathy using a proteomics method with fluorogenic derivatization-liquid chromatography-tandem mass spectrometry	PLOS ONE			English	Article							INTERSTITIAL RENAL FIBROSIS; DIABETIC-RAT KIDNEY; UP-REGULATION; D-LACTATE; METHYLGLYOXAL; PROTEINS; GLYCATION; DAMAGE; DYSFUNCTION; EXPRESSION	Prednisolone is involved in glucose homeostasis and has been used for treatment for aristolochic acid (AA) nephropathy (AAN), but its effect on glycolysis in kidney has not yet been clarified. This study aims to investigate the effect in terms of altered proteins after prednisolone treatment in a mice model of AAN using a proteomics technique. The six-week C3H/He female mice were administrated AA (0.5 mg/kg/day) for 56 days. AA+P group mice were then given prednisolone (2 mg/kg/day) via oral gavage for the next 14 days, and AA group mice were fed water instead. The tubulointerstitial damage was improved after prednisolone treatment comparing to that of AA group. Kidney homogenates were harvested to perform the proteomics analysis with fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method (FD-LC-MS/MS). On the other hand, urinary methylglyoxal and D-lactate levels were determined by high performance liquid chromatography with fluorescence detection. There were 47 altered peaks and 39 corresponding proteins on day 14 among the groups, and the glycolysis-related proteins, especially glyoxalase 1 (GLO1), fructosebisphosphate aldolase B (aldolase B), and triosephosphate isomerase (TPI), decreased in the AA+P group. Meanwhile, prednisolone decreased the urinary amount of methylglyoxal (AA+P: 2.004 +/- 0.301 mu g vs. AA: 2.741 +/- 0.630 mu g, p < 0.05), which was accompanied with decrease in urinary amount of D-lactate (AA+P: 54.07 +/- 5.45 mu mol vs. AA: 86.09 +/- 8.44 mu mol, p < 0.05). Prednisolone thus alleviated inflammation and interstitial renal fibrosis. The renal protective mechanism might be associated with down-regulation of GLO1 via reducing the contents of methylglyoxal derived from glycolysis. With the aid of proteomics analysis and the determination of methylglyoxal and its metabolite-D-lactate, we have demonstrated for the first time the biochemical efficacy of prednisolone, and urinary methylglyoxal and its metabolite-D-lactate might be potential biomarkers for AAN.	[Chen, Shih-Ming; Lin, Chia-En; Chen, Hung-Hsiang; Cheng, Yu-Fan; Cheng, Hui-Wen] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Imai, Kazuhiro] Musashino Univ, Res Inst Pharmaceut Sci, Tokyo, Japan; [Chen, Shih-Ming; Lin, Chia-En; Chen, Hung-Hsiang; Cheng, Yu-Fan; Cheng, Hui-Wen] Taipei Med Univ, Taipei, Taiwan	Taipei Medical University; Taipei Medical University	Chen, SM (corresponding author), Taipei Med Univ, Sch Pharm, Taipei, Taiwan.	smchen@tmu.edu.tw			Cathay General Hospital [108CGH-TMU-06]	Cathay General Hospital	We are grateful to the financial support from the Cathay General Hospital (108CGH-TMU-06).; We are grateful to the Yung Shin Pharmaceutical Co. (Taiwan) for their contribution of an API 4000 triple quadrupole mass spectrometer. We appreciate that Prof Ueda Shiro supplied our team the suggestion about animal experiments and metabolic cages. We thank for Prof Jen-Ai Lee supplying the technology of FD-LC-MS/MS. We are grateful to the financial support from the Cathay General Hospital (108CGH-TMU-06).	Baudoux T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23565-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouwers O, 2014, DIABETOLOGIA, V57, P224, DOI 10.1007/s00125-013-3088-5; Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308; Chen G, 2019, CHIN PUB ADM REV-US, V10, P18; Chen YY, 2010, ONCOL REP, V24, P141, DOI 10.3892/or_00000839; Chong SAC, 2007, J BIOL CHEM, V282, P8510, DOI 10.1074/jbc.M609859200; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Espinosa-Mansilla A, 2007, ANAL BIOCHEM, V371, P82, DOI 10.1016/j.ab.2007.07.028; Giacco F, 2014, DIABETES, V63, P291, DOI 10.2337/db13-0316; Hattori A, 2001, BIOMED CHROMATOGR, V15, P95, DOI 10.1002/bmc.42; HOPPER DJ, 1972, BIOCHEM J, V128, P321, DOI 10.1042/bj1280321; Huang TC, 2014, LIFE SCI, V114, P4, DOI 10.1016/j.lfs.2014.07.034; Huang TC, 2013, BIOMED CHROMATOGR, V27, P1100, DOI 10.1002/bmc.2908; Huang YL, 2017, ENERGIES, V10, DOI 10.3390/en10010031; Ichibangase T, 2007, J PROTEOME RES, V6, P2841, DOI 10.1021/pr070094c; Ichibangase T, 2014, J PHARMACEUT BIOMED, V101, P31, DOI 10.1016/j.jpba.2014.05.036; Jadot I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020297; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Kumagai T, 2009, AM J PHYSIOL-RENAL, V296, pF912, DOI 10.1152/ajprenal.90575.2008; Kumar V, 2003, NAT PROD REP, V20, P565, DOI 10.1039/b303648k; LEABACK DH, 1961, BIOCHEM J, V78, P151, DOI 10.1042/bj0780151; Lee JA, 2005, ANAL CHIM ACTA, V534, P185, DOI 10.1016/j.aca.2004.11.033; Li X, 2015, THORAC CANCER, V6, P80, DOI 10.1111/1759-7714.12151; Li YC, 2012, BIOCHEM BIOPH RES CO, V423, P832, DOI 10.1016/j.bbrc.2012.06.049; Lim SS, 2001, B RHEUM DIS, V50, P1; Lin CE, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4127; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Ma DH, 2016, NEPHROLOGY, V21, P835, DOI 10.1111/nep.12684; Masuda M, 2004, ANAL CHEM, V76, P728, DOI 10.1021/ac034840i; Nigro C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010188; Nowotny K, 2014, ARCH BIOCHEM BIOPHYS, V542, P56, DOI 10.1016/j.abb.2013.12.007; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Qi HY, 2017, DIABETES, V66, P763, DOI 10.2337/db16-0695; Qi XM, 2007, TOXICOL APPL PHARM, V222, P105, DOI 10.1016/j.taap.2007.03.029; Rabbani N, 2014, BIOCHEM SOC T, V42, P425, DOI 10.1042/BST20140018; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Ruiz-Arruza I, 2015, AUTOIMMUN REV, V14, P875, DOI 10.1016/j.autrev.2015.05.011; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Sharma N, 2005, J PHYSIOL-LONDON, V562, P593, DOI 10.1113/jphysiol.2004.075713; Sousa AR, 2017, CLIN EXP ALLERGY, V47, P890, DOI 10.1111/cea.12954; Silva MS, 2013, BIOCHEM J, V453, P1, DOI 10.1042/BJ20121743; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Tsai PY, 2013, BIOMED CHROMATOGR, V27, P382, DOI 10.1002/bmc.2803; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Vanherweghem JL, 1996, AM J KIDNEY DIS, V27, P209, DOI 10.1016/S0272-6386(96)90542-9; Yuen A, 2010, MATRIX BIOL, V29, P537, DOI 10.1016/j.matbio.2010.04.004; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083408	51	9	9	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0227838	10.1371/journal.pone.0227838	http://dx.doi.org/10.1371/journal.pone.0227838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968011	Green Published, gold, Green Submitted			2022-12-26	WOS:000534373000021
J	Li, CY; Zhou, JQ; Liu, ZJ; Zhou, JL; Yao, W; Tao, JL; Shen, M; Liu, HL				Li, Chengyu; Zhou, Jiaqi; Liu, Zhaojun; Zhou, Jilong; Yao, Wang; Tao, Jingli; Shen, Ming; Liu, Honglin			FSH prevents porcine granulosa cells from hypoxia-induced apoptosis via activating mitophagy through the HIF-1 alpha-PINK1-Parkin pathway	FASEB JOURNAL			English	Article						apoptosis; FSH; HIF-1 alpha; hypoxia; mitophagy; Parkin; PINK1; porcine granulosa cells	MOLECULAR-MECHANISMS; FAMILY PROTEASES; HIF-ALPHA; AUTOPHAGY; BCL-2; ANGIOGENESIS; DESTRUCTION; INVOLVEMENT; EXPRESSION; SURVIVAL	In developing follicles, the granulosa cells (GCs) live in a hypoxic environment due to the devoid of blood supply. Upon hypoxic conditions, several types of mammalian cells have been reported to undergo apoptosis. Follicle-stimulating hormone (FSH) is known as the primary survival factor for antral follicles by preventing GCs apoptosis. Mitophagy is a type of organelle-specific autophagy that removes damaged or stressed mitochondria to maintain cellular health. This study provides the first evidence suggesting that FSH-mediated mitophagy protected porcine GCs from hypoxia-induced apoptosis. Our data showed that the GCs apoptosis caused by mitochondrial pathway upon hypoxia stress was markedly attenuated after FSH treatment, which was correlated with enhanced activation of mitophagy. Interestingly, FSH also stimulated mitochondrial biogenesis as suggested by increased expression of mitochondrial transcription factor A and nuclear respiratory factor 1 during hypoxia exposure. Notably, the protein level of hypoxia inducible factor-1 alpha (HIF-1 alpha) was significantly increased in hypoxic GCs following FSH treatment, accompanied by elevated mitophagic activity and dampened apoptotic signaling. Blocking HIF-1 alpha inhibited mitophagy and restored hypoxia-induced apoptosis despite FSH treatment. Importantly, FSH promoted the expression of serine/threonine kinase PTEN induced putative kinase 1 (PINK1) and the E3 ligase Parkin during hypoxia stress through a HIF-1 alpha dependent manner. This induced the mitophagic clearance of damaged mitochondria, hence inhibiting apoptosis by reducing cytochrome c releasing. The inhibition of HIF-1 alpha and/or PINK1 using inhibitor or RNAi further confirmed the role of the FSH-HIF-1 alpha-PINK1-Parkin-mitophagy axis in suppressing GC apoptosis under hypoxic conditions. These findings highlight a novel function of FSH in preserving GCs viability against hypoxic damage by activating HIF-1 alpha-PINK1-Parkin-mediated mitophagy.	[Li, Chengyu; Zhou, Jiaqi; Liu, Zhaojun; Yao, Wang; Tao, Jingli; Shen, Ming; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Peoples R China; [Zhou, Jilong] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Inst Stem Cell & Regenerat Biol, Wuhan, Peoples R China	Nanjing Agricultural University; Huazhong Agricultural University	Shen, M; Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Peoples R China.	shenm2015@njau.edu.cn; liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022; liu, zhao/GXV-6141-2022	liu, honglin/0000-0002-1254-3163; 	National Natural Science Foundation of China (NSFC) [31630072, 31601939, 31972564]; Priority Academic Program Development of Jiangsu Higher Education Institutions [DKQB201903]; fundamental research funds for the central universities [KJQN201705]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31630072, 31601939 and 31972564; A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Grant/Award Number: No. DKQB201903; the fundamental research funds for the central universities, Grant/Award Number: No. KJQN201705	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bianco F, 2005, VET RES COMMUN, V29, P157, DOI 10.1007/s11259-005-0031-3; Chen L, 2009, EXP MOL MED, V41, P849, DOI 10.3858/emm.2009.41.12.103; Cheng Y, 2013, PHARMACOL REV, V65, P1162, DOI 10.1124/pr.112.007120; Chun SY, 1996, ENDOCRINOLOGY, V137, P1447, DOI 10.1210/en.137.4.1447; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dlamini Z, 2004, PHARMACOL THERAPEUT, V101, P1, DOI 10.1016/j.pharmthera.2003.08.005; Dong Z, 2016, CELL DEATH DIFFER, V23, P1602, DOI 10.1038/cdd.2016.47; Fadhillah, 2014, J REPROD DEVELOP, V60, P194, DOI 10.1262/jrd.2014-014; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greijer AE, 2008, VIRCHOWS ARCH, V452, P535, DOI 10.1007/s00428-008-0578-9; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koh MY, 2008, MOL CANCER THER, V7, P90, DOI 10.1158/1535-7163.MCT-07-0463; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Neeman M, 1997, INT J EXP PATHOL, V78, P57, DOI 10.1046/j.1365-2613.1997.d01-247.x; Nishimura R, 2016, REPROD FERT DEVELOP, V28, P1479, DOI 10.1071/RD15010; PRINTZ RH, 1972, ANAT REC, V173, P157, DOI 10.1002/ar.1091730205; Redding GP, 2007, REPRODUCTION, V133, P1095, DOI 10.1530/REP-06-0171; Redmer D A, 1996, Rev Reprod, V1, P182; Rico C, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115634; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.400; Shen M, 2017, AUTOPHAGY, V13, P1364, DOI 10.1080/15548627.2017.1327941; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; Shimizu S, 1996, AM J PHYSIOL-GASTR L, V271, pG949, DOI 10.1152/ajpgi.1996.271.6.G949; Shimizu S, 1996, CANCER RES, V56, P2161; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Suzuki T, 1998, HUM REPROD, V13, P953, DOI 10.1093/humrep/13.4.953; Temple-Smith P, 2013, HUM REPROD, V28, P35; Wu H, 2015, ANTIOXID REDOX SIGN, V22, P1032, DOI 10.1089/ars.2014.6204; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhou JL, 2018, BIOL REPROD, V99, P308, DOI 10.1093/biolre/ioy061; Zhou JL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.371	42	17	18	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3631	3645		10.1096/fj.201901808RRR	http://dx.doi.org/10.1096/fj.201901808RRR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960530				2022-12-26	WOS:000508661300001
J	Broekelmann, TJ; Bodmer, NK; Mecham, RP				Broekelmann, Thomas J.; Bodmer, Nicholas K.; Mecham, Robert P.			Identification of the growth factor?binding sequence in the extracellular matrix protein MAGP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; transforming growth factor beta (TGF?); cell signaling; bone morphogenetic protein (BMP); growth factor; fibrillar; growth factor signaling; MFAP2; microfibril; microfibril associated glycoprotein (MAGP); TGF?; fibrillin; extracellular cellular matrix (ECM); protein-protein interaction	MICROFIBRIL-ASSOCIATED GLYCOPROTEIN-1; TGF-BETA ACTIVATION; TRANSFORMING GROWTH-FACTOR-BETA-1; TERNARY COMPLEX; BINDING DOMAIN; FIBRILLIN; TROPOELASTIN; FIBRONECTIN; COMPONENTS; ELASTIN	Microfibril-associated glycoprotein-1 (MAGP-1) is a component of vertebrate extracellular matrix (ECM) microfibrils that, together with the fibrillins, contributes to microfibril function. Many of the phenotypes associated with MAGP-1 gene inactivation are consistent with dysregulation of the transforming growth factor ? (TGF?)/bone morphogenetic protein (BMP) signaling system. We have previously shown that full-length MAGP-1 binds active TGF?-1 and some BMPs. The work presented here further defines the growth factor?binding domain of MAGP-1. Using recombinant domains and synthetic peptides, along with surface plasmon resonance analysis to measure the kinetics of the MAGP-1?TGF?-1 interaction, we localized the TGF?- and BMP-binding site in MAGP-1 to a 19-amino acid?long, highly acidic sequence near the N terminus. This domain was specific for binding active, but not latent, TGF?-1. Growth factor activity experiments revealed that TGF?-1 retains signaling activity when complexed with MAGP-1. Furthermore, when bound to fibrillin, MAGP-1 retained the ability to interact with TGF?-1, and active TGF?-1 did not bind fibrillin in the absence of MAGP-1. The absence of MAGP was sufficient to raise the amount of total TGF? stored in the ECM of cultured cells, suggesting that the MAGPs compete with the TGF? large latent complex for binding to microfibrils. Together, these results indicate that MAGP-1 plays an active role in TGF? signaling in the ECM.	[Broekelmann, Thomas J.; Bodmer, Nicholas K.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mecham, RP (corresponding author), Campus Box 8228,660 South Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu			NHLBI, National Institutes of Health [R01 HL53325, R01 HL105314]; National Institutes of Health [T32 HL125241, T32 HL07317]; Ines Mandl Research Foundation	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ines Mandl Research Foundation	This work was supported by NHLBI, National Institutes of Health Grants R01 HL53325 and R01 HL105314 (to R. P. M.) and by National Institutes of Health Training Grants T32 HL125241 and T32 HL07317 (to N. K. B.), and also by the Ines Mandl Research Foundation (to R. P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcaraz LB, 2014, J CELL BIOL, V205, P409, DOI 10.1083/jcb.201308031; Barbier M, 2014, AM J HUM GENET, V95, P736, DOI 10.1016/j.ajhg.2014.10.018; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Combs MD, 2013, J BIOL CHEM, V288, P28869, DOI 10.1074/jbc.M113.497727; Craft CS, 2018, MATRIX BIOL, V71-72, P100, DOI 10.1016/j.matbio.2018.03.006; Craft CS, 2014, DIABETES, V63, P1920, DOI 10.2337/db13-1604; Craft CS, 2012, J CELL BIOCHEM, V113, P93, DOI 10.1002/jcb.23331; Craft CS, 2010, J BIOL CHEM, V285, P23858, DOI 10.1074/jbc.M110.113019; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Davis EC, 2002, J STRUCT BIOL, V139, P65, DOI 10.1016/S1047-8477(02)00559-2; DAVISON IG, 1995, J EXP BIOL, V198, P2185; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; GOLDFISCHER S, 1985, TISSUE CELL, V17, P441, DOI 10.1016/0040-8166(85)90023-0; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchinson MH, 2006, J CHROMATOGR A, V1128, P125, DOI 10.1016/j.chroma.2006.06.050; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Kurcinski M, 2019, BIOINFORMATICS, V35, P4170, DOI 10.1093/bioinformatics/btz185; Lee H, 2015, NUCLEIC ACIDS RES, V43, pW431, DOI 10.1093/nar/gkv495; Lee J, 2015, GLYCOBIOLOGY, V25, P1491, DOI 10.1093/glycob/cwv064; Liu YJ, 2004, J CLIN ENDOCR METAB, V89, P875, DOI 10.1210/jc.2003-030774; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Mazzieri R, 2000, METH MOL B, V142, P13; McConnell CJ, 1997, J PHYSIOL-LONDON, V499, P513, DOI 10.1113/jphysiol.1997.sp021945; Mecham RP, 2015, MATRIX BIOL, V47, P13, DOI 10.1016/j.matbio.2015.05.003; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Moulin A, 2014, PROTEIN SCI, V23, P1698, DOI 10.1002/pro.2548; Murphy-Ullrich JE, 2018, MATRIX BIOL, V68-69, P28, DOI 10.1016/j.matbio.2017.12.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Smaldone S, 2016, J BONE MINER RES, V31, P86, DOI 10.1002/jbmr.2598; Stoilov I, 2018, METHOD CELL BIOL, V143, P133, DOI 10.1016/bs.mcb.2017.08.008; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 1999, BIOCHEM J, V340, P693, DOI 10.1042/0264-6021:3400693; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tumbarello DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162698; Villain G, 2018, FEBS J, V285, P4394, DOI 10.1111/febs.14680; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Walji TA, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00087; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Weinbaum JS, 2010, MACROMOL BIOSCI, V10, P1338, DOI 10.1002/mabi.201000121; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zhao B, 2018, J BIOL CHEM, V293, P1579, DOI 10.1074/jbc.M117.809657	66	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2687	2697		10.1074/jbc.RA119.010540	http://dx.doi.org/10.1074/jbc.RA119.010540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31988245	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000519969100014
J	Weidlich, D; Klostermeier, D				Weidlich, Daniela; Klostermeier, Dagmar			Functional interactions between gyrase subunits are optimized in a species-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA topoisomerase; DNA gyrase; ATPase; DNA-protein interaction; DNA binding protein; decatenation; genome integrity; species specificity; subunit interaction; supercoiling mechanism; heterologous protein-protein interaction; GyrA; GyrB	COLI DNA-GYRASE; C-TERMINAL-DOMAIN; COMPLETE GENOME SEQUENCE; SUPERCOILING SET-POINT; BACILLUS-SUBTILIS DNA; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; II TOPOISOMERASE; ATPASE ACTIVITY; MECHANISM	DNA gyrase is a bacterial DNA topoisomerase that catalyzes ATP-dependent negative DNA supercoiling and DNA decatenation. The enzyme is a heterotetramer comprising two GyrA and two GyrB subunits. Its overall architecture is conserved, but species-specific elements in the two subunits are thought to optimize subunit interaction and enzyme function. Toward understanding the roles of these different elements, we compared the activities of Bacillus subtilis, Escherichia coli, and Mycobacterium tuberculosis gyrases and of heterologous enzymes reconstituted from subunits of two different species. We show that B. subtilis and E. coli gyrases are proficient DNA-stimulated ATPases and efficiently supercoil and decatenate DNA. In contrast, M. tuberculosis gyrase hydrolyzes ATP only slowly and is a poor supercoiling enzyme and decatenase. The heterologous enzymes are generally less active than their homologous counterparts. The only exception is a gyrase reconstituted from mycobacterial GyrA and B. subtilis GyrB, which exceeds the activity of M. tuberculosis gyrase and reaches the activity of the B. subtilis gyrase, indicating that the activities of enzymes containing mycobacterial GyrB are limited by ATP hydrolysis. The activity pattern of heterologous gyrases is in agreement with structural features present: B. subtilis gyrase is a minimal enzyme, and its subunits can functionally interact with subunits from other bacteria. In contrast, the specific insertions in E. coli and mycobacterial gyrase subunits appear to prevent efficient functional interactions with heterologous subunits. Understanding the molecular details of gyrase adaptations to the specific physiological requirements of the respective organism might aid in the development of species-specific gyrase inhibitors.	[Weidlich, Daniela; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany	University of Munster	Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.	dagmar.klostermeier@uni-muenster.de			Deutsche Forschungsgemeinschaft [KL1153/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KL1153/9-1. The authors declare that they have no conflicts of interest with the contents of this article.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blower TR, 2016, P NATL ACAD SCI USA, V113, P1706, DOI 10.1073/pnas.1525047113; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; CHAMPOUX JJ, 1981, J BIOL CHEM, V256, P4805; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; DEPEW RE, 1978, J BIOL CHEM, V253, P511; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gubaev A, 2016, NUCLEIC ACIDS RES, V44, P10354, DOI 10.1093/nar/gkw740; Gubaev A, 2014, DNA REPAIR, V16, P23, DOI 10.1016/j.dnarep.2014.01.011; Gubaev A, 2012, J BIOL CHEM, V287, P10916, DOI 10.1074/jbc.M111.308247; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Hartmann S, 2017, J MOL BIOL, V429, P3717, DOI 10.1016/j.jmb.2017.10.005; Hashimi SM, 2008, ANTIMICROB AGENTS CH, V52, P1382, DOI 10.1128/AAC.01551-07; Hearnshaw SJ, 2015, ACTA CRYSTALLOGR D, V71, P996, DOI 10.1107/S1399004715002916; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Jude KM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt413; Klostermeier D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051489; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Lanz MA, 2014, J BIOL CHEM, V289, P12275, DOI 10.1074/jbc.M114.547745; LIU LF, 1979, J BIOL CHEM, V254, P1082; Lulchev P, 2014, NUCLEIC ACIDS RES, V42, P8200, DOI 10.1093/nar/gku589; Madhusudan K, 1995, MICROBIOL-SGM, V141, P3029, DOI 10.1099/13500872-141-12-3029; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960; ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723; ORR E, 1982, J BACTERIOL, V151, P524, DOI 10.1128/JB.151.1.524-527.1982; Papillon J, 2013, NUCLEIC ACIDS RES, V41, P7815, DOI 10.1093/nar/gkt560; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; Petrella S, 2019, STRUCTURE, V27, P579, DOI 10.1016/j.str.2019.01.004; Rovinskiy NS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030081; Rudolph MG, 2013, J MOL BIOL, V425, P2632, DOI 10.1016/j.jmb.2013.04.010; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Sengupta S, 2008, FEMS MICROBIOL LETT, V279, P40, DOI 10.1111/j.1574-6968.2007.01005.x; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Stelljes JT, 2018, NUCLEIC ACIDS RES, V46, P6773, DOI 10.1093/nar/gky470; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; SUGINO A, 1980, NUCLEIC ACIDS RES, V8, P3865, DOI 10.1093/nar/8.17.3865; Taneja B, 2007, P NATL ACAD SCI USA, V104, P14670, DOI 10.1073/pnas.0701989104; Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tretter EM, 2012, J BIOL CHEM, V287, P18636, DOI 10.1074/jbc.M112.345678; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; TSE YC, 1980, J BIOL CHEM, V255, P5560; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Wu LCC, 1995, ARCH BIOCHEM BIOPHYS, V324, P123, DOI 10.1006/abbi.1995.9919	66	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2299	2312		10.1074/jbc.RA119.010245	http://dx.doi.org/10.1074/jbc.RA119.010245			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953321	Green Published, hybrid			2022-12-26	WOS:000517330200013
J	Eick, SM; Meeker, JD; Swartzendruber, A; Rios-McConnell, R; Brown, P; Velez-Vega, C; Shen, Y; Alshawabkeh, AN; Cordero, JF; Ferguson, KK				Eick, Stephanie M.; Meeker, John D.; Swartzendruber, Andrea; Rios-McConnell, Rafael; Brown, Phil; Velez-Vega, Carmen; Shen, Ye; Alshawabkeh, Akram N.; Cordero, Jose F.; Ferguson, Kelly K.			Relationships between psychosocial factors during pregnancy and preterm birth in Puerto Rico	PLOS ONE			English	Article							AFRICAN-AMERICAN; PSYCHOLOGICAL DISTRESS; MATERNAL STRESS; SOCIAL SUPPORT; LIFE EVENTS; WOMEN; OUTCOMES; IMPACT; DEPRESSION; SYMPTOMS	Psychosocial stress during pregnancy has been associated with adverse pregnancy outcomes including preterm birth (PTB). This has not been studied in Puerto Rico, an area with high PTB rates. Our objective was to develop a conceptual model describing the interrelationships between measures of psychosocial stress and depression, a result of stress, among pregnant women in Puerto Rico and to examine their associations with PTB. We used data from the Puerto Rico Testsite for Exploring Contamination Threats pregnancy cohort (PROTECT, N = 1,047) to examine associations among depression and different continuous measures of psychosocial stress using path analysis. Psychosocial stress during pregnancy was assessed using validated measures of perceived stress, negative life experiences, neighborhood perceptions and social support. Logistic regression was used to examine associations between psychosocial stress measures in tertiles and PTB. Perceived stress, negative life experiences, and neighborhood perceptions influenced depression through multiple pathways. Our model indicated that perceived stress had the strongest direct effect on depression, where one standard deviation (SD) increase in perceived stress was associated with a 57% SD increase in depression. Negative life experiences were directly but also indirectly, through perceived stress, associated with depression. Finally, neighborhood perceptions directly influenced negative life experiences and perceived stress and consequently had an indirect effect on depression. Psychosocial stress was not associated with PTB across any of the measures examined. Our study examined interrelationships between multiple measures of psychosocial stress and depression among a pregnant Puerto Rican population and identified negative neighborhood perceptions as important upstream factors leading to depression. Our findings highlight the complex relationship between psychosocial stress measures and indicate that psychosocial stress and depression, assessed using 5 different scales, were not associated with PTB. Future research should investigate other environmental and behavioral risk factors contributing to higher rates of PTB in this population.	[Eick, Stephanie M.; Swartzendruber, Andrea; Shen, Ye; Cordero, Jose F.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA USA; [Eick, Stephanie M.] Univ Calif San Francisco, Program Reprod Hlth & Environm, Dept Obstet Gynecol & Reprod Serv, San Francisco, CA 94143 USA; [Meeker, John D.; Ferguson, Kelly K.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Rios-McConnell, Rafael; Velez-Vega, Carmen] Univ Puerto Rico, Grad Sch Publ Hlth, UPR Med Sci Campus, San Juan, PR 00936 USA; [Brown, Phil] Northeastern Univ, Dept Sociol & Anthropol, Boston, MA 02115 USA; [Brown, Phil] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA; [Alshawabkeh, Akram N.] Northeastern Univ, Coll Engn, Boston, MA 02115 USA; [Ferguson, Kelly K.] NIEHS, Epidemiol Branch, POB 12233, Res Triangle Pk, NC 27709 USA	University System of Georgia; University of Georgia; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Northeastern University; Northeastern University; Northeastern University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Ferguson, KK (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.; Ferguson, KK (corresponding author), NIEHS, Epidemiol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	kelly.ferguson2@nih.gov	Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250; Eick, Stephanie/0000-0001-6695-3291; Meeker, John/0000-0001-8357-5085	National Institute of Environmental Health Sciences [P42ES017198, P50ES026049]; National Institutes of Health Office of the Director grants [UG3OD023251, UH3OD023251]; Intramural Research Program of the NIEHS, NIH	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Office of the Director grants; Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences grants P42ES017198 (PI AA) and P50ES026049 (PI AA) and the National Institutes of Health Office of the Director grants UG3OD023251 (PI AA) and UH3OD023251 (PI AA). Funding was provided by the Intramural Research Program of the NIEHS, NIH (KKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; [Anonymous], 2014, Obstet Gynecol, V124, P863, DOI 10.1097/01.AOG.0000454932.15177.be; Canino G, 2019, SOCIAL PSYCHIAT PSYC; Chen MJ, 2011, AM J OBSTET GYNECOL, V205, P402, DOI 10.1016/j.ajog.2011.05.003; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; de Mendoza VB, 2018, J INTERPERS VIOLENCE, V33, P938, DOI 10.1177/0886260515613346; Dolatian M, 2016, J OBSTET GYNAECOL RE, V42, P822, DOI 10.1111/jog.12991; Dole N, 2004, AM J PUBLIC HEALTH, V94, P1358, DOI 10.2105/AJPH.94.8.1358; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Eick SM, 2019, FREE RADICAL BIOL ME; Eick SM, 2018, PAEDIATR PERINAT EP, V32, P318, DOI 10.1111/ppe.12465; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Falcon LM, 2009, AGING MENT HEALTH, V13, P863, DOI 10.1080/13607860903046552; Ferguson KK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217770; Ferguson KK, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.007; Ferranti EP, 2013, RES NURS HEALTH, V36, P242, DOI 10.1002/nur.21532; Giurgescu C, 2006, NURS RES, V55, P356, DOI 10.1097/00006199-200609000-00008; Giurgescu C, 2015, SOC SCI MED, V130, P172, DOI 10.1016/j.socscimed.2015.02.006; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kinser PA, 2018, J WOMENS HEALTH, V27, P369, DOI 10.1089/jwh.2017.6426; Littleton HL, 2007, AM J OBSTET GYNECOL, V196, P424, DOI 10.1016/j.ajog.2007.03.042; Lobel M, 2000, HEALTH PSYCHOL, V19, P544, DOI 10.1037/0278-6133.19.6.544; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; March of Dimes, 2018, PREM BIRTH REP CARDS; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Mattei J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5359-z; Meeker JD, 2013, ENVIRON SCI TECHNOL, V47, P3439, DOI 10.1021/es400510g; Mehta PK, 2017, WOMEN HEALTH ISS, V27, P441, DOI 10.1016/j.whi.2017.01.007; Mitchell Pamela H, 2003, J Cardiopulm Rehabil, V23, P398, DOI 10.1097/00008483-200311000-00001; Olson DM, 2015, INT J MOL SCI, V16, P29856, DOI 10.3390/ijms161226209; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Sealy-Jefferson S, 2016, J URBAN HEALTH, V93, P984, DOI 10.1007/s11524-016-0083-4; Shapiro GD, 2013, J PERINAT MED, V41, P631, DOI 10.1515/jpm-2012-0295; Shriver Eunice Kennedy, 2017, NATL CHILDRENS STUDY; Sibai BM, 2006, SEMIN PERINATOL, V30, P16, DOI 10.1053/j.semperi.2006.01.008; Steger MF, 2009, J COUNS PSYCHOL, V56, P289, DOI 10.1037/a0015416; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wesselink AK, 2018, AM J EPIDEMIOL, V187, P2662, DOI 10.1093/aje/kwy186; Witt WP, 2015, AM J PUBLIC HEALTH, V105, P1044, DOI 10.2105/AJPH.2015.302566; Xiong Xu, 2010, Am J Disaster Med, V5, P181; Yang SM, 2015, MATERN CHILD HLTH J, V19, P1142, DOI 10.1007/s10995-014-1623-8; Yu YX, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.003	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227976	10.1371/journal.pone.0227976	http://dx.doi.org/10.1371/journal.pone.0227976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995596	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400034
J	Kielbassa, AM; Leimer, MR; Hartmann, J; Harm, S; Pasztorek, M; Ulrich, IB				Kielbassa, Andrej M.; Leimer, Marlene R.; Hartmann, Jens; Harm, Stephan; Pasztorek, Markus; Ulrich, Ina B.			Ex vivo investigation on internal tunnel approach/internal resin infiltration and external nanosilver-modified resin infiltration of proximal caries exceeding into dentin	PLOS ONE			English	Article							SHEAR BOND STRENGTH; AMORPHOUS CALCIUM-PHOSPHATE; APPROXIMAL CARIOUS LESIONS; MARGINAL RIDGE STRENGTH; SURFACE-ROUGHNESS; QUATERNARY AMMONIUM; FRACTURE-RESISTANCE; PREPARED TEETH; NANO-SILVER; ENAMEL	This ex vivo proof-of-concept study aimed to investigate the effect of nanosilver particles (AgNP) added to a conventional infiltrant resin (Icon) on external penetration into natural proximal enamel caries exceeding into dentin after internal tunnel preparation and internal infiltration. Carious lesions (ICDAS codes 2/3) of extracted human (pre-)molars revealing proximal caries radiographically exceeding into dentin (E2/D1 lesions) were preselected. Then, 48 of those specimens showing demineralized areas transcending the enamel-dentin border as assessed by means of near-infrared light transillumination (DIAGNOcam) were deproteinized (NaOCl, 5%). Using an internal tunnel approach, occlusal cavities central to the marginal ridge were prepared. Excavation of carious dentin, total etch procedure (H3PO4, 40%), and internal resin infiltration (FITC-labeled) followed, along with final restorations (flowable composite resin). Outer lesion surfaces were etched (HCl, 15%) prior to external infiltration (RITC-labeled). Group 1 (control; n = 24) used non-modified infiltrant, while an infiltrant/AgNP mixture (20 nm; 5.5 wt%) was used with experimental Group 2 (n = 24). Non-infiltrated pores of cut lesions were stained (Berberine), and specimens were analyzed using confocal laser scanning microscopy. Compared to the non-filled infiltrant, incorporation of AgNP had no effect on the resin's external penetration. Between the groups, no significant differences regarding internal or external infiltration could be detected, and non-infiltrated lesion areas did not differ significantly (p> 0.109; t-test). The internal tunnel preparation in combination with both an internal resin infiltration and an additional external infiltration approach using a nanosilver-modified infiltrant resin leads to increased infiltrated lesion areas, thus occluding and adhesively stabilizing the porous volume of the demineralized enamel. While exerting antimicrobial effects by the nanosilver particles, this approach should have the potential as a viable treatment alternative for proximal lesions extending into dentin, thus avoiding the sacrifice of sound enamel, postponing the frequently inevitable restoration/re-restoration cycle of conventional proximal caries treatment, and improving dental health.	[Kielbassa, Andrej M.; Leimer, Marlene R.; Ulrich, Ina B.] Danube Private Univ, Univ Dent Med & Oral Hlth, Ctr Operat Dent Periodontol & Endodontol, Krems, Austria; [Hartmann, Jens; Harm, Stephan; Pasztorek, Markus] Danube Univ, Dept Biomed Res, Krems, Austria	Danube University Krems	Kielbassa, AM (corresponding author), Danube Private Univ, Univ Dent Med & Oral Hlth, Ctr Operat Dent Periodontol & Endodontol, Krems, Austria.	andrej.kielbassa@dp-uni.ac.at	Ulrich, Ina Brigitte/I-8829-2019; Kielbassa, Andrej Michael/C-1062-2019	Kielbassa, Andrej Michael/0000-0001-7493-2175; Harm, Stephan/0000-0003-1944-9898; Ulrich, Ina Brigitte/0000-0003-2781-8008				Abdelaziz M, 2018, J DENT, V70, P40, DOI 10.1016/j.jdent.2017.12.008; Arnold WH, 2016, OPEN DENT J, V10, P505, DOI 10.2174/1874210601610010505; Arslan S, 2015, DENT MATER J, V34, P25, DOI 10.4012/dmj.2014-078; Askar H, 2018, J DENT, V74, P56, DOI 10.1016/j.jdent.2018.03.010; Astvaldsdottir A, 2012, INT J DENT, V2012, DOI 10.1155/2012/326401; Attin R, 2012, ANGLE ORTHOD, V82, P56, DOI 10.2319/012311-48.1; Azarsina Mohadese, 2013, J Contemp Dent Pract, V14, P1014; Aziznezhad Mahdiye, 2017, Electron Physician, V9, P3934, DOI 10.19082/3934; Bakhshandeh A, 2018, ACTA ODONTOL SCAND, V76, P509, DOI 10.1080/00016357.2018.1444201; Bapat RA, 2018, MAT SCI ENG C-MATER, V91, P881, DOI 10.1016/j.msec.2018.05.069; Blocher S, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0024-8; Borges Alessandra Buhler, 2019, F1000Res, V8, P1743, DOI 10.12688/f1000research.20523.1; Boston DW, 2015, AM J DENT, V28, P183; Burgers R, 2009, ARCH ORAL BIOL, V54, P595, DOI 10.1016/j.archoralbio.2009.03.004; Caglar E, 2015, ACTA STOMATOL CROAT, V49, P304, DOI 10.15644/asc49/4/5; Cameron SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072030; Freitas MCCD, 2018, ARCH ORAL BIOL, V95, P118, DOI 10.1016/j.archoralbio.2018.07.011; Central Ethical Review Committee, 2003, US HUM BOD MAT PURP; Chatzimarkou S, 2018, J DENT, V77, P8, DOI 10.1016/j.jdent.2018.08.004; Chen M, 2019, EUR REV MED PHARMACO, V23, P7722, DOI 10.26355/eurrev_201909_18981; Cheng L, 2016, INT J ORAL SCI, V8, P172, DOI 10.1038/ijos.2016.13; Cheng L, 2012, J BIOMED MATER RES B, V100B, P1378, DOI 10.1002/jbm.b.32709; Cheng L, 2012, DENT MATER, V28, P561, DOI 10.1016/j.dental.2012.01.005; Chu CH, 2013, CLIN COSMET INVESTIG, V5, P43, DOI 10.2147/CCIDE.S48567; Nobrega MTC, 2020, DENT MATER J, V39, P449, DOI 10.4012/dmj.2019-108; de Freitas A R, 1994, Quintessence Int, V25, P419; Ferreira DAD, 2018, CARIES RES, V52, P580, DOI 10.1159/000488211; Durner J, 2011, DENT MATER, V27, P631, DOI 10.1016/j.dental.2011.03.003; Ebert J, 2012, QUINTESSENCE INT, V43, P93; EHRNFORD LE, 1994, SWED DENT J, V18, P207; Ei TZ, 2019, DENT MATER, V35, pE74, DOI 10.1016/j.dental.2019.01.008; Enan ET, 2019, J ESTHET RESTOR DENT, V31, P353, DOI 10.1111/jerd.12471; Fasbinder D J, 1991, Am J Dent, V4, P77; FDI World Dent Federation, 2017, INT DENT J, V67, P6, DOI 10.1111/idj.12308; Finer Y, 2004, J DENT RES, V83, P22, DOI 10.1177/154405910408300105; Foster LV, 1998, BRIT DENT J, V185, P353, DOI 10.1038/sj.bdj.4809812; Garrocho-Rangel A, 2015, EUR J PAEDIATR DENT, V16, P212; Campos SDG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183432; Gurdogan EB, 2017, J ESTHET RESTOR DENT, V29, P201, DOI 10.1111/jerd.12279; Horsted-Bindslev P, 2005, CLIN ORAL INVEST, V9, P233, DOI 10.1007/s00784-005-0011-6; Horuztepe SA, 2017, J ESTHET RESTOR DENT, V29, P378, DOI 10.1111/jerd.12308; Huang B, 2018, ACTA BIOMATER, V71, P330, DOI 10.1016/j.actbio.2018.02.020; Ismail AI, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-S1-S9; Ji W, 2009, DENT MATER, V25, P1363, DOI 10.1016/j.dental.2009.06.007; Jia LH, 2013, CLIN ORAL INVEST, V17, P643, DOI 10.1007/s00784-012-0727-z; Jia LH, 2012, J ADHES DENT, V14, P569, DOI 10.3290/j.jad.a25685; Kasraei Shahin, 2014, Restor Dent Endod, V39, P109, DOI 10.5395/rde.2014.39.2.109; Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056; Kielbassa AM, 1999, ARCH ORAL BIOL, V44, P243, DOI 10.1016/S0003-9969(98)00123-X; Kielbassa AM, 2010, MED EVOL, V16, P3, DOI DOI 10.13140/RG.2.2.36646.37443; Kielbassa AM, 2006, J DENT, V34, P817, DOI 10.1016/j.jdent.2006.04.001; Kielbassa AM, 2017, INT J ORAL SCI, V9, P117, DOI 10.1038/ijos.2017.15; Kielbassa AM, 2017, QUINTESSENCE INT, V48, P357, DOI 10.3290/j.qi.a37799; Kielbassa AM, 2009, QUINTESSENCE INT, V40, P663; Kinomoto Y, 2004, AM J DENT, V17, P253; Kuhnisch J, 2019, AM J DENT, V32, P74; Laske M, 2019, CARIES RES, V53, P204, DOI 10.1159/000490626; Li F, 2013, DENT MATER, V29, P450, DOI 10.1016/j.dental.2013.01.012; Liang Y, 2018, CLIN ORAL INVEST, V22, P2675, DOI 10.1007/s00784-018-2605-9; Lin NJ, 2018, DENT MATER, V34, P776, DOI 10.1016/j.dental.2018.02.003; Liu Yong-Hong, 2012, Zhonghua Kou Qiang Yi Xue Za Zhi, V47, P684, DOI 10.3760/cma.j.issn.1002-0098.2012.11.011; Liu Yonghong, 2015, Zhonghua Kou Qiang Yi Xue Za Zhi, V50, P737; Maltz M, 2012, J DENT, V40, P776, DOI 10.1016/j.jdent.2012.05.011; Marggraf T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21842-8; Martignon S, 2019, BRIT DENT J, V227, P353, DOI 10.1038/s41415-019-0678-8; Melo M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50850-5; Moheb A, 2019, QUINTESSENCE INT, V50, P840, DOI 10.3290/j.qi.a43234; Mueller J, 2011, QUINTESSENCE INT, V42, P135; Naidu E, 2013, ANGLE ORTHOD, V83, P306, DOI 10.2319/052112-409.1; Nedeljkovic I, 2017, J DENT, V63, P36, DOI 10.1016/j.jdent.2017.05.015; Neres EY, 2017, OPER DENT, V42, P428, DOI 10.2341/16-144-L; Noronha VT, 2017, DENT MATER, V33, P1110, DOI 10.1016/j.dental.2017.07.002; Ntovas P, 2018, BRIT DENT J, V225, P299, DOI 10.1038/sj.bdj.2018.647; Oong EM, 2008, J AM DENT ASSOC, V139, P271, DOI 10.14219/jada.archive.2008.0156; Panduric V, 2009, COLLEGIUM ANTROPOL, V33, P449; Paris S, 2007, DENT MATER J, V26, P582, DOI 10.4012/dmj.26.582; Paris S, 2011, EUR J ORAL SCI, V119, P182, DOI 10.1111/j.1600-0722.2011.00807.x; Perdigao J, 2020, J ESTHET RESTOR DENT, V32, P317, DOI 10.1111/jerd.12550; Peters MC, 2019, J DENT RES, V98, P1497, DOI 10.1177/0022034519876853; Peters MC, 2018, J DENT, V79, P24, DOI 10.1016/j.jdent.2018.09.005; Pinto LD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38684-7; Pitts NB, 2013, COMMUNITY DENT ORAL, V41, pe41, DOI 10.1111/cdoe.12025; PURK JH, 1995, AM J DENT, V8, P75; Quock RL, 2011, MED HYPOTHESES, V77, P315, DOI 10.1016/j.mehy.2011.05.002; Ratledge DK, 2001, CARIES RES, V35, P8; Ratledge DK, 2001, CARIES RES, V35, P3; REEH ES, 1989, J DENT RES, V68, P1540, DOI 10.1177/00220345890680111401; REEH ES, 1989, J ENDODONT, V15, P512, DOI 10.1016/S0099-2399(89)80191-8; Roperto R, 2019, QUINTESSENCE INT, V50, P350, DOI 10.3290/j.qi.a42369; Sadeghinejad L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165760; Schneider H, 2017, J DENT, V60, P94, DOI 10.1016/j.jdent.2017.03.004; Schwendicke F, 2016, Adv Dent Res, V28, P58, DOI 10.1177/0022034516639271; SEPPA L, 1985, ARCH ORAL BIOL, V30, P595, DOI 10.1016/0003-9969(85)90078-0; Shahrbaf S, 2007, OPER DENT, V32, P285, DOI 10.2341/06-83; Sideridou ID, 2011, DENT MATER, V27, P1003, DOI 10.1016/j.dental.2011.06.007; Sokolowski J, 2014, ACTA BIOENG BIOMECH, V16, P51, DOI 10.5277/abb140107; Strand G V, 1995, Int Dent J, V45, P117; STRAND GV, 1993, SCAND J DENT RES, V101, P270; Strand GV, 2000, QUINTESSENCE INT, V31, P453; Strand GV, 1999, CEMENT CONCRETE RES, V29, P645, DOI 10.1016/S0008-8846(99)00005-8; Tanagawa M, 1999, CARIES RES, V33, P366, DOI 10.1159/000016535; Tawakoli PN, 2016, J DENT, V48, P40, DOI 10.1016/j.jdent.2016.03.006; Torres CRG, 2012, OPER DENT, V37, P363, DOI 10.2341/11-070-L; Tschoppe P, 2010, QUINTESSENCE INT, V41, P321; Ulrich I, 2015, CLIN ORAL INVEST, V19, P1473, DOI 10.1007/s00784-014-1372-5; Urquhart O, 2019, J DENT RES, V98, P14, DOI 10.1177/0022034518800014; Urzua I, 2019, OPER DENT, V44, P589, DOI 10.2341/17-314-C; Wenzel A, 2014, ACTA ODONTOL SCAND, V72, P251, DOI 10.3109/00016357.2014.888757; Yang F, 2012, ODONTOLOGY, V100, P172, DOI 10.1007/s10266-011-0031-4; Yazkan B, 2018, ACTA ODONTOL SCAND, V76, P473, DOI 10.1080/00016357.2018.1437217; Yoshida K, 1999, EUR J ORAL SCI, V107, P290, DOI 10.1046/j.0909-8836.1999.eos107409.x; Young DA, 2015, J AM DENT ASSOC, V146, P79, DOI 10.1016/j.adaj.2014.11.018; Zandona AF, 2012, J DENT RES, V91, P841, DOI 10.1177/0022034512455030; Zantner C, 2006, ACTA ODONTOL SCAND, V64, P115, DOI 10.1080/00016350500443297; Zhao X, 2016, OPER DENT, V41, P617, DOI 10.2341/15-319-L	115	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228249	10.1371/journal.pone.0228249	http://dx.doi.org/10.1371/journal.pone.0228249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990942	gold, Green Submitted, Green Published			2022-12-26	WOS:000534605400051
J	Henning, SW; Jaishankar, D; Barse, LW; Dellacecca, ER; Lancki, N; Webb, K; Janusek, L; Mathews, HL; Price, RN; Le Poole, IC				Henning, Steven W.; Jaishankar, Dinesh; Barse, Levi W.; Dellacecca, Emilia R.; Lancki, Nicola; Webb, Kirsten; Janusek, Linda; Mathews, Herbert L.; Price, Ronald N., Jr.; Le Poole, I. Caroline			The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; METABOLIC SYNDROME; OXIDATIVE STRESS; AUTOIMMUNE-DISEASES; IMMUNE FUNCTION; ASSOCIATION; DYSFUNCTION; PREVALENCE; DEPRESSION; ADULTS	Vitiligo is a T-cell mediated skin disorder characterized by progressive loss of skin color. In individuals genetically predisposed to the disease, various triggers contribute to the initiation of vitiligo. Precipitating factors can stress the skin, leading to T-cell activation and recruitment. Though hereditary factors are implicated in the pathogenesis of vitiligo, it is unknown whether precipitating, stressful events play a role in vitiligo. To understand this, we utilized a validated perceived stress scale (PSS) to measure this parameter in vitiligo patients compared to persons without vitiligo. Additionally, we probed a clinical database, using a knowledge linking software called ROCKET, to gauge stress-related conditions in the vitiligo patient population. From a pool of patients in an existing database, a hundred individuals with vitiligo and twenty-five age- and sex-matched comparison group of individuals without vitiligo completed an online survey to quantify their levels of perceived stress. In parallel, patients described specifics of their disease condition, including the affected body sites, the extent, duration and activity of their vitiligo. Perceived stress was significantly higher among vitiligo individuals compared to those without vitiligo. ROCKET analyses suggested signs of metabolic-related disease (i.e., 'stress') preceding vitiligo development. No correlation was found between perceived stress and the stage or the extent of disease, suggesting that elevated stress may not be a consequence of pigment loss alone. The data provide further support for stress as a precipitating factor in vitiligo development.	[Henning, Steven W.; Barse, Levi W.] Loyola Univ Chicago, Oncol Res Inst, Maywood, IL USA; [Jaishankar, Dinesh; Dellacecca, Emilia R.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Lancki, Nicola; Le Poole, I. Caroline] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Webb, Kirsten] Loyola Univ Chicago, Div Dermatol, Maywood, IL USA; [Janusek, Linda] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Maywood, IL USA; [Mathews, Herbert L.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL USA; [Price, Ronald N., Jr.] Loyola Univ Chicago, Off Informat & Syst Dev, Maywood, IL USA; [Le Poole, I. Caroline] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL USA	Loyola University Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Northwestern University; Feinberg School of Medicine	Jaishankar, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA.	dinesh.jaishankar@northwestern.edu		Dellacecca, Emilia/0000-0001-9031-2240; Le Poole, I. Caroline/0000-0001-6853-4007	National Cancer Institute [R01CA191317]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CLP, R01CA191317, National Cancer Institute; https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harbi Mana, 2013, Skinmed, V11, P327; Al-Shobaili HA, 2011, INT J HEALTH SCI-IJH, V5, P167; ALABADIE MSK, 1994, BRIT J DERMATOL, V131, P160; ALBERT DM, 1979, OPHTHALMOLOGY, V86, P1145; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Amer AAA, 2016, INT J DERMATOL, V55, P608, DOI 10.1111/ijd.13198; Asea A, 2007, J BIOSCIENCES, V32, P579, DOI 10.1007/s12038-007-0057-5; Atas H, 2017, BALK MED J, V34, P219, DOI 10.4274/balkanmedj.2016.1005; Baldini E, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00290; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Carella AM, 2010, CURR DIABETES REV, V6, P215, DOI 10.2174/157339910791658844; Cedercreutz K, 2010, J DERMAT NURSES ASSO, V2, P265, DOI 10.1097/JDN.0b013e3181fe9b33; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; COHEN Y, 1988, J CHEM SOC PERK T 2, P31, DOI 10.1039/p29880000031; Cupertino F, 2017, CLIN DERMATOL, V35, P292, DOI 10.1016/j.clindermatol.2017.01.001; Dell'Anna ML, 2010, J CELL PHYSIOL, V223, P187, DOI 10.1002/jcp.22027; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; El-Sayed MIK, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00197; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; Garvey WT, 2006, HDB CLIN NUTR, P357; Gill L, 2016, J AM ACAD DERMATOL, V74, P295, DOI 10.1016/j.jaad.2015.08.063; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; He YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42394; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Jin Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08337-4; Kammerer R, 2002, J IMMUNOL, V168, P108, DOI 10.4049/jimmunol.168.1.108; Karsli N, 2014, J INT MED RES, V42, P799, DOI 10.1177/0300060513516294; Kruger C, 2015, ACTA DERM-VENEREOL, V95, P553, DOI 10.2340/00015555-1981; Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x; Lacetera N., 2016, INNATE IMMUNE RESPON, P107; Lazzeri L, 2016, BIOMED RES INT, V2016, P5, DOI [10.3389/fgene.2016.00003, DOI 10.3389/FGENE.2016.00003]; Le Poole IC, 2004, J INVEST DERM SYMP P, V9, P68, DOI 10.1111/j.1087-0024.2004.00825.x; Le Poole IC, 2001, PIGM CELL RES, V14, P475, DOI 10.1034/j.1600-0749.2001.140608.x; Liana Manolache D P-S, 2013, WORLD J DERMATOL, V2, P16; Manolache L, 2007, J EUR ACAD DERMATOL, V21, P921, DOI 10.1111/j.1468-3083.2006.02106.x; Mason CP, 2005, CLIN EXP DERMATOL, V30, P344, DOI 10.1111/j.1365-2230.2005.01779.x; Mastore M, 2005, FEBS J, V272, P2407, DOI 10.1111/j.1742-4658.2005.04661.x; Mohamed ES, 2017, EGYPT J OTOLARYNGOL, V33, P594, DOI 10.4103/ejo.ejo_6_17; Mosenson JA, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12208; Mosenson JA, 2012, PIGM CELL MELANOMA R, V25, P88, DOI 10.1111/j.1755-148X.2011.00916.x; Nagarajan A, 2015, INDIAN J DERMATOL, V60, DOI 10.4103/0019-5154.147844; Nicolaidou E, 2012, J AM ACAD DERMATOL, V66, P954, DOI 10.1016/j.jaad.2011.07.010; Onder G, 2005, J GERONTOL A-BIOL, V60, P1168, DOI 10.1093/gerona/60.9.1168; Ott C, 2009, CURR HYPERTENS REP, V11, P143, DOI 10.1007/s11906-009-0025-6; Papadopoulos L, 1998, CLIN EXP DERMATOL, V23, P243; Parsad Davinder, 2003, Health Qual Life Outcomes, V1, P58, DOI 10.1186/1477-7525-1-58; Peng QL, 2020, CLIN EXP IMMUNOL, V199, P314, DOI 10.1111/cei.13404; Phillips A.C., 2013, ENCY BEHAV MED, V2nd ed., P1453, DOI [10.1007/978-1-4419-1005-9_479, DOI 10.1007/978-1-4419-1005-9_479]; Picardo M, 2015, J INVEST DERMATOL, V135, P1713, DOI 10.1038/jid.2015.92; Pietrzak A, 2012, DERMATOL THER, V25, pS41, DOI 10.1111/dth.12012; Pizzagalli DA, 2007, BEHAV RES THER, V45, P2742, DOI 10.1016/j.brat.2007.07.013; Plantinga L, 2017, LUPUS, V26, P1064, DOI 10.1177/0961203317693095; Pyykko nen AJ, 2009, BOT STUDY, P1935; Ryu H, 2018, NAT IMMUNOL, V19, P583, DOI 10.1038/s41590-018-0102-6; SALZER BA, 1995, DERMATOLOGY, V190, P109, DOI 10.1159/000246657; Sangma LN, 2015, INDIAN J DERMATOL, V60, P142, DOI 10.4103/0019-5154.152508; Shen CB, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00003; Silverberg JI, 2015, CUTIS, V95, P255; Slangier U, 2003, PSYCHOL ASSESSMENT, V15, P532, DOI 10.1037/1040-3590.15.4.532; Small HY, 2018, FREE RADICAL BIO MED, V125, P104, DOI 10.1016/j.freeradbiomed.2018.05.085; Stojanovich L, 2008, AUTOIMMUN REV, V7, P209, DOI 10.1016/j.autrev.2007.11.007; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Thompson AR, 2002, BRIT J HEALTH PSYCH, V7, P213, DOI 10.1348/135910702169457; Treharne GJ, 2007, BRIT J HEALTH PSYCH, V12, P323, DOI 10.1348/135910706X109288; Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4; Wolf VL, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0914-2; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yang LF, 2015, CURR NEUROPHARMACOL, V13, P494, DOI 10.2174/1570159X1304150831150507; Yang RL, 2008, J CLIN BIOCHEM NUTR, V43, P154, DOI 10.3164/jcbn.2008044; Yildirim M, 2003, J DERMATOL, V30, P104, DOI 10.1111/j.1346-8138.2003.tb00356.x; Zhang YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163806	75	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227909	10.1371/journal.pone.0227909	http://dx.doi.org/10.1371/journal.pone.0227909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986193	Green Published, gold			2022-12-26	WOS:000534603400032
J	Schutte, C; Forsythe, S; Mdala, JF; Zieman, B; Linder, R; Vu, L				Schutte, Carl; Forsythe, Steven; Mdala, Johnface Fedes; Zieman, Brady; Linder, Rachael; Vu, Lung			The short-term effects of the implementation of the "Treat All" guidelines on ART service delivery costs in Namibia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV-1 TRANSMISSION; PREVENTION; INITIATION; INTERVENTIONS	The introduction of "Treat All" (TA) has been promoted to increase the effectiveness of HIV/AIDS treatment by having patients initiate antiretroviral therapy at an earlier stage of their illness. The impact of introducing TA on the unit cost of treatment has been less clear. The following study evaluated how costs changed after Namibia's introduction of TA in April 2017. A two-year analysis assessed the costs of antiretroviral therapy (ART) during the 12 months before TA (Phase I-April 1, 2016 to March 31, 2017) and the 12 months following (Phase II-April 1, 2017 to March 31, 2018). The analysis involved interviewing staff at ten facilities throughout Namibia, collecting data on resources utilized in the treatment of ART patients and analyzing how costs changed before and after the introduction of TA. An analysis of treatment costs indicated that the unit cost of treatment declined from USD360 per patient per year in Phase I to USD301 per patient per year in Phase II, a reduction of 16%. This decline in unit costs was driven by 3 factors: 1) shifts in antiretroviral (ARV) regimens that resulted in lower costs for drugs and consumables, 2) negotiated reductions in the cost of viral load tests and 3) declines in personnel costs. It is unlikely that the first two of these factors were significantly influenced by the introduction of TA. It is unclear if TA might have had an influence on personnel costs. The reduction in personnel costs may have either represented a positive development (fewer personnel costs associated with increased numbers of healthier patients and fewer visits required) or alternatively may reflect constraints in Namibia's staffing. Prior to this study, it was expected that the introduction of TA would lead to a significant increase in the number of ART patients. However, there was less than a 4% increase in the number of adult patients at the 10 studied facilities. From a financial point of view, TA did not significantly increase the resources required in the ten sampled facilities, either by raising unit costs or significantly increasing the number of ART patients.	[Schutte, Carl] Genesis Analyt, Johannesburg, South Africa; [Forsythe, Steven; Linder, Rachael] Avenir Hlth, Fountain Hills, AZ 85268 USA; [Mdala, Johnface Fedes] IntraHealth, Windhoek, Namibia; [Zieman, Brady; Vu, Lung] Populat Council, Washington, DC USA	Population Council	Forsythe, S (corresponding author), Avenir Hlth, Fountain Hills, AZ 85268 USA.	sforsythe@avenirhealth.org		Forsythe, Steven/0000-0002-4409-5991	USAID [AID-OAA-A-14-00060]	USAID(United States Agency for International Development (USAID))	All funding for this activity has been provided by USAID under a Cooperative Agreement called Project SOAR (AID-OAA-A-14-00060). Avenir Health, Genesis Analytics and IntraHealth are private contractors who receive funds from international donor organizations to conduct technical assistance and research. The funder (USAID) provided support in the form of salaries for authors (CS, SF, BZ, RL, LV), but did not have any additional role in the study design, data collection and analysis, or decision to publish. The fact that Avenir Health, IntraHealth and Genesis Analytics are private contractors does not alter our adherence to PLOS ONE policies on sharing data and materials.	Alistar SS, 2014, BMC MED, P12, DOI [10.1186/1741-7015-12-12, DOI 10.1186/1741-7015-12-12]; [Anonymous], 2017, PAY GRADING STRUCTUR; Atun R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009656; Bango F, 2016, TROP MED INT HEALTH, V21, P1115, DOI 10.1111/tmi.12736; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Edwards S., 2018, INSIDE DEV; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Evans CJ, 2000, SCIENCEDIRECT COM VA, P3; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kato M, 2014, CURRENT HIV AIDS REP; Long LC, 2017, AIDS, V31, P1611, DOI 10.1097/QAD.0000000000001528; Ministerio da Saude, 2014, B EP HIV AIDS, DOI [DOI 14/56677/BOLETIM2014FINALPDF15565.PDF, 14/56677/boletim2014finalpdf15565.pdf]; Ministry of Health and Social Services Directorate of Special Programmes, 2017, NAT STRAT FRAM HIV A, P116; Namibia Ministry of Health and Social Services, 2017, NAM 2014 15 HLTH ACC; Namibia Ministry of Health and Social Services, 2016, NAT GUID ANT THER; Nsanzimana S., 2015, RAPID ASSESSMENT REP; PHIA Project, 2018, SUMMARY SHEET NAMIBI; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shade SB, 2017, TOPICS ANTIVIRAL MED, V32, P2179; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; The Namibia Ministry of Minstry of Health and Social Services (MOHSS), 2013, DEM HLTH SURV; UN Joint Programme on HIV/AIDS (UNAIDS), 2018, UNAIDS DAT 2018, P2; UNAIDS, 2017, COUNTR FACTSH NAM; UNAIDS, 2019, UNAIDS DAT 2019; UNAIDS, 2014, 90 90 90 AMB TREATM; Vassall Anna, 2017, GHCC DRAFT REFERENCE; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2012, GUID OR PREEXP PROPH; Wu ZY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001874; Zulliger R, 2014, AIDS BEHAV, V18, P697, DOI 10.1007/s10461-013-0641-7	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228135	10.1371/journal.pone.0228135	http://dx.doi.org/10.1371/journal.pone.0228135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986182	Green Published, gold			2022-12-26	WOS:000534603400038
J	Vecoven, N; Ernst, D; Wehenkel, A; Drion, G				Vecoven, Nicolas; Ernst, Damien; Wehenkel, Antoine; Drion, Guillaume			Introducing neuromodulation in deep neural networks to learn adaptive behaviours	PLOS ONE			English	Article							PRINCIPLES	Animals excel at adapting their intentions, attention, and actions to the environment, making them remarkably efficient at interacting with a rich, unpredictable and ever-changing external world, a property that intelligent machines currently lack. Such an adaptation property relies heavily on cellular neuromodulation, the biological mechanism that dynamically controls intrinsic properties of neurons and their response to external stimuli in a context-dependent manner. In this paper, we take inspiration from cellular neuromodulation to construct a new deep neural network architecture that is specifically designed to learn adaptive behaviours. The network adaptation capabilities are tested on navigation benchmarks in a meta-reinforcement learning context and compared with state-of-the-art approaches. Results show that neuromodulation is capable of adapting an agent to different tasks and that neuromodulation-based approaches provide a promising way of improving adaptation of artificial systems.	[Vecoven, Nicolas; Ernst, Damien; Wehenkel, Antoine; Drion, Guillaume] Univ Liege, Dept Elect Engn, Liege, Belgium; [Vecoven, Nicolas; Ernst, Damien; Wehenkel, Antoine; Drion, Guillaume] Univ Liege, Comp Sci Montefiore Inst, Liege, Belgium	University of Liege; University of Liege	Vecoven, N (corresponding author), Univ Liege, Dept Elect Engn, Liege, Belgium.	nvecoven@uliege.be			Belgian National Fund of Scientific Research	Belgian National Fund of Scientific Research(Fonds de la Recherche Scientifique - FNRS)	Nicolas Vecoven and Antoine Wehenkel gratefully acknowledge the financial support of the Belgian National Fund of Scientific Research.	Agostinelli F., 2014, LEARNING ACTIVATION; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Drion G, 2015, IEEE DECIS CONTR P, P1923, DOI 10.1109/CDC.2015.7402491; Garnelo M., 2018, ARXIV180701613, V80, P1704; Ha D, 2016, HYPERNETWORKS; Lin M, 2013, 13124400 ARXIV; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; Miconi T, 2018, BACKPROPAMINE TRAINI; Miconi T, 2018, PR MACH LEARN RES, V80; Schulman J., 2015, INT C LEARN REPR; Schulman J., 2017, PROXIMAL POLICY OPTI, DOI 10.48550/arXiv.1707.06347; Wang JW, 2017, ACTA OPHTHALMOL, V95, pE10, DOI 10.1111/aos.13227	14	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227922	10.1371/journal.pone.0227922	http://dx.doi.org/10.1371/journal.pone.0227922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986189	Green Submitted, gold, Green Published			2022-12-26	WOS:000534603400033
J	Paruszewska-Achtel, M; Dombek, M; Badura, M; Elminowska-Wenda, G; Dabrowska, M; Grzonkowska, M; Baumgart, M; Szpinda-Barczynska, A; Szpinda, M				Paruszewska-Achtel, Monika; Dombek, Malgorzata; Badura, Mateusz; Elminowska-Wenda, Gabriela; Dabrowska, Maria; Grzonkowska, Magdalena; Baumgart, Mariusz; Szpinda-Barczynska, Anna; Szpinda, Michal			Morphometric study of the diaphragmatic surface of the liver in the human fetus	PLOS ONE			English	Article							BIRTH-WEIGHT PREDICTION; 3-DIMENSIONAL ULTRASONOGRAPHY; OSSIFICATION CENTERS; 1ST TRIMESTER; FETAL; LENGTH; ULTRASOUND; GROWTH; REPRODUCIBILITY; MALFORMATIONS	This study aimed to examine age-specific reference intervals and growth dynamics of the best fit for liver dimensions on the diaphragmatic surface of the fetal liver. The research material consisted of 69 human fetuses of both sexes (32 male, 37 female) aged 18-30 weeks. Using methods of anatomical dissection, digital image analysis and statistics, a total of 10 measurements and 2 calculations were performed. No statistical significant differences between sexes were found (p>0.05). The parameters studied displayed growth models that followed natural logarithmic functions. The mean value of the transverse-to-vertical diameter ratio of the liver throughout the analyzed period was 0.71 +/- 0.11. The isthmic ratio decreased significantly from 0.81 +/- 0.12 in the 18-19th week to 0.62 +/- 0.06 in the 26-27th week, and then increased to 0.68 +/- 0.11 in the 28-30th week of fetal life (p<0.01). The morphometric parameters of the diaphragmatic surface of the liver present age-specific reference data. No sex differences are found. The transverse-to-vertical diameter ratio supports a proportionate growth of the fetal liver. Quantitative anatomy of the growing liver may be of relevance in both the ultrasound monitoring of the fetal development and the early detection of liver anomalies.	[Paruszewska-Achtel, Monika; Dombek, Malgorzata; Badura, Mateusz; Elminowska-Wenda, Gabriela; Dabrowska, Maria; Grzonkowska, Magdalena; Baumgart, Mariusz; Szpinda, Michal] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Normal Anat, Bydgoszcz, Poland; [Szpinda-Barczynska, Anna] Med Univ Warsaw, Dept Orthodont, Warsaw, Poland	Nicolaus Copernicus University; Medical University of Warsaw	Szpinda, M (corresponding author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Normal Anat, Bydgoszcz, Poland.	kizanat@cm.umk.pl	Baumgart, Mariusz/E-7902-2014; Dąbrowska, Maria/AAN-7177-2020	Badura, Mateusz/0000-0003-0798-4295				Albay S, 2005, SAUDI MED J, V26, P1710; Anderson NG, 2008, ULTRASOUND OBST GYN, V31, P529, DOI 10.1002/uog.5298; Archie JG, 2006, AM J CLIN PATHOL, V126, P256, DOI 10.1309/FK9D5WBA1UEPT5BB; Aviram R, 2004, EARLY HUM DEV, V80, P1, DOI 10.1016/j.earlhumdev.2004.02.005; Breeze ACG, 2008, ULTRASOUND OBST GYN, V31, P187, DOI 10.1002/uog.5199; Chang FM, 1997, ULTRASOUND MED BIOL, V23, P381, DOI 10.1016/S0301-5629(96)00218-9; Dimaano NC, 2017, ULTRASOUND OBSTERICS, V50, P257; Fleischer AC, 2000, SONOGRAPHY PRINCIPLE, P109; Hata T, 1998, OBSTET GYNECOL, V91, P218, DOI 10.1016/S0029-7844(97)00598-X; Hata T, 1997, HUM REPROD, V12, P1800, DOI 10.1093/humrep/12.8.1800; Hedrick HL, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.001; Hosapatna Mamatha, 2019, Kurume Med J, V65, P31, DOI 10.2739/kurumemedj.MS652003; Hubbard Anne M, 2003, Semin Pediatr Surg, V12, P143; IFFY L, 1975, PEDIATRICS, V56, P173; Jaiswal A, 2018, JAS, V26, P24; Lee W, 1997, J ULTRAS MED, V16, P799; Lee W, 2009, ULTRASOUND OBST GYN, V34, P556, DOI 10.1002/uog.7327; Lee W, 2001, J ULTRAS MED, V20, P1283; Merz E, 1997, ULTRASOUND OBST GYN, V9, P237, DOI 10.1046/j.1469-0705.1997.09040237.x; MERZ E, 1995, ULTRASOUND OBST GYN, V5, P222, DOI 10.1046/j.1469-0705.1995.05040222.x; Mirghani H, 2007, J CLIN ULTRASOUND, V35, P34, DOI 10.1002/jcu.20294; Paruszewska-Achtel M., 2014, THESIS; Paruszewska-Achtel M, 2018, ADV CLIN EXP MED, V27, P1131, DOI 10.17219/acem/74375; Phatihattakorn Chayawat, 2004, Journal of the Medical Association of Thailand, V87, P750; Roberts AB, 2001, AM J OBSTET GYNECOL, V184, P1251, DOI 10.1067/mob.2001.112975; ROBERTS AB, 1989, AM J OBSTET GYNECOL, V161, P42, DOI 10.1016/0002-9378(89)90229-9; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Szpinda M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/858162; Szpinda M, 2015, SURG RADIOL ANAT, V37, P439, DOI 10.1007/s00276-015-1437-4; Szpinda M, 2014, SURG RADIOL ANAT, V36, P813, DOI 10.1007/s00276-014-1269-7; Szpinda M, 2014, SURG RADIOL ANAT, V36, P55, DOI 10.1007/s00276-013-1145-x; Szpinda M, 2013, SURG RADIOL ANAT, V35, P901, DOI 10.1007/s00276-013-1107-3; Szpinda M, 2013, SURG RADIOL ANAT, V35, P701, DOI 10.1007/s00276-013-1093-5; Szpinda M, 2013, SURG RADIOL ANAT, V35, P395, DOI 10.1007/s00276-012-1045-5; Szpinda M, 2012, SURG RADIOL ANAT, V34, P317, DOI 10.1007/s00276-011-0878-7; Tongprasert F, 2010, J CLIN ULTRA, V39, P274; Toprak E, 2015, J ACAD RES MED, V5, P60, DOI 10.5152/jarem.2015.665; VINTZILEOS AM, 1986, OBSTET GYNECOL, V68, P162; Weiner S, 1978, PERINATAL MED MANAGE, P267	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227872	10.1371/journal.pone.0227872	http://dx.doi.org/10.1371/journal.pone.0227872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978157	Green Published, gold			2022-12-26	WOS:000534599100072
J	Raigani, S; Karimian, N; Huang, V; Zhang, AM; Beijert, I; Geerts, S; Nagpal, S; Hafiz, EOA; Fontan, FM; Aburawi, MM; Mahboub, P; Markmann, JF; Porte, RJ; Uygun, K; Yarmush, M; Yeh, H				Raigani, Siavash; Karimian, Negin; Huang, Viola; Zhang, Anna M.; Beijert, Irene; Geerts, Sharon; Nagpal, Sonal; Hafiz, Ehab O. A.; Fontan, Fermin M.; Aburawi, Mohamed M.; Mahboub, Paria; Markmann, James F.; Porte, Robert J.; Uygun, Korkut; Yarmush, Martin; Yeh, Heidi			Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies	PLOS ONE			English	Article							FATTY LIVER; REPERFUSION INJURY; OXIDATIVE STRESS; ACID-METABOLISM; REACTIVE-OXYGEN; TRANSPLANTATION; HEPATOCYTES; ISCHEMIA; PATHOPHYSIOLOGY; SUPPLEMENTATION	There continues to be a significant shortage of donor livers for transplantation. One impediment is the discard rate of fatty, or steatotic, livers because of their poor post-transplant function. Steatotic livers are prone to significant ischemia-reperfusion injury (IRI) and data regarding how best to improve the quality of steatotic livers is lacking. Herein, we use normothermic (37 degrees C) machine perfusion in combination with metabolic and lipidomic profiling to elucidate deficiencies in metabolic pathways in steatotic livers, and to inform strategies for improving their function. During perfusion, energy cofactors increased in steatotic livers to a similar extent as non-steatotic livers, but there were significant deficits in anti-oxidant capacity, efficient energy utilization, and lipid metabolism. Steatotic livers appeared to oxidize fatty acids at a higher rate but favored ketone body production rather than energy regeneration via the tricyclic acid cycle. As a result, lactate clearance was slower and transaminase levels were higher in steatotic livers. Lipidomic profiling revealed omega-3 polyunsaturated fatty acids increased in non-steatotic livers to a greater extent than in steatotic livers. The novel use of metabolic and lipidomic profiling during ex situ normothermic machine perfusion has the potential to guide the resuscitation and rehabilitation of steatotic livers for transplantation.	[Raigani, Siavash; Markmann, James F.; Uygun, Korkut; Yarmush, Martin; Yeh, Heidi] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Div Transplantat, Boston, MA 02115 USA; [Karimian, Negin; Huang, Viola; Beijert, Irene; Geerts, Sharon; Nagpal, Sonal; Fontan, Fermin M.; Aburawi, Mohamed M.; Mahboub, Paria; Uygun, Korkut; Yarmush, Martin] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; [Karimian, Negin; Huang, Viola; Beijert, Irene; Geerts, Sharon; Nagpal, Sonal; Fontan, Fermin M.; Aburawi, Mohamed M.; Mahboub, Paria; Uygun, Korkut; Yarmush, Martin] Shriners Hosp Children, Boston, MA USA; [Zhang, Anna M.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Beijert, Irene; Geerts, Sharon; Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Hafiz, Ehab O. A.] Theodor Bilharz Res Inst, Electron Microscopy Res Div, Giza, Egypt	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Tufts University; University of Groningen; Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI)	Yeh, H (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Div Transplantat, Boston, MA 02115 USA.	hyeh@partners.org	Hafiz, Ehab/ABC-7389-2020	Hafiz, Ehab/0000-0002-1551-4309; Yarmush, Martin/0000-0003-4986-8444; Beijert, Irene/0000-0002-0510-2300; Raigani, Siavash/0000-0003-2762-7287	US National Institutes of Health [R01DK096075, R01DK107875, R21EB020819, R01DK084053, R01DK114506]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work received funding from the US National Institutes of Health (grants R01DK096075, R01DK107875, R21EB020819, R01DK084053 and R01DK114506) to HY, KU, MY. The hemoglobin-based oxygen carrier, Hemopure was kindly provided by HbO<INF>2</INF> Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2017, SURG ENDOSC, V31, P1361, DOI 10.1007/s00464-016-5121-5; Baker MA, 2018, SURGERY, V163, P1035, DOI 10.1016/j.surg.2017.10.071; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Barros MAP, 2015, TRANSPL P, V47, P2478, DOI 10.1016/j.transproceed.2015.08.001; Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0; Boteon YL, 2019, LIVER TRANSPLANT, V25, P1007, DOI 10.1002/lt.25439; Bruinsma BG, 2014, AM J TRANSPLANT, V14, P1400, DOI 10.1111/ajt.12727; Bruinsma BG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22415; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chu MJJ, 2015, J GASTROINTEST SURG, V19, P1713, DOI 10.1007/s11605-015-2832-1; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; de Vries Y, 2019, AM J TRANSPLANT, V19, P1202, DOI 10.1111/ajt.15228; Eccleston HB, 2011, ANTIOXID REDOX SIGN, V15, P447, DOI 10.1089/ars.2010.3395; Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Hasegawa T, 2007, AM J PHYSIOL-GASTR L, V292, pG1385, DOI 10.1152/ajpgi.00246.2006; Kamisoglu K, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00091; Karaa A, 2005, FREE RADICAL BIO MED, V39, P1320, DOI 10.1016/j.freeradbiomed.2005.06.014; Karimian N, 2015, JOVE-J VIS EXP, DOI 10.3791/52688; Laing RW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017733; Laing RW, 2017, TRANSPLANTATION, V101, P2746, DOI 10.1097/TP.0000000000001821; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Lee K, 2003, METAB ENG, V5, P221, DOI 10.1016/S1096-7176(03)00042-9; Lee K, 2018, MOL CELL PROTEOMICS, V17, P2371, DOI 10.1074/mcp.RA118.000961; Liu Q, 2013, TRANSPL P, V45, P3209, DOI 10.1016/j.transproceed.2013.05.005; Liu Q, 2018, LIVER TRANSPLANT, V24, P233, DOI 10.1002/lt.24972; Manne V, 2018, CLIN LIVER DIS, V22, P23, DOI 10.1016/j.cld.2017.08.007; Matton APM, 2018, LIVER TRANSPLANT, V24, P528, DOI 10.1002/lt.25005; Moosburner Simon, 2018, HPB Surg, V2018, P6094936, DOI 10.1155/2018/6094936; Nair S, 2003, AM J GASTROENTEROL, V98, P466, DOI 10.1016/S0002-9270(02)05889-6; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Nativ NI, 2014, LIVER TRANSPLANT, V20, P1000, DOI 10.1002/lt.23905; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Phelps DL, 2018, BRIT J CANCER, V118, P1349, DOI 10.1038/s41416-018-0048-3; Reiniers MJ, 2014, ANTIOXID REDOX SIGN, V21, P1119, DOI 10.1089/ars.2013.5486; Sacco R, 2016, MINERVA GASTROENTERO, V62, P316; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Siscovick DS, 2017, CIRCULATION, V135, pe867, DOI 10.1161/CIR.0000000000000482; St John ER, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0845-2; Sumida Y, 2018, J GASTROENTEROL, V53, P362, DOI 10.1007/s00535-017-1415-1; Sun Y, 2014, WORLD J GASTROENTERO, V20, P15289, DOI 10.3748/wjg.v20.i41.15289; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Tobin D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081126; Vetelainen R, 2007, BRIT J SURG, V94, P1002, DOI 10.1002/bjs.5672; Vilar-Gomez E, 2020, HEPATOLOGY, V71, P495, DOI 10.1002/hep.30368; Watson CJE, 2018, AM J TRANSPLANT, V18, P2005, DOI 10.1111/ajt.14687; Yan JH, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000012271, 10.1097/md.0000000000012271]; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	53	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228011	10.1371/journal.pone.0228011	http://dx.doi.org/10.1371/journal.pone.0228011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978172	gold, Green Published			2022-12-26	WOS:000534599100094
J	Tieges, Z; Stott, DJ; Shaw, R; Tang, E; Rutter, LM; Nouzova, E; Duncan, N; Clarke, C; Weir, CJ; Assi, V; Ensor, H; Barnett, JH; Evans, J; Green, S; Hendry, K; Thomson, M; McKeever, J; Middleton, DG; Parks, S; Walsh, T; Weir, AJ; Wilson, E; Quasim, T; MacLullich, AMJ				Tieges, Zoe; Stott, David J.; Shaw, Robert; Tang, Elaine; Rutter, Lisa-Marie; Nouzova, Eva; Duncan, Nikki; Clarke, Caoimhe; Weir, Christopher J.; Assi, Valentina; Ensor, Hannah; Barnett, Jennifer H.; Evans, Jonathan; Green, Samantha; Hendry, Kirsty; Thomson, Meigan; McKeever, Jenny; Middleton, Duncan G.; Parks, Stuart; Walsh, Tim; Weir, Alexander J.; Wilson, Elizabeth; Quasim, Tara; MacLullich, Alasdair M. J.			A smartphone-based test for the assessment of attention deficits in delirium: A case-control diagnostic test accuracy study in older hospitalised patients	PLOS ONE			English	Article							AGITATION-SEDATION SCALE; DETECT DELIRIUM; COGNITIVE TEST; DEMENTIA; VALIDATION; INATTENTION; RELIABILITY	Background Delirium is a common and serious acute neuropsychiatric syndrome which is often missed in routine clinical care. Inattention is the core cognitive feature. Diagnostic test accuracy (including cut-points) of a smartphone Delirium App (DelApp) for assessing attention deficits was assessed in older hospital inpatients. Methods This was a case-control study of hospitalised patients aged >= 65 years with delirium (with or without pre-existing cognitive impairment), who were compared to patients with dementia without delirium, and patients without cognitive impairment. Reference standard delirium assessment, which included a neuropsychological test battery, was based on Diagnostic and Statistical Manual of Mental Disorders-5 criteria. A separate blinded assessor administered the DelApp arousal assessment (score 0-4) and attention task (0-6) yielding an overall score of 0 to 10 (lower scores indicate poorer performance). Analyses included receiver operating characteristic curves and sensitivity and specificity. Optimal cut-points for delirium detection were determined using Youden's index. Results A total of 187 patients were recruited, mean age 83.8 (range 67-98) years, 152 (81%) women; n = 61 with delirium; n = 61 with dementia without delirium; and n = 65 without cognitive impairment. Patients with delirium performed poorly on the DelApp (median score = 4/10; inter-quartile range 3.0, 5.5) compared to patients with dementia (9.0; 5.5, 10.0) and those without cognitive impairment (10.0; 10.0, 10.0). Area under the curve for detecting delirium was 0.89 (95% Confidence Interval 0.84, 0.94). At an optimal cut-point of <= 8, sensitivity was 91.7% (84.7%, 98.7%) and specificity 74.2% (66.5%, 81.9%) for discriminating delirium from the other groups. Specificity was 68.3% (56.6%, 80.1%) for discriminating delirium from dementia (cut-point <= 6). Conclusion Patients with delirium (with or without pre-existing cognitive impairment) perform poorly on the DelApp compared to patients with dementia and those without cognitive impairment. A cut-point of <= 8/10 is suggested as having optimal sensitivity and specificity. The DelApp is a promising tool for assessment of attention deficits associated with delirium in older hospitalised adults, many of whom have prior cognitive impairment, and should be further validated in representative patient cohorts.	[Tieges, Zoe; Tang, Elaine; Rutter, Lisa-Marie; Nouzova, Eva; Green, Samantha; McKeever, Jenny; MacLullich, Alasdair M. J.] Univ Edinburgh, Edinburgh Delirium Res Grp, Edinburgh, Midlothian, Scotland; [Tieges, Zoe; MacLullich, Alasdair M. J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Stott, David J.; Shaw, Robert; Tang, Elaine; Duncan, Nikki; Clarke, Caoimhe; Hendry, Kirsty; Thomson, Meigan] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Weir, Christopher J.; Assi, Valentina; Ensor, Hannah] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Barnett, Jennifer H.] Cambridge Cognit Ltd, Cambridge, England; [Barnett, Jennifer H.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Evans, Jonathan] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Middleton, Duncan G.; Parks, Stuart; Weir, Alexander J.] West Glasgow Ambulatory Care Hosp, Med Devices Unit, Glasgow, Lanark, Scotland; [Walsh, Tim] Univ Edinburgh, Crit Care Med & Anaesthesia, Edinburgh, Midlothian, Scotland; [Wilson, Elizabeth] Royal Infirm Edinburgh NHS Trust, Crit Care Med & Anaesthesia, Edinburgh, Midlothian, Scotland; [Quasim, Tara] Glasgow Royal Infirm, Anaesthesia Crit Care & Pain Med, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Edinburgh; University of Cambridge; University of Glasgow; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Glasgow	Tieges, Z (corresponding author), Univ Edinburgh, Edinburgh Delirium Res Grp, Edinburgh, Midlothian, Scotland.; Tieges, Z (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	zoe.tieges@ed.ac.uk	Tieges, Zoe/ABA-2817-2020; Weir, Alexander/F-1353-2011	Weir, Christopher/0000-0002-6494-4903; Ensor, Hannah/0000-0003-3052-7287; Thomson, Meigan/0000-0002-2171-9159; MacLullich, Alasdair/0000-0003-3159-9370; Quasim, Tara/0000-0002-9872-3623; Weir, Alexander/0000-0002-2800-9053; Tieges, Zoe/0000-0002-3820-3917; Green, Samantha/0000-0002-3277-8330; Middleton, Duncan/0000-0003-2909-0049	Medical Research Council [MR/L023210/1]; BBSRC as part of the LLHW [MR/K026992/1]; MRC as part of the LLHW [MR/K026992/1]; NHS Lothian via the Edinburgh Clinical Trials Unit; MRC [G0700704, MR/L023210/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC as part of the LLHW(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC as part of the LLHW(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS Lothian via the Edinburgh Clinical Trials Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council through a Developmental Pathway Funding Scheme, reference MR/L023210/1 (PI: AMJM). AMJM, ZT, DJS, AW, CJW, JB, JE, SP, EJW, TQ and TW acquired the funding. AMJM and ZT are members of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology which was funded by the BBSRC and MRC as part of the LLHW (MR/K026992/1). CJW was also supported in this work by NHS Lothian via the Edinburgh Clinical Trials Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Brown LJE, 2011, J NEUROL NEUROSUR PS, V82, P1334, DOI 10.1136/jnnp.2010.208827; Collins N, 2010, AGE AGEING, V39, P131, DOI 10.1093/ageing/afp201; Davis DHJ, 2012, BRAIN, V135, P2809, DOI 10.1093/brain/aws190; European Delirium Association, 2014, BMC Med, V12, P141, DOI 10.1186/s12916-014-0141-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guenther U, 2012, AM J CRIT CARE, V21, pE12, DOI 10.4037/ajcc2012735; Han JH, 2015, ACAD EMERG MED, V22, P878, DOI 10.1111/acem.12706; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kakuma R, 2003, J AM GERIATR SOC, V51, P443, DOI 10.1046/j.1532-5415.2003.51151.x; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Leonard M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009212; Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501; Marcantonio ER, 2014, ANN INTERN MED, V161, P554, DOI 10.7326/M14-0865; Meagher DJ, 2010, J NEUROL NEUROSUR PS, V81, P876, DOI 10.1136/jnnp.2009.200956; Meagher J, 2015, WORLD J PSYCHIATR, V5, P305, DOI 10.5498/wjp.v5.i3.305; Morandi A, 2017, J AM MED DIR ASSOC, V18, P12, DOI 10.1016/j.jamda.2016.07.014; Morandi A, 2012, J AM GERIATR SOC, V60, P2005, DOI 10.1111/j.1532-5415.2012.04199.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Institute for Health and Clinical Excellence, 2010, DEL DIAGN PREV MAN; Numan T, 2017, J AM GERIATR SOC, V65, P1932, DOI 10.1111/jgs.14933; Oh ES, 2017, JAMA-J AM MED ASSOC, V318, P1161, DOI 10.1001/jama.2017.12067; Oudewortel L, 2019, INT PSYCHOGERIATR, V31, P73, DOI 10.1017/S1041610218000522; Partridge JSL, 2013, INT J GERIATR PSYCH, V28, P804, DOI 10.1002/gps.3900; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Reynish EL, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0899-0; Richardson SJ, 2017, INT PSYCHOGERIATR, V29, P1585, DOI 10.1017/S1041610217000916; Royal College of Psychiatrists, 2013, NATL AUDIT DEMENTIA; Rutter LM, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0901-5; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Simon SE, 2006, J AM MED DIR ASSOC, V7, P412, DOI 10.1016/j.jamda.2006.02.006; Tanaka H, 2015, DEMENT GERIATR COGN, V40, P94, DOI 10.1159/000430089; Tieges Z, 2018, INT J GERIATR PSYCH, V33, P1501, DOI 10.1002/gps.4711; Tieges Z, 2015, INT PSYCHOGERIATR, V27, P1251, DOI 10.1017/S1041610215000186; Tieges Z, 2014, INT J GERIATR PSYCH, V29, P1185, DOI 10.1002/gps.4131; Tieges Z, 2013, AM J GERIAT PSYCHIAT, V21, P1244, DOI 10.1016/j.jagp.2013.05.003; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Voyer P, 2016, INT PSYCHOGERIATR, V28, P1293, DOI 10.1017/S1041610216000533; Young J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5042	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227471	10.1371/journal.pone.0227471	http://dx.doi.org/10.1371/journal.pone.0227471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978127	Green Published, Green Accepted, gold			2022-12-26	WOS:000534599100040
J	Lane, SL; Doyle, AS; Bales, ES; Houck, JA; Lorca, RA; Moore, LG; Julian, CG				Lane, Sydney L.; Doyle, Alexandrea S.; Bales, Elise S.; Houck, Julie A.; Lorca, Ramon A.; Moore, Lorna G.; Julian, Colleen G.			Peroxisome proliferator-activated receptor gamma blunts endothelin-1-mediated contraction of the uterine artery in a murine model of high-altitude pregnancy	FASEB JOURNAL			English	Article						hypoxia; intrauterine growth restriction; thiazolidinedione; vascular function	INTRAUTERINE GROWTH RESTRICTION; PLASMA ENDOTHELIN LEVELS; PPAR-GAMMA; BLOOD-FLOW; BIRTH-WEIGHT; VASODILATOR RESPONSE; INSULIN-RESISTANCE; CHRONIC HYPOXIA; PROTEIN-KINASE; FETAL-GROWTH	The environmental hypoxia of high altitude (HA) increases the incidence of intrauterine growth restriction (IUGR) approximately threefold. The peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated nuclear receptor that promotes vasorelaxation by increasing nitric oxide and downregulating endothelin-1 (ET-1) production, has been implicated in IUGR. Based on our prior work indicating that pharmacologic activation of the PPAR gamma pathway protects against hypoxia-associated IUGR, we used an experimental murine model to determine whether such effects may be attributed to vasodilatory effects in the uteroplacental circulation. Using wire myography, ex vivo vasoreactivity studies were conducted in uterine arteries (UtA) isolated from pregnant mice exposed to hypoxia or normoxia from gestational day 14.5 to 18.5. Exposure to troglitazone, a high-affinity PPAR gamma agonist-induced vasorelaxation in UtA preconstricted with phenylephrine, with HA-UtA showing increased sensitivity. Troglitazone blunted ET-1-induced contraction of UtA in hypoxic and normoxic dams equivalently. Immunohistological analysis revealed enhanced staining for ET-1 receptors in the placental labyrinthine zone in hypoxic compared to normoxic dams. Our results suggest that pharmacologic PPAR-gamma activation, via its vasoactive properties, may protect the fetal growth under hypoxic conditions by improving uteroplacental perfusion and thereby justify further investigation into PPAR gamma as a therapeutic target for IUGR in pregnancies complicated by hypoxia.	[Lane, Sydney L.] Univ Colorado, Grad Sch, Integrated Physiol Program, Aurora, CO USA; [Lane, Sydney L.; Bales, Elise S.; Lorca, Ramon A.; Moore, Lorna G.] Univ Colorado, Dept Obstet & Gynecol, Sch Med, Aurora, CO USA; [Doyle, Alexandrea S.; Houck, Julie A.] Colorado Mesa Univ, Dept Biochem, Grand Junction, CO USA; [Julian, Colleen G.] Univ Colorado, Dept Med, Sch Med, 12700 E 19th Ave,Mailstop 8611,3rd Floor, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Julian, CG (corresponding author), Univ Colorado, Dept Med, Sch Med, 12700 E 19th Ave,Mailstop 8611,3rd Floor, Aurora, CO 80045 USA.	colleen.julian@cuanschutz.edu		Lane, Sydney/0000-0003-0345-2849	American Heart Association [7PRE33410652]; NIH [R01 HL138181, R01 HD088590]	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Heart Association Pre-Doctoral Award 7PRE33410652 (SLL), NIH R01 HL138181 (CGJ), and NIH R01 HD088590 (LGM, CGJ)	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aljunaidy MM, 2016, AM J PHYSIOL-REG I, V311, pR1068, DOI 10.1152/ajpregu.00119.2016; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Barrett-O'Keefe Z, 2013, AM J PHYSIOL-HEART C, V304, pH162, DOI 10.1152/ajpheart.00603.2012; Bashir SO, 2015, ACTA PHYSIOL HUNG, V102, P391, DOI 10.1556/036.102.2015.4.6; Bjarnegard N, 2013, ULTRASOUND OBST GYN, V41, P177, DOI 10.1002/uog.12314; Browne VA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0068; Browne VA, 2011, AM J PHYSIOL-REG I, V300, pR1221, DOI 10.1152/ajpregu.91046.2008; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Chen ZG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12650; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Derosa G, 2005, HYPERTENS RES, V28, P917, DOI 10.1291/hypres.28.917; Diaz M, 2012, J CLIN ENDOCR METAB, V97, pE1468, DOI 10.1210/jc.2012-1064; Erdem A, 2003, J PERINAT MED, V31, P52, DOI 10.1515/JPM.2003.008; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Froment P, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/73986; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; FURUHASHI N, 1995, GYNECOL OBSTET INVES, V39, P88, DOI 10.1159/000292386; Geach Tim, 2015, Nat Rev Endocrinol, V11, P446, DOI 10.1038/nrendo.2015.101; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Gilbert WM, 2003, AM J OBSTET GYNECOL, V188, P1596, DOI 10.1067/mob.2003.384; Gokina NI, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00184; Gong KZ, 2011, AM J PHYSIOL-LUNG C, V301, pL899, DOI 10.1152/ajplung.00062.2011; Holobotovskyy V, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5038; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Julian CG, 2014, FASEB J, V28, P1268, DOI 10.1096/fj.13-239749; Julian CG, 2008, AM J PHYSIOL-REG I, V295, pR906, DOI 10.1152/ajpregu.00164.2008; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Kang BY, 2016, AM J RESP CELL MOL, V54, P136, DOI 10.1165/rcmb.2014-0337OC; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Ketsawatsomkron P, 2015, CURR OPIN NEPHROL HY, V24, P123, DOI 10.1097/MNH.0000000000000103; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Konje JC, 2003, BJOG-INT J OBSTET GY, V110, P301, DOI 10.1016/S1470-0328(02)02963-4; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Lane SL, 2019, FASEB J, V33, P8999, DOI 10.1096/fj.201900214R; LE SQ, 1993, AM J OBSTET GYNECOL, V169, P919, DOI 10.1016/0002-9378(93)90027-G; LICHTY JA, 1957, AMA J DIS CHILD, V93, P666, DOI 10.1001/archpedi.1957.02060040668009; Lorca RA, 2019, HYPERTENSION, V73, P1319, DOI 10.1161/HYPERTENSIONAHA.119.12641; Martin-Nizard F, 2002, J CARDIOVASC PHARM, V40, P822, DOI 10.1097/00005344-200212000-00003; Mateev S, 2003, AM J PHYSIOL-HEART C, V284, pH820, DOI 10.1152/ajpheart.00701.2002; McCarthy FP, 2011, HYPERTENSION, V58, P882, DOI 10.1161/HYPERTENSIONAHA.111.179440; National Research Council, 2011, GUIDE CARE USE LAB A; NELSON DM, 1989, J CLIN ENDOCR METAB, V68, P676, DOI 10.1210/jcem-68-3-676; Nielsen AH, 2000, PLACENTA, V21, P468, DOI 10.1053/plac.2000.0535; Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; Tache V, 2013, STEM CELLS DEV, V22, P2815, DOI 10.1089/scd.2012.0596; Thaete LG, 2004, J SOC GYNECOL INVEST, V11, P16, DOI 10.1016/j.jsgi.2003.07.001; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; UNGER C, 1988, JAMA-J AM MED ASSOC, V259, P3427, DOI 10.1001/jama.259.23.3427; Usha K, 2011, J OBSTET GYN INDIA, V61, P505, DOI 10.1007/s13224-011-0092-x; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Waite LL, 2005, J CLIN ENDOCR METAB, V90, P620, DOI 10.1210/jc.2004-0849; WALSH SW, 1995, J CLIN ENDOCR METAB, V80, P1888, DOI 10.1210/jc.80.6.1888; WALSH SW, 1985, AM J OBSTET GYNECOL, V152, P335, DOI 10.1016/S0002-9378(85)80223-4; Wang YF, 2015, J MOL MED, V93, P327, DOI 10.1007/s00109-014-1216-4; White MM, 2000, AM J PHYSIOL-HEART C, V278, pH2069, DOI 10.1152/ajpheart.2000.278.6.H2069; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; ZAMUDIO S, 1995, J APPL PHYSIOL, V79, P7, DOI 10.1152/jappl.1995.79.1.7; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou JJ, 2013, HYPERTENSION, V62, P599, DOI 10.1161/HYPERTENSIONAHA.113.01449	68	1	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4283	4292		10.1096/fj.201902264RR	http://dx.doi.org/10.1096/fj.201902264RR		JAN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31970838	Bronze, Green Accepted			2022-12-26	WOS:000508878800001
J	Ngere, I; Boru, WG; Isack, A; Muiruri, J; Obonyo, M; Matendechero, S; Gura, Z				Ngere, Isaac; Boru, Waqo Gufu; Isack, Abdikadir; Muiruri, Joshua; Obonyo, Mark; Matendechero, Sultani; Gura, Zeinab			Burden and risk factors of cutaneous leishmaniasis in a peri-urban settlement in Kenya, 2016	PLOS ONE			English	Article							PHLEBOTOMINE SANDFLIES; BARINGO DISTRICT; EPIDEMIOLOGY; INFECTION	Background Cutaneous leishmaniasis is a neglected disease known to cause significant morbidity among the poor. We investigated a suspected outbreak to determine the magnitude of cases, characterize the cases and identify risk factors of cutaneous leishmaniasis in Gilgil, a peri-urban settlement in Central Kenya. Methods Hospital records for the period 2010-2016 were reviewed and additional cases were identified through active case search. Clinical diagnosis of cutaneous leishmaniasis was made based on presence of ulcerative, nodular or papular skin lesion. The study enrolled 58 cases matched by age and neighbourhood to 116 controls in a case control study. Data was collected using structured questionnaires and simple proportions, means and medians were computed, and logistic regression models were constructed for analysis of individual, indoor and outdoor risk factors. Results Of the 255 suspected cases of cutaneous leishmaniasis identified, females constituted 56% (142/255) and the median age was 7 years (IQR 7-21). Cases occurred in clusters and up to 43% of cases originated from Gitare (73/255) and Kambi-Turkana (36/255) villages. A continuous transmission pattern was depicted throughout the period under review. Individual risk factors included staying outside the residence in the evening after sunset (OR 4.1, CI 1.2-16.2) and visiting forests (OR 4.56, CI 2.04-10.22). Sharing residence with a case (OR 14.4, CI 3.8-79.3), residing in a thatched house (OR 7.9, CI 1.9-45.7) and cracked walls (OR 2.3, CI 1.0-4.9) were identified among indoor factors while sighting rock hyraxes near residence (OR 5.3, CI 2.2-12.7), residing near a forest (OR 7.8, CI 2.8-26.4) and having a close neighbour with cutaneous leishmaniasis (OR 6.8, CI 2.8-16.0) were identified among outdoor factors. Conclusions We identify a large burden of cutaneous leishmaniasis in Gilgil with evidence of individual, indoor and outdoor factors of disease spread. The role of environmental factors and rodents in disease transmission should be investigated further	[Ngere, Isaac] Washington State Univ, Global Hlth Program Kenya, Nairobi, Kenya; [Ngere, Isaac; Boru, Waqo Gufu; Isack, Abdikadir; Muiruri, Joshua; Gura, Zeinab] Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Boru, Waqo Gufu; Isack, Abdikadir; Muiruri, Joshua; Obonyo, Mark; Matendechero, Sultani; Gura, Zeinab] Minist Hlth, Nairobi, Kenya	Washington State University	Ngere, I (corresponding author), Washington State Univ, Global Hlth Program Kenya, Nairobi, Kenya.; Ngere, I (corresponding author), Field Epidemiol & Lab Training Program, Nairobi, Kenya.	isaac.ngere@wsu.edu		Ngere, Isaac/0000-0002-6688-3390	Kenya Ministry of Health (MoH), Field epidemiology and laboratory training program (KFELTP); Ministry of Health; Ministry of Agriculture, Livestock and Fisheries (MoALF)	Kenya Ministry of Health (MoH), Field epidemiology and laboratory training program (KFELTP); Ministry of Health; Ministry of Agriculture, Livestock and Fisheries (MoALF)	This field investigation was funded by the Kenya Ministry of Health (MoH), Field epidemiology and laboratory training program (KFELTP). The KFELTP is a competency-based program with mandate to build epidemiological capacity undertaken jointly by the of Ministries of Health and that of Agriculture, Livestock and Fisheries (MoALF) by offering scholarships to employees within the two government ministries to pursue a two-year masters degree program in field epidemiology. Among the competencies needed to be achieved by the trainees is participating in an outbreak investigations in-country or abroad. The KFELTP mentors who are co-authors in this paper, were assigned to mentor the corresponding author at that time of the investigation and they assisted in designing the investigations and conducting preliminary analysis and generation of outbreak report. However the KFELTP had no role in data collection, decision to publish or preparation of the manuscript.	Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; Anjili CO, 2011, J VECTOR DIS, V48, P183; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118; Blanco VM, 2013, AM J TROP MED HYG, V89, P359, DOI 10.4269/ajtmh.12-0784; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Castellucci LA, 2005, AM J TROP MED HYG, V73, P69, DOI 10.4269/ajtmh.2005.73.69; CDC-Centers for Disease Control, 2015, CDC LEISHM RES HLTH; Dean AG, OPENEPI OPEN SOURCE; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Kaimowitz D., 2003, NOT BREAD ALONE FORE; Ministry of Health, 2018, KEN KEN HLTH INF SYS; Ministry of Health Kenya, 2010, MAL IND SURV 2010; MUIGAI R, 1987, T ROY SOC TROP MED H, V81, P600, DOI 10.1016/0035-9203(87)90422-6; Mutinga M.J., 1991, Parassitologia (Rome), V33, P453; MUTINGA MJ, 1990, E AFR MED J, V67, P319; MUTINGA MJ, 1992, E AFR MED J, V69, P9; Mwangi SW, 2000, ENVIRON URBAN, V12, P77, DOI 10.1177/095624780001200207; Odiwuor S, 2012, IDENTIFICATION LEISH; Oryan A., 2014, TROP MED SURG, V2; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; Reithinger R, 2003, EMERG INFECT DIS, V9, P727; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Sang D, 1993, ZOONOTIC FOCUS CUTAN; SANG DK, 1994, T ROY SOC TROP MED H, V88, P35, DOI 10.1016/0035-9203(94)90486-3; Toroitich AK, 1995, EPIDEMIOLOGY CUTANEO; Votypka J, 2012, T ROY SOC TROP MED H, V106, P186, DOI 10.1016/j.trstmh.2011.12.004; WEIGLE KA, 1993, J INFECT DIS, V168, P709, DOI 10.1093/infdis/168.3.709; WHO, LEISH KEY FACTS; WHO, 2017, LEISHM COUNTR PROF K; WHO| Leishmaniasis, 2013, WHO BURD DISTR; Yadon ZE, 2003, AM J TROP MED HYG, V68, P519, DOI 10.4269/ajtmh.2003.68.519	34	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227697	10.1371/journal.pone.0227697	http://dx.doi.org/10.1371/journal.pone.0227697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971945	gold, Green Published			2022-12-26	WOS:000534374400014
J	van der Wal, T; Lambooij, JP; van Amerongen, R				van der Wal, Tanne; Lambooij, Jan-Paul; van Amerongen, Renee			TMEM98 is a negative regulator of FRAT mediated Wnt/beta-catenin signalling	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN 98; BETA-CATENIN; SUBCELLULAR-LOCALIZATION; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; TRANS-GOLGI; WNT; DATABASE; PROGRESSION; EXPRESSION	Wnt/beta-catenin signalling is crucial for maintaining the balance between cell proliferation and differentiation, both during tissue morphogenesis and in tissue maintenance throughout postnatal life. Whereas the signalling activities of the core Wnt/beta-catenin pathway components are understood in great detail, far less is known about the precise role and regulation of the many different modulators of Wnt/beta-catenin signalling that have been identified to date. Here we describe TMEM98, a putative transmembrane protein of unknown function, as an interaction partner and regulator of the GSK3-binding protein FRAT2. We show that TMEM98 reduces FRAT2 protein levels and, accordingly, inhibits the FRAT2-mediated induction of beta-catenin/TCF signalling. We also characterize the intracellular trafficking of TMEM98 in more detail and show that it is recycled between the plasma membrane and the Golgi. Together, our findings not only reveal a new layer of regulation for Wnt/beta-catenin signalling, but also a new biological activity for TMEM98.	[van der Wal, Tanne; van Amerongen, Renee] Univ Amsterdam, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [van der Wal, Tanne; van Amerongen, Renee] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands; [Lambooij, Jan-Paul] Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Netherlands Cancer Institute	van Amerongen, R (corresponding author), Univ Amsterdam, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands.; van Amerongen, R (corresponding author), Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands.	r.vanamerongen@uva.nl			MacGillavry fellowship from the University of Amsterdam	MacGillavry fellowship from the University of Amsterdam	This work was funded by a MacGillavry fellowship from the University of Amsterdam (to RvA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awadalla MS, 2014, JAMA OPHTHALMOL, V132, P970, DOI 10.1001/jamaophthalmol.2014.946; Bannasch D, 2004, NUCLEIC ACIDS RES, V32, pD505, DOI 10.1093/nar/gkh022; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Bilio J, 2007, SCIENCE 80, DOI [10.1126/science.1137065, DOI 10.1126/SCIENCE.1137065]; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chang KT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19744-w; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/nmeth.3891, 10.1038/NMETH.3891]; Cross SH, 2019, MISSENSE MUTATIONS H, DOI [10.1101/513846, DOI 10.1101/513846]; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DeBruine ZJ, 2017, BRIT J PHARMACOL, V174, P4564, DOI 10.1111/bph.14048; Delevoye C, 2014, CELL REP, V6, P445, DOI 10.1016/j.celrep.2014.01.002; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Fu WW, 2015, J INTERF CYTOK RES, V35, P720, DOI 10.1089/jir.2014.0110; Gammons M, 2018, CURR OPIN CELL BIOL, V51, P42, DOI 10.1016/j.ceb.2017.10.008; Garnai SJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008130; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, DOI [10.1128/MCB.22.4.1172-1183.2002, DOI 10.1128/MCB.22.4.1172-1183.2002]; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Guo G, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/289750; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Huang H, 2018, J NEUROSCI, V38, P9829, DOI 10.1523/JNEUROSCI.0154-18.2018; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jonkers J, 1997, EMBO J, V16, P441, DOI 10.1093/emboj/16.3.441; Jonkers J, 1999, MECH DEVELOP, V88, P183, DOI 10.1016/S0925-4773(99)00187-2; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Khorram D, 2015, MOL VIS; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao M, 2015, INT J CLIN EXP PATHO, V8, P15661; Mehrle A, 2006, NUCLEIC ACIDS RES, V34, pD415, DOI 10.1093/nar/gkj139; Ng KTP, 2014, MOL CANCER THER, V13, P1285, DOI 10.1158/1535-7163.MCT-13-0806; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Szenker-Ravi E, 2018, NATURE, DOI [10.1038/s41586-0118-v, DOI 10.1038/S41586-0118-V]; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; van Amerongen R, 2004, J BIOL CHEM, V279, P26967, DOI 10.1074/jbc.M400439200; van Amerongen R, 2010, ONCOGENE, V29, P93, DOI 10.1038/onc.2009.310; Villasenor R, 2016, CURR OPIN CELL BIOL, V39, P53, DOI 10.1016/j.ceb.2016.02.002; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Walf-Vorderwulbecke V, 2012, BLOOD, V120, P4819, DOI 10.1182/blood-2012-05-432534; Wang Y, 2006, BRIT J CANCER, V94, P686, DOI 10.1038/sj.bjc.6602988; Wang YH, 2008, INT J CANCER, V123, P561, DOI 10.1002/ijc.23600; Weaver C, 2003, DEVELOPMENT, V130, P5425, DOI 10.1242/dev.00737; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zhang Y, 2012, TUMOR BIOL, V33, P1437, DOI 10.1007/s13277-012-0394-3; Zhang Y, 2011, VIRCHOWS ARCH, V459, P255, DOI 10.1007/s00428-011-1135-5	72	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227435	10.1371/journal.pone.0227435	http://dx.doi.org/10.1371/journal.pone.0227435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961879	Green Submitted, Green Published, gold			2022-12-26	WOS:000534372000030
J	Stewart, TM; Khomutov, M; Foley, JR; Guo, X; Holbert, CE; Dunston, TT; Schwartz, CE; Gabrielson, K; Khomutov, A; Casero, RA				Stewart, Tracy Murray; Khomutov, Maxim; Foley, Jackson R.; Guo, Xin; Holbert, Cassandra E.; Dunston, Tiffany T.; Schwartz, Charles E.; Gabrielson, Kathleen; Khomutov, Alexey; Casero, Robert A., Jr.			(R,R)-1,12-Dimethylspermine can mitigate abnormal spermidine accumulation in Snyder?Robinson syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polyamine; spermidine; neurodevelopment; neurological disease; osteoporosis; (R; R)-1; 12-dimethylspermine (Me2SPM); alpha-methylated polyamine; polyamine mimetic; Snyder?Robinson Syndrome; spermine synthase	LINKED MENTAL-RETARDATION; ALPHA-METHYL POLYAMINES; SYNTHASE DEFICIENCY; PUTRESCINE; MUTATION; LIVER; N-1-ACETYLTRANSFERASE; DERIVATIVES; METABOLISM; INDUCTION	Snyder?Robinson syndrome (SRS) is an X-linked intellectual disability syndrome caused by a loss-of-function mutation in the spermine synthase (SMS) gene. Primarily affecting males, the main manifestations of SRS include osteoporosis, hypotonic stature, seizures, cognitive impairment, and developmental delay. Because there is no cure for SRS, treatment plans focus on alleviating symptoms rather than targeting the underlying causes. Biochemically, the cells of individuals with SRS accumulate excess spermidine, whereas spermine levels are reduced. We recently demonstrated that SRS patient-derived lymphoblastoid cells are capable of transporting exogenous spermine and its analogs into the cell and, in response, decreasing excess spermidine pools to normal levels. However, dietary supplementation of spermine does not appear to benefit SRS patients or mouse models. Here, we investigated the potential use of a metabolically stable spermine mimetic, (R,R)-1,12-dimethylspermine (Me2SPM), to reduce the intracellular spermidine pools of SRS patient-derived cells. Me2SPM can functionally substitute for the native polyamines in supporting cell growth while stimulating polyamine homeostatic control mechanisms. We found that both lymphoblasts and fibroblasts from SRS patients can accumulate Me2SPM, resulting in significantly decreased spermidine levels with no adverse effects on growth. Me2SPM administration to mice revealed that Me2SPM significantly decreases spermidine levels in multiple tissues. Importantly, Me2SPM was detectable in brain tissue, the organ most affected in SRS, and was associated with changes in polyamine metabolic enzymes. These findings indicate that the (R,R)-diastereomer of 1,12-Me2SPM represents a promising lead compound in developing a treatment aimed at targeting the molecular mechanisms underlying SRS pathology.	[Stewart, Tracy Murray; Foley, Jackson R.; Holbert, Cassandra E.; Dunston, Tiffany T.; Casero, Robert A., Jr.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Rm 551, Baltimore, MD 21287 USA; [Khomutov, Maxim; Khomutov, Alexey] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Guo, Xin; Gabrielson, Kathleen] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA	Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Johns Hopkins University; Johns Hopkins Medicine; Greenwood Genetic Center	Casero, RA (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Rm 551, Baltimore, MD 21287 USA.	rcasero@jhmi.edu	, WaNgtJ/AAR-7045-2020; Stewart, Tracy Murray/B-6137-2017; Khomutov, Alex/G-2128-2015	Stewart, Tracy Murray/0000-0001-8679-6414; Khomutov, Maxim/0000-0003-2833-9834; Khomutov, Alex/0000-0001-6833-7855; Holbert, Cassandra/0000-0002-4869-1301	NCI, National Institutes of Health [R01CA204345, R01CA235863, P30CA006973, R21CA229582]; NINDS, National Institutes of Health [R01NS073854]; Million Dollar Bike Ride, Orphan Disease Center at the University of Pennsylvania [MDBR-18-127-SR, MDBR-20-135-SRS]; South Carolina Department of Disabilities and Special Needs; Russian Science Foundation [17-74-20049]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Million Dollar Bike Ride, Orphan Disease Center at the University of Pennsylvania; South Carolina Department of Disabilities and Special Needs; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by NCI, National Institutes of Health Grants R01CA204345 and R01CA235863 (to R. A. C.), P30CA006973 (to S. K. C. C. C.) and R21CA229582 (to K. G.) and NINDS, National Institutes of Health Grant R01NS073854 (to C. E. S.). This work was also supported by funding from the Million Dollar Bike Ride, Orphan Disease Center at the University of Pennsylvania Grants MDBR-18-127-SR (to R. A. C.) and MDBR-20-135-SRS (to R. A. C. and T. M. S.) and a grant from the South Carolina Department of Disabilities and Special Needs (to C. E. S.). Synthesis of 1,12-Me2SPM was supported by Russian Science Foundation Grant 17-74-20049 (to A. K.).	Albert JS, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0235-8; Arena JF, 1996, AM J MED GENET, V64, P50, DOI 10.1002/(SICI)1096-8628(19960712)64:1<50::AID-AJMG7>3.3.CO;2-4; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; CASERO RA, 1989, CANCER RES, V49, P3829; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; Goodwin AC, 2011, METHODS MOL BIOL, V720, P173, DOI 10.1007/978-1-61779-034-8_10; Grigorenko NA, 2007, TETRAHEDRON, V63, P2257, DOI 10.1016/j.tet.2006.12.065; HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Hyvonen MT, 2009, BIOCHEM J, V422, P321, DOI 10.1042/BJ20090737; Jarvinen A, 2005, J BIOL CHEM, V280, P6595, DOI 10.1074/jbc.M412788200; Jarvinen AJ, 2006, J MED CHEM, V49, P399, DOI 10.1021/jm050872h; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Khomutov M, 2019, J MED CHEM, V62, P11335, DOI 10.1021/acs.jmedchem.9b01666; Kim JI, 2015, SCIENCE, V350, P102, DOI 10.1126/science.aac4690; LAKANEN JR, 1992, J MED CHEM, V35, P724, DOI 10.1021/jm00082a013; Larcher L, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.103777; Li C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01289-7; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; Murray-Stewart Tracy, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6040112; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Pegg AE, 2010, CELL MOL LIFE SCI, V67, P113, DOI 10.1007/s00018-009-0165-5; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peron A, 2013, AM J MED GENET A, V161, P2316, DOI 10.1002/ajmg.a.36116; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; SEELY JE, 1983, METHOD ENZYMOL, V94, P158; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; SEILER N, 1981, Neurochemistry International, V3, P95, DOI 10.1016/0197-0186(81)90027-9; SEILER N, 1975, BIOCHEM J, V152, P201, DOI 10.1042/bj1520201; Sequerra EB, 2007, NEUROSCIENCE, V146, P489, DOI 10.1016/j.neuroscience.2007.01.062; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; Starks Rachel, 2018, Autops Case Rep, V8, pe2018031, DOI 10.4322/acr.2018.031; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; Til HP, 1997, FOOD CHEM TOXICOL, V35, P337, DOI 10.1016/S0278-6915(97)00121-X; Wang XJ, 2009, J BIOL CHEM, V284, P930, DOI 10.1074/jbc.M807758200; YANG JN, 1995, J CELL PHYSIOL, V165, P71, DOI 10.1002/jcp.1041650109; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008	43	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3247	3256		10.1074/jbc.RA119.011572	http://dx.doi.org/10.1074/jbc.RA119.011572			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996374	Green Published, hybrid			2022-12-26	WOS:000519597300029
J	Biggs, MA; Brown, K; Foster, DG				Biggs, M. Antonia; Brown, Katherine; Foster, Diana Greene			Perceived abortion stigma and psychological well-being over five years after receiving or being denied an abortion	PLOS ONE			English	Article							STRATIFIED REPRODUCTION; MENTAL-HEALTH; WOMENS; DISCLOSURE; SCALE; CARE	Objective To prospectively assess perceptions of abortion stigma after receiving or being denied an abortion over 5 years, the factors associated with perceived abortion stigma, and the effects of perceived abortion stigma on psychological well-being. Methods We recruited people seeking abortion from 30 facilities across the US, and interviewed them by phone one week post-abortion seeking, then semiannually for 5 years. We used adjusted mixed effects regression analyses to examine the abortion stigma trajectories of those who obtained an abortion near a facility's gestational age limit (Near-limits) compared to those denied an abortion because they were just over the limit and carried their pregnancies to term (Turnaway- births). Results Of the 956 people recruited, we removed 28 due to ineligibility or missing data, leaving a final sample of 928. In unadjusted analyses, at one-week post-abortion seeking, over half of those seeking abortion perceived that if others knew they had sought an abortion, they would be looked down upon at least "a little bit" by people close to them (60%) or by people in their community (56%). In longitudinal adjusted analyses, people denied an abortion and who carried their pregnancies to term (Turnaway-birth group) reported significantly lower baseline perceived abortion stigma from people close to them (-0.38; 95% CI, -0.59, -0.16) and from people in their community (0.30; 95% CI, -0.52, -0.08), than Near-limits, differences that remained statistically significant for 1.5 years. Overall perceived abortion stigma declined significantly (p <.001) for both study groups. High perceived abortion stigma at baseline was associated with higher odds of experiencing psychological distress years later (adjusted Odds Ratio, 3.98; 95% CI, 1.39, 11.37). Conclusions Most people considering abortion perceive some abortion stigma, which is associated with psychological distress years later.	[Biggs, M. Antonia; Foster, Diana Greene] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Adv New Stand Reprod Hlth ANSIRH, Bixby Ctr Global Reprod Hlth, Oakland, CA 94607 USA; [Brown, Katherine] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Biggs, MA (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Adv New Stand Reprod Hlth ANSIRH, Bixby Ctr Global Reprod Hlth, Oakland, CA 94607 USA.	antonia.biggs@ucsf.edu	Biggs, Antonia/AAG-6338-2020	Biggs, M. Antonia/0000-0002-3904-3177	Wallace Alexander Gerbode Foundation; David and Lucile Packard Foundation	Wallace Alexander Gerbode Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This study was supported by a gift from the Wallace Alexander Gerbode Foundation (http://foundationcenter.org/grantmaker/gerbode/, to DGF), a research grant from an anonymous foundation (to DGF), and an institutional grant from the David and Lucile Packard Foundation (http://www.packard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astbury-Ward E, 2012, J SEX MED, V9, P3137, DOI 10.1111/j.1743-6109.2011.02604.x; Beynon-Jones SM, 2017, FEM PSYCHOL, V27, P225, DOI 10.1177/0959353517696515; Biggs MA, 2017, JAMA PSYCHIAT, V74, P169, DOI 10.1001/jamapsychiatry.2016.3478; Biggs MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009698; Biggs MA, 2015, AM J PUBLIC HEALTH, V105, P2557, DOI 10.2105/AJPH.2015.302803; Bommaraju A, 2016, SEX REPROD HEALTHC, V10, P62, DOI 10.1016/j.srhc.2016.10.008; Cockrill K, 2013, DEVIANT BEHAV, V34, P973, DOI 10.1080/01639625.2013.800423; Cockrill K, 2013, PERSPECT SEX REPRO H, V45, P79, DOI 10.1363/4507913; Cowan SK, 2017, SOC SCI MED, V177, P259, DOI 10.1016/j.socscimed.2017.01.011; Dehlendorf C, 2011, PERSPECT SEX REPRO H, V43, P224, DOI 10.1363/4322411; Derogatis, 2001, BRIEF SYMPTOM INVENT; Foster DG, 2015, PSYCHOL MED, V45, P2073, DOI 10.1017/S0033291714003213; Gelman A, 2017, PERSPECT SEX REPRO H, V49, P29, DOI 10.1363/psrh.12014; Hanschmidt F, 2016, PERSPECT SEX REPRO H, V48, P169, DOI 10.1363/48e8516; Harris LF, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-76; Harris LH, 2014, CURR OPIN OBSTET GYN, V26, P539, DOI 10.1097/GCO.0000000000000121; Hoggart L, 2017, FEM PSYCHOL, V27, P186, DOI 10.1177/0959353517698997; Husain J, 2017, DEVIANT BEHAV, V38, P575, DOI 10.1080/01639625.2016.1197566; Jagannathan R, 2001, AM J PUBLIC HEALTH, V91, P1825, DOI 10.2105/AJPH.91.11.1825; Jones RK, 2017, AM J PUBLIC HEALTH, V107, P1904, DOI 10.2105/AJPH.2017.304042; Kimport K, 2012, CONTRACEPTION, V85, P204, DOI 10.1016/j.contraception.2011.05.020; Kimport K, 2011, PERSPECT SEX REPRO H, V43, P103, DOI 10.1363/4310311; Kumar A, 2009, CULT HEALTH SEX, V11, P625, DOI 10.1080/13691050902842741; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735; Lopez MM, 2019, SALUD MENT, V42, P25, DOI [10.17711/sm.0185-3325.2019.004, 10.17711/SM.0185-3325.2019.004]; Norris A, 2011, WOMEN HEALTH ISS, V21, pS49, DOI 10.1016/j.whi.2011.02.010; Pescosolido BA, 2015, ANNU REV SOCIOL, V41, P87, DOI 10.1146/annurev-soc-071312-145702; Rice WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174210; Roberts DE, 1997, KILLING BLACK BODY R; Rocca CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128832; Rocca CH, 2013, PERSPECT SEX REPRO H, V45, P122, DOI 10.1363/4512213; Ross Loretta J, 2017, REPROD JUSTICE INTRO, DOI DOI 10.1525/9780520963207; Shellenberg KM, 2012, INT J GYNECOL OBSTET, V118, pS152, DOI 10.1016/S0020-7292(12)60015-0; Shellenberg KM, 2011, GLOB PUBLIC HEALTH, V6, pS111, DOI 10.1080/17441692.2011.594072; Steinberg JR, 2016, SOC SCI MED, V150, P67, DOI 10.1016/j.socscimed.2015.12.007; Weitz TA, 2010, PATIENT EDUC COUNS, V81, P409, DOI 10.1016/j.pec.2010.09.003; Woodruff K, 2018, SEX RES SOC POLICY, V15, P452, DOI 10.1007/s13178-018-0325-1; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	39	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226417	10.1371/journal.pone.0226417	http://dx.doi.org/10.1371/journal.pone.0226417			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995559	Green Published, gold			2022-12-26	WOS:000534609400010
J	Dodero-Rojas, E; Ferreira, LG; Leite, VBP; Onuchic, JN; Contessoto, VG				Dodero-Rojas, Esteban; Ferreira, Luiza G.; Leite, Vitor B. P.; Onuchic, Jose N.; Contessoto, Vinicius G.			Modeling Chikungunya control strategies and Mayaro potential outbreak in the city of Rio de Janeiro	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; VIRUS-INFECTION; AEDES-AEGYPTI; YELLOW-FEVER; SAO-PAULO; DENGUE; EPIDEMIC; RISK; TRANSMISSION; MOSQUITO	Mosquito-borne diseases have become a significant health issue in many regions around the world. For tropical countries, diseases such as Dengue, Zika, and Chikungunya, became epidemic in the last decades. Health surveillance reports during this period were crucial in providing scientific-based information to guide decision making and resources allocation to control outbreaks. In this work, we perform data analysis of the last Chikungunya epidemics in the city of Rio de Janeiro by applying a compartmental mathematical model. Sensitivity analyses were performed in order to describe the contribution of each parameter to the outbreak incidence. We estimate the "basic reproduction number" for those outbreaks and predict the potential epidemic outbreak of the Mayaro virus. We also simulated several scenarios with different public interventions to decrease the number of infected people. Such scenarios should provide insights about possible strategies to control future outbreaks.	[Dodero-Rojas, Esteban; Onuchic, Jose N.; Contessoto, Vinicius G.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Dodero-Rojas, Esteban] Univ Costa Rica, Theoret & Computat Phys Lab, San Jose, Costa Rica; [Ferreira, Luiza G.; Onuchic, Jose N.] Rice Univ, Dept Chem, Houston, TX USA; [Leite, Vitor B. P.] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci, Dept Phys, UNESP, Sao Jose Do Rio Preto, SP, Brazil; [Onuchic, Jose N.] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Onuchic, Jose N.] Rice Univ, Dept Biosci, Houston, TX USA; [Contessoto, Vinicius G.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, Campinas, SP, Brazil	Rice University; Universidad Costa Rica; Rice University; Universidade Estadual Paulista; Rice University; Rice University	Contessoto, VG (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Contessoto, VG (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, Campinas, SP, Brazil.	contessoto@rice.edu	Contessoto, Vinícius/K-7960-2019	Contessoto, Vinícius/0000-0002-1891-9563; Dodero Rojas, Esteban/0000-0001-9054-9555	Center for Theoretical Biological Physics - NSF [PHY-1427654]; NSF-CHE [1614101]; FAPESP (Sao Paulo Research Foundation) [2016/13998-8, 2017/09662-7]; CAPES; Higher Education Personnel Improvement Coordination; FAPESP [2018/18668-1]	Center for Theoretical Biological Physics - NSF; NSF-CHE(National Science Foundation (NSF)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Higher Education Personnel Improvement Coordination; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Center for Theoretical Biological Physics sponsored by the NSF (https://www.nsf.gov) (Grant PHY-1427654) and by NSF-CHE 1614101. JNO is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research. VGC was funded by Grant 2016/13998-8 and 2017/09662-7, FAPESP (Sao Paulo Research Foundation and Higher Education Personnel -http://www.fapesp.br) and CAPES and (Higher Education Personnel Improvement Coordination -http://www.capes.gov.br/).VBPL also acknowledges FAPESP Grant 2018/18668-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5; ANDERSON R M, 1991; [Anonymous], 2019, B EPIDEMIOLOGICO, V50; Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540; Brustolin M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006895; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Coordenacao de Vigilancia Epidemiologica, 2018, INF EP; Coordenacao de Vigilancia Epidemiologica, 2019, INF EP; Coordenaco de Vigilancia Epidemiologica, 2016, INF EP; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Erguler K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174293; Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Izurieta RO, 2011, J GLOB INFECT DIS, V3, P317, DOI 10.4103/0974-777X.91049; Kantor AM, 2019, J MED ENTOMOL, V56, P832, DOI 10.1093/jme/tjy241; Kantor AM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100571; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359; MACDONAL.G, 1965, T ROY SOC TROP MED H, V59, P489, DOI 10.1016/0035-9203(65)90152-5; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/S0034-89102003000400013; Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1; Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x; Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997; Pan American Health Organization & World Health Organization, 2019, EP AL MAY FEV; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Pego PN, 2014, J HUMAN VIROLOGY RET; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Renault P, 2007, AM J TROP MED HYG, V77, P727; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; Samsuzzoha M, 2013, APPL MATH MODEL, V37, P903, DOI 10.1016/j.apm.2012.03.029; Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358; Wearing HJ, 2016, PARASITOLOGY, V143, P860, DOI 10.1017/S0031182016000421; Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322; Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448	45	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0222900	10.1371/journal.pone.0222900	http://dx.doi.org/10.1371/journal.pone.0222900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990920	Green Published, gold			2022-12-26	WOS:000534605400005
J	Garcia-Contreras, C; Madsen, O; Groenen, MAM; Lopez-Garcia, A; Vazquez-Gomez, M; Astiz, S; Nunez, Y; Benitez, R; Fernandez, A; Isabel, B; Rey, AI; Gonzalez-Bulnes, A; Ovilo, C				Garcia-Contreras, Consolacion; Madsen, Ole; Groenen, Martien A. M.; Lopez-Garcia, Adrian; Vazquez-Gomez, Marta; Astiz, Susana; Nunez, Yolanda; Benitez, Rita; Fernandez, Almudena; Isabel, Beatriz; Rey, Ana Isabel; Gonzalez-Bulnes, Antonio; Ovilo, Cristina			Impact of genotype, body weight and sex on the prenatal muscle transcriptome of Iberian pigs	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; LARGE WHITE; MATERNAL UNDERNUTRITION; POSTNATAL-DEVELOPMENT; EXPRESSION PROFILES; GESTATIONAL-AGE; FETUIN-A; GENE; DIFFERENTIATION	Growth is dependent on genotype and diet, even at early developmental stages. In this study, we investigated the effects of genotype, sex, and body weight on the fetal muscle transcriptome of purebred Iberian and crossbred Iberian x Large White pigs sharing the same uterine environment. RNA sequencing was performed on 16 purebred and crossbred fetuses with high body weight (340 +/- 14g and 415 +/- 14g, respectively) and 16 with low body weight (246 +/- 14g and 311 +/- 14g, respectively), on gestational day 77. Genotype had the greatest effect on gene expression, with 645 genes identified as differentially expressed (DE) between purebred and crossbred animals. Functional analysis showed differential regulation of pathways involved in energy and lipid metabolism, muscle development, and tissue disorders. In purebred animals, fetal body weight was associated with 35 DE genes involved in development, lipid metabolism and adipogenesis. In crossbred animals, fetal body weight was associated with 60 DE genes involved in muscle development, viability, and immunity. Interestingly, the results suggested an interaction genotype*weight for some DE genes. Fetal sex had only a modest effect on gene expression. This study allowed the identification of genes, metabolic pathways, biological functions and regulators related to fetal genotype, weight and sex, in animals sharing the same uterine environment. Our findings contribute to a better understanding of the molecular events that influence prenatal muscle development and highlight the complex interactions affecting transcriptional regulation during development.	[Garcia-Contreras, Consolacion; Lopez-Garcia, Adrian; Nunez, Yolanda; Benitez, Rita; Fernandez, Almudena; Ovilo, Cristina] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Anim Breeding, Madrid, Spain; [Madsen, Ole; Groenen, Martien A. M.] Wageningen Univ & Res, Anim Breeding & Genom, Wageningen, Netherlands; [Vazquez-Gomez, Marta; Isabel, Beatriz; Rey, Ana Isabel] Complutense Univ Madrid UCM, Fac Vet Med, Madrid, Spain; [Astiz, Susana; Gonzalez-Bulnes, Antonio] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Anim Reprod, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Wageningen University & Research; Complutense University of Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Ovilo, C (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Anim Breeding, Madrid, Spain.	ovilo@inia.es	Gonzalez-Bulnes, Antonio/K-7691-2015; MUÑOZ, ANA ISABEL REY/G-9894-2016; Ovilo, Cristina/N-9931-2014; Muñoz, Almudena Fernández/AAB-4608-2019; Garcia Contreras, Consolacion/AAX-2057-2021; Astiz, Susana/AAN-8769-2021; Vázquez-Gómez, Marta/L-7054-2014; Madsen, Ole/E-3730-2012; Garcia-Contreras, Consolacion/GSE-0766-2022; Groenen, Martien/D-8408-2012	Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; MUÑOZ, ANA ISABEL REY/0000-0003-4403-9225; Ovilo, Cristina/0000-0002-5738-8435; Muñoz, Almudena Fernández/0000-0002-4495-9366; Vázquez-Gómez, Marta/0000-0002-8916-2086; Madsen, Ole/0000-0001-8082-7881; Garcia-Contreras, Consolacion/0000-0003-4624-2585; Groenen, Martien/0000-0003-0484-4545; Lopez-Garcia, Adrian/0000-0002-8649-750X	Ministry of Economy and competitiveness [AGL2013-48121-C3-R, AGL2016-79321-C2-R]; FEDER; Spanish Government (FPU National Program) [FPU014/01285]; Spanish Government (FPI National Program) [BES-2014-070464]	Ministry of Economy and competitiveness; FEDER(European Commission); Spanish Government (FPU National Program); Spanish Government (FPI National Program)	The experimental work was supported by funds from the Ministry of Economy and competitiveness (projects AGL2013-48121-C3-R and AGL2016-79321-C2-R), co-funded by FEDER. MVG and CGC are granted by the Spanish Government (MVG: FPU National Program Grant Number FPU014/01285. CGC: FPI National Program Grant Number BES-2014-070464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azemi M, 2017, CLIN EXP OBSTET GYN, V44, P98, DOI 10.12891/ceog3295.2017; Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; Alvarenga ALN, 2013, REPROD FERT DEVELOP, V25, P387, DOI 10.1071/RD12021; Andres AI, 1999, ANN ZOOTECHNIE; Armour SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00772-5; ASHMORE CR, 1973, J ANIM SCI, V36, P1088, DOI 10.2527/jas1973.3661088x; Astiz S, 2014, EXP PHYSIOL, V99, P1241, DOI 10.1113/expphysiol.2014.081455; Ayuso M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167858; Ayuso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145162; Barb CR, 2001, DOMEST ANIM ENDOCRIN, V21, P297, DOI 10.1016/S0739-7240(01)00123-0; BEDI KS, 1982, BRIT J NUTR, V47, P417, DOI 10.1079/BJN19820053; Bee G, 2004, J ANIM SCI, V82, P826; BEERMANN DH, 1978, J ANIM SCI, V46, P125, DOI 10.2527/jas1978.461125x; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bressan MC, 2016, J ANIM SCI, V94, P2592, DOI 10.2527/jas.2016-0276; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Ceddia RB, 2001, FRONT BIOSCI-LANDMRK, V6, pD90, DOI 10.2741/ceddia; Cogollos L, 2017, REPROD FERT DEVELOP, V29, P1155, DOI 10.1071/RD15385; Cohen RM, 2012, CLIN CHEM, V58, P1615, DOI 10.1373/clinchem.2012.196139; Constance CM, 1996, MOL CELL BIOL, V16, P3878; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; dos Reis EP, 2016, GENET MOL BIOL, V39, P589, DOI [10.1590/1678-4685-GMB-2015-0295, 10.1590/1678-4685-gmb-2015-0295]; Dwyer CM, 1995, REPROD FERT DEVELOP, V7, P1285, DOI 10.1071/RD9951285; Estelle J, 2006, ANIM GENET, V37, P589, DOI 10.1111/j.1365-2052.2006.01535.x; Fan B, 2009, ANIM GENET, V40, P788, DOI 10.1111/j.1365-2052.2009.01885.x; Fernandez-Figares I, 2007, LIVEST SCI, V110, P73, DOI 10.1016/j.livsci.2006.10.002; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Gao Y, 2013, CELL PHYSIOL BIOCHEM, V31, P452, DOI 10.1159/000343381; Gao Y, 2011, GENE, V487, P170, DOI 10.1016/j.gene.2011.07.005; Garcia-Contreras C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061171; Gerfault V, 1999, GEN COMP ENDOCR, V114, P396, DOI 10.1006/gcen.1999.7271; Gibson CE, 2018, HORM RES PAEDIAT, V89, P413, DOI 10.1159/000488347; Goff L, 2013, R PACKAGE VERSION, V2; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; Gonzalez-Anover P, 2011, THERIOGENOLOGY, V75, P34, DOI 10.1016/j.theriogenology.2010.07.009; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Gonzalez-Bulnes Antonio, 2016, EuPA Open Proteom, V10, P50, DOI 10.1016/j.euprot.2016.01.001; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Kralisch S, 2017, METABOLISM, V68, P88, DOI 10.1016/j.metabol.2016.11.017; Kume S, 2016, EBIOMEDICINE, V13, P168, DOI 10.1016/j.ebiom.2016.10.038; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Laughlin GA, 2013, DIABETES CARE, V36, P1994, DOI 10.2337/dc12-1870; Lee KT, 2012, J ANIM SCI, V90, P1081, DOI 10.2527/jas.2011-4228; Listrat  A., 2016, SCI WORLD J; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; Lu YZ, 2016, BLOOD, V128, P93, DOI 10.1182/blood-2016-01-692251; Maltin CA, 2001, REPRODUCTION, V122, P359, DOI 10.1530/rep.0.1220359; Merbitz-Zahradnik T, 2015, FEBS LETT, V589, P1516, DOI 10.1016/j.febslet.2015.05.024; Michiels J, 2013, BRIT J NUTR, V109, P65, DOI 10.1017/S0007114512000670; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Munshi A, 2012, J NEUROL SCI, V318, P51, DOI 10.1016/j.jns.2012.04.006; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Okamoto S, 2018, CELL REP, V22, P706, DOI 10.1016/j.celrep.2017.11.102; ORKIN SH, 1992, BLOOD, V80, P575; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-413, 10.1186/s12863-014-0148-x]; Ovilo C, 2014, BRIT J NUTR, V111, P735, DOI 10.1017/S0007114513002948; Ovilo C, 2010, MAMM GENOME, V21, P583, DOI 10.1007/s00335-010-9307-1; Palma-Granados P, 2018, ANIM PROD SCI, V58, P2132, DOI 10.1071/AN16375; Pas MFWT, 2005, J MUSCLE RES CELL M, V26, P157, DOI 10.1007/s10974-005-7004-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2000, LIVEST PROD SCI, V66, P177, DOI 10.1016/S0301-6226(00)00225-6; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sangild PT, 2003, ACTA VET SCAND, P105; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sollero BP, 2011, ANIM GENET, V42, P600, DOI 10.1111/j.1365-2052.2011.02186.x; SPOONER PM, 1979, J BIOL CHEM, V254, P21; Stanimirov B, 2012, ACTA GASTRO-ENT BELG, V75, P389; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SZPIRER C, 1992, GENOMICS, V13, P293, DOI 10.1016/0888-7543(92)90245-N; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Torres-Rovira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066728; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazquez-Gomez M, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0240-6; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wang FR, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0049-3; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; WIGMORE PMC, 1983, J ANAT, V137, P235; Wise T, 1997, J ANIM SCI, V75, P2197; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Xi G, 2007, J ANIM SCI, V85, P143, DOI 10.2527/jas.2006-351; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu XX, 2019, ANIM BIOTECHNOL, V30, P63, DOI 10.1080/10495398.2018.1437045; Xu YQ, 2015, BBA-GEN SUBJECTS, V1850, P2552, DOI 10.1016/j.bbagen.2015.09.008; Yang XR, 2015, ANIMAL, V9, P28, DOI 10.1017/S1751731114002316; Zhang RP, 2011, J BIOL CHEM, V286, P41083, DOI 10.1074/jbc.M111.258715; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7	105	9	9	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227861	10.1371/journal.pone.0227861	http://dx.doi.org/10.1371/journal.pone.0227861			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990923	Green Published, gold			2022-12-26	WOS:000534605400022
J	Miller, TR; Waehrer, GM; Oh, DL; Boparai, SP; Walker, SO; Marques, SS; Harris, NB				Miller, Ted R.; Waehrer, Geetha M.; Oh, Debora L.; Boparai, Sukhdip Purewal; Walker, Sheila Ohlsson; Marques, Sara Silverio; Harris, Nadine Burke			Adult health burden and costs in California during 2013 associated with prior adverse childhood experiences	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ADJUSTED LIFE YEAR; HOUSEHOLD DYSFUNCTION; STRESS; RISK; CARE; MALTREATMENT; VALIDITY; DISEASE; ABUSE	Objectives To estimate the adult health burden and costs in California during 2013 associated with adults' prior Adverse Childhood Experiences (ACEs). Methods We analyzed five ACEs-linked conditions (asthma, arthritis, COPD, depression, and cardiovascular disease) and three health risk factors (lifetime smoking, heavy drinking, and obesity). We estimated ACEs-associated fractions of disease risk for people aged 18+ for these conditions by ACEs exposure using inputs from a companion study of California Behavioral Risk Factor Surveillance System data for 2008-2009, 2011, and 2013. We combined these estimates with published estimates of personal healthcare spending and Disability-Adjusted-Life-Years (DALYs) in the United States by condition during 2013. DALYs captured both the years of healthy life lost to disability and the years of life lost to deaths during 2013. We applied a published estimate of cost per DALY. Results Among adults in California, 61% reported ACEs. Those ACEs were associated with $10.5 billion in excess personal healthcare spending during 2013, and 434,000 DALYs valued at approximately $102 billion dollars. During 2013, the estimated health burden per exposed adult included $589 in personal healthcare expenses and 0.0224 DALYs valued at $5,769. Conclusions Estimates of the costs of childhood adversity are far greater than previously understood and provide a fiscal rationale for prevention efforts.	[Miller, Ted R.; Waehrer, Geetha M.] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA; [Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Oh, Debora L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Boparai, Sukhdip Purewal] Human Impact Partners, Oakland, CA USA; [Walker, Sheila Ohlsson] George Washington Univ, Childrens Natl Med Ctr, Washington, DC USA; [Marques, Sara Silverio; Harris, Nadine Burke] Ctr Youth Wellness, San Francisco, CA USA	Pacific Institute for Research & Evaluation (PIRE); Curtin University; University of California System; University of California San Francisco; Children's National Health System; George Washington University	Miller, TR (corresponding author), Pacific Inst Res & Evaluat, Calverton, MD 20705 USA.; Miller, TR (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.	miller@pire.org		Miller, Ted/0000-0002-0958-2639	JPB Foundation [542]	JPB Foundation	TRM received funding from grant no. 542 from JPB Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.jpbfoundation.org.	Afifi TO, 2018, CHILD ABUSE NEGLECT, V83, pA1, DOI [10.1016/j.chiabu.2018.07.035, 10.1016/j.chiabu.2018.03.007]; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; Bair-Merritt MH, 2016, JAMA PEDIATR, V170, P313, DOI 10.1001/jamapediatrics.2015.4459; Bellis M, 2017, J HEALTH SERV RES PO, V22, P168, DOI 10.1177/1355819617706720; Bernard K, 2015, JAMA PEDIATR, V169, P112, DOI 10.1001/jamapediatrics.2014.2369; Bhan N, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2013-000016; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Blincoe LJ, 2015, EC SOC IMPACT MOROT; Bombard JM, 2005, AM J PREV MED, V28, P251, DOI 10.1016/j.amepre.2004.12.004; Bonomi AE, 2008, J GEN INTERN MED, V23, P294, DOI 10.1007/s11606-008-0516-1; Boparai SKP, 2018, CHILD ABUSE NEGL, V81; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; Brody GH, 2017, PREV MED, V100, P117, DOI 10.1016/j.ypmed.2017.04.017; Brown DS, 2011, AM J PREV MED, V41, P627, DOI 10.1016/j.amepre.2011.08.013; Bucci Monica, 2016, Adv Pediatr, V63, P403, DOI 10.1016/j.yapd.2016.04.002; Bureau of Economic Analysis (BEA), 2018, NAT DAT NAT INC PROD; Campbell JA, 2016, AM J PREV MED, V50, P344, DOI 10.1016/j.amepre.2015.07.022; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; CHROUSOS GP, 1997, GROWTH GENET HORM, V13, P1; Cicchetti D, 2011, DEV PSYCHOPATHOL, V23, P789, DOI 10.1017/S0954579411000307; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cossman Ronald E, 2008, J Health Hum Serv Adm, V30, P503; Cunningham TJ, 2014, INT J CHRONIC OBSTR, V9, P1033, DOI 10.2147/COPD.S68226; Cutler DM, 1998, AM ECON REV, V88, P97; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dubowitz H, 2012, ACAD PEDIATR, V12, P259, DOI 10.1016/j.acap.2012.03.005; Ehring T, 2014, CLIN PSYCHOL REV, V34, P645, DOI 10.1016/j.cpr.2014.10.004; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Felitti VJ, 2014, CHADWICKS CHILD MALT, V2, P203; Finkelhor D, 2018, CHILD ABUSE NEGLECT, V85, P174, DOI 10.1016/j.chiabu.2017.07.016; Garner AS, 2012, PEDIATRICS, V129, pE224, DOI 10.1542/peds.2011-2662; Gilbert LK, 2015, AM J PREV MED, V48, P345, DOI 10.1016/j.amepre.2014.09.006; Gillespie RJ., 2017, JOURN CHILD ADOL TRA, V10, P249, DOI [DOI 10.1007/S40653-017-0138-Z, 10.1007/s40653-017-0138-z]; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Glaser R, 1999, JAMA-J AM MED ASSOC, V281, P2268, DOI 10.1001/jama.281.24.2268; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Glowa PT, 2016, J AM BOARD FAM MED, V29, P303, DOI 10.3122/jabfm.2016.03.150310; Gyrd-Hansen D, 2003, HEALTH ECON, V12, P1049, DOI 10.1002/hec.799; Haggerty RJ., 1996, STRESS RISK RESILIEN; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; HERD JA, 1991, PHYSIOL REV, V71, P305, DOI 10.1152/physrev.1991.71.1.305; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Hoye J.R., 2015, THESIS U DELAWARE; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; King JT, 2005, MED DECIS MAKING, V25, P667, DOI 10.1177/0272989X05282640; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Miller GE, 2014, P NATL ACAD SCI USA, V111, P11287, DOI 10.1073/pnas.1406578111; Miller T.R., 2012, INJURY RES THEORIES, P641, DOI DOI 10.1007/978-1-4614-1599-2_36; Miller TR, 2017, ALCOHOL CLIN EXP RES, V41, P758, DOI 10.1111/acer.13337; Miller TR, 1989, ESTIMATING VALUING M; Miller TR, 2000, J FORENSIC EC, V13, P145, DOI DOI 10.5085/0898-5510-13.2.145; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Nimdet K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122760; Oppenheimer R, 1986, ANOREXIA NERVOSA BUL, P357; Patten SB, 2015, EPIDEMIOL PSYCH SCI, V24, P158, DOI 10.1017/S2045796014000018; Ryan-Ibarra S, 2013, CALIFORNIA BEHAV RIS; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Sheikh MA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00727; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; U.S. Centers for Medicare & Medicaid Services, 2019, TOT ALL PAYERS STAT; United States Census Bureau, 2017, ISL AR SUMM STAT MAL; Viscusi WK, 2017, J BENEFIT-COST ANAL, V8, P226, DOI 10.1017/bca.2017.12; Waehrer GM, 2020, PLOS ONE; Waehrer GM, 2018, ASS ADVERSE CHILDHOO; Williamson DF, 2002, INT J OBESITY, V26, P1075, DOI 10.1038/sj.ijo.0802038	73	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228019	10.1371/journal.pone.0228019	http://dx.doi.org/10.1371/journal.pone.0228019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8ZJ	31990957	Green Published, gold			2022-12-26	WOS:000534605400035
J	Alam, MA; Richard, SA; Fahim, SM; Mahfuz, M; Nahar, B; Das, S; Shrestha, B; Koshy, B; Mduma, E; Seidman, JC; Murray-Kolb, LE; Caulfield, LE; Ahmed, T				Alam, Md Ashraful; Richard, Stephanie A.; Fahim, Shah Mohammad; Mahfuz, Mustafa; Nahar, Baitun; Das, Subhasish; Shrestha, Binod; Koshy, Beena; Mduma, Estomih; Seidman, Jessica C.; Murray-Kolb, Laura E.; Caulfield, Laura E.; Ahmed, Tahmeed			Impact of early-onset persistent stunting on cognitive development at 5 years of age: Results from a multi-country cohort study	PLOS ONE			English	Article							ED BIRTH COHORT; LINEAR GROWTH; SOCIOECONOMIC-STATUS; CHILD-DEVELOPMENT; EARLY-LIFE; HEALTH; INCOME; DETERMINANTS; COUNTRIES; UNDERNUTRITION	Background Globally more than 150 million children under age 5 years were stunted in 2018, primarily in low- and middle-income countries (LMICs), and the impact of early-onset, persistent stunting has not been well explored. To explore the association between early-onset persistent stunting in children and cognitive development at 5 years of age, and to identify the factors associated with early-onset stunting. Methods and findings Children from the MAL-ED cohort study were followed from birth to 5 years of age in six LMICs. The Wechsler Preschool Primary Scales of Intelligence (WPPSI) was used to assess cognitive abilities (fluid reasoning) at 5 years and was adapted for each culture. Stunting was categorized as early-onset persistent (first stunted at 1-6 months and persisting at 60 months), early-onset recovered (first stunted at 1-6 months and not stunted at 60 months), late-onset persistent (first stunted at 7-24 months and persisting at 60 months), late-onset recovered (first stunted at 7-24 months and not stunted at 60 months), and never (never stunted). Mixed effects linear models were used to estimate the relationship between stunting status and cognitive development. Children with early-onset persistent stunting had significantly lower cognitive scores (-2.10 (95% CI: -3.85, -0.35)) compared with those who were never stunted. Transferrin receptor (TfR) was also negatively associated with cognitive development (-0.31 (95% CI: -0.49, -0.13)), while the HOME inventory, an index of quality of the home environment (0.46 (95% CI: 0.21, 0.72)) and socio-economic status (1.50 (95% CI: 1.03, 1.98)) were positively associated with cognitive development. Conclusions Early-onset persistent stunting was associated with lower cognitive development in children at 5 years of age in this cohort of children.	[Alam, Md Ashraful; Fahim, Shah Mohammad; Mahfuz, Mustafa; Nahar, Baitun; Das, Subhasish; Ahmed, Tahmeed] Shaheed Tajuddin Ahmed Sarani, Icddr B, Dhaka, Bangladesh; [Richard, Stephanie A.; Seidman, Jessica C.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Shrestha, Binod] Water Reed AFRIMS Res Unit Nepal WARUN, Kathmandu, Nepal; [Koshy, Beena] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Mduma, Estomih] Haydom Lutheran Hosp, Haydom, Tanzania; [Murray-Kolb, Laura E.] Penn State Univ, University Pk, PA 16802 USA; [Caulfield, Laura E.] Johns Hopkins Univ, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Christian Medical College & Hospital (CMCH) Vellore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University	Mahfuz, M (corresponding author), Shaheed Tajuddin Ahmed Sarani, Icddr B, Dhaka, Bangladesh.	mustafa@icddrb.org	Alam, Ashraful/AAA-3893-2020; Das, Subhasish/AAW-3940-2021; Fahim, Shah Mohammad/AAS-3550-2020; Mahfuz, Mustafa/H-5923-2017; alam, mohammed/GXH-3645-2022	Alam, Ashraful/0000-0003-1389-8510; Das, Subhasish/0000-0002-7852-6569; Fahim, Shah Mohammad/0000-0002-3627-202X; Mahfuz, Mustafa/0000-0002-4090-785X; Koshy, Beena/0000-0002-9058-1392	Bill & Melinda Gates Foundation; Foundation for the National Institutes of Health; National Institutes of Health, Fogarty International Center	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development Project (MAL-ED) is a collaborative project supported by the Bill & Melinda Gates Foundation, the Foundation for the National Institutes of Health, and the National Institutes of Health, Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Ahmed T, 2014, CLIN INFECT DIS, V59, pS280, DOI 10.1093/cid/ciu458; Akombi BJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0770-z; Alam MA, 2017, INDIAN PEDIATR, V54, P373, DOI 10.1007/s13312-017-1109-z; Algarin C, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00054; Ambikapathi R, 2016, MATERN CHILD NUTR, V12, P740, DOI 10.1111/mcn.12352; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Bessong PO, 2014, CLIN INFECT DIS, V59, pS317, DOI 10.1093/cid/ciu418; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Casale D, 2016, J DEV ORIG HLTH DIS, V7, P163, DOI 10.1017/S2040174415007175; Cattell R. B., 1987, INTELLIGENCE ITS STR; Chang SM, 2002, J CHILD PSYCHOL PSYC, V43, P775, DOI 10.1111/1469-7610.00088; Checkley W, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002408; Cheung YB, 2010, ACTA PAEDIATR, V99, P1719, DOI 10.1111/j.1651-2227.2009.01593.x; Child Trends, 2018, IMMIGRANT CHILDREN; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; Contreras D, 2015, INT J EDUC DEV, V40, P217, DOI 10.1016/j.ijedudev.2014.06.010; CRONK L, 1989, AM ANTHROPOL, V91, P414, DOI 10.1525/aa.1989.91.2.02a00090; Crookston BT, 2013, AM J CLIN NUTR, V98, P1555, DOI 10.3945/ajcn.113.067561; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; DeOnis M, 2007, WHO CHILD GROWTH STA; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Duncan GJ, 2000, CHILD DEV, V71, P188, DOI 10.1111/1467-8624.00133; Fanzo J, 2018, 2018 GLOBAL NUTR REP; Fink G, 2014, AM J CLIN NUTR, V100, P182, DOI 10.3945/ajcn.113.080960; Gandhi M, 2011, ACTA PAEDIATR, V100, P1113, DOI 10.1111/j.1651-2227.2011.02254.x; Gottfredson L. S., 1997, MAINSTREAM SCI INTEL; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; John SM, 2014, CLIN INFECT DIS, V59, pS295, DOI 10.1093/cid/ciu390; Jones PC, 2017, J SCHOOL PSYCHOL, V64, P109, DOI 10.1016/j.jsp.2017.06.001; Kamal S., 2011, MALAYSIAN J NUTR, V17, P1; Kavosi E, 2014, INT J HEALTH POLICY, V3, P71, DOI 10.15171/ijhpm.2014.63; Kowalski AJ, 2018, J NUTR, V148, P1852, DOI 10.1093/jn/nxy191; Lima AAM, 2014, CLIN INFECT DIS, V59, pS287, DOI 10.1093/cid/ciu438; Linver MR, 2002, DEV PSYCHOL, V38, P719, DOI 10.1037//0012-1649.38.5.719; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; McCormick BJJ, 2019, J NUTR, V149, P1460, DOI 10.1093/jn/nxz055; McCormick BJJ, 2017, AM J TROP MED HYG, V96, P465, DOI 10.4269/ajtmh.16-0496; Mduma ER, 2014, CLIN INFECT DIS, V59, pS325, DOI 10.1093/cid/ciu439; Acosta AM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000752; Acosta AM, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000370; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Namaste SML, 2017, AM J CLIN NUTR, V106, p333S, DOI 10.3945/ajcn.116.142273; Naudeau S, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8526-5; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nkrumah B, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-5; Nkurunziza S, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0929-2; Northrop-Clewes C., 2007, INTERPRETATION INDIC; Ocansey ME, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12834; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Padonou G, 2014, ACTA TROP, V135, P1, DOI 10.1016/j.actatropica.2014.03.005; Yori PP, 2014, CLIN INFECT DIS, V59, pS310, DOI 10.1093/cid/ciu460; Platts-Mills JA, 2014, CLIN INFECT DIS, V59, pS233, DOI 10.1093/cid/ciu408; Pongcharoen T, 2012, ARCH PEDIAT ADOL MED, V166, P411, DOI 10.1001/archpediatrics.2011.1413; Psaki SR, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-8; Richard SA, 2019, AM J CLIN NUTR; Richard SA, 2014, CLIN INFECT DIS, V59, pS220, DOI 10.1093/cid/ciu435; Ronfani L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127052; Ruan-Iu L, 2019, J PSYCHOEDUCATIONAL; Shrestha PS, 2014, CLIN INFECT DIS, V59, pS300, DOI 10.1093/cid/ciu459; Sokolovic N, 2014, EUR J CLIN NUTR, V68, P14, DOI 10.1038/ejcn.2013.208; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Teivaanmaki T, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12326; Tiwari R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-239; Tucker WH, 2010, CATTELL CONTROVERSY; Turab A, 2014, CLIN INFECT DIS, V59, pS304, DOI 10.1093/cid/ciu391; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Wamani H., 2007, BMC Pediatrics, V7; Wechsler D., 2002, WESCHLER PRESCHOOL P; WHO, 2016, WORLD HLTH STAT 2016; Zamora TG, 2016, PEDIATR RES, V79, P922, DOI 10.1038/pr.2016.20	77	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227839	10.1371/journal.pone.0227839	http://dx.doi.org/10.1371/journal.pone.0227839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978156	Green Published, gold			2022-12-26	WOS:000534599100067
J	Bayegan, AH; Clote, P				Bayegan, Amir H.; Clote, Peter			RNAmountAlign: Efficient software for local, global, semiglobal pairwise and multiple RNA sequence/structure alignment	PLOS ONE			English	Article							STRUCTURAL ALIGNMENT; SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; WEB SERVER; ALGORITHM; FAMILIES; FEATURES; SEARCH; GENOME; ENERGY	Alignment of structural RNAs is an important problem with a wide range of applications. Since function is often determined by molecular structure, RNA alignment programs should take into account both sequence and base-pairing information for structural homology identification. This paper describes C++ software, RNAmountAlign, for RNA sequence/structure alignment that runs in O(n(3)) time and O(n(2)) space for two sequences of length n; moreover, our software returns a p-value (transformable to expect value E) based on Karlin-Altschul statistics for local alignment, as well as parameter fitting for local and global alignment. Using incremental mountain height, a representation of structural information computable in cubic time, RNAmountAlign implements quadratic time pairwise local, global and global/semiglobal (query search) alignment using a weighted combination of sequence and structural similarity. RNAmountAlign is capable of performing progressive multiple alignment as well. Benchmarking of RNAmountAlign against LocARNA, LARA, FOLDALIGN, DYNALIGN, STRAL, MXSCARNA, and MUSCLE shows that RNAmountAlign has reasonably good accuracy and faster run time supporting all alignment types. Additionally, our extension of RNAmountAlign, called RNAmountAlignScan, which scans a target genome sequence to find hits having high sequence and structural similarity to a given query sequence, outperforms RSEARCH and sequence-only query scans and runs faster than FOLDALIGN query scan.	[Bayegan, Amir H.; Clote, Peter] Boston Coll, Biol Dept, Chestnut Hill, MA 02167 USA	Boston College	Clote, P (corresponding author), Boston Coll, Biol Dept, Chestnut Hill, MA 02167 USA.	clote@bc.edu			NSF [DBI-1262439]; National Science Foundation	NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	PC received NSF grant DBI-1262439, National Science Foundation (www.nsf.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], P 31 ANN ACM S APPL, DOI 10.1145/2851613.2851868; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bauer M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-271; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Dalli D, 2006, BIOINFORMATICS, V22, P1593, DOI 10.1093/bioinformatics/btl142; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ferre F, 2007, NUCLEIC ACIDS RES, V35, pW659, DOI 10.1093/nar/gkm334; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gusfield D., 1997, ALGORITHMS STRINGS T; Havgaard J, 2012, CURR PROTOC BIOINFOR, V0, pO; Havgaard JH, 2005, BIOINFORMATICS, V21, P1815, DOI 10.1093/bioinformatics/bti279; Hertel J, 2009, NUCLEIC ACIDS RES, V37, P1602, DOI 10.1093/nar/gkn1084; Hofacker IL, 2004, BIOINFORMATICS, V20, P2222, DOI 10.1093/bioinformatics/bth229; HOGEWEG P, 1984, NUCLEIC ACIDS RES, V12, P67, DOI 10.1093/nar/12.1Part1.67; Huynen M, 1997, J MOL BIOL, V267, P1104, DOI 10.1006/jmbi.1997.0889; Huynen MA, 1996, J COMPUT BIOL, V3, P253, DOI 10.1089/cmb.1996.3.253; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KARLIN S, 1990, ANN STAT, V18, P571, DOI 10.1214/aos/1176347616; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Moulton V, 2000, J COMPUT BIOL, V7, P277, DOI 10.1089/10665270050081522; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pang HX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-257; SELLERS PH, 1974, SIAM J APPL MATH, V26, P787, DOI 10.1137/0126070; SHAPIRO BA, 1988, COMPUT APPL BIOSCI, V4, P387; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Smith MA, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1371-3; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sokal R. R., 1973, PRINCIPLES PRACTICE; Sundfeld D, 2016, BIOINFORMATICS, V32, P1238, DOI 10.1093/bioinformatics/btv748; Tabei Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-33; Tabei Y, 2006, BIOINFORMATICS, V22, P1723, DOI 10.1093/bioinformatics/btl177; Tabei Y, 2009, BIOINFORMATICS, V25, P1498, DOI 10.1093/bioinformatics/btp261; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Torarinsson E, 2007, BIOINFORMATICS, V23, P926, DOI 10.1093/bioinformatics/btm049; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Voss B, 2004, BIOINFORMATICS, V20, P1573, DOI 10.1093/bioinformatics/bth129; Waterman M.S., 1995, INTRO COMPUTATIONAL; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Xu ZJ, 2011, BIOINFORMATICS, V27, P626, DOI 10.1093/bioinformatics/btq726; Xu ZZ, 2016, METHODS MOL BIOL, V1490, P35, DOI 10.1007/978-1-4939-6433-8_3	53	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227177	10.1371/journal.pone.0227177	http://dx.doi.org/10.1371/journal.pone.0227177			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KH6NA	31978147	Green Published, Green Submitted, gold			2022-12-26	WOS:000510767000001
J	Nyangoma, M; Bajunirwe, F; Atwine, D				Nyangoma, Miria; Bajunirwe, Francis; Atwine, Daniel			Non-disclosure of tuberculosis diagnosis by patients to their household members in south western Uganda	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; TRANSMISSION; ADHERENCE; HIV	Background Tuberculosis (TB) non-disclosure by adult patients to all household members is a setback to TB control efforts. It reduces the likelihood that household contacts will seek early TB screening, initiation on preventive or curative treatment, but also hinders the implementation of infection controls and home-based directly observed treatment. Therefore, the purpose of this study was to determine the level of TB non-disclosure, its predictors and the effects of disclosure among adult TB patients in Uganda. Methods We conducted a cross-sectional study at a large regional referral hospital in Mbarara, southwestern Uganda. Questionnaires were administered to collect patients' sociodemographic and their TB disclosure data. Non-disclosure was considered if a patient did not reveal their TB diagnosis to all household members within 2 weeks post-treatment initiation. Univariate and multivariate logistic regression models were fitted for predictors of non-disclosure. Results We enrolled 62 patients, 74% males, mean age of 32 years, and median of five people per household. Non-disclosure rate was 30.6%. Post-disclosure experiences were positive in 98.3% of patients, while negative experiences suggestive of severe stigma occurred in 12.3% of patients. Being female (OR 6.5, 95% CI: 1.4-29.3) and belonging to Muslim faith (OR 12.4, 95% CI: 1.42-109.1) were significantly associated with TB non-disclosure to household members. Conclusions There is a high rate of TB non-disclosure to all household members by adult patients in rural Uganda, particularly among women and muslim patients. Interventions enhancing TB disclosure at household level while minimizing negative effects of stigma should be developed and prioritized.	[Nyangoma, Miria; Atwine, Daniel] Mbarara Univ Sci & Technol, Dept Informat Technol, Mbarara, Uganda; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Atwine, Daniel] Epicentre, Dept Clin Res, Mbarara, Uganda	Mbarara University of Science & Technology; Mbarara University of Science & Technology	Atwine, D (corresponding author), Mbarara Univ Sci & Technol, Dept Informat Technol, Mbarara, Uganda.; Atwine, D (corresponding author), Epicentre, Dept Clin Res, Mbarara, Uganda.	daniel.atwine@must.ac.ug		Atwine, Daniel/0000-0002-3373-1999	Mbarara University of Science and Technology; German Academic Exchange Service; DAAD In-Country/In-Region Scholarship for Postgraduates, Eastern Africa	Mbarara University of Science and Technology; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); DAAD In-Country/In-Region Scholarship for Postgraduates, Eastern Africa	This work was majorly supported by Mbarara University of Science and Technology, with as small part supported by funds from The German Academic Exchange Service or DAAD In-Country/In-Region Scholarship for Postgraduates, Eastern Africa as part of the sponsorship which was awarded to the first author (MN) for her postgraduate studies. No direct funding was received for this study, hence no Grant number. The funder of the study had no role in study design, data collection, analysis, interpretation, or writing of the report. The first and last authors had full access to all data and had final responsibility for the decision to submit the manuscript for publication.	Amo-Adjei J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3842-y; [Anonymous], 2017, TREATM TUB GUID TREA; [Anonymous], 2015, IMPL END TB STRAT ES; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809; Kansiime N., 2017, J NUTR METABOLISM, V2017, P1; Lee RS, 2015, J INFECT DIS, V211, P1905, DOI 10.1093/infdis/jiv011; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Shrestha A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2828-4; WHO, 2017, ETH GUID IMPL END TB; World Health Organisation, 2017, MIN HLTH PARTN REV N; World Health Organization, 2019, GLOB TUB REP GEN; World Health Organization, 2016, TREATM TUB GUID; Wynne A., 2014, INT J AFRICA NURS SC, V1, P6, DOI [10.1016/j.ijans.2014.05.001, DOI 10.1016/J.IJANS.2014.05.001]; Zou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-75	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0216689	10.1371/journal.pone.0216689	http://dx.doi.org/10.1371/journal.pone.0216689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978111	Green Published, Green Submitted, gold			2022-12-26	WOS:000534599100001
J	Vanausdall, RA; Dinsmore, SJ				Vanausdall, Rachel A.; Dinsmore, Stephen J.			Detection and density of breeding marsh birds in Iowa wetlands	PLOS ONE			English	Article							AFFECTING DETECTION PROBABILITY; PRAIRIE POTHOLE WETLANDS; RESTORED WETLANDS; HABITAT ASSOCIATIONS; INVERTEBRATE ABUNDANCE; NATURAL WETLANDS; SEDIMENT LOAD; UPPER-MIDWEST; COMMUNITIES; VEGETATION	Accounting for imperfect detection is an important process when obtaining estimates of density or abundance for breeding birds, and this is particularly true when researchers are monitoring birds to assess the success of restored wetlands. Due to the dramatic decline in areal cover and habitat quality, wetland restoration in the Prairie Pothole Region (PPR) is critically important to breeding birds. The Shallow Lakes Restoration Project (SLRP), a partnership between the Iowa Department of Natural Resources and Ducks Unlimited, Inc., aims to restore degraded shallow lakes throughout the Iowa PPR. We conducted unlimited-radius point counts with call-broadcast surveys for breeding marsh birds at 30 shallow lakes in various stages of restoration in 2016 and 2017. Our goals were to assess the impact of covariates on detection probability and estimate density of these species at non-restored, younger (1-5 years since restoration), and older (6-11 years since restoration) restorations. Detection probability ranged between 0.07 +/- 0.009 (SE) for Red-winged Blackbird and 0.40 +/- 0.09 (SE) for Common Yellowthroat. Percent cattail had a positive quadratic effect on detection probability for four species, with detection decreasing sharply as percent cattail increased and increasing slightly with 100% cattail cover. Wind speed negatively influenced the detection probability of Pied-billed Grebes but had a negative quadratic effect on the detection probability of Marsh Wrens. Both restored shallow lakes had greater densities of breeding Pied-billed Grebes, Marsh Wrens, and Yellow-headed Blackbirds than non-restored shallow lakes, but there was no significant difference between younger and older restorations. Including both habitat and environmental covariates on models for detection probability can improve the precision of estimates for density and should be considered when assessing bird populations pre- and post-restoration of shallow lakes.	[Vanausdall, Rachel A.; Dinsmore, Stephen J.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA 50011 USA	Iowa State University	Vanausdall, RA (corresponding author), Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA 50011 USA.	Rachel.Vanausdall@colostate.edu		Vanausdall, Rachel/0000-0003-2649-0602	U.S. Fish and Wildlife Service (Prairie Pothole Joint Venture) [F15AP00612]; Iowa Department of Natural Resources (Resource Enhancement and Protection License Plate Funds)	U.S. Fish and Wildlife Service (Prairie Pothole Joint Venture); Iowa Department of Natural Resources (Resource Enhancement and Protection License Plate Funds)	Funding for this project was provided by the U.S. Fish and Wildlife Service (Prairie Pothole Joint Venture, grant number F15AP00612) and the Iowa Department of Natural Resources (Resource Enhancement and Protection License Plate Funds) to S. J. Dinsmore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the U.S. Fish and Wildlife Service (Prairie Pothole Joint Venture, grant number F15AP00612) and the Iowa Department of Natural Resources (Resource Enhancement and Protection License Plate Funds). We thank S. Moodie and J. Mize for assistance with field work. We thank B. J. Wilsey and T. W. Stewart for providing edits and advice on field methods and analyses. We also thank M. Gulick, T. Bishop, D. Janke, B. Hellyer, S. Woodruff, T. J. Herrick, C. Maddix, C. LaRue, K. Kinkead, K. Murphy, and T. Harms for help with planning and logistics.	Akaike H, 1973, 2 INT S INF THEOR, P276; Alldredge MW, 2007, J WILDLIFE MANAGE, V71, P2759, DOI 10.2193/2006-161; Anteau MJ, 2008, WETLANDS, V28, P184, DOI 10.1672/07-53.1; Anteau MJ, 2009, WETLANDS, V29, P704, DOI 10.1672/08-157.1; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Aronson MFJ, 2008, WETLANDS, V28, P883, DOI 10.1672/08-142.1; Badiou P, 2011, WETL ECOL MANAG, V19, P237, DOI 10.1007/s11273-011-9214-6; Bas Y, 2008, ACCOUNTING WEATHER T, P3403; BISHOP R A, 1981, Proceedings of the Iowa Academy of Science, V88, P11; Bortolotti LE, 2016, FRESHWATER BIOL, V61, P1874, DOI 10.1111/fwb.12822; Brown SC, 1998, J WILDLIFE MANAGE, V62, P1480, DOI 10.2307/3802014; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1981, STUDIES AVIAN BIOL, V6, P324; Carter V., 1979, CLASSIFICATION WETLA, P79; Chow-Fraser P, 2005, HYDROBIOLOGIA, V539, P189, DOI 10.1007/s10750-004-4868-1; Conway C.J., 2009, WILDLIFE RES REPORT; Conway CJ, 2004, J WILDLIFE MANAGE, V68, P360, DOI 10.2193/0022-541X(2004)068[0360:FADPOC]2.0.CO;2; Conway CJ, 2003, J WILDLIFE MANAGE, V67, P501, DOI 10.2307/3802708; Conway CJ, 2011, WATERBIRDS, V34, P319, DOI 10.1675/063.034.0307; Conway CJ, 2011, WETLANDS, V31, P403, DOI 10.1007/s13157-011-0155-x; Dahl T.E., 2014, STATUS TRENDS PRAIRI; Darrah AJ, 2010, WATERBIRDS, V33, P367, DOI 10.1675/063.033.0314; DELPHEY PJ, 1993, WETLANDS, V13, P200, DOI 10.1007/BF03160881; Devries JH, 2008, J WILDLIFE MANAGE, V72, P1790, DOI 10.2193/2007-513; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; DRIVER EA, 1977, CHIRONOMID COMMUNITI, V7, P121; Epners CA, 2010, FRESHWATER BIOL, V55, P2265, DOI 10.1111/j.1365-2427.2010.02432.x; Fox AD, 2019, HYDROBIOLOGIA, V830, P33, DOI 10.1007/s10750-018-3848-9; Galatowitsch SM, 1996, WETLANDS, V16, P75, DOI 10.1007/BF03160647; Galatowitsch SM, 1996, ECOL APPL, V6, P102, DOI 10.2307/2269557; Geisthardt E, 2013, SHALLOW LAKES SUMMAR, P65; GIBBS JP, 1993, J WILDLIFE MANAGE, V57, P27, DOI 10.2307/3808996; Gibbs JP, 2001, FACTORS INFLUENCING; Gleason RA, 2003, WETLANDS, V23, P26, DOI 10.1672/0277-5212(2003)023[0026:EOSLOE]2.0.CO;2; Gleason RA, 1998, GREAT PLAINS RES, V8, P97; Glisson WJ, 2015, J WILDLIFE MANAGE, V79, P1101, DOI 10.1002/jwmg.937; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guzy M. J, 1999, BIRDS N AM, DOI [10.2173/bna.448, DOI 10.2173/BNA.448]; HANSON MA, 1994, HYDROBIOLOGIA, V279, P457, DOI 10.1007/BF00027877; HANSON MA, 1994, CAN J FISH AQUAT SCI, V51, P1180, DOI 10.1139/f94-117; Hanson MA, 2017, HYDROBIOLOGIA, V787, P45, DOI 10.1007/s10750-016-2865-9; Harms TM, 2011, WILDLIFE ECOLOGY; Harms TM, 2018, J FIELD ORNITHOL, V89, P276, DOI 10.1111/jofo.12265; Harms TM, 2015, WILSON J ORNITHOL, V127, P670, DOI 10.1676/15-001.1; Harms TM, 2014, WILSON J ORNITHOL, V126, P30, DOI 10.1676/13-150.1; Harms TM, 2013, WETLANDS, V33, P561, DOI 10.1007/s13157-013-0414-0; Harms TM, 2012, WATERBIRDS, V35, P208, DOI 10.1675/063.035.0203; HICKMAN S, 1994, ECOL ENG, V3, P485, DOI 10.1016/0925-8574(94)00014-X; Hilt S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00194; Holt RD, 2019, J WILDLIFE MANAGE, V83, P638, DOI 10.1002/jwmg.21612; Iowa Association of Naturalists, 2001, IOW WETL, P24; JURIK TW, 1994, WETLANDS, V14, P159, DOI 10.1007/BF03160652; Kantrud H. A., 1989, Northern prairie wetlands., P132; Kroodsma D. E., 1997, BIRDS N AM, V308, DOI [10.2173/bna.308, DOI 10.2173/BNA.308]; LAGRANGE T G, 1989, Prairie Naturalist, V21, P39; Lor S, 2006, WATERBIRDS, V29, P427, DOI 10.1675/1524-4695(2006)29[427:BEANHA]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manning JA, 2011, J WILDLIFE MANAGE, V75, P1558, DOI 10.1002/jwmg.192; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; MARTIN DB, 1987, WATER AIR SOIL POLL, V34, P45; Mccauley LA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00494.1; Miller BA, 2009, WETLANDS, V29, P1146, DOI 10.1672/08-158.1; Miller DL, 2019, J STAT SOFTW, V89, P1, DOI 10.18637/jss.v089.i01; Moreno-Ostos E, 2008, AQUAT ECOL, V42, P701, DOI 10.1007/s10452-007-9141-z; Mowbray T. B, 1997, BIRDS N AM, DOI [10.2173/bna.279, DOI 10.2173/BNA.279]; Mulhouse JM, 2003, PLANT ECOL, V169, P143, DOI 10.1023/A:1026221302606; MURKIN EJ, 1992, WETLANDS, V12, P45, DOI 10.1007/BF03160543; Murkin HR, 1997, ECOL APPL, V7, P1144; Mushet DM, 2002, WETLANDS, V22, P126, DOI 10.1672/0277-5212(2002)022[0126:FQAOON]2.0.CO;2; Nadeau CP, 2008, WILSON J ORNITHOL, V120, P513, DOI 10.1676/07-041.1; Neely R. K., 1989, Northern prairie wetlands., P92; R Core Team, 2018, R LANG EN STAT COMP; Ralph C. J., 1995, PSWGTR149; Ratti JT, 2001, J WILDLIFE MANAGE, V65, P676, DOI 10.2307/3803019; Rehm EM, 2007, WILSON J ORNITHOL, V119, P648, DOI 10.1676/06-060.1; Robertson EP, 2014, J WILDLIFE MANAGE, V78, P1293, DOI 10.1002/jwmg.769; Rush SA, 2009, WILSON J ORNITHOL, V121, P399, DOI 10.1676/08-096.1; Sauer JR, 2017, CONDOR, V119, P576, DOI 10.1650/CONDOR-17-83.1; Sauer JR, 2013, J WILDLIFE MANAGE, V77, P117, DOI 10.1002/jwmg.442; Seabloom EW, 2003, WETLANDS, V23, P1, DOI 10.1672/0277-5212(2003)023[0001:PDCAIO]2.0.CO;2; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Sondergaard M, 2007, J APPL ECOL, V44, P1095, DOI 10.1111/j.1365-2664.2007.01363.x; Stewart R.E., 1971, CLASSIFICATION NATUR; Tiner RW, 1984, WETLANDS US CURRENT, P1; Tozer DC, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-01063-120208; Tozer DC, 2016, AVIAN CONSERV ECOL, V11, DOI 10.5751/ACE-00875-110203; TWEDT D, 1995, YELLOW HEADED BLACKB; Twedt DJ, 2017, FOREST ECOL MANAG, V384, P180, DOI 10.1016/j.foreco.2016.10.031; U.S. Fish and Wildlife Service Division of Migratory Bird Management, 2008, BIRDS CONS 2008; Vanausdall RA, 2018, IMPACTS SHALLOW LAKE; VANDERVALK AG, 1976, CAN J BOT, V54, P1832, DOI 10.1139/b76-197; VanReesSiewert KL, 1996, WETLANDS, V16, P577, DOI 10.1007/BF03161348; Verner J., 2019, CONDOR, V67, P125; VOIGTS DK, 1976, AM MIDL NAT, V95, P313, DOI 10.2307/2424396; Weller MW, 1965, ROLE HABITAT DISTRIB, P31; Yasukawa K., 2019, RED WINGED BLACKBIRD, DOI [10.2173/bna.rewbla.02, DOI 10.2173/BNA.REWBLA.02]; Zedler JB, 2000, TRENDS ECOL EVOL, V15, P402, DOI 10.1016/S0169-5347(00)01959-5; Zimmer KD, 2003, CAN J FISH AQUAT SCI, V60, P721, DOI 10.1139/F03-060; Zimmer KD, 2000, CAN J FISH AQUAT SCI, V57, P76, DOI 10.1139/cjfas-57-1-76; Zohrer JJ, 2001, P 17 N AM PRAIR C, P136	102	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227825	10.1371/journal.pone.0227825	http://dx.doi.org/10.1371/journal.pone.0227825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978167	gold, Green Published			2022-12-26	WOS:000534599100065
J	Tian, XH; Xie, JM; Yu, JH				Tian, Xuehui; Xie, Jianming; Yu, Jihua			Physiological and transcriptomic responses of Lanzhou Lily (Lilium davidii, var. unicolor) to cold stress	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; ANTIOXIDANT ENZYMES; FREEZING TOLERANCE; DORMANCY BREAKING; GENE-EXPRESSION; GROWTH; PHOTOSYNTHESIS; FLUORESCENCE; ACCLIMATION; PROLINE	Low temperature induces changes in plants at physiological and molecular levels, thus affecting growth and development. The Lanzhou lily (Lilium davidii, var. unicolor) is an important medicinal plant with high economic value. However, the molecular mechanisms underlying its photosynthetic and antioxidation responses to low temperature still remain poorly understood. This study subjected the Lanzhou lily to the two temperatures of 20 degrees C (control) and 4 degrees C (low temperature) for 24 h. Physiological parameters related to membrane integrity, photosynthesis, antioxidant system, and differentially expressed genes were investigated. Compared with control, low temperature increased the relative electrical conductivity by 43.2%, while it decreased net photosynthesis rate, ratio of variable to maximal fluorescence, and catalase activity by 47.3%, 10.1%, and 11.1%, respectively. In addition, low temperature significantly increased the content of soluble protein, soluble sugar, and proline, as well as the activity of superoxide dismutase and peroxidase. Comparative transcriptome profiling showed that a total of 238,109 differentially expressed genes were detected. Among these, 3,566 were significantly upregulated while 2,982 were significantly downregulated in response to low temperature. Gene Ontology enrichment analysis indicated that in response to low temperature, the mostly significantly enriched differentially expressed genes were mainly involved in phosphorylation, membrane and protein kinase activity, as well as photosynthesis, light harvesting, light reaction, and alpha,alpha-trehalose-phosphate synthase activity. Kyoto Encyclopedia of Genes and Genomes enrichment analysis also indicated that the most significantly enriched pathways involved ribosome biogenesis in eukaryotes, phenylalanine metabolism, circadian rhythm, porphyrin and chlorophyll metabolism, photosynthesis of antenna proteins, photosynthesis, and carbon fixation in photosynthetic organisms. Moreover, the expression patterns of 10 randomly selected differentially expressed genes confirmed the RNA-Seq results. These results expand the understanding of the physiological and molecular mechanisms underlying the response of the Lanzhou lily to low temperature stress.	[Tian, Xuehui; Xie, Jianming; Yu, Jihua] Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China; [Tian, Xuehui] Yangling Vocat & Tech Coll, Dept Ecol Environm & Engn, Yangling, Shanxi, Peoples R China	Gansu Agricultural University; Yangling Vocational & Technical College	Xie, JM (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China.	xiejianminggs@126.com		Xie, Jianming/0000-0002-9882-2074	key research and development project in China [2016YFD0201005]; natural science foundation of Yangling Vocational and Technical College [A2017027]	key research and development project in China; natural science foundation of Yangling Vocational and Technical College	This study was funded by the key research and development project in China (2016YFD0201005) and the natural science foundation of Yangling Vocational and Technical College (A2017027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Key Laboratory of Protected Horticulture Engineering in Northwest Agriculture and Forestry University for providing an excellent experimental platform and the Beijing Allwegene Technology Co., Ltd., Beijing, China, for their services with regard to high throughput sequencing and transcriptome data analysis. Also, we acknowledge Dr Tonghua Pan for his technological support in this study. In addition, we thank all the good comments and suggestions from those anonymous reviewers.	Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Barrero-Gil J, 2016, PLANT CELL ENVIRON, V39, P2303, DOI 10.1111/pce.12799; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Berghage R. D., 1990, Acta Horticulturae, P91; Chakrabarty D., 2009, J HORTIC FOR, V1, P113, DOI [DOI 10.5897/JHF.9000081, 10.5897/JHF.9000081]; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; de Klerk GJ, 2009, PROPAG ORNAM PLANTS, V9, P102; Devacht S, 2011, PHOTOSYNTHETICA, V49, P161, DOI 10.1007/s11099-011-0015-1; Eremina M, 2016, CELL MOL LIFE SCI, V73, P797, DOI 10.1007/s00018-015-2089-6; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gomes FP, 2010, SCI HORTIC-AMSTERDAM, V126, P379, DOI 10.1016/j.scienta.2010.07.036; Guidi L, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00174; He XF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21193-4; Hu ZH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01351; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Joanna T. D., 2019, PLANT SCI, V177, P648, DOI [10.1016/j.plantsci.2009.09.001, DOI 10.1016/J.PLANTSCI.2009.09.001]; Kalisz A, 2016, HORTIC ENVIRON BIOTE, V57, P330, DOI 10.1007/s13580-016-0095-8; Kim SI, 2011, EUPHYTICA, V178, P437, DOI 10.1007/s10681-010-0343-4; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Langens-Gerrits MM, 2003, PLANT GROWTH REGUL, V40, P267, DOI 10.1023/A:1025018728178; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li NN, 2017, BIOL PLANTARUM, V61, P95, DOI 10.1007/s10535-016-0657-8; Li WQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2955-0; LingFei X, 2009, SCI HORTIC-AMSTERDAM, V119, P458, DOI 10.1016/j.scienta.2008.08.026; Liu T, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1254-0; Liu XH, 2014, MOL BIOL REP, V41, P6619, DOI 10.1007/s11033-014-3545-3; Lootens P, 2004, PHOTOSYNTHETICA, V42, P187, DOI 10.1023/B:PHOT.0000040589.09614.a0; Perez-Bueno ML, 2015, PHYSIOL PLANTARUM, V153, P161, DOI 10.1111/ppl.12237; Meng L, 2010, BIOTECHNOL J, V5, P183, DOI 10.1002/biot.200900211; Mhamdi A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24181; MILLER WB, 1990, HORTSCIENCE, V25, P463, DOI 10.21273/HORTSCI.25.4.463; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Nie HT, 2016, FISH SHELLFISH IMMUN, V55, P358, DOI 10.1016/j.fsi.2016.06.008; Nievola Catarina C, 2017, Temperature (Austin), V4, P371, DOI 10.1080/23328940.2017.1377812; Pan TH, 2019, HORTSCIENCE, V54, P246, DOI [10.21273/HORTSCI13709-18, 10.21273/hortsci13709-18]; Petric M, 2013, ACTA PHYSIOL PLANT, V35, P3223, DOI 10.1007/s11738-013-1357-z; Prisa D, 2013, POSTHARVEST BIOL TEC, V79, P39, DOI 10.1016/j.postharvbio.2012.12.018; Puyaubert J, 2014, PLANT CELL ENVIRON, V37, P2623, DOI 10.1111/pce.12329; Ranwala AP, 2000, POSTHARVEST BIOL TEC, V19, P85, DOI 10.1016/S0925-5214(00)00072-7; Rees T, 1981, RECENT ADVANCES IN T, P41; ROH M S, 1990, Acta Horticulturae (Wageningen), P141; Rui HJ, 2010, J SCI FOOD AGR, V90, P1557, DOI 10.1002/jsfa.3993; Sapeta H, 2013, ENVIRON EXP BOT, V85, P76, DOI 10.1016/j.envexpbot.2012.08.012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi YT, 2015, PLANT CELL PHYSIOL, V56, P7, DOI 10.1093/pcp/pcu115; Shin KS, 2002, SCI HORTIC-AMSTERDAM, V96, P195, DOI 10.1016/S0304-4238(02)00087-0; Sorrentino G, 1997, SCI HORTIC-AMSTERDAM, V69, P259, DOI 10.1016/S0304-4238(97)00016-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Toker C, 2005, GENET RESOUR CROP EV, V52, P1, DOI 10.1007/s10722-005-1743-5; Torninaga J, 2014, BIOMASS BIOENERG, V67, P279, DOI 10.1016/j.biombioe.2014.05.010; Villacorta-Martin C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1675-1; Wang JM, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-203, 10.1186/1471-2156-15-33, 10.1186/1471-2164-15-415]; Wang W, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4536-x; Weiss J, 2009, J APPL GENET, V50, P311, DOI 10.1007/BF03195689; Xie ZY, 2019, GENOMICS, V111, P1006, DOI 10.1016/j.ygeno.2018.05.014; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang J, 2009, ACTA PHYSIOL PLANT, V31, P285, DOI 10.1007/s11738-008-0231-x; Yang QZ, 2012, HORTIC ENVIRON BIOTE, V53, P505, DOI 10.1007/s13580-012-0101-8; Yang TW, 2005, PLANT SCI, V169, P987, DOI 10.1016/j.plantsci.2005.07.005; Yong YB, 2018, BIOL PLANTARUM, V62, P287, DOI 10.1007/s10535-017-0767-y; Zhao BT, 2013, FOOD HYDROCOLLOID, V31, P346, DOI 10.1016/j.foodhyd.2012.11.021; Zhao LH, 2014, BIOCHEM SYST ECOL, V55, P184, DOI 10.1016/j.bse.2014.03.024; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020	65	19	21	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227921	10.1371/journal.pone.0227921	http://dx.doi.org/10.1371/journal.pone.0227921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971962	Green Published, gold			2022-12-26	WOS:000534374400028
J	Choy, MHV; Wong, RMY; Li, MC; Wang, BY; Liu, XD; Lee, W; Cheng, JCY; Chow, SKH; Cheung, WH				Choy, Man-Huen Victoria; Wong, Ronald Man-Yeung; Li, Meng-Chen; Wang, Bai Yan; Liu, Xiao Dong; Lee, Wayne; Cheng, Jack Chun-Yiu; Chow, Simon Kwoon-Ho; Cheung, Wing-Hoi			Can we enhance osteoporotic metaphyseal fracture healing through enhancing ultrastructural and functional changes of osteocytes in cortical bone with low-magnitude high-frequency vibration?	FASEB JOURNAL			English	Article						lacuna-canalicular network (LCN); mechanical loading; osteocytes; osteoporotic fracture healing; vibration	ESTROGEN-RECEPTOR-ALPHA; DENTIN MATRIX PROTEIN-1; IN-VIVO; MECHANICAL STIMULATION; CALLUS FORMATION; RAT MODEL; ER-ALPHA; EXPRESSION; MINERALIZATION; DENSITY	Fragility fractures are related to the loss of bone integrity and deteriorated morphology of osteocytes. Our previous studies have reported that low-magnitude high-frequency vibration (LMHFV) promoted osteoporotic fracture healing. As osteocytes are known for mechanosensing and initiating bone repair, we hypothesized that LMHFV could enhance osteoporotic fracture healing through enhancing morphological changes in the osteocyte lacuna-canalicular network (LCN) and mineralization. A metaphyseal fracture model was established in female Sprague-Dawley rats to investigate changes in osteocytes and healing outcomes from early to late phase post-fracture. Our results showed that the LCN exhibited an exuberant outgrowth of canaliculi in the osteoporotic fractured bone at day 14 after LMHFV. LMHFV upregulated the E11, dentin matrix protein 1 (DMP1), and fibroblast growth factor 23 (FGF23), but downregulated sclerostin (Sost) in osteocytes. Moreover, LMHFV promoted mineralization with significant enhancements of Ca/P ratio, mineral apposition rate (MAR), mineralizing surface (MS/BS), and bone mineral density (BMD) in the osteoporotic group. Consistently, better healing was confirmed by microarchitecture and mechanical properties, whereas the enhancement in osteoporotic group was comparable or even greater than the normal group. This is the first report to reveal the enhancement effect of LMHFV on the osteocytes' morphology and functions in osteoporotic fracture healing.	[Choy, Man-Huen Victoria; Wong, Ronald Man-Yeung; Li, Meng-Chen; Lee, Wayne; Cheng, Jack Chun-Yiu; Chow, Simon Kwoon-Ho; Cheung, Wing-Hoi] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Wang, Bai Yan] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Liu, Xiao Dong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Hong Kong, Peoples R China; [Cheng, Jack Chun-Yiu; Chow, Simon Kwoon-Ho; Cheung, Wing-Hoi] Chinese Univ Hong Kong, Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong, Shenzhen	Cheung, WH (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, 5-F Clin Sci Bldg, Hong Kong, Peoples R China.	louis@ort.cuhk.edu.hk	Cheung, Wing-Hoi/J-2150-2018; Chow, Simon Kwoon-ho/J-1554-2018; Cheng, Jack/J-3878-2018; Wong, Ronald Man Yeung/GYU-4740-2022; Lee, Wayne YW/H-8298-2013	Cheung, Wing-Hoi/0000-0003-3247-8255; Chow, Simon Kwoon-ho/0000-0003-1742-980X; Cheng, Jack/0000-0001-8153-364X; Lee, Wayne YW/0000-0002-0486-360X; Wong, Ronald Man Yeung/0000-0001-5615-6627; Li, Meng Chen Michelle/0000-0001-8720-2008	Research Grants Council, University Grants Committee (RGC, UGC) [14113018]; General Research Fund [14113018]; CUHK [2017.045]; university research grant of CUHK [2017.045]	Research Grants Council, University Grants Committee (RGC, UGC); General Research Fund; CUHK(Chinese University of Hong Kong); university research grant of CUHK	Research Grants Council, University Grants Committee (RGC, UGC), Grant/Award Number: Ref: 14113018; direct grant, university research grant of CUHK, Grant/Award Number: Ref: 2017.045; General Research Fund, Grant/Award Number: 14113018; CUHK, Grant/Award Number: 2017.045	Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034; Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Batra GS, 2003, J PATHOL, V200, P65, DOI 10.1002/path.1332; Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Cadena E, 2016, PEERJ, V4, DOI 10.7717/peerj.1618; Carpentier VT, 2012, BONE, V50, P688, DOI 10.1016/j.bone.2011.11.021; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Chen WT, 2015, ACTA ORTHOP, V86, P238, DOI 10.3109/17453674.2014.1003127; Cheung WH, 2012, ULTRASOUND MED BIOL, V38, P2120, DOI 10.1016/j.ultrasmedbio.2012.07.025; Chow DHK, 2011, J ORTHOP RES, V29, P746, DOI 10.1002/jor.21303; Chow SKH, 2016, OSTEOPOROSIS INT, V27, P2989, DOI 10.1007/s00198-016-3619-2; Chow SK, 2014, ARCH ORTHOP TRAUM SU, V134, P1405, DOI 10.1007/s00402-014-2070-0; Claes L, 2011, J ORTHOP RES, V29, P425, DOI 10.1002/jor.21227; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Ehrlich PJ, 2002, J BONE MINER RES, V17, P1646, DOI 10.1359/jbmr.2002.17.9.1646; Fan W, 2008, BONE, V42, P81, DOI 10.1016/j.bone.2007.08.048; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Goebel S, 2009, J ORTHOP RES, V27, P1141, DOI 10.1002/jor.20857; Hadjiargyrou M, 2001, BONE, V29, P149, DOI 10.1016/S8756-3282(01)00489-6; Haffner-Luntzer M, 2018, BONE, V110, P11, DOI 10.1016/j.bone.2018.01.017; Hazenberg JG, 2006, J BIOMECH, V39, P2096, DOI 10.1016/j.jbiomech.2005.06.006; Hernandez CJ, 2004, BONE, V35, P1095, DOI 10.1016/j.bone.2004.07.002; Himeno-Ando A, 2012, BIOCHEM BIOPH RES CO, V417, P765, DOI 10.1016/j.bbrc.2011.12.031; Inagaki Y, 2015, VIRCHOWS ARCH, V466, P445, DOI 10.1007/s00428-014-1706-3; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kruck B, 2018, J BONE MINER RES, V33, P1686, DOI 10.1002/jbmr.3454; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; Li CY, 2011, BONE, V49, P1178, DOI 10.1016/j.bone.2011.08.012; Li YF, 2016, INT J CLIN EXP MED, V9, P13329; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Maginot M, 2015, BONE, V81, P602, DOI 10.1016/j.bone.2015.08.018; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Mullender MG, 1996, BONE, V18, P109, DOI 10.1016/8756-3282(95)00444-0; Neagu TP, 2016, ROM J MORPHOL EMBRYO, V57, P1051; Okata H, 2015, ORAL DIS, V21, P74, DOI 10.1111/odi.12212; Power J, 2002, BONE, V30, P859, DOI 10.1016/S8756-3282(02)00731-7; Ren Y, 2014, CONNECT TISSUE RES, V55, P129, DOI 10.3109/03008207.2014.923879; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; ROSCHGER P, 1995, SCANNING MICROSCOPY, V9, P75; Sapir-Koren R, 2014, OSTEOPOROSIS INT, V25, P2685, DOI 10.1007/s00198-014-2808-0; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Shah FA, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5779-1; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Skedros JG, 2005, CELLS TISSUES ORGANS, V180, P215, DOI 10.1159/000088938; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Swift SN, 2014, J APPL PHYSIOL, V117, P1349, DOI 10.1152/japplphysiol.00588.2013; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Thompson WR, 2011, J BONE MINER RES, V26, P618, DOI 10.1002/jbmr.236; Toyosawa S, 2004, BONE, V35, P553, DOI 10.1016/j.bone.2004.03.030; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Wong RMY, 2019, EUR CELLS MATER, V37, P420, DOI 10.22203/eCM.v037a25; Wong RMY, 2018, BONE JOINT RES, V7, P6, DOI 10.1302/2046-3758.71.BJR-2016-0334.R2; Yang DQ, 2013, BIOCHEM BIOPH RES CO, V440, P62, DOI 10.1016/j.bbrc.2013.09.030; Yeni YN, 1998, BONE, V22, P79, DOI 10.1016/S8756-3282(97)00227-5; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhou XZ, 2009, BONE, V45, P704, DOI 10.1016/j.bone.2009.06.026	73	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4234	4252		10.1096/fj.201901595R	http://dx.doi.org/10.1096/fj.201901595R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961009				2022-12-26	WOS:000508663200001
J	Parente, A; Boukredine, A; Baraige, F; Duprat, N; Gondran-Tellier, V; Magnol, L; Blanquet, V				Parente, Alexis; Boukredine, Axel; Baraige, Fabienne; Duprat, Nathalie; Gondran-Tellier, Victor; Magnol, Laetitia; Blanquet, Veronique			GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics	FASEB JOURNAL			English	Article						muscle; myostatin; GASP-1; GASP-2; hypertrophy; hyperplasia	SKELETAL-MUSCLE; STRIATED-MUSCLE; MYOSTATIN; GROWTH; WFIKKN2; CELLS	Muscle atrophy is associated with many diseases including genetic disorders, sarcopenia, or cachexia syndromes. Myostatin (Mstn), a transforming growth factor-beta (TGF-beta) member, plays a key role in skeletal muscle homeostasis as a powerful negative regulator. Over the last decade, about 15 clinical trials aimed at inhibiting the Mstn pathway, failed to produce conclusive results. In this context, we investigated whether growth and differentiation factor-associated serum protein-1 (GASP-1) or GASP-2, two natural inhibitors of Mstn, might represent a potential therapeutic. As we previously reported, mice overexpressing Gasp-1 (Tg(Gasp-1)) present an increase of muscle mass but develop metabolic disorders with aging. Here, we showed that overexpression of Gasp-2 increases the muscular mass without metabolic defects. We also found that Tg(Gasp-2) mice displayed, like Mstn(-/-) mice, a switch from slow- to fast-twitch myofibers whereas Tg(Gasp-1) mice exhibit a reverse switch. Our studies supported the fact that GASP-2 has less affinity than GASP-1 for Mstn, leading to a constitutive Mstn upregulation only in Tg(Gasp-1) mice, responsible for the observed phenotypic differences. Altogether, our findings highlighted a gene expression regulatory network of TGF-beta members and their inhibitors in muscle.	[Parente, Alexis; Boukredine, Axel; Baraige, Fabienne; Duprat, Nathalie; Gondran-Tellier, Victor; Magnol, Laetitia; Blanquet, Veronique] Univ Limoges, INRA, GAMAA, PEIRENE EA7500,USC1061, 123 Av A Thomas, F-87060 Limoges, France	INRAE; Universite de Limoges	Blanquet, V (corresponding author), Univ Limoges, INRA, GAMAA, PEIRENE EA7500,USC1061, 123 Av A Thomas, F-87060 Limoges, France.	veronique.blanquet@unilim.fr		Parente, Alexis/0000-0002-6746-2520	European Union; Limousin Regional Council; French National Institute for Agricultural Research	European Union(European Commission); Limousin Regional Council; French National Institute for Agricultural Research	European Union; Limousin Regional Council; French National Institute for Agricultural Research	Al-Zaidy Samiah A, 2015, J Neuromuscul Dis, V2, P185; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Brun C, 2014, CELL PHYSIOL BIOCHEM, V34, P1241, DOI 10.1159/000366335; Brun C, 2012, CELL PHYSIOL BIOCHEM, V30, P791, DOI 10.1159/000341458; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231; Hoogaars WMH, 2018, ADV EXP MED BIOL, V1088, P153, DOI 10.1007/978-981-13-1435-3_8; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Lee Se-Jin, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P183; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendell JR, 2017, MOL THER, V25, P870, DOI 10.1016/j.ymthe.2017.02.015; Meunier B, 2010, HISTOCHEM CELL BIOL, V134, P307, DOI 10.1007/s00418-010-0733-7; Monestier O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-541; OLIVER MH, 1989, J CELL SCI, V92, P513; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; Parente A, 2019, METHODS MOL BIOL, V1889, P229, DOI 10.1007/978-1-4939-8897-6_13; Perie L, 2017, CELL PHYSIOL BIOCHEM, V44, P1896, DOI 10.1159/000485878; Perie Luce, 2016, Biochem Biophys Rep, V6, P39, DOI 10.1016/j.bbrep.2016.03.001; Pirruccello-Straub M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20524-9; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Walker RG, 2015, J BIOL CHEM, V290, P7506, DOI 10.1074/jbc.M114.624130; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zhang YH, 2017, ONCOTARGET, V8, P81604, DOI 10.18632/oncotarget.20258	31	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4026	4040		10.1096/fj.201901220R	http://dx.doi.org/10.1096/fj.201901220R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960486	hybrid, Green Published			2022-12-26	WOS:000508839900001
J	Wang, FF; Wu, HS; Fan, MJ; Yu, RK; Zhang, Y; Liu, JX; Zhou, XJ; Cai, YS; Huang, SH; Hu, ZH; Jin, XD				Wang, Feifan; Wu, Hongshen; Fan, Mengjing; Yu, Rikao; Zhang, Yan; Liu, Jiaxin; Zhou, Xuejian; Cai, Yueshu; Huang, Shihan; Hu, Zhenghui; Jin, Xiaodong			Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells	FASEB JOURNAL			English	Article						apoptosis; autophagy; bladder cancer; migration; miR-139-5p; Bmi-1 axis; reactive oxygen species (ROS); sodium butyrate	OXYGEN SPECIES ROS; IN-VITRO; MITOCHONDRIAL; PREVENTION; TARGET	Bladder cancer is one of the most frequently occurring malignant tumors in the urinary system. Sodium butyrate (NaB) is a histone deacetylase inhibitor and exerts remarkable antitumor effects in various cancer cells. MicroRNAs (miRNAs) and autophagy play crucial roles in cancer occurrence and development. In the present study, we evaluated the anticancer effects, including cell migration inhibition and the apoptotic effects of NaB in human bladder cancer cells. Furthermore, we found that NaB inhibited migration and induced AMPK/mTOR pathway-activated autophagy and reactive oxygen species (ROS) overproduction via the miR-139-5p/Bmi-1 axis. In addition, we found that ROS overproduction contributed to NaB-induced caspase-dependent apoptosis and autophagy. The interplay between autophagy and apoptosis in NaB treatment was clarified. Our findings provide a further understanding of EMT reversion, apoptosis and autophagy induced by antitumor drugs and a novel perspective and alternative strategy for bladder cancer chemotherapy.	[Wang, Feifan; Wu, Hongshen; Yu, Rikao; Zhang, Yan; Liu, Jiaxin; Zhou, Xuejian; Cai, Yueshu; Huang, Shihan; Hu, Zhenghui; Jin, Xiaodong] Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Mengjing] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Cent Lab,Biomed Res Ctr, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Jin, XD (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	xiaodong-jin@zju.edu.cn		Jin, Xiao-Dong/0000-0003-2734-3882	Natural Science Foundation of Zhejiang Province [LGF18H050001, LY17H050004, LY16H050002]; National Natural Science Foundation of China [81370799]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of Zhejiang Province, Grant/Award Number: LGF18H050001, Xiaodong Jin; LY17H050004, Zhenghui Hu and LY16H050002, Geming Chen. National Natural Science Foundation of China, Grant/Award Number: 81370799, Xiaodong Jin	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bharathy N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau7632; Burge F, 2016, UROL INT, V97, P373, DOI 10.1159/000449256; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Deng S, 2019, CANCER-AM CANCER SOC, V125, P1228, DOI 10.1002/cncr.31978; Dey A, 2016, AUTOPHAGY, V12, P659, DOI 10.1080/15548627.2016.1147670; Dobruch J, 2016, EUR UROL, V69, P300, DOI 10.1016/j.eururo.2015.08.037; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Fransolet M, 2019, J ASSIST REPROD GEN, V36, P349, DOI 10.1007/s10815-018-1353-8; Grimmel M, 2015, CELLS-BASEL, V4, P202, DOI 10.3390/cells4020202; Hsieh TH, 2015, MOL THER, V23, P656, DOI 10.1038/mt.2014.247; Huang KM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0166-5; Huang LL, 2017, ONCOL LETT, V14, P1215, DOI 10.3892/ol.2017.6351; Jiang F, 2018, INT J MOL MED, V42, P1295, DOI 10.3892/ijmm.2018.3712; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Kamat AM, 2014, J UROLOGY, V192, P305, DOI 10.1016/j.juro.2014.02.2573; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Lai TH, 2016, CLIN CANCER RES, V22, P3537, DOI 10.1158/1078-0432.CCR-15-1063; Lang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129196; Lemasters JJ, 1998, GASTROENTEROLOGY, V115, P783, DOI 10.1016/S0016-5085(98)70160-X; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu YQ, 2014, J BIOL CHEM, V289, P4116, DOI 10.1074/jbc.M113.533505; Lu SJ, 2015, EUR J PHARM SCI, V72, P57, DOI 10.1016/j.ejps.2015.03.006; Luo HB, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317718414; Maruyama T, 2012, J INFECT CHEMOTHER, V18, P288, DOI 10.1007/s10156-011-0322-2; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patel N, 2016, LIFE SCI, V164, P60, DOI 10.1016/j.lfs.2016.08.028; Pero ME, 2018, THERIOGENOLOGY, V108, P127, DOI 10.1016/j.theriogenology.2017.11.031; Salimi V, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0593-4; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Santamaria PG, 2017, MOL ONCOL, V11, P718, DOI 10.1002/1878-0261.12091; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Su LY, 2017, AUTOPHAGY, V13, P1496, DOI 10.1080/15548627.2017.1332549; Sylvester RJ, 2016, EUR UROL, V69, P231, DOI 10.1016/j.eururo.2015.05.050; Tailor D, 2014, MITOCHONDRION, V16, P55, DOI 10.1016/j.mito.2013.10.004; Thorstenson A, 2016, SCAND J UROL, V50, P292, DOI 10.3109/21681805.2016.1158207; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937; Xu ZY, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700844; Yonemori M, 2016, CANCER SCI, V107, P1233, DOI 10.1111/cas.13002; Yue ZY, 2008, AUTOPHAGY, V4, P94, DOI 10.4161/auto.5202; Zhang HD, 2015, TUMOR BIOL, V36, P1355, DOI 10.1007/s13277-015-3199-3; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867	58	40	43	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4266	4282		10.1096/fj.201902626R	http://dx.doi.org/10.1096/fj.201902626R		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957111				2022-12-26	WOS:000508135800001
J	Zafalon, RVA; Risolia, LW; Vendramini, THA; Rodrigues, RBA; Pedrinelli, V; Teixeira, FA; Rentas, MF; Perini, MP; Alvarenga, IC; Brunetto, MA				Amorim Zafalon, Rafael Vessecchi; Risolia, Larissa Wunsche; Annibale Vendramini, Thiago Henrique; Ayres Rodrigues, Roberta Bueno; Pedrinelli, Vivian; Teixeira, Fabio Alves; Rentas, Mariana Fragoso; Perini, Mariana Pamplona; Alvarenga, Isabella Corsato; Brunetto, Marcio Antonio			Nutritional inadequacies in commercial vegan foods for dogs and cats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; BONE-MINERAL DENSITY; TAURINE DEFICIENCY; DILATED CARDIOMYOPATHY; SECONDARY HYPERPARATHYROIDISM; PLASMA TAURINE; IN-VITRO; NUTRIENT DIGESTIBILITY; RETINAL DEGENERATION; VEGETARIAN DIETS	The objective of this study was to evaluate the macronutrients composition, fatty acid and amino acid profiles, and essential minerals content of all vegan foods for dogs and cats available in the Brazilian market, and to compare results with FEDIAF (2019) and AAFCO (2019) recommendations. Four vegan pet foods were assessed (three for dogs and one for cats). The comparisons were made in a descriptive manner. All foods met the minimum recommendations for macronutrients. Arachidonic acid was not reported in any food label. Regarding the FEDIAF recommendations, one food for dogs had low calcium, another had low potassium and a third had low sodium. The cat food presented potassium content lower than recommended. The Ca:P ratio did not meet the minimum recommendation of FEDIAF (2019) and AAFCO (2019) in any of the dog's foods analyzed, and the cat food also did not present the minimum recommendation based on FEDIAF (2019). Copper concentrations exceeded the legal limit in all foods. Zinc concentrations exceeded this limit in two foods (one for dogs and one for cats) and iron levels exceeded the legal limit in one dog food. One of the dog foods did not meet the minimum recommendation for methionine and the cat food did not meet the minimum recommendation for arginine. In addition, when the amount of nutrients consumed by animals with low energy requirements was simulated, in addition to the same non-conformities described above, it was observed that the cat food does not meet the minimum recommended of protein and taurine in unit/Kg(0.67). It was concluded that all foods analyzed had one or more nutrients below the recommended levels and some presented zinc and copper excess, therefore, these foods should not be recommended for dogs and cats, because dietary deficiencies found may lead to health risks for dogs and cats. Furthermore, manufacturers should review their formulations to ensure the nutritional adequacy of these foods.	[Amorim Zafalon, Rafael Vessecchi; Risolia, Larissa Wunsche; Annibale Vendramini, Thiago Henrique; Ayres Rodrigues, Roberta Bueno; Pedrinelli, Vivian; Teixeira, Fabio Alves; Rentas, Mariana Fragoso; Perini, Mariana Pamplona; Brunetto, Marcio Antonio] Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, SP, Brazil; [Alvarenga, Isabella Corsato] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA	Universidade de Sao Paulo; Kansas State University	Brunetto, MA (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, SP, Brazil.	mabrunetto@usp.br	Brunetto, Marcio/AAQ-9767-2021; Pedrinelli, Vivian/AFG-3190-2022; Pedrinelli, Vivian/AAH-4103-2019; Pedrinelli, Vivian/AAF-1350-2022	Pedrinelli, Vivian/0000-0001-5954-4086; Pedrinelli, Vivian/0000-0001-5954-4086; Alves Teixeira, Fabio/0000-0001-6198-9367; Fragoso Rentas, Mariana/0000-0001-9423-9976; Brunetto, Marcio/0000-0003-3240-0343; , Mariana Pamplona Perini/0000-0001-6071-8565; Vendramini, Thiago/0000-0003-4457-8392				AOAC, 2006, OFFICIAL METHODS ANA; Association of American Feed Control Officials, 2019, 2019 OFF PUBL; BACKUS RC, 1995, J NUTR, V125, P2650; Backus RC, 2003, J AM VET MED ASSOC, V223, P1130, DOI 10.2460/javma.2003.223.1130; BARNETT KC, 1980, J SMALL ANIM PRACT, V21, P521, DOI 10.1111/j.1748-5827.1980.tb01354.x; Bednar GE, 2000, ARCH ANIM NUTR, V53, P127, DOI 10.1080/17450390009381942; Belanger MC, 2005, J AM ANIM HOSP ASSOC, V41, P284, DOI 10.5326/0410284; Chiu JF, 1997, CALCIFIED TISSUE INT, V60, P245, DOI 10.1007/PL00005812; COOK SD, 1983, CLIN ORTHOP RELAT R, P105; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; CZARNECKI GL, 1984, J NUTR, V114, P581, DOI 10.1093/jn/114.3.581; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; de Fomel-Thibaud P, 2007, J AM ANIM HOSP ASSOC, V43, P52, DOI 10.5326/0430052; Dirksen K, 2017, VET CLIN N AM-SMALL, V47, P631, DOI 10.1016/j.cvsm.2016.11.011; Dodd SAS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210806; Fascetti AJ, 2003, J AM VET MED ASSOC, V223, P1137, DOI 10.2460/javma.2003.223.1137; FEDIAF, 2019, NUTR GUID COMPL COMP; Freeman LM, 2018, JAVMA-J AM VET MED A, V253, P1390, DOI 10.2460/javma.253.11.1390; Funaba M, 2002, AM J VET RES, V63, P1247, DOI 10.2460/ajvr.2002.63.1247; Galvao JFD, 2013, J VET EMERG CRIT CAR, V23, P134, DOI 10.1111/vec.12036; Gray CM, 2004, JAVMA-J AM VET MED A, V225, P1670, DOI 10.2460/javma.2004.225.1670; Hayes K C, 1988, Nutr Res Rev, V1, P99, DOI 10.1079/NRR19880009; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; HAYES KC, 1982, CAN VET J, V23, P2; HICKMAN MA, 1992, J NUTR, V122, P1019, DOI 10.1093/jn/122.4.1019; Hill RC, 2001, J ANIM SCI, V79, P2162; IMAKI H, 1986, DEV NEUROSCI-BASEL, V8, P160, DOI 10.1159/000112251; International Organization for Standardization (ISO), 1978, 5509 ISO; JACOBSON SG, 1987, EXP EYE RES, V45, P481, DOI 10.1016/S0014-4835(87)80059-3; Jaffey J, 2017, J VET INTERN MED, V31, P775; Jaffey JA, 2018, VET J, V236, P31, DOI 10.1016/j.tvjl.2018.04.010; Kanakubo K, 2015, JAVMA-J AM VET MED A, V247, P385, DOI 10.2460/javma.247.4.385; KAWAGUCHI K, 1993, JPN J VET RES, V41, P89; Kienzle E., 2001, COMPENDIUM, V23, P81; KIM SW, 1995, J NUTR, V125, P2831; KIRK CA, 2000, SMALL ANIMAL CLIN NU, P291; Kittleson MD, 1997, J VET INTERN MED, V11, P204, DOI 10.1111/j.1939-1676.1997.tb00092.x; Ko Kwang Suk, 2016, Journal of Animal Science and Technology, V58, P29, DOI 10.1186/s40781-016-0112-6; KRAMER GA, 1995, J VET INTERN MED, V9, P253, DOI 10.1111/j.1939-1676.1995.tb01076.x; Kunakornsawat S, 2004, J STEROID BIOCHEM, V89-90, P409, DOI 10.1016/j.jsbmb.2004.03.009; Kunakornsawat S, 2001, ANTICANCER RES, V21, P3355; Lau EMC, 1998, EUR J CLIN NUTR, V52, P60, DOI 10.1038/sj.ejcn.1600516; Laws EJ, 2018, J SMALL ANIM PRACT, V59, P222, DOI 10.1111/jsap.12791; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Loureiro BA, 2018, P 22 C EUR SOC VET C, P123; MACDONALD ML, 1984, AM J VET RES, V45, P1310; Malone EK, 2010, VET COMP ONCOL, V8, P209, DOI 10.1111/j.1476-5829.2010.00223.x; Montaser A., 1998, INDUCTIVELY COUPLED; MORRIS JG, 1978, SCIENCE, V199, P431, DOI 10.1126/science.619464; MORRIS JG, 1985, J NUTR, V115, P524, DOI 10.1093/jn/115.4.524; Morris JG, 2002, J ANIM PHYSIOL AN N, V86, P229, DOI 10.1046/j.1439-0396.2002.00379.x; Morris JG, 1994, VET CLIN NUTR, V1, P118; Morris JH, 1992, METABOLIC BASIS TAUR, P33; Motlagh BM, 2015, IRAN J BASIC MED SCI, V18, P672; NAP RC, 1994, VET QUART, V16, P50, DOI 10.1080/01652176.1994.9694417; National Research Council, 2006, NUTR REQ DOGS CATS; NEIRINCK K, 1991, J NUTR, V121, pS64, DOI 10.1093/jn/121.suppl_11.S64; NOVOTNY MJ, 1994, CAN J VET RES, V58, P6; Parker VJ, 2017, JAVMA-J AM VET MED A, V250, P1259, DOI 10.2460/javma.250.11.1259; Pawlosky RJ, 1996, J NUTR, V126, pS1081, DOI 10.1093/jn/126.suppl_4.1081S; Pedrinelli V., 2018, ESVCN P 2018, P236; Pion PD, 1998, VET CLIN N AM-SMALL, V28, P1495, DOI 10.1016/S0195-5616(98)50134-9; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Rassnick KM, 2008, CANCER CHEMOTH PHARM, V62, P881, DOI 10.1007/s00280-008-0678-x; RENTSCHLER LA, 1986, COMP BIOCHEM PHYS B, V84, P319, DOI 10.1016/0305-0491(86)90084-2; RIVERS JPW, 1975, NATURE, V258, P171, DOI 10.1038/258171a0; Rodriguez-Cortes A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03662-4; ROGERS QR, 1985, J NUTR, V115, P146, DOI 10.1093/jn/115.1.146; Schaffer S, 2016, AMINO ACIDS, V48, P549, DOI 10.1007/s00726-015-2110-2; Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2; Spitze AR, 2003, J ANIM PHYSIOL AN N, V87, P251, DOI 10.1046/j.1439-0396.2003.00434.x; STURMAN JA, 1992, J NUTR, V122, P82, DOI 10.1093/jn/122.1.82; SVANBERG G, 1973, SCAND J DENT RES, V81, P155; Tomsa C, 1999, J SMALL ANIM PRACT, V40, P533, DOI 10.1111/j.1748-5827.1999.tb03015.x; Wakefield LA, 2006, JAVMA-J AM VET MED A, V229, P70, DOI 10.2460/javma.229.1.70; Williams RD, 1935, J BIOL CHEM, V108, P653	76	19	19	15	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227046	10.1371/journal.pone.0227046	http://dx.doi.org/10.1371/journal.pone.0227046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951617	gold, Green Published			2022-12-26	WOS:000534370500008
J	Agarwal, T; Lyngdoh, T; Dudbridge, F; Chandak, GR; Kinra, S; Prabhakaran, D; Reddy, KS; Relton, CL; Smith, GD; Ebrahim, S; Gupta, V; Walia, GK				Agarwal, Tripti; Lyngdoh, Tanica; Dudbridge, Frank; Chandak, Giriraj Ratan; Kinra, Sanjay; Prabhakaran, Dorairaj; Reddy, K. Srinath; Relton, Caroline L.; Smith, George Davey; Ebrahim, Shah; Gupta, Vipin; Walia, Gagandeep Kaur			Causal relationships between lipid and glycemic levels in an Indian population: A bidirectional Mendelian randomization approach	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; INSULIN-RESISTANCE SYNDROME; HIGH-DENSITY-LIPOPROTEIN; HDL-CHOLESTEROL; PREVALENCE; GLUCOSE; LINKAGE; PLASMA; RISK; LOCI	Background Dyslipidemia and abnormal glycemic traits are leading causes of morbidity and mortality. Although the association between the two traits is well established, there still exists a gap in the evidence for the direction of causality. Objective This study aimed to examine the direction of the causal relationship between lipids and glycemic traits in an Indian population using bidirectional Mendelian randomization (BMR). Methods The BMR analysis was conducted on 4900 individuals (2450 sib-pairs) from the Indian Migration Study. Instrument variables were generated for each lipid and glycemic trait (fasting insulin, fasting glucose, HOMA-IR, HOMA-beta, LDL-cholesterol, HDL-cholesterol, total cholesterol and triglycerides) to examine the causal relationship by applying two-stage least squares (2SLS) regression in both directions. Results Lipid and glycemic traits were found to be associated observationally, however, results from 2SLS showed that only triglycerides, defined by weighted genetic risk score (wGRS) of 3 SNPs (rs662799 at APOAV, rs780094 at GCKR and rs4420638 at APOE/C1/C4), were observed to be causally effecting 1.15% variation in HOMA-IR (SE = 0.22, P = 0.010), 1.53% in HOMA-beta (SE = 0.21, P = 0.001) and 1.18% in fasting insulin (SE = 0.23, P = 0.009). No evidence for a causal effect was observed in the reverse direction or between any other lipid and glycemic traits. Conclusion The study findings suggest that triglycerides may causally impact various glycemic traits. However, the findings need to be replicated in larger studies.	[Agarwal, Tripti; Lyngdoh, Tanica] Publ Hlth Fdn India, Indian Inst Publ Hlth Delhi, Gurgaon, India; [Dudbridge, Frank] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Chandak, Giriraj Ratan] CSIR Ctr Cellular & Mol Biol, Hyderabad, India; [Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Prabhakaran, Dorairaj; Reddy, K. Srinath; Walia, Gagandeep Kaur] Publ Hlth Fdn India, Gurgaon, India; [Relton, Caroline L.; Smith, George Davey] Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi, India	Public Health Foundation of India; University of Leicester; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Bristol; University of Delhi	Walia, GK (corresponding author), Publ Hlth Fdn India, Gurgaon, India.; Gupta, V (corresponding author), Univ Delhi, Dept Anthropol, Delhi, India.	udaiig@gmail.com; gkaurw@gmail.com	Prabhakaran, Dorairaj/B-4147-2011; Davey Smith, George/A-7407-2013	Prabhakaran, Dorairaj/0000-0002-3172-834X; Davey Smith, George/0000-0002-1407-8314; Chandak, Giriraj Ratan/0000-0002-3095-9453; Relton, Caroline/0000-0003-2052-4840; Kinra, Sanjay/0000-0001-6690-4625; Agarwal, Tripti/0000-0002-0675-0879	Wellcome Trust [GR070797MF, 083541/Z/07/Z]; Wellcome Trust/DBT India Alliance [IA/CPHE/16/1/502649]; MRC [MC_UU_00011/5, MC_UU_12013/2] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Indian Migration Study was funded by the Wellcome Trust (grant number GR070797MF to Prof. Shah Ebrahim, LSHTM, UK). The genetic data generation was funded by a project grant from the Wellcome Trust (083541/Z/07/Z to Prof. Shah Ebrahim, LSHTM, UK). The present analyses were supported by Wellcome Trust/DBT India Alliance (grant no. IA/CPHE/16/1/502649 to Dr. Gagandeep Kaur Walia, PHFI). The funders were not involved in study design, data collection, analyses, manuscript preparation or decision for submission.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; Ahmad S, 2019, ARTERIOSCL THROM VAS, V39, P97, DOI 10.1161/ATVBAHA.118.311562; BI Y, 2015, PLOS GENET, V11, DOI DOI 10.1371/JOURNAL.PGEN.1005204; Brunham LR, 2010, CURR DIABETES REP, V10, P55, DOI 10.1007/s11892-009-0090-x; Bu So Young, 2019, J Lipid Atheroscler, V8, P132, DOI 10.12997/jla.2019.8.2.132; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Christie S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00102-1; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Deepa R, 2002, INDIAN J MED RES, V115, P118; Dey D, 2006, MOL CELL ENDOCRINOL, V246, P60, DOI 10.1016/j.mce.2005.12.014; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Erol M, 2017, ARCH ARGENT PEDIATR, V115, P133, DOI [10.5546/aap.2017.eng.133, 10.5546/aap.2017.133]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Giorgio B, 2019, END CONN, V8, P1318; Gupta A, 2003, DIABETES RES CLIN PR, V61, P69, DOI 10.1016/S0168-8227(03)00085-8; Gupta D, 1999, DIABETES RES CLIN PR, V46, P1, DOI 10.1016/S0168-8227(99)00067-4; Gupta V, 2012, DIABETOLOGIA, V55, P349, DOI 10.1007/s00125-011-2355-6; Haase CL, 2015, DIABETES, V64, P3328, DOI 10.2337/db14-1603; Han TS, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0469-3; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Justesen JM, 2016, J LIPID RES, V57, P2193, DOI 10.1194/jlr.P068379; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kuchay MS, 2017, ARCH ENDOCRIN METAB, V61, P198, DOI 10.1590/2359-3997000000244; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lu XF, 2017, NAT GENET, V49, P1722, DOI 10.1038/ng.3978; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Mittra S, 2008, DRUG DISCOV TODAY, V13, P211, DOI 10.1016/j.drudis.2008.01.006; Muniyappa R, 2008, ENDOCRIN METAB CLIN, V37, P685, DOI 10.1016/j.ecl.2008.06.001; Natali A, 2017, METABOLISM, V69, P33, DOI 10.1016/j.metabol.2017.01.001; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-155; Rayasam GV, 2007, EXPERT OPIN THER TAR, V11, P661, DOI 10.1517/14728222.11.5.661; Schweiger M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14859, 10.1038/ncomms15490]; Seghieri M, 2017, DIABETES METAB, V43, P314, DOI 10.1016/j.diabet.2017.04.010; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Trico D, 2018, DIABETES OBES METAB, V20, P2905, DOI 10.1111/dom.13467; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Viscarra JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8596; von Eckardstein A, 2014, CARDIOVASC RES, V103, P384, DOI 10.1093/cvr/cvu143; White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	47	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228269	10.1371/journal.pone.0228269	http://dx.doi.org/10.1371/journal.pone.0228269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995593	Green Published, gold			2022-12-26	WOS:000534609400058
J	Sanchez-Garcia, M; Martinez-Cantin, R; Guerrero, JJ				Sanchez-Garcia, Melani; Martinez-Cantin, Ruben; Guerrero, Jose J.			Semantic and structural image segmentation for prosthetic vision	PLOS ONE			English	Article							MOBILITY PERFORMANCE; OBJECT RECOGNITION; ARTIFICIAL VISION; PERCEPTION; SIMULATION	Prosthetic vision is being applied to partially recover the retinal stimulation of visually impaired people. However, the phosphenic images produced by the implants have very limited information bandwidth due to the poor resolution and lack of color or contrast. The ability of object recognition and scene understanding in real environments is severely restricted for prosthetic users. Computer vision can play a key role to overcome the limitations and to optimize the visual information in the prosthetic vision, improving the amount of information that is presented. We present a new approach to build a schematic representation of indoor environments for simulated phosphene images. The proposed method combines a variety of convolutional neural networks for extracting and conveying relevant information about the scene such as structural informative edges of the environment and silhouettes of segmented objects. Experiments were conducted with normal sighted subjects with a Simulated Prosthetic Vision system. The results show good accuracy for object recognition and room identification tasks for indoor scenes using the proposed approach, compared to other image processing methods.	[Sanchez-Garcia, Melani; Martinez-Cantin, Ruben; Guerrero, Jose J.] Univ Zaragoza, Inst Invest Ingn Aragon I3A, Zaragoza, Spain	University of Zaragoza	Sanchez-Garcia, M (corresponding author), Univ Zaragoza, Inst Invest Ingn Aragon I3A, Zaragoza, Spain.	mesangar@unizar.es	Guerrero, Jose J/K-5435-2014; Martinez-Cantin, Ruben/F-8981-2011	Guerrero, Jose J/0000-0001-5209-2267; Martinez-Cantin, Ruben/0000-0002-6741-844X; Sanchez-Garcia, Melani/0000-0002-5656-1582	MINECO/FEDER, UE [DPI2015-65962-R, RTI2018-096903-B-I00]; MINECO [BES-2016-078426]	MINECO/FEDER, UE(Spanish Government); MINECO(Spanish Government)	This work was supported by projects DPI2015-65962-R, RTI2018-096903-B-I00 (MINECO/FEDER, UE) and BES-2016-078426 (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Al-Atabany W, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/3493826; Balthasar CD, 2008, INT J MOD PHYS C, V49, P2303, DOI DOI 10.1142/S2010194512005272; Barnes N, 2012, IMAGE VISION COMPUT, V30, P478, DOI 10.1016/j.imavis.2012.05.007; Barriga-Rivera A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00620; Beyeler M, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa795e; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Biederman I., 2017, PERCEPTUAL ORG, P213; Boucart M, 2011, OBJECT RECOGNITION; Bourkiza B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073592; BRICE CR, 1970, ARTIF INTELL, V1, P205, DOI 10.1016/0004-3702(70)90008-1; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Bruce V., 2003, VISUAL PERCEPTION PH, V4th; Cao XH, 2017, POLYMER, V112, P1, DOI 10.1016/j.polymer.2017.01.068; CHA K, 1992, VISION RES, V32, P1367, DOI 10.1016/0042-6989(92)90229-C; Chang MH, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046012; Chen SC, 2007, J NEURAL ENG, V4, pS108, DOI 10.1088/1741-2560/4/1/S13; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; Cheng DL, 2017, CURR EYE RES, V42, P334, DOI 10.1080/02713683.2016.1270326; Choi C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01824-6; Dagnelie G, 2006, INVEST OPHTH VIS SCI, V47, P1241, DOI 10.1167/iovs.05-0157; Dagnelie G, 2007, J NEURAL ENG, V4, pS92, DOI 10.1088/1741-2560/4/1/S11; Dagnelie G, 2006, EXPERT REV MED DEVIC, V3, P315, DOI 10.1586/17434440.3.3.315; Dai JF, 2016, PROC CVPR IEEE, P3150, DOI 10.1109/CVPR.2016.343; Eiber CD, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/011002; Facil JM, 2017, IEEE ROBOT AUTOM LET, V2, P1994, DOI 10.1109/LRA.2017.2715400; Feng D, 2013, IEEE ENG MED BIO, P5283, DOI 10.1109/EMBC.2013.6610741; Fernandez-Labrador Clara, 2018, ARXIV180809879; Fornos AP, 2005, INVEST OPHTH VIS SCI, V46, P3906, DOI 10.1167/iovs.04-1173; García Herrera Arístides Lázaro, 2017, Rev.Med.Electrón., P1; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Guo F, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/3198342; HARALICK R, 1985, APPL ARTIF INTELL, V548, P2; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayes JS, 2003, ARTIF ORGANS, V27, P1016, DOI 10.1046/j.1525-1594.2003.07309.x; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; Hu J, 2014, ARTIF ORGANS, V38, P159, DOI 10.1111/aor.12147; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; Irons JL, 2017, VISION RES, V137, P61, DOI 10.1016/j.visres.2017.06.002; Kirillov A, 2019, PROC CVPR IEEE, P9396, DOI 10.1109/CVPR.2019.00963; KOENDERINK JJ, 1984, PERCEPTION, V13, P321, DOI 10.1068/p130321; Li H, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa966d; Li H, 2018, ARTIF INTELL MED, V84, P64, DOI 10.1016/j.artmed.2017.11.001; Li H, 2017, INFORM SCIENCES, V415, P1, DOI 10.1016/j.ins.2017.06.014; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Lin Tsung-Yi, 2017, CVPR, DOI DOI 10.1109/CVPR.2017.106; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lovell NH, 2007, HDB NEURAL ENG, P337; Lu Y, 2014, ARTIF ORGANS, V38, pE10, DOI 10.1111/aor.12174; Luo YHL, 2016, PROG RETIN EYE RES, V50, P89, DOI 10.1016/j.preteyeres.2015.09.003; Mace MJM, 2015, ARTIF ORGANS, V39, pE102, DOI 10.1111/aor.12476; Mallya A, 2015, IEEE I CONF COMP VIS, P936, DOI 10.1109/ICCV.2015.113; McCarthy C, 2013, IEEE INT CONF MULTI; McKone E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204361; Minsky MA, 1967, PROJECT MAC PROGR RE; Nanduri D, 2008, IEEE ENG MED BIO, P1785, DOI 10.1109/IEMBS.2008.4649524; Parikh N, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026017; Perez-Yus A, 2017, IEEE INT CONF COMP V, P1516, DOI 10.1109/ICCVW.2017.179; Peterson M. A., 2003, PERCEPTION FACES OBJ; Qiu C, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.5.29; Quattoni A, 2009, PROC CVPR IEEE, P413, DOI 10.1109/CVPRW.2009.5206537; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sanchez-Garcia M, 2019, PROCEEDINGS OF THE 14TH INTERNATIONAL JOINT CONFERENCE ON COMPUTER VISION, IMAGING AND COMPUTER GRAPHICS THEORY AND APPLICATIONS (VISAPP), VOL 5, P218, DOI 10.5220/0007257602180225; Sanocki T, 1998, J EXP PSYCHOL HUMAN, V24, P340, DOI 10.1037/0096-1523.24.1.340; Sinclair NC, 2016, INVEST OPHTH VIS SCI, V57, P4948, DOI 10.1167/iovs.15-18991; Snaith M, 1998, IMAGE VISION COMPUT, V16, P225, DOI 10.1016/S0262-8856(97)00094-2; Sommerhalder J, 2003, VISION RES, V43, P269, DOI 10.1016/S0042-6989(02)00481-9; Sun M, 2014, IEEE T PATTERN ANAL, V36, P1370, DOI 10.1109/TPAMI.2013.193; Terasawa Y, 2008, IEICE ELECTRON EXPR, V5, P574, DOI 10.1587/elex.5.574; Thompson RW, 2003, INVEST OPHTH VIS SCI, V44, P5035, DOI 10.1167/iovs.03-0341; Tighe J, 2014, PROC CVPR IEEE, P3748, DOI 10.1109/CVPR.2014.479; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van Rheede JJ, 2010, J VISION, V10, DOI 10.1167/10.14.32; Vergnieux V, 2017, ARTIF ORGANS, V41, P852, DOI 10.1111/aor.12868; Vergnieux V, 2014, IEEE ENG MED BIO, P2585, DOI 10.1109/EMBC.2014.6944151; Vurro M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00816; Wang J, 2018, INT CON DISTR COMP S, P1385, DOI 10.1109/ICDCS.2018.00139; Wang J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046009; Wang J, 2014, INFORM SCIENCES, V277, P512, DOI 10.1016/j.ins.2014.02.136; Wang WJ, 2019, IEEE ACCESS, V7, P47918, DOI 10.1109/ACCESS.2019.2907564; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Wertheimer M., 1938, PSYCOL FORSCHUNG, P301; Yao J, 2012, P CVPR CIT; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yu Fisher, 2015, ARXIV150603365; Zhang ZY, 2020, INFORM SCIENCES, V506, P1, DOI 10.1016/j.ins.2019.08.003; Zhou DD, 2013, IEEE INT CONF MULTI, DOI 10.1109/ICMEW.2013.6618428; Zhu HY, 2016, J VIS COMMUN IMAGE R, V34, P12, DOI 10.1016/j.jvcir.2015.10.012	91	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227677	10.1371/journal.pone.0227677	http://dx.doi.org/10.1371/journal.pone.0227677			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995568	Green Published, gold			2022-12-26	WOS:000534609400025
J	Ely, B				Ely, Bert			Recombination and gene loss occur simultaneously during bacterial horizontal gene transfer	PLOS ONE			English	Article							CAULOBACTER-CRESCENTUS; GENOME	Bacteria can acquire new genes by incorporating environmental DNA into their genomes, yet genome sizes stay relatively constant. In nature, gene acquisition is a rare event so it is difficult to observe. However, the Caulobacter crescentus CB2A genome contains 114 insertions of genetic material from the closely-related NA1000 strain, providing a unique opportunity to analyze the horizontal transfer of genetic material. Analyses of these insertions led to a new model that involves preferential recombination at non-homologous regions that are flanked by regions of homology and does not involve any mutational processes. The net result is the replacement of segments of the recipient genome instead of the simple addition of genetic material during horizontal gene transfer. Analyses of the genomes of closely related strains of other bacterial and archaea genera, suggested that horizontal gene transfer occurs preferentially in non-homologous regions in these organisms as well. Thus, it appears to be a general phenomenon that prokaryotic horizontal gene transfer occurs preferentially at sites where the incoming DNA contains a non-homologous region that is flanked by regions of homology. Therefore, gene replacement is a common phenomenon during horizontal gene transfer.	[Ely, Bert] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Ely, B (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	ely@sc.edu						BARRETT JT, 1982, J BACTERIOL, V149, P889, DOI 10.1128/JB.149.3.889-896.1982; Berrios L, 2018, CURR MICROBIOL, V75, P1642, DOI 10.1007/s00284-018-1572-3; Bolotin E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01536; Bolotin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35168; Castillo A, 2018, RNA BIOL, V15, P492, DOI 10.1080/15476286.2017.1408765; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dixit PD, 2015, P NATL ACAD SCI USA, V112, P9070, DOI 10.1073/pnas.1510839112; ELY B, 1977, GENETICS, V87, P391; ELY B, 1979, J BACTERIOL, V138, P933, DOI 10.1128/JB.138.3.933-943.1979; Ely B, 2018, CURR MICROBIOL, V76, P159, DOI DOI 10.1007/s00284-018-1606-x; Fischer S, 2016, ENV MICROBIOL REP, V8, P227, DOI 10.1111/1758-2229.12372; Friedman R, 2012, CURR MICROBIOL, V65, P639, DOI 10.1007/s00284-012-0205-5; Halldorsson BV, 2019, SCIENCE, V363, P364, DOI 10.1126/science.aau1043; Halldorsson BV, 2016, NAT GENET, V48, P1377, DOI 10.1038/ng.3669; Lassalle F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004941; NEWTON A, 1975, GENETICS, V80, P1; Sela I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195571; SMIT J, 1984, J BACTERIOL, V160, P1137, DOI 10.1128/JB.160.3.1137-1145.1984; Webster MT, 2012, TRENDS GENET, V28, P101, DOI 10.1016/j.tig.2011.11.002; Wilson K, 2019, J GEN VIROL, V100, P321, DOI 10.1099/jgv.0.001218	20	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227987	10.1371/journal.pone.0227987	http://dx.doi.org/10.1371/journal.pone.0227987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990919	gold, Green Published			2022-12-26	WOS:000534605400030
J	Bose, A; Durr, T; Klenke, RA; Henle, K				Bose, Anushika; Duerr, Tobias; Klenke, Reinhard A.; Henle, Klaus			Predicting strike susceptibility and collision patterns of the common buzzard at wind turbine structures in the federal state of Brandenburg, Germany	PLOS ONE			English	Article							BUTEO-BUTEO; HABITAT SELECTION; BREEDING DENSITY; NEST-SITE; RED KITE; FARMS; MORTALITY; IMPACTS; LEVEL; POINT	With the increase in wind turbines, bird collisions have developed as a potential hazard. In the federal state of Brandenburg, Germany, despite the on-going mitigation efforts of increasing the distances of wind turbines from the breeding areas of the more severely affected populations of red kites (Milvus milvus), the additional detrimental influences on the buzzard populations (Buteo buteo) have added to the challenges for wind power expansion. Using data on the regional distribution of the buzzards, along with their carcass detections around the wind turbines (WTs), we aimed to better understand their collision distribution patterns in relation to their habitat use patterns to predict their exposure to collision risk using boosted regression trees (BRTs). Additionally, we integrated the developed collision potential map with the regional density map of buzzards to identify areas of increased strike susceptibility in turbine installations. Our study showed that the buzzard collisions were primarily concentrated at the turbines situated at sensitive distances from the edges of watercourses (> 1000 metres), as well as those along the edges of grasslands (> 750 metres), in the green open areas around/areas with minimal settlements (750 metres-1750 metres), and along the edges of bushlands (> 1500 metres), together explaining 58% of the variance in their collision distribution. Conclusively, our study is applicable to conservation because it demonstrates the identification of potential collision areas along with the causes of the collisions, in addition to demonstrating the benefits of incorporating a species collision dataset as a proxy for species presence into species distribution models to make informed management decisions to eventually combat biodiversity loss.	[Bose, Anushika; Klenke, Reinhard A.; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Permoserstr, Leipzig, Germany; [Duerr, Tobias] Brandenburg State Bird Conservat Ctr, Brandenburg State Agcy Environm, Nennhausen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Bose, A (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Permoserstr, Leipzig, Germany.	anushika.bose@ufz.de		Bose, Anushika/0000-0003-0486-7974	Deutscher Akademischer Austauschdienst [91540899]; project SCALES - Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales of the EU 7th Framework Program [226852]; Naturschutzfachliches Monitoring des Ausbaus der Erneuerbaren Energien im Strombereich und Entwicklung von Instrumenten zur Verminderung der Beeintrachtigung von Natur und Landschaft of the Federal Ministry for the Environment, Nature Conservation and Nucl [3515822700]	Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); project SCALES - Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales of the EU 7th Framework Program; Naturschutzfachliches Monitoring des Ausbaus der Erneuerbaren Energien im Strombereich und Entwicklung von Instrumenten zur Verminderung der Beeintrachtigung von Natur und Landschaft of the Federal Ministry for the Environment, Nature Conservation and Nucl	Anushika Bose was funded by Deutscher Akademischer Austauschdienst with a PhD Scholarship (ID 91540899). Reinhard A. Klenke was supported by the project SCALES - Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales of the EU 7th Framework Program (Grant Agreement 226852) and Naturschutzfachliches Monitoring des Ausbaus der Erneuerbaren Energien im Strombereich und Entwicklung von Instrumenten zur Verminderung der Beeintrachtigung von Natur und Landschaft of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (Grant No. 3515822700).	ABBO Arbeitsgemeinschaft Berlin-Brandenburgischer Ornithologen, 2001, VOG BRAND BERL; [Anonymous], 2012, WINDPOWER WIND TURBI; Bauer HG, 2002, BER VOGELSCHUTZ, V3, P50; Bellebaum J, 2013, J NAT CONSERV, V21, P394, DOI 10.1016/j.jnc.2013.06.001; Bergen F., 2001, THESIS; Beston JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150813; BMU, 2010, BMU GERMAN GOVT ENER; Bose A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22178-z; BTLNK-Brandenburg Landesamt fur Umwelt Landwirtschaft und Geologie, 2011, LANDWIRTSCHAFT GEOLO; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Cerasoli M, 1996, J RAPTOR RES, V30, P130; de Lucas M, 2005, BIODIVERS CONSERV, V14, P3289, DOI 10.1007/s10531-004-0447-z; De Lucas M, 2004, BIODIVERS CONSERV, V13, P395, DOI 10.1023/B:BIOC.0000006507.22024.93; de Lucas M, 2007, BIRDS WIND FARMS RIS, P280; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Der NEP, 2012, NEUE NETZE NEUE ENER; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Duarr T., 2009, INF DIENST NAT SCHUT, V29, P185; Durr T, 2014, VOGELVERLUSTE WINDEN; Durr T., 2006, POPULATIONSOKOLOGIE, V5, P483; Durr T, 2011, DER FALKE, V58, P498; EEG-Anlagenregister Berlin, 2011, EEG ANL BERL; Eichhorn M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04594-170201; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ender C, 2015, DEWI MAGAZINE, V46, P26; Erickson WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107491; ESRI Inc, 2012, ARCGIS 10 1; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Glutz von Blotzheim UN, 1989, HDB VOGEL MITTELEURO, V9; GRAHAM IM, 1995, BIRD STUDY, V42, P165, DOI 10.1080/00063659509477162; Grunkorn T, 2016, PROGNOSIS ASSESSMENT; Grunkorn T., 2017, WIND ENERGY WILDLIFE, P43, DOI DOI 10.1007/978-3-319-51272-3_3; Grunkorn T, 2009, NATUR LANDSCHAFT, V84, P309, DOI DOI 10.1371/JOURNAL.PONE.0162638; Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Heuck C, 2013, J ORNITHOL, V154, P911, DOI 10.1007/s10336-013-0955-2; Hohmann U, 1994, P 4 WORLD C BIRDS PR, P359; Hotker H, 2013, GREIFVOGEL WINDKRAFT; HUBERT C, 1993, J RAPTOR RES, V27, P102; Hull CL, 2010, AUSTRALAS J ENV MAN, V17, P77, DOI 10.1080/14486563.2010.9725253; Hunt WG, 2002, P50002043F PUBL INT, P72; Illner H, 2012, EULEN RUNDBLICK, V62, P83; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Kenward RE, 2001, J APPL ECOL, V38, P813, DOI 10.1046/j.1365-2664.2001.00636.x; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Krone O, 2003, J RAPTOR RES, V37, P174; Kuemmerle T, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/6/064020; LAG VSW (Landerarbeitsgemeinschaft der Staatlichen Vogelschutzwarten in Deutschland), 2015, ABST WIND BED VOG BR; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Langgemach T, 2015, INFORMATIONEN EINFLU; Langston R.H.W., 2003, WINDFARMS BIRDS ANAL; LBV, 2010, STRUKT BRAND; LBV, 2012, STRUKT LAND BRAND; LUGV-Landesamt fur Umwelt Gesundheit und Verbraucherschutz Brandenburg, 2014, WINDKR LAND BRAND; Martin B, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1192-z; Meyerhoff J, 2010, ENERG POLICY, V38, P82, DOI 10.1016/j.enpol.2009.08.055; Moeller C, 2014, RENEW ENERG, V72, P39, DOI 10.1016/j.renene.2014.06.042; Mulner Barbara, 2000, Egretta, V43, P20; Newton I, 1990, POPULATION ECOLOGY R; Penteriani V, 1997, J RAPTOR RES, V31, P208; Probst R, 2002, CARINTHIA 2, V114, P509; Quitter J, 2010, WIND POWER MONTHLY; R Development Core Team, 2017, R LANG ENV STAT COMP; Rasran L, 2013, GREIFVOGEL WINDKRAFT; Reid T, 2015, J APPL ECOL, V52, P881, DOI 10.1111/1365-2664.12468; Rheinbach Stadt, 2015, ARTENSCHUTZRECHTLICH, P65; Ryslavy T, 2011, BRUTVOGEL BRANDENBUR, V19; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Schaub M, 2012, BIOL CONSERV, V155, P111, DOI 10.1016/j.biocon.2012.06.021; Schindler S, 2012, J RAPTOR RES, V46, P149; Schreiber Von Matthias, 2014, Naturschutz und Landschaftsplanung, V46, P361; Sinning F, 1999, BREMER BEITRAGE NATU, V4, P53; Tikkanen H, 2018, ORNIS FENNICA, V95, P137; Tikkanen H, 2018, ENVIRON IMPACT ASSES, V71, P120, DOI 10.1016/j.eiar.2018.04.006; Torres LG, 2013, DIVERS DISTRIB, V19, P1138, DOI 10.1111/ddi.12069; Twele J, 2012, SZENARIOBERECHNUNG S; Vasilakis DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172685; Vasilakis DP, 2016, BIOL CONSERV, V196, P10, DOI 10.1016/j.biocon.2016.01.014; Walker B, 2010, WIND POWER MONTHLY; Walker G, 2010, ENERG POLICY, V38, P2655, DOI 10.1016/j.enpol.2009.05.055; Watson RT, 2018, J RAPTOR RES, V52, P1, DOI 10.3356/JRR-16-100.1; Weinhold N, 2016, ERNEUERBARE ENERGIEN; Weitekamp S, 2015, WIND ENERGY WILDLIFE, P242	90	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227698	10.1371/journal.pone.0227698	http://dx.doi.org/10.1371/journal.pone.0227698			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978066	Green Published, gold			2022-12-26	WOS:000534599100052
J	Donno, B; Migliorati, D; Zappasodi, F; Perrucci, MG; Costantini, M				Donno, Brunella; Migliorati, Daniele; Zappasodi, Filippo; Perrucci, Mauro Gianni; Costantini, Marcello			The impact of body posture on intrinsic brain activity: The role of beta power at rest	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; MENTAL TRANSFORMATIONS; BAND OSCILLATIONS; EEG; FREQUENCY; OBJECTS; DYNAMICS; SYSTEM; DESYNCHRONIZATION; REPRESENTATIONS	Tying the hands behind the back has detrimental effects on sensorimotor perceptual tasks. Here we provide evidence that beta band oscillatory activity in a resting state condition might play a crucial role in such detrimental effects. EEG activity at rest was measured from thirty young participants (mean age = 24.03) in two different body posture conditions. In one condition participants were required to keep their hands freely resting on the table. In the other condition, participants' hands were tied behind their back. Increased beta power was observed in the left inferior frontal gyrus during the tied hands condition compared to the free hands condition. A control experiment ruled out alternative explanations for observed change in beta power, including muscle tension. Our findings provide new insights on how body postural manipulations impact on perceptual tasks and brain activity.	[Donno, Brunella; Migliorati, Daniele; Zappasodi, Filippo; Perrucci, Mauro Gianni] Univ G dAnnunzio Chieti, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Donno, Brunella; Migliorati, Daniele; Zappasodi, Filippo; Perrucci, Mauro Gianni; Costantini, Marcello] Univ G dAnnunzio Chieti, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Migliorati, Daniele] Univ Delaware, Ctr Biomed Brain Imaging, Newark, DE USA; [Costantini, Marcello] G dAnnunzio Univ Chieti Pescara, Dept Psychol Hlth & Terr Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Delaware; G d'Annunzio University of Chieti-Pescara	Donno, B (corresponding author), Univ G dAnnunzio Chieti, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.; Donno, B; Costantini, M (corresponding author), Univ G dAnnunzio Chieti, Inst Adv Biomed Technol ITAB, Chieti, Italy.; Costantini, M (corresponding author), G dAnnunzio Univ Chieti Pescara, Dept Psychol Hlth & Terr Sci, Chieti, Italy.	brunella.donno@unich.it; marcello.costantini@unich.it	Zappasodi, Filippo/AAC-2414-2022					Androulidakis AG, 2007, EUR J NEUROSCI, V25, P3758, DOI 10.1111/j.1460-9568.2007.05620.x; Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Brinkman L, 2014, J NEUROSCI, V34, P14783, DOI 10.1523/JNEUROSCI.2039-14.2014; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cohen RG, 2011, PSYCHOL RES-PSYCH FO, V75, P341, DOI 10.1007/s00426-010-0311-6; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dijkstra K, 2007, COGNITION, V102, P139, DOI 10.1016/j.cognition.2005.12.009; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fell J, 2005, BIOL CYBERN, V92, P92, DOI 10.1007/s00422-004-0538-7; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frenkel-Toledo S, 2013, BRAIN RES, V1509, P43, DOI 10.1016/j.brainres.2013.03.004; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Ionta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034382; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Lopez C, 2009, J VISION, V9, DOI 10.1167/9.5.1; Martinovic J, 2011, INT J PSYCHOPHYSIOL, V79, P32, DOI 10.1016/j.ijpsycho.2010.07.004; Natraj N, 2013, NEUROPSYCHOLOGIA, V51, P506, DOI 10.1016/j.neuropsychologia.2012.12.003; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012160; Overney  LS, 2005, COGNITIVE BRAIN RES, V25, P722, DOI 10.1016/j.cogbrainres.2005.09.024; Pascual-Marqui R.D., 2007, ARXIV07103341; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Proverbio AM, 2012, BIOL PSYCHOL, V91, P1, DOI 10.1016/j.biopsycho.2012.04.003; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G., 1988, NEUROBIOLOGY NEOCORT, P269; Rowlands Mark, 2010, NEW SCI MIND EXTENDE; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Shapiro L., 2010, EMBODIED COGNITION; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Tallon-Baudry C, 2009, FRONT BIOSCI-LANDMRK, V14, P321, DOI 10.2741/3246; Thibault RT, 2016, BRAIN IMAGING BEHAV, V10, P772, DOI 10.1007/s11682-015-9447-8; Wach C, 2013, BEHAV BRAIN RES, V241, P1, DOI 10.1016/j.bbr.2012.11.038; Wilson R. A., 2011, EMBODIED COGNITION; Zakeri Z, 2014, 13 MED C MED BIOL EN; Zavala B, 2015, MOVEMENT DISORD, V30, P328, DOI 10.1002/mds.26072; Zimmermann M, 2013, J NEUROSCI, V33, P5930, DOI 10.1523/JNEUROSCI.5570-12.2013	66	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0218977	10.1371/journal.pone.0218977	http://dx.doi.org/10.1371/journal.pone.0218977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978115	Green Published, gold, Green Submitted			2022-12-26	WOS:000534599100003
J	Hu, CY; Rao, J; Song, Y; Chan, SA; Tohge, T; Cui, B; Lin, H; Fernie, AR; Zhang, DB; Shi, JX				Hu, Chaoyang; Rao, Jun; Song, Yue; Chan, Shen-An; Tohge, Takayuki; Cui, Bo; Lin, Hong; Fernie, Alisdair R.; Zhang, Dabing; Shi, Jianxin			Dissection of flag leaf metabolic shifts and their relationship with those occurring simultaneously in developing seed by application of non-targeted metabolomics	PLOS ONE			English	Article							PIPECOLIC ACID; NATURAL VARIATION; AMINO-ACID; GAS-CHROMATOGRAPHY; RICE PHLOEM; SENESCENCE; FLAVONOIDS; SECONDARY; YIELD; BIOSYNTHESIS	Rice flag leaves are major source organs providing more than half of the nutrition needed for rice seed development. The dynamic metabolic changes in rice flag leaves and the detailed metabolic relationship between source and sink organs in rice, however, remain largely unknown. In this study, the metabolic changes of flag leaves in two japonica and two indica rice cultivars were investigated using non-targeted metabolomics approach. Principal component analysis (PCA) revealed that flag leaf metabolomes varied significantly depending on both species and developmental stage. Only a few of the metabolites in flag leaves displayed the same change pattern across the four tested cultivars along the process of seed development. Further association analysis found that levels of 45 metabolites in seeds that are associated with human nutrition and health correlated significantly with their levels in flag leaves. Comparison of metabolomics of flag leaves and seeds revealed that some flavonoids were specific or much higher in flag leaves while some lipid metabolites such as phospholipids were much higher in seeds. This reflected not only the function of the tissue specific metabolism but also the different physiological properties and metabolic adaptive features of these two tissues.	[Hu, Chaoyang] Ningbo Univ, Sch Marine Sci, Key Lab Marine Biotechnol Zhejiang Prov, Key Lab Appl Marine Biotechnol,Minist Educ, Ningbo, Peoples R China; [Hu, Chaoyang; Cui, Bo; Lin, Hong; Zhang, Dabing; Shi, Jianxin] Shanghai Jiao Tong Univ, SJTU Univ Adelaide Joint Ctr Agr & Hlth, Sch Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, Shanghai, Peoples R China; [Rao, Jun] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China; [Song, Yue; Chan, Shen-An] Agilent Technol Inc Co, Shanghai, Peoples R China; [Tohge, Takayuki; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Cent Metab Grp, Golm b, Germany	Ningbo University; Shanghai Jiao Tong University; Max Planck Society	Shi, JX (corresponding author), Shanghai Jiao Tong Univ, SJTU Univ Adelaide Joint Ctr Agr & Hlth, Sch Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, Shanghai, Peoples R China.	jianxin.shi@sjtu.edu.cn	Zhang, Dabing/AAR-6473-2020; Tohge, Takayuki/G-7924-2017	Tohge, Takayuki/0000-0001-5555-5650; shi, jianxin/0000-0002-7717-0863	National Natural Science Foundation for the Youth of China [31701400]; China National Transgenic Plant Special Fund [2016ZX08012-002]; Program of Introducing Talents of Discipline to Universities (111 Project) [B14016]; K.C. Wong Magna Fund in Ningbo University	National Natural Science Foundation for the Youth of China(National Natural Science Foundation of China (NSFC)); China National Transgenic Plant Special Fund; Program of Introducing Talents of Discipline to Universities (111 Project)(Ministry of Education, China - 111 Project); K.C. Wong Magna Fund in Ningbo University	This work was partly supported by grants from the National Natural Science Foundation for the Youth of China (Grant No. 31701400), the China National Transgenic Plant Special Fund (Grant No. 2016ZX08012-002), and the Program of Introducing Talents of Discipline to Universities (111 Project, B14016). This research was also sponsored by the K.C. Wong Magna Fund in Ningbo University. Yue Song and Shen-An Chan are employed by Agilent Technologies Incorporated Company. Agilent Technologies Incorporated Company provided support in the form of salaries for authors YS and SC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Ali MA, 2010, INT J AGRIC BIOL, V12, P509; Andersen TG, 2013, PLANT CELL, V25, P3133, DOI 10.1105/tpc.113.110890; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; [Anonymous], 2010, BIOMEDICAL INFORM CA; Araujo WL, 2011, PHYTOCHEMISTRY, V72, P838, DOI 10.1016/j.phytochem.2011.02.028; BONNEAU L, 1994, PLANT GROWTH REGUL, V15, P75, DOI 10.1007/BF00024679; BORRELL AK, 1989, ANN BOT-LONDON, V63, P527, DOI 10.1093/oxfordjournals.aob.a087778; Buchananwollaston V, 2010, PLANT BIOTECHNOL J, V1, P3; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Bylka W, 2004, J AM NUTRACEUT ASS, V7, P1; Chen MJ, 2011, PLANT CELL, V23, P2991, DOI 10.1105/tpc.111.085829; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Chen YC, 2018, P NATL ACAD SCI USA, V115, pE4920, DOI 10.1073/pnas.1805291115; Cornelius S, 2011, J EXP BOT, V62, P5623, DOI 10.1093/jxb/err251; Deng ZY, 2013, PROTEOMICS, V13, P1784, DOI 10.1002/pmic.201200389; Ding PT, 2016, PLANT CELL, V28, P2603, DOI 10.1105/tpc.16.00486; Dong XK, 2015, MOL PLANT, V8, P111, DOI 10.1016/j.molp.2014.11.003; Dong XK, 2014, J INTEGR PLANT BIOL, V56, P876, DOI 10.1111/jipb.12204; Fukao T, 2012, PLANT PHYSIOL, V160, P1795, DOI 10.1104/pp.112.207738; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; Galili G, 2016, ANNU REV PLANT BIOL, V67, P153, DOI 10.1146/annurev-arplant-043015-112213; Geigenberger P, 2005, PLANT CELL, V17, P2077, DOI 10.1105/tpc.105.033548; Gepstein S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-212; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Guijas C, 2018, ANAL CHEM, V90, P3156, DOI 10.1021/acs.analchem.7b04424; Hong J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060767; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Hu CY, 2016, PLANT J, V87, P442, DOI 10.1111/tpj.13209; Hu CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20942; Lee RH, 2004, PLANT MOL BIOL, V55, P281, DOI 10.1007/s11103-004-0641-0; Lee SC, 2003, J AGR FOOD CHEM, V51, P4400, DOI 10.1021/jf0300285; [凌冰 LING Bing], 2007, [生态学报, Acta Ecologica Sinica], V27, P1300; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Macoy DM, 2015, J PLANT BIOL, V58, P156, DOI 10.1007/s12374-015-0104-y; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Nueda MJ, 2007, BIOINFORMATICS, V23, P1792, DOI 10.1093/bioinformatics/btm251; Okumoto S, 2011, MOL PLANT, V4, P453, DOI 10.1093/mp/ssr003; Peanparkdee M, 2018, FOOD BIOPROCESS TECH, V11, P713, DOI 10.1007/s11947-017-2047-4; Pukacka S, 2010, PHYSIOL PLANTARUM, V72, P89; Raviv B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082455; Schiltz S, 2005, PLANT PHYSIOL, V137, P1463, DOI 10.1104/pp.104.056713; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Shan LB, 2018, CELL, V173, P286, DOI 10.1016/j.cell.2018.03.045; Shitan N, 2016, BIOSCI BIOTECH BIOCH, V80, P1283, DOI 10.1080/09168451.2016.1151344; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Sreenivasulu N, 2013, ANNU REV PLANT BIOL, V64, P189, DOI 10.1146/annurev-arplant-050312-120215; Stevenson PC, 1996, ENTOMOL EXP APPL, V80, P246, DOI 10.1007/BF00194767; Tanabe K, 2016, J INTEGR PLANT BIOL, V58, P903, DOI 10.1111/jipb.12480; Tao H, 2017, MOL PLANT BREEDING, V6, P87; Tegeder M, 2010, MOL PLANT, V3, P997, DOI 10.1093/mp/ssq047; Travieso María del C, 2015, cultrop, V36, P148; Trethewey J. A. K, 2010, SEED S SEEDS FUT P J; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Vergara B.S., 1991, RICE, P13, DOI DOI 10.1007/978-1-4899-3754-4_2; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Wang CX, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4509; Wang P, 2011, THEOR APPL GENET, V123, P1319, DOI 10.1007/s00122-011-1669-6; Watanabe M, 2013, PLANT PHYSIOL, V162, P1290, DOI 10.1104/pp.113.217380; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yang ZG, 2014, METABOLOMICS, V10, P543, DOI 10.1007/s11306-013-0619-5; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; Zhang AH, 2010, J PLANT PHYSIOL, V167, P1380, DOI 10.1016/j.jplph.2010.05.011; Zhang HP, 2018, EUR J AGRON, V96, P70, DOI 10.1016/j.eja.2018.03.005; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zhang ZF, 2015, ENTOMOL EXP APPL, V156, P14, DOI 10.1111/eea.12307; Zhou JM, 2010, PHYTOCHEM REV, V9, P413, DOI 10.1007/s11101-009-9161-5; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	74	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227577	10.1371/journal.pone.0227577	http://dx.doi.org/10.1371/journal.pone.0227577			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978163	gold, Green Published			2022-12-26	WOS:000534599100045
J	Naim, F; Shand, K; Hayashi, S; O'Brien, M; McGree, J; Johnson, AAT; Dugdale, B; Waterhouse, PM				Naim, Fatima; Shand, Kylie; Hayashi, Satomi; O'Brien, Martin; McGree, James; Johnson, Alexander A. T.; Dugdale, Benjamin; Waterhouse, Peter M.			Are the current gRNA ranking prediction algorithms useful for genome editing in plants?	PLOS ONE			English	Article							SILENCING-SUPPRESSOR; SGRNA DESIGN; ENDONUCLEASE; PROTEIN; GUIDE	Introducing a new trait into a crop through conventional breeding commonly takes decades, but recently developed genome sequence modification technology has the potential to accelerate this process. One of these new breeding technologies relies on an RNA-directed DNA nuclease (CRISPR/Cas9) to cut the genomic DNA, in vivo, to facilitate the deletion or insertion of sequences. This sequence specific targeting is determined by guide RNAs (gRNAs). However, choosing an optimum gRNA sequence has its challenges. Almost all current gRNA design tools for use in plants are based on data from experiments in animals, although many allow the use of plant genomes to identify potential off-target sites. Here, we examine the predictive uniformity and performance of eight different online gRNA-site tools. Unfortunately, there was little consensus among the rankings by the different algorithms, nor a statistically significant correlation between rankings and in vivo effectiveness. This suggests that important factors affecting gRNA performance and/or target site accessibility, in plants, are yet to be elucidated and incorporated into gRNA-site prediction tools.	[Naim, Fatima; Shand, Kylie; Hayashi, Satomi; Dugdale, Benjamin; Waterhouse, Peter M.] Queensland Univ Technol, Sci & Engn Fac, Ctr Trop Crops & Biocommod, Brisbane, Qld, Australia; [Naim, Fatima] Curtin Univ, Sch Mol & Life Sci, Ctr Crop & Dis Management, Bentley, WA, Australia; [O'Brien, Martin; Johnson, Alexander A. T.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [McGree, James] Queensland Univ Technol, Sch Math Sci, Sci & Engn Fac, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Curtin University; University of Melbourne; Queensland University of Technology (QUT)	Naim, F; Waterhouse, PM (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Ctr Trop Crops & Biocommod, Brisbane, Qld, Australia.; Naim, F (corresponding author), Curtin Univ, Sch Mol & Life Sci, Ctr Crop & Dis Management, Bentley, WA, Australia.	fatima.naim@curtin.edu.au; peter.waterhouse@qut.edu.au		Naim, Fatima/0000-0001-8451-1104; Hayashi, Satomi/0000-0002-2468-713X; Waterhouse, Peter/0000-0002-2812-3753	Australian Research Council [FL160100155]	Australian Research Council(Australian Research Council)	FL160100155 awarded to PMW funded by Australian Research Council, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajic M, 2018, METHODS MOL BIOL, V1675, P183, DOI 10.1007/978-1-4939-7318-7_12; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Brazelton VA, 2015, GM CROPS FOOD, V6, P266, DOI 10.1080/21645698.2015.1137690; Chari R, 2017, ACS SYNTH BIOL, V6, P902, DOI 10.1021/acssynbio.6b00343; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coutu C, 2007, TRANSGENIC RES, V16, P771, DOI 10.1007/s11248-007-9066-2; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Fusaro AF, 2012, VIROLOGY, V426, P178, DOI 10.1016/j.virol.2012.01.026; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Liu H, 2017, MOL PLANT, V10, P530, DOI 10.1016/j.molp.2017.01.003; Maher KA, 2018, PLANT CELL, V30, P15, DOI 10.1105/tpc.17.00581; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naim F, 2018, TRANSGENIC RES; Naim F, 2016, PLANT BIOTECHNOL J, V14, P1418, DOI 10.1111/pbi.12506; Naim F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052717; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Philips JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171311; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu H, 2015, GENOME RES; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	30	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227994	10.1371/journal.pone.0227994	http://dx.doi.org/10.1371/journal.pone.0227994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978124	Green Published, gold			2022-12-26	WOS:000534599100093
J	Rubinow, KB; den Hartigh, LJ; Goodspeed, L; Wang, S; Oz, OK				Rubinow, Katya B.; den Hartigh, Laura J.; Goodspeed, Leela; Wang, Shari; Oz, Orhan K.			Aromatase deficiency in hematopoietic cells improves glucose tolerance in male mice through skeletal muscle-specific effects	PLOS ONE			English	Article							INSULIN-RESISTANCE; ESTROGEN-RECEPTOR; DISTINCT ROLES; ARKO MICE; PHENOTYPE; ANDROGEN; TISSUE; BONE; MASS; 17-BETA-ESTRADIOL	Estrogens are important for maintaining metabolic health in males. However, the key sources of local estrogen production for regulating energy metabolism have not been fully defined. Immune cells exhibit aromatase activity and are resident in metabolic tissues. To determine the relative contribution of immune cell-derived estrogens for metabolic health in males, C57BL6/J mice underwent bone marrow transplant with marrow from either wildtype (WT(WT)) or aromatase-deficient (WT(ArKO)) donors. Body weight, body composition, and glucose and insulin tolerance were assessed over 24 weeks with mice maintained on a regular chow diet. No differences were found in insulin sensitivity between groups, but WT (ArKO) mice were more glucose tolerant than WT(WT) mice 20 weeks after transplant, suggestive of enhanced glucose disposal (AUC(glucose) 6061 +/- 3349 in WT(WT) mice versus 3406 +/- 1367 in WT(ArKO) mice, p = 0.01). Consistent with this, skeletal muscle from WT(ArKO) mice showed higher expression of the mitochondrial genes Ppargc1a (p = 0.03) and Nrf1 (p = 0.01), as well as glucose transporter type 4 (GLUT4, Scl2a4; p = 0.02). Skeletal muscle from WT(ArKO) mice had a lower concentration of 17 beta-estradiol (5489 +/- 2189 pg/gm in WT (WT) mice versus 3836 +/- 2160 pg/gm in WT(ArKO) mice, p = 0.08) but higher expression of estrogen receptor-alpha (ER alpha, Esr1), raising the possibility that aromatase deficiency in immune cells led to a compensatory increase in ER alpha signaling. No differences between groups were found with regard to body weight, adiposity, or gene expression within adipose tissue or liver. Immune cells are a key source of local 17 beta-estradiol production and contribute to metabolic regulation in males, particularly within skeletal muscle. The respective intracrine and paracrine roles of immune cell-derived estrogens require further delineation, as do the pathways that regulate aromatase activity in immune cells specifically within metabolic tissues.	[Rubinow, Katya B.; den Hartigh, Laura J.; Goodspeed, Leela; Wang, Shari] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Oz, Orhan K.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rubinow, KB (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	rubinow@uw.edu	Oz, Orhan/GVT-7264-2022		University of Washington Diabetes Research Center [P30 DK01704]; American Heart Association [16GRNT30700006]; NIH National Center for Complimentary and Integrative Health [K01 AT007177]	University of Washington Diabetes Research Center; American Heart Association(American Heart Association); NIH National Center for Complimentary and Integrative Health	This work was supported by funding from the University of Washington Diabetes Research Center grant P30 DK01704 (KBR, http://depts.washington.edu/diabetes/), the American Heart Association grant 16GRNT30700006 (KBR, www.heart.org) and the NIH National Center for Complimentary and Integrative Health grant K01 AT007177 (LJdH, https://nccih.nih.gov/).The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Barbosa MR, 2016, INT J SPORTS MED, V37, P841, DOI 10.1055/s-0042-107247; BLANKENSTEIN MA, 1992, GYNECOL ENDOCRINOL, V6, P13, DOI 10.3109/09513599209081001; Brown NM, 2001, LAB INVEST, V81, P735, DOI 10.1038/labinvest.3780282; Chao J, 2016, J CLIN ENDOCR METAB, V101, P3724, DOI 10.1210/jc.2016-1482; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; den Hartigh LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172912; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaikwad NW, 2013, ANAL CHEM, V85, P4951, DOI 10.1021/ac400016e; Gibb FW, 2016, J CLIN ENDOCR METAB, V101, P2040, DOI 10.1210/jc.2015-4146; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Inada A, 2016, ENDOCRINOLOGY, V157, P4691, DOI 10.1210/en.2016-1261; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Katiraei S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175524; Maggi A, 2011, BBA-MOL BASIS DIS, V1812, P1054, DOI 10.1016/j.bbadis.2011.05.001; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; Mor G, 1998, J STEROID BIOCHEM, V67, P403, DOI 10.1016/S0960-0760(98)00143-5; Nelson RE, 2004, CLIN CHEM, V50, P373, DOI 10.1373/clinchem.2003.025478; Nylander V, 2016, DIABETES, V65, P3573, DOI 10.2337/db16-0364; Ohlsson C, 2017, AM J PHYSL ENDOCRINO; Oz OK, 2000, J BONE MINER RES, V15, P507, DOI 10.1359/jbmr.2000.15.3.507; Oz OK, 2001, J STEROID BIOCHEM, V79, P49, DOI 10.1016/S0960-0760(01)00130-3; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Rubinow KB, 2015, ANDROLOGY-US, V3, P787, DOI 10.1111/andr.12055; Rubinow KB, 2013, J BIOL CHEM; Rubinow KB, 2017, AM J PHYSL ENDOCRINO; Samy TSA, 2001, ENDOCRINOLOGY, V142, P3519, DOI 10.1210/en.142.8.3519; Schmidt M, 2005, ARTHRITIS RES THER, V7, pR938, DOI 10.1186/ar1769; Simpson ER, 2007, ERNST SCHERING FOUND, V1, P45, DOI 10.1007/2789_2006_016; Simpson ER, 2004, SEMIN REPROD MED, V22, P11; Simpson ER, 1998, MOL CELL ENDOCRINOL, V145, P55, DOI 10.1016/S0303-7207(98)00169-5; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Stellato C, 2016, PROTEOMICS, V16, P288, DOI 10.1002/pmic.201500261; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; Van Sinderen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087230; Wang F, 2013, J CLIN ENDOCR METAB, V98, P4923, DOI 10.1210/jc.2013-2605; Zerwekh JE, 2007, BONE, V40, P553, DOI 10.1016/j.bone.2006.08.014	41	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227830	10.1371/journal.pone.0227830	http://dx.doi.org/10.1371/journal.pone.0227830			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971970	Green Published, gold			2022-12-26	WOS:000534374400021
J	Mayr, SJ; Roper, J; Schwarz, G				Mayr, Simon J.; Roeper, Juliane; Schwarz, Guenter			Alternative splicing of the bicistronic gene molybdenum cofactor synthesis 1 (MOCS1) uncovers a novel mitochondrial protein maturation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; iron-sulfur protein; mitochondrial transport; molybdenum; S-adenosylmethionine (SAM); molybdenum cofactor; radical SAM enzyme	DEFICIENCY TYPE-A; GENOMIC STRUCTURE; BIOSYNTHESIS; MUTATIONS; SEQUENCES; ENZYMES; RNA; PH	Molybdenum cofactor (Moco) biosynthesis is a highly conserved multistep pathway. The first step, the conversion of GTP to cyclic pyranopterin monophosphate (cPMP), requires the bicistronic gene molybdenum cofactor synthesis 1 (MOCS1). Alternative splicing of MOCS1 within exons 1 and 9 produces four different N-terminal and three different C-terminal products (type I?III). Type I splicing results in bicistronic transcripts with two open reading frames, of which only the first, MOCS1A, is translated, whereas type II/III splicing produces MOCS1AB proteins. Here, we first report the cellular localization of alternatively spliced human MOCS1 proteins. Using fluorescence microscopy, fluorescence spectroscopy, and cell fractionation experiments, we found that depending on the alternative splicing of exon 1, type I splice variants (MOCS1A) either localize to the mitochondrial matrix (exon 1a) or remain cytosolic (exon 1b). MOCS1A proteins required exon 1a for mitochondrial translocation, but fluorescence microscopy of MOCS1AB variants (types II and III) revealed that they were targeted to mitochondria independently of exon 1 splicing. In the latter case, cell fractionation experiments displayed that mitochondrial matrix import was facilitated via an internal motif overriding the N-terminal targeting signal. Within mitochondria, MOCS1AB underwent proteolytic cleavage resulting in mitochondrial matrix localization of the MOCS1B domain. In conclusion, MOCS1 produces two functional proteins, MOCS1A and MOCS1B, which follow different translocation routes before mitochondrial matrix import for cPMP biosynthesis involving both proteins. MOCS1 protein maturation provides a novel alternative splicing mechanism that ensures the coordinated mitochondrial targeting of two functionally related proteins encoded by a single gene.	[Mayr, Simon J.; Roeper, Juliane; Schwarz, Guenter] Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; [Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-5931 Cologne, Germany	University of Cologne; University of Cologne	Schwarz, G (corresponding author), Zulpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021	Schwarz, Guenter/0000-0002-2118-9338; Mayr, Simon Julius/0000-0002-0465-1121	Deutsche Forschungsgemeinschaft (DFG) [SCHW 759/10-1/2, SFB1218]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SCHW 759/10-1/2 (to G. S. and S. J. M.) and SFB1218, B08 (to G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arenas M, 2009, J INHERIT METAB DIS, V32, P560, DOI 10.1007/s10545-009-1151-7; Backes S, 2018, J CELL BIOL, V217, P1369, DOI 10.1083/jcb.201708044; Belaidi AA, 2013, BIOCHEM J, V450, P149, DOI 10.1042/BJ20121078; Ciofi-Baffoni S, 2018, METALLOMICS, V10, P49, DOI 10.1039/c7mt00269f; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gray TA, 2000, RNA, V6, P928, DOI 10.1017/S1355838200000182; Gross-Hardt S, 2002, MOL GENET METAB, V76, P340, DOI 10.1016/S1096-7192(02)00100-2; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hartmann B, 2016, ELIFE, V5, DOI 10.7554/eLife.16078; Hover BM, 2015, P NATL ACAD SCI USA, V112, P6347, DOI 10.1073/pnas.1500697112; Hover BM, 2015, J AM CHEM SOC, V137, P3352, DOI 10.1021/ja512997j; Judes A, 2015, FEBS LETT, V589, P904, DOI 10.1016/j.febslet.2015.02.024; Kang YL, 2018, SEMIN CELL DEV BIOL, V76, P142, DOI 10.1016/j.semcdb.2017.07.028; Kugler S, 2007, AM J HUM GENET, V80, P291, DOI 10.1086/511281; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lu YM, 2013, AMINO ACIDS, V44, P597, DOI 10.1007/s00726-012-1380-1; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Mayr SJ, 2018, J INHERIT METAB DIS, V41, P187, DOI 10.1007/s10545-018-0138-7; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Reiss J, 2011, HUM MUTAT, V32, P10, DOI 10.1002/humu.21390; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Schwahn BC, 2015, LANCET, V386, P1955, DOI 10.1016/S0140-6736(15)00124-5; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Veldman A, 2010, PEDIATRICS, V125, pE1249, DOI 10.1542/peds.2009-2192; Wuebbens MM, 2000, STRUCTURE, V8, P709, DOI 10.1016/S0969-2126(00)00157-X	37	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3029	3039		10.1074/jbc.RA119.010720	http://dx.doi.org/10.1074/jbc.RA119.010720			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996372	hybrid, Green Published			2022-12-26	WOS:000519597300013
J	Reyes-Vargas, E; Barker, AP; Zhou, ZM; He, X; Jensen, PE				Reyes-Vargas, Eduardo; Barker, Adam P.; Zhou, Zemin; He, Xiao; Jensen, Peter E.			HLA-DM catalytically enhances peptide dissociation by sensing peptide?MHC class II interactions throughout the peptide-binding cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; antigen processing; major histocompatibility complex (MHC); peptide interaction; kinetics; fluorescence anisotropy; catalysis; Michaelis-Menten; immunogenicity; immunology	MHC PROTEIN HLA-DR1; ANTIGEN PRESENTATION; INVARIANT CHAIN; CUTTING EDGE; HYDROGEN-BONDS; DR MOLECULES; CRYSTAL-STRUCTURE; COMPLEX; SUSCEPTIBILITY; EXCHANGE	Human leukocyte antigen-DM (HLA-DM) is an integral component of the major histocompatibility complex class II (MHCII) antigen-processing and -presentation pathway. HLA-DM shapes the immune system by differentially catalyzing peptide exchange on MHCII molecules, thereby editing the peptide-MHCII (pMHCII) repertoire by imposing a bias on the foreign and self-derived peptide cargos that are presented on the cell surface for immune surveillance and tolerance induction by CD4(+) T cells. To better understand DM selectivity, here we developed a real-time fluorescence anisotropy assay to delineate the pMHCII intrinsic stability, DM-binding affinity, and catalytic turnover, independent kinetic parameters of HLA-DM enzymatic activity. We analyzed prominent pMHCII contacts by differentiating the kinetic parameters in pMHCII homologs, observing that peptide interactions throughout the MHCII-binding cleft influence both the rate of peptide dissociation from the DM-pMHCII catalytic complex and the binding affinity of HLA-DM for a pMHCII. We show that the intrinsic stability of a pMHCII linearly correlates with DM catalytic turnover, but is nonlinearly correlated with its binding affinity. Surprisingly, interactions at the peptides N terminus up to and including MHCII position one (P1) anchor affected the catalytic turnover, suggesting that the active DM-pMHCII catalytic complex operates on pMHCII complexes with full peptide occupancy. Furthermore, interactions at the peptide C terminus modulated DM-binding affinity, suggesting distal communication between peptide interactions with the MHCII and the DM-pMHCII binding interface. Our results imply an intimate linkage between the DM-pMHCII interface and peptide-MHCII interactions throughout the peptide-binding cleft.	[Reyes-Vargas, Eduardo; Barker, Adam P.; Zhou, Zemin; He, Xiao; Jensen, Peter E.] Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT 84112 USA; [Barker, Adam P.; Jensen, Peter E.] ARUP Inst Clin & Expt Pathol, Dept Pathol, ARUP Labs, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	He, X; Jensen, PE (corresponding author), Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT 84112 USA.; Jensen, PE (corresponding author), ARUP Inst Clin & Expt Pathol, Dept Pathol, ARUP Labs, Salt Lake City, UT 84108 USA.	xiao.he@path.utah.edu; peter.jensen@path.utah.edu		Jensen, Peter/0000-0002-1639-8223; Reyes-Vargas, Eduardo/0000-0003-3984-9274; He, Xiao/0000-0002-9286-9859	University of Utah Endowed Chair Fund	University of Utah Endowed Chair Fund	This work was supported by the University of Utah Endowed Chair Fund (to P. E. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Bandyopadhyay A, 2008, MOL IMMUNOL, V45, P1248, DOI 10.1016/j.molimm.2007.09.011; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Belmares MP, 2001, BIOCHEMISTRY-US, V40, P10284, DOI 10.1021/bi010156r; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Escobar H, 2008, J IMMUNOL, V181, P4874, DOI 10.4049/jimmunol.181.7.4874; Ferrante A, 2015, J IMMUNOL, V195, P1251, DOI 10.4049/jimmunol.1402367; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; Jensen PE, 1999, IMMUNOL REV, V172, P229, DOI 10.1111/j.1600-065X.1999.tb01368.x; Jensen PE, 1997, BIOPOLYMERS, V43, P303; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; Rosloniec EF, 2006, J IMMUNOL, V177, P3884, DOI 10.4049/jimmunol.177.6.3884; Runnels HA, 1997, MOL IMMUNOL, V34, P471, DOI 10.1016/S0161-5890(97)00043-6; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; Schulze MSED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069228; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Vacchino JF, 2001, J IMMUNOL, V166, P6680, DOI 10.4049/jimmunol.166.11.6680; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wieczorek M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13224; WOLF PR, 1995, NATURE, V376, P464, DOI 10.1038/376464a0; Yin LS, 2015, J IMMUNOL, V195, P706, DOI 10.4049/jimmunol.1403190; Yin LS, 2014, J BIOL CHEM, V289, P23449, DOI 10.1074/jbc.M114.585539; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zhou ZM, 2017, EUR J IMMUNOL, V47, P314, DOI 10.1002/eji.201646656; Zhou ZM, 2016, EUR J IMMUNOL, V46, P834, DOI 10.1002/eji.201545942; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	58	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2959	2973		10.1074/jbc.RA119.010645	http://dx.doi.org/10.1074/jbc.RA119.010645			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31969393	Green Published, hybrid			2022-12-26	WOS:000519597300008
J	Sovova, Z; Stikarova, J; Kaufmanova, J; Majek, P; Suttnar, J; Sacha, P; Maly, M; Dyr, JE				Sovova, Zofie; Stikarova, Jana; Kaufmanova, Jirina; Majek, Pavel; Suttnar, Jiri; Sacha, Pavel; Maly, Martin; Dyr, Jan E.			Impact of posttranslational modifications on atomistic structure of fibrinogen	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; OXIDATIVE MODIFICATION; CLOT STRUCTURE; PLASMA-PROTEINS; GAMMA-CHAIN; CORONARY THROMBUS; CRYSTAL-STRUCTURE; STRESS; MYELOPEROXIDASE; PEROXYNITRITE	Oxidative stress in humans is related to various pathophysiological processes, which can manifest in numerous diseases including cancer, cardiovascular diseases, and Alzheimer's disease. On the atomistic level, oxidative stress causes posttranslational modifications, thus inducing structural and functional changes into the proteins structure. This study focuses on fibrinogen, a blood plasma protein that is frequently targeted by reagents causing posttranslational modifications in proteins. Fibrinogen was in vitro modified by three reagents, namely sodium hypochlorite, malondialdehyde, and 3-morpholinosydnonimine that mimic the oxidative stress in diseases. Newly induced posttranslational modifications were detected via mass spectrometry. Electron microscopy was used to visualize changes in the fibrin networks, which highlight the extent of disturbances in fibrinogen behavior after exposure to reagents. We used molecular dynamics simulations to observe the impact of selected posttranslational modifications on the fibrinogen structure at the atomistic level. In total, 154 posttranslational modifications were identified, 84 of them were in fibrinogen treated with hypochlorite, 51 resulted from a reaction of fibrinogen with malondialdehyde, and 19 were caused by 3-morpholinosydnonimine. Our data reveal that the stronger reagents induce more posttranslational modifications in the fibrinogen structure than the weaker ones, and they extensively alter the architecture of the fibrin network. Molecular dynamics simulations revealed that the effect of posttranslational modifications on fibrinogen secondary structure varies from negligible alternations to serious disruptions. Among the serious disruptions is the oxidation of gamma R375 resulting in the release of Ca2+ ion that is necessary for appropriate fibrin fiber formation. Folding of amino acids gamma E72-gamma N77 into a short alpha-helix is a result of oxidation of gamma P76 to glutamic acid. The study describes behaviour of fibrinogen coiled-coil connecter in the vicinity of plasmin and hementin cleavage sites.	[Sovova, Zofie; Stikarova, Jana; Majek, Pavel; Suttnar, Jiri; Dyr, Jan E.] Inst Hematol & Blood Transfus, Dept Biochem, Prague, Czech Republic; [Kaufmanova, Jirina] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic; [Sacha, Pavel] Inst Organ Chem & Biochem ASCR, Proteases Human Pathogens, Vvi, Prague, Czech Republic; [Maly, Martin] Charles Univ Prague, Mil Univ Hosp, Prague, Czech Republic	Institute of Hematology Prague; University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Military University Hospital Prague	Sovova, Z (corresponding author), Inst Hematol & Blood Transfus, Dept Biochem, Prague, Czech Republic.	sovova@uhkt.cz	Maly, Martin/E-4294-2017; Suttnar, Jiri/AAL-3889-2021; Sacha, Pavel/G-9729-2014	Maly, Martin/0000-0001-7346-9828; Sacha, Pavel/0000-0001-6198-9826; Majek, Pavel/0000-0002-9946-3819; Kaufmanova, Jirina/0000-0003-0337-8204; Stikarova, Jana/0000-0002-5964-0526; Suttnar, Jiri/0000-0003-4305-9718	Ministry of Health, Czech Republic [00023736]; Czech Science Foundation [P205/12/G118, 19-02739S]; European Regional Development Fund; OP RDE [CZ.02.1.01/0.0/0.0/16_025/0007428]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); OP RDE	Authors were supported by following grants: Ministry of Health, Czech Republic; grant number 00023736; https://www.mzcr.cz/the Czech Science Foundation; grant numbers P205/12/G118 and 19-02739S; https://gacr.cz/European Regional Development Fund; OP RDE (CZ.02.1.01/0.0/0.0/16_025/0007428); https://opvvv.msmt.cz/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BAILEY K, 1951, NATURE, V167, P233, DOI 10.1038/167233a0; Becatti M, 2014, ARTERIOSCL THROM VAS, V34, P1355, DOI 10.1161/ATVBAHA.114.303785; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brennan SO, 2002, HEPATOLOGY, V36, P652, DOI 10.1053/jhep.2002.35063; BUDZYNSKI AZ, 1991, BLOOD COAGUL FIBRIN, V2, P149, DOI 10.1097/00001721-199102000-00022; Burney PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086981; Burton RA, 2007, BIOCHEMISTRY-US, V46, P8550, DOI 10.1021/bi700606v; Bychkova AV, 2017, DOKL BIOCHEM BIOPHYS, V474, P173, DOI 10.1134/S1607672917030115; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DOOLITTLE RF, 1983, ANN NY ACAD SCI, V408, P13, DOI 10.1111/j.1749-6632.1983.tb23231.x; Doolittle RF, 2012, PROTEIN SCI, V21, P1808, DOI 10.1002/pro.2177; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; FU YP, 1994, P NATL ACAD SCI USA, V91, P2625, DOI 10.1073/pnas.91.7.2625; Ghimenti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028182; Gole MD, 2000, AM J PHYSIOL-LUNG C, V278, pL961, DOI 10.1152/ajplung.2000.278.5.L961; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; Headlam HA, 2004, FREE RADICAL BIO MED, V36, P1175, DOI 10.1016/j.freeradbiomed.2004.02.017; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; Hugenholtz GCG, 2016, J THROMB HAEMOST, V14, P1054, DOI 10.1111/jth.13278; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kohler S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004346; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIBONDI T, 1994, INT J PEPT PROT RES, V44, P342; Lomonaco T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114430; Lomonaco T, 2013, J CHROMATOGR A, V1314, P54, DOI 10.1016/j.chroma.2013.08.091; LORAND L, 1951, NATURE, V167, P992, DOI 10.1038/167992a0; Ly B, 1972, PATHOPHYSIOL HAEMO T, V1, P204; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Margreitter C, 2013, NUCLEIC ACIDS RES, V41, pW422, DOI 10.1093/nar/gkt416; Martinez M, 2013, FREE RADICAL BIO MED, V65, P411, DOI 10.1016/j.freeradbiomed.2013.06.039; Martinez M, 2012, FREE RADICAL BIO MED, V53, P230, DOI 10.1016/j.freeradbiomed.2012.05.004; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Medved L, 2009, J THROMB HAEMOST, V7, P355, DOI 10.1111/j.1538-7836.2008.03242.x; Mitchell AM, 2008, ACAD EMERG MED, V15, P800, DOI 10.1111/j.1553-2712.2008.00204.x; MOSESSON MW, 1972, J BIOL CHEM, V247, P5223; Nowak P, 2007, THROMB RES, V121, P163, DOI 10.1016/j.thromres.2007.03.017; Pederson EN, 2019, PROTEINS STRUCTURE F; Petrov D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003154; Pignatelli B, 2001, CANCER RES, V61, P778; Piroddi M, 2011, AMINO ACIDS, V40, P653, DOI 10.1007/s00726-010-0693-1; Ponczek MB, 2014, CENT EUR J BIOL, V9, P233, DOI 10.2478/s11535-013-0259-9; Rankinen T, 2000, THROMB RES, V99, P453, DOI 10.1016/S0049-3848(00)00271-1; Rosenfeld MA, 2016, FREE RADICAL BIO MED, V95, P55, DOI 10.1016/j.freeradbiomed.2016.03.005; Sadowski M, 2014, ATHEROSCLEROSIS, V237, P555, DOI 10.1016/j.atherosclerosis.2014.10.020; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schmidt D, 2007, CLIN CHEM, V53, P2105, DOI 10.1373/clinchem.2007.093179; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber MA, 2013, DEGENER NEUROL NEURO, V3, P1, DOI 10.2147/DNND.S36917; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Sies H, 2007, CELL MOL LIFE SCI, V64, P2181, DOI 10.1007/s00018-007-7230-8; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Silvain J, 2011, J AM COLL CARDIOL, V57, P1359, DOI 10.1016/j.jacc.2010.09.077; Stikarova J, 2013, SCI WORLD J, DOI 10.1155/2013/359621; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Torbitz VD, 2015, INFLAMMATION, V38, P1201, DOI 10.1007/s10753-014-0085-x; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Upchurch GR, 1998, J THROMB THROMBOLYS, V5, P9, DOI 10.1023/A:1008859729045; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Wang L, 2016, BIOCHEM J, V473, P4373, DOI 10.1042/BCJ20160702; Weaver TM, 2000, PROTEIN SCI, V9, P201; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weisel JW, 2017, SUBCELL BIOCHEM, V82, P405, DOI 10.1007/978-3-319-49674-0_13; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036; Xu YJ, 2012, PROTEIN CELL, V3, P627, DOI 10.1007/s13238-012-2057-y; Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8; YOSHIDA N, 1992, J BIOL CHEM, V267, P2753; Yurina LV, 2019, DOKL BIOCHEM BIOPHYS, V484, P37, DOI 10.1134/S1607672919010101; Zabczyk M, 2017, POL ARCH INTERN MED, V127, P873, DOI 10.20452/pamw.4165; Zhmurov A, 2018, STRUCTURE, V26, P857, DOI 10.1016/j.str.2018.04.005; Zuev YF, 2017, J PHYS CHEM B, V121, P7833, DOI 10.1021/acs.jpcb.7b05654	81	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227543	10.1371/journal.pone.0227543	http://dx.doi.org/10.1371/journal.pone.0227543			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995579	gold, Green Submitted, Green Published			2022-12-26	WOS:000534609400024
J	Sultana, F; Roeske, L; Malloy, MJ; McDermott, TL; Saville, M; Brotherton, JML				Sultana, Farhana; Roeske, Lara; Malloy, Michael J.; McDermott, Tracey L.; Saville, Marion; Brotherton, Julia M. L.			Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses	PLOS ONE			English	Article							HPV	The National Cervical Screening Program (NCSP) in Australia underwent major changes on December 1st, 2017. The program changed from 2-yearly Pap testing for women aged 1869 years to 5-yearly HPV testing for women aged 25-74 years including differential management pathways for oncogenic HPV 16/18 positive versus HPV non16/18 positive test results and the option of self-collection for under-screened women. We conducted a survey among cervical screening providers in primary care to assess their level of preparedness in undertaking cervical screening before (pre-renewal) and after (post-renewal) the new program was implemented. Surveys were conducted between 14th August and 30th November 2017 (pre-renewal) and 9th February and 26th October 2018 (post-renewal) among cervical screening providers who attended education sessions related to the new guidelines. Preparedness was assessed in three areas: 1) level of comfort implementing the new guidelines (7 questions), 2) level of confidence in their ability to convey information about the new guidelines (9 questions) and 3) level of agreement regarding access to resources to support implementation (11 questions). Proportions were calculated for each question response and pre-and post-renewal periods compared using generalised linear models. Open-ended questions related to anticipated barriers and ways to overcome barriers were also included in the questionnaires. Compared to the pre-renewal period, a higher proportion of practitioners in the post-renewal period were more comfortable offering routine screening to women >= 25 years (p = 0.005) and more confident explaining the rationale for not screening before 25 years (p = 0.015); confident explaining a positive HPV 16/18 (p = 0.04) and HPV non 16/ 18(p = 0.013) test result and were comfortable with not referring women with a positive HPV non 16/18 test result and low grade/negative cytology for colposcopy (p = 0.01). A higher proportion of Victorian practitioners in the post-renewal period sample were also comfortable (p = 0.04) and confident (p = 0.015) recommending self-collection to under-screened women and agreed that self-collection is a reliable test (p = 0.003). The most commonly reported suggestion was to provide information, education and communication materials to both patients and practitioners. Compared to the pre-renewal period, practitioners in the post-renewal period were better prepared to implement the renewed screening program. Healthcare providers require further support to implement the self-collection pathway.	[Sultana, Farhana; Malloy, Michael J.; McDermott, Tracey L.; Saville, Marion; Brotherton, Julia M. L.] VCS Fdn, VCS Populat Hlth, East Melbourne, Vic, Australia; [Sultana, Farhana; Malloy, Michael J.; Brotherton, Julia M. L.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia; [Roeske, Lara; Saville, Marion] VCS Fdn, VCS Pathol, Carlton, Vic, Australia; [Saville, Marion] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Brotherton, JML (corresponding author), VCS Fdn, VCS Populat Hlth, East Melbourne, Vic, Australia.; Brotherton, JML (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia.	jbrother@vcs.org.au		McDermott, Tracey/0000-0002-1067-8646	NHMRC Centre for Research Excellence in Cervical Cancer Control [APP1135172]; Roche Molecular Systems; Ventana Inc. USA	NHMRC Centre for Research Excellence in Cervical Cancer Control(National Health and Medical Research Council (NHMRC) of Australia); Roche Molecular Systems; Ventana Inc. USA	JMLB and MS are chief investigators of the NHMRC Centre for Research Excellence in Cervical Cancer Control (APP1135172) from which FS (formerly) & TLM receives salary support. JMLB, MS and LR are investigators of a trial of primary HPV screening in Australia (Compass) that has received a part funding contribution from Roche Molecular Systems, Ventana Inc. USA. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	AIHW Australian Institute of Health and Welfare, 2018, CERV SCREEN AUSTR 20; Aminisani N, 2012, CANCER EPIDEMIOL, V36, pE394, DOI 10.1016/j.canep.2012.08.009; [Anonymous], 2011, STAT STAT SOFTW REL; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Britt H, 2016, GEN PRACTICE SERIES, V40; Brotherton JML, 2010, SEX HEALTH, V7, P291, DOI 10.1071/SH09135; Cancer Council Australia Cervical Cancer Screening Guidelines Working Party, 2016, NAT CERV SCREEN PROG; Canfell K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016700; Denham O, 2016, J FAMILY MED DIS PRE, V2; Federation of Ethnic Communities' Councils of Australia, 2010, CANC CULT LING DIV C; Hall MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0185332; Kong FYS, 2011, MED J AUSTRALIA, V194, P249, DOI 10.5694/j.1326-5377.2011.tb02957.x; Lew JB, 2017, LANCET PUBLIC HEALTH, V2, pE96, DOI 10.1016/S2468-2667(17)30007-5; McSherry LA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-73; Medical Services Advisory Committee, 2014, NAT CERV SCREEN PROG; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Roland KB, 2013, PREV MED, V57, P419, DOI 10.1016/j.ypmed.2013.04.012; Smith M, 2019, PUBLIC HEALTH RES PR, V29, DOI 10.17061/phrp2921914; StataCorp, 2011, STAT STAT SOFTW REL; Victorian Cervical Cytology Registry (VCCR), 2015, VICT CERV CYT REG ST; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228042	10.1371/journal.pone.0228042	http://dx.doi.org/10.1371/journal.pone.0228042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995585	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400039
J	Chan, YC; Chang, YC; Chuang, HH; Yang, YC; Lin, YF; Huang, MS; Hsiao, M; Yang, CJ; Hua, KT				Chan, Yung-Chieh; Chang, Yu-Chan; Chuang, Hsiang-Hao; Yang, Yi-Chieh; Lin, Yuan-Feng; Huang, Ming-Shyan; Hsiao, Michael; Yang, Chih-Jen; Hua, Kuo-Tai			Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFN gamma axis	ONCOGENE			English	Article							L-SERINE BIOSYNTHESIS; NEU-LAXOVA SYNDROME; PYRUVATE-KINASE M2; PHOSPHOSERINE AMINOTRANSFERASE; PHOSPHORYLATED PATHWAY; DNA METHYLATION; BREAST; EXPRESSION; DEFICIENCY; CELLS	An increasing number of enzymes involved in serine biosynthesis have been identified and correlated with malignant evolution in various types of cancer. Here we showed that the overexpression of phosphoserine aminotransferase 1 (PSAT1) is widely found in lung cancer tissues compared with nontumor tissues and predicts a poorer prognosis in patients with lung adenocarcinoma. PSAT1 expression was examined in a tissue microarray by immunohistochemistry. The data show that the knockdown of PSAT1 dramatically inhibits the in vitro and in vivo metastatic potential of highly metastatic lung cancer cells; conversely, the enforced expression of exogenous PSAT1 predominantly enhances the metastatic potential of lung cancer cells. Importantly, manipulating PSAT1 expression regulates the in vivo tumor metastatic abilities in lung cancer cells. Adjusting the glucose and glutamine concentrations did not alter the PSAT1-driven cell invasion properties, indicating that this process might not rely on the activation of its enzymatic function. RNA microarray analysis of transcriptional profiling from PSAT1 alternation in CL1-5 and CL1-0 cells demonstrated that interferon regulatory factor 1 (IRF1) acts as a crucial regulator of PSAT1-induced gene expression upon metastatic progression. Decreasing the IRF1-IFIH1 axis compromised the PSAT1-prompted transcriptional reprogramming in cancer cells. Our results identify PSAT1 as a key regulator by a novel PSAT1/IRF1 axis in lung cancer progression, which may serve as a potential biomarker and therapeutic target for the treatment of lung cancer patients.	[Chan, Yung-Chieh] Show Chwan Mem Hosp, Innovat Ctr, Changhua, Taiwan; [Chang, Yu-Chan; Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Chuang, Hsiang-Hao; Yang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Yang, Yi-Chieh] Tungs Taichung MetroHarbor Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Yi-Chieh; Lin, Yuan-Feng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Huang, Ming-Shyan] E DA Canc Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Hsiao, Michael] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hua, Kuo-Tai] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan	Show Chwan Memorial Hospital; Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tungs' Taichung MetroHarbor Hospital; Taipei Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; National Taiwan University	Yang, CJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.; Yang, CJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Hua, KT (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan.	chjeya@cc.kmu.edu.tw; kthua@ntu.edu.tw	Chan, yung-chieh/E-4091-2012; Chang, Yu-Chan/W-3582-2019; Hsiao, Michael/U-6238-2019; Chuang, Hsiang-Hao/AFR-5829-2022	Chang, Yu-Chan/0000-0003-0474-9935; Hsiao, Michael/0000-0001-8529-9213; Chuang, Hsiang-Hao/0000-0002-3590-5622; Hua, Kuo-Tai/0000-0002-8468-4977	Ministry of Science and Technology [MOST 104-0210-01-09-02, MOST 105-0210-01-13-01, MOST 106-0210-01-15-02, MOST 108-2628-B-002-014]; Academia Sinica	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica(Academia Sinica - Taiwan)	This study is supported by grants from Academia Sinica and Ministry of Science and Technology grants (MOST 104-0210-01-09-02, MOST 105-0210-01-13-01, MOST 106-0210-01-15-02, and MOST 108-2628-B-002-014). We like to thank Miss Tracy Tsai for her assists in immunohistochemistry works. And also like to thank the GRC Instrument Core Facilities for their support for the Affymetrix microarray, IVIS spectrum, and Aperio digital pathology analyses.	Acuna-Hidalgo R, 2014, AM J HUM GENET, V95, P285, DOI 10.1016/j.ajhg.2014.07.012; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bachmann SB, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-125; Baek JY, 2003, BIOCHEM J, V373, P191, DOI 10.1042/BJ20030144; Basurko MJ, 1999, IUBMB LIFE, V48, P525, DOI 10.1080/713803557; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Bu DW, 2013, CANCER EPIDEM BIOMAR, V22, P2212, DOI 10.1158/1055-9965.EPI-13-0208; Chen FF, 2013, ONCOL LETT, V5, P417, DOI 10.3892/ol.2012.1051; Cheng TY, 2018, ONCOGENE, V37, P1730, DOI 10.1038/s41388-017-0086-y; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Gromova I, 2015, MOL ONCOL, V9, P1636, DOI 10.1016/j.molonc.2015.05.003; Hanley Matthew P, 2015, Curr Pharmacol Rep, V1, P197; Harrison C, 2012, THER ADV HEMATOL, V3, P341, DOI 10.1177/2040620712459746; Hart CE, 2007, AM J HUM GENET, V80, P931, DOI 10.1086/517888; Hu Y, 2014, APOPTOSIS, V19, P1627, DOI 10.1007/s10495-014-1030-z; Jaeken J, 1996, J INHERIT METAB DIS, V19, P223, DOI 10.1007/BF01799435; KNOX WE, 1969, ARCH BIOCHEM BIOPHYS, V132, P397, DOI 10.1016/0003-9861(69)90381-6; Ksienzyk A, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19405; Ksienzyk A, 2011, CANCER RES, V71, P6410, DOI 10.1158/0008-5472.CAN-11-1565; Kwon JE, 2014, NEOPLASMA, V61, P566, DOI 10.4149/neo_2014_069; LEE YC, 1985, JPN J CLIN ONCOL, V15, P637; Liu JL, 2013, J NEURO-ONCOL, V111, P245, DOI 10.1007/s11060-012-1018-x; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LUND K, 1985, ARCH BIOCHEM BIOPHYS, V237, P186, DOI 10.1016/0003-9861(85)90268-1; Ma B, 2016, SCI REP-UK, V6, DOI 10.1038/srep26299; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Martens JWM, 2005, CANCER RES, V65, P4101, DOI 10.1158/0008-5472.CAN-05-0064; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Noh S, 2014, TUMOR BIOL, V35, P4457, DOI 10.1007/s13277-013-1588-z; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Quezada SA, 2014, NAT IMMUNOL, V15, P703, DOI 10.1038/ni.2945; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Shaheen R, 2014, AM J HUM GENET, V94, P898, DOI 10.1016/j.ajhg.2014.04.015; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; Tisserand J, 2011, J BIOL CHEM, V286, P33369, DOI 10.1074/jbc.M111.225680; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Wang N, 2015, MOL CANCER THER, V14, P982, DOI 10.1158/1535-7163.MCT-14-0751; Yang Y, 2015, INT J CANCER, V136, pE39, DOI 10.1002/ijc.29150; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yin K, 2015, ONCOTARGETS THER, V8, P1069, DOI 10.2147/OTT.S82433; Yu XF, 2016, CANCER RES, V76, P2166, DOI 10.1158/0008-5472.CAN-15-2142; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	49	15	17	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2509	2522		10.1038/s41388-020-1160-4	http://dx.doi.org/10.1038/s41388-020-1160-4		JAN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31988456				2022-12-26	WOS:000509655100005
J	Javaid, S; Saad, SM; Zafar, H; Malik, R; Khan, KM; Choudhary, MI; Rahman, AU				Javaid, Sumaira; Saad, Syed Muhammad; Zafar, Humaira; Malik, Rizwana; Khan, Khalid Mohammed; Choudhary, M. Iqbal; Rahman, Atta-ur			Thymidine phosphorylase and prostrate cancer cell proliferation inhibitory activities of synthetic 4-hydroxybenzohydrazides: In vitro, kinetic, and in silico studies	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACCURATE DOCKING; POTENT; GLIDE; IDENTIFICATION; HYDRAZONES; ANALOGS; BINDING; PROTEIN	Over-expression of thymidine phosphorylase (TP) plays a key role in many pathological complications, including angiogenesis which leads to cancer cells proliferation. Thus in search of new anticancer agents, a series of 4-hydroxybenzohydrazides (1-29) was synthesized, and evaluated for in vitro thymidine phosphorylase inhibitory activity. Twenty compounds 1-3, 6-14, 16, 19, 22-24, and 27-29 showed potent to weak TP inhibitory activities with IC50 values in the range of 6.8 to 229.5 mu M, in comparison to the standards i.e. tipiracil (IC50 = 0.014 +/- 0.002 mu M) and 7-deazaxanthine (IC50 = 41.0 +/- 1.63 mu M). Kinetic studies on selected inhibitors 3, 9, 14, 22, 27, and 29 revealed uncompetitive and non-competitive modes of inhibition. Molecular docking studies of these inhibitors indicated that they were able to interact with the amino acid residues present in allosteric site of TP, including Asp391, Arg388, and Leu389. Antiproliferative (cytotoxic) activities of active compounds were also evaluated against mouse fibroblast (3T3) and prostate cancer (PC3) cell lines. Compounds 1, 2, 19, and 22-24 exhibited anti-proliferative activities against PC3 cells with IC50 values between 6.5 to 10.5 mu M, while they were largely non-cytotoxic to 3T3 (mouse fibroblast) cells proliferation. Present study thus identifies a new class of dual inhibitors of TP and cancer cell proliferation, which deserves to be further investigated for anti-cancer drug development.	[Javaid, Sumaira; Zafar, Humaira; Malik, Rizwana; Choudhary, M. Iqbal; Rahman, Atta-ur] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Saad, Syed Muhammad; Khan, Khalid Mohammed; Choudhary, M. Iqbal; Rahman, Atta-ur] Univ Karachi, Int Ctr Chem & Biol Sci, Res Inst Chem, HEJ, Karachi, Pakistan; [Saad, Syed Muhammad] Univ Karachi, Dept Chem, Karachi, Pakistan; [Khan, Khalid Mohammed] Imam Abdulrahman Bin Faisal Univ, Inst Res & Med Consultat IRMC, Dept Clin Pharm, Dammam, Saudi Arabia; [Choudhary, M. Iqbal] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia	University of Karachi; University of Karachi; University of Karachi; Imam Abdulrahman Bin Faisal University; King Abdulaziz University	Javaid, S (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.; Khan, KM (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Res Inst Chem, HEJ, Karachi, Pakistan.; Khan, KM (corresponding author), Imam Abdulrahman Bin Faisal Univ, Inst Res & Med Consultat IRMC, Dept Clin Pharm, Dammam, Saudi Arabia.	sumairajavaid17@yahoo.com; khalid.khan@iccs.edu	Saad, Syed Muhammad/B-1266-2016	Saad, Syed Muhammad/0000-0001-7925-7471; , Sumaira/0000-0002-6422-3022	KMK Research project Higher Education Commission (HEC), Pakistan [20-1910]; Searle, Pakistan	KMK Research project Higher Education Commission (HEC), Pakistan; Searle, Pakistan	KMK Research project No. 20-1910 Higher Education Commission (HEC), Pakistan, https://www.hec.gov.pk/english/pages/home.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Searle, Pakistan for financial support (APC charges) through project entitled as Discovery of New Therapeutic Application of Existing Drugs by Repositioning and Purposing Approach.	Abbasi MA, 2004, PLANTA MED, V70, P1189, DOI 10.1055/s-2004-835850; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; [Anonymous], 2015, LIGPREP; [Anonymous], 2015, PROT PREP WIZ 2015 4; [Anonymous], 2015, SCHROD REL 2015 4 SI; Ayyannan G, 2017, APPL ORGANOMET CHEM, V31; Backes GL, 2014, BIOORGAN MED CHEM, V22, P4629, DOI 10.1016/j.bmc.2014.07.022; Balzarini J, 1998, FEBS LETT, V438, P91, DOI 10.1016/S0014-5793(98)01271-X; Bera H, 2013, BIOORG CHEM, V50, P34, DOI 10.1016/j.bioorg.2013.07.004; Bouzidi N, 2013, BIOORG MED CHEM LETT, V23, P2624, DOI 10.1016/j.bmcl.2013.02.100; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Bruin M, 2006, CANC THERAPY, V4, P99; Cardozo TJ, 2012, U.S. Patent Application, Patent No. [14/353,438, 14353438]; DeBenedetti A, 2013, U.S. Patent Application, Patent No. [14/377,457, 143777457]; Dimas K, 1998, PLANTA MED, V64, P208, DOI 10.1055/s-2006-957410; Distinto S, 2012, EUR J MED CHEM, V50, P216, DOI 10.1016/j.ejmech.2012.01.056; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Huang HW, 2010, ACTA CRYSTALLOGR E, V66, pO3143, DOI 10.1107/S1600536810045502; Hussain S, 2009, J ASIAN NAT PROD RES, V11, P159, DOI 10.1080/10286020802618860; Javaid S, 2017, BIOORG CHEM, V70, P44, DOI 10.1016/j.bioorg.2016.11.007; Javaid S, 2015, BIOORG CHEM, V63, P142, DOI 10.1016/j.bioorg.2015.10.006; Khan KM, 2013, MED CHEM RES, V22, P6022, DOI 10.1007/s00044-013-0588-2; Khan KM, 2009, BIOORGAN MED CHEM, V17, P2983, DOI 10.1016/j.bmc.2009.03.020; Kim BK, 2016, EUR J MED CHEM, V120, P202, DOI 10.1016/j.ejmech.2016.03.085; Leigh M, 2011, CHEMMEDCHEM, V6, P1107, DOI 10.1002/cmdc.201100054; Leigh M, 2011, CHEMMEDCHEM, V6, P612, DOI 10.1002/cmdc.201000429; Mayer RJ, 2015, NEW ENGL J MED, V372, P1909, DOI 10.1056/NEJMoa1414325; Norman RA, 2004, STRUCTURE, V12, P75, DOI 10.1016/j.str.2003.11.018; Padmini K., 2013, INT J PHARM RES REV, V2, P43; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Pham VN, 2008, TAP CHI HOA HOC, V46, P744; Plank M., 2003, J THEOR MED, V5, P137, DOI DOI 10.1080/10273360410001700843; Reigan P, 2005, J MED CHEM, V48, P392, DOI 10.1021/jm049494r; Sapra A, 2014, Drug Res (Stuttg), V64, P17, DOI 10.1055/s-0033-1349866; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schrodinger, 2015, GLID VERS 6 9; Sorna V, 2013, J MED CHEM, V56, P9496, DOI 10.1021/jm400870h; Timofeev V, 2014, ACTA CRYSTALLOGR D, V70, P1155, DOI 10.1107/S1399004714001904; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; Vrdoljak V, 2016, NEW J CHEM, V40, P9263, DOI 10.1039/c6nj01036a; WALTER MR, 1990, J BIOL CHEM, V265, P14016; Wang XY, 2008, ACTA CRYSTALLOGR E, V64, pO2022, DOI 10.1107/S1600536808030304	45	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227549	10.1371/journal.pone.0227549	http://dx.doi.org/10.1371/journal.pone.0227549			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986186	Green Published, gold			2022-12-26	WOS:000534603400023
J	Ricci, B; Millner, TO; Pomella, N; Zhang, XY; Guglielmi, L; Badodi, S; Ceric, D; Gemma, C; Cognolato, E; Zhang, Y; Brandner, S; Barnes, MR; Marino, S				Ricci, Barbara; Millner, Thomas O.; Pomella, Nicola; Zhang, Xinyu; Guglielmi, Loredana; Badodi, Sara; Ceric, Dario; Gemma, Carolina; Cognolato, Erica; Zhang, Ying; Brandner, Sebastian; Barnes, Michael R.; Marino, Silvia			Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma	ONCOGENE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSFORMATION; MALIGNANT GLIOMA; SELF-RENEWAL; STEM-CELLS; BMI1; TUMOR; PROLIFERATION; MUTATIONS; NETWORK	Glioblastoma (GBM) is the most common and most aggressive intrinsic brain tumour in adults. Integrated transcriptomic and epigenomic analyses of glioblastoma initiating cells (GIC) in a mouse model uncovered a novel epigenetic regulation of EfnA5. In this model, Bmi1 enhances H3K27me3 at the EfnA5 locus and reinforces repression of selected target genes in a cellular context-dependent fashion. EfnA5 mediates Bmi1-dependent proliferation and invasion in vitro and tumour formation in an allograft model. Importantly, we show that this novel Polycomb feed-forward loop is also active in human GIC and we provide pre-clinical evidence of druggability of the EFNA5 signalling pathway in GBM xenografts overexpressing Bmi1.	[Ricci, Barbara; Millner, Thomas O.; Pomella, Nicola; Zhang, Xinyu; Guglielmi, Loredana; Badodi, Sara; Ceric, Dario; Cognolato, Erica; Marino, Silvia] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England; [Gemma, Carolina] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London W12 0NN, England; [Zhang, Ying; Brandner, Sebastian] Univ Coll London Hosp NHS Fdn, Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England; [Barnes, Michael R.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Translat Bioinformat, London EC1M 6BQ, England	University of London; Queen Mary University London; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; Queen Mary University London	Marino, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England.	s.marino@qmul.ac.uk	Brandner, Sebastian/J-4562-2014; Badodi, Sara/GNH-3404-2022	Brandner, Sebastian/0000-0002-9821-0342; Millner, Thomas/0000-0001-5638-3918; Marino, Silvia/0000-0002-9612-2883; Pomella, Nicola/0000-0003-0028-4878; Gemma, Carolina/0000-0002-4890-9972; Badodi, Sara/0000-0002-8407-8336; Zhang, Ying/0000-0003-2194-7116	MRC [1365533]; Brain Tumour Charity [BTC 8/128, GN-000389]; Barts Charity; Brain Tumour Research (Centre of Excellence award); UCL-ORS; UCLH; National Institute of Health Research; Medical Research Council [1365533] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brain Tumour Charity; Barts Charity; Brain Tumour Research (Centre of Excellence award); UCL-ORS; UCLH; National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by grants from the MRC (1365533.studentship to BR), The Brain Tumour Charity (GN-000389 clinical research training fellowship to TM and BTC 8/128 to SB), Barts Charity (project and programme grants to SM) and Brain Tumour Research (Centre of Excellence award to SM); YZ was supported by a PhD Overseas research scholarship, UCL-ORS and UCLH Trustees. This research also forms a part of the research themes contributing to the translational research portfolio of Barts and the London Biomedical Research Centre, which is supported and funded by the National Institute of Health Research. LC-MS measurements of doxazosin were carried out by Dr Roberto Buccafusca, SBCS Mass Spectrometry Facility, QMUL. All xenograft tumour histology was performed by IQPath, UCLH, London.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Acquati S, 2013, STEM CELLS, V31, P190, DOI 10.1002/stem.1274; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Danussi C, 2013, CANCER RES, V73, P5140, DOI 10.1158/0008-5472.CAN-13-1168-T; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Day BW, 2014, BRIT J CANCER, V111, P1255, DOI 10.1038/bjc.2014.73; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Entrevan M, 2016, TRENDS CELL BIOL, V26, P511, DOI 10.1016/j.tcb.2016.04.009; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferluga S, 2016, ONCOTARGET, V7, P59860, DOI 10.18632/oncotarget.10978; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gucciardo E, 2014, CELL MOL LIFE SCI, V71, P3685, DOI 10.1007/s00018-014-1633-0; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Henrich CJ, 2007, MOL CANCER THER, V6, P3271, DOI 10.1158/1535-7163.MCT-07-0352; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Hu BL, 2016, CELL, V167, P1281, DOI 10.1016/j.cell.2016.10.039; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jin X, 2017, NAT MED, V23, P1352, DOI 10.1038/nm.4415; KAYE B, 1986, BRIT J CLIN PHARMACO, V21, pS19, DOI 10.1111/j.1365-2125.1986.tb02849.x; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Kyprianou N, 2000, CANCER RES, V60, P4550; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; Lin Fan, 2013, CNS Oncol, V2, P271, DOI 10.2217/cns.13.15; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Mohammad F, 2017, NAT MED, V23, P483, DOI 10.1038/nm.4293; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Pollak J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172884; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Segerman A, 2016, CELL REP, V17, P2994, DOI 10.1016/j.celrep.2016.11.056; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subkhankulova T, 2010, MOL CELL NEUROSCI, V45, P151, DOI 10.1016/j.mcn.2010.06.006; Testa G, 2011, BIOESSAYS, V33, P519, DOI 10.1002/bies.201100021; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Voncken JW, 1999, J CELL SCI, V112, P4627; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Yadirgi G, 2011, STEM CELLS, V29, P700, DOI 10.1002/stem.614; Yan Y, 2015, FEBS LETT, V589, P756, DOI 10.1016/j.febslet.2015.02.005; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong CL, 1997, MOL BIOL CELL, V8, P2329, DOI 10.1091/mbc.8.11.2329	66	9	10	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2523	2538		10.1038/s41388-020-1161-3	http://dx.doi.org/10.1038/s41388-020-1161-3		JAN 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31988455	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000509655100004
J	Song, B; Lee, JM; Park, YJ; Kim, IK; Kim, BS; Shin, KS; Jeon, I; Koh, CH; Bae, EA; Seo, H; Byun, Y; Kang, CY				Song, Boyeong; Lee, Jeong-Mi; Park, Young-Jun; Kim, Il-Kyu; Kim, Byung-Seok; Shin, Kwang-Soo; Jeon, Insu; Koh, Choong-Hyun; Bae, Eun-Ah; Seo, Hyungseok; Byun, Youngro; Kang, Chang-Yuil			Differentiation of c-Kit(+)CD24(+) natural killer cells into myeloid cells in a GATA-2-dependent manner	FASEB JOURNAL			English	Article						CD24; c-Kit; GATA-2; myeloid cell development; natural killer cell	PRECURSOR ACUTE-LEUKEMIA; NK-CELLS; T-CELLS; UP-REGULATION; STEM-CELLS; B-CELLS; LINEAGE; PROGENITOR; CONVERSION; IDENTIFICATION	Myeloid progenitor cells have generally been considered the predominant source of myeloid cells under steady-state conditions. Here we show that NK cells contributed to a myeloid cell lineage pool in naive and tumor-bearing mice. Using fate tracing of NKp46(+) cells, we found that myeloid cells could be derived from NK cells. Notably, among mature CD11b(+)CD27(+) NK cells, c-Kit(+)CD24(+) NK cells were capable of differentiating into a range of myeloid lineages in vitro and produced neutrophils and monocytes in vivo. The differentiation was completely inhibited by NK-stimulating cytokines. In addition to the potential for differentiation into myeloid cells, c-Kit(+)CD24(+) NK cells retained NK cell phenotypes and effector functions. Mechanistically, GATA-2 was necessary for the differentiation of c-Kit(+)CD24(+) NK cells. Therefore, we discovered that GATA-2-dependent differentiation of c-Kit(+)CD24(+) NK cells contributes to myeloid cell development and identified a novel pathway for myeloid lineage commitment under physiological conditions.	[Song, Boyeong; Jeon, Insu; Bae, Eun-Ah; Seo, Hyungseok; Kang, Chang-Yuil] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Lab Immunol, Seoul, South Korea; [Lee, Jeong-Mi; Shin, Kwang-Soo; Koh, Choong-Hyun; Kang, Chang-Yuil] Seoul Natl Univ, Coll Pharm, Lab Immunol, Seoul, South Korea; [Park, Young-Jun; Kim, Byung-Seok] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea; [Kim, Il-Kyu; Seo, Hyungseok] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Lab Immunol, Seoul, South Korea; [Byun, Youngro] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, CY (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Lab Immunol, Seoul, South Korea.	cykang@snu.ac.kr	Park, Youngjun/AAK-2026-2020	Seo, hyungseok/0000-0002-6632-1208; Bae, Eunah/0000-0003-2670-4578	National Research Foundation of Korea (NRF) [NRF-2018R1A2A1A05077627, NRF-2016M3A9B5941426]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2A1A05077627 and NRF-2016M3A9B5941426	Abel AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01869; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ayre DC, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00146; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benson DM, 2009, BLOOD, V113, P2706, DOI 10.1182/blood-2008-05-159285; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; CARSON WE, 1994, P NATL ACAD SCI USA, V91, P7553, DOI 10.1073/pnas.91.16.7553; Chen BB, 2009, INT J HEMATOL, V89, P365, DOI 10.1007/s12185-009-0282-9; Chen QF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15118; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cichocki F, 2014, SEMIN IMMUNOL, V26, P114, DOI 10.1016/j.smim.2014.02.003; Cieslar-Pobuda A, 2017, BBA-MOL CELL RES, V1864, P1359, DOI 10.1016/j.bbamcr.2017.04.017; Cirovic B, 2017, STEM CELL REP, V8, P346, DOI 10.1016/j.stemcr.2016.12.015; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Collier AJ, 2017, CELL STEM CELL, V20, P874, DOI 10.1016/j.stem.2017.02.014; Colucci F, 2000, BLOOD, V95, P984, DOI 10.1182/blood.V95.3.984.003k40_984_991; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Ehlers M, 2012, ENDOCRINOLOGY, V153, P4367, DOI 10.1210/en.2012-1247; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3; Gao X, 2013, J EXP MED, V210, P2833, DOI 10.1084/jem.20130733; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hu TY, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00268; Kang H, 2018, STEM CELL REP, V11, P197, DOI 10.1016/j.stemcr.2018.05.002; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Loyon R, 2016, J IMMUNOL, V197, P85, DOI 10.4049/jimmunol.1501147; Lui JB, 2015, CELL REP, V10, P574, DOI 10.1016/j.celrep.2014.12.053; Marquez C, 1998, BLOOD, V91, P2760, DOI 10.1182/blood.V91.8.2760.2760_2760_2771; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Nakayama M, 2011, P NATL ACAD SCI USA, V108, P18360, DOI 10.1073/pnas.1110584108; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Omi A, 2014, EUR J IMMUNOL, V44, P2638, DOI 10.1002/eji.201444570; Park E, 2019, ELIFE, V8, DOI 10.7554/eLife.47605; Park YJ, 2013, CANCER RES, V73, P5669, DOI 10.1158/0008-5472.CAN-13-0545; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Pradier A, 2014, EUR J IMMUNOL, V44, P511, DOI 10.1002/eji.201343868; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Pulecio J, 2016, CELL REP, V17, P671, DOI 10.1016/j.celrep.2016.09.036; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shakiba N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8329; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Suzuki R, 1999, LEUKEMIA RES, V23, P615, DOI 10.1016/S0145-2126(98)00194-5; Suzuki R, 1997, BLOOD, V90, P2417; Terme M, 2012, CANCER RES, V72, P2757, DOI 10.1158/0008-5472.CAN-11-3379; Theurich S, 2017, CELL METAB, V26, P171, DOI 10.1016/j.cmet.2017.05.018; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; [于丽娜 Yu Lina], 2017, [现代化工, Modern Chemical Industry], V37, P1	72	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4462	4481		10.1096/fj.201902662R	http://dx.doi.org/10.1096/fj.201902662R		JAN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31989715				2022-12-26	WOS:000509780000001
J	Takumi, S; Mitta, S; Komura, S; Ikeda, TM; Matsunaka, H; Sato, K; Yoshida, K; Murai, K				Takumi, Shigeo; Mitta, Seito; Komura, Shoya; Ikeda, Tatsuya M.; Matsunaka, Hitoshi; Sato, Kazuhiro; Yoshida, Kentaro; Murai, Koji			Introgression of chromosomal segments conferring early heading date from wheat diploid progenitor, Aegilops tauschii Coss., into Japanese elite wheat cultivars	PLOS ONE			English	Article							FLOWERING-RELATED TRAITS; PUROINDOLINE-B; D-GENOME; ALLELIC VARIATION; LEAF TRANSCRIPTS; STORAGE PROTEINS; GRAIN HARDNESS; DURUM-WHEAT; TIME; IDENTIFICATION	The breeding of agriculturally useful genes from wild crop relatives must take into account recent and future climate change. In Japan, the development of early heading wheat cultivars without the use of any major gene controlling the heading date is desired to avoid overlap of the harvesting time before the rainy season. Here, we backcrossed two early heading lines of a synthetic hexaploid wheat, derived from a crossing between durum wheat and the wild wheat progenitor Aegilops tauschii, with four Japanese elite cultivars to develop early heading lines of bread wheat. In total, nine early heading lines that showed a heading date two to eight days earlier than their parental cultivars in field conditions were selected and established from the selfed progenies of the two- or three-times backcrossed populations. The whole appearance and spike shape of the selected early heading lines looked like their parental wheat cultivars. The mature grains of the selected lines had the parental cultivars' characteristics, although the grains exhibited longer and narrower shapes. RNA sequencing-based genotyping was performed to detect single nucleotide polymorphisms between the selected lines and their parental wheat cultivars, which revealed the chromosomal regions transmitted from the parental synthetic wheat to the selected lines. The introgression regions could shorten wheat heading date, and their chromosomal positions were dependent on the backcrossed wheat cultivars. Therefore, early heading synthetic hexaploid wheat is useful for fine-tuning of the heading date through introgression of Ae. tauschii chromosomal regions.	[Takumi, Shigeo; Komura, Shoya; Yoshida, Kentaro] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo, Japan; [Mitta, Seito; Murai, Koji] Fukui Prefectural Univ, Yoshida, Fukui, Japan; [Ikeda, Tatsuya M.] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima, Japan; [Matsunaka, Hitoshi] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan; [Sato, Kazuhiro] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Kobe University; Fukui Prefectural University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Okayama University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo, Japan.; Murai, K (corresponding author), Fukui Prefectural Univ, Yoshida, Fukui, Japan.	takumi@kobe-u.ac.jp; murai@fpu.ac.jp	SATO, Kazuhiro/B-2504-2011	SATO, Kazuhiro/0000-0001-8818-5203	Ministry of Agriculture, Forestry, and Fisheries of Japan (Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries) [BGW-2202]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H04862]	Ministry of Agriculture, Forestry, and Fisheries of Japan (Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-inAid from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries, BGW-2202), and by a Grant-in-Aid for Scientific Research (B) No. 16H04862 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bullrich L, 2002, THEOR APPL GENET, V105, P585, DOI 10.1007/s00122-002-0982-5; Chichti E, 2018, J CEREAL SCI, V83, P58, DOI 10.1016/j.jcs.2018.07.009; DEXTER JE, 1989, J CEREAL SCI, V10, P19, DOI 10.1016/S0733-5210(89)80031-1; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fujiwara Y, 2010, BREEDING SCI, V60, P286, DOI 10.1270/jsbbs.60.286; Gautier MF, 2000, PLANT SCI, V153, P81, DOI 10.1016/S0168-9452(99)00258-7; Gedye KR, 2004, THEOR APPL GENET, V109, P1597, DOI 10.1007/s00122-004-1788-4; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; Gorafi YSA, 2018, THEOR APPL GENET, V131, P1615, DOI 10.1007/s00122-018-3102-x; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Hao M, 2019, THEOR APPL GENET, V132, P2285, DOI 10.1007/s00122-019-03354-9; Huang L, 2012, GENET RESOUR CROP EV, V59, P1027, DOI 10.1007/s10722-011-9741-2; Ishikawa G., 2007, Wheat Information Service, P1; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Jones H, 2013, THEOR APPL GENET, V126, P1793, DOI 10.1007/s00122-013-2093-x; Masaru IJC, 2012, DNA RES, V19, P487, DOI 10.1093/dnares/dss028; Kajimura T, 2011, BREEDING SCI, V61, P130, DOI 10.1270/jsbbs.61.130; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kosugi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075402; Koyama K, 2019, AEGILOPS TAUSCHII; Kuchel H, 2006, THEOR APPL GENET, V113, P1103, DOI 10.1007/s00122-006-0370-7; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lillemo M, 2000, THEOR APPL GENET, V100, P1100, DOI 10.1007/s001220051392; Lin F, 2008, EUPHYTICA, V164, P769, DOI 10.1007/s10681-008-9724-3; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Miki Y, 2019, DNA RES, V26, P171, DOI 10.1093/dnares/dsy047; Moore G, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.18, 10.1038/nplants.2015.18]; Morris CF, 2008, J CEREAL SCI, V48, P277, DOI 10.1016/j.jcs.2007.09.012; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Nguyen AT, 2013, EUPHYTICA, V192, P401, DOI 10.1007/s10681-013-0873-7; Nguyen AT, 2015, GENES GENET SYST, V90, P89, DOI 10.1266/ggs.90.89; Nishijima R, 2016, MOL GENET GENOMICS, V291, P1681, DOI 10.1007/s00438-016-1211-2; Okada M, 2018, J CEREAL SCI, V83, P153, DOI 10.1016/j.jcs.2018.08.011; Okamoto Y, 2012, GENES GENET SYST, V87, P299, DOI 10.1266/ggs.87.299; Oury FX, 2015, THEOR APPL GENET, V128, P913, DOI 10.1007/s00122-015-2479-z; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; Prohens J, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1938-9; R Core Team, 2020, R LANG ENV STAT COMP; Rasheed A, 2018, ANN BOT-LONDON, V121, P603, DOI 10.1093/aob/mcx148; SCARTH R, 1983, HEREDITY, V51, P607, DOI 10.1038/hdy.1983.73; Seki M, 2013, BREEDING SCI, V63, P309, DOI 10.1270/jsbbs.63.309; Shindo C, 2002, GENOME, V45, P563, DOI [10.1139/g02-015, 10.1139/G02-015]; SINGH NK, 1988, THEOR APPL GENET, V75, P628, DOI 10.1007/BF00289132; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Snape JW, 1996, EUPHYTICA, V89, P27, DOI 10.1007/BF00015715; Sourdille P, 1996, THEOR APPL GENET, V93, P580, DOI 10.1007/BF00417951; Takumi S, 2009, PLANT BREEDING, V128, P585, DOI 10.1111/j.1439-0523.2009.01630.x; Tanabata T, 2012, PLANT PHYSIOL, V160, P1871, DOI 10.1104/pp.112.205120; Xiang ZG, 2009, AGR SCI CHINA, V8, P1, DOI 10.1016/S1671-2927(08)60016-4; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yu K, 2017, THEOR APPL GENET, V130, P53, DOI 10.1007/s00122-016-2791-2; Zikhali M, 2014, MOL BREEDING, V34, P1023, DOI 10.1007/s11032-014-0094-3	57	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228397	10.1371/journal.pone.0228397	http://dx.doi.org/10.1371/journal.pone.0228397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986184	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400046
J	Weng, CC; Hwang, DK; Liu, CJL				Weng, Chang-Chi; Hwang, De-Kuang; Liu, Catherine Jui-Ling			Repeatability of the amplitude of accommodation measured by a new generation autorefractor	PLOS ONE			English	Article							PRESBYOPIA; AGE	Significance This is the first study to validate the repeatability of objective measurements of amplitude of accommodation (AA) using the TONOREF III (NIDEK Co., Ltd., Japan), which can measure the AA in 30 seconds. Purpose To evaluate the repeatability of objective measurements of AA using the TONOREF III and explored the association between objectively measured AA and factors, including age, sex, spherical equivalent, baseline pupil size and pupil size change during accommodation. Methods This cross-sectional study recruited 35 healthy subjects aged 26 to 52 years. The Bland-Alt-man method and intraclass correlation coefficients (ICCs) were used to assess the repeatability of TONOREF III measurements. The relationships between AA and age, sex, baseline pupil size, changes in pupil size (Delta PS) during accommodation were analyzed using linear regression for univariate and multivariate analysis. Results The mean difference in AA (Delta AA) between two sessions of TONOREF III measurements was 0.23 D (95% CI: -1.07 to +1.53 D), while no significant correlation was found between the mean and Delta AA (p = .14). The ICCs of the TONOREF III was 0.96. Age, sex, and Delta PS during accommodation were significant factors affecting the AA in multivariate analysis. Conclusions The repeatability of objective AA measurements using the TONOREF III was good. Measuring AA using the TONOREF (TM) III in clinical practice is feasible.	[Weng, Chang-Chi; Hwang, De-Kuang; Liu, Catherine Jui-Ling] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hwang, De-Kuang; Liu, Catherine Jui-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Hwang, DK; Liu, CJL (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Hwang, DK; Liu, CJL (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.	m95gbk@gmail.com; cjlliu317@gmail.com	Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485; Weng, Chang-Chi/0000-0003-2178-5612				Abraham Lekha Mary, 2005, Indian Journal of Ophthalmology, V53, P105; Adnan, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15376; Anderson HA, 2008, INVEST OPHTH VIS SCI, V49, P2919, DOI 10.1167/iovs.07-1492; Anderson HA, 2014, OPTOMETRY VISION SCI, V91, P1290, DOI 10.1097/OPX.0000000000000402; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cerman E, 2017, CAN J OPHTHALMOL, V52, P20, DOI 10.1016/j.jcjo.2016.07.025; Chen YY, 2017, CLIN EXP OPTOM, V100, P155, DOI 10.1111/cxo.12469; Gualdi L, 2017, J REFRACT SURG, V33, P578, DOI 10.3928/1081597X-20170621-05; Hashemi H, 2017, CLIN EXP OPTOM, V100, P162, DOI 10.1111/cxo.12431; Hashemi H, 2012, CLIN EXP OPHTHALMOL, V40, P863, DOI 10.1111/j.1442-9071.2012.02799.x; Hickenbotham A, 2012, INVEST OPHTH VIS SCI, V53, P3215, DOI 10.1167/iovs.12-9791; Iyamu Eghosasere, 2012, ISRN Ophthalmol, V2012, P295613, DOI 10.5402/2012/295613; Jaiswal S, 2019, CLIN EXP OPTOM, V102, P463, DOI 10.1111/cxo.12851; Khan A, 2017, DIABETIC MED, V34, P478, DOI 10.1111/dme.13296; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; McDougal DH, 2015, COMPR PHYSIOL, V5, P439, DOI 10.1002/cphy.c140014; Richdale K, 2016, OPTOMETRY VISION SCI, V93, P3, DOI 10.1097/OPX.0000000000000757; Satgunam P, 2019, EYE, V33, P1254, DOI 10.1038/s41433-019-0402-6; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Win-Hall DM, 2008, J CATARACT REFR SURG, V34, P774, DOI 10.1016/j.jcrs.2007.12.033; Win-Hall DM, 2007, OPTOMETRY VISION SCI, V84, P879, DOI 10.1097/OPX.0b013e3181559ace; Wold JE, 2003, J CATARACT REFR SURG, V29, P1878, DOI 10.1016/S0886-3350(03)00667-9; Wu PC, 2016, ASIA-PAC J OPHTHALMO, V5, P386, DOI 10.1097/APO.0000000000000236; Yekta A, 2017, STRABISMUS, V25, P5, DOI 10.1080/09273972.2016.1276937	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0224733	10.1371/journal.pone.0224733	http://dx.doi.org/10.1371/journal.pone.0224733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986151	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400010
J	Aguilera-Diaz, A; Vazquez, I; Ariceta, B; Manu, A; Blasco-Iturri, Z; Palomino-Echeverria, S; Larrayoz, MJ; Garcia-Sanz, R; Prieto-Conde, MI; Chillon, MD; Alfonso-Pierola, A; Prosper, F; Fernandez-Mercado, M; Calasanz, MJ				Aguilera-Diaz, Almudena; Vazquez, Iria; Ariceta, Benat; Manu, Amagoia; Blasco-Iturri, Zurine; Palomino-Echeverria, Sara; Larrayoz, Maria Jose; Garcia-Sanz, Ramon; Prieto-Conde, Maria Isabel; Chillon, Maria del Carmen; Alfonso-Pierola, Ana; Prosper, Felipe; Fernandez-Mercado, Marta; Calasanz, Maria Jose			Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design	PLOS ONE			English	Article							MYELOPROLIFERATIVE NEOPLASMS; MYELODYSPLASTIC SYNDROMES; MOLECULAR PATHOGENESIS; SOMATIC MUTATIONS; SETBP1 MUTATIONS; COHESIN COMPLEX; CEBPA MUTATIONS; GENE-MUTATIONS; FLT3 GENE; DIAGNOSIS	The diagnosis of myeloid neoplasms (MN) has significantly evolved through the last few decades. Next Generation Sequencing (NGS) is gradually becoming an essential tool to help clinicians with disease management. To this end, most specialized genetic laboratories have implemented NGS panels targeting a number of different genes relevant to MN. The aim of the present study is to evaluate the performance of four different targeted NGS gene panels based on their technical features and clinical utility. A total of 32 patient bone marrow samples were accrued and sequenced with 3 commercially available panels and 1 custom panel. Variants were classified by two geneticists based on their clinical relevance in MN. There was a difference in panel's depth of coverage. We found 11 discordant clinically relevant variants between panels, with a trend to miss long insertions. Our data show that there is a high risk of finding different mutations depending on the panel of choice, due both to the panel design and the data analysis method. Of note, CEBPA, CALR and FLT3 genes, remains challenging the use of NGS for diagnosis of MN in compliance with current guidelines. Therefore, conventional molecular testing might need to be kept in place for the correct diagnosis of MN for now.	[Aguilera-Diaz, Almudena; Prosper, Felipe; Fernandez-Mercado, Marta] Univ Navarra, Ctr Appl Med Res CIMA, Adv Genom Lab, Hematooncol, Pamplona, Spain; [Aguilera-Diaz, Almudena; Vazquez, Iria; Larrayoz, Maria Jose; Prosper, Felipe; Calasanz, Maria Jose] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain; [Vazquez, Iria; Ariceta, Benat; Manu, Amagoia; Blasco-Iturri, Zurine; Palomino-Echeverria, Sara; Larrayoz, Maria Jose; Fernandez-Mercado, Marta; Calasanz, Maria Jose] Univ Navarra, CIMA LAB Diagnost, Hematol Dis Lab, Pamplona, Spain; [Garcia-Sanz, Ramon; Prieto-Conde, Maria Isabel; Chillon, Maria del Carmen] Univ Hosp Salamanca, IBSAL, Hematol Dept, Salamanca, Spain; [Garcia-Sanz, Ramon; Prieto-Conde, Maria Isabel; Chillon, Maria del Carmen] CIBERONC, Salamanca, Spain; [Alfonso-Pierola, Ana; Prosper, Felipe] Clin Univ Navarra CUN, Hematol Dept, Pamplona, Spain; [Fernandez-Mercado, Marta] Univ Navarra, Sch Engn, Biomed Engn Dept, San Sebastian, Spain; [Calasanz, Maria Jose] Univ Navarra, CIMA LAB Diagnost, Pamplona, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; University of Navarra	Fernandez-Mercado, M (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Adv Genom Lab, Hematooncol, Pamplona, Spain.; Fernandez-Mercado, M (corresponding author), Univ Navarra, CIMA LAB Diagnost, Hematol Dis Lab, Pamplona, Spain.; Fernandez-Mercado, M (corresponding author), Univ Navarra, Sch Engn, Biomed Engn Dept, San Sebastian, Spain.	mfmercado@unav.es	Alfonso-Pierola, Ana/N-6349-2015; Chillón, M. Carmen/E-1339-2018; Calasanz, MJ/R-5813-2016; Prosper, Felipe/H-6859-2017; Garcia-Sanz, Ramon/B-7986-2017	Alfonso-Pierola, Ana/0000-0002-2478-5354; Chillón, M. Carmen/0000-0003-1624-6059; Calasanz, MJ/0000-0002-0374-3008; Prosper, Felipe/0000-0001-6115-8790; Aguilera Diaz, Almudena/0000-0002-1897-3914; Garcia-Sanz, Ramon/0000-0003-4120-2787	Spanish Association against Cancer (AECC) [AIO2014]; Government of Navarra, Department of Industry, Energy and Innovation (Project DIANA) [0011-1411-2017-000028]; Instituto de Salud Carlos III [PI16/00159, PI17/00701]; CIMAs fellowship; Pethema Foundation; ISCIII (Ministerio de Economia y Competitividad of Spanish central government) [PI16/00159]; Pethema; ISCIII [PI17/00701]; CIMA LAB Diagnostics research program	Spanish Association against Cancer (AECC); Government of Navarra, Department of Industry, Energy and Innovation (Project DIANA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIMAs fellowship; Pethema Foundation; ISCIII (Ministerio de Economia y Competitividad of Spanish central government); Pethema; ISCIII(Instituto de Salud Carlos III); CIMA LAB Diagnostics research program	This work was supported by CIMA LAB Diagnostics research program and grants from the Spanish Association against Cancer (AECC, AIO2014), Government of Navarra, Department of Industry, Energy and Innovation (Project DIANA, 0011-1411-2017-000028) (FP, IV, MJL, MFM, MJC, http://www.proyectodiana.es/), and Instituto de Salud Carlos III (PI16/00159 and PI17/00701) (MFM, AAD, FP, https://www.isciii.es/Paginas/Inicio.aspx).AAD is supported by a CIMAs fellowship, and IV is supported by Pethema Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Government of Navarra, Department of Industry, Energy and Innovation (Project DIANA, 0011-1411-2017-000028); and supported by CIMA LAB Diagnostics research program.; AAD is supported by a CIMAs fellowship; MFM and her research is supported by the Spanish Association against Cancer (AECC, AIO2014) and ISCIII (Ministerio de Economia y Competitividad of Spanish central government, PI16/00159); IV is supported by Pethema; FP aknowledges funding from ISCIII (PI17/00701).	Albitar A, 2018, LEUKEMIA, V32, P227, DOI 10.1038/leu.2017.271; Alonso CM, 2019, J MOL DIAGN, V21, P228, DOI 10.1016/j.jmoldx.2018.09.009; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Au CH, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0456-8; Babushok DV, 2016, LEUKEMIA LYMPHOMA, V57, P520, DOI 10.3109/10428194.2015.1115041; Bacher U, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0148-6; Baker SC, 2017, GENET ENG BIOTECHNOL, V37; Bannon SA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060838; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Bello E, 2015, BRIT J HAEMATOL, V171, P210, DOI 10.1111/bjh.13563; Boudry-Labis E, 2013, AM J HEMATOL, V88, P306, DOI 10.1002/ajh.23403; Bullinger L, 2017, J CLIN ONCOL, V35, P934, DOI 10.1200/JCO.2016.71.2208; Cabagnols X, 2016, BLOOD, V127, P333, DOI 10.1182/blood-2015-07-661983; Crispino JD, 2017, BLOOD, V129, P2103, DOI 10.1182/blood-2016-09-687889; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Feenstra JDM, 2016, BLOOD, V127, P325, DOI 10.1182/blood-2015-07-661835; Gill H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040440; Gombart AF, 2013, MUTATIONS GENE ENCOD, V99, P1332, DOI [10.1182/blood.V99.4.1332, DOI 10.1182/BLOOD.V99.4.1332]; Ha JS, 2011, AM J HEMATOL, V86, P866, DOI 10.1002/ajh.22107; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hattori K, 2018, CANCER SCI, V109, P225, DOI 10.1111/cas.13450; Herbaux C, 2015, AM J HEMATOL, V90, P737, DOI 10.1002/ajh.24073; Hirabayashi S, 2017, INT J HEMATOL, V106, P175, DOI 10.1007/s12185-017-2285-2; Hu Y, 2017, ONCOGENE, V36, P1038, DOI 10.1038/onc.2016.275; Hung SS, 2018, J MOL DIAGN, V20, P203, DOI 10.1016/j.jmoldx.2017.11.010; Hurtado C, 2011, LEUKEMIA RES, V35, P1537, DOI 10.1016/j.leukres.2011.07.009; Itzykson R, 2013, J CLIN ONCOL, V31, P2428, DOI 10.1200/JCO.2012.47.3314; Jager R, 2010, LEUKEMIA, V24, P1290, DOI 10.1038/leu.2010.99; Kadri S, 2015, J MOL DIAGN, V17, P635, DOI 10.1016/j.jmoldx.2015.06.005; Kantarjian HM, 2018, CANCER-AM CANCER SOC, V124, P4301, DOI 10.1002/cncr.31669; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Korn C, 2017, BLOOD, V129, P811, DOI 10.1182/blood-2016-09-670224; Lasho TL, 2012, LEUKEMIA, V26, P1135, DOI 10.1038/leu.2011.320; Lasho TL, 2011, LEUKEMIA, V25, P1056, DOI 10.1038/leu.2011.45; Lee J, 2017, OCEAN SYST ENG, V7, P1, DOI 10.12989/ose.2017.7.1.001; Lin LI, 2005, CLIN CANCER RES, V11, P1372, DOI 10.1158/1078-0432.CCR-04-1816; Luskin MR, 2016, BLOOD, V127, P1551, DOI 10.1182/blood-2015-07-657403; Makishima H, 2017, INT J HEMATOL, V105, P732, DOI 10.1007/s12185-017-2241-1; Makishima H, 2017, NAT GENET, V49, P204, DOI 10.1038/ng.3742; Mangaonkar AA, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0051-1; Marconi C, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0382-y; Maslah N, 2017, LEUKEMIA, V31, P1661, DOI 10.1038/leu.2017.139; Meggendorfer M, 2013, LEUKEMIA, V27, P1852, DOI 10.1038/leu.2013.133; Metzeler KH, 2012, LEUKEMIA, V26, P1106, DOI 10.1038/leu.2011.342; Metzeler KH, 2016, BLOOD, V128, P686, DOI 10.1182/blood-2016-01-693879; Mori T, 2016, LEUKEMIA, V30, P2270, DOI 10.1038/leu.2016.212; Mughal TI, 2015, HAEMATOLOGICA, V100, P1117, DOI 10.3324/haematol.2014.114660; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Nakao M, 1996, LEUKEMIA, V10, P1911; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pabst T, 2009, BRIT J CANCER, V100, P1343, DOI 10.1038/sj.bjc.6604977; Palomo L, 2020, BRIT J HAEMATOL, V188, P605, DOI 10.1111/bjh.16175; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pardanani A, 2013, LEUKEMIA, V27, P1870, DOI 10.1038/leu.2013.122; Patel KP, 2011, J MOL DIAGN, V13, P678, DOI 10.1016/j.jmoldx.2011.06.004; Patnaik MM, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.5; Patnaik MM, 2018, LEUKEMIA LYMPHOMA, V59, P2273, DOI 10.1080/10428194.2017.1399312; Pellagatti A, 2018, BLOOD, V132, P1225, DOI 10.1182/blood-2018-04-843771; Pellagatti A, 2015, EUR J HAEMATOL, V95, P3, DOI 10.1111/ejh.12515; Perry AM, 2014, SEMIN HEMATOL, V51, P282, DOI 10.1053/j.seminhematol.2014.08.005; Petrova L, 2018, CLIN BIOCHEM, V61, P34, DOI 10.1016/j.clinbiochem.2018.08.012; Pippucci T, 2011, AM J HUM GENET, V88, P115, DOI 10.1016/j.ajhg.2010.12.006; Qin SC, 2017, BLOOD CANCER J, V7, DOI 10.1038/s41408-017-0014-y; Rack KA, 2019, LEUKEMIA, V33, P1851, DOI 10.1038/s41375-019-0378-z; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schnittger S, 2012, GENE CHROMOSOME CANC, V51, P910, DOI 10.1002/gcc.21975; Schranz Katrin, 2018, Oncotarget, V9, P30128, DOI 10.18632/oncotarget.25729; Serrati S, 2016, ONCOTARGETS THER, V9, P7355, DOI 10.2147/OTT.S99807; Song JM, 2017, AM J CLIN PATHOL, V147, P444, DOI [10.1093/AJCP/AQW222, 10.1093/ajcp/aqw222]; Stenzinger A, 2014, ONCOTARGET, V5, P6404, DOI 10.18632/oncotarget.2223; Stone RM, 2017, BEST PRACT RES CL HA, V30, P312, DOI 10.1016/j.beha.2017.09.006; Taylor J, 2017, BLOOD, V130, P410, DOI 10.1182/blood-2017-02-734541; Tefferi A, 2017, AM J HEMATOL, V92, P1311, DOI 10.1002/ajh.24901; Terada K, 2018, GENE CHROMOSOME CANC, V57, P401, DOI 10.1002/gcc.22542; Thol F, 2014, BLOOD, V123, P914, DOI 10.1182/blood-2013-07-518746; Thomas M, 2017, ARCH PATHOL LAB MED, V141, P759, DOI 10.5858/arpa.2016-0547-RA; Varettoni M, 2013, BLOOD, V121, P2522, DOI 10.1182/blood-2012-09-457101; Wong CC, 2014, NAT GENET, V46, P33, DOI 10.1038/ng.2846; Wong TN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02858-0; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Zoi K, 2017, J CLIN ONCOL, V35, P947, DOI 10.1200/JCO.2016.70.7968	84	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227986	10.1371/journal.pone.0227986	http://dx.doi.org/10.1371/journal.pone.0227986			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978184	Green Published, gold			2022-12-26	WOS:000534599100092
J	Broustas, CG; Duval, AJ; Chaudhary, KR; Friedman, RA; Virk, RK; Lieberman, HB				Broustas, Constantinos G.; Duval, Axel J.; Chaudhary, Kunal R.; Friedman, Richard A.; Virk, Renu K.; Lieberman, Howard B.			Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents	ONCOGENE			English	Article							SIGNAL-REGULATED KINASE-5; H2AX PHOSPHORYLATION; ERK ACTIVATION; HISTONE H2AX; EXPRESSION; INHIBITION; CELLS; RADIATION; RADIOSENSITIZATION; MEK5-ALPHA	Radiotherapy is commonly used to treat a variety of solid human tumors, including localized prostate cancer. However, treatment failure often ensues due to tumor intrinsic or acquired radioresistance. Here we find that the MEK5/ERK5 signaling pathway is associated with resistance to genotoxic stress in aggressive prostate cancer cells. MEK5 knockdown by RNA interference sensitizes prostate cancer cells to ionizing radiation (IR) and etoposide treatment, as assessed by clonogenic survival and short-term proliferation assays. Mechanistically, MEK5 downregulation impairs phosphorylation of the catalytic subunit of DNA-PK at serine 2056 in response to IR or etoposide treatment. Although MEK5 knockdown does not influence the initial appearance of radiation- and etoposide-induced gamma H2AX and 53BP1 foci, it markedly delays their resolution, indicating a DNA repair defect. A cell-based assay shows that nonhomologous end joining (NHEJ) is compromised in cells with ablated MEK5 protein expression. Finally, MEK5 silencing combined with focal irradiation causes strong inhibition of tumor growth in mouse xenografts, compared with MEK5 depletion or radiation alone. These findings reveal a convergence between MEK5 signaling and DNA repair by NHEJ in conferring resistance to genotoxic stress in advanced prostate cancer and suggest targeting MEK5 as an effective therapeutic intervention in the management of this disease.	[Broustas, Constantinos G.; Duval, Axel J.; Chaudhary, Kunal R.; Lieberman, Howard B.] Columbia Univ, Ctr Radiol Res, Vagelos Coll Phys & Surg, Irving Med Ctr, New York, NY 10032 USA; [Friedman, Richard A.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Biomed Informat Shared Resource, Irving Med Ctr, New York, NY USA; [Friedman, Richard A.] Columbia Univ, Dept Biomed Informat, Irving Med Ctr, New York, NY USA; [Virk, Renu K.] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY USA; [Lieberman, Howard B.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Broustas, CG (corresponding author), Columbia Univ, Ctr Radiol Res, Vagelos Coll Phys & Surg, Irving Med Ctr, New York, NY 10032 USA.	cgb2117@cumc.columbia.edu	Chaudhary, Kunal/AAF-7187-2021	Chaudhary, Kunal/0000-0001-5423-3174; Broustas, Constantinos/0000-0001-7169-807X	Department of Defense Prostate Cancer Research Program [W81XWH-15-1-0296];  [P30CA013696]	Department of Defense Prostate Cancer Research Program(United States Department of Defense); 	This work is supported by the Department of Defense Prostate Cancer Research Program, W81XWH-15-1-0296 (CGB). This study also used the resources of the Herbert Irving Comprehensive Cancer Center Flow Cytometry, Radiation Research, and Confocal and Specialized Microscopy Shared Resources funded in part through Center Grant P30CA013696. We thank Theresa Swayne and Laura Munteanu from the Confocal and Specialized Microscopy Shared Resource of the Irving Cancer Research Center (ICRC) and Drs. Siu-Hong Ho, Wei Wang, and Caisheng Lu from the Flow Cytometry Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center for their help in performing the immunofluorescence and flow cytometry experiments.	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Benito-Jardon L, 2019, CANCER RES, V79, P2244, DOI 10.1158/0008-5472.CAN-18-2762; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Bouchaert P, 2012, INT J RADIAT ONCOL, V84, P1179, DOI 10.1016/j.ijrobp.2012.02.014; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cameron SJ, 2004, J BIOL CHEM, V279, P1506, DOI 10.1074/jbc.M308755200; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Collis SJ, 2003, CANCER RES, V63, P1550; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Estrada-Bernal A, 2015, CELL CYCLE, V14, P3713, DOI 10.1080/15384101.2015.1104437; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Ghosh AK, 2005, J BIOL CHEM, V280, P14325, DOI 10.1074/jbc.M413313200; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Jiang WW, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0209-3; Kim MR, 2015, MOL CANCER RES, V13, P319, DOI 10.1158/1541-7786.MCR-14-0098-T; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Loveridge CJ, 2017, CANCER RES, V77, P3158, DOI 10.1158/0008-5472.CAN-16-2565; McCracken SRC, 2008, ONCOGENE, V27, P2978, DOI 10.1038/sj.onc.1210963; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Ni XH, 2011, J CLIN INVEST, V121, P2383, DOI 10.1172/JCI45109; Nyati MK, 2006, CANCER RES, V66, P11554, DOI 10.1158/0008-5472.CAN-06-1935; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Palacios DA, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-4; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Pavan S, 2018, ONCOGENE, V37, P4197, DOI 10.1038/s41388-018-0270-8; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Ramsay AK, 2011, BRIT J CANCER, V104, P664, DOI 10.1038/sj.bjc.6606062; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Schweppe RE, 2006, J BIOL CHEM, V281, P20993, DOI 10.1074/jbc.M604208200; Seyfried J, 2005, MOL CELL BIOL, V25, P9820, DOI 10.1128/MCB.25.22.9820-9828.2005; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tusa I, 2018, ONCOGENE, V37, DOI 10.1038/s41388-018-0164-9; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wei FX, 2013, BBA-MOL CELL RES, V1833, P90, DOI 10.1016/j.bbamcr.2012.10.016; Wu CC, 2017, INT J RADIAT ONCOL, V99, P191, DOI 10.1016/j.ijrobp.2017.05.016; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	50	7	7	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2467	2477		10.1038/s41388-020-1163-1	http://dx.doi.org/10.1038/s41388-020-1163-1		JAN 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31980741	Green Accepted, Green Submitted			2022-12-26	WOS:000509176900001
J	Fabre, N; Lhuisset, L; Bernal, C; Bois, J				Fabre, Nicolas; Lhuisset, Lena; Bernal, Caroline; Bois, Julien			Effect of epoch length on intensity classification and on accuracy of measurement under controlled conditions on treadmill: Towards a better understanding of accelerometer measurement	PLOS ONE			English	Article							PHYSICAL-ACTIVITY ASSESSMENT; COMPUTER-SCIENCE; VALIDITY; CHILDREN; MONITOR	Purpose The aim of this study was to analyze the effect of epoch length on intensity classification during continuous and intermittent activities. Methods Ten active students exercised under controlled conditions on a treadmill for four 5-min bouts by combining two effort intensities (running and walking) and two physical activity (PA) patterns (continuous or intermittent). The testing session was designed to generate a known level of moderate to vigorous PA (MVPA) for each condition. These PA levels were used as criterion measures to compare with the accelerometer measures. Data obtained from the accelerometer were reintegrated into 1-sec, 10-sec, 30-sec and 60-sec epochs. Equivalence testing was used to examine measurement agreements between MVPA values obtained with the different epochs and the reference values. Mean absolute percent errors (MAPE) were also calculated to provide an indicator of overall measurement error. Results During the intermittent conditions, only the value obtained with the 1-sec epoch was significantly equivalent to the reference value. With longer epochs the difference increased for both intermittent conditions but in an opposite way: with longer epochs, MVPA decreased during walking but increased during running. Regarding the measurement accuracy, the pattern of variations according to the epoch length selected during the intermittent conditions was identical between walking and running: MAPE increased with the increase in epoch length. MAPE remained low only for the 1-sec epoch (7.6% and 2.7% for walking and running, respectively), increased at 31.3% and 34% for the 10-sec epoch and until near 100% with the 30- and 60-sec epoch lengths. Conclusion This study highlighted the misclassification of exercise intensity based on accelerometer measurement and described for the first time the extent and the direction of this misclassification. Moreover, we can confirm that the shorter epochs are more accurate to measure the real exercise intensity during intermittent PA whatever the intensity.	[Fabre, Nicolas; Lhuisset, Lena; Bernal, Caroline; Bois, Julien] Univ Pau & Pays Adour, e2s UPPA, MEPS, Tarbes, France	Universite de Pau et des Pays de l'Adour	Fabre, N (corresponding author), Univ Pau & Pays Adour, e2s UPPA, MEPS, Tarbes, France.	nicolas_fabre@hotmail.com		Fabre, Nicolas/0000-0001-5167-5583; Bois, Julien/0000-0003-0659-3954	European Regional Development Fund (FEDER) Interreg V-A Espagne-France-Andorre (POCTEFA 2014-2020) [EFA0995/15]	European Regional Development Fund (FEDER) Interreg V-A Espagne-France-Andorre (POCTEFA 2014-2020)	This work was supported by the European Regional Development Fund (FEDER) Interreg V-A Espagne-France-Andorre (POCTEFA 2014-2020) (EFA0995/15) - https://www.poctefa.eu The beneficiaries are NF, LL and JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121238; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Chomistek AK, 2017, MED SCI SPORT EXER, V49, P1935, DOI 10.1249/MSS.0000000000001299; Dixon PM, 2018, MED SCI SPORT EXER, V50, P837, DOI 10.1249/MSS.0000000000001481; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gastin PB, 2018, J SCI MED SPORT, V21, P291, DOI 10.1016/j.jsams.2017.07.022; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Kim YW, 2016, J SCI MED SPORT, V19, P35, DOI 10.1016/j.jsams.2014.10.002; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Organizacion Mundial de la Salud (OMS), 2010, GLOB REC PHYS ACT HL; Orme M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-34; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Sagelv EH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225670; SALLIS JF, 1991, RES Q EXERCISE SPORT, V62, P124, DOI 10.1080/02701367.1991.10608701; SANDERS T, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0092040; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost S G, 2001, Exerc Sport Sci Rev, V29, P32, DOI 10.1097/00003677-200101000-00007; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Tudor-Locke C, 2018, BRIT J SPORT MED, V52, P776, DOI 10.1136/bjsports-2017-097628; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Welk GJ, 2000, MED SCI SPORT EXER, V32, pS489, DOI 10.1097/00005768-200009001-00008; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	27	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227740	10.1371/journal.pone.0227740	http://dx.doi.org/10.1371/journal.pone.0227740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978093	Green Published, gold			2022-12-26	WOS:000534599100054
J	Moen, V; Brudin, L; Ebberyd, A; Sennstrom, M; Ekman-Ordeberg, G; Rundgren, M; Irestedt, L				Moen, Vibeke; Brudin, Lars; Ebberyd, Anette; Sennstrom, Maria; Ekman-Ordeberg, Gunvor; Rundgren, Mats; Irestedt, Lars			Hyponatraemia reversibly affects human myometrial contractility. An in vitro pilot study	PLOS ONE			English	Article							SMOOTH-MUSCLE; LABOR; OXYTOCIN; CA2+	Background In a previous study we found a significant correlation between dystocia and hyponatraemia that developed during labour. The present study examined a possible causal relationship. In vitro studies often use area under the curve (AUC) determined by frequency and force of contractions as a measure of myometrial contractility. However, a phase portrait plot of isometric contraction, obtained by plotting the first derivate of contraction against force of contraction, could indicate that bi-or multiphasic contractions might be less effective compared to the smooth contractions. Material and methods Myometrial biopsies were obtained from 17 women undergoing elective caesarean section at term. Each biopsy was divided into 8 strips and mounted isometrically in a force transducer. Seven biopsies were used in the first part of the study when half of the strips were immersed in the hyponatraemic study solution S containing Na+ 120 mmol/L and observed for 1 hour, followed by 1 hour in normonatraemic control solution C containing Na+ 136 mmol/L, then again in S for 1 hour, and finally 1 hour in C. The other half of the strips were studied in reverse order, C-S-C-S. The remaining ten biopsies were included in the second part of the study. Response to increasing doses of oxytocin (OT) in solutions S and C was studied. In the first part of the study we calculated AUC, and created phase portrait plots of two different contractions from the same strip, one smooth and one biphasic. In both parts of the study we registered frequency and force of contractions, and described appearance of the contractions. Results First part of the study: Mean (median) contractions per hour in C: 8.7 (7.6), in S 14,3 (13). Mean (SD) difference between groups 5.6 (4.2), p = 0.018. Force of contractions in C: 11.8 (10.2) mN, in S: 10.8 (9.2) mN, p = 0.09, AUC increased in S; p = 0.018. Bi-/multiphasic contractions increased from 8% in C to 18% in S, p = 0.001. All changes were reversible in C. Second part of the study: Frequency after OT 1.65 x 10-(9) M in C:3.4 (2.9), in S: 3.8 (3.2), difference between groups: p = 0.48. After OT 1.65 x 10-(7) M in C: 7.8 (8.9), increase from previous OT administration: p = 0.09, in S: 8.7 (9.0), p = 0.04, difference between groups, p = 0.32. Only at the highest dose of OT dose was there an increase in force of contraction in S, p = 0.05, difference between groups, p = 0.33. Initial response to OT was more frequently bi/multiphasic in S, reaching significance at the highest dose of OT(1.65 x 10-(7) M), p = 0.015. when almost all contractions were bi/multiphasic. Conclusion Hyponatraemia reversibly increased frequency of contractions and appearance of bi-or multiphasic contractions, that could reduce myometrial contractility. This could explain the correlation of hyponatraemia and instrumental delivery previously observed. Contractions in the hyponatraemic solution more frequently showed initial multiphasic contractions when OT was added in increasing doses. Longer lasting labours carry the risk both of hyponatraemia and OT administration, and their negative interaction could be significant. Further studies should address this possibility.	[Moen, Vibeke] Dept Anaesthesiol & Intens Care, Kalmar, Region Kalmar C, Sweden; [Moen, Vibeke; Irestedt, Lars] Karolinska Inst, Dept Physiol & Pharmacol, Div Anaesthesiol & Intens Care, Stockholm, Sweden; [Moen, Vibeke; Brudin, Lars] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Ebberyd, Anette; Rundgren, Mats] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Sennstrom, Maria; Ekman-Ordeberg, Gunvor] Karolinska Inst, Dept Women & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Linkoping University; Karolinska Institutet; Karolinska Institutet	Moen, V (corresponding author), Dept Anaesthesiol & Intens Care, Kalmar, Region Kalmar C, Sweden.; Moen, V (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Div Anaesthesiol & Intens Care, Stockholm, Sweden.; Moen, V (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	vibeke.moen@ltkalrmar.se		Sennstrom, Maria/0000-0002-6532-022X	Patient Insurance Claims in Sweden [VIMO20120207]	Patient Insurance Claims in Sweden	This work was supported by: VM, Grant from the Patient Insurance Claims in Sweden, https://lof.se, Grant number: VIMO20120207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, GUIDELINE PREVENTION; Arrowsmith S, 2014, J NEUROENDOCRINOL, V26, P356, DOI 10.1111/jne.12154; CUMMISKEY KC, 1989, OBSTET GYNECOL, V74, P869; Ekman-Ordeberg G, 2009, ACTA OBSTET GYN SCAN, V88, P984, DOI 10.1080/00016340903176818; Eslamian L, 2006, INT J GYNECOL OBSTET, V93, P102, DOI 10.1016/j.ijgo.2006.01.023; Garite TJ, 2000, AM J OBSTET GYNECOL, V183, P1544, DOI 10.1067/mob.2000.107884; Gullam JE, 2009, EUR J OBSTET GYN R B, V144, pS20, DOI 10.1016/j.ejogrb.2009.02.020; Hoorn EJ, 2017, J AM SOC NEPHROL, V28, P1340, DOI 10.1681/ASN.2016101139; Johansson S, 2002, ACTA PAEDIATR, V91, P811, DOI 10.1080/08035250213218; KAMIZAKI J, 1988, JPN J PHARMACOL, V47, P179, DOI 10.1254/jjp.47.179; Moen V, 2009, BJOG-INT J OBSTET GY, V116, P552, DOI 10.1111/j.1471-0528.2008.02063.x; Moritz ML, 2007, NAT CLIN PRACT NEPHR, V3, P374, DOI 10.1038/ncpneph0526; Reinl EL, 2015, MOL HUM REPROD, V21, P816, DOI 10.1093/molehr/gav038; Salamalekis E., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P21; Shmygol A, 2007, ANN NY ACAD SCI, V1101, P97, DOI 10.1196/annals.1389.031; SPERELAKIS N, 1992, MOL CELL BIOCHEM, V114, P79; Tribe RM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.11.001; Valerio Enrico, 2015, Matern Health Neonatol Perinatol, V1, P25, DOI 10.1186/s40748-015-0027-0; Wray S, 2015, ACTA PHYSIOL, V213, P417, DOI 10.1111/apha.12431	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0220020	10.1371/journal.pone.0220020	http://dx.doi.org/10.1371/journal.pone.0220020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971939	Green Published, gold			2022-12-26	WOS:000534374400001
J	Mohammed, S; Vineetha, NS; James, S; Aparna, JS; Lankadasari, MB; Maeda, T; Ghosh, A; Saha, S; Li, QZ; Spiegel, S; Harikumar, KB				Mohammed, Sabira; Vineetha, Nalanda S.; James, Shirley; Aparna, Jayasekharan S.; Lankadasari, Manendra Babu; Maeda, Takahiro; Ghosh, Abhirupa; Saha, Sudipto; Li, Quan-Zhen; Spiegel, Sarah; Harikumar, Kuzhuvelil B.			Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity	FASEB JOURNAL			English	Article						auto-immunity; interferon; plasmacytoid dendritic cells; sphingosine 1-Phosphate; sphingosine kinase; systemic lupus erythematosus	PLASMACYTOID DENDRITIC CELLS; IFN-ALPHA PRODUCTION; INDUCED LUPUS; SPHINGOSINE; SPHINGOSINE-1-PHOSPHATE; MICE; FTY720; MODULATION; EXPRESSION; INHIBITOR	Plasmacytoid dendritic cells (pDCs) express Toll like receptors (TLRs) that modulate the immune response by production of type I interferons. Here, we report that sphingosine kinase 1 (SphK1) which produces the bioactive sphingolipid metabolite, sphingosine 1-phosphate (S1P), plays a critical role in the pDC functions and interferon production. Although dispensable for the pDC development, SphK1 is essential for the pDC activation and production of type I IFN and pro-inflammatory cytokines stimulated by TLR7/9 ligands. SphK1 interacts with TLRs and specific inhibition or deletion of SphK1 in pDCs mitigates uptake of CpG oligonucleotide ligands by TLR9 ligand. In the pristane-induced murine lupus model, pharmacological inhibition of SphK1 or its genetic deletion markedly decreased the IFN signature, pDC activation, and glomerulonephritis. Moreover, increases in the SphK1 expression and S1P levels were observed in human lupus patients. Taken together, our results indicate a pivotal regulatory role for the SphK1/S1P axis in maintaining the balance between immunosurveillance and immunopathology and suggest that specific SphK1 inhibitors might be a new therapeutic avenue for the treatment of type I IFN-linked autoimmune disorders.	[Mohammed, Sabira; James, Shirley; Aparna, Jayasekharan S.; Lankadasari, Manendra Babu; Harikumar, Kuzhuvelil B.] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Mohammed, Sabira; Lankadasari, Manendra Babu] MAHE, Manipal, India; [Vineetha, Nalanda S.] Govt Med Coll, Dept Nephrol, Thiruvananthapuram, Kerala, India; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Isl Med Res Inst, Dept Isl & Community Med, Nagasaki, Japan; [Ghosh, Abhirupa; Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, India; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA; [Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Nagasaki University; Department of Science & Technology (India); Bose Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University	Harikumar, KB (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India.	harikumar@rgcb.res.in	Ghosh, Abhirupa/GWC-7986-2022; Harikumar, Kuzhuvelil/AAC-2407-2020; Lankadasari, Manendra/AAI-9639-2021	Ghosh, Abhirupa/0000-0002-3980-4749; Harikumar, Kuzhuvelil/0000-0002-1763-4179; Saha, Sudipto/0000-0001-9433-8894; Jazir, Sabira Mohammed/0000-0002-0332-3660	Deaprtment of Science and Technology [SR/FT/LS-159/2012]; Department of Biotechnology, Ministry of Science and Technology (DBT) [BT/RLF/Reentry/38/2011]; Council of Scientific and Industrial Research (CSIR) [37 (1720)/18/EMR-II]; National Institute of Health, USA [R01GM043880]	Deaprtment of Science and Technology; Department of Biotechnology, Ministry of Science and Technology (DBT); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Deaprtment of Science and Technology, Grant/Award Number: SR/FT/LS-159/2012; Department of Biotechnology, Ministry of Science and Technology (DBT), Grant/Award Number: BT/RLF/Reentry/38/2011; Council of Scientific and Industrial Research (CSIR), Grant/Award Number: No.37 (1720)/18/EMR-II; National Institute of Health, USA, Grant/Award Number: R01GM043880	Alculumbre S, 2019, SEMIN CELL DEV BIOL, V86, P24, DOI 10.1016/j.semcdb.2018.02.014; Aloia AL, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.32; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dillmann C, 2016, J IMMUNOL, V196, P1579, DOI 10.4049/jimmunol.1403168; Freitas E, 2017, CLIN RHEUMATOL, V36, P2403, DOI 10.1007/s10067-017-3811-6; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Guerrier T, 2014, J AUTOIMMUN, V51, P23, DOI 10.1016/j.jaut.2014.02.005; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Janovec V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00364; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Kienhofer D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92920; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Lankadasari MB, 2018, THERANOSTICS, V8, P3824, DOI 10.7150/thno.25308; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Liao XF, 2015, J IMMUNOL, V195, P4578, DOI 10.4049/jimmunol.1501157; Lima S, 2018, AUTOPHAGY, V14, P942, DOI 10.1080/15548627.2018.1429875; Lima S, 2017, J BIOL CHEM, V292, P3074, DOI 10.1074/jbc.M116.762377; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meyer-Schwesinger C, 2011, J IMMUNOL, V187, P3218, DOI 10.4049/jimmunol.1003451; Mohammed S, 2019, FASEB J, V33, P7061, DOI 10.1096/fj.201802535R; Newton J, 2017, FASEB J, V31, P1719, DOI 10.1096/fj.201601041R; Okazaki H, 2002, J RHEUMATOL, V29, P707; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Scott JL, 2017, CLIN IMMUNOL, V175, P109, DOI 10.1016/j.clim.2016.12.009; Seo YJ, 2010, J VIROL, V84, P8124, DOI 10.1128/JVI.00510-10; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Steinhagen F, 2016, EUR J IMMUNOL, V46, P647, DOI 10.1002/eji.201545911; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sui MS, 2012, MOL BIOL REP, V39, P389, DOI 10.1007/s11033-011-0750-1; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Teijaro JR, 2016, P NATL ACAD SCI USA, V113, P1351, DOI 10.1073/pnas.1525356113; Theofilopoulos AN, 2012, J CLIN INVEST, V122, P3464, DOI 10.1172/JCI63835; Vijayan M, 2014, VIROLOGY, V450, P55, DOI 10.1016/j.virol.2013.11.039; Watson L, 2012, J CLIN IMMUNOL, V32, P1019, DOI 10.1007/s10875-012-9710-3; Xu Y, 2015, ARTHRITIS RHEUMATOL, V67, P225, DOI 10.1002/art.38882; Young MM, 2016, CELL REP, V17, P1532, DOI 10.1016/j.celrep.2016.10.019; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587; Zhou ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20373; Zhuang HY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00291	65	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4329	4347		10.1096/fj.201902847R	http://dx.doi.org/10.1096/fj.201902847R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31971297	Green Accepted			2022-12-26	WOS:000508880400001
J	Lenz, D; Winker, P				Lenz, David; Winker, Peter			Measuring the diffusion of innovations with paragraph vector topic models	PLOS ONE			English	Article								Measuring the diffusion of innovations from textual data sources besides patent data has not been studied extensively. However, early and accurate indicators of innovation and the recognition of trends in innovation are mandatory to successfully promote economic growth through technological progress via evidence-based policy making. In this study, we propose Paragraph Vector Topic Model (PVTM) and apply it to technology-related news articles to analyze innovation-related topics over time and gain insights regarding their diffusion process. PVTM represents documents in a semantic space, which has been shown to capture latent variables of the underlying documents, e.g., the latent topics. Clusters of documents in the semantic space can then be interpreted and transformed into meaningful topics by means of Gaussian mixture modeling. In using PVTM, we identify innovation-related topics from 170, 000 technology news articles published over a span of 20 years and gather insights about their diffusion state by measuring the topic importance in the corpus over time. Our results suggest that PVTM is a credible alternative to widely used topic models for the discovery of latent topics in (technology-related) news articles. An examination of three exemplary topics shows that innovation diffusion could be assessed using topic importance measures derived from PVTM. Thereby, we find that PVTM diffusion indicators for certain topics are Granger causal to Google Trend indices with matching search terms.	[Lenz, David; Winker, Peter] Justus Liebig Univ, Dept Econ, Giessen, Germany	Justus Liebig University Giessen	Lenz, D; Winker, P (corresponding author), Justus Liebig Univ, Dept Econ, Giessen, Germany.	david.lenz@wirtschaft.uni-giessen.de; peter.winker@wirtschaft.uni-giessen.de	Winker, Peter/D-1389-2011	Winker, Peter/0000-0003-3412-4207; Lenz, David/0000-0002-2418-6239	German Federal Ministry of Education and Research [16IFI001]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The German Federal Ministry of Education and Research provided funding for the research project (TOBI - Text Data BasedOutput Indicators as Base of a New Innovation Metric; funding ID: 16IFI001, Prof. Dr. Peter Winker) https://www.bmbf.de/en/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abood A, 2018, ARTIF INTELL LAW, V26, P103, DOI 10.1007/s10506-018-9222-4; Anandarajan M., 2019, PRACTICAL TEXT ANALY, P117, DOI [10.1007/978-3-319-95663-3_8, DOI 10.1007/978-3-319-95663-3_8]; Bendersky Michael, 2011, P 2016 ACM INT C THE, DOI DOI 10.1145/2970398.2970409; Bergeaud A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176310; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bridle John S, 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28; Chavalarias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054847; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Choi J, 2014, TECHNOL FORECAST SOC, V83, P170, DOI 10.1016/j.techfore.2013.07.004; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duwe D., 2018, P 18 PORTL INT C MAN, P1, DOI [10.23919/PICMET.2018.8481971, DOI 10.23919/PICMET.2018.8481971]; Feuerriegel S, DECISION SCI; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; GRANGER CWJ, 1995, ECONOMET THEOR, V11, P530, DOI 10.1017/S0266466600009397; Hansen S, 2018, Q J ECON, V133, P801, DOI 10.1093/qje/qjx045; Hansen S, 2016, J INT ECON, V99, pS114, DOI 10.1016/j.jinteco.2015.12.008; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hashimoto K, 2016, J BIOMED INFORM, V62, P59, DOI 10.1016/j.jbi.2016.06.001; Hidasi B, 2016, PROCEEDINGS OF THE 10TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'16), P241, DOI 10.1145/2959100.2959167; Hisano R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064846; Kelly B, 2018, MEASURING TECHNOLOGI, P25266; Kilian L, 2017, THEME MOD ECONOMET, P1, DOI 10.1017/9781108164818; Landgraf AJ, ABS170509755 CORR; Larsen VH, 2019, J ECONOMETRICS, V210, P203, DOI 10.1016/j.jeconom.2018.11.013; Lau JH, ABS160705368 CORR; Le Q, 2014, 31 INT C MACH LEARN, P4; Lee WJ, 2018, J THEOR APPL EL COMM, V13, P1, DOI 10.4067/S0718-18762018000200102; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Loper E., 2002, P ACL 02 WORKSHOP EF, V1, P63, DOI DOI 10.3115/1118108.1118117; Ludering J, 2016, JAHRB NATL STAT, V236, P483, DOI 10.1515/jbnst-2015-1026; Mikolov T., 2013, ADV NEURAL INFORM PR, V26; Mikolov T., 2013, P WORKSH ICLR 2013; Miner G, 2012, PRACTICAL TEXT MINING AND STATISTICAL ANALYSIS FOR NON-STRUCTURED TEXT DATA APPLICATIONS, P53, DOI 10.1016/B978-0-12-386979-1.00004-9; Mizuno T, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0123-7; Nichols LG, 2014, SCIENTOMETRICS, V100, P741, DOI 10.1007/s11192-014-1319-2; Niu L, ABS150608422 CORR; Prollochs N., 2018, INFORM MANAGEMENT; Reynolds DA, 2000, DIGIT SIGNAL PROCESS, V10, P19, DOI 10.1006/dspr.1999.0361; Reynolds DA., 2009, ENCY BIOMETRICS, V741, P659; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Sammut C., 2017, ENCY MACHINE LEARNIN, V2nd, DOI DOI 10.1007/978-1-4899-7687-1_68; Santosh D., 2013, INT J SOFT COMPUTING, V3, P114; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sorodoc I., 2017, P 15 C EACL, V2, P701, DOI [10.18653/v1/E17-2111, DOI 10.18653/V1/E17-2111]; Varian HR, 2014, J ECON PERSPECT, V28, P3, DOI 10.1257/jep.28.2.3; Wehrheim L, 2019, CLIOMETRICA, V13, P83, DOI 10.1007/s11698-018-0171-7; Yoon B., 2004, J HIGH TECHNOLOGY MA, V15, P37, DOI [DOI 10.1016/J.IPM.2006.11.011, 10.1016/j.hitech.2003.09.003, DOI 10.1016/J.HITECH.2003.09.003]; Yu D, 2015, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4471-5779-3	49	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0226685	10.1371/journal.pone.0226685	http://dx.doi.org/10.1371/journal.pone.0226685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5QT	31967999	Green Submitted, Green Published, gold			2022-12-26	WOS:000534373000007
J	Aranda-Garcia, E; Cristiani-Urbina, E				Aranda-Garcia, Erick; Cristiani-Urbina, Eliseo			Hexavalent chromium removal and total chromium biosorption from aqueous solution by Quercus crassipes acorn shell in a continuous up-flow fixed-bed column: Influencing parameters, kinetics, and mechanism	PLOS ONE			English	Article							OIL PALM BIOMASS; CR(VI); ADSORPTION; BATCH; OPTIMIZATION; ADSORBENTS; REDUCTION; SUBSTRATE; SORPTION; SEAWEED	Continuous fixed-bed column studies were carried out, utilizing acorn shell from Quercus crassipes Humb. & Bonpl. (QCS), in order to remove total chromium and Cr(VI) from aqueous solution. Effects of various fixed-bed column parameters such as influent solution pH, influent flow rate, QCS bed height, and influent Cr(VI) concentration were investigated. Results from the fixed-bed column experiments demonstrate that total chromium biosorption and Cr(VI) removal by QCS depend strongly on the pH of influent solution. The highest capacities for Cr(VI) removal and total chromium biosorption are about 181.56 and 110.35 mg g(-1) and are achieved at influent solution pH of 1.0 and 2.0, respectively. Besides this, total chromium biosorption capacities increased from 104.25 to 116.14 mg g(-1), 109.07 to 117.44 mg g(-1), and 85.02 to 129.87 mg g(-1), as bed height, inlet flow rate, and influent Cr(VI) concentration increased from 1.7 to 6.5 cm, 0.25 to 1 mL min(-1), and 50 to 400 mg L-1, respectively. The dose-response model defines the entire breakthrough curve for total chromium biosorption onto QCS, under all experimental conditions. X-ray photoelectron spectroscopy (XPS) and biosorption kinetic studies revealed that QCS is able to remove toxic Cr (VI) from acidic liquid solution by means of a complex mechanism that involves the binding of Cr(VI) oxyanions to positively charged groups present at the QCS surface, after which the Cr(VI) species are reduced to Cr(III) by adjacent electron donor groups, and the generated Cr(III) ions then become partially bound to the QCS biomass and partially released into the liquid phase. Results show that QCS can be employed as an easily accessible, abundant, eco-friendly, and inexpensive biosorbent for the removal of total chromium and Cr(VI) from Cr(VI) solutions, in continuous operation.	[Aranda-Garcia, Erick; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Unidad Profes Adolfo Lopez Mateos, Ave Wilfrido Massieu S-N, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Unidad Profes Adolfo Lopez Mateos, Ave Wilfrido Massieu S-N, Mexico City, DF, Mexico.	ecristianiu@yahoo.com.mx	Aranda-García, Erick/AAB-9048-2021	Aranda-García, Erick/0000-0002-4435-0577; Cristiani-Urbina, Eliseo/0000-0002-8470-0711				Agency for Toxic Substances and Disease Registry, 2017, ATSDRS SUBST PRIOR L; Ahmad T, 2012, ENVIRON SCI POLLUT R, V19, P1464, DOI 10.1007/s11356-011-0709-8; Ahmad T, 2011, J ENVIRON SCI HEAL C, V29, P177, DOI 10.1080/10590501.2011.601847; Aranda-Garcia E, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3775-4; Aranda-Garcia E, 2010, J BIOTECHNOL, V150, pS228, DOI 10.1016/j.jbiotec.2010.09.066; Aranda-Garcia E, 2019, ENVIRON SCI POLLUT R, V26, P3157, DOI 10.1007/s11356-017-0248-z; Aranda-Garcia E, 2014, ENVIRON MONIT ASSESS, V186, P6207, DOI 10.1007/s10661-014-3849-8; Bharathi KS, 2013, APPL WATER SCI, V3, P673, DOI 10.1007/s13201-013-0103-4; Calero M, 2009, J HAZARD MATER, V171, P886, DOI 10.1016/j.jhazmat.2009.06.082; Calero M, 2016, DESALIN WATER TREAT, V57, P25140, DOI 10.1080/19443994.2016.1150209; Chatterjee A, 2011, CLEAN-SOIL AIR WATER, V39, P874, DOI 10.1002/clen.201000482; Chen SH, 2012, BIORESOURCE TECHNOL, V113, P114, DOI 10.1016/j.biortech.2011.11.110; Company Hach, 2008, HACH WATER ANAL HDB; Danish M, 2012, J ANAL APPL PYROL, V97, P19, DOI 10.1016/j.jaap.2012.06.001; Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345; Farooq U, 2013, ENVIRON MONIT ASSESS, V185, P845, DOI 10.1007/s10661-012-2595-z; Fiol N, 2006, REACT FUNCT POLYM, V66, P795, DOI 10.1016/j.reactfunctpolym.2005.11.006; Gokhale SV, 2009, J HAZARD MATER, V170, P735, DOI 10.1016/j.jhazmat.2009.05.005; Hasan SH, 2009, APPL MICROBIOL BIOT, V83, P567, DOI 10.1007/s00253-009-1984-x; Hasan SH, 2010, BIORESOURCES, V5, P563; Jafari SA, 2016, KOREAN J CHEM ENG, V33, P1296, DOI 10.1007/s11814-015-0261-1; Jobby R, 2018, CHEMOSPHERE, V207, P255, DOI 10.1016/j.chemosphere.2018.05.050; Kumar D, 2016, ALGAL RES, V18, P95, DOI 10.1016/j.algal.2016.05.026; Malkoc E, 2006, CHEM ENG J, V119, P61, DOI 10.1016/j.cej.2006.01.019; Mertens D., 2005, OFFICIAL METHODS ANA, V18th ed., P1; Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329+; Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007; Rangabhashiyam S., 2016, J ENV BIOTECH RES, V5, P39; Netzahuatl-Munoz AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137086; Netzahuatl-Munoz AR, 2012, WATER AIR SOIL POLL, V223, P625, DOI 10.1007/s11270-011-0888-4; Samuel J, 2013, BIORESOURCE TECHNOL, V128, P423, DOI 10.1016/j.biortech.2012.10.116; Senthilkumar R, 2010, ENVIRON PROG SUSTAIN, V29, P334, DOI 10.1002/ep.10416; Silva B, 2012, INT BIODETER BIODEGR, V74, P116, DOI 10.1016/j.ibiod.2012.05.026; Vakili M, 2014, REV ENVIRON CONTAM T, V232, P61, DOI 10.1007/978-3-319-06746-9_3; Lopez-Nunez PV, 2014, ENVIRON ENG MANAG J, V13, P1927; Vieira MGA, 2008, BIORESOURCE TECHNOL, V99, P3094, DOI 10.1016/j.biortech.2007.05.071; Xia SP, 2019, CRIT REV ENV SCI TEC, V49, P1027, DOI 10.1080/10643389.2018.1564526; Xu TT, 2017, APPL SURF SCI, V402, P294, DOI 10.1016/j.apsusc.2017.01.114; Zang TT, 2017, ECOL ENG, V99, P358, DOI 10.1016/j.ecoleng.2016.11.070; Zhang YW, 2018, INT J BIOL MACROMOL, V107, P1193, DOI 10.1016/j.ijbiomac.2017.09.099	40	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227953	10.1371/journal.pone.0227953	http://dx.doi.org/10.1371/journal.pone.0227953			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LG0AK	31961884	Green Published, gold			2022-12-26	WOS:000527773500001
J	Li, Z; Rotival, M; Patin, E; Michel, F; Pellegrini, S				Li, Zhi; Rotival, Maxime; Patin, Etienne; Michel, Frederique; Pellegrini, Sandra			Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage	PLOS ONE			English	Article							GENETIC ASSOCIATION; INTERFERON; EXPRESSION; RECEPTOR; POLYMORPHISMS; SUSCEPTIBILITY; MUTATIONS; CHINESE; QUANTIFICATION; RESISTANCE	TYK2 belongs to the JAK protein tyrosine kinase family and mediates signaling of numerous antiviral and immunoregulatory cytokines (type I and type III IFNs, IL-10, IL-12, IL-22, IL-23) in immune and non-immune cells. After many years of genetic association studies, TYK2 is recognized as a susceptibility gene for some inflammatory and autoimmune diseases (AID). Seven TYK2 variants have been associated with AIDs in Europeans, and establishing their causality remains challenging. Previous work showed that a protective variant (P1104A) is hypomorphic and also a risk allele for mycobacterial infection. Here, we have studied two AID-associated common TYK2 variants: rs12720270 located in intron 7 and rs2304256, a non-synonymous variant in exon 8 that causes a valine to phenylalanine substitution (c.1084 G > T, Val362Phe). We found that this amino acid substitution does not alter TYK2 expression, catalytic activity or ability to relay signaling in EBV-B cell lines or in reconstituted TYK2-null cells. Based on in silico predictions that these variants may impact splicing of exon 8, we: i) analyzed TYK2 transcripts in genotyped EBV-B cells and in CRISPR/Cas9edited cells, ii) measured splicing using minigene assays, and iii) performed eQTL (expression quantitative trait locus) analysis of TYK2 transcripts in primary monocytes and whole blood cells. Our results reveal that the two variants promote the inclusion of exon 8, which, we demonstrate, is essential for TYK2 binding to cognate receptors. In addition and in line with GTEx (Genetic Tissue Expression) data, our eQTL results show that rs2304256 mildly enhances TYK2 expression in whole blood. In all, these findings suggest that these TYK2 variants are not neutral but instead have a potential impact in AID.	[Li, Zhi; Michel, Frederique; Pellegrini, Sandra] Inst Pasteur, Unit Cytokine Signaling, INSERM, U1221, Paris, France; [Rotival, Maxime; Patin, Etienne] Inst Pasteur, Unit Human Evolutionary Genet, CNRS, UMR2000, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pellegrini, S (corresponding author), Inst Pasteur, Unit Cytokine Signaling, INSERM, U1221, Paris, France.	sandra.pellegrini@pasteur.fr		VAL, Thierry/0000-0002-5749-8570	Institut Pasteur; Fondation pour la Recherche Medicale [Equipe FRM DEQ20170336741, Equipe FRM DEQ20180339214]; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); French Government's Investissement d'Avenir program; Laboratoires d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Milieu Interieur [ANR-10-LABX-69-01]	Institut Pasteur(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Government's Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoires d'Excellence "Integrative Biology of Emerging Infectious Diseases"; Milieu Interieur	Research in the Unit of Cytokine Signaling funded by the Institut Pasteur, the Fondation pour la Recherche Medicale (Equipe FRM DEQ20170336741) and the Institut National de la Sante et de la Recherche Medicale (INSERM). ZL is supported by the Centre National de la Recherche Scientifique (CNRS). Research in the Unit of Human Evolutionary Genetics funded by the Institut Pasteur, the French Government's Investissement d'Avenir program, Laboratoires d'Excellence "Integrative Biology of Emerging Infectious Diseases" (ANR-10-LABX-62-IBEID), "Milieu Interieur" (ANR-10-LABX-69-01) and the Fondation pour la Recherche Medicale (Equipe FRM DEQ20180339214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Boisson-Dupuis S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau8714; Castel SE, 2018, NAT GENET, V50, P1327, DOI 10.1038/s41588-018-0192-y; Charbit-Henrion F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205826; Dand N, 2017, HUM MOL GENET, V26, P4301, DOI 10.1093/hmg/ddx328; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Derecka M, 2012, CELL METAB, V16, P814, DOI 10.1016/j.cmet.2012.11.005; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Duffy D, 2014, IMMUNITY, V40, P436, DOI 10.1016/j.immuni.2014.03.002; EID P, 1995, J INTERF CYTOK RES, V15, P205, DOI 10.1089/jir.1995.15.205; Enerback C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25282-2; Ferrao R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00071; Ferrao RD, 2018, ELIFE, V7, DOI 10.7554/eLife.38089; Franco LM, 2019, J EXP MED, V216, P384, DOI 10.1084/jem.20180595; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gorman JA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00044; Graham DSC, 2007, RHEUMATOLOGY, V46, P927, DOI 10.1093/rheumatology/kel449; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Hellquist A, 2009, J RHEUMATOL, V36, P1631, DOI 10.3899/jrheum.081160; Izumi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7748; Kerner G, 2019, P NATL ACAD SCI USA, V116, P10430, DOI 10.1073/pnas.1903561116; Kreins AY, 2015, J EXP MED, V212, P1641, DOI 10.1084/jem.20140280; Kyogoku C, 2009, MOD RHEUMATOL, V19, P401, DOI 10.1007/s10165-009-0173-1; Leitner NR, 2017, CYTOKINE, V89, P209, DOI 10.1016/j.cyto.2015.10.015; Li P, 2011, J RHEUMATOL, V38, P177, DOI 10.3899/jrheum.100424; Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Lopez-Isac E, 2016, ANN RHEUM DIS, V75, P1521, DOI 10.1136/annrheumdis-2015-208154; Manning KS, 2017, NAT REV MOL CELL BIO, V18, P102, DOI 10.1038/nrm.2016.139; Matesanz F, 2015, HUM MOL GENET, V24, P5619, DOI 10.1093/hmg/ddv256; Morris DL, 2016, NAT GENET, V48, P940, DOI 10.1038/ng.3603; Nagafuchi S, 2015, EBIOMEDICINE, V2, P744, DOI 10.1016/j.ebiom.2015.05.004; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Odhams CA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007071; Papp K, 2018, NEW ENGL J MED, V379, P1313, DOI 10.1056/NEJMoa1806382; Park E, 2018, AM J HUM GENET, V102, P11, DOI 10.1016/j.ajhg.2017.11.002; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Potla R, 2006, MOL CELL BIOL, V26, P8562, DOI 10.1128/MCB.00497-06; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Quatrini L, 2018, NAT IMMUNOL, V19, P954, DOI 10.1038/s41590-018-0185-0; Ragimbeau J, 2001, J BIOL CHEM, V276, P30812, DOI 10.1074/jbc.M103559200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Rotival M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09689-7; Sato K, 2009, J CLIN IMMUNOL, V29, P815, DOI 10.1007/s10875-009-9320-x; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Tang L, 2015, INFLAMM RES, V64, P817, DOI 10.1007/s00011-015-0865-2; Thomas AO, 2015, J ALLERGY CLIN IMMUN, V136, P282, DOI 10.1016/j.jaci.2014.12.1927; Thomas S, 2015, CLIN IMMUNOL, V157, P277, DOI 10.1016/j.clim.2014.12.004; Tovey MG, 2010, PHARMACEUTICALS, V3, P1162, DOI 10.3390/ph3041162; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Koetsveld PM, 2013, ENDOCR-RELAT CANCER, V20, P443, DOI 10.1530/ERC-12-0217; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Westra HJ, 2018, NAT GENET, V50, P1366, DOI 10.1038/s41588-018-0216-7; Zouein FA, 2011, GROWTH FACTORS, V29, P245, DOI 10.3109/08977194.2011.614949	69	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0225289	10.1371/journal.pone.0225289	http://dx.doi.org/10.1371/journal.pone.0225289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961910	Green Published, gold, Green Submitted			2022-12-26	WOS:000534372000005
J	Chan, TO; Armen, RS; Yadav, S; Shah, S; Zhang, J; Tiegs, BC; Keny, N; Blumhof, B; Deshpande, DA; Rodeck, U; Penn, RB				Chan, Tung O.; Armen, Roger S.; Yadav, Santosh; Shah, Sushrut; Zhang, Jin; Tiegs, Brian C.; Keny, Nikhil; Blumhof, Brian; Deshpande, Deepak A.; Rodeck, Ulrich; Penn, Raymond B.			A tripartite cooperative mechanism confers resistance of the protein kinase A catalytic subunit to dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PKA; phosphatase; Akt PKB; serine; threonine protein kinase; signal transduction; structure?function; cAMP-dependent protein kinase; dephosphorylation; protein kinase B	TERMINAL TAIL; ATP-BINDING; AKT KINASES; PDK1; ACTIVATION; ADENOSINE; SITES; AUTOPHOSPHORYLATION; PHOSPHORYLATION; MYRISTYLATION	Phosphorylation of specific residues in the activation loops of AGC kinase group (protein kinase A, G, and C families) is required for activity of most of these kinases, including the catalytic subunit of PKA (PKAc). Although many phosphorylated AGC kinases are sensitive to phosphatase-mediated dephosphorylation, the PKAc activation loop uniquely resists dephosphorylation, rendering it ?constitutively? phosphorylated in cells. Previous biophysical experiments and structural modeling have suggested that the N-terminal myristoylation signal and the C-terminal FXXF motif in PKAc regulate its thermal stability and catalysis. Here, using site-directed mutagenesis, molecular modeling, and in cell-free and cell-based systems, we demonstrate that substitutions of either the PKAc myristoylation signal or the FXXF motif only modestly reduce phosphorylation and fail to affect PKAc function in cells. However, we observed that these two sites cooperate with an N-terminal FXXW motif to cooperatively establish phosphatase resistance of PKAc while not affecting kinase-dependent phosphorylation of the activation loop. We noted that this tripartite cooperative mechanism of phosphatase resistance is functionally relevant, as demonstrated by changes in morphology, adhesion, and migration of human airway smooth muscle cells transfected with PKAc variants containing amino acid substitutions in these three sites. These findings establish that three allosteric sites located at the PKAc N and C termini coordinately regulate the phosphatase sensitivity of this enzyme. This cooperative mechanism of phosphatase resistance of AGC kinase opens new perspectives toward therapeutic manipulation of kinase signaling in disease.	[Chan, Tung O.; Yadav, Santosh; Shah, Sushrut; Zhang, Jin; Tiegs, Brian C.; Keny, Nikhil; Blumhof, Brian; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Chan, Tung O.; Yadav, Santosh; Shah, Sushrut; Zhang, Jin; Tiegs, Brian C.; Keny, Nikhil; Blumhof, Brian; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Korman Resp Inst, Dept Med, Philadelphia, PA 19107 USA; [Rodeck, Ulrich] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Armen, Roger S.] Thomas Jefferson Univ, Coll Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA; [Chan, Tung O.; Rodeck, Ulrich] Thomas Jefferson Univ, Sydney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Chan, TO (corresponding author), Thomas Jefferson Univ, Dept Med, 1020 Locust St,JAH Rm 543, Philadelphia, PA 19107 USA.	tung.chan@jefferson.edu	YADAV, SANTOSH KUMAR/AAU-6594-2020; Yadav, Santosh/GQZ-7569-2022	YADAV, SANTOSH KUMAR/0000-0001-7375-1698; Chan, Tung/0000-0001-6574-9555; Shah, Sushrut/0000-0002-4201-6532	American Heart Association research award; American Lung Association research award; W. W. Smith Charitable Trust medical research award; National Institutes of Health [RO1 HL58506]; U.S. Department of Defense [W81XWH-16-1-0679]	American Heart Association research award(American Heart Association); American Lung Association research award; W. W. Smith Charitable Trust medical research award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense)	This work was supported by an American Heart Association research award, an American Lung Association research award, and aW. W. Smith Charitable Trust medical research award (to T. O. C.), National Institutes of Health Grant RO1 HL58506 (to R. B. P.) and U.S. Department of Defense Grant W81XWH-16-1-0679 (to U. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bastidas AC, 2012, J MOL BIOL, V422, P215, DOI 10.1016/j.jmb.2012.05.021; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BECHTEL PJ, 1977, J BIOL CHEM, V252, P2691; BENNETT PA, 1993, J CELL SCI, V106, P891; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chan TO, 2015, BIOCHEM J, V471, P37, DOI 10.1042/BJ20150325; Chan TO, 2012, CELL CYCLE, V11, P475, DOI 10.4161/cc.11.3.19059; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; di Blasio L, 2015, J CELL SCI, V128, P863, DOI 10.1242/jcs.149294; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Heijerman HGM, 2019, LANCET, V394, P1940, DOI 10.1016/S0140-6736(19)32597-8; Herberg FW, 1997, PROTEIN SCI, V6, P569; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Koop A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-41; Langer T, 2005, FEBS LETT, V579, P4049, DOI 10.1016/j.febslet.2005.06.015; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Middleton PG, 2019, NEW ENGL J MED, V381, P1809, DOI 10.1056/NEJMoa1908639; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Rahaman O, 2011, J CHEM INF MODEL, V51, P2047, DOI 10.1021/ci1003009; Rettenmaier TJ, 2014, P NATL ACAD SCI USA, V111, P18590, DOI 10.1073/pnas.1415365112; Sakkal LA, 2017, J COMPUT CHEM, V38, P1209, DOI 10.1002/jcc.24728; Schulze JO, 2016, CELL CHEM BIOL, V23, P1193, DOI 10.1016/j.chembiol.2016.06.017; SHOJI S, 1979, J BIOL CHEM, V254, P6211; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; TONERWEBB J, 1992, J BIOL CHEM, V267, P25174; VERON M, 1993, P NATL ACAD SCI USA, V90, P10618, DOI 10.1073/pnas.90.22.10618; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348	49	0	0	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3316	3329		10.1074/jbc.RA119.010004	http://dx.doi.org/10.1074/jbc.RA119.010004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31964716	hybrid, Green Published			2022-12-26	WOS:000519597300034
J	Romero, C; Lambert, LJ; Sheffler, DJ; De Backer, LJS; Raveendra-Panickar, D; Celeridad, M; Grotegut, S; Rodiles, S; Holleran, J; Sergienko, E; Pasquale, EB; Cosford, NDP; Tautz, L				Romero, Celeste; Lambert, Lester J.; Sheffler, Douglas J.; De Backer, Laurent J. S.; Raveendra-Panickar, Dhanya; Celeridad, Maria; Grotegut, Stefan; Rodiles, Socorro; Holleran, John; Sergienko, Eduard; Pasquale, Elena B.; Cosford, Nicholas D. P.; Tautz, Lutz			A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tyrosine-protein phosphatase (tyrosine phosphatase); anticancer drug; drug discovery; protein drug interaction; small molecule; allosteric inhibitors; cellular target engagement; cellular thermal shift assay; PTPN11; SHP2	PROTEIN-TYROSINE PHOSPHATASES; CANCER; CELLS	The nonreceptor protein-tyrosine phosphatase (PTP) SHP2 is encoded by the proto-oncogene PTPN11 and is a ubiquitously expressed key regulator of cell signaling, acting on a number of cellular processes and components, including the Ras/Raf/Erk, PI3K/Akt, and JAK/STAT pathways and immune checkpoint receptors. Aberrant SHP2 activity has been implicated in all phases of tumor initiation, progression, and metastasis. Gain-of-function PTPN11 mutations drive oncogenesis in several leukemias and cause developmental disorders with increased risk of malignancy such as Noonan syndrome. Until recently, small molecule-based targeting of SHP2 was hampered by the failure of orthosteric active-site inhibitors to achieve selectivity and potency within a useful therapeutic window. However, new SHP2 allosteric inhibitors with excellent potency and selectivity have sparked renewed interest in the selective targeting of SHP2 and other PTP family members. Crucially, drug discovery campaigns focusing on SHP2 would greatly benefit from the ability to validate the cellular target engagement of candidate inhibitors. Here, we report a cellular thermal shift assay that reliably detects target engagement of SHP2 inhibitors. Using this assay, based on the DiscoverX InCell Pulse enzyme complementation technology, we characterized the binding of several SHP2 allosteric inhibitors in intact cells. Moreover, we demonstrate the robustness and reliability of a 384-well miniaturized version of the assay for the screening of SHP2 inhibitors targeting either WT SHP2 or its oncogenic E76K variant. Finally, we provide an example of the assay's ability to identify and characterize novel compounds with specific cellular potency for either WT or mutant SHP2.	[Romero, Celeste; Lambert, Lester J.; Sheffler, Douglas J.; De Backer, Laurent J. S.; Raveendra-Panickar, Dhanya; Celeridad, Maria; Cosford, Nicholas D. P.; Tautz, Lutz] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Canc Metab & Signaling Networks Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Grotegut, Stefan; Rodiles, Socorro; Holleran, John; Sergienko, Eduard] Sanford Burnham Prebys Med Discovery Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Tautz, L (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Canc Metab & Signaling Networks Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	tautz@sbpdiscovery.org	; Tautz, Lutz/M-9989-2014	Romero, Celeste/0000-0001-6232-392X; Tautz, Lutz/0000-0002-4075-6238	National Institutes of Health [1R21CA195422, 1R21NS067502]; NCI Experimental Therapeutics (NExT) Program [Leidos-16X113-SHP2]; Epstein Family Foundation Award; NCI Cancer Center Support Grant [P30CA030199]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Experimental Therapeutics (NExT) Program; Epstein Family Foundation Award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants 1R21CA195422 (to L. T.) and 1R21NS067502 (to E. B. P.), NCI Experimental Therapeutics (NExT) Program Grant Leidos-16X113-SHP2 (to L. T.), Epstein Family Foundation Award (to N. D. P. C.), and NCI Cancer Center Support Grant P30CA030199. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; [Anonymous], 2019, US MAN INCELL PULS T; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Benjamin G., 2010, HDB CELL SIGNALING, P771; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen C.H.-T., 2018, Patent, Patent No. [US20180201623, 20180201623]; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Elson A, 2018, INT J BIOCHEM CELL B, V96, P135, DOI 10.1016/j.biocel.2017.09.013; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Gurzov EN, 2015, TRENDS ENDOCRIN MET, V26, P30, DOI 10.1016/j.tem.2014.10.004; Herr RJ, 2002, BIOORGAN MED CHEM, V10, P3379, DOI 10.1016/S0968-0896(02)00239-0; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; LaRochelle JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06823-9; Lauriol J, 2015, SEMIN CELL DEV BIOL, V37, P73, DOI 10.1016/j.semcdb.2014.09.013; Lombroso Paul J, 2016, F1000Res, V5, DOI 10.12688/f1000research.8571.1; McNulty DE, 2018, SLAS DISCOV, V23, P34, DOI 10.1177/2472555217732014; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nichols RJ, 2018, NAT CELL BIOL, V20, P1064, DOI 10.1038/s41556-018-0169-1; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Ran H, 2016, CANCER CELL, V30, P194, DOI 10.1016/j.ccell.2016.07.010; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Scott LM, 2010, CURR PHARM DESIGN, V16, P1843; Senis YA, 2018, MOLECULES, V23, DOI 10.3390/molecules23030569; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Sun X, 2018, LEUKEMIA, V32, P1246, DOI 10.1038/s41375-018-0020-5; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tautz L, 2015, J CLIN INVEST, V125, P2931, DOI 10.1172/JCI83192; Tautz L, 2015, BIOORGAN MED CHEM, V23, P2786, DOI 10.1016/j.bmc.2015.03.075; Tautz L, 2013, METHODS MOL BIOL, V1053, P223, DOI 10.1007/978-1-62703-562-0_14; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tsutsumi R, 2018, FEBS OPEN BIO, V8, P1405, DOI 10.1002/2211-5463.12493; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Yu ZH, 2018, CHEM REV, V118, P193, DOI 10.1021/acs.chemrev.7b00105; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang ZY, 2015, TRENDS PHARMACOL SCI, V36, P661, DOI 10.1016/j.tips.2015.07.003	46	9	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2601	2613		10.1074/jbc.RA119.010838	http://dx.doi.org/10.1074/jbc.RA119.010838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31953320	Green Published, hybrid			2022-12-26	WOS:000519969100007
J	Ustinova, K; Novakova, Z; Saito, M; Meleshin, M; Mikesova, J; Kutil, Z; Baranova, P; Havlinova, B; Schutkowski, M; Matthias, P; Barinka, C				Ustinova, Kseniya; Novakova, Zora; Saito, Makoto; Meleshin, Marat; Mikesova, Jana; Kutil, Zsofia; Baranova, Petra; Havlinova, Barbora; Schutkowski, Mike; Matthias, Patrick; Barinka, Cyril			The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; substrate specificity; protein-protein interaction; microtubule-associated protein (MAP); tubulin; intrinsically disordered protein; histone deacetylase 6 (HDAC6); protein motif; total internal reflection fluorescence (TIRF); cytoskeleton; post-translational modification	HISTONE; ACETYLATION; BRAIN; ACTIVATION; MECHANISMS; CLEARANCE; ISOTYPES; MEMORY; MOTORS; TAU	Histone deacetylase 6 (HDAC6) is a multidomain cytosolic enzyme having tubulin deacetylase activity that has been unequivocally assigned to the second of the tandem catalytic domains. However, virtually no information exists on the contribution of other HDAC6 domains on tubulin recognition. Here, using recombinant protein expression, site-directed mutagenesis, fluorimetric and biochemical assays, microscale thermophoresis, and total internal reflection fluorescence microscopy, we identified the N-terminal, disordered region of HDAC6 as a microtubule-binding domain and functionally characterized it to the single-molecule level. We show that the microtubule-binding motif spans two positively charged patches comprising residues Lys-32 to Lys-58. We found that HDAC6-microtubule interactions are entirely independent of the catalytic domains and are mediated by ionic interactions with the negatively charged microtubule surface. Importantly, a crosstalk between the microtubule-binding domain and the deacetylase domain was critical for recognition and efficient deacetylation of free tubulin dimers both in vitro and in vivo. Overall, our results reveal that recognition of substrates by HDAC6 is more complex than previously appreciated and that domains outside the tandem catalytic core are essential for proficient substrate deacetylation.	[Ustinova, Kseniya; Novakova, Zora; Mikesova, Jana; Kutil, Zsofia; Baranova, Petra; Havlinova, Barbora; Barinka, Cyril] Czech Acad Sci, BIOCEV, Inst Biotechnol, Prumyslova 595, Vestec 25250, Czech Republic; [Ustinova, Kseniya] Charles Univ Prague, Fac Nat Sci, Dept Biochem, Albertov 6, Prague 2, Czech Republic; [Saito, Makoto; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Meleshin, Marat; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Inst Biochem & Biotechnol, Dept Enzymol, D-06120 Halle, Germany; [Saito, Makoto; Matthias, Patrick] Univ Basel, Fac Sci, CH-4031 Basel, Switzerland	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague; Friedrich Miescher Institute for Biomedical Research; Martin Luther University Halle Wittenberg; University of Basel	Barinka, C (corresponding author), Vvi, Inst Biotechnol, Struct Biol Lab, Prumyslova 595, Vestec 25250, Czech Republic.	cyril.barinka@ibt.cas.cz	Saito, Makoto/GLR-4232-2022; Ustinova, Kseniya/AAO-7143-2021; Kutil, Zsofia/O-1096-2013; Novakova, Zora/G-8665-2014; Ustinova, Kseniya/L-7261-2017	Ustinova, Kseniya/0000-0001-6632-5850; Novakova, Zora/0000-0001-9804-6346; Ustinova, Kseniya/0000-0001-6632-5850; Matthias, Patrick/0000-0002-3927-1452; Barinka, Cyril/0000-0003-2751-3060; Saito, Makoto/0000-0001-8619-5176	Czech-BioImaging large RI projects (MEYS CR) [LM2015062, CZ.02.1.01/0.0/0.0/16_013/0001775]; MEYS CR [LM2015043]	Czech-BioImaging large RI projects (MEYS CR); MEYS CR	We thank I. Jelinkova for the excellent technical assistance, M. Hubalek for MS analysis, and A. Kozikowski for the gift of Nexturastat A. We acknowledge the Imaging Methods Core Facility at BIOCEV, institution supported by the Czech-BioImaging large RI projects (LM2015062 and CZ.02.1.01/0.0/0.0/16_013/0001775, funded by MEYS CR) and the Biophysics facility of CMS supported by MEYS CR (LM2015043) for their support with obtaining scientific data presented in this article.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Du YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123191; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hai Y, 2016, NAT CHEM BIOL, V12, P741, DOI 10.1038/nchembio.2134; Hansen BK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09024-0; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hard RL, 2010, BIOCHEMISTRY-US, V49, P10737, DOI 10.1021/bi101014s; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; HYMAN AA, 1991, J CELL SCI, P125; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kellogg EH, 2016, P NATL ACAD SCI USA, V113, P9430, DOI 10.1073/pnas.1609903113; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kozikowski AP, 2019, ACS CHEM NEUROSCI, V10, P1679, DOI 10.1021/acschemneuro.8b00600; Kutil Z, 2019, FASEB J, V33, P4035, DOI 10.1096/fj.201801680R; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Lernoux M, 2018, PHARMACOL RES, V129, P337, DOI 10.1016/j.phrs.2017.11.004; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Nahhas F, 2007, MOL CELL BIOCHEM, V303, P221, DOI 10.1007/s11010-007-9478-6; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saito M, 2019, NAT CHEM BIOL, V15, P51, DOI 10.1038/s41589-018-0180-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Thiede C, 2013, BIOPHYS J, V104, P432, DOI 10.1016/j.bpj.2012.11.3810; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13897-w; Wang Q, 2014, P NATL ACAD SCI USA, V111, P11347, DOI 10.1073/pnas.1403135111; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao ZQ, 2010, PROTEIN PEPTIDE LETT, V17, P555, DOI 10.2174/092986610791112620; Zhuang Y, 2010, BIOCHEM BIOPH RES CO, V392, P608, DOI 10.1016/j.bbrc.2010.01.091; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	65	16	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2614	2628		10.1074/jbc.RA119.011243	http://dx.doi.org/10.1074/jbc.RA119.011243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31953325	Green Published, hybrid			2022-12-26	WOS:000519969100008
J	Toya, T; Corban, MT; Marrietta, E; Horwath, IE; Lerman, LO; Murray, JA; Lerman, A				Toya, Takumi; Corban, Michel T.; Marrietta, Eric; Horwath, Irina E.; Lerman, Lilach O.; Murray, Joseph A.; Lerman, Amir			Coronary artery disease is associated with an altered gut microbiome composition	PLOS ONE			English	Article							FECAL MICROBIOTA; ATHEROSCLEROSIS	Alteration of gut microbiome composition has been linked to cardiovascular diseases. To identify specific bacterial communities associated with coronary artery diseases (CAD), we conducted a case-control study with 53 advanced CAD patients and 53 age-, sex-, race-, and BMI-matched controls. V3-V5 regions of the 16S rDNA from the fecal gut material were analyzed to compare the gut microbiome composition between CAD patients and controls. The alpha diversity, including Chao-1, Shannon-index, and the number of observed taxonomy units were significantly decreased in CAD patients indicating, decreased richness and evenness of gut microbiome. Among 23 different abundant taxa at the genus level, 12 taxa belonged to Lachnospiraceae family, which are known to produce butyrate. Further, we identified five taxa which showed more than two log-fold changes with maximum proportion >0.002, including Ruminococcus gnavus, Lachnospiraceae anaerosporobacter, Lachnospiraceae NK4B4 group, Lachnospiraceae UCG-004, and Ruminococcus gauvreauii. After adjustment for coronary risk factors (diabetes mellitus and dyslipidemia), decreased relative abundance of Lachnospiraceae NK4B4 group and Ruminococcus Gauvreauii and increased relative abundance of Ruminococcus gnavus were associated with the presence of advanced CAD. The observed differences in taxa between CAD patients and controls in this study may provide insight into the link between the gut microbiome and CAD.	[Toya, Takumi; Corban, Michel T.; Lerman, Amir] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Toya, Takumi] Natl Def Med Coll, Dept Cardiol, Tokorozawa, Saitama, Japan; [Marrietta, Eric; Horwath, Irina E.; Murray, Joseph A.] Mayo Clin, Dept Gastroenterol, Rochester, MN USA; [Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA	Mayo Clinic; National Defense Medical College - Japan; Mayo Clinic; Mayo Clinic	Lerman, A (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.	Lerman.Amir@mayo.edu		Toya, Takumi/0000-0002-4681-2798; Lerman, Amir/0000-0002-9446-5313	SonomaCeuticals, LLC; dba Whole-Vine Products; Mayo Clinic	SonomaCeuticals, LLC; dba Whole-Vine Products; Mayo Clinic	This study was sponsored by unrestricted grants from SonomaCeuticals, LLC, dba Whole-Vine Products (info@wholevine.com) and Mayo Clinic (https://www.mayoclinic.org) to AL. The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.	Breban M, 2017, ANN RHEUM DIS, V76, P1614, DOI 10.1136/annrheumdis-2016-211064; Catry E, 2018, GUT, V67, P271, DOI 10.1136/gutjnl-2016-313316; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Domingo MC, 2008, INT J SYST EVOL MICR, V58, P1393, DOI 10.1099/ijs.0.65259-0; Fuentes S, 2017, ISME J, V11, P1877, DOI 10.1038/ismej.2017.44; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Griffin JL, 2015, CIRC-CARDIOVASC GENE, V8, P187, DOI 10.1161/CIRCGENETICS.114.000219; Hall AB, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0490-5; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Min Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10440-5; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Skye SM, 2018, CIRC RES, V123, P1164, DOI 10.1161/CIRCRESAHA.118.313142; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tailford LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8624; Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yacoub R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184789; Yoshida N, 2005, METABOLISM, V54, P345, DOI 10.1016/j.metabol.2004.09.014; Yoshida N, 2018, CIRCULATION, V138, P2486, DOI 10.1161/CIRCULATIONAHA.118.033714; Zheng HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166026	37	31	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227147	10.1371/journal.pone.0227147	http://dx.doi.org/10.1371/journal.pone.0227147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995569	Green Published, gold			2022-12-26	WOS:000534609400019
J	Wu, Y; Da, CRQ; Liu, J; Yan, XM				Wu, Yuan; Da, Ci Ren Qiong; Liu, Jiang; Yan, Xiaoming			Intraocular pressure and axial length changes during altitude acclimatization from Beijing to Lhasa	PLOS ONE			English	Article								Purpose To investigate changes in intraocular pressure (IOP) and axial length (AL) on the ascent to high altitude from Beijing to Lhasa. Patients and methods Twenty volunteers (17 men, 3 women) who had been sent to work in Lhasa, Tibet for more than 6 months were enrolled. One of their journeys from Beijing to Lhasa was chosen as the time for the examination. IOP, AL, corneal curvature (K), and blood pressure (BP) were measured in Beijing (altitude 43 m) and Lhasa (altitude 3658 m). Their first examination was conducted at least 1 day before arriving in Lhasa and the second examination after they had stayed in Lhasa for 7 days. The data from the highland and lowland examinations were analyzed with a paired-sample T test and Pearson's correlation coefficient was calculated for the association between IOP and average BP. Results The mean IOP was 12.65 +/- 2.34 mmHg in Beijing and 14.85 +/- 3.1 mmHg in Lhasa. The mean AL was 24.61 +/- 1.50mm in Beijing, and 24.98 +/- 1.45 mm in Lhasa. The IOP and AL showed a significant elevation in highland compared with lowland (P<0.05). The mean K was 43.58 +/- 2.25 D in Beijing and 43.56 +/- 2.21 D in Lhasa and no significant difference was found in this study (P>0.05). A positive correlation between variance of IOP and ACD was found (r = 0.475, P<0.05) and no correlation between IOP and average BP was noted. Conclusions High altitude may lead to a small but significant change in IOP and axial length. However, the shape of the corneal surface was not influenced by the hypobaric and hypoxic conditions.	[Wu, Yuan; Yan, Xiaoming] Peking Univ, Hosp 1, Dept Ophthalmol, Beijing, Peoples R China; [Da, Ci Ren Qiong; Liu, Jiang] Tibet Autonomous Reg Peoples Hosp, Dept Ophthalmol, Lhasa, Tibet Autonomou, Peoples R China	Peking University	Yan, XM (corresponding author), Peking Univ, Hosp 1, Dept Ophthalmol, Beijing, Peoples R China.	yanxiaoming7908@163.com		Wu, Yuan/0000-0003-2080-1414	the'Natural Science Foundation of Tibet Autonomous Region [XZ2017ZR-ZY032]	the'Natural Science Foundation of Tibet Autonomous Region	This work was supported by the'Natural Science Foundation of Tibet Autonomous Region (NO XZ2017ZR-ZY032). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer A, 2008, CURR EYE RES, V33, P345, DOI 10.1080/02713680801958672; Bosch MM, 2010, INVEST OPHTH VIS SCI, V51, P1609, DOI 10.1167/iovs.09-4306; Bosch MM, 2009, J APP PHYSL; BRINCHMANNHANSEN O, 1989, AVIAT SPACE ENVIR MD, V60, P970; Chaitanya A, 2016, OMAN J OPHTHALMOL; Ersanli D, 2006, AVIAT SPACE ENVIR MD, V77, P704; Fischer MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036155; Fischer MD, 2015, INVESTIG OPHTHALMOL; Karadag R, 2015, INDIAN J OPHTHALMOL; Karakucuk S, 2012, AVIAT SP ENV MED; Kim NR, 2011, CURR EYE RES; Klein BEK, 2005, BR J OPHTHALMOL; Kofoed PK, 2009, INVESTIG OPHTHALMOL; McCafferty S, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.5.4; Morris DS, 2007, CORNEA; Ortiz GJ, 1988, INVESTIG OPHTHALMOL; Passo MS, 1991, ARCH OPHTHALMOL; Pavlidis M, 2006, GRAEF ARCH CLIN EXP, V244, P298, DOI 10.1007/s00417-005-1174-1; Somner JEA, 2007, INVEST OPHTH VIS SCI, V48, P1622, DOI 10.1167/iovs.06-1238; Willmann G, 2014, HIGH ALT MED BIOL; Willmann G, 2013, INVEST OPHTHALMOL VI; Willmann G, 2017, HIGH ALT MED BIOL, V18, P114, DOI 10.1089/ham.2016.0115	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228267	10.1371/journal.pone.0228267	http://dx.doi.org/10.1371/journal.pone.0228267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995608	gold, Green Published			2022-12-26	WOS:000534609400057
J	Nord, A; Miller, NR; Mariki, W; Drinkwater, L; Snapp, S				Nord, Alison; Miller, Neil R.; Mariki, Wilfred; Drinkwater, Laurie; Snapp, Sieglinde			Investigating the diverse potential of a multi-purpose legume, Lablab purpureus (L.) Sweet, for smallholder production in East Africa	PLOS ONE			English	Article							SHORT-SEASON ACCESSIONS; CROPPING SYSTEMS; GRAIN LEGUMES; ENVIRONMENT; MAIZE; YIELD; INTENSIFICATION; PREFERENCES; INTERCROPS	Climate change is posing severe challenges in Africa, where resilient crops are urgently needed to withstand drought periods and unreliable rainfall. Multi-purpose legume species, such as lablab (Lablab purpureus (L.) Sweet), have been under-utilized yet have the potential to overcome climate challenges. While lablab is native to Africa, there are few characterized varieties and it is under-utilized by smallholder farmers due to a lack of information and access to varieties. Knowledge is especially lacking on the performance of this crop by genotype, management, and environment. We conducted a two-year field study at two sites to evaluate 29 lablab cultivars under sole and maize intercrop management, with 14 cultivars selected for in-depth study. Cultivars were evaluated on vegetative biomass and grain yield production, with N fixation assessed for one site year. Biomass and grain production differed across environments and cultivars, with only biomass affected by intercropping. Average grain yield was substantially reduced to only 37 kg ha(-1) in environments with maximum temperatures greater than 33 degrees C, but biomass production yielded comparable amounts across high temperatures and in dry (< 500 mm rainfall) environments. Tradeoffs were found between biomass and grain yield across high yielding cultivars, with the top three grain accessions averaging 612 kg ha(-1) of grain and 1.97 Mg ha(-1) biomass whereas the top three biomass accessions produced 327 kg ha(-1) grain and 2.52 Mg ha(-1) biomass across all environments. In a comparison of production and N fixation measurements, cultivars were identified which may have high performance in both. Suitability of lablab for grain and biomass production were visualized across Tanzania in a map comparing max temperature thresholds for grain and biomass against average regional livestock populations. This provides a way forward for identifying potential areas for lablab cultivation as a novel means to enhance fodder and pulse production with smallholder farmers.	[Nord, Alison; Snapp, Sieglinde] Michigan State Univ, Plant Soil & Microbial Sci Dept, E Lansing, MI 48824 USA; [Miller, Neil R.] Canadian Foodgrains Bank, Arusha, Tanzania; [Mariki, Wilfred] Tanzania Agr Res Inst, Selian Ctr, Arusha, Tanzania; [Drinkwater, Laurie] Cornell Univ, Sch Integrat Plant Sci, Hort, Ithaca, NY 14853 USA	Michigan State University; Cornell University	Nord, A (corresponding author), Michigan State Univ, Plant Soil & Microbial Sci Dept, E Lansing, MI 48824 USA.	nordalis@msu.edu	Snapp, Sieg/GWQ-5774-2022; Snapp, Sieglinde/AAU-8121-2020; Nord, Alison/AAC-7462-2021	Snapp, Sieglinde/0000-0002-9738-0649; Nord, Alison/0000-0002-2522-4794; Drinkwater, Laurie/0000-0002-0746-6765	United States Agency for International Development (USAID) [AID-OAA-L-14-00006]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was made possible by the support of the American People provided to the Feed the Future Innovation Lab for Sustainable Intensification through the United States Agency for International Development (USAID)(https://www.usaid.gov).The contents are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Program activities are funded by the United States Agency for International Development (USAID) under Cooperative Agreement No. AID-OAA-L-14-00006 received by authors S.S., A.N, N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebisi AA, 2004, PLANT RESOURCES TROP, P343; Armstrong KL, 2008, CROP SCI, V48, P371, DOI 10.2135/cropsci2007.04.0244; Becker M, 1998, BIOL FERT SOILS, V27, P358, DOI 10.1007/s003740050444; Beebe S, 2011, CROP ADAPTATION TO CLIMATE CHANGE, P356; Chibarabada TP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010060; DeHaan LR, 2014, AM J BOT, V101, P1801, DOI 10.3732/ajb.1400084; Duc G, 2015, CRIT REV PLANT SCI, V34, P381, DOI 10.1080/07352689.2014.898469; Ewansiha SU, 2007, TROP GRASSLANDS, V41, P277; FAOSTAT, 2015, FAOSTAT TRAD CROPS L, P1; Franke A., 2017, AQUAC RES, P1; Giller K.E., 2001, NITROGEN FIXATION TR, V2nd ed., DOI [DOI 10.1079/9780851994178.0000, 10.1079/9780851994178.0000]; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; HarvestChoice, 2015, TROP LIV UN TLU 2005; Hendrie FN, 2014, AFRICAN J AGR RES, V9, P255; Isaacs KB, 2016, FOOD SECUR, V8, P491, DOI 10.1007/s12571-016-0582-x; Kabululu M. S., 2014, International Journal of Vegetable Science, V20, P270, DOI 10.1080/19315260.2013.813889; Kang MS, 2006, J CROP IMPROV, V15, P97, DOI 10.1300/J411v15n01_08; Lithourgidis AS, 2011, AUST J CROP SCI, V5, P396; Maasdorp BV, 1997, ANIM FEED SCI TECH, V69, P241, DOI 10.1016/S0377-8401(97)81639-2; Maass BL, 2016, ORIGIN DOMESTICATION, P5; Maass Brigitte L, 2010, Trop Plant Biol, V3, P123, DOI 10.1007/s12042-010-9046-1; Macharia PN, 2010, GRASS FORAGE SCI, V65, P456, DOI 10.1111/j.1365-2494.2010.00764.x; Miller N., 2018, HDB CLIMATE CHANGE R, V2, P1; Ochieng HO, 2019, EXP AGR; Ojiem JO, 2007, PLANT SOIL, V292, P119, DOI 10.1007/s11104-007-9207-7; Pengelly BC, 2001, GENET RESOUR CROP EV, V48, P261, DOI 10.1023/A:1011286111384; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Reiss ER, 2018, ECOL APPL, V28, P62, DOI 10.1002/eap.1629; Sanginga N, 2003, PLANT SOIL, V252, P25, DOI 10.1023/A:1024192604607; Sennhenn A, 2017, CROP PASTURE SCI, V68, P442, DOI 10.1071/CP16416; Sennhenn A, 2017, EXP AGR, V53, P375, DOI 10.1017/S0014479716000429; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; SIMMONDS NW, 1991, THEOR APPL GENET, V82, P363, DOI 10.1007/BF02190624; Sinclair TR, 2012, CROP PASTURE SCI, V63, P501, DOI 10.1071/CP12128; Snapp S, 2019, EXP AGR, V55, P251, DOI 10.1017/S0014479718000066; Snapp SS, 2002, PLANT SOIL, V245, P181, DOI 10.1023/A:1020658715648; The World Food Programme (WFP) National Bureau of Statistics (NBS), 2010, COMPR FOOD SEC VULN; Torres FE, 2016, GENET MOL RES, V15, DOI [10.4238/gmr.15027991, 10.4238/gmr.15028272]; Van Bogaert E., 2012, GLOBAL LAND COVER MA; Waddington SR, 2007, EXP AGR, V43, P489, DOI 10.1017/S0014479707005303; Waldman KB, 2016, FOOD SECUR, V8, P1087, DOI 10.1007/s12571-016-0616-4; Wan Z, 2015, NASA EOSDIS L PROCES; Whitbread AM, 2011, AFR J RANGE FOR SCI, V28, P21, DOI 10.2989/10220119.2011.570950; WILLEY RW, 1985, EXP AGR, V21, P119, DOI 10.1017/S0014479700012400; Yan W, 2006, CAN J PLANT SCI, V86, P623, DOI 10.4141/P05-169; Yan WK, 2007, CROP SCI, V47, P643, DOI 10.2135/cropsci2006.06.0374	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227739	10.1371/journal.pone.0227739	http://dx.doi.org/10.1371/journal.pone.0227739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986164	gold, Green Published			2022-12-26	WOS:000534603400027
J	Urstadt, KR; Berridge, KC				Urstadt, Kevin R.; Berridge, Kent C.			Optogenetic mapping of feeding and self-stimulation within the lateral hypothalamus of the rat	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; D-ASPARTIC ACID; ELECTRICAL-STIMULATION; REVERSE MICRODIALYSIS; VENTRAL PALLIDUM; NEURONS; REWARD; DOPAMINE; LESIONS; TASTE	The lateral hypothalamus (LH) includes several anatomical subregions involved in eating and reward motivation. This study explored localization of function across different LH subregions in controlling food intake stimulated by optogenetic channelrhodopsin excitation, and in supporting laser self-stimulation. We particularly compared the tuberal LH subregion, the posterior LH subregion, and the lateral preoptic area. Local diameters of tissue optogenetically stimulated within the LH were assessed by measuring laser-induced Fos plumes and Jun plumes via immunofluorescence surrounding optic fiber tips. Those plume diameters were used to map localization of function for behavioral effects elicited by LH optogenetic stimulation. Optogenetic stimulation of the tuberal subsection of the LH produced the most robust eating behavior and food intake initially, but produced only mild laser self-stimulation in the same rats. However, after repeated exposures to optogenetic stimulation, tuberal LH behavioral profiles shifted toward more self-stimulation and less food intake. By contrast, stimulation of the lateral preoptic area produced relatively little food intake or self-stimulation, either initially or after extended stimulation experience. Stimulation in the posterior LH subregion supported moderate self-stimulation, but not food intake, and at higher laser intensity shifted valence to evoke escape behaviors. We conclude that the tuberal LH subregion may best mediate stimulation-bound increases in food intake stimulated by optogenetic excitation. However, incentive motivational effects of tuberal LH stimulation may shift toward self-stimulation behavior after repeated stimulation. By contrast, the lateral preoptic area and posterior LH do not as readily elicit either eating behavior or laser self-stimulation, and may be more prone to higher-intensity aversive effects.	[Urstadt, Kevin R.; Berridge, Kent C.] Univ Michigan, Psychol Dept, Ann Arbor, MI 48109 USA; [Urstadt, Kevin R.] Occidental Coll, Cognit Sci Dept, Los Angeles, CA 90041 USA	University of Michigan System; University of Michigan; Occidental College	Urstadt, KR (corresponding author), Univ Michigan, Psychol Dept, Ann Arbor, MI 48109 USA.; Urstadt, KR (corresponding author), Occidental Coll, Cognit Sci Dept, Los Angeles, CA 90041 USA.	kurst001@gmail.com	Berridge, Kent C/C-1525-2009; Core, Vector/CAF-4832-2022	Berridge, Kent C/0000-0002-6031-2626; Urstadt, Kevin/0000-0002-8981-7863	National Institutes of Health [DC00011]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author KCB received grants from the National Institutes of Health (DA015188 and MH63649). The author KRU received a training grant from the National Institutes of Health (DC00011). Additional information about such grants can be found through https://grants.nih.gov/grants/oer.htm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; Arias-Gil G., 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.4.045007; BERRIDGE KC, 1989, BEHAV NEUROSCI, V103, P36, DOI 10.1037/0735-7044.103.1.36; BERRIDGE KC, 1991, BEHAV NEUROSCI, V105, P3, DOI 10.1037/0735-7044.105.1.3; BURTON MJ, 1976, EXP NEUROL, V51, P668, DOI 10.1016/0014-4886(76)90189-8; Castro DC, 2014, J NEUROSCI, V34, P4239, DOI 10.1523/JNEUROSCI.4458-13.2014; COX VC, 1969, BRAIN BEHAV EVOLUT, V2, P359, DOI 10.1159/000125888; CROMWELL HC, 1993, BRAIN RES, V624, P1, DOI 10.1016/0006-8993(93)90053-P; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Duva MA, 2005, NEUROSCI RES, V52, P95, DOI 10.1016/j.neures.2005.02.001; Duva MA, 2002, BRAIN RES, V925, P141, DOI 10.1016/S0006-8993(01)03269-3; Elias CF, 2000, J COMP NEUROL, V423, P261; Flores C, 1997, BEHAV BRAIN RES, V87, P239, DOI 10.1016/S0166-4328(97)02288-2; GALLISTEL CR, 1981, PSYCHOL REV, V88, P228, DOI 10.1037/0033-295X.88.3.228; Gigante ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158885; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; HALL S, 1988, PHYSIOL BEHAV, V44, P469, DOI 10.1016/0031-9384(88)90307-1; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Herrick CJ, 1910, J COMP NEUROL PSYCHO, V20, P413, DOI 10.1002/cne.920200502; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Junyent F, 2015, CURR OPIN PHARMACOL, V24, P86, DOI 10.1016/j.coph.2015.08.004; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Krieg WJS, 1932, J COMP NEUROL, V55, P19, DOI 10.1002/cne.900550104; Lee DJ, 2018, THER ADV PSYCHOPHARM, V8, P73, DOI 10.1177/2045125317743435; MARSHALL JF, 1974, J COMP PHYSIOL PSYCH, V87, P808, DOI 10.1037/h0037223; MORA F, 1976, EXP NEUROL, V53, P508, DOI 10.1016/0014-4886(76)90089-3; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Olds J, 1973, BRAIN STIMULATION MO; Panditharatna E, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou256.23; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Qualls-Creekmore E, 2017, J NEUROSCI, V37, P6053, DOI 10.1523/JNEUROSCI.0155-17.2017; Rada P, 1997, BRAIN RES, V768, P338, DOI 10.1016/S0006-8993(97)00788-9; Robinson T, 2014, ASIA-PAC J CLIN ONCO, V10, P34; SAPER CB, 1979, J COMP NEUROL, V183, P689, DOI 10.1002/cne.901830402; SCHALLERT T, 1978, J COMP PHYSIOL PSYCH, V92, P720, DOI 10.1037/h0077504; SCHALLERT T, 1982, J COMP PHYSIOL PSYCH, V96, P604, DOI 10.1037/h0077906; SCHWARTZBAUM JS, 1988, PHYSIOL BEHAV, V44, P507, DOI 10.1016/0031-9384(88)90313-7; Singh J, 1996, BRAIN RES BULL, V41, P399, DOI 10.1016/S0361-9230(96)00217-1; STANLEY BG, 1993, BRAIN RES, V630, P41; STELLAR E, 1954, PSYCHOL REV, V61, P5, DOI 10.1037/0033-295X.101.2.301; Stratford TR, 2012, BEHAV BRAIN RES, V226, P548, DOI 10.1016/j.bbr.2011.10.014; STRICKER EM, 1976, HUNGER BASIC MECHANI, P19; Sweeney P, 2016, J NEUROSCI, V36, P11185, DOI 10.1523/JNEUROSCI.2042-16.2016; TEITELBAUM P, 1962, PSYCHOL REV, V69, P74, DOI 10.1037/h0039285; Tomczak M., 2014, TRENDS SPORT SCI, V1, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; Turenius CI, 2009, BRAIN RES, V1283, P65, DOI 10.1016/j.brainres.2009.05.064; Urstadt KR, 2013, BEHAV BRAIN RES, V257, P230, DOI 10.1016/j.bbr.2013.09.048; VALENSTEIN ES, 1970, J COMP PHYSIOL PSYCH, V70, P189, DOI 10.1037/h0028708; VALENSTEIN ES, 1968, SCIENCE, V159, P1119, DOI 10.1126/science.159.3819.1119; VALENSTEIN ES, 1970, PSYCHOL REV, V77, P16, DOI 10.1037/h0028581; Warlow SM, 2017, J NEUROSCI, V37, P8330, DOI 10.1523/JNEUROSCI.3141-16.2017; WINN P, 1984, NEUROSCIENCE, V12, P225, DOI 10.1016/0306-4522(84)90149-0; WYRWICKA W, 1960, SCIENCE, V132, P805, DOI 10.1126/science.132.3430.805; YEOMANS JS, 1989, NEUROSCI BIOBEHAV R, V13, P91, DOI 10.1016/S0149-7634(89)80016-8; Yu K, 2017, NAT NEUROSCI, V20, P1680, DOI 10.1038/s41593-017-0009-9	59	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0224301	10.1371/journal.pone.0224301	http://dx.doi.org/10.1371/journal.pone.0224301			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986148	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400009
J	Ban, J; Chen, LZ				Ban, Jin; Chen, Longzhu			Evaluation of the factors influencing the housing safety awareness of residents in Shanghai	PLOS ONE			English	Article							INSPECTION SCHEME MBIS; MIXED LOGIT MODEL; RISK-MANAGEMENT; EMPIRICAL SURVEY; URBAN; CONFLICT; CHINA; LAND; RELIABILITY; PERSPECTIVE	Shanghai has experienced rapid urbanization and has a serious housing aging problem. The situation of urban housing safety management needs to be strengthened. However, in China, housing safety management (HSM) is just in its beginning stage and it lacks thorough research. Housing safety awareness is one of the most significant aspects of housing safety management. Therefore, in order to investigate the housing safety awareness of Shanghai residents, this paper investigates the safety attitudes of residents living in housing of different ages using consulting questionnaires and Statistical Package for Social Science (SPSS) software. The results show that in Shanghai, the residents lack an understanding of housing management law, policy, and awareness of safety use and have low willingness to buy commercial insurance. Based on these results, the factors that affect the safety awareness of Shanghai residents are summarized as follows: (1) asymmetric information; (2) assessment of the safety status of the premises; and (3) differences in house users.	[Ban, Jin; Chen, Longzhu] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai, Peoples R China	Shanghai Jiao Tong University	Ban, J (corresponding author), Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai, Peoples R China.	banban1009@163.com			Science and Technology Commission of Shanghai Municipality [15DZ1204500]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The research work described herein was funded by the Science and Technology Commission of Shanghai Municipality (Grant No. 15DZ1204500) to LC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	bryman a., 2021, QUANTITATIVE DATA AN; Chan DWM, 2015, FACILITIES, V33, P337, DOI 10.1108/F-09-2013-0066; Chan DWM, 2014, BUILT ENVIRON PROJ A, V4, P71, DOI 10.1108/BEPAM-07-2012-0040; Chan DWM, 2010, J SAFETY RES, V41, P433, DOI 10.1016/j.jsr.2010.07.001; Chan FKS, 2018, LAND USE POLICY, V76, P772, DOI 10.1016/j.landusepol.2018.03.005; Chan KW, 2019, SOCIAL CONSTRUCTION; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Chen LJ, 2014, AUTOMAT CONSTR, V46, P64, DOI 10.1016/j.autcon.2014.05.009; Cui DQ, 2015, T TECH PUBLICATIONS, V1073, P1239, DOI [10.4028/www.scientific.net/AMR.1073-1076.1239, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.1073-1076.1239]; Doling J., 2014, HOUSING E ASIA SOCIO; Gao Y, 2015, HABITAT INT, V49, P138, DOI 10.1016/j.habitatint.2015.05.019; Gavin M., 2017, HOUSING POLICY BRITA; Geldhof GJ, 2014, PSYCHOL METHODS, V19, P72, DOI 10.1037/a0032138; Goretzko D, 2021, CURR PSYCHOL, V40, P3510, DOI 10.1007/s12144-019-00300-2; Gravetter F.J., 2016, STAT BEHAV SCI; Hayden J, 2014, NURS EDUC PERSPECT, V35, P244, DOI 10.5480/13-1130.1; He JQ, 2017, ECOL INDIC, V77, P185, DOI 10.1016/j.ecolind.2017.01.017; Huang Y, 2015, NAT HAZARDS, V75, P2067, DOI 10.1007/s11069-014-1414-y; Jiao L, 2010, THESIS; Leung KW., 2018, LANDSLIDE RISK ASSES, P251, DOI [10.1201/9780203749524-15, DOI 10.1201/9780203749524-15]; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Li CZ, 2016, HABITAT INT, V57, P74, DOI 10.1016/j.habitatint.2016.07.002; Liu JY, 2014, J GEOGR SCI, V24, P195, DOI 10.1007/s11442-014-1082-6; Long HL, 2012, J GEOGR SCI, V22, P548, DOI 10.1007/s11442-012-0946-x; Luciani M, 2015, J APPL ECONOMET, V30, P199, DOI 10.1002/jae.2318; Maniatis P, 2016, J CLEAN PROD, V132, P215, DOI 10.1016/j.jclepro.2015.02.067; Mao Y., 2018, 2017 7 INT C ED MANA, DOI [10.2991/icem-17.2018.160, DOI 10.2991/ICEM-17.2018.160]; Mo X, 2014, INT REV SPAT PLAN SU, V2, P44, DOI 10.14246/irspsd.2.4_44; Mole, 1999, STRUCTURAL SURVEY, V17, P170, DOI [10.1108/02630809910291352, DOI 10.1108/02630809910291352]; Munns, 1997, J QUALITY MAINTENANC, V31, P273, DOI DOI 10.1108/13552519710176881; Paul JD, 2018, WIRES WATER, V5, DOI 10.1002/wat2.1262; Pettersen C, 2017, THESIS, DOI [10.1108/02630809910291352, DOI 10.1108/02630809910291352]; Prudon P., 2015, COMPREHENSIVE PSYCHO, V4, P10, DOI [DOI 10.2466/03.CP.4.10, 10.2466/03.CP.4.10]; Qian QH, 2016, J ROCK MECH GEOTECH, V8, P423, DOI 10.1016/j.jrmge.2016.04.001; Reio TG, 2015, ADV DEV HUM RESOUR, V17, P12, DOI 10.1177/1523422314559804; Sakaluk JK, 2017, J SEX RES, V54, P1, DOI 10.1080/00224499.2015.1137538; Schwartz A.F., 2014, HOUSING POLICY US, V3rd; Shan LP, 2017, HABITAT INT, V59, P90, DOI 10.1016/j.habitatint.2016.11.009; Shanghai Institute of Real Estate Science(SIRES), 2017, GEN REP RES DEM SAF; Shanghai Municipal Commission of Construction and Transportation (SMCCT), 2006, SHANGH MUN REG DEEP; Shanghai Municipal Housing Security and Building (SMHSB), 2018, SHANGH STAT YB; Sun LL, 2016, HABITAT INT, V53, P133, DOI 10.1016/j.habitatint.2015.11.013; Wang J, 2006, CHIN J GEOTECH ENG, V28, P1328; Wang XS, 2016, ACCIDENT ANAL PREV, V96, P12, DOI 10.1016/j.aap.2016.07.028; Wang XS, 2014, ACCIDENT ANAL PREV, V70, P215, DOI 10.1016/j.aap.2014.04.005; Will C, 2016, TRANSPORT RES C-EMER, V71, P198, DOI 10.1016/j.trc.2016.07.006; Wu Q, 2014, ACCIDENT ANAL PREV, V72, P105, DOI 10.1016/j.aap.2014.06.014; Wu YH, 2018, ENRGY PROCED, V152, P815, DOI 10.1016/j.egypro.2018.09.195; Yu DL, 2017, HABITAT INT, V69, P104, DOI 10.1016/j.habitatint.2017.09.007; Yu T, 2017, INT J PROJ MANAG, V35, P925, DOI 10.1016/j.ijproman.2017.04.004; Yue WZ, 2014, STOCH ENV RES RISK A, V28, P783, DOI 10.1007/s00477-012-0623-8; Yung EHK, 2014, SUSTAIN DEV, V22, P95, DOI 10.1002/sd.534	53	4	4	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227871	10.1371/journal.pone.0227871	http://dx.doi.org/10.1371/journal.pone.0227871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978070	Green Published, gold			2022-12-26	WOS:000534599100071
J	Bergkvist, L; Richards, DR; Bernardo-Gancedo, A; Kumita, JR; Nilsson, PR; Brorsson, AC				Bergkvist, Liza; Richards, Daniel R.; Bernardo-Gancedo, Ana; Kumita, Janet R.; Nilsson, Peter R.; Brorsson, Ann-Christin			Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme	PLOS ONE			English	Article							FLUORESCENT ASSIGNMENT; IN-VITRO; FIBRILS; OLIGOMERS; DISEASE; OLIGOTHIOPHENES; DEPOSITS	Many conflicting reports about the involvement of serum amyloid P component (SAP) in amyloid diseases have been presented over the years; SAP is known to be a universal component of amyloid aggregates but it has been suggested that it can both induce and suppress amyloid formation. By using our Drosophila model of systemic lysozyme amyloidosis, SAP has previously been shown to reduce the toxicity induced by the expression of the disease-associated lysozyme variant, F57I, in the Drosophila central nervous system. This study further investigates the involvement of SAP in modulating lysozyme toxicity using histochemistry and spectral analyses on the double transgenic WT and F57I lysozyme flies to probe; i) formation of aggregates, ii) morphological differences of the aggregated lysozyme species formed in the presence or absence of SAP, iii) location of lysozyme and iv) co-localisation of lysozyme and SAP in the fly brain. We found that SAP can counteract the toxicity (measured by the reduction in the median survival time) induced by F57I lysozyme by converting toxic F57I species into less toxic amyloid-like structures, as reflected by the spectral changes that p-FTAA undergoes when bound to lysozyme deposits in F57I-F57I-SAP flies as compared to F57I-F57I flies. Indeed, when SAP was introduced to in vitro lysozyme fibril formation, the endpoint fibrils had enhanced ThT fluorescence intensity as compared to lysozyme fibrils alone. This suggests that a general mechanism for SAP's role in amyloid diseases may be to promote the formation of stable, amyloid-like fibrils, thus decreasing the impact of toxic species formed along the aggregation pathway.	[Bergkvist, Liza; Nilsson, Peter R.; Brorsson, Ann-Christin] Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, Linkoping, Sweden; [Richards, Daniel R.; Bernardo-Gancedo, Ana; Kumita, Janet R.] Univ Cambridge, Dept Chem, Ctr Misfolding Dis, Cambridge, England	Linkoping University; University of Cambridge	Brorsson, AC (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, Linkoping, Sweden.	ann.christin.brorsson@liu.se	Kumita, Janet/AAO-5254-2021	Bergkvist, Liza/0000-0001-7433-2647; Brorsson, Ann-Christin/0000-0001-7651-3556	Torsten Soderbergs stiftelse [MT9/16]; Ahlen-stiftelsen [mC49/h16]; Stiftelsen Apotekare Hedbergs fond; Sthones stiftelse; Centre for Misfolding Diseases	Torsten Soderbergs stiftelse; Ahlen-stiftelsen; Stiftelsen Apotekare Hedbergs fond; Sthones stiftelse; Centre for Misfolding Diseases	AC. Brorsson: Torsten Soderbergs stiftelse (MT9/16), Ahlen-stiftelsen (mC49/h16), Stiftelsen Apotekare Hedbergs fond, Sthones stiftelse. D.R.R., A.B-G., J.R.K are supported by the Centre for Misfolding Diseases.	Ahn M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14739-5; Andersson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055766; Arja K, 2013, MACROMOL RAPID COMM, V34, P723, DOI 10.1002/marc.201200817; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Bergkvist L, 2016, BIOL OPEN, V5, P1030, DOI 10.1242/bio.017194; BRAND AH, 1993, DEVELOPMENT, V118, P401; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Coker AR, 2000, FEBS LETT, V473, P199, DOI 10.1016/S0014-5793(00)01530-1; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Hagan CL, 2010, PROTEIN ENG DES SEL, V23, P499, DOI 10.1093/protein/gzq023; HAMAZAKI H, 1995, BIOCHEM BIOPH RES CO, V211, P349, DOI 10.1006/bbrc.1995.1819; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; HANSEN NE, 1972, J CLIN INVEST, V51, P1146, DOI 10.1172/JCI106907; Helmfors L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159294; JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041, DOI 10.1074/jbc.270.44.26041; Jonson M, 2018, CELL CHEM BIOL, V25, P595, DOI 10.1016/j.chembiol.2018.03.006; Jonson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133272; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Klingstedt T, 2013, CHEMBIOCHEM, V14, P607, DOI 10.1002/cbic.201200731; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Kumita JR, 2012, FASEB J, V26, P192, DOI 10.1096/fj.11-185983; Magnusson K, 2014, PRION, V8, P319, DOI 10.4161/pri.29239; Malisauskas M, 2006, BIOCHEMISTRY-MOSCOW+, V71, P505, DOI 10.1134/S0006297906050063; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; Mold M, 2012, J ALZHEIMERS DIS, V29, P875, DOI 10.3233/JAD-2012-120076; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nasr SH, 2017, J AM SOC NEPHROL, V28, P431, DOI 10.1681/ASN.2016090951; Ozawa D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29077; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Richards DB, 2015, NEW ENGL J MED, V373, P1106, DOI 10.1056/NEJMoa1504942; Rydh A, 1998, EUR J NUCL MED, V25, P709; Sattianayagam PT, 2012, J INTERN MED, V272, P36, DOI 10.1111/j.1365-2796.2011.02470.x; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Sjolander D, 2016, AMYLOID, V23, P98, DOI 10.3109/13506129.2016.1158159; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	39	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227227	10.1371/journal.pone.0227227	http://dx.doi.org/10.1371/journal.pone.0227227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KH6NC	31978114	Green Published, Green Submitted, gold			2022-12-26	WOS:000510767200001
J	Bhowmik, KR; Das, S; Islam, MA				Bhowmik, Kakoli Rani; Das, Sumonkanti; Islam, Md. Atiqul			Modelling the number of antenatal care visits in Bangladesh to determine the risk factors for reduced antenatal care attendance	PLOS ONE			English	Article							MATERNAL HEALTH-SERVICES; ZERO-INFLATED POISSON; REGRESSION; TRENDS	The existence of excess zeros in the distribution of antenatal care (ANC) visits in Bangladesh raises the research question of whether there are two separate generating processes in taking ANC and the frequency of ANC. Thus the main objective of this study is to identify a proper count regression model for the number of ANC visits by pregnant women in Bangladesh covering the issues of overdispersion, zero-inflation, and intra-cluster correlation with an additional objective of determining risk factors for ANC use and its frequency. The data have been extracted from the nationally representative 2014 Bangladesh Demographic and Health Survey, where 22% of the total 4493 women did not take any ANC during pregnancy. Since these zero ANC visits can be either structural or sampling zeros, two-part zero-inflated and hurdle regression models are investigated along with the standard one-part count regression models. Correlation among response values has been accounted for by incorporating cluster-specific random effects in the models. The hurdle negative binomial regression model with cluster-specific random intercepts in both the zero and the count part is found to be the best model according to various diagnostic tools including likelihood ratio and uniformity tests. The results show that women who have poor education, live in poor households, have less access to mass media, or belong to the Sylhet and Chittagong regions are less likely to use ANC and also have fewer ANC visits. Additionally, women who live in rural areas, depend on family members' decisions to take health care, and have unintended pregnancies had fewer ANC visits. The findings recommend taking both cluster-specific random effects and overdispersion and zero-inflation into account in modelling the ANC data of Bangladesh. Moreover, safe motherhood programmes still need to pay particular attention to disadvantaged and vulnerable subgroups of women.	[Bhowmik, Kakoli Rani] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Das, Sumonkanti] Maastricht Univ, Dept Quantitat Econ, Maastricht, Netherlands; [Das, Sumonkanti; Islam, Md. Atiqul] Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh; [Das, Sumonkanti] Univ Wollongong, Fac Engn & Informat Sci, Wollongong, NSW, Australia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Shahjalal University of Science & Technology (SUST); University of Wollongong	Islam, MA (corresponding author), Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh.	atique-sta@sust.edu	Das, Sumonkanti/AAY-3810-2020	Das, Sumonkanti/0000-0003-1560-2349; ISLAM, MD ATIQUL/0000-0003-2683-0945				Ali MM, 2012, INDIAN ECON J, V60, P91; Ali N, 2018, HEALTH SERV RES MANA, V5, DOI 10.1177/2333392818781729; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amrin A, 2016, INT J SCI RES METHOD, V5, P49; [Anonymous], [No title captured]; Anwar I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120309; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bangladesh Bureau of Statistics, 2017, PREL REP HOUS INC EX; Beeckman K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-527; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cameron A. Colin, 2013, ECONOMETRIC SOC MONO, V53; CAMERON AC, 2001, COMPANION THEORETICA, P331; Das S, 2019, J STAT COMPUT SIM, V89, P1090, DOI 10.1080/00949655.2018.1553242; Das S, 2017, J R STAT SOC A STAT, V180, P1137, DOI 10.1111/rssa.12311; Guliani H, 2014, HEALTH POLICY PLANN, V29, P589, DOI 10.1093/heapol/czt045; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Haque M., 2009, INTERNET J HLTH, V8, P1; He Hua, 2014, Shanghai Arch Psychiatry, V26, P236, DOI 10.3969/j.issn.1002-0829.2014.04.008; Hinde J, 1998, COMPUT STAT DATA AN, V27, P151, DOI 10.1016/S0167-9473(98)00007-3; Hossain B., 2015, J DEV AREAS, V49, P109, DOI [10.1353/jda.2015.0045, DOI 10.1353/JDA.2015.0045]; Islam MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204752; Islam MR, 2011, RURAL REMOTE HEALTH, V11; Jahan M, 2017, INT J COMMUNITY MED, V3, P925; Kabir R, 2013, IOSR J NURSING HLTH, V2; Kamal S. M. M., 2009, Asian Population Studies, V5, P153, DOI 10.1080/17441730902992075; Mamun MAA, 2014, THESIS; Min YY, 2005, STAT MODEL, V5, P1, DOI 10.1191/1471082X05st084oa; Ministry of Health and Family Welfare, 2017, HLTH POPULATION NUTR; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; NIPORT International Centre for Diarrhoeal Disease Research Bangladesh MEASURE Evaluation, 2017, BANGL MAT MORT HLTH; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Rahman M., 2008, HLTH POLICY DEV, V6, P117; Rahman MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157760; Sepehri A, 2008, SOC SCI MED, V67, P1009, DOI 10.1016/j.socscimed.2008.06.005; Shahabuddin ASM, 2015, TROP MED INT HEALTH, V20, P822, DOI 10.1111/tmi.12503; Shahjahan M, 2017, MIDWIFERY, V52, P42, DOI 10.1016/j.midw.2017.05.011; Staub KE, 2013, HEALTH ECON, V22, P673, DOI 10.1002/hec.2844; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; World Health Organization, 2007, INT MAN PREGN CHILD; Yau KKW, 2001, STAT MED, V20, P2907, DOI 10.1002/sim.860	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228215	10.1371/journal.pone.0228215	http://dx.doi.org/10.1371/journal.pone.0228215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978200	Green Published, gold			2022-12-26	WOS:000534599100128
J	Bobardt, M; Kuo, J; Chatterji, U; Wiedemann, N; Vuagniaux, G; Gallay, P				Bobardt, Michael; Kuo, Joseph; Chatterji, Udayan; Wiedemann, Norbert; Vuagniaux, Gregoire; Gallay, Philippe			The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; IMMUNE-RESPONSES; IN-VIVO; CANCER; INFECTION; VIREMIA; MANIPULATION; REPLICATION; MODULATION	The immune checkpoint programmed cell death protein 1 (PD-1) plays a major role in T cell exhaustion in cancer and chronic HIV infection. The inhibitor of apoptosis protein antagonist Debio 1143 (D1143) enhances tumor cell death and synergizes with anti-PD-1 agents to promote tumor immunity and displayed HIV latency reversal activity in vitro. We asked in this study whether D1143 would stimulate the potency of an anti-human PD-1 monoclonal antibody (mAb) to reduce HIV loads in humanized mice. Anti-PD-1 mAb treatment decreased PD-1+ CD8+ cell population by 32.3% after interruption of four weeks treatment, and D1143 co-treatment further reduced it from 32.3 to 73%. Anti-PD-1 mAb administration reduced HIV load in blood by 94%, and addition of D1143 further enhanced this reduction from 94 to 97%. D1143 also more profoundly promoted with the anti-PD-1-mediated reduction of HIV loads in all tissues analyzed including spleen (71 to 96.4%), lymph nodes (64.3 to 80%), liver (64.2 to 94.4), lung (64.3 to 80.1%) and thymic organoid (78.2 to 98.2%), achieving a > 5 log reduction of HIV loads in CD4+ cells isolated from tissues 2 weeks after drug treatment interruption. Ex vivo anti-CD3/CD28 stimulation increased the ability to activate exhausted CD8+ T cells in infected mice having received in vivo anti-PD-1 treatment by 7.9-fold (5 to 39.6%), and an additional increase by 1.7-fold upon D1143 co-treatment (39.6 to 67.3%). These findings demonstrate for the first time that an inhibitor of apoptosis protein antagonist enhances in a statistically manner the effects of an immune check point inhibitor on antiviral immunity and on HIV load reduction in tissues of humanized mice, suggesting that the combination of two distinct classes of immunomodulatory agents constitutes a promising anti-HIV immunotherapeutic approach.	[Bobardt, Michael; Kuo, Joseph; Chatterji, Udayan; Gallay, Philippe] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Wiedemann, Norbert; Vuagniaux, Gregoire] Debiopharm Int SA, Lausanne, Switzerland	Scripps Research Institute; Debiopharm	Gallay, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	gallay@scripps.edu			Debiopharm	Debiopharm	P.G. received funding from Debiopharm. N.W. and G. V. are employees of Debiopharm. The two employees of Debiopharm International S.A. (Funder) -N.W. and G. V. -contributed to the study design, but not in data collection and analysis, decision to publish, or preparation of the manuscript.	Attinger A, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-4703; Bai LC, 2014, PHARMACOL THERAPEUT, V144, P82, DOI 10.1016/j.pharmthera.2014.05.007; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Bobardt M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211746; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Brinkmann K, 2014, LEUKEMIA LYMPHOMA, V55, P645, DOI 10.3109/10428194.2013.807925; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dai Y, 2009, AM J TRANSL RES, V1, P1; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Dougan SK, 2018, IMMUNOTHERAPY-UK, V10, P787, DOI 10.2217/imt-2017-0185; Dyck L, 2017, EUR J IMMUNOL, V47, P765, DOI 10.1002/eji.201646875; Gallay Philippe A, 2018, Open Virol J, V12, P1, DOI 10.2174/1874357901812010001; Gallay PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184303; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Juergens RA, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2599; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Knights AJ, 2013, CANCER IMMUNOL IMMUN, V62, P321, DOI 10.1007/s00262-012-1342-1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kulpa DA, 2013, SEMIN IMMUNOL, V25, P219, DOI 10.1016/j.smim.2013.02.002; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Langdon CG, 2015, ONCOTARGET, V6, P37419, DOI 10.18632/oncotarget.6138; Lecis D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.449; Liu NB, 2014, AM J CANCER RES, V4, P943; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Matzinger O, 2015, RADIOTHER ONCOL, V116, P495, DOI 10.1016/j.radonc.2015.05.017; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Muller-Sienerth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021556; Nachmias B, 2007, EUR J IMMUNOL, V37, P3467, DOI 10.1002/eji.200636600; Oberoi-Khanuja TK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.311; Palmer BE, 2013, J IMMUNOL, V190, P211, DOI 10.4049/jimmunol.1201108; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Porichis F, 2012, CURR HIV-AIDS REP, V9, P81, DOI [10.1007/s11904-011-0106-4, 10.1007/s11904-011-0106]; Rao M, 2017, INT J INFECT DIS, V56, P221, DOI 10.1016/j.ijid.2017.01.028; Sakthivel P, 2012, REV RECENT CLIN TRIA, V7, P10, DOI 10.2174/157488712799363262; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seung E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077780; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tao Z, 2019, CLIN CANCER RES, V25, P1113, DOI 10.1158/1078-0432.CCR-17-3852; Thibault B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35860-z; Trautmann L, 2006, NAT MED, V12, P1329, DOI 10.1038/nm1106-1329b; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; UNAIDS, 2016, UNAIDS 2016 GLOB FAC; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Verhagen AM, 2001, GENOME BIOL, V2; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yang OO, 1999, J VIROL, V73, P4582, DOI 10.1128/JVI.73.6.4582-4589.1999; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	60	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227715	10.1371/journal.pone.0227715	http://dx.doi.org/10.1371/journal.pone.0227715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978106	Green Published, gold			2022-12-26	WOS:000534599100053
J	Boveda, P; Toledano-Diaz, A; Castano, C; Esteso, MC; Lopez-Sebastian, A; Rizos, D; Bielli, A; Ungerfeld, R; Santiago-Moreno, J				Boveda, Paula; Toledano-Diaz, Adolfo; Castano, Cristina; Cristina Esteso, Milagros; Lopez-Sebastian, Antonio; Rizos, Dimitrios; Bielli, Alejandro; Ungerfeld, Rodolfo; Santiago-Moreno, Julian			Ultra-rapid cooling of ibex sperm by spheres method does not induce a vitreous extracellular state and increases the membrane damages	PLOS ONE			English	Article							CAPRA-PYRENAICA; HUMAN SPERMATOZOA; ELECTRON-MICROSCOPY; EQUILIBRATION TIME; EPIDIDYMAL SPERM; BULL SPERM; ICE-CREAM; CRYO-SEM; CRYOPRESERVATION; VITRIFICATION	Sperm cryopreservation by ultra-rapid cooling based on dropping small volumes of sperm suspension directly into liquid nitrogen, has been successful in some wild ruminant species, including the Iberian ibex (Capra pyrenaica). In ultra-rapid cooling, the contents of these droplets are expected to enter a stable, glass-like state, but to the best of our knowledge no information exists regarding the presence or absence of ice formation in the extracellular milieu when using this technique. Different modifications to the extracellular milieu likely inflict different types of damage on the plasmalemma, the acrosome and mitochondrial membranes. The aims of the present work were: 1) to examine the physical state of the extracellular milieu after cryopreservation at slow and ultra-rapid cooling rates-and thus determine whether ultra-rapid cooling vitrifies the extracellular milieu; and 2) to compare, using conventional sperm analysis techniques and scanning and transmission electron microscopy, the damage to sperm caused by these two methods. Sperm samples were obtained by the transrectal ultrasound-guided massage method (TUMASG) from anesthetized Iberian ibexes, and cryopreserved using slow and ultra-rapid cooling techniques. Sperm motility (22.95 +/- 3.22% vs 4.42 +/- 0.86%), viability (25.64 +/- 3.71% vs 12.8 +/- 2.50%), acrosome integrity (41.45 +/- 3.73% vs 27.00 +/- 1.84%) and mitochondrial membrane integrity (16.52 +/- 3.75% vs 4.00 +/- 0.65%) were better after slow cooling (P<0.001) than after ultrarapid technique. Cryo-scanning electron microscopy (Cryo-SEM) suggested that the vitrified state was not achieved by ultra-rapid cooling, and that the ice crystals formed were smaller and had more stretchmarks (P<0.001) than after slow cooling. Scanning electron microscopy revealed no differences in the types of damage caused by the examined techniques, although transmission electron microscopy showed the damage to the plasmalemma and mitochondrial membrane to be worse after ultra-rapid cooling. In conclusion ultra-rapid cooling provoked more membrane damage than slow cooling, perhaps due to the extracellular ice crystals formed.	[Boveda, Paula; Toledano-Diaz, Adolfo; Castano, Cristina; Cristina Esteso, Milagros; Lopez-Sebastian, Antonio; Rizos, Dimitrios; Santiago-Moreno, Julian] INIA, Dpto Reprod Anim, Madrid, Spain; [Bielli, Alejandro] Univ Republica, Fac Vet, Dpto Morfol & Desarrollo, Montevideo, Uruguay; [Ungerfeld, Rodolfo] Univ Republica, Fac Vet, Dpto Fisiol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Santiago-Moreno, J (corresponding author), INIA, Dpto Reprod Anim, Madrid, Spain.	moreno@inia.es	Ungerfeld, Rodolfo/GRR-7813-2022; Rizos, Dimitrios/E-7058-2012; SANTIAGO, JULIAN/K-5547-2017	Rizos, Dimitrios/0000-0001-6813-3940; SANTIAGO, JULIAN/0000-0001-5551-8120	MINECO/AEI/FEDER; EU [AGL2014-52081-R, AGL2017-85753-R]; MINECO (AEI/FSE, UE)	MINECO/AEI/FEDER; EU(European Commission); MINECO (AEI/FSE, UE)	The study reported here was funded by MINECO/AEI/FEDER and EU grants AGL2014-52081-R and AGL2017-85753-R. P. Boveda was the recipient of a grant for pre-doctoral researchers from MINECO (AEI/FSE, UE).	Aboagla EME, 2004, THERIOGENOLOGY, V62, P1160, DOI 10.1016/j.theriogenology.2004.01.013; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; AUGER J, 1989, J ANDROL, V10, P439; Bagchi A, 2008, EXPERT REV MED DEVIC, V5, P359, DOI 10.1586/17434440.5.3.359; CALDWELL KB, 1992, FOOD STRUCT, V11, P11; Caturla-Sanchez E, 2018, CRYOBIOLOGY, V80, P126, DOI 10.1016/j.cryobiol.2017.11.001; CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C; Colas C, 2009, MICROSC RES TECHNIQ, V72, P566, DOI 10.1002/jemt.20710; Coloma MA, 2011, THERIOGENOLOGY, V76, P1695, DOI 10.1016/j.theriogenology.2011.07.001; Constantin JG, 2016, J PHYS CHEM B, V120, P5047, DOI 10.1021/acs.jpcb.6b01841; Cook KLK, 2010, COMPR REV FOOD SCI F, V9, P213, DOI 10.1111/j.1541-4337.2009.00101.x; Courtens J. L., 1985, Proceedings, 1st International Conference on Deep Freezing of Boar Semen, Uppsala, Sweden, 25-27 August 1985., P61; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Dubochet J, 2007, METHOD CELL BIOL, V79, P7, DOI 10.1016/S0091-679X(06)79001-X; Ekwall H, 2007, THERIOGENOLOGY, V67, P1463, DOI 10.1016/j.theriogenology.2007.03.004; Emamverdi M, 2015, ANIM PROD SCI, V55, P551, DOI 10.1071/AN13215; Esteso MC, 2015, ANIM REPROD SCI, V155, P42, DOI 10.1016/j.anireprosci.2015.01.014; Esteso MC, 2003, CRYOLETTERS, V24, P261; Forero-Gonzalez RA, 2012, ANDROLOGIA, V44, P154, DOI 10.1111/j.1439-0272.2010.01154.x; Gonzalez-Fernandez L, 2012, THERIOGENOLOGY, V78, P415, DOI 10.1016/j.theriogenology.2012.02.021; Gravance CG, 1998, J ANDROL, V19, P704; HOFMO PO, 1989, CRYOBIOLOGY, V26, P124, DOI 10.1016/0011-2240(89)90042-4; Isachenko E, 2008, REPRODUCTION, V136, P167, DOI 10.1530/REP-07-0463; Isachenko Eugenia, 2003, Reprod Biomed Online, V6, P191; Isachenko V, 2004, BIOL REPROD, V71, P1167, DOI 10.1095/biolreprod.104.028811; Isachenko V, 2012, REPROD FERT DEVELOP, V24, P323, DOI 10.1071/RD11061; Katkov II, 2012, CURRENT FRONTIERS IN CRYOBIOLOGY, P3; KROGENAES A, 1994, ACTA VET SCAND, V35, P17; Lopera-Vasquez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148083; Marco-Jimenez F, 2014, ZYGOTE, V22, P204, DOI 10.1017/S0967199412000524; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Merino O, 2012, ANDROLOGIA, V44, P390, DOI 10.1111/j.1439-0272.2011.01196.x; Morris GJ, 2007, THERIOGENOLOGY, V68, P804, DOI 10.1016/j.theriogenology.2007.06.009; Morris GJ, 2006, HUM REPROD, V21, P2075, DOI 10.1093/humrep/del116; Morris GJ, 2012, CRYOBIOLOGY, V64, P71, DOI 10.1016/j.cryobiol.2011.12.002; NATH J, 1972, CRYOBIOLOGY, V9, P240, DOI 10.1016/0011-2240(72)90041-7; Nawroth F, 2002, CRYOLETTERS, V23, P93; O'Brien E, 2019, THERIOGENOLOGY, V129, P160, DOI 10.1016/j.theriogenology.2019.02.024; Oliveira LZ, 2011, J VET SCI, V12, P267, DOI 10.4142/jvs.2011.12.3.267; Pegg DE, 2015, METHODS MOL BIOL, V1257, P3, DOI 10.1007/978-1-4939-2193-5_1; Piomboni P, 2012, INT J ANDROL, V35, P109, DOI 10.1111/j.1365-2605.2011.01218.x; Pradiee J, 2018, THERIOGENOLOGY, V108, P314, DOI 10.1016/j.theriogenology.2017.11.021; Pradiee J, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12629; Pradiee J, 2016, ANIM REPROD SCI, V171, P121, DOI 10.1016/j.anireprosci.2016.06.007; Pradiee J, 2015, THERIOGENOLOGY, V84, P1513, DOI 10.1016/j.theriogenology.2015.07.036; Pradiee J, 2014, THERIOGENOLOGY, V82, P525, DOI 10.1016/j.theriogenology.2014.05.012; Rijsselaere T, 2004, THERIOGENOLOGY, V62, P1292, DOI 10.1016/j.theriogenology.2004.01.005; Said TM, 2010, REPROD BIOMED ONLINE, V21, P456, DOI 10.1016/j.rbmo.2010.05.011; Sanchez R, 2011, ANDROLOGIA, V43, P233, DOI 10.1111/j.1439-0272.2010.01054.x; Santiago-Moreno J, 2013, THERIOGENOLOGY, V79, P383, DOI 10.1016/j.theriogenology.2012.10.011; Santiago-Moreno J, 2010, SOC REPROD FERTIL, V67, P431; Santiago-Moreno J, 2006, THERIOGENOLOGY, V66, P283, DOI 10.1016/j.theriogenology.2005.11.012; Sharafi M, 2015, CELL TISSUE BANK, V16, P261, DOI 10.1007/s10561-014-9458-5; Shaw JM, 2003, HUM REPROD UPDATE, V9, P583, DOI 10.1093/humupd/dmg041; SHERMAN JK, 1982, CRYOBIOLOGY, V19, P503, DOI 10.1016/0011-2240(82)90179-1; Somanath PR, 2004, SMALL RUMINANT RES, V53, P67, DOI 10.1016/j.smallrumres.2003.07.008; Teixeira AS, 2014, PLANT CELL TISS ORG, V119, P269, DOI 10.1007/s11240-014-0531-3; Teixeira AS, 2012, CURRENT MICROSCOPY C, P872; UMRATH W, 1983, MIKROSKOPIE, V40, P9; Woelders H, 1997, CRYOBIOLOGY, V35, P93, DOI 10.1006/cryo.1997.2028	60	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227946	10.1371/journal.pone.0227946	http://dx.doi.org/10.1371/journal.pone.0227946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978160	gold, Green Published			2022-12-26	WOS:000534599100082
J	Ferraro, FV; Gavin, JP; Wainwright, TW; McConnell, AK				Ferraro, Francesco Vincenzo; Gavin, James Peter; Wainwright, Thomas William; McConnell, Alison K.			Comparison of balance changes after inspiratory muscle or Otago exercise training	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HUMAN DIAPHRAGM; PROGRAM; OLDER; FALLS; PREVENTION; STRENGTH; ADULTS; CHAIR	The inspiratory muscles contribute to balance via diaphragmatic contraction and by increasing intra-abdominal pressure. We have shown inspiratory muscle training (IMT) improves dynamic balance significantly with healthy community-dwellers. However, it is not known how the magnitude of balance improvements following IMT compares to that of an established balance program. This study compared the effects of 8-week of IMT for community-dwellers, to 8-week of the Otago exercise program (OEP) for care-residents, on balance and physical performance outcomes. Nineteen healthy community-dwellers (74 +/- 4 years) were assigned to self-administered IMT. Eighteen, healthy care-residents (82 +/- 4 years) were assigned to instructor-led OEP. The IMT involved 30 breaths twice-daily at similar to 50% of maximal inspiratory pressure (MIP). The OEP group undertook resistance and mobility exercises for similar to 60 minutes, twice-weekly. Balance and physical performance were assessed using the mini Balance Evaluation System Test (mini-BEST) and time up and go (TUG). After 8-week, both groups improved balance ability significantly (mini-BEST: IMT by 24 +/- 34%; OEP by 34 +/- 28%), with no between-group difference. Dynamic balance sub-tasks improved significantly more for the IMT group (P < 0.01), than the OEP group and vice versa for static balance sub-tasks (P = 0.01). The IMT group also improved MIP (by 66 +/- 97%), peak inspiratory power (by 31 +/- 12%) and TUG (by -11 +/- 27%); whereas the OEP did not. IMT and OEP improved balance ability similarly, with IMT eliciting greater improvement in dynamic balance, whilst OEP improved static balance more than IMT. Unlike IMT, the OEP did not provide additional benefits in inspiratory muscle function and TUG performance. Our findings suggest that IMT offers a novel method of improving dynamic balance in older adults, which may be more relevant to function than static balance and potentially a useful adjunct to the OEP in frailty prevention.	[Ferraro, Francesco Vincenzo; Wainwright, Thomas William] Bournemouth Univ, Dept Human Sci & Publ Hlth, Bournemouth, Dorset, England; [Gavin, James Peter] Univ Southampton, Sch Hlth Sci, Southampton, Hants, England; [Wainwright, Thomas William] Bournemouth Univ, Res Inst, Orthopaed Res Inst, Bournemouth, Dorset, England; [McConnell, Alison K.] The Burrow, Christchurch, New Zealand	Bournemouth University; University of Southampton; Bournemouth University	Ferraro, FV (corresponding author), Bournemouth Univ, Dept Human Sci & Publ Hlth, Bournemouth, Dorset, England.	fferraro@bournemouth.ac.uk	McConnell, Alison/ABB-1170-2020; Wainwright, Thomas/F-5130-2015; Gavin, James/J-3803-2019	Wainwright, Thomas/0000-0001-7860-2990; Ferraro, Francesco Vincenzo/0000-0002-4902-7760; Gavin, James/0000-0003-0574-0502	Bournemouth University	Bournemouth University	We also confirm that the project was part of (FF) PhD project and therefore received limited funding from Bournemouth University as part of (FF) PhD scholarship.; The authors would like to thank all participants who volunteered their time to help with the research. We would also like to express great appreciation to the managers and the staff of Anchor Westmorland Court, Richmondwood Residential Home, Belvedere Court and Williams Court of Stonewater and Sunrise in Westbourne for their help and support.	Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; Beaumont M, 2018, CLIN RESPIR J, V12, P2178, DOI 10.1111/crj.12905; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; Binns E., 2011, NZ J PHYSIOTHER, V39, P63; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Commandeur D, 2018, GAIT POSTURE; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Farrance C, 2016, PREV MED, V87, P155, DOI 10.1016/j.ypmed.2016.02.037; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferraro FV, 2018, J APPL PHYSL; Granacher U, 2013, SPORTS MED, V43, P627, DOI 10.1007/s40279-013-0041-1; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 1997, J PHYSIOL-LONDON, V505, P539, DOI 10.1111/j.1469-7793.1997.539bb.x; Hodges PW, 2005, J BIOMECH, V38, P1873, DOI 10.1016/j.jbiomech.2004.08.016; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kocic M, 2018, ARCH GERONTOL GERIAT, V75, P112, DOI 10.1016/j.archger.2017.12.001; Kolar P, 2010, J APPL PHYSIOL, V109, P1064, DOI 10.1152/japplphysiol.01216.2009; Kyrdalen IL, 2014, PHYSIOTHER RES INT, V19, P108, DOI 10.1002/pri.1571; Langer D, 2013, RESP MED, V107, P633, DOI 10.1016/j.rmed.2013.01.020; Lomax M, 2009, RESPIRATION, V78, P197, DOI 10.1159/000211229; McConnell A., 2013, RESP MUSCLE TRAINING; McGill SM, 1999, ARCH PHYS MED REHAB, V80, P941, DOI 10.1016/S0003-9993(99)90087-4; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mills DE, 2015, MED SCI SPORT EXER, V47, P691, DOI 10.1249/MSS.0000000000000474; Mourey F, 2000, J GERONTOL A-BIOL, V55, pB425, DOI 10.1093/gerona/55.9.B425; O'Hoski S, 2015, GAIT POSTURE, V42, P301, DOI 10.1016/j.gaitpost.2015.06.006; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Romer LM, 2003, MED SCI SPORT EXER, V35, P237, DOI 10.1249/01.MSS.0000048642.58419.1E; Sherrington C., 2016, COCHRANE DATABASE SY; Shubert TE, 2018, J APPL GERONTOL, V37, P79, DOI 10.1177/0733464816675422; Thomas S, 2010, AGE AGEING, V39, P681, DOI 10.1093/ageing/afq102; Volianitis S, 2001, MED SCI SPORT EXER, V33, P803	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227379	10.1371/journal.pone.0227379	http://dx.doi.org/10.1371/journal.pone.0227379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978126	Green Accepted, gold, Green Published			2022-12-26	WOS:000534599100035
J	Giummarra, MJ; Tardif, H; Blanchard, M; Tonkin, A; Arnold, CA				Giummarra, Melita J.; Tardif, Hilarie; Blanchard, Megan; Tonkin, Andrew; Arnold, Carolyn A.			Hypertension prevalence in patients attending tertiary pain management services, a registry-based Australian cohort study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; REPORTING CHRONIC PAIN; HEART-RATE-VARIABILITY; STRESS SCALES DASS-21; BODY-MASS INDEX; LOW-BACK-PAIN; BLOOD-PRESSURE; GENERAL-POPULATION; SELF-REPORTS; DEPRESSION	Persistent pain and hypertension often co-occur, and share several biological and lifestyle risk factors. The present study aimed to provide insight into the prevalence of, and factors associated with, hypertension in the largest cohort of patients seeking treatment in 43 tertiary pain clinics in Australia. Adults aged > = 18 years registered to the electronic Persistent Pain Outcomes Collaboration registry between 2013 and 2018 were included if they had persistent non-cancer pain (N = 43,789). Risk Ratios (RRs) compared prevalence of self-reported hypertension with the general and primary care Australian populations, and logistic regression examined factors associated with hypertension. One in four (23.9%) patients had hypertension, which was higher than the Australian adult population (2014-15: RR = 5.86, 95%CI: 5.66, 6.06; 2017-18: RR = 9.40, 95%CI: 9.01, 9.80), and in primary care patients (2011-13: RR = 1.17, 95%CI: 1.15, 1.20). Adjusting for covariates, patients with higher odds of hypertension were older, lived in regions with higher socioeconomic disadvantage, had higher levels of BMI, were born outside the Oceania/Australasia region, and had comorbid arthritis, diabetes, or severe-extremely severe anxiety symptoms. Female patients and those with depression symptoms had lower adjusted odds. Unadjusted analyses showed an association between widespread pain, pain duration, pain severity and interference, and lower pain self-efficacy with hypertension; however, only pain severity remained significant in adjusted analyses. Hypertension was more prevalent in people with persistent pain than in the general community, was associated with more severe pain, and commonly co-occurred with pain-related impairments. Routine hypertension screening and treatment targeting shared mechanisms of hypertension and pain may improve treatment outcomes in the pain clinic setting.	[Giummarra, Melita J.; Tonkin, Andrew] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Giummarra, Melita J.; Arnold, Carolyn A.] Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia; [Tardif, Hilarie; Blanchard, Megan] Univ Wollongong, Australian Hlth Serv Res Inst, Wollongong, NSW, Australia; [Arnold, Carolyn A.] Monash Univ, Sch Med Nursing & Hlth Sci, Acad Board Anaesthesia & Perioperat Med, Clayton, Vic, Australia	Monash University; University of Wollongong; Monash University	Giummarra, MJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Giummarra, MJ (corresponding author), Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia.	melita.giummarra@monash.edu	Arnold, Carolyn Anne/AAP-8961-2021; Giummarra, Melita/H-8387-2012	Giummarra, Melita/0000-0001-7839-6058; Blanchard, Megan/0000-0002-8423-0203	ARC DECRA fellowship [DE170100726]	ARC DECRA fellowship(Australian Research Council)	This work was supported by an ARC DECRA fellowship (DE170100726) to MJG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HI, 2009, DISABIL REHABIL, V31, P1980, DOI 10.3109/09638280902874154; [Anonymous], 2013, SOC IND AR SEIFA; Atkinson TM, 2010, PAIN MED, V11, P337, DOI 10.1111/j.1526-4637.2009.00774.x; Australia Bureau of Statistics, 2016, STAND AUSTR CLASS CO; Australian Bureau of Statistics, 2016, NAT HLTH SURV 1 RES; Australian Bureau of Statistics, 2018, 4364055001D0003 AUST; Babu AS, 2016, HEART LUNG CIRC, V25, P333, DOI 10.1016/j.hlc.2015.10.015; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bertisch SM, 2009, J PSYCHOSOM RES, V66, P511, DOI 10.1016/j.jpsychores.2008.12.003; Bhat SK, 2017, J HYPERTENS, V35, P1983, DOI [10.1097/HJH.0000000000001410, 10.1097/hjh.0000000000001410]; Birk JL, 2019, HEALTH PSYCHOL, V38, P802, DOI 10.1037/hea0000737; Bramlage P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-18; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Bruehl S, 2005, CLIN J PAIN, V21, P147, DOI 10.1097/00002508-200503000-00006; Bruehl S, 2018, PAIN, V159, P119, DOI 10.1097/j.pain.0000000000001070; Burns JW, 2015, J BEHAV MED, V38, P372, DOI 10.1007/s10865-014-9608-z; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Buse DC, 2010, J NEUROL NEUROSUR PS, V81, P428, DOI 10.1136/jnnp.2009.192492; Chung OY, 2008, ANESTH ANALG, V107, P1018, DOI 10.1213/ane.0b013e31817f8dfe; Cleeland C, 1991, PAIN RES GR, P143; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; Deloitte Access Economics, 2019, COST PAIN AUSTR; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Garg N., 2012, J MUSCULOSKELET MED, V29, P13; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Ghosh A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-557; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Goncalves VSS, 2018, J HYPERTENS, V36, P970, DOI 10.1097/HJH.0000000000001648; Goodson NJ, 2013, PAIN, V154, P1595, DOI 10.1016/j.pain.2013.04.043; Hansson P, 2014, PAIN, V155, P1932, DOI 10.1016/j.pain.2014.07.016; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoeper MM, 2005, EUR RESPIR J, V26, P858, DOI 10.1183/09031936.05.00075305; Kerkhoff AC, 2012, J HYPERTENS, V30, P2112, DOI 10.1097/HJH.0b013e3283588268; Khattar RS, 1999, CIRCULATION, V100, P1071, DOI 10.1161/01.CIR.100.10.1071; Kurita GP, 2012, PAIN, V153, P2332, DOI 10.1016/j.pain.2012.07.023; Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Lovibond SH, 1995, MANUAL DEPRESSION AN; MBF Foundation, 2007, HIGH PRIC PAIN EC IM; McLean SA, 2011, SPINE, V36, pS226, DOI 10.1097/BRS.0b013e3182387fb4; Meeus M, 2013, SEMIN ARTHRITIS RHEU, V43, P279, DOI 10.1016/j.semarthrit.2013.03.004; Mentz G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-312; Mundal I, 2016, J PAIN, V17, P1246, DOI 10.1016/j.jpain.2016.08.006; Nicholas N, ANN C BRIT PSYCH SOC; Nolet PS, 2012, J MANIP PHYSIOL THER, V35, P176, DOI 10.1016/j.jmpt.2012.01.006; Nuttall Frank Q, 2015, Nutr Today, V50, P117; O'Connor SR, 2015, ARCH PHYS MED REHAB, V96, P724, DOI 10.1016/j.apmr.2014.12.003; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Olsen RB, 2013, PAIN, V154, P257, DOI 10.1016/j.pain.2012.10.020; Pandey A, 2015, CIRC-HEART FAIL, V8, P1032, DOI 10.1161/CIRCHEARTFAILURE.115.002130; Park C, 2013, J CLIN PSYCHOL, V69, P45, DOI 10.1002/jclp.21910; Parkitny L, 2012, J CLIN EPIDEMIOL, V65, P189, DOI 10.1016/j.jclinepi.2011.05.010; Parsons S, 2015, EUR J PAIN, V19, P167, DOI 10.1002/ejp.533; Paterniti S, 2000, BRIT J PSYCHIAT, V176, P464, DOI 10.1192/bjp.176.5.464; Rubin DB., 2004, MULTIPLE IMPUTATION; Sarink D, 2016, EUR J PREV CARDIOL, V23, P23, DOI 10.1177/2047487314554865; Searle A, 2015, CLIN REHABIL, V29, P1155, DOI 10.1177/0269215515570379; Semlitsch T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008274.pub3; Shrestha PL, 2016, CURR OPIN CARDIOL, V31, P376, DOI 10.1097/HCO.0000000000000298; Smith N, 2016, PAIN MED, V17, P278, DOI 10.1093/pm/pnv048; Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383; Sullivan M.J., 2009, PAIN CATASTROPHIZING; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tardif H, 2016, PAIN MED MALDEN MASS; Tracy LM, 2016, PAIN, V157, P7, DOI 10.1097/j.pain.0000000000000360; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van den Akker M, 2015, EUR J GEN PRACT, V21, P45, DOI 10.3109/13814788.2014.907266; Vernooij RWM, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0419-1; von Baeyer CL, 2011, PAIN MANAG, V1, P61, DOI 10.2217/PMT.10.2; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wood BM, 2010, PAIN MED, V11, P1780, DOI 10.1111/j.1526-4637.2010.01005.x; Wooden M., 2008, HILDA PROJECT TECHNI; World Health Organization, 2013, BOD MASS IND BMI CLA; Xue J., 2014, INTEGRATIVE MED INT, V1, P162	76	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228173	10.1371/journal.pone.0228173	http://dx.doi.org/10.1371/journal.pone.0228173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978196	Green Published, gold			2022-12-26	WOS:000534599100123
J	Min, KR; Galvis, A; Nole, KLB; Sinha, R; Clarke, J; Kirsner, RS; Ajdic, D				Min, Kyung R.; Galvis, Adriana; Nole, Katherine L. Baquerizo; Sinha, Rohita; Clarke, Jennifer; Kirsner, Robert S.; Ajdic, Dragana			Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs	PLOS ONE			English	Article							DIABETIC FOOT INFECTIONS; ARTHROBACTER-CUMMINSII; SURGICAL DEBRIDEMENT; CLINICAL-OUTCOMES; GLOBAL PREVALENCE; SP-NOV; MICROBIOME; SKIN; ULCERS; IDENTIFICATION	Diabetic foot ulcers (DFUs) lead to nearly 100,000 lower limb amputations annually in the United States. DFUs are colonized by complex microbial communities, and infection is one of the most common reasons for diabetes-related hospitalizations and amputations. In this study, we examined how DFU microbiomes respond to initial sharp debridement and off-loading and how the initial composition associates with 4 week healing outcomes. We employed 16S rRNA next generation sequencing to perform microbial profiling on 50 samples collected from 10 patients with vascularized neuropathic DFUs. Debrided wound samples were obtained at initial visit and after one week from two DFU locations, wound bed and wound edge. Samples of the foot skin outside of the wounds were also collected for comparison. We showed that DFU wound beds are colonized by a greater number of distinct bacterial phylotypes compared to the wound edge or skin outside the wound. However, no significant microbiome diversity changes occurred at the wound sites after one week of standard care. Finally, increased initial abundance of Gram-positive anaerobic cocci (GPAC), especially Peptoniphilus (p < 0.05; n = 5 subjects), was associated with impaired healing; thus, GPAC's abundance could be a predictor of the wound-healing outcome.	[Min, Kyung R.; Galvis, Adriana; Nole, Katherine L. Baquerizo; Kirsner, Robert S.; Ajdic, Dragana] Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Sinha, Rohita; Clarke, Jennifer] Univ Nebraska, Dept Stat, Lincoln, NE USA	University of Miami; University of Nebraska System; University of Nebraska Lincoln	Ajdic, D (corresponding author), Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	dajdic@med.miami.edu		Clarke, Jennifer/0000-0002-2723-7249	University of Miami Miller School of Medicine [SAC 2014-11R2]	University of Miami Miller School of Medicine	Initials of the author who received award: D.A. Grant number: SAC 2014-11R2 The full name of each funder: The University of Miami Miller School of Medicine pilot grant program URL of funder website: http://research.med.miami.edu/funding-opportunities/internal-awards/sac The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Brem H, 2006, PLAST RECONSTR SURG, V117, p193S, DOI 10.1097/01.prs.0000225459.93750.29; Cardinal M, 2009, WOUND REPAIR REGEN, V17, P306, DOI 10.1111/j.1524-475X.2009.00485.x; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Charles PGP, 2015, ANAEROBE, V34, P8, DOI 10.1016/j.anaerobe.2015.03.009; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Choi Y, 2019, MICROB ECOL, V77, P808, DOI 10.1007/s00248-018-1231-z; Citron DM, 2007, J CLIN MICROBIOL, V45, P2819, DOI 10.1128/JCM.00551-07; Davies CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edmonds M, 2004, AM J SURG, V187, p25S, DOI 10.1016/S0002-9610(03)00300-3; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; Funke G, 1998, J CLIN MICROBIOL, V36, P1539, DOI 10.1128/JCM.36.6.1539-1543.1998; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Funke G, 1996, J CLIN MICROBIOL, V34, P2356, DOI 10.1128/JCM.34.10.2356-2363.1996; Gardner SE, 2006, WOUND REPAIR REGEN, V14, P548, DOI 10.1111/j.1743-6109.2006.00162.x; Gardner SE, 2014, DIABETES CARE, V37, P2693, DOI 10.2337/dc14-0051; Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771; Gardner SE, 2009, BIOL RES NURS, V11, P119, DOI 10.1177/1099800408326169; Goldstein David E, 2003, Diabetes Care, V26 Suppl 1, pS106; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Gordon Katherine A, 2012, Skinmed, V10, P24; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Kalan LR, 2019, CELL HOST MICROBE, V25, P641, DOI 10.1016/j.chom.2019.03.006; Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183; Kurd SK, 2009, WOUND REPAIR REGEN, V17, P318, DOI 10.1111/j.1524-475X.2009.00487.x; Lebrun E, 2013, JAMA DERMATOL, V149, P1059, DOI 10.1001/jamadermatol.2013.4959; Lebrun E, 2010, WOUND REPAIR REGEN, V18, P433, DOI 10.1111/j.1524-475X.2010.00619.x; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Malone M, 2017, NEXT GENERATION DNA; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Margolis DJ, 2003, DIABETES CARE, V26, P1696, DOI 10.2337/diacare.26.6.1696; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Mendes JJ, 2012, DIABETES RES CLIN PR, V95, P153, DOI 10.1016/j.diabres.2011.10.001; Murphy EC, 2013, FEMS MICROBIOL REV, V37, P520, DOI 10.1111/1574-6976.12005; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Oksanen F.J., 2017, VEGAN COMMUNITY ECOL; PITCHER DG, 1984, J CLIN PATHOL, V37, P1395, DOI 10.1136/jcp.37.12.1395; Price LB, 2011, WOUND REPAIR REGEN, V19, P80, DOI 10.1111/j.1524-475X.2010.00628.x; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; REIBER GE, 1995, NIH PUBLICATION, P409; Roglic G., 2016, GLOBAL REPORT DIABET; ROSSAU R, 1987, INT J SYST BACTERIOL, V37, P198, DOI 10.1099/00207713-37-3-198; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Sloan TJ, 2019, J MED MICROBIOL, V68, P230, DOI 10.1099/jmm.0.000907; Tena D, 2015, JPN J INFECT DIS, V68, P128, DOI 10.7883/yoken.JJID.2014.164; Tipton CD, 2017, WOUND REPAIR REGEN, V25, P673, DOI 10.1111/wrr.12555; Upadhyay J, 2014, NEW ENGL J MED, V371, P285, DOI 10.1056/NEJMc1406009; Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolcott RD, 2016, WOUND REPAIR REGEN, V24, P163, DOI 10.1111/wrr.12370	56	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227006	10.1371/journal.pone.0227006	http://dx.doi.org/10.1371/journal.pone.0227006			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978071	Green Published, gold			2022-12-26	WOS:000534599100024
J	Winkworth, RC; Nelson, BCW; Bellgard, SE; Probst, CM; McLenachan, PA; Lockhart, PJ				Winkworth, Richard C.; Nelson, Briana C. W.; Bellgard, Stanley E.; Probst, Chantal M.; McLenachan, Patricia A.; Lockhart, Peter J.			A LAMP at the end of the tunnel: A rapid, field deployable assay for the kauri dieback pathogen, Phytophthora agathidicida	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; MULTILOCUS PHYLOGENY; PCR; MITOCHONDRIAL; AGATHIS; DISEASE	The root rot causing oomycete, Phytophthora agathidicida, threatens the long-term survival of the iconic New Zealand kauri. Currently, testing for this pathogen involves an extended soil bioassay that takes 14-20 days and requires specialised staff, consumables, and infrastructure. Here we describe a loop-mediated isothermal amplification (LAMP) assay for the detection of P. agathidicida that targets a portion of the mitochondrial apocytochrome b coding sequence. This assay has high specificity and sensitivity; it did not cross react with a range of other Phytophthora isolates and detected as little as 1 fg of total P. agathidicida DNA or 116 copies of the target locus. Assay performance was further investigated by testing plant tissue baits from flooded soil samples using both the extended soil bioassay and LAMP testing of DNA extracted from baits. In these comparisons, P. agathidicida was detected more frequently using the LAMP test. In addition to greater sensitivity, by removing the need for culturing, the hybrid baiting plus LAMP approach is more cost effective than the extended soil bioassay and, importantly, does not require a centralised laboratory facility with specialised staff, consumables, and equipment. Such testing will allow us to address outstanding questions about P. agathidicida. For example, the hybrid approach could enable monitoring of the pathogen beyond areas with visible disease symptoms, allow direct evaluation of rates and patterns of spread, and allow the effectiveness of disease control to be evaluated. The hybrid LAMP bioassay also has the potential to empower local communities to evaluate the pathogen status of local kauri stands, providing information for disease management and conservation initiatives.	[Winkworth, Richard C.; Lockhart, Peter J.] Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand; [Winkworth, Richard C.; Nelson, Briana C. W.; McLenachan, Patricia A.; Lockhart, Peter J.] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand; [Bellgard, Stanley E.; Probst, Chantal M.] Manaaki Whenua Landcare Res, Auckland, New Zealand	Massey University; Massey University; Landcare Research - New Zealand	Winkworth, RC (corresponding author), Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand.; Winkworth, RC (corresponding author), Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand.	r.c.winkworth@massey.ac.nz		Winkworth, Richard/0000-0001-5394-3094	BioProtection Research Centre [BPRC_MU_2016_1]; New Zealand Ministry of Business, Innovation and Employment Catalyst: Seeding Fund [MAU1702]; Massey University [NP94607]; New Zealand Ministry of Business, Innovation and Employment Strategic Science Investment Fund [C09X1704]	BioProtection Research Centre; New Zealand Ministry of Business, Innovation and Employment Catalyst: Seeding Fund; Massey University; New Zealand Ministry of Business, Innovation and Employment Strategic Science Investment Fund	P.J.L. and R.C.W., BPRC_MU_2016_1, BioProtection Research Centre (https://bioprotection.org.nz).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. P.J.L. and R.C.W., MAU1702, New Zealand Ministry of Business, Innovation and Employment Catalyst: Seeding Fund (https://royalsociety.org.nz/what-we-do/funds-and-opportunities/catalyst-fund/catalyst-seeding/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. R.C.W. and P.J.L., NP94607, Massey University (https://massey.ac.nz).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.E.B, C09X1704, New Zealand Ministry of Business, Innovation and Employment Strategic Science Investment Fund (https://www.mbie.govt.nz/science-and-technology/science-and-innovation/funding-information-and-opportunities/investment-funds/strategic-science-investment-fund/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglietti C, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0774-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beever RE, 2010, DETECTION PHYTOPHTHO; Beever RE, 2011, P 4 M INT UN FOR RES, P74; Bellgard SE, 2016, FOREST PATHOL, V46, P622, DOI 10.1111/efp.12280; Bellgard S. E., 2016, FOREST PHYTOPHTHORAS, V6, DOI [10.5399/osu/ fp.5.1.3748, DOI 10.5399/OSU/FP.5.1.3748]; Best N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204310; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bourret TB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192502; Cevallos W, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005672; Chen QH, 2013, EUR J PLANT PATHOL, V137, P597, DOI 10.1007/s10658-013-0273-9; Dai TT, 2019, PLANT DIS, V103, P3101, DOI 10.1094/PDIS-04-19-0781-RE; Dong ZM, 2015, CAN J PLANT PATHOL, V37, P485, DOI 10.1080/07060661.2015.1119733; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farooq U, 2015, IRAN J VET RES, V16, P331; GADGIL P D, 1974, New Zealand Journal of Forestry Science, V4, P59; GUO LY, 1993, APPL ENVIRON MICROB, V59, P2323, DOI 10.1128/AEM.59.7.2323-2325.1993; Hansen ZR, 2016, J APPL MICROBIOL, V120, P1010, DOI 10.1111/jam.13079; Horner IJ, 1996, PHYTOPATHOLOGY, V86, P1133, DOI 10.1094/Phyto-86-1133; Huberli D., 1995, THESIS; JEFFERS SN, 1986, PLANT DIS, V70, P1038, DOI 10.1094/PD-70-1038; Jeffers SN, 2006, IDENTIFYING SPECIES; KATO S, 1990, J GEN MICROBIOL, V136, P2127, DOI 10.1099/00221287-136-10-2127; Khaliq I, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy048; Khan MR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01920; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Li BJ, 2015, J PHYTOPATHOL, V163, P185, DOI 10.1111/jph.12305; Li YM, 2017, MICROB PATHOGENESIS, V107, P54, DOI 10.1016/j.micpath.2017.03.016; Manessis G, 2019, BIOMEDICAL J SCI TEC, V14; Martin FN, 2014, FUNGAL GENET BIOL, V66, P19, DOI 10.1016/j.fgb.2014.02.006; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; McCarthy CGP, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00095-17, 10.1128/msphere.00095-17]; McDougal R, 2014, 53789 MPI; Miles TD, 2015, PHYTOPATHOLOGY, V105, P265, DOI 10.1094/PHYTO-05-14-0134-R; Minerdi D, 2008, EUR J PLANT PATHOL, V122, P227, DOI 10.1007/s10658-008-9276-3; NEWHOOK F. J., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P808; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Seki M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00057; Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693; Than DJ, 2013, FOREST PATHOL, V43, P324, DOI 10.1111/efp.12034; Vashist SK, 2017, BIOSENSORS-BASEL, V7, DOI 10.3390/bios7040062; Waipara N. W., 2013, New Zealand Plant Protection, V66, P235; Weir BS, 2015, PHYTOTAXA, V205, P21, DOI 10.11646/phytotaxa.205.1.2; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814; Zhang SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39874-z; Zhao W, 2015, J PLANT DIS PROTECT, V122, P66, DOI 10.1007/BF03356533; Zou YP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003916	51	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0224007	10.1371/journal.pone.0224007	http://dx.doi.org/10.1371/journal.pone.0224007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978166	gold, Green Published, Green Submitted			2022-12-26	WOS:000534599100007
J	Seiner, J; Karam, C; Beauchet, A; Dallongeville, A; Binsse, S; Blivet, S; Bourgault-Villada, I; Charron, P; Chinet, T; Eyries, M; Fagnou, C; Lesniak, J; Lesur, G; Lucas, J; Nicod-Tran, A; Ozanne, A; Palmyre, A; Soubrier, F; El Hajjam, M; Lacombe, P				Seiner, Jacques; Karam, Carma; Beauchet, Alain; Dallongeville, Axel; Binsse, Stephen; Blivet, Sandra; Bourgault-Villada, Isabelle; Charron, Philippe; Chinet, Thierry; Eyries, Melanie; Fagnou, Carole; Lesniak, Jerome; Lesur, Gilles; Lucas, Jerome; Nicod-Tran, Agnes; Ozanne, Augustin; Palmyre, Aurelien; Soubrier, Florent; El Hajjam, Mostafa; Lacombe, Pascal			Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors	PLOS ONE			English	Article							INVOLVEMENT; EXPERIENCE; MANAGEMENT; MUTATIONS; DIAGNOSIS	Background Splenic artery aneurysm (SAA) is a rare but potentially fatal condition. Rupture results in 25% mortality up to 75% in pregnant women with 95% fetal mortality. Brief reports suggest an increased risk of developing SAA in patients with HHT. Methods We analyzed enhanced multidetector CT data in 186 HHT patients matched (gender and +/- 5 year old) with 186 controls. We screened for SAA and recorded diameter of splenic and hepatic arteries and hepatic, pancreatic and splenic parenchymal involvements. We determined by univariate and multivariate analysis, the relationship with age, sex, genetic status, cardiovascular risk factors (CVRF) and visceral involvement. Results SAA concerned 24.7% of HHT patients and 5.4% of controls, p<0.001. Factors associated with increased risk of SAA in HHT were female gender (p = 0.04, OR = 2.12, IC 95% = 1.03-4.50), age (p = 0.0003, OR = 1.04, 95% CI = 1.02-1.06) and pancreatic parenchymal involvement (p = 0.04, OR = 2.13, 95% CI = 1.01-4.49), but not type of mutation, hepatic or splenic parenchymal involvements, splenic size or splenic artery diameter or CVRF. Conclusions We found a 4.57 higher rate of SAA in HHT patients without evidence of splenic high output related disease or increased CVRF. These results suggest the presence of a vascular intrinsic involvement. It should lead to screening all HHT patients for SAA. The vasculopathy hypothesis could require a change in management as screening of all systemic arteries and even the aorta and to further research in the field.	[Seiner, Jacques; Karam, Carma; Beauchet, Alain; Dallongeville, Axel; Binsse, Stephen; Blivet, Sandra; Bourgault-Villada, Isabelle; Chinet, Thierry; Fagnou, Carole; Lesniak, Jerome; Lesur, Gilles; Lucas, Jerome; Nicod-Tran, Agnes; Ozanne, Augustin; Palmyre, Aurelien; El Hajjam, Mostafa; Lacombe, Pascal] Univ Versailles St Quentin Yvelines, Ambroise Pare Hosp, AP HP, St Quentin en Yvelines, France; [Charron, Philippe; Eyries, Melanie; Soubrier, Florent] Pitie Salpetrie Re Hosp, AP HP, Dept Genet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP)	Karam, C (corresponding author), Univ Versailles St Quentin Yvelines, Ambroise Pare Hosp, AP HP, St Quentin en Yvelines, France.	carma.karam@aphp.fr	EYRIES, melanie/ABF-1034-2020					Abbas MA, 2002, ANN VASC SURG, V16, P442, DOI 10.1007/s10016-001-0207-4; Al-Habbal Y, 2010, SURG-J R COLL SURG E, V8, P223, DOI 10.1016/j.surge.2009.11.011; Arthur H, 2015, ANGIOGENESIS, V18, P511, DOI 10.1007/s10456-015-9482-5; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P463, DOI 10.1002/ajmg.a.31101; Beaussier M, 1770, J MED CLIN PHARM; BEDFORD PD, 1960, GUT, V1, P312, DOI 10.1136/gut.1.4.312; Bensalah M, 2013, HEMATOLOGY REPORTS, V5, P6; Buscarini E, 2011, DIGEST DIS SCI, V56, P2166, DOI 10.1007/s10620-011-1585-2; CAILLOUETTE JC, 1993, AM J OBSTET GYNECOL, V168, P1810, DOI 10.1016/0002-9378(93)90694-E; Dave SP, 2000, ANN VASC SURG, V14, P223, DOI 10.1007/s100169910039; Delvi Mohamad Bilal, 2004, Middle East Journal of Anesthesiology, V17, P1135; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Garcia-Tsao G, 2007, J HEPATOL, V46, P499, DOI 10.1016/j.jhep.2006.12.008; HALPERN M, 1968, RADIOLOGY, V90, P1143, DOI 10.1148/90.6.1143; Jones JA, 2009, J VASC RES, V46, P119, DOI 10.1159/000151766; Lacout A, 2010, RADIOLOGY, V254, P479, DOI 10.1148/radiol.09090096; LANDE A, 1976, ANGIOLOGY, V27, P223, DOI 10.1177/000331977602700404; Maillard M, 2010, J RADIOL, V91, P1103, DOI 10.1016/S0221-0363(10)70155-4; MATTAR SG, 1995, AM J SURG, V169, P580, DOI 10.1016/S0002-9610(99)80225-6; Moore S W, 1970, Bull Soc Int Chir, V29, P210; Moulinet T, 2014, INT J CARDIOL, V176, P1414, DOI 10.1016/j.ijcard.2014.08.016; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; Sadat Umar, 2008, Int J Surg, V6, P261, DOI 10.1016/j.ijsu.2007.08.002; Schuster NH, 1937, J PATHOL BACTERIOL, V44, P29, DOI 10.1002/path.1700440105; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; STANLEY JC, 1986, J VASC SURG, V3, P836, DOI 10.1067/mva.1986.avs0030836; TRASTEK VF, 1982, SURGERY, V91, P694	29	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0226681	10.1371/journal.pone.0226681	http://dx.doi.org/10.1371/journal.pone.0226681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971937	gold, Green Published			2022-12-26	WOS:000534374400006
J	Tareke, M; Birehanu, M; Amare, D; Abate, A				Tareke, Minale; Birehanu, Minychil; Amare, Desalegne; Abate, Andargie			Common mental illness among epilepsy patients in Bahir Dar city, Ethiopia: A cross-sectional study	PLOS ONE			English	Article							PSYCHIATRIC COMORBIDITIES; NORTHWEST ETHIOPIA; ADDIS-ABABA; DEPRESSION; PREVALENCE; DISORDERS; PEOPLE; ANXIETY; ADULTS; COMMUNITY	Background Common mental illness has a substantial impact on seizure control and negatively affects the overall quality of life among individuals with epilepsy. However, there is a dearth of studies that examined the associated factors of common mental illness among epilepsy patients in Ethiopia, particularly in the study area. This study aimed to assess the magnitude and factors associated with common mental disorders in epilepsy patients who attended government health institutions in Bahir Dar city, Ethiopia. Method Health institution based cross-sectional study was conducted using a systematic sampling technique among people living with epilepsy in Bahir Dar City Administration. Common mental illness was assessed using a self-reporting questionnaire and a semi-structured questionnaire was employed to collect data on socio-demographic and clinical related characteristics. Data were analyzed using descriptive statistics, univariate logistic regression, and multivariable logistic regression. Results The magnitude of comorbid common mental illness among people living with epilepsy was found 35.4%. High magnitude of common mental illness was reported among females (39.9%) when compared to males (32.3%). The most prevalent common mental disorders symptoms include being worried, unhappy feeling, trouble thinking clearly, and difficult to enjoy daily activities. Family history of epilepsy, frequent seizures attacks, side effects of antiepileptic drugs, lack of social support and not adherent to antiepileptic drugs were factors associated with common mental illness. Conclusions Common mental illness was found to be prevalent among people living with epilepsy. Therefore, it is recommended that great attention should be given to mental illness besides controlling seizure attacks.	[Tareke, Minale] Bahir Dar Univ, Coll Med & Hlth Sci, Psychiat Dept, Bahir Dar, Ethiopia; [Birehanu, Minychil; Amare, Desalegne; Abate, Andargie] Bahir Dar Univ, Coll Med & Hlth Sci, Nursing Dept, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Tareke, M (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Psychiat Dept, Bahir Dar, Ethiopia.	minale23@gmail.com	Tareke, Minale/AAA-9018-2021	Tareke, Minale/0000-0003-0218-1039				Alsaadi T, 2015, EPILEPSY BEHAV, V52, P194, DOI 10.1016/j.yebeh.2015.09.008; Altinoz AE, 2016, SEIZURE-EUR J EPILEP, V40, P133, DOI 10.1016/j.seizure.2016.06.016; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amruth G, 2014, EPILEPSY BEHAV, V33, P94, DOI 10.1016/j.yebeh.2014.02.001; Babtain FA, 2013, SEIZURE-EUR J EPILEP, V22, P542, DOI 10.1016/j.seizure.2013.04.002; Barr WB, 2015, CLIN HDB NEUROPSYCHO, P224; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yebeh.2005.04.009; BEAR MF, 2016, NEUROSCIENCE EXPLORI, P650; Beusenberg M., 1994, WHOMNHPSF948; Bifftu BB, 2015, AFR HEALTH SCI, V15, P1211, DOI 10.4314/ahs.v15i4.21; Bifftu Berhanu Boru, 2015, BMC Res Notes, V8, P585, DOI 10.1186/s13104-015-1515-z; Bragatti JA, 2010, EPILEPTIC DISORD, V12, P283, DOI 10.1684/epd.2010.0345; Chaka A, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0197-z; Chandrasekharan SC, 2017, J NEUROSCI RURAL PRA, V8, P13, DOI 10.4103/jnrp.jnrp_21_17; Charfi N, 2017, EUR PSYCHIAT, V41, pS470, DOI 10.1016/j.eurpsy.2017.01.536; Dessie Y, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.95.2173; Dominguez-Aguilera MC, 2017, PREVALENCE PSYCHIAT; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fiest KM, 2015, NEUROL CLIN, P1, DOI [10.1016/j.ncl.2014.09.010, DOI 10.1016/J.NCL.2014.09.010]; Gelaye Bizu, 2012, Clin Pract Epidemiol Ment Health, V8, P126, DOI 10.2174/1745017901208010126; Getinet Alemu W, 2016, HLTH SCI J, V10; Haile K, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0174-6; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Henning OJ, 2010, ACTA NEUROL SCAND, V122, P18, DOI 10.1111/j.1600-0404.2010.01370.x; Henok A, 2017, ETHIOP J HEALTH SCI, V27, P47, DOI 10.4314/ejhs.v27i1.7; Hesdorffer DC, 2012, EPILEPSIA, V53, P301, DOI 10.1111/j.1528-1167.2011.03351.x; Insel BJ, 2018, EPILEPSIA, V59, P431, DOI 10.1111/epi.13985; Jackson MJ, 2005, J NEUROL NEUROSUR PS, V76, pI45, DOI 10.1136/jnnp.2004.060467; Josephson CB, 2017, INT REV PSYCHIAT; Kanner AM, 2016, NAT REV NEUROL, V12, P106, DOI 10.1038/nrneurol.2015.243; Keezer MR, 2015, LANCET NEUROL, P1; Kwon OY, 2014, J CLIN NEUROL, V10, P175, DOI 10.3988/jcn.2014.10.3.175; Lacey CJ, 2009, EPILEPSIA, V50, P1991, DOI 10.1111/j.1528-1167.2009.02165.x; Leekassa R, 2004, LEPROSY REV, V75, P367; Letvak Susan, 2002, Issues Ment Health Nurs, V23, P249, DOI 10.1080/016128402753542992; Li T., 2017, NEUROPSYCHIATRY-LOND, V7, P1, DOI [10.4172/Neuropsychiatry.1000e101, DOI 10.4172/NEUROPSYCHIATRY.1000E101]; M'bayo T, 2017, INT J EPILEPSY, V61, P1, DOI [10.1016/j.ijep.2016.12.002, DOI 10.1016/J.IJEP.2016.12.002]; Mama SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154035; Mbewe EK, 2013, EPILEPSY BEHAV, V27, P296, DOI 10.1016/j.yebeh.2013.01.025; Melese Biniam, 2016, BMC Res Notes, V9, P485; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Mula M, 2016, NEUROPSYCH SYMP NEUR, P1, DOI 10.1007/978-3-319-22159-5; Mula M., 2013, CLIN PRACT, V10, P293, DOI [10.2217/cpr.13.18, DOI 10.2217/CPR.13.18]; O'Rourke G, 2017, SEIZURE-EUR J EPILEP, V45, P160, DOI 10.1016/j.seizure.2016.12.006; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; RANI R, 2018, INT J CURR RES MED S, V4, P90; Selamawit Z, 2015, J AIDS CLIN RES, V6; Sezibera V., 2013, RWANDA J, V1, P67, DOI [10.4314/rj.v1i1.5F, DOI 10.4314/RJ.V1I1.5F]; Stephen LJ, 2017, EPILEPSY BEHAV, V71, P73, DOI 10.1016/j.yebeh.2017.04.003; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; Tawar Shabeena, 2014, Indian J Community Med, V39, P43, DOI 10.4103/0970-0218.126359; Tegegne MT, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0589-4; Tsegabrhan H, 2014, NEUROL INDIA, V62, P649, DOI 10.4103/0028-3886.149391; Verrotti A, 2014, J NEUROL SCI, V343, P23, DOI 10.1016/j.jns.2014.05.043; Wang JY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1736-5; World Health Organization, 2010, EP WHO E MED REG BRI; Yimam K, 2014, J DEPRESS ANXIETY, V1, P2167; Zeleke W, 2015, INT J MENTAL HLTH PS, V1, P1	59	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227854	10.1371/journal.pone.0227854	http://dx.doi.org/10.1371/journal.pone.0227854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5RH	31971965	gold, Green Published			2022-12-26	WOS:000534374400022
J	Kaiser, HA; Saied, NN; Kokoefer, AS; Saffour, L; Zoller, JK; Helwani, MA				Kaiser, Heiko A.; Saied, Nahel N.; Kokoefer, Andreas S.; Saffour, Lina; Zoller, Jonathan K.; Helwani, Mohammad A.			Incidence and prediction of intraoperative and postoperative cardiac arrest requiring cardiopulmonary resuscitation and 30-day mortality in non-cardiac surgical patients	PLOS ONE			English	Article							RISK-FACTORS; ANESTHESIA; OUTCOMES; SURVIVAL	Background The incidence, prediction and mortality outcomes of intraoperative and postoperative cardiac arrest requiring cardiopulmonary resuscitation (CPR) in surgical patients are under investigated and have not been studied concurrently in a single study. Methods A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program data between 2008 and 2012. Firth's penalized logistic regression was used to study the incidence and identify risk factors for intraand postoperative CPR and 30-day mortality. simplified prediction model was constructed and internally validated to predict the studied outcomes. Results Among about 1.86 million non-cardiac operations, the incidence rate of intraoperative CPR was 0.03%, and for postoperative CPR was 0.33%. The 30-day mortality incidence rate was 1.25%. The incidence rate of events decreased overtime between 2008-2012. Of the 29 potential predictors, 14 were significant for intraoperative CPR, 23 for postoperative CPR, and 25 for 30-day mortality. The five strongest predictors (highest odd ratios) of intraoperative CPR were the American Society of Anesthesiologists (ASA) physical status, Systemic Inflammatory Response Syndrome (SIRS)/sepsis, surgery type, urgent/emergency case and anesthesia technique. Intraoperative CPR, ASA, age, functional status and end stage renal disease were the most significant predictors for postoperative CPR. The most significant predictors of 30-day mortality were ASA, age, functional status, SIRS/sepsis, and disseminated cancer. The predictions with the simplified five-factor model performed well and was comparable to the full prediction model. Postoperative cardiac arrest requiring CPR, compared to intraoperative, was associated with much higher mortality. Conclusions The incidence of cardiac arrest requiring CPR in surgical patients decreased overtime. Risk factors for intraoperative CPR, postoperative CPR and perioperative mortality are overlapped. We proposed a simplified approach compromised of five-factor model to identify patients at high risk. Postoperative, compare to intraoperative, cardiac arrest requiring CPR was associated with much higher mortality.	[Kaiser, Heiko A.; Kokoefer, Andreas S.; Saffour, Lina; Zoller, Jonathan K.; Helwani, Mohammad A.] Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA; [Kaiser, Heiko A.] Univ Bern, Dept Anesthesiol & Pain Med, Inselspital, Bern Univ Hosp, Freiburgstr, Bern, Switzerland; [Saied, Nahel N.] Univ Arkansas Med Sci, Dept Anesthesiol & Crit Care, Little Rock, AR 72205 USA; [Kokoefer, Andreas S.] Paracelsus Med Univ Salzburg, Dept Anesthesiol Perioperat Care & Intens Care Me, Strubergasse, Salzburg, Austria	Washington University (WUSTL); University of Bern; University Hospital of Bern; University of Arkansas System; University of Arkansas Medical Sciences; Paracelsus Private Medical University	Helwani, MA (corresponding author), Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA.	helwanim@wustl.edu	Kaiser, Heiko/AAB-1198-2021	Saied, Nahel/0000-0001-9242-4764; Zoller, Jonathan/0000-0002-3827-6163; Kaiser, Heiko/0000-0002-6082-9510				[Anonymous], 2013, APPL LOGISTIC REGRES; [Anonymous], 1993, BIOMETRIKA; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Ellis SJ, 2014, ANESTHESIOLOGY, V120, P829, DOI 10.1097/ALN.0000000000000153; Fleisher LA, 2014, CIRCULATION, V130, P2215, DOI 10.1161/CIR.0000000000000105; Harrell FE Jr, 2016, PACKAGE HMISC; Heinze G PM, 2013, FIRTHS BIAS REDUCED; Helwani MA, 2015, J BONE JOINT SURG AM, V97A, P186, DOI 10.2106/JBJS.N.00612; Hohn A, 2018, EUR J ANAESTH, V35, P266, DOI 10.1097/EJA.0000000000000685; Kazaure HS, 2013, JAMA SURG, V148, P14, DOI 10.1001/jamasurg.2013.671; King GZL, 2001, POLITICAL ANAL, V9; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Nunnally ME, 2015, ANESTH ANALG, V120, P364, DOI 10.1213/ANE.0000000000000527; Ofoma UR, 2018, J AM COLL CARDIOL, V71, P402, DOI 10.1016/j.jacc.2017.11.043; Ramachandran SK, 2013, ANESTHESIOLOGY, V119, P1322, DOI 10.1097/ALN.0b013e318289bafe; Saied NN, 2017, BRIT J ANAESTH, V118, P105, DOI 10.1093/bja/aew383; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	17	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0225939	10.1371/journal.pone.0225939	http://dx.doi.org/10.1371/journal.pone.0225939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31967987	Green Published, gold			2022-12-26	WOS:000534373000003
J	Robinson, C; Dilkina, B; Moreno-Cruz, J				Robinson, Caleb; Dilkina, Bistra; Moreno-Cruz, Juan			Modeling migration patterns in the USA under sea level rise	PLOS ONE			English	Article							CLIMATE-CHANGE; ADAPTATION; FLOOD	Sea level rise in the United States will lead to large scale migration in the future. We propose a framework to examine future climate migration patterns using models of human migration. Our framework requires that we distinguish between historical versus climate driven migration and recognizes how the impacts of climate change can extend beyond the affected area. We apply our framework to simulate how migration, driven by sea level rise, differs from baseline migration patterns. Specifically, we couple a sea level rise model with a data-driven model of human migration and future population projections, creating a generalized joint model of climate driven migration that can be used to simulate population distributions under potential future sea level rise scenarios. The results of our case study suggest that the effects of sea level rise are pervasive, expanding beyond coastal areas via increased migration, and disproportionately affecting some areas of the United States.	[Robinson, Caleb] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA; [Dilkina, Bistra] Univ Southern Calif, Viterbi Sch Engn, Los Angeles, CA 90007 USA; [Moreno-Cruz, Juan] Univ Waterloo, Sch Environm Enterprise & Dev, Waterloo, ON, Canada	University System of Georgia; Georgia Institute of Technology; University of Southern California; University of Waterloo	Dilkina, B (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Los Angeles, CA 90007 USA.	dilkina@usc.edu		Dilkina, Bistra/0000-0002-6784-473X	National Science Foundation [CCF-1522054, 1510510, BCS-1638268]; Canada Research Chairs program	National Science Foundation(National Science Foundation (NSF)); Canada Research Chairs program(Canada Research Chairs)	J.M-C was funded by the National Science Foundation with grant number 1510510 and the Canada Research Chairs program. C.R. was funded the National Science Foundation with grants numbered CCF-1522054 and Microsoft AI for Earth gift. B.D. was funded by the National Science Foundation with grants numbered CCF-1522054 and BCS-1638268 (https://www.nsf.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SB, 2012, POPULATION DISTRIBUT, P161; Black R, 2011, GLOBAL ENVIRON CHANG, V21, pS3, DOI 10.1016/j.gloenvcha.2011.10.001; Borjas GJ, 2016, LABOR MARKET CONSEQU; Brown TC, 2019, EARTHS FUTURE, V7, P219, DOI 10.1029/2018EF001091; Church JA, 2013, SEA LEVEL CHANGE CHA; Crossett K, 2014, NATL COASTAL POPULAT, V10; Curtis KJ, 2011, POPUL ENVIRON, V33, P28, DOI 10.1007/s11111-011-0136-2; Davis KF, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac4d4; Erlander S, 1990, VSP16; Feng SZ, 2010, P NATL ACAD SCI USA, V107, P14257, DOI 10.1073/pnas.1002632107; Findlay AM, 2011, GLOBAL ENVIRON CHANG, V21, pS50, DOI 10.1016/j.gloenvcha.2011.09.004; Fussell E, 2014, POPUL ENVIRON, V35, P305, DOI 10.1007/s11111-014-0204-5; Gordon K., 2014, EC RISKS CLIMATE CHA; Guneralp B, 2015, GLOBAL ENVIRON CHANG, V31, P217, DOI 10.1016/j.gloenvcha.2015.01.002; Hauer ME, 2017, NAT CLIM CHANGE, V7, P321, DOI [10.1038/nclimate3271, 10.1038/NCLIMATE3271]; Hauer ME, 2016, NAT CLIM CHANGE, V6, P691, DOI [10.1038/nclimate2961, 10.1038/NCLIMATE2961]; Hugo G, 2011, GLOBAL ENVIRON CHANG, V21, pS21, DOI 10.1016/j.gloenvcha.2011.09.008; Kahn ME, 2013, CLIMATOPOLIS OUR CIT; Keenan JM, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabb32; Lenormand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045985; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Marcy D, 2011, SOLUTIONS COASTAL DI, P474, DOI [DOI 10.1061/41185(417)42, 10.1061/9780784411858]; McLeman R, 2006, CLIMATIC CHANGE, V76, P31, DOI 10.1007/s10584-005-9000-7; McLeman R., 2013, CLIMATIC CHANGE, P1; Nicholls RJ, 2002, PHYS CHEM EARTH, V27, P1455, DOI 10.1016/S1474-7065(02)00090-6; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Piguet E, 2010, WIRES CLIM CHANGE, V1, P517, DOI 10.1002/wcc.54; Robinson C, 2018, P 1 ACM SIGCAS C COM, P30; Shayegh S, 2017, NAT CLIM CHANGE, V7, P828, DOI 10.1038/NCLIMATE3420; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sweet WV, 2017, 083 NOAA NOS COOPS; Thiede BC, 2017, POPUL ENVIRON, V39, P147, DOI 10.1007/s11111-016-0265-8; U S Internal Revenue Service, 2017, TAX STATS MIGR DAT; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wilby RL, 2012, PROG PHYS GEOG, V36, P348, DOI 10.1177/0309133312438908; Willekens F, 2016, SCIENCE, V352, P897, DOI 10.1126/science.aaf6545; Wyett K, 2014, ASIA PAC POLICY STUD, V1, P171, DOI 10.1002/app5.7; Yang Yingxiang, 2014, SCI REPORTS, V4	40	30	30	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0227436	10.1371/journal.pone.0227436	http://dx.doi.org/10.1371/journal.pone.0227436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5QT	31968017	Green Published, gold			2022-12-26	WOS:000534373000016
J	Moonira, T; Chachra, SS; Ford, BE; Marin, S; Alshawi, A; Adam-Primus, NS; Arden, C; Al-Oanzi, ZH; Foretz, M; Viollet, B; Cascante, M; Agius, L				Moonira, Tabassum; Chachra, Shruti S.; Ford, Brian E.; Marin, Silvia; Alshawi, Ahmed; Adam-Primus, Natasha S.; Arden, Catherine; Al-Oanzi, Ziad H.; Foretz, Marc; Viollet, Benoit; Cascante, Marta; Agius, Loranne			Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; metformin; glycolysis; phosphofructokinase; hepatocyte; glucose 6-phosphate	GENE-EXPRESSION; FRUCTOSE 2,6-BISPHOSPHATE; INTRAVENOUS METFORMIN; REGULATORY PROTEIN; COMPLEX I; MITOCHONDRIAL; LIVER; GLUCOKINASE; GLUCONEOGENESIS; PHOSPHATE	The chronic effects of metformin on liver gluconeogenesis involve repression of the G6pc gene, which is regulated by the carbohydrate-response element?binding protein through raised cellular intermediates of glucose metabolism. In this study we determined the candidate mechanisms by which metformin lowers glucose 6-phosphate (G6P) in mouse and rat hepatocytes challenged with high glucose or gluconeogenic precursors. Cell metformin loads in the therapeutic range lowered cell G6P but not ATP and decreased G6pc mRNA at high glucose. The G6P lowering by metformin was mimicked by a complex 1 inhibitor (rotenone) and an uncoupler (dinitrophenol) and by overexpression of mGPDH, which lowers glycerol 3-phosphate and G6P and also mimics the G6pc repression by metformin. In contrast, direct allosteric activators of AMPK (A-769662, 991, and C-13) had opposite effects from metformin on glycolysis, gluconeogenesis, and cell G6P. The G6P lowering by metformin, which also occurs in hepatocytes from AMPK knockout mice, is best explained by allosteric regulation of phosphofructokinase-1 and/or fructose bisphosphatase-1, as supported by increased metabolism of [3-H-3]glucose relative to [2-H-3]glucose; by an increase in the lactate m2/m1 isotopolog ratio from [1,2-C-13(2)]glucose; by lowering of glycerol 3-phosphate an allosteric inhibitor of phosphofructokinase-1; and by marked G6P elevation by selective inhibition of phosphofructokinase-1; but not by a more reduced cytoplasmic NADH/NAD redox state. We conclude that therapeutically relevant doses of metformin lower G6P in hepatocytes challenged with high glucose by stimulation of glycolysis by an AMP-activated protein kinase?independent mechanism through changes in allosteric effectors of phosphofructokinase-1 and fructose bisphosphatase-1, including AMP, P-i, and glycerol 3-phosphate.	[Moonira, Tabassum; Chachra, Shruti S.; Ford, Brian E.; Alshawi, Ahmed; Adam-Primus, Natasha S.; Arden, Catherine; Al-Oanzi, Ziad H.; Agius, Loranne] Newcastle Univ, Med Sch, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Marin, Silvia; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, E-08007 Barcelona, Spain; [Marin, Silvia] Inst Salud Carlos III, CIBEREHD, Madrid 28029, Spain; [Marin, Silvia] Inst Salud Carlos III, Metabol Node INB Bioinformat Platform, Madrid 28029, Spain; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Alshawi, Ahmed] Al Furat Al Awsat Tech Univ, Kufa Inst, Med Lab Tech Dept, Kufa, Iraq; [Al-Oanzi, Ziad H.] Jouf Univ, Med Lab Sci, POB 2014, Sakaka, Saudi Arabia	Newcastle University - UK; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Al-Furat Al-Awsat Technical University; Al Jouf University	Agius, L (corresponding author), Newcastle Univ, Med Sch, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	loranne.agius@ncl.ac.uk	CASCANTE, MARTA/AAG-4355-2022; Viollet, Benoit/O-6927-2017; Al-Oanzi, Ziad/AAI-4296-2020; Viollet, Benoit/N-2397-2019; Alshawi, Ahmed/J-1256-2019; CASCANTE, MARTA/AFK-5991-2022; Marin, Silvia/C-5492-2017; Ford, Brian E/G-5875-2010; FORETZ, Marc/O-7334-2017	CASCANTE, MARTA/0000-0002-2062-4633; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Alshawi, Ahmed/0000-0002-0328-3486; CASCANTE, MARTA/0000-0002-2062-4633; Marin, Silvia/0000-0003-0693-2207; Ford, Brian E/0000-0003-0543-4978; FORETZ, Marc/0000-0001-7017-9032	Diabetes UK [13/0004701]; Medical Research Council [MR/P002854/1]; Higher Committee for Education Development Iraq Grant 2015-2019; Agencia Catalana d'Ajuts Universitaris i de Recerca [2017SGR1033]; ICREA Foundation, Generalitat de Catalunya; MRC [MR/P002854/1] Funding Source: UKRI	Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Committee for Education Development Iraq Grant 2015-2019; Agencia Catalana d'Ajuts Universitaris i de Recerca; ICREA Foundation, Generalitat de Catalunya(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Diabetes UK Grant 13/0004701 and Medical Research Council Grant MR/P002854/1 (to L. A.). This work was also supported in part by a Higher Committee for Education Development Iraq Grant 2015-2019 (to A. A.) and by Agencia Catalana d'Ajuts Universitaris i de Recerca (2017SGR1033) and ICREA Foundation, Generalitat de Catalunya (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agius L, 2016, P NUTR SOC, V75, P10, DOI 10.1017/S0029665115002451; Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002; Agius L, 2013, BIOCHEM PHARMACOL, V85, P306, DOI 10.1016/j.bcp.2012.09.019; AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Al-Oanzi ZH, 2017, DIABETES OBES METAB, V19, P1078, DOI 10.1111/dom.12910; Alshawi A, 2019, J BIOL CHEM, V294, P2839, DOI 10.1074/jbc.RA118.006670; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; BERRY MN, 1994, EUR J BIOCHEM, V225, P557, DOI 10.1111/j.1432-1033.1994.00557.x; BONORA E, 1984, CURR MED RES OPIN, V9, P47, DOI 10.1185/03007998409109558; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Bridges HR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0287-9; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Cameron AR, 2018, REDOX BIOL, V14, P187, DOI 10.1016/j.redox.2017.08.018; Chakera AJ, 2015, DIABETES CARE, V38, P1383, DOI 10.2337/dc14-2769; Christensen MMH, 2015, DIABETOLOGIA, V58, P2494, DOI 10.1007/s00125-015-3733-2; Codner GF, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0530-7; COOK DE, 1973, J BIOL CHEM, V248, P5272; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CRAWFORD JM, 1983, BIOCHEM J, V212, P595, DOI 10.1042/bj2120585; Dawed AY, 2017, DIABETOLOGIA, V60, P2231, DOI 10.1007/s00125-017-4404-2; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Dong Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21111446; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Glossmann HH, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172782; Grefhorst A, 2010, BIOCHEM J, V432, P249, DOI 10.1042/BJ20101225; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hampson LJ, 2005, DIABETES, V54, P617, DOI 10.2337/diabetes.54.3.617; Harndahl L, 2006, FEBS J, V273, P336, DOI 10.1111/j.1742-4658.2005.05067.x; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; HUE L, 1982, BIOCHEM J, V206, P359, DOI 10.1042/bj2060359; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; KATZ J, 1963, J BIOL CHEM, V238, P517; Kim MS, 2016, J CLIN INVEST, V126, P4372, DOI 10.1172/JCI81993; Kraev A, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-18; Li MQ, 2019, CELL METAB, V30, P508, DOI 10.1016/j.cmet.2019.05.018; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Marin S, 2004, BIOCHEM J, V381, P287, DOI 10.1042/BJ20031737; MCCUNE SA, 1989, BIOCHEM J, V259, P925, DOI 10.1042/bj2590925; MOYLE J, 1973, BIOCHEM J, V132, P571, DOI 10.1042/bj1320571; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; Neal A, 2015, TOXICOL SCI, V148, P594, DOI 10.1093/toxsci/kfv208; Otto M, 2003, DIABETES OBES METAB, V5, P189, DOI 10.1046/j.1463-1326.2003.00263.x; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Payne VA, 2005, DIABETES, V54, P1949, DOI 10.2337/diabetes.54.7.1949; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; SIES H, 1977, EUR J BIOCHEM, V72, P301, DOI 10.1111/j.1432-1033.1977.tb11253.x; SIES H, 1975, FEBS LETT, V54, P274, DOI 10.1016/0014-5793(75)80091-3; Stein BD, 2019, CELL REP, V29, P3331, DOI 10.1016/j.celrep.2019.10.117; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; SUM CF, 1992, DIABETIC MED, V9, P61, DOI 10.1111/j.1464-5491.1992.tb01716.x; THOMAS AP, 1981, BIOCHEM J, V198, P551, DOI 10.1042/bj1980551; VANSCHAFTINGEN E, 1984, BIOCHEM J, V222, P511, DOI 10.1042/bj2220511; VANSTAPEL F, 1990, BIOCHEM J, V266, P207, DOI 10.1042/bj2660207; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275	74	11	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3330	3346		10.1074/jbc.RA120.012533	http://dx.doi.org/10.1074/jbc.RA120.012533			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974165	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000519597300035
J	Winters, CM; Hong-Brown, LQ; Chiang, HL				Winters, Chelsea M.; Hong-Brown, Ly Q.; Chiang, Hui-Ling			Intracellular vesicle clusters are organelles that synthesize extracellular vesicle?associated cargo proteins in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; exosome (vesicle); extracellular vesicles; protein synthesis; gluconeogenesis; cell-cell communication; intracellular vesicle clusters; proteomics; vacuole import and degradation (Vid) pathway; CLICK chemistry; Saccharomyces cerevisiae; secreted protein	CRYPTOCOCCUS-NEOFORMANS; VACUOLE IMPORT; ACTIN PATCHES; VID VESICLES; EXOSOMES; DEGRADATION; ENDOCYTOSIS; FRUCTOSE-1,6-BISPHOSPHATASE; ASSOCIATION; SECRETION	Extracellular vesicles (EVs) play important roles in cell-cell communication. In budding yeast (Saccharomyces cerevisiae), EVs function as carriers to transport cargo proteins into the periplasm for storage during glucose starvation. However, intracellular organelles that synthesize these EV-associated cargo proteins have not been identified. Here, we investigated whether cytoplasmic organelles?called intracellular vesicle clusters (IVCs)?serve as sites for the synthesis of proteins targeted for secretion as EV-associated proteins. Using proteomics, we identified 377 IVC-associated proteins in yeast cells grown under steady-state low-glucose conditions, with the largest group being involved in protein translation. Isolated IVCs exhibited protein synthesis activities that required initiation and elongation factors. We have also identified 431 newly synthesized proteins on isolated IVCs. Expression of 103Q-GFP, a foreign protein with a long polyglutamine extension, resulted in distribution of this protein as large puncta that co-localized with IVC markers, including fructose-1,6-bisphosphatase (FBPase) and the vacuole import and degradation protein Vid24p. We did not observe this pattern in cycloheximide-treated cells or in cells lacking VID genes, required for IVC formation. The induction of 103Q-GFP on IVCs adversely affected total protein synthesis in intact cells and on isolated IVCs. This expression also decreased levels of EV-associated cargo proteins in the extracellular fraction without affecting the number of secreted EVs. Our results provide important insights into the functions of IVCs as sites for the synthesis of EV-associated proteins targeted for secretion to the periplasm.	[Winters, Chelsea M.; Hong-Brown, Ly Q.; Chiang, Hui-Ling] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	hchiang@pennstatehealth.psu.edu			NIGMS, National Institutes of Health [GM59480]; Penn State Gift Fund	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Penn State Gift Fund	This study was supported in part by NIGMS, National Institutes of Health Grant GM59480 and a Penn State Gift Fund (to H.-L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Tables S1-S4.	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Atay Safinur, 2014, Commun Integr Biol, V7, pe28231, DOI 10.4161/cib.28231; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Coleman BM, 2015, SEMIN CELL DEV BIOL, V40, P89, DOI 10.1016/j.semcdb.2015.02.007; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Giardina BJ, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23497; Giardina BJ, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-9; Giardina BJ, 2013, J BIOL CHEM, V288, P11636, DOI 10.1074/jbc.M112.419895; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Harischandra DS, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau4543; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Jalalian SH, 2019, ANAL BIOCHEM, V571, P1, DOI 10.1016/j.ab.2019.02.013; Kao CY, 2019, CURR OPIN BIOTECH, V60, P89, DOI 10.1016/j.copbio.2019.01.005; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Oliveira Debora L, 2010, Commun Integr Biol, V3, P533, DOI 10.4161/cib.3.6.12756; Oliveira DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011113; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Salehi M, 2018, J CELL PHYSIOL, V233, P6370, DOI 10.1002/jcp.26481; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stein K, 2017, BIOL CELL, V109, P190, DOI 10.1111/boc.201600060; Stein K, 2014, MEMBRANES-BASEL, V4, P608, DOI 10.3390/membranes4030608; Tickner JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00127; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039463; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; Vilaca-Faria H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020118; Winters CM, 2017, DNA CELL BIOL, V36, P909, DOI 10.1089/dna.2017.3847; Winters CM, 2016, CURR PROTEIN PEPT SC, V17, P808, DOI 10.2174/1389203717666160226144457; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118	41	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2650	2663		10.1074/jbc.RA119.008612	http://dx.doi.org/10.1074/jbc.RA119.008612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31974164	hybrid, Green Published			2022-12-26	WOS:000519969100011
J	Hausmann, A; Diller, J; Moriniere, J; Hocherl, A; Floren, A; Haszprunar, G				Hausmann, Axel; Diller, Juliane; Moriniere, Jerome; Hoecherl, Amelie; Floren, Andreas; Haszprunar, Gerhard			DNA barcoding of fogged caterpillars in Peru: A novel approach for unveiling host-plant relationships of tropical moths (Insecta, Lepidoptera)	PLOS ONE			English	Article							HERBIVORES; ECUADOR	The present study aimed to perform molecular identification of lepidopteran larvae from canopy fogging including gut-content analyses. A total of 130 lepidopteran larvae were selected from 37 fogging samples at the Panguana station, district Yuyapichis, province Puerto Inca, department Hua ' nuco, Peru. Target trees were pre-identified and subsequently submitted to molecular confirmation of identity with three markers (rbcL, psbA and trnL-F). The COI gene of 119 lepidopteran larvae was successfully sequenced and found to belong to 92 species: Comparison of DNA barcodes with the reference database of adult moths resulted in 65 (55%) matches at species level, 32 (27%) at genus level, 19 (16%) at subfamily or family level, three just to order level. Three larvae could not be assigned to a family. For these larvae the fogged target tree now suggests a potential host-plant relationship. Molecular gut content analysis, based on High-Throughput-Sequencing was successfully tested for ten larvae corroborating feeding on the target plant in some cases but elucidating several other cases of potential 'alternative feeding'. We propose a larger-scale approach using this rapid and efficient method including molecular gut-content analyses for comprehensively testing the ratio of 'alternative feeders' and pitfalls caused by collateral fogging of larvae from neighboring trees.	[Hausmann, Axel; Diller, Juliane; Moriniere, Jerome; Hoecherl, Amelie; Haszprunar, Gerhard] SNSB Zool Staatssammlung Munchen, Munich, Germany; [Moriniere, Jerome] Adv Identificat Methods GmbH, Munich, Germany; [Floren, Andreas] Julius Maximilians Univ, Wurzburg, Germany	University of Wurzburg	Hausmann, A (corresponding author), SNSB Zool Staatssammlung Munchen, Munich, Germany.	hausmann.a@snsb.de		Hausmann, Axel/0000-0002-0358-9928	State of Bavaria [1/2017]	State of Bavaria	The authors GH, JD, AxH recieved financial support from the State of Bavaria in the framework of the SNSB Innovativ program (1/2017; Staatliche Bayerische Naturwissenschaftliche Sammlungen; https://www.snsb.de/index.php/de/) allowing to engage the author JM, as manager of AIM (Advanced Identification Methods GmbH, Munchen, Germany), to perform part of the plant barcoding and metabarcoding analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (State of Bavaria) provided also support in the form of salaries for authors GH, JD, AF, AxH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.; We thank "Moro" Carlos Vasquez Modena (Panguana) and Hamilton Paredes (Museum of Natural History, Lima) for identification of the target trees. We furthermore thank Julio Monzon (Lima/Freiburg) for providing the fogger and the chemicals. Vi ' ctor Meyer Ruiz Chota (Yuyapichis) was very helpful in taking the fogging samples, Johanna Brunner, Sarah Augustin and Stefanie Wothe (Munich) helped to take the cambium/sapwood samples. Dr. Andreas Fleischmann (SNSB, Botanische Staatssammlung, Munich) gave advice concerning the botanical aspects of the study. The genetic analyses have received considerable support from Paul D. N. Hebert and the Biodiversity Institute of Ontario (BIO) and the Canadian Centre for DNA Barcoding (CCDB University of Guelph). The data management and analysis system BOLD was provided by Sujeevan Ratnasingham. This study was part of the program `SNSB Innovativ'. We thank the Peruvian nature conservation authority and forestry office (Servicio Forestal y de Fauna Silvestre, SERFOR, Ministerio de Agricultura y Riego, MINAGRI) for collection permits (No 007-2014-SERFOR-DGGSPFFS; No 0406-2017-SERFOR-DGGSPFFS) and exportation permits (fauna: No 003281-SERFOR, No 003320-SERFOR; flora: No 003284-SERFOR + No 161-2018-MINAGRI-SERFOR-DGGSPFFS, No 003333-SERFOR).	[Anonymous], 1999, GEOMETRID MOTHS WORL; [Anonymous], 1999, GEOMETRID MOTHS WORL; Bodner F, 2015, J TROP ECOL, V31, P473, DOI 10.1017/S0266467415000243; Bodner F, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6701; Brehm Gunnar, 2003, Nachrichten des Entomologischen Vereins Apollo, V24, P29; Davis EE, MINIRISK ASSESSMENT; Dyer LA, CATERPILLARS PARASIT; Emery VJ, 2009, MOL ECOL RESOUR, V9, P217, DOI 10.1111/j.1755-0998.2009.02647.x; Floren Andreas, 2010, Abc Taxa, V8, P158; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Gossner Martin M., 2009, Mitteilungen Muenchener Entomologischen Gesellschaft, V99, P135; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2016, SHILAP-REV LEPIDOPT, V44, P463; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Hernandez-Ruiz A, 2017, ENTOMOL NEWS, V126, P415, DOI 10.3157/021.126.0511; Hobern D., 2019, BARCODE B; Janzen D.H., 1986, GUANACASTE NATL PARK; Janzen DH, 2019, CATERPILLARS PUPAE B; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kitson JJN, 2013, MOL ECOL, V22, P5441, DOI 10.1111/mec.12477; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lamas G, 2004, ZOOTAXA, P1; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Matheson CD, 2007, ORG DIVERS EVOL, V7, P294, DOI 10.1016/j.ode.2006.09.002; Miller M.A., 2007, RUSSIAN ENTOMOLOGICA, V15, P427; Miller SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0339; Miller SE, 2013, P ENTOMOL SOC WASH, V115, P107, DOI 10.4289/0013-8797.115.1.107; Moriniere J, 2019, MOL ECOL RESOUR, V19, P900, DOI 10.1111/1755-0998.13022; Moriniere J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155497; Nino LMJ, 2019, J INSECT CONSERV, V23, P751, DOI 10.1007/s10841-019-00168-4; Pinzon-Navarro S, 2010, MOL PHYLOGENET EVOL, V56, P281, DOI 10.1016/j.ympev.2010.02.022; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Robinson GS., HOSTS DATABASE WORLD; San Blas G, 2013, REV MEX BIODIVERS, V84, P1153, DOI 10.7550/rmb.36317; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scoble Malcolm J., 1995, Journal of the Lepidopterists' Society, V49, P136; Seifert CL, 2016, ECOL ENTOMOL, V41, P698, DOI 10.1111/een.12345; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Wallinger C, 2013, MOL ECOL RESOUR, V13, P75, DOI 10.1111/1755-0998.12032; Zawadneak Maria A. C, 2016, Idesia, V34, P91	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0224188	10.1371/journal.pone.0224188	http://dx.doi.org/10.1371/journal.pone.0224188			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999713	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400005
J	Kang, MW; Park, S; Lee, S; Lee, Y; Cho, S; Han, K; Cho, H; Kim, Y; Kim, YC; Han, SS; Lee, H; Lee, JP; Joo, KW; Lim, CS; Kim, YS; Kim, DK				Kang, Min Woo; Park, Sehoon; Lee, Soojin; Lee, Yeonhee; Cho, Semin; Han, Kyungdo; Cho, Hanna; Kim, Yaerim; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki			Glomerular hyperfiltration is associated with dementia: A nationwide population-based study	PLOS ONE			English	Article							RENAL HYPERFILTRATION; COGNITIVE IMPAIRMENT; ENDOTHELIAL FUNCTION; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; FILTRATION-RATE; MECHANISMS; RISK; INHIBITION; HUMANS	Background Glomerular hyperfiltration may be a clinical phenotype of endothelial dysfunction. Endothelial dysfunction may cause vascular dementia through the deterioration of cerebral blood flow. We aimed to identify the risk of dementia in people with glomerular hyperfiltration. Methods Using the Korean National Health Information Database, we included subjects aged >= 45 years who underwent national health screening examinations between 2012 and 2015 and who had no previous history of end-stage renal disease or dementia (n = 2,244,582). The primary exposure was glomerular hyperfiltration. We divided the subjects into groups by sex and five-year age intervals and categorized each group into 8 intervals according to estimated glomerular filtration (eGFR). The subjects with an eGFR >= 95th percentile in each group were defined as the hyperfiltration group. The outcomes were development of all types of dementia, Alzheimer's dementia and vascular dementia. Multivariable Cox proportional hazards models were used to analyze the hazard ratios (HRs) for outcomes. Results The Hyperfiltration group showed a higher risk for the development of all types of dementia [adjusted HR 1.09 (95% CI, 1.03-1.15)] and vascular dementia [adjusted HR 1.33 (95% CI, 1.14-1.55)] than the reference group. However, the association between hyperfiltration and Alzheimer's dementia was not statistically significant. Conclusions Glomerular hyperfiltration may be associated with dementia. In this respect, subjects with glomerular hyperfiltration should be monitored more closely for signs and symptoms of dementia.	[Kang, Min Woo; Park, Sehoon; Lee, Soojin; Lee, Yeonhee; Cho, Semin; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kang, Min Woo; Park, Sehoon; Lee, Soojin; Lee, Yeonhee; Cho, Semin; Lee, Jung Pyo; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Sehoon; Lim, Chun Soo] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Med Stat, Seoul, South Korea; [Cho, Hanna] Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Yaerim] Keimyung Sch Med, Dept Internal Med, Seoul, South Korea; [Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Kidney Res Inst, Coll Med, Seoul, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, DK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Kidney Res Inst, Coll Med, Seoul, South Korea.	dkkim73@gmail.com	Han, Seung Seok/HGD-2825-2022; Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Kim, Yaerim/0000-0003-1596-1528; Cho, Hanna/0000-0001-5936-1546	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI17C0530]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI17C0530).	Altay S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-160; Alzheimer's Disease International, 2018, STAT ART DEM RES NEW; Antoine V, 2004, NEPHROLOGIE, V25, P89; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2019, NEPHRON, V143, P38, DOI 10.1159/000499486; Cherney DZI, 2008, DIABETES, V57, P688, DOI 10.2337/db07-1230; Cherney DZI, 2012, AM J PHYSIOL-REG I, V303, pR710, DOI 10.1152/ajpregu.00286.2012; Cherney DZI, 2010, DIABETES CARE, V33, P2068, DOI 10.2337/dc10-0767; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Emdin CA, 2016, STROKE, V47, P1429, DOI 10.1161/STROKEAHA.116.012658; Eriksen BO, 2014, KIDNEY INT, V86, P146, DOI 10.1038/ki.2013.470; Fehrman-Ekholm I, 2004, SCAND J UROL NEPHROL, V38, P73, DOI 10.1080/00365590310015750; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Iadecola C, 2003, CELL MOL NEUROBIOL, V23, P681, DOI 10.1023/A:1025092617651; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Kurella M, 2006, NEPHROL DIAL TRANSPL, V21, P2543, DOI 10.1093/ndt/gfl275; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Liu CK, 1998, NEUROLOGY, V50, P1572, DOI 10.1212/WNL.50.6.1572; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Mielke Michelle M, 2018, Psychiatr Times, V35, P14; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Perng CH, 2018, PSYCHOPHARMACOLOGY, V235, P1571, DOI 10.1007/s00213-018-4867-y; Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI 10.1186/1471-2318-8-36; Prince M, 2015, EPIDEMIOLOGY IMPACT; Puddu PE, 2014, INT J CARDIOL, V171, P361, DOI 10.1016/j.ijcard.2013.12.029; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raz L, 2016, J CEREBR BLOOD F MET, V36, P172, DOI 10.1038/jcbfm.2015.164; Reboldi G, 2018, KIDNEY INT, V93, P195, DOI 10.1016/j.kint.2017.07.013; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; SCHMIEDER RE, 1990, JAMA-J AM MED ASSOC, V264, P2775, DOI 10.1001/jama.264.21.2775; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; Steinicke R, 2012, STROKE, V43, P2382, DOI 10.1161/STROKEAHA.111.645713; Tsoi KKF, 2016, J AM MED DIR ASSOC, V17, P24, DOI 10.1016/j.jamda.2015.08.007; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Venkat P, 2015, EXP NEUROL, V272, P97, DOI 10.1016/j.expneurol.2015.05.006; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Zhong GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118333; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	53	7	7	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228361	10.1371/journal.pone.0228361	http://dx.doi.org/10.1371/journal.pone.0228361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990949	Green Published, gold			2022-12-26	WOS:000534605400054
J	Kordy, K; Gaufin, T; Mwangi, M; Li, F; Cerini, C; Lee, DJ; Adisetiyo, H; Woodward, C; Pannaraj, PS; Tobin, NH; Aldrovandi, GM				Kordy, Kattayoun; Gaufin, Thaidra; Mwangi, Martin; Li, Fan; Cerini, Chiara; Lee, David J.; Adisetiyo, Helty; Woodward, Cora; Pannaraj, Pia S.; Tobin, Nicole H.; Aldrovandi, Grace M.			Contributions to human breast milk microbiome and enteromammary transfer of Bifidobacterium breve	PLOS ONE			English	Article							BACTERIAL DIVERSITY; LACTATION; LACTOBACILLI; MASTITIS; MOTHER; MODE	Increasing evidence supports the importance of the breast milk microbiome in seeding the infant gut. However, the origin of bacteria in milk and the process of milk microbe-mediated seeding of infant intestine need further elucidation. Presumed sources of bacteria in milk include locations of mother-infant and mother-environment interactions. We investigate the role of mother-infant interaction on breast milk microbes. Shotgun metagenomics and 16S rRNA gene sequencing identified milk microbes of mother-infant pairs in breastfed infants and in infants that have never latched. Although breast milk has low overall biomass, milk microbes play an important role in seeding the infant gut. Breast milk bacteria were largely comprised of Staphylococcus, Streptococcus, Acinetobacter, and Enterobacter primarily derived from maternal areolar skin and infant oral sites in breastfeeding pairs. This suggests that the process of breastfeeding is a potentially important mechanism for propagation of breast milk microbes through retrograde flux via infant oral and areolar skin contact. In one infant delivered via Caesarian section, a distinct strain of Bifidobacteria breve was identified in maternal rectum, breast milk and the infant's stool potentially suggesting direct transmission. This may support the existence of microbial translocation of this anaerobic bacteria via the enteromammary pathway in humans, where maternal bacteria translocate across the maternal gut and are transferred to the mammary glands. Modulating sources of human milk microbiome seeding potentially imply opportunities to ultimately influence the development of the infant microbiome and health.	[Kordy, Kattayoun; Li, Fan; Cerini, Chiara; Lee, David J.; Adisetiyo, Helty; Pannaraj, Pia S.] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90007 USA; [Kordy, Kattayoun; Li, Fan; Pannaraj, Pia S.] Univ Southern Calif, Dept Pediat, Los Angeles, CA 90007 USA; [Gaufin, Thaidra; Mwangi, Martin; Li, Fan; Woodward, Cora; Tobin, Nicole H.; Aldrovandi, Grace M.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of California System; University of California Los Angeles	Aldrovandi, GM (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.	GAldrovandi@mednet.ucla.edu	mwangi, martin/AAT-7655-2021	Kordy, Kattayoun/0000-0003-0242-589X	NIH K12 Child Health Research Career Development Award [HD052954]	NIH K12 Child Health Research Career Development Award	This study was supported in part by the NIH K12 Child Health Research Career Development Award (HD052954) to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2009, J PEDIATR GASTR NUTR, V49, P349, DOI 10.1097/MPG.0b013e31818f091b; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Asnicar F, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00164-16; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Bender JM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0543-z; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Donnet-Hughes A, 2010, P NUTR SOC, V69, P407, DOI 10.1017/S0029665110001898; Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gaufin T, 2018, CURR OPIN PEDIATR, V30, P117, DOI 10.1097/MOP.0000000000000576; Ho NT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06473-x; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47; Marcobal A, 2012, CLIN MICROBIOL INFEC, V18, P12, DOI 10.1111/j.1469-0691.2012.03863.x; Martin R, 2004, TRENDS FOOD SCI TECH, V15, P121, DOI 10.1016/j.tifs.2003.09.010; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Patole SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150775; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Ramsay DT, 2004, PEDIATRICS, V113, P361, DOI 10.1542/peds.113.2.361; Rodriguez JM, 2014, ADV NUTR, V5, P779, DOI 10.3945/an.114.007229; Ruiz L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42514-1; Simpson MR, 2018, J DAIRY SCI, V101, P889, DOI 10.3168/jds.2017-13411; Tobin NH, 2018, JOVE-J VIS EXP, DOI 10.3791/56974; Toscano M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02100	34	42	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0219633	10.1371/journal.pone.0219633; 10.1371/journal.pone.0219633.r001; 10.1371/journal.pone.0219633.r002; 10.1371/journal.pone.0219633.r003; 10.1371/journal.pone.0219633.r004	http://dx.doi.org/10.1371/journal.pone.0219633; 10.1371/journal.pone.0219633.r001; 10.1371/journal.pone.0219633.r002; 10.1371/journal.pone.0219633.r003; 10.1371/journal.pone.0219633.r004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KL0RN	31990909	Green Published, Green Submitted, gold			2022-12-26	WOS:000513140400001
J	Odipio, J; Getu, B; Chauhan, RD; Alicai, T; Bart, R; Nusinow, DA; Taylor, NJ				Odipio, John; Getu, Beyene; Chauhan, R. D.; Alicai, Titus; Bart, Rebecca; Nusinow, Dmitri A.; Taylor, Nigel J.			Transgenic overexpression of endogenous FLOWERING LOCUS T-like gene MeFT1 produces early flowering in cassava	PLOS ONE			English	Article							MANIHOT-ESCULENTA; INFORMATION; TOBACCO	Endogenous FLOWERING LOCUS T homolog MeFT1 was transgenically overexpressed under control of a strong constitutive promoter in cassava cultivar 60444 to determine its role in regulation of flowering and as a potential tool to accelerate cassava breeding. Early profuse flowering was recorded in-vitro in all ten transgenic plant lines recovered, causing eight lines to die within 21 days of culture. The two surviving transgenic plant lines flowered early and profusely commencing as soon as 14 days after establishment in soil in the greenhouse. Both transgenic lines sustained early flowering across the vegetative propagation cycle, with first flowering recorded 30-50 days after planting stakes compared to 90 days for non-transgenic controls. Transgenic plant lines completed five flowering cycles within 200 days in the greenhouse as opposed to twice flowering event in the controls. Constitutive overexpression of MeFT1 generated fully mature male and female flowers and produced a bushy phenotype due to significantly increased flowering-induced branching. Flower induction by MeFT1 overexpression was not graft-transmissible and negatively affected storage root development. Accelerated flowering in transgenic plants was associated with significantly increased mRNA levels of MeFT1 and the three floral meristem identity genes MeAP1, MeLFY and MeSOC1 in shoot apical tissues. These findings imply that MeFT1 encodes flower induction and triggers flowering by recruiting downstream floral meristem identity genes.	[Odipio, John; Getu, Beyene; Chauhan, R. D.; Bart, Rebecca; Nusinow, Dmitri A.; Taylor, Nigel J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Odipio, John; Alicai, Titus] Natl Crops Resources Res Inst, Kampala, Uganda; [Odipio, John] Univ Ghent, Fac Sci, Vlaams Inst Biotechnol, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium	Donald Danforth Plant Science Center; Flanders Institute for Biotechnology (VIB); Ghent University	Taylor, NJ (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	ntaylor@danforthcenter.org	Nusinow, Dmitri A/K-9129-2013; Alicai, Titus/AEN-1873-2022	Nusinow, Dmitri A/0000-0002-0497-1723; Alicai, Titus/0000-0002-4489-3133; Bart, Rebecca/0000-0003-1378-3481; Duguma, Getu/0000-0002-4194-1267	Bill and Melinda Gates Foundation [OPP1152626]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	J.O, N.T., G.D., R.C., T.A. received OPP1152626 from the Bill and Melinda Gates Foundation, https://www.gatesfoundation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo OS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181460; Adeyemo OS, 2019, PLANT REPROD, V32, P181, DOI 10.1007/s00497-018-00354-5; Alves Alfredo Augusto Cunha, 2001, P67, DOI 10.1079/9780851995243.0067; Bull SE, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6020022; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Collani S, 2019, PLANT PHYSIOL, V180, P367, DOI 10.1104/pp.18.01505; Doyle JJ, 1990, FOCUS; Flachowsky H, 2011, NEW PHYTOL, V192, P364, DOI 10.1111/j.1469-8137.2011.03813.x; Fukuda W. M. G., 2002, Crop Breeding and Applied Biotechnology, V2, P617; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Guan X., 2017, THESIS; Guira F, 2017, FOOD SCI NUTR, V5, P415, DOI 10.1002/fsn3.408; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kotoda N, 2006, J AM SOC HORTIC SCI, V131, P74, DOI 10.21273/JASHS.131.1.74; Le Roux PM, 2012, MOL BREEDING, V30, P857, DOI 10.1007/s11032-011-9669-4; Lee R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3884; Li CQ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-125; LIAN TS, 1979, FIELD CROP RES, V2, P281, DOI 10.1016/0378-4290(79)90029-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094171; McGarry RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036746; Moraes TS, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00097; Moreno I, 2011, J VIROL METHODS, V177, P49, DOI 10.1016/j.jviromet.2011.06.013; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Odipio J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01780; Olas JJ, 2019, NEW PHYTOL, V223, P814, DOI 10.1111/nph.15812; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; R Core Team, 2015, R LANG ENV STAT COMP, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Ravi V, 2006, ADV HORTIC SCI; Reincke K, 2018, FOOD SECUR, V10, P911, DOI 10.1007/s12571-018-0814-3; Romera-Branchat M, 2014, CURR OPIN PLANT BIOL, V21, P120, DOI 10.1016/j.pbi.2014.07.006; Song GQ, 2015, J AM SOC HORTIC SCI, V140, P203, DOI 10.21273/JASHS.140.3.203; Souza LS, 2018, SCI HORTIC-AMSTERDAM, V240, P544, DOI 10.1016/j.scienta.2018.06.070; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Taylor NJ, 2015, FRONT PLANT SCI, V62, P251, DOI [10.3389/fpls.2015.00492, DOI 10.3389/FPLS.2015.00492]; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Nocker S, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.22; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092	46	13	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227199	10.1371/journal.pone.0227199	http://dx.doi.org/10.1371/journal.pone.0227199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990916	gold, Green Published, Green Submitted			2022-12-26	WOS:000534605400012
J	Ciapponi, A; Virgilio, SA; Berrueta, M; Soto, NC; Ciganda, A; Illanes, MFR; Martinez, BR; Gamba, J; Salazar, CAG; Rodriguez, JNR; Scarpellini, B; Perdomo, AMB; Machnicki, G; Aldunate, L; De Paula, J; Bardach, A				Ciapponi, Agustin; Alexis Virgilio, Sacha; Berrueta, Mabel; Claire Soto, Natalie; Ciganda, Alvaro; Rojas Illanes, Moises Freddy; Rubio Martinez, Briseida; Gamba, Johana; Gonzalez Salazar, Carlos Arturo; Rocha Rodriguez, Jose Nicolas; Scarpellini, Bruno; Bravo Perdomo, Ana Maria; Machnicki, Gerardo; Aldunate, Leandro; De Paula, Juan; Bardach, Ariel			Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CLINICAL EPIDEMIOLOGY; CROHNS-DISEASE; PREVALENCE; POPULATION; MORTALITY; COHORT; MORBIDITY; TRENDS	Background and aims Ulcerative Colitis (UC) and Crohn's Disease (CD) have a major impact on quality of life and medical costs. The aim of the study was to estimate the prevalence, incidence and clinical phenotypes of Inflammatory Bowel Disease (IBD) cases in Mexico and Colombia. Methods We analyzed official administrative and health databases, used mathematical modelling to estimate the incidence and complete prevalence, and performed a case-series of IBD patients at a referral center both in Mexico and Colombia. Results The age-adjusted complete prevalence of UC per 100,000 inhabitants for 2015/2016 ranged from 15.65 to 71.19 in Mexico and from 27.40 to 69.97 in Colombia depending on the model considered. The prevalence of CD per 100,000 inhabitants in Mexico ranged from 15.45 to 18.08 and from 16.75 to 18.43 in Colombia. In Mexico, the age-adjusted incidence of UC per 100,000 inhabitants per year ranged from 0.90 to 2.30, and from 0.55 to 2.33 in Colombia. The incidence for CD in Mexico ranged from 0.35 to 0.66 whereas in Colombia, the age-adjusted incidence of CD ranged from 0.30 to 0.57. The case-series included 200 IBD patients from Mexico and 204 patients from Colombia. The UC/CD prevalence ratio in Mexico and Colombia was 1.50:1 and 4.5:1 respectively. In Mexico, the female/male prevalence ratio for UC was 1.50:1 and 1.28:1 for CD, while in Colombia this ratio was 0.68:1 for UC and 0.8:1 for CD. In Mexico the relapse rate for UC was 63.3% and 72.5% for CD, while those rates in Colombia were 58.2% for UC and 58.3% for CD. Conclusions The estimated burden of disease of IBD in Mexico and Colombia is not negligible. Although these findings need to be confirmed by population-based studies, they are useful for decision-makers, practitioners and patients with this condition.	[Ciapponi, Agustin; Alexis Virgilio, Sacha; Berrueta, Mabel; Claire Soto, Natalie; Ciganda, Alvaro; Bardach, Ariel] Inst Efectividad Clin & Sanitaria IECS, Buenos Aires, DF, Argentina; [Rojas Illanes, Moises Freddy; Rubio Martinez, Briseida] Hosp Dr Bernardo Sepulveda, Mexico City, DF, Mexico; [Gamba, Johana; Gonzalez Salazar, Carlos Arturo; Rocha Rodriguez, Jose Nicolas] Fdn Univ Sanitas, Bogota, Colombia; [Scarpellini, Bruno] Janssen Cilag Farmaceut Ltda, Sao Paulo, Brazil; [Bravo Perdomo, Ana Maria] Janssen Cilag Farmaceut Ltda, Bogota, Colombia; [Machnicki, Gerardo; Aldunate, Leandro] Janssen Cilag Farmaceut Ltda, Buenos Aires, DF, Argentina; [De Paula, Juan] Hosp Italiano Buenos Aires HIBA, Buenos Aires, DF, Argentina		Ciapponi, A (corresponding author), Inst Efectividad Clin & Sanitaria IECS, Buenos Aires, DF, Argentina.	aciapponi@iecs.org.ar	Scarpellini, Bruno/AAK-2424-2020; Bardach, Ariel/H-9566-2019	Bardach, Ariel/0000-0003-4437-0073; ROCHA, JOSE NICOLAS/0000-0001-6169-2758	Janssen-Cilag Pharmaceutical	Janssen-Cilag Pharmaceutical	This work was funded by Janssen-Cilag Pharmaceutical. Authors BS, AMBP, GM, and LA received funding in the form of salaries from Janssen-Cilag Pharmaceutical. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis or decision to publish.	[Anonymous], MED INTERNA MEXICO; Appleyard CB, 2004, INFLAMM BOWEL DIS, V10, P106, DOI 10.1097/00054725-200403000-00007; Arantes Jhelly Aparecida Valcanaia, 2017, J. Coloproctol. (Rio J.), V37, P273, DOI 10.1016/j.jcol.2017.06.004; Banos F. J., 2010, REV COLOMB GASTROENT, V25, P240; Barendregt JJ., 2003, POPUL HEALTH METR, V1, P4, DOI [DOI 10.1186/1478-7954-1-4, 10.1186/1478-7954-1-4]; Barros Petrille André Cavalcante de, 2014, J. Coloproctol. (Rio J.), V34, P131, DOI 10.1016/j.jcol.2014.05.004; Bendaño Teófilo, 2010, Rev. gastroenterol. Perú, V30, P17; Bernstein CN, 2012, INFLAMM BOWEL DIS, V18, P1498, DOI 10.1002/ibd.21878; Bosques-Padilla F J, 2011, Rev Gastroenterol Mex, V76, P34; Buenavida Gaby, 2011, Acta Gastroenterol Latinoam, V41, P281; Calderon Maria, 2018, Value Health Reg Issues, V17, P126, DOI 10.1016/j.vhri.2018.03.010; CAMPOS Fábio Guilherme, 2013, Arq. Gastroenterol., V50, P123, DOI 10.1590/S0004-28032013000200021; Castano-Milla C, 2014, ALIMENT PHARM THER, V39, P645, DOI 10.1111/apt.12651; Chebli JMF, 2002, J CLIN GASTROENTEROL, V35, P71, DOI 10.1097/00004836-200207000-00015; Choquet A, 2004, REV INVEST CLIN, V56, P11; da Silva BC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/359130; de Jesus Yepes Barreto I, 2010, REV COLOMB GASTROENT, V25, P107; DEANGELIS G, 1994, COMPUT METH PROG BIO, V44, P99, DOI 10.1016/0169-2607(94)90091-4; Delmondes LM, 2015, GASTROENTEROL RES, V8, P207, DOI 10.14740/gr649w; Direccion General de Informacion en Salud (DGIS), 2017, DEF CIFR OF DEF EGR; Dolcini H, 1967, Am J Proctol, V18, P132; SANTOS Rachael Miranda dos, 2017, Arq. Gastroenterol., V54, P96, DOI [10.1590/S0004-2803.201700000-01, 10.1590/s0004-2803.201700000-01]; Edwards CN, 2008, INFLAMM BOWEL DIS, V14, P1419, DOI 10.1002/ibd.20495; Figueroa C, 2005, REV MED CHILE, V133, P1295; Fragoso Arbelo T, 1946, REV CUBANA PEDIATRIA; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Hardt Marcelo Rassweiler, 2012, J. Coloproctol. (Rio J.), V32, P395; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Iade B, 2005, REV MED URUG, V21, P303; Iade B, 2005, REV MED URUG, V21, P298; Institute for Health Metrics and Evaluation (IHME), 2017, GBD COMP DAT VIS; Jess T, 2013, CLIN GASTROENTEROL H, V11, P43, DOI 10.1016/j.cgh.2012.09.026; Juliao Banos F, 2017, PERS COMMUN; Kane SV, 2006, ALIMENT PHARM THER, V23, P577, DOI 10.1111/j.1365-2036.2006.02809.x; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kleinubing H, 2011, ABCD-ARQ BRAS CIR DI, V24, P200, DOI 10.1590/S0102-67202011000300004; Lima CA, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176374, 10.1590/1414-431x20176374]; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Luciano MJ, 2018, J CROHNS COLITIS, V12, pS458; Parente JML, 2015, WORLD J GASTROENTERO, V21, P1197, DOI 10.3748/wjg.v21.i4.1197; Martins AL, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0822-y; Melendez JD, 2011, P R HEALTH SCI J, V30, P3; Micames C, 1983, Bol Asoc Med P R, V75, P106; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Molodecky NA, 2011, INFLAMM BOWEL DIS, V17, P1792, DOI 10.1002/ibd.21511; Moreno J M, 1989, Bol Asoc Med P R, V81, P214; Mudambi K, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.05.03; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Otros I, 2012, BAS DAT EGR HOSP SEC; Paredes-Méndez Juan, 2016, Rev. gastroenterol. Perú, V36, P209; Pineda L. F. Ovalle, 2010, REV COLOMB GASTROENT, V25, P235; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quintana C, 2012, ISRN Gastroenterol, V2012, P285475, DOI 10.5402/2012/285475; Ruiz JA, 2009, GASTROENTEROLOGY, V136, pA356; Sandoval ER, REV GASTROENTEROL ME, V73, P38; Sandoval ERG, 2008, REV GASTROENTEROL ME, V73, P38; Santana GO, 2007, WORLD J GASTROENTERO, V13, P4489; Sarmiento A, 2018, J GASTRO, V113; Simian D, 2016, WORLD J GASTROENTERO, V22, P5267, DOI 10.3748/wjg.v22.i22.5267; SOUZA Marcellus Henrique L. P., 2002, Arq. Gastroenterol., V39, P98, DOI 10.1590/S0004-28032002000200006; Torres EA, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/574079; Vad ND, DAN MED J; Vendrell Roberto, 2013, Bol Asoc Med P R, V105, P15; VERDECCHIA A, 1989, STAT MED, V8, P201, DOI 10.1002/sim.4780080207; Victoria Carlos Roberto, 2009, Arq. Gastroenterol., V46, P20, DOI 10.1590/S0004-28032009000100009; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wolters FL, 2006, GUT, V55, P510, DOI 10.1136/gut.2005.072793; Yamamoto Furusho JK, REV GASTROENTEROL ME, V73, P47; Yamamoto-Furusho J K, 2010, Rev Gastroenterol Mex, V75, P30; Yamamoto-Furusho JK, 2015, CAN J GASTROENTEROL, V29, P435, DOI 10.1155/2015/473726; Yamamoto-Furusho JK, 2009, J CLIN GASTROENTEROL, V43, P221, DOI 10.1097/MCG.0b013e31817a76b4	71	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228256	10.1371/journal.pone.0228256	http://dx.doi.org/10.1371/journal.pone.0228256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986191	Green Published, gold			2022-12-26	WOS:000534603400042
J	Lemoine, M; Gmel, G; Foster, S; Marmet, S; Studer, J				Lemoine, Melissa; Gmel, Gerhard; Foster, Simon; Marmet, Simon; Studer, Joseph			Multiple trajectories of alcohol use and the development of alcohol use disorder: Do Swiss men mature-out of problematic alcohol use during emerging adulthood?	PLOS ONE			English	Article							SINGLE-OCCASION DRINKING; SUBSTANCE USE; HEAVY DRINKING; BINGE DRINKING; LONGITUDINAL PHENOTYPES; YOUNG MEN; CONSUMPTION; ADOLESCENCE; ASSOCIATION; TRANSITION	(a) Objective This study aimed to identify trajectories of alcohol use (AU) and their associations with the development of alcohol use disorder (AUD) among young men with different weekly drinking patterns. (b) Method A longitudinal latent class analysis integrating several aspects of AU, such as drinking quantity and frequency on weekends vs workweek days, involving 4719 young Swiss men at ages 20, 21, and 25, and collected by the Cohort Study on Substance Use Risk Factors, was used to identify different AU trajectories over time. The development of AUD scores in these trajectories was investigated using generalized linear mixed models. (c) Results Six AU trajectory classes, similar to those described in the literature, were identified: 'abstainers-light drinkers', 'light workweek increasers', 'light decreasers', 'moderate weekend decreasers', 'moderate workweek increasers', and 'heavy drinkers'. Only 12% of participants were assigned to a trajectory class with decreasing AU associated with a decline in their AUD score. AUD scores increased in trajectory classes exhibiting increasing AU on workweek days, despite low and moderate general AU. Finally, more than 59% of participants were on an AU trajectory presenting no change in their mean AUD score over time. (d) Conclusions Maturing out of problematic AU in emerging adulthood is not the norm in Switzerland, and the AUD score developed in late adolescence remains until at least emerging adulthood. AU on workweek days is a more practical marker of potentially problematic AU. This calls for timely interventions in adolescence and concerning regular drinking on workweek days in emerging adulthood.	[Lemoine, Melissa; Gmel, Gerhard; Marmet, Simon; Studer, Joseph] Lausanne Univ Hosp CHUV, Addict Med, Rue Bugnon, Lausanne, Switzerland; [Gmel, Gerhard] Addict Switzerland, Lausanne, Switzerland; [Gmel, Gerhard] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gmel, Gerhard] Univ West England, Bristol, Avon, England; [Foster, Simon] Zurich Univ, Swiss Res Inst Publ Hlth & Addict, Konradstr, Zurich, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of West England; University of Zurich	Lemoine, M (corresponding author), Lausanne Univ Hosp CHUV, Addict Med, Rue Bugnon, Lausanne, Switzerland.	melissa.lemoine@gmail.com	Gachoud, Céline/K-1104-2018	Studer, Joseph/0000-0002-1390-7707; Marmet, Simon/0000-0002-9060-8567	Swiss National Science Foundation [33CSC0-122679, 33CSC30-139467, 33CSC30-148493]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by Swiss National Science Foundation grants 33CSC0-122679, 33CSC30-139467 and 33CSC30-148493 to GG.	Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Astudillo M, 2014, DRUG ALCOHOL REV, V33, P526, DOI 10.1111/dar.12149; Auerbach KJ, 2006, J STUD ALCOHOL, V67, P917, DOI 10.15288/jsa.2006.67.917; Bachman J. G., 2002, RES MONOGRAPHS ADOLE; Baggio S, 2018, INT J PUBLIC HEALTH, P1; Baggio S, 2015, DRUG ALCOHOL DEPEN, V154, P260, DOI 10.1016/j.drugalcdep.2015.07.008; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Bruckner H., 2005, STRUCTURE LIFE COURS, V9, P27, DOI [10.1016/S1040-2608(04)09002-1, DOI 10.1016/S1040-2608(04)09002-1]; Burchi E, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00070; Cahannes M, 1981, ALCOHOL SOC STATE, V2, P61; Capaldi DM, 2013, ALCOHOL CLIN EXP RES, V37, pE347, DOI 10.1111/j.1530-0277.2012.01876.x; Casswell S, 2002, ADDICTION, V97, P1427, DOI 10.1046/j.1360-0443.2002.00220.x; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Chassin L, 2002, J CONSULT CLIN PSYCH, V70, P67, DOI 10.1037//0022-006X.70.1.67; Chung H, 2005, STAT MED, V24, P2895, DOI 10.1002/sim.2148; Crum RM, 2013, JAMA PSYCHIAT, V70, P718, DOI 10.1001/jamapsychiatry.2013.1098; Dawson DA, 2008, J STUD ALCOHOL DRUGS, V69, P866, DOI 10.15288/jsad.2008.69.866; Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023; Feldman BJ, 2009, DEV PSYCHOL, V45, P652, DOI 10.1037/a0014851; Foster S, 2019, INT J DRUG POLICY, V65, P86, DOI 10.1016/j.drugpo.2019.01.014; Foster S, 2016, EUR J PUBLIC HEALTH, V26, P850, DOI 10.1093/eurpub/ckv247; Frone MR, 2016, WORK STRESS, V30, P374, DOI 10.1080/02678373.2016.1252971; Gaudet S., 2007, EMERGING ADULTHOOD N; Gmel G, 1999, SUBST USE MISUSE, V34, P1619, DOI 10.3109/10826089909039419; Gmel G., 2017, MONITORAGE SUISSE AD; Gmel G, 2008, ALCOHOL ALCOHOLISM, V43, P692, DOI 10.1093/alcalc/agn070; Gmel G, 2013, SUBST USE MISUSE, V48, P1085, DOI 10.3109/10826084.2013.799017; Gmel G, 2011, ADDICTION, V106, P1037, DOI 10.1111/j.1360-0443.2010.03167.x; Grazioli VS, 2018, J AFFECT DISORDERS, V232, P243, DOI 10.1016/j.jad.2018.02.028; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Health Canada, 2010, CAN ALC DRUGS US MON; Heeb JL, 2008, INT J METH PSYCH RES, V17, P1, DOI 10.1002/mpr.238; Hill KG, 2000, ALCOHOL CLIN EXP RES, V24, P892, DOI 10.1111/j.1530-0277.2000.tb02071.x; Jackson KM, 2005, PSYCHOL ADDICT BEHAV, V19, P339, DOI 10.1037/0893-164X.19.4.339; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Jester JM, 2016, DEV PSYCHOPATHOL, V28, P1531, DOI 10.1017/S0954579415001157; Kuitunen-Paul S, 2018, J SUBST ABUSE TREAT, V86, P94, DOI 10.1016/j.jsat.2017.12.011; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; Kuntsche E, 2010, DRUG ALCOHOL DEPEN, V110, P259, DOI 10.1016/j.drugalcdep.2010.02.021; Kuntsche S, 2016, ADDICT BEHAV, V54, P59, DOI 10.1016/j.addbeh.2015.12.011; Labhart F, 2014, ALCOHOL ALCOHOLISM, V49, P327, DOI 10.1093/alcalc/agu001; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Lee JO, 2012, DRUG ALCOHOL DEPEN, V121, P213, DOI 10.1016/j.drugalcdep.2011.08.028; Littlefield AK, 2009, J ABNORM PSYCHOL, V118, P360, DOI 10.1037/a0015125; Livingston M, 2009, DRUG ALCOHOL DEPEN, V101, P169, DOI 10.1016/j.drugalcdep.2008.12.014; Maggs Jennifer L, 2005, Recent Dev Alcohol, V17, P29, DOI 10.1007/0-306-48626-1_2; Marmet S, 2013, ALCOHOL ATTRIBUTABLE; Meier MH, 2013, DEV PSYCHOPATHOL, V25, P785, DOI 10.1017/S0954579413000175; Mezquita L, 2011, EUR ADDICT RES, V17, P250, DOI 10.1159/000328510; Muthen BO, 2000, J STUD ALCOHOL, V61, P290, DOI 10.15288/jsa.2000.61.290; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nelson SE, 2015, DEV PSYCHOPATHOL, V27, P253, DOI 10.1017/S0954579414000650; Nielsen MB, 2018, SUBST USE MISUSE, V53, P574, DOI 10.1080/10826084.2017.1349797; O'Malley PM, 2004, ALCOHOL RES HEALTH, V28, P202; Proust-Lima C, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i02; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Rehm J, 2000, J SUBST ABUSE, V12, P155, DOI 10.1016/S0899-3289(00)00045-6; Richard JB, 2015, EVOLUTIONS, P32; Room R, 2000, J STUD ALCOHOL, V61, P475, DOI 10.15288/jsa.2000.61.475; Schulenberg J, 1996, J STUD ALCOHOL, V57, P289, DOI 10.15288/jsa.1996.57.289; Sironi M, 2015, ADV LIFE COURSE RES, V26, P89, DOI 10.1016/j.alcr.2015.09.004; Sironi M, 2012, POPUL DEV REV, V38, P609, DOI 10.1111/j.1728-4457.2012.00529.x; Stephens MAC, 2012, ALCOHOL RES CURRENT; Studer J, 2014, PSYCHOL ADDICT BEHAV, V28, P651, DOI 10.1037/a0035668; Studer J, 2013, DRUG ALCOHOL DEPEN, V132, P316, DOI 10.1016/j.drugalcdep.2013.02.029; Thompson K, 2014, ADDICTION, V109, P894, DOI 10.1111/add.12499; Tuithof M, 2014, ALCOHOL CLIN EXP RES, V38, P249, DOI 10.1111/acer.12248; van de Schoot R, 2017, STRUCT EQU MODELING, V24, P451, DOI 10.1080/10705511.2016.1247646; Vermunt JK, 2007, GROWTH MODELS CATEGO; WINICK C, 1962, B NARCOTICS, V14, P1; WYLLIE A, 1994, ADDICTION, V89, P425, DOI 10.1111/j.1360-0443.1994.tb00917.x	73	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0220232	10.1371/journal.pone.0220232	http://dx.doi.org/10.1371/journal.pone.0220232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986142	Green Accepted, gold, Green Published			2022-12-26	WOS:000534603400003
J	de Alencar, JB; Zacarias, JMV; Tsuneto, PY; de Souza, VH; Silva, CDE; Visentainer, JEL; Sell, AM				de Alencar, Josiane Bazzo; Valentini Zacarias, Joana Maira; Tsuneto, Patricia Yumeko; de Souza, Victor Hugo; de Oliveira e Silva, Cleverson; Laguila Visentainer, Jeane Eliete; Sell, Ana Maria			Influence of inflammasome NLRP3, and IL1B and IL2 gene polymorphisms in periodontitis susceptibility	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; CYTOKINE LEVELS; RISK-FACTORS; ASSOCIATION; EXPRESSION; DISEASE; INFECTION; PHASE; CELLS; AIM2	The pathogenesis of periodontitis (PD) involves several molecules of the immune system that interact in a network to eliminate the periodontopathogens, yet, they contribute to periodontal tissue destruction. The different mechanisms that lead to periodontal tissue damage are not clear. Despite this, immune response genes have been related to the development of PD previously, such as those involved in inflammasomes which are multiprotein complexes and cytokines including Interleukin-1. The aim of the study was to evaluate the polymorphisms in NLRP3 inflammasome, cytokine and receptor of cytokines genes in the development of periodontitis. This case-control study was conducted in 186 patients with PD (stage II and III and grade B) and 208 controls (localized gingivitis and periodontally healthy individuals). Genotyping was performed using PCR-RFLP for the SNP rs4612666 in NLRP3 and using PCR-SSP for IL1A, IL1B, IL1R, IL1RN, IL4RA, INFG, TGFB1, TNF, IL2, IL4, IL6, and IL10. Cytokine serum levels were measured using Luminex technology. SNPStats and OpenEpi software were used to perform statistical analysis. The higher frequencies of NLRP3 T/C and IL1B -511 T/T genotypes and IL2 (+166, -330) GT haplotype were observed in patients with PD compared to controls. The SNPs in NLRP3, IL1R +1970, IL6-174, TNF -308, IL2 +166 and -330, TGFB1 +869 and +915, IL4RA +1902, IL4-1098 and -590 were associated to PD in men. In conclusion, polymorphisms in NLRP3, IL1B and IL2 genes were associated to PD susceptibility. Men carrying the NLRP3, IL1R, IL6, TNF, IL2, TGFB1, IL4RA and IL4 polymorphisms had greater susceptibility than women for developing PD.	[de Alencar, Josiane Bazzo; Valentini Zacarias, Joana Maira; Tsuneto, Patricia Yumeko; de Souza, Victor Hugo; Laguila Visentainer, Jeane Eliete; Sell, Ana Maria] Univ Estadual Maringa, Postgrad Program Biosci & Physiophatol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil; [de Oliveira e Silva, Cleverson] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil; [Laguila Visentainer, Jeane Eliete; Sell, Ana Maria] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Alencar, JB (corresponding author), Univ Estadual Maringa, Postgrad Program Biosci & Physiophatol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.	josibazzo@gmail.com	Visentainer, Jeane/AAJ-1618-2021; Silva, Cléverson O/G-5907-2012	Silva, Cléverson O/0000-0002-7103-9100; Souza, Victor/0000-0002-6620-540X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Laboratorio de Imunogenetica da UEM (LIG-UEM); Fundacao Araucaria do Estado do Parana, Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Laboratorio de Imunogenetica da UEM (LIG-UEM); Fundacao Araucaria do Estado do Parana, Brazil	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Laboratorio de Imunogenetica da UEM (LIG-UEM) and Fundacao Araucaria do Estado do Parana, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, DRUG TODAY, V45, P105; Al-Rassam Z. T., 2014, INT J SCI BASIC APPL, V16, P339; Al-Tayeb D, 2008, EGYPTIAN DENT J, V54, P1; Albandar JM, 2002, PERIODONTOL 2000, V29, P177, DOI 10.1034/j.1600-0757.2002.290109.x; AlJehani YA, 2014, INT J DENT, V2014, DOI 10.1155/2014/182513; Andrukhov O, 2011, J PERIODONTOL, V82, P885, DOI 10.1902/jop.2010.100425; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Aral K, 2020, J PERIODONTOL, V91, P606, DOI 10.1002/JPER.19-0222; Aral K, 2019, ORAL DIS, V25, P839, DOI 10.1111/odi.13032; Arias-Bujanda N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35920-4; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Becerik S, 2012, J PERIODONTOL, V83, P1304, DOI 10.1902/jop.2012.110616; Belibasakis GN, 2012, CYTOKINE, V59, P124, DOI 10.1016/j.cyto.2012.03.016; Bergstrom J, 2000, J PERIODONTOL, V71, P1338, DOI 10.1902/jop.2000.71.8.1338; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Bostanci N, 2011, CELL IMMUNOL, V270, P88, DOI 10.1016/j.cellimm.2011.04.002; Bostrom EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134608; Bui FQ, 2016, CELL MICROBIOL, V18, P970, DOI 10.1111/cmi.12560; CERDAN C, 1995, J IMMUNOL, V154, P1007; Cetinkaya B, 2013, J PERIODONTOL, V84, P84, DOI 10.1902/jop.2012.110467; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Contreras A, 2015, PERIODONTOL 2000, V67, P58, DOI 10.1111/prd.12074; Dagenais M, 2012, CELL DEATH DIFFER, V19, P5, DOI 10.1038/cdd.2011.159; Fang YY, 2005, J CLIN PERIODONTOL, V32, P1200, DOI 10.1111/j.1600-051X.2005.00845.x; Fiorillo L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071908; Garcia-Hernandez AL, 2018, ORAL DIS, V25; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Garlet GP, 2008, MICROBES INFECT, V10, P489, DOI 10.1016/j.micinf.2008.01.010; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Goutoudi P, 2004, J DENT, V32, P511, DOI 10.1016/j.jdent.2004.04.003; Guo W, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0115-6; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; Heidari Z, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0715-7; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019; Holmlund A, 2004, J CLIN PERIODONTOL, V31, P475, DOI 10.1111/j.1600-051X.2004.00504.x; Honda T, 2006, CLIN EXP IMMUNOL, V144, P35, DOI 10.1111/j.1365-2249.2006.03028.x; Hong M, 2016, KOREAN J INTERN MED, V31, P910, DOI 10.3904/kjim.2016.031; HOU LT, 1995, J CLIN PERIODONTOL, V22, P162; Isaza-Guzman DM, 2017, J PERIODONTOL, V88, P1329, DOI 10.1902/jop.2017.170244; Isaza-Guzman DM, 2016, ARCH ORAL BIOL, V65, P44, DOI 10.1016/j.archoralbio.2016.01.013; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; Kavrikova D, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2061868; KIMURA S, 1991, INFECT IMMUN, V59, P4418, DOI 10.1128/IAI.59.12.4418-4424.1991; Kitaura H, 2014, SCI WORLD J, DOI 10.1155/2014/617032; Lavu V, 2015, GENET TEST MOL BIOMA, V19, P175, DOI 10.1089/gtmb.2014.0275; Li GY, 2012, CYTOKINE, V60, P552, DOI 10.1016/j.cyto.2012.06.239; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; McAllister MJ, 2018, OSTEOARTHR CARTILAGE, V26, P612, DOI 10.1016/j.joca.2018.02.901; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Miranda TS, 2019, CLIN ORAL INVEST, V23, P641, DOI 10.1007/s00784-018-2471-5; Ribeiro MSM, 2016, CONTEMP CLIN DENT, V7, P349, DOI 10.4103/0976-237X.188560; Naito Mariko, 2007, Int J Med Sci, V4, P216; Nazir Muhammad Ashraf, 2017, Int J Health Sci (Qassim), V11, P72; Nibali L, 2017, J CLIN PERIODONTOL, V44, pS52, DOI 10.1111/jcpe.12639; Nikolopoulos GK, 2008, J CLIN PERIODONTOL, V35, P754, DOI 10.1111/j.1600-051X.2008.01298.x; Okui T., 2014, CURR ORAL HLTH REP, V1, P114, DOI [10.1007/s40496-014-0013-z, DOI 10.1007/S40496-014-0013-Z]; Papapanou PN, 2018, J PERIODONTOL, V89, pS173, DOI 10.1002/JPER.17-0721; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Perozini C, 2010, QUINTESSENCE INT, V41, P877; Probst CM, 2000, HUM BIOL, V72, P597; Reichert S, 2009, J PERIODONTAL RES, V44, P628, DOI 10.1111/j.1600-0765.2008.01173.x; Reis PG, 2018, HLA, V92, P298, DOI 10.1111/tan.13368; RIES WL, 1989, J PERIODONTAL RES, V24, P242, DOI 10.1111/j.1600-0765.1989.tb01788.x; Rocha FRG, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.10.004; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Scarel-Caminaga RM, 2002, J CLIN PERIODONTOL, V29, P587, DOI 10.1034/j.1600-051X.2002.290701.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sell Ana Maria, 2017, IMMUNOPATHOGENESIS C, Vi, P13, DOI [10.5772/intechopen.69045, DOI 10.5772/INTECHOPEN.69045]; SHENKER BJ, 1995, INFECT IMMUN, V63, P4830, DOI 10.1128/IAI.63.12.4830-4836.1995; SHENKER BJ, 1982, J IMMUNOL, V128, P148; Silva N, 2015, J APPL ORAL SCI, V23, P329, DOI 10.1590/1678-775720140259; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Talvan, 2017, ARCH MED, V9, DOI [10.21767/1989-5216.1000219, DOI 10.21767/1989-5216.1000219]; Tanaka K, 2014, DNA CELL BIOL, V33, P227, DOI 10.1089/dna.2013.2202; Taneja V., 2018, MEDIAT INFLAMM, V9, P1931, DOI 10.3389/fimmu.2018.01931; Taneja V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01931; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; Tomas I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06674-2; Trevilatto PC, 2011, ARCH ORAL BIOL, V56, P54, DOI 10.1016/j.archoralbio.2010.09.004; Tsuneto PY, 2019, MEDIAT INFLAMM, V2019, P1; Vahabi S, 2018, J INVESTIG CLIN DENT, V9, DOI 10.1111/jicd.12319; Wang HF, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019315; Xue F, 2015, ARCH ORAL BIOL, V60, P948, DOI 10.1016/j.archoralbio.2015.03.005; Yamazaki K, 2005, J PERIODONTAL RES, V40, P53, DOI 10.1111/j.1600-0765.2004.00772.x; Yilmaz O, 2015, PERIODONTOL 2000, V69, P83, DOI 10.1111/prd.12084; Zhao D, 2016, ONCOTARGET, V7, P68292, DOI 10.18632/oncotarget.11944; Zhen Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00276; Zheng YY, 2013, GENE, V530, P151, DOI 10.1016/j.gene.2013.07.082; Zhou XY, 2019, J PERIODONTOL, V90, P1032, DOI 10.1002/JPER.18-0528	93	19	19	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227905	10.1371/journal.pone.0227905	http://dx.doi.org/10.1371/journal.pone.0227905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978095	gold, Green Published			2022-12-26	WOS:000534599100075
J	Visakorpi, K; Riutta, T; Malhi, Y; Salminen, JP; Salinas, N; Gripenberg, S				Visakorpi, Kristiina; Riutta, Terhi; Malhi, Yadvinder; Salminen, Juha-Pekka; Salinas, Norma; Gripenberg, Sofia			Changes in oak (Quercus robur) photosynthesis after winter moth (Operophtera brumata) herbivory are not explained by changes in chemical or structural leaf traits	PLOS ONE			English	Article							PLANT-GROWTH; SECONDARY METABOLITES; LITTER DECOMPOSITION; INSECT HERBIVORY; MOUNTAIN BIRCH; DEFENSE; TANNINS; PERFORMANCE; RESISTANCE; PHENOLICS	Insect herbivores have the potential to change both physical and chemical traits of their host plant. Although the impacts of herbivores on their hosts have been widely studied, experiments assessing changes in multiple leaf traits or functions simultaneously are still rare. We experimentally tested whether herbivory by winter moth (Operophtera brumata) caterpillars and mechanical leaf wounding changed leaf mass per area, leaf area, leaf carbon and nitrogen content, and the concentrations of 27 polyphenol compounds on oak (Quercus robur) leaves. To investigate how potential changes in the studied traits affect leaf functioning, we related the traits to the rates of leaf photosynthesis and respiration. Overall, we did not detect any clear effects of herbivory or mechanical leaf damage on the chemical or physical leaf traits, despite clear effect of herbivory on photosynthesis. Rather, the trait variation was primarily driven by variation between individual trees. Only leaf nitrogen content and a subset of the studied polyphenol compounds correlated with photosynthesis and leaf respiration. Our results suggest that in our study system, abiotic conditions related to the growth location, variation between tree individuals, and seasonal trends in plant physiology are more important than herbivory in determining the distribution and composition of leaf chemical and structural traits.	[Visakorpi, Kristiina] Univ Oxford, Dept Zool, Oxford, England; [Visakorpi, Kristiina; Riutta, Terhi; Malhi, Yadvinder; Salinas, Norma] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford, England; [Riutta, Terhi] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Salminen, Juha-Pekka] Univ Turku, Dept Chem, Nat Chem Res Grp, Turku, Finland; [Salinas, Norma] Pontificia Univ Catolica Peru, Secc Quim, Lima, Peru; [Gripenberg, Sofia] Univ Reading, Sch Biol Sci, Reading, England	University of Oxford; University of Oxford; Imperial College London; University of Turku; Pontificia Universidad Catolica del Peru; University of Reading	Visakorpi, K (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Visakorpi, K (corresponding author), Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford, England.	kristiina.matilda@gmail.com	Gripenberg, Sofia/AAA-3410-2022; Salinas, Norma/K-8960-2015	Gripenberg, Sofia/0000-0002-8788-2258; Salinas, Norma/0000-0001-9941-2109; , Kristiina/0000-0003-2478-0518	Osk. Huttunen Foundation; Finnish Cultural Foundation; Hester Cordelia Parsons Fund	Osk. Huttunen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Hester Cordelia Parsons Fund	KV was funded by Osk. Huttunen Foundation (http://www.oskhuttusensaatio.net/index.html) and the Finnish Cultural Foundation (https://skr.fi).The polyphenol analyses were funded by Hester Cordelia Parsons Fund (no URL available). SG is a Royal Society (https://royalsociety.org) University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Anten NPR, 2001, FUNCTIONAL ECOLOGY, V15; Ayres MP, 1997, ECOLOGY, V78, P1696, DOI 10.1890/0012-9658(1997)078[1696:DOSAAA]2.0.CO;2; Barbehenn RV, 2013, CHEMOECOLOGY, V23, P219, DOI 10.1007/s00049-013-0136-z; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barbehenn RV, 2009, OECOLOGIA, V159, P777, DOI 10.1007/s00442-008-1268-7; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Beyaert I, 2012, P ROY SOC B-BIOL SCI, V279, P101, DOI 10.1098/rspb.2011.0468; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Campos ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12570; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Chomel M, 2016, J ECOL, V104, P1527, DOI 10.1111/1365-2745.12644; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Crawley M.J., 2007, R BOOK; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; EDWARDS PJ, 1986, OECOLOGIA, V69, P316, DOI 10.1007/BF00377640; Elderd BD, 2013, P NATL ACAD SCI USA, V110, P14978, DOI 10.1073/pnas.1300759110; Engstrom MT, 2019, J AGR FOOD CHEM, V67, P6798, DOI 10.1021/acs.jafc.9b02188; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; FAETH SH, 1986, ECOLOGY, V67, P479, DOI 10.2307/1938591; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Fischbach RJ, 1999, PLANT CELL ENVIRON, V22, P27, DOI 10.1046/j.1365-3040.1999.00390.x; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Haukioja E, 2002, ENTOMOL EXP APPL, V104, P125, DOI 10.1023/A:1021280106023; Havko NE, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5010007; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hunter M.D., 1992, P287; HUNTER MD, 1995, ECOLOGY, V76, P1226, DOI 10.2307/1940929; Hwang SY, 1997, OECOLOGIA, V111, P99, DOI 10.1007/s004420050213; Josse J, 2016, J STAT SOFTW, V70; Kaitaniemi P, 1998, OECOLOGIA, V116, P182, DOI 10.1007/s004420050578; Kang ZW, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00778; KARBAN R, 1997, INDUCED RESPONSES HE; Kazakou E, 2014, J VEG SCI, V25, P235, DOI 10.1111/jvs.12066; Kliebenstein DJ, 2016, PHYSIOL MOL PLANT P, V95, P55, DOI 10.1016/j.pmpp.2016.02.004; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lankau RA, 2009, J ECOL, V97, P78, DOI 10.1111/j.1365-2745.2008.01448.x; Lempa K, 2004, J CHEM ECOL, V30, P303, DOI 10.1023/B:JOEC.0000017979.94420.78; Li FR, 2010, ACTA OECOL, V36, P1, DOI 10.1016/j.actao.2009.09.002; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Moilanen J, 2008, CHEMOECOLOGY, V18, P73, DOI 10.1007/s00049-007-0395-7; Nabity PD, 2013, J EXP BOT, V64, P685, DOI 10.1093/jxb/ers364; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Nelson AC, 1999, CHEMOECOLOGY, V9, P81, DOI 10.1007/s000490050037; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Ohse B, 2017, FUNCT ECOL, V31, P340, DOI 10.1111/1365-2435.12717; Oksanen, 2015, MULTIVARIATE ANAL EC; Onkokesung N, 2014, J EXP BOT, V65, P2203, DOI 10.1093/jxb/eru096; Osier TL, 2000, ECOL ENTOMOL, V25, P197, DOI 10.1046/j.1365-2311.2000.00245.x; Pascacio-Villafan C, 2014, J CHEM ECOL, V40, P297, DOI 10.1007/s10886-014-0404-6; R Core Team, 2021, R LANGUAGE ENV STAT; Roskov Y., 2018, SPECIES 2000 ITIS CA; Roslin T, 2006, OIKOS, V113, P106, DOI 10.1111/j.0030-1299.2006.14460.x; Roslin T, 2008, OIKOS, V117, P1560, DOI 10.1111/j.0030-1299.2008.16725.x; ROSSITER M, 1988, ECOLOGY, V69, P267, DOI 10.2307/1943182; Roth S, 1998, GLOBAL CHANGE BIOL, V4, P419, DOI 10.1046/j.1365-2486.1998.00164.x; Salminen JP, 2004, J CHEM ECOL, V30, P1693, DOI 10.1023/B:JOEC.0000042396.40756.b7; Salminen JP, 2011, FUNCT ECOL, V25, P325, DOI 10.1111/j.1365-2435.2010.01826.x; SCHULTZ JC, 1982, AM J BOT, V69, P753, DOI 10.2307/2442965; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; Siefert A, 2015, ECOL LETT, V18, P1406, DOI 10.1111/ele.12508; Smilanich AM, 2016, NEW PHYTOL, V210, P1044, DOI 10.1111/nph.13875; Stamp NE, 1998, ENTOMOL EXP APPL, V88, P81, DOI 10.1023/A:1003290510565; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Top SM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00423; TUOMI J, 1988, AM NAT, V132, P602, DOI 10.1086/284875; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Visakorpi K, 2018, NEW PHYTOL, V220, P799, DOI 10.1111/nph.15338; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zust T, 2017, ANNU REV PLANT BIOL, V68, P513, DOI 10.1146/annurev-arplant-042916-040856	79	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228157	10.1371/journal.pone.0228157	http://dx.doi.org/10.1371/journal.pone.0228157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978155	Green Accepted, Green Published, gold			2022-12-26	WOS:000534599100118
J	Zante, B; Hautz, WE; Schefold, JC				Zante, Bjoern; Hautz, Wolf E.; Schefold, Joerg C.			Physiology education for intensive care medicine residents: A 15-minute interactive peer-led flipped classroom session	PLOS ONE			English	Article							STUDENTS; MOTIVATION; CONSTRUCTIVISM; DYSFUNCTION; PATIENT; TAUGHT; LEARN	Introduction In acute care medicine, knowledge of the underlying (patho)-physiology is of paramount importance. This may be especially relevant in intensive care medicine, where individual competence and proficiency greatly depend on knowledge and understanding of critical care physiology. In settings with time constraints such as intensive care units (ICUs), time allotted to education is often limited. We evaluated whether introduction of a short, interactive, peer-led flipped classroom session is feasible and can provide ICU residents with a better understanding of critical care physiology. Materials and methods Using the flipped classroom concept, we developed a 15-minute peer-led interactive "physiology education" session to introduce a total of 44 residents to critical care physiology. Using a nine-item electronic survey with open questions and a five-point Likert scale, we analysed the overall concept with regard to feasibility, motivation, and subjective learning of critical care physiology. Results The overall rate of response to the survey was 70.5% (31/44). The residents reported that these sessions sparked their interest (p = 0.005, Chi square 10.52), and that discussion and interaction during these sessions had promoted their knowledge and understanding. Both novice and experienced residents reported that new knowledge was imparted (both p< 0.0001, Chi-square 32.97 and 25.04, respectively). Conclusions In an environment with time constraints such as the ICU, a 15-minute, interactive, peer-led flipped classroom teaching session was considered feasible and generally appeared useful for teaching critical care physiology to ICU residents. Responses to questions on questionnaires indicated that teaching sessions sparked interest and increased motivation. This approach may theoretically induce a modification in professional behaviour and promote self-directed learning. We therefore support the use of peer-led flipped classroom training sessions in the ICU. Whether these sessions result in improved ICU care should be addressed in subsequent studies.	[Zante, Bjoern; Schefold, Joerg C.] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland; [Hautz, Wolf E.] Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Zante, B (corresponding author), Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland.	bjoern.zante@insel.ch		Hautz, Wolf/0000-0002-2445-984X; Schefold, Joerg C./0000-0001-9162-5724				Allen RSF V, 1976, CHILDREN AS TEACHERS; Beard DA, 2011, AM J PHYSIOL-HEART C, V301, pH629, DOI 10.1152/ajpheart.00228.2011; Brandon AF, CONSTRUCTIVISM THEOR, P1536; BRUNER JS, 1961, HARVARD EDUC REV, V31, P21; Candela L, 2015, TEACHING NURSING GUI; Chen F, SYSTEMATIC REV EFFEC, P1365; Chen F, 2017, MED EDUC, V51, P585, DOI 10.1111/medu.13272; Colthorpe KL, 2018, ADV PHYSIOL EDUC, V42, P555, DOI 10.1152/advan.00102.2018; Cook DA, 2016, MED EDUC, V50, P997, DOI 10.1111/medu.13074; Croley WC, 2007, CRIT CARE MED, V35, pS117, DOI 10.1097/01.CCM.0000252917.25301.18; Curley G, 2010, CRIT CARE, V14, DOI 10.1186/cc8926; Custers EJFM, 2011, MED EDUC, V45, P422, DOI 10.1111/j.1365-2923.2010.03889.x; DeGrave WS, 1996, INSTR SCI, V24, P321, DOI 10.1007/BF00118111; Dennick R, 2016, INT J MED EDUC, V7, P200, DOI 10.5116/ijme.5763.de11; Dickinson BL, 2018, ADV PHYSIOL EDUC, V42, P118, DOI 10.1152/advan.00174.2017; Dybowski C, 2014, TEACH LEARN MED, V26, P393, DOI 10.1080/10401334.2014.910467; Ernst H, 2007, ADV PHYSIOL EDUC, V31, P41, DOI 10.1152/advan.00107.2006; Eva KW, 2009, MED EDUC, V43, P294, DOI 10.1111/j.1365-2923.2009.03342.x; Funk DJ, 2013, CRIT CARE MED, V41, P255, DOI 10.1097/CCM.0b013e3182772ab6; Joyce MF, 2017, WORLD J CRIT CARE ME, V6, P1, DOI DOI 10.5492/WJCCM.V6.I1.1; Kiani Q, 2014, CLIN TEACH, V11, P203, DOI 10.1111/tct.12109; Kimmoun A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0896-7; Knowles EFH M.S, 2011, ADULT LEARNER DEFINI; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kusurkar RA, 2011, MED TEACH, V33, pE242, DOI 10.3109/0142159X.2011.558539; Legan SJ, 2001, ADV PHYSIOL EDUC, V25, P228, DOI 10.1152/advances.2001.25.4.228; Lockspeiser TM, 2008, ADV HEALTH SCI EDUC, V13, P361, DOI 10.1007/s10459-006-9049-8; Magder S, 2012, CRIT CARE, V16, DOI 10.1186/cc11395; Mahler D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207252; Michael JA, 1999, ADV PHYSIOL EDUC, V22, pS127, DOI 10.1152/advances.1999.277.6.S127; Michael J, 2007, ADV PHYSIOL EDUC, V31, P34, DOI 10.1152/advan.00057.2006; Miranda M, 2016, AM J PHYSIOL-HEART C, V311, pH24, DOI 10.1152/ajpheart.00034.2016; MOUST JHC, 1994, INSTR SCI, V22, P287; Orsini C, 2015, J EDUC EVAL HEALTH P, V12, DOI 10.3352/jeehp.2015.12.8; Pfortmueller CA, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0174-5; Piagnerelli M, 2003, INTENS CARE MED, V29, P1052, DOI 10.1007/s00134-003-1783-2; Prakash ES, 2010, ADV PHYSIOL EDUC, V34, P93, DOI 10.1152/advan.00025.2010; Qiao YQ, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-79; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Rovick AA, 1999, ADV PHYSIOL EDUC, V21, pS93, DOI 10.1152/advances.1999.276.6.S93; Sarbin TR, 1976, CHILDREN AS TEACHERS; Schefold JC, 2016, NAT REV NEPHROL, V12, P610, DOI 10.1038/nrneph.2016.113; Sefton AJ, 2005, ADV PHYSIOL EDUC, V29, P189, DOI 10.1152/advan.00001.2005; Smits PBA, 2004, MED EDUC, V38, P758, DOI 10.1111/j.1365-2929.2004.01846.x; Srivastava TK, 2015, J CLIN DIAGN RES, V9, pJC1, DOI 10.7860/JCDR/2015/15018.6323; Sunagawa K, 2017, J PHYSIOL SCI, V67, P447, DOI 10.1007/s12576-017-0533-0; Tainter CR, 2015, J CRIT CARE, V30, P550, DOI 10.1016/j.jcrc.2015.02.001; Takala J, 2003, INTENS CARE MED, V29, P890, DOI 10.1007/s00134-003-1749-4; Takala J, 2007, INTENS CARE MED, V33, P908, DOI 10.1007/s00134-007-0546-x; Ten Cate O, 2007, MED TEACH, V29, P591, DOI 10.1080/01421590701606799; Ten Cate O, 2007, MED TEACH, V29, P546, DOI 10.1080/01421590701583816; Topping K. J., 2005, ED PSYCHOL, V25, P631, DOI DOI 10.1080/01443410500345172; Vansteenkiste M, 2005, J EDUC PSYCHOL, V97, P468, DOI 10.1037/0022-0663.97.3.468; Vari RC, 2001, ADV PHYSIOL EDUC, V25, P241, DOI 10.1152/advances.2001.25.4.241; Vassilakopoulos T, 2008, INTENS CARE MED, V34, P1336, DOI 10.1007/s00134-008-1095-7; Vincent JL, 2018, CHEST, V154, P1267, DOI 10.1016/j.chest.2018.07.020; von Anrep G, 1912, J PHYSIOL-LONDON, V45, P307; Vygotsky L.S., 1978, MIND SOC DEV HIGHER, P79, DOI DOI 10.2307/J.CTVJF9VZ4.11; Walley KR, 2011, AM J RESP CRIT CARE, V184, P514, DOI 10.1164/rccm.201010-1584CI; Wlodkowski R., 2008, ENHANCING ADULT MOTI; Young JQ, 2014, MED TEACH, V36, P371, DOI 10.3109/0142159X.2014.889290	62	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228257	10.1371/journal.pone.0228257	http://dx.doi.org/10.1371/journal.pone.0228257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978206	Green Published, gold			2022-12-26	WOS:000534599100133
J	van Laarhoven, CJHCM; Pourier, VEC; Lindgren, AE; Vergouwen, MDI; Jaaskelainen, JE; Rinkel, GJE; de Kleijn, DPV; de Borst, GJ				van Laarhoven, Constance J. H. C. M.; Pourier, Vanessa E. C.; Lindgren, Antti E.; Vergouwen, Mervyn D., I; Jaaskelainen, Juha E.; Rinkel, Gabriel J. E.; de Kleijn, Dominique P., V; de Borst, Gert J.			Co-prevalence of extracranial carotid aneurysms differs between European intracranial aneurysm cohorts	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; ARTERY ANEURYSMS; RISK	Background and purpose Previously, we showed that co-prevalence of extracranial carotid artery aneurysms (ECAAs) in patients with intracranial aneurysms (IAs) was 2% in a Dutch cohort. In order to obtain more precise estimates and discover potential predictors of ECAA co-prevalence in the European population, we retrospectively compared differences and similarities of our Dutch cohort with a Finnish cohort using protocolled imaging of the cerebrovascular tree. Methods IA patients within the prospective database of the Kuopio University Hospital were eligible for this study (n = 1,118). Image analysis and hospital chart review were conducted. Results In total, 458 patients with complete carotid imaging conform protocol were analyzed. Twenty-four ECAAs in 21 patients were identified (4.6%, 95% CI 2.9-6.9), a higher co-prevalence than in the Dutch cohort (1.9%; 95% CI 1.0-3.3), prevalence odds ratio (POR) 2.45 (95% CI 1.19-5.03). In the Finnish cohort, 25% of all ECAAs were located around the carotid bifurcation, others in the internal carotid artery distally from the bifurcation. Independent predictors for ECAA co-prevalence were origin of country (POR 2.41, 95% CI 1.15-5.06) and male gender (POR 2.25, 95% CI 1.09-4.64). Conclusion The co-prevalence of ECAA in IA patients was twice as high in the Finnish compared to the Dutch IA cohort, with origin of country and male gender as independent predictors. Twenty-five percent of ECAAs would be missed, if the carotid bifurcation was not imaged. Therefore, we propose to always include imaging of the carotid bifurcation as the gold standard technique to identify ECAA in IA patients.	[van Laarhoven, Constance J. H. C. M.; Pourier, Vanessa E. C.; de Kleijn, Dominique P., V; de Borst, Gert J.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Lindgren, Antti E.; Jaaskelainen, Juha E.] Kuopio Univ Hosp, NeuroCtr, Dept Neurosurg, Kuopio, Finland; [Vergouwen, Mervyn D., I; Rinkel, Gabriel J. E.] Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Kuopio University Hospital; University of Eastern Finland; Utrecht University; Utrecht University Medical Center	de Borst, GJ (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands.	g.j.deborst-2@umcutrecht.nl	Lindgren, Antti/J-2517-2019	Lindgren, Antti/0000-0002-1264-7667; van Laarhoven, Constance/0000-0002-8817-7315				Agricola E, 2013, INT J CARDIOL, V168, P3147, DOI 10.1016/j.ijcard.2013.04.162; Attigah N, 2009, EUR J VASC ENDOVASC, V37, P127, DOI 10.1016/j.ejvs.2008.10.020; Dawson I, 1997, BRIT J SURG, V84, P293; De Borst GJ, 2016, OXFORD TXB VASCULAR, P462; Diwan A, 2000, J VASC SURG, V31, P863, DOI 10.1067/mva.2000.105955; Donas KP, 2009, J VASC SURG, V49, P93, DOI 10.1016/j.jvs.2008.08.006; Hultgren R, 2012, ANN VASC SURG, V26, P918, DOI 10.1016/j.avsg.2012.01.023; Kuzmik GA, 2010, AM J CARDIOL, V105, P417, DOI 10.1016/j.amjcard.2009.09.049; Miyazawa N, 2007, ACTA NEUROCHIR, V149, P221, DOI 10.1007/s00701-006-1077-x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nordanstig J, 2014, ANN VASC SURG, V28, P882, DOI 10.1016/j.avsg.2013.08.011; Norman PE, 2010, CIRCULATION, V121, P560, DOI 10.1161/CIRCULATIONAHA.109.880724; Pourier VEC, 2018, EUR J NEUROL, V25, P1285, DOI 10.1111/ene.13720; Pourier VEC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187479; Pourier VEC, 2016, J CARDIOVASC SURG, V57, P152; Ravn H, 2008, BRIT J SURG, V95, P571, DOI 10.1002/bjs.6074; Rouchaud A, 2016, AM J NEURORADIOL, V37, P1664, DOI 10.3174/ajnr.A4827; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; van't Hof FNG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002603; Wallinder J, 2018, EUR J VASC ENDOVASC, V56, P435, DOI 10.1016/j.ejvs.2018.05.015; Wanhainen A, 2019, EUR J VASC ENDOVASC, V57, P8, DOI 10.1016/j.ejvs.2018.09.020; Welleweerd JC, 2015, EUR J VASC ENDOVASC, V50, P141, DOI 10.1016/j.ejvs.2015.05.002; Welleweerd JC, 2018, J CARDIOVASC SURG, V59, P692, DOI 10.23736/S0021-9509.16.08637-7	23	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228041	10.1371/journal.pone.0228041	http://dx.doi.org/10.1371/journal.pone.0228041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971973	Green Published, Green Submitted, gold			2022-12-26	WOS:000534374400035
J	Vos, M; Boers, R; Vriends, ALM; Boers, J; van Kuijk, PF; van Houdt, WJ; van Leenders, GJLH; Wagrodzki, M; van IJcken, WFJ; Gribnau, J; Grunhagen, DJ; Verhoef, C; Sleijfer, S; Wiemer, EAC				Vos, Melissa; Boers, Ruben; Vriends, Anne L. M.; Boers, Joachim; van Kuijk, Patricia F.; van Houdt, Winan J.; van Leenders, Geert J. L. H.; Wagrodzki, Michal; van IJcken, Wilfred F. J.; Gribnau, Joost; Grunhagen, Dirk J.; Verhoef, Cornelis; Sleijfer, Stefan; Wiemer, Erik A. C.			MicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma	PLOS ONE			English	Article							SUPPRESSOR; REGULATOR; MIR-155; TISSUES	Approximately one-third of the patients with well-differentiated liposarcoma (WDLPS) will develop a local recurrence. Not much is known about the molecular relationship between the primary tumor and the recurrent tumor, which is important to reveal potential drivers of recurrence. Here we investigated the biology of recurrent WDLPS by comparing paired primary and recurrent WDLPS using microRNA profiling and genome-wide DNA methylation analyses. In total, 27 paired primary and recurrent WDLPS formalin-fixed and paraffin-embedded tumor samples were collected. MicroRNA expression profiles were determined using TaqMan (R) Low Density Array (TLDA) cards. Genome-wide DNA methylation and differentially methylated regions (DMRs) were assessed by methylated DNA sequencing (MeD-seq). A supervised cluster analysis based on differentially expressed microRNAs between paired primary and recurrent WDLPS did not reveal a clear cluster pattern separating the primary from the recurrent tumors. The clustering was also not based on tumor localization, time to recurrence, age or status of the resection margins. Changes in DNA methylation between primary and recurrent tumors were extremely variable, and no consistent DNA methylation changes were found. As a result, a supervised clustering analysis based on DMRs between primary and recurrent tumors did not show a distinct cluster pattern based on any of the features. Subgroup analysis for tumors localized in the extremity or the retroperitoneum also did not yield a clear distinction between primary and recurrent WDLPS samples. In conclusion, microRNA expression profiles and DNA methylation profiles do not distinguish between primary and recurrent WDLPS and no putative common drivers could be identified.	[Vos, Melissa; Vriends, Anne L. M.; van Kuijk, Patricia F.; Sleijfer, Stefan; Wiemer, Erik A. C.] Erasmus MC, Dept Med Oncol, Canc Inst, Rotterdam, Netherlands; [Vos, Melissa; Grunhagen, Dirk J.; Verhoef, Cornelis] Erasmus MC, Dept Surg Oncol, Canc Inst, Rotterdam, Netherlands; [Boers, Ruben; Boers, Joachim; Gribnau, Joost] Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands; [van Houdt, Winan J.] Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands; [van Leenders, Geert J. L. H.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Wagrodzki, Michal] Maria Sklodowska Curie Inst, Dept Pathol, Oncol Ctr, Warsaw, Poland; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Maria Sklodowska-Curie National Research Institute of Oncology; Erasmus University Rotterdam; Erasmus MC	Vos, M; Wiemer, EAC (corresponding author), Erasmus MC, Dept Med Oncol, Canc Inst, Rotterdam, Netherlands.; Vos, M (corresponding author), Erasmus MC, Dept Surg Oncol, Canc Inst, Rotterdam, Netherlands.	m.vos.2@erasmusmc.nl; e.wiemer@erasmusmc.nl	Boers, Ruben/AAF-8181-2020; van ijcken, willem/N-9805-2018; Verhoef, Cornelis/ABD-3648-2020; Grünhagen, Dirk/ABE-5102-2020; Wągrodzki, Michał/AAF-7849-2021	Boers, Ruben/0000-0002-3377-2897; van ijcken, willem/0000-0002-0421-8301; Verhoef, Cornelis/0000-0001-9980-8613; Grünhagen, Dirk/0000-0001-8293-6002; Wągrodzki, Michał/0000-0001-5211-0736; Wiemer, Erik/0000-0002-0673-7236				Boers R, 2018, GENOME RES, V28, P88, DOI 10.1101/gr.222885.117; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Davidovic R, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0682-9; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Garsed DW, 2014, CANCER CELL, V26, P653, DOI 10.1016/j.ccell.2014.09.010; Gits CMM, 2014, INT J CANCER, V135, P348, DOI 10.1002/ijc.28694; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hoekstra HJ, 2017, ANN SURG ONCOL, V24, P3279, DOI 10.1245/s10434-017-6003-3; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kapodistrias N, 2017, ONCOTARGET, V8, P6896, DOI 10.18632/oncotarget.14320; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lam CSC, 2017, ONCOTARGET, V8, P26858, DOI 10.18632/oncotarget.15844; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; Lee DH, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.10; Liu Y, 2019, ONCOL LETT, V17, P1996, DOI 10.3892/ol.2018.9768; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mazzu YZ, 2017, CANCER RES, V77, P5728, DOI 10.1158/0008-5472.CAN-16-2253; Nezu Y, 2016, ONCOGENE, V35, P6177, DOI 10.1038/onc.2016.157; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Otsu H, 2017, CLIN CHEM LAB MED, V55, P626, DOI 10.1515/cclm-2016-0449; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Renner M, 2012, GENE CHROMOSOME CANC, V51, P982, DOI 10.1002/gcc.21980; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Su M, 2018, ONCOL LETT, V16, P65, DOI 10.3892/ol.2018.8645; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Sun RR, 2015, DISCOV MED, V20, P311; Taylor BS, 2011, CANCER DISCOV, V1, P587, DOI 10.1158/2159-8290.CD-11-0181; The Netherlands Comprehensive Cancer Registry, 2014, BIJLAGE DEELRAPPORTA; Ugras S, 2011, CANCER RES, V71, P5659, DOI 10.1158/0008-5472.CAN-11-0890; Vincenzi B, 2015, ONCOTARGET, V6, P10586, DOI 10.18632/oncotarget.3201; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhang PY, 2012, CANCER RES, V72, P1751, DOI 10.1158/0008-5472.CAN-11-3027; Zhou J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4115-6	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228014	10.1371/journal.pone.0228014	http://dx.doi.org/10.1371/journal.pone.0228014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971976	Green Published, gold, Green Submitted			2022-12-26	WOS:000534374400032
J	de Azevedo, LFC; Ferreira, TAA; Melo, KM; Dias, CLP; Bastos, CEMC; Santos, SF; Santos, AD; Nagamachi, CY; Pieczarka, JC				Calandrini de Azevedo, Luana Franca; Alves Ferreira, Tassia Alana; Melo, Karina Motta; Porfirio Dias, Clara Louise; Matos Carvalho Bastos, Carlos Eduardo; Santos, Seidel Ferreira; Santos, Alberdan da Silva; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar			Aqueous ethanol extract of Libidibia ferrea (Mart. Ex Tul) LP Queiroz (juca) exhibits antioxidant and migration-inhibiting activity in human gastric adenocarcinoma (ACP02) cells	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; DNA-DAMAGE; IN-VITRO; ASSAY; LINE	Libidibia ferrea (juca) is a plant belonging to the Fabaceae (Leguminosae) family, whose antioxidant activity has been widely described in the literature. We evaluated this parameter of Aqueous ethanol extract (AE), ethyl acetate (ACO), chloroform (CLO) and hexane (HEX) extracts of L. ferrea. We then tested the most active extract for its toxicity and ability to inhibit migratory activity in the ACP02 gastric adenocarcinoma cell line in vitro. The AE and ACO extracts both had antioxidant activity, the AE extract showing greater potential. This may reflect that both extracts contained phenolic compounds. Although AE extract showed no cytotoxic, mutagenic or genotoxic effect, it altered cell morphology and migration activity. Analysis of apoptosis/necrosis indicated that this parameter does not appear to account for the apparent ability of AE to inhibit cancer cell migration. We speculate that the morphological changes in AE-treated cells could be due to cytoskeleton alterations related to the presence of myo-inositol in AE extract. Together, our results demonstrate this extract of L. ferrea can act as an exogenous antioxidant and might prove useful in efforts to fight secondary tumors.	[Calandrini de Azevedo, Luana Franca; Alves Ferreira, Tassia Alana; Melo, Karina Motta; Porfirio Dias, Clara Louise; Matos Carvalho Bastos, Carlos Eduardo; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] Univ Fed Para, Ctr Estudos Avancados Biodiversidade, Inst Ciencias Biol, Lab Citogenet, Belem, Para, Brazil; [Santos, Seidel Ferreira; Santos, Alberdan da Silva] Univ Fed Para, Lab Invest Sistemat Biotecnol & Biodiversidade Mo, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Pieczarka, JC (corresponding author), Univ Fed Para, Ctr Estudos Avancados Biodiversidade, Inst Ciencias Biol, Lab Citogenet, Belem, Para, Brazil.	juliopieczarka@gmail.com	Nagamachi, Cleusa/AAV-8985-2021; Pieczarka, Julio C/E-7585-2016	Pieczarka, Julio C/0000-0003-2951-8877; Ferreira, Tassia/0000-0002-1096-0262	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [047/2012]; Banco Nacional de Desenvolvimento Economico e Social [2.318.697.0001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Edital Pro-Amazonia Biodiversidade e Sustentabilidade) [047/2012]; Banco Nacional de Desenvolvimento Economico e Social-BNDES [2.318.697.0001]; CAPES	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Banco Nacional de Desenvolvimento Economico e Social; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Edital Pro-Amazonia Biodiversidade e Sustentabilidade)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Banco Nacional de Desenvolvimento Economico e Social-BNDES; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JCP received the grant 047/2012 from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (https://www.capes.gov.br) and 2.318.697.0001 from Banco Nacional de Desenvolvimento Economico e Social (http://www.bndes.gov.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES; Edital Pro-Amazonia Biodiversidade e Sustentabilidade 047/2012) and Banco Nacional de Desenvolvimento Economico e Social-BNDES (Operation 2.318.697.0001) in projects coordinated by Julio Cesar Pieczarka. This study is part of the mastership dissertation of Luana Franca Calandrini de Azevedo in the post-graduation program in Genetics and Molecular Biology of the Universidade Federal do Para ' (scholarship granted by CAPES).	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alizadeh AM, 2014, TUMOR BIOL, V35, P8483, DOI 10.1007/s13277-014-2421-z; Andrighetti-Frohner CR, 2006, MUTAT RES-GEN TOX EN, V603, P97, DOI 10.1016/j.mrgentox.2005.11.001; [Anonymous], 2016, IN VITR MAMM CELL MI, DOI DOI 10.1787/9789264264861-EN; Ayres M., 2007, BIOESTAT 50 APLICACO; Barroso GM, 1999, FRUTOS SEMENTES MORF, DOI DOI 10.17801/0101-3122/RBS.V21N2P64-69; Broinizi PRB, 2007, CIENCIA TECNOL ALIME, V27, P902, DOI 10.1590/S0101-20612007000400035; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BURK RR, 1973, P NATL ACAD SCI USA, V70, P369, DOI 10.1073/pnas.70.2.369; Carvalho A.C.B., 2011, THESIS; Chappill J. A, 1995, ADV LEGUME SYSTEMATI, V7; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; Cunha A. P., 2012, PLANTAS E PRODUTOS V; De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017; de Almeida MV, 2003, QUIM NOVA, V26, P105, DOI 10.1590/S0100-40422003000100018; DeguYspari CH., 2004, VISAO ACAD, V5, P33, DOI [10.5380/acd.v5i1.540, DOI 10.5380/ACD.V5I1.540]; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; Elias ST, 2014, THESIS; GRIN-USDA ARS National Genetic Resources Program, 2017, NAT GEN RES PROGR; Guerra A.C.V.A, 2017, THESIS; Harvey AL, 1998, TOXICON, V36, P1635, DOI 10.1016/S0041-0101(98)00156-1; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Krug M.S, 2013, THESIS; Leal MF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/631268; Lewis G.P., 1987, LEGUMES BAHIA; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lotfi CFP, 1996, MUTAT RES-FUND MOL M, V349, P77, DOI 10.1016/0027-5107(95)00160-3; Maryas J, 2014, PROTEOMICS, V14, P426, DOI 10.1002/pmic.201300264; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; da Silva LCN, 2011, FOOD CHEM TOXICOL, V49, P2222, DOI 10.1016/j.fct.2011.06.019; Oliveira A.F., 2010, Rev. bras. plantas med., V12, P302, DOI 10.1590/S1516-05722010000300007; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Port's PD, 2013, FOOD RES INT, V53, P875, DOI 10.1016/j.foodres.2013.02.010; Ramos J., 2012, THESIS U ZARAGOZA; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reisa A, 2017, THESIS; Sampaio FC, 2009, J ETHNOPHARMACOL, V124, P289, DOI 10.1016/j.jep.2009.04.034; Schummer C, 2009, TALANTA, V77, P1473, DOI 10.1016/j.talanta.2008.09.043; Silva EM, 2007, FOOD CHEM, V101, P1012, DOI 10.1016/j.foodchem.2006.02.055; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Souza T. M., 2007, Revista de Ciencias Farmaceuticas Basica e Aplicada, V28, P221; Sperotto RA, 2014, PROTOCOLOS METODOS A; Valente T.O.N, 2014, THESIS; Yunes RA, 2001, QUIM NOVA, V24, P147, DOI 10.1590/S0100-40422001000100025	46	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0226979	10.1371/journal.pone.0226979	http://dx.doi.org/10.1371/journal.pone.0226979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31952077	Green Published, gold			2022-12-26	WOS:000534370500007
J	Tossounian, MA; Truong, ACK; Buts, L; Wahni, K; Mourenza, A; Leermakers, M; Vertommen, D; Mateos, LM; Volkov, AN; Messens, J				Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Buts, Lieven; Wahni, Khadija; Mourenza, Alvaro; Leermakers, Martine; Vertommen, Didier; Mateos, Luis Mariano; Volkov, Alexander N.; Messens, Joris			Methionine sulfoxide reductase B from Corynebacterium diphtheriae catalyzes sulfoxide reduction via an intramolecular disulfide cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme structure; nuclear magnetic resonance (NMR); kinetics; redox regulation; biochemistry; hydrogen peroxide; methionine sulfoxide	MYCOBACTERIUM-TUBERCULOSIS; MYCOTHIOL PEROXIDASE; ARABIDOPSIS-THALIANA; ARSENATE REDUCTASE; OXIDIZED PROTEINS; OXIDATIVE STRESS; MECHANISM; THIOREDOXIN; GLUTATHIONE; RESIDUES	Corynebacterium diphtheriae is a human pathogen that causes diphtheria. In response to immune system-induced oxidative stress, C. diphtheriae expresses antioxidant enzymes, among which are methionine sulfoxide reductase (Msr) enzymes, which are critical for bacterial survival in the face of oxidative stress. Although some aspects of the catalytic mechanism of the Msr enzymes have been reported, several details still await full elucidation. Here, we solved the solution structure of C. diphtheriae MsrB (Cd-MsrB) and unraveled its catalytic and oxidation-protection mechanisms. Cd-MsrB catalyzes methionine sulfoxide reduction involving three redox-active cysteines. Using NMR heteronuclear single-quantum coherence spectra, kinetics, biochemical assays, and MS analyses, we show that the conserved nucleophilic residue Cys-122 is S-sulfenylated after substrate reduction, which is then resolved by a conserved cysteine, Cys-66, or by the nonconserved residue Cys-127. We noted that the overall structural changes during the disulfide cascade expose the Cys-122?Cys-66 disulfide to recycling through thioredoxin. In the presence of hydrogen peroxide, Cd-MsrB formed reversible intra- and intermolecular disulfides without losing its Cys-coordinated Zn2+, and only the nonconserved Cys-127 reacted with the low-molecular-weight (LMW) thiol mycothiol, protecting it from overoxidation. In summary, our structure-function analyses reveal critical details of the Cd-MsrB catalytic mechanism, including a major structural rearrangement that primes the Cys-122?Cys-66 disulfide for thioredoxin reduction and a reversible protection against excessive oxidation of the catalytic cysteines in Cd-MsrB through intra- and intermolecular disulfide formation and S-mycothiolation.	[Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Buts, Lieven; Wahni, Khadija; Volkov, Alexander N.; Messens, Joris] VUB, VIB, Ctr Structural Biol, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Wahni, Khadija; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Buts, Lieven; Wahni, Khadija; Volkov, Alexander N.; Messens, Joris] Vrije Univ Brussels, Struct Biol Brussels, B-1050 Brussels, Belgium; [Volkov, Alexander N.] Vrije Univ Brussels, Struct Biol Brussels, Jean Jeener NMR Ctr, B-1050 Brussels, Belgium; [Mourenza, Alvaro; Mateos, Luis Mariano] Univ Leon, Area Microbiol, Dept Mol Biol, E-24071 Leon, Spain; [Leermakers, Martine] Vrije Univ Brussels, Analyt Environm & Geochem AMGC, Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Truong, Anh-Co Khanh] VIB, Lab Angiogenesis & Vasc Metab, VIB Ctr Canc Biol, B-3000 Leuven, Belgium; [Truong, Anh-Co Khanh] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Dept Oncol, Leuven Canc Inst, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universidad de Leon; Vrije Universiteit Brussel; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven	Messens, J (corresponding author), VUB, VIB, Ctr Structural Biol, B-1050 Brussels, Belgium.	joris.messens@vub.vib.be	Mourenza, Alvaro/AAA-5385-2020; Messens, Joris/AAH-3008-2020	Mourenza, Alvaro/0000-0003-4926-3891; Messens, Joris/0000-0002-2128-8264; Tossounian, Maria-Armineh/0000-0003-3679-7376; Volkov, Alexander/0000-0002-0103-059X; Truong, Anh-Co Khanh/0000-0002-9806-4293	Vlaams Instituut voor Biotechnologie (VIB), a FWO Ph.D. fellowship grant; Anaerobic Workstation Grant from FWO [1508316N]; Hercules Foundation [HERC16]; Vrije Universiteit Brussel [SRP34]	Vlaams Instituut voor Biotechnologie (VIB), a FWO Ph.D. fellowship grant; Anaerobic Workstation Grant from FWO; Hercules Foundation; Vrije Universiteit Brussel	This work was supported by the Vlaams Instituut voor Biotechnologie (VIB), a FWO Ph.D. fellowship grant (to M. A. T.), Hercules Foundation Grant HERC16, Anaerobic Workstation Grant 1508316N from FWO, and Strategic Research Programme Grant SRP34 of the Vrije Universiteit Brussel (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao ZB, 2018, BIOCHEM J, V475, P827, DOI 10.1042/BCJ20170929; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Chi BK, 2014, ANTIOXID REDOX SIGN, V20, P589, DOI 10.1089/ars.2013.5423; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Couturier J, 2012, FEBS LETT, V586, P3894, DOI 10.1016/j.febslet.2012.09.020; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; FRELINGER AL, 1986, ARCH BIOCHEM BIOPHYS, V244, P641, DOI 10.1016/0003-9861(86)90632-6; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee SH, 2014, J EXP BOT, V65, P5049, DOI 10.1093/jxb/eru270; Leermakers M, 2005, WATER AIR SOIL POLL, V166, P265, DOI 10.1007/s11270-005-6671-7; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lillig CH, 2013, BBA-GEN SUBJECTS, V1830, P3137, DOI 10.1016/j.bbagen.2013.02.019; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Messens J, 2004, J MOL BIOL, V339, P527, DOI 10.1016/j.jmb.2004.04.016; Messens J, 2002, P NATL ACAD SCI USA, V99, P8506, DOI 10.1073/pnas.132142799; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pedre B, 2015, MOL MICROBIOL, V96, P1176, DOI 10.1111/mmi.12998; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Reyes AM, 2018, ANTIOXID REDOX SIGN, V28, P487, DOI 10.1089/ars.2017.7074; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Saha SS, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw260; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Si MR, 2017, J GEN APPL MICROBIOL, V63, P280, DOI 10.2323/jgam.2017.01.005; Si MR, 2015, BIOCHEM J, V469, P45, DOI 10.1042/BJ20141080; Tarrago L, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1097, DOI 10.1134/S0006297912100021; Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520; Tossounian MA, 2018, BBA-GEN SUBJECTS, V1862, P775, DOI 10.1016/j.bbagen.2017.10.007; Tossounian MA, 2015, J BIOL CHEM, V290, P11365, DOI 10.1074/jbc.M114.632596; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Volkov AN, 2013, BIOCHEMISTRY-US, V52, P2165, DOI 10.1021/bi400220w; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	64	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3664	3677		10.1074/jbc.RA119.012438	http://dx.doi.org/10.1074/jbc.RA119.012438			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31992594	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000527725300023
J	Ganz, P; Ijato, T; Porras-Murillo, R; Stuhrwohldt, N; Ludewig, U; Neuhauser, B				Ganz, Pascal; Ijato, Toyosi; Porras-Murillo, Romano; Stuehrwohldt, Nils; Ludewig, Uwe; Neuhaeuser, Benjamin			A twin histidine motif is the core structure for high-affinity substrate selection in plant ammonium transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ammonia; membrane transport; plant; substrate specificity; transporter; ammonium transporter; channel pore; ion transport; substrate deprotonation; twin-histidine motif	POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; AMTB; NH3; ARRANGEMENT; AMT/MEP/RH; MECHANISMS; FAMILY; ROOTS	Ammonium transporters (AMT), methylamine permeases (Mep), and the more distantly related rhesus factors (Rh) are trimeric membrane proteins present in all domains of life. AMT/Mep/Rhs are highly selective membrane proteins required for ammonium uptake or release, and they efficiently exclude the similarly sized K+ ion. Previously reported crystal structures have revealed that each transporter subunit contains a unique hydrophobic but occluded central pore, but it is unclear whether the base (NH3) or NH3 coupled with an H+ are transported. Here, using expression of two plant AMTs (AtAMT1;2 and AMT2) in budding yeast, we found that systematic replacements in the conserved twin-histidine motif, a hallmark of most AMT/Mep/Rh, alter substrate recognition, transport capacities, N isotope selection, and selectivity against K+. AMT-specific differences were found for histidine variants. Variants that completely lost ammonium N isotope selection, a feature likely associated with NH4+ deprotonation during passage, substantially transported K+ in addition to NH4+. Of note, the twin-histidine motif was not essential for ammonium transport. However, it conferred key AMT features, such as high substrate affinity and selectivity against alkali cations via an NH4 + deprotonation mechanism. Our findings indicate that the twin-His motif is the core structure responsible for substrate deprotonation and isotopic preferences in AMT pores and that decreased deprotonation capacity is associated with reduced selectivity against K+. We conclude that optimization for ammonium transport in plant AMT represents a compromise between substrate deprotonation for optimal selectivity and high substrate affinity and transport rates.	[Ganz, Pascal; Ijato, Toyosi; Porras-Murillo, Romano; Ludewig, Uwe; Neuhaeuser, Benjamin] Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, Fruwirthstr 20, D-70593 Stuttgart, Germany; [Stuehrwohldt, Nils] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Neuhauser, B (corresponding author), Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, Fruwirthstr 20, D-70593 Stuttgart, Germany.	benjamin.neuhaeuser@uni-hohenheim.de		Stuhrwohldt, Nils/0000-0003-4166-3786; Neuhauser, Benjamin/0000-0002-2391-0598; Porras-Murillo, Romano/0000-0002-3934-2206	University of Hohenheim; DFG [NE 1727/2-2]	University of Hohenheim; DFG(German Research Foundation (DFG))	We thank D. Schnell for technical experimental assistance, Dr. W. Armbruster for isotope analysis, Dr. F. Rubio (Murcia, Spain) for the W Delta 3 yeast strain, and Dr. M. Dynowski for help with the AtAMT1;2 model. Work in the laboratory was partially funded by the University of Hohenheim and the DFG (NE 1727/2-2).	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Ariz I, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3599; Bindel N, 2019, 820712 BIORXIV, DOI 10.1101/820712; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FINDENEGG GR, 1987, PLANT SOIL, V103, P239, DOI 10.1007/BF02370395; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Ganz P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53333-9; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Hall JA, 2013, J BIOL CHEM, V288, P14080, DOI 10.1074/jbc.M113.457952; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Haro R, 1999, MOL MICROBIOL, V31, P511, DOI 10.1046/j.1365-2958.1999.01192.x; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEINER D, 1981, BIOCHIM BIOPHYS ACTA, V639, P41, DOI 10.1016/0304-4173(81)90004-5; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ludewlg U, 2007, FEBS LETT, V581, P2301, DOI 10.1016/j.febslet.2007.03.034; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Mirandela GD, 2019, FASEB J, V33, P1989, DOI 10.1096/fj.201800782R; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Neuhauser B, 2014, CHANNELS, V8, P496, DOI 10.4161/19336950.2014.967618; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Palffy A, 2010, CONTEMP PHYS, V51, P471, DOI 10.1080/00107514.2010.493325; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; RODRIGUEZNAVARRO A, 1986, J GEN PHYSIOL, V87, P649, DOI 10.1085/jgp.87.5.649; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; van den Berg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11337; WANG MY, 1994, PLANT PHYSIOL, V104, P899, DOI 10.1104/pp.104.3.899; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	40	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3362	3370		10.1074/jbc.RA119.010891	http://dx.doi.org/10.1074/jbc.RA119.010891			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988244	Green Published, hybrid			2022-12-26	WOS:000519597300037
J	Murakami, C; Hoshino, F; Sakai, H; Hayashi, Y; Yamashita, A; Sakane, F				Murakami, Chiaki; Hoshino, Fumi; Sakai, Hiromichi; Hayashi, Yasuhiro; Yamashita, Atsushi; Sakane, Fumio			Diacylglycerol kinase ? and sphingomyelin synthase?related protein functionally interact via their sterile ? motif domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diacylglycerol kinase (DGK; DAGK); diacylglycerol; phosphatidic acid; dimerization; phosphatidylethanolamine; lipid signaling; metabolism; signal transduction; second messenger; heterodimer; sphingomyelin synthase-related protein; sterile ? motif domain	MULTIPLE SEQUENCE ALIGNMENT; SAM DOMAIN; PHOSPHATIDIC-ACID; C ACTIVITY; DELTA; CERAMIDE; INSULIN; ACTIVATION; LOCALIZATION; EXPRESSION	The ? isozyme of diacylglycerol kinase (DGK?) plays critical roles in lipid signaling by converting diacylglycerol (DG) to phosphatidic acid (PA). We previously demonstrated that DGK? preferably phosphorylates palmitic acid (16:0)- and/or palmitoleic acid (16:1)-containing DG molecular species, but not arachidonic acid (20:4)-containing DG species, which are recognized as DGK substrates derived from phosphatidylinositol turnover, in high glucose-stimulated myoblasts. However, little is known about the origin of these DG molecular species. DGK? and two DG-generating enzymes, sphingomyelin synthase (SMS) 1 and SMS-related protein (SMSr), contain a sterile ? motif domain (SAMD). In this study, we found that SMSr?SAMD, but not SMS1?SAMD, co-immunoprecipitates with DGK??SAMD. Full-length DGK? co-precipitated with full-length SMSr more strongly than with SMS1. However, SAMD-deleted variants of SMSr and DGK? interacted only weakly with full-length DGK? and SMSr, respectively. These results strongly suggested that DGK? interacts with SMSr through their respective SAMDs. To determine the functional outcomes of the relationship between DGK? and SMSr, we used LC-MS/MS to investigate whether overexpression of DGK? and/or SMSr in COS-7 cells alters the levels of PA species. We found that SMSr overexpression significantly enhances the production of 16:0- or 16:1-containing PA species such as 14:0/16:0-, 16:0/16:0-, 16:0/18:1-, and/or 16:1/18:1-PA in DGK?-overexpressing COS-7 cells. Moreover, SMSr enhanced DGK? activity via their SAMDs in vitro. Taken together, these results strongly suggest that SMSr is a candidate DG-providing enzyme upstream of DGK? and that the two enzymes represent a new pathway independent of phosphatidylinositol turnover.	[Murakami, Chiaki; Hoshino, Fumi; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Sakai, Hiromichi] Shimane Univ, Org Res & Acad Informat, Interdisciplinary Ctr Sci Res, Dept Biosignaling & Radioisotope Expt, Izumo, Shimane 6938501, Japan; [Hayashi, Yasuhiro; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan	Chiba University; Shimane University; Teikyo University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan.	sakane@faculty.chiba-u.jp	Sakane, Fumio/H-2693-2017; Murakami, Chiaki/O-2622-2016	Sakane, Fumio/0000-0003-0857-0377; Murakami, Chiaki/0000-0003-3645-8382; Hoshino, Fumi/0000-0003-4213-0631	MEXT/JSPS KAKENHI [JP18J20003, 25116704, 26291017, 17H03650, 15K14470]; Japan Science and Technology Agency [AS251Z01788Q, AS2621643Q]; Futaba Electronic Memorial Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Asahi Group Foundation; Japan Milk Academic Alliance; Japan Food Chemical Research Foundation; SENSHIN Medical Research Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Futaba Electronic Memorial Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Asahi Group Foundation; Japan Milk Academic Alliance; Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported in part by MEXT/JSPS KAKENHI Grants JP18J20003 (to C. M.) and 25116704, 26291017, 17H03650, and 15K14470 (to F. S.), Japan Science and Technology Agency Grants AS251Z01788Q and AS2621643Q (to F. S.), the Futaba Electronic Memorial Foundation (to F. S.), the Ono Medical Research Foundation (to F. S.), the Japan Foundation for Applied Enzymology (to F. S.), the Food Science Institute Foundation (to F. S.), the Skylark Food Science Institute to (F. S.), the Hamaguchi Foundation for the Advancement of Biochemistry (to F. S.), the Daiichi-Sankyo Foundation of Life Science (to F. S.), the Terumo Life Science Foundation (to F. S.), the Asahi Group Foundation (to F. S.), the Japan Milk Academic Alliance (to F. S.), the Japan Food Chemical Research Foundation (to F. S.), and the SENSHIN Medical Research Foundation (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Barrera FN, 2003, J BIOL CHEM, V278, P46878, DOI 10.1074/jbc.M307846200; Bickert A, 2015, J LIPID RES, V56, P821, DOI 10.1194/jlr.M055269; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cabukusta B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41290; Cabukusta B, 2016, J BIOL CHEM, V291, P24735, DOI 10.1074/jbc.M116.749812; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fang NB, 2003, J AGR FOOD CHEM, V51, P6676, DOI 10.1021/jf034793v; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hayashi Y, 2018, J BIOL CHEM, V293, P17505, DOI 10.1074/jbc.RA118.002048; Hayashi Y, 2017, J BIOL CHEM, V292, P1122, DOI 10.1074/jbc.M116.746602; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; HEYDRICK SJ, 1991, DIABETES, V40, P1707, DOI 10.2337/diabetes.40.12.1707; Honda S, 2019, LIPIDS, V54, P763, DOI 10.1002/lipd.12201; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Imai S, 2009, BBA-MOL CELL BIOL L, V1791, P246, DOI 10.1016/j.bbalip.2009.01.024; Kol M, 2017, J LIPID RES, V58, P962, DOI 10.1194/jlr.M076133; Komenoi S, 2019, BIOCHEM BIOPHYS REP, V19, DOI 10.1016/j.bbrep.2019.100660; Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f; Massart J, 2019, TRENDS ENDOCRIN MET, V30, P603, DOI 10.1016/j.tem.2019.06.003; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Mizuno S, 2012, FEBS OPEN BIO, V2, P267, DOI 10.1016/j.fob.2012.08.006; Murakami C, 2017, ANAL BIOCHEM, V526, P43, DOI 10.1016/j.ab.2017.03.010; Murakami E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162997; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ogushi F, 2012, CHEM PHYS LETT, V522, P96, DOI 10.1016/j.cplett.2011.11.057; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rajakulendran T, 2008, P NATL ACAD SCI USA, V105, P2836, DOI 10.1073/pnas.0709705105; Sakai H, 2014, J BIOL CHEM, V289, P26607, DOI 10.1074/jbc.M114.590950; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sakane Fumio, 2018, Advances in Biological Regulation, V67, P101, DOI 10.1016/j.jbior.2017.09.003; Sato M, 2013, PHARMACOLOGY, V92, P99, DOI 10.1159/000351849; Sato Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1170, DOI 10.1016/j.bbapap.2016.06.012; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Takeuchi M, 2012, BBA-MOL CELL RES, V1823, P2210, DOI 10.1016/j.bbamcr.2012.08.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Yamaki A, 2019, J CELL BIOCHEM, V120, P10043, DOI 10.1002/jcb.28288; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	52	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2932	2947		10.1074/jbc.RA119.012369	http://dx.doi.org/10.1074/jbc.RA119.012369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31980461	Green Published, hybrid			2022-12-26	WOS:000519597300006
J	Walenna, NF; Kurihara, Y; Chou, B; Ishii, K; Soejima, T; Hiromatsu, K				Walenna, Nirwana Fitriani; Kurihara, Yusuke; Chou, Bin; Ishii, Kazunari; Soejima, Toshinori; Hiromatsu, Kenji			Chlamydia pneumoniae infection?induced endoplasmic reticulum stress causes fatty acid?binding protein 4 secretion in murine adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydia; bacteria; infection; adipocyte; fatty acid binding protein; endoplasmic reticulum stress (ER stress); lipolysis; unfolded protein response (UPR); oxidative stress; metabolic disorder	ACID-BINDING PROTEIN; INTRACELLULAR GROWTH; INSULIN-RESISTANCE; RISK-FACTOR; ER STRESS; ATHEROSCLEROSIS; MECHANISMS; FABP4; AP2	Fatty acid?binding protein 4 (FABP4) is predominantly expressed in adipocytes and macrophages and regulates metabolic and inflammatory pathways. FABP4 is secreted from adipocytes during lipolysis, and elevated circulating FABP4 levels are associated with obesity, metabolic disease, and cardiac dysfunction. We previously reported that the bacterial respiratory pathogen Chlamydia pneumoniae infects murine adipocytes and exploits host FABP4 to mobilize fat and replicate within adipocytes. However, whether C. pneumoniae induces FABP4 secretion from adipocytes has not been determined. Here, we show that FABP4 is actively secreted by murine adipocytes upon C. pneumoniae infection. Chemical inhibition of lipase activity and genetic deficiency of hormone-sensitive lipase blocked FABP4 secretion from C. pneumoniae?infected adipocytes. Mechanistically, C. pneumoniae infection induced endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), resulting in elevated levels of mitochondrial reactive oxygen species and cytosolic Ca2+. Of note, exposure to a mitochondrial reactive oxygen species?specific scavenger, MitoTEMPO, reduced FABP4 release from C. pneumoniae?infected adipocytes. Furthermore, treatment with azoramide, which protects cells against ER stress, decreased FABP4 release from C. pneumoniae?infected adipocytes. Using gene silencing of CHOP (C/EBP homologous protein), a central regulator of ER stress, we further validated the role of C. pneumoniae infection?induced ER stress/UPR in promoting FABP4 secretion. Overall, these results indicate that C. pneumoniae infection robustly induces FABP4 secretion from adipocytes by stimulating ER stress/UPR. Our findings shed additional light on the etiological link between C. pneumoniae infection and metabolic syndrome.	[Walenna, Nirwana Fitriani; Kurihara, Yusuke; Chou, Bin; Ishii, Kazunari; Soejima, Toshinori; Hiromatsu, Kenji] Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Fukuoka 8140180, Japan; [Walenna, Nirwana Fitriani] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Higashi Ku, Fukuoka 8128582, Japan; [Walenna, Nirwana Fitriani] Hasanuddin Univ, Fac Med, Makassar, South Sulawesi, Indonesia	Fukuoka University; Kyushu University; Universitas Hasanuddin	Hiromatsu, K (corresponding author), Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	khiromatsu@fukuoka-u.ac.jp		Walenna, Nirwana Fitriani/0000-0002-3992-5604	Japan Society for the Promotion of Science [19K166590002]; Indonesia Endowment Fund for Education scholarship from Ministry of Finance of the Republic of Indonesia	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Indonesia Endowment Fund for Education scholarship from Ministry of Finance of the Republic of Indonesia	This work was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 19K166590002. This work was also supported in part by an Indonesia Endowment Fund for Education scholarship from Ministry of Finance of the Republic of Indonesia (to N. F. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson JL, 2005, NEW ENGL J MED, V352, P1706, DOI 10.1056/NEJMe058019; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Blessing E, 2000, INFECT IMMUN, V68, P7195, DOI 10.1128/IAI.68.12.7195-7197.2000; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Campbell LA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00034; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Ertunc ME, 2015, J LIPID RES, V56, P423, DOI 10.1194/jlr.M055798; Fernandez-Real JM, 2006, DIABETES CARE, V29, P1058, DOI 10.2337/dc05-2068; Fu SN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9134; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; George Z, 2017, J INFECT DIS, V215, P456, DOI 10.1093/infdis/jiw569; Grayston JT, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu015; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Itoh R, 2014, BIOCHEM BIOPH RES CO, V452, P689, DOI 10.1016/j.bbrc.2014.08.128; Kajimoto K, 2012, ENDOCRINOLOGY, V153, P5629, DOI 10.1210/en.2012-1456; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; Kralisch S, 2014, INT J OBESITY, V38, P1251, DOI 10.1038/ijo.2013.232; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Li SS, 2015, CRIT REV MICROBIOL, V41, P150, DOI 10.3109/1040841X.2013.813899; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pillich Helena, 2016, Mol Cell Pediatr, V3, P9, DOI 10.1186/s40348-016-0037-7; Schlottmann I, 2014, INT J OBESITY, V38, P1221, DOI 10.1038/ijo.2013.241; Suzuki T, 2017, CELL REP, V18, P2045, DOI 10.1016/j.celrep.2017.01.076; Villeneuve J, 2018, J CELL BIOL, V217, P649, DOI 10.1083/jcb.201705047; Walenna NF, 2018, BIOCHEM BIOPH RES CO, V495, P353, DOI 10.1016/j.bbrc.2017.11.005; Wang CM, 2009, J INFECT DIS, V200, P279, DOI 10.1086/599796; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Xu HL, 2015, MOL CELL BIOL, V35, P1055, DOI 10.1128/MCB.01122-14; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112	44	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2713	2723		10.1074/jbc.RA119.010683	http://dx.doi.org/10.1074/jbc.RA119.010683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31992597	hybrid, Green Published			2022-12-26	WOS:000519969100016
J	Klein, WM; Sonnemans, LJP; Franckenberg, S; Fliss, B; Gascho, D; Prokop, M; Lamers, WH; Hikspoors, JPJM; Thali, MJ; Flach, PM				Klein, Willemijn M.; Sonnemans, Lianne J. P.; Franckenberg, Sabine; Fliss, Barbara; Gascho, Dominic; Prokop, Mathias; Lamers, Wouter H.; Hikspoors, Jill P. J. M.; Thali, Michael J.; Flach, Patricia M.			Pseudolesion in the right parafissural liver parenchyma on CT: The base is found in embryology and collagen content	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; FALCIFORM LIGAMENT; FATTY LIVER; POSTMORTEM; PREVALENCE; SPLEEN	Background Computed tomography (CT) images of livers may show a hypo-attenuated structure alongside the falciform ligament, which can be a focal fatty pseudolesion and can mimic a malignancy. The preferred location is on the right parafissural site, ventral in segment IVa/b. The etiology is not clear, nor is it known how the histology of this location develops. These are evaluated in this study. Methods 40 adult cadavers with autopsy and / or postmortem CT in a university hospital and a forensic center were included. Liver biopsies were taken at the left side of the falciform ligament as control, and at the right side as the possible precursor of a pseudolesion; these were examined for collagen and fat content. Cadavers with steatotic (> 5% fat) or fibrotic (> 2% collagen) control samples were excluded. Results Significantly more collagen was present in the right parafissural liver parenchyma: median 0.68% (IQR: 0.32-1.17%), compared to the left side 0.48% (IQR: 0.21-0.75%) (p 0.008), with equal fat content and CT attenuation values. The etiophysiology goes back to the demise of the umbilical venes in the early embryonic and neonatal period. Conclusions The right parafissural area contains more collagen and an equal amount of fat compared to the control left side. This supports the hypothesis of delayed, 'third' inflow: the postnatal change in blood supply from umbilical to portal leaves the downstream parafissural area hypoperfused leading to hypoxia which in turn results in collagen accumulation and the persistence of paraumbilical veins of Sappey.	[Klein, Willemijn M.; Sonnemans, Lianne J. P.; Prokop, Mathias] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands; [Franckenberg, Sabine; Fliss, Barbara; Gascho, Dominic; Thali, Michael J.; Flach, Patricia M.] Univ Zurich, Inst Forens Med, Dept Forens Med & Imaging, Zurich, Switzerland; [Lamers, Wouter H.; Hikspoors, Jill P. J. M.] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Franckenberg, Sabine] Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Flach, Patricia M.] Cantonal Hosp St Gallen, Clin Radiol & Nucl Med, St Gallen, Switzerland	Radboud University Nijmegen; University of Zurich; Maastricht University; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen	Klein, WM (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands.	Willemijn.Klein@radboudumc.nl	Franckenberg, Sabine/AAN-7127-2021; Hikspoors, Jill/ABA-3124-2020; Hikspoors, Jill/AAA-7755-2022; Prokop, W.M./H-8081-2014; Gascho, Dominic/Y-4933-2019	Franckenberg, Sabine/0000-0002-8326-0777; Hikspoors, Jill/0000-0003-2940-1812; klein, willemijn/0000-0003-4309-533X; Gascho, Dominic/0000-0001-9004-4362; Sonnemans, Lianne/0000-0001-8025-9669; Prokop, Mathias/0000-0001-8157-8055				Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; Calvaruso V, 2009, HEPATOLOGY, V49, P1236, DOI 10.1002/hep.22745; Couinaud C, 1999, DIGEST SURG, V16, P459, DOI 10.1159/000018770; Flach PM, 2014, FORENSIC SCI MED PAT, V10, P583, DOI 10.1007/s12024-014-9555-6; Genchellac H, 2007, J COMPUT ASSIST TOMO, V31, P526, DOI 10.1097/01.rct.0000284387.68449.ec; Hikspoors JPJM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16840-1; Ibukuro K, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150925; Klein WM, 2016, J FORENSIC RADIOL IM, V4, P47, DOI 10.1016/j.jofri.2015.11.006; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kobayashi S, 2001, BRIT J RADIOL, V74, P273, DOI 10.1259/bjr.74.879.740273; Koseoglu K, 2005, EUR J RADIOL, V54, P388, DOI 10.1016/j.ejrad.2004.07.016; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Molina DK, 2015, AM J FOREN MED PATH, V36, P182, DOI 10.1097/PAF.0000000000000175; Okuma H, 2016, INT J LEGAL MED, V130, P1081, DOI 10.1007/s00414-016-1337-0; Petaja EM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050633; Sonnemans LJP, 2015, ABDOM IMAGING, V40, P2306, DOI 10.1007/s00261-015-0442-8; Suzuki T, 2014, WORLD J GASTROENTERO, V20, P15087, DOI 10.3748/wjg.v20.i41.15087; Venkatesh SK, 2017, ABDOM RADIOL, V42, P1374, DOI 10.1007/s00261-016-1002-6; Vummidi Dharshan, 2010, Radiol Case Rep, V5, P394, DOI 10.2484/rcr.v5i3.394; Wang D, 2013, J COMPUT ASSIST TOMO, V37, P149, DOI 10.1097/RCT.0b013e318281114f; Yoshimitsu K, 2001, RADIOGRAPHICS, V21, pS81, DOI 10.1148/radiographics.21.suppl_1.g01oc06s81	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0221544	10.1371/journal.pone.0221544	http://dx.doi.org/10.1371/journal.pone.0221544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986149	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400007
J	Matsuoka, N; Fujita, Y; Temmoku, J; Furuya, MY; Asano, T; Sato, S; Matsumoto, H; Kobayashi, H; Watanabe, H; Suzuki, E; Kozuru, H; Yastuhashi, H; Migita, K				Matsuoka, Naoki; Fujita, Yuya; Temmoku, Jumpei; Furuya, Makiko Yashiro; Asano, Tomoyuki; Sato, Shuzo; Matsumoto, Haruki; Kobayashi, Hiroko; Watanabe, Hiroshi; Suzuki, Eiji; Kozuru, Hideko; Yastuhashi, Hiroshi; Migita, Kiyoshi			Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus	PLOS ONE			English	Article							ACTIVITY INDEX; TIM-3; VALIDATION; DAMAGE; MANIFESTATIONS; EXPRESSION; CHEMOKINES	Background Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by elevated interferon (IFN) signature genes. Galectin-9 (Gal-9) is a beta-galactoside-binding lectin that is reportedly useful as a biomarker for IFN gene signatures. In a cross-sectional study of Japanese patients with recent-onset SLE, we aimed to determine whether raised serum Gal-9 levels were associated with the disease activity or organ damage seen in SLE patients. Methods The current study included 58 Japanese patients with SLE and 31 age-matched healthy individuals. Disease activity and organ damage were assessed using SLE Disease Activity 2000 (SLEDAI-2K) and Systemic Lupus International Collaborating Clinics (SLICC) damage index. Serum and cerebrospinal fluid (CSF) Gal-9 concentrations were quantified using ELISA. Correlation analyses between Gal-9 and clinical parameters including disease activity were performed. Results Serum levels of Gal-9 were significantly increased in patients with SLE compared with the control group (16.6 ng/ml, [interquartile range (IQR); 3.6-59.7] versus 4.74 ng/ml, [IQR; 3.0-9.5], p<0.0001). Gal-9 was significantly correlated with disease activity measures in the SLEDAI-2K. Serum Gal-9 levels were significantly greater in patients with SLE-related organ involvement (23.1 ng/ml, [IQR; 5.1-59.7] versus 12.5ng/ml, [IQR; 3.6-39.0], p = 0.013). Whereas there was no difference in serum levels of CXCL10 or M2BPGi between patients with and without SLE-related organ involvement. Serum levels of Gal-9 were significantly higher in SLE patients with active renal involvement determined by BILAG renal score (A-B) compared to those without active renal involvement (C-E). Whereas there was no significant difference in serum levels of Gal-9 between SLE patients with or without active other organ involvements (neurological or hematological) determined by BILAG score. SLE patients with detectable circulating IFN-alpha had raised serum Gal-9 levels. Levels of Gal-9 were significantly higher in the CSF from patients with recent-onset neuropsychiatric SLE (NPSLE) than in those from non-SLE controls (3.5 ng/ml, [IQR; 1.0-27.2] versus 1.2 ng/ml, [IQR; 0.9-2.1], p = 0.009). Conclusions Gal-9 could be a serologic marker of disease activity and organ involvement in SLE patients. Future studies evaluating the role of Gal-9 in the SLE phenotype may provide insights into SLE pathogenesis.	[Matsuoka, Naoki; Fujita, Yuya; Temmoku, Jumpei; Furuya, Makiko Yashiro; Asano, Tomoyuki; Sato, Shuzo; Matsumoto, Haruki; Kobayashi, Hiroko; Watanabe, Hiroshi; Suzuki, Eiji; Migita, Kiyoshi] Fukushima Med Univ, Dept Rheumatol, Sch Med, Fukushima, Japan; [Kozuru, Hideko; Yastuhashi, Hiroshi; Migita, Kiyoshi] Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan	Fukushima Medical University	Migita, K (corresponding author), Fukushima Med Univ, Dept Rheumatol, Sch Med, Fukushima, Japan.; Migita, K (corresponding author), Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan.	migita@fmu.ac.jp			Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development, AMED	Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	The study was supported by the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development, AMED.	Ahn SS, 2018, LUPUS, V27, P771, DOI 10.1177/0961203317747719; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Bengtsson A, 1999, J AUTOIMMUN, V13, P111, DOI 10.1006/jaut.1999.0300; Bianco GA, 2006, AUTOIMMUN REV, V5, P349, DOI 10.1016/j.autrev.2006.02.003; Crow MK, 2014, CURR OPIN RHEUMATOL, V26, P467, DOI 10.1097/BOR.0000000000000087; Duarte-Delgado NP, 2019, AUTOIMMUN REV, V18, P426, DOI 10.1016/j.autrev.2018.12.004; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Fragoso-Loyo H, 2007, ARTHRITIS RHEUM-US, V56, P1242, DOI 10.1002/art.22451; Fragoso-Loyo H, 2013, RHEUMATOLOGY, V52, P2218, DOI 10.1093/rheumatology/ket294; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Griffiths B, 2005, BEST PRACT RES CL RH, V19, P685, DOI 10.1016/j.berh.2005.03.010; Hagberg N, 2015, SCAND J IMMUNOL, V82, P199, DOI 10.1111/sji.12330; Hanly JG, 2019, ARTHRITIS RHEUMATOL, V71, P33, DOI 10.1002/art.40591; Hanly JG, 2014, NAT REV RHEUMATOL, V10, P338, DOI 10.1038/nrrheum.2014.15; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Jeltsch-David H, 2014, NAT REV NEUROL, V10, P579, DOI 10.1038/nrneurol.2014.148; Jiao QQ, 2016, ARCH DERMATOL RES, V308, P553, DOI 10.1007/s00403-016-1665-4; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lopez R, 2012, RHEUMATOLOGY, V51, P491, DOI 10.1093/rheumatology/ker368; Merrill JT, 2005, BEST PRACT RES CL RH, V19, P709, DOI 10.1016/j.berh.2005.05.004; Nishikawa H, 2016, HEPATOL RES, V46, P613, DOI 10.1111/hepr.12596; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Schwartz N, 2019, NAT REV RHEUMATOL, V15, P137, DOI 10.1038/s41584-018-0156-8; Stoll T, 2004, RHEUMATOLOGY, V43, P1039, DOI 10.1093/rheumatology/keh238; Stoll T, 1996, ANN RHEUM DIS, V55, P756, DOI 10.1136/ard.55.10.756; van den Hoogen LL, 2018, ANN RHEUM DIS; van den Hoogen LL, 2018, ANN RHEUM DIS, V77, P1810, DOI 10.1136/annrheumdis-2018-213497; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wienke J, 2019, ARTHRITIS RHEUMATOL, V71, P1377, DOI 10.1002/art.40881; Wu HJ, 2017, AUTOIMMUN REV, V16, P391, DOI 10.1016/j.autrev.2017.02.011; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Zharkova O, 2017, RHEUMATOLOGY, V56, P55, DOI 10.1093/rheumatology/kew427; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	37	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227069	10.1371/journal.pone.0227069	http://dx.doi.org/10.1371/journal.pone.0227069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986153	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400016
J	Albrecht, BM; Stalling, I; Recke, C; Bammann, K				Albrecht, Birte Marie; Stalling, Imke; Recke, Carina; Bammann, Karin			Accelerometer-assessed outdoor physical activity is associated with meteorological conditions among older adults: Cross-sectional results from the OUTDOOR ACTIVE study	PLOS ONE			English	Article							WEATHER CONDITIONS; OSTEOARTHRITIS; POPULATION; JAPANESE; WALKING; PEOPLE	Background Meteorological conditions are potential determinants of physical activity (PA). A profound understanding of the determinants of PA behaviour is required for PA promotion. This study examined the association between accelerometer-assessed PA and meteorological conditions among older adults. Methods This cross-sectional study included data of 577 adults aged 65-75 years living in Bremen, Germany (52% female; 3278 days). PA was measured with accelerometers for seven consecutive days (10/15-08/16). A threshold of 240 lx was used to differentiate between outdoor physical activity (OPA) and indoor physical activity (IPA). Linear mixed models estimated the association between PA (daily accelerometer counts per minute (CPM)) and meteorological factors (temperature, cloud cover, wind, and no precipitation) derived by principal component analysis. Results The analyses showed associations between PA in CPM and the meteorological factors temperature (93.7; 95%-CL: 64.9, 122.5) and no precipitation (48.4; 95%-CL: 19.8, 77.0) in women and wind (-40.3; 95%-CL: -59.7, -20.8) and no precipitation (30.1; 95%-CL: 5.6, 54.6) in men. After distinguishing in OPA and IPA for a subsample of 128 participants (473 days), the sex differences were no longer present. OPA in CPM was associated with temperature (women: 174.5; 95%-CL: 81.3, 267.6; men: 183.3; 95%-CL: 81.2, 285.4), cloud cover (women: -153.0; 95%-CL: -200.3, -105.7; men: -123.2; 95%-CL: -174.7, -71.7), and wind (women: -118.6; 95%-CL: -189.6; -47.7; men: -96.9; 95%-CL: -177.0, -16.7). No association between OPA and no precipitation was found (women: 2.9; 95%-CL: -89.0, 94.8; men: -17.1; 95%-CL: -116.7, 82.4). Conclusions The results of this study emphasize the importance of meteorological conditions as environmental determinants of PA among older adults. Meteorological conditions should be accounted for in the unbiased assessment of habitual PA and the development of PA promotion programs. Future research should focus on the associations of OPA and IPA with meteorological conditions in different climatic regions.	[Albrecht, Birte Marie; Stalling, Imke; Recke, Carina; Bammann, Karin] Univ Bremen, Inst Publ Hlth & Nursing Sci IPP, Bremen, Germany	University of Bremen	Albrecht, BM (corresponding author), Univ Bremen, Inst Publ Hlth & Nursing Sci IPP, Bremen, Germany.	b.albrecht@uni-bremen.de		Bammann, Karin/0000-0002-5623-8160; Albrecht, Birte/0000-0002-1072-6767	German Federal Ministry of Education and Research (BMBF) [01EL1422B]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The OUTDOOR ACTIVE study is funded by the German Federal Ministry of Education and Research (BMBF; https://www.bmbf.de/; grant number: 01EL1422B). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault S, 2017, J AGING PHYS ACTIV, V27, P128; Aspvik NP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199463; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Blatteis CM, 2012, GERONTOLOGY, V58, P289, DOI 10.1159/000333148; Brandon CA, 2009, APPL PHYSIOL NUTR ME, V34, P182, DOI 10.1139/H09-004; Cepeda M, 2018, MATURITAS, V110, P41, DOI 10.1016/j.maturitas.2018.01.016; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; Flynn JI, 2014, MED SCI SPORT EXER, V46, P201, DOI 10.1249/MSS.0b013e3182a388c0; Forberger S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040379; Garatachea N, 2010, NUTR HOSP, V25, P224, DOI 10.3305/nh.2010.25.2.4439; Halbert J, 2001, ARTHRIT RHEUM-ARTHR, V45, P228, DOI 10.1002/1529-0131(200106)45:3<228::AID-ART253>3.0.CO;2-2; Hoppmann CA, 2017, J GERONTOL B-PSYCHOL, V72, P792, DOI 10.1093/geronb/gbv107; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; Jones GR, 2017, ARCH GERONTOL GERIAT, V71, P28, DOI 10.1016/j.archger.2017.02.012; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Klenk J, 2012, J EPIDEMIOL COMMUN H, V66, P474, DOI 10.1136/jech.2010.128090; Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6; Lohne-Seiler H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-284; Moran M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-79; Peel NM, 2005, AM J PREV MED, V28, P298, DOI 10.1016/j.amepre.2004.12.002; Price AE, 2012, J PHYS ACT HEALTH, V9, P718, DOI 10.1123/jpah.9.5.718; Prins RG, 2015, AGE AGEING, V44, P886, DOI 10.1093/ageing/afv103; Rikli R.E., 2012, SENIOR FITNESS TEST, V2nd; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sartini C, 2017, J PHYS ACT HEALTH, V14, P265, DOI 10.1123/jpah.2016-0468; Schepps MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25145-w; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Timmermans EJ, 2016, J PHYS ACT HEALTH, V13, P1385, DOI 10.1123/jpah.2016-0040; Togo F, 2005, INT J BIOMETEOROL, V50, P83, DOI 10.1007/s00484-005-0277-z; UNESCO, 2006, INT STANDARD CLASSIF; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Witham MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085331; Wu YT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177767; Yasunaga A, 2008, J AGING PHYS ACTIV, V16, P3, DOI 10.1123/japa.16.1.3; Yasunaga A, 2007, J AGING PHYS ACTIV, V15, P398, DOI 10.1123/japa.15.4.398	37	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228053	10.1371/journal.pone.0228053	http://dx.doi.org/10.1371/journal.pone.0228053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978178	gold, Green Published			2022-12-26	WOS:000534599100103
J	Christodoulou, A; Ierodiakonou, D; Awofala, AA; Petrou, M; Kales, SN; Christiani, DC; Mantzoros, CS; Christophi, CA				Christodoulou, Andria; Ierodiakonou, Despo; Awofala, Awoyemi A.; Petrou, Michael; Kales, Stefanos N.; Christiani, David C.; Mantzoros, Christos S.; Christophi, Costas A.			Variants in ADIPOQ gene are linked to adiponectin levels and lung function in young males independent of obesity	PLOS ONE			English	Article							POLYMORPHISMS; ASSOCIATION; RISK; ASTHMA; FAMILY; COHORT; ADULTS	Background Obesity is a major risk factor for many chronic diseases, including reduced lung function. The role of polymorphisms of the adiponectin gene, though linked with cardiometabolic consequences of obesity, has not been studied in relation to lung function. Objectives The aim of this study is to examine polymorphisms in the ADIPOQ, ADIPOR1, and ADIPOR2 genes in relation to adiponectin serum levels, BMI, and adiposity in 18-year old Cypriot males, as well as determine whether BMI, adipokines levels and polymorphisms in adipokine related genes are associated with lung function levels. Results From the participants, 8% were classified as obese, 22% as overweight, and the remaining 71% as normal. We found that rs266729 and rs1501299 in ADIPOQ and rs10920531 in ADIPOR1 were significantly associated with serum adiponectin levels, after adjusting for ever smoking. In addition, there was an overall significant increase in FEV1% predicted with increasing BMI (beta = 0.53, 95% CI: 0.27, 0.78) and in FVC % predicted (beta = 1.02, 95% CI: 0.73, 1.30). There was also a decrease in FEV1/FVC with increasing BMI (beta = -0.53, 95% CI: -0.71, -0.35). Finally, rs1501299 was associated with lung function measures. Discussion Functional variants in the ADIPOQ gene were linked with lung function in young males. Further studies should concentrate on the role of adipokines on lung function which may direct novel therapeutic approaches.	[Christodoulou, Andria; Christophi, Costas A.] Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus; [Ierodiakonou, Despo] Univ Crete, Dept Social Med, Fac Med, Iraklion, Greece; [Awofala, Awoyemi A.] Tai Solarin Univ Educ, Dept Biol Sci, Ijagun, Ogun State, Nigeria; [Petrou, Michael] Cyprus Antidoping Author, Nicosia, Cyprus; [Kales, Stefanos N.; Christiani, David C.; Christophi, Costas A.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Kales, Stefanos N.] Harvard Med Sch, Cambridge Hlth Alliance, Cambridge, MA USA; [Mantzoros, Christos S.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Mantzoros, Christos S.] Harvard Med Sch, Boston, MA 02115 USA	Cyprus International Institute for Environmental & Public Health; Cyprus University of Technology; University of Crete; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Cambridge Health Alliance; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Christodoulou, A (corresponding author), Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus.	Christodoulou_andria@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020; AWOFALA, Adeyemi Abayomi/AAR-2834-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; AWOFALA, Adeyemi Abayomi/0000-0003-3145-6011; PETROU, Michael/0000-0002-6379-1220; Christodoulou, Andria/0000-0002-1704-3133; Ierodiakonou, Despo/0000-0002-7862-2016	Cyprus Research Promotion Foundation; Harvard Cyprus Program	Cyprus Research Promotion Foundation; Harvard Cyprus Program	The study was funded by the Cyprus Research Promotion Foundation and the Harvard Cyprus Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Andreou E, 2012, HIPPOKRATIA, V16, P256; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Balsan GA, 2015, REV ASSOC MED BRAS, V61, P72, DOI 10.1590/1806-9282.61.01.072; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bekkers MB, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0032-0; CHEN Y, 1993, THORAX, V48, P375, DOI 10.1136/thx.48.4.375; Cibella F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127154; Cohen SS, 2011, OBESITY, V19, P2053, DOI 10.1038/oby.2010.346; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; Guenther M, 2014, TRANSL RES, V164, P270, DOI 10.1016/j.trsl.2014.04.008; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Jartti T, 2009, ALLERGY, V64, P770, DOI 10.1111/j.1398-9995.2008.01872.x; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Liu PC, 2013, J ADV NURS, V69, P1446, DOI 10.1111/jan.12129; Loos RJF, 2007, AM J CLIN NUTR, V85, P26, DOI 10.1093/ajcn/85.1.26; Mather KJ, 2012, DIABETIC MED, V29, P1579, DOI 10.1111/j.1464-5491.2012.03662.x; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Melo LC, 2014, EINSTEIN-SAO PAULO, V12, P120, DOI 10.1590/S1679-45082014RW2691; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Obeidat M, 2015, LANCET RESP MED, V3, P782, DOI 10.1016/S2213-2600(15)00380-X; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rizvi AA, 2010, METAB SYNDR RELAT D, V8, P287, DOI 10.1089/met.2009.0116; Salah A, 2015, EGYPT J CHEST DIS TU, V64, P529, DOI 10.1016/j.ejcdt.2015.02.012; Seidell JC, 2015, ANN NUTR METAB, V66, P7, DOI 10.1159/000375143; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Sutton BS, 2005, HUM GENET, V117, P107, DOI 10.1007/s00439-005-1260-9; Tenório Luís Henrique S., 2012, Rev. paul. pediatr., V30, P423; Thyagarajan B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-176; Ukkola O, 2005, ANN MED, V37, P141, DOI 10.1080/07853890510007241; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Warodomwichit D, 2009, OBESITY, V17, P510, DOI 10.1038/oby.2008.583; Winck Aline Dill, 2016, Rev. paul. pediatr., V34, P510, DOI [10.1016/j.rpped.2016.02.008, 10.1016/j.rppede.2016.03.013]; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang WS, 2003, J MOL MED-JMM, V81, P428, DOI 10.1007/s00109-002-0409-4	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0225662	10.1371/journal.pone.0225662	http://dx.doi.org/10.1371/journal.pone.0225662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978107	Green Published, gold			2022-12-26	WOS:000534599100011
J	Park, C; Park, SY; Gurney, KR; Gerbig, C; DiGangi, JP; Choi, Y; Lee, HW				Park, Changhyoun; Park, Soon-Young; Gurney, Kevin R.; Gerbig, Christoph; DiGangi, Joshua P.; Choi, Yonghoon; Lee, Hwa Woon			Numerical simulation of atmospheric CO2 concentration and flux over the Korean Peninsula using WRF-VPRM model during Korus-AQ 2016 campaign	PLOS ONE			English	Article							CARBON-DIOXIDE; LAND-USE; VARIABILITY; CALIFORNIA; VEGETATION; EMISSIONS; TRANSPORT; SYSTEM; BUDGET; CHINA	We conducted regional scale CO2 simulations using the Weather Research and Forecasting model (WRF) coupled with the Vegetation Photosynthesis and Respiration Model (VPRM). We contrasted simulated concentrations with column, ground and aircraft observations during the Korea-United States Air Quality (KORUS-AQ) 2016 field campaign. Overall, WRF-VPRM slightly underestimates CO2 concentrations at ground and column monitoring sites, but it significantly underestimates at an inland tower measurement site, especially within the stable (nocturnal) boundary layer in nighttime. The model successfully captures the airborne vertical profiles but showed a large offset within the planetary boundary layer (PBL) in the areas surrounding Seoul and around the Taeahn point source emissions in the west coastal area of the Korean Peninsula. A case study flight intended to capture Chinese influence observed no clear signals of long-range transport of CO2, due mainly to the much larger magnitude of background CO2 concentrations. The calculated Net Ecosystem Exchange (NEE) with flux measurements at a tower site in the South Korean Peninsula has also been evaluated comparing with CO2 flux measurements at a flux tower site, resulting in the under-estimation by less than a factor of 1.	[Park, Changhyoun] Pusan Natl Univ, Inst Environm Studies, Busan, South Korea; [Park, Soon-Young; Lee, Hwa Woon] Pusan Natl Univ, Dept Atmospher Environm Sci, Busan, South Korea; [Gurney, Kevin R.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Gerbig, Christoph] Max Plank Inst Biogeochem, Dept Biogeochem Syst, Jena, Germany; [DiGangi, Joshua P.; Choi, Yonghoon] Natl Aeronaut & Space Langley Res Ctr, Hampton, VA USA	Pusan National University; Pusan National University; Arizona State University; Arizona State University-Tempe; Max Planck Society	Park, C (corresponding author), Pusan Natl Univ, Inst Environm Studies, Busan, South Korea.	chpark@live.com	DiGangi, Joshua/AAK-8497-2021	Park, Soon-Young/0000-0001-6858-6392	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03034021]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	The corresponding author acknowledges the financial support by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1B03034021).	Ahmadov R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008552; [Anonymous], DATABASE; [Anonymous], [No title captured]; Asefi-Najafabady S, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD021296; Aubinet M, 2012, EDDY COVARIANCE PRAC, P133, DOI DOI 10.1007/978-94-007-2351-1_5; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; California Institute of Technology, TCCON DAT ANM KR REL; Chevallier F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026496; Feng S, 2016, ATMOS CHEM PHYS, V16, P9019, DOI 10.5194/acp-16-9019-2016; Forster P, CLIMATE CHANGE 2007; Gurney KR, 2009, ENVIRON SCI TECHNOL, V43, P5535, DOI 10.1021/es900806c; Gurney R, FOSSIL FUEL DATA ASS; Hansis E, 2015, GLOBAL BIOGEOCHEM CY, V29, P1230, DOI 10.1002/2014GB004997; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Jamroensan A, 2013, THESIS; Jung M, 2006, REMOTE SENS ENVIRON, V101, P534, DOI 10.1016/j.rse.2006.01.020; Korea Meteorological Administration, MET DAT OP PORT; Korea Power Exchange, POW STAT INF SYST; Kotthaus S, 2012, ATMOS ENVIRON, V57, P301, DOI 10.1016/j.atmosenv.2012.04.024; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Liang Q, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004402; Mahadevan P, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002735; MAHRT L, 1981, BOUND-LAY METEOROL, V21, P3, DOI 10.1007/BF00119363; NASA, INTR KORUS AQ RAP SC; Nassar R, 2013, J GEOPHYS RES-ATMOS, V118, P917, DOI 10.1029/2012JD018196; National Aeronautics and Space Administration, KORUS AQ WHIT PAP; NOAA, TRENDS ATMOSPHERIC C; Oh HR, 2015, ATMOS ENVIRON, V109, P23, DOI 10.1016/j.atmosenv.2015.03.005; Park C, 2018, J APPL METEOROL CLIM, V57, P1337, DOI 10.1175/JAMC-D-17-0358.1; Park C, 2016, J ENVIRON QUAL, V45, P253, DOI 10.2134/jeq2015.02.0115; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Peylin P, 2005, ATMOS CHEM PHYS, V5, P3173, DOI 10.5194/acp-5-3173-2005; Pillai D, 2011, ATMOS CHEM PHYS, V11, P7445, DOI 10.5194/acp-11-7445-2011; Rayner PJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013439; Saito M, 2009, BIOGEOSCIENCES, V6, P585, DOI 10.5194/bg-6-585-2009; Tang WF, 2018, ATMOS CHEM PHYS, V18, P11007, DOI 10.5194/acp-18-11007-2018; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Turnbull JC, 2011, ATMOS CHEM PHYS, V11, P705, DOI 10.5194/acp-11-705-2011; United Nations Statistics Division, POP DENS URB; Velasco E, 2013, ATMOS CHEM PHYS, V13, P10185, DOI 10.5194/acp-13-10185-2013; Wang LT, 2014, ATMOS CHEM PHYS, V14, P3151, DOI 10.5194/acp-14-3151-2014; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; World Meteorological Organization, GLOB ATM WATCH	46	6	6	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228106	10.1371/journal.pone.0228106	http://dx.doi.org/10.1371/journal.pone.0228106			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978112	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100111
J	van den Bogaart, EHA; Spreeuwenberg, MD; Kroese, MEAL; van den Boogaart, MW; Boymans, TAEJ; Ruwaard, D				van den Bogaart, Esther H. A.; Spreeuwenberg, Marieke D.; Kroese, Marielle E. A. L.; van den Boogaart, Mark W.; Boymans, Tim A. E. J.; Ruwaard, Dirk			Referral decisions and its predictors related to orthopaedic care. A retrospective study in a novel primary care setting	PLOS ONE			English	Article							MUSCULOSKELETAL DISORDERS; SERVICES; COSTS; SURGEONS; BURDEN; SYSTEM; DUTCH	Due to the ageing population, the prevalence of musculoskeletal disorders will continue to rise, as well as healthcare expenditure. To overcome these increasing expenditures, integration of orthopaedic care should be stimulated. The Primary Care Plus (PC+) intervention aimed to achieve this by facilitating collaboration between primary care and the hospital, in which specialised medical care is shifted to a primary care setting. The present study aims to evaluate the referral decision following orthopaedic care in PC+ and in particular to evaluate the influence of diagnostic tests on this decision. Therefore, retrospective monitoring data of patients visiting PC+ for orthopaedic care was used. Data was divided into two periods; P1 and P2. During P2, specialists in PC+ were able to request additional diagnostic tests (such as ultrasounds and MRIs). A total of 2,438 patients visiting PC+ for orthopaedic care were included in the analysis. The primary outcome was the referral decision following PC+ (back to the general practitioner (GP) or referral to outpatient hospital care). Independent variables were consultation- and patient-related predictors. To describe variations in the referral decision, logistic regression modelling was used. Results show that during P2, significantly more patients were referred back to their GP. Moreover, the multivariable analysis show a significant effect of patient age on the referral decision (OR 0.86, 95% CI = 0.810.91) and a significant interaction was found between the treating specialist and the period (p = 0.015) and between patient's diagnosis and the period (p. 0.001). Despite the significant impact of the possibility of requesting additional diagnostic tests in PC+, it is important to discuss the extent to which the availability of diagnostic tests fits within the vision of PC+. In addition, selecting appropriate profiles for specialists and patients for PC+ are necessary to further optimise the effectiveness and cost of care.	[van den Bogaart, Esther H. A.; Spreeuwenberg, Marieke D.; Kroese, Marielle E. A. L.; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands; [Spreeuwenberg, Marieke D.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands; [van den Boogaart, Mark W.; Boymans, Tim A. E. J.] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University	van den Bogaart, EHA (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands.	e.vandenbogaart@maastrichtuniversity.nl	Boymans, Tim/AAY-6216-2021	van den Bogaart, Esther/0000-0001-6489-9586; Ruwaard, Dirk/0000-0003-4887-8413	CZ (in Dutch: Centraal Ziekenfonds); VGZ (in Dutch: Stichting Volksgezondheidszorg Zuid Nederland) via the cooperative "Reinforcing Primar Care South of the Netherlands" (in Dutch: Versterking Eerstelijn ZuidNederland); Province of Limburg, the Netherlands	CZ (in Dutch: Centraal Ziekenfonds); VGZ (in Dutch: Stichting Volksgezondheidszorg Zuid Nederland) via the cooperative "Reinforcing Primar Care South of the Netherlands" (in Dutch: Versterking Eerstelijn ZuidNederland); Province of Limburg, the Netherlands(Netherlands Government)	Funding was received from the non-profit private health insurers, CZ (in Dutch: Centraal Ziekenfonds) and VGZ (in Dutch: Stichting Volksgezondheidszorg Zuid Nederland) via the cooperative "Reinforcing Primar Care South of the Netherlands" (in Dutch: Versterking Eerstelijn ZuidNederland), and the Province of Limburg, the Netherlands. The funders had no influence on the research, which was conducted by independent researchers.	Andersson G, 2008, AM ACAD ORTHOPAEDIC; BAILEY JJ, 1994, BRIT MED J, V308, P1083, DOI 10.1136/bmj.308.6936.1083; Becker SJE, 2015, CLIN ORTHOP RELAT R, V473, P1111, DOI 10.1007/s11999-014-3912-3; Bentsen B G, 1986, Scand J Prim Health Care, V4, P43, DOI 10.3109/02813438609013970; Bevan S, 2015, BEST PRACT RES CL RH, V29, P356, DOI 10.1016/j.berh.2015.08.002; Brekke KR, 2007, J HEALTH ECON, V26, P149, DOI 10.1016/j.jhealeco.2006.04.004; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Enthoven AC, 2007, NEW ENGL J MED, V357, P2421, DOI 10.1056/NEJMp078199; Gillum R, 2008, J HEALTH CARE POOR U, V19, P1013; Goodwin N, 2010, MANAGING PEOPLE LONG; Gruen R L, 2004, Cochrane Database Syst Rev, pCD003798, DOI 10.1002/14651858.CD003798.pub2; Gupta DM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0555-2; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; Leveille SG, 2004, CURR OPIN RHEUMATOL, V16, P114, DOI 10.1097/00002281-200403000-00007; Lipitz-Snyderman A, 2013, JAMA INTERN MED, V173, P1277, DOI 10.1001/jamainternmed.2013.6181; Lubeck DP, 2003, BEST PRACT RES CL RH, V17, P529, DOI 10.1016/S1521-6942(03)00023-8; MacKay C, 2010, ARTHRIT CARE RES, V62, P161, DOI 10.1002/acr.20064; Maempel JF, 2015, ACTA ORTHOP, V86, P451, DOI 10.3109/17453674.2015.1040304; McBride D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6267; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NIVEL, 2018, MEEST CONS BIJ HUIS; Pedhazur EJ, 1991, MEASUREMENT DESIGN A; Roberts C, 2002, RHEUMATOLOGY, V41, P503, DOI 10.1093/rheumatology/41.5.503; ROLAND MO, 1991, BRIT MED J, V302, P1124, DOI 10.1136/bmj.302.6785.1124; Ruwaard D, 2014, TRIPLE AIM TOEPASSIN; Santaguida PL, 2008, CAN J SURG, V51, P428; Schellevis FG, 2005, MED KLIN, V100, P656, DOI 10.1007/s00063-005-1090-5; Singh D, 2006, MAKING SHIFT KEY SUC; Speed CA, 2005, RHEUMATOLOGY, V44, P469, DOI 10.1093/rheumatology/keh504; Stolk Elly A, 2005, Eur J Health Econ, VSuppl, P53; Storheim K, 2014, ANN RHEUM DIS, V73, P949, DOI 10.1136/annrheumdis-2014-205327; van Hoof SJM, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0498-8; van Hoof SJM, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2446; van Rhijn L, 2013, MEDISCH CONTACT, V68, P283; Vegting IL, 2012, EUR J INTERN MED, V23, P70, DOI 10.1016/j.ejim.2011.07.003; Verheij RA, 2010, LANDELIJK INFORMATIE; VIERHOUT WPM, 1995, LANCET, V346, P990, DOI 10.1016/S0140-6736(95)91686-5; Volksgezondheidenzorg.info, 2017, KOST ZORG ARTR; Volksgezondheidenzorg.info, 2017, TRENDS; Walters K, 2001, FAM PRACT, V18, P277, DOI 10.1093/fampra/18.3.277; Wildeboer JA, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0688-z; Winpenny E, 2016, OUTPATIENT SERVICES; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; World Health Organization, 2003, BURD MUSC COND START; ZIO, 2015, JAARV	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227863	10.1371/journal.pone.0227863	http://dx.doi.org/10.1371/journal.pone.0227863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971964	Green Published, gold			2022-12-26	WOS:000534374400023
J	Mot, AC; Coman, C; Hadade, N; Damian, G; Silaghi-Dumitrescu, R; Heering, H				Mot, Augustin C.; Coman, Cristina; Hadade, Niculina; Damian, Grigore; Silaghi-Dumitrescu, Radu; Heering, Hendrik			"Yellow" laccase from Sclerotinia sclerotiorum is a blue laccase that enhances its substrate affinity by forming a reversible tyrosyl-product adduct	PLOS ONE			English	Article							EXTRACELLULAR LACCASE; THERMOSTABLE LACCASE; CATALYTIC-PROPERTIES; WHITE LACCASE; PURIFICATION; PROTEINS; RICH	Yellow laccases lack the typical blue type 1 Cu absorption band around 600 nm; however, multi-copper oxidases with laccase properties have been reported. We provide the first evidence that the yellow laccase isolated from Sclerotinia sclerotiorum is obtained from a blue form by covalent, but nevertheless reversible modification with a phenolic product. After separating the phenolics from the extracellular medium, a typical blue laccase is obtained. With ABTS as model substrate for this blue enzyme, a non-natural purple adduct is formed with a spectrum nearly identical to that of the 1:1 adduct of an ABTS radical and Tyr. This modification significantly increases the stability and substrate affinity of the enzyme, not by acting primarily as bound mediator, but by structural changes that also alters the type 1 Cu site. The HPLC-MS analyses of the ABTS adduct trypsin digests revealed a distinct tyrosine within a unique loop as site involved in the modification of the blue laccase form. Thus, S. sclerotiorum yellow laccase seems to be an intrinsically blue multi-copper oxidase that boosts its activity and stability with a radical-forming aromatic substrate. This particular case could, at least in part, explain the enigma of the yellow laccases.	[Mot, Augustin C.; Coman, Cristina; Hadade, Niculina; Silaghi-Dumitrescu, Radu] Babes Bolyai Univ, Fac Chem & Chem Engn, Cluj Napoca, Romania; [Mot, Augustin C.] Natl Inst Res & Dev Isotop & Mol Technol, Dept Biomol Phys, Cluj Napoca, Romania; [Mot, Augustin C.; Heering, Hendrik] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [Damian, Grigore] Babes Bolyai Univ, Fac Phys, Cluj Napoca, Romania	Babes Bolyai University from Cluj; National Institute for Research & Development of Isotopic & Molecular Technologies Cluj-Napoca; Leiden University; Leiden University - Excl LUMC; Babes Bolyai University from Cluj	Mot, AC (corresponding author), Babes Bolyai Univ, Fac Chem & Chem Engn, Cluj Napoca, Romania.; Mot, AC (corresponding author), Natl Inst Res & Dev Isotop & Mol Technol, Dept Biomol Phys, Cluj Napoca, Romania.; Mot, AC (corresponding author), Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.	augustinmot@chem.ubbcluj.ro	Hadade, Niculina Daniela D./F-9489-2011; Mot, Augustin C./D-3017-2011; Mot, Augustin/AAP-4356-2021; Silaghi-Dumitrescu, Radu/A-2883-2008	Hadade, Niculina Daniela D./0000-0001-5882-5759; Mot, Augustin C./0000-0002-1679-0487; Mot, Augustin/0000-0002-1679-0487; Silaghi-Dumitrescu, Radu/0000-0003-3038-7747	UEFISCDI Romania [PN-III-P1-1.1-PD-2016-0121]	UEFISCDI Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was partly financially supported by the UEFISCDI Romania, project number PN-III-P1-1.1-PD-2016-0121 to ACM. https://uefiscdi.gov.ro/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Andberg M, 2009, FEBS J, V276, P6285, DOI 10.1111/j.1742-4658.2009.07336.x; Chen B, 2015, INT J BIOL MACROMOL, V76, P39, DOI 10.1016/j.ijbiomac.2015.02.019; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chernykh A, 2008, J APPL MICROBIOL, V105, P2065, DOI 10.1111/j.1365-2672.2008.03924.x; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Claus H, 2004, MICRON, V35, P93, DOI 10.1016/j.micron.2003.10.029; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Daroch M, 2014, ENZYME MICROB TECH, V58-59, P1, DOI 10.1016/j.enzmictec.2014.02.003; DEVRIES OMH, 1986, J GEN MICROBIOL, V132, P2817; Edens WA, 1999, APPL ENVIRON MICROB, V65, P3071; Galai S, 2014, J CHEM TECHNOL BIOT, V89, P1741, DOI 10.1002/jctb.4254; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Huang WT, 2011, PROCESS BIOCHEM, V46, P1469, DOI 10.1016/j.procbio.2011.03.020; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kaneko S, 2009, BIOSCI BIOTECH BIOCH, V73, P939, DOI 10.1271/bbb.80740; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lee DY, 2009, ANAL CHEM, V81, P3957, DOI 10.1021/ac900281n; Ike PTL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1464-y; Leontievsky A, 1997, FEBS LETT, V413, P446, DOI 10.1016/S0014-5793(97)00953-8; Leontievsky AA, 1997, FEMS MICROBIOL LETT, V156, P9, DOI 10.1111/j.1574-6968.1997.tb12698.x; Leontievsky AA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1150; Lisov AV, 2007, FEMS MICROBIOL LETT, V275, P46, DOI 10.1111/j.1574-6968.2007.00858.x; Litthauer D, 2007, ENZYME MICROB TECH, V40, P563, DOI 10.1016/j.enzmictec.2006.05.011; Lupan A, 2011, STUD U BABES BOLYAI; Lyashenko AV, 2006, J BIOL INORG CHEM, V11, P963, DOI 10.1007/s00775-006-0158-x; Mate DM, 2013, BIOCATAL BIOTRANSFOR, V31, P8, DOI 10.3109/10242422.2012.749463; Mate DM, 2013, BIOCATAL BIOTRANSFOR, DOI [10.3109/10242422.2013.858712, DOI 10.3109/10242422.2013.858712]; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Min KL, 2001, ARCH BIOCHEM BIOPHYS, V392, P279, DOI 10.1006/abbi.2001.2459; Mot AC, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1395, DOI 10.1134/S0006297912120085; Mot AC, 2012, PROCESS BIOCHEM, V47, P968, DOI 10.1016/j.procbio.2012.03.006; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Pardo I, 2015, CELL MOL LIFE SCI, V72, P897, DOI 10.1007/s00018-014-1824-8; Pozdnyakova NN, 2006, APPL BIOCHEM MICRO+, V42, P56, DOI 10.1134/S000368380601008X; Pozdnyakova NN, 2004, J MOL CATAL B-ENZYM, V30, P19, DOI 10.1016/j.molcatb.2004.03.005; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Rodakiewicz-Nowak J, 1999, BIOSCIENCE REP, V19, P589, DOI 10.1023/A:1020223130115; Shleev SV, 2004, BIOCHIMIE, V86, P693, DOI 10.1016/j.biochi.2004.08.005; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang SN, 2018, BIOCHIMIE, V148, P46, DOI 10.1016/j.biochi.2018.02.015; WOOD DA, 1980, J GEN MICROBIOL, V117, P327; WYNN RM, 1983, FEBS LETT, V156, P23, DOI 10.1016/0014-5793(83)80240-3; Zhang HB, 2009, BIOTECHNOL LETT, V31, P837, DOI 10.1007/s10529-009-9945-0; Zhou PD, 2014, BIORESOURCES, V9, P1964	46	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0225530	10.1371/journal.pone.0225530	http://dx.doi.org/10.1371/journal.pone.0225530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961889	gold, Green Published			2022-12-26	WOS:000534372000006
J	Dekker, LJM; Wu, SY; Jurriens, C; Mustafa, DAN; Grevers, F; Burgers, PC; Smitt, PAES; Kros, JM; Luider, TM				Dekker, Lennard J. M.; Wu, Suying; Jurriens, Cherise; Mustafa, Dana A. N.; Grevers, Frederieke; Burgers, Peter C.; Smitt, Peter A. E. Sillevis; Kros, Johan M.; Luider, Theo M.			Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level	FASEB JOURNAL			English	Article						glioma; glutaminolysis; IDH1 mutation; metabolism; proteomics; TCA cycle	BRAIN ENERGY; GLUTAMATE; LACTATE; HEALTH	The discovery of the IDH1 R132H (IDH1 mut) mutation in low-grade glioma and the associated change in function of the IDH1 enzyme has increased the interest in glioma metabolism. In an earlier study, we found that changes in expression of genes involved in the aerobic glycolysis and the TCA cycle are associated with IDH1 mut. Here, we apply proteomics to FFPE samples of diffuse gliomas with or without IDH1 mutations, to map changes in protein levels associated with this mutation. We observed significant changes in the enzyme abundance associated with aerobic glycolysis, glutamate metabolism, and the TCA cycle in IDH1 mut gliomas. Specifically, the enzymes involved in the metabolism of glutamate, lactate, and enzymes involved in the conversion of alpha-ketoglutarate were increased in IDH1 mut gliomas. In addition, the bicarbonate transporter (SLC4A4) was increased in IDH1 mut gliomas, supporting the idea that a mechanism preventing intracellular acidification is active. We also found that enzymes that convert proline, valine, leucine, and isoleucine into glutamate were increased in IDH1 mut glioma. We conclude that in IDH1 mut glioma metabolism is rewired (increased input of lactate and glutamate) to preserve TCA-cycle activity in IDH1 mut gliomas.	[Dekker, Lennard J. M.; Wu, Suying; Jurriens, Cherise; Burgers, Peter C.; Smitt, Peter A. E. Sillevis; Luider, Theo M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Mustafa, Dana A. N.; Grevers, Frederieke; Kros, Johan M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus MC, Dept Neurol, Labs Neurooncol Clin & Canc Prote, POB 2040, NL-3000 CA Rotterdam, Netherlands.	t.luider@erasmusmc.nl	Mustafa, Dana/AAQ-6530-2021	Mustafa, Dana/0000-0003-0644-078X	Netherlands Organisation for Scientific Research (NWO) [1631]; Eurostars-2 joint program; European Union Horizon 2020 research and innovation program (Eurostars project) [10688]; British Brain Tumour Charity [GN-000540]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Eurostars-2 joint program; European Union Horizon 2020 research and innovation program (Eurostars project); British Brain Tumour Charity	The mass spectrometry equipment used for this publication is (partly) financed by the Netherlands Organisation for Scientific Research (NWO) infrastructure grant number 1631. This work has received funding from the Eurostars-2 joint program with co-funding from the European Union Horizon 2020 research and innovation program (Eurostars project 10688 (GlioPhos)) and by the British Brain Tumour Charity (GN-000540)	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Bogdanovic E, 2015, BBA-GEN SUBJECTS, V1850, P1781, DOI 10.1016/j.bbagen.2015.04.014; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Dekker LJM, 2018, J PROTEOME RES, V17, P1654, DOI 10.1021/acs.jproteome.7b00911; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fuss Taylor L, 2016, Top Magn Reson Imaging, V25, P223; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Izquierdo-Garcia JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118781; Khurshed M, 2017, ONCOTARGET, V8, P49165, DOI 10.18632/oncotarget.17106; Kopinja J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14065-w; Lenting K, 2019, FASEB J, V33, P557, DOI 10.1096/fj.201800907RR; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marcadier JL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-98; Mondesir J, 2016, J BLOOD MED, V7, P171, DOI 10.2147/JBM.S70716; Mustafa DAN, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-6; Oppermann H, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0131-9; Parker SJ, 2015, PHARMACOL THERAPEUT, V152, P54, DOI 10.1016/j.pharmthera.2015.05.003; Riske L, 2017, THER ADV PSYCHOPHARM, V7, P85, DOI 10.1177/2045125316675579; Soleimani M, 2000, KIDNEY INT, V57, P371, DOI 10.1046/j.1523-1755.2000.00857.x; Suijker J, 2015, ONCOTARGET, V6, P12505, DOI 10.18632/oncotarget.3723; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Vartanian A, 2016, ONCOTARGET, V7, P69518, DOI 10.18632/oncotarget.11680; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546; Yao JW, 2019, NEURO-ONCOLOGY, V21, P1184, DOI 10.1093/neuonc/noz078; Ye ZX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183800; Zhao H, 2016, ONCOTARGET, V7, P20486, DOI 10.18632/oncotarget.7974; Zhou LN, 2019, J PROTEOME RES, V18, P960, DOI 10.1021/acs.jproteome.8b00663; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	35	13	13	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3646	3657		10.1096/fj.201902352R	http://dx.doi.org/10.1096/fj.201902352R		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960518	hybrid, Green Published			2022-12-26	WOS:000508840000001
J	Zhu, LP; Wang, WJ; Xie, TH; Zou, J; Nie, XW; Wang, XL; Zhang, MY; Wang, ZY; Gu, S; Zhuang, M; Tan, JX; Shen, CY; Dai, YA; Yang, XS; Yao, Y; Wei, TT				Zhu, Lingpeng; Wang, Wenjuan; Xie, Tian-Hua; Zou, Jian; Nie, Xiaowei; Wang, Xiaolu; Zhang, Meng-Yuan; Wang, Zhong-Yuan; Gu, Shun; Zhuang, Miao; Tan, Jianxin; Shen, Chenyou; Dai, Youai; Yang, Xusheng; Yao, Yong; Wei, Ting-Ting			TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling	FASEB JOURNAL			English	Article						bile acid; diabetic retinopathy; RhoA; ROCK; TGR5; vascular leakage	BILE-ACIDS; PROTEIN; RATS; DYSFUNCTION; EXPRESSION; FASUDIL; CELLS; STAR; RHO	Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus. Abnormal energy metabolism in microvascular endothelium is involved in the progression of diabetic retinopathy. Bile Acid G-Protein-Coupled Membrane Receptor (TGR5) has emerged as a novel regulator of metabolic disorders. However, the role of TGR5 in diabetes mellitus-induced microvascular dysfunction in retinas is largely unknown. Herein, enzyme-linked immunosorbent assay was used for analyzing bile acid (BA) profiles in diabetic rat retinas and retinal microvascular endothelial cells (RMECs) cultured in high glucose medium. The effects of TGR5 agonist on streptozotocin (STZ)-induced diabetic retinopathy were evaluated by HE staining, TUNEL staining, retinal trypsin digestion, and vascular permeability assay. A pharmacological inhibitor of RhoA was used to study the role of TGR5 on the regulation of Rho/Rho-associated coiled-coil containing protein kinase (ROCK) and western blot, immunofluorescence and siRNA silencing were performed to study the related signaling pathways. Here we show that bile acids were downregulated during DR progression in the diabetic rat retinas and RMECs cultured in high glucose medium. The TGR5 agonist obviously ameliorated diabetes-induced retinal microvascular dysfunction in vivo, and inhibited the effect of TNF-alpha on endothelial cell proliferation, migration, and permeability in vitro. In contrast, knockdown of TGR5 by siRNA aggravated TNF-alpha-induced actin polymerization and endothelial permeability. Mechanistically, the effects of TGR5 on the improvement of endothelial function was due to its regulatory role on the ROCK signaling pathway. An inhibitor of RhoA significantly reversed the loss of tight junction protein under TNF-alpha stimulation. Taken together, our findings suggest that insufficient BA signaling plays an important pathogenic role in the development of DR. Upregulation or activation of TGR5 may inhibit RhoA/ROCK-dependent actin remodeling and represent an important therapeutic intervention for DR.	[Zhu, Lingpeng; Wang, Wenjuan; Xie, Tian-Hua; Wang, Xiaolu; Zhang, Meng-Yuan; Wang, Zhong-Yuan; Gu, Shun; Zhuang, Miao; Yao, Yong; Wei, Ting-Ting] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Ophthalmol, 299 Qingyang Rd, Wuxi, Jiangsu, Peoples R China; [Zhu, Lingpeng; Wang, Wenjuan; Zou, Jian; Nie, Xiaowei; Wang, Xiaolu; Tan, Jianxin; Shen, Chenyou; Dai, Youai; Yang, Xusheng; Wei, Ting-Ting] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Ctr Clin Res, Wuxi, Jiangsu, Peoples R China; [Zhu, Lingpeng; Wang, Wenjuan; Zou, Jian; Nie, Xiaowei; Wang, Xiaolu; Tan, Jianxin; Shen, Chenyou; Dai, Youai; Yang, Xusheng; Wei, Ting-Ting] Wuxi Inst Translat Med, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yao, Y; Wei, TT (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Ophthalmol, 299 Qingyang Rd, Wuxi, Jiangsu, Peoples R China.	yongyao@njmu.edu.cn; sunnytingtingwei@126.com		Nie, Xiaowei/0000-0003-2443-0569	National Natural Science Foundation of China (NSFC) [81770941, 81800845]; Nanjing Medical University (NMU) [NMUB2018363]; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) [BK20190149, BK20180170]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Nanjing Medical University (NMU); Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)(Natural Science Foundation of Jiangsu Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770941 and 81800845; Nanjing Medical University (NMU), Grant/Award Number: NMUB2018363; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), Grant/Award Number: BK20190149 and BK20180170	Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Ahmadieh H, 2013, JAMA OPHTHALMOL, V131, P923, DOI 10.1001/jamaophthalmol.2013.143; Baptissart M, 2014, HEPATOLOGY, V60, P1054, DOI 10.1002/hep.27204; Battson ML, 2017, J VASC RES, V54, P280, DOI 10.1159/000479967; Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158; Cat AND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21087-5; Chen J, 2017, ATHEROSCLEROSIS, V257, P152, DOI 10.1016/j.atherosclerosis.2016.12.007; Chou JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50489; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Han YW, 2018, EUR J PHARMACOL, V839, P12, DOI 10.1016/j.ejphar.2018.09.018; Iban-Arias R, 2018, DIABETES, V67, P321, DOI 10.2337/db17-0391; IBRAHIM E, 2018, SCI REP UK, V8; Jena PK, 2018, FASEB J, V32, P2866, DOI 10.1096/fj.201700984RR; Kundu S, 2017, MEDCHEMCOMM, V8, P2248, DOI 10.1039/c7md00475c; Lai DW, 2017, J MOL MED, V95, P155, DOI 10.1007/s00109-016-1469-1; Lee DH, 2018, MOL CELLS, V41, P771, DOI 10.14348/molcells.2018.0207; Li CY, 2015, J AM SOC HYPERTENS, V9, P507, DOI 10.1016/j.jash.2015.04.006; Li SC, 2018, J AM SOC NEPHROL, V29, P2658, DOI 10.1681/ASN.2018030271; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; Lyu D, 2019, INT IMMUNOPHARMACOL, V71, P93, DOI 10.1016/j.intimp.2019.02.044; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Merlen G, 2020, GUT, V69, P146, DOI 10.1136/gutjnl-2018-316975; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Ouyang H, 2018, EUR J PHARMACOL, V840, P20, DOI 10.1016/j.ejphar.2018.09.027; Pan YY, 2018, BIOMED PHARMACOTHER, V97, P1694, DOI 10.1016/j.biopha.2017.11.151; Provost AC, 2003, CR BIOL, V326, P841, DOI 10.1016/j.crvi.2003.09.001; Ren SL, 2004, J LIPID RES, V45, P2123, DOI 10.1194/jlr.M400233-JLR200; Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119; Sheikh AQ, 2014, AM J PHYSIOL-CELL PH, V306, pC768, DOI 10.1152/ajpcell.00201.2013; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vasam G, 2017, DIABETES, V66, P505, DOI 10.2337/db16-1039; Wang M, 2019, DIABETOLOGIA, V62, P335, DOI 10.1007/s00125-018-4755-3; Wang XXX, 2018, J AM SOC NEPHROL, V29, P118, DOI 10.1681/ASN.2017020222; WONG TY, 2016, NAT REV DIS PRIMERS, V2; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012	41	20	20	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4189	4203		10.1096/fj.201902496RR	http://dx.doi.org/10.1096/fj.201902496RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957105				2022-12-26	WOS:000508135900001
J	Grolla, AA; Miggiano, R; Di Marino, D; Bianchi, M; Gori, A; Orsomando, G; Gaudino, F; Galli, U; Del Grosso, E; Mazzola, F; Angeletti, C; Guarneri, M; Torretta, S; Calabro, M; Boumya, S; Fan, XR; Colombo, G; Travelli, C; Rocchio, F; Aronica, E; Wohlschlegel, JA; Deaglio, S; Rizzi, M; Genazzani, AA; Garavaglia, S				Grolla, Ambra A.; Miggiano, Riccardo; Di Marino, Daniele; Bianchi, Michele; Gori, Alessandro; Orsomando, Giuseppe; Gaudino, Federica; Galli, Ubaldina; Del Grosso, Erika; Mazzola, Francesca; Angeletti, Carlo; Guarneri, Martina; Torretta, Simone; Calabro, Marta; Boumya, Sara; Fan, Xiaorui; Colombo, Giorgia; Travelli, Cristina; Rocchio, Francesca; Aronica, Eleonora; Wohlschlegel, James A.; Deaglio, Silvia; Rizzi, Menico; Genazzani, Armando A.; Garavaglia, Silvia			A nicotinamide phosphoribosyltransferase?GAPDH interaction sustains the stress-induced NMN/NAD(+) salvage pathway in the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD biosynthesis; NAMPT; melanoma; nicotinamide adenine dinucleotide (NAD); metabolism; GAPDH; NAD compartmentalization; nucleus; nicotinamide mononucleotide (NMN); protein-protein interaction; cell stress; redox cycling; NMN; NAD plus salvage pathway	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPDH; METABOLISM; DYNAMICS; NAD(+); INSIGHTS; COMPLEX; DEATH; NAMPT	All cells require sustained intracellular energy flux, which is driven by redox chemistry at the subcellular level. NAD(+), its phosphorylated variant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all redox cofactors with key roles in energy metabolism and are substrates for several NAD-consuming enzymes (e.g. poly(ADP-ribose) polymerases, sirtuins, and others). The nicotinamide salvage pathway, constituted by nicotinamide mononucleotide adenylyltransferase (NMNAT) and nicotinamide phosphoribosyltransferase (NAMPT), mainly replenishes NAD(+) in eukaryotes. However, unlike NMNAT1, NAMPT is not known to be a nuclear protein, prompting the question of how the nuclear NAD(+) pool is maintained and how it is replenished upon NAD(+) consumption. In the present work, using human and murine cells; immunoprecipitation, pulldown, and surface plasmon resonance assays; and immunofluorescence, small-angle X-ray scattering, and MS-based analyses, we report that GAPDH and NAMPT form a stable complex that is essential for nuclear translocation of NAMPT. This translocation furnishes NMN to replenish NAD(+) to compensate for the activation of NAD-consuming enzymes by stressful stimuli induced by exposure to H2O2 or S-nitrosoglutathione and DNA damage inducers. These results indicate that by forming a complex with GAPDH, NAMPT can translocate to the nucleus and thereby sustain the stress-induced NMN/NAD(+) salvage pathway.	[Grolla, Ambra A.; Miggiano, Riccardo; Bianchi, Michele; Galli, Ubaldina; Del Grosso, Erika; Guarneri, Martina; Torretta, Simone; Calabro, Marta; Boumya, Sara; Colombo, Giorgia; Rocchio, Francesca; Rizzi, Menico; Genazzani, Armando A.; Garavaglia, Silvia] Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2, I-28100 Novara, Italy; [Di Marino, Daniele] Polytech Univ Marche, Dept Life & Environm Sci, New York Marche Struct Biol Ctr NY MaSBiC, Via Brecce Bianche, I-60131 Ancona, Italy; [Gori, Alessandro] CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy; [Orsomando, Giuseppe; Mazzola, Francesca; Angeletti, Carlo] Polytech Univ Marche, Sect Biochem, Dept Clin Sci DISCO, Via Ranieri 67, I-60128 Ancona, Italy; [Gaudino, Federica; Deaglio, Silvia] Univ Turin, Dept Med Sci, Via Nizza 52, I-10126 Turin, Italy; [Fan, Xiaorui; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Travelli, Cristina] Univ Amsterdam, Amsterdam UMC, Dept Neuro Pathol, Amsterdam Neurosci, NL-1001 NK Amsterdam, Netherlands; [Aronica, Eleonora] Univ Pavia, Dept Pharmaceut Sci, Via Taramelli 12-14, I-27100 Pavia, Italy; [Deaglio, Silvia] Italian Inst Genom Med, Via Nizza 52, I-10126 Turin, Italy	University of Eastern Piedmont Amedeo Avogadro; Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Marche Polytechnic University; University of Turin; University of California System; University of California Los Angeles; University of Amsterdam; Vrije Universiteit Amsterdam; University of Pavia; Italian Institute for Genomic Medicine (IIGM)	Genazzani, AA; Garavaglia, S (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2, I-28100 Novara, Italy.	armando.genazzani@uniupo.it; silvia.garavaglia@uniupo.it	Rocchio, Francesca/AAA-6754-2019; Gori, Alessandro/A-1357-2019; del grosso, erika/ABH-9491-2022; Miggiano, Riccardo/AAO-7887-2020; Orsomando, Giuseppe/L-2120-2015; Di Marino, Daniele/ABB-2333-2020; Travelli, Cristina/AAA-9450-2022; Mazzola, Francesca/ADC-1197-2022; garavaglia, silvia/AIA-1816-2022	Rocchio, Francesca/0000-0002-2145-2642; del grosso, erika/0000-0002-2398-5944; MIGGIANO, Riccardo/0000-0002-2159-3314; Galli, Ubaldina/0000-0003-1126-0142; Colombo, Giorgia/0000-0002-8280-2589; grolla, ambra/0000-0003-0233-0700; garavaglia, silvia/0000-0001-8494-1729; Genazzani, Armando/0000-0003-1923-7430; Orsomando, Giuseppe/0000-0001-6640-097X	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG2018 21842]; PRIN 2017 CBNCYT from the Italian Ministry of Health; Fondazione Umberto Veronesi Grant 2018; SIF-Merck scholarship; Universita del Piemonte Orientale Grant FAR 2015	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); PRIN 2017 CBNCYT from the Italian Ministry of Health; Fondazione Umberto Veronesi Grant 2018; SIF-Merck scholarship; Universita del Piemonte Orientale Grant FAR 2015	This work was supported in part by Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG2018 21842 (to A. A. Genazzani), by PRIN 2017 CBNCYT from the Italian Ministry of Health (to A. A. Genazzani), by Fondazione Umberto Veronesi Grant 2018 (to A. A. Genazzani), and by a SIF-Merck scholarship (to A. A. Genazzani), and Universita del Piemonte Orientale Grant FAR 2015 (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Amici A, 2017, CELL CHEM BIOL, V24, P553, DOI 10.1016/j.chembiol.2017.03.010; Audrito V, 2020, SEMIN CELL DEV BIOL, V98, P192, DOI 10.1016/j.semcdb.2019.05.001; Bockwoldt M, 2019, P NATL ACAD SCI USA, V116, P15957, DOI 10.1073/pnas.1902346116; Buonvicino D, 2018, CELL CHEM BIOL, V25, P471, DOI 10.1016/j.chembiol.2018.01.012; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Danshina PV, 2016, MOL HUM REPROD, V22, P410, DOI 10.1093/molehr/gaw016; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; Di Marino D, 2015, J CHEM THEORY COMPUT, V11, P3401, DOI 10.1021/ct500431h; Di Marino D, 2014, J BIOMOL STRUCT DYN, V32, P337, DOI 10.1080/07391102.2013.768552; Donini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175815; Donini S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01057-z; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gaudino F, 2019, ANTIOXID REDOX SIGN, V31, P1150, DOI 10.1089/ars.2019.7799; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258; Grolla AA, 2016, BRIT J PHARMACOL, V173, P2182, DOI 10.1111/bph.13505; Grolla AA, 2015, PIGM CELL MELANOMA R, V28, P718, DOI 10.1111/pcmr.12420; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Maldi E, 2013, PIGM CELL MELANOMA R, V26, P144, DOI 10.1111/pcmr.12037; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; Mori V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113939; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Opitz CA, 2015, BIOCHEM SOC T, V43, P1127, DOI 10.1042/BST20150133; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Ryu KW, 2018, SCIENCE, V360, DOI 10.1126/science.aan5780; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover M.A., 2017, MOONLIGHTING PROTEIN, VVolume 8, P147; Svoboda P, 2019, J BIOL CHEM, V294, P8676, DOI 10.1074/jbc.RA118.003505; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wilsbacher JL, 2017, MOL CANCER THER, V16, P1236, DOI 10.1158/1535-7163.MCT-16-0819; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang RY, 2011, ANAL BIOCHEM, V412, P18, DOI 10.1016/j.ab.2010.12.035; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	50	15	16	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3635	3651		10.1074/jbc.RA119.010571	http://dx.doi.org/10.1074/jbc.RA119.010571			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31988240	Green Published, hybrid			2022-12-26	WOS:000527725300021
J	Wei, XM; Zhang, Y; Li, C; Ai, KT; Li, K; Li, HY; Yang, JL				Wei, Xiumei; Zhang, Yu; Li, Cheng; Ai, Kete; Li, Kang; Li, Huiying; Yang, Jialong			The evolutionarily conserved MAPK/Erk signaling promotes ancestral T-cell immunity in fish via c-Myc?mediated glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T cell; evolution; mitogen-activated protein kinase (MAPK); cellular immune response; glycolysis; adaptive immunity; ancestral T cells; immune regulation; MAPK; Erk; teleost	ACTIVATED PROTEIN-KINASES; MAP KINASES; FEEDBACK LOOP; DIFFERENTIATION; TRANSDUCTION; METABOLISM; FAMILY; MYC; TRANSLOCATION; TRANSCRIPTION	The mitogen-activated protein kinase (MAPK) cascade is an ancient and evolutionarily conserved signaling pathway involved in numerous physiological processes. Despite great advances in understanding MAPK-mediated regulation of adaptive immune responses in mammals, its contribution to T-cell immunity in early vertebrates remains unclear. Herein, we used Nile tilapia (Oreochromis niloticus) to investigate the regulatory roles of MAPK/extracellular signal?regulated kinase (Erk) signaling in ancestral T-cell immunity of jawed fish. We found that Nile tilapia possesses an evolutionarily conserved MAPK/Erk axis that is activated through a classical three-tier kinase cascade, involving sequential phosphorylation of RAF proto-oncogene serine/threonine-protein kinase (Raf), MAPK/Erk kinase 1/2 (Mek1/2), and Erk1/2. In Nile tilapia, MAPK/Erk signaling participates in adaptive immune responses during bacterial infection. Upon T-cell activation, the MAPK/Erk axis is robustly activated, and MAPK/Erk blockade by specific inhibitors severely impairs T-cell activation. Furthermore, signals from MAPK/Erk were indispensable for primordial T cells to proliferate and exert their effector functions. Mechanistically, activation of the MAPK/Erk axis promoted glycolysis via induction of the transcriptional regulator proto-oncogene c-Myc (c-Myc), to ensure the proper activation and proliferation of fish T cells. Our results reveal the regulatory mechanisms of MAPK/Erk signaling in T-cell immunity in fish and highlight a close link between immune signals and metabolic programs. We propose that regulation of T-cell immunity by MAPK/Erk is a basic and sophisticated strategy that evolved before the emergence of the tetrapod lineage. These findings shed light on the evolution of the adaptive immune system.	[Wei, Xiumei; Zhang, Yu; Li, Cheng; Ai, Kete; Li, Kang; Li, Huiying; Yang, Jialong] East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China; [Yang, Jialong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China	East China Normal University; Qingdao National Laboratory for Marine Science & Technology	Yang, JL (corresponding author), East China Normal Univ, Shanghai 200241, Peoples R China.	jlyang@bio.ecnu.edu.cn	kang, li/HCH-5087-2022	Yang, Jialong/0000-0002-3112-5012	National Natural Science Foundation of China [31972822, 31872591]; Shanghai Pujiang Program [18PJ1402700]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31972822 and 31872591, Shanghai Pujiang Program Grant 18PJ1402700, and the Fundamental Research Funds for the Central Universities (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Li D, 2019, J BIOL CHEM, V294, P16440, DOI 10.1074/jbc.RA119.010247; Linke M, 2017, FEBS LETT, V591, P3089, DOI 10.1002/1873-3468.12711; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Menon MB, 2016, BIOCHEM J, V473, P2995, DOI 10.1042/BCJ20160672C; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Nakanishi Teruyuki, 2015, Biology-Basel, V4, P640, DOI 10.3390/biology4040640; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pahl A, 2002, BRIT J PHARMACOL, V135, P1915, DOI 10.1038/sj.bjp.0704656; Papa S, 2019, ONCOGENE, V38, P2223, DOI 10.1038/s41388-018-0582-8; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun JJ, 2016, J BIOL CHEM, V291, P7488, DOI 10.1074/jbc.M115.698134; Sun JJ, 2019, J IMMUNOL, V203, P1845, DOI 10.4049/jimmunol.1900238; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Takizawa F, 2016, J IMMUNOL, V196, P4522, DOI 10.4049/jimmunol.1600222; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Tiedje C, 2014, J INTERF CYTOK RES, V34, P220, DOI 10.1089/jir.2013.0146; Tripathi P, 2012, IMMUNOL CELL BIOL, V90, P676, DOI 10.1038/icb.2011.87; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Wan F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00675; Wang LJ, 2018, FASEB J, V32, P875, DOI 10.1096/fj.201700672RR; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wei XM, 2020, J IMMUNOL, V204, P569, DOI 10.4049/jimmunol.1901065; Wei XM, 2019, J IMMUNOL, V203, P1172, DOI 10.4049/jimmunol.1900008; Wei XM, 2019, FISH SHELLFISH IMMUN, V89, P281, DOI 10.1016/j.fsi.2019.04.003; Wei XM, 2019, FISH SHELLFISH IMMUN, V86, P507, DOI 10.1016/j.fsi.2018.11.072; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002; Zhai W, 2018, BRIT J CANCER, V119, P591, DOI 10.1038/s41416-018-0196-5; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zhou DA, 2017, J CELL MOL MED, V21, P2465, DOI 10.1111/jcmm.13168; Zhu LY, 2012, J IMMUNOL, V188, P5571, DOI 10.4049/jimmunol.1102259	70	17	19	10	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3000	3016		10.1074/jbc.RA119.012231	http://dx.doi.org/10.1074/jbc.RA119.012231			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996375	hybrid, Green Published			2022-12-26	WOS:000519597300011
J	Rojo-Bartolome, I; de Souza, JES; de Cerio, OD; Cancio, I				Rojo-Bartolome, Iratxe; Santana de Souza, Jorge Estefano; Diaz de Cerio, Oihane; Cancio, Ibon			Duplication and subfunctionalisation of the general transcription factor IIIA (gtf3a) gene in teleost genomes, with ovarian specific transcription of gtf3ab	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; SEX-DIFFERENTIATION; ENDOCRINE DISRUPTION; JAPANESE FLOUNDER; DISCONTINUED EXPOSURE; DIMORPHIC EXPRESSION; AROMATASE INHIBITOR; GONAD DEVELOPMENT; RIBOSOMAL-RNA; FISH	Fish oogenesis is characterised by a massive growth of oocytes each reproductive season. This growth requires the stockpiling of certain molecules, such as ribosomal RNAs to assist the rapid ribosomal assembly and protein synthesis required to allow developmental processes in the newly formed embryo. Massive 5S rRNA expression in oocytes, facilitated by transcription factor 3A (Gtf3a), serves as marker of intersex condition in fish exposed to xenoestrogens. Our present work on Gtf3a gene evolution has been analysed in silico in teleost genomes and functionally in the case of the zebrafish Danio rerio. Synteny-analysis of fish genomes has allowed the identification of two gtf3a paralog genes, probably emerged from the teleost specific genome duplication event. Functional analyses demonstrated that gtf3ab has evolved as a gene specially transcribed in oocytes as observed in Danio rerio, and also in Oreochromis niloticus. Instead, gtf3aa was observed to be ubiquitously expressed. In addition, in zebrafish embryos gtf3aa transcription began with the activation of the zygotic genome (similar to 8 hpf), while gtf3ab transcription began only at the onset of oogenesis. Under exposure to 100 ng/L 17 beta-estradiol, fully feminised 61 dpf zebrafish showed transcription of ovarian gtf3ab, while masculinised (100 ng/L 17 alpha-methyltestosterone treated) zebrafish only transcribed gtf3aa. Sex related transcription of gtf3ab coincided with that of cyp19a1a being opposite to that of amh and dmrt1. Such sex dimorphic pattern of gtf3ab transcription was not observed earlier in larvae that had not yet shown any signs of gonad formation after 26 days of oestradiol exposure. Thus, gtf3ab transcription is a consequence of oocyte differentiation and not a direct result of estrogen exposure, and could constitute a useful marker of gonad feminisation and intersex condition.	[Rojo-Bartolome, Iratxe; Diaz de Cerio, Oihane; Cancio, Ibon] Univ Basque Country UPV EHU, CBET Res Grp, Ctr Expt Marine Biol & Biotechnol, PiE UPV EHU,Dept Zool & Cell Biol,Fac Sci & Techn, Bilbao, Basque Country, Spain; [Santana de Souza, Jorge Estefano] Univ Fed Rio Grande do Norte, Bioinformat Multidisciplinary Environm BioME, Natal, RN, Brazil	University of Basque Country; Universidade Federal do Rio Grande do Norte	Cancio, I (corresponding author), Univ Basque Country UPV EHU, CBET Res Grp, Ctr Expt Marine Biol & Biotechnol, PiE UPV EHU,Dept Zool & Cell Biol,Fac Sci & Techn, Bilbao, Basque Country, Spain.	ibon.cancio@ehu.eus	de cerio, Oihane Diaz/H-3336-2015; Cancio, Ibon/M-4594-2019	de cerio, Oihane Diaz/0000-0002-5605-8434; Cancio, Ibon/0000-0003-4841-0079	MINECO [AGL2012-33477, AGL2015-63936_R]; Basque-Government [S-PE13UN101, IT81013]	MINECO(Spanish Government); Basque-Government(Basque Government)	This work has been funded through research projects of MINECO (AGL2012-33477 and AGL2015-63936_R), Basque-Government (PhD fellowship to IRB, S-PE13UN101 & IT81013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L., 2000, TEMA NORD, V555; Bahamonde PA, 2013, GEN COMP ENDOCR, V192, P25, DOI 10.1016/j.ygcen.2013.04.005; Baumann L, 2014, ENVIRON TOXICOL CHEM, V33, P2488, DOI 10.1002/etc.2698; Baumann L, 2014, TOXICOL APPL PHARM, V278, P230, DOI 10.1016/j.taap.2014.04.025; Bizarro C, 2014, MAR ENVIRON RES, V96, P19, DOI 10.1016/j.marenvres.2013.10.009; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; de Cerio OD, 2012, ENVIRON SCI TECHNOL, V46, P7763, DOI 10.1021/es301132b; Fenske M, 2005, ENVIRON TOXICOL CHEM, V24, P1088, DOI 10.1897/04-096R1.1; Fenske M, 2004, AQUAT TOXICOL, V67, P105, DOI 10.1016/j.aquatox.2003.10.008; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitano T, 1999, J MOL ENDOCRINOL, V23, P167, DOI 10.1677/jme.0.0230167; Kitano T, 2000, MOL REPROD DEV, V56, P1, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;1::AID-MRD1&gt;3.0.CO;2-3; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Koger CS, 2000, MAR ENVIRON RES, V50, P201, DOI 10.1016/S0141-1136(00)00068-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsen MG, 2008, AQUAT TOXICOL, V87, P234, DOI 10.1016/j.aquatox.2008.02.003; Lawrence C, 2008, ENVIRON BIOL FISH, V81, P239, DOI 10.1007/s10641-007-9195-8; Layat E, 2013, BBA-GENE REGUL MECH, V1829, P274, DOI 10.1016/j.bbagrm.2012.10.013; Leet JK, 2011, J APPL TOXICOL, V31, P379, DOI 10.1002/jat.1682; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Luzio A, 2015, AQUAT TOXICOL, V166, P83, DOI 10.1016/j.aquatox.2015.07.015; Luzio A, 2016, AQUAT TOXICOL, V174, P22, DOI 10.1016/j.aquatox.2016.02.003; Maack G, 2004, COMP BIOCHEM PHYS C, V139, P47, DOI 10.1016/j.cca.2004.09.004; Maack G., 2008, FISH PHYSIOL BIOCHEM, V28, P125; Martin KJ, 2017, J EXP ZOOL PART B, V328, P638, DOI 10.1002/jez.b.22726; Maugars G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135184; Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209; Nguyen NTT, 2018, NUCLEIC ACIDS RES, V46, pD816, DOI 10.1093/nar/gkx1003; Ogilvie MK, 1997, GENE, V203, P103, DOI 10.1016/S0378-1119(97)00499-X; Orn S, 2006, ARCH ENVIRON CON TOX, V51, P237, DOI 10.1007/s00244-005-0103-y; Ortiz-Zarragoitia M, 2014, MAR DRUGS, V12, P4756, DOI 10.3390/md12094756; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Penberthy WT, 2003, GENE, V305, P205, DOI 10.1016/S0378-1119(03)00384-6; PIFERRER F, 1994, J EXP ZOOL, V270, P255, DOI 10.1002/jez.1402700304; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rojo-Bartolome I, 2017, MAR POLLUT BULL, V121, P292, DOI 10.1016/j.marpolbul.2017.06.027; Rojo-Bartolome I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149711; Santos D, 2017, AQUAT TOXICOL, V191, P141, DOI 10.1016/j.aquatox.2017.08.005; Schulz RW, 2007, ENVIRON SCI TECHNOL, V41, P6305, DOI 10.1021/es070785+; Segner H, 2013, GEN COMP ENDOCR, V191, P190, DOI 10.1016/j.ygcen.2013.05.015; Seki M, 2004, ENVIRON TOXICOL CHEM, V23, P774, DOI 10.1897/03-26; Silva P, 2012, AQUAT TOXICOL, V124, P1, DOI 10.1016/j.aquatox.2012.07.002; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Valencia A, 2017, GEN COMP ENDOCR, V245, P10, DOI 10.1016/j.ygcen.2016.06.017; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Vialle RA, 2018, GENOME BIOL EVOL, V10, P2366, DOI 10.1093/gbe/evy130; VICARIOPARES U, 2014, J NANO PART RES, V16, DOI DOI 10.1007/S11051-014-2550-5; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wilson CA, 2014, GENETICS, V198, P1291, DOI 10.1534/genetics.114.169284; Yoshinaga N, 2004, BIOCHEM BIOPH RES CO, V322, P508, DOI 10.1016/j.bbrc.2004.07.162; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	58	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227690	10.1371/journal.pone.0227690	http://dx.doi.org/10.1371/journal.pone.0227690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999691	Green Published, gold			2022-12-26	WOS:000534612400028
J	Hubbe, M; Mata, AT; Herrera, B; Sanvicente, MEB; Gonzalez, AG; Sandoval, CR; Olguin, JA; Nunez, EA; Von Cramon-Taubadel, N				Hubbe, Mark; Terrazas Mata, Alejandro; Herrera, Brianne; Benavente Sanvicente, Martha E.; Gonzalez Gonzalez, Arturo; Rojas Sandoval, Carmen; Aviles Olguin, Jeronimo; Acevez Nunez, Eugenio; Von Cramon-Taubadel, Noreen			Morphological variation of the early human remains from Quintana Roo, Yucatan Peninsula, Mexico: Contributions to the discussions about the settlement of the Americas	PLOS ONE			English	Article							HUMAN SKELETAL REMAINS; LATE PLEISTOCENE HUMAN; CRANIAL MORPHOLOGY; LAGOA-SANTA; POPULATION HISTORY; HUMAN OCCUPATION; SHAPE VARIATION; SOUTH-AMERICA; SITE; BRAZIL	The human settlement of the Americas has been a topic of intense debate for centuries, and there is still no consensus on the tempo and mode of early human dispersion across the continent. When trying to explain the biological diversity of early groups across North, Central and South America, studies have defended a wide range of dispersion models that tend to oversimplify the diversity observed across the continent. In this study, we aim to contribute to this debate by exploring the cranial morphological affinities of four late Pleistocene/early Holocene specimens recovered from the caves of Quintana Roo, Mexico. The four specimens are among the earliest human remains known in the continent and permit the contextualization of biological diversity present during the initial millennia of human presence in the Americas. The specimens were compared to worldwide reference series through geometric morphometric analyses of 3D anatomical landmarks. Morphological data were analyzed through exploratory visual multivariate analyses and multivariate classification based on Mahalanobis distances. The results show very different patterns of morphological association for each Quintana Roo specimen, suggesting that the early populations of the region already shared a high degree of morphological diversity. This contrasts with previous studies of South American remains and opens the possibility that the initial populations of North America already had a high level of morphological diversity, which was reduced as populations dispersed into the southern continent. As such, the study of these rare remains illustrates that we are probably still underestimating the biological diversity of early Americans.	[Hubbe, Mark; Herrera, Brianne] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Hubbe, Mark] Univ Catolica Norte, Inst Arqueol & Antropol, San Pedro De Atacama, Chile; [Terrazas Mata, Alejandro] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Ciudad De Mexico, Mexico; [Benavente Sanvicente, Martha E.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Lab Prehist & Evoluc, Ciudad De Mexico, Mexico; [Gonzalez Gonzalez, Arturo] Museo Desierto AC, Saltillo, Coahuila, Mexico; [Rojas Sandoval, Carmen] Inst Nacl Antropol & Hist, Ciudad De Mexico, Mexico; [Aviles Olguin, Jeronimo; Acevez Nunez, Eugenio] Inst Prehist Amer AC, Playa Del Carmen, Mexico; [Von Cramon-Taubadel, Noreen] SUNY Buffalo, Dept Anthropol, Buffalo, NY USA	University System of Ohio; Ohio State University; Universidad Catolica del Norte; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hubbe, M (corresponding author), Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA.; Hubbe, M (corresponding author), Univ Catolica Norte, Inst Arqueol & Antropol, San Pedro De Atacama, Chile.	hubbe.1@osu.edu	Hubbe, Mark/G-3440-2012	Hubbe, Mark/0000-0003-4433-3942				Acosta Josede, 1894, HIST NATURAL MORAL I; Adams DC, 2019, R PACKAGE VERSION 31; [Anonymous], 2019, R LANG ENV STAT COMP; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Chatters JC, 2000, AM ANTIQUITY, V65, P291, DOI 10.2307/2694060; de Azevedo S, 2011, AM J PHYS ANTHROPOL, V146, P539, DOI 10.1002/ajpa.21564; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; Galland M, 2016, AM J HUM BIOL, V28, P646, DOI 10.1002/ajhb.22845; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez A.H., 2014, PALEOAMERICAN ODYSSE, P323; Gonzalez A.H., 2008, CURR RES PLEISTOCENE, V25, P1; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GUIDON N, 1986, NATURE, V321, P769, DOI 10.1038/321769a0; Hair J.F., 2019, MULTIVARIATE DATA AN, V8th; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Harvati K, 2009, J HUM EVOL, V57, P751, DOI 10.1016/j.jhevol.2009.07.008; Hering F, 2018, J QUATERNARY SCI, V33, P444, DOI 10.1002/jqs.3025; Herrera B, 2017, AM J PHYS ANTHROPOL, V163, P75, DOI 10.1002/ajpa.23186; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; Howells W. W., 1989, SKULL SHAPES MAP CRA; Howells W.W., 1995, WHOS WHO SKULLS ETHN; Hrdlicka A, 1912, EARLY MAN S AM; Hubbe M, 2014, AM J PHYS ANTHROPOL, V155, P546, DOI 10.1002/ajpa.22607; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P169; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Lahaye C, 2013, J ARCHAEOL SCI, V40, P2840, DOI 10.1016/j.jas.2013.02.019; Malaspinas AS, 2014, CURR BIOL, V24, pR1035, DOI 10.1016/j.cub.2014.09.078; Moreno-Mayar JV, 2018, SCIENCE, V362, DOI 10.1126/science.aav2621; Nettle D, 1999, P NATL ACAD SCI USA, V96, P3325, DOI 10.1073/pnas.96.6.3325; Neves W. A., 2014, PALEOAMERICAN ODYSSE, P397; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Neves WA, 2007, AM J PHYS ANTHROPOL, V133, P1080, DOI 10.1002/ajpa.20637; Neves WA, 2007, J HUM EVOL, V52, P16, DOI 10.1016/j.jhevol.2006.07.012; Neves WA, 2014, AM J PHYS ANTHROPOL, V153, P195; Nichols J, 2008, CURR ANTHROPOL, V49, P1107, DOI 10.1086/592436; Oksanen J., 2019, R package version 2.5-6; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Renne PR, 2005, NATURE, V438, pE7, DOI 10.1038/nature04425; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Smart PL, 2006, PERSPECTIVES KARST G; Stinnesbeck SR, 2018, HOLOCENE, V28, P1992, DOI 10.1177/0959683618798124; Stinnesbeck W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183345; Strauss A, 2015, AM J PHYS ANTHROPOL, V157, P202, DOI 10.1002/ajpa.22703; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Taylor RE, 2009, RADIOCARBON, V51, P173, DOI 10.1017/S0033822200033774; Terrazas A, 2006, 20 S INT HOMBR TEMP, P189; van Vark GN, 2003, AM J PHYS ANTHROPOL, V121, P181, DOI 10.1002/ajpa.10176; Venables WN, 2002, MODERN APPL STAT S, pxi; von Cramon-Taubadel N, 2017, P NATL ACAD SCI USA, V114, P8917, DOI 10.1073/pnas.1711475114; von Cramon-Taubadel N, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602289; von Cramon-Taubadel N, 2009, EVOL ANTHROPOL, V18, P237, DOI 10.1002/evan.20233; von Cramon-Taubadel N, 2009, AM J PHYS ANTHROPOL, V140, P205, DOI 10.1002/ajpa.21041; Waguespack NM, 2007, EVOL ANTHROPOL, V16, P63, DOI 10.1002/evan.20124; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	70	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227444	10.1371/journal.pone.0227444	http://dx.doi.org/10.1371/journal.pone.0227444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995578	gold, Green Published			2022-12-26	WOS:000534609400021
J	Marquez, C; Atukunda, M; Balzer, LB; Chamie, G; Kironde, J; Ssemmondo, E; Ruel, TD; Mwangwa, F; Tram, KH; Clark, TD; Kwarisiima, D; Petersen, M; Kamya, MR; Charlebois, ED; Havlir, DV				Marquez, Carina; Atukunda, Mucunguzi; Balzer, Laura B.; Chamie, Gabriel; Kironde, Joel; Ssemmondo, Emmanuel; Ruel, Theodore D.; Mwangwa, Florence; Tram, Khai Hoan; Clark, Tamara D.; Kwarisiima, Dalsone; Petersen, Maya; Kamya, Moses R.; Charlebois, Edwin D.; Havlir, Diane, V			The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda	PLOS ONE			English	Article							TRANSMISSION; PREVALENCE; COMMUNITY	Background The age-specific epidemiology of child and adolescent tuberculosis (TB) is poorly understood, especially in rural areas of East Africa. We sought to characterize the age-specific prevalence and predictors of TB infection among children and adolescents living in rural Uganda, and to explore the contribution of household TB exposure on TB infection. Methods From 2015-2016 we placed and read 3,121 tuberculin skin tests (TST) in children (5-11 years old) and adolescents (12-19 years old) participating in a nested household survey in 9 rural Eastern Ugandan communities. TB infection was defined as a positive TST (induration >= 10mm or >= 5mm if living with HIV). Age-specific prevalence was estimated using inverse probability weighting to adjust for incomplete measurement. Generalized estimating equations were used to assess the association between TB infection and multi-level predictors. Results The adjusted prevalence of TB infection was 8.5% (95%CI: 6.9-10.4) in children and 16.7% (95% CI:14.0-19.7) in adolescents. Nine percent of children and adolescents with a prevalent TB infection had a household TB contact. Among children, having a household TB contact was strongly associated with TB infection (aOR 5.5, 95% CI: 1.7-16.9), but the strength of this association declined among adolescents and did not meet significance (aOR 2.3, 95% CI: 0.8-7.0). The population attributable faction of TB infection due to a household TB contact was 8% for children and 4% among adolescents. Mobile children and adolescents who travel outside of their community for school had a 1.7 (95% CI 1.0-2.9) fold higher odds of TB infection than those who attended school in the community. Conclusion Children and adolescents in this area of rural eastern Uganda suffer a significant burden of TB. The majority of TB infections are not explained by a known household TB contact. Our findings underscore the need for community-based TB prevention interventions, especially among mobile youth.	[Marquez, Carina; Chamie, Gabriel; Clark, Tamara D.; Havlir, Diane, V] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Atukunda, Mucunguzi; Kironde, Joel; Ssemmondo, Emmanuel; Mwangwa, Florence; Kwarisiima, Dalsone; Kamya, Moses R.] Infect Dis Res Collaborat, Kampala, Uganda; [Balzer, Laura B.] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Ruel, Theodore D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Tram, Khai Hoan] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Kwarisiima, Dalsone; Kamya, Moses R.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Petersen, Maya] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Charlebois, Edwin D.] Univ Calif San Francisco, Ctr AIDS Prevent CAPS, San Francisco, CA 94143 USA; [Tram, Khai Hoan] Washington Univ, Dept Med, St Louis, MO USA	University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California San Francisco; Stanford University; Makerere University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Washington University (WUSTL)	Marquez, C (corresponding author), Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA.	carina.marquez@ucsf.edu		Marquez, Carina/0000-0002-7622-6562; Tram, Khai Hoan/0000-0003-1129-7674; Balzer, Laura B./0000-0002-3730-410X	Division of AIDS, NIAID of the National Institutes of Health [K23AI118592, U01AI099959]; President's Emergency Plan for AIDS Relief; Bill and Melinda Gates Foundation	Division of AIDS, NIAID of the National Institutes of Health; President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Research reported in this manuscript was supported by the Division of AIDS, NIAID of the National Institutes of Health under award number K23AI118592 (CM) and U01AI099959 (DVH, MRK, MP), and in part by the President's Emergency Plan for AIDS Relief, Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331; Balen J, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-7; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Havlir DV, N ENGL J MED; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Mansournia MA, BMJ; Marquez C, 2016, PEDIATR INFECT DIS J, V35, P524, DOI 10.1097/INF.0000000000001062; Martinez L, 2019, LANCET RESP MED, V7, P544, DOI 10.1016/S2213-2600(19)30137-7; Martinez L, 2017, AM J EPIDEMIOL, V185, P1327, DOI 10.1093/aje/kwx025; Martinez L, 2016, AM J RESP CRIT CARE, V194, P1152, DOI 10.1164/rccm.201511-2146OC; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Middelkoop K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-221; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Mumpe-Mwanja D, 2015, AFR HEALTH SCI, V15, P851, DOI 10.4314/ahs.v15i3.20; Seddon JA, 2016, THORAX, V71, P932, DOI 10.1136/thoraxjnl-2015-207687; Snow KJ, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02352-2017; Uganda Ministry of Education and Sports, 2015, ED SPORTS SECT FACT; UNCST,, 2014, UG NAT COUNC SCI TEC; WHO, GLOB TUB REP 2018; WHO, ROADM END CHILDR AD	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228102	10.1371/journal.pone.0228102	http://dx.doi.org/10.1371/journal.pone.0228102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995631	Green Published, gold			2022-12-26	WOS:000534609400043
J	Price, JT; Phiri, WM; Freeman, BL; Vwalika, B; Winston, J; Bwalya, M; Mulenga, HB; Stringer, JS				Price, Joan T.; Phiri, Winifreda M.; Freeman, Bethany L.; Vwalika, Bellington; Winston, Jennifer; Bwalya, Memory; Mulenga, Helen B.; Stringer, Jeffrey S.			Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study	PLOS ONE			English	Article							DOUBLE-BLIND; IMMUNE ACTIVATION; SHORT CERVIX; BIRTH; PROPHYLAXIS; MULTICENTER; ADHERENCE; OUTCOMES; ASSAY; RISK	Antenatal vaginal progesterone (VP) reduces the risk of preterm birth (PTB) in women with shortened cervical length, and we hypothesize that it may also prevent PTB in women with HIV as their primary risk factor. We conducted a pilot feasibility study in Lusaka, Zambia to investigate uptake, adherence, and retention in preparation for a future efficacy trial. This was a double-masked, placebo-controlled, randomized trial of 200mg daily self-administered VP suppository or placebo. Pregnant women with HIV who were initiating or continuing antiretroviral therapy were eligible for participation. Potential participants underwent ultrasound to assess eligibility; we excluded those >= 24 gestational weeks, with non-viable, multiple gestation, or extrauterine pregnancies, with short cervix (<2.0cm), or with prior spontaneous PTB. Participants initiated study product between 20-24 weeks of gestation and continued to 37 weeks (or delivery, if sooner). The primary outcome was adherence (proportion achieving.80% study product use), assessed by dye stain assay of returned single-use vaginal applicators. Secondary outcomes with predefined feasibility targets were: uptake (>= 50% eligible participants enrolled) and retention (>=`90% ascertainment of delivery outcomes). We also evaluated preliminary efficacy by comparing the risk of spontaneous PTB < 37 weeks between groups. From July 2017 to June 2018, 208 HIV-infected pregnant women were eligible for screening and 140 (uptake = 67%) were randomly allocated to VP (n = 70) or placebo (n = 70). Mean adherence was 94% (SD +/- 9.4); 91% (n = 125/137) achieved overall adherence >= 80%. Delivery outcomes were ascertained from 134 (96%) participants. Spontaneous PTB occurred in 10 participants (15%) receiving placebo and 8 (12%) receiving progesterone (RR 0.82; 95%CI:0.34-1.97). Spontaneous PTB < 34 weeks occurred in 6 (9%) receiving placebo and 4 (6%) receiving progesterone (RR 0.67; 95%CI:0.20-2.67). In contrast to findings from vaginal microbicide studies in HIV-uninfected, non- pregnant women, our trial participants were highly adherent to daily self-administered vaginal progesterone. The study's a priori criteria for uptake, adherence, and retention were met, indicating that a phase III efficacy trial would be feasible.	[Price, Joan T.; Freeman, Bethany L.; Winston, Jennifer; Stringer, Jeffrey S.] Univ N Carolina, Dept Obstet & Gynecol, Div Global Womens Hlth, Chapel Hill, NC 27515 USA; [Price, Joan T.; Vwalika, Bellington] Univ Zambia, Sch Med, Dept Obstet & Gynaecol, Lusaka, Zambia; [Phiri, Winifreda M.; Bwalya, Memory] UNC Global Projects Zambia, Lusaka, Zambia; [Mulenga, Helen B.] Pharmaceut Soc Zambia, Lusaka, Zambia	University of North Carolina; University of North Carolina Chapel Hill; University of Zambia	Price, JT (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Div Global Womens Hlth, Chapel Hill, NC 27515 USA.; Price, JT (corresponding author), Univ Zambia, Sch Med, Dept Obstet & Gynaecol, Lusaka, Zambia.	joan_price@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216; Mabula-Bwalya, Chileshe/0000-0002-6329-5534	United States National Institutes of Health [R21 HD090987]; National Institutes of Health [T32 HD075731, K01 TW010857, D43 TW010558]; UNC Center for AIDS Research [P30A150410]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Center for AIDS Research	The clinical trial presented in this article is funded through an award from the United States National Institutes of Health (R21 HD090987), which supports JSAS. Trainee support has been provided through the National Institutes of Health for JTP (T32 HD075731 and K01 TW010857) and for CMB (D43 TW010558). JSAS is also supported in part by the UNC Center for AIDS Research (P30A150410). The conclusions and opinions expressed in this article are those of the authors and do not necessarily reflect those of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Austin MN, 2009, SEX TRANSM DIS, V36, P368, DOI 10.1097/OLQ.0b013e3181972397; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Howson C, 2012, BORN TOO SOON GLOBAL; Katzen LL, 2011, SEX TRANSM DIS, V38, P1050, DOI 10.1097/OLQ.0b013e31822e6160; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Norman JE, 2016, LANCET, V387, P2106, DOI 10.1016/S0140-6736(16)00350-0; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Price JT, 2019, INT J GYNECOL OBSTET, V144, P9, DOI 10.1002/ijgo.12686; Price Joan T, 2018, Pilot Feasibility Stud, V4, P21, DOI 10.1186/s40814-017-0170-7; Romero R, 2018, AM J OBSTET GYNECOL, V218, P161, DOI 10.1016/j.ajog.2017.11.576; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Spencer LY, 2016, JAIDS-J ACQ IMM DEF, V71, P155, DOI 10.1097/QAI.0000000000000823; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2013, SEX TRANSM DIS, V40, P950, DOI 10.1097/OLQ.0000000000000053; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012; Wong JMH, 2017, INT J WOMENS HEALTH, V9, DOI 10.2147/IJWH.S136191	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0224874	10.1371/journal.pone.0224874	http://dx.doi.org/10.1371/journal.pone.0224874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995557	Green Published, gold, Green Submitted			2022-12-26	WOS:000534609400006
J	McGinn, O; Ward, AV; Fettig, LM; Riley, D; Ivie, J; Paul, KV; Kabos, P; Finlay-Schultz, J; Sartorius, CA				McGinn, Olivia; Ward, Ashley, V; Fettig, Lynsey M.; Riley, Duncan; Ivie, Joshua; Paul, Kiran, V; Kabos, Peter; Finlay-Schultz, Jessica; Sartorius, Carol A.			Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells	ONCOGENE			English	Article							NEGATIVE RESPONSE ELEMENTS; GROWTH-FACTOR RECEPTOR; STEM-CELLS; KERATIN 17; PROGESTERONE-RECEPTORS; EPITHELIAL PROGENITORS; ESTROGEN-RECEPTOR; MASS-SPECTROMETRY; RETINOIC ACID; CROSS-TALK	Estrogen receptor (ER) positive breast cancers often contain subpopulations of cells that express the intermediate filament protein cytokeratin 5 (CK5). CK5+ cells are enriched in cancer stem cell (CSC) properties, can be induced by progestins, and predict poor prognosis in ER+ breast cancer. We established through CK5 knockout and overexpression in ER+ breast cancer cell lines that CK5 is important for tumorsphere formation, prompting us to speculate that CK5 has regulatory activity in CSCs. To interrogate CK5 interacting proteins that may be functionally cooperative, we performed immunoprecipitation-mass spectrometry for CK5 in ER+ breast cancer cells. Focusing on proteins with signaling activity, we identified beta-catenin, a key transcription factor of the Wnt signaling pathway and cell adhesion molecule, as a CK5 interactor, which we confirmed by co-immunoprecipitation in several breast cancer models. We interrogated the dual functions of beta-catenin in relation to CK5. Knockout or knockdown of CK5 ablated beta-catenin transcriptional activity in response to progestins and Wnt stimuli. Conversely, CK5 induced by progestins or overexpression was sufficient to promote the loss of beta-catenin at the cell membrane and total E-cadherin loss. A breast cancer patient-derived xenograft showed similar loss of membrane beta-catenin and E-cadherin in CK5+ but not intratumoral CK5- cells and single-cell RNA sequencing found the top enriched pathways in the CK5+ cell cluster were cell junction remodeling and signaling. This report highlights that CK5 actively remodels cell morphology and that blockade of CK5-beta-catenin interaction may reverse the detrimental properties of CK5+ breast cancer cells.	[McGinn, Olivia; Ward, Ashley, V; Fettig, Lynsey M.; Riley, Duncan; Ivie, Joshua; Finlay-Schultz, Jessica; Sartorius, Carol A.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Paul, Kiran, V; Kabos, Peter] Univ Colorado, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sartorius, CA (corresponding author), Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA.	Carol.Sartorius@cuanschutz.edu	; McGinn, Olivia/J-8337-2015	Riley, Duncan/0000-0003-1829-7116; Vinod Paul, Kiran/0000-0002-1212-4217; Finlay-Schultz, Jessica/0000-0002-7855-9870; McGinn, Olivia/0000-0003-0769-5581	National Institutes of Health [NIH F31 CA232456, NIH 2R01 CA140985]; Breast Cancer Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation	We thank the University of Colorado School of Medicine Biological Mass Spectrometry Facility and Advanced Light Microscopy Core for their assistance. This work was supported by National Institutes of Health grants NIH F31 CA232456 (OM), NIH 2R01 CA140985 (CAS), and the Breast Cancer Research Foundation (CAS).	Abdelrahman AE, 2017, ANN DIAGN PATHOL, V28, P43, DOI 10.1016/j.anndiagpath.2017.01.009; Axlund SD, 2013, HORM CANCER-US, V4, P36, DOI 10.1007/s12672-012-0127-5; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Boecker W, 2003, CELL PROLIFERAT, V36, P73, DOI 10.1046/j.1365-2184.36.s.1.7.x; Boudreau A, 2013, P NATL ACAD SCI USA, V110, pE3937, DOI 10.1073/pnas.1315022110; Brisken C, 2000, GENE DEV, V14, P650; Callipo L, 2010, ANAL BIOCHEM, V400, P195, DOI 10.1016/j.ab.2010.01.039; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Melo FDE, 2016, CANCERS, V8, DOI 10.3390/cancers8070060; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Escobar-Hoyos LF, 2015, CANCER RES, V75, P3650, DOI 10.1158/0008-5472.CAN-15-0293; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Farahani E, 2014, CARCINOGENESIS, V35, P747, DOI 10.1093/carcin/bgu045; Fettig LM, 2017, ONCOGENE, V36, P6074, DOI 10.1038/onc.2017.204; Finlay-Schultz J, 2017, CANCER RES, V77, P4934, DOI 10.1158/0008-5472.CAN-16-3541; Furthauer M, 2009, MOL ONCOL, V3, P339, DOI 10.1016/j.molonc.2009.05.006; Goodman CR, 2016, ONCOGENE, V35, P1373, DOI 10.1038/onc.2015.193; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/nchembio.1367, 10.1038/NCHEMBIO.1367]; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Jho SH, 2001, J BIOL CHEM, V276, P45914, DOI 10.1074/jbc.M103144200; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kabos P, 2012, BREAST CANCER RES TR, V135, P415, DOI 10.1007/s10549-012-2164-8; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Khanom R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161163; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Laakso M, 2006, CLIN CANCER RES, V12, P4185, DOI 10.1158/1078-0432.CCR-06-0353; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lindstrom LS, 2018, JNCI-J NATL CANCER I, V110, P726, DOI 10.1093/jnci/djx270; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mikami T, 2015, VIRCHOWS ARCH, V466, P559, DOI 10.1007/s00428-015-1735-6; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Radoja N, 1997, J INVEST DERMATOL, V109, P566, DOI 10.1111/1523-1747.ep12337483; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Sankar S, 2013, MOL CELL BIOL, V33, P4448, DOI 10.1128/MCB.00241-13; Sartorius CA, 2005, CANCER RES, V65, P9779, DOI 10.1158/0008-5472.CAN-05-0505; Sato T, 2014, ONCOGENE, V33, P2215, DOI 10.1038/onc.2013.172; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Siitonen SMKJ, 1995, ANAT PATHOL, V105, P394; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Sutton LM, 2010, AM J CLIN PATHOL, V134, P782, DOI 10.1309/AJCPRMD3ARUO5WPN; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Truong TH, 2019, ENDOCRINOLOGY, V160, P430, DOI 10.1210/en.2018-00990; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wheelock MJ, 2001, J MAMMARY GLAND BIOL, V6, P275, DOI 10.1023/A:1011319507155	71	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2478	2492		10.1038/s41388-020-1164-0	http://dx.doi.org/10.1038/s41388-020-1164-0		JAN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31988452	Green Accepted			2022-12-26	WOS:000509655100002
J	Angoa-Perez, M; Zagorac, B; Winters, AD; Greenberg, JM; Ahmad, M; Theis, KR; Kuhn, DM				Angoa-Perez, Mariana; Zagorac, Branislava; Winters, Andrew D.; Greenberg, Jonathan M.; Ahmad, Madison; Theis, Kevin R.; Kuhn, Donald M.			Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice	PLOS ONE			English	Review							DOPAMINE NERVE-ENDINGS; 3,4-METHYLENEDIOXYPYROVALERONE MDPV; BATH SALTS; METHYLENEDIOXYPYROVALERONE MDPV; METHAMPHETAMINE-SEEKING; GLUTAMATE TRANSPORTER; PLACE PREFERENCE; MEPHEDRONE; NEUROTOXICITY; METHYLONE	The list of pharmacological agents that can modify the gut microbiome or be modified by it continues to grow at a high rate. The greatest amount of attention on drug-gut microbiome interactions has been directed primarily at pharmaceuticals used to treat infection, diabetes, cardiovascular conditions and cancer. By comparison, drugs of abuse and addiction, which can powerfully and chronically worsen human health, have received relatively little attention in this regard. Therefore, the main objective of this study was to characterize how selected synthetic psychoactive cathinones (aka "Bath Salts") and amphetamine stimulants modify the gut microbiome. Mice were treated with mephedrone (40 mg/kg), methcathinone (80 mg/kg), methamphetamine (5 mg/kg) or 4-methyl-methamphetamine (40 mg/kg), following a binge regimen consisting of 4 injections at 2h intervals. These drugs were selected for study because they are structural analogs that contain a beta- keto substituent (methcathinone), a 4-methyl group (4-methyl-methamphetamine), both substituents (mephedrone) or neither (methamphetamine). Mice were sacrificed 1, 2 or 7 days after treatment and DNA from caecum contents was subjected to 16S rRNA sequencing. We found that all drugs caused significant time- and structure-dependent alterations in the diversity and taxonomic structure of the gut microbiome. The two phyla most changed by drug treatments were Firmicutes (methcathinone, 4-methyl-methamphetamine) and Bacteriodetes (methcathinone, 4-methyl-methamphetamine, methamphetamine, mephedrone). Across time, broad microbiome changes from the phylum to genus levels were characteristic of all drugs. The present results signify that these selected psychoactive drugs, which are thought to exert their primary effects within the CNS, can have profound effects on the gut microbiome. They also suggest new avenues of investigation into the possibility that gut-derived signals could modulate drug abuse and addiction via altered communication along the gut-brain axis.	[Angoa-Perez, Mariana; Zagorac, Branislava; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Angoa-Perez, Mariana; Zagorac, Branislava; Kuhn, Donald M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48202 USA; [Winters, Andrew D.; Greenberg, Jonathan M.; Ahmad, Madison; Theis, Kevin R.] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI USA; [Theis, Kevin R.] Wayne State Univ, Sch Med, Perinatal Res Initiat Maternal Perinatal & Child, Detroit, MI USA	Wayne State University; Wayne State University; Wayne State University	Kuhn, DM (corresponding author), John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA.; Kuhn, DM (corresponding author), Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48202 USA.	donald.kuhn@wayne.edu		Kuhn, Donald/0000-0002-8546-9507	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulseoud OA, 2012, BRAIN RES, V1456, P14, DOI 10.1016/j.brainres.2012.03.045; Albers DS, 1995, J PHARMACOL EXP THER, V275, P1104; Althobaiti YS, 2016, NEUROSCI LETT, V634, P25, DOI 10.1016/j.neulet.2016.09.058; Angoa-Perez M, 2013, J NEUROCHEM, V125, P102, DOI 10.1111/jnc.12114; Angoa-Perez M, 2012, J NEUROCHEM, V120, P1097, DOI 10.1111/j.1471-4159.2011.07632.x; Anneken JH, 2017, J PHARMACOL EXP THER, V360, P417, DOI 10.1124/jpet.116.237768; Anneken JH, 2015, J NEUROCHEM, V133, P211, DOI 10.1111/jnc.13048; Attarzadeh-Yazdi G, 2014, PROG NEURO-PSYCHOPH, V53, P142, DOI 10.1016/j.pnpbp.2014.04.008; Baker JH, 2010, INT J EAT DISORDER, V43, P648, DOI 10.1002/eat.20856; Barr T, 2018, GUT MICROBES, V9, P338, DOI 10.1080/19490976.2018.1441663; Baumann MH, 2016, NEUROPSYCHOPHARMACOL, V41, P663, DOI 10.1038/npp.2015.260; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Bonano JS, 2014, PSYCHOPHARMACOLOGY, V231, P199, DOI 10.1007/s00213-013-3223-5; Brannan Temple A, 2004, MedGenMed, V6, P6; CALDWELL J, 1973, J PHARM PHARMACOL, V25, P422, DOI 10.1111/j.2042-7158.1973.tb10043.x; Cameron K, 2013, PSYCHOPHARMACOLOGY, V227, P493, DOI 10.1007/s00213-013-2967-2; Carlson Terri L, 2012, Hawaii J Med Public Health, V71, P44; Chi L, 2017, CHEM RES TOXICOL, V30, P2110, DOI 10.1021/acs.chemrestox.7b00162; Choi JG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217194; Choi JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19646-x; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Dinan TG, 2017, GASTROENTEROL CLIN N, V46, P77, DOI 10.1016/j.gtc.2016.09.007; El Aidy S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00222; Eshleman AJ, 2017, J PHARMACOL EXP THER, V360, P33, DOI 10.1124/jpet.116.236349; Eshleman AJ, 2013, BIOCHEM PHARMACOL, V85, P1803, DOI 10.1016/j.bcp.2013.04.004; Fantegrossi WE, 2013, NEUROPSYCHOPHARMACOL, V38, P563, DOI 10.1038/npp.2012.233; Flack A, 2017, EUR J NEUROSCI, V46, P1918, DOI 10.1111/ejn.13630; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Gatch MB, 2017, PSYCHOPHARMACOLOGY, V234, P1237, DOI 10.1007/s00213-017-4562-4; German CL, 2014, LIFE SCI, V97, P2, DOI 10.1016/j.lfs.2013.07.023; Gregg RA, 2016, NEUROPHARMACOLOGY, V108, P111, DOI 10.1016/j.neuropharm.2016.04.014; Gregorowski C, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-289; Greig CJ, 2016, J SURG RES, V206, P151, DOI 10.1016/j.jss.2016.07.021; Gygi MP, 1997, J PHARMACOL EXP THER, V283, P1350; Gygi MP, 1996, J PHARMACOL EXP THER, V276, P1066; Gygi MP, 1996, NEUROPHARMACOLOGY, V35, P751, DOI 10.1016/0028-3908(96)84647-8; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Halpin LE, 2014, NEUROPSYCHOPHARMACOL, V39, P1031, DOI 10.1038/npp.2013.306; Halpin LE, 2012, J NEUROSCI, V32, P13155, DOI 10.1523/JNEUROSCI.2530-12.2012; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey EL, 2016, PSYCHOPHARMACOLOGY, V233, P673, DOI 10.1007/s00213-015-4142-4; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; HERR RD, 1991, AM J EMERG MED, V9, P406, DOI 10.1016/0735-6757(91)90073-S; JONES BD, 1988, J BACTERIOL, V170, P3342, DOI 10.1128/jb.170.8.3342-3349.1988; Karila L, 2018, NEUROPHARMACOLOGY, V134, P65, DOI 10.1016/j.neuropharm.2017.10.007; Karila L, 2016, BRAIN RES BULL, V126, P61, DOI 10.1016/j.brainresbull.2016.03.005; Karlsson L, 2014, BASIC CLIN PHARMACOL, V115, P411, DOI 10.1111/bcpt.12253; Kiraly DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35455; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lai F, 2018, NEUROCHEM RES, V43, P1986, DOI 10.1007/s11064-018-2620-x; Lee K, 2018, NEUROPSYCHOPHARMACOL, V43, P2606, DOI 10.1038/s41386-018-0211-9; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li BG, 2019, CELL REP, V26, P2720, DOI 10.1016/j.celrep.2019.02.015; Li HK, 2016, EXPERT OPIN DRUG MET, V12, P31, DOI 10.1517/17425255.2016.1121234; Li ZS, 2010, J NEUROSCI, V30, P16730, DOI 10.1523/JNEUROSCI.2276-10.2010; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Marusich JA, 2012, NEUROTOXICOLOGY, V33, P1305, DOI 10.1016/j.neuro.2012.08.003; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Motbey CP, 2013, J PSYCHOPHARMACOL, V27, P823, DOI 10.1177/0269881113490325; Ning TT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01620; Persons AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190078; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Rawson R, 2000, J PSYCHOACTIVE DRUGS, V32, P233, DOI 10.1080/02791072.2000.10400234; Ridge EA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40803-3; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scorza C, 2019, NEUROTOX RES, V35, P111, DOI 10.1007/s12640-018-9936-9; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shortall SE, 2016, ADDICT BIOL, V21, P1127, DOI 10.1111/adb.12283; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Simon SL, 2002, J ADDICT DIS, V21, P35; Sparago M, 1996, J PHARMACOL EXP THER, V279, P1043; STEPHANS SE, 1995, BRAIN RES, V700, P99, DOI 10.1016/0006-8993(95)00938-M; Tackett JJ, 2017, J SURG RES, V208, P198, DOI 10.1016/j.jss.2016.09.036; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Tremlett H, 2017, ANN NEUROL, V81, P369, DOI 10.1002/ana.24901; Wade PR, 1996, J NEUROSCI, V16, P2352; White CM, 2016, J CLIN PHARMACOL, V56, P1319, DOI 10.1002/jcph.742; Winstock AR, 2011, ADDICTION, V106, P154, DOI 10.1111/j.1360-0443.2010.03130.x; Xiao HW, 2018, TOXICOL LETT, V287, P23, DOI 10.1016/j.toxlet.2018.01.021; Xu YC, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43453; Zhang L, 2019, P NATL ACAD SCI USA, V116, P13523, DOI 10.1073/pnas.1901182116	84	15	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227774	10.1371/journal.pone.0227774	http://dx.doi.org/10.1371/journal.pone.0227774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978078	Green Published, gold			2022-12-26	WOS:000534599100059
J	Gera, A; O'Keefe, JA; Ouyang, B; Liu, YQ; Ruehl, S; Buder, M; Joyce, J; Purcell, N; Pal, G				Gera, Anjali; O'Keefe, Joan A.; Ouyang, Bichun; Liu, Yuanqing; Ruehl, Samantha; Buder, Mark; Joyce, Jessica; Purcell, Nicolette; Pal, Gian			Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; GBA MUTATIONS; DEMENTIA; GENOTYPE; BALANCE; PD	Background GBA mutation carriers with PD (PD-GBA) are at higher risk of cognitive decline, but there is limited data regarding whether there are differences in gait dysfunction between GBA mutation and non-mutation carriers with PD. Objectives/Methods The primary aim of this study was to use quantitative inertial sensor-based gait analysis to compare gait asymmetry in 17 PD-GBA subjects, 17 non-mutation carriers with PD, and 15 healthy control subjects using parameters that had gait laterality and were markers of bradykinesia, in particular arm swing velocity and arm swing range of motion and stride length. Results Arm swing velocity was more symmetric in PD-GBA subjects vs. non-mutation carriers in the OFF state (12.5 +/- 8.3 vs. 22.9 +/- 11.8%, respectively, p = 0.018). In the ON-medication state, non-mutation carriers with PD, but not PD-GBA subjects, exhibited arm swing velocity (16.8 +/- 8.6 vs. 22.9 +/- 11.8%, p = 0.006) and arm range of motion (26.7 +/- 16.3 vs. 33.4 +/- 18.6%, p = 0.02) that was more asymmetric compared with the OFF-medication state. Conclusions In the OFF medication state, arm swing velocity asymmetry may be a useful parameter in helping to distinguish GBA mutation carriers with PD from non-mutation carriers.	[Gera, Anjali; Ouyang, Bichun; Liu, Yuanqing; Ruehl, Samantha; Buder, Mark; Pal, Gian] Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA; [O'Keefe, Joan A.; Joyce, Jessica; Purcell, Nicolette] Rush Univ, Cell & Mol Med, Chicago, IL 60612 USA	Rush University; Rush University	Pal, G (corresponding author), Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA.	gian_d_pal@rush.edu		Pal, Gian/0000-0003-1048-6182	National Institutes of Health [K01 HD088762]; National Institute of Neurological Disorders and Stroke [K23-NS097625-03]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JOK received research support from the National Institutes of Health (K01 HD088762). www.nih.gov.She reports no conflicts of interests related to this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GP received support from the 2016 Rush University Cohn Fellowship Foundation (https://www.rushu.rush.edu/news/cohn-fellowship-award-winners), and from the National Institute of Neurological Disorders and Stroke (K23-NS097625-03) www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Angeli A, 2013, MOVEMENT DISORD, V28, P1370, DOI 10.1002/mds.25535; Beavan M, 2015, JAMA NEUROL, V72, P201, DOI 10.1001/jamaneurol.2014.2950; Beavan MS, 2013, ANN MED, V45, P511, DOI 10.3109/07853890.2013.849003; Chien SL, 2006, PARKINSONISM RELAT D, V12, P438, DOI 10.1016/j.parkreldis.2006.04.004; Cilia R, 2016, ANN NEUROL, V80, P662, DOI 10.1002/ana.24777; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Curtze C, 2015, MOVEMENT DISORD, V30, P1361, DOI 10.1002/mds.26269; Davis MY, 2016, JAMA NEUROL, V73, P1217, DOI 10.1001/jamaneurol.2016.2245; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dewey DC, 2014, J NEUROL SCI, V345, P131, DOI 10.1016/j.jns.2014.07.026; Gasca-Salas C, 2016, HUM BRAIN MAPP, V37, P968, DOI 10.1002/hbm.23080; Malek N, 2018, J NEUROL NEUROSUR PS, V89, P702, DOI 10.1136/jnnp-2017-317348; Mancini M, 2016, EXPERT REV MED DEVIC, V13, P455, DOI 10.1586/17434440.2016.1153421; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McGlinchey RP, 2013, BIOCHEM SOC T, V41, P1509, DOI 10.1042/BST20130158; McNeill A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069190; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; Pal G, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00054; Pankratz N, 2009, NEUROLOGY, V73, P279, DOI 10.1212/WNL.0b013e3181af7a33; Postuma RB, 2018, MOVEMENT DISORD, V33, P1601, DOI 10.1002/mds.27362; Roggendorf J, 2012, GAIT POSTURE, V35, P116, DOI 10.1016/j.gaitpost.2011.08.020; Sardi SP, 2019, PARKINSONISM RELAT D, V59, P32, DOI 10.1016/j.parkreldis.2018.10.025; Sardi SP, 2017, P NATL ACAD SCI USA, V114, P2699, DOI 10.1073/pnas.1616152114; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Scholz SW, 2015, NEUROLOGY, V84, P866, DOI 10.1212/WNL.0000000000001321; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; THOMPSON B, 1988, MEAS EVAL COUNS DEV, V21, P99, DOI 10.1080/07481756.1988.12022889; Winder-Rhodes SE, 2013, BRAIN, V136, P392, DOI 10.1093/brain/aws318; Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226494	10.1371/journal.pone.0226494	http://dx.doi.org/10.1371/journal.pone.0226494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978134	Green Published, gold			2022-12-26	WOS:000534599100015
J	Wieczorek, K; Wolkowicz, T; Osek, J				Wieczorek, Kinga; Wolkowicz, Tomasz; Osek, Jacek			MLST-based genetic relatedness of Campylobacter jejuni isolated from chickens and humans in Poland	PLOS ONE			English	Article							MULTILOCUS SEQUENCE TYPES; ANTIBIOTIC-RESISTANCE; POPULATION-STRUCTURE; ANTIMICROBIAL RESISTANCE; POULTRY CARCASSES; EPIDEMIOLOGY; DIVERSITY; GENOTYPES	Campylobacter jejuni infection is one of the most frequently reported foodborne bacterial diseases worldwide. The main transmission route of these microorganisms to humans is consumption of contaminated food, especially of chicken origin. The aim of this study was to analyze the genetic relatedness of C. jejuni from chicken sources (feces, carcasses, and meat) and from humans with diarrhea as well as to subtype the isolates to gain better insight into their population structure present in Poland. C. jejuni were genotyped using multilocus sequence typing (MLST) and sequence types (STs) were assigned in the MLST database. Among 602 isolates tested, a total of 121 different STs, including 70 (57.9%) unique to the isolates' origin, and 32 STs that were not present in the MLST database were identified. The most prevalent STs were ST464 and ST257, with 58 (9.6%) and 52 (8.6%) C. jejuni isolates, respectively. Isolates with some STs (464, 6411, 257, 50) were shown to be common in chickens, whereas others (e.g. ST21 and ST572) were more often identified among human C. jejuni. It was shown that of 47 human sequence types, 26 STs (106 isolates), 23 STs (102 isolates), and 29 STs (100 isolates) were also identified in chicken feces, meat, and carcasses, respectively. These results, together with the high and similar proportional similarity indexes (PSI) calculated for C. jejuni isolated from patients and chickens, may suggest that human campylobacteriosis was associated with contaminated chicken meat or meat products or other kinds of food cross-contaminated with campylobacters of chicken origin. The frequency of various sequence types identified in the present study generally reflects of the prevalence of STs in other countries which may suggest that C. jejuni with some STs have a global distribution, while other genotypes may be more restricted to certain countries.	[Wieczorek, Kinga; Osek, Jacek] Natl Vet Res Inst, Dept Hyg Food Anim Origin, Pulawy, Poland; [Wolkowicz, Tomasz] Natl Inst Hyg, Dept Bacteriol & Biocontaminat Control, Natl Inst Publ Hlth, Warsaw, Poland	National Veterinary Institute - National Research Institute; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH)	Osek, J (corresponding author), Natl Vet Res Inst, Dept Hyg Food Anim Origin, Pulawy, Poland.	josek@piwet.pulawy.pl	Osek, Jacek/ABD-3337-2020	Osek, Jacek/0000-0003-2295-8837	National Science Centre, Poland [UMO-2014/15/B/NZ7/00874]; One Health EJP project from the European Union's Horizon 2020 research and innovation programme [773830]	National Science Centre, Poland(National Science Centre, Poland); One Health EJP project from the European Union's Horizon 2020 research and innovation programme	This study was financially supported by National Science Centre, Poland, on the basis of Decision UMO-2014/15/B/NZ7/00874 (JO). The present work was in part supported by the One Health EJP project that has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 773830 (2018-2022) (KW). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colles FM, 2012, MICROBIOL-SGM, V158, P2695, DOI 10.1099/mic.0.062000-0; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Garrett N, 2007, J APPL MICROBIOL, V103, P2113, DOI 10.1111/j.1365-2672.2007.03437.x; Griekspoor P, 2015, VET MICROBIOL, V178, P94, DOI 10.1016/j.vetmic.2015.04.025; Habib I, 2009, APPL ENVIRON MICROB, V75, P4264, DOI 10.1128/AEM.00168-09; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iglesias-Torrens Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01676; Islam Z, 2014, EUR J CLIN MICROBIOL, V33, P2173, DOI 10.1007/s10096-014-2184-x; Jay-Russell MT, 2013, J CLIN MICROBIOL, V51, P195, DOI 10.1128/JCM.01845-12; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Kittl S, 2011, J APPL MICROBIOL, V110, P513, DOI 10.1111/j.1365-2672.2010.04906.x; Kittl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081796; Kovac J, 2018, ZOONOSES PUBLIC HLTH, V65, P51, DOI 10.1111/zph.12366; Kovanen SM, 2014, J CLIN MICROBIOL, V52, P4147, DOI 10.1128/JCM.01959-14; Llarena AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116585; Mickan L, 2007, J APPL MICROBIOL, V102, P144, DOI 10.1111/j.1365-2672.2006.03049.x; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Newell DG, 2001, APPL ENVIRON MICROB, V67, P2636, DOI 10.1128/AEM.67.6.2636-2640.2001; Nielsen LN, 2010, J APPL MICROBIOL, V108, P591, DOI 10.1111/j.1365-2672.2009.04444.x; Ohishi T, 2017, J INFECT CHEMOTHER, V23, P165, DOI 10.1016/j.jiac.2016.11.011; Prachantasena S, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0149585, 10.1371]; Ramonaite S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2535-1; Ravel A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183790; Rosenquist H, 2006, INT J FOOD MICROBIOL, V108, P226, DOI 10.1016/j.ijfoodmicro.2005.12.007; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Skarp CPA, 2016, CLIN MICROBIOL INFEC, V22, P103, DOI 10.1016/j.cmi.2015.11.019; Smid JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055029; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stone D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/794643; Tresse O, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01908; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1055, DOI 10.1099/00207713-47-4-1055; Vidal AB, 2016, APPL ENVIRON MICROB, V82, P2347, DOI 10.1128/AEM.03693-15; Vinueza-Burgos C, 2017, POULTRY SCI, V96, P2366, DOI 10.3382/ps/pew487; Wieczorek K, 2017, POULTRY SCI, V96, P703, DOI 10.3382/ps/pew343; Wieczorek K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01508; Wieczorek K, 2013, J FOOD PROTECT, V76, P1451, DOI 10.4315/0362-028X.JFP-13-035; Wieczorek K, 2013, FOOD MICROBIOL, V34, P130, DOI 10.1016/j.fm.2012.12.003; Wirz SE, 2010, APPL ENVIRON MICROB, V76, P6377, DOI 10.1128/AEM.00813-10	43	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226238	10.1371/journal.pone.0226238	http://dx.doi.org/10.1371/journal.pone.0226238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978059	Green Published, gold			2022-12-26	WOS:000534599100013
J	Hamdan, M; Haddad, B; Isleem, U; Yaghi, R; Hamad, SB; Al-Balkhi, R; Afifi, R; Alryalat, SA; Hadidi, F; Khanfar, A; Shatarat, A				Hamdan, Mohammad; Haddad, Bassem; Isleem, Ula; Yaghi, Rami; Hamad, Salsabiela Bani; Al-Balkhi, Rahaf; Afifi, Rami; Alryalat, Saif Aldeen; Hadidi, Fadi; Khanfar, Aws; Shatarat, Amjad			Use of magnetic resonance imaging to determine laterality of meniscal size in healthy volunteers	PLOS ONE			English	Article							HEIGHT	Introduction The menisci are responsible for several functions. They are shock absorbers during dynamic loading on the knee and provide a broader surface area on which to distribute stress evenly to the tibia and femur. These functions allow for smoother movement and greater stability of the knee joint. Meniscal injury can be a great impediment to the function of the knee. Therefore, in the case of meniscal injury, our main concern is the relief of patient symptoms, followed by consequent restoration of meniscal function to the greatest of our ability. To prevent the long terms effects of a meniscectomy, meniscal allograft transplantation (MAT) was developed. The potential of using the size of the contralateral healthy menisci, to determine the size of the menisci to be replaced, will be discussed. Methods Knee MRIs done on healthy patients in the past 5 years were reviewed. Magnetic Resonance Imaging was performed using a 3-T scanner. Each individual was examined with knee joints in full extension. Measurements were performed two separate times, two weeks apart. A mean of three measurements was made during each session to reduce error. Thirty-eight normal bilateral knee joints MRIs remained (16 males, 22 females). Participants were sampled from the institutional Picture Archiving and Communication System (PACS). Age, gender, and the medial meniscal and lateral meniscal size of both knees were recorded. The laterality of the menisci was compared between both knees in each patient. Results A total of 38 patients were included in this study, with a mean age of 37.39 (+/- 9.50) years. They were 16 (42.1%) men and 22 (57.9%) women. We didn't find any significant difference in the mid-coronal section between left and right knees meniscal measurements. None of the measurements were significantly different between men and women. There was no significant difference in the medial mid-sagittal section or lateral mid-sagittal section between left and right knee meniscal measurements. Conclusion The results obtained in this study may support the use of MRI of the bilateral knee to obtain an appropriately sized allograft.	[Hamdan, Mohammad; Haddad, Bassem; Yaghi, Rami] Jordan Univ Hosp, Dept Orthopaed Surg, Queen Rania St, Amman, Jordan; [Isleem, Ula; Hamad, Salsabiela Bani; Al-Balkhi, Rahaf; Afifi, Rami; Hadidi, Fadi; Khanfar, Aws] Univ Jordan, Fac Med, Queen Rania St, Amman, Jordan; [Alryalat, Saif Aldeen] Jordan Univ Hosp, Dept Opthalmol, Queen Rania St, Amman, Jordan; [Shatarat, Amjad] Univ Jordan, Dept Anat, Queen Rania St, Amman, Jordan	University of Jordan; University of Jordan; University of Jordan; University of Jordan	Isleem, U (corresponding author), Univ Jordan, Fac Med, Queen Rania St, Amman, Jordan.	ulaisleem289@gmail.com	hadidi, Fadi/J-3063-2016; AlRyalat, Saif Aldeen/J-7528-2016; Haddad, Bassem/AAT-8910-2021; khanfar, aws/U-5437-2019; Hamdan, Mohammad/V-7979-2018	hadidi, Fadi/0000-0002-7456-9377; AlRyalat, Saif Aldeen/0000-0001-5588-9458; khanfar, aws/0000-0001-9477-5752; Hamdan, Mohammad/0000-0003-2382-5585; Haddad, Bassem I./0000-0001-7246-2384; Al Balkhi, Rahaf/0000-0002-2990-5060; Shatarat, Dr. Amjad/0000-0002-2101-0174; Isleem, Ula/0000-0002-3965-3071				Danso EK, 2017, J MECH BEHAV BIOMED, V67, P51, DOI 10.1016/j.jmbbm.2016.12.002; Dienst M, 2007, AM J SPORT MED, V35, P34, DOI 10.1177/0363546506291404; Fox AJS, 2015, CLIN ANAT, V28, P269, DOI 10.1002/ca.22456; Kaleka CC, 2016, AM J SPORT MED, V44, P2876, DOI 10.1177/0363546516653203; Netto AD, 2018, KNEE SURG SPORT TR A, V26, P772, DOI 10.1007/s00167-017-4461-6; Pollard ME, 1995, ARTHROSCOPY, V11, P684, DOI 10.1016/0749-8063(95)90110-8; Prodromos CC, 2007, ARTHROSCOPY, V23, P1174, DOI 10.1016/j.arthro.2007.06.018; Rosso F, 2015, AM J SPORT MED, V43, P998, DOI 10.1177/0363546514536021; Shaffer B, 2000, AM J SPORT MED, V28, P524, DOI 10.1177/03635465000280041301; Stone KR, 2007, ARTHROSCOPY, V23, P503, DOI 10.1016/j.arthro.2006.12.025; Walker PS, 2015, J BIOMECH, V48, P1383, DOI 10.1016/j.jbiomech.2015.02.055; Yoon JR, 2014, ARTHROSCOPY, V30, P1287, DOI 10.1016/j.arthro.2014.05.009	12	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228040	10.1371/journal.pone.0228040	http://dx.doi.org/10.1371/journal.pone.0228040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971967	Green Published, gold			2022-12-26	WOS:000534374400034
J	Huang, MW; Wang, Q; Long, F; Di, Y; Wang, JH; Zhu, YZ; Liu, XH				Huang, Mengwei; Wang, Qing; Long, Fen; Di, Yang; Wang, Jinghuan; Zhu, Yi Zhun; Liu, Xinhua			Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice	FASEB JOURNAL			English	Article						bone marrow-derived macrophages; inflammatory bowel disease; Jmjd3; NLRP3	SULFATE SODIUM DSS; PATTERN-RECOGNITION; NLRP3; NRF2; EXPRESSION; MECHANISM; RECEPTORS; DISEASE; GENES	The intracellular NOD-like receptor nucleotide-binding domain-like receptors Family Pyrin Domain Containing 3 (NLRP3) is a pivotal regulator of intestinal homeostasis through regulating a variety of inflammatory and autoimmune diseases. The Jumonji domain-containing 3 (Jmjd3) plays important role in inflammatory responses and thus has been proposed as a novel attractive epigenetic target for the treatment of inflammatory diseases. We here investigated whether targeting Jmjd3 regulates NLRP3 inflammasome during experimental colitis. Jmjd3 specific inhibitor GSK J4 or knocking down Jmjd3 significantly inhibited NLRP3 inflammasome activation in lipopolysaccharide (LPS) and nigericin-stimulated bone marrow-derived macrophages. Chromatin immunoprecipitation-PCR analysis validated that GSK J4 rescued the decreased repressive H3K27me3 recruitment level on the promotors of nuclear factor-erythroid 2-related factor 2 (Nrf2) in LPS plus nigericin-induced macrophages. Nrf2 knockdown abolished NLRP3 inflammasome activation. Notably, oral administration of GSK J4 attenuated the disease progression in dextran sodium sulfate-induced colitis mouse model, including reduced disease activity index, improved body weight, rescued bowel shortening and NLRP3 inflammasome activation. Overall, our study reveals that Jmjd3 is a potential epigenetic regulator for the treatment of inflammatory bowel disease (IBD), suggesting that Nrf2 is a potential target gene of Jmjd3 by mediating methylation status of trimethylated H3 lysine 27 (H3K27me3) in the promotor and is required for NLRP3 inflammasome activation, thereby providing the platform for potential future therapeutic interventions in IBD.	[Huang, Mengwei; Wang, Qing; Long, Fen; Di, Yang; Wang, Jinghuan; Zhu, Yi Zhun; Liu, Xinhua] Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China; [Zhu, Yi Zhun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhu, Yi Zhun] Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China	Fudan University; Macau University of Science & Technology; Macau University of Science & Technology	Liu, XH (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	liuxinhua@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Natural Science Foundation of China (NSFC) [81673428, 81872861]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673428 and 81872861	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Das ND, 2012, CELL BIOCHEM FUNCT, V30, P224, DOI 10.1002/cbf.1839; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Donas C, 2016, J AUTOIMMUN, V75, P105, DOI 10.1016/j.jaut.2016.07.011; Dumont NA, 2013, AM J PATHOL, V182, P505, DOI 10.1016/j.ajpath.2012.10.010; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim Y, 2018, FOOD RES INT, V106, P335, DOI 10.1016/j.foodres.2017.12.058; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu XT, 2017, ANTIOXID REDOX SIGN, V26, P28, DOI 10.1089/ars.2015.6615; Liu XT, 2016, BIOCHEM PHARMACOL, V112, P37, DOI 10.1016/j.bcp.2016.05.002; Loher F, 2004, J PHARMACOL EXP THER, V308, P583, DOI 10.1124/jpet.103.057059; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Luo XL, 2018, CARDIOVASC RES, V114, P1894, DOI 10.1093/cvr/cvy176; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yu SQ, 2017, BIOCHEM BIOPH RES CO, V485, P62, DOI 10.1016/j.bbrc.2017.02.020; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	38	20	20	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4107	4119		10.1096/fj.201902200RR	http://dx.doi.org/10.1096/fj.201902200RR		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31971317	Bronze			2022-12-26	WOS:000508880900001
J	Zhu, DW; Shi, XF; Nicholas, S; He, P				Zhu, Dawei; Shi, Xuefeng; Nicholas, Stephen; He, Ping			Regional disparities in health care resources in traditional Chinese medicine county hospitals in China	PLOS ONE			English	Article							PERFORMANCE; MORTALITY	Objective We aimed to analyze regional disparities of health care resources in traditional Chinese medicine (TCM) county hospitals and their time trends, and to assess the changes of regional disparities before and after 2009 health care reforms. Methods We used hospital-based, longitudinal data from all TCM county hospitals in China between 2004 and 2016. To measure the key development features of TCM county hospitals, data were collected on government hospital investment, hospital numbers (the average number of TCM hospitals per county), hospital scale (the number of medical staff and hospital beds) and doctors' workload (the daily visits and inpatient stays per doctor). We used segmented linear regression to test the time trend for outcome variables. We set a breakpoint at 2011, dividing the pre-reform (2004-2011) and post-reform (2012-2016) periods. Results After the 2009 health reforms, TCM hospitals continued to display large disparities in the number, scale, and doctors' workload across the three regions. In the pre-reform period, yearly government subsidies for TCM hospitals in western area were roughly RMB0.6 million (US$89 thousand) more than those in central and eastern region, which increased under the 2009 reforms to roughly RMB2 million (US$298 thousand) more per yer in post-reform period. These increased subsidies saw an increase in the number of TCM hospitals in the western area, partly addressing regional disparities. But there was no improvement in the regional disparities in terms of scale (number of beds) and the doctors' workload (daily outpatient visits and inpatients per doctor) increased or remained unchanged between the western and other regions. Conclusion Although TCM hospital number, scale, and doctors' workload increased over the past 13 years, substantial regional disparities remained. The 2009 health reforms did not significantly change the regional disparities in health care resources, especially between the eastern and western regions.	[Zhu, Dawei; He, Ping] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China; [Shi, Xuefeng] Beijing Univ Chinese Med, Sch Management, Beijing, Peoples R China; [Shi, Xuefeng] Beijing Univ Chinese Med, Natl Inst Chinese Med Dev & Strategy, Beijing, Peoples R China; [Nicholas, Stephen] Guangdong Univ Foreign Studies, Res Inst Int Strategies, Guangzhou, Guangdong, Peoples R China; [Nicholas, Stephen] Tianjin Normal Univ, Sch Econ & Sch Management, Tianjin, Peoples R China; [Nicholas, Stephen] TOP Educ Inst, Sydney, NSW, Australia; [Nicholas, Stephen] Univ Newcastle, Newcastle Business Sch, Newcastle, NSW, Australia	Peking University; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Guangdong University of Foreign Studies; Tianjin Normal University; University of Newcastle	He, P (corresponding author), Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China.	phe@pku.edu.cn	NICHOLAS, STEPHEN/ABE-4726-2021	Nicholas, Stephen/0000-0001-6770-7105; Zhu, Dawei/0000-0003-0167-6603	Peking University's Start-up Fund [BMU2018YJ004]	Peking University's Start-up Fund	This paper was supported by Peking University's Start-up Fund (No. BMU2018YJ004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3310; Chen L, 2016, CHIN HOSP MANAG, V36, P1; Chen TX, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0827-8; China's state council, 2016, OUTL STRAT PLANN DEV; China's state council, 2009, IMPLEMENTATION PLAN; China's state council, 2016, WHIT PAP DEV TRAD CH; Division of the Eastern Central and Western China, 2000, CHINA POPUL TODAY, V3; Fan SG, 2011, REV DEV FINANC, V1, P47, DOI 10.1016/j.rdf.2010.10.001; Fang PQ, 2010, HEALTH POLICY, V94, P14, DOI 10.1016/j.healthpol.2009.08.002; GUO S, 2015, MODERN EC, V6, P871, DOI DOI 10.4236/ME.2015.68082; Han B.T., 2013, THESIS; He CH, 2017, LANCET GLOB HEALTH, V5, pE186, DOI [10.1016/S2214-109X(16)30334-5, 10.1016/s2214-109x(16)30334-5]; Horev T, 2004, HEALTH POLICY, V68, P223, DOI 10.1016/j.healthpol.2003.09.011; Jiang S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2780-4; Jin J, 2015, IRAN J PUBLIC HEALTH, V44, P13; Kanbur SR, 1999, WHY IS INEQUALITY BA; Keppel K, 2013, VITAL HLTH STAT, V34; Li HB, 2005, J PUBLIC ECON, V89, P1743, DOI 10.1016/j.jpubeco.2004.06.009; Liang D, 2016, INQUIRY-J HEALTH CAR, V53, DOI 10.1177/0046958016631699; Liu D, 2015, INT J HEALTH ECON MA, V15, P407, DOI 10.1007/s10754-015-9175-z; Lu LM, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0882-1; Murray CJL, 2000, B WHO, V15; National Health and Family Planning Commission, 2016, CHIN HLTH FAM PLANN; Pan J, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0467-9; Wagstaff A, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7982-0; Wang L, 2017, INT J HEALTH POLICY, V6, P19, DOI 10.15171/ijhpm.2016.72; Wang SP, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0896-8; World Bank, 2016, 1 WORLD BANK, p1e12; WPRO, 2011, HLTH SECT REF CHIN; Wu Q, 2016, CHIN HOSP MANAG, V36, P11; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang T, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0543-9; Zhou KY, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0089-0; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	34	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227956	10.1371/journal.pone.0227956	http://dx.doi.org/10.1371/journal.pone.0227956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5QJ	31961912	Green Published, gold			2022-12-26	WOS:000534372000020
J	Goodall, KJ; Nguyen, A; McKenzie, C; Eckle, SBG; Sullivan, LC; Andrews, DM				Goodall, Katharine Jennifer; Nguyen, Angela; McKenzie, Craig; Eckle, Sidonia Barbara Guiomar; Sullivan, Lucy Catherine; Andrews, Daniel Mark			The murine CD94/NKG2 ligand, Qa-1(b), is a high-affinity, functional ligand for the CD8?? homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						major histocompatibility complex (MHC); innate immunity; lymphocyte; T-cell biology; cell biology; CD8aa; MHC class I antigen E (HLA-E); MHC-Ib; Qa-1b; T cell; TL; cell surface glycoprotein; MHC class I antigen E (HLA-E)	CLASS-IB MOLECULE; DELTA-T-CELLS; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; STRUCTURAL BASIS; DIFFERENTIAL EXPRESSION; CORECEPTOR FUNCTION; CRYSTAL-STRUCTURE; LEUKEMIA ANTIGEN; DENDRITIC CELLS; HLA-E	The immune co-receptor CD8 molecule (CD8) has two subunits, CD8? and CD8?, which can assemble into homo or heterodimers. Nonclassical (class-Ib) major histocompatibility complex (MHC) molecules (MHC-Ibs) have recently been identified as ligands for the CD8?? homodimer. This was demonstrated by the observation that histocompatibility 2, Q region locus 10 (H2-Q10) is a high-affinity ligand for CD8?? which also binds the MHC-Ib molecule H2-TL. This suggests that MHC-Ib proteins may be an extended source of CD8?? ligands. Expression of H2-T3/TL and H2-Q10 is restricted to the small intestine and liver, respectively, yet CD8??-containing lymphocytes are present more broadly. Therefore, here we sought to determine whether murine CD8?? binds only to tissue-specific MHC-Ib molecules or also to ubiquitously expressed MHC-Ib molecules. Using recombinant proteins and surface plasmon resonance?based binding assays, we show that the MHC-Ib family furnishes multiple binding partners for murine CD8??, including H2-T22 and the CD94/NKG2-A/B-activating NK receptor (NKG2) ligand Qa-1(b). We also demonstrate a hierarchy among MHC-Ib proteins with respect to CD8?? binding, in which Qa-1(b) > H2-Q10 > TL. Finally, we provide evidence that Qa-1(b) is a functional ligand for CD8??, distinguishing it from its human homologue MHC class I antigen E (HLA-E). These findings provide additional clues as to how CD8??-expressing cells are controlled in different tissues. They also highlight an unexpected immunological divergence of Qa-1(b)/HLA-E function, indicating the need for more robust studies of murine MHC-Ib proteins as models for human disease.	[Goodall, Katharine Jennifer; Nguyen, Angela; McKenzie, Craig; Andrews, Daniel Mark] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia; [Eckle, Sidonia Barbara Guiomar; Sullivan, Lucy Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Andrews, Daniel Mark] RMIT Univ, Bioproperties Pty Ltd, Bundoora Campus, Bundoora, Vic 3083, Australia	Monash University; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Goodall, KJ (corresponding author), Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	katharine.goodall@monash.edu	Eckle, Sidonia/O-8146-2014	Eckle, Sidonia/0000-0003-0766-171X; Sullivan, Lucy/0000-0003-2907-4989; Goodall, Katharine/0000-0001-5812-8515; Andrews, Dan/0000-0002-5896-7885; Nguyen, Angela/0000-0003-1610-515X	National Health and Medical Research Council (NHMRC) [APP1141950]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Grant APP1141950 (to L. C. S.).	Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Attinger A, 2005, J IMMUNOL, V174, P3501, DOI 10.4049/jimmunol.174.6.3501; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Colmenero P, 2007, J IMMUNOL, V179, P4608, DOI 10.4049/jimmunol.179.7.4608; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; COSMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P4947, DOI 10.1073/pnas.79.16.4947; Della Chiesa M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00573; DISANTO JP, 1988, EMBO J, V7, P3465, DOI 10.1002/j.1460-2075.1988.tb03221.x; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Goodall KJ, 2019, IMMUNOL CELL BIOL, V97, P326, DOI 10.1111/imcb.12222; Goodall KJ, 2019, MOL IMMUNOL, V115, P31, DOI [10.1016/jmolimm.2018.05.001, 10.1016/j.molimm.2018.05.001]; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Kadivar M, 2016, J IMMUNOL, V197, P4584, DOI 10.4049/jimmunol.1601146; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kenna T, 2004, CLIN IMMUNOL, V113, P56, DOI 10.1016/j.clim.2004.05.003; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Khairallah C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004702; KRESS M, 1983, CELL, V34, P189, DOI 10.1016/0092-8674(83)90149-6; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; LEW AM, 1986, J IMMUNOL, V136, P254; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; McNicol AM, 2007, EUR J IMMUNOL, V37, P1634, DOI 10.1002/eji.200636900; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; OHTSUKA K, 1994, CELL IMMUNOL, V153, P52, DOI 10.1006/cimm.1994.1005; Ohtsuka M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-178; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; SATO K, 1993, IMMUNOLOGY, V80, P380; Sipes SL, 1996, IMMUNOGENETICS, V45, P108, DOI 10.1007/s002510050178; Sullivan LC, 2017, J BIOL CHEM, V292, P21149, DOI 10.1074/jbc.M117.807719; Sullivan LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135972; Tang XL, 2007, J IMMUNOL, V178, P6043, DOI 10.4049/jimmunol.178.10.6043; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; TORRESNAGEL N, 1992, EUR J IMMUNOL, V22, P2841, DOI 10.1002/eji.1830221113; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WEI XH, 1990, HUM IMMUNOL, V29, P131, DOI 10.1016/0198-8859(90)90076-2; WU M, 1991, J EXP MED, V174, P213, DOI 10.1084/jem.174.1.213	52	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3239	3246		10.1074/jbc.RA119.010509	http://dx.doi.org/10.1074/jbc.RA119.010509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31992596	hybrid, Green Published			2022-12-26	WOS:000519597300028
J	Chen, ZH; Yang, LK; Chen, L; Li, J; Zhang, FT; Xing, YF; Zhao, J				Chen, Zhaohui; Yang, Likun; Chen, Liang; Li, Jin; Zhang, Futian; Xing, Yifei; Zhao, Jun			miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma	FASEB JOURNAL			English	Article						bladder cancer; micro-RNA; NLRC3 expression; Wnt; beta-catenin and mTOR signaling	MTOR; FAMILY	Bladder cancer is one of the most common urogenital malignancies. However, its pathogenesis, especially molecular mechanisms remain elusive. Thus, understanding the molecular mechanisms underlying bladder cancer is important for the discovery of novel therapeutic paradigms for these diseases. In current study, we found that micro-RNA (miR)-190b is highly expressed in bladder cancer tissues and cells. Overexpression of miR-190b enhanced the proliferation, growth, migration and invasion capabilities, and angiogenesis of bladder cancer cells, whereas downregulation of miR-190b reversed these effects. Target prediction and dual luciferase reporter assays identified NLR family CARD domain containing 3 (NLRC3) as a potential target of miR-190b. Pathway analysis indicated that miR-190b promotes bladder cancer progression via the Wnt/beta-catenin and mTOR signaling pathways. Taken together, our findings imply that miR-190b acts as a critical regulator for bladder cancer development by repressing NLRC3 and partly through the Wnt/beta-catenin and mTOR pathways. Our study suggests that miR-190b may be served as a potential therapeutic target for bladder cancer treatment.	[Chen, Zhaohui; Yang, Likun; Chen, Liang; Zhang, Futian; Xing, Yifei; Zhao, Jun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Li, Jin] Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang, Jiangxi, Peoples R China	Huazhong University of Science & Technology; Nanchang University	Xing, YF; Zhao, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	yifei_xing@163.com; zhaojun19621231@126.com						Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Guo LT, 2017, INT J MOL MED, V40, P898, DOI 10.3892/ijmm.2017.3077; Hu B, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0573-9; Hu SF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007266; Karki R, 2017, CELL CYCLE, V16, P1243, DOI 10.1080/15384101.2017.1317414; Karki R, 2016, NATURE, V540, P583, DOI 10.1038/nature20597; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leavy O, 2017, NAT REV IMMUNOL, V17, P79, DOI 10.1038/nri.2016.152; Liu JY, 2018, ONCOGENE, V37, P3937, DOI 10.1038/s41388-018-0223-2; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tartey S, 2019, IMMUNOLOGY, V156, P329, DOI 10.1111/imm.13046; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Wang Q, 2019, CANCER LETT, V444, P9, DOI 10.1016/j.canlet.2018.11.024; Woolbright BL, 2018, UROL ONCOL-SEMIN ORI, V36, P327, DOI 10.1016/j.urolonc.2018.04.010; Zha LH, 2019, J CELL PHYSIOL, V234, P15963, DOI 10.1002/jcp.28255	18	8	9	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4072	4084		10.1096/fj.201901764R	http://dx.doi.org/10.1096/fj.201901764R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31953872	Bronze			2022-12-26	WOS:000519218400043
J	Razai, AS; Eckelman, BP; Salvesen, GS				Razai, Amir S.; Eckelman, Brendan P.; Salvesen, Guy S.			Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; antibody; metalloprotease; protease inhibitor; single-domain antibody; sdAb; nanobody; matrix metalloproteinase; protease; MMP10; MMP3; antibody selectivity; camelid; orthosteric inhibitor	ALPHA-1-PROTEINASE INHIBITOR; THERAPEUTIC TARGETS; TISSUE INHIBITOR; NANOBODIES	Since their discovery, the matrix metalloproteinase (MMP) family proteases have been considered as therapeutic targets in numerous diseases and disorders. Unfortunately, clinical trials with MMP inhibitors have failed to yield any clinical benefits of these inhibitors. These failures were largely due to a lack of MMP-selective agents; accordingly, it has become important to identify a platform with which high selectivity can be achieved. To this end, we propose using MMP-targeting antibodies that can achieve high specificity in interactions with their targets. Using a scaffold of single-domain antibodies, here we raised a panel of MMP10-selective antibodies through immunization of llamas, a member of the camelid family, whose members generate conventional heavy/light-chain antibodies and also smaller antibodies lacking light-chain and CH1 domains. We report the generation of a highly selective and tightly binding MMP10 inhibitor (K-i < 2 nm). Using bio-layer interferometry?based binding assays, we found that this antibody interacts with the MMP10 active site. Activity assays demonstrated that the antibody selectively inhibits MMP10 over its closest relative, MMP3. The ability of a single-domain antibody to discriminate between the most conserved MMP pair via an active site?directed mechanism of inhibition reported here supports the potential of this antibody as a broadly applicable scaffold for the development of selective, tightly binding MMP inhibitors.	[Razai, Amir S.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Razai, Amir S.; Eckelman, Brendan P.] Inhibrx, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Salvesen, GS (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	Gsalvesen@sbpdiscovery.org			NIGMS, National Institutes of Health [GM-099040]; Academic/Industry Fellowship from Inhibrx	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Academic/Industry Fellowship from Inhibrx	This work was supported by NIGMS, National Institutes of Health, Grant GM-099040 (to G. S. S.) and an Academic/Industry Fellowship from Inhibrx (to A. S. R.). The authors declare the following financial relationships. Amir S. Razai and Guy S. Salvesen consult for Inhibrx, and Brendan P. Eckelman is employed by Inhibrx. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brown PD, 1999, APMIS, V107, P174, DOI 10.1111/j.1699-0463.1999.tb01541.x; Buelens K, 2010, J THROMB HAEMOST, V8, P1302, DOI 10.1111/j.1538-7836.2010.03816.x; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Fingleton Barbara, 2008, P759, DOI 10.1007/978-0-387-69057-5_36; Gatto C, 1999, CLIN CANCER RES, V5, P3603; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Liotta L A, 1982, Cancer Metastasis Rev, V1, P277, DOI 10.1007/BF00124213; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Mariya T, 2016, ONCOTARGET, V7, P26806, DOI 10.18632/oncotarget.8645; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; MAST AE, 1991, J BIOL CHEM, V266, P15810; Mazurek SGN, 2011, J PHARMACOL TOX MET, V64, P89, DOI 10.1016/j.vascn.2011.02.002; Muyldermans S, 2001, J Biotechnol, V74, P277; Nagase H, 1999, ANN NY ACAD SCI, V878, P1, DOI 10.1111/j.1749-6632.1999.tb07670.x; Nagase H, 2002, ARTHRITIS RES THER, V4, pS51, DOI 10.1186/ar573; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Peterson JT, 2004, HEART FAIL REV, V9, P63, DOI 10.1023/B:HREV.0000011395.11179.af; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Revets H, 2005, EXPERT OPIN BIOL TH, V5, P111, DOI 10.1517/14712598.5.1.111; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Santamaria S, 2019, BRIT J PHARMACOL, V176, P52, DOI 10.1111/bph.14186; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2464	2472		10.1074/jbc.RA119.011712	http://dx.doi.org/10.1074/jbc.RA119.011712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953328	hybrid, Green Published			2022-12-26	WOS:000517330200026
J	Vilades, D; Martinez-Camblor, P; Ferrero-Gregori, A; Bar, C; Lu, DC; Xiao, K; Vea, A; Nasarre, L; Vega, JS; Leta, R; Carreras, F; Thum, T; Llorente-Cortes, V; de Gonzalo-Calvo, D				Vilades, David; Martinez-Camblor, Pablo; Ferrero-Gregori, Andreu; Baer, Christian; Lu, Dongchao; Xiao, Ke; Vea, Angela; Nasarre, Laura; Sanchez Vega, Jesus; Leta, Ruben; Carreras, Francesc; Thum, Thomas; Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David		EU CardioRNA COST Action	Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker	FASEB JOURNAL			English	Article						atherosclerosis; biomarker; chronic coronary syndrome; circular RNA; circSMARCA5; coronary artery disease; coronary heart disease; hsa_circ_0001445; ischemic heart disease; SMARCA5; stability	MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; CT ANGIOGRAPHY; MICRORNA; PREDICTION; ATHEROSCLEROSIS; EXPRESSION; ABUNDANT	The role of circular RNAs (circRNAs) as biomarkers remains poorly characterized. Here, we investigated the performance of the circRNA hsa_circ_0001445 as a biomarker of coronary artery disease (CAD) in a real-world clinical practice setting. Plasma hsa_circ_0001445 was measured in a study population of 200 consecutive patients with suspected stable CAD who had undergone coronary computed tomographic angiography (CTA). Multivariable logistic models were constructed combining conventional risk factors with established biomarkers and hsa_circ_0001445. Model robustness was internally validated by the bootstrap technique. Biomarker accuracy was evaluated using the C-index. The integrated discrimination improvement (IDI) and net reclassification improvement (NRI) were also calculated. Risk groups were developed via classification tree models. The stability of plasma hsa_circ_0001445 was evaluated under different clinical conditions. hsa_circ_0001445 levels were associated with higher coronary atherosclerosis extent and severity with a 2-fold increase across tertiles (28.4%-50.0%). Levels of hsa_circ_0001445 were proportional to coronary atherosclerotic burden, even after comprehensive adjustment for cardiovascular risk factors, medications, and established biomarkers (fully adjusted OR = 0.432 for hsa_circ_0001445 as a continuous variable and fully adjusted OR = 0.277 for hsa_circ_0001445 as a binary variable). The classification of patients was improved with the incorporation of hsa_circ_0001445 into a base clinical model (CM) composed of conventional cardiovascular risk factors, showing an IDI of 0.047 and NRI of 0.482 for hsa_circ_0001445 as a continuous variable and an IDI of 0.056 and NRI of 0.373 for hsa_circ_0001445 as a binary variable. A trend toward higher discrimination capacity was also observed (C-index(CM) = 0.833, C-index(CM+continuous hsa_circ_0001445) = 0.856 and C-index(CM+binary hsa_circ_0001445) = 0.855). Detailed analysis of stability showed that hsa_circ_0001445 was present in plasma in a remarkably stable form. In vitro, hsa_circ_0001445 was downregulated in extracellular vesicles secreted by human coronary smooth muscle cells upon exposure to atherogenic conditions. In patients with suspected stable CAD referred for coronary CTA, plasma hsa_circ_0001445 improves the identification of coronary artery atherosclerosis.	[Vilades, David; Sanchez Vega, Jesus; Leta, Ruben; Carreras, Francesc] UAB, Hosp Santa Creu & St Pau, Cardiol Serv, Cardiac Imaging Unit, Barcelona, Spain; [Martinez-Camblor, Pablo] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Ferrero-Gregori, Andreu] UAB, Hosp Santa Creu & St Pau, Cardiol Serv, Barcelona, Spain; [Ferrero-Gregori, Andreu; Carreras, Francesc; Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David] Inst Hlth Carlos III, CIBER Cardiovasc CIBERCV, Madrid, Spain; [Baer, Christian; Lu, Dongchao; Xiao, Ke; Thum, Thomas; de Gonzalo-Calvo, David] Hannover Med Sch, IMTTS, Hannover, Germany; [Baer, Christian; Thum, Thomas] Hannover Med Sch, REBIRTH Ctr Translat Regenerat Med, Hannover, Germany; [Vea, Angela; Nasarre, Laura; Carreras, Francesc; Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David] CSIC, Spanish Natl Res Council, Inst Biomed Res Barcelona IIBB, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Dartmouth College; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hannover Medical School; Hannover Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB)	Llorente-Cortes, V; de Gonzalo-Calvo, D (corresponding author), Hosp Santa Creu & Sant Pau, CSIC, Spanish Natl Res Council, Inst Biomed Res Barcelona IIBB, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	cllorente@santpau.cat; david.degonzalo@gmail.com	de Gonzalo-Calvo, David/F-6108-2018; Bär, Christian/AAC-5914-2019; LU, Dongchao/AAN-6150-2020	de Gonzalo-Calvo, David/0000-0003-2240-3532; Bar, Christian/0000-0001-9276-9383; LU, Dongchao/0000-0002-8578-3790; Carreras, Francesc/0000-0002-1944-0562; Vea Badenes, Angela/0000-0001-7856-6635	Ministry of Science Innovation and Universities [IJCI-2016-29393]; Carlos III Health Institute [CB16/11/00403, CB16/11/00276, FIS PI18/01584]; European Fund for Regional Development (EFRD); Deutsche Forschungsgemeinschaft [SFB/Transregio TRR267]; European Research Commission Consolidator Grant LONGHEART	Ministry of Science Innovation and Universities; Carlos III Health Institute(Instituto de Salud Carlos III); European Fund for Regional Development (EFRD)(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Commission Consolidator Grant LONGHEART	DdG-C was a recipient of a Juan de la Cierva-Incorporacion grant from the Ministry of Science Innovation and Universities (IJCI-2016-29393). CIBER Cardiovascular (CB16/11/00403 to VLl-C and DdG-C and CB16/11/00276 to AFG) are projects from Carlos III Health Institute. This work was supported by FIS PI18/01584 (to VLl-C) grant from Carlos III Health Institute, cofinanced by the European Fund for Regional Development (EFRD). This work was supported by Deutsche Forschungsgemeinschaft (SFB/Transregio TRR267, to CB and TT) and European Research Commission Consolidator Grant LONGHEART to TT.	Adamson PD, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004227; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Ayoub C, 2017, J CARDIOVASC COMPUT, V11, P258, DOI 10.1016/j.jcct.2017.05.001; Cury RC, 2014, J CARDIOVASC COMPUT, V8, P480, DOI 10.1016/j.jcct.2014.10.002; de Gonzalo-Calvo D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060780; de Gonzalo-Calvo D, 2019, J INTERN MED, V286, P341, DOI 10.1111/joim.12921; de Gonzalo-Calvo D, 2019, EUR HEART J, V40, P1643, DOI 10.1093/eurheartj/ehy234; de Gonzalo-Calvo D, 2017, J MOL CELL CARDIOL, V106, P55, DOI 10.1016/j.yjmcc.2017.03.005; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devaux Y, 2017, EUR J HEART FAIL, V19, P701, DOI 10.1002/ejhf.801; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Egeland GM, 2019, J INTERN MED, V286, P562, DOI 10.1111/joim.12948; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Gnanenthiran SR, 2019, EUR HEART J-CARD IMG, V20, P1279, DOI 10.1093/ehjci/jez067; Gupta SK, 2018, CIRC RES, V122, P246, DOI 10.1161/CIRCRESAHA.117.311335; Hagstrom E, 2018, J INTERN MED, V283, P83, DOI 10.1111/joim.12692; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kass GV, 1980, J R STAT SOC C-APPL, P119; Khan MAF, 2016, CIRC RES, V119, P996, DOI 10.1161/CIRCRESAHA.116.309568; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liu MJ, 2019, ARTERIOSCL THROM VAS, V39, P1715, DOI 10.1161/ATVBAHA.119.312131; Maass PG, 2017, J MOL MED, V95, P1179, DOI 10.1007/s00109-017-1582-9; McCarthy CP, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007975; McCarthy CP, 2018, AM HEART J, V196, P82, DOI 10.1016/j.ahj.2017.10.016; Memczak S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141214; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Park KC, 2017, CARDIOVASC RES, V113, P1708, DOI 10.1093/cvr/cvx183; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Santer L, 2019, MOL THER, V27, P1350, DOI 10.1016/j.ymthe.2019.07.001; Schulte C, 2019, CIRC RES, V125, P328, DOI 10.1161/CIRCRESAHA.119.314937; Stocker TJ, 2018, EUR HEART J, V39, P3715, DOI 10.1093/eurheartj/ehy546; Tan WLW, 2017, CARDIOVASC RES, V113, P298, DOI 10.1093/cvr/cvw250; Tesche C, 2016, J CARDIOVASC COMPUT, V10, P458, DOI 10.1016/j.jcct.2016.08.003; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Umekage S., 2012, INNOVATIONS BIOTECHN, P75; Vausort M, 2016, J AM COLL CARDIOL, V68, P1247, DOI 10.1016/j.jacc.2016.06.040; Vea A, 2018, NONCODING RNA INVEST, V2, P1; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang LY, 2019, ATHEROSCLEROSIS, V286, P88, DOI 10.1016/j.atherosclerosis.2019.05.006; Warburton DER, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020274; Werfel S, 2016, J MOL CELL CARDIOL, V98, P103, DOI 10.1016/j.yjmcc.2016.07.007; Wong LL, 2019, J AM COLL CARDIOL, V73, P1300, DOI 10.1016/j.jacc.2018.11.060; Zhao ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39918	51	59	60	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4403	4414		10.1096/fj.201902507R	http://dx.doi.org/10.1096/fj.201902507R		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31999007	Green Submitted			2022-12-26	WOS:000510165300001
J	Bergman, F; Edin, K; Renklint, R; Olsson, T; Sorlin, A				Bergman, Frida; Edin, Kerstin; Renklint, Rebecka; Olsson, Tommy; Sorlin, Ann			The ability to benefit from an intervention to encourage use of treadmill workstations: Experiences of office workers with overweight or obesity	PLOS ONE			English	Article							SEDENTARY TIME; METAANALYSIS; ASSOCIATION; MORTALITY; ADULTS	One way to increase physical activity in offices is to install treadmill workstations, where office workers can walk on a treadmill while performing their normal tasks. However, the experiences of people using these treadmill workstations over a long period of time is not known. In this 13-month study, we explored the experiences of office workers with treadmill workstations available in their offices. After completing a larger randomized controlled trial with 80 office workers ages 40 to 67 years with overweight or obesity, we interviewed 20 participants from the intervention group, using a semi-structured interview guide. Data were analyzed using a grounded theory approach with constant comparison of emerging codes, subcategories, and categories, followed by connecting the categories to create a core category. The core category is described as the "Ability to benefit." Although all participants had a rather high motivational level and pre-existing knowledge about the health benefits of increasing physical activity at work, they had different capacities for benefiting from the intervention. The categories are described as ideal types: the Convinced, the Competitive, the Responsible, and the Vacillating. These ideal types do not represent any single participant but suggest generalized abstractions of experiences and strategies emerging from the coding of the interviews. One participant could easily have more than one ideal type. Because of differences in ideal type strategies and paths used throughout the course of the study, participants had different abilities to benefit from the intervention. Knowledge regarding the ideal types may be applied to facilitate the use of the treadmill workstations. Because different ideal types might require different prompts for behavior change, tailored intervention strategies directed towards specific ideal types could be necessary.	[Bergman, Frida; Renklint, Rebecka; Olsson, Tommy] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Edin, Kerstin] Umea Univ, Dept Nursing, Umea, Sweden; [Sorlin, Ann] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden	Umea University; Umea University; Umea University	Bergman, F (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	frida.bergman@umu.se		Bergman, Frida/0000-0002-0923-5813	Vasterbotten County Council [500-2878-11]	Vasterbotten County Council	The study is supported by grants to TO from Umea University, reference number 500-2878-11, and from the Vasterbotten County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman F, 2018, LANCET PUBLIC HEALTH, V3, pE523, DOI 10.1016/S2468-2667(18)30163-4; Bergman F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2017-6; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brakenridge CL, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0441-3; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Chu AHY, 2016, OBES REV, V17, P467, DOI 10.1111/obr.12388; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Cifuentes M, 2015, AM J HLTH PROMOT; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Fogg BJ, 2009, P 4 INT C PERS TECN; Fogg BJ, BJ FOGGS BEHAV MODEL; Miller CK, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1127-4; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Swedberg R, 2018, J CLASS SOCIOL, V18, P181, DOI 10.1177/1468795X17743643; Thompson WG, 2008, BRIT J SPORT MED, V42, P225, DOI 10.1136/bjsm.2007.039479; Thompson WG, 2011, WORK, V40, P473, DOI 10.3233/WOR-2011-1258; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Tudor-Locke C, 2014, APPL PHYSIOL NUTR ME, V39, P1104, DOI 10.1139/apnm-2013-0435	18	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228194	10.1371/journal.pone.0228194	http://dx.doi.org/10.1371/journal.pone.0228194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990954	Green Published, gold			2022-12-26	WOS:000534605400047
J	Mora-Lagos, B; Cartas-Espinel, I; Riquelme, I; Parker, AC; Piccolo, SR; Viscarra, T; Reyes, ME; Zanella, L; Buchegger, K; Ili, C; Brebi, P				Mora-Lagos, Barbara; Cartas-Espinel, Irene; Riquelme, Ismael; Parker, Alyssa C.; Piccolo, Stephen R.; Viscarra, Tamara; Reyes, Maria Elena; Zanella, Louise; Buchegger, Kurt; Ili, Carmen; Brebi, Priscilla			Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines	PLOS ONE			English	Article							COPPER TRANSPORTER 1; DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; CONFERS CHEMORESISTANCE; MOLECULAR-MECHANISMS; RECEPTOR NR4A2; EXPRESSION; CHEMOTHERAPY; IDENTIFICATION; CYTOKINES	Gastric cancer (GC) is a significant cancer-related cause of death worldwide. The most used chemotherapeutic regimen in GC is based on platinum drugs such as cisplatin (CDDP). However, CDDP resistance reduces advanced GC survival. In vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize new models of CDDP-resistant GC cell lines (AGS R-CDDP and MKN-28 R-CDDP) obtained through a stepwise increasing drug doses method, in order to understand the molecular mechanisms underlying chemoresistance as well as identify new therapeutic targets for the treatment of GC. Cell viability assays, cell death assays and the expression of resistance molecular markers confirmed that AGS R-CDDP and MKN-28 R-CDDP are reliable CDDP-resistant models. RNA-seq and bioinformatics analyses identified a total of 189 DEGs, including 178 up-regulated genes and 11 down-regulated genes, associated mainly to molecular functions involved in CDDP-resistance. DEGs were enriched in 23 metabolic pathways, among which the most enriched was the inflammation mediated by chemokine and cytokine signaling pathway. Finally, the higher mRNA expression of SERPINA1, BTC and CCL5, three up-regulated DEGs associated to CDDP resistance found by RNA-seq analysis was confirmed. In summary, this study showed that AGS R-CDDP and MKN-28 R-CDDP are reliable models of CDDP resistance because resemble many of resistant phenotype in GC, being also useful to assess potential therapeutic targets for the treatment of gastric cancers resistant to CDDP. In addition, we identified several DEGs associated with molecular functions such as binding, catalytic activity, transcription regulator activity and transporter activity, as well as signaling pathways associated with inflammation process, which could be involved in the development of CDDP resistance in GC. Further studies are necessary to clarify the role of inflammatory processes in GC resistant to CDDP and these models could be useful for these purposes.	[Mora-Lagos, Barbara; Cartas-Espinel, Irene; Viscarra, Tamara; Reyes, Maria Elena; Zanella, Louise; Buchegger, Kurt; Ili, Carmen; Brebi, Priscilla] Univ La Frontera, Ctr Excellence Translat Med BIOREN CEMT, Lab Integrat Biol LIBi Sci & Technol Bioresource, Temuco, Chile; [Mora-Lagos, Barbara] Univ Autonoma Chile, Direcc Invest Vicerrectoria Invest & Postgrad, Temuco, Chile; [Riquelme, Ismael] Univ Autonoma Chile, Fac Ciencias Salud, Inst Ciencias Biomed, Temuco, Chile; [Parker, Alyssa C.; Piccolo, Stephen R.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Buchegger, Kurt] Univ La Frontera, Sch Med, Dept Basic Sci, Temuco, Chile	Universidad de La Frontera; Universidad Autonoma de Chile; Universidad Autonoma de Chile; Brigham Young University; Universidad de La Frontera	Ili, C; Brebi, P (corresponding author), Univ La Frontera, Ctr Excellence Translat Med BIOREN CEMT, Lab Integrat Biol LIBi Sci & Technol Bioresource, Temuco, Chile.	carmen.ili@ufrontera.cl; brebimieville@gmail.com	Buchegger, Kurt/AAH-4678-2021; Zanella, Louise/AAT-2292-2021	Zanella, Louise/0000-0001-8891-6002; Ili, Carmen/0000-0002-4009-4406; Buchegger, Kurt/0000-0002-3872-2522; Cartas-Espinel, Irene/0000-0002-5575-8578; Brebi, Priscilla/0000-0002-3896-146X	National Commission for Scientific and Technological Research (CONICYT) [21150862, 21150650]; National Funding for Scientific and Technologic Development of Chile (FONDECYT) [11150802, 11150622, 3170826]	National Commission for Scientific and Technological Research (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); National Funding for Scientific and Technologic Development of Chile (FONDECYT)	This work was supported by national scholarship funding by National Commission for Scientific and Technological Research (CONICYT) under Grants 21150862 (BM) and 21150650 (IC), as well as National Funding for Scientific and Technologic Development of Chile (FONDECYT) under Grants 11150802 (PB), 11150622 (CI) and 3170826 (IR). The authors report no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2019, BIOMOL THER, V27, P302, DOI 10.4062/biomolther.2018.133; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Alfarouk KO, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0221-1; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2009, FREE SOFTWARE FUNDAT; [Anonymous], 2007, BEVERLY TEICHER CANC, P288; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; BARRANCO SC, 1983, CANCER RES, V43, P1703; Bian XC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09660-w; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle J., 2008, BIOCH MOL BIOL ED, V36, P317, DOI DOI 10.1002/BMB.20192; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Byeon SJ, 2017, PATHOBIOLOGY, V84, P210, DOI 10.1159/000464250; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Coley HM, 1970, CANC CELL CULT, V88, P267; de Visser KE, 2009, CURR PHARM DESIGN, V15, P1844, DOI 10.2174/138161209788453239; Deng ZW, 2019, MED SCI MONITOR, V25, P2386, DOI 10.12659/MSM.915866; Digklia A, 2016, WORLD J GASTROENTERO, V22, P2403, DOI 10.3748/wjg.v22.i8.2403; Fang HH, 2018, CANCER SCI, V109, P1949, DOI 10.1111/cas.13593; Fang YN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170609; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Ham IH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0972-8; Han YF, 2013, EUR J CANCER, V49, P3420, DOI 10.1016/j.ejca.2013.06.001; Han YF, 2013, CANCER-AM CANCER SOC, V119, P3436, DOI 10.1002/cncr.28228; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Ho EA, 2006, CURR CANC DRUG TARGE; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Huang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20502; Huang H, 2016, TUMOR BIOL, V37, P3527, DOI 10.1007/s13277-015-4144-1; Hultsch S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4757-z; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; James DH, 1995, PANTHER GRAND STREET, DOI [10.2307/25007829, DOI 10.2307/25007829]; Jones VS, 2016, BBA-REV CANCER, V1865, P255, DOI 10.1016/j.bbcan.2016.03.005; Kalayda GV, 2012, J INORG BIOCHEM, V116, P1, DOI 10.1016/j.jinorgbio.2012.07.010; Kato T, 2013, CYTOKINE, V64, P251, DOI 10.1016/j.cyto.2013.06.313; KEEHN RJ, 1981, LANCET, V1, P323; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kindt TJ, 2008, IMMUNOLOGY, DOI [10.1016/j.lingua.2003.07.003, DOI 10.1016/J.LINGUA.2003.07.003]; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kohno K, 2005, EUR J CANCER, V41, P2577, DOI 10.1016/j.ejca.2005.08.007; Larson CA, 2009, MOL PHARMACOL, V75, P324, DOI 10.1124/mol.108.052381; Lau JKC, 2010, PHYS CHEM CHEM PHYS, V12, P10348, DOI 10.1039/b918301a; Li ZH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-21; Liedert B, 2003, J INVEST DERMATOL, V121, P172, DOI 10.1046/j.1523-1747.2003.12313.x; Ma J, 2019, CANCER RES TREAT, V51, P194, DOI 10.4143/crt.2018.031; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mansoori B, 2017, ADV PHARM BULL, V7, P339, DOI 10.15171/apb.2017.041; Marin JJG, 2016, ANTI-CANCER AGENT ME, V16, P318, DOI 10.2174/1871520615666150803125121; Maslakova A.A., 2015, MOSCOW U BIOLSCI B, V70, P127, DOI [10.3103/S0096392515030086, DOI 10.3103/S0096392515030086]; McDermott M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00040; Men X, 2018, ONCOTARGET, V9, P4074, DOI 10.18632/oncotarget.23694; Michlewski G, 2019, RNA, V25, P1, DOI 10.1261/rna.068692.118; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Pajuelo-Lozano N, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01197; Pasquier J, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0787-z; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Python Software Foundation, 2016, PYTH 6ANG REF VERS 3; Safaei R, 2004, J INORG BIOCHEM, V98, P1607, DOI 10.1016/j.jinorgbio.2004.05.006; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Shi WJ, 2016, WORLD J GASTRO ONCOL, V8, P673, DOI 10.4251/wjgo.v8.i9.673; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Team RDC R Development Core Team R, 2016, R FOUND STAT COMPUT, DOI [10.1007/s11222-014-9485-x, DOI 10.1007/S11222-014-9485-X]; Tozawa K, 2008, ANTICANCER RES; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Viscarra T, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0220-0; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Wu WJ, 2016, INT J ONCOL, V49, P1651, DOI 10.3892/ijo.2016.3652; Xavier CPR, 2016, CURR CANCER DRUG TAR, V16, P226, DOI 10.2174/1568009616666151113120705; Xie SM, 2010, J ONCOL, V2010, DOI 10.1155/2010/915046; Xu WX, 2018, INT J BIOL SCI, V14, P1054, DOI 10.7150/ijbs.25349; Yang J, 2015, TUMOR BIOL, V36, P5109, DOI 10.1007/s13277-015-3163-2; Yang ML, 2018, MOL MED REP, V17, P6211, DOI 10.3892/mmr.2018.8704; Ye F, 2015, FASEB J, V29, P4268, DOI 10.1096/fj.14-266718; Yi EH, 2013, MOL CANCER RES, V11, P31, DOI 10.1158/1541-7786.MCR-12-0217; Zhang DX, 2010, FUTURE ONCOL, V6, P527, DOI [10.2217/fon.10.21, 10.2217/FON.10.21]; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhou B, 2016, INT J ONCOL, V48, P2087, DOI 10.3892/ijo.2016.3442; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhu S, 2017, J CANCER, V8, P1952, DOI 10.7150/jca.19029	87	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228331	10.1371/journal.pone.0228331	http://dx.doi.org/10.1371/journal.pone.0228331			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990955	Green Published, gold			2022-12-26	WOS:000534605400053
J	Shi, Y; Han, Y; Xin, C; Hu, M; Oatts, J; Cao, K; Wang, HZ; Wang, NL				Shi, Yan; Han, Ying; Xin, Chen; Hu, Man; Oatts, Julius; Cao, Kai; Wang, Huaizhou; Wang, Ningli			Disease-related and age-related changes of anterior chamber angle structures in patients with primary congenital glaucoma: An in vivo high-frequency ultrasound biomicroscopy-based study	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; TRABECULAR MESHWORK; INTRAOCULAR-PRESSURE	Objectives To provide in vivo measurements of anterior chamber angle structures and their relationship with age as evaluated by high-frequency ultrasound biomicroscopy (UBM) in patients with primary congenital glaucoma (PCG) Methods High-frequency UBM was done for 51 PCG eyes from 40 patients (aged from 3 to 96 months) and 11 unaffected contralateral eyes. Parameters, including the proportion of observable abnormal tissue membrane and Schlemm's canal, the largest cross-sectional area (CSA) of Schlemm's canal (SC), SC meridional diameter, trabecular-iris angle (TIA), trabecular meshwork (TM) thickness, iris thickness, ciliary process length, and corneal limbus thickness were compared between the two groups and their relationship with age was explored in PCG eyes. Results Abnormal tissue membrane was detected in 27.5% of PCG eyes and none in unaffected eyes. SC was observed in 73.1% of PGC eyes compared to 100% in unaffected eyes (P<0.001). The largest CSA of SC, SC meridional diameter, iris thickness, and corneal limbus thickness were all significantly smaller in PCG eyes compared to unaffected eyes (all P<0.05). TIA and ciliary process length in unaffected eyes were smaller than PCG eyes (both P<0.05). The largest CSA of SC, TM thickness, iris thickness, and ciliary process length were all significantly correlated to age in PCG eyes (P<0.05). Conclusions The anatomical information evaluated by high-frequency UBM may provide glaucoma specialists a useful tool to aid in understanding the dysgenesis and changes with age of anterior chamber angle in PCG.	[Shi, Yan; Xin, Chen; Cao, Kai; Wang, Huaizhou; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Han, Ying; Oatts, Julius] Univ Calif San Francisco, Dept Ophthalmol, San Francisco Sch Med, San Francisco, CA USA; [Hu, Man] Capital Med Univ, Beijing Childrens Hosp, Dept Ophthalmol, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China	Capital Medical University; University of California System; University of California San Francisco; Capital Medical University	Wang, HZ; Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China.	wningli@vip.163.com; trhz_wang@163.com		wang, huaizhou/0000-0002-4126-100X; Oatts, Julius/0000-0002-3945-2077	Beijing Municipal Science & Technology Commission [Z181100001718044]; priming scientific research foundation for the junior researcher in Beijing Tongren Hospital, Capital Medical University [2018-YJJ-ZZL-028]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); priming scientific research foundation for the junior researcher in Beijing Tongren Hospital, Capital Medical University	Yan Shi received fundings from Beijing Municipal Science & Technology Commission (No. Z181100001718044) and the priming scientific research foundation for the junior researcher in Beijing Tongren Hospital, Capital Medical University (No.2018-YJJ-ZZL-028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 1996, EXP EYE RES, V62, P101, DOI 10.1006/exer.1996.0012; Amini H, 2012, MIDDLE EAST AFR J OP, V19, P194, DOI 10.4103/0974-9233.95248; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; AzuaraBlanco A, 1997, OPHTHALMOLOGY, V104, P1116, DOI 10.1016/S0161-6420(97)30175-4; Bayoumi Nader Hl, 2017, J Curr Glaucoma Pract, V11, P28, DOI 10.5005/jp-journals-10008-1217; Chen ZQ, 2018, EYE, V32, P1621, DOI 10.1038/s41433-018-0148-6; Day AC, 2013, BRIT J OPHTHALMOL, V97, P189, DOI 10.1136/bjophthalmol-2012-302147; Dietlein TS, 2000, BRIT J OPHTHALMOL, V84, P1354, DOI 10.1136/bjo.84.12.1354; Engels BF, 1999, KLIN MONATSBL AUGENH, V215, P338, DOI 10.1055/s-2008-1034728; Garcia-Anton MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176386; Gupta V, 2007, J AAPOS, V11, P546, DOI 10.1016/j.jaapos.2007.06.014; Gupta V, 2017, INVEST OPHTH VIS SCI, V58, P6000, DOI 10.1167/iovs.17-22695; Hann CR, 2009, INVEST OPHTH VIS SCI, V50, P1692, DOI 10.1167/iovs.08-2375; Henriques MJ, 2004, J GLAUCOMA, V13, P185, DOI 10.1097/00061198-200406000-00002; Hollander DA, 2006, AM J OPHTHALMOL, V142, P993, DOI 10.1016/j.ajo.2006.07.054; Hong JX, 2013, OPHTHALMOLOGY, V120, P709, DOI 10.1016/j.ophtha.2012.10.008; Hussein TR, 2014, CLIN OPHTHALMOL, V8, P1725, DOI 10.2147/OPTH.S66682; Kagemann L, 2015, JOVE-J VIS EXP, V100; Kagemann L, 2014, BRIT J OPHTHALMOL, V98, P10, DOI 10.1136/bjophthalmol-2013-304629; Kagemann L, 2010, INVEST OPHTH VIS SCI, V51, P4054, DOI 10.1167/iovs.09-4559; Keller KE, 2011, INVEST OPHTH VIS SCI, V52, P5049, DOI 10.1167/iovs.10-6948; Kobayashi H, 1999, BRIT J OPHTHALMOL, V83, P559, DOI 10.1136/bjo.83.5.559; Li M, 2017, CURR EYE RES, V42, P1389, DOI 10.1080/02713683.2017.1324631; Lopes JF, 2007, J PEDIAT OPHTH STRAB, V44, P112, DOI 10.3928/01913913-20070301-05; Lutjen E, 1968, GRAEFES ARCH CLIN EX, V176, P1; Oberacher-Velten I, 2008, GRAEF ARCH CLIN EXP, V246, P397, DOI 10.1007/s00417-007-0690-6; Perry LP, 2012, J AAPOS, V16, P565, DOI 10.1016/j.jaapos.2012.06.012; Rohen J W, 1970, Trans Ophthalmol Soc U K, V89, P431; Rojas B., 2006, Arch Soc Esp Oftalmol, V81, P65; SAMPAOLESI R, 1977, INVEST OPHTH VIS SCI, V16, P302; SAMPAOLESI R, 1982, ARCH OPHTHALMOL-CHIC, V100, P574; SHAFFER R N, 1955, Trans Am Acad Ophthalmol Otolaryngol, V59, P297; Shi Y, 2018, AM J OPHTHALMOL, V196, P57, DOI 10.1016/j.ajo.2018.08.022; Swain DL, 2015, INVEST OPHTH VIS SCI, V56, P1638, DOI 10.1167/iovs.14-15593; Tandon A, 2017, J AAPOS, V21, P234, DOI 10.1016/j.jaapos.2017.03.011; Tai TYT, 2006, J GLAUCOMA, V15, P524, DOI 10.1097/01.ijg.0000212293.93292.c9; TAWARA A, 1981, AM J OPHTHALMOL, V92, P508, DOI 10.1016/0002-9394(81)90644-9; Thomson BR, 2017, J CLIN INVEST, V127, P4421, DOI 10.1172/JCI95545; Wang N, 1998, Yan Ke Xue Bao, V14, P83; Yan XQ, 2016, INVEST OPHTH VIS SCI, V57, P4733, DOI 10.1167/iovs.16-19475; Yan XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145824; Yang CYC, 2013, INVEST OPHTH VIS SCI, V54, P5859, DOI 10.1167/iovs.12-10930; Zhao YJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00630	43	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227602	10.1371/journal.pone.0227602	http://dx.doi.org/10.1371/journal.pone.0227602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990918	Green Published, gold			2022-12-26	WOS:000534605400019
J	El-Sayes, J; Turco, CV; Skelly, LE; Locke, MB; Gibala, MJ; Nelson, AJ				El-Sayes, Jenin; Turco, Claudia V.; Skelly, Lauren E.; Locke, Mitchell B.; Gibala, Martin J.; Nelson, Aimee J.			Acute high-intensity and moderate-intensity interval exercise do not change corticospinal excitability in low fit, young adults	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; GROWTH-FACTOR-I; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; SINGLE BOUT; FITNESS; MEMORY; RESPONSES; MATTER; RISK	Previous research has demonstrated a lack of neuroplasticity induced by acute exercise in low fit individuals, but the influence of exercise intensity is unclear. In the present study, we assessed the effect of acute high-intensity (HI) or moderate-intensity (MOD) interval exercise on neuroplasticity in individuals with low fitness, as determined by a peak oxygen uptake (VO2peak) test (n = 19). Transcranial magnetic stimulation (TMS) was used to assess corticospinal excitability via area under the motor evoked potential (MEP) recruitment curve before and following training. Corticospinal excitability was unchanged after HI and MOD, suggesting no effect of acute exercise on neuroplasticity as measured via TMS in sedentary, young individuals. Repeated bouts of exercise, i.e., physical training, may be required to induce short-term changes in corticospinal excitability in previously sedentary individuals.	[El-Sayes, Jenin; Turco, Claudia V.; Skelly, Lauren E.; Locke, Mitchell B.; Gibala, Martin J.; Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	Nelson, AJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	nelsonaj@mcmaster.ca		Turco, Claudia/0000-0002-5569-5634	Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN-2015-06309]; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs)	This work was funded by a Natural Sciences and Engineering Research Council of Canada grant (NSERC RGPIN-2015-06309) to AJN and the Canada Research Chairs Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abdoli-Eramaki M, 2012, J ELECTROMYOGR KINES, V22, P908, DOI 10.1016/j.jelekin.2012.04.009; Allison MK, 2017, MED SCI SPORT EXER, V49, P298, DOI 10.1249/MSS.0000000000001188; Andrews SC, 2020, CEREB CORTEX, V30, P101, DOI 10.1093/cercor/bhz075; Ardawi MSM, 2012, J CLIN ENDOCR METAB, V97, P3691, DOI 10.1210/jc.2011-3361; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Combes A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12462; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CSEP, 2013, CSEP PARTH PHYS ACT; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; El-Sayes J, 2019, NEUROSCIENCE, V410, P29, DOI 10.1016/j.neuroscience.2019.04.054; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gillen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111489; Jimenez-Pavon D, 2017, BRIT J SPORT MED, V51, P1319, DOI 10.1136/bjsports-2016-097015; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kraemer RR, 2004, EXP BIOL MED, V229, P240, DOI 10.1177/153537020422900304; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Li X, 2019, TOP STROKE REHABIL, V26, P405, DOI 10.1080/10749357.2019.1623458; Lulic T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173672; MacDonald MA, 2019, APPL PHYSIOL NUTR ME, V44, P869, DOI 10.1139/apnm-2018-0643; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; Mang CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12422-3; Mang CS, 2016, MED SCI SPORT EXER, V48, P2477, DOI 10.1249/MSS.0000000000001040; Marquez CMS, 2015, J APPL PHYSIOL, V119, P1363, DOI 10.1152/japplphysiol.00126.2015; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; Nanda B, 2013, J CLIN DIAGN RES, V7, P1883, DOI 10.7860/JCDR/2013/5855.3341; Neva JL, 2017, EUR J NEUROSCI, V45, P1343, DOI 10.1111/ejn.13569; Nicolini C, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14140; Nofuji Y, 2012, J SPORT SCI MED, V11, P83; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opie GM, 2019, NEUROSCIENCE, V412, P29, DOI 10.1016/j.neuroscience.2019.05.049; Ozyemisci-Taskiran O, 2008, CLIN BIOMECH, V23, P231, DOI 10.1016/j.clinbiomech.2007.08.027; Petriz BA, 2017, J CELL PHYSIOL, V232, P257, DOI 10.1002/jcp.25477; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schwarz AJ, 1996, J CLIN ENDOCR METAB, V81, P3492, DOI 10.1210/jc.81.10.3492; Sexton CE, 2016, NEUROIMAGE, V131, P81, DOI 10.1016/j.neuroimage.2015.09.071; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith AE, 2014, EXP BRAIN RES, V232, P1875, DOI 10.1007/s00221-014-3879-z; Snow NP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150039, 10.1371/journal.pone.0146712]; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Stavrinos EL, 2017, J COGNITIVE NEUROSCI, V29, P593, DOI 10.1162/jocn_a_01078; Stoykov ME, 2015, J NEUROL PHYS THER, V39, P33, DOI 10.1097/NPT.0000000000000065; Thomas BP, 2013, J MAGN RESON IMAGING, V38, P1177, DOI 10.1002/jmri.24090; Thomas R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159589; Turco CV, 2018, J PHYSIOL-LONDON, V596, P5267, DOI 10.1113/JP276710; Vega SR, 2012, INT J SPORTS MED, V33, P8, DOI 10.1055/s-0031-1285929; Warburton DER, 2011, APPL PHYSIOL NUTR ME, V36, pS266, DOI [10.1139/H11-062, 10.1139/h11-062]; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Zimmerman B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00059	55	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227581	10.1371/journal.pone.0227581	http://dx.doi.org/10.1371/journal.pone.0227581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978065	gold, Green Published			2022-12-26	WOS:000534599100046
J	Nilsen, AR; Teasdale, SE; Guy, PL; Summerfield, TC; Orlovich, DA				Nilsen, Andy R.; Teasdale, Suliana E.; Guy, Paul L.; Summerfield, Tina C.; Orlovich, David A.			Fungal diversity in canopy soil of silver beech, Nothofagus menziesii (Nothofagaceae)	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; NEW-ZEALAND; FOREST; COMMUNITIES; MYCORRHIZAL; SEQUENCES; ABUNDANCE; BIOMASS; SEARCH; ROOTS	Adventitious roots in canopy soils associated with silver beech (Nothofagus menziesii Hook. f. (Nothofagaceae)) form ectomycorrhizal associations. We investigated the extent to which canopy ectomycorrhizal communities contribute to overall diversity of ectomycorrhizal fungi associated with silver beech. Hyphal ingrowth bags were buried for 12 months in canopy and terrestrial soils of five trees at one site. We used amplicon sequencing of the nuclear ribosomal internal transcribed spacer 2 region (ITS2) to assess diversity of both ectomycorrhizal and non-ectomycorrhizal OTUs in hyphal ingrowth bags. There was a significant difference in ectomycorrhizal fungal community diversity between the terrestrial and canopy hyphal ingrowth bag communities. Ectomycorrhizal community composition of the terrestrial and canopy environments was also significantly different. Some ectomycorrhizal taxa were significantly differentially represented in either the terrestrial or canopy environment. The hyphal ingrowth bags also accumulated non-ectomycorrhizal species. The non-ectomycorrhizal fungi also had significantly different diversity and community composition between the canopy and terrestrial environments. Like the ectomycorrhizal community, some non-ectomycorrhizal taxa were significantly differentially represented in either the terrestrial or canopy environment. The canopy soil microhabitat provides a novel environment for growth of ectomycorrhizal adventitious roots and enables the spatial partitioning of ectomycorrhizal and non-ectomycorrhizal fungal diversity in the forest.	[Nilsen, Andy R.; Teasdale, Suliana E.; Guy, Paul L.; Summerfield, Tina C.; Orlovich, David A.] Univ Otago, Dept Bot, Dunedin, New Zealand	University of Otago	Orlovich, DA (corresponding author), Univ Otago, Dept Bot, Dunedin, New Zealand.	david.orlovich@otago.ac.nz	; Orlovich, David/L-8581-2013	Teasdale, Suliana/0000-0003-1821-0244; Nilsen, Andy/0000-0003-4724-6289; Orlovich, David/0000-0002-9266-2188	Australia and Pacific Science Foundation [APSF136]; University of Otago Research Grant; University of Otago Pacific Island Masters Scholarship	Australia and Pacific Science Foundation; University of Otago Research Grant; University of Otago Pacific Island Masters Scholarship	This work was funded by the Australia and Pacific Science Foundation to DAO, TCS and PLG (project APSF136), and a University of Otago Research Grant to DAO. SET was supported by a University of Otago Pacific Island Masters Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Averill C, 2016, ECOL LETT, V19, P937, DOI 10.1111/ele.12631; Bastias BA, 2006, NEW PHYTOL, V172, P149, DOI 10.1111/j.1469-8137.2006.01793.x; Baylis G.T.S., 1980, NEW ZEAL J ECOL, V3, P151, DOI DOI 10.1111/J.1469-8137.1989.TB00308.X; BEEVER RE, 2014, AUCKLAND BOT SOC J, V69, P170; Beever RE, 1993, SO TEMPERATE ECOSYST; Beker HJ, 2010, N AM FUNGI, V5, P51; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Curlevski NJA, 2010, J SOIL SEDIMENT, V10, P1278, DOI 10.1007/s11368-010-0239-x; Eberhardt U, 2016, FUNGAL BIOL-UK, V120, P72, DOI 10.1016/j.funbio.2015.09.014; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Froslev TG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01312-x; Grippa CR, 2007, MYCORRHIZA, V17, P235, DOI 10.1007/s00572-006-0090-5; Hertel D, 2011, BIOTROPICA, V43, P401, DOI 10.1111/j.1744-7429.2011.00792.x; Hertel D, 2010, PLANT ECOL DIVERS, V3, P141, DOI 10.1080/17550874.2010.511293; Hertel D, 2011, PEDOBIOLOGIA, V54, P119, DOI 10.1016/j.pedobi.2010.11.003; Hofstede RGM, 2001, J BIOGEOGR, V28, P1033, DOI 10.1046/j.1365-2699.2001.00613.x; HORAK E, 1990, Sydowia, V42, P88; Johnston PR, 2010, NEW ZEAL J ECOL, V34, P175; Kjoller R, 2006, FEMS MICROBIOL ECOL, V58, P214, DOI 10.1111/j.1574-6941.2006.00166.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lindo Z, 2011, PLANT SOIL, V342, P141, DOI 10.1007/s11104-010-0678-6; Longcore JE, 2005, AUST J BOT, V53, P259, DOI 10.1071/BT04048; Mark AF, 1998, J ROY SOC NEW ZEAL, V28, P657, DOI 10.1080/03014223.1998.9517579; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nadkarni NM, 2002, PEDOBIOLOGIA, V46, P24, DOI 10.1078/0031-4056-00110; NADKARNI NM, 1981, SCIENCE, V214, P1023, DOI 10.1126/science.214.4524.1023; Neuwirth E, 2014, RCOLORBREWER; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Nieder J, 2001, PLANT ECOL, V153, P51, DOI 10.1023/A:1017517119305; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Orlovich DA, 2004, NEW ZEAL J BOT, V42, P721, DOI 10.1080/0028825X.2004.9512926; Orlovich DA, 2013, MYCOLOGIA, V105, P52, DOI 10.3852/11-307; Ploner A, 2015, HEATPLUS HEATMAPS RO; Rains KC, 2003, MYCORRHIZA, V13, P257, DOI 10.1007/s00572-003-0224-y; Rees BJ, 2013, MYCOLOGIA, V105, P1043, DOI 10.3852/12-404; Richardson S. J., 2011, New Zealand Journal of Forestry, V56, P3; Smith ME, 2017, NEW PHYTOL, V215, P443, DOI 10.1111/nph.14570; Stephenson SL, 2015, MYCOSPHERE, V6, P74, DOI 10.5943/mycosphere/6/1/9; Stephenson SL, 2018, PHYTOTAXA, V360, P161, DOI 10.11646/phytotaxa.360.2.8; Teasdale SE, 2013, FUNGAL DIVERS, V58, P299, DOI 10.1007/s13225-012-0218-1; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Wallander H, 2001, NEW PHYTOL, V151, P753, DOI 10.1046/j.0028-646x.2001.00199.x; Wardle DA, 2003, SCIENCE, V301, P1717, DOI 10.1126/science.1087809; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zotz G., 2016, PLANTS PLANTS BIOL V	52	4	4	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227860	10.1371/journal.pone.0227860	http://dx.doi.org/10.1371/journal.pone.0227860			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978185	gold, Green Published			2022-12-26	WOS:000534599100068
J	Diallo, M; Behanzin, L; Guedou, FA; Geraldo, N; Goma-Matsetse, E; Kania, D; Keke, RK; Bachabi, M; Affolabi, D; Diabate, S; Gangbo, F; Zannou, MD; Alary, M				Diallo, Mamadou; Behanzin, Luc; Guedou, Fernand A.; Geraldo, Nassirou; Goma-Matsetse, Ella; Kania, Dramane; Keke, Rene Kpemahouton; Bachabi, Moussa; Affolabi, Dissou; Diabate, Souleymane; Gangbo, Flore; Zannou, Marcel Djimon; Alary, Michel			HIV treatment response among female sex workers participating in a treatment as prevention demonstration project in Cotonou, Benin	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; TRANSMISSION; PROPHYLAXIS; POPULATION; INFECTIONS; ADHERENCE; BEHAVIOR; RISK	Objectives Female sex workers (FSWs) play a key role in HIV transmission in West Africa, while they have limited access to antiretroviral therapy (ART). In line with UNAIDS recommendations extending ART to all HIV-infected individuals, we conducted this demonstration project on immediate treatment as prevention (TasP) among FSWs in Cotonou, Benin. We report data on treatment response and its relation to adherence, as well as on ART-resistant genotypes. Methods Complete follow-up varied between 12 and 24 months. At each three-monthly visit, a questionnaire was administered, clinical examinations were carried out and blood samples collected. Adherence to treatment was estimated by self-report. Viral RNA was genotyped at baseline and final visits for drug resistance. Generalized estimating equations for repeated measures with a log-binomial link were used to analyze time trends and the association between adherence and virological response to treatment. Results One-hundred-seven HIV-positive and ART-naive FSWs were enrolled; 59.8% remained in the cohort till study completion and 62.6% had a final visit. Viral load<1000 (below quantification limit [<50]) was attained in 73.1% (64.6%) of participants at month-6, 84.8% (71.2%) at month-12, and 80.9% (65.1%) at the final visit. The proportion of women with suppressed (below quantification limit) viral load increased with increasing self-reported adherence (p = 0.06 (0.003), tests for trend). The proportion of participants with CD4 <= 500 also decreased drastically throughout follow-up (p < .0001). Twelve participants exhibited ART-resistant genotypes at baseline, but only two at their final visit. Conclusion Our findings indicate that TasP is widely accepted among FSWs in Cotonou and could be implemented with relative success. However, due to mobility in this population, follow-up was sub-optimal, suggesting that large geographical coverage of FSW-friendly clinics is needed for sustained treatment implementation. We also fell short of the UNAIDS objective of 90% viral suppression among treated patients, underlining the need for better adherence support programs.	[Diallo, Mamadou; Diabate, Souleymane; Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Diallo, Mamadou; Behanzin, Luc; Guedou, Fernand A.; Diabate, Souleymane; Alary, Michel] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Behanzin, Luc; Guedou, Fernand A.; Geraldo, Nassirou; Goma-Matsetse, Ella] Ctr Sante Communal Cotonou 1, Dispensaire IST, Cotonou, Benin; [Behanzin, Luc] Univ Parakou, Ecole Natl Format Techniciens Super Sante Publ &, Parakou, Benin; [Kania, Dramane] Natl Reference Lab Viral Hemorrhag Fever Ctr MURA, Bobo Dioulasso, Burkina Faso; [Keke, Rene Kpemahouton; Bachabi, Moussa; Gangbo, Flore] Programme Sante Lutte Sida PSLS, Cotonou, Benin; [Affolabi, Dissou; Gangbo, Flore; Zannou, Marcel Djimon] Ctr Natl Hosp Univ HMK Cotonou, Cotonou, Benin; [Affolabi, Dissou; Gangbo, Flore; Zannou, Marcel Djimon] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Diabate, Souleymane] Univ Alassane Ouattara, Bouake, Cote Ivoire; [Alary, Michel] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada	Laval University; Laval University; University of Abomey Calavi; Institut national de sante publique du Quebec (INSPQ)	Alary, M (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.; Alary, M (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada.; Alary, M (corresponding author), Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.	malary@uresp.ulaval.ca			Bill and Melinda Gates Foundation [OPP1098973]; Canadian Institutes of Health Research [ROH-115205, FDN-143218]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Bill and Melinda Gates Foundation (grant #OPP1098973). Complementary funding was provided by the Canadian Institutes of Health Research (grants #ROH-115205 and #FDN-143218). SD Bioline HIV/Syphilis duo test was provided free of charge by Standard Diagnostics.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; [Anonymous], 2013, GLOB REP UNAIDS REP; [Anonymous], 2016, CONS GUID US ANT DRU; [Anonymous], ENQ SURV DEUX GEN RE; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Boily MC, 2015, JAIDS-J ACQ IMM DEF, V68, pS74, DOI 10.1097/QAI.0000000000000437; Chamberland A, 2012, SEX TRANSM INFECT, V88, P179, DOI 10.1136/sextrans-2011-050209; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cowan FM, 2017, JAIDS-J ACQ IMM DEF, V74, P375, DOI 10.1097/qai.0000000000001255; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Diabate S, 2013, AIDS CARE, V25, P1426, DOI 10.1080/09540121.2013.772279; Eakle R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002444; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kane CT, 2009, INT J STD AIDS, V20, P793, DOI 10.1258/ijsa.2008.008414; Labbe AC, 2012, SEX TRANSM DIS, V39, P253, DOI 10.1097/OLQ.0b013e318244aaa0; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Mboup A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25208; Mishra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101690; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; Moses S, 2008, AIDS, V22, pS101, DOI 10.1097/01.aids.0000343768.85325.92; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Nagot N, 2002, J ACQ IMMUN DEF SYND, V29, P517, DOI 10.1097/00126334-200204150-00013; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Rodes B, 2007, J CLIN MICROBIOL, V45, P88, DOI 10.1128/JCM.01613-06; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Sobela F, 2009, JAIDS-J ACQ IMM DEF, V51, P216, DOI 10.1097/QAI.0b013e31819c170f; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2017, UNAIDS DAT BOOK 2017; UNAIDS, 2014, UND FAST TRACK ACC A; Van Laethem K, ALGORITHM USE GENOTY; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Vuylsteke B, 2015, JAIDS-J ACQ IMM DEF, V68, pS99, DOI 10.1097/QAI.0000000000000442; Wang HB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-198	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227184	10.1371/journal.pone.0227184	http://dx.doi.org/10.1371/journal.pone.0227184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971957	Green Published, gold			2022-12-26	WOS:000534374400010
J	Gherardini, J; Uchida, Y; Hardman, JA; Cheret, J; Mace, K; Bertolini, M; Paus, R				Gherardini, Jennifer; Uchida, Youhei; Hardman, Jonathan A.; Cheret, Jeremy; Mace, Kimberly; Bertolini, Marta; Paus, Ralf			Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo	PLOS ONE			English	Article							DENDRITIC CELLS; PROLIFERATION; MATURATION; STRESS; NEUROPEPTIDE; RECRUITMENT; ACTIVATION; MONOCYTES; DYNAMICS; ADHESION	Besides monocyte (MO)-derived macrophages (MACs), self-renewing tissue-resident macrophages (trMACs) maintain the intracutaneous MAC pool in murine skin. Here, we have asked whether the same phenomenon occurs in human skin using organ-cultured, full-thickness skin detached from blood circulation and bone marrow. Skin stimulation ex vivo with the neuropeptide substance P (SP), mimicking neurogenic skin inflammation, significantly increased the number of CD68(+) MACs in the papillary dermis without altering intracutaneous MAC proliferation or apoptosis. Since intraluminal CD14(+) MOs were undetectable in the non-perfused dermal vasculature, new MACs must have differentiated from resident intracutaneous progenitor cells in human skin. Interestingly, CD68(+) MACs were often seen in direct cell-cell-contact with cells expressing both, the hematopoietic stem cell marker CD34 and SP receptor (neurokinin-1 receptor [NK1R]). These cell-cell contacts and CD34(+) cell proliferation were up-regulated in SP-treated skin samples. Collectively, our study provides the first evidence that resident MAC progenitors, from which mature MACs can rapidly differentiate within the tissue, do exist in normal adult human skin. That these NK1R(+) trMAC-progenitor cells quickly respond to a key stress-associated neuroinflammatory stimulus suggests that this may satisfy increased local MAC demand under conditions of wounding/stress.	[Gherardini, Jennifer; Bertolini, Marta; Paus, Ralf] Monasterium Lab GmbH, Munster, Germany; [Uchida, Youhei] Kagoshima Univ, Dept Dermatol, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Hardman, Jonathan A.; Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Hardman, Jonathan A.; Paus, Ralf] Univ Manchester, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Cheret, Jeremy; Paus, Ralf] Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Mace, Kimberly] Univ Manchester, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England	Kagoshima University; University of Manchester; University of Manchester; University of Miami; University of Manchester	Paus, R (corresponding author), Monasterium Lab GmbH, Munster, Germany.; Paus, R (corresponding author), Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England.; Paus, R (corresponding author), Univ Manchester, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.; Paus, R (corresponding author), Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	ralf.paus@manchester.ac.uk		Hardman-Smart, Jonathan/0000-0002-1653-7908; Cheret, Jeremy/0000-0003-1901-0551; Mace, Kimberly/0000-0002-3184-878X	Monasterium Laboratory GmbH, Munster; NIHR Manchester Biomedical Research Centre; University of Miami start-up funds	Monasterium Laboratory GmbH, Munster; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); University of Miami start-up funds	This work was initiated and mainly performed while RP, JG, MB, JC, YU were affiliated to the University of Munster and continued when the authors moved their affiliations to Monasterium Laboratory, and/or University of Miami. The work was partially supported by a basic research grant and a PhD fellowship (salary) awarded to JG from Monasterium Laboratory GmbH, Munster, as well as by the NIHR Manchester Biomedical Research Centre, and by University of Miami start-up funds. RP is the founder and CEO of Monasterium laboratory, while JG, MB, JC are or were employed of Monasterium Laboratory GmbH. The funders had no role in data collection and analysis. The specific roles of these authors are articulated in the `author contributions' section.	Angel CE, 2007, IMMUNOL CELL BIOL, V85, P363, DOI 10.1038/sj.icb.7100047; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Arck PC, 2001, FASEB J, V15, P2536, DOI 10.1096/fj.00-0699fje; Azimi E, 2017, J ALLERGY CLIN IMMUN, V140, P447, DOI 10.1016/j.jaci.2016.12.980; Azimi E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89362; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Batchelor Nick, 2006, MedGenMed, V8, P10; Bertolini M, 2016, BR J DERMATOL; Bertolini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094260; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Burke B., 2002, MACROPHAGE; Carlsen ED, 2015, CLIN EXP IMMUNOL, V182, P109, DOI 10.1111/cei.12674; Choi JE, 2018, SEMIN IMMUNOPATHOL, V40, P249, DOI 10.1007/s00281-018-0675-z; Clark GJ, 2019, SEMIN CELL DEV BIOL, V86, P3, DOI 10.1016/j.semcdb.2018.02.013; Emile JF, 2000, BLOOD, V96, P58; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2017, PFLUG ARCH EUR J PHY, V469, P365, DOI 10.1007/s00424-017-1945-7; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Haldar M, 2014, IMMUNOL REV, V262, P25, DOI 10.1111/imr.12215; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hume DA, 2019, TRENDS IMMUNOL, V40, P98, DOI 10.1016/j.it.2018.11.007; Inoue T, 2017, INT J CLIN ONCOL; Ito N, 2010, J INVEST DERMATOL, V130, P995, DOI 10.1038/jid.2009.387; Jackson-Jones LH, 2016, EUR J IMMUNOL, V46, P2311, DOI 10.1002/eji.201646442; Jappinen N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08065-1; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Joachim RA, 2008, AM J PATHOL, V173, P1379, DOI 10.2353/ajpath.2008.080105; Lai SM, 2018, CELL REP, V25, P3099, DOI 10.1016/j.celrep.2018.11.059; Langan EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060819; Leal EC, 2015, AM J PATHOL; Lim YC, 1998, J IMMUNOL, V161, P2501; Lo Schiavo A, 2014, CLIN DERMATOL, V32, P646, DOI 10.1016/j.clindermatol.2014.04.012; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nicolas-Avila JA, 2018, J LEUKOC BIOL; Ochoa MT, 2008, J INVEST DERMATOL, V128, P2225, DOI 10.1038/jid.2008.56; Purba TS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15038-9; Purba TS, 2016, EXP DERMATOL, V25, P663, DOI 10.1111/exd.13046; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sugawara K, 2013, J ALLERGY CLIN IMMUN, V132, P182, DOI 10.1016/j.jaci.2013.01.002; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Suvas S, 2017, J IMMUNOL, V199, P1543, DOI 10.4049/jimmunol.1601751; Suzuki K, 2007, INT J HEMATOL, V85, P384, DOI 10.1532/IJH97.06213; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Uchida Y, 2017, J DERMATOL SCI, V86, pe59; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varricchi G, 2019, INT ARCH ALLERGY IMM, V179, P247, DOI 10.1159/000500088; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Vidali S, 2016, J INVEST DERMATOL, V136, P2003, DOI 10.1016/j.jid.2016.05.118; Vogel G, 2018, STEM CELL RES, V26, P47, DOI 10.1016/j.scr.2017.11.013; Watanabe S, 2019, J CLIN INVEST, V130; Xiao YL, 2015, STEM CELL REP, V4, P984, DOI 10.1016/j.stemcr.2015.04.012; Young HL, 2017, J EXP MED, V214, P1691, DOI 10.1084/jem.20160855; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227817	10.1371/journal.pone.0227817	http://dx.doi.org/10.1371/journal.pone.0227817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971954	gold, Green Published			2022-12-26	WOS:000534374400020
J	Khan, IA; Khan, MR; Baig, MHA; Hussain, Z; Hameed, N; Khan, JA				Khan, Iftikhar Ahmad; Khan, Mobushir Riaz; Baig, Muhammad Hasan Ali; Hussain, Zaker; Hameed, Nasir; Khan, Junaid Aziz			Assessment of forest cover and carbon stock changes in sub-tropical pine forest of Azad Jammu & Kashmir (AJK), Pakistan using multi-temporal Landsat satellite data and field inventory	PLOS ONE			English	Article							RESOURCES ASSESSMENT; ABOVEGROUND BIOMASS; CLASSIFICATION; VEGETATION; DEFORESTATION; DEGRADATION; AREA; EMISSIONS; DYNAMICS; AMAZON	This study aimed at estimating temporal (1989-2018) change in forest cover, carbon stock and trend in corresponding CO2 emissions/sequestration of a sub-tropical pine forest (STPF) in AJK, Pakistan. Our field inventory estimation shows an average above ground biomass (AAGB) accumulation of 0.145 Kt/ha with average carbon stock (ACS) value of 0.072 Kt/ha. Landsat TM, ETM+ and OLI images of 1989, 1993, 1999, 2005, 2010, 2015 and 2018 were used to extract vegetation fractions through Linear Spectral Mixture Analysis (LSMA) and forest area was calculated for respective years. Based on the forest area and estimated ACS value, the biomass carbon stock with corresponding CO2 emissions/sequestration was worked out for each time and change in forest carbon stock was determined for different time periods from 1989 to 2018. Our analysis shows net increase of 561 ha in forest cover and 40.39 Kt of ACS along with increase in corresponding CO2 sequestrations of 147.83 Kt over the study period. The results based on combination of remote sensing and field inventory provide valuable information and scientific basis to plan and ensure sustainable forest management (SFM) through reforestation, protection and conservation to enhance and maintain adequate forest cover and reduce CO2 emissions.	[Khan, Iftikhar Ahmad; Hussain, Zaker] Dept Forest, Azad, Jammu & Kashmir, India; [Khan, Iftikhar Ahmad; Khan, Mobushir Riaz; Baig, Muhammad Hasan Ali] PMAS Arid Agr Univ Rawalpindi, Inst Geoinformat & Earth Observat IGEO, Rawalpindi, Pakistan; [Hameed, Nasir] Planning & Dev Dept, Land Use Planning Sect, Azad, Jammu & Kashmir, India; [Khan, Junaid Aziz] Natl Univ Sci & Technol Islamabad, Inst Geog Informat Syst, Islamabad, Pakistan	Arid Agriculture University; National University of Sciences & Technology - Pakistan	Khan, IA (corresponding author), Dept Forest, Azad, Jammu & Kashmir, India.; Khan, IA (corresponding author), PMAS Arid Agr Univ Rawalpindi, Inst Geoinformat & Earth Observat IGEO, Rawalpindi, Pakistan.	ik188960@gmail.com	Khan, Junaid Aziz/AAQ-4578-2020; Baig, Muhammad Hasan Ali/A-1313-2017	Khan, Junaid Aziz/0000-0001-9158-8003; Baig, Muhammad Hasan Ali/0000-0001-6513-4921; Khan, Mobushir Riaz/0000-0002-6533-0743; Khan, Iftikhar Ahmad/0000-0002-8930-9658				ADAMS JB, 1995, REMOTE SENS ENVIRON, V52, P137, DOI 10.1016/0034-4257(94)00098-8; [Anonymous], 2005, SOURCEBOOK LAND USE; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Collado AD, 2002, J ARID ENVIRON, V52, P121, DOI 10.1016/S0140-1963(01)90980-2; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; Deng YB, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040349; Dibaba A, 2019, CARBON BAL MANAGE, V14, DOI 10.1186/s13021-019-0116-x; FAO, 2005, 147 FAO; Federici S, 2015, FOREST ECOL MANAG, V352, P89, DOI 10.1016/j.foreco.2015.04.022; Foody GM, 2013, REMOTE SENS LETT, V4, P783, DOI 10.1080/2150704X.2013.798708; Foody GM, 2009, REMOTE SENS ENVIRON, V113, P1658, DOI 10.1016/j.rse.2009.03.014; Furby S., 2002, LAND COVER CHANGE SP; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; HARMON ME, 1991, BIOSCIENCE, V41, P604, DOI 10.2307/1311697; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Huang CQ, 2008, REMOTE SENS ENVIRON, V112, P970, DOI 10.1016/j.rse.2007.07.023; Jia K, 2012, INT J REMOTE SENS, V33, P170, DOI 10.1080/01431161.2011.587844; Jina B., 2009, ECOPRINT AN INT J EC, V15, P75, DOI DOI 10.3126/eco.v15i0.1946; Karimi N, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-015-2250-4; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kumar K. K., 2016, Journal of Geographic Information System, V8, P506; Langley SK, 2001, J ARID ENVIRON, V49, P401, DOI 10.1006/jare.2000.0771; Liu T, 2013, REMOTE SENS ENVIRON, V133, P251, DOI 10.1016/j.rse.2013.02.020; Lu DS, 2003, REMOTE SENS ENVIRON, V87, P456, DOI 10.1016/j.rse.2002.06.001; Lunetta RS, 1998, REMOTE SENSING CHANG; MacDicken KG, 2015, FOREST ECOL MANAG, V352, P47, DOI 10.1016/j.foreco.2015.02.005; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Maliqi E., 2018, JOURNAL, V1, P1; McRoberts RE, 2018, CAN J FOREST RES, V48, P1535, DOI 10.1139/cjfr-2018-0295; Munawar S, 2015, INT BIODETER BIODEGR, V102, P316, DOI 10.1016/j.ibiod.2015.02.027; Ningthoujam RK, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070577; Nizami Syed Moazzam, 2012, Journal of Forestry Research (Harbin), V23, P377, DOI 10.1007/s11676-012-0273-1; Nordberg ML, 2005, LAND DEGRAD DEV, V16, P139, DOI 10.1002/ldr.660; Phua MH, 2008, J ENVIRON MANAGE, V88, P784, DOI 10.1016/j.jenvman.2007.04.011; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; Quintano C, 2012, INT J REMOTE SENS, V33, P5307, DOI 10.1080/01431161.2012.661095; Reno VF, 2011, REMOTE SENS ENVIRON, V115, P3446, DOI 10.1016/j.rse.2011.08.008; Salih AAM, 2017, EGYPT J REMOTE SENS, V20, pS21, DOI 10.1016/j.ejrs.2016.12.008; Satish KV, 2014, ENVIRON MONIT ASSESS, V186, P8125, DOI 10.1007/s10661-014-3991-3; Shaheen H, 2016, PAK J BOT, V48, P2351; Sharma CM, 2010, FOREST ECOL MANAG, V260, P2170, DOI 10.1016/j.foreco.2010.09.014; Siddiqui K. M, 1997, APFSOSWP11 FAO UN; Sloan S, 2015, FOREST ECOL MANAG, V352, P134, DOI 10.1016/j.foreco.2015.06.013; SMITH MO, 1990, REMOTE SENS ENVIRON, V31, P1, DOI 10.1016/0034-4257(90)90074-V; Souza C, 2003, REMOTE SENS ENVIRON, V87, P494, DOI 10.1016/j.rse.2002.08.002; Souza CM, 2013, REMOTE SENS-BASEL, V5, P5493, DOI 10.3390/rs5115493; Stern Nicholas, 2006, STERN REV EC CLIMATE; Thenkabail PS, 2009, INT J REMOTE SENS, V30, P3679, DOI 10.1080/01431160802698919; Tomppo E., 2010, NATL FOREST INVENTOR, P541, DOI DOI 10.1007/978-90-481-3233-1; Townshend JR, 2012, INT J DIGIT EARTH, V5, P373, DOI 10.1080/17538947.2012.713190; Turner BL, 1994, CHANGE LAND USE LAND, P4; vanNoordwijk M, 1997, GEODERMA, V79, P187, DOI 10.1016/S0016-7061(97)00042-6; Watson C., 2009, FOREST CARBON ACCOUN; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005	56	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0226341	10.1371/journal.pone.0226341	http://dx.doi.org/10.1371/journal.pone.0226341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971948	Green Published, gold			2022-12-26	WOS:000534374400004
J	Qiu, DW; Xu, H; Luo, D; Ye, Q; Li, SF; Wang, T; Ding, KL				Qiu, Dongwei; Xu, Hao; Luo, Dean; Ye, Qing; Li, Shaofu; Wang, Tong; Ding, Keliang			A rainwater control optimization design approach for airports based on a self-organizing feature map neural network model	PLOS ONE			English	Article							URBAN DRAINAGE SYSTEMS; GREEN INFRASTRUCTURE; UNCERTAINTY; IMPACTS; SURFACE; RUNOFF	To address the problems of high overflow rate of pipe network inspection well and low drainage efficiency, a rainwater control optimization design approach based on a self-organizing feature map neural network model (SOFM) was proposed in this paper. These problems are caused by low precision parameter design in various rainwater control measures such as the diameter of the rainwater pipe network and the green roof area ratio. This system is to be combined with the newly built rainwater pipe control optimization design project of China International Airport in Daxing District of Beijing, China. Through the optimization adjustment of the pipe network parameters such as the diameter of the rainwater pipe network, the slope of the pipeline, and the green infrastructure (GI) parameters such as the sinking green area and the green roof area, reasonable control of airport rainfall and the construction of sustainable drainage systems can be achieved. This research indicates that compared with the result of the drainage design under the initial value of the parameter, the green roof model and the conceptual model of the mesoscale sustainable drainage system, in the case of a hundred-year torrential rainstorm, the overflow rate of pipe network inspection wells has reduced by 36% to 67.5%, the efficiency of drainage has increased by 26.3% to 61.7%, which achieves the requirements for reasonable control of airport rainwater and building a sponge airport and a sustainable drainage system.	[Qiu, Dongwei; Xu, Hao; Luo, Dean; Li, Shaofu; Wang, Tong; Ding, Keliang] Beijing Univ Civil Engn & Architecture, Sch Geomat & Urban Spatial Informat, Beijing, Peoples R China; [Ye, Qing] Beijing Univ Civil Engn & Architecture, Sch Humanity & Law, Beijing, Peoples R China	Beijing University of Civil Engineering & Architecture; Beijing University of Civil Engineering & Architecture	Qiu, DW; Luo, D (corresponding author), Beijing Univ Civil Engn & Architecture, Sch Geomat & Urban Spatial Informat, Beijing, Peoples R China.	qiudw@bucea.edu.cn; luodean@bucea.edu.cn	Qiu, Dongwei/AAD-3331-2022	XU, HAO/0000-0002-7431-3814; Qiu, Dongwei/0000-0002-1665-7440; , Shaofu Li/0000-0002-9825-2075				Ashley R, 2018, ECOSYST SERV, V33, P237, DOI 10.1016/j.ecoser.2018.08.011; Cimorelli L, 2016, J IRRIG DRAIN ENG, V142, DOI 10.1061/(ASCE)IR.1943-4774.0000927; Deitch MJ, 2019, J ENVIRON MANAGE, V243, P127, DOI 10.1016/j.jenvman.2019.05.018; Eaton TT, 2018, J ENVIRON MANAGE, V209, P495, DOI 10.1016/j.jenvman.2017.12.068; Guo JQ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072351; Haghighatafshar S, 2018, WATER-SUI, V10, DOI 10.3390/w10081041; HR Wallingford, 2010, DROGH SEW NETW IMPR, DOI [10.1016/j.jenvman.2019.05.018, DOI 10.1016/J.JENVMAN.2019.05.018]; Kim HI, 2019, WATER-SUI, V11, DOI 10.3390/w11020293; Lopez-Vicente M, 2017, LAND DEGRAD DEV, V28, P1298, DOI 10.1002/ldr.2531; Manocha N, 2018, ENVIRON SCI POLICY, V90, P11, DOI 10.1016/j.envsci.2018.09.012; Martinez C, 2018, WATER RESOUR MANAG, V32, P4329, DOI 10.1007/s11269-018-2054-x; MARTINEZSOLANO FJ, 2016, WATER-SUI, V8, DOI DOI 10.3390/W8060259; Meng-ge Y, 2018, SPECTROSC SPECT ANAL, V38, P1874, DOI [10.3964/j.issn.1000-0593(2018)06-1874-06, DOI 10.3964/J.ISSN.1000-0593(2018)06-1874-06]; Mora-Melia D, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041130; Palumbo A, 2014, CIV ENG ENVIRON SYST, V31, P79, DOI 10.1080/10286608.2013.820277; Schubert JE, 2017, ADV WATER RESOUR, V108, P55, DOI 10.1016/j.advwatres.2017.07.009; Shao DN, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7718-6; WANG S, 2019, ANIMALS BASEL, V9; Wu M, 2017, WATER SA, V43, P450, DOI 10.4314/wsa.v43i3.10; Wu MC, 2017, WATER-SUI, V9, DOI 10.3390/w9110836; Xiong LY, 2019, T GIS, V23, P259, DOI 10.1111/tgis.12516; Yang Y, 2018, J ENVIRON MANAGE, V206, P1090, DOI 10.1016/j.jenvman.2017.11.064; Yazdi J, 2018, WATER RESOUR MANAG, V32, P4561, DOI 10.1007/s11269-018-2069-3; Yazdi J, 2018, WATER RESOUR MANAG, V32, P721, DOI 10.1007/s11269-017-1835-y; Zhang HM, 2017, CATENA, V151, P174, DOI 10.1016/j.catena.2016.12.009; Zheng P, 2019, POL J ENVIRON STUD, V28, P771, DOI 10.15244/pjoes/85348; Zischg J, 2019, SCI TOTAL ENVIRON, V651, P1709, DOI 10.1016/j.scitotenv.2018.10.061; Zolch T, 2017, ENVIRON RES, V157, P135, DOI 10.1016/j.envres.2017.05.023	28	3	3	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227901	10.1371/journal.pone.0227901	http://dx.doi.org/10.1371/journal.pone.0227901			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961903	gold, Green Published			2022-12-26	WOS:000534372000016
J	Adler, AJ; Mittal, P; Hagymasi, AT; Menoret, A; Shen, C; Agliano, F; Wright, KT; Grady, JJ; Kuo, CL; Ballesteros, E; Claffey, KP; Vella, AT				Adler, Adam J.; Mittal, Payal; Hagymasi, Adam T.; Menoret, Antoine; Shen, Chen; Agliano, Federica; Wright, Kyle T.; Grady, James J.; Kuo, Chia-Ling; Ballesteros, Enrique; Claffey, Kevin P.; Vella, Anthony T.			GRK2 enforces androgen receptor dependence in the prostate and prostate tumors	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTOR; RAF KINASE INHIBITOR; MOUSE MODEL; NEUROENDOCRINE DIFFERENTIATION; REGULATED EXPRESSION; CANCER; PTEN; GENE; ADENOCARCINOMA; METASTASIS	Metastatic tumors that have become resistant to androgen deprivation therapy represent the major challenge in treating prostate cancer. Although these recurrent tumors typically remain dependent on the androgen receptor (AR), non-AR-driven tumors that also emerge are particularly deadly and becoming more prevalent. Here, we present a new genetically engineered mouse model for non-AR-driven prostate cancer that centers on a negative regulator of G protein-coupled receptors that is downregulated in aggressive human prostate tumors. Thus, prostate-specific expression of a dominant-negative G protein-coupled receptor kinase 2 (GRK2-DN) transgene diminishes AR and AR target gene expression in the prostate, and confers resistance to castration-induced involution. Further, the GRK2-DN transgene dramatically accelerates oncogene-initiated prostate tumorigenesis by increasing primary tumor size, potentiating visceral organ metastasis, suppressing AR, and inducing neuroendocrine marker mRNAs. In summary, GRK2 enforces AR-dependence in the prostate, and the loss of GRK2 function in prostate tumors accelerates disease progression toward the deadliest stage.	[Adler, Adam J.; Mittal, Payal; Hagymasi, Adam T.; Menoret, Antoine; Shen, Chen; Agliano, Federica; Wright, Kyle T.; Vella, Anthony T.] UConn Hlth, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Grady, James J.; Kuo, Chia-Ling] UConn Hlth, Sch Med, Dept Community Med & Hlth Care, Farmington, CT USA; [Ballesteros, Enrique] UConn Hlth, Sch Med, Dept Pathol & Lab Med, Farmington, CT USA; [Claffey, Kevin P.] UConn Hlth, Sch Med, Dept Cell Biol, Farmington, CT USA; [Mittal, Payal] Merck Res Labs, Oncol Dept, Boston, MA 02115 USA; [Hagymasi, Adam T.] Univ Connecticut, Sch Med, Carole & Ray Neag Comprehens Canc Ctr, Farmington, CT USA	Merck & Company; University of Connecticut	Adler, AJ; Vella, AT (corresponding author), UConn Hlth, Dept Immunol, Sch Med, Farmington, CT 06030 USA.	aadler@uchc.edu; vella@uchc.edu		Agliano, Federica/0000-0002-1093-171X	National Institutes of Health [R01CA109339, R01AI094640]; Carole and Ray Neag Comprehensive Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carole and Ray Neag Comprehensive Cancer Center	This work was supported by National Institutes of Health Grants R01CA109339 and R01AI094640 (to AJA and ATV) and by the Carole and Ray Neag Comprehensive Cancer Center. The authors thank Dr. Jeffrey Benovic for providing the GRK2-DN (beta ARK-K220R) construct, Dr. Robert Matusik for providing the ARR<INF>2</INF>PB construct as well as helpful discussions and critical reading of the paper, Dr. Stefan Brocke for advice regarding in vitro forskolin stimulations, and Dr. Christopher Bonin for editing the paper.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Alanee S, 2015, ANTICANCER RES, V35, P4145; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bishop JL, 2017, CANCER DISCOV, V7, P54, DOI 10.1158/2159-8290.CD-15-1263; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Cai JA, 2010, TRANSL ONCOL, V3, P195, DOI 10.1593/tlo.09328; Carver BS, 2016, CANCER CELL, V29, P431, DOI 10.1016/j.ccell.2016.03.023; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027; Drake CG, 2014, ONCOLOGY-NY, V28, P974; Escara-Wilke J, 2015, PROSTATE, V75, P292, DOI 10.1002/pros.22915; Fu XB, 2013, J BIOL CHEM, V288, P7738, DOI 10.1074/jbc.M112.428078; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Gingrich J, 1999, PROSTATE CANCER P D, V6, P1; Gingrich JR, 1996, CANCER RES, V56, P4096; Gingrich JR, 1997, CANCER RES, V57, P4687; Grabowska MM, 2014, CANCER METAST REV, V33, P377, DOI 10.1007/s10555-013-9487-8; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; GREENBERG NM, 1994, MOL ENDOCRINOL, V8, P230, DOI 10.1210/me.8.2.230; Han GZ, 2001, J BIOL CHEM, V276, P11204, DOI 10.1074/jbc.M008207200; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hu MM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005171; Hurwitz AA, 2000, CANCER RES, V60, P2444; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Khasnavis S, 2013, J BIOL CHEM, V288, P20843, DOI 10.1074/jbc.M112.443556; Komolov KE, 2017, CELL SIGNAL, V41, P17, DOI 10.1016/j.cellsig.2017.07.004; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Lin BY, 1999, CANCER RES, V59, P4180; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nogues L, 2017, MOL PHARMACOL, V91, P220, DOI 10.1124/mol.116.107185; Palmgren JS, 2007, SEMIN ONCOL, V34, P22, DOI 10.1053/j.seminoncol.2006.10.026; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prowatke I, 2007, BRIT J CANCER, V96, P82, DOI 10.1038/sj.bjc.6603490; Purayil HT, 2015, ONCOGENE, V34, P3144, DOI 10.1038/onc.2014.252; Qiao JB, 2016, ONCOTARGET, V7, P61955, DOI 10.18632/oncotarget.11326; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsurutani N, 2016, J IMMUNOL, V196, P124, DOI 10.4049/jimmunol.1501217; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang ZQ, 2017, CANCER LETT, V408, P10, DOI 10.1016/j.canlet.2017.08.013; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wright KT, 2013, J IMMUNOL, V191, P708, DOI 10.4049/jimmunol.1203486; Xu LL, 2000, CANCER RES, V60, P6568; Xu ZW, 2017, CANCER CHEMOTH PHARM, V79, P747, DOI 10.1007/s00280-017-3267-z; Yowell Charles W, 2002, Clin Prostate Cancer, V1, P177, DOI 10.3816/CGC.2002.n.020; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zou M, 2017, CANCER DISCOV, V7, P736, DOI 10.1158/2159-8290.CD-16-1174	77	3	3	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	11					2424	2436		10.1038/s41388-020-1159-x	http://dx.doi.org/10.1038/s41388-020-1159-x		JAN 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KU0ZS	31959897	Green Accepted			2022-12-26	WOS:000508322900002
J	Arrowsmith, S; Fang, YX; Sharp, A				Arrowsmith, Sarah; Fang, Yongxiang; Sharp, Andrew			Comparison of the myometrial transcriptome from singleton and twin pregnancies by RNA-Seq	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; SPONTANEOUS HUMAN LABOR; MECHANICAL STRETCH; GENE-EXPRESSION; RECEPTOR EXPRESSION; OXYTOCIN RECEPTOR; TERM; PROGESTERONE; MICROARRAY; PREVENTION	Preterm birth is recognized as the primary cause of infant mortality worldwide. Twin pregnancies are significantly more at risk of preterm birth than singleton pregnancies. A greater understanding of why this is and better modes of treatment and prevention are needed. Key to this is determining the differing pathophysiological mechanisms of preterm birth in twins, including the role of the myometrium and premature uterine contraction. We performed RNA sequencing (RNA-Seq) of human myometrium from singleton and twin pregnancies at term (> 37(+0) weeks) and preterm (< 37(+0) weeks), collected during pre-labour Caesarean Section. RNA-Seq libraries were prepared from polyA-selected RNA and sequenced on the Illumina HiSeq 4000 platform. Differentially expressed genes (DEGs), GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment were conducted using R software. Significance was determined with a false discovery rate-adjusted Pvalue of <0.05. Only 3 DEGs were identified between gestational age-matched singleton and twin myometrium and only 1 DEG identified between singleton term and twin preterm tissues. Comparison of singleton preterm myometrium with twin term myometrium however, revealed 75 down-regulated and 24 up-regulated genes in twin myometrium. This included genes associated with inflammation and immune response, T cell maturation and differentiation and steroid biosynthesis. GO and KEGG enrichment analyses for biologically relevant processes and functions also revealed several terms related to inflammation and immune response, as well as cytokine-cytokine receptor interaction and chemokine receptor signalling. Data indicate that little or no differences exist in the transcriptome of singleton and twin myometrium when matched for gestational age. The significant up- and down-regulation of genes identified between preterm singleton and twin myometrium at term may point to transcriptome changes associated with the chronic levels of uterine stretch in twin pregnancy or genes associated with the myometrium transitioning to labour onset.	[Arrowsmith, Sarah; Sharp, Andrew] Univ Liverpool, Harris Wellbeing Preterm Birth Res Ctr, Inst Translat Med, Liverpool, Merseyside, England; [Fang, Yongxiang] Univ Liverpool, Ctr Genom Res, Liverpool, Merseyside, England; [Sharp, Andrew] Univ Liverpool, Liverpool, Merseyside, England; [Sharp, Andrew] Liverpool Womens NHS Fdn Trust, Liverpool, Merseyside, England; [Sharp, Andrew] Liverpool Hlth Partners, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Arrowsmith, S (corresponding author), Univ Liverpool, Harris Wellbeing Preterm Birth Res Ctr, Inst Translat Med, Liverpool, Merseyside, England.	s.arrowsmith@liverpool.ac.uk		sharp, andrew/0000-0003-3396-7464; Arrowsmith, Sarah/0000-0003-1102-1934	Twins Trust; British Maternal and Fetal Medicine Society (BMFMS); Harris-Wellbeing Preterm Birth Research Centre grant	Twins Trust; British Maternal and Fetal Medicine Society (BMFMS); Harris-Wellbeing Preterm Birth Research Centre grant	This work was funded by a joint research bursary from the Twins Trust (https://twinstrust.org) and British Maternal and Fetal Medicine Society (BMFMS, https://www.bmfms.org.uk), awarded to AS and SA. SA is supported by a Harris-Wellbeing Preterm Birth Research Centre grant administered by Wellbeing of Women, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arrowsmith S, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.08.015; Arrowsmith S, 2016, REPROD SCI, V23, P98, DOI 10.1177/1933719115597788; Arrowsmith Sarah, 2010, Obstet Gynaecol Reprod Med, V20, P241; Aye ILMH, 2018, J CLIN ENDOCR METAB, V103, P1056, DOI 10.1210/jc.2017-02195; Bacelis J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022929; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bethin KE, 2003, MOL ENDOCRINOL, V17, P1454, DOI 10.1210/me.2003-0007; Biggio JR, 2015, CLIN OBSTET GYNECOL, V58, P654, DOI 10.1097/GRF.0000000000000120; Bollopragada S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.032; Breuiller-Fouche M, 2006, REPRODUCTION, V131, P837, DOI 10.1530/rep.1.00725; Bukowski R, 2006, PLOS MED, V3, P918, DOI 10.1371/journal.pmed.0030169; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; Esplin MS, 2005, AM J OBSTET GYNECOL, V193, P404, DOI 10.1016/j.ajog.2004.12.021; Girotti M, 2003, ENDOCRINOLOGY, V144, P2254, DOI 10.1210/en.2002-0196; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Havelock OC, 2005, BIOL REPROD, V72, P707, DOI 10.1095/biolreprod.104.032979; Hua RY, 2013, AM J REPROD IMMUNOL, V69, P21, DOI 10.1111/aji.12025; Jarde A, 2019, BJOG-INT J OBSTET GY, V126, P556, DOI 10.1111/1471-0528.15566; Jarde A, 2017, BJOG-INT J OBSTET GY, V124, P1163, DOI 10.1111/1471-0528.14513; Jozwiak M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001233.pub2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee YH, 2015, CELL MOL IMMUNOL, V12, P231, DOI 10.1038/cmi.2014.39; Loudon JAZ, 2004, MOL HUM REPROD, V10, P895, DOI 10.1093/molehr/gah112; Lyall F, 2002, J SOC GYNECOL INVEST, V9, P299, DOI 10.1016/S1071-5576(02)00175-2; Lye SJ, 2001, FRONT HORM RES, V27, P165; MANABE Y, 1985, PROSTAGLANDINS, V30, P141, DOI 10.1016/S0090-6980(85)80018-6; MANABE Y, 1982, ACTA OBSTET GYN SCAN, V61, P279, DOI 10.3109/00016348209156572; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Migale R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0632-4; Mittal P, 2010, J PERINAT MED, V38, P617, DOI [10.1515/JPM.2010.097, 10.1515/jpm.2010.097]; Murray SR, 2018, OBSTET GYNAECOL, V20, P57, DOI 10.1111/tog.12460; NICE, 2011, CLIN GUID MULT PREGN; Ramsey E., 1994, THE UTERUS, P18; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Salomonis N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r12; Schoen CN, 2018, ACTA OBSTET GYN SCAN, V97, P1051, DOI 10.1111/aogs.13353; Sharp GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155413; Shynlova O, 2013, REPROD SCI, V20, P154, DOI 10.1177/1933719112446084; Shynlova O, 2010, REPRODUCTION, V139, P247, DOI 10.1530/REP-09-0260; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Sokolowski P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011037; Sooranna SR, 2004, MOL HUM REPROD, V10, P109, DOI 10.1093/molehr/gah021; STANFIELD Z, 2019, FRONT GENET, V10, DOI DOI 10.3389/FGENE.2019; Stock S, 2010, SEMIN FETAL NEONAT M, V15, P336, DOI 10.1016/j.siny.2010.06.006; Terzidou V, 2005, J CLIN ENDOCR METAB, V90, P237, DOI 10.1210/jc.2004-0277; Turton P, 2009, EUR J OBSTET GYN R B, V144, pS40, DOI 10.1016/j.ejogrb.2009.02.011; Waldorf KMA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.028; Yin ZZ, 2018, BIOCHEM PHARMACOL, V152, P252, DOI 10.1016/j.bcp.2018.03.021	51	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227882	10.1371/journal.pone.0227882	http://dx.doi.org/10.1371/journal.pone.0227882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951633	gold, Green Published			2022-12-26	WOS:000534370500033
J	Canalis, E; Grossman, TR; Carrer, M; Schilling, L; Yu, J				Canalis, Ernesto; Grossman, Tamar R.; Carrer, Michele; Schilling, Lauren; Yu, Jungeun			Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; osteoporosis; bone; Notch receptor; osteoclast; antisense oligonucleotides; bone resorption; cell fate; Hajdu-Cheney syndrome; osteoclastogenesis	BONE MASS; MUTATIONS; LIGAND; INHIBITION; KIDNEY; ACROOSTEOLYSIS; ARCHITECTURE; INCREASES; DISORDER; ANTIBODY	Notch receptors play critical roles in cell-fate decisions and in the regulation of skeletal development and bone remodeling. Gain?of?function NOTCH2 mutations can cause Hajdu-Cheney syndrome, an untreatable disease characterized by osteoporosis and fractures, craniofacial developmental abnormalities, and acro-osteolysis. We have previously created a mouse model harboring a point 6955C?T mutation in the Notch2 locus upstream of the PEST domain, and we termed this model Notch2(tm1.1Ecan). Heterozygous Notch2(tm1.1Ecan) mutant mice exhibit severe cancellous and cortical bone osteopenia due to increased bone resorption. In this work, we demonstrate that the subcutaneous administration of Notch2 antisense oligonucleotides (ASO) down-regulates Notch2 and the Notch target genes Hes-related family basic helix?loop?helix transcription factor with YRPW motif 1 (Hey1), Hey2, and HeyL in skeletal tissue from Notch2(tm1.1Ecan) mice. Results of microcomputed tomography experiments indicated that the administration of Notch2 ASOs ameliorates the cancellous osteopenia of Notch2(tm1.1Ecan) mice, and bone histomorphometry analysis revealed decreased osteoclast numbers in Notch2 ASO-treated Notch2(tm1.1Ecan) mice. Notch2 ASOs decreased the induction of mRNA levels of TNF superfamily member 11 (Tnfsf11, encoding the osteoclastogenic protein RANKL) in cultured osteoblasts and osteocytes from Notch2(tm1.1Ecan) mice. Bone marrow-derived macrophage cultures from the Notch2(tm1.1Ecan) mice displayed enhanced osteoclastogenesis, which was suppressed by Notch2 ASOs. In conclusion, Notch2(tm1.1Ecan) mice exhibit cancellous bone osteopenia that can be ameliorated by systemic administration of Notch2 ASOs.	[Canalis, Ernesto; Yu, Jungeun] UConn Hlth, Dept Orthopaed Surg, 263 Farmington Ave, Farmington, CT 06030 USA; [Canalis, Ernesto] UConn Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Canalis, Ernesto; Schilling, Lauren; Yu, Jungeun] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Grossman, Tamar R.; Carrer, Michele] Ionis Pharmaceut Inc, Carlsbad, CA 92010 USA	Ionis Pharmaceuticals, Inc.	Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, 263 Farmington Ave, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	canalis@uchc.edu		Carrer, Michele/0000-0002-6464-9584	National Institutes of Health from the NIDDK [DK045227]; National Institutes of Health from the NIAMS [AR076747]	National Institutes of Health from the NIDDK; National Institutes of Health from the NIAMS	This work was supported by National Institutes of Health Grant DK045227 (to E. C.) from the NIDDK and Grant AR076747 (to E. C.) from the NIAMS. T. R. G. and M. C. are employed by Ionis Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adami G, 2016, BONE, V92, P150, DOI 10.1016/j.bone.2016.08.025; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bennett CF, 2017, ANNU REV PHARMACOL, V57, P81, DOI 10.1146/annurev-pharmtox-010716-104846; Blumenauer BT, 2002, CLIN EXP RHEUMATOL, V20, P574; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2018, J BIOL CHEM, V293, P14165, DOI 10.1074/jbc.RA118.004242; Canalis E, 2018, METABOLISM, V80, P48, DOI 10.1016/j.metabol.2017.08.002; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2017, J CELL PHYSIOL, V232, P363, DOI 10.1002/jcp.25433; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; CHENEY WD, 1965, AMER J ROENTGENOL RA, V94, P595; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gray MJ, 2012, EUR J HUM GENET, V20, P122, DOI 10.1038/ejhg.2011.125; HAJDU N, 1948, BRIT J RADIOL, V21, P42, DOI 10.1259/0007-1285-21-241-42; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; Ilagan MXG, 2013, CANCER CELL, V23, P267, DOI 10.1016/j.ccr.2013.02.020; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Limmroth V, 2014, NEUROLOGY, V83, P1780, DOI 10.1212/WNL.0000000000000926; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; McCright B, 2001, DEVELOPMENT, V128, P491; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Murray SF, 2015, INVEST OPHTH VIS SCI, V56, P6362, DOI 10.1167/iovs.15-16400; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; NYE JS, 1994, DEVELOPMENT, V120, P2421; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ryeom SW, 2011, J CLIN INVEST, V121, P508, DOI 10.1172/JCI45976; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sakka S, 2017, J CLIN ENDOCR METAB, V102, P4163, DOI 10.1210/jc.2017-01102; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Shy ME, 2018, J CLIN INVEST, V128, P110, DOI 10.1172/JCI98617; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; UDELL J, 1986, ARTHRITIS RHEUM, V29, P1032, DOI 10.1002/art.1780290815; Vollersen N, 2018, J BONE MINER RES, V33, P70, DOI 10.1002/jbmr.3283; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Wang FS, 2011, BONE, V49, P1080, DOI 10.1016/j.bone.2011.08.006; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Yorgan T, 2016, BONE, V87, P136, DOI 10.1016/j.bone.2016.04.012; Yu J, 2019, J BIOL CHEM, V294, P14203, DOI 10.1074/jbc.RA119.009824; Yu JG, 2020, J CELL PHYSIOL, V235, P210, DOI 10.1002/jcp.28960; Yu JG, 2018, AM J PATHOL, V188, P149, DOI 10.1016/j.ajpath.2017.09.010; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhao HT, 2018, J CLIN INVEST, V128, P359, DOI 10.1172/JCI96499; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5; Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344	78	11	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3952	3964		10.1074/jbc.RA119.011440	http://dx.doi.org/10.1074/jbc.RA119.011440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	31992595	hybrid, Green Published			2022-12-26	WOS:000527704400020
J	Hayes, ML; Santibanez, PI				Hayes, Michael L.; Santibanez, Paola I.			A plant pentatricopeptide repeat protein with a DYW-deaminase domain is sufficient for catalyzing C-to-U RNA editing in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA editing; mitochondria; organelle; metalloenzyme; metal ion-protein interaction; C-to-U editing; deaminase; DYW domain; pentatricopeptide repeat (PPR); PPR65	TRANSITION-STATE; IDENTIFICATION; ZINC; SITE; INVOLVEMENT; SUBSTRATE; REVEALS; BINDING; MOTIF	Pentatricopeptide repeat (PPR) proteins with C-terminal DYW domains are present in organisms that undergo C-to-U editing of organelle RNA transcripts. PPR domains act as specificity factors through electrostatic interactions between a pair of polar residues and the nitrogenous bases of an RNA target. DYW-deaminase domains act as the editing enzyme. Two moss (Physcomitrella patens) PPR proteins containing DYW-deaminase domains, PPR65 and PPR56, can convert Cs to Us in cognate, exogenous RNA targets co-expressed in Escherichia coli. We show here that purified, recombinant PPR65 exhibits robust editase activity on synthetic RNAs containing cognate, mitochondrial PpccmFC sequences in vitro, indicating that a PPR protein with a DYW domain is solely sufficient for catalyzing C-to-U RNA editing in vitro. Monomeric fractions possessed the highest conversion efficiency, and oligomeric fractions had reduced activity. Inductively coupled plasma (ICP)?MS analysis indicated a stoichiometry of two zinc ions per highly active PPR65 monomer. Editing activity was sensitive to addition of zinc acetate or the zinc chelators 1,10-o-phenanthroline and EDTA. Addition of ATP or nonhydrolyzable nucleotide analogs stimulated PPR65-catalyzed RNA-editing activity on PpccmFC substrates, indicating potential allosteric regulation of PPR65 by ATP. Unlike for bacterial cytidine deaminase, addition of two putative transition-state analogs, zebularine and tetrahydrouridine, failed to disrupt RNA-editing activity. RNA oligonucleotides with a single incorporated zebularine also did not disrupt editing in vitro, suggesting that PPR65 cannot bind modified bases due to differences in the structure of the active site compared with other zinc-dependent nucleotide deaminases.	[Hayes, Michael L.; Santibanez, Paola I.] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Hayes, ML (corresponding author), Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA.	mhayes3@calstatela.edu		Hayes, Michael/0000-0002-0210-0182	National Institutes of Health SCORE SC2 Grant [SC2 GM122718]; National Institutes of Health NIGMS [R25 GM61331]	National Institutes of Health SCORE SC2 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health SCORE SC2 Grant SC2 GM122718 (to M. L. H.) and National Institutes of Health NIGMS Grant R25 GM61331 to the RISE MS-to-Ph.D. program (to P. I. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bobik K, 2017, PLANT J, V91, P114, DOI 10.1111/tpj.13550; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Carlow D, 1998, BIOCHEMISTRY-US, V37, P11873, DOI 10.1021/bi980959n; Diaz MF, 2017, PLANT J, V92, P638, DOI 10.1111/tpj.13709; Gerke P, 2020, NEW PHYTOL, V225, P1974, DOI 10.1111/nph.16297; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Haudenschild BL, 2004, J AM CHEM SOC, V126, P11213, DOI 10.1021/ja0472073; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Krishnan A, 2018, P NATL ACAD SCI USA, V115, pE3201, DOI 10.1073/pnas.1720897115; Kvach MV, 2019, BIOCHEMISTRY-US, V58, P391, DOI 10.1021/acs.biochem.8b00858; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Oldenkott B, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0328-3; Pham P, 2016, DNA REPAIR, V43, P48, DOI 10.1016/j.dnarep.2016.05.029; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sandoval R, 2019, PLANT J, V99, P1116, DOI 10.1111/tpj.14384; Schallenberg-Rudinger M, 2013, RNA BIOL, V10, P1549, DOI 10.4161/rna.25755; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Spears JL, 2011, J BIOL CHEM, V286, P20366, DOI 10.1074/jbc.M111.243568; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Takenaka M, 2003, J BIOL CHEM, V278, P47526, DOI 10.1074/jbc.M305341200; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wilkins MR, 1999, METH MOL B, V112, P531	37	27	29	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3497	3505		10.1074/jbc.RA119.011790	http://dx.doi.org/10.1074/jbc.RA119.011790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31996373	hybrid, Green Published			2022-12-26	WOS:000527725300011
J	Haldenby, S; Bronowski, C; Nelson, C; Kenny, J; Martinez-Rodriguez, C; Chaudhuri, R; Williams, NJ; Forbes, K; Strachan, NJ; Pulman, J; Winstanley, IN; Corless, CE; Humphrey, TJ; Bolton, FJ; O'Brien, SJ; Hall, N; Hertz-Fowler, C; Winstanley, C				Haldenby, Sam; Bronowski, Christina; Nelson, Charlotte; Kenny, John; Martinez-Rodriguez, Carmen; Chaudhuri, Roy; Williams, Nicola J.; Forbes, Ken; Strachan, Norval J.; Pulman, Jane; Winstanley, Ian N.; Corless, Caroline E.; Humphrey, Tom J.; Bolton, Frederick J.; O'Brien, Sarah J.; Hall, Neil; Hertz-Fowler, Christiane; Winstanley, Craig			Increasing prevalence of a fluoroquinolone resistance mutation amongst Campylobacter jejuni isolates from four human infectious intestinal disease studies in the United Kingdom	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-STRUCTURE; SEQUENCE; CIPROFLOXACIN; ALIGNMENT; CHICKEN; EPIDEMIOLOGY; MECHANISMS; EMERGENCE	Background Campylobacter jejuni is the most common bacterial cause of human infectious intestinal disease. Methods We genome sequenced 601 human C. jejuni isolates, obtained from two large prospective studies of infectious intestinal disease (IID1 [isolates from 1993-1996; n = 293] and IID2 [isolates from 2008-2009; n = 93]), the INTEGRATE project [isolates from 2016-2017; n = 52] and the ENIGMA project [isolates from 2017; n = 163]. Results There was a significant increase in the prevalence of the T86I mutation conferring resistance to fluoroquinolone between each of the three later studies (IID2, INTEGRATE and ENIGMA) and IID1. Although the distribution of major multilocus sequence types (STs) was similar between the studies, there were changes in both the abundance of minority STs associated with the T86I mutation, and the abundance of clones within single STs associated with the T86I mutation. Discussion Four population-based studies of community diarrhoea over a 25 year period revealed an increase over time in the prevalence of the T86I amongst isolates of C. jejuni associated with human gastrointestinal disease in the UK. Although associated with many STs, much of the increase is due to the expansion of clones associated with the resistance mutation.	[Haldenby, Sam; Nelson, Charlotte; Kenny, John; Pulman, Jane; Winstanley, Ian N.; Hertz-Fowler, Christiane] Univ Liverpool, Ctr Genom Res, Liverpool, Merseyside, England; [Bronowski, Christina; Martinez-Rodriguez, Carmen; Williams, Nicola J.; Winstanley, Craig] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Chaudhuri, Roy] Univ Sheffield, Dept Biol & Biotechnol, Sheffield, S Yorkshire, England; [Forbes, Ken] Univ Aberdeen, Sch Med Med Sci & Nutr, Foresterhill, Aberdeen, Scotland; [Strachan, Norval J.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Corless, Caroline E.] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Infect & Immun, Liverpool Clin Labs, Liverpool, Merseyside, England; [Humphrey, Tom J.] Swansea Univ, Med Microbiol & Infect Dis, Sch Med, Swansea, W Glam, Wales; [Bolton, Frederick J.; O'Brien, Sarah J.] Univ Liverpool, Dept Publ Hlth & Policy, Inst Populat Hlth Sci, Liverpool, Merseyside, England; [Bolton, Frederick J.; O'Brien, Sarah J.] Univ Liverpool, NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool, Merseyside, England; [Hall, Neil] Norwich Res Pk, Earlham Inst, Norwich, Norfolk, England; [Hall, Neil] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England	University of Liverpool; University of Liverpool; University of Sheffield; University of Aberdeen; University of Aberdeen; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Swansea University; University of Liverpool; University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; University of East Anglia	Winstanley, C (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.	C.Winstanley@liv.ac.uk	Kenny, John/HCI-1952-2022; Chaudhuri, Roy/E-3774-2014	Kenny, John/0000-0003-2994-6169; Chaudhuri, Roy/0000-0001-5037-2695; Hall, Neil/0000-0003-2808-0009; Bronowski, Christina/0000-0001-8089-4021; Martinez-Rodriguez, Carmen/0000-0001-5773-6455	Food Standards Agency, UK (FSA Project) [FS101072]; Medical Research Council; Natural Environment Research Council; Economic and Social Research Council; Biotechnology and Biosciences Research Council; Food Standards Agency through the Environmental and Social Ecology of Human Infectious Diseases Initiative (ESEI) [G1100799/1]; Wellcome Trust; Department of Health through the Health Innovation Challenge Fund (HICF) [HICF-T5-354]; BBSRC [BB/L014777/1, BB/M012638/1, BBS/E/T/000PR9818] Funding Source: UKRI; MRC [G0900753, G1100799] Funding Source: UKRI	Food Standards Agency, UK (FSA Project); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Food Standards Agency through the Environmental and Social Ecology of Human Infectious Diseases Initiative (ESEI); Wellcome Trust(Wellcome Trust); Department of Health through the Health Innovation Challenge Fund (HICF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by CW, RC, NJW, NH, SJO: Food Standards Agency, UK (FSA Project FS101072); https://www.food.gov.uk/.SJO, KF, NJS, TJH, FJB, NH, CW: ENIGMA was funded by the Medical Research Council, Natural Environment Research Council, Economic and Social Research Council, Biotechnology and Biosciences Research Council and Food Standards Agency through the Environmental and Social Ecology of Human Infectious Diseases Initiative (ESEI) (Project no. G1100799/1); https://mrc.ukri.org/.SJO, FJB, CHF, CW: INTEGRATE was funded by the Wellcome Trust and Department of Health through the Health Innovation Challenge Fund (HICF) (Grant Reference: HICF-T5-354); https://wellcome.ac.uk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BPC, 2017, BRIT POULTR COUNC BP; Cha W, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00818; Cody AJ, 2012, J CLIN MICROBIOL, V50, P3193, DOI 10.1128/JCM.01086-12; Dingle KE, 2008, EMERG INFECT DIS, V14, P1620, DOI 10.3201/eid1410.071109; Elhadidy M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01014; Facciola A, 2017, J Prev Med Hyg, V58, pE79; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; French N, 2005, ENVIRON MICROBIOL, V7, P1116, DOI 10.1111/j.1462-2920.2005.00782.x; Habib I, 2009, APPL ENVIRON MICROB, V75, P4264, DOI 10.1128/AEM.00168-09; Han J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00021; Hanninen ML, 2007, J ANTIMICROB CHEMOTH, V60, P1251, DOI 10.1093/jac/dkm345; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Humphrey TJ, 2005, ANTIMICROB AGENTS CH, V49, P690, DOI 10.1128/AAC.49.2.690-698.2005; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jesse TW, 2006, J APPL MICROBIOL, V100, P682, DOI 10.1111/j.1365-2672.2005.02796.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Kovac J, 2014, EPIDEMIOL INFECT, V142, P2595, DOI 10.1017/S0950268813003245; Kovac J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01169; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lim SK, 2016, J VET MED SCI, V78, P1791, DOI 10.1292/jvms.16-0307; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McIntyre KM, 2019, JMIR RES PROTOC, V8, DOI 10.2196/13941; Mercade-Prieto R, 2008, INT J FOOD ENG, V4, DOI 10.2202/1556-3758.1421; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; NICE, 2017, NAT I HLTH CAR EXC G; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Price LB, 2005, ENVIRON HEALTH PERSP, V113, P557, DOI 10.1289/ehp.7647; Ragimbeau C, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0205-7; Sahl JW, 2014, PEERJ, V2, DOI 10.7717/peerj.332; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sproston EL, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000198; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strachan NJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079331; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; VARSS, 2015, UK VET ANT RES SAL S; VARSS, 2016, UK VET ANT RES SAL S; Wei B, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4526576; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Wimalarathna HML, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-160; Wirz SE, 2010, APPL ENVIRON MICROB, V76, P6377, DOI 10.1128/AEM.00813-10; Zhao S, 2016, APPL ENVIRON MICROB, V82, P459, DOI 10.1128/AEM.02873-15	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227535	10.1371/journal.pone.0227535	http://dx.doi.org/10.1371/journal.pone.0227535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999701	Green Published, gold, Green Accepted			2022-12-26	WOS:000534612400020
J	Raimondo, D; Remoli, C; Astrologo, L; Burla, R; La Torre, M; Verni, F; Tagliafico, E; Corsi, A; Del Giudice, S; Persichetti, A; Giannicola, G; Robey, PG; Riminucci, M; Saggio, I				Raimondo, Domenico; Remoli, Cristina; Astrologo, Letizia; Burla, Romina; La Torre, Mattia; Verni, Fiammetta; Tagliafico, Enrico; Corsi, Alessandro; Del Giudice, Simona; Persichetti, Agnese; Giannicola, Giuseppe; Robey, Pamela G.; Riminucci, Mara; Saggio, Isabella			Changes in gene expression in human skeletal stem cells transduced with constitutively active Gs alpha correlates with hallmark histopathological changes seen in fibrous dysplastic bone	PLOS ONE			English	Article							IN-VITRO; PARATHYROID-HORMONE; RECEPTOR ACTIVATOR; ADIPOSE-TISSUE; PROTEIN; KINASE; FAT; DIFFERENTIATION; PROLACTIN; RELEASE	Fibrous dysplasia (FD) of bone is a complex disease of the skeleton caused by dominant activating mutations of the GNAS locus encoding for the a subunit of the G protein-coupled receptor complex (Gs alpha). The mutation involves a substitution of arginine at position 201 by histidine or cysteine (Gs alpha(R201H) or (R201C)), which leads to overproduction of cAMP. Several signaling pathways are implicated downstream of excess cAMP in the manifestation of disease. However, the pathogenesis of FD remains largely unknown. The overall FD phenotype can be attributed to alterations of skeletal stem/progenitor cells which normally develop into osteogenic or adipogenic cells (in cis), and are also known to provide support to angiogenesis, hematopoiesis, and osteoclastogenesis (in trans). In order to dissect the molecular pathways rooted in skeletal stem/progenitor cells by FD mutations, we engineered human skeletal stem/progenitor cells with the Gsa(R201C) mutation and performed transcriptomic analysis. Our data suggest that this FD mutation profoundly alters the properties of skeletal stem/progenitor cells by pushing them towards formation of disorganized bone with a concomitant alteration of adipogenic differentiation. In addition, the mutation creates an altered in trans environment that induces neovascularization, cytokine/chemokine changes and osteoclastogenesis. In silico comparison of our data with the signature of FD craniofacial samples highlighted common traits, such as the upregulation of ADAM (A Disintegrin and Metalloprotease) proteins and other matrix-related factors, and of PDE7B (Phosphodiesterase 7B), which can be considered as a buffering process, activated to compensate for excess cAMP. We also observed high levels of CEBPs (CCAAT-Enhancer Binding Proteins) in both data sets, factors related to browning of white fat. This is the first analysis of the reaction of human skeletal stem/progenitor cells to the introduction of the FD mutation and we believe it provides a useful background for further studies on the molecular basis of the disease and for the identification of novel potential therapeutic targets.	[Raimondo, Domenico; Remoli, Cristina; Corsi, Alessandro; Persichetti, Agnese; Riminucci, Mara] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Astrologo, Letizia; Burla, Romina; La Torre, Mattia; Verni, Fiammetta; Del Giudice, Simona; Saggio, Isabella] Sapienza Univ Rome, Dept Biol & Biotechnol, Rome, Italy; [Tagliafico, Enrico] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, NIH, DHHS, Bethesda, MD USA; [Giannicola, Giuseppe] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthopaed Sci, Rome, Italy; [Saggio, Isabella] Nanyang Technol Univ, Sch Biol Sci, NTU Inst Struct Biol, Singapore, Singapore; [Astrologo, Letizia] Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland; [Astrologo, Letizia] Univ Bern, Dept BioMed Res, Urol Res Lab, Bern, Switzerland	Sapienza University Rome; Sapienza University Rome; Universita di Modena e Reggio Emilia; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Sapienza University Rome; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Bern; University of Bern	Riminucci, M (corresponding author), Sapienza Univ Rome, Dept Mol Med, Rome, Italy.; Saggio, I (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol, Rome, Italy.; Saggio, I (corresponding author), Nanyang Technol Univ, Sch Biol Sci, NTU Inst Struct Biol, Singapore, Singapore.	mara.riminucci@uniroma1.it; isabella.saggio@uniroma1.it	Robey, Pamela Gehron/H-1429-2011; Saggio, Isabella/H-2417-2015; La Torre, Mattia/AHD-9999-2022; La Torre, Mattia/AAR-2612-2021; Riminucci, Mara/AAC-3906-2022; Tagliafico, Enrico/C-9079-2009	Robey, Pamela Gehron/0000-0002-5316-5576; La Torre, Mattia/0000-0002-1178-6948; saggio, isabella/0000-0002-9497-7415; Burla, Romina/0000-0002-5640-4464; raimondo, domenico/0000-0002-1780-7295; del giudice, simona/0000-0002-4573-269X; Tagliafico, Enrico/0000-0003-0981-2542	EU FP7 Brainvectors [286071]; Telethon [GGP15198, PRF 2016-67]; Progetti di Ricerca, Sapienza University of Rome [RP1181642E87148C]; FIRC [22392]; CIB; Avvio alla Ricerca, Sapienza University of Rome [AR2181642B6F2E48, AR1181642EE61111]; University of Pennsylvania Orphan Disease Center; Fibrous Dysplasia Foundation [MDBR16-114-FD/MAS, MDBR17-114-FD/MAS]; Sapienza University [RP11715C7C4DC57A]; IRP, NIH, DHHS [ZIA DE000380]	EU FP7 Brainvectors; Telethon(Fondazione Telethon); Progetti di Ricerca, Sapienza University of Rome; FIRC(Fondazione AIRC per la ricerca sul cancro); CIB; Avvio alla Ricerca, Sapienza University of Rome; University of Pennsylvania Orphan Disease Center; Fibrous Dysplasia Foundation; Sapienza University; IRP, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been supported by Grants EU FP7 Brainvectors (n. 286071), Telethon GEP15033, PRF 2016-67, Progetti di Ricerca, Sapienza University of Rome (RP1181642E87148C) to IS, FIRC (22392) and CIB to MLT and IS; Avvio alla Ricerca, Sapienza University of Rome (AR2181642B6F2E48, AR1181642EE61111) to RB, SDG and IS; Telethon GGP15198, University of Pennsylvania Orphan Disease Center in partnership with the Fibrous Dysplasia Foundation MDBR16-114-FD/MAS and MDBR17-114-FD/MAS to MR; Sapienza University (RP11715C7C4DC57A) to AC; the IRP, NIH, DHHS (ZIA DE000380) to PGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Aubert J, 1999, J BIOL CHEM, V274, P24965, DOI 10.1074/jbc.274.35.24965; Bharti AC, 2004, J IMMUNOL, V172, P5940, DOI 10.4049/jimmunol.172.10.5940; Bianco P, 2000, J BONE MINER RES, V15, P120, DOI 10.1359/jbmr.2000.15.1.120; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Bianco P, 2012, PEDIATRIC BONE: BIOLOGY & DISEASES, 2ND EDITION, P589, DOI 10.1016/B978-0-12-382040-2.10022-X; Bianco P, 2010, HUM GENE THER, V21, P1057, DOI 10.1089/hum.2010.136; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Burla R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005167; CANDELIERE GA, 1995, NEW ENGL J MED, V332, P1546, DOI 10.1056/NEJM199506083322304; Chapurlat RD, 2000, BEST PRACT RES CL RH, V14, P385, DOI 10.1053/berh.1999.0071; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Collins MT, 2007, PRIMER METABOLIC BON, P423; de Castro LF, 2019, J BONE MINER RES, V34, P290, DOI 10.1002/jbmr.3602; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; DiCaprio MR, 2005, J BONE JOINT SURG AM, V87A, P1848, DOI 10.2106/JBJS.D.02942; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Gunther T, 2007, NAT CELL BIOL, V9, P1229, DOI 10.1038/ncb1107-1229; Ha J, 2010, J IMMUNOL, V184, P4717, DOI 10.4049/jimmunol.0902444; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janos K, 2010, AM J MED GENET A, V152A, P2211, DOI 10.1002/ajmg.a.33559; Johnston J, 2010, TRANSGENIC RES, V19, P1017, DOI 10.1007/s11248-010-9376-7; Kalaszczynska I, 2013, BIORESEARCH OPEN ACC, V2, P356, DOI 10.1089/biores.2013.0029; Kawanami D, 2009, J BIOL CHEM, V284, P20522, DOI 10.1074/jbc.M109.025346; Khan SK, 2018, P NATL ACAD SCI USA, V115, pE418, DOI 10.1073/pnas.1714313114; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Macedo Maria F., 2008, Inflammation & Allergy Drug Targets, V7, P41, DOI 10.2174/187152808784165162; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; McFarland-Mancini M, 2006, BIOCHEM BIOPH RES CO, V344, P9, DOI 10.1016/j.bbrc.2006.03.168; Miura Y, 1998, CELL TRANSPLANT, V7, P453, DOI 10.1016/S0963-6897(98)00033-5; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nanbu-Wakao R, 2000, MOL ENDOCRINOL, V14, P307, DOI 10.1210/me.14.2.307; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Onan D, 2009, ENDOCRINOLOGY, V150, P2244, DOI 10.1210/en.2008-1597; Palmisano B, 2019, J BONE MINER RES, V34, P2171, DOI 10.1002/jbmr.3828; Piersanti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133607; Piersanti S, 2010, J BONE MINER RES, V25, P1103, DOI 10.1359/jbmr.091036; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Riminucci A, 2003, BONE, V33, P434, DOI 10.1016/S8756-3282(03)00064-4; Riminucci M, 2006, J BONE MINER RES, V21, pP125, DOI 10.1359/JBMR.06S224; Riminucci M, 2010, J MOL ENDOCRINOL, V45, P355, DOI 10.1677/JME-10-0097; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Saggio I, 2014, J BONE MINER RES, V29, P2357, DOI 10.1002/jbmr.2267; SASSONECORSI P, 1995, NEW ENGL J MED, V332, P1576, DOI 10.1056/NEJM199506083322311; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Sharaf-Eldin WE, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1908365; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Simao D, 2015, TISSUE ENG PT A, V21, P654, DOI [10.1089/ten.tea.2014.0079, 10.1089/ten.TEA.2014.0079]; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Yuvaraj S, 2009, MOL CANCER RES, V7, P1399, DOI 10.1158/1541-7786.MCR-08-0589; Zhao XF, 2018, P NATL ACAD SCI USA, V115, pE428, DOI 10.1073/pnas.1713710115; Zhou SH, 2014, INT J CLIN EXP PATHO, V7, P8532	77	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227279	10.1371/journal.pone.0227279	http://dx.doi.org/10.1371/journal.pone.0227279			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999703	Green Published, gold			2022-12-26	WOS:000534612400014
J	Prairie, MW; Frisbie, SH; Rao, KK; Saksri, AH; Parbat, S; Mitchell, EJ				Prairie, Michael W.; Frisbie, Seth H.; Rao, K. Kesava; Saksri, Anyamanee H.; Parbat, Shreyas; Mitchell, Erika J.			An accurate, precise, and affordable light emitting diode spectrophotometer for drinking water and other testing with limited resources	PLOS ONE			English	Article								Spectrophotometers are commonly used to measure the concentrations of a wide variety of analytes in drinking water and other matrixes; however, many laboratories with limited resources cannot afford to buy these very useful instruments. To meet this need, an accurate, precise, and affordable light emitting diode (LED) spectrophotometer was designed and built using best engineering practices and modern circuit design. The cost and performance of this LED spectrophotometer was compared against 4 common commercial spectrophotometers. More specifically, the performance of these spectrophotometers was evaluated from the upper limits of linear range, upper limits of operational range, calibration sensitivities, R-2 values, precisions of standards, estimated limits of detection, and percent calibration check standard recoveries for the determinations of iron (Fe), manganese (Mn), and fluoride (F-) in drinking water. This evaluation was done in the United States (U.S.) and India. Our LED spectrophotometer costs $63 United States Dollars (USD) for parts. The 4 commercial spectrophotometers ranged in cost from $2,424 to $7,644 USD. There are no practical differences in the upper limits of linear range, upper limits of operational range, R2 values, precisions of standards, and estimated limits of detection for our LED spectrophotometer and the 4 commercial spectrophotometers. For 2 of the 3 analytes, there is a practical difference in the calibration sensitivities our LED spectrophotometer and the 4 commercial spectrophotometers. More specifically, the calibration sensitivities for Mn and F using our LED spectrophotometer were 65.2% and 67.0% of those using the 4 commercial spectrophotometers, respectively. In conclusion, this paper describes the design, use, and performance of an accurate, precise, and extremely affordable LED spectrophotometer for drinking water and other testing with limited resources.	[Prairie, Michael W.] Norwich Univ, Dept Elect & Comp Engn, Northfield, VT USA; [Frisbie, Seth H.; Saksri, Anyamanee H.] Norwich Univ, Dept Chem & Biochem, Northfield, VT 05663 USA; [Rao, K. Kesava; Parbat, Shreyas] Indian Inst Sci, Dept Chem Engn, Bangalore, Karnataka, India; [Mitchell, Erika J.] Better Life Labs Inc, East Calais, VT USA	Indian Institute of Science (IISC) - Bangalore	Frisbie, SH (corresponding author), Norwich Univ, Dept Chem & Biochem, Northfield, VT 05663 USA.	sfrisbie@norwich.edu	/GLN-2665-2022	Frisbie, Seth/0000-0001-6611-6039; Mitchell, Erika/0000-0003-2580-5799	Norwich University; Ministry of Human Resource Development, Government of India	Norwich University; Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India)	Non-specific support was provided by Norwich University and the Ministry of Human Resource Development, Government of India. EJM is affiliated with Better Life Laboratories and did not receive support in the form of a salary. Better Life Laboratories also provided no funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agilent Technologies, 2018, CAR 60 UV VIS; Albert DR, 2012, J CHEM, V89, P1432, DOI 10.1021/ed200829d; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; APHA AWWA WEF, 2012, STANDARD METHODS EXA, P541; Asheim J, 2014, J CHEM, V91, P1037; Ashfaque-E-Alam M, 2017, INT CONF ADV ELECTR, P653; Bishop ML, 2013, CLIN CHEM PRINCIPLES, p[101, 110, 157]; Chaianantakul N, 2018, SPECTROCHIM ACTA A, V204, P670, DOI 10.1016/j.saa.2018.06.107; Christian GD, 1986, ANAL CHEM, p[371, 385]; Davis S., 2011, SCHOTTKY DIODES OLD; Davis S., 2004, ELECT DESIGN POWER L; Dewitte K, 2002, CLIN CHEM, V48, P799; Forbes PBC, 2014, S AFR J SCI, V110, P49, DOI 10.1590/sajs.2014/20130096; Frisbie S.H., 2005, INT J APPL MAT THEOR, V1, P14, DOI [10.11648/j.ijamtp.20150102.11, DOI 10.11648/J.IJAMTP.20150102.11]; Frisbie SH, 2002, ENVIRON HEALTH PERSP, V110, P1147, DOI 10.1289/ehp.021101147; Frisbie SH., 2015, INT J APPL MATH THEO, V1, P9; Frisbie SH, METALS GENETICS; Gibbons R. D, 2001, STAT METHODS DETECTI, P48; de Lima KMG, 2012, MICROCHEM J, V103, P62, DOI 10.1016/j.microc.2012.01.003; Gong WD, 2009, IEEE SENS J, V9, P862, DOI 10.1109/JSEN.2009.2020659; Hach Company, 2018, SPECTR; Hach Company, 2014, 1 2 PYR 2 NAPHTH PAN; Harris DC, 1999, QUANTITATIVE CHEM AN, P103; Horowitz P, 2015, ART ELECT, p[16, 202, 465, 829, 841]; Kvittingen EV, 2016, J CHEM, V93, P1814, DOI 10.1021/acs; Makarov SN, 2016, PRACTICAL ELECT ENG, P827; McNaught AD, 1997, XML ON LINE CORRECTE; Mestha LK, 2006, ICIS '06: INTERNATIONAL CONGRESS OF IMAGING SCIENCE, FINAL PROGRAM AND PROCEEDINGS, P95; Mohammad K.A., 2015, IJET, DOI [10.14419/ijet.v4i2.4504, DOI 10.14419/IJET.V4I2.4504]; Nandiyanto A.B.D., 2018, TELKOMNIKA, V16, P580; Neter J, 1985, APPLIED LINEAR STATI, P300; O'Donoghue J, 2019, J CHEM EDUC, V96, P1136, DOI 10.1021/acs.jchemed.9b00301; Place BJ, 2019, J CHEM EDUC, V96, P714, DOI 10.1021/acs.jchemed.8b00515; Santos WG, 2015, J CHEM EDUC, V92, P1709, DOI 10.1021/ed500931p; Skoog D.A., 2014, FUNDAMENTALS ANAL CH, P658; Skoog DA, 2018, PRINCIPLES INSTRUMEN, p[16, 142, 160, 304]; Snedecor GW, 1982, STAT METHODS, P31; Sodkomkham D, 2016, KNOWL-BASED SYST, V94, P1, DOI 10.1016/j.knosys.2015.09.013; Thal MA, 2001, J CHEM EDUC, V78, P1510, DOI 10.1021/ed078p1510; Thermo Fisher Scientific, 2018, SPECTR 200 SPECTR; Thorlabs, 2019, UNM LEDS; Tzanavaras PD, 2007, ANAL CHIM ACTA, V588, P1, DOI 10.1016/j.aca.2007.01.060; [United States Agency for International Development Prepared by the Bangladesh Rural Electrification Board. Funded by U.S. AID], 1997, III3880070 US AID RE; United States Environmental Protection Agency, 2014, EPA DRINK WAT METH F; US Bureau of Labor Statistics (BLS), 2019, CPI INFL CALC; US EPA, 1994, 2008 US EPA; Veras G, 2009, TALANTA, V77, P1155, DOI 10.1016/j.talanta.2008.08.014; WHO, 2011, GUID DRINK WAT QUAL, P472; Widenhorn R, 2002, P SOC PHOTO-OPT INS, V4669, P193, DOI 10.1117/12.463446; Wilsont MV, 2017, J CHEM EDUC, V94, P44, DOI 10.1021/acs.jchemed.6b00515; World Health Organization (WHO), 2017, GUID DRINK WAT QUAL, P472	51	7	10	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226761	10.1371/journal.pone.0226761	http://dx.doi.org/10.1371/journal.pone.0226761			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995571	gold, Green Published			2022-12-26	WOS:000534609400014
J	Cury, C; Scelsi, MA; Toro, R; Frouin, V; Artiges, E; Grigis, A; Heinz, A; Lemaitre, H; Martinot, JL; Poline, JB; Smolka, MN; Walter, H; Schumann, G; Altmann, A; Colliot, O				Cury, Claire; Scelsi, Marzia Antonella; Toro, Roberto; Frouin, Vincent; Artiges, Eric; Grigis, Antoine; Heinz, Andreas; Lemaitre, Herve; Martinot, Jean-Luc; Poline, Jean-Baptiste; Smolka, Michael N.; Walter, Henrik; Schumann, Gunter; Altmann, Andre; Colliot, Olivier		IMAGEN Consortium	Genome wide association study of incomplete hippocampal inversion in adolescents	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; DEPRESSED-PATIENTS; BRAIN-DEVELOPMENT; GENE-EXPRESSION; COMMON; HERITABILITY; DATABASE; OPTIMIZATION; REGISTRATION; METAANALYSIS	Incomplete hippocampal inversion (IHI), also called hippocampal malrotation, is an atypical presentation of the hippocampus present in about 20% of healthy individuals. Here we conducted the first genome-wide association study (GWAS) in IHI to elucidate the genetic underpinnings that may contribute to the incomplete inversion during brain development. A total of 1381 subjects contributed to the discovery cohort obtained from the IMAGEN database. The incidence rate of IHI was 26.1%. Loci with P<1e-5 were followed up in a validation cohort comprising 161 subjects from the PING study. Summary statistics from the discovery cohort were used to compute IHI heritability as well as genetic correlations with other traits. A locus on 18q11.2 (rs9952569; OR = 1.999; Z = 5.502; P = 3.755e-8) showed a significant association with the presence of IHI. A functional annotation of the locus implicated genes AQP4 and KCTD1. However, neither this locus nor the other 16 suggestive loci reached a significant p-value in the validation cohort. The h(2) estimate was 0.54 (sd: 0.30) and was significant (Z = 1.8; P = 0.036). The top three genetic correlations of IHI were with traits representing either intelligence or education attainment and reached nominal P < = 0.013.	[Cury, Claire; Scelsi, Marzia Antonella; Altmann, Andre] UCL, Ctr Med Image Comp, Dept Med Phys & Biomed Engn, London, England; [Toro, Roberto] Inst Pasteur, URA, Ctr Natl Rech Sci Genes Synapses & Cognit, Paris, France; [Toro, Roberto] Inst Pasteur, Human Genet & Cognit Funct, Paris, France; [Frouin, Vincent; Grigis, Antoine] Univ Paris Saclay, CEA, NeuroSpin, Gif Sur Yvette, France; [Artiges, Eric; Martinot, Jean-Luc] Univ Paris 05, Univ Paris Sud, Neuroimaging & Psychiat, Inserm U 1000,Sorbonne Paris Cite, Paris, France; [Artiges, Eric] Orsay Hosp, Psychiat Dept 91G16, Paris, France; [Heinz, Andreas; Walter, Henrik] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Charite Mitte,Charitepl 1, Berlin, Germany; [Lemaitre, Herve] Univ Paris Sud, Fac Med, Neuroimaging & Psychiat, Inserm U 1000, Le Kremlin Bicetre, France; [Lemaitre, Herve] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Martinot, Jean-Luc] Maison Solenn, Paris, France; [Poline, Jean-Baptiste] McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, McConnell Brain Imaging Ctr, Fac Med,Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat, Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, Dresden, Germany; [Schumann, Gunter] Kings Coll London, Med Res Council, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Colliot, Olivier] ICM, Inst Cerveau & Moelle Epiniere, Paris, France; [Colliot, Olivier] INSERM, U 1127, Paris, France; [Colliot, Olivier] CNRS, UMR 7225, Paris, France; [Colliot, Olivier] Sorbonne Univ, Paris, France; [Colliot, Olivier] INRIA, Aramis Project Team, Paris, France; [Cury, Claire] Univ Rennes, INRIA, INSERM, CNRS,IRISA UMR 6074,Empen Ex VISAGES,ERL U 1228, Rennes, France	University of London; University College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; McGill University; Technische Universitat Dresden; Technische Universitat Dresden; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Inria; Centre National de la Recherche Scientifique (CNRS); Inria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Cury, C (corresponding author), UCL, Ctr Med Image Comp, Dept Med Phys & Biomed Engn, London, England.; Cury, C (corresponding author), Univ Rennes, INRIA, INSERM, CNRS,IRISA UMR 6074,Empen Ex VISAGES,ERL U 1228, Rennes, France.	claire.cury.pro@gmail.com	Walter, Henrik/O-2612-2013; Artiges, Eric/AAT-7219-2021; Lemaitre, Herve/ABB-5427-2020; Altmann, Andre/ABF-1675-2020; Heinz, Andreas/ABB-7736-2020; Cury, Claire/AAO-8486-2020; Colliot, Olivier/B-2092-2012	Artiges, Eric/0000-0003-4461-7646; Lemaitre, Herve/0000-0002-5952-076X; Altmann, Andre/0000-0002-9265-2393; Heinz, Andreas/0000-0001-5405-9065; Cury, Claire/0000-0002-9903-7940; Toro, Roberto/0000-0002-6671-858X; Scelsi, Marzia/0000-0002-5861-6452; Walter, Henrik/0000-0002-9403-6121; Colliot, Olivier/0000-0002-9836-654X; Schumann, Gunter/0000-0003-4905-5523	EPSRC [EP/L016478/1]; MRC eMedLab Medical Bioinformatics Career Development Fellowship; Medical Research Council [MR/L016311/1]; program "Investissements d'avenir" [ANR-10-IAIHU-06]; "Contrat d'Interface Local" program from Assistance Publique-Hopitaux de Paris (AP-HP); Research Domain Criteria (RDoC) project; Pediatric Imaging, Neurocognition and Genetics Study (PING) (National Institutes of Health) [RC2DA029475]; European Union [LSHM-CT-2007-037286]; MRC [MR/L016311/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC eMedLab Medical Bioinformatics Career Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); program "Investissements d'avenir"(French National Research Agency (ANR)); "Contrat d'Interface Local" program from Assistance Publique-Hopitaux de Paris (AP-HP); Research Domain Criteria (RDoC) project; Pediatric Imaging, Neurocognition and Genetics Study (PING) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MAS acknowledges financial support by the EPSRC-funded UCL Centre for Doctoral Training in Medical Imaging (EP/L016478/1). AA holds an MRC eMedLab Medical Bioinformatics Career Development Fellowship. This work was supported by the Medical Research Council [grant number MR/L016311/1]. The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06 (Agence Nationale de la Recherche-10-IA Institut Hospitalo-Universitaire-6) and from the "Contrat d'Interface Local" program (to OC) from Assistance Publique-Hopitaux de Paris (AP-HP). Data and/or research tools used in the preparation of this manuscript were obtained and analyzed from the controlled access datasets distributed from the NIMH-supported research Domain Criteria Database (RDoCdb). RDoCdb is a collaborative informatics system created by the National Institute of Mental Health to store and share data resulting from grants funded through the Research Domain Criteria (RDoC) project. Dataset identifier(s): #2607. Data collection and sharing for this project was funded by the Pediatric Imaging, Neurocognition and Genetics Study (PING) (National Institutes of Health Grant RC2DA029475). IMAGEN was supported by the European Union-funded FP6 (LSHM-CT-2007-037286. The funders had no role in study design, data collection (except for PING and IMAGEN grants) and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andrade DM, 2013, CAN J NEUROL SCI, V40, P652, DOI 10.1017/S0317167100014876; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Bajic D, 2012, AM J NEURORADIOL, V33, P513, DOI 10.3174/ajnr.A2814; Bajic D, 2008, EUR RADIOL, V18, P138, DOI 10.1007/s00330-007-0735-6; Bajic D, 2010, NEURORADIOLOGY, V52, P489, DOI 10.1007/s00234-010-0673-x; Bajic D, 2009, EUR RADIOL, V19, P2544, DOI 10.1007/s00330-009-1438-y; BAKER LL, 1992, AM J NEURORADIOL, V13, P115; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Baulac M, 1998, ANN NEUROL, V44, P223, DOI 10.1002/ana.410440213; Bernasconi N, 2005, BRAIN, V128, P2442, DOI 10.1093/brain/awh599; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Binder DK, 2006, ACTA NEUROCHIR, P96; BRONEN RA, 1991, MAGN RESON IMAGING, V9, P497, DOI 10.1016/0730-725X(91)90035-K; Bulik-Sullivan B, 2015, NATURE; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Colenutt J, 2018, J NEUROIMAGING, V28, P422, DOI 10.1111/jon.12509; Colle R, 2016, NEUROIMAGE-CLIN, V12, P949, DOI 10.1016/j.nicl.2016.04.009; Colle R, 2015, J PSYCHIATR RES, V61, P13, DOI 10.1016/j.jpsychires.2014.12.010; Colom R, 2013, INTELLIGENCE, V41, P129, DOI 10.1016/j.intell.2013.01.002; Cury C., 2015, STAT SHAPE ANAL ANAT; Cury C, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00160; Das A, 2012, NEUROSCIENCE, V220, P237, DOI 10.1016/j.neuroscience.2012.06.002; de Zubicaray GI, 2008, BRAIN IMAGING BEHAV, V2, P258, DOI 10.1007/s11682-008-9029-0; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jernigan TL, 2016, NEUROIMAGE, V124, P1149, DOI 10.1016/j.neuroimage.2015.04.057; Kim H, 2012, NEUROIMAGE, V59, P3178, DOI 10.1016/j.neuroimage.2011.11.040; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; LEHERICY S, 1995, AM J NEURORADIOL, V16, P617; Li XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094343; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; MACHIELA MJ, 2015, BIOINFORMATICS, V31, P3555, DOI DOI 10.1093/BI0INF0RMATICS/BTV402; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Marneros AG, 2013, AM J HUM GENET, V92, P621, DOI 10.1016/j.ajhg.2013.03.002; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Okada Y, 2003, NEUROREPORT, V14, P1405, DOI 10.1097/01.wnr.0000078381.40088.d0; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qiu A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.79; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Righini A, 2006, AM J NEURORADIOL, V27, P2093; Roshchupkin GV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13738; Samann PG, 2013, EUR NEUROPSYCHOPHARM, V23, P1503, DOI 10.1016/j.euroneuro.2013.07.004; Satterthwaite TD, 2014, NEUROIMAGE, V86, P544, DOI 10.1016/j.neuroimage.2013.07.064; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Travis SG, 2016, J AFFECT DISORDERS, V201, P34, DOI 10.1016/j.jad.2016.04.049; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	74	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227355	10.1371/journal.pone.0227355	http://dx.doi.org/10.1371/journal.pone.0227355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990937	Green Published, Green Submitted, gold			2022-12-26	WOS:000534605400015
J	Fellner, M; Varga, B; Grolmusz, V				Fellner, Mate; Varga, Balint; Grolmusz, Vince			The Frequent Network Neighborhood Mapping of the human hippocampus shows much more frequent neighbor sets in males than in females	PLOS ONE			English	Article							HUMAN CONNECTOME PROJECT; MRI; TRACTOGRAPHY; PAGERANK	In the study of the human connectome, the vertices and the edges of the network of the human brain are analyzed: the vertices of the graphs are the anatomically identified gray matter areas of the subjects; this set is exactly the same for all the subjects. The edges of the graphs correspond to the axonal fibers, connecting these areas. In the biological applications of graph theory, it happens very rarely that scientists examine numerous large graphs on the very same, labeled vertex set. Exactly this is the case in the study of the connectomes. Because of the particularity of these sets of graphs, novel, robust methods need to be developed for their analysis. Here we introduce the new method of the Frequent Network Neighborhood Mapping for the connectome, which serves as a robust identification of the neighborhoods of given vertices of special interest in the graph. We apply the novel method for mapping the neighborhoods of the human hippocampus and discover strong statistical asymmetries between the connectomes of the sexes, computed from the Human Connectome Project. We analyze 413 braingraphs, each with 463 nodes. We show that the hippocampi of men have much more significantly frequent neighbor sets than women; therefore, in a sense, the connections of the hippocampi are more regularly distributed in men and more varied in women. Our results are in contrast to the volumetric studies of the human hippocampus, where it was shown that the relative volume of the hippocampus is the same in men and women.	[Fellner, Mate; Varga, Balint; Grolmusz, Vince] Eotvos Lorand Univ, PIT Bioinformat Grp, Budapest, Hungary; [Grolmusz, Vince] Uratim Ltd, Budapest, Hungary	Eotvos Lorand University	Grolmusz, V (corresponding author), Eotvos Lorand Univ, PIT Bioinformat Grp, Budapest, Hungary.; Grolmusz, V (corresponding author), Uratim Ltd, Budapest, Hungary.	grolmusz@pitgroup.org	Varga, Bálint/AAC-4316-2021	Varga, Bálint/0000-0001-8827-6754; Grolmusz, Vince/0000-0001-9456-8876	National Research, Development and Innovation Office of Hungary [KH-126472, K-127909]; European Union; European Social Fund [EFOP-3.6.3-VEKOP-16-2017-00002]; 16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University [1U54MH091657]	National Research, Development and Innovation Office of Hungary; European Union(European Commission); European Social Fund(European Social Fund (ESF)); 16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); McDonnell Center for Systems Neuroscience at Washington University	VG and MF and BV were supported by the KH-126472 and the K-127909 grants of the National Research, Development and Innovation Office of Hungary. MF was supported by the European Union, co-financed by the European Social Fund (EFOP-3.6.3-VEKOP-16-2017-00002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Uratim Ltd provided support in the form of salaries for author VG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Data were provided in part by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. Vince Grolmusz is the CEO of Uratim Ltd. Uratim Ltd provided support in the form of salary for author VG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Agrawal R., 1993, P 1993 ACM SIGMOD IN, P207, DOI DOI 10.1145/170035.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; Banky D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054204; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gerhard S., 2011, FRONT NEUROINFORM, V5, P1, DOI [DOI 10.3389/FNINF.2011.00003, 10.3389/fninf.2011.00003]; Goll J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-223; Grolmusz V, 2015, INFORM PROCESS LETT, V115, P633, DOI 10.1016/j.ipl.2015.02.015; Grolmusz VI, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140252; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Han J, 2006, DATA MINING CONCEPTS; HOLM S, 1979, SCAND J STAT, V6, P65; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Kerepesi C, 2018, NEUROSCI LETT, V673, P51, DOI 10.1016/j.neulet.2018.02.052; Kerepesi C, 2018, NEUROSCI LETT, V662, P17, DOI 10.1016/j.neulet.2017.10.003; Kerepesi C, 2017, COGN NEURODYNAMICS, V11, P483, DOI 10.1007/s11571-017-9445-1; Kerepesi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158680; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Nees F, 2014, FRONT NEUROL NEUROSC, V34, P85, DOI 10.1159/000356427; Santin LJ, 2000, REV NEUROLOGIA, V31, P455, DOI 10.33588/rn.3105.2000103; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Szalkai B., 2016, ARXIV160300904; Szalkai B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215473; Szalkai B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16326-0; Szalkai B, 2018, BRAIN IMAGING BEHAV, V12, P663, DOI 10.1007/s11682-017-9720-0; Szalkai B, 2017, COGN NEURODYNAMICS, V11, P113, DOI 10.1007/s11571-016-9407-z; Szalkai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130045; Szalkai B, 2015, NEUROSCI LETT, V595, P60, DOI 10.1016/j.neulet.2015.03.071; Tan A, 2016, NEUROIMAGE, V124, P350, DOI 10.1016/j.neuroimage.2015.08.050; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Voineskos AN, 2015, HUM BRAIN MAPP, V36, P3020, DOI 10.1002/hbm.22825; Zhan L, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/frogi.2015.00048, 10.3389/fnagi.2015.00048]	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227910	10.1371/journal.pone.0227910	http://dx.doi.org/10.1371/journal.pone.0227910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990956	Green Published, gold, Green Submitted			2022-12-26	WOS:000534605400027
J	Gil-Sanchez, JM; Barea-Azcon, JM; Jaramillo, J; Herrera-Sanchez, FJ; Jimenez, J; Virgos, E				Maria Gil-Sanchez, Jose; Miguel Barea-Azcon, Jose; Jaramillo, Javier; Javier Herrera-Sanchez, F.; Jimenez, Jose; Virgos, Emilio			Fragmentation and low density as major conservation challenges for the southernmost populations of the European wildcat	PLOS ONE			English	Article							SPATIAL CAPTURE-RECAPTURE; CATS FELIS-SILVESTRIS; DOMESTIC CATS; SPECIES DISTRIBUTION; ORYCTOLAGUS-CUNICULUS; HABITAT SELECTION; IBERIAN LYNX; LIVING CATS; HYBRIDIZATION; MODELS	Knowledge of population dynamics of threatened species in the wild is key to effective conservation actions. However, at present, there are many examples of endangered animals for which their current situation is unknown, and not just in remote areas and less developed countries. We have explored this topic by studying the paradigmatic case of the European wildcat (Felis silvestris silvestris), an endangered small carnivore whose status has been subjectively established on the basis of non-systematic approaches and opportunistic records. Little is known about its demographic situation, prompting the need for information to improve conservation measures. However, the secretive behaviour of felines along with its low density in natural conditions have prevented the gathering of sufficient data. We developed a field sampling strategy for one of the largest populations (Andalusia, South Spain, 87,268 km(2)), based on a logistically viable systematic non-intrusive survey by camera-trapping. This study offers the first large-scale estimation for any European wildcat population, based on analytical approaches applied on Species Distribution Models. A hierarchical approach based on a Maxent model for distribution estimation was used, along with Generalised Linear Models for density estimation from explicit spatial capture-recapture data. Our results show that the distribution range is smaller and more highly fragmented than previously assumed. The overall estimated density was very low (0.069 +/- 0.0019 wildcats/km(2)) and the protected areas network seems to be insufficient to cover a significant part of the population or a viable nucleus in demographic terms. Indeed, the most important areas remain unprotected. Our main recommendations are to improve the protected area network and/or vigilance programs in hunting estates, in addition to studying and improving connectivity between the main population patches.	[Maria Gil-Sanchez, Jose] Univ Granada, Dept Zool, Granada, Spain; [Miguel Barea-Azcon, Jose; Jaramillo, Javier] Junta Andalucia, Consejeria Agr Ganaderia Pesca & Desarrollo Soste, Agencia Medio Ambiente & Agua, Gerencia Granada, Edificio Zeus 3, Granada, Spain; [Javier Herrera-Sanchez, F.] Harmusch, Wildlife Res & Conservat, Ubrique, Spain; [Jimenez, Jose] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Virgos, Emilio] Univ Rey Juan Carlos, Dept Biol Geol Phys & Inorgan Chem, ESCET, Madrid, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidad Rey Juan Carlos	Gil-Sanchez, JM (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	jmgilsanchez@yahoo.es	Sánchez, Jose María Gil/J-4282-2017; Gil-Sánchez, Jose María/AAW-1016-2021	Gil-Sánchez, Jose María/0000-0002-7052-8332; HERRERA SANCHEZ, FRANCISCO JAVIER/0000-0002-6023-4437; Jimenez, Jose/0000-0003-0607-6973	Consejeria de Medio Ambiente y Ordenacion del Territorio through the European Union (FEDER Project); Prometeo fellowship from the SENESCYT; national agency for Education and Science of the Government of Ecuador	Consejeria de Medio Ambiente y Ordenacion del Territorio through the European Union (FEDER Project); Prometeo fellowship from the SENESCYT; national agency for Education and Science of the Government of Ecuador	The research was partially funded by the Consejeria de Medio Ambiente y Ordenacion del Territorio (www.juntadeandalucia.es > medioambiente > site > portalweb) through the European Union (FEDER Project http://www.juntadeandalucia.es/medioambiente/site/portalweb/menuitem.6ffc7f4a4459b86a1daa5c105510e1c/? vgnextoid=05cf8706a8bb9510VgnVCM10000013 25e50aRCRD&vgnextchannel=05cf8706a8bb9510 VgnVCM1000001325e50aRCRD) and is part of the Global Change Observatory of Sierra Nevada (https://digibug.ugr.es/handle/10481/54686).J.M.G.-S.was supported by a Prometeo fellowship from the SENESCYT and the national agency for Education and Science of the Government of Ecuador (https://www.educacionsuperior.gob.ec/prometeo/).There aren't specific grant numbers or funding from commercial companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2002, POPULATION VIABILITY ANALYSIS, P50; Anile S, 2014, J ZOOL, V293, P252, DOI 10.1111/jzo.12141; Anile S., 2012, Wildlife Biology in Practice, V8, P1; Anile S, 2010, ITAL J ZOOL, V77, P241, DOI 10.1080/11250000903419731; Ballesteros-Duperon E, 2015, MAMMALIA, V79, P101, DOI 10.1515/mammalia-2013-0026; Balme G.A., 2007, J WILDLIFE MANAGE, V73, P433; Barton R., 2013, R PACKAGE VERSION 1; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Burgman MA, 1993, RISK ASSESSMENT CONS; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Can OE, 2011, ORYX, V45, P112, DOI 10.1017/S0030605310001328; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Cushman SA, 2010, SPATIAL COMPLEXITY I, DOI [10.1007/978-4-431-87771-4_18, DOI 10.1007/978-4-431-87771-4_18]; da Rocha DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154624; Daniels MJ, 2003, WILDLIFE RES, V30, P213, DOI 10.1071/WR02045; Daniels MJ, 2001, J APPL ECOL, V38, P146, DOI 10.1046/j.1365-2664.2001.00580.x; de Valpine P, 2017, J COMPUT GRAPH STAT, V26, P403, DOI 10.1080/10618600.2016.1172487; Devillard S, 2014, J ZOOL SYST EVOL RES, V52, P154, DOI 10.1111/jzs.12049; Dimitrijevic S., 1980, ARHIV BIOL NAUKA BEO, V58, P219; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fernandez N, 2003, ECOL APPL, V13, P1310, DOI 10.1890/02-5081; Ferreira JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026978; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Gelin ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188877; Gelman A., 2003, BAYESIAN DATA ANAL; Gil Sanchez J. M., 1998, Miscellania Zoologica (Barcelona), V21, P57; Gil-Sanchez JM, 2015, ZOOLOGY, V118, P377, DOI 10.1016/j.zool.2015.08.001; Gil-Sanchez JM, 1999, ACTA THERIOL, V44, P421, DOI 10.4098/AT.arch.99-40; Gil-Sanchez JM, 2011, EUR J WILDLIFE RES, V57, P1203, DOI 10.1007/s10344-011-0533-y; Goldsmith F.B., 2012, MONITORING CONSERVAT, V3; Gomez Chicano FJ, 2007, ALMORAIMA, V35, P203; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A., 2017, APPL R; Hertwig ST, 2009, J ZOOL SYST EVOL RES, V47, P283, DOI 10.1111/j.1439-0469.2009.00536.x; HUBBARD AL, 1992, BIOL CONSERV, V61, P203, DOI 10.1016/0006-3207(92)91117-B; Jedrzejewski W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194719; Junta de Andalucia, LIST CAT FLOR FAUN S; Kery M, 2011, CONSERV BIOL, V25, P356, DOI 10.1111/j.1523-1739.2010.01616.x; Khorozyan IG, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P331, DOI 10.1007/978-4-431-87771-4_18; Kitchener AC, 2005, ANIM CONSERV, V8, P223, DOI 10.1017/S1367943005002301; Klar N, 2008, BIOL CONSERV, V141, P308, DOI 10.1016/j.biocon.2007.10.004; Lancia Ricard A., 1994, P215; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Loidi J., 2017, VEGETATION IBERIAN P; Lozano J, 2010, ANIM BIODIV CONSERV, V33, P143; Lozano J, 2003, BIODIVERS CONSERV, V12, P921, DOI 10.1023/A:1022821708594; Lozano J., 2012, MEDITERRANEAN ECOSYS, P1; Lozano J, 2007, BIOL CONSERV, V138, P321, DOI 10.1016/j.biocon.2007.04.027; Lozano J, 2006, J BIOGEOGR, V33, P1076, DOI 10.1111/j.1365-2699.2006.01474.x; Lozano J, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-16; Macdonald David W., 2010, P471; Malo AF, 2004, J ZOOL, V263, P401, DOI 10.1017/S0952836904005448; Martin-Diaz P, 2018, MAMM BIOL, V88, P114, DOI 10.1016/j.mambio.2017.10.006; Mattucci F, 2013, ECOL EVOL, V3, P2443, DOI 10.1002/ece3.569; Mattucci F, 2016, ECOL EVOL, V6, P3, DOI 10.1002/ece3.1815; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moleon M, 2003, J ZOOL, V260, P17, DOI 10.1017/S0952836902003370; Monterroso P, 2009, J ZOOL, V279, P27, DOI 10.1111/j.1469-7998.2009.00585.x; Morin DJ, 2018, POPUL ECOL, V60, P197, DOI 10.1007/s10144-018-0606-9; NIMBLE Development Team, 2017, NIMBLE US MAN; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Oliveira R, 2008, PHILOS T R SOC B, V363, P2953, DOI 10.1098/rstb.2008.0052; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Oliveira T, 2018, ECOL EVOL, V8, P9464, DOI 10.1002/ece3.4442; Palomo LJ, 1992, SECEM SECEMU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pierpaoli M, 2003, MOL ECOL, V12, P2585, DOI 10.1046/j.1365-294X.2003.01939.x; R Development Core Team, 2018, R LANG ENV STAT COMP; Randi E, 2001, MOL BIOL EVOL, V18, P1679, DOI 10.1093/oxfordjournals.molbev.a003956; Recio MR, 2015, CURR ZOOL, V61, P793, DOI 10.1093/czoolo/61.5.793; Robert AL, 2008, NONINVASIVE SURVEY M; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sarmento P, 2009, ACTA THERIOL, V54, P31, DOI 10.1007/BF03193135; Scott J. M., 2002, PREDICTING SPECIES O; Simon Mata MA, 2012, 10 YEARS CONSERVING; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Soto CA, 2014, MAMMALIA, V78, P57, DOI 10.1515/mammalia-2013-0054; Sunquist ME, 2002, WILD CATS WORLD; Thompson WL, 2004, SAMPLING RARE ELUSIV; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; WILLIAMS B. K., 2001, ANAL MANAGEMENT ANIM; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Witzenberger KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106083; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yamaguchi N, 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-2.RLTS.T60354712A50652361.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T60354712A50652361.EN]; Zimmermann F, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P653; [No title captured], DOI DOI 10.1038/S41598-016-0028-X	93	16	17	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227708	10.1371/journal.pone.0227708	http://dx.doi.org/10.1371/journal.pone.0227708			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990935	Green Published, gold			2022-12-26	WOS:000534605400021
J	McFarlane, SJ; Garcia, JE; Verhagen, DS; Dyer, AG				McFarlane, Stuart J.; Garcia, Jair E.; Verhagen, Darrin S.; Dyer, Adrian G.			Alarm tones, music and their elements: Analysis of reported waking sounds to counteract sleep inertia	PLOS ONE			English	Article							AUDITORY SEQUENCES; CAFFEINE GUM; BLUE-LIGHT; PERCEPTION; DISCRIMINATION; PERFORMANCE; TEMPO; TIME; EXPECTANCIES; RECOGNITION	Sleep inertia is a potentially dangerous reduction in human alertness and occurs 0-4 hours after waking. The type of sound people set as their alarm for waking has been shown to reduce the effects of sleep inertia, however, the elemental musical factors that underpin these waking sounds and their relationships remain unclear. The goal of this research is to understand how a particular sound or music chosen to assist waking may counteract sleep inertia, and more specifically, what elements of these sounds may contribute to its reduction. Through an anonymous, self-report online questionnaire, fifty participants (N = 50) reported attributes of their preferred waking sound, their feeling towards the waking sound, and perceived sleep inertia after waking. This data enabled the analysis and comparison between these responses to identify statistically significant relationships. Our results did not return any significant association between sleep inertia and the reported waking sound type, nor the subject's feeling towards their sound. However, the analysis did reveal that a sound which is ranked as melodic by participants shows a significant relationship to reports of reductions in perceived sleep inertia, and in contrast, sound rated as neutral (neither unmelodic nor melodic) returns a significant relationship to the reports of increases in perceived sleep inertia. Additionally, our secondary analysis revealed that a sound rated as melodic is considered to be more rhythmic than a melodically neutral interpretation. Together these findings raise questions regarding the impact melody and rhythm may hold with respect to sleep inertia intensity. Considering that the implementation of auditory assisted awakening is a common occurrence, the musical elements of a chosen waking sound may be an area to further interrogate with respect to counteracting sleep inertia.	[McFarlane, Stuart J.; Garcia, Jair E.; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Verhagen, Darrin S.] RMIT Univ, Sch Design, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Dyer, AG (corresponding author), RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia.	adrian.dyer@rmit.edu.au	Campailla, Jasmin/AAK-2420-2021	McFarlane, Stuart/0000-0001-8218-2626; Garcia, Jair/0000-0001-8456-4759; Dyer, Adrian/0000-0002-2632-9061	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the Australian Government Research Training Program Scholarship to SJM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford Christopher A., 2009, P207, DOI 10.1007/978-3-7643-9923-8_13; [Anonymous], 2011, M F ALMOST 60 1634 Y; Apple, APPL IPHONE; Armentrout JJ, 2006, AVIAT SPACE ENVIR MD, V77, P963; Asaoka S, 2010, J SLEEP RES, V19, P436, DOI 10.1111/j.1365-2869.2009.00811.x; Aviation GoIMoC, 2010, REP ACC AIR IND EXPR; Avila EH, 2018, FRONT PHYSIOL, V9, DOI [10.3389/fphys.2018.00525, DOI 10.3389/FPHYS.2018.00525]; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Blaikie N., 2003, ANAL QUANTITATIVE DA; Boksteen BK, 2013, PROC INT SYMP POWER, P237, DOI 10.1109/ISPSD.2013.6694460; BOLTZ M, 1991, MEM COGNITION, V19, P239, DOI 10.3758/BF03211148; BOLTZ MG, 1993, PERCEPT PSYCHOPHYS, V53, P585, DOI 10.3758/BF03211736; Brian Wilson ML, 1966, GOOD VIBRATIONS; Canada TSBo, 2011, A11F0012 CAN TSBO; Carlsen JC., 1981, PSYCHOMUSICOLOGY J R, V1, P12, DOI [10.1037/h0094276, DOI 10.1037/H0094276]; Carlsen JC, 1970, B COUN RES MUSIC ED, P4; Centofanti SA, 2018, SLEEP, V41, pA78, DOI 10.1093/sleep/zsy061.199; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Clarke Eric F., 1999, PSYCHOL MUSIC, P473, DOI DOI 10.1016/B978-012213564-4/50014-7; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper G., 1963, RHYTHMIC STRUCTURE M; CUDDY LL, 1995, PERCEPT PSYCHOPHYS, V57, P451, DOI 10.3758/BF03213071; Dalton B, 2007, EFFECTS SOUND TYPES, P153; Deutsch D., 2013, PSYCHOL MUSIC, DOI [10.1177/0305735611425897, DOI 10.1177/0305735611425897]; Dictionary OE, 2019, OXFORD ENGLISH DICT; DOWLING WJ, 1987, PERCEPT PSYCHOPHYS, V41, P642, DOI 10.3758/BF03210496; DOWLING WJ, 1977, PERCEPT PSYCHOPHYS, V21, P60, DOI 10.3758/BF03199469; DOWLING WJ, 1972, PERCEPT PSYCHOPHYS, V12, P417, DOI 10.3758/BF03205852; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Duffy Jeanne F, 2015, Rev Hum Factors Ergon, V10, P29; Erin Flynn-Evans KG, 2016, EVIDENCE REPORT RISK; Figueiro MG, 2019, NAT SCI SLEEP, V11, P45, DOI 10.2147/NSS.S195563; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; Fraisse P, 1963, PSYCHOL TIME; Frances R., 1988, PERCEPTION MUSIC; Frischeisen-Kohler I, 1933, CHARACT PERSON, V1, P301; Gabel V, 2013, CHRONOBIOL INT, V30, P988, DOI 10.3109/07420528.2013.793196; Geerdink M, 2016, J BIOL RHYTHM, V31, P483, DOI 10.1177/0748730416657462; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GOODDY W, 1958, LANCET, V1, P1139; Grondin S., 2016, PSYCHOL PERCEPTION, P17; Hallam S., 2016, OXFORD HDB MUSIC PSY; Handel S, 1998, J EXP PSYCHOL HUMAN, V24, P1546, DOI 10.1037/0096-1523.24.5.1546; HANDEL S, 1993, PERCEPT PSYCHOPHYS, V54, P370, DOI 10.3758/BF03205273; Hayashi M, 2003, CLIN NEUROPHYSIOL, V114, P2268, DOI 10.1016/S1388-2457(03)00255-4; Hayashi M, 2004, SLEEP BIOL RHYTHMS, V2, P184, DOI [10.1111/j.1479-8425.2004.00142.x, DOI 10.1111/J.1479-8425.2004.00142.X]; Hebert S, 2002, PERCEPT PSYCHOPHYS, V64, P909, DOI 10.3758/BF03196795; Huron D.B., 2006, SWEET ANTICIPATION M; Hwang S-M, 2005, DEV HI FI MICROSPEA; IBM, 2018, SPSS; IDSON WL, 1978, PERCEPT PSYCHOPHYS, V24, P551, DOI 10.3758/BF03198783; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; JONES MR, 1982, PERCEPT PSYCHOPHYS, V32, P211, DOI 10.3758/BF03206225; K Catchpole C, 1995, BIRD SONG BIOL THEME, P1; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kanady C., 2015, DEV VALIDATION SLEEP; Kanady JC, 2015, COGNITIVE THER RES, V39, P601, DOI 10.1007/s10608-015-9686-4; Kaplan KA, 2018, BEHAV RES THER, V111, P106, DOI 10.1016/j.brat.2018.10.009; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P334, DOI 10.1037/h0090424; Kennedy M, 2013, OXFORD DICT MUSIC201; Krauchi K, 2006, AM J PHYSIOL-REG I, V290, pR1052, DOI 10.1152/ajpregu.00381.2005; Krauchi K, 2004, J SLEEP RES, V13, P121, DOI 10.1111/j.1365-2869.2004.00398.x; Maness CB, 2019, SLEEP, V42, pA249, DOI [10.1093/sleep/zsz067..625, DOI 10.1093/SLEEP/ZSZ067..625, 10.1093/sleep/zsz067.625, DOI 10.1093/SLEEP/ZSZ067.625]; Marzano C, 2011, NEUROSCIENCE, V176, P308, DOI 10.1016/j.neuroscience.2010.12.014; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; McDonald J.H., 2009, HDB BIOL STAT; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Microsoft, 2018, MICR EXC; Moelants D., 2002, P 7 INT C MUS PERC C; Nettl B, 2000, ORIGINS OF MUSIC, P463; Newman RA, 2013, PERCEPT MOTOR SKILL, V116, P280, DOI 10.2466/29.22.25.PMS.116.1.280-293; Ockelford A, 2013, PSYCHOL MUSIC, V41, P139, DOI 10.1177/0305735612442582; Owen H., 2000, MUSIC THEORY RESOURC; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Reyner LA, 1997, PSYCHOPHYSIOLOGY, V34, P721, DOI 10.1111/j.1469-8986.1997.tb02148.x; Rosekind MR, 1995, J SLEEP RES, V4, P62, DOI 10.1111/j.1365-2869.1995.tb00229.x; ROSS J, 1994, PERCEPT PSYCHOPHYS, V56, P19, DOI 10.3758/BF03211687; Rothenberg D, 2014, HEARING RES, V308, P71, DOI 10.1016/j.heares.2013.08.016; Rubinstein RY, WILEY SERIES PROBABI; Santhi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079688; SCHMUCKLER MA, 1989, MUSIC PERCEPT, V7, P109; Smith R., 1985, CLOSE ME HEAD DOOR; SMOLL FL, 1978, PERCEPT MOTOR SKILL, V46, P883, DOI 10.2466/pms.1978.46.3.883; Stevens C., 2009, OXFORD HDB MUSIC PSY, P14; Stevenson A., 2010, OXFORD DICT ENGLISH2; Stuster J., 2010, REV ANAL ASTRONAUT J; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; TASSI P, 1992, PERCEPT MOTOR SKILL, V75, P291, DOI 10.2466/PMS.75.4.291-302; Tassi P, 2000, SLEEP INERTIA, P341, DOI [10.1053/smrv.2000.0098, DOI 10.1053/SMRV.2000.0098]; THELEN E, 1979, ANIM BEHAV, V27, P699, DOI 10.1016/0003-3472(79)90006-X; TREHUB SE, 1989, CAN J PSYCHOL, V43, P217, DOI 10.1037/h0084223; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Trotti LM, 2017, SLEEP MED REV, V35, P76, DOI 10.1016/j.smrv.2016.08.005; Vallat R, 2019, NEUROIMAGE, V184, P266, DOI 10.1016/j.neuroimage.2018.09.033; Van Dongen HPA, 2001, SLEEP, V24, P813, DOI 10.1093/sleep/24.7.813; Wertz AT, 2006, JAMA-J AM MED ASSOC, V295, P163, DOI 10.1001/jama.295.2.163; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Yost W.A., 2013, FUNDAMENTALS HEARING, V5th	101	5	5	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0215788	10.1371/journal.pone.0215788	http://dx.doi.org/10.1371/journal.pone.0215788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8ZJ	31990906	Green Published, Green Submitted, gold			2022-12-26	WOS:000534605400001
J	Springer, BC; Frankenberger, M; Pettinger, KH				Springer, Bernhard Christian; Frankenberger, Martin; Pettinger, Karl-Heinz			Lamination of Separators to Electrodes using Electrospinning	PLOS ONE			English	Article							ION BATTERIES	This study shows the feasibility of the Electrospinning method as a process step for advanced and fast production Li ion cells. Lamination is a key technology for Lithium-ion battery production. It bares different advantages, such as a fast production line speed by fixing the separator to the electrodes. Unfortunately, this technology is inapplicable for separator and electrode formulations not based on thermoplastic binders. Using Electrospinning, this disadvantage can be overcome. In our study, beaded PVDF polymer nanofibres were spun onto a fibre-reinforced, inorganic-filled separator. This modified separator was then laminated onto a NMC111-cathode using a temperature profile of 110/110/120 degrees C within the laminator. After Lamination, the separator was pulled-off again and placed in a SEM to see the adhesive behaviour of the applied polymer. The information gathered with SEM clearly shows a successful lamination of the separator to the electrode.	[Springer, Bernhard Christian; Frankenberger, Martin; Pettinger, Karl-Heinz] Univ Appl Sci Landshut, Technol Ctr Energy, Ruhstorf, Bavaria, Germany		Springer, BC (corresponding author), Univ Appl Sci Landshut, Technol Ctr Energy, Ruhstorf, Bavaria, Germany.	bernhard.springer@haw-landshut.de		Frankenberger, Martin/0000-0001-6129-6771	Bayerische Forschungsstiftung (Bavarian Research Foundation) [AZ-1353-18]	Bayerische Forschungsstiftung (Bavarian Research Foundation)	This research was funded by the Bayerische Forschungsstiftung (Bavarian Research Foundation), Grant number AZ-1353-18.	Agarwal S, 2016, ELECTROSPINNING PRAC; Babinec S. J., 2014, United States Patent, Patent No. [US8697290B2, 8697290]; Bae HS, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0158-9; Celebioglu A, 2011, MATER LETT, V65, P2291, DOI 10.1016/j.matlet.2011.04.039; Chen TQ, 2014, J MATER CHEM A, V2, P4117, DOI 10.1039/c3ta14806h; Frankenberger M, 2019, J ELECTROANAL CHEM, V837, P151, DOI 10.1016/j.jelechem.2019.02.030; Gozdz A. S., 1996, United States Patent, Patent No. [US5587253, 5587253]; Hun L., 2013, THESIS; Jossen A, 2019, MODERNE AKKUMULATORE, Vsecond; Kwade A, 2018, NAT ENERGY, V3, P290, DOI 10.1038/s41560-018-0130-3; Li H., 2016, NON WOVEN FABRICS; Li JB, 2018, CHEM ENG J, V354, P172, DOI 10.1016/j.cej.2018.08.024; Li JL, 2018, CHEM ENG J, V332, P260, DOI 10.1016/j.cej.2017.09.088; Weber CJ, 2014, AIP CONF PROC, V1597, P66, DOI 10.1063/1.4878480; Zeng J, 2003, E-POLYMERS, V3, P102, DOI DOI 10.1515/EPOLY.2003.3.1.102; Zheng F, 2018, J POWER SOURCES, V389, P198, DOI 10.1016/j.jpowsour.2018.04.022	16	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227903	10.1371/journal.pone.0227903	http://dx.doi.org/10.1371/journal.pone.0227903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990950	Green Submitted, Green Published, gold			2022-12-26	WOS:000534605400025
J	Mani, C; Tripathi, K; Luan, S; Clark, DW; Andrews, JF; Vindigni, A; Thomas, G; Palle, K				Mani, Chinnadurai; Tripathi, Kaushlendra; Luan, Shan; Clark, David W.; Andrews, Joel F.; Vindigni, Alessandro; Thomas, Gary; Palle, Komaraiah			The multifunctional protein PACS-1 is required for HDAC2-and HDAC3-dependent chromatin maturation and genomic stability	ONCOGENE			English	Article							HISTONE DEACETYLASE 3; REPLICATION STRESS; DNA-REPLICATION; DELETION; HDAC3; CELLS; 11Q13; ROLES; ACETYLATION; TRAFFICKING	Phosphofurin acidic cluster sorting protein-1 (PACS-1) is a multifunctional membrane traffic regulator that plays important roles in organ homeostasis and disease. In this study, we elucidate a novel nuclear function for PACS-1 in maintaining chromosomal integrity. PACS-1 progressively accumulates in the nucleus during cell cycle progression, where it interacts with class I histone deacetylases 2 and 3 (HDAC2 and HDAC3) to regulate chromatin dynamics by maintaining the acetylation status of histones. PACS-1 knockdown results in the proteasome-mediated degradation of HDAC2 and HDAC3, compromised chromatin maturation, as indicated by elevated levels of histones H3K9 and H4K16 acetylation, and, consequently, increased replication stress-induced DNA damage and genomic instability.	[Mani, Chinnadurai; Palle, Komaraiah] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Mani, Chinnadurai; Tripathi, Kaushlendra; Clark, David W.; Andrews, Joel F.; Palle, Komaraiah] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Luan, Shan; Thomas, Gary] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Luan, Shan; Thomas, Gary] Univ Pittsburgh, Canc Inst, Pittsburgh, PA 15239 USA; [Luan, Shan; Thomas, Gary] Univ Pittsburgh, Sch Med, 5117 Ctr Ave, Pittsburgh, PA 15213 USA; [Vindigni, Alessandro] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Palle, Komaraiah] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of South Alabama; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Palle, K (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.; Palle, K (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA.; Palle, K (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA.	komaraiah.palle@ttuhsc.edu			Abraham Mitchell Cancer Research Scholar Endowment grant; NIH [DK114855, DK112844, R01GM108648, R01GM098956, R01CA219187]; DOD BRCP [BC151728]	Abraham Mitchell Cancer Research Scholar Endowment grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BRCP(United States Department of Defense)	We thank Steve McClellan, Mitchell Cancer Institute for flow cytometry. This work is supported by grants from Abraham Mitchell Cancer Research Scholar Endowment grant, and partly by NIH grants R01GM098956 and R01CA219187 to KP, the NIH grants DK114855 and DK112844 to GT, the NIH grant R01GM108648 and DOD BRCP Breakthrough Award BC151728 to AV.	Atkins KM, 2014, CELL REP, V8, P1545, DOI 10.1016/j.celrep.2014.07.049; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Clark DW, 2015, ONCOTARGET, V6, P28816, DOI 10.18632/oncotarget.5006; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Crump CM, 2003, J VIROL, V77, P11105, DOI 10.1128/JVI.77.20.11105-11113.2003; De Souza C, 2015, RECENT PAT ANTI-CANC, V10, P145; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gilbert N, 2005, INT REV CYTOL, V242, P283; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Godman CA, 2008, CANCER BIOL THER, V7, P1570, DOI 10.4161/cbt.7.10.6561; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Hinners I, 2003, EMBO REP, V4, P1182, DOI 10.1038/sj.embor.7400018; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Khurana S, 2015, GENES-BASEL, V6, P858, DOI 10.3390/genes6030858; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; Leman AR, 2013, GENES-BASEL, V4, P1, DOI 10.3390/genes4010001; Ma PP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003377; Mendonca MS, 2004, GENE CHROMOSOME CANC, V39, P277, DOI 10.1002/gcc.20007; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Srivatsan ES, 2002, ONCOGENE, V21, P5631, DOI 10.1038/sj.onc.1205698; Srivatsan ES, 2000, GENE CHROMOSOME CANC, V29, P157, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1024>3.0.CO;2-P; Stengel KR, 2015, ANTIOXID REDOX SIGN, V23, P51, DOI 10.1089/ars.2014.5915; Stern D, 2017, CLIN GENET, V92, P221, DOI 10.1111/cge.12956; Summers AR, 2013, J CLIN INVEST, V123, P3112, DOI 10.1172/JCI60806; Thomas G, 2017, J CELL SCI, V130, P1865, DOI 10.1242/jcs.199463; Tripathi K, 2016, ONCOTARGET, V7, P12537, DOI 10.18632/oncotarget.7247; Tripathi K, 2015, ONCOTARGET, V6, P5237, DOI 10.18632/oncotarget.3026; Tripathi K, 2014, J BIOL CHEM, V289, P31513, DOI 10.1074/jbc.M114.606483; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wells CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068915; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zainabadi K, 2014, GENOMICS, V103, P276, DOI 10.1016/j.ygeno.2014.01.001; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	53	11	11	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2583	2596		10.1038/s41388-020-1167-x	http://dx.doi.org/10.1038/s41388-020-1167-x		JAN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31988453	Green Accepted			2022-12-26	WOS:000509655100006
J	Pienkowska, J; Brzeska, B; Kaszubowski, M; Kozak, O; Jankowska, A; Szurowska, E				Pienkowska, Joanna; Brzeska, Beata; Kaszubowski, Mariusz; Kozak, Oliwia; Jankowska, Anna; Szurowska, Edyta			The correlation between the MRI-evaluated ectopic fat accumulation and the incidence of diabetes mellitus and hypertension depends on body mass index and waist circumference ratio	PLOS ONE			English	Article							BETA-CELL FUNCTION; PANCREAS DISEASE; RISK-FACTORS; STEATOSIS; LIVER; INFILTRATION; ASSOCIATION; PREVALENCE; BMI	The widespread presence of overweight and obesity increases with every decade, and the number of people with body mass index (BMI) >30 kg/m(2) has doubled in the last 30 years. The aim of the study is to assess the correlation between MRI-evaluated ectopic fat accumulation in pancreas, skeletal muscles and liver and the incidence of type 2 diabetes and hypertension, depending on BMI and waist circumference ratio. This prospective study included 267 consecutive patients who were referred to abdominal MRI and underwent a standard clinical assessment with BMI and waist circumference ratio calculation. Ectopic fat accumulation in pancreas, skeletal muscles and liver was evaluated in magnetic resonance imaging using the fat-water separated Dixon imaging. There were statistically significant differences in mean steatosis of all assessed organs in the group of patients with type 2 diabetes or hypertension in comparison to the non-diabetic group as well as to the group without hypertension. It has been observed that pancreas and skeletal muscles are more susceptible to fat accumulation than liver. According to our results, there is a relation between the fat content in muscles, pancreas and liver, the incidence of type 2 diabetes and hypertension and also body mass index and waist circumference ratio. We believe that future studies should aim to determine whether the use of fat content measurement in certain organs could be used as a biomarker that can enable early detection of reversible metabolic changes, as well as their subsequent monitoring.	[Pienkowska, Joanna; Brzeska, Beata; Szurowska, Edyta] Med Univ Gdansk, Fac Hlth Sci, Dept Radiol 2, Gdansk, Poland; [Brzeska, Beata] Med Univ Gdansk, Fac Pharm, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Brzeska, Beata] Med Univ Gdansk, Fac Hlth Sci, Dept Human Physiol, Gdansk, Poland; [Kaszubowski, Mariusz] Gdansk Univ Technol, Fac Management & Econ, Inst Stat, Dept Econ Sci, Gdansk, Poland; [Kozak, Oliwia] Med Univ Gdansk, Fac Med, Dept Radiol 1, Gdansk, Poland; [Jankowska, Anna] Univ Clin Ctr Gdansk, Dept Radiol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Pienkowska, J (corresponding author), Med Univ Gdansk, Fac Hlth Sci, Dept Radiol 2, Gdansk, Poland.	jpienkowska@gumed.edu.pl	; Pienkowska, Joanna/U-6195-2018	Brzeska, Beata/0000-0003-0383-8792; Szurowska, Edyta/0000-0002-7042-4381; Pienkowska, Joanna/0000-0002-7087-9888	Medical University of Gdansk, Poland [ST-111]	Medical University of Gdansk, Poland(Medical University Gdansk)	The study was financially supported by Medical University of Gdansk, Poland (grant no. ST-111). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Begovatz P, 2015, DIABETOLOGIA, V58, P1646, DOI 10.1007/s00125-015-3544-5; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Catanzaro R, 2016, WORLD J GASTROENTERO, V22, P7660, DOI 10.3748/wjg.v22.i34.7660; Della Corte C, 2015, CLIN ENDOCRINOL, V83, P656, DOI 10.1111/cen.12862; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heber SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177154; Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073; Kim SR, 2018, TRANSL RES, V194, P1, DOI 10.1016/j.trsl.2017.10.009; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Lee JS, 2009, WORLD J GASTROENTERO, V15, P1869, DOI 10.3748/wjg.15.1869; Lesmana CRA, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0404-1; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Mathieu P, 2014, REV ENDOCR METAB DIS, V15, P289, DOI 10.1007/s11154-014-9299-3; OECD, 2018, OECD OB UPD 2017; Pienkowska J, 2019, DIABETES METAB SYNDR, V12, P623, DOI 10.2147/DMSO.S194690; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Schweitzer L, 2016, J NUTR, V146, P2143, DOI 10.3945/jn.116.236844; Sepe PS, 2011, GASTROINTEST ENDOSC, V73, P987, DOI 10.1016/j.gie.2011.01.015; Singh RG, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2918; Singh RG, 2017, METABOLISM, V69, P1, DOI 10.1016/j.metabol.2016.12.012; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tariq H, 2016, GASTROENTEROL RES, V9, P87, DOI 10.14740/gr731w; Taylor R, 2013, DIABETES CARE, V36, P1047, DOI 10.2337/dc12-1805; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; Wang CY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000297; Wong VWS, 2014, AM J GASTROENTEROL, V109, P589, DOI 10.1038/ajg.2014.1; World Health Organization, 2017, OB OV; Wu WC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-77; Yamazaki H, 2016, DIABETES CARE, V39, P1677, DOI 10.2337/dc16-0074; Yu TY, 2017, J DIABETES INVEST, V8, P735, DOI 10.1111/jdi.12665	36	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0226889	10.1371/journal.pone.0226889	http://dx.doi.org/10.1371/journal.pone.0226889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986155	Green Published, gold			2022-12-26	WOS:000534603400013
J	Bahta, M; Tesfamariam, S; Weldemariam, DG; Yemane, H; Tesfamariam, EH; Alem, T; Russom, M				Bahta, Merhawi; Tesfamariam, Sirak; Weldemariam, Dawit G.; Yemane, Hermella; Tesfamariam, Eyasu H.; Alem, Tesfamariam; Russom, Mulugeta			Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method	PLOS ONE			English	Article							COMMUNITY PHARMACIES; MEDICATION; RESISTANCE; SALE	Dispensing antibiotics without prescription is irrational and can hasten the emergence and spread of antibiotic resistance. This study aims at determining the extent of this practice and its determinants in all drug retail outlets of Eritrea. A cross-sectional simulated client method was used to conduct the study. Data was collected between July and August 2019, entered and analyzed using Statistical Package for Social Science version 22. Descriptive analysis was performed using mean (standard deviation), median (interquartile range), frequency, percentage, as appropriate, for independent variables. Logistic regression, at bivariate and multivariate levels, along with odds ratio (95% confidence interval) was used to determine the association between the dispensing of antibiotics without prescription and independent variables. P-values less than 0.05 were considered as statistically significant. The extent of dispensing antibiotics without prescription was found to be 87.6% with the most frequently dispensed antibiotics being ciprofloxacin (47.8%) and co-trimoxazole (37.5%). Furthermore, 12.4% of the drug retail outlet attendants did not dispense antibiotics because they preferred a referral to health facilities (52.6%), were following administrative restrictions not to sell antibiotics (42.1%), or did not have the necessary antibiotics (31.6%). Private community pharmacies (AOR = 7.68, 95% CI: 1.67, 35.37; p = 0.009) and private drug shops (AOR = 10.65, 95% CI: 1.96, 57.93; p = 0.006) were more likely to dispense antibiotics compared to the governmental community pharmacies. Dispensing antibiotics without prescription was more likely to occur in the Maekel (central) region (AOR = 3.76, 95% CI: 1.19, 11.92; p = 0.024) compared to the remaining regions combined. In conclusion, the sales of antibiotics without prescription in the drug retail outlets of Eritrea is alarming which requires immediate attention from policymakers.	[Bahta, Merhawi; Alem, Tesfamariam] Orotta Coll Med & Hlth Sci, Dept Med Sci, Pharm Unit, Asmera, Eritrea; [Tesfamariam, Sirak] Nakfa Hosp, Pharm, Nakfa, Eritrea; [Weldemariam, Dawit G.] Hazhaz Zonal Referral Hosp, Pharm, Asmera, Eritrea; [Yemane, Hermella] Southern Red Sea Zonal Med Store, Assab, Eritrea; [Tesfamariam, Eyasu H.] Eritrean Inst Technol, Dept Stat, Coll Sci, Biostat & Epidemiol Unit, Mai Nefhi, Eritrea; [Russom, Mulugeta] Natl Med & Food Adm, Eritrean Pharmacovigilance Ctr, Asmera, Eritrea		Weldemariam, DG (corresponding author), Hazhaz Zonal Referral Hosp, Pharm, Asmera, Eritrea.	dawitghiwet100@gmail.com	Russom, Mulugeta/ACM-0020-2022	Russom, Mulugeta/0000-0003-1939-5842; Weldemariam, Dawit/0000-0001-7179-4993; Tesfamariam, Sirak/0000-0003-4348-5952	NMFA; ERIPA's	NMFA; ERIPA's	The authors would like to thank the data collectors, NMFA as well as ERIPA's support in conducting the study. The authors' sincere gratitude also goes to Mr. Meswaiti Teklezghi, Mr. Tesfasilasie Ghedel, and Mr. Michael Ghirmay for their technical assistance in retrieving the detailed information of the dispensers.	Ateshim Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7020-x; Berger K, 2005, J CLIN PHARM THER, V30, P45, DOI 10.1111/j.1365-2710.2004.00611.x; Bisht R, 2009, ASIAN J PHARM CLIN R, P34; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Cars O., 2005, International Journal of Risk & Safety in Medicine, V17, P103; Chang J, 2017, J ANTIMICROB CHEMOTH, V72, P1235, DOI 10.1093/jac/dkw519; CHUA SS, 2006, INT J PHARM PRACT, V14, P171, DOI DOI 10.1211/ijpp.14.3.0003; Damisie G, 2019, J PHARMACEUTICS, V2019, DOI 10.1155/2019/3510659; Economist Intelligence Unit, 2014, FUT HEALTHC AFR; Economist Intelligence Unit, 2011, FUT HEALTHC AFR; Farah R, 2015, J INFECT PUBLIC HEAL, V8, P37, DOI 10.1016/j.jiph.2014.07.003; Gastelurrutia Miguel Angel, 2013, Pharm Pract (Granada), V11, P185; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2007, PHARMACOEPIDEM DR S, V16, P1234, DOI 10.1002/pds.1479; Haddadin RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216115; Horumpende PG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207465; Hoxha I., 2005, LANCET, V365, P579, DOI DOI 10.1016/S0140-6736(05)17907-0; Kalungia AC, 2016, EXPERT REV ANTI-INFE, V14, P1215, DOI 10.1080/14787210.2016.1227702; Llor C, 2010, EUROSURVEILLANCE, V15; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Markovic-Pekovic V, 2017, J RES PHARM PRACT, V6, P120, DOI 10.4103/jrpp.JRPP_17_12; Roque F, 2013, INT J CLIN PHARM-NET, V35, P417, DOI 10.1007/s11096-013-9753-4; Schneider CR, 2009, ANN PHARMACOTHER, V43, P1512, DOI 10.1345/aph.1M086; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; WHO, 2015, GLOB ACT PLAN ABT RE; World Health Organisation, 2018, WHO REP SURV ANT CON; World Health Organization, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2019, WHO MOD LIST ESS MED; Xu Tina, 2012, Int J Pharm Pract, V20, P307, DOI 10.1111/j.2042-7174.2012.00201.x; Zapata-Cachafeiro M, 2019, J ANTIMICROB CHEMOTH, V74, P511, DOI 10.1093/jac/dky440; Zawahir S, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0510-x	31	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228013	10.1371/journal.pone.0228013	http://dx.doi.org/10.1371/journal.pone.0228013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978180	Green Published, gold, Green Submitted			2022-12-26	WOS:000534599100095
J	Lee, S; Park, DW; Kim, TY; Kim, DS; Lee, JY; Lee, YJ; Kim, CK				Lee, Sangjoon; Park, Dong Woo; Kim, Tae Yoon; Kim, Dong Sun; Lee, Ji Young; Lee, Young-Jun; Kim, Chun Ki			A novel visual ranking system based on arterial spin labeling perfusion imaging for evaluating perfusion disturbance in patients with ischemic stroke	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MRI	We developed a visual ranking system by combining the parenchymal perfusion deficits (PPD) and hyperintense vessel signals (HVS) on arterial spin labeling (ASL) imaging. This study aimed to assess the performance of this ranking system by correlating with subtypes classified based on dynamic susceptibility contrast (DSC) imaging for evaluating the perfusion disturbance observed in patients with ischemic stroke. 32 patients with acute or subacute infarcts detected by DSC imaging were reviewed. Each patient's brain was divided into 12 areas. ASL ranks were defined by the presence (+) or absence (-) of PPD/HVS as follows; I:-/-, II:-/+, III: +/+, and IV: +/-. DSC imaging findings were categorized based on cerebral blood flow (CBF) and time to peak (TTP) as normal (normal CBF/TTP), mis-matched (normal CBF/delayed TTP), and matched (decreased CBF/delayed TTP). Two reviewers rated perfusion abnormalities in the total of 384 areas. The four ASL ranks correlated well with the DSC subtypes (Spearman's r = 0.82). The performance of ASL ranking system was excellent as indicated by the area under the curve value of 0.94 using either matched or mismatched DSC subtype as the gold standard and 0.97 using only the matched DSC subtype as the gold standard. The two methods were in good-to-excellent agreement (maximum kappa-values, 0.86). Inter-observer agreement was excellent (kappa-value, 0.98). Although the number of patients was small and the number of dropouts was high, our proposed, ASL-based visual ranking system represented by PPD and HVS provides good, graded estimates of perfusion disturbance that agree well with those obtained by DSC perfusion imaging.	[Lee, Sangjoon; Park, Dong Woo; Kim, Tae Yoon; Kim, Dong Sun] Hanyang Univ, Guri Hosp, Dept Radiol, Coll Med, Guri, South Korea; [Lee, Ji Young; Lee, Young-Jun] Hanyang Univ, Hanyang Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Chun Ki] Hanyang Univ, Hanyang Univ Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea; [Lee, Sangjoon] Kangwon Natl Univ Hosp, Dept Radiol, Chunchon, Gangwon Do, South Korea	Hanyang University; Hanyang University; Hanyang University Hospital; Hanyang University; Hanyang University Hospital; Kangwon National University; Kangwon National University Hospital	Park, DW (corresponding author), Hanyang Univ, Guri Hosp, Dept Radiol, Coll Med, Guri, South Korea.	dwpark@hanyang.ac.kr	; Park, Dong Woo/E-6763-2015	Lee, Sangjoon/0000-0001-6492-514X; Park, Dong Woo/0000-0002-7507-1175; Kim, Chun/0000-0001-8048-0187				Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1998, RADIOLOGY, V208, P410, DOI 10.1148/radiology.208.2.9680569; Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; Bokkers RPH, 2012, STROKE, V43, P1290, DOI 10.1161/STROKEAHA.110.589234; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Detre JA, 1998, NEUROLOGY, V50, P633, DOI 10.1212/WNL.50.3.633; Huck S, 2012, CLIN NEURORADIOL, V22, P29, DOI 10.1007/s00062-011-0126-x; Nael K, 2013, STROKE, V44, P3090, DOI 10.1161/STROKEAHA.113.002377; Niibo T, 2013, STROKE, V44, P2601, DOI 10.1161/STROKEAHA.113.002097; Tada Y, 2014, CEREBROVASC DIS, V38, P191, DOI 10.1159/000365653; Wang DJJ, 2012, STROKE, V43, P1018, DOI 10.1161/STROKEAHA.111.631929; Wang R, 2014, EUR RADIOL, V24, P1135, DOI 10.1007/s00330-014-3098-9; Wittsack HJ, 2002, RADIOLOGY, V222, P397, DOI 10.1148/radiol.2222001731; Yoo RE, 2015, STROKE, V46, P564, DOI 10.1161/STROKEAHA.114.007797; Yun TJ, 2016, RADIOLOGY, V278, P205, DOI 10.1148/radiol.2015141865; Zaharchuk G, 2009, RADIOLOGY, V252, P797, DOI 10.1148/radiol.2523082018; Zhang B, 2013, SCI REP-UK, V3, DOI 10.1038/srep01836	17	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227747	10.1371/journal.pone.0227747	http://dx.doi.org/10.1371/journal.pone.0227747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978097	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100055
J	Shiiba, T; Arimura, Y; Nagano, M; Takahashi, T; Takaki, A				Shiiba, Takuro; Arimura, Yuki; Nagano, Miku; Takahashi, Tenma; Takaki, Akihiro			Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography	PLOS ONE			English	Article							DIAGNOSIS; QUANTIFICATION; IMAGES	Objective To assess the classification performance between Parkinson's disease (PD) and normal control (NC) when semi-quantitative indicators and shape features obtained on dopamine transporter (DAT) single photon emission computed tomography (SPECT) are combined as a feature of machine learning (ML). Methods A total of 100 cases of both PD and normal control (NC) from the Parkinson's Progression Markers Initiative database were evaluated. A summed image was generated and regions of interests were set to the left and right striata. Area, equivalent diameter, major axis length, minor axis length, perimeter and circularity were calculated as shape features. Striatum binding ratios (SBRputamen and SBRcaudate) were used as comparison features. The classification performance of the PD and NC groups according to receiver operating characteristic analysis of the shape features was compared in terms of SBRs. Furthermore, we compared the classification performance of ML when shape features or SBRs were used alone and in combination. Results The shape features (except minor axis length) and SBRs indicated significant differences between the NC and PD groups (p < 0.05). The top five areas under the curves (AUC) were as follows: circularity (0.972), SBRputamen (0.972), major axis length (0.945), SBRcaudate (0.928) and perimeter (0.896). When classification was done using ML, AUC was as follows: circularity and SBRs (0.995), circularity alone (0.990), and SBRs (0.973). The classification performance was significantly improved by combining SBRs and circularity than by SBRs alone (p = 0.018). Conclusion We found that the circularity obtained from DAT-SPECT images could help in distinguishing NC and PD. Furthermore, the classification performance of ML was significantly improved using circularity in SBRs together.	[Shiiba, Takuro; Takaki, Akihiro] Teikyo Univ, Fac Fukuoka Med Technol, Dept Radiol Technol, Omuta, Fukuoka, Japan; [Arimura, Yuki] Kokura Med Ctr, Dept Radiol, Kokura Minami Ku, Kitakyushu, Fukuoka, Japan; [Nagano, Miku; Takahashi, Tenma] Univ Miyazaki Hosp, Dept Radiol, Kiyotake Cho, Miyazaki, Miyazaki, Japan	Teikyo University; University of Miyazaki	Shiiba, T (corresponding author), Teikyo Univ, Fac Fukuoka Med Technol, Dept Radiol Technol, Omuta, Fukuoka, Japan.	shiiba@fmt.teikyo-u.ac.jp	Shiiba, Takuro/AAC-6600-2020	Shiiba, Takuro/0000-0001-5515-091X	JSPS KAKENHI [18K15565]; Michael J. Fox Foundation for Parkinson's Research; Abbvie; Avid; Biogen; Bristol-Myers Squib; Covance; GE Healthcare; Genentech; GlaxoSmithKline; Eli Lilly Co; Lundbeck; Merck; Meso Scale Discovery; Pfizer; Piramal; Roche; Servier; UCB	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Michael J. Fox Foundation for Parkinson's Research; Abbvie(AbbVie); Avid; Biogen(Biogen); Bristol-Myers Squib; Covance; GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly Co(Eli Lilly); Lundbeck(Lundbeck Corporation); Merck(Merck & Company); Meso Scale Discovery; Pfizer(Pfizer); Piramal; Roche(Roche Holding); Servier(Servier); UCB(UCB Pharma SA)	This work received a grant from JSPS KAKENHI (Grant Number 18K15565) to TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data used in this study were obtained from the PPMI database (www.ppmi-info.org/data).PPMI, a public-private partnership, is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbvie, Avid, Biogen, Bristol-Myers Squib, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Eli Lilly & Co, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Servier and UCB.	Augimeri A, 2016, EJNMMI PHYS, V3, DOI 10.1186/s40658-016-0140-9; Benamer HTS, 2000, MOVEMENT DISORD, V15, P692, DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V; Bonab AA, 2000, J NUCL MED, V41, P1086; Darcourt J, 2010, EUR J NUCL MED MOL I, V37, P443, DOI 10.1007/s00259-009-1267-x; Davidsson A, 2014, ANN NUCL MED, V28, P851, DOI 10.1007/s12149-014-0878-x; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Habraken JBA, 1999, J NUCL MED, V40, P1091; Huertas-Fernandez I, 2015, EUR J NUCL MED MOL I, V42, P112, DOI 10.1007/s00259-014-2882-8; Illan IA, 2012, MED PHYS, V39, P5971, DOI 10.1118/1.4742055; Kahraman D, 2012, J NEUROL, V259, P251, DOI 10.1007/s00415-011-6163-1; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Lloyd JJ, 2018, NEUROIMAGE-CLIN, V20, P823, DOI 10.1016/j.nicl.2018.09.012; Marek K, 2011, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2011.09, DOI 10.1016/J.PNEUROBIO.2011.09]; Martinez-Murcia FJ, 2014, MED PHYS, V41, DOI 10.1118/1.4845115; Oliveira FPM, 2018, EUR J NUCL MED MOL I, V45, P1052, DOI 10.1007/s00259-017-3918-7; Oliveira FPM, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026008; Rahmim A, 2016, NEUROIMAGE-CLIN, V12, pE1, DOI 10.1016/j.nicl.2016.02.012; Rocca WA, 2018, LANCET NEUROL, V17, P928, DOI 10.1016/S1474-4422(18)30355-7; Shiiba T, 2015, ANN NUCL MED, V29, P149, DOI 10.1007/s12149-014-0923-9; Staff RT, 2009, NUCL MED COMMUN, V30, P194, DOI 10.1097/MNM.0b013e328314b863; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tossici-Bolt L, 2006, EUR J NUCL MED MOL I, V33, P1491, DOI 10.1007/s00259-006-0155-x; Wisniewski G, DATSCAN SPECT IMAGE; Zhang YC, 2017, J DIGIT IMAGING, V30, P615, DOI 10.1007/s10278-016-9910-0	24	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228289	10.1371/journal.pone.0228289	http://dx.doi.org/10.1371/journal.pone.0228289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978154	gold, Green Published			2022-12-26	WOS:000534599100138
J	Teshale, AB; Tsegaye, AT; Wolde, HF				Teshale, Achamyeleh Birhanu; Tsegaye, Adino Tesfahun; Wolde, Haileab Fekadu			Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling	PLOS ONE			English	Article							INFECTED PATIENTS; PROGRAMS; INCOME; INITIATION; RETENTION; MORTALITY; REGION	Introduction Loss to follow up after the initiation of antiretroviral therapy (ART) is common in Africa, particularly in Ethiopia and it is a considerable obstacle for the effectiveness of the ART program. Mortality is a competing risk of loss to follow up but it is often overlooked and there is limited evidence about the incidence and predictors of loss to follow up in the presence of competing events. Objective To assess the Incidence and predictors of loss to follow up among adult HIV patients on ART in University of Gondar Comprehensive Specialized Hospital between January 1, 2015, and December 31, 2018. Methods Institution based retrospective follow up study was conducted in University of Gondar Comprehensive Specialized Hospital. A Gray's test and cumulative incidence curve were used to compare the cumulative incidence function of loss to follow up. Bivariable and multivariable competing risk regression models were fitted to identify the predictors of lost to follow up and those variables with p-value < 0.05 in the multivariable analysis was considered as significant predictors of lost to follow up. Result A total of 531 adult HIV patients on ART were included in the analysis. The incidence rate of loss to follow up in this study was 10.90 (95% CI: 8.9-13.2) per 100 person years. Being age group 15-30 years (aSHR = 2.01; 95%CI;1.11-3.63), being daily laborer(aSHR = 2.60; 95% CI;1.45-4.66), not receiving cotrimoxazole preventive therapy (aSHR = 2.66; 95%CI;1.68-4.21), not receiving isoniazid preventive therapy(aSHR = 4.57; 95% CI;1.60-13.08), ambulatory functional status (aSHR = 1.61; 95% CI; 1.02-2.51) and taking AZT-3TC-NVP medication at start of ART(aSHR = 2.01; 95% CI; 1.16-3.78) were significant predictors of lost to follow up. Conclusion In this study the incidence of lost to follow up was high. Young people, daily laborer, ambulatory patients and those taking AZT-3TC-NVP as well as those who did not take opportunistic prophylaxis were at higher risk of loss to follow up. Therefore, giving special attention to the high-risk groups for lost to follow up highlighted in this study could decrease the rate of LTFU.	[Teshale, Achamyeleh Birhanu; Tsegaye, Adino Tesfahun; Wolde, Haileab Fekadu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Teshale, Achamyeleh/0000-0002-7572-9993				Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V42, P262; Agaba PA, 2012, TREATMENT OUTCOMES O, P1; Akilimali PZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171407; Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; Asiimwe SB, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1392-7; Assemie Moges Agazhe, 2018, BMC Res Notes, V11, P287, DOI 10.1186/s13104-018-3407-5; Awino MS., 2014, PREVALENCE MANAGEMEN; Ayele W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2176-5; Bartlett JA, 2009, LANCET INFECT DIS, V9, P637, DOI 10.1016/S1473-3099(09)70227-0; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cohen CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003028; Dadi TL, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/5792925; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Eshun-Wilson I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210408; Etenyi JO, 2018, FRONT PHARMACOL, V9, P1; Ethiopia Ministry of Health, 2020, NATL GUIDELINES COMP; Fisaha Haile KT, 2014, J AIDS CLIN RES, V5; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Haile Fisaha T K, 2015, J AIDS CLIN RES, V5; Honge BL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003499; Huo Y, 2017, LOSS FOLLOW UP TREND, V44, P1; Insaniputri P, 2017, ASIAN J PHARM CLIN R, V10, P93, DOI [10.22159/ajpcr.2017.v10s5.23107, DOI 10.22159/AJPCR.2017.V10S5.23107]; Marson KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078900; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mberi MN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0912-2; Megerso A, 2016, HIV AIDS-RES PALLIAT, V8, P83, DOI 10.2147/HIV.S98137; Mehari D, 2015, J AIDS HIV RES, V7, P1, DOI [10.5897/jahr2014.0315, DOI 10.5897/JAHR2014.0315]; Mekonnen N, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4154-y; Meloni ST, 2012, TIME DEPENDENT PREDI; Mukamba N, 2020, AIDS BEHAV, V24, P1151, DOI 10.1007/s10461-019-02712-4; Odafe S, 2012, PATIENTS DEMOGRAPHIC, P1; Onoka CA, 2012, PATHOG GLOB HEALTH, V106, P46, DOI 10.1179/2047773211Y.0000000018; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parkes-Ratanshi Rosalind, 2015, J Int Assoc Provid AIDS Care, V14, P455, DOI 10.1177/2325957414557264; PEPFAR, 2017, DIFF CAR ETH WAY; Schaecher KL, 2013, AM J MANAG CARE, V19, pS231; Seifu W, 2018, BMC INFECT DIS, V18, P1; Tiruneh YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156619; UNAIDS, 2018, HIV AIDS E SO AFR RE; Wang H, 2009, AIDS RES HUM RETROVI, V25; Webb S, 2018, MALAWI MED J, V30, P73, DOI 10.4314/mmj.v30i2.4; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; World Health Organization, 2016, ANT THER ART COV ALL; WUBSHET M, 2012, AIDS, V2012, P1, DOI DOI 10.5402/2012/721720; Zhou JL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/375217	49	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227473	10.1371/journal.pone.0227473	http://dx.doi.org/10.1371/journal.pone.0227473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978137	gold, Green Published			2022-12-26	WOS:000534599100041
J	Jaakkola, MS; Aalto, SAM; Hyrkas-Palmu, H; Jaakkola, JJK				Jaakkola, Maritta S.; Aalto, Sirpa A. M.; Hyrkas-Palmu, Henna; Jaakkola, Jouni J. K.			Association between regular exercise and asthma control among adults: The population-based Northern Finnish Asthma Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DAMPNESS; MOLDS	Previously those with asthma were often advised to avoid strenuous exercise because of fear for exercise-induced asthmatic reactions, but recent findings suggest many beneficial effects on health related to exercise. We elaborated on the relation between regular exercise and asthma control among adults. This was a population-based cross-sectional Northern Finnish Asthma Study (NoFAS), in which altogether 1922 adult subjects 17-73 years old living in Northern Finland answered the NoFAS questionnaire. The determinant of interest was the total amount of regular exercise during leisure time, measured in hours per week and categorized into no, low (> 0 <= 2h per week), medium (> 2 <= 5h), high (> 5 <= 10h) and very high (> 10h) exercise categories. The outcome of interest was asthma control, which was assessed based on the Asthma Control Test (ACT). As statistical methods we applied analysis of variance (ANOVA) and Poisson regression. ACT score increased gradually, i.e. asthma control improved, with an increasing amount of exercise from no exercise (mean ACT = 19.4; difference from the reference:-1.57, 95% CI-2.12 to-1.01) to high exercise reference category (mean = 21.0), but was slightly lower (mean = 20.3;-0.64, 95% CI-1.27 to -0.02) in the very high exercise category. Such non-linear relation was present both in women and in men. In conclusion, we provide evidence that moderate to high regular exercise improves asthma control among adults with asthma. Advice about regular exercise should be included as an important part of asthma management for adults.	[Jaakkola, Maritta S.; Aalto, Sirpa A. M.; Hyrkas-Palmu, Henna; Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res CERH, Oulu, Finland; [Jaakkola, Maritta S.; Aalto, Sirpa A. M.; Hyrkas-Palmu, Henna; Jaakkola, Jouni J. K.] Univ Oulu, Med Res Ctr Oulu MRC Oulu, Oulu, Finland; [Jaakkola, Maritta S.; Aalto, Sirpa A. M.; Hyrkas-Palmu, Henna; Jaakkola, Jouni J. K.] Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Jaakkola, MS (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res CERH, Oulu, Finland.; Jaakkola, MS (corresponding author), Univ Oulu, Med Res Ctr Oulu MRC Oulu, Oulu, Finland.; Jaakkola, MS (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.	maritta.jaakkola@oulu.fi	Jaakkola, Jouni J.K./G-4314-2012	Hyrkas-Palmu, Henna/0000-0002-7567-4638; Jaakkola, Jouni/0000-0003-4168-4683; Jaakkola, Maritta S./0000-0003-1373-7784	Research Foundation of the Pulmonary Diseases; Jalmari and Rauha Ahokas Foundation; Vainoand Laina Kivi Foundation; Finnish Anti-Tuberculosis Association Foundation; University of Oulu strategic funds	Research Foundation of the Pulmonary Diseases; Jalmari and Rauha Ahokas Foundation; Vainoand Laina Kivi Foundation; Finnish Anti-Tuberculosis Association Foundation; University of Oulu strategic funds	This study was supported by The Research Foundation of the Pulmonary Diseases MSJ, JJKJ), The Jalmari and Rauha Ahokas Foundation, The Vainoand Laina Kivi Foundation, The Finnish Anti-Tuberculosis Association Foundation (SAMA), and the University of Oulu strategic funds (JJKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Heikkinen SAM, 2018, J ASTHMA, V55, P726, DOI 10.1080/02770903.2017.1366510; Heikkinen SAM, 2012, EUR J EPIDEMIOL, V27, P397, DOI 10.1007/s10654-012-9684-8; Heloma A, 2003, ADDICTION, V98, P1111, DOI 10.1046/j.1360-0443.2003.00429.x; Henneberger PK, 2011, AM J RESP CRIT CARE, V184, P368, DOI 10.1164/rccm.812011ST; Hyrkas H, 2016, RESP MED, V113, P1, DOI 10.1016/j.rmed.2016.02.005; Jaakkola JJK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48484-8; Jaakkola JJK, 2010, AM J EPIDEMIOL, V172, P451, DOI 10.1093/aje/kwq110; Jaakkola MS, 2002, ENVIRON HEALTH PERSP, V110, P543, DOI 10.1289/ehp.02110543; Kleinman K, 2010, DATA MANAGEMENT STAT, P131; Loponen J, 2018, EUR CLIN RESPIR J, V5, DOI 10.1080/20018525.2018.1533753; Lucas SR, 2005, J ALLERGY CLIN IMMUN, V115, P928, DOI 10.1016/j.jaci.2005.01.033; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Pallasaho P, 2011, RESP MED, V105, P1449, DOI 10.1016/j.rmed.2011.04.013; Mendes FAR, 2011, MED SCI SPORT EXER, V43, P197, DOI 10.1249/MSS.0b013e3181ed0ea3; Russell MA, 2017, J ASTHMA, V54, P938, DOI 10.1080/02770903.2017.1281293; The Finnish Medical Society Duodecim: Best practice working group, 2012, CURR CAR GUID; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	18	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227983	10.1371/journal.pone.0227983	http://dx.doi.org/10.1371/journal.pone.0227983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971974	Green Published, gold			2022-12-26	WOS:000534374400030
J	Rotkopf, LT; Wiestler, B; Preibisch, C; Liesche-Starnecker, F; Pyka, T; Norenberg, D; Bette, S; Gempt, J; Thierfelder, KM; Zimmer, C; Huber, T				Rotkopf, Lukas T.; Wiestler, Benedikt; Preibisch, Christine; Liesche-Starnecker, Friederike; Pyka, Thomas; Norenberg, Dominik; Bette, Stefanie; Gempt, Jens; Thierfelder, Kolja M.; Zimmer, Claus; Huber, Thomas			The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; ACUTE ISCHEMIC-STROKE; CT PERFUSION; PREDICTS SURVIVAL; RECURRENT GLIOMA; CLASSIFICATION; SPECTROSCOPY; DISTINCTION	Background Wavelet transformed reconstructions of dynamic susceptibility contrast (DSC) MR perfusion (wavelet-MRP) are a new and elegant way of visualizing vascularization. Wavelet-MRP maps yield a clear depiction of hypervascular tumor regions, as recently shown. Objective The aim of this study was to elucidate a possible connection of the wavelet-MRP power spectrum in glioblastoma (GBM) with local vascularity and cell proliferation. Methods For this IRB-approved study 12 patients (63.0+/-14.9y; 7m) with histologically confirmed IDH-wildtype GBM were included. Target regions for biopsies were prospectively marked on tumor regions as seen on preoperative 3T MRI. During subsequent neurosurgical tumor resection 43 targeted biopsies were taken from these target regions, of which all 27 matching samples were analyzed. All specimens were immunohistochemically analyzed for endothelial cell marker CD31 and proliferation marker Ki67 and correlated to the wavelet-MRP power spectrum as derived from DSC perfusion weighted imaging. Results There was a strong correlation between wavelet-MRP power spectrum (median = 4.41) and conventional relative cerebral blood volume (median = 5.97 ml/100g) in Spearman's rank-order correlation (kappa = .83, p < .05). In a logistic regression model, the wavelet-MRP power spectrum showed a significant correlation to CD31 dichotomized to no or present staining (p = .04), while rCBV did not show a significant correlation to CD31 (p = .30). No significant association between Ki67 and rCBV or wavelet-MRP was found (p = .62 and p = .70, respectively). Conclusion The wavelet-MRP power spectrum derived from existing DSC-MRI data might be a promising new surrogate for tumor vascularity in GBM.	[Rotkopf, Lukas T.; Wiestler, Benedikt; Preibisch, Christine; Pyka, Thomas; Zimmer, Claus] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Munich, Germany; [Liesche-Starnecker, Friederike] Tech Univ Munich, Inst Pathol, Dept Neuropathol, Munich, Germany; [Norenberg, Dominik; Huber, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Bette, Stefanie] Univ Klinikum Augsburg, Dept Diagnost & Intervent Radiol & Neuroradiol, Augsburg, Germany; [Gempt, Jens] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, Munich, Germany; [Thierfelder, Kolja M.] Univ Med Ctr Rostock, Inst Diagnost & Intervent Radiol Pediat Radiol &, Rostock, Germany	Technical University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; University of Rostock	Rotkopf, LT (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Munich, Germany.	lukas.rotkopf@gmail.com	Rotkopf, Lukas/AAN-9679-2021	Rotkopf, Lukas/0000-0001-9862-218X; Wiestler, Benedikt/0000-0002-2963-7772; Gempt, Jens/0000-0003-4123-4690; Liesche-Starnecker, Friederike/0000-0003-1948-1580	German Research Foundation DFG [PR 1039/4-1, FO 886/1-1]	German Research Foundation DFG(German Research Foundation (DFG))	This study was supported by funding from the German Research Foundation DFG (grants to CP, PR 1039/4-1, and TP, FO 886/1-1). Smart Reporting GmbH provided support in the form of salaries for LR, DN, and TH. Brainlab AG provided support in the form of a salary for SB. The specific roles of these authors are articulated in the 'author contributions' section. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Ameratunga M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008218.pub4; Bennett IE, 2017, J NEURO-ONCOL, V131, P321, DOI 10.1007/s11060-016-2300-0; Bette S, 2017, RADIOLOGY, V283, P499, DOI 10.1148/radiol.2016152832; Brat DJ, 2018, ACTA NEUROPATHOL, V136, P805, DOI 10.1007/s00401-018-1913-0; Chuang MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141438; Coskun E, 2013, APPL PHYS B-LASERS O, V113, P243, DOI 10.1007/s00340-013-5465-7; Havla L, 2016, MED PHYS, V43, P702, DOI 10.1118/1.4939224; Havla L, 2015, EUR RADIOL, V25, P2354, DOI 10.1007/s00330-015-3651-1; Hedderich D, 2019, J NEURORADIOLOGY, V46, P44, DOI 10.1016/j.neurad.2018.04.006; Hojjati M, 2018, J NEUROIMAGING, V28, P118, DOI 10.1111/jon.12460; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Huber T, 2019, EUR RADIOL, V29, P2669, DOI 10.1007/s00330-018-5892-2; Jain R, 2015, AM J NEURORADIOL, V36, P2030, DOI 10.3174/ajnr.A4405; Juan-Albarracin J, 2018, RADIOLOGY, V287, P944, DOI 10.1148/radiol.2017170845; Ken S, 2015, J NEURO-ONCOL, V124, P465, DOI 10.1007/s11060-015-1860-8; Kluge A, 2016, MAGN RESON IMAGING, V34, P410, DOI 10.1016/j.mri.2015.12.015; Kunz WG, 2017, EUR RADIOL, V27, P2657, DOI 10.1007/s00330-016-4613-y; Leu K, 2014, CANCER IMAGING, V14, DOI 10.1186/s40644-014-0031-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Melguizo-Gavilanes I, 2015, J NEURO-ONCOL, V123, P141, DOI 10.1007/s11060-015-1774-5; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; Preibisch C, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3775; Singh R, 2016, AM J NEURORADIOL, V37, P1838, DOI 10.3174/ajnr.A4823; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Welker K, 2015, AM J NEURORADIOL, V36, pE41, DOI 10.3174/ajnr.A4341; Wintermark M, 2004, AM J NEURORADIOL, V25, P720; Woodworth G, 2005, NEUROL RES, V27, P358, DOI 10.1179/016164105X40057; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016; Zeng QS, 2007, J NEURO-ONCOL, V84, P63, DOI 10.1007/s11060-007-9341-3; Zeng QS, 2007, INT J RADIAT ONCOL, V68, P151, DOI 10.1016/j.ijrobp.2006.12.001	33	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228030	10.1371/journal.pone.0228030	http://dx.doi.org/10.1371/journal.pone.0228030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971966	Green Published, gold			2022-12-26	WOS:000534374400033
J	Ul Hasnain, MJ; Shoaib, M; Qadri, S; Afzal, B; Anwar, T; Abbas, SH; Sarwar, A; Malik, HMT; Pervez, MT				Ul Hasnain, Mirza Jawad; Shoaib, Muhammad; Qadri, Salman; Afzal, Bakhtawar; Anwar, Tehreem; Abbas, Syed Hassan; Sarwar, Amina; Malik, Hafiz Muhammad Talha; Pervez, Muhammad Tariq			Computational analysis of functional single nucleotide polymorphisms associated with SLC26A4 gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PENDRED-SYNDROME; HEARING-LOSS; VESTIBULAR AQUEDUCT; HUMAN-DISEASE; PDS GENE; MUTATIONS; IDENTIFICATION; EXPRESSION; PREDICTION	Single Nucleotide Polymorphisms (SNPs) are the most common candidate mutations in human beings that play a vital role in the genetic basis of certain diseases. Previous studies revealed that Solute Carrier Family 26 Member 4 (SLC26A4) being an essential gene of the multi-faceted transporter family SLC26 facilitates reflexive movement of Iodide into follicular lumen through apical membrane of thyrocyte. SLC26A4 gene encodes Pendred protein, a membrane glycoprotein, highly hydrophobic in nature, present at the apical membrane of thyrocyte functioning as transporter of iodide for thyroid cells. A minor genetic variation in SLC26A4 can cause Pendred syndrome, a syndrome associated with thyroid glands and deafness. In this study, we performed in-silico analysis of 674 missense SNPs of SLC26A4 using different computational platforms. The bunch of tools including SNPNEXUS, SNAP-2, PhD-SNP, SNPs&GO, I-Mutant, ConSurf, and ModPred were used to predict 23 highly confident damaging and disease causing nsSNPs (G209V, G197R, L458P, S427P, Q101P, W472R, N392Y, V359E, R409C, Q235R, R409P, G139V, G497S, H723R, D87G, Y127H, F667C, G334A, G95R, S427C, R291W, Q383H and E384G) that could potentially alter the SLC26A4 gene. Moreover, protein structure prediction, protein-ligand docking and Molecular Dynamics simulation were performed to confirm the impact of two evident alterations (Y127H and G334A) on the protein structure and function.	[Ul Hasnain, Mirza Jawad; Anwar, Tehreem; Abbas, Syed Hassan; Sarwar, Amina; Pervez, Muhammad Tariq] Virtual Univ Pakistan, Dept Bioinformat, Lahore, Pakistan; [Shoaib, Muhammad] UET, Dept Comp Sci & Engn, Lahore, Pakistan; [Qadri, Salman] Islamia Univ Bahawalpur, Dept CS&IT, Bahawalpur, Pakistan; [Afzal, Bakhtawar] COMSATS Univ, Dept Biosci, Islamabad, Pakistan; [Malik, Hafiz Muhammad Talha] Alpha Genom Private Ltd, PWD, Islamabad, Pakistan	Virtual University of Pakistan; Islamia University of Bahawalpur; COMSATS University Islamabad (CUI)	Pervez, MT (corresponding author), Virtual Univ Pakistan, Dept Bioinformat, Lahore, Pakistan.	m.tariq@vu.edu.pk	Qadri, Salman/ABF-5862-2021	Qadri, Salman/0000-0002-3503-6535; Abbas, Syed Hassan/0000-0002-9672-8076; Malik, Hafiz Muhammad Talha/0000-0002-7309-4541				Abe S, 1997, ANN OTO RHINOL LARYN, V106, P1063, DOI 10.1177/000348949710601210; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Baig MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112456; Bidart JM, 2000, J CLIN ENDOCR METAB, V85, P2028, DOI 10.1210/jc.85.5.2028; Blaszczyk M, 2013, NUCLEIC ACIDS RES, V41, pW406, DOI 10.1093/nar/gkt462; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; Desai M, 2018, COMPUT BIOL CHEM, V74, P20, DOI 10.1016/j.compbiolchem.2018.02.022; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Everett LA, 1997, NAT GENET, V17, P13; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Klein J, 1994, P NATL ACAD SCI; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Krawczak M, 2000, HUM MUTAT, V15, P7, DOI [10.1002/(SICI)1098-1004(200001)15:7::AID-3.0.CO;2-N, DOI 10.1002/(SICI)1098-1004(200001)15:7::AID-3.0.CO;2-N]; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Ullah AZD, 2018, NUCLEIC ACIDS RES, V46, pW109, DOI 10.1093/nar/gky399; VALVASSORI GE, 1978, LARYNGOSCOPE, V88, P723; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; Wall SM, 2006, NOVART FDN SYMP, V273, P61; Wall SM, 2006, NOVART FDN SYMP, V273, P9; Wall Susan M, 2006, Novartis Found Symp, V273, P231; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0225368	10.1371/journal.pone.0225368	http://dx.doi.org/10.1371/journal.pone.0225368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971949	Green Published, gold			2022-12-26	WOS:000534374400003
J	Kim, MH; Ha, IJ; Kim, E; Kim, K				Kim, Min Hee; Ha, In Jin; Kim, Eunok; Kim, Kyuseok			Integrated targeted serum metabolomic profile and its association with gender, age, disease severity, and pattern identification in acne	PLOS ONE			English	Article							ADULT FEMALE ACNE; TEENAGE ACNE; VULGARIS; WOMEN; DEFICIENCY; EXPRESSION; HISTIDINE; MTORC1; GIRLS; SKIN	Background Westernized diet and nutritional metabolism are important in acne pathogenesis, especially in adult patients. However, clinical and basic data are lacking. Pattern identification (PI) is a tool that results in a diagnostic conclusion based on a cluster of concurrent symptoms and signs in traditional medicine. Acne can be classified by PI. However, whether the metabolomic profile differs according to the PI of acne is unknown. Metabolomic data would help clarify the pathogenesis of acne. Methods We conducted a cross-sectional study involving 40 healthy controls and 60 subjects with acne. We evaluated androgens, serum lipids, essential amino acids, nonessential amino acids, other amino acids, and pro-inflammatory cytokines of all subjects and compared the metabolomic profiles between acne subjects and healthy controls, and in subgroups according to gender, age, severity, and PI. Results Dehydroepiandrosterone sulfate and serum fatty acids were significantly higher in female subjects, adolescents, and those with disharmony of the thoroughfare and conception vessels. The total essential and nonessential amino acids were significantly lower in the overall, female, adult, severe, and phlegm-stasis group. The latter group exhibited elevated serum levels of interleukin-1 beta and -6. Conclusions This is the first study to investigate serum lipids, amino acids, and cytokines in subjects with acne. We analyzed the differences between metabolomic profiles to determine the diagnostic value of PI. Prospective studies with more patients are needed to confirm the characteristics of each PI and lipidomic data will enrich knowledge concerning lipid mechanism.	[Kim, Min Hee; Kim, Kyuseok] Kyung Hee Univ, Coll Korean Med, Dept Ophthalmol & Otolaryngol & Dermatol, Seoul, South Korea; [Ha, In Jin; Kim, Eunok; Kim, Kyuseok] Kyung Hee Univ, Korean Med Clin Trial Ctr, Korean Med Hosp, Seoul, South Korea; [Kim, Eunok] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University	Kim, K (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Ophthalmol & Otolaryngol & Dermatol, Seoul, South Korea.; Kim, K (corresponding author), Kyung Hee Univ, Korean Med Clin Trial Ctr, Korean Med Hosp, Seoul, South Korea.	kmdkskim@khu.ac.kr		Kim, Kyuseok/0000-0002-3802-8717	Traditional Korean Medicine R&D program - Ministry of Health & Welfare through the Korea Health Industry Development Institute [HI16C0801]; National Research Foundation of Korea Grant - Korean Government [NRF-2017R1A1A1A05001218]	Traditional Korean Medicine R&D program - Ministry of Health & Welfare through the Korea Health Industry Development Institute; National Research Foundation of Korea Grant - Korean Government	This work was supported by the Traditional Korean Medicine R&D program funded by the Ministry of Health & Welfare through the Korea Health Industry Development Institute (grant number HI16C0801, https://www.khidi.or.kr/kps) and a National Research Foundation of Korea Grant, funded by the Korean Government (NRF-2017R1A1A1A05001218, http://www.nrf.re.kr/index) to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque RGR, 2014, ARCH DERMATOL RES, V306, P683, DOI 10.1007/s00403-014-1482-6; Arora MK, 2014, CLIN LAB, V60, P1201, DOI 10.7754/Clin.Lab.2013.120811; Barnes S, 2016, J Mass Spectrom, V51, pii, DOI 10.1002/jms.3672; Burris J, 2013, J ACAD NUTR DIET, V113, P416, DOI 10.1016/j.jand.2012.11.016; Camera E, 2016, J LIPID RES, V57, P1051, DOI 10.1194/jlr.M067942; Cerman AA, 2016, J AM ACAD DERMATOL, V75, P155, DOI 10.1016/j.jaad.2016.02.1220; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Collier CN, 2008, J AM ACAD DERMATOL, V58, P56, DOI 10.1016/j.jaad.2007.06.045; Cong TX, 2019, ARCH DERMATOL RES, V311, P337, DOI 10.1007/s00403-019-01908-x; Dreno B, 2015, J EUR ACAD DERMATOL, V29, P14, DOI 10.1111/jdv.13188; Evans DM, 2005, BRIT J DERMATOL, V152, P579, DOI 10.1111/j.1365-2133.2005.06387.x; Firooz A, 2012, SCI WORLD J, DOI 10.1100/2012/386936; GERBER DA, 1975, J CLIN INVEST, V55, P1164, DOI 10.1172/JCI108033; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Holzmann R, 2014, SKIN PHARMACOL PHYS, V27, P3, DOI 10.1159/000354887; Im M, 2012, J INVEST DERMATOL, V132, P2700, DOI 10.1038/jid.2012.202; JEH SUNG KYUNG, 2004, [Korean Journal of Dermatology, 대한피부과학회지], V42, P1241; Jiang H, 2015, J DERMATOL, V42, P296, DOI 10.1111/1346-8138.12761; Ju Q, 2017, CLIN DERMATOL, V35, P130, DOI 10.1016/j.clindermatol.2016.10.004; Ju QA, 2011, EXP DERMATOL, V20, P320, DOI 10.1111/j.1600-0625.2010.01204.x; Kim H, 2017, ANN DERMATOL, V29, P20, DOI 10.5021/ad.2017.29.1.20; Kim J, 2005, DERMATOLOGY, V211, P193, DOI 10.1159/000087011; Kim JH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215244; Kim K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008554; Lian F, 2014, CHIN J INTEGR MED, V20, P503, DOI 10.1007/s11655-014-1712-y; Lucky AW, 1997, J PEDIATR-US, V130, P30, DOI 10.1016/S0022-3476(97)70307-X; LUCKY AW, 1994, ARCH DERMATOL, V130, P308, DOI 10.1001/archderm.130.3.308; Lynn DD, 2016, ADOLESC HEALTH MED T, V7, P13, DOI 10.2147/AHMT.S55832; Melnik BC, 2018, CLIN DERMATOL, V36, P29, DOI 10.1016/j.clindermatol.2017.09.006; Melnik BC, 2012, DERM-ENDOCRINOL, V4, P20, DOI 10.4161/derm.19828; Melnik BC, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-41; Melnik BC, 2011, NESTLE NUTR WORKS SE, V67, P131, DOI 10.1159/000325580; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; 신준혁, 2015, [The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology, 한방안이비인후피부과학회지], V28, P23, DOI 10.6114/jkood.2015.28.2.023; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Preneau S, 2012, J EUR ACAD DERMATOL, V26, P277, DOI 10.1111/j.1468-3083.2011.04214.x; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Rodrigues L, 2001, SKIN PHARMACOL APPL, V14, P52, DOI 10.1159/000056334; Seleit I, 2014, ANAL QUANT CYTOPATHO, V36, P267; Sharif E, 2017, INT J WOMENS HEALTH, V9, P1, DOI 10.2147/IJWH.S120027; Skroza Nevena, 2018, J Clin Aesthet Dermatol, V11, P21; Szabo Kornelia, 2011, Hum Immunol, V72, P766, DOI 10.1016/j.humimm.2011.05.012; Valeyrie-Allanore L, 2007, DRUG SAFETY, V30, P1011, DOI 10.2165/00002018-200730110-00003; Wang Y, 2013, CHIN J INTEGR MED, V19, P616, DOI 10.1007/s11655-012-1230-8; Watanabe M, 2008, AM J CLIN NUTR, V87, P1860, DOI 10.1093/ajcn/87.6.1860; Weber SU, 2003, FREE RADICAL BIO MED, V34, P170, DOI 10.1016/S0891-5849(02)01187-5; Williams C, 2006, AM J CLIN DERMATOL, V7, P281, DOI 10.2165/00128071-200607050-00002; Wolkenstein P, 2015, DERMATOLOGY, V230, P34, DOI 10.1159/000366195; World Health Organization, 2007, W PAC REG PARTN FOR; Zhang MF, 2015, CANCER-AM CANCER SOC, V121, P1681, DOI 10.1002/cncr.29216; Zhou M, 2018, BRIT J DERMATOL, V179, P732, DOI 10.1111/bjd.16655; Zouboulis CC, 2014, J EUR ACAD DERMATOL, V28, P527, DOI 10.1111/jdv.12298; Zouboulis CC, 2014, CLIN DERMATOL, V32, P389, DOI 10.1016/j.clindermatol.2013.11.005	53	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0228074	10.1371/journal.pone.0228074	http://dx.doi.org/10.1371/journal.pone.0228074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951642	Green Published, gold			2022-12-26	WOS:000534370500039
J	Seki, T; Kanagawa, M; Kobayashi, K; Kowa, H; Yahata, N; Maruyama, K; Iwata, N; Inoue, H; Toda, T				Seki, Tsuneyoshi; Kanagawa, Motoi; Kobayashi, Kazuhiro; Kowa, Hisatomo; Yahata, Naoki; Maruyama, Kei; Iwata, Nobuhisa; Inoue, Haruhisa; Toda, Tatsushi			Galectin 3?binding protein suppresses amyloid-? production by modulating ?-cleavage of amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; induced pluripotent stem cell (iPS cell) (iPSC); amyloid-beta (AB); amyloid precursor protein (APP); lectin; beta-secretase 1 (BACE1); microarray; neurodegeneration; galectin 3?binding protein (GAL3BP); glycophosphatidylinositol-specific phospholipase D1 (GPLD1)	ALZHEIMERS-DISEASE; A-BETA; ANCHORED PROTEINS; CELL BIOLOGY; SECRETASE; HYPOTHESIS; A-BETA-40; PEPTIDES; MUTATION; TARGETS	Alzheimer's disease (AD) is the most common type of dementia, and its pathogenesis is associated with accumulation of ?-amyloid (A?) peptides. A? is produced from amyloid precursor protein (APP) that is sequentially cleaved by ?- and ?-secretases. Therefore, APP processing has been a target in therapeutic strategies for managing AD; however, no effective treatment of AD patients is currently available. Here, to identify endogenous factors that modulate A? production, we performed a gene microarray?based transcriptome analysis of neuronal cells derived from human induced pluripotent stem cells, because A? production in these cells changes during neuronal differentiation. We found that expression of the glycophosphatidylinositol-specific phospholipase D1 (GPLD1) gene is associated with these changes in A? production. GPLD1 overexpression in HEK293 cells increased the secretion of galectin 3?binding protein (GAL3BP), which suppressed A? production in an AD model, neuroglioma H4 cells. Mechanistically, GAL3BP suppressed A? production by directly interacting with APP and thereby inhibiting APP processing by ?-secretase. Furthermore, we show that cells take up extracellularly added GAL3BP via endocytosis and that GAL3BP is localized in close proximity to APP in endosomes where amyloidogenic APP processing takes place. Taken together, our results indicate that GAL3BP may be a suitable target of AD-modifying drugs in future therapeutic strategies for managing AD.	[Seki, Tsuneyoshi; Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Kowa, Hisatomo] Kobe Univ, Dept Rehabil Sci, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Yahata, Naoki] Fujita Hlth Univ, Dept Anat 1, Sch Med, Toyoake, Aichi 4701192, Japan; [Maruyama, Kei] Saitama Med Univ, Dept Pharmacol, Fac Med, Saitama 3500495, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Genome Based Drug Discovery, Nagasaki 8528521, Japan; [Yahata, Naoki; Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Inoue, Haruhisa] RIKEN BioResource Res Ctr BRC, IPSC Based Drug Discovery & Dev Team, Kyoto 6190238, Japan; [Inoue, Haruhisa] RIKEN Ctr Adv Intelligence Project AIP, Med Risk Avoidance Based iPS Cells Team, Kyoto 6068507, Japan; [Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan	Kobe University; Kobe University; Fujita Health University; Saitama Medical University; Nagasaki University; Kyoto University; RIKEN; RIKEN; University of Tokyo	Toda, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan.	toda@m.u-tokyo.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398; Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science (JSPS) [17H06421]; CREST	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant 17H06421 (to M. K.) and by CREST (to H. I., N. I., and T. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Arbor S, 2017, NEURAL REGEN RES, V12, P207, DOI 10.4103/1673-5374.200800; Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5; Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Ashraf GM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00430; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cheret C, 2013, EMBO J, V32, P2015, DOI 10.1038/emboj.2013.146; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Darcissac ECA, 2001, CLIN EXP IMMUNOL, V126, P287, DOI 10.1046/j.1365-2249.2001.01670.x; Deeg MA, 2001, J LIPID RES, V42, P442; Deeg MA, 2012, BBA-MOL CELL BIOL L, V1821, P381, DOI 10.1016/j.bbalip.2011.12.009; Deroo EP, 2015, BLOOD, V125, P1813, DOI 10.1182/blood-2014-04-569939; Grassadonia A, 2013, DIS MARKERS, V2013, P747, DOI 10.1155/2013/214595; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122120; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Klein AM, 1999, ANN NY ACAD SCI, V893, P314, DOI 10.1111/j.1749-6632.1999.tb07845.x; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Ooi A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00300; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; SCALLON BJ, 1991, SCIENCE, V252, P446, DOI 10.1126/science.2017684; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang XX, 2015, AM J ALZHEIMERS DIS, V30, P729, DOI 10.1177/1533317513495107; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788	48	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3678	3691		10.1074/jbc.RA119.008703	http://dx.doi.org/10.1074/jbc.RA119.008703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31996371	Green Published, hybrid			2022-12-26	WOS:000527725300024
J	Rathkey, JK; Xiao, TS; Abbott, DW				Rathkey, Joseph K.; Xiao, Tsan S.; Abbott, Derek W.			Human polymorphisms in GSDMD alter the inflammatory response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; inflammasome; genetics; inflammation; genetic polymorphism; SNP	GASDERMIN-D; ACTIVE CASPASE-1; PYROPTOSIS; PORE; MECHANISM; DRIVEN	Exomic studies have demonstrated that innate immune genes exhibit an even higher degree of variation than the majority of other gene families. However, the phenotypic implications of this genetic variation are not well understood, with effects ranging from hypomorphic to silent to hyperfunctioning. In this work, we study the functional consequences of this variation by investigating polymorphisms in gasdermin D, the key pyroptotic effector protein. We find that, although SNPs affecting potential posttranslational modifications did not affect gasdermin D function or pyroptosis, polymorphisms disrupting sites predicted to be structurally important dramatically alter gasdermin D function. The manner in which these polymorphisms alter function varies from conserving normal pyroptotic function to inhibiting caspase cleavage to disrupting oligomerization and pore formation. Further, downstream of inflammasome activation, polymorphisms that cause loss of gasdermin D function convert inflammatory pyroptotic cell death into immunologically silent apoptotic cell death. These findings suggest that human genetic variation can alter mechanisms of cell death in inflammation.	[Rathkey, Joseph K.; Xiao, Tsan S.; Abbott, Derek W.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Abbott, DW (corresponding author), Rm 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu	Xiao, Tsan/I-7616-2013	Xiao, Tsan/0000-0001-9688-475X; Abbott, Derek/0000-0003-4387-8094	NIDDK, National Institutes of Health [P01-DK091222]; NIGMS, National Institutes of Health [R01GM086550]; National Institutes of Health [R21AR069908, R01GM127609]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIDDK, National Institutes of Health Grant P01-DK091222 (to D. W. A.); NIGMS, National Institutes of Health Grant R01GM086550 (to D. W. A.); and National Institutes of Health Grants R21AR069908 and R01GM127609 (to T. S. X.).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Chirieleison SM, 2017, J BIOL CHEM, V292, P9666, DOI 10.1074/jbc.M117.781500; Chirieleison SM, 2016, J IMMUNOL, V196, P4291, DOI 10.4049/jimmunol.1502631; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lei XB, 2017, J VIROL, V91, DOI 10.1128/JVI.01069-17; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Rathkey JK, 2017, J BIOL CHEM, V292, P14649, DOI 10.1074/jbc.M117.797217; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi PL, 2015, BIOCHEM J, V468, P325, DOI 10.1042/BJ20150204; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115	28	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3228	3238		10.1074/jbc.RA119.010604	http://dx.doi.org/10.1074/jbc.RA119.010604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988247	hybrid, Green Published			2022-12-26	WOS:000519597300027
J	Hu, X; Cao, JC; Yang, HY; Li, DH; Qiao, Y; Zhao, JL; Zhang, ZX; Huang, L				Hu, Xin; Cao, Jiachang; Yang, Hanyu; Li, Dahui; Qiao, Yue; Zhao, Jialin; Zhang, Zhixia; Huang, Lei			Pb2+ biosorption from aqueous solutions by live and dead biosorbents of the hydrocarbon-degrading strain Rhodococcus sp. HX-2	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; COMPETITIVE BIOSORPTION; WASTE-WATER; EFFICIENT BIOSORPTION; ARTHROBACTER VISCOSUS; ADSORPTION-KINETICS; HEXAVALENT CHROMIUM; HEAVY-METALS; REMOVAL; LEAD	In this study, the Pb2+ biosorption potential of live and dead biosorbents of the hydrocarbon degrading strain Rhodococcus sp. HX-2 was analyzed. Optimal biosorption conditions were determined via single factor optimization, which were as follows: temperature, 25 degrees C; pH, 5.0, and biosorbent dose, 0.75 g L-1. A response surface software (Design Expert 10.0) was used to analyze optimal biosorption conditions. The biosorption data for live and dead biosorbents were suitable for the Freundlich model at a Pb2+ concentration of 200 mg L-1. At this same concentration, the maximum biosorption capacity was 88.74 mg g(-1) (0.428 mmol g(-1)) for live biosorbents and 125.5 mg g(-1) (0.606 mmol g(-1)) for dead biosorbents. Moreover, in comparison with the pseudo-first-order model, the pseudo-second-order model seemed better to depict the biosorption process. Dead biosorbents seemed to have lower binding strength than live biosorbents, showing a higher desorption capacity at pH 1.0. The order of influence of competitive metal ions on Pb2+ adsorption was Cu2+ > Cd2+ > Nit Fourier-transform infrared spectroscopy analyses revealed that several functional groups were involved in the biosorption process of dead biosorbents. Scanning electron microscopy showed that Pb2+ attached to the surface of dead biosorbents more readily than on the surface of live biosorbents, whereas transmission electron microscopy confirmed the transfer of biosorbed Pb2+ into the cells in the case of both live and dead biosorbents. It can thus be concluded that dead biosorbents are better than live biosorbents for Pb2+ biosorption, and they can accordingly be used for wastewater treatment.	[Hu, Xin; Cao, Jiachang; Li, Dahui; Qiao, Yue; Zhao, Jialin; Zhang, Zhixia; Huang, Lei] Tianjin Univ Technol, Tianjin Key Lab Organ Solar Cells & Photochem Con, Tianjin Key Lab Drug Targeting & Bioimaging, Coll Chem & Chem Engn, Tianjin, Peoples R China; [Yang, Hanyu] Capital Univ Econ & Business, Coll Management Sci & Engn, Beijing, Peoples R China	Tianjin University of Technology; Capital University of Economics & Business	Huang, L (corresponding author), Tianjin Univ Technol, Tianjin Key Lab Organ Solar Cells & Photochem Con, Tianjin Key Lab Drug Targeting & Bioimaging, Coll Chem & Chem Engn, Tianjin, Peoples R China.	huanglei@tjut.edu.cn			National Natural Science Foundation of China [21777113]; Natural Science Foundation of Tianjin City [15JCQNJC08800]; National Undergraduate Training Programs for Innovation and Entrepreneurship [201610060037, 201710060027]; Training Project of the Innovation Team of Colleges and Universities in Tianjin; Nankai laboratory	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin); National Undergraduate Training Programs for Innovation and Entrepreneurship; Training Project of the Innovation Team of Colleges and Universities in Tianjin; Nankai laboratory	This work was supported by the Nankai laboratory, the National Natural Science Foundation of China (Grant No. 21777113), the Natural Science Foundation of Tianjin City (Grant No. 15JCQNJC08800), the National Undergraduate Training Programs for Innovation and Entrepreneurship (No. 201610060037 and 201710060027), and the Training Project of the Innovation Team of Colleges and Universities in Tianjin. And the grant recipient is corresponding author: Lei Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hasan H, 2016, J IND ENG CHEM, V37, P295, DOI 10.1016/j.jiec.2016.03.038; Abu-Danso E, 2020, J HAZARD MATER, V381, DOI 10.1016/j.jhazmat.2019.120871; Amor M, 2018, GEOCHIM COSMOCHIM AC, V232, P225, DOI 10.1016/j.gca.2018.04.020; Aryal M, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4173-z; Barakat MA, 2011, ARAB J CHEM, V4, P361, DOI 10.1016/j.arabjc.2010.07.019; Bayramoglu G, 2008, CHEM ENG J, V143, P133, DOI 10.1016/j.cej.2008.01.002; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Bushra R, 2015, J IND ENG CHEM, V21, P1112, DOI 10.1016/j.jiec.2014.05.022; Cai Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040702; Chatterjee A, 2014, CHEM ENG J, V244, P105, DOI 10.1016/j.cej.2013.12.017; Chen SH, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3931-x; Cheng JF, 2017, J APPL PHYCOL, V29, P211, DOI 10.1007/s10811-016-0916-2; Cheng L, 2015, RELIAB ENG SYST SAFE, V142, P9, DOI 10.1016/j.ress.2015.04.020; Das D, 2014, ECOL ENG, V64, P136, DOI 10.1016/j.ecoleng.2013.12.051; Das GS, 2019, NEW J CHEM, V43, P14575, DOI 10.1039/c9nj02344e; Dhoble RM, 2018, ENVIRON SCI POLLUT R, V25, P19657, DOI 10.1007/s11356-018-1792-x; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Fan JJ, 2014, J HAZARD MATER, V279, P236, DOI 10.1016/j.jhazmat.2014.07.016; Farooq M, 2015, AGRON SUSTAIN DEV, V35, P461, DOI 10.1007/s13593-015-0287-0; Ghasemi M, 2014, J IND ENG CHEM, V20, P2193, DOI 10.1016/j.jiec.2013.09.050; Hadiani MR, 2018, J ENVIRON CHEM ENG, V6, P4980, DOI 10.1016/j.jece.2018.07.034; Hlihor RM, 2017, WATER SCI TECHNOL, V76, P1726, DOI 10.2166/wst.2017.360; Hlihor RM, 2017, PROCESS SAF ENVIRON, V108, P44, DOI 10.1016/j.psep.2016.06.016; Hlihor RM, 2015, NEW BIOTECHNOL, V32, P358, DOI 10.1016/j.nbt.2014.08.003; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Munoz AJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/719060; Jobby R, 2018, CHEMOSPHERE, V207, P255, DOI 10.1016/j.chemosphere.2018.05.050; Khadivinia E, 2014, J IND ENG CHEM, V20, P4304, DOI 10.1016/j.jiec.2014.01.037; Kim S, 2015, J HAZARD MATER, V283, P657, DOI 10.1016/j.jhazmat.2014.10.008; Kiran I, 2006, BIOCHEM ENG J, V31, P197, DOI 10.1016/j.bej.2006.07.008; Kwak HW, 2015, ALGAL RES, V7, P92, DOI 10.1016/j.algal.2014.12.006; Li HF, 2010, J HAZARD MATER, V179, P151, DOI 10.1016/j.jhazmat.2010.02.072; Li XH, 2018, J IND ENG CHEM, V57, P64, DOI 10.1016/j.jiec.2017.08.008; Li XP, 2018, GEOMICROBIOL J, V35, P174, DOI 10.1080/01490451.2017.1348405; Liu JC, 2009, CARBOHYD POLYM, V78, P704, DOI 10.1016/j.carbpol.2009.06.003; Luna AS, 2010, BIORESOURCE TECHNOL, V101, P5104, DOI 10.1016/j.biortech.2010.01.138; Ma XM, 2015, BIORESOURCE TECHNOL, V185, P70, DOI 10.1016/j.biortech.2015.02.074; Mahamadi C, 2010, BIORESOURCE TECHNOL, V101, P859, DOI 10.1016/j.biortech.2009.08.097; Mahmoud ME, 2015, J ENVIRON CHEM ENG, V3, P1320, DOI 10.1016/j.jece.2014.11.027; Malkoc S, 2016, DESALIN WATER TREAT, V57, P15445, DOI 10.1080/19443994.2015.1073181; Masoumi F, 2016, J ENVIRON CHEM ENG, V4, P950, DOI 10.1016/j.jece.2015.12.025; Mishra V, 2017, APPL WATER SCI, V7, P3173, DOI 10.1007/s13201-016-0463-7; Mohapatra RK, 2019, J ENVIRON MANAGE, V247, P121, DOI 10.1016/j.jenvman.2019.06.073; Munoz AJ, 2012, CHEM ENG J, V210, P325, DOI 10.1016/j.cej.2012.09.007; Nadeem R, 2016, J IND ENG CHEM, V35, P185, DOI 10.1016/j.jiec.2015.12.030; Naushad M, 2015, J IND ENG CHEM, V25, P35, DOI 10.1016/j.jiec.2014.10.010; Naushad M, 2014, CHEM ENG J, V235, P100, DOI 10.1016/j.cej.2013.09.013; Naushad M, 2015, IONICS, V21, P2237, DOI 10.1007/s11581-015-1401-7; Pan XH, 2017, INORG CHEM COMMUN, V75, P21, DOI 10.1016/j.inoche.2016.11.012; Paul ML, 2012, CHEM ENG J, V187, P104, DOI 10.1016/j.cej.2012.01.106; Perelomov LV, 2018, ECOTOX ENVIRON SAFE, V151, P178, DOI 10.1016/j.ecoenv.2018.01.018; Puyen ZM, 2012, BIORESOURCE TECHNOL, V126, P233, DOI 10.1016/j.biortech.2012.09.036; Rahman Z, 2019, J BASIC MICROB, V59, P477, DOI 10.1002/jobm.201900024; Rajput S, 2016, J COLLOID INTERF SCI, V468, P334, DOI 10.1016/j.jcis.2015.12.008; Ramadass K, 2016, INT J ENVIRON SCI TE, V13, P2863, DOI 10.1007/s13762-016-1113-1; Reddy DHK, 2010, J HAZARD MATER, V174, P831, DOI 10.1016/j.jhazmat.2009.09.128; Ren GM, 2015, ECOTOX ENVIRON SAFE, V117, P141, DOI 10.1016/j.ecoenv.2015.03.033; Russo V, 2016, CHEM ENG J, V283, P1197, DOI 10.1016/j.cej.2015.08.066; Sahmoune MN, 2016, CHEM ENG TECHNOL, V39, P1617, DOI 10.1002/ceat.201500541; Serrano-Gomez J, 2015, INT J ENVIRON SCI TE, V12, P2559, DOI 10.1007/s13762-014-0665-1; Shi L, 2015, BIORESOURCE TECHNOL, V194, P297, DOI 10.1016/j.biortech.2015.07.029; Shukla S, 2019, ACS APPL MATER INTER, V11, P18165, DOI 10.1021/acsami.9b02857; Simonin JP, 2016, CHEM ENG J, V300, P254, DOI 10.1016/j.cej.2016.04.079; Singh R, 2011, INDIAN J PHARMACOL, V43, P246, DOI 10.4103/0253-7613.81505; Su JF, 2016, MAR POLLUT BULL, V109, P87, DOI 10.1016/j.marpolbul.2016.06.017; Sulaymon A.H., 2012, J ENG-NY, V18, P710; Sulaymon AH, 2012, DESALIN WATER TREAT, V45, P331, DOI 10.1080/19443994.2012.692032; Tabaraki R, 2014, INT BIODETER BIODEGR, V93, P145, DOI 10.1016/j.ibiod.2014.03.022; Tan IAW, 2009, J HAZARD MATER, V164, P473, DOI 10.1016/j.jhazmat.2008.08.025; Trakal L, 2016, BIORESOURCE TECHNOL, V203, P318, DOI 10.1016/j.biortech.2015.12.056; Tripathi KM, 2017, J NANOMATER, V2017, DOI 10.1155/2017/7029731; Vela-Cano M., 2014, ADV MICROBIOL, V48851, DOI [10.4236/aim.2014.410070, DOI 10.4236/AIM.2014.410070]; Wang CQ, 2018, CARBOHYD POLYM, V182, P21, DOI 10.1016/j.carbpol.2017.11.004; Wang HM, 2014, WATER RES, V66, P219, DOI 10.1016/j.watres.2014.08.013; Yin K, 2018, CHEM ENG J, V1553, P1563; Yu De-shuang, 2018, Huanjing Kexue, V39, P1688, DOI 10.13227/j.hjkx.201706023; Zou CL, 2019, ENVIRON SCI POLLUT R, V26, P1315, DOI 10.1007/s11356-018-3652-0	77	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226557	10.1371/journal.pone.0226557	http://dx.doi.org/10.1371/journal.pone.0226557			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995615	Green Published, Green Submitted, gold			2022-12-26	WOS:000534609400011
J	Ball, T; Monte, D; Aidara-Kane, A; Matheu, J; Ru, HY; Thakur, S; Ejobi, F; Fedorka-Cray, P				Ball, Takiyah; Monte, Daniel; Aidara-Kane, Awa; Matheu, Jorge; Ru, Hongyu; Thakur, Siddhartha; Ejobi, Francis; Fedorka-Cray, Paula			International lineages of Salmonella enterica serovars isolated from chicken farms, Wakiso District, Uganda	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; ESCHERICHIA-COLI; KENTUCKY; SEQUENCE; TYPHIMURIUM; PLASMIDS	The growing occurrence of multidrug-resistant (MDR) Salmonella enterica in poultry has been reported with public health concern worldwide. We reported, recently, the occurrence of Escherichia coli and Salmonella enterica serovars carrying clinically relevant resistance genes in dairy cattle farms in the Wakiso District, Uganda, highlighting an urgent need to monitor food-producing animal environments. Here, we present the prevalence, antimicrobial resistance, and sequence type of 51 Salmonella isolates recovered from 379 environmental samples from chicken farms in Uganda. Among the Salmonella isolates, 32/51 (62.7%) were resistant to at least one antimicrobial, and 10/51 (19.6%) displayed multiple drug resistance. Through PCR, five replicon plasmids were identified among chicken Salmonella isolates including IncFIIS 17/51 (33.3%), IncI1 alpha 12/51 (23.5%), IncP 8/51 (15.7%), IncX1 8/51 (15.7%), and IncX2 1/51 (2.0%). In addition, we identified two additional replicons through WGS (Whole Genome Sequencing; ColpVC and IncFIB). A significant seasonal difference between chicken sampling periods was observed (p = 0.0017). We conclude that MDR Salmonella highlights the risks posed to animals and humans. Implementing a robust, integrated surveillance system will aid in monitoring MDR zoonotic threats.	[Ball, Takiyah; Ru, Hongyu; Thakur, Siddhartha; Fedorka-Cray, Paula] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Coll Vet Med, Raleigh, NC 27695 USA; [Monte, Daniel] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, Sao Paulo, Brazil; [Aidara-Kane, Awa; Matheu, Jorge] World Hlth Org WHO, Dept Food Safety & Zoonoses, Geneva, Switzerland; [Ejobi, Francis] Makerere Univ, Dept Biosecur Ecosyst & Vet Publ Hlth, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda	University of North Carolina; North Carolina State University; Universidade de Sao Paulo; World Health Organization; Makerere University	Ball, T; Fedorka-Cray, P (corresponding author), North Carolina State Univ, Dept Populat Hlth & Pathobiol, Coll Vet Med, Raleigh, NC 27695 USA.	taball@ncsu.edu; pjcray@ncsu.edu	Monte, Daniel F. M./B-7690-2016	Monte, Daniel F. M./0000-0003-3787-1988; Thakur, Siddhartha/0000-0003-3787-9939	NC State College of Veterinary Medicine, Makerere College of Veterinary Medicine (FE-Project) [SPHQ14-APW-3945]; World Health Organization	NC State College of Veterinary Medicine, Makerere College of Veterinary Medicine (FE-Project); World Health Organization(World Health Organization)	Funding sources of this project include NC State College of Veterinary Medicine, Makerere College of Veterinary Medicine (FE-Project number SPHQ14-APW-3945) who partially funded this project for collection and culture of the samples and the the World Health Organization as the funder of the grant.	Afema JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152130; Akil L, 2014, FOODBORNE PATHOG DIS, V11, P974, DOI 10.1089/fpd.2014.1802; Ball TA, 2019, FOODBORNE PATHOG DIS, V16, P54, DOI 10.1089/fpd.2018.2528; Byarugaba DK, 2008, POULTRY SECTOR COUNT; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Djeffal S, 2018, VET WORLD, V11, P1102, DOI 10.14202/vetworld.2018.1102-1108; Ejobi F, 2013, QUALITATIVE RISK ASS; Elnekave E, 2018, CLIN INFECT DIS, V66, P877, DOI 10.1093/cid/cix909; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; Fedorka-Cray PJ, 1996, SALMONELLA INFECT HE; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Kigozi R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1549-2; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Nadimpalli M, 2019, J ANTIMICROB CHEMOTH, V74, P342, DOI 10.1093/jac/dky451; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Plumb I, 2019, MMWR MORB MORTAL WKL, V2019; Popowska M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00044; Ramadan H, 2018, J GLOB ANTIMICROB RE, V14, P101, DOI 10.1016/j.jgar.2018.06.012; Rickert-Hartman R, 2014, EMERG INFECT DIS, V20, P910, DOI 10.3201/eid2005.131575; Toro M, 2016, APPL ENVIRON MICROB, V82, P6223, DOI 10.1128/AEM.01760-16; Weill FX, 2006, EMERG INFECT DIS, V12, P1611, DOI 10.3201/eid1210.060589; Wright JG, 2005, EMERG INFECT DIS, V11, P1235, DOI 10.3201/eid1108.050111; Wu XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19000; Zurfluh K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00555	28	6	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0220484	10.1371/journal.pone.0220484	http://dx.doi.org/10.1371/journal.pone.0220484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990938	Green Submitted, Green Published, gold			2022-12-26	WOS:000534605400003
J	Trindade, PHE; Hartmann, E; Keeling, LJ; Andersen, PH; Ferraz, GD; da Costa, MJRP				Esteves Trindade, Pedro Henrique; Hartmann, Elke; Keeling, Linda J.; Andersen, Pia Haubro; Ferraz, Guilherme de Camargo; Rodrigues Paranhos da Costa, Mateus Jose			Effect of work on body language of ranch horses in Brazil	PLOS ONE			English	Article							BEHAVIORAL-ASSESSMENT; FACIAL EXPRESSIONS; POSTOPERATIVE PAIN; INTENSE EXERCISE; RESPONSES; STRESS; SCALE	The horses' responses to exercise are commonly monitored using physiological variables, nonetheless physical and mental states can also be expressed through body language. The aims of this study were: (i) to identify how facial expressions and other behavioural variables change in ranch horses after a routine workday, and (ii) to investigate if these changes can be used as indicators of physical tiredness by relating them to known variables of physical fitness and workload. Fourteen crossbred ranch horses were assessed pre- and post-workday on two farms, recording the body language, physiological and workload variables. Statistical analysis consisted of four stages: (i) comparisons between the sampling times (pre- vs post-workday) using linear mixed-effects models with repeated measures and a paired Wilcoxon test; (ii) selection of the most powerful variables by applying Kaiser-Meyer-Olkin test and principal components analyses (PCA); (iii) evaluations of the relationships within these selected variables utilizing PCA and Spearman rank coefficients; and (iv) identifying a critical level of the most robust behavioural indicators using a non-hierarchical cluster analysis. Results showed that after a workday the horses increased the frequency/duration of body language indicative of resting. They also decreased the frequency/duration of body language indicative of attention and movements to avoid flies. However, some of these behaviours are also shown when horses are in pain, leading us to suggest that some ranch horses were probably experiencing a combination of of tiredness and slight soreness. Of particular interest, because of the ease with which it can be assessed on the farm and generalized to other situations, we suggest that the frequency of shifting weight between the forelegs has potential to be used as an indicator of physical tiredness in horses. The results can also be used in the development of tools to improve the welfare of ranch horses as well as horses used in other activities, although more research is needed to validate this assumption.	[Esteves Trindade, Pedro Henrique] Sao Paulo State Univ, UNESP, Fac Agr & Vet Sci, Grad Program Anim Sci, Jaboticabal, SP, Brazil; [Esteves Trindade, Pedro Henrique; Rodrigues Paranhos da Costa, Mateus Jose] Sao Paulo State Univ, UNESP, Fac Agr & Vet Sci, Ethol & Anim Ecol Res Grp Grp ETCO,Dept Anim Sci, Jaboticabal, SP, Brazil; [Hartmann, Elke; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden; [Andersen, Pia Haubro] Univ Agr Sci Uppsala, Dept Large Anim Sci, Uppsala, Sweden; [Ferraz, Guilherme de Camargo] Sao Paulo State Univ, UNESP, Fac Agr & Vet Sci, Dept Anim Morphol & Physiol, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Universidade Estadual Paulista	da Costa, MJRP (corresponding author), Sao Paulo State Univ, UNESP, Fac Agr & Vet Sci, Ethol & Anim Ecol Res Grp Grp ETCO,Dept Anim Sci, Jaboticabal, SP, Brazil.	mateus.paranhos@unesp.br	Ferraz, Guilherme/ADE-4760-2022; da Costa, Mateus Paranhos/V-4750-2019; Ferraz, Guilherme/G-4954-2012; da Costa, Mateus J.R. Paranhos/C-5993-2012; Andersen, Pia Haubro/B-7077-2015; Keeling, Linda/K-6542-2012; Esteves Trindade, Pedro Henrique/K-1178-2017	da Costa, Mateus Paranhos/0000-0002-0088-4008; Ferraz, Guilherme/0000-0002-6463-6628; da Costa, Mateus J.R. Paranhos/0000-0002-0088-4008; Andersen, Pia Haubro/0000-0002-6039-7439; Keeling, Linda/0000-0003-2629-0117; Hartmann, Elke/0000-0002-0853-554X; Esteves Trindade, Pedro Henrique/0000-0002-8522-5553	FAPESP (Sao Paulo State Research Foundation) [2015/14421-3, 2016/15374-1]; FAPESP [2015/26738-1]	FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	P. H. E. Trindade was sponsored by FAPESP (Sao Paulo State Research Foundation, www.fapesp.br), which supported him with two scholarships during the development of this research (master degree - grant no. 2015/14421-3) and abroad internship - grant no. 2016/15374-1). Financial support was also given by FAPESP (grant no 2015/26738-1). FAPESP did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2016, EQUINE VET EDUC, V28, P89, DOI 10.1111/eve.12410; Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Cerqueira JA, 2018, RES VET SCI, V121, P31, DOI 10.1016/j.rvsc.2018.10.004; Costa ED, 2014, ANIM WELFARE, V23, P323, DOI 10.7120/09627286.23.3.323; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Dawkins MS, 2004, ANIM WELFARE, V13, pS3; de Graaf-Roelfsema E, 2007, VET QUART, V29, P82, DOI 10.1080/01652176.2007.9695232; de Grauw JC, 2016, VET J, V209, P14, DOI 10.1016/j.tvjl.2015.07.030; Descovich KA., 2017, FACIAL EXPRESSION UN; Di Giminiani P, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00100; Finlayson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166446; Fleming PA, 2013, APPL ANIM BEHAV SCI, V144, P80, DOI 10.1016/j.applanim.2012.12.001; Giannetto C, 2012, BIOL RHYTHM RES, V43, P681, DOI 10.1080/09291016.2011.632231; Gleerup KB, 2015, VET ANAESTH ANALG, V42, P103, DOI 10.1111/vaa.12212; Gleerup KB, 2015, APPL ANIM BEHAV SCI, V171, P25, DOI 10.1016/j.applanim.2015.08.023; Goransson L., 2016, PORCINE PAIN FACE ID; Guesgen MJ, 2016, BEHAV PROCESS, V132, P49, DOI 10.1016/j.beproc.2016.09.010; Hall C, 2014, J VET BEHAV, V9, P22, DOI 10.1016/j.jveb.2013.09.005; Hodgson D.R., 2014, ATHLETIC HORSE PRINC, V2nd ed.., P1; Hyyppa S, 2005, LIVEST PROD SCI, V92, P113, DOI 10.1016/j.livprodsci.2004.11.014; Kay R, 2009, APPL ANIM BEHAV SCI, V116, P237, DOI 10.1016/j.applanim.2008.08.013; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Lage J, 2017, J ANIM SCI, V95, P2488, DOI 10.2527/jas.2016.1270; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; LIMA R. A. S., 2006, ESTUDO COMPLEXO AGRO; LIMA R.A.S., 2016, REVISAO ESTUDO COMPL; Lindegaard C, 2010, VET ANAESTH ANALG, V37, P171, DOI 10.1111/j.1467-2995.2009.00521.x; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McDonnell S.M., 2003, PRACTICAL FIELD GUID; McGowan CM, 2008, COMP EXERC PHYSIOL, V5, P57, DOI 10.1017/S1478061508979202; McLean AN, 2017, APPL ANIM BEHAV SCI, V190, P18, DOI 10.1016/j.applanim.2017.02.020; McLennan KM, 2016, APPL ANIM BEHAV SCI, V176, P19, DOI 10.1016/j.applanim.2016.01.007; Mullard J, 2017, J VET BEHAV, V18, P7, DOI 10.1016/j.jveb.2016.11.005; Munoz A, 2017, J EQUINE VET SCI, V51, P24, DOI 10.1016/j.jevs.2016.12.002; Popescu S, 2013, J EQUINE VET SCI, V33, P1, DOI 10.1016/j.jevs.2012.04.001; Price J, 2003, VET ANAESTH ANALG, V30, P124, DOI 10.1046/j.1467-2995.2003.00139.x; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Raekallio M, 1997, VET SURG, V26, P150, DOI 10.1111/j.1532-950X.1997.tb01478.x; Rietmann TR, 2004, J VET MED A, V51, P218, DOI 10.1111/j.1439-0442.2004.00627.x; Rogers C. W., 2007, Equine and Comparative Exercise Physiology, V4, P1, DOI 10.1017/S1478061507727408; Silva L. A. C. da, 2005, ARQUIVOS ZOOTECNIA, V54, P510; Strand SC, 2002, APPL ANIM BEHAV SCI, V78, P145, DOI 10.1016/S0168-1591(02)00106-5; Stratton R, 2014, INDICATORS GOOD WELF; Teixeira-Neto AR, 2012, PESQUISA VET BRASIL, V32, P951, DOI 10.1590/S0100-736X2012000900023; Trindade P. H. E., 2016, AN 34 ENC AN ET JAB, P176; van Eps A, 2010, VET CLIN N AM-EQUINE, V26, P287, DOI 10.1016/j.cveq.2010.06.007; van Loon JPAM, 2015, VET J, V206, P356, DOI 10.1016/j.tvjl.2015.08.023; Wageningen UR Livestock Research, 2011, 569 WAGENINGEN UR LI, P1; Wagner AE, 2010, VET CLIN N AM-EQUINE, V26, P481, DOI 10.1016/j.cveq.2010.07.001; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Williams DC, 2008, J VET INTERN MED, V22, P630, DOI 10.1111/j.1939-1676.2008.0096.x; Yeon SC, 2012, J VET BEHAV, V7, P179, DOI 10.1016/j.jveb.2011.08.004; Zobba R, 2011, J EQUINE VET SCI, V31, P542, DOI 10.1016/j.jevs.2011.03.010	55	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228130	10.1371/journal.pone.0228130	http://dx.doi.org/10.1371/journal.pone.0228130			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990951	Green Published, gold			2022-12-26	WOS:000534605400042
J	Hattori, RS; Yoshinaga, TT; Butzge, AJ; Hattori-Ihara, S; Tsukamoto, RY; Takahashi, NS; Tabata, YA				Hattori, Ricardo Shohei; Yoshinaga, Tulio Teruo; Butzge, Arno Juliano; Hattori-Ihara, Shoko; Tsukamoto, Ricardo Yasuichi; Takahashi, Neuza Sumico; Tabata, Yara Aiko			Generation of a white-albino phenotype from cobalt blue and yellow-albino rainbow trout (Oncorhynchus mykiss): Inheritance pattern and chromatophores analysis	PLOS ONE			English	Article							CELL FATE; VARIANT; PIGMENTATION; COLORATION; ZEBRAFISH; STRAINS; SMOLTIFICATION; XANTHOPHORE; APPEARANCE; EXPRESSION	Albinism is the most common color variation described in fish and is characterized by a white or yellow phenotype according to the species. In rainbow trout Oncorhynchus mykiss, aside from yellow-albino phenotypes, cobalt blue variants with autosomal, recessive inheritance have also been reported. In this study, we investigated the inheritance pattern and chromatophores distribution/abundance of cobalt blue trouts obtained from a local fish farm. Based on crosses with wild-type and dominant yellow-albino lines, we could infer that cobalt blue are dominant over wild-type and co-dominant in relation to yellow-albino phenotype, resulting in a fourth phenotype: the white-albino. Analysis of chromatophores revealed that cobalt blue trouts present melanophores, as the wild-type, and a reduced number of xanthophores. As regards to the white-albino phenotype, they were not only devoid of melanophores but also presented a reduced number of xanthophores. Cobalt blue and white-albino trouts also presented reduced body weight and a smaller pituitary gland compared to wild-type and yellow-albino phenotypes. The transcription levels of tshb and trh were up regulated in cobalt blue compared to wild type, suggesting the involvement of thyroid hormone in the expression of blue color. These phenotypes represent useful models for research on body pigmentation in salmonids and on the mechanisms behind endocrine control of color patterning.	[Hattori, Ricardo Shohei; Tabata, Yara Aiko] Agencia Paulista Tecnol Agronegocios, Secretaria Agr, Unidade Pesquisa & Desenvolvimento Campos Jordao, Salmonid Expt Stn Campos Jordao, Sao Paulo, Brazil; [Yoshinaga, Tulio Teruo] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil; [Butzge, Arno Juliano] Sao Paulo State Univ, Grad Program Biol Sci Genet, Inst Biosci Botucatu, Botucatu, SP, Brazil; [Hattori-Ihara, Shoko] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Tokyo, Japan; [Tsukamoto, Ricardo Yasuichi] Puriaqua Limitada, Sao Paulo, Brazil; [Takahashi, Neuza Sumico] Agencia Paulista Tecnol Agronegocios, Secretaria Agr, Sao Paulo Fisheries Inst, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Tokyo University of Marine Science & Technology	Hattori, RS (corresponding author), Agencia Paulista Tecnol Agronegocios, Secretaria Agr, Unidade Pesquisa & Desenvolvimento Campos Jordao, Salmonid Expt Stn Campos Jordao, Sao Paulo, Brazil.	hattori.fish@gmail.com	Yoshinaga, Tulio Teruo/AAL-7295-2021	Yoshinaga, Tulio Teruo/0000-0001-6610-3115; Butzge, Arno Juliano/0000-0002-4580-7145	FAPESP [2013/17612-9, 2014/00569-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP to RSH (2013/17612-9 and 2014/00569-6). The funder provided support in the form of fellowship for author [RSH], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Commercial affiliation of RYT did not play a role in the study.	Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bjornsson BT, 2011, GEN COMP ENDOCR, V170, P290, DOI 10.1016/j.ygcen.2010.07.003; Blanc JM, 2006, J HERED, V97, P89, DOI 10.1093/jhered/esj010; Blanc JM, 2003, J WORLD AQUACULT SOC, V34, P425, DOI 10.1111/j.1749-7345.2003.tb00081.x; Blanc JM, 2002, J WORLD AQUACULT SOC, V33, P278, DOI 10.1111/j.1749-7345.2002.tb00504.x; Boonanuntanasarn S, 2004, PIGM CELL RES, V17, P413, DOI 10.1111/j.1600-0749.2004.00166.x; CHOURROUT D, 1980, REPROD NUTR DEV, V20, P727, DOI 10.1051/rnd:19800415; Colihueque N, 2010, REV FISH BIOL FISHER, V20, P71, DOI 10.1007/s11160-009-9121-6; Crouse CC, 2018, AQUAC RES, V49, P1672, DOI 10.1111/are.13623; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Dobosz S, 2000, J APPL ICHTHYOL, V16, P117, DOI 10.1046/j.1439-0426.2000.00147.x; Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622; Farias EC, 1986, BOL INST PESCA, V13, P115; FOLMAR LC, 1980, AQUACULTURE, V21, P1, DOI 10.1016/0044-8486(80)90123-4; Goda M, 2001, ZOOL SCI, V18, P165, DOI 10.2108/zsj.18.165; Goda M, 1998, ZOOL SCI, V15, P323, DOI 10.2108/zsj.15.323; Granier S, 2011, CAN J ZOOL, V89, P190, DOI 10.1139/Z10-108; Hilsdorf AWS, 2002, PIGM CELL RES, V15, P57, DOI 10.1034/j.1600-0749.2002.00058.x; Hofreiter M, 2010, CELL MOL LIFE SCI, V67, P2591, DOI 10.1007/s00018-010-0333-7; Ineno T, 2018, FISHERIES SCI, V84, P671, DOI 10.1007/s12562-018-1217-2; Kaleta K, 2009, B VET I PULAWY, V53, P117; KANEKO T, 1993, GEN COMP ENDOCR, V92, P31, DOI 10.1006/gcen.1993.1140; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Kimura T, 2014, P NATL ACAD SCI USA, V111, P7343, DOI 10.1073/pnas.1311254111; KINCAID HL, 1975, J HERED, V66, P100, DOI 10.1093/oxfordjournals.jhered.a108578; Krauss J, 2014, PIGM CELL MELANOMA R, V27, P827, DOI 10.1111/pcmr.12272; Kristensen TN, 2005, ANIM SCI, V80, P121, DOI 10.1079/ASC41960121; Landgrebe FW, 1941, J EXP BIOL, V18, P162; Le Guyader S, 2002, PIGM CELL RES, V15, P27; Nakamura K, 2001, MOL GENET GENOMICS, V265, P687, DOI 10.1007/s004380100464; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Odenthal J, 1996, DEVELOPMENT, V123, P391; OGURI M, 1976, B JPN SOC SCI FISH, V42, P823; OGURI M, 1993, NIPPON SUISAN GAKK, V59, P569, DOI 10.2331/suisan.59.569; OGURI M, 1992, NIPPON SUISAN GAKK, V58, P803, DOI 10.2331/suisan.58.803; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Price AC, 2008, ZEBRAFISH, V5, P297, DOI 10.1089/zeb.2008.0551; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; ROBERTSON OH, 1951, ENDOCRINOLOGY, V48, P658, DOI 10.1210/endo-48-6-658; ROBERTSON OH, 1949, J EXP ZOOL, V110, P337, DOI 10.1002/jez.1401100303; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skold HN, 2016, INT REV CEL MOL BIO, V321, P171, DOI 10.1016/bs.ircmb.2015.09.005; STOREBAKKEN T, 1992, AQUACULTURE, V100, P209, DOI 10.1016/0044-8486(92)90372-R; Thorgaard GH, 1995, AQUACULTURE, V137, P121, DOI 10.1016/0044-8486(95)01116-1; Wagner EJ, 2006, J AQUAT ANIM HEALTH, V18, P128, DOI 10.1577/H05-039.1; Yada T, 2002, GEN COMP ENDOCR, V128, P36, DOI 10.1016/S0016-6480(02)00047-3; YAMAZAKI F, 1974, B JPN SOC SCI FISH, V40, P17	47	14	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0214034	10.1371/journal.pone.0214034	http://dx.doi.org/10.1371/journal.pone.0214034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986190	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400001
J	Renjifo, LM; Amaya-Villarreal, AM; Butchart, SHM				Miguel Renjifo, Luis; Maria Amaya-Villarreal, Angela; Butchart, Stuart H. M.			Tracking extinction risk trends and patterns in a mega-diverse country: A Red List Index for birds in Colombia	PLOS ONE			English	Article							FOREST FRAGMENTATION; CONSERVATION STATUS; COCA CULTIVATION; BIODIVERSITY; DEFORESTATION; AVAILABILITY; INDICATORS; PROGRESS; IMPACTS; POVERTY	Monitoring trends in the extinction risk of species is important for tracking conservation effectiveness. The Red List index (RLI) reflects changes in aggregate extinction risk for sets of species over time (a value of zero means that all species are extinct, a value of one means that all species are categorized as Least Concern). We calculated the first national RLI for birds in Colombia for the period 2002-2016, and disaggregated indices by ecosystems, regions, and species groups. Overall, the status of birds in Colombia has moderately deteriorated during 2002-2016, declining by 0.0000714% per year (the global RLI for birds declined by 0.0297% per year). High Andean forest, paramo, and freshwater are the ecosystems in worst condition. The two regions with the greatest avian diversity contrasted: the Andes has the lowest RLI, and the Amazon the highest. Among species groups, gamebirds, parrots, large frugivores, and forest raptors are the most threatened. Habitat loss from expansion of illicit crops and population declines from hunting were the most important threats. Agricultural expansion, invasive alien animal species, illegal logging and illegal mining are significant threats for some species. Tracking species' extinction risk is important in a country with the highest bird species richness in the world, dynamic spatial patterns of habitat loss, and high levels of endemism. Recent developments provide reasons for both hope and despair. In 2016, a peace agreement ended 50 years of armed conflict. New opportunities for biodiversity conservation, local development based on bird-watching tourism, and advancement in scientific knowledge of birds now occur alongside dramatic increases in deforestation. These new conservation opportunities and challenges provide strong motivation to take advantage of the fact that the overall risk of extinction of birds in Colombia is still relatively low and stable. Effective action is urgently needed while there still is the opportunity to prevent extinctions and safeguard species, particularly those in higher risk categories.	[Miguel Renjifo, Luis; Maria Amaya-Villarreal, Angela] Pontificia Univ Javeriana, Sch Environm & Rural Studies, Dept Ecol & Terr, Bogota, DC, Colombia; [Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, BirdLife Int, Cambridge, England	Pontificia Universidad Javeriana; BirdLife International; University of Cambridge	Renjifo, LM (corresponding author), Pontificia Univ Javeriana, Sch Environm & Rural Studies, Dept Ecol & Terr, Bogota, DC, Colombia.	lmrenjifo@javeriana.edu.co	Butchart, Stuart/AAJ-1852-2021	Butchart, Stuart/0000-0002-1140-4049; AMAYA-VILLARREAL, ANGELA MARIA/0000-0002-7099-9484; Renjifo, Luis Miguel/0000-0003-1907-2760	 [7284]		LMR. This work was made possible with funding Vice-presidency for research of Pontificia Universidad Javeriana (VRI Project number 7284).	Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; [Anonymous], 2016, AR WORLDS FOR CHANG; Arcila OH, 2011, AMAZONIA COLOMBIANA; Armenteras D, 2019, NAT ECOL EVOL, V3, P20, DOI 10.1038/s41559-018-0727-8; Armenteras D, 2013, REG ENVIRON CHANGE, V13, P1181, DOI 10.1007/s10113-013-0433-7; Armenteras D, 2011, REG ENVIRON CHANGE, V11, P693, DOI 10.1007/s10113-010-0200-y; Asociacion Colombiana de Ornitologia checklist committee, 2018, SPEC LISTS BIRDS S A; Avendano J.E., 2017, ORNITOL COLUMBIANA, V16, P1; Ayerbe F, 2018, GUIA ILUSTRADA AVIFA; Ayerbe-Quinones F, 2016, LIBRO ROJO AVES COLO, VII, P119; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P203, DOI 10.1111/geb.12093; Bibes P., 2001, J CONTEMP CRIM JUST, V17, P243, DOI DOI 10.1177/1043986201017003004; BirdLife International, 2018, IUCN RED LIST BIRDS; BirdLife International, 2018, STAT WORLDS BIRDS 20; BirdLife International, 2018, COUNTR PROF COL; Blomley Karla van Eynde Tom, 2015, EST FLUJ COM MAD ACT; Brummitt NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135152; Bubb P.J., 2009, IUCN RED LIST INDEX; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2008, BIRD CONSERV INT, V18, pS245, DOI 10.1017/S095927090800035X; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2018, BIOL CONSERV, V227, P9, DOI 10.1016/j.biocon.2018.08.014; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Castillo J, 2018, NOTAS ESTRATEGICAS; Cavelier J, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P541; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Clastornik J, 2016, 9TH INTERNATIONAL CONFERENCE ON THEORY AND PRACTICE OF ELECTRONIC GOVERNANCE (ICEGOV 2016), P64, DOI 10.1145/2910019.2910070; Davalos LM, 2014, BIOL CONSERV, V170, P64, DOI 10.1016/j.biocon.2013.12.018; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; Davalos LM, 2009, INT J DRUG POLICY, V20, P381, DOI 10.1016/j.drugpo.2008.08.007; Dion ML, 2008, J LAT AM STUD, V40, P399, DOI 10.1017/S0022216X08004380; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Duffy R, 2016, CONSERV BIOL, V30, P14, DOI 10.1111/cobi.12622; Etter A, 2008, ANN ASSOC AM GEOGR, V98, P2, DOI 10.1080/00045600701733911; Farrier D, 2007, ENVIRON SCI POLICY, V10, P219, DOI 10.1016/j.envsci.2006.12.001; Faulkner Stephen, 2004, Urban Ecosystems, V7, P89, DOI 10.1023/B:UECO.0000036269.56249.66; Feng M, 2016, REMOTE SENS ENVIRON, V184, P73, DOI 10.1016/j.rse.2016.06.012; Finer M, 2019, MAAP, V106; Fjeldsa J, 2005, AMBIO, V34, P205, DOI 10.1639/0044-7447(2005)034[0205:ICAACA]2.0.CO;2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gregory RD, 2019, ECOL INDIC, V103, P676, DOI 10.1016/j.ecolind.2019.04.064; Grima N, 2019, LAND USE POLICY, V81, P267, DOI 10.1016/j.landusepol.2018.10.056; GRUBB PJ, 1971, NATURE, V229, P44, DOI 10.1038/229044a0; Haken J., 2011, GLOBAL FINANCIAL INT, V12, P11; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hazzi NA, 2018, P NATL ACAD SCI USA, V115, P7985, DOI 10.1073/pnas.1803908115; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; HOFFMANN HJ, 2017, HETEROPTERON     MAY, P3; IDEAM, 2017, RES MON DEF 2017; IDEAM, 2018, B DET TEMPR DEF, V17; International Union for Conservation of Nature (IUCN) and BirdLife International (BLI), 2017, MET SUST DEV GOAL IN; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2003, GUID APPL IUCN RED L; Janssen R, 2011, ENERG POLICY, V39, P5717, DOI 10.1016/j.enpol.2011.01.047; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Lewis OT, 2011, J INSECT CONSERV, V15, P121, DOI 10.1007/s10841-010-9329-8; Lopez-Angarita J, 2016, FOREST ECOL MANAG, V368, P151, DOI 10.1016/j.foreco.2016.03.020; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maldonado JH, 2018, WORLD DEV, V106, P78, DOI 10.1016/j.worlddev.2018.01.015; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; McGowan PJK, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12588; McMullan M., 2018, FIELD GUIDE BIRDS CO; Renjifo Luis Miguel, 2017, Rev. acad. colomb. cienc. exact. fis. nat., V41, P490, DOI 10.18257/raccefyn.461; Mision de verificacion de la ONU, 2019, BIO AN EXP REC VID; MME-Ministerio de Minas y Energa, 2012, CENS MIN DEP 2010 20; Saiz JCM, 2015, CONSERV BIOL, V29, P910, DOI 10.1111/cobi.12437; Mosquera-Andrade DH., 2014, REV INSTITUCIONAL UN, V33, P96; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ocampo-Penuela N, 2017, TROP CONSERV SCI, V10, P1, DOI 10.1177/1940082917733862; Oficina Internacional de los Derechos Humanos Accion Colombia (OIDHACO), 2014, INF PNUD; Pardo T., 2019, PERIODICO TIEMPO; Penaranda I, 2017, PEACE ACCORD VIOLENC; Peters NE, 2000, WATER INT, V25, P185, DOI 10.1080/02508060008686817; Quayle JF, 2005, CONSERV BIOL, V19, P1306, DOI 10.1111/j.1523-1739.2005.00083.x; Regan EC, 2015, CONSERV LETT, V8, P397, DOI 10.1111/conl.12162; Renjifo LM, 1999, CONSERV BIOL, V13, P1124, DOI 10.1046/j.1523-1739.1999.98311.x; Renjifo LM, 2014, LIBRO ROJO AVES COLO, VI; Renjifo LM, 2016, LIBRO ROJO AVES COLO, VII; Renjifo LM, 2002, LIBRO ROJO AVES COLO; Ruiz AR, 2013, ECOL INDIC, V34, P103, DOI 10.1016/j.ecolind.2013.04.008; Rios MM, 2014, LIBRO ROJO AVES COLO, VI, P77; Robinson J.G., 1991, NEOTROPICAL WILDLIFE; Rodrigues ASL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113934; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rosselli L, 2012, WATERBIRDS, V35, P453, DOI 10.1675/063.035.0310; RUNAP (RegistroUnico Nacional de Areas Protegidas), 2018, RUN CIFR PARQ NAC NA; Sanchez-Cuervo AM, 2013, ECOSYSTEMS, V16, P1052, DOI 10.1007/s10021-013-9667-y; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Sarti FM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07934-200422; Schulenberg TS, 2018, NEOTROPICAL BIRDS ON; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; SIMCI-UNODC, 2018, INF MON TERR AF CULT; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; Stratford JA, 2015, BIOL CONSERV, V188, P109, DOI 10.1016/j.biocon.2015.01.017; Szabo JK, 2012, BIOL CONSERV, V148, P61, DOI 10.1016/j.biocon.2012.01.062; Themner A, 2011, ROUT STUD INTERV STA, P1; United Nations, 2018, SUST DEV GOAL REP 20, P11; United Nations, 2018, SUST DEV GOALS REP 2; Velasquez-Tibata J, 2016, LIBRO ROJO AVES COLO, P54; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Whelan CJ, 2015, J ORNITHOL, V156, pS227, DOI 10.1007/s10336-015-1229-y; Wotton SR, 2020, ORYX, V54, P62, DOI 10.1017/S0030605317001181; WWF, 2018, LIVING PLANET REPORT; Xu HG, 2009, BIOSCIENCE, V59, P843, DOI 10.1525/bio.2009.59.10.6; Young RP, 2014, BIOL CONSERV, V180, P84, DOI 10.1016/j.biocon.2014.09.039	109	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227381	10.1371/journal.pone.0227381	http://dx.doi.org/10.1371/journal.pone.0227381			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986160	Green Published, gold, Green Submitted			2022-12-26	WOS:000534603400021
J	Woo, HM; Jeong, H; Yoon, BJ				Woo, Hyun-Myung; Jeong, Hyundoo; Yoon, Byung-Jun			NAPAbench 2: A network synthesis algorithm for generating realistic protein-protein interaction (PPI) network families	PLOS ONE			English	Article							DATABASE; ALIGNMENT	Comparative network analysis provides effective computational means for gaining novel insights into the structural and functional compositions of biological networks. In recent years, various methods have been developed for biological network alignment, whose main goal is to identify important similarities and critical differences between networks in terms of their topology and composition. A major impediment to advancing network alignment techniques has been the lack of gold-standard benchmarks that can be used for accurate and comprehensive performance assessment of such algorithms. The original NAPAbench (network alignment performance assessment benchmark) was developed to address this problem, and it has been widely utilized by many researchers for the development, evaluation, and comparison of novel network alignment techniques. In this work, we introduce NAPAbench 2-a major update of the original NAPAbench that was introduced in 2012. NAPAbench 2 includes a completely redesigned network synthesis algorithm that can generate protein-protein interaction (PPI) network families whose characteristics closely match those of the latest real PPI networks. Furthermore, the network synthesis algorithm comes with an intuitive GUI that allows users to easily generate PPI network families with an arbitrary number of networks of any size, according to a flexible user-defined phylogeny. In addition, NAPAbench 2 provides updated benchmark datasets-created using the redesigned network synthesis algorithm-which can be used for comprehensive performance assessment of network alignment algorithms and their scalability.	[Woo, Hyun-Myung; Yoon, Byung-Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Jeong, Hyundoo] Incheon Natl Univ, Dept Mechatron Engn, Incheon, South Korea; [Yoon, Byung-Jun] Texas A&M Univ, TEES AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77843 USA; [Yoon, Byung-Jun] Brookhaven Natl Lab, Computat Sci Initiat, Upton, NY 11973 USA	Texas A&M University System; Texas A&M University College Station; Incheon National University; Texas A&M University System; Texas A&M University College Station; United States Department of Energy (DOE); Brookhaven National Laboratory	Yoon, BJ (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Yoon, BJ (corresponding author), Texas A&M Univ, TEES AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77843 USA.; Yoon, BJ (corresponding author), Brookhaven Natl Lab, Computat Sci Initiat, Upton, NY 11973 USA.	bjyoon@ece.tamu.edu	Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101; Woo, Hyun-Myung/0000-0002-5997-4059	National Research Foundation of Korea - Korea government (MSIT) [NRF-2019R1G1A1004803]	National Research Foundation of Korea - Korea government (MSIT)	Hyundoo Jeong was supported by the National Research Foundation of Korea (NRF: https://www.nrf.re.kr/eng/index) grant funded by the Korea government (MSIT) (NRF-2019R1G1A1004803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag AE, 2013, BIOINFORMATICS, V29, P917, DOI 10.1093/bioinformatics/btt071; Alkan F, 2014, BIOINFORMATICS, V30, P531, DOI 10.1093/bioinformatics/btt713; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; CHATRARYAMONTRI A, 2007, NUCLEIC ACIDS RES, V35, pD57, DOI DOI 10.1093/NAR/GKL950; Clark C, 2015, BIOINFORMATICS, V31, P1988, DOI 10.1093/bioinformatics/btv063; Crawford J, 2015, 2015 IEEE INT C BIOI, DOI [10.1109/2Fbibm.2015.7359684, DOI 10.1109/2FBIBM.2015.7359684]; Elmsallati A, 2018, IEEE ACM T COMPUT BI, V15, P330, DOI 10.1109/TCBB.2016.2613098; Hashemifar S, 2016, J COMPUT BIOL, V23, P903, DOI 10.1089/cmb.2016.0025; Janjic V, 2014, SCI REP-UK, V4, DOI 10.1038/srep04273; Jeong H, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; LIU M, 2017, COMBINATORIAL OPTIMI, P567, DOI DOI 10.1007/2F978-3-319-71150-8_5.; Malod-Dognin N, 2015, BIOINFORMATICS, V31, P2182, DOI 10.1093/bioinformatics/btv130; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Micale G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098750; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Mohammadi S, 2015, TRIANGULAR ALIGNMENT; Park D, 2011, NUCLEIC ACIDS RES, V39, pD295, DOI 10.1093/nar/gkq1234; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Przulj N, 2006, J R SOC INTERFACE, V3, P711, DOI 10.1098/rsif.2006.0147; Sahraeian SME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067995; Sahraeian SME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041474; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shao MY, 2014, BRIEF BIOINFORM, V15, P823, DOI 10.1093/bib/bbt014; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Sreenivasaiah PK, 2012, NUCLEIC ACIDS RES, V40, pD803, DOI 10.1093/nar/gkr1208; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tuncay EG, 2016, COMPUT BIOL CHEM, V63, P41, DOI 10.1016/j.compbiolchem.2016.03.003; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yoon BJ, 2012, IEEE SIGNAL PROC MAG, V29, P22, DOI 10.1109/MSP.2011.942819	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227598	10.1371/journal.pone.0227598	http://dx.doi.org/10.1371/journal.pone.0227598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986158	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400024
J	Bloomer, C; Wang, S; Kontson, K				Bloomer, Conor; Wang, Sophie; Kontson, Kimberly			Kinematic analysis of motor learning in upper limb body-powered bypass prosthesis training	PLOS ONE			English	Article							WHEELCHAIR; MOVEMENTS; USERS; ARM; RECOVERY; AMPUTEES; JERK; PAIN	Motor learning and compensatory movement are important aspects of prosthesis training yet relatively little quantitative evidence supports our current understanding of how motor control and compensation develop in the novel body-powered prosthesis user. The goal of this study is to assess these aspects of prosthesis training through functional, kinematic, and kinetic analyses using a within-subject paradigm compared across two training time points. The joints evaluated include the left and right shoulders, torso, and right elbow. Six abled-bodied subjects (age 27 +/- 3) using a body-powered bypass prosthesis completed the Jebsen-Taylor Hand Function Test and the targeted Box and Blocks Test after five training sessions and again after ten sessions. Significant differences in movement parameters included reduced times to complete tasks, reduced normalized jerk for most joints and tasks, and more variable changes in efficiency and compensation parameters for individual tasks and joints measured as range of motion, maximum angle, and average moment. Normalized jerk, joint specific path length, range of motion, maximum angle, and average moment are presented for the first time in this unique training context and for this specific device type. These findings quantitatively describe numerous aspects of motor learning and control in able-bodied subjects that may be useful in guiding future rehabilitation and training of body-powered prosthesis users.	[Bloomer, Conor; Wang, Sophie; Kontson, Kimberly] US FDA, Div Biomed Phys, Silver Spring, MD 20993 USA; [Wang, Sophie] Univ Maryland, Dept Bioengn, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park	Kontson, K (corresponding author), US FDA, Div Biomed Phys, Silver Spring, MD 20993 USA.	Kimberly.Kontson@fda.hhs.gov		Wang, Sophie/0000-0003-1439-9203; KONTSON, KIMBERLY/0000-0002-4978-6011	DARPA-BTO [IAA 224-14-6009]; FDA Critical Path Initiative [CPOSEL13]	DARPA-BTO; FDA Critical Path Initiative	This work was funded in part by an interagency agreement with DARPA-BTO (IAA 224-14-6009), and by the FDA Critical Path Initiative (CPOSEL13). Authors CB and SW were on both funds throughout the course of this work. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, UPP BOD MOD PLUG IN; [Anonymous], 1999, DET UPP LIMB KIN DYN; Atkins DJ, 1989, ADULT UPPER LIMB PRO, P39; Bernshtein NA, 1967, COORDINATION REGULAT; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Bloomer CWS, 2018, PHYS MED REHABILITAT; Bouwsema H, 2014, J NEUROENGINEERING R; Carey SL, 2008, CLIN BIOMECH, V23, P1128, DOI 10.1016/j.clinbiomech.2008.05.008; Chang JJ, 2007, ARCH PHYS MED REHAB, V88, P1332, DOI 10.1016/j.apmr.2007.07.016; Choi A, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-20; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Colombo R, 2008, NEUROREHAB NEURAL RE, V22, P50, DOI 10.1177/1545968307303401; Cowley J, 2017, PROSTHET ORTHOT INT, V41, P33, DOI 10.1177/0309364616631348; Cutti AG, 2005, GAIT POSTURE, V21, P341, DOI 10.1016/j.gaitpost.2004.04.001; Davids JR, 2006, J BONE JOINT SURG AM, V88A, P1294, DOI 10.2106/JBJS.E.00982; Egermann M, 2009, INT ORTHOP, V33, P1101, DOI 10.1007/s00264-008-0615-y; Freddolini M, 2018, J BIOMECH, V72, P46, DOI 10.1016/j.jbiomech.2018.02.021; Haubert LL, 2020, J SPINAL CORD MED, V43, P594, DOI 10.1080/10790268.2019.1570436; Huinink LHB, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0197-7; Jayaraman C, 2015, J BIOMECH, V48, P3937, DOI 10.1016/j.jbiomech.2015.09.018; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kloosterman MGM, 2015, MED ENG PHYS, V37, P961, DOI 10.1016/j.medengphy.2015.07.004; Kontson K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177965; Kontson KL, 2017, IEEE T NEUR SYS REH, V25, P1874, DOI 10.1109/TNSRE.2017.2693234; Kontson KL, J HAND THERAPY; Kristianslund E, 2014, J BIOMECH, V47, P193, DOI 10.1016/j.jbiomech.2013.09.016; Levin MF, 2016, NEUROREHAB NEURAL RE, V30, P635, DOI 10.1177/1545968315613863; Li JW, 2016, TECHNOL HEALTH CARE, V24, pS707, DOI 10.3233/THC-161199; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; Muratori LM, 2013, J HAND THER, V26, P94, DOI 10.1016/j.jht.2012.12.007; Murphy MA, 2015, PHYS THERAPY REV, V20; Ostlie K, 2012, DISABIL REHABIL-ASSI, V7, P479, DOI 10.3109/17483107.2011.653296; Ostlie K, 2012, DISABIL REHABIL-ASSI, V7, P294, DOI 10.3109/17483107.2011.635405; Ostlie K, 2011, ARCH PHYS MED REHAB, V92, P1967, DOI 10.1016/j.apmr.2011.06.026; Postema SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049727; Resnik LJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191326; Schwarz A, 2019, STROKE; Shishov N, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00082; SILCOX DH, 1993, J BONE JOINT SURG AM, V75A, P1781, DOI 10.2106/00004623-199312000-00007; Stagni RF, 2005, GAIT POSTURE, V21, P341; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Thies SB, 2017, MED ENG PHYS, V47, P137, DOI 10.1016/j.medengphy.2017.03.010; Tsai CY, 2018, CLIN BIOMECH, V55, P79, DOI 10.1016/j.clinbiomech.2018.04.008; VA/DoD, 2014, MAN UPP EXTR AMP REH; Yan JH, 2000, J APPL BIOMECH, V16, P196, DOI 10.1123/jab.16.2.196	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226563	10.1371/journal.pone.0226563	http://dx.doi.org/10.1371/journal.pone.0226563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978051	gold, Green Published			2022-12-26	WOS:000534599100017
J	Bono, MS; Beasley, S; Hanhauser, E; Hart, AJ; Karnik, R; Vaishnav, C				Bono, Michael S., Jr.; Beasley, Sydney; Hanhauser, Emily; Hart, A. John; Karnik, Rohit; Vaishnav, Chintan			Fieldwork-based determination of design priorities for point-of-use drinking water quality sensors for use in resource-limited environments	PLOS ONE			English	Article							DISCRETE-CHOICE EXPERIMENTS; FECAL CONTAMINATION; CONJOINT-ANALYSIS; ESCHERICHIA-COLI; LOW-COST; TESTS; BEHAVIOR; GALACTOSIDASE; REQUIREMENTS; DIAGNOSTICS	Improved capabilities in microfluidics, electrochemistry, and portable assays have resulted in the development of a wide range of point-of-use sensors intended for environmental, medical, and agricultural applications in resource-limited environments of developing countries. However, these devices are frequently developed without direct interaction with their often-remote intended user base, creating the potential for a disconnect between users' actual needs and those perceived by sensor developers. As different analytical techniques have inherent strengths and limitations, effective measurement solution development requires determination of desired sensor attributes early in the development process. In this work, we present our findings on design priorities for point-of-use microbial water sensors based on fieldwork in rural India, as well as a guide to fieldwork methodologies for determining desired sensor attributes. We utilized group design workshops for initial identification of design priorities, and then conducted choice-based conjoint analysis interviews for quantification of user preferences among these priorities. We found the highest user preference for integrated reporting of contaminant concentration and recommended actions, as well as significant preferences for mostly reusable sensor architectures, same-day results, and combined ingredients. These findings serve as a framework for future microbial sensor development and a guide for fieldwork-based understanding of user needs.	[Bono, Michael S., Jr.; Hanhauser, Emily; Hart, A. John; Karnik, Rohit] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Bono, Michael S., Jr.; Beasley, Sydney; Hanhauser, Emily; Vaishnav, Chintan] MIT, Tata Ctr Technol & Design, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Beasley, Sydney] MIT, Technol & Policy Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Beasley, Sydney] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA; [Vaishnav, Chintan] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bono, MS (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Bono, MS; Vaishnav, C (corresponding author), MIT, Tata Ctr Technol & Design, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vaishnav, C (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msb294@cornell.edu; chintanv@mit.edu	Hart, A. John/A-9027-2010; Vaishnav, Chintan/AAH-7717-2021	Hart, A. John/0000-0002-7372-3512; Vaishnav, Chintan/0000-0002-1153-8880; Bono, Michael/0000-0002-6969-1300	Tata Center for Technology and Design at MIT; Abdul Latif Jameel Water and Food Security Lab (J-WAFS) at MIT; Tata Trusts; Tata Center; J-WAFS; Mohammed Abdul Latif Jameel	Tata Center for Technology and Design at MIT; Abdul Latif Jameel Water and Food Security Lab (J-WAFS) at MIT; Tata Trusts; Tata Center(Tata Institute of Fundamental Research (TIFR)); J-WAFS; Mohammed Abdul Latif Jameel	This research was supported by the Tata Center for Technology and Design at MIT (https://tatacenter.mit.edu/), which was funded with generous support from the Tata Trusts. Travel for EH was funded by the Abdul Latif Jameel Water and Food Security Lab (J-WAFS) at MIT (https://jwafs.mit.edu/), which was funded with generous support from Mohammed Abdul Latif Jameel. Both Tata Center and J-WAFS funding was awarded to CV, RK, and AJH. Employees of the Tata Trusts assisted with arranging travel logistics and stakeholder engagement activities, and employees of the Himmotthan Society, an associate organization of Tata Trusts, assisted with recruitment and translation for the conjoint analysis interviews. Other than the aforementioned assistance, the funders had no role in data collection, and the funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The views and conclusions expressed in this article are solely those of the authors, and do not represent the views of the funders for this work.	Albert DR, 2012, J CHEM EDUC, V89, P1432, DOI 10.1021/ed200829d; Annala L, 2016, STREAMLINING METHODO; [Anonymous], 2012, 10500 IS; [Anonymous], 1981, 1622 IS; Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030; Bain R, 2012, INT J ENV RES PUB HE, V9, P1609, DOI 10.3390/ijerph9051609; Barbosa AI, 2015, BIOSENS BIOELECTRON, V70, P5, DOI 10.1016/j.bios.2015.03.006; Beasley SB, 2018, IMPLEMENTING WATER S; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bono MS, 2017, U.S. PCT Patent Application, Patent No. [PCT/US2017/057265, 2017057265]; Braganza S, 2016, POINT OF USE SOIL DI; BROOKS D, 1979, WATER RES, V13, P33, DOI 10.1016/0043-1354(79)90251-3; Brown J, 2017, J ENVIRON ECON MANAG, V86, P141, DOI 10.1016/j.jeem.2016.08.005; Burnet JB, 2019, WATER RES, V152, P241, DOI 10.1016/j.watres.2018.12.060; Crocker J, 2014, INT J ENV RES PUB HE, V11, P7333, DOI 10.3390/ijerph110707333; Davis C., 2003, ARSENIC EXPOSURE HLT, VV; de Bekker-Grob EW, 2015, PATIENT, V8, P373, DOI 10.1007/s40271-015-0118-z; Delaire C, 2017, ENVIRON SCI TECHNOL, V51, P5869, DOI 10.1021/acs.est.6b06442; Department of Drinking Water and Sanitation, 2011, STRAT PLAN 2011 2022; Derda R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003676; Derda R, 2013, ANAL CHEM, V85, P7213, DOI 10.1021/ac400961b; Farber S, 2000, ENVIRON SCI TECHNOL, V34, P1407, DOI 10.1021/es990727r; Gautam A., 2019, WATER SECURITY SANIT; GORCHEV HG, 1984, WHO CHRON, V38, P104; GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756; Gunda NSK, 2019, J ELECTROCHEM SOC, V166, pB3031, DOI 10.1149/2.0081909jes; Gunda NSK, 2016, ANALYST, V141, P2920, DOI [10.1039/C6AN00400H, 10.1039/c6an00400h]; Gunda NSK, 2014, ANAL METHODS, V6, P6139; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; Hamoudi A, 2012, AM J TROP MED HYG, V87, P18, DOI 10.4269/ajtmh.2012.12-0051; Hinkley TC, 2018, ANALYST, V143, P4074, DOI [10.1039/c8an00781k, 10.1039/C8AN00781K]; Hui R, 2019, GEOFORUM, V102, P255, DOI 10.1016/j.geoforum.2018.01.008; Indian Council of Medical Research, 2017, NAT ETH GUID BIOM HL; Jalan J, 2008, J DEV ECON, V87, P14, DOI 10.1016/j.jdeveco.2007.10.002; Jaworska E, 2014, ANALYST, V139, P6010, DOI 10.1039/c4an01277a; Jiang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04137; Jokerst JC, 2012, ANAL CHEM, V84, P2900, DOI 10.1021/ac203466y; Kessels R, 2011, J CHOICE MODEL, V4, P52, DOI 10.1016/S1755-5345(13)70042-3; Khan AA, 2014, J HAZARD MATER, V264, P84, DOI 10.1016/j.jhazmat.2013.10.061; Kosack CS, 2017, B WORLD HEALTH ORGAN, V95, P639, DOI 10.2471/BLT.16.187468; Kronimus A, 2004, WATER RES, V38, P3473, DOI 10.1016/j.watres.2004.04.054; Kumar AA, 2015, ANGEW CHEM INT EDIT, V54, P5835, DOI 10.1002/anie.201411741; Laczka O, 2010, ANAL CHIM ACTA, V677, P156, DOI 10.1016/j.aca.2010.08.001; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Louviere JJ, 1988, ANAL DECISION MAKING, V67; Lovecraft AL, 2013, POLAR GEOGR, V36, P105, DOI 10.1080/1088937X.2012.733893; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; MANJA KS, 1982, B WORLD HEALTH ORGAN, V60, P797; Mbuya MNN, 2015, CLIN INFECT DIS, V61, pS703, DOI 10.1093/cid/civ845; Medecins du Monde, 2011, THE KAP SURVEY MODEL; Midstokke PK, 2018, ADAPTING HAZARDS RIS; Mosler HJ, 2012, INT J ENVIRON HEAL R, V22, P431, DOI 10.1080/09603123.2011.650156; Murcott S, 2015, PROCEDIA ENGINEER, V107, P237, DOI 10.1016/j.proeng.2015.06.078; Nie ZH, 2010, LAB CHIP, V10, P3163, DOI [10.1039/c0lc00237b, 10.1039/c01c00237b]; O'Toole M, 2008, SENSORS-BASEL, V8, P2453, DOI 10.3390/s8042453; Park TS, 2015, IEEE SENS J, V15, P1902, DOI 10.1109/JSEN.2014.2367039; Peal A., 2010, HYGIENE SANITATION S; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1522, 10.1038/nrmicro1568, 10.1038/nrmico1522]; Poulos C, 2012, SOC SCI MED, V75, P738, DOI 10.1016/j.socscimed.2012.02.059; Rodriguez NM, 2015, ANAL CHEM, V87, P7872, DOI 10.1021/acs.analchem.5b01594; Rosenberg R, 2016, SCREEN PRINTED ION S; Rosenberg R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203862; Ryzinska-Paier G, 2014, WATER SCI TECHNOL, V69, P1349, DOI 10.2166/wst.2014.032; Schriewer A, 2015, AM J TROP MED HYG, V93, P509, DOI 10.4269/ajtmh.14-0824; Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep09919; Simon KP., 2015, APPL DESIGN VALUE DI; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Song YJ, 2014, ANAL CHEM, V86, P1575, DOI 10.1021/ac403196b; Stephenson D, 2016, APPL SPECTROSC, V70, P874, DOI 10.1177/0003702816638292; Trent M, 2018, ENVIRON SCI TECHNOL, V52, P5319, DOI 10.1021/acs.est.8b00035; Tryland I, 1998, APPL ENVIRON MICROB, V64, P1018; UNICEF, 2015, PROGR SAN DRINK WAT; Vaishnav C, 2017, 35 INT C SYST DYN SE; Wescoat JL, 2016, WATER POLICY, V18, P1015, DOI 10.2166/wp.2016.158; Whitmore GA, 1974, DECISION SCI, V5, P614, DOI [10.1111/j.1540-5915.1974.tb00641.x, DOI 10.1111/J.1540-5915.1974.TB00641.X]; WHO, 2002, RED RISKS PROM HLTH; World Health Organization, 2008, ADVOCACY COMMUNICATI; Wright JA, 2012, TROP MED INT HEALTH, V17, P94, DOI 10.1111/j.1365-3156.2011.02887.x; Yamada K, 2017, LAB CHIP, V17, P1206, DOI 10.1039/c6lc01577h; Zysk AM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793736	82	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228140	10.1371/journal.pone.0228140	http://dx.doi.org/10.1371/journal.pone.0228140			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978158	Green Published, gold, Green Submitted			2022-12-26	WOS:000534599100114
J	Chamard, C; Daien, V; Han, H; Greenfield, DS; Villain, M				Chamard, Chloe; Daien, Vincent; Han, Hyosun; Greenfield, David S.; Villain, Max			Efficacy and safety of ultrasonic circular cyclocoagulation with second-generation probe in glaucoma: A retrospective study	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; OPEN-ANGLE GLAUCOMA; THERAPEUTIC ULTRASOUND; DEVICE; TRIAL	Background To assess the efficacy and safety of the second-generation probe of ultrasonic circular cyclocoagulation (UC3) in naive or refractory glaucoma, with a 6-month follow-up. Methods A retrospective consecutive case-series study included patients having a UC3 procedure with the second-generation probe of the EyeOP1 device, intraocular pressure (IOP). 21 mmHg and under maximum tolerated medical treatment, with or without previous glaucoma surgery. Surgical success was defined at the 6-month post-operative visit as IOP > 5 and. 21 mmHg with IOP reduction. 20% from baseline, without any reoperation, and visual acuity better than negative light perception. Results 100 patients were included and 97 (97.0%; 97 eyes) attended the 6-month follow-up. At 6 months, surgical success was obtained in 48 eyes (49.5%). Intraocular pressure was reduced from a mean +/- SD preoperative value of 28.0 +/- 5.6 mmHg to 19.3 +/- 7.1 mmHg at 6 months (p< 0.0001). The proportion of eyes requiring oral acetazolamide decreased from 57.0% to 30.0% between baseline and 6 months after surgery (p = 0.0007). We observed 15 (15.0%) cases of postsurgical macular edema, 8 (8.0%) of hypotony, and 20 (20.0%) of visual acuity loss > 2 Snellen lines. Postsurgical macular edema was associated with a history of epiretinal membranes, uveitis or retinal detachment. Risk factors for hypotony were a history of diabetes or trabeculectomy. Conclusions The second-generation UC3 probe significantly reduced IOP in eyes with naive and refractory glaucoma but severe post-operative complications were often observed. Further studies are needed to better identify responders and decrease the high risk for complications associated with the procedure.	[Chamard, Chloe; Daien, Vincent; Han, Hyosun; Villain, Max] Gui de Chauliac Hosp, Dept Ophthalmol, Montpellier, France; [Daien, Vincent] INSERM, Montpellier, France; [Daien, Vincent] Univ Sydney, Sydney Med Sch, Save Sight Inst, Sydney, NSW, Australia; [Greenfield, David S.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Palm Beach Gardens, FL USA	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Sydney; Bascom Palmer Eye Institute	Chamard, C (corresponding author), Gui de Chauliac Hosp, Dept Ophthalmol, Montpellier, France.	chloe.chamard@gmail.com	Chamard, Chloe/Z-1728-2019	Chamard, Chloe/0000-0003-0501-1932				Aptel F, 2016, ACTA OPHTHALMOL, V94, pe268, DOI [10.1111/aos.12913, 10.1111/j.1755-3768.2016.0447]; Aptel F, 2014, CURR MED RES OPIN, V30, P1599, DOI 10.1185/03007995.2014.910509; Aptel F, 2011, INVEST OPHTH VIS SCI, V52, P8747, DOI 10.1167/iovs.11-8137; Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P5092, DOI 10.1167/iovs.09-5135; BURGESS SEP, 1986, OPHTHALMOLOGY, V93, P831; CAPRIOLI J, 1985, OPHTHALMOLOGY, V92, P947; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Charrel T, 2011, ULTRASOUND MED BIOL, V37, P742, DOI 10.1016/j.ultrasmedbio.2011.01.017; COLEMAN DJ, 1985, OPHTHALMOLOGY, V92, P347; Dastiridou AI, 2018, ADV THER, V35, P2103, DOI 10.1007/s12325-018-0837-3; Deb-Joardar N, 2018, INDIAN J OPHTHALMOL, V66, P517, DOI 10.4103/ijo.IJO_1024_17; Denis P, 2015, INVEST OPHTH VIS SCI, V56, P1089, DOI 10.1167/iovs.14-14973; Dunphy E B, 1941, Trans Am Ophthalmol Soc, V39, P193; Emanuel ME, 2017, J GLAUCOMA, V26, P726, DOI 10.1097/IJG.0000000000000715; European Glaucoma society terminology and guidelines for glaucoma, 2017, BRIT J OPHTHALMOL, V101, P130, DOI [10.1136/bjophthalmol-2016-egsguideline.003, DOI 10.1136/BJOPHTHALMOL-2016-EGSGUIDELINE.003]; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P804, DOI 10.1016/j.ajo.2011.10.024; Giannaccare G, 2017, GRAEF ARCH CLIN EXP, V255, P599, DOI 10.1007/s00417-016-3563-z; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hodapp E, 1993, CLIN DECISIONS GLAUC; Huang GF, 2012, DEV OPHTHALMOL, V50, P173, DOI 10.1159/000334800; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Mastropasqua R, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7136275; Melamed S, 2015, EUR J OPHTHALMOL, V25, P483, DOI 10.5301/ejo.5000620; Ndulue JK, 2018, J OPHTHAL VIS RES, V13, P55, DOI 10.4103/jovr.jovr_190_17; Shaarawy T., 2009, GUIDELINES DESIGN RE; SILVERMAN RH, 1991, AM J OPHTHALMOL, V111, P327, DOI 10.1016/S0002-9394(14)72318-9; STERK CC, 1989, GRAEF ARCH CLIN EXP, V227, P36, DOI 10.1007/BF02169822; von Elm E, 2008, GAC SANIT, V22, P144, DOI 10.1157/13119325	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227389	10.1371/journal.pone.0227389	http://dx.doi.org/10.1371/journal.pone.0227389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978165	Green Published, gold			2022-12-26	WOS:000534599100036
J	Chung, YW; Gwak, HJ; Moon, S; Rho, M; Ryu, JH				Chung, Youn Wook; Gwak, Ho-Jin; Moon, Sungmin; Rho, Mina; Ryu, Ji-Hwan			Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses	PLOS ONE			English	Article							GENE-EXPRESSION; XENOBIOTICS; ALIGNMENT; CATALOG	Background Microbial communities of the mouse gut have been extensively studied; however, their functional roles and regulation are yet to be elucidated. Metagenomic and metatranscriptomic analyses may allow us a comprehensive profiling of bacterial composition and functions of the complex gut microbiota. The present study aimed to investigate the active functions of the microbial communities in the murine cecum by analyzing both metagenomic and metatranscriptomic data on specific bacterial species within the microbial communities, in addition to the whole microbiome. Results Bacterial composition of the healthy mouse gut microbiome was profiled using the following three different approaches: 16S rRNA-based profiling based on amplicon and shotgun sequencing data, and genome-based profiling based on shotgun sequencing data. Consistently, Bacteroidetes, Firmicutes, and Deferribacteres emerged as the major phyla. Based on NCBI taxonomy, Muribaculaceae, Lachnospiraceae, and Deferribacteraceae were the predominant families identified in each phylum. The genes for carbohydrate metabolism were upregulated in Muribaculaceae, while genes for cofactors and vitamin metabolism and amino acid metabolism were upregulated in Deferribacteraceae. The genes for translation were commonly enhanced in all three families. Notably, combined analysis of metagenomic and metatranscriptomic sequencing data revealed that the functions of translation and metabolism were largely upregulated in all three families in the mouse gut environment. The ratio of the genes in the metagenome and their expression in the metatranscriptome indicated higher expression of carbohydrate metabolism in Muribaculum, Duncaniella, and Mucispirillum. Conclusions We demonstrated a fundamental methodology for linking genomic and transcriptomic datasets to examine functional activities of specific bacterial species in a complicated microbial environment. We investigated the normal flora of the mouse gut using three different approaches and identified Muribaculaceae, Lachnospiraceae, and Deferribacteraceae as the predominant families. The functional distribution of these families was reflected in the entire microbiome. By comparing the metagenomic and metatranscriptomic data, we found that the expression rates differed for different functional categories in the mouse gut environment. Application of these methods to track microbial transcription in individuals over time, or before and after administration of a specific stimulus will significantly facilitate future development of diagnostics and treatments.	[Chung, Youn Wook] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea; [Chung, Youn Wook; Moon, Sungmin; Ryu, Ji-Hwan] Yonsei Univ, Severance Biomed Sci Inst, Seoul, South Korea; [Gwak, Ho-Jin; Rho, Mina] Hanyang Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Moon, Sungmin; Ryu, Ji-Hwan] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea; [Rho, Mina] Hanyang Univ, Dept Biomed Informat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Hanyang University; Yonsei University; Yonsei University Health System; Hanyang University	Ryu, JH (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Seoul, South Korea.; Rho, M (corresponding author), Hanyang Univ, Dept Comp Sci & Engn, Seoul, South Korea.; Rho, M (corresponding author), Hanyang Univ, Dept Biomed Informat, Seoul, South Korea.	minarho@hanyang.ac.kr; yjh@yuhs.ac		Chung, Youn Wook/0000-0002-4382-1410; Gwak, Ho-Jin/0000-0001-7765-0827	Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017M3A9F3041229, 2017M3A9F3041232]	Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017M3A9F3041229 to J.-H.R.), (2017M3A9F3041232 to M.R.).	Benitez-Paez A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-311; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Corridoni D, 2017, MUCOSAL IMMUNOL, V10, P971, DOI 10.1038/mi.2016.98; Daniel SG, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00065-17; Duran-Pinedo AE, 2015, APPL ENVIRON MICROB, V81, P6688, DOI 10.1128/AEM.01782-15; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; He SM, 2010, ENVIRON MICROBIOL, V12, P1205, DOI 10.1111/j.1462-2920.2010.02163.x; Hibberd MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4069; Hugenholtz F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194066; Jenior ML, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00261-18, 10.1128/msphere.00261-18]; Jiang Y, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0146-x; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Just S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0510-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Shih-Wei, 2016, PLoS One, V11, pe0159066, DOI 10.1371/journal.pone.0159066; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Petersen LM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0320-4; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Schwab C, 2014, MICROB BIOTECHNOL, V7, P347, DOI 10.1111/1751-7915.12126; Solbiati J, 2018, J DENT RES, V97, P492, DOI 10.1177/0022034518761644; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Ursell LK, 2013, CELL METAB, V17, P317, DOI 10.1016/j.cmet.2013.02.013; Velmurugan G, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1134-6; Versluis D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11981; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Xiong XJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0327-x; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016; Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3	43	40	44	9	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227886	10.1371/journal.pone.0227886	http://dx.doi.org/10.1371/journal.pone.0227886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978162	Green Published, gold			2022-12-26	WOS:000534599100073
J	Lumngwena, EN; Abrahams, B; Shuping, L; Cicala, C; Arthos, J; Woodman, Z				Lumngwena, Evelyn Ngwa; Abrahams, Bianca; Shuping, Liliwe; Cicala, Claudia; Arthos, James; Woodman, Zenda			Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; DC-SIGN; GENITAL-TRACT; EXPRESSING CELLS; TRANS-INFECTION; BINDING; TRANSMITTED/FOUNDER; IDENTIFICATION; GLYCOPROTEIN	Envelope (Env) phenotype(s) that provide transmitted founders (TF) with a selective advantage during HIV-1 transmission would be the ideal target for preventative therapy. We generated Env clones from four individuals infected with a single virus and one participant infected with multiple variants at transmission and compared phenotype with matched Envs from chronic infection (CI). When we determined whether pseudovirus (PSV) of the five TF and thirteen matched CI Env clones differed in their ability to 1) enter TZM-bl cells, 2) bind DC-SIGN, and 3) trans-infect CD4+ cells there was no association between time post-infection and variation in Env phenotype. However, when we compared the ability of PSV to induce monocyte-derived dendritic cells (MDDCs) to secrete Interleukin-10 (IL-10), we found that only TF Envs from single variant transmission cases induced MDDCs to secrete either higher or similar levels of IL-10 as the CI clones. Furthermore, interaction between MDDC DC-SIGN and Env was required for secretion of IL-10. When variants were grouped according to time post-infection, TF PSV induced the release of higher levels of IL-10 than their CI counterparts although this relationship varied across MDDC donors. The selection of variants during transmission is therefore likely a complex event dependent on both virus and host genetics. Our findings suggest that, potentially due to overall variation in N-glycosylation across variants, nuanced differences in binding of TF Env to DC-SIGN might trigger alternative DC immune responses (IRs) in the female genital tract (FGT) that favour HIV-1 survival and facilitate transmission.	[Lumngwena, Evelyn Ngwa] Univ Cape Town, Fac Hlth Sci, Dept Med, Cape Town, South Africa; [Lumngwena, Evelyn Ngwa] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Lumngwena, Evelyn Ngwa] Minist Sci Res & Innovat MINRESI, Inst Med Res & Med Plants Studies IMPM, Yaounde, Cameroon; [Abrahams, Bianca; Woodman, Zenda] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Cape Town, South Africa; [Shuping, Liliwe] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Cicala, Claudia; Arthos, James] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Cape Town; University of Cape Town; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lumngwena, EN (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Cape Town, South Africa.; Lumngwena, EN (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Lumngwena, EN (corresponding author), Minist Sci Res & Innovat MINRESI, Inst Med Res & Med Plants Studies IMPM, Yaounde, Cameroon.; Woodman, Z (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Cape Town, South Africa.	lumngwena@yahoo.co.uk; Zl.woodman@uct.ac.za	Lumngwena, Evelyn Ngwa/AAK-4163-2021	Lumngwena, Evelyn Ngwa/0000-0002-9302-8218	National Research Foundation [TTK20100723000013129]; Poliomyelitis Research Foundation [13/25]; Carnegie Corporation 'Developing the Next Generation of Academics' Fellowship; HIV Research Trust Scholarship; Journal of Cell Science (Company of Biologists) Travelling Fellowship; National Research Foundation; Poliomyelitis Research Foundation bursaries of South Africa	National Research Foundation; Poliomyelitis Research Foundation; Carnegie Corporation 'Developing the Next Generation of Academics' Fellowship; HIV Research Trust Scholarship; Journal of Cell Science (Company of Biologists) Travelling Fellowship; National Research Foundation; Poliomyelitis Research Foundation bursaries of South Africa	ZW was funded by a TTK20100723000013129 grant from the National Research Foundation and a 13/25 grant from the Poliomyelitis Research Foundation. Any opinion, finding and conclusion or recommendation expressed in this material is that of the author(s) and the NRF does not accept any liability in this regard. EN was funded by a Carnegie Corporation 'Developing the Next Generation of Academics' Fellowship, HIV Research Trust Scholarship, Journal of Cell Science (Company of Biologists) Travelling Fellowship, National Research Foundation and Poliomyelitis Research Foundation bursaries of South Africa. For all funded individuals the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Alexandre KB, 2012, VIROLOGY, V423, P175, DOI 10.1016/j.virol.2011.12.001; Anthony C, 2017, J VIROL, V91, DOI 10.1128/JVI.00828-17; Bebell LM, 2008, J INFECT DIS, V198, P710, DOI 10.1086/590503; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buchbinder Susan, 2009, Top HIV Med, V17, P37; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; den Dunnen J, 2009, CANCER IMMUNOL IMMUN, V58, P1149, DOI 10.1007/s00262-008-0615-1; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; He Q, 2005, J IMMUNOL, V174, P4860, DOI 10.4049/jimmunol.174.8.4860; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Hong PWP, 2007, J VIROL, V81, P8325, DOI 10.1128/JVI.01765-06; Howard C. J., 2004, Animal Health Research Reviews, V5, P1, DOI [10.1079/AHRR200464, 10.1079/AHR200468]; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Levast B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174550; Liao CF, 2011, AIDS RES HUM RETROV, V27, P831, DOI [10.1089/AID.2010.0215, 10.1089/aid.2010.0215]; Lumngwena EN, 2019, BMC RES NOTES, P1, DOI [10.1186/s13104-018-4038-6, DOI 10.1186/S13104-018-4038-6]; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Masson L, 2014, SEX TRANSM INFECT, V90, P580, DOI 10.1136/sextrans-2014-051601; McDonald D, 2010, VIRUSES-BASEL, V2, P1404, DOI 10.3390/v2081704; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Nabatov AA, 2006, FEBS J, V273, P4944, DOI 10.1111/j.1742-4658.2006.05491.x; Nasi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00244; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Perona-Wright G, 2006, EUR J IMMUNOL, V36, P2367, DOI 10.1002/eji.200535722; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Sagar M, 2010, J INFECT DIS, V202, pS289, DOI 10.1086/655656; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schmidt SV, 2012, FRONT IMMUNOL, V3, P1, DOI DOI 10.3389/FLMMU.2012.00274; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; van Kooyk Y, 2004, CURR OPIN IMMUNOL, V16, P488, DOI 10.1016/j.coi.2004.05.010; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu Li, 2004, Retrovirology, V1, P14, DOI 10.1186/1742-4690-1-14	67	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227533	10.1371/journal.pone.0227533	http://dx.doi.org/10.1371/journal.pone.0227533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978062	Green Published, gold			2022-12-26	WOS:000534599100042
J	Norris, MH; Zincke, D; Leiser, OP; Kreuzer, H; Hadfied, TL; Blackburn, JK				Norris, Michael H.; Zincke, Diansy; Leiser, Owen P.; Kreuzer, Helen; Hadfied, Ted L.; Blackburn, Jason K.			Laboratory strains of Bacillus anthracis lose their ability to rapidly grow and sporulate compared to wildlife outbreak strains	PLOS ONE			English	Article							EXPRESSION	Bacillus anthracis is the causative agent of anthrax in animals and humans. The organism lies in a dormant state in the soil until introduced into an animal via, ingestion, cutaneous inoculation or inhalation. Once in the host, spores germinate into rapidly growing vegetative cells elaborating toxins. When animals die of anthrax, vegetative bacteria sporulate upon nutrient limitation in the carcass or soil while in the presence of air. After release into the soil environment, spores form a localized infectious zone (LIZ) at and around the carcass. Laboratory strains of B. anthracis produce fewer proteins associated with growth and sporulation compared to wild strains isolated from recent zoonotic disease events. We verified wild strains grow more rapidly than lab strains demonstrating a greater responsiveness to nutrient availability. Sporulation was significantly more rapid in these wild strains compared to lab strains, indicating wild strains are able to sporulate faster due to nutrient limitation while laboratory strains have a decrease in the speed at which they utilize nutrients and an increase in time to sporulation. These findings have implications for disease control at the LIZ as well as on the infectious cycle of this dangerous zoonotic pathogen.	[Norris, Michael H.; Zincke, Diansy; Hadfied, Ted L.; Blackburn, Jason K.] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA; [Norris, Michael H.; Zincke, Diansy; Hadfied, Ted L.; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Leiser, Owen P.; Kreuzer, Helen] Pacific Northwest Natl Lab, Chem & Biol Signature Sci, Richland, WA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Blackburn, JK (corresponding author), Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA.; Blackburn, JK (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	jkblackburn@ufl.edu	Blackburn, Jason/AAV-9445-2020; Leiser, Owen/ABA-8089-2021	Blackburn, Jason/0000-0003-0928-4831; Norris, Michael/0000-0002-5285-0432	Emerging Pathogens Institute at the University of Florida	Emerging Pathogens Institute at the University of Florida	This study was funded by the Emerging Pathogens Institute at the University of Florida startup funds to M.H.N. and J.K.B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2012, VECTOR-BORNE ZOONOT, V12, P1005, DOI 10.1089/vbz.2012.0987; [Anonymous], 2008, INF NC B PIK USNL M; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Blackburn JK, 2014, VECTOR-BORNE ZOONOT, V14, P576, DOI 10.1089/vbz.2013.1538; Blackburn JK, 2014, J WILDLIFE DIS, V50, P393, DOI 10.7589/2013-08-204; Blackburn JK, 2013, J WILDLIFE DIS, V49, P699, DOI 10.7589/2012-10-253; Carlson CJ, 2019, NAT MICROBIOL, V4, P1337, DOI 10.1038/s41564-019-0435-4; Carlson CJ, 2018, BIOL REV, V93, P1813, DOI 10.1111/brv.12420; DAVIES D. G., 1960, JOUR HYG, V58, P177; Dragon DC, 2001, LETT APPL MICROBIOL, V33, P100, DOI 10.1046/j.1472-765x.2001.00966.x; Halvorson Harlyn O., 1997, Microbiologia (Madrid), V13, P131; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Leiser OP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209120; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; MANCHEE RJ, 1981, NATURE, V294, P254, DOI 10.1038/294254a0; Mignot T, 2002, MOL MICROBIOL, V43, P1615, DOI 10.1046/j.1365-2958.2002.02852.x; MINETT FC, 1950, J COMP PATHOL THERAP, V60, P161, DOI 10.1016/S0368-1742(50)80016-4; Mullins J, 2013, COMBINING GENETIC DI; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Ravel J, 2009, J BACTERIOL, V191, P445, DOI 10.1128/JB.01347-08; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sastalla I, 2012, MICROBES INFECT, V14, P387, DOI 10.1016/j.micinf.2011.11.009; Sastalla I, 2010, APPL ENVIRON MICROB, V76, P6318, DOI 10.1128/AEM.00950-10; SMITH NR, 1964, J GEN MICROBIOL, V34, P269, DOI 10.1099/00221287-34-2-269; Sterne M, 1937, ONDERSTEPOORT J VET, V8; Turner WC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1785; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Wilson K, 2007, OVERLAND, P5; Yang A, 2019, AM J TROPICAL MED HY	30	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228270	10.1371/journal.pone.0228270	http://dx.doi.org/10.1371/journal.pone.0228270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978128	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100137
J	Zawada, SG; von Fricken, ME; Weppelmann, TA; Sikaroodi, M; Gillevet, PM				Zawada, Sonya G.; von Fricken, Michael E.; Weppelmann, Thomas A.; Sikaroodi, Masoumeh; Gillevet, Patrick M.			Optimization of tissue sampling for Borrelia burgdorferi in white-footed mice (Peromyscus leucopus)	PLOS ONE			English	Article							LYME-DISEASE SURVEILLANCE; POPULATION; EXPANSION	Peromyscus leucopus (the white-footed mouse) is a known reservoir of the Lyme disease spirochete Borrelia burgdorferi. Sampling of white-footed mice allows for year-round B. burgdorferi surveillance as well as opportunities to establish the diversity of the different variants in a geographic region. This study explores the prevalence of B. burgdorferi infections in the tissues of white-footed mice, investigates the correlations between B. burgdorferi infected tissues, and determines the optimum field methods for surveillance of B. burgdorferi in P. leucopus. A total of 90 mice and 573 tissues (spleen, liver, ear, tongue, tail, heart, and kidney) were screened via nested PCR for B. burgdorferi infections. A large number of infections were found in the 90 mice as well as multiple infections within individual mice. Infections in a single mouse tissue (spleen, liver, ear, tongue and tail) were predictive of concurrent infection in other tissues of the same mouse at a statistically significant level. Ear tissue accounted for 68.4% of detected infections, which increased to 78.9% of the infected mice with the inclusion of tail samples. The use of ear punch or tail snip samples (used individually or in tandem) have multiple advantages over current Lyme disease ecological studies and surveillance methodologies, including lower associated costs, minimization of delays, year-round B. burgdorferi testing opportunities, as well as longitudinal monitoring of B. burgdorferi in defined geographic regions. In the absence of an effective vaccine, personal prevention measures are currently the most effective way to reduce Lyme disease transmission to humans. Thus, the identification and monitoring of environmental reservoirs to inform at-risk populations remains a priority. The sampling methods proposed in this study provide a reasonable estimate of B. burgdorferi in white-footed mice in a timely and cost-effective manner.	[Zawada, Sonya G.] George Mason Univ, Dept Environm Sci & Publ Policy, Fairfax, VA 22030 USA; [Zawada, Sonya G.] Univ Mary Washington, Dept Biol, Fredericksburg, VA 22401 USA; [von Fricken, Michael E.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Weppelmann, Thomas A.] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Sikaroodi, Masoumeh; Gillevet, Patrick M.] George Mason Univ, Dept Biol, Fairfax, VA 22030 USA	George Mason University; George Mason University; State University System of Florida; Florida International University; George Mason University	Zawada, SG (corresponding author), George Mason Univ, Dept Environm Sci & Publ Policy, Fairfax, VA 22030 USA.; Zawada, SG (corresponding author), Univ Mary Washington, Dept Biol, Fredericksburg, VA 22401 USA.	sonyazawada@gmail.com		von Fricken, Michael/0000-0003-2938-4549; Gillevet, Patrick/0000-0001-7734-5566				ANDERSON JF, 1987, J CLIN MICROBIOL, V25, P1564, DOI 10.1128/JCM.25.8.1564-1566.1987; Cartter ML, 2018, ZOONOSES PUBLIC HLTH, V65, P227, DOI 10.1111/zph.12448; HOFMEISTER EK, 1995, J WILDLIFE DIS, V31, P345, DOI 10.7589/0090-3558-31.3.345; Khatchikian CE, 2015, EVOLUTION, V69, P1678, DOI 10.1111/evo.12690; Kugeler KJ, 2015, EMERG INFECT DIS, V21, P1455, DOI 10.3201/eid2108.141878; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; Rutz HJ, 2018, ZOONOSES PUBLIC HLTH, V65, P247, DOI 10.1111/zph.12275; Shapiro ED, 2000, CLIN INFECT DIS, V31, P533, DOI 10.1086/313982; Shen AK, 2011, CLIN INFECT DIS, V52, pS247, DOI 10.1093/cid/ciq115; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Wang IN, 1999, GENETICS, V151, P15	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226798	10.1371/journal.pone.0226798	http://dx.doi.org/10.1371/journal.pone.0226798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978068	Green Published, gold			2022-12-26	WOS:000534599100019
J	Kinoshita, R; Homma, Y; Fukuda, M				Kinoshita, Riko; Homma, Yuta; Fukuda, Mitsunori			Rab35?GEFs, DENND1A and folliculin differentially regulate podocalyxin trafficking in two- and three-dimensional epithelial cell cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell polarity; epithelial cell; guanine nucleotide exchange factor (GEF); membrane trafficking; Rab; small GTPase; 3D cell culture; podocalyxin; tissue development	RAB GTPASES; CONNECDENN; DOMAIN; FAMILY; POLARITY; PROTEIN; GEFS	Polarized epithelial cells have functionally distinct apical and basolateral membranes through which they communicate with external and internal bodily environments, respectively. The establishment and maintenance of this asymmetric structure depend on polarized trafficking of specific cargos, but the precise molecular mechanism is incompletely understood. We previously showed that Rab35, a member of the Rab family small GTPases, differentially regulates the trafficking of an apical cargo, podocalyxin (PODXL), in two-dimensional (2D) and three-dimensional (3D) Madin?Darby canine kidney (MDCK) II cell cultures through specific interactions with two distinct effectors, OCRL inositol polyphosphate-5-phosphatase (OCRL) and ArfGAP with coiled-coil, ankyrin repeat and pleckstrin homology domains 2 (ACAP2), respectively. However, whether the upstream regulators of Rab35 also differ depending on the culture conditions remains completely unknown. Here, we investigated four known guanine nucleotide exchange factors (GEFs) of Rab35, namely DENN domain?containing 1A (DENND1A), DENND1B, DENND1C, and folliculin (FLCN), and demonstrate that DENND1A and FLCN exhibit distinct requirements for Rab35-dependent PODXL trafficking under the two culture conditions. In 3D cell cultures, only DENDN1A-knockout cysts exhibited the inverted localization of PODXL similar to that of Rab35-knockout cysts. Moreover, the DENN domain, harboring GEF activity toward Rab35, was required for proper PODXL trafficking to the apical membrane. By contrast, FLCN-knockdown cells specifically accumulated PODXL in actin-rich structures similar to the Rab35-knockdown cells in 2D cell cultures. Our findings indicate that two distinct functional cascades of Rab35, the FLCN-Rab35-OCRL and the DENND1A-Rab35-ACAP2 axes, regulate PODXL trafficking in 2D and 3D MDCK II cell cultures, respectively.	[Kinoshita, Riko; Homma, Yuta; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Integrat Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Homma, Y; Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Integrat Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	y-homma@biology.tohoku.ac.jp; nori@tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015; Homma, Yuta/T-3089-2018	Fukuda, MItsunori/0000-0002-8620-5853; Homma, Yuta/0000-0002-3676-6089	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18K14692]; MEXT [19H03220]; Japan Science and Technology Agency (JST) CREST [JPMJCR17H4]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by Grant-in-Aid for Young Scientists 18K14692 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to Y. H.); Grant-in-Aid for Scientific Research (B) 19H03220 from MEXT (to M. F.); and Japan Science and Technology Agency (JST) CREST Grant JPMJCR17H4 (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Cauvin C, 2016, CURR BIOL, V26, P120, DOI 10.1016/j.cub.2015.11.040; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Cheng SY, 2015, J CELL BIOL, V210, P485, DOI 10.1083/jcb.201501038; Etoh K, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226977; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Haley R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007558; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Kinoshita R., 2020, METHODS MOL BIOL; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Kulasekaran G, 2015, J BIOL CHEM, V290, P17999, DOI 10.1074/jbc.M115.636712; Lamber EP, 2019, CURR OPIN CELL BIOL, V59, P34, DOI 10.1016/j.ceb.2019.03.004; Laviolette LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15866; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mrozowska Paulina S, 2016, Small GTPases, V7, P231; Mrozowska PS, 2016, J CELL BIOL, V213, P355, DOI 10.1083/jcb.201512024; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nishikimi A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005199; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roman-Fernandez A, 2016, TRAFFIC, V17, P1244, DOI 10.1111/tra.12417; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Yasuda Takao, 2015, Methods Mol Biol, V1298, P127, DOI 10.1007/978-1-4939-2569-8_11; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zheng JC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00688	44	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3652	3663		10.1074/jbc.RA119.011646	http://dx.doi.org/10.1074/jbc.RA119.011646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31992598	Green Published, hybrid			2022-12-26	WOS:000527725300022
J	Rabkin, M; Strauss, M; Mantell, JE; Mapingure, M; Masvawure, TB; Lamb, MR; Zech, JM; Musuka, G; Chingombe, I; Msukwa, M; Boccanera, R; Gwanzura, C; George, G; Apollo, T				Rabkin, Miriam; Strauss, Michael; Mantell, Joanne E.; Mapingure, Munyaradzi; Masvawure, Tsitsi B.; Lamb, Matthew R.; Zech, Jennifer M.; Musuka, Godfrey; Chingombe, Innocent; Msukwa, Martin; Boccanera, Rodrigo; Gwanzura, Clorata; George, Gavin; Apollo, Tsitsi			Optimizing differentiated treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study	PLOS ONE			English	Article							CARE; PREFERENCES; DELIVERY; HEALTH	Introduction Zimbabwe is scaling up HIV differentiated service delivery (DSD) to improve treatment outcomes and health system efficiencies. Shifting stable patients into less-intensive DSD models is a high priority in order to accommodate the large numbers of newly-diagnosed people living with HIV (PLHIV) needing treatment and to provide healthcare workers with the time and space needed to treat people with advanced HIV disease. DSD is also seen as a way to improve service quality and enhance retention in care. National guidelines support five differentiated antiretroviral treatment models (DART) for stable HIV-positive adults, but little is known about patient preferences, a critical element needed to guide DART scale-up and ensure person-centered care. We designed a mixed-methods study to explore treatment preferences of PLHIV in urban Zimbabwe. Methods The study was conducted in Harare, and included 35 health care worker (HCW) key informant interviews (KII); 8 focus group discussions (FGD) with 54 PLHIV; a discrete choice experiment (DCE) in which 500 adult DART-eligible PLHIV selected their preferences for health facility (HF) vs. community location, individual vs. group meetings, provider cadre and attitude, clinic operation times, visit frequency, visit duration and cost to patient; and a survey with the 500 DCE participants exploring DART knowledge and preferences. Results Patient preferences were consistent in the FGDs, DCE and survey. Participants strongly preferred respectful HCWs, HF-based services, individual DART models, and less costly services. Patients also preferred less frequent visits and shorter wait times. They were indifferent to variations in HCW cadre and distances from home to HF. These preferences were mostly homogenous, with only minor differences between male vs. female and older vs. younger patients. HCWs in the KII correctly characterized facility-based individual models as the one most favored by patients; HCWs also preferred this model, which they felt decongested HFs and reduced their workload. Conclusions DART-eligible PLHIV in Harare found it relatively easy to access HFs, and preferred attributes associated with facility-based individual models. Prioritizing these for scale-up in urban areas may be the most efficient way to sustain positive patient outcomes and increase health system performance.	[Rabkin, Miriam; Lamb, Matthew R.; Zech, Jennifer M.] Columbia Univ, ICAP, New York, NY 10027 USA; [Rabkin, Miriam; Lamb, Matthew R.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Strauss, Michael; George, Gavin] Univ KwaZulu Natal, Hlth Econ & HIV AIDS, Res Div HEARD, Durban, South Africa; [Mantell, Joanne E.] Columbia Univ, Dept Psychiat, Div Gender Sexual & Hlth, New York, NY USA; [Mantell, Joanne E.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Mapingure, Munyaradzi; Musuka, Godfrey; Chingombe, Innocent] Columbia Univ, ICAP, Harare, Zimbabwe; [Masvawure, Tsitsi B.] Coll Holy Cross, Dept Sociol & Anthropol, Worcester, MA 01610 USA; [Msukwa, Martin] Columbia Univ, ICAP, Pretoria, South Africa; [Boccanera, Rodrigo] Hlth Resources & Serv Adm HRSA, Bethesda, MD USA; [Gwanzura, Clorata; Apollo, Tsitsi] Minist Hlth & Child Care, HIV AIDS & STIs Unit, Harare, Zimbabwe	Columbia University; Columbia University; University of Kwazulu Natal; Columbia University; New York State Psychiatry Institute; College of the Holy Cross; United States Health Resources & Service Administration (HRSA)	Rabkin, M (corresponding author), Columbia Univ, ICAP, New York, NY 10027 USA.; Rabkin, M (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	mr84@columbia.edu	Msukwa, Martin/GXF-8370-2022	Musuka, Godfrey/0000-0001-9077-4429; Mapingure, Munyaradzi Paul/0000-0002-7777-9492; Rabkin, Miriam/0000-0002-2342-4362	U.S. President's Emergency Plan for AIDS Relief, through the Health Resources and Services Administration; U.S. Department of Health and Human Services [UJ7HA31180]	U.S. President's Emergency Plan for AIDS Relief, through the Health Resources and Services Administration; U.S. Department of Health and Human Services	This project was supported by the U.S. President's Emergency Plan for AIDS Relief, through the Health Resources and Services Administration (www.HRSA.gov) of the U.S. Department of Health and Human Services under grant UJ7HA31180. This information or content and conclusions should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. MR was the principal investigator for this award. RB is a HRSA employee; he participated in study planning and reviewed the manuscript prior to submission.	Akullian AN, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20171; [Anonymous], 2017, OP SERV DEL MAN PREV; Ehrenkranz P, 2018, CURR OPIN HIV AIDS; El-Sadr WM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002421; El-Sadr WM, 2016, AIDS, V30, P2145, DOI 10.1097/QAD.0000000000001192; Eshun-Wilson I, 2019, DIFFERENTIATED CARE; Eshun-Wilson I, 2019, JAIDS-J ACQ IMM DEF, V81, P540, DOI 10.1097/QAI.0000000000002070; Gannon BN, 2016, J ASSOC NURSE AIDS C, V27, P419, DOI 10.1016/j.jana.2016.02.004; Garrison D. R., 2006, INTERNET HIGH EDUC, V9, P1, DOI [10.1016/j.iheduc.2005.11.001, DOI 10.1016/J.IHEDUC.2005.11.001]; Grimsrud Anna, 2017, J Int AIDS Soc, V20, P22024, DOI 10.7448/IAS.20.5.22024; Grimsrud A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21484; International AIDS Society, 2016, DIFF CAR HIV DEC FRA; Kruk ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160764; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Magadi MA, 2017, J PUBLIC HEALTH-UK, V39, pE63, DOI 10.1093/pubmed/fdw065; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Mele NL, 2008, NURS RES, V57, P220, DOI 10.1097/01.NNR.0000319499.52122.d2; Mwamba C, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001007; Mwamba PC, 2018, ANTICIPATED LIVED EX; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Ryan M, 2001, Health Technol Assess, V5, P1; Schwartz SR, 2019, BMJ QUAL SAF, V28, P257, DOI 10.1136/bmjqs-2018-008339; Strauss M, 2019, OPTIMIZING TREATMENT; Street DJ, 2005, INT J RES MARK, V22, P459, DOI 10.1016/j.ijresmar.2005.09.003; Tafuma TA, 2018, S AFR J HIV MED, V19, P721; WHO Geneva Switzerland, 2012, CONDUCT DISCRETE CHO; Zanolini A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002636	27	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228148	10.1371/journal.pone.0228148	http://dx.doi.org/10.1371/journal.pone.0228148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8ZJ	31990930	gold, Green Published			2022-12-26	WOS:000534605400046
J	Moore-Colyer, M; Longland, A; Harris, P; Zeef, L; Crosthwaite, S				Moore-Colyer, Meriel; Longland, Annette; Harris, Patricia; Zeef, Leo; Crosthwaite, Susan			Mapping the bacterial ecology on the phyllosphere of dry and post soaked grass hay for horses	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE; MICROBIAL-FLORA; FORAGE; FERMENTATION; SOAKING; HARVEST; DUST	Soaking hay fodder to reduce dust and soluble carbohydrate (WSC) contents prior to feeding is common practice among horse owners. Soaking can increase bacteria load in hay but no information exists on how this process alters the bacteria profile, which could pose a health risk or digestive challenge, to horses by introducing foreign bacteria into the gastrointestinal tract and so altering the normal profile. The current objectives were to map the bacterial profile of 3 different hays and determine how soaking alters this with the aim of improving best practice when feeding stabled horses. A Perennial Rye grass hay and two meadow s hays were soaked for 0, 1.5, 9 or 16 hours. Pre and post treatment, hays were analysed for WSC and total aerobic bacteria (CFU/g), and differences in bacteria family profiles were determined using ANOVA with significance set at P<0.05. Bacteria were identified via genomic DNA extraction and 16S library preparation (V3 and V4 variable region of 16S rRNA) according to the Illumina protocol. Differences in family operational taxonomic units (OTUs) between individual dry hays and different soaking times were identified via paired ttests on the DESeq2 normalised data and false discovery rates accounted for using Padj (P<0.05). Mean % WSC losses and actual g/kg lost on DM basis (+/- SE) increased with soaking time being 18% = 30 (10.7), 38% = 72 (43.7), and 42% = 80 (38.8) for 1.5, 9 and 16 hours soak respectively. No relationship existed between WSC leaching and bacteria growth or profile. Grass type influenced bacterial profiles and their responses to soaking, but no differences were seen in richness or Shannon diversity indices. PCA analyses showed clustering of bacteria between meadow hays which differed from the perennial rye grass hay and this difference increased post soaking. Soaking hay pre-feeding causes inconsistent WSC leaching, bacteria growth and alterations in bacterial profiles which are unpredictable but may decrease the hygienic quality of the fodder.	[Moore-Colyer, Meriel] Royal Agr Univ, Sch Equine Management & Sci, Cirencester, Glos, England; [Longland, Annette] Equine & Livestock Nutr Serv, Tregaron, Ceredigion, Wales; [Harris, Patricia] Mars Horsecare United Kingdom LTD, Milton Keynes, Bucks, England; [Harris, Patricia] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England; [Zeef, Leo] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Crosthwaite, Susan] NIAB, EMR, East Mailing, Kent, England	Mars; WALTHAM Petcare Science Institute; University of Manchester	Moore-Colyer, M (corresponding author), Royal Agr Univ, Sch Equine Management & Sci, Cirencester, Glos, England.	meriel.moore-colyer@rau.ac.uk			Equine and Livestock Nutrition Services; Mars Horsecare UK LTD; WALTHAM	Equine and Livestock Nutrition Services; Mars Horsecare UK LTD; WALTHAM	The funder, Equine and Livestock Nutrition Services, Mars Horsecare UK LTD, provided support for experimental costs in the form of genomic DNA extraction and bioinformatics data analyses which were performed at Faculty of Biology, Medicine and Health, University of Manchester, UK, M13 9PT. No other support was received from Mars Horsecare. The role of the funders in the study was via Prof Pat Harris of Mars Pet Care who was involved in the conception of the study and the preparation of the manuscript. Thanks go to WALTHAM for financial support for the DNA laboratory analyses. The funder played no part in the data collection, laboratory analyses nor data analyses. Mars Pet Care have no commercial interest in hay for horses, so they had no financial gain or otherwise from supporting this study.	Barfoot C, 2014, P 7 EUR WORKSH EQ NU, P82; Beattie GA, 2002, PHYLLOSPHERE MICROBIOLOGY, P3; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; Behrendt U, 1997, MICROBIOL RES, V152, P75, DOI 10.1016/S0944-5013(97)80026-2; Blackman M, 1998, ANIM SCI, V66, P745, DOI 10.1017/S1357729800009334; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown SS, 2013, INT POLIT ECON SER, P104; BUNSTER L, 1989, APPL ENVIRON MICROB, V55, P1340, DOI 10.1128/AEM.55.6.1340-1345.1989; Butcher E, 2006, FEED MAGAZINE KRAFTF, V6, P16; Cookson WR, 2000, GRASS FORAGE SCI, V55, P314, DOI 10.1046/j.1365-2494.2000.00233.x; Couetil LL, 2016, J VET INTERN MED, V30, P503, DOI 10.1111/jvim.13824; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ericsson AC, 2016, PLOS ONE; Frank N, 2010, J VET INTERN MED, V24, P467, DOI 10.1111/j.1939-1676.2010.0503.x; Harris PA, 2017, ANIMAL, V11, P958, DOI 10.1017/S1751731116002469; Harris PA, 2010, EAAP PUBLICATION; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hotchkiss JW, 2007, EQUINE VET J, V39, P294, DOI 10.2746/042516407X177538; Jacobs JL, 2001, APPL ENVIRON MICROB, V67, P5488, DOI 10.1128/AEM.67.12.5488-5496.2001; King L, 2012, THESIS; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuczynski J Gregory Caporaso Justin, 2010, NATURE METHODS, V2010, DOI [10.1038/nmeth.f, DOI 10.1038/NMETH.F]; Leggatt P., 2013, P BRIT SOC AN SCI NO; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Longland AC, 2011, VET REC, V168, DOI 10.1136/vr.d157; Longland A.C., 2009, J EQUINE VET SCI, V29, P383, DOI [10.1016/j.jevs.2009.04.085, DOI 10.1016/J.JEVS.2009.04.085]; Moore-Colyer M.J.S., 2012, FORAGES GRAZING HORS, P101, DOI DOI 10.3920/978-90-8686-755-4_9; Moore-Colyer M.J.S, 2012, P BRIT SOC AN SCI NO; Moore-Colyer MJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114079; MooreColyer MJS, 1996, ANIM SCI, V63, P337, DOI 10.1017/S1357729800014892; Morris CE, 1997, APPL ENVIRON MICROB, V63, P1570, DOI 10.1128/AEM.63.4.1570-1576.1997; Morris CE, 1998, APPL ENVIRON MICROB, V64, P4789; Muller CE, 2009, GRASS FORAGE SCI, V64, P328, DOI 10.1111/j.1365-2494.2009.00695.x; Muller CE, 2008, LIVEST SCI, V119, P116, DOI 10.1016/j.livsci.2008.03.007; Muller CE, 2015, LIVEST SCI, DOI [10.1155/2019/5129526, DOI 10.1155/2019/5129526]; Muller CE, 2015, J EQUINE VET SCI, V35, P622, DOI 10.1016/j.jevs.2015.06.005; OBRIEN RD, 1989, PHYTOPATHOLOGY, V79, P619, DOI 10.1094/Phyto-79-619; PCR Amplicon, 2013, 16S MET SEQ LIB PREP; Petrie A, 1999, STAT VET ANIMAL SCI; Rotz CA, 2003, ADV DAIRY TECHNOL, V15, P227; Taylor J, 2013, GHENT; THOMPSON IP, 1995, FEMS MICROBIOL ECOL, V16, P205, DOI 10.1111/j.1574-6941.1995.tb00284.x; TUKEY HB, 1970, ANN REV PLANT PHYSIO, V21, P305, DOI 10.1146/annurev.pp.21.060170.001513; Virkajarvi P., 2012, FORAGES GRAZING HORS, P17, DOI DOI 10.3920/978-90-8686-755-4_1; Warr EM, 1992, EQUINE VET EDUC, V5, P169	46	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227151	10.1371/journal.pone.0227151	http://dx.doi.org/10.1371/journal.pone.0227151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986161	Green Published, gold, Green Accepted			2022-12-26	WOS:000534603400017
J	Patry, C; Doniga, T; Lenz, F; Viergutz, T; Weiss, C; Tonshoff, B; Kalenka, A; Yard, B; Krebs, J; Schaible, T; Beck, G; Rafat, N				Patry, Christian; Doniga, Thalia; Lenz, Franziska; Viergutz, Tim; Weiss, Christel; Toenshoff, Burkhard; Kalenka, Armin; Yard, Benito; Krebs, Joerg; Schaible, Thomas; Beck, Grietje; Rafat, Neysan			Increased mobilization of mesenchymal stem cells in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE LUNG INJURY; GROWTH-FACTOR; BONE-MARROW; PERIPHERAL-BLOOD; STROMAL CELLS; SEPSIS; MODEL; VEGF; ARDS	Background The acute respiratory distress syndrome (ARDS) is characterized by pulmonary epithelial and endothelial barrier dysfunction and injury. In severe forms of ARDS, extracorporeal membrane oxygenation (ECMO) is often the last option for life support. Endothelial progenitor (EPC) and mesenchymal stem cells (MSC) can regenerate damaged endothelium and thereby improve pulmonary endothelial dysfunction. However, we still lack sufficient knowledge about how ECMO might affect EPC- and MSC-mediated regenerative pathways in ARDS. Therefore, we investigated if ECMO impacts EPC and MSC numbers in ARDS patients. Methods Peripheral blood mononuclear cells from ARDS patients undergoing ECMO (n = 16) and without ECMO support (n = 12) and from healthy volunteers (n = 16) were isolated. The number and presence of circulating EPC and MSC was detected by flow cytometry. Serum concentrations of vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2) were determined. Results In the ECMO group, MSC subpopulations were higher by 71% compared to the non-ECMO group. Numbers of circulating EPC were not significantly altered. During ECMO, VEGF and Ang2 serum levels remained unchanged compared to the non-ECMO group (p = 0.16), but Ang2 serum levels in non-survivors of ARDS were significantly increased by 100% (p = 0.02) compared to survivors. Conclusions ECMO support in ARDS is specifically associated with an increased number of circulating MSC, most likely due to enhanced mobilization, but not with a higher numbers of EPC or serum concentrations of VEGF and Ang2.	[Patry, Christian; Toenshoff, Burkhard; Rafat, Neysan] Heidelberg Univ, Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Doniga, Thalia; Schaible, Thomas; Rafat, Neysan] Heidelberg Univ, Univ Childrens Hosp Mannheim, Dept Neonatol, Heidelberg, Germany; [Lenz, Franziska; Viergutz, Tim; Kalenka, Armin; Krebs, Joerg] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anaesthesiol & Intens Care Med, Heidelberg, Germany; [Weiss, Christel] Heidelberg Univ, Med Fac Mannheim, Dept Med Stat & Biomath, Heidelberg, Germany; [Kalenka, Armin] Hosp Bergstrasse, Dept Anaesthesiol & Intens Care Med, Heppenheim, Germany; [Yard, Benito] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med 5, Heidelberg, Germany; [Beck, Grietje] Dr Horst Schmidt Clin, Dept Anaesthesiol & Intens Care Med, Wiesbaden, Germany; [Rafat, Neysan] Bahai Inst Higher Educ BIHE, Dept Pharmaceut Sci, Tehran, Iran	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rafat, N (corresponding author), Heidelberg Univ, Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany.; Rafat, N (corresponding author), Heidelberg Univ, Univ Childrens Hosp Mannheim, Dept Neonatol, Heidelberg, Germany.; Rafat, N (corresponding author), Bahai Inst Higher Educ BIHE, Dept Pharmaceut Sci, Tehran, Iran.	Neysan.Rafat@umm.de	Krebs, Joerg/AHD-7504-2022	Krebs, Joerg/0000-0003-3037-0144; Patry, Christian/0000-0002-1270-6508	Physician Scientist-Program of the Medical Faculty of the University of Heidelberg	Physician Scientist-Program of the Medical Faculty of the University of Heidelberg	C.P. & N.R. were supported by research scholarships from the Physician Scientist-Program of the Medical Faculty of the University of Heidelberg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen AD, 2014, J HISTOCHEM CYTOCHEM, V62, P103, DOI 10.1369/0022155413516347; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bui KCT, 2010, AM J RESP CRIT CARE, V181, P226, DOI 10.1164/rccm.200812-1901OC; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Burnham EL, 2010, AM J RESP CELL MOL, V43, P326, DOI 10.1165/rcmb.2009-0015OC; Cho HJ, 2019, ASAIO J; CULLEN DJ, 1994, CRIT CARE MED, V22, P1406, DOI 10.1097/00003246-199409000-00009; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Gallagher DC, 2008, SHOCK, V29, P656, DOI 10.1097/SHK.0b013e31815dd92f; Gill KA, 2005, BIOCHEM BIOPH RES CO, V336, P392, DOI 10.1016/j.bbrc.2005.08.097; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Hermida-Gomez T, 2011, J RHEUMATOL, V38, P339, DOI 10.3899/jrheum.100614; Hillebrands JL, 2002, NAT MED, V8, P194, DOI 10.1038/nm0302-194; Hoesli SJ, 2010, J PERINATOL, V30, P724, DOI 10.1038/jp.2010.35; Jain R, 2007, NAT PROTOC, V2, P805; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Karlsson S, 2008, ANESTH ANALG, V106, P1820, DOI 10.1213/ane.0b013e31816a643f; Koning JJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00049; Kumar S, 2012, BONE, V50, P1012, DOI 10.1016/j.bone.2012.01.027; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lehle K, 2016, ARTIF ORGANS, V40, P577, DOI 10.1111/aor.12599; Makdisi G, 2015, J THORAC DIS, V7, pE166, DOI 10.3978/j.issn.2072-1439.2015.07.17; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Millar JE, 2019, THORAX, V74, P194, DOI 10.1136/thoraxjnl-2017-211439; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Ou H, 2016, MOL MED REP, V14, P3862, DOI 10.3892/mmr.2016.5694; Patry C, 2015, INTENSIVE CARE MED, V41; Patry C, 2018, AM J PHYSIOL-RENAL, V315, pF861, DOI 10.1152/ajprenal.00633.2017; Patry C, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0186-7; Patry C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195064; Patry C, 2015, INTENS CARE MED, V41, P1986, DOI 10.1007/s00134-015-4005-9; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rohban R, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5173732; Tsangaris I, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/6758721; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; Voswinckel R, 2003, CIRC RES, V93, P372, DOI 10.1161/01.RES.0000087643.60150.C2; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Xu Z, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1739615; Zhou Y, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2339-3	46	5	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227460	10.1371/journal.pone.0227460	http://dx.doi.org/10.1371/journal.pone.0227460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986159	gold, Green Published			2022-12-26	WOS:000534603400022
J	Khamduang, W; Kaewbundit, A; Duangmano, A; Hongjaisee, S; Klinbuayaem, V; Halue, G; Chutanunta, A; Sirirungsi, W; Jourdain, G; Ngo-Giang-Huong, N				Khamduang, Woottichai; Kaewbundit, Ampika; Duangmano, Amonrat; Hongjaisee, Sayamon; Klinbuayaem, Virat; Halue, Guttiga; Chutanunta, Apichat; Sirirungsi, Wasna; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole			HIV RNA measurement in dried blood spots of HIV-infected patients in Thailand using Abbott m2000 system	PLOS ONE			English	Article							REAL-TIME PCR; VIRAL LOAD; DRUG-RESISTANCE; PLASMA; SPECIMENS; ASSAY; QUANTIFICATION; AMPLIFICATION; QUANTITATION; DIAGNOSIS	World Health Organization recommends using dried blood spots (DBS) for HIV RNA viral load (VL) measurement whenever plasma processing is not convenient or feasible. DBS collected from 80 treatment-naive HIV-infected patients presenting in three hospitals of two different regions of Thailand were shipped to a central laboratory along with corresponding plasma specimens. Viral load was measured in both DBS and plasma using the Abbott m2000 system. HIV RNA levels were strongly correlated (r = 0.94) with a mean of differences of 0.23 log(10) copies/mL. Using the 1,000 copies/mL cut-off, the sensitivity of DBS was 97% (95%CI, 91-100%) and specificity was 75% (95%CI, 19-99%). DBS are useful to scale-up HIV RNA VL testing in settings with limited access to VL testing.	[Khamduang, Woottichai; Sirirungsi, Wasna; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiangmai, Thailand; [Khamduang, Woottichai] Chiang Mai Univ, Fac Associated Med Sci, Div Clin Microbiol, Dept Med Technol,Infect Dis Res Unit, Chiangmai, Thailand; [Khamduang, Woottichai; Kaewbundit, Ampika; Duangmano, Amonrat; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole] Inst Rech Dev IRD, Chiangmai, Thailand; [Hongjaisee, Sayamon] Chiang Mai Univ, Res Inst Hlth Sci, Chiangmai, Thailand; [Klinbuayaem, Virat] Sanpatong Hosp, Chiangmai, Thailand; [Halue, Guttiga] Phayao Hosp, Phayao, Thailand; [Chutanunta, Apichat] Samut Sakorn Hosp, Samut Sakorn, Thailand; [Jourdain, Gonzague; Ngo-Giang-Huong, Nicole] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Chiang Mai University; Chiang Mai University; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health	Ngo-Giang-Huong, N (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiangmai, Thailand.; Ngo-Giang-Huong, N (corresponding author), Inst Rech Dev IRD, Chiangmai, Thailand.; Ngo-Giang-Huong, N (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	nicole.ngo-giang-huong@phpt.org	Khamduang, Woottichai/AFG-2454-2022; Jourdain, Gonzague/F-9117-2017; HONGJAISEE, SAYAMON/AHB-8178-2022; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; HONGJAISEE, SAYAMON/0000-0002-5294-5861; Khamduang, Woottichai/0000-0003-0196-5691; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234	National Research University Project of Thailand Office of Higher Education Commission	National Research University Project of Thailand Office of Higher Education Commission	This work was supported by the National Research University Project of Thailand Office of Higher Education Commission 2014, Chiang Mai University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; Andreotti M, 2010, J CLIN VIROL, V47, P4, DOI 10.1016/j.jcv.2009.11.006; Bertagnolio S, 2010, AIDS REV, V12, P195; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Leelawiwat W, 2009, J VIROL METHODS, V155, P109, DOI 10.1016/j.jviromet.2008.09.022; Marconi A, 2009, CLIN MICROBIOL INFEC, V15, P93, DOI 10.1111/j.1469-0691.2008.02116.x; Mbida AD, 2009, JAIDS-J ACQ IMM DEF, V52, P9, DOI 10.1097/QAI.0b013e3181aeccbc; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; National Health Security Office, 2016, NAT HLTH SEC FUND MA, V2; Ngo-Giang-Huong N, 2008, JAIDS-J ACQ IMM DEF, V49, P465, DOI 10.1097/QAI.0b013e31818e2531; Nyagupe C, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030086; Pannus P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005475; Rutstein SE, 2014, J CLIN VIROL, V60, P392, DOI 10.1016/j.jcv.2014.05.005; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Taieb F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191920; Taieb F, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw142; Tang N, 2017, J CLIN VIROL, V92, P56, DOI 10.1016/j.jcv.2017.05.002; The Joint United Nations Programme on HIV/AIDS, 2016, 90 90 90 RIGHT TRACK; The Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK END AIDS; Thepbundit V, 2019, J MED VIROL, V91, P1652, DOI 10.1002/jmv.25506; Vidya M, 2012, J VIROL METHODS, V181, P177, DOI 10.1016/j.jviromet.2012.02.006; Zeh C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179316	25	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227929	10.1371/journal.pone.0227929	http://dx.doi.org/10.1371/journal.pone.0227929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978113	Green Published, gold, Green Submitted			2022-12-26	WOS:000534599100081
J	Liao, JY; Lee, CTC; Lin, TY; Liu, CM				Liao, Jung-Yu; Lee, Charles Tzu-Chi; Lin, Tsung-Yi; Liu, Chin-Mei			Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; HEARING-LOSS; GUT-BRAIN; HIPPOCAMPAL ATROPHY; MICROBIOTA; RISK; HEALTH; METAANALYSIS; DEPRESSION; DISORDERS	Studies have identified prior conditions associated with late-onset Alzheimer's disease dementia (LOAD), but all prior diseases have rarely been screened simultaneously in the literature. Our objective in the present study was to identify prior conditions associated with LOAD and construct pathways for them. We conducted a population-based matched case-control study based on data collected in the National Health Insurance Research database of Taiwan and the Catastrophic Illness Certificate database for the years 1997-2013. Prior diseases definitions were based on the first three digits of the codes listed in the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Inclusion criteria required that each ICD-code existed for at least 1 year and incurred at least 2 outpatient visits or inpatient diagnosis. The case group comprised 4,600 patients newly diagnosed with LOAD in 2007-2013. The LOAD patients were matched by sex and age to obtain 4,600 controls. Using stepwise multivariate logistic regression analysis, diseases were screened for 1, 2 ..., 9 years prior to the first diagnosis of LOAD. Path analysis was used to construct pathways between prior diseases and LOAD. Our results revealed that the following conditions were positively associated with the incidence of LOAD: anxiety (ICD-code 300), functional digestive disorder (ICD code 564), psychopathology-specific symptoms (ICD-code 307), disorders of the vestibular system (ICD-code 386), concussion (ICD-code 850), disorders of the urethra and urinary tract (ICD-code 599), disorders of refraction and accommodation (ICD-code 367), and hearing loss (ICD-code 389). A number of the prior diseases have previously been described in the literature in a manner identical to that in the present study. Our study supports the assertion that mental, hearing, vestibular system, and functional digestive disorders may play an important role in the pathogenesis of LOAD.	[Liao, Jung-Yu; Lee, Charles Tzu-Chi; Lin, Tsung-Yi; Liu, Chin-Mei] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Lin, Tsung-Yi] Hsing Wu Univ, Dept Mkt & Distribut Management, New Taipei, Taiwan; [Liu, Chin-Mei] Taiwan Ctr Dis Control, Taipei, Taiwan	National Taiwan Normal University	Liu, CM (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.; Liu, CM (corresponding author), Taiwan Ctr Dis Control, Taipei, Taiwan.	uu0850@gmail.com	Liao, Jung-Yu/AAG-4350-2021	Liao, Jung-Yu/0000-0001-5083-9531; Lin, Tsung-Yi/0000-0002-0358-2523				Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bate A, 2017, PHARMACOEPIDEM DR S, V26, P1013, DOI 10.1002/pds.4305; Boyle PA, 2008, NEUROLOGY, V70, P1534, DOI 10.1212/01.wnl.0000304345.14212.38; Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chen CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144589; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Daulatzai MA, 2014, NEUROCHEM RES, V39, P624, DOI 10.1007/s11064-014-1266-6; Davies HR, 2017, J AM GERIATR SOC, V65, P2074, DOI 10.1111/jgs.14986; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; Deal JA, 2017, J GERONTOL A-BIOL, V72, P703, DOI 10.1093/gerona/glw069; Fan YC, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0236-z; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Guthrie DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192971; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hooper D., 2008, ARTICLES, V2, DOI DOI 10.1080/10705519909540118; Hughes SE, 2018, EAR HEARING, V39, P922, DOI 10.1097/AUD.0000000000000553; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Leue C, 2017, NAT REV UROL, V14, P153, DOI 10.1038/nrurol.2016.227; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lin FC, 2015, MEDICINE, V94, P2143; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Liu CM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8112; Livingston GSA, 2017, LANCET, DOI http://dx.doi; Lucieer F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00026; Lucieer F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00352; Mah L, 2016, CURR OPIN PSYCHIATR, V29, P56, DOI 10.1097/YCO.0000000000000223; Martin S, 2014, DISBILITY DEMENTIA F; Moon B, 2017, J ALZHEIMERS DIS, V58, P1255, DOI 10.3233/JAD-170225; Moonga I, 2017, EUR J NEUROL, V24, P1173, DOI 10.1111/ene.13374; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Powell N, 2017, NAT REV GASTRO HEPAT, V14, P143, DOI 10.1038/nrgastro.2016.191; Previc FH, 2013, MED HYPOTHESES, V80, P360, DOI 10.1016/j.mehy.2012.12.023; Ronnberg J, 2010, NOISE HEALTH, V12, P263, DOI 10.4103/1463-1741.70505; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shen YL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00394; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Smith PA, 2015, NATURE, V526, P312, DOI 10.1038/526312a; Strupp Michael, 2010, Front Neurol, V1, P121, DOI 10.3389/fneur.2010.00121; Su PJ, 2017, EUR ARCH OTO-RHINO-L, V274, P2327, DOI 10.1007/s00405-017-4471-5; Szablewski L, 2018, J ALZHEIMERS DIS, V62, P549, DOI 10.3233/JAD-170908; Tapiainen V, 2017, EUR PSYCHIAT, V43, P92, DOI 10.1016/j.eurpsy.2017.02.486; Thomson RS, 2017, LARYNGOSCOPE INVEST, V2, P69, DOI 10.1002/lio2.65; Tolppanen AM, 2017, ALZHEIMERS DEMENT, V13, P1371, DOI 10.1016/j.jalz.2017.04.010; Tsai CP, 2019, AMYOTROPH LAT SCL FR, V20, P82, DOI 10.1080/21678421.2018.1522354; Van der Mussele S, 2014, J ALZHEIMERS DIS, V42, P1239, DOI 10.3233/JAD-140405; Wen YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003658; World Health Organization, 2004, INT STAT CLASS DIS R; Zheng YQ, 2017, NEUROL SCI, V38, P233, DOI 10.1007/s10072-016-2779-3	55	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228172	10.1371/journal.pone.0228172	http://dx.doi.org/10.1371/journal.pone.0228172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978130	gold, Green Published			2022-12-26	WOS:000534599100122
J	Sun, YQ; Richmond, RC; Chen, Y; Mai, XM				Sun, Yi-Qian; Richmond, Rebecca C.; Chen, Yue; Mai, Xiao-Mei			Mixed evidence for the relationship between periodontitis and Alzheimer's disease: A bidirectional Mendelian randomization study	PLOS ONE			English	Article							METAANALYSIS; LOCI	Recent experimental studies indicated that a periodontitis-causing bacterium might be a causal factor for Alzheimer's disease (AD). We applied a two-sample Mendelian randomization (MR) approach to examine the potential causal relationship between chronic periodontitis and AD bidirectionally in the population of European ancestry. We used publicly available data of genome-wide association studies (GWAS) on periodontitis and AD. Five single-nucleotide polymorphisms (SNPs) were used as instrumental variables for periodontitis. For the MR analysis of periodontitis on risk of AD, the causal odds ratio (OR) and 95% confidence interval (CI) were derived from the GWAS of periodontitis (4,924 cases vs. 7,301 controls) and from the GWAS of AD (21,982 cases vs. 41,944 controls). Seven non-overlapping SNPs from another latest GWAS of periodontitis was used to validate the above association. Twenty SNPs were used as instrumental variables for AD. For the MR analysis of liability to AD on risk of periodontitis, the causal OR was derived from the GWAS of AD including 30,344 cases and 52,427 controls and from the GWAS of periodontitis consisted of 12,289 cases and 22,326 controls. We employed multiple methods of MR. Using the five SNPs as instruments of periodontitis, there was suggestive evidence of genetically predicted periodontitis being associated with a higher risk of AD (OR 1.10, 95% CI 1.02 to 1.19, P = 0.02). However, this association was not verified using the seven independent SNPs (OR 0.97, 95% CI 0.87 to 1.08, P = 0.59). There was no association of genetically predicted AD with the risk of periodontitis (OR 1.00, 95% CI 0.96 to 1.04, P = 0.85). In summary, we did not find convincing evidence to support periodontitis being a causal factor for the development of AD. There was also limited evidence to suggest genetic liability to AD being associated with the risk of periodontitis.	[Sun, Yi-Qian] Ctr Oral Hlth Serv & Res Mid Norway TkMidt, Trondheim, Norway; [Sun, Yi-Qian] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med IKOM, Trondheim, Norway; [Richmond, Rebecca C.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Chen, Yue] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Mai, Xiao-Mei] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); University of Bristol; University of Ottawa; Norwegian University of Science & Technology (NTNU)	Sun, YQ (corresponding author), Ctr Oral Hlth Serv & Res Mid Norway TkMidt, Trondheim, Norway.; Sun, YQ (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med IKOM, Trondheim, Norway.	yiqsu@tkmidt.no		Sun, Yi-Qian/0000-0002-9634-9236; Richmond, Rebecca/0000-0003-0574-5071	Norwegian Cancer Society [5769155-2015]; Research Council of Norway "Gaveforsterkning"	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway "Gaveforsterkning"(Research Council of Norway)	YQS's research is supported by funding from The Norwegian Cancer Society (project ID 5769155-2015) and The Research Council of Norway "Gaveforsterkning". RCR is a de Pass VC Research Fellow at the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burgess S, 2018, EUR J EPIDEMIOL, V33, P947, DOI 10.1007/s10654-018-0424-6; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Caton JG, 2018, J CLIN PERIODONTOL, V45, pS1, DOI 10.1111/jcpe.12935; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; DAVIES NM, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K601; Divaris K, 2013, HUM MOL GENET, V22, P2312, DOI 10.1093/hmg/ddt065; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Ide M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151081; Ilievski V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204941; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Kinane DF, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.38; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Larsson SC, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5375; Mokry LE, 2016, NEUROLOGY, V87, P2567, DOI 10.1212/WNL.0000000000003430; Munz M, 2019, EUR J HUM GENET, V27, P102, DOI 10.1038/s41431-018-0265-5; Noble JM, 2009, J NEUROL NEUROSUR PS, V80, P1206, DOI 10.1136/jnnp.2009.174029; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Shungin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10630-1; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Zhao Q, 2019, STAT INFERENCE TWO S; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	24	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228206	10.1371/journal.pone.0228206	http://dx.doi.org/10.1371/journal.pone.0228206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978120	gold, Green Published			2022-12-26	WOS:000534599100127
J	Woolley, CSC; Handel, IG; Bronsvoort, BM; Schoenebeck, JJ; Clements, DN				Woolley, Charlotte S. C.; Handel, Ian G.; Bronsvoort, B. Mark; Schoenebeck, Jeffrey J.; Clements, Dylan N.			Is it time to stop sweeping data cleaning under the carpet? A novel algorithm for outlier management in growth data	PLOS ONE			English	Article							BIOLOGICALLY IMPLAUSIBLE VALUES; SELF-REPORTED HEIGHT; BODY-MASS INDEX; COHORT PROFILE; WEIGHT; ACCURACY; BMI; IDENTIFICATION; CIRCUMFERENCE; OVERWEIGHT	All data are prone to error and require data cleaning prior to analysis. An important example is longitudinal growth data, for which there are no universally agreed standard methods for identifying and removing implausible values and many existing methods have limitations that restrict their usage across different domains. A decision-making algorithm that modified or deleted growth measurements based on a combination of pre-defined cut-offs and logic rules was designed. Five data cleaning methods for growth were tested with and without the addition of the algorithm and applied to five different longitudinal growth datasets: four uncleaned canine weight or height datasets and one pre-cleaned human weight dataset with randomly simulated errors. Prior to the addition of the algorithm, data cleaning based on non-linear mixed effects models was the most effective in all datasets and had on average a minimum of 26.00% higher sensitivity and 0.12% higher specificity than other methods. Data cleaning methods using the algorithm had improved data preservation and were capable of correcting simulated errors according to the gold standard; returning a value to its original state prior to error simulation. The algorithm improved the performance of all data cleaning methods and increased the average sensitivity and specificity of the non-linear mixed effects model method by 7.68% and 0.42% respectively. Using non-linear mixed effects models combined with the algorithm to clean data allows individual growth trajectories to vary from the population by using repeated longitudinal measurements, identifies consecutive errors or those within the first data entry, avoids the requirement for a minimum number of data entries, preserves data where possible by correcting errors rather than deleting them and removes duplications intelligently. This algorithm is broadly applicable to data cleaning anthropometric data in different mammalian species and could be adapted for use in a range of other domains.	[Woolley, Charlotte S. C.; Bronsvoort, B. Mark; Schoenebeck, Jeffrey J.; Clements, Dylan N.] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Woolley, Charlotte S. C.; Handel, Ian G.; Bronsvoort, B. Mark; Schoenebeck, Jeffrey J.; Clements, Dylan N.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Woolley, CSC (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland.; Woolley, CSC (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh, Midlothian, Scotland.	s1576473@sms.ed.ac.uk		Schoenebeck, Jeffrey/0000-0003-4964-2138; Woolley, Charlotte/0000-0001-9176-8389; Clements, Dylan/0000-0002-0596-1885	Biotechnology and Biological Sciences Research Council [BB/J004235/1, BB/J01446X/1]; BBSRC [1801023, BBS/E/D/20211551, BBS/E/D/20002173] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Institute Strategic Programme Grant from the Biotechnology and Biological Sciences Research Council (https://bbsrc.ukri.org/) to the Roslin Institute [BB/J004235/1] and the lead author was funded by the Biotechnology and Biological Sciences Research Council under the EASTBIO (http://www.eastscotbiodtp.ac.uk/) doctoral training programme [BB/J01446X/1 to CW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Kennel Club, 1994, OFF STAND LABR RETR; Andritsos P., 2006, P 22 INT C DAT ENG I, V30, P1, DOI [10.1109/ICDE.2006.35, DOI 10.1109/ICDE.2006.35]; Arribas-Gil A, 2014, BIOSTATISTICS, V15, P603, DOI 10.1093/biostatistics/kxu006; Banfield Pet Hospital, 2018, US; Bann D, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002214; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Boone-Heinonen J, 2019, ANN EPIDEMIOL, V31, P69, DOI 10.1016/j.annepidem.2019.01.006; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carsley Sarah, 2018, J Innov Health Inform, V25, P963, DOI 10.14236/jhi.v25i1.963; Chen S, 2018, AM J CLIN NUTR, V107, P420, DOI 10.1093/ajcn/nqx056; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Clements DN, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-13; Cohort and Longitudinal Studies Enhancement Resources, 2017, HARM HEIGHT WEIGHT B, DOI 10.5255/UKDA-SN-8207-1; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Daymont C, 2017, J AM MED INFORM ASSN, V24, P1080, DOI 10.1093/jamia/ocx037; DeEyto E, 2016, NETLAKE TOOLBOX ANAL, P2; Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69; Dubois L, 2007, INT J EPIDEMIOL, V36, P132, DOI 10.1093/ije/dyl281; Eager CD, 2017, MIXED EFFECTS MODELS; Elliott J, 2006, INT J EPIDEMIOL, V35, P836, DOI 10.1093/ije/dyl174; Engstrom JL, 2003, J MIDWIFERY WOM HEAL, V48, P338, DOI 10.1016/S1526-9523(03)00281-2; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2019, OBESITY, V27, P1711, DOI 10.1002/oby.22591; Freedman DS, 2015, AM J CLIN NUTR, V102, P1000, DOI 10.3945/ajcn.115.115576; GOLDSTEI.H, 1970, ROY STAT SOC C-APP, V19, P145; Gundersen C, 2008, J NUTR, V138, P371, DOI 10.1093/jn/138.2.371; Hansen K., 2014, MILLENNIUM COHORT ST; Hardy R, 2016, CLOSER WORK PACKAGE; Horn PS, 2001, CLIN CHEM, V47, P2137; Huybrechts I, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-63; Johnson W, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001828; Kim J, 2005, AM J PUBLIC HEALTH, V95, P1588, DOI 10.2105/AJPH.2004.054015; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lawman HG, 2015, AM J EPIDEMIOL, V182, P359, DOI 10.1093/aje/kwv057; Lo JC, 2014, PEDIATR OBES, V9, P167, DOI 10.1111/j.2047-6310.2013.00154.x; Monge A.E., 2000, IEEE DATA ENG B, V23, P14; MONGE A. E, 1997, DMKD, P23; Muthalagu A, 2014, APPL CLIN INFORM, V5, P118, DOI 10.4338/ACI-2013-09-RA-0074; Okamoto N, 2017, OBES SCI PRACT, V3, P417, DOI 10.1002/osp4.122; Osborne JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00370; Osborne JW, 2010, NEWBORN INFANT NURS, V10, P37, DOI 10.1053/j.nainr.2009.12.009; Poon WB, 2014, ANN ACAD MED SINGAP, V43, P296; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; PRITZKER L, 1965, B INT STATIST INST, V41, P442; Radford A, 2010, VET REC, V167, P472, DOI 10.1136/vr.c5180; Ripon KSN, 2010, J COMPUT, V5, P1800, DOI 10.4304/jcp.5.12.1800-1809; Salt C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182064; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Shi J, 2018, ANN EPIDEMIOL, V28, P204, DOI 10.1016/j.annepidem.2018.01.007; Spooner S, 2016, AAP COUNC CLIN INF T, DOI [10.1542/peds.141.1_MeetingAbstract.21, DOI 10.1542/PEDS.141.1_MEETINGABSTRACT.21]; Stein RJ, 2005, PUBLIC HEALTH REP, V120, P266, DOI 10.1177/003335490512000308; Surkan PJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-185; Tukey JW, 1977, EXPLORATORY DATA ANA; Van den Broeck J, 2005, PLOS MED, V2, P966, DOI 10.1371/journal.pmed.0020267; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Welch C, 2012, PHARMACOEPIDEM DR S, V21, P725, DOI 10.1002/pds.2270; Woolley C, 2019, DOGSLIFE HEIGHT WEIG; Wu Danny T Y, 2018, AMIA Annu Symp Proc, V2018, P1103; Yang S, 2016, ANN EPIDEMIOL, V26, P77, DOI 10.1016/j.annepidem.2015.10.002; Yorkin M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1194; Youth Risk Behavior Surveillance System, 2012, 2013 YRBS DAT US GUI; Zhang AQ, 2017, PROC VLDB ENDOW, V10, P1046, DOI 10.14778/3115404.3115410	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228154	10.1371/journal.pone.0228154	http://dx.doi.org/10.1371/journal.pone.0228154			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978151	gold, Green Published			2022-12-26	WOS:000534599100117
J	O'Halloran, DM				O'Halloran, Damien M.			Module for SWC neuron morphology file validation and correction enabled for high throughput batch processing	PLOS ONE			English	Article							TOOL	SWC files are a widely used format to store neuron morphologies, and are used to share digitally reconstructed neurons using NeuroMorpho.org as well as predict functional attributes using simulation environments such as NEURON. Here we set out to develop an easily accessible tool to validate and correct SWC formatted files with an emphasis on high throughput batch processing. SWC_BATCH_CHECK is a package that provides a suite of methods to parse and correct the syntactic structure of a directory of SWC files. This tool ensures that user specified structures such as the soma or basal dendrite are correctly connected while fixing morphological features. This tool will report on missing or invalid data values while also returning basic statistical features for each file. SWC_BATCH_CHECK was validated and tested using thousands of individual SWC files to benchmark runtime performance and efficacy in both reporting on and correcting disparate SWC file features. SWC_BATCH_CHECK is open source and freely available to all users without restriction with guidelines and requirements provided to ensure straightforward installation and execution.	[O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	O'Halloran, DM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	damienoh@gwu.edu			George Washington University (GWU) Columbian College of Arts and Sciences; GWU Department of Biological Sciences	George Washington University (GWU) Columbian College of Arts and Sciences; GWU Department of Biological Sciences	Funded by The George Washington University (GWU) Columbian College of Arts and Sciences, and the GWU Department of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; Feng LQ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0049-14.2014; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Luisi J, 2011, NEUROINFORMATICS, V9, P305, DOI 10.1007/s12021-011-9115-0; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; STOCKLEY EW, 1993, J NEUROSCI METH, V47, P39, DOI 10.1016/0165-0270(93)90020-R	11	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228091	10.1371/journal.pone.0228091	http://dx.doi.org/10.1371/journal.pone.0228091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971963	gold, Green Published			2022-12-26	WOS:000534374400038
J	Valero-Moreno, S; Castillo-Corullon, S; Montoya-Castilla, I; Perez-Marin, M				Valero-Moreno, Selene; Castillo-Corullon, Silvia; Montoya-Castilla, Inmaculada; Perez-Marin, Marian			Primary ciliary dyskinesia and psychological well-being in adolescence	PLOS ONE			English	Article							HOSPITAL ANXIETY; ILLNESS; CHILDREN	Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disease with low prevalence in pediatrics. Health studies have not sufficiently analyzed the role of psychological variables in rare diseases such as PCD. This paper studies the psychological characteristics of a group of pediatric patients diagnosed with PCD compared to their healthy peers. The sample consisted of 48 preadolescents-adolescents, aged 9-18 years (M = 12.96; SD = 2.71), with similar distribution by sex, and 25% of the patients having dyskinesia. Clinical anxiety-depression, self-esteem and psychological well-being were evaluated using questionnaires: the Adolescent Psychological Well-being Scale (BIEPS-J), the Hospital Anxiety and Depression Scale (HADS) and the Rosenberg SelfEsteem Scale (RSE). Data were analysed using descriptive, mean comparison (t-test) and diffuse comparative qualitative analysis (QCA). The results show no differences were found between healthy and PCD patients in the variables analyzed, except for social ties showing the latter greater well-being in this aspect. In QCA models, the variables that best explained the high or low levels of well-being were depression and selfesteem, and primary ciliary dyskinesia was not a necessary condition for presenting low levels of well-being. In conclusion, our results highlight the need to explore psychological aspects in pediatric patients with rare diseases.	[Valero-Moreno, Selene; Montoya-Castilla, Inmaculada; Perez-Marin, Marian] Univ Valencia, Fac Psychol, Dept Personal Assessment & Psychol Treatments, Valencia, Spain; [Castillo-Corullon, Silvia] Hosp Clin Univ Valencia, Pediat Pneumol Unit, Valencia, Spain	University of Valencia	Perez-Marin, M (corresponding author), Univ Valencia, Fac Psychol, Dept Personal Assessment & Psychol Treatments, Valencia, Spain.	marian.perez@uv.es	Castillo-Corullón, Silvia/ABH-3730-2020; Perez-Marin, Marian/G-9394-2011; Montoya-Castilla, Inmaculada/G-8963-2011; Valero-Moreno, Selene/Y-8905-2019	Castillo-Corullón, Silvia/0000-0002-0121-2676; Perez-Marin, Marian/0000-0003-3532-8818; Montoya-Castilla, Inmaculada/0000-0003-2536-2019; Valero-Moreno, Selene/0000-0002-5228-2738	Government of the Valencian Community; European Social Fund [ACIF17]; Spanish Association of Psychopathology and Clinical Psychology (AECP17) [1/2013]; Spanish Federation of Family Therapy [FEATF16, 1/2017 AEPCP]	Government of the Valencian Community; European Social Fund(European Social Fund (ESF)); Spanish Association of Psychopathology and Clinical Psychology (AECP17); Spanish Federation of Family Therapy	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study has been financed by: a) Grant for the predoctoral recruitment of the Government of the Valencian Community and the European Social Fund (ACIF17), http://www.ceice.gva.es/es/web/ciencia/convocatorias_2017/-/asset_publisher/ZNDlw4rfNUCX/content/subvenciones-para-la-contratacion-de-personal-investigador-de-caracterpredoctoral?redirect=http%3A%2F%2Fwww.ceice.gva.es%2Fes%2Fweb%2Fciencia% 2Fconvocatorias_2017%3Fp_p_id%3D101_ INSTANCE_ZNDlw4rfNUCX%26p_p_lifecycle% 3D0%26p_p_state%3Dnormal%26p_p_mode% 3Dview%26p_p_col_id%3Dcolumn-2%26p_p_ col_pos%3D1%26p_p_col_count%3D2 b) The research prize of the Spanish Association of Psychopathology and Clinical Psychology (AECP17) (Proyect Ref: 1/2013) http://www.aepcp.net/c) The research prize of the Spanish Federation of Family Therapy (FEATF16) Ref: 1/2017 AEPCP) http://www.aepcp.net/.	Akkus PZ, 2019, EUR J PEDIATR, V178, P995, DOI 10.1007/s00431-019-03382-z; Askew K, 2017, CLIN MED, V17, P121, DOI 10.7861/clinmedicine.17-2-121; ASLAM B, 2015, ANN AM THORAC SOC, V12, DOI DOI 10.1587/ELEX.12.20150623; Atienza FL., 2000, REV PSICOLOG A UNIVE, V22, P29; Behan L, 2017, QUAL LIFE RES, V26, P2265, DOI 10.1007/s11136-017-1564-y; Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851; Carotenuto M, 2013, PSYCHOL COGNITIVE MA, V9; Casullo Maria, 2000, REV PSICOLOGIA, VXVIII, P35, DOI [10.18800/psico.200001.002, DOI 10.18800/PSICO.200001.002]; Catastini P, 2016, PEDIATR PULM, V51, P1311, DOI 10.1002/ppul.23566; Claude R., 2014, ACQ; Cruz M. S., 2002, ESCALA BIENESTAR PSI, P65; De Las Cuevas Castresana C., 1995, AN PSIQUIATR, V11, P126; Desueza Flores W, 2018, MED PROGRAMA FORMACI, V12, P3719, DOI [10.1016/j.med.2018.09.013, DOI 10.1016/J.MED.2018.09.013]; Dudeney J, 2017, PEDIATR PULM, V52, P1121, DOI 10.1002/ppul.23689; Eng S, 2012, ADDICT BEHAV, V37, P541, DOI 10.1016/j.addbeh.2011.11.034; Fiss PC, 2011, ACAD MANAGE J, V54, P393, DOI 10.5465/AMJ.2011.60263120; Gonzalez-Fuentes M., 2016, REV IBEROAMERICANA D, V2, P39; Goutaki M, 2016, EUR RESPIR J, V48, P1081, DOI 10.1183/13993003.00736-2016; Hosie PH, 2015, J PAEDIATR CHILD H, V51, P722, DOI 10.1111/jpc.12791; Leigh Margaret W, 2019, Transl Sci Rare Dis, V4, P51, DOI 10.3233/TRD-190036; Leigh MW, 2016, ANN AM THORAC SOC, V13, P1305, DOI 10.1513/AnnalsATS.201511-748OC; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Mihalca AM, 2015, PSYCHIATR POL, V49, P1071, DOI 10.12740/PP/38139; Morgan LC, 2016, PAEDIATR RESPIR REV, V18, P33, DOI 10.1016/j.prrv.2015.09.006; Mullins AJ, 2017, J AM COLL HEALTH, V65, P352, DOI 10.1080/07448481.2017.1312415; Oliva A., 2011, INSTRUMENTOS EVALUAC, V148; Pinquart M, 2013, CHILD CARE HLTH DEV, V39, P153, DOI 10.1111/j.1365-2214.2012.01397.x; Portuondo Leyva Reyna, 2014, Rev Cubana Pediatr, V86, P514; Ragin C. C, 2008, REDESIGNING SOCIAL I; Rosenberg R. L, 1965, SOC ADOLESCENT SELF; Saez-Flores E, 2018, J PEDIATR PSYCHOL, V43, P625, DOI 10.1093/jpepsy/jsx155; Secinti E, 2017, J CHILD PSYCHOL PSYC, V58, P753, DOI 10.1111/jcpp.12727; Shapiro AJ, 2016, STATE ART DIAGNOSIS, V132, P115; Sicouri G, 2017, BEHAV RES THERAPY, V97; Valero-Moreno S, 2019, ARCH ARGENT PEDIAT, V117; Valero-Moreno S, 2019, ARCH ARGENT PEDIATR, V117, P252, DOI 10.5546/aap.2019.eng.252; Woodside AG, 2013, J BUS RES, V66, P463, DOI 10.1016/j.jbusres.2012.12.021; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227888	10.1371/journal.pone.0227888	http://dx.doi.org/10.1371/journal.pone.0227888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5RH	31971980	gold, Green Published			2022-12-26	WOS:000534374400025
J	Zalay, OC				Zalay, Osbert C.			Blind method for discovering number of clusters in multidimensional datasets by regression on linkage hierarchies generated from random data	PLOS ONE			English	Article							TEXTURE	Determining intrinsic number of clusters in a multidimensional dataset is a commonly encountered problem in exploratory data analysis. Unsupervised clustering algorithms often rely on specification of cluster number as an input parameter. However, this is typically not known a priori. Many methods have been proposed to estimate cluster number, including statistical and information-theoretic approaches such as the gap statistic, but these methods are not always reliable when applied to non-normally distributed datasets containing outliers or noise. In this study, I propose a novel method called hierarchical linkage regression, which uses regression to estimate the intrinsic number of clusters in a multidimensional dataset. The method operates on the hypothesis that the organization of data into clusters can be inferred from the hierarchy generated by partitioning the dataset, and therefore does not directly depend on the specific values of the data or their distribution, but on their relative ranking within the partitioned set. Moreover, the technique does not require empirical data to train on, but can use synthetic data generated from random distributions to fit regression coefficients. The trained hierarchical linkage regression model is able to infer cluster number in test datasets of varying complexity and differing distributions, for image, text and numeric data, using the same regression model without retraining. The method performs favourably against other cluster number estimation techniques, and is also robust to parameter changes, as demonstrated by sensitivity analysis. The apparent robustness and generalizability of hierarchical linkage regression make it a promising tool for unsupervised exploratory data analysis and discovery.	[Zalay, Osbert C.] Queens Univ, Dept Oncol, Div Radiat Oncol, Kingston, ON, Canada; [Zalay, Osbert C.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Queens University - Canada; Harvard University; Dana-Farber Cancer Institute	Zalay, OC (corresponding author), Queens Univ, Dept Oncol, Div Radiat Oncol, Kingston, ON, Canada.; Zalay, OC (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	o.zalay@queensu.ca		Zalay, Osbert/0000-0002-2967-4071	Queen's University Department of Oncology Cancer Research and Education Trust Fund	Queen's University Department of Oncology Cancer Research and Education Trust Fund	O.Z. received less than $500 CAD from the Queen's University Department of Oncology Cancer Research and Education Trust Fund as a one time contribution for departmental research. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, DATABASE THEORY ICDT; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Bewick Viv, 2004, Crit Care, V8, P196, DOI 10.1186/cc2857; Bezdek JC, 1998, IEEE T SYST MAN CY B, V28, P301, DOI 10.1109/3477.678624; BLASHFIELD RK, 1976, PSYCHOL BULL, V83, P377, DOI 10.1037/0033-2909.83.3.377; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Dana KJ, 1999, ACM T GRAPHIC, V18, P1, DOI 10.1145/300776.300778; Dar-Jen Chang, 2009, 22nd International Conference on Parallel and Distributed Computing and Communication Systems. PDCCS 2009, P7; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dua D., UCI MACHINE LEARNING; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Flexa C, 2019, EXPERT SYST APPL, V128, P225, DOI 10.1016/j.eswa.2019.03.027; Forina M., 1990, J CHEMOMETR, V4, P191, DOI DOI 10.1002/cem.1180040210; Franti P, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0122-y; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gui Tao, 2017, P 2017 C EMP METH NA, P2411; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Hayman E, 2004, LECT NOTES COMPUT SC, V2034, P253; Hopkins M, SPAMBASE DATA SET; Kingma D. P., 2017, ADAM METHOD STOCHAST; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Liu Y, 2010, 2010 IEEE INT C DATA, P911, DOI [10.1109/ICDM.2010.35, DOI 10.1109/ICDM.2010.35]; Mikolov Tomas, 2013, P ICLR WORKSH; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Mullner Daniel, 2011, ARXIV11092378CSSTAT; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Rossignol M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197450; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; SCHENKER N, 1985, J AM STAT ASSOC, V80, P360, DOI 10.2307/2287897; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Yu XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171429; Zalay O, HIERARCHICAL LINKAGE	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227788	10.1371/journal.pone.0227788	http://dx.doi.org/10.1371/journal.pone.0227788			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971953	Green Published, gold			2022-12-26	WOS:000534374400018
J	Martin, D; Gil, J; Zanol, J; Meca, MA; Portela, RP				Martin, Daniel; Gil, Joao; Zanol, Joana; Meca, Miguel A.; Portela, Rocio Perez			Digging the diversity of Iberian bait worms Marphysa (Annelida, Eunicidae)	PLOS ONE			English	Article							INDO-WEST PACIFIC; SANGUINEA MONTAGU; POLYCHAETA EUNICIDAE; COMPLEX POLYCHAETA; QUATREFAGES; PHYLOGENY; COAST; REDESCRIPTION; FISHERIES; GENUS	During a visit to polychaete-rearing facilities in the vicinity of Bay of Ca ' diz (SW Iberian Peninsula, Atlantic Ocean), we sampled two populations of Marphysa (Annelida, Eunicidae) originally occurring at nearby intertidal soft bottoms, one being more than twice as long as the other at the same age. We analysed them using partial sequences of two mitochondrial genes, 16S rDNA and Cytochrome Oxidase I, and classical morphological observations. Our molecular results confirmed that the two populations corresponded to two different species, with PTP species delimitation values ranging from 0.973 (long-bodied species) to 0.999 (short-bodied species). Morphologically, the short-bodied species resembles the recently redescribed M. sanguinea (Montagu, 1813), but differs mainly in having some parapodia with two subacicular hooks (one bidentate and one unidentate) and three types of pectinate chaetae, Two isodont present all along the body, and one particularly large anodont asymmetric appearing only from mid-posterior parapodia. The long-bodied species resembles Marphysa aegypti Elgetany, El-Ghobashy, Ghoneim and Struck, 2018 both in size and in having very robust, unidentate subacicular hooks (single in most parapodia, two-both similar in size and form-in some posterior parapodia), but differs, among other features, in the maxillary formula, the number of acicula per parapodia and the number and shape of pectinate chaetae. Accordingly, we are here fully illustrating and formally describing the two Iberian populations as Marphysa gaditana sp. nov. (short-bodied) and Marphysa chirigota sp. nov. (long-bodied) and we are emending the description of M. aegypti based on our revision of the type material. Also, we discuss on the distribution of the species of the sanguinea-group and on the relevancy of taxonomically robust studies when dealing with species of commercial interest having the potential of being globally spread through human activities, as well as on the misunderstandings caused by the incorrect use of the "cosmopolitan species" concept.	[Martin, Daniel; Meca, Miguel A.] Ctr Adv Studies Blanes CEAB CSIC, Catalunya, Blanes, Spain; [Gil, Joao] Univ Algarve, Ctr Marine Sci, CCMAR, Campus Gambelas, Faro, Portugal; [Zanol, Joana] Univ Fed Rio de Janeiro, Dept Invertebrados, Museu Nacl, Rio De Janeiro, Brazil; [Meca, Miguel A.] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Portela, Rocio Perez] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Portela, Rocio Perez] Rey Juan Carlos Univ, Dept Biol Geol Phys & Inorgan Chem, Mostoles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Universidade do Algarve; Universidade Federal do Rio de Janeiro; University of Bergen; University of Miami; Universidad Rey Juan Carlos	Martin, D (corresponding author), Ctr Adv Studies Blanes CEAB CSIC, Catalunya, Blanes, Spain.	dani@ceab.csic.es	Martin, Daniel/G-5232-2010; Pérez-Portela, Rocío/I-9911-2014; Zanol, Joana/J-6263-2016	Martin, Daniel/0000-0001-6350-7384; Pérez-Portela, Rocío/0000-0003-3697-6526; Zanol, Joana/0000-0002-2178-791X; Meca, Miguel Angel/0000-0002-3798-6809; Gil, Joao/0000-0002-1856-3333	Linnean Society of London [2915]; Systematics Association [2915]; Consolidated Research Group on Marine Benthic Ecology, Generalitat de Catalunya [2017SGR378]; Agencia Estatal de Investigacion (AEI) [CTM2017-88080/PopCOmics]; European Regional Development Fund (FEDER) [CTM2017-88080/PopCOmics]	Linnean Society of London; Systematics Association; Consolidated Research Group on Marine Benthic Ecology, Generalitat de Catalunya; Agencia Estatal de Investigacion (AEI); European Regional Development Fund (FEDER)(European Commission)	This study received funds from the Linnean Society of London and the Systematics Association through the 2915 Systematics Research Fund call. The project funded was entitled "Cryptic Fish Baits." DM received funding from the Consolidated Research Group on Marine Benthic Ecology, Generalitat de Catalunya (http://agaur.gencat.cat), grant 2017SGR378 and the Agencia Estatal de Investigacio ' n (AEI) (http://www.ciencia.gob.es/portal/site/MICINN/aei), EuropeanRegional Development Fund (FEDER) (https://ec.europa.eu/regional_policy/en/funding/erdf/), grant CTM2017-88080/PopCOmics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E.J., 1915, J MAR BIOL ASSOC UK, V10, P592, DOI [DOI 10.1017/S002531540000919X, 10.1017/S002531540000919X]; Arias A, 2013, ESTUAR COAST SHELF S, V131, P117, DOI 10.1016/j.ecss.2013.08.017; Audouin JV., 1833, ANN SCI NATURELLES P, V29, P195, DOI DOI 10.5962/BHL.PART.8010; Augener H., 1918, BEITRAGE KENNTNIS ME, V2, P67, DOI DOI 10.5962/BHL.TITLE.7400; Aylagas E, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00096; Baird W, 1869, J LINNEAN SOC LONDON, V10, P341, DOI [10.1111/j.1096-3642.1869.tb00665.x, DOI 10.1111/J.1096-3642.1869.TB00665.X]; Bassindale R., 1960, Field Studies, V1, P1; Batista F. M., 2003, Boletin Instituto Espanol de Oceanografia, V19, P443; Berthold A. A., 1827, LATREILLES NATURLICH; BEUKEMA JJ, 1995, NETH J SEA RES, V33, P219, DOI 10.1016/0077-7579(95)90008-X; Birchenough S, 2013, 186 FES UK MMO FISH; Bischoff AA, 2009, AQUACULTURE, V296, P271, DOI 10.1016/j.aquaculture.2009.09.002; BOYDEN C R, 1977, Field Studies, V4, P477; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Carrera-Parra LF, 1998, J MAR BIOL ASSOC UK, V78, P145, DOI 10.1017/S0025315400040005; Carvalho S, 2013, ESTUAR COAST SHELF S, V132, P65, DOI 10.1016/j.ecss.2011.06.017; Cinar ME, 2013, J MAR BIOL ASSOC UK, V93, P1257, DOI 10.1017/S0025315412001646; Claparede A. R. E., 1863, BEOBACHTUNGEN ANATOM; Cole VJ, 2018, REV FISH BIOL FISHER, V28, P543, DOI 10.1007/s11160-018-9523-4; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P157, DOI 10.1017/S0025315400014909; Crossland C, 1903, P ZOOL SOC LOND, V1903, P169; Crothers J.H., 1966, FIELD STUDIES S2, V2, P1; Dales R.P., 1962, P ZOOL SOC LOND, V139, P389, DOI DOI 10.1111/J.1469-7998.1962.TB01837.X; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Day J. H., 1967, Brit Mus (Nat Hist) London Publ, Vno. 656, P1; Edwards Alasdair, 1992, Field Studies, V8, P59; Ehlers E., 1887, MEMOIRS MUSEUM COMP, V15, P1, DOI DOI 10.5962/BHL.TITLE.65639; Elgetany Asmaa H., 2018, Invertebrate Zoology, V15, P71; Fauchald K., 1970, Allan Hancock Monogr. mar. Biol., VNo. 5, P1; Fauvel P., 1953, ANNELIDA POLYCHAETA, P507; Font T, 2018, AQUAT CONSERV, V28, P651, DOI 10.1002/aqc.2873; Gambi M. Christina, 1994, Memoires du Museum National d'Histoire Naturelle, V162, P593; Garces JP, 2011, AQUACULT INT, V19, P523, DOI 10.1007/s10499-010-9368-x; Garces J, 2009, SCI MAR, V73, P605, DOI 10.3989/scimar.2009.73n3605; George JD, 1985, POLYCHAETES BRIT AMP, V32; Gil J.C.F., 2011, EUROPEAN FAUNA ANNEL; Gittenberger A, 2017, 201713 GIMARIS, P1; Glasby CJ, 2019, ZOOTAXA, V4674, P264, DOI 10.11646/zootaxa.4674.2.7; Glasby CJ, 2010, ZOOTAXA, P29; Gravier Ch., 1908, Bulletin du Museum Paris, V13; Grube AE., 1857, VIDENSKABETIGE MEDDE, P158; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen G. A., 1882, MEMOIRES COURONNES M, V44, P1; HARTMAN OLGA, 1961, ALLAN HANCOCK EXPED, V25, P1; Hutchings PA, 2003, HYDROBIOLOGIA, V496, P87, DOI 10.1023/A:1026124310552; Hutchings P, 2018, INVERTEBR SYST, V32, P1, DOI 10.1071/IS17035; Hutchings P, 2012, AQUAT INVASIONS, V7, P277, DOI 10.3391/ai.2012.7.2.014; Idris I., 2013, Asian Journal of Animal and Veterinary Advances, V8, P409, DOI 10.3923/ajava.2013.409.436; Idris Izwandy, 2014, Memoirs of Museum Victoria, V71, P109; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Izuka A, 1907, ZOOL MAG, V19, P139; Izuka A, 1912, J COLL SCI IMP U TOK, V30, P1, DOI DOI 10.1126/SCIENCE.NS-18.446.109; Kara J, 2015, THESIS; Katoh K., 2017, BRIEF BIOINFORM, DOI [10.1093/bib/bbx108, doi.org/10.1093/bib/bbx108, DOI 10.1093/BIB/BBX108]; Katsanevakis S, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00032; KEEGAN BF, 1974, CAH BIOL MAR, V15, P513; Keegan BF, 1987, P ROYAL IRISH ACAD B; Kinberg J. G. H., 1865, OEfvere af K Vet-Akad Forh Arg, V21, P559; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kott P., 1951, Journal of the Royal Society of Western Australia, V35, P85; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lamarck J.B., 1818, HIST NATURELLE ANIMA, V5; Lavesque N, 2019, ZOOKEYS, P1, DOI 10.3897/zookeys.859.34117; Lavesque N, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.716.14070; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lewis C, 2008, J MAR BIOL ASSOC UK, V88, P277, DOI 10.1017/S002531540800009X; Li SL, 2016, MITOCHONDRIAL DNA A, V27, P42, DOI 10.3109/19401736.2013.869686; Liu YB, 2018, ZOOTAXA, V4377, P191, DOI 10.11646/zootaxa.4377.2.3; Liu YB, 2017, ZOOTAXA, V4263, P228, DOI 10.11646/zootaxa.4263.2.2; Lobo J, 2016, MOL ECOL RESOUR, V16, P298, DOI 10.1111/1755-0998.12441; Maddison WP, 2018, MESQUITE MODULAR SYS; Marion AF, 1875, ANN SCI NATURELLES, V2, P2; Martin D, 2003, HYDROBIOLOGIA, V496, P145, DOI 10.1023/A:1026184529208; McIntosh WC, 1873, MONOGRAPH BRIT ANN 1, P1, DOI [DOI 10.5962/BHL.TITLE.54725, 10.5962/bhl.title.54725]; Miller M, 2012, RITUAL FESTIV CELEBR, V2, P1; Molina-Acevedo IC, 2018, ZOOTAXA, V4480, P1, DOI 10.11646/zootaxa.4480.1.1; Molina-Acevedo IC, 2017, ZOOTAXA, V4241, P1, DOI 10.11646/zootaxa.4241.1.1; Molina-Acevedo IC, 2015, ZOOTAXA, V3925, P37, DOI 10.11646/zootaxa.3925.1.3; Monro C.C.A., 1933, P ZOOL SOC LOND, V1933, P1, DOI [10.1111/j.1096-3642.1933.tb01578.x, DOI 10.1111/J.1096-3642.1933.TB01578.X]; Montagu G., 1816, T LINNEAN SOC LONDON, V11, P179, DOI [10.1111/j.1096-3642.1813.tb00047.x, DOI 10.1111/J.1096-3642.1813.TB00047.X]; Moore J. Percy, 1909, Proceedings of the Academy of Natural Sciences of Philadelphia, V61; Moreno E, 2012, ACT 3 S INT CIENC MA; MOYSE J., 1964, JOUR ANIMAL ECOL, V33, P183; Munoz Lechuga R, 2015, 15 C NAC 1 C IB AC, P412; NEWELL G. E., 1954, ANN AND MAG NAT HIST, V7, P321; Nisbet R. H., 1960, Essex Naturalist, V30, P247; NODA N, 1994, J BIOCHEM-TOKYO, V116, P435, DOI 10.1093/oxfordjournals.jbchem.a124543; Nygren A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198356; Nygren A, 2014, ZOOL SCR, V43, P172, DOI 10.1111/zsc.12044; Okuda S., 1933, Annotationes Zoologicae Japonenses, V14, P243; OKUDA SHIRO, 1934, PROC IMP ACAD [TOKYO], V10, P521; Olive PJW, 1999, HYDROBIOLOGIA, V402, P175, DOI 10.1023/A:1003744610012; Peters W.C.H., 1854, BER, V21, P607; Pillai T. G., 1958, Ceylon Journal of Science Biol Sci, V1, P94; Prevedelli D, 2007, MAR ECOL-EVOL PERSP, V28, P384, DOI 10.1111/j.1439-0485.2007.00160.x; Prezant RS, 2008, RAFFLES B ZOOL, P57; Quatrefages A., 1866, ANNELIDES GEPHYRIENS, V2, P1; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Read G, 1866, MARPHYSA QUATREFAGES; Risso A., 1826, HIST NATURELLE PRINC, Vtroisieme, DOI DOI 10.5962/BHL.TITLE.58984; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Siddall ME, 2001, MOL PHYLOGENET EVOL, V21, P346, DOI 10.1006/mpev.2001.1021; Stair J.B., 1847, P ZOOL SOC LOND, V15, P17; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Todd RA, 1906, VICTORIA HIST COUNTY, Vone; Treadwell A.L., 1921, CARNEGIE I WASHINGTO, V15, P1, DOI DOI 10.5962/BHL.PART.20335; TREADWELL AARON, 1939, AMER MUS NOVITATES, V1023, P1; TREADWELL AARON L., 1936, PROC U S NAT MUS, V83, P261; Treadwell AL, 1917, CARNEGIE I WASHINGTO, VIX, P255; van der Have TM, 2015, 15151 BUR WAARD BV E; Verrill A. E., 1900, T CONNECTICUT ACAD A, V10, P595, DOI [10.5962/bhl.part.7035, DOI 10.5962/BHL.PART.7035]; Villegas EM, 2016, CULTIVO INTEGRAL BIO; Wang Z, 2018, ZOOL STUD, V57, DOI 10.6620/ZS.2018.57-48; Watson GJ, 2017, FISH FISH, V18, P374, DOI 10.1111/faf.12178; Webster H.E., 1884, B US NATL MUSEUM, V25, P307, DOI DOI 10.5479/SI.03629236.25.305; Wehe Thomas, 2002, V19, P7; Wijnhoven S, 2010, AQUAT INVASIONS, V5, P431, DOI 10.3391/ai.2010.5.4.13; WINSNES IM, 1989, ZOOL SCR, V18, P483, DOI 10.1111/j.1463-6409.1989.tb00142.x; Zanol J, 2017, ZOOTAXA, V4268, P411, DOI 10.11646/zootaxa.4268.3.6; Zanol J, 2016, INVERTEBR BIOL, V135, P328, DOI 10.1111/ivb.12146; Zanol J, 2014, ZOOL SCR, V43, P79, DOI 10.1111/zsc.12034; Zanol J, 2010, MOL PHYLOGENET EVOL, V55, P660, DOI 10.1016/j.ympev.2009.12.024; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zintzen V, 2010, BELG J ZOOL, V140, P20	125	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0226749	10.1371/journal.pone.0226749	http://dx.doi.org/10.1371/journal.pone.0226749			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31967996	gold, Green Published			2022-12-26	WOS:000534373000008
J	Day, P; Alves, N; Daniell, E; Dasgupta, D; Ogborne, R; Steeper, A; Raza, M; Ellis, C; Fawcett, J; Keynes, R; Muir, E				Day, Priscilla; Alves, Nuno; Daniell, Esther; Dasgupta, Debayan; Ogborne, Rosalie; Steeper, Ashley; Raza, Mansoor; Ellis, Clare; Fawcett, James; Keynes, Roger; Muir, Elizabeth			Targeting chondroitinase ABC to axons enhances the ability of chondroitinase to promote neurite outgrowth and sprouting	PLOS ONE			English	Article							SULFATE PROTEOGLYCANS; RECOVERY; INJURY; PTEN; ACTIVATION; DIGESTION; DELETION; TUBULIN; NEURONS; GROWTH	Background There is currently no effective treatment for promoting regeneration of injured nerves in patients who have sustained injury to the central nervous system such as spinal cord injury. Chondroitinase ABC is an enzyme, which promotes neurite outgrowth and regeneration. It has shown considerable promise as a therapy for these conditions. The aim of the study is to determine if targeting chondroitinase ABC expression to the neuronal axon can further enhance its ability to promote axon outgrowth. Long-distance axon regeneration has not yet been achieved, and would be a significant step in attaining functional recovery following spinal cord injury. Methodology/Principal findings To investigate this, neuronal cultures were transfected with constructs encoding axon-targeted chondroitinase, non-targeted chondroitinase or GFP, and the effects on neuron outgrowth and sprouting determined on substrates either permissive or inhibitory to neuron regeneration. The mechanisms underlying the observed effects were also explored. Targeting chondroitinase to the neuronal axon markedly enhances its ability to promote neurite outgrowth. The increase in neurite length is associated with an upregulation of beta-integrin staining at the axonal cell surface. Staining for phosphofocal adhesion kinase, is also increased, indicating that the beta-integrins are in an activated state. Expression of chondroitinase within the neurons also resulted in a decrease in expression of PTEN and RhoA, molecules which present a block to neurite outgrowth, thus identifying two of the pathways by which ChABC promotes neurite outgrowth. Conclusions / Significance The novel finding that targeting ChABC to the axon significantly enhances its ability to promote neurite extension, suggests that this may be an effective way of promoting long-distance axon regeneration following spinal cord injury. It could also potentially improve its efficacy in the treatment of other pathologies, where it has been shown to promote recovery, such as myocardial infarction, stroke and Parkinson's disease.	[Day, Priscilla; Daniell, Esther; Dasgupta, Debayan; Ogborne, Rosalie; Steeper, Ashley; Raza, Mansoor; Ellis, Clare; Keynes, Roger; Muir, Elizabeth] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Alves, Nuno; Fawcett, James] Univ Cambridge, John Van Geest Ctr Brain Repair, Cambridge, England	University of Cambridge; University of Cambridge	Muir, E (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	emm1@cam.ac.uk		Fawcett, James/0000-0002-7990-4568; Dasgupta, Debayan/0000-0002-1064-0541; Ogborne, Rosalie/0000-0003-3327-6030	Isaac Newton Trust [RG46400]; Wellcome Trust [RG45123]; BBSRC [BBS/E/F/000PR10347] Funding Source: UKRI	Isaac Newton Trust; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Isaac Newton Trust (URL https://www.newtontrust.cam.ac.uk/Award number: RG46400) and a project grant from the Wellcome Trust (URL https://wellcometrust.cam.ac.uk/Award number: RG45123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Prof Michael Coleman for his advice on the axon-targeting sequence. We also thank Prof Joost Verhaagen for generating the ChABC lentivirus for the PTEN experiments and Prof Stephen Duffy for advice on statistical methods.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CACERES A, 1986, J NEUROSCI, V6, P714; Chen XR, 2014, BRAIN RES, V1543, P324, DOI 10.1016/j.brainres.2013.12.002; Danilov CA, 2015, EXP NEUROL, V266, P147, DOI 10.1016/j.expneurol.2015.02.012; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gardner RJ, 2013, J NEUROSCI, V33, P18469, DOI 10.1523/JNEUROSCI.2197-13.2013; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gheardini L, 2015, CEREB CORTEX, V1, P202; HOLM S, 1979, SCAND J STAT, V6, P65; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Lander C, 1998, J NEUROSCI, V18, P174; Lee DH, 2014, J NEUROSCI, V34, P15347, DOI 10.1523/JNEUROSCI.1935-14.2014; Lee HJ, 2012, J NEUROTRAUM, V29, P1850, DOI 10.1089/neu.2011.2290; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Mak LH, 2015, METHODS, V77-78, P63, DOI 10.1016/j.ymeth.2015.02.007; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Mondello SE, 2015, EXP NEUROL, V267, P64, DOI 10.1016/j.expneurol.2015.02.028; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Muir E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186759; Muir EM, 2010, J BIOTECHNOL, V145, P103, DOI 10.1016/j.jbiotec.2009.11.002; Orlando C, 2012, J NEUROSCI, V32, P18009, DOI 10.1523/JNEUROSCI.2406-12.2012; Perdigoto AL, 2011, MOL CELL NEUROSCI, V46, P235, DOI 10.1016/j.mcn.2010.09.006; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sackett SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28857-1; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivak WN, 2017, J TISSUE ENG REGEN M, V11, P733, DOI 10.1002/term.1970; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Walker BA, 2012, GENE THER, V19, P947, DOI 10.1038/gt.2011.217; Walker BA, 2012, J NEUROSCI METH, V201, P228; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003	39	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0221851	10.1371/journal.pone.0221851	http://dx.doi.org/10.1371/journal.pone.0221851			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961897	Green Published, gold			2022-12-26	WOS:000534372000002
J	Sousa, DM; Martins, PS; Leitao, L; Alves, CJ; Gomez-Lazaro, M; Neto, E; Conceicao, F; Herzog, H; Lamghari, M				Sousa, Daniela M.; Martins, Pedro S.; Leitao, Luis; Alves, Cecilia J.; Gomez-Lazaro, Maria; Neto, Estrela; Conceicao, Francisco; Herzog, Herbert; Lamghari, Meriem			The lack of neuropeptide Y-Y-1 receptor signaling modulates the chemical and mechanical properties of bone matrix	FASEB JOURNAL			English	Article						biomechanical properties; bone quality; bone strength; Y-1 receptor	Y1 RECEPTORS; DIFFERENTIATION; OSTEOCYTES; GUIDELINES; INCREASES; QUALITY	Genetic and pharmacological functional studies have provided evidence that the lack of Neuropeptide Y-Y-1 receptor (Y1R) signaling pathway induces a high bone mass phenotype in mice. However, clinical observations have shown that drug or genetic mediated improvement of bone mass might be associated to alterations to bone extracellular matrix (ECM) properties, leading to bone fragility. Hence, in this study we propose to characterize the physical, chemical and biomechanical properties of mature bone ECM of germline NPY-Y1R knockout (Y1R-/-) mice, and compare to their wild-type (WT) littermates. Our results demonstrated that the high bone mass phenotype observed in Y1R-/- mice involves alterations in Y(1)R(-/- )bone ECM ultrastructure, as a result of accelerated deposition of organic and mineral fractions. In addition, Y1R-/- bone ECM displays enhanced matrix maturation characterized by greater number of mature/highly packed collagen fibers without pathological accumulation of immature/mature collagen crosslinks nor compromise of mineral crystallinity. These unique features of Y1R-/- bone ECM improved the biochemical properties of Y(1)R(-/- )bones, reflected by mechanically robust bones with diminished propensity to fracture, contributing to greater bone strength. These findings support the future usage of drugs targeting Y1R signaling as a promising therapeutic strategy to treat bone loss-related pathologies.	[Sousa, Daniela M.; Leitao, Luis; Alves, Cecilia J.; Gomez-Lazaro, Maria; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal; [Sousa, Daniela M.; Leitao, Luis; Alves, Cecilia J.; Gomez-Lazaro, Maria; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, INEB Inst Engn Biomed, Porto, Portugal; [Martins, Pedro S.] Univ Porto, Fac Engn, INEGI Inst Ciencia & Inovacao Engn Mecan & Engn I, Porto, Portugal; [Leitao, Luis; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, ICBAS, Porto, Portugal; [Herzog, Herbert] St Vincents Hosp, Garvan Inst Med Res, Neurosci Res Program, Darlinghurst, NSW, Australia	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Lamghari, M (corresponding author), Univ Porto, i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal.	lamghari@ineb.up.pt	Neto, Estrela C/M-2561-2013; Martins, Pedro A.L.S./H-4313-2011; Conceição, Francisco/HCI-8740-2022; Martins, Pedro/GWC-7702-2022; Lazaro, Maria Gomez/J-5931-2018; Sousa, Daniela/C-1485-2014; Lamghari, Meriem/K-2159-2013	Neto, Estrela C/0000-0003-2334-2292; Martins, Pedro A.L.S./0000-0001-9732-4498; Lazaro, Maria Gomez/0000-0002-8836-396X; Sousa, Daniela/0000-0001-8498-0664; Conceicao, Francisco/0000-0003-4587-2470; Lamghari, Meriem/0000-0002-2500-4548	FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT/MCTES [POCI-01-0145-FEDER-030158, PTDC/MED-PAT/30158/2017]; i3S Scientific Platforms Bioimaging [PPBI-POCI-01-0145-FEDER-022122]; HEMS (Histology and Electron Microscopy Services) [PPBI-POCI-01-0145-FEDER-022122];  [SFRH/BPD/115341/2016];  [SFRH/BD/109686/2015];  [SFRH/BD/128771/2017]	FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT/MCTES; i3S Scientific Platforms Bioimaging; HEMS (Histology and Electron Microscopy Services); ; ; 	This work was financed by FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT/MCTES in the framework of the project "SproutOC" (POCI-01-0145-FEDER-030158, PTDC/MED-PAT/30158/2017). DMS is a recipient of a Post-Doc fellowship (SFRH/BPD/115341/2016). LL and FC are recipients of Ph.D. fellowships (SFRH/BD/109686/2015 and SFRH/BD/128771/2017, respectively). The authors would like to acknowledge Claudia Machado for helping with histology analysis and Carla Oliveira for the help with linear regression analysis. The authors acknowledge the support of the i3S Scientific Platforms Bioimaging and HEMS (Histology and Electron Microscopy Services), members of the national infrastructure PPBI - Portuguese Platform of Bioimaging (PPBI-POCI-01-0145-FEDER-022122).	Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Allison SJ, 2009, J BONE MINER RES, V24, P294, DOI [10.1359/jbmr.081013, 10.1359/JBMR.081013]; Alves CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165465; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Bhan Arti, 2018, Bone Rep, V8, P125, DOI 10.1016/j.bonr.2018.03.005; Bi XH, 2011, J BIOMECH, V44, P297, DOI 10.1016/j.jbiomech.2010.10.009; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boskey AL., 2013, OSTEOPOROSIS, P235, DOI [10.1016/B978-0-12-415853-5.00011-X, DOI 10.1016/B978-0-12-415853-5.00011-X]; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Compston Juliet, 2006, Arq Bras Endocrinol Metab, V50, P579, DOI 10.1590/S0004-27302006000400003; Dole NS, 2017, CELL REP, V21, P2585, DOI 10.1016/j.celrep.2017.10.115; Donnelly E, 2011, CLIN ORTHOP RELAT R, V469, P2128, DOI 10.1007/s11999-010-1702-0; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Franquinho F, 2010, FEBS J, V277, P3664, DOI 10.1111/j.1742-4658.2010.07774.x; Fuchs RK, 2019, WOODH PUBL SER BIOM, P15, DOI 10.1016/B978-0-08-102451-5.00002-0; Goodyear SR, 2019, METHODS MOL BIOL, V1914, P651, DOI 10.1007/978-1-4939-8997-3_35; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Jin A, 2017, BONE JOINT RES, V6, P602, DOI 10.1302/2046-3758.610.BJR-2016-0321.R1; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Kremer R, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00190; Lee NJ, 2011, BONE, V48, P461, DOI 10.1016/j.bone.2010.10.174; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Leitao L, 2019, FASEB J, V33, P8697, DOI 10.1096/fj.201900454R; Licata A, 2009, CLEV CLIN J MED, V76, P331, DOI 10.3949/ccjm.76a.08041; Mandair GS, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2014.115; McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258; Mertz EL, 2016, MATRIX BIOL, V52-54, P29, DOI 10.1016/j.matbio.2016.03.005; Oest ME, 2016, BONE, V86, P91, DOI 10.1016/j.bone.2016.03.003; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; Schwarcz HP, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00039; Sousa DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33470; Sousa DM, 2013, J ORTHOP RES, V31, P1570, DOI 10.1002/jor.22400; Sousa DM, 2012, BONE, V51, P8, DOI 10.1016/j.bone.2012.03.020; Stark Z, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-5; Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194; Treager C, 2017, ORTHOPEDIC SURG CLER, P743; Vijayan V, 2017, J ENDOCRINOL, V233, P243, DOI 10.1530/JOE-16-0562; Zengin A, 2010, TRENDS ENDOCRIN MET, V21, P411, DOI 10.1016/j.tem.2010.02.004; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	42	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4163	4177		10.1096/fj.201902796R	http://dx.doi.org/10.1096/fj.201902796R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960508				2022-12-26	WOS:000508661500001
J	Halpert, JR				Halpert, James R.			So many roads traveled: A career in science and administration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						pharmacology; toxicology; chemical biology; cytochrome P450; structure-function; CYP2B enzymes	RAT-LIVER CYTOCHROME-P-450; SUBSTRATE RECOGNITION SITES; AMINO-ACID-SEQUENCE; ACTIVE-SITE; PRESYNAPTIC NEUROTOXIN; DIRECTED MUTAGENESIS; SUICIDE INACTIVATION; OXYGEN-AFFINITY; LIGAND-BINDING; RED-CELLS	I have traveled many roads during my career. After spending my first 19 years in Los Angeles, I became somewhat of an academic nomad, studying and/or working in six universities in the United States and three in Sweden. In chronological order, I have a B.A. in Scandinavian languages and literature from UCLA, a Ph.D. in biochemistry from Uppsala University, and an M.S. in toxicology from the Karolinska Institute. I have been in schools of natural science, pharmacy, and medicine and have worked in multiple basic science departments and one clinical department. I have served as a research-track and tenured faculty member, department chair, associate dean, and dean. My research has spanned toxinology, biochemistry, toxicology, and pharmacology. Through all the moves, I have gained much and lost some. For the past 40 years, my interest has been cytochrome P450 structure-function and structure-activity relationships. My lab has focused on CYP2B enzymes using X-ray crystallography, site-directed mutagenesis, deuterium-exchange MS, isothermal titration calorimetry, and computational methods in conjunction with a variety of functional assays. This comprehensive approach has enabled detailed understanding of the structural basis of the remarkable substrate promiscuity of CYP2B enzymes. We also have investigated the mechanisms of CYP3A4 allostery using biophysical and advanced spectroscopic techniques, and discovered a pivotal role of P450-P450 interactions and of multiple-ligand binding. A major goal of this article is to provide lessons that may be useful to scientists in the early and middle stages of their careers and those more senior scientists contemplating an administrative move.	[Halpert, James R.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA	University of Connecticut	Halpert, JR (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	james.halpert@uconn.edu			National Institutes of Health [ES00151, ES003619, ES004995, GM54995]; National Science Foundation [IOS-1461359]; PhRMA Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); PhRMA Foundation	The research described was supported by National Institutes of Health Grants ES00151, ES003619, ES004995, and GM54995; by National Science Foundation Grant IOS-1461359; and by a Starter Grant and Faculty Development Award from the PhRMA Foundation. I thank the many members of my research group, friends, and colleagues whom I was not able to mention in the text.	BRANN EG, 1973, SCIENCE, V179, P593, DOI 10.1126/science.179.4073.593; CIACCIO PJ, 1991, BIOCHIM BIOPHYS ACTA, V1088, P319, DOI 10.1016/0167-4781(91)90072-T; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; DUIGNAN DB, 1987, ARCH BIOCHEM BIOPHYS, V255, P290, DOI 10.1016/0003-9861(87)90396-1; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; Gay SC, 2011, BIOCHEMISTRY-US, V50, P4903, DOI 10.1021/bi200482g; Gay SC, 2010, BIOCHEMISTRY-US, V49, P8709, DOI 10.1021/bi100914z; Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570; HAAPARANTA T, 1983, CANCER RES, V43, P5131; HALPERT J, 1980, MOL PHARMACOL, V17, P427; HALPERT J, 1979, J BIOL CHEM, V254, P7434; HALPERT J, 1983, MOL PHARMACOL, V23, P445; HALPERT J, 1976, FEBS LETT, V61, P72, DOI 10.1016/0014-5793(76)80174-3; HALPERT J, 1975, J BIOL CHEM, V250, P6990; HALPERT J, 1976, J BIOL CHEM, V251, P7343; HALPERT J, 1980, J BIOL CHEM, V255, P1080; HALPERT J, 1981, BIOCHEM PHARMACOL, V30, P875, DOI 10.1016/S0006-2952(81)80010-X; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; HALPERT JR, 1985, J BIOL CHEM, V260, P8397; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; HASLER JA, 1994, MOL PHARMACOL, V46, P338; He YA, 1997, BIOCHEMISTRY-US, V36, P8831, DOI 10.1021/bi970182i; HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011; KAMATAKI T, 1976, MOL PHARMACOL, V12, P933; KEDZIE KM, 1991, J BIOL CHEM, V266, P22515; Khan KK, 2002, MOL PHARMACOL, V61, P495, DOI 10.1124/mol.61.3.495; Kobayashi Y, 1998, BIOCHEMISTRY-US, V37, P6679, DOI 10.1021/bi9731450; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Lee SC, 2013, P NATL ACAD SCI USA, V110, pE1203, DOI 10.1073/pnas.1221442110; Liu JB, 2016, BIOCHEMISTRY-US, V55, P1997, DOI 10.1021/acs.biochem.5b01330; MACGEOCH C, 1984, J BIOL CHEM, V259, P5433; Muralidhara BK, 2007, J AM CHEM SOC, V129, P2015, DOI 10.1021/ja066303w; Neal RA, 1996, ANNU REV PHARMACOL, V36, P35; OSKI FA, 1972, SCIENCE, V175, P1372, DOI 10.1126/science.175.4028.1372; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P2123, DOI 10.1021/bi101797v; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Shah MB, 2017, ACS CHEM BIOL, V12, P1204, DOI 10.1021/acschembio.7b00056; Shah Manish B, 2016, Mol Pharmacol, V89, P435, DOI 10.1124/mol.115.102111; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Spatzenegger M, 2001, MOL PHARMACOL, V59, P475, DOI 10.1124/mol.59.3.475; STEVENS JC, 1988, MOL PHARMACOL, V33, P103; Strobel SM, 1997, BIOCHEMISTRY-US, V36, P11697, DOI 10.1021/bi9710176; SZKLARZ GD, 1995, BIOCHEMISTRY-US, V34, P14312, DOI 10.1021/bi00044a008; Wilderman PR, 2014, TOXICOL APPL PHARM, V274, P393, DOI 10.1016/j.taap.2013.12.005; Wilderman PR, 2012, CURR DRUG METAB, V13, P167; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	51	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					822	832		10.1074/jbc.X119.012206	http://dx.doi.org/10.1074/jbc.X119.012206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31953248	Green Published, hybrid			2022-12-26	WOS:000508382900013
J	Huang, XL; Duddy, OP; Silpe, JE; Paczkowski, JE; Cong, JP; Henke, BR; Bassler, BL				Huang, Xiuliang; Duddy, Olivia P.; Silpe, Justin E.; Paczkowski, Jon E.; Cong, Jianping; Henke, Brad R.; Bassler, Bonnie L.			Mechanism underlying autoinducer recognition in the Vibrio cholerae DPO-VqmA quorum-sensing pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; Vibrio cholerae; crystallography; bacteria; gene regulation; 3; 5-dimethyl-pyrazin-2-ol (DPO); autoinducer; binding; N-alanyl-aminoacetone (Ala-AA); VqmA	CONTROLS BIOFILM FORMATION; PAS DOMAINS; REGULATOR; VIRULENCE; BINDING; LIGAND; SIGNAL; SPECIFICITY; ACTIVATION; GLYOXYLATE	Quorum sensing is a bacterial communication process whereby bacteria produce, release, and detect extracellular signaling molecules called autoinducers to coordinate collective behaviors. In the pathogen Vibrio cholerae, the quorum-sensing autoinducer 3,5-dimethyl-pyrazin-2-ol (DPO) binds the receptor and transcription factor VqmA. The DPO-VqmA complex activates transcription of vqmR, encoding the VqmR small RNA, which represses genes required for biofilm formation and virulence factor production. Here, we show that VqmA is soluble and properly folded and activates basal-level transcription of its target vqmR in the absence of DPO. VqmA transcriptional activity is increased in response to increasing concentrations of DPO, allowing VqmA to drive the V. cholerae quorum-sensing transition at high cell densities. We solved the DPO-VqmA crystal structure to 2.0 ? resolution and compared it with existing structures to understand the conformational changes VqmA undergoes upon DNA binding. Analysis of DPO analogs showed that a hydroxyl or carbonyl group at the 2?-position is critical for binding to VqmA. The proposed DPO precursor, a linear molecule, N-alanyl-aminoacetone (Ala-AA), also bound and activated VqmA. Results from site-directed mutagenesis and competitive ligand-binding analyses revealed that DPO and Ala-AA occupy the same binding site. In summary, our structure-function analysis identifies key features required for VqmA activation and DNA binding and establishes that, whereas VqmA binds two different ligands, VqmA does not require a bound ligand for folding or basal transcriptional activity. However, bound ligand is required for maximal activity.	[Huang, Xiuliang; Duddy, Olivia P.; Silpe, Justin E.; Paczkowski, Jon E.; Cong, Jianping; Henke, Brad R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Huang, Xiuliang; Henke, Brad R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bassler, Bonnie L.] Optimol Consulting LLC, Cary, NC 27513 USA; [Paczkowski, Jon E.] Wadsworth Ctr, New York State Dept Hlth, Div Genet, Albany, NY 12201 USA	Princeton University; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab 329, Princeton, NJ 08544 USA.	bbassler@princeton.edu	; Silpe, Justin/B-6956-2013	Duddy, Olivia/0000-0002-6221-7841; Bassler, Bonnie/0000-0002-0043-746X; Silpe, Justin/0000-0002-6264-8553; HUANG, XIULIANG/0000-0002-1596-4617	DOE Office of Science [DE-SC0012704]; NIGMS, National Institutes of Health, through Biomedical Technology Research Resource P41 Grant [P41GM111244]; DOE Office of Biological and Environmental Research Grant [KP1605010]	DOE Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health, through Biomedical Technology Research Resource P41 Grant; DOE Office of Biological and Environmental Research Grant(United States Department of Energy (DOE))	We thank Dr. Phillip Jeffrey of the Macromolecular Crystallography Core Facility, Dr. Saw Kyin of the Proteomics and Mass Spectrometry Core Facility, and Dr. Venu Vandasvasi of the Biophysics Core Facility, all at Princeton University, for expert assistance. We thank Dr. Frederick Hughson for thoughtful discussions. We thank the Bassler group for insight into the research. This research used resources FMX and AMX of the National Synchrotron Light Source II, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under Contract DE-SC0012704. The Life Science Biomedical Technology Research resource is primarily supported by NIGMS, National Institutes of Health, through Biomedical Technology Research Resource P41 Grant P41GM111244 and by DOE Office of Biological and Environmental Research Grant KP1605010. The authors received expert technical support from Dr. Martin Fuchs and Dr. Jean Jakoncic of the NSLS II FMX and AMX beamlines.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Collier LS, 1998, J BACTERIOL, V180, P2493, DOI 10.1128/JB.180.9.2493-2501.1998; EBERHARD A, 1986, ARCH MICROBIOL, V146, P35, DOI 10.1007/BF00690155; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerdt JP, 2017, ACS CHEM BIOL, V12, P2457, DOI 10.1021/acschembio.7b00458; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Herzog R, 2019, NUCLEIC ACIDS RES, V47, P3171, DOI 10.1093/nar/gky1320; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Joyce MG, 2010, ACTA CRYSTALLOGR D, V66, P358, DOI 10.1107/S0907444909053074; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Ke XB, 2015, MOL MICROBIOL, V95, P127, DOI 10.1111/mmi.12852; KURIHARA T, 1991, J HETEROCYCLIC CHEM, V28, P1557, DOI 10.1002/jhet.5570280616; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; McCready AR, 2019, P NATL ACAD SCI USA, V116, P245, DOI 10.1073/pnas.1817239116; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MUKHERJEE JJ, 1987, J BIOL CHEM, V262, P14441; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Papenfort K, 2017, NAT CHEM BIOL, V13, P551, DOI [10.1038/NCHEMBIO.2336, 10.1038/nchembio.2336]; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silpe JE, 2019, CELL, V176, P268, DOI 10.1016/j.cell.2018.10.059; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652; Wu H, 2019, BIOCHEM BIOPH RES CO, V520, P399, DOI 10.1016/j.bbrc.2019.10.063; Wu H, 2019, J BIOL CHEM, V294, P2580, DOI 10.1074/jbc.RA118.006082; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	48	15	16	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2916	2931		10.1074/jbc.RA119.012104	http://dx.doi.org/10.1074/jbc.RA119.012104			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31964715	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000519597300005
J	Muller, YA; Hage, S; Alkhashrom, S; Hollriegl, T; Weigert, S; Dolles, S; Hof, K; Walzer, SA; Egerer-Sieber, C; Conrad, M; Holst, S; Losing, J; Sonntag, E; Sticht, H; Eichler, J; Marschall, M				Muller, Yves A.; Haege, Sigrun; Alkhashrom, Sewar; Hoellriegl, Tobias; Weigert, Sebastian; Dolles, Simon; Hof, Kerstin; Walzer, Sascha A.; Egerer-Sieber, Claudia; Conrad, Marcus; Holst, Stephanie; Loesing, Josephine; Sonntag, Eric; Sticht, Heinrich; Eichler, Jutta; Marschall, Manfred			High-resolution crystal structures of two prototypical ?- and ?-herpesviral nuclear egress complexes unravel the determinants of subfamily specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; structure-function; energetics; confocal microscopy; crystal structure; alanine scan; Epstein-Barr virus; Human cytomegalovirus; nuclear egress complex; Protein-protein interactions	CYTOMEGALOVIRUS PUL50; WEB SERVER; PROTEIN; INFECTION; INSIGHTS; FEATURES; LAMINA; DOMAIN	Herpesviruses uniquely express two essential nuclear egress-regulating proteins forming a heterodimeric basic structure of the nuclear egress complex (core NEC). These core NECs serve as a hexameric lattice-structured platform for capsid docking and recruit viral and cellular NEC-associated factors that jointly exert nuclear lamina- and membrane-rearranging functions (multicomponent NEC). Here, we report the X-ray structures of ?- and ?-herpesvirus core NECs obtained through an innovative recombinant expression strategy based on NEC-hook::NEC-groove protein fusion constructs. This approach yielded the first structure of ?-herpesviral core NEC, namely the 1.56 ? structure of Epstein-Barr virus (EBV) BFRF1?BFLF2, as well as an increased resolution 1.48 ? structure of human cytomegalovirus (HCMV) pUL50-pUL53. Detailed analysis of these structures revealed that the prominent hook segment is absolutely required for core NEC formation and contributes approximately 80% of the interaction surface of the globular domains of NEC proteins. Moreover, using HCMV::EBV hook domain swap constructs, computational prediction of the roles of individual hook residues for binding, and quantitative binding assays with synthetic peptides presenting the HCMV- and EBV-specific NEC hook sequences, we characterized the unique hook-into-groove NEC interaction at various levels. Although the overall physicochemical characteristics of the protein interfaces differ considerably in these ?- and ?-herpesvirus NECs, the binding free energy contributions of residues displayed from identical positions are similar. In summary, the results of our study reveal critical details of the molecular mechanism of herpesviral NEC interactions and highlight their potential as an antiviral drug target.	[Muller, Yves A.; Hoellriegl, Tobias; Weigert, Sebastian; Hof, Kerstin; Walzer, Sascha A.; Egerer-Sieber, Claudia] Friedrich Alexander Univ Erlangen Nurnberg FAU, Div Biotechnol, Dept Biol, D-91054 Erlangen, Germany; [Haege, Sigrun; Loesing, Josephine; Sonntag, Eric; Marschall, Manfred] Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Ctr, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Alkhashrom, Sewar; Dolles, Simon; Holst, Stephanie; Eichler, Jutta] Friedrich Alexander Univ Erlangen Nurnberg FAU, Div Med Chem, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Conrad, Marcus; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Biochem, Div Bioinformat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Div Biotechnol, Dept Biol, D-91054 Erlangen, Germany.; Marschall, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Ctr, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	yves.muller@fau.de; manfred.marschall@fau.de	Eichler, Jutta/H-7847-2018; Muller, Yves/R-5397-2016	Eichler, Jutta/0000-0001-6683-9456; Muller, Yves/0000-0003-0519-8928; Weigert, Sebastian/0000-0002-0469-1545	Deutsche Forschungsgemeinschaft [MA 1289/8-1, EI 423/4-1, MU 1477/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants MA 1289/8-1, EI 423/4-1, and MU 1477/10-1 (to Y. A. M., J. E., and M. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], [No title captured]; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bailer SM, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040046; Bigalke JM, 2015, EMBO J, V34, P2921, DOI 10.15252/embj.201592359; Bigalke JM, 2015, J VIROL, V89, P9150, DOI 10.1128/JVI.02530-14; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Diewald B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102908; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gross A, 2015, CHEMBIOCHEM, V16, P446, DOI 10.1002/cbic.201402545; Hellberg T, 2016, ADV VIRUS RES, V94, P81, DOI 10.1016/bs.aivir.2015.10.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jha HC, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010018; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kumar KSD, 2015, J APPL CRYSTALLOGR, V48, P939, DOI 10.1107/S1600576715006287; Leigh KE, 2015, P NATL ACAD SCI USA, V112, P9010, DOI 10.1073/pnas.1511140112; Lye MF, 2015, EMBO J, V34, P2937, DOI 10.15252/embj.201592651; Marschall M, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1934; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2012, J BIOL CHEM, V287, P24004, DOI 10.1074/jbc.M111.331207; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sonntag E, 2016, J GEN VIROL, V97, P1676, DOI 10.1099/jgv.0.000495; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Walzer SA, 2015, J BIOL CHEM, V290, P27452, DOI 10.1074/jbc.C115.686527; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeev-Ben-Mordehai T, 2015, CELL REP, V13, P2645, DOI 10.1016/j.celrep.2015.11.008	35	16	16	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3189	3201		10.1074/jbc.RA119.011546	http://dx.doi.org/10.1074/jbc.RA119.011546			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31980459	Green Published, hybrid			2022-12-26	WOS:000519597300024
J	Douglas, NM; Kenangalemm, E; Hasanuddin, A; Anstey, NM; Sugiarto, P; Price, RN; Poespoprodjo, JR				Douglas, Nicholas M.; Kenangalemm, Enny; Hasanuddin, Afdhal; Anstey, Nicholas M.; Sugiarto, Paulus; Price, Ric N.; Poespoprodjo, Jeanne Rini			Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study	PLOS ONE			English	Article							PLASMODIUM-VIVAX; FALCIPARUM-MALARIA; CHILDREN; RISK; PERFORMANCE; INFECTIONS; MORTALITY	Background In endemic regions, the age distribution of malaria varies according to the infecting Plasmodium species. We aimed to delineate the pattern of malaria-related hospitalization from birth in Timika, Papua-an area co-endemic for P. falciparum and P. vivax Methods Between April 2004 and December 2013, infants born at Mitra Masyarakat Hospital, or presenting within the first 7 days of life, were enrolled retrospectively into a cohort study and followed passively using routinely-collected hospital surveillance data. Outcomes were stratified by the presence or absence of Plasmodium parasitemia and included re-presentation to hospital, requirement for hospital admission and death. Results Overall, 11,408 infants were enrolled into the cohort. Median follow-up was 4.3 (maximum 9.7) years. In total, 7,847 (68.9%) infants made 90,766 re-presentations to hospital, 18,105 (19.9%) of which were associated with Plasmodium parasitemia. The incidence of re-presentations with malaria during the first year of life was 213 per 1,000 person-years (py) for P. vivax and 79 per 1,000py for P. falciparum (Incidence Rate Ratio (IRR) = 2.69, 95% Confidence Interval (95%CI): 2.48-2.92). After the age of 5 years, the incidence of P. vivax had fallen to 77/1,000py and the incidence of P. falciparum had risen to 95/1,000py (IRR = 0.80, 95%CI: 0.73-0.88). Overall, 79.7% (14,431/18,105) of malaria re-presentations were recurrences rather than initial infections. Malaria accounted for 31.7% (2,126/3,120) of all hospital admissions. The infant mortality rate in this study was 52 deaths per 1,000 live births. Beyond the early neonatal period, 13.4% of deaths were associated with Plasmodium parasitemia. Conclusions In Papua, Indonesia, malaria is a major cause of hospital presentation and admission in early life. The initial predominance of P. vivax over P. falciparum inverts after five years of age. Malaria is directly associated with nearly one in seven deaths after the early neonatal period.	[Douglas, Nicholas M.; Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Douglas, Nicholas M.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Infect Dis, Darwin, NT, Australia; [Kenangalemm, Enny; Poespoprodjo, Jeanne Rini] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Program, Timika, Papua, Indonesia; [Kenangalemm, Enny] Mimika Dist Hlth Author, Timika, Papua, Indonesia; [Hasanuddin, Afdhal; Sugiarto, Paulus] Rumah Sakit Mitra Masyarakat, Dept Paediat, Timika, Papua, Indonesia; [Price, Ric N.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England; [Price, Ric N.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Poespoprodjo, Jeanne Rini] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Child Hlth, Yogyakarta, Indonesia; [Poespoprodjo, Jeanne Rini] Rumah Sakit Umum Daerah, Dept Paediat, Timika, Papua, Indonesia	Charles Darwin University; Menzies School of Health Research; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Gadjah Mada University	Douglas, NM (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Douglas, NM (corresponding author), Royal Darwin Hosp, Div Infect Dis, Darwin, NT, Australia.	nicholas.douglas@gmail.com	Douglas, Nicholas/ABC-3052-2021	Douglas, Nicholas/0000-0002-7214-4244; Price, Richard/0000-0003-2000-2874	Wellcome Trust [200909, 099875]; Bill and Melinda Gates Foundation [OPP1054404]; Australian National Health and Medical Research Council [1132975, 1037304]; Australian National Health and Medical Research Council (Australian Centre of Research Excellence on Malaria Elimination, ACREME) [1134989]; Australian Department of Foreign Affairs and Trade (DFAT); Australian National Health and Medical Research Council (HOT NORTH initiative) [1131932, 1135820]	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council (Australian Centre of Research Excellence on Malaria Elimination, ACREME); Australian Department of Foreign Affairs and Trade (DFAT)(Australian Government); Australian National Health and Medical Research Council (HOT NORTH initiative)	The study was funded by the Wellcome Trust (Senior Fellowship in Clinical Science to RNP 200909 and Training Fellowship in Tropical Medicine to JRP 099875), the Bill and Melinda Gates Foundation (OPRA, OPP1054404), and the Australian National Health and Medical Research Council (Program grants #1132975 and #1037304; the HOT NORTH initiative #1131932 and a Fellowship to NMA #1135820; and the Australian Centre of Research Excellence on Malaria Elimination, ACREME #1134989). The Timika Research Facility and Papuan Community Health Foundation is supported by the Australian Department of Foreign Affairs and Trade (DFAT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Betuela I, 2012, J INFECT DIS, V206, P1771, DOI 10.1093/infdis/jis580; Chu CS, 2018, CLIN INFECT DIS, V67, P1543, DOI 10.1093/cid/ciy319; Commons RJ, 2018, LANCET INFECT DIS, V18, P1025, DOI 10.1016/S1473-3099(18)30348-7; Devine A, 2018, AM J TROP MED HYG, V98, P543, DOI 10.4269/ajtmh.17-0680; Douglas NM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002379; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; Faiz MA, 2005, LANCET, V366, P717; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Galappaththy GNL, 2008, COCHRANE DB SYST REV, DOI [10.1002/, DOI 10.1002/]; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Karyana M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1588-8; Kenangalem E, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002815; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Mimika District Health Office, 2013, ANN STAT; Pava Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165340; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Poespoprodjo JR, 2011, J INFECT DIS, V204, P1613, DOI 10.1093/infdis/jir558; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Thriemer K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1784-1; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; UNICEF World Health Organization Bank World United Nations Department of Economic and Social Affairs, 2018, LEV TRENDS CHILD MOR; White MT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05860-8; WHO, 2019, WORLD MALARIA REPORT	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228018	10.1371/journal.pone.0228018	http://dx.doi.org/10.1371/journal.pone.0228018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995581	Green Published, gold			2022-12-26	WOS:000534609400037
J	Ji, RY; Shen, YX; Shi, B; Li, H; Tang, WQ; Xia, CY; Lu, K; Lamu, DQ; Hong, Y; Sun, XQ; Liu, JZ; Zhang, LQ; Zhu, CG				Ji, Rongyi; Shen, Yuanxi; Shi, Bin; Li, Hao; Tang, Wenqiang; Xia, Chenyang; Lu, Ke; Lamu, Danqu; Hong, Yang; Sun, Xueqiang; Liu, Jianzhi; Zhang, Lanqi; Zhu, Chuangang			An ELISA based on soluble egg antigens for the serodiagnosis of animal schistosomiasis turkestanica	PLOS ONE			English	Article								Background The existing diagnostic techniques for detecting schistosomiasis turkestanica, such as aetiological assays, identify infection by parasitic worms via the incubation of miracidia from faeces or observing eggs under microscopy. However, they are limited in the diagnosis of low-grade and prepatent infections, which lead to a high misdetection rates. Therefore, a new method for parasite diagnosis with increased sensitivity is urgently needed. Methods Goats in Nimu County (Tibet, China) infected with Schistosoma turkestanicum in an epidemic area were selected according positivity for the infection by faecal examination. Adult worms were collected, eggs were extracted by the sodium hydroxide (NaOH) erosion method, and soluble worm antigen preparation (SWAP) and soluble egg antigen (SEA) were isolated. The best coating concentration of the antigens and the best degree of dilution for serum were determined by square array experiments, and the optimal blocking solution and serum diluents were selected. The specificity, sensitivity and crossover of the ELISA method were determined using 48 samples of goat sera positive for S. turkestanicum, 100 samples of goat sera negative for S. turkestanicum, and 54 samples of buffalo sera positive for S. japonicum. Serological assays were established with samples from goats naturally grazed in a rural area of Nimu County, Tibet Province, by using the indirect ELISA method for the diagnosis of schistosomiasis, and faeces were collected for miracidia hatching. The sensitivity of the two detection methods was compared. Results Eggs of S. turkestanicum were distributed in the host duodenum and small intestine. Eggs in the host intestinal wall were extracted by the NaOH erosion method, which provided intact eggs with reduced impurities. The testing results obtained by isolating SEA were more stable than those obtained by using SWAP and less affected by the coating concentration and serum dilution. Additionally, the value of positive serum/negative (P/N) serum for SEA was much higher than that for SWAP. The optimal coating concentration of SEA was 0.5 mu g/ml, and the optimal serum dilution was 1:100. The specificity and sensitivity of the indirect ELISA based on SEA (S. turkestanicum) were both 100%, and no cross-reactivity was found with schistosomiasis japonica. An epidemiological survey of goats in naturally infected areas showed that the prevalence rate of schistosomiasis turkestanica was 93%, and the infection rate increased with the ages of the goats. Conclusion We aimed to develop a sensitive method to utilize in the mass field screening of livestock. As a diagnostic antigen, SEA (S. turkestanicum) was more suitable for serological testing than SWAP (S. turkestanicum). The indirect ELISA using SEA (S. turkestanicum) exhibited good sensitivity, specificity and no cross-reactivity with schistosomiasis japonica. The degree of infectivity and prevalence of S. turkestanicum infection in endemic areas are serious and should be a focus of concern among local departments.	[Ji, Rongyi; Shen, Yuanxi; Li, Hao; Lu, Ke; Hong, Yang; Zhang, Lanqi; Zhu, Chuangang] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China; [Ji, Rongyi; Hong, Yang; Zhu, Chuangang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Shi, Bin; Tang, Wenqiang; Xia, Chenyang; Lamu, Danqu; Liu, Jianzhi] Tibet Acad Agr & Anim Husb Sci, Inst Anim Sci, Tibet Lhasa, Peoples R China; [Sun, Xueqiang] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; China Animal Health & Epidemiology Center	Zhu, CG (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China.; Zhu, CG (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	zcg@shvri.ac.cn			National Key Research and Development Program of China [2017YFD0501306]	National Key Research and Development Program of China	This study was financially supported by The National Key Research and Development Program of China (2017YFD0501306. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhoun JA, 2012, SYST PARASITOL, V82, P81, DOI 10.1007/s11230-012-9349-8; Dutt S. C., 1955, P 42 SCI C, p[285, 1955]; He Wei, 2007, Chinese Journal of Schistosomiasis Control, V19, P107; Jiang SF, 2014, SE ASIAN J TROP MED, V45, P568; Kumar V., 1986, Helminthological Abstracts. Series A., V55, P469; Li L, 2008, CHINESE VET SCI, V38, P273; Li L, 2007, JILIN ANIMAL HUSBAND, V28, P23, DOI [10.3969/j.issn.1672-2078.2007.10.008, DOI 10.3969/J.ISSN.1672-2078.2007.10.008]; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Rollinson D, 1997, INT J PARASITOL, V27, P11, DOI 10.1016/S0020-7519(96)00169-5; Shazly SE., 2006, TANTA MED SCI J, V1, P1; Shi Bin, 2017, Southwest China Journal of Agricultural Sciences, V30, P1458; Wang CR, 2006, VET PARASITOL, V140, P378, DOI 10.1016/j.vetpar.2006.04.008; Wang CR, 2009, ACTA TROP, V109, P171, DOI 10.1016/j.actatropica.2008.11.009; Wang CR, 2002, PROGR VET MED, V25, P91, DOI [10.16437/j.cnki.1007-5038.2002.05.031, DOI 10.16437/J.CNKI.1007-5038.2002.05.031]; Wei J, 2005, J HEBEI UNIVERCITY S, V19, P70, DOI [10.3969/j.issn.1672-7983.2005.01.017, DOI 10.3969/J.ISSN.1672-7983.2005.01.017]; Witenberg G., 1966, Refuah Veterinarith, V23, P67; Xu J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000949; Ye NN, 2017, TECHNICAL ADVISOR AN, P158, DOI [10.19369/j.cnki.2095-9737.2017.08.148, DOI 10.19369/J.CNKI.2095-9737.2017.08.148]; Yu J, 1998, AM J TROP MED HYG, V59, P370, DOI 10.4269/ajtmh.1998.59.370; Yu WC, 2003, CHINESE VET PARASITI, V11, P18, DOI [10.3969/j.issn.1674-6422.2003.02.005, DOI 10.3969/J.ISSN.1674-6422.2003.02.005]; Zhang M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003454; Zhang M, 2013, J PROTEOME RES, V12, P5260, DOI 10.1021/pr400476a; Zhao DY, 2014, CHINESE J ANIMAL INF, P58, DOI [10.3969/j.issn, DOI 10.3969/J.ISSN]; Zhou SL, 2001, SCHISTOSOMES	24	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228184	10.1371/journal.pone.0228184	http://dx.doi.org/10.1371/journal.pone.0228184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995591	Green Published, gold			2022-12-26	WOS:000534609400052
J	Zhang, JC; Lin, XX; Wu, LF; Huang, JJ; Jiang, WQ; Kipps, TJ; Zhang, SP				Zhang, Jianchao; Lin, Xinxin; Wu, Liufeng; Huang, Jia-Jia; Jiang, Wen-Qi; Kipps, Thomas J.; Zhang, Suping			Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis	ONCOGENE			English	Article							OCT4 INTERACTION; POOR-PROGNOSIS; STEM-CELLS; EXPRESSION; PHOSPHORYLATION; OVEREXPRESSION; EMT; TRANSCRIPTION; REPRESSION; PLASTICITY	Aurora B is a serine/threonine kinase that has been implicated in regulating cell proliferation in distinct cancers, including breast cancer. Here we show that Aurora B expression is elevated in basal-like breast cancer (BLBC) compared with other breast cancer subtypes. This high level of expression seems to correlate with poor metastasis-free survival and relapse-free survival in affected patients. Mechanistically, we show that elevated Aurora B expression in breast cancer cells activates AKT/GSK3 beta to stabilize Snail1 protein, a master regulator of epithelial-mesenchymal transition (EMT), leading to EMT induction in a kinase-dependent manner. Conversely, Aurora B knock down by short-hairpin RNAs (shRNAs) suppresses AKT/GSK3 beta/Snail1 signaling, reverses EMT and reduces breast cancer metastatic potential in vitro and in vivo. Finally, we identified a specific OCT4 phosphorylation site (T343) responsible for mediating Aurora B-induced AKT/GSK3 beta/Snail1 signaling and EMT that could be attenuated by Aurora B kinase inhibitor treatment. These findings support that Aurora B induces EMT to promote breast cancer metastasis via OCT4/AKT/GSK3 beta/Snail1 signaling. Pharmacologic Aurora B inhibition might be a potential effective treatment for breast cancer patients with metastatic disease.	[Zhang, Jianchao; Lin, Xinxin; Wu, Liufeng; Zhang, Suping] Shenzhen Univ, Hlth Sci Ctr, Int Canc Ctr,Dept Pharmacol,Guangdong Key Lab Gen, Base Int Sci & Technol Cooperat Carson Canc Stem, Shenzhen 518055, Peoples R China; [Huang, Jia-Jia; Jiang, Wen-Qi] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou 510060, Peoples R China; [Kipps, Thomas J.; Zhang, Suping] Univ Calif San Diego, Moores UCSD Canc Ctr, 9310 Athena Circle, San Diego, CA 92093 USA	Shenzhen University; State Key Lab Oncology South China; Sun Yat Sen University; University of California System; University of California San Diego	Zhang, SP (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Int Canc Ctr,Dept Pharmacol,Guangdong Key Lab Gen, Base Int Sci & Technol Cooperat Carson Canc Stem, Shenzhen 518055, Peoples R China.; Zhang, SP (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, 9310 Athena Circle, San Diego, CA 92093 USA.	s9zhang@szu.edu.cn	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81672912, 81972753, 81502537]; Science and Technology Program of Guangdong Province, China [2017B030301016, 2016A030310128]; Shenzhen Basic Research Program [JCYJ20170818143630465, JCYJ20170818101638620, JCYJ20180507182203049]; Shenzhen Peacock Innovation Team Project [KQTD20140630100658078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province, China; Shenzhen Basic Research Program; Shenzhen Peacock Innovation Team Project	This study was supported by the National Natural Science Foundation of China (81672912, 81972753, and 81502537), the Science and Technology Program of Guangdong Province, China (2017B030301016 and 2016A030310128), the Shenzhen Basic Research Program (JCYJ20170818143630465, JCYJ20170818101638620, and JCYJ20180507182203049) and the Shenzhen Peacock Innovation Team Project (KQTD20140630100658078). The authors would like to thank Dr Jessica Tamanini (Shenzhen University, ETediting) for editing the paper prior to submission. We acknowledge the help of the Instrumental Analysis Center of Shenzhen University (Xili Campus) for technical assistance.	Abulaiti X, 2017, STEM CELL REP, V9, P1630, DOI 10.1016/j.stemcr.2017.09.001; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Calabro A, 2009, BREAST CANCER RES TR, V116, P69, DOI 10.1007/s10549-008-0105-3; Campbell PA, 2013, STEM CELLS, V31, P1107, DOI 10.1002/stem.1365; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chieffi P, 2006, PROSTATE, V66, P326, DOI 10.1002/pros.20345; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Gonzalez-Loyola A, 2015, MOL CELL BIOL, V35, P3566, DOI 10.1128/MCB.01286-14; Guise AJ, 2012, MOL CELL PROTEOMICS, V11, P1220, DOI 10.1074/mcp.M112.021030; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Jezequel P, 2012, BREAST CANCER RES TR, V131, P765, DOI 10.1007/s10549-011-1457-7; Jin Y, 2015, CANCER LETT, V362, P70, DOI 10.1016/j.canlet.2015.03.037; Kai K, 2015, MOL CANCER THER, V14, P2687, DOI 10.1158/1535-7163.MCT-15-0096; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu ZC, 2014, BBA-GEN SUBJECTS, V1840, P3096, DOI 10.1016/j.bbagen.2014.07.018; Ma YX, 2015, J MOL MED, V93, P427, DOI 10.1007/s00109-014-1228-0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Nadler Y, 2008, CLIN CANCER RES, V14, P4455, DOI 10.1158/1078-0432.CCR-07-5268; Pattabiraman DR, 2016, COLD SH Q B, V81, P11, DOI 10.1101/sqb.2016.81.030957; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porcelli L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0385-4; Portella G, 2011, CURR MED CHEM, V18, P482, DOI 10.2174/092986711794480203; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schmidt JM, 2015, CELL REP, V10, P131, DOI 10.1016/j.celrep.2014.12.032; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shin J, 2016, ELIFE, V5, DOI 10.7554/eLife.10877; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wang C, 2016, EUR J PHARMACOL, V779, P1, DOI 10.1016/j.ejphar.2015.11.049; Wang D, 2014, ONCOTARGET, V5, P10803, DOI 10.18632/oncotarget.2506; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806; Zhang A, 2013, ONCOL LETT, V6, P339, DOI 10.3892/ol.2013.1385; Zhang YQ, 2015, INT J CLIN EXP PATHO, V8, P751; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhu XP, 2014, EXP THER MED, V7, P560, DOI 10.3892/etm.2014.1491	56	20	19	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2550	2567		10.1038/s41388-020-1165-z	http://dx.doi.org/10.1038/s41388-020-1165-z		JAN 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31996785				2022-12-26	WOS:000510136400002
J	Almagro, P; Ponce, A; Komal, S; Villaverde, MD; Castrillo, C; Grau, G; Simon, L; de la Sierra, A				Almagro, Pere; Ponce, Ana; Komal, Shakeel; de la Asuncion Villaverde, Maria; Castrillo, Cristina; Grau, Gemma; Simon, Lluis; de la Sierra, Alex			Multimorbidity gender patterns in hospitalized elderly patients	PLOS ONE			English	Article							PROGNOSTIC INDEX; CARE; COMORBIDITY; MORBIDITY; FRAILTY	Patients with multimorbidity and complex health care needs are usually vulnerable elders with several concomitant advanced chronic diseases. Our research aim was to evaluate differences in patterns of multimorbidity by gender in this population and their possible prognostic implications, measured as in-hospital mortality, 1-month readmissions, and 1-year mortality. We focused on a cohort of elderly patients with well-established multimorbidity criteria admitted to a specific unit for chronic complex-care patients. Multimorbidity criteria, the Charlson, PROFUND and Barthel indexes, and the Pfeiffer test were collected prospectively during their stays. A total of 843 patients (49.2% men) were included, with a median age of 84 [interquartile range (IQR) 79-89] years. The women were older, with greater functional dependence [Barthel index: 40 (IQR:10-65) vs. 60 (IQR: 25-90)], showed more cognitive deterioration [Pfeiffer test: 5 (IQR:1-9) vs. 1 (0-6)], and had worse scores on the PROFUND index [15 (IQR:9-18) vs. 11.5 (IQR: 6-15)], all p < 0.0001, while men had greater comorbidity measured with the Charlson index [5 (IQR: 3-7) vs. 4 (IQR: 3-6); p = 0.002]. In the multimorbidity criteria scale, heart failure, autoimmune diseases, dementia, and osteoarticular diseases were more frequent in women, while ischemic heart disease, chronic respiratory diseases, and neoplasms predominated in men. In the analysis of grouped patterns, neurological and osteoarticular diseases were more frequent in females, while respiratory and cancer predominated in males. We did not find gender differences for in-hospital mortality, 1-month readmissions, or 1-year mortality. In the multivariate analysis age, the Charlson, Barthel and PROFUND indexes, along with previous admissions, were independent predictors of 1-year mortality, while gender was non-significant. The Charlson and PROFUND indexes predicted mortality during follow-up more accurately in men than in women (AUC 0.70 vs. 0.57 and 0.74 vs. 0.62, respectively), with both p<0.001. In conclusion, our study shows differing patterns of multimorbidity by gender, with greater functional impairment in women and more comorbidity in men, although without differences in the prognosis. Moreover, some of these prognostic indicators had differing accuracy for the genders in predicting mortality.	[Almagro, Pere; Ponce, Ana; Komal, Shakeel; de la Asuncion Villaverde, Maria; Castrillo, Cristina; Grau, Gemma; Simon, Lluis; de la Sierra, Alex] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Serv, Multimorbid Unit, Terrassa, Spain; [Almagro, Pere; Ponce, Ana; Komal, Shakeel; de la Asuncion Villaverde, Maria; Castrillo, Cristina; Grau, Gemma; Simon, Lluis; de la Sierra, Alex] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Terrassa, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona	Almagro, P (corresponding author), Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Serv, Multimorbid Unit, Terrassa, Spain.; Almagro, P (corresponding author), Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Terrassa, Spain.	19908pam@comb.cat		Malik Khanam, Komal/0000-0001-9761-8445; Almagro, Pere/0000-0002-8476-4942				Almagro P, 2010, RESP MED, V104, P253, DOI 10.1016/j.rmed.2009.09.019; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; [Anonymous], 2018, PLAN ATENCION INTEGR; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bernabeu-Wittel M, 2014, J PAIN SYMPTOM MANAG, V47, P551, DOI 10.1016/j.jpainsymman.2013.04.011; Blinderman CD, 2015, NEW ENGL J MED, V373, P2549, DOI 10.1056/NEJMra1411746; Brown CJ, 2009, J AM GERIATR SOC, V57, P1660, DOI 10.1111/j.1532-5415.2009.02393.x; Buja A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208875; Buja A, 2020, J AGING HEALTH, V32, P259, DOI 10.1177/0898264318817091; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clerencia-Sierra M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132909; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Diez-Manglano J, 2019, MED CLIN-BARCELONA, V153, P196, DOI 10.1016/j.medcli.2019.01.034; Diez-Manglano J, 2015, INTERN EMERG MED, V10, P915, DOI 10.1007/s11739-015-1252-2; Evans SJ, 2014, AGE AGEING, V43, P127, DOI 10.1093/ageing/aft156; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Goldwater Deena S, 2018, J Hosp Med, V13, DOI 10.12788/jhm.2986; Gomez-Aguirre N, 2019, AGING CLIN EXP RES, V31, P393, DOI 10.1007/s40520-018-0980-3; Gordon EH, 2017, EXP GERONTOL, V89, P30, DOI 10.1016/j.exger.2016.12.021; Gordon EH, 2018, MATURITAS, V107, P13, DOI 10.1016/j.maturitas.2017.09.011; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jardine M, 2018, GERIATRICS-BASEL, V3, DOI 10.3390/geriatrics3040066; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Le Reste JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115796; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; MAHONEY F I, 1965, Md State Med J, V14, P61; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Martinez-Camblor P, 2016, J STAT COMPUT SIM, V86, P3582, DOI 10.1080/00949655.2016.1175442; Ministry of Health social services and equality, STAT INF HOSP STAT S; National Institute for Health and Care Excellence (NICE), MULT CLIN ASS MAN; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rijken M, 2017, EUROPEAN OBSERVATORY; Rijken M, 2018, HEALTH POLICY, V122, P44, DOI 10.1016/j.healthpol.2017.10.002; Sociedad Espanola de Medicina Interna, INF RECALMIN; Stewart K, 2016, CLIN MED, V16, P530, DOI 10.7861/clinmedicine.16-6-530; Suarez-Dono J, 2016, EUR J INTERN MED, V36, P25, DOI 10.1016/j.ejim.2016.08.002; Taylor DR, 2014, THORAX, V69, P497, DOI 10.1136/thoraxjnl-2013-204943; Ungar A, 2011, AGE AGEING, V40, P696, DOI 10.1093/ageing/afr109; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	43	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227252	10.1371/journal.pone.0227252	http://dx.doi.org/10.1371/journal.pone.0227252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8ZJ	31990911	Green Published, gold			2022-12-26	WOS:000534605400014
J	Arnesen, CH; Johnsen, CB; Costanzi, JM; Rosell, F				Arnesen, Charlotte Holmstad; Johnsen, Christin Beate; Costanzi, Jean-Marc; Rosell, Frank			Canines (Canis lupus familiaris) as biodetectors for conservation work: Can they discriminate the rock ptarmigan (Lagopus muta) from the willow grouse (L. lagopus) in a yes/no task?	PLOS ONE			English	Article							SCAT DETECTION DOGS; COGNITIVE IMPAIRMENT; OLFACTORY DETECTION; POPULATION; BIRDS; MICE; WORLDWIDE; BEHAVIOR; FACTS	Alpine and arctic bird populations have shown an unmistakable decrease over the last three decades, and the need for conservation is highly necessary. We investigated the use of five privately-owned dogs (Canis lupus familiaris) as a non-invasive tool to determine the presence of rock ptarmigan (Lagopus muta), through sniffing out faecal pellets, using a yes/no training regime. We carried out 36 double-blind experimental trials per dog and hypothesised that dogs could discriminate the rock ptarmigan from similar species, such as black grouse (Tetrao tetrix), western capercaillie (T. urogallus) and willow grouse (L. lagopus). Our dogs detected differences between the avian species with an average accuracy of 65.9%, sensitivity of 66.7% and specificity of 65.3%. We showed that privately-owned dogs have the potential to be used as biodetectors for conservational work within controlled laboratory conditions for declining species, but overall, only one dog was considered proficient enough. We concluded that dogs could be used as a non-invasive tool to detect the rock ptarmigan, and with further field training and testing, operate in the field for detection surveys.	[Arnesen, Charlotte Holmstad; Johnsen, Christin Beate; Costanzi, Jean-Marc; Rosell, Frank] Univ South Eastern Norway, Fac Technol Nat Sci & Environm Hlth, Bo I Telemark, Norway		Rosell, F (corresponding author), Univ South Eastern Norway, Fac Technol Nat Sci & Environm Hlth, Bo I Telemark, Norway.	Frank.Rosell@usn.no		Rosell, Frank/0000-0003-1047-0156				[Anonymous], 2000, CADAVER DOG HDB FORE; Arandjelovic M, 2015, ROYAL SOC OPEN SCI, V2, P140; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Beckoff M, 1996, CARNIVORE BEHAV ECOL, P14; Beebe SC, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00096; Bevanger K, 2000, WILDLIFE BIOL, V6, P121, DOI 10.2981/wlb.2000.001; BirdLife I, 2016, IUCN RED LIST THREAT, V2016; BirdLife I, 2015, IUCN RED LIST THREAT, V2015; BirdLife I, 2016, IUCN RED LIST THREAT, V2016; Byrkjedal Ingvar, 2012, Ornis Norvegica, V35, P43; Chiandetti C, 2016, APPL ANIM BEHAV SCI, V184, P109, DOI 10.1016/j.applanim.2016.08.006; Concha A, 2014, CHEM SENSES, V39, P749, DOI 10.1093/chemse/bju045; Cooper JJ, 2003, APPL ANIM BEHAV SCI, V81, P229, DOI 10.1016/S0168-1591(02)00284-8; Costanzi JM, 2019, ECOL EVOL, V9, P3837, DOI 10.1002/ece3.5007; Costanzi Jean-Marc, 2018, BMC Research Notes, V11, P147, DOI 10.1186/s13104-018-3249-1; Cristescu RH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08349; Cunningham CL, 2014, ANIM COGN, V17, P805, DOI 10.1007/s10071-013-0714-z; Dahlgren D.K., 2012, WILDLIFE TECHNIQUES, P140; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; Edwards TL, 2017, J VET BEHAV, V20, P59, DOI 10.1016/j.jveb.2017.05.002; EEA, 2010, EUR EC BACKB REC TRU; Elliker KR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-22; Fischer-Tenhagen C, 2017, CHEM SENSES, V42, P435, DOI 10.1093/chemse/bjx020; Fischer-Tenhagen C, 2011, APPL ANIM BEHAV SCI, V131, P63, DOI 10.1016/j.applanim.2011.01.006; Fjellanger R., 2002, INT J COMP PSYCHOL, V15, P278; Furton K, 2010, 231952 FLOR INT U; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; Gadbois S., 2016, Dog Behavior, V2, P26; Gadbois S, 2014, DOMESTIC DOG COGNITI, P3, DOI DOI 10.1007/978-3-642-53994-7_1; Greenwood Jeremy J. D., 1996, P11; GYLLENSTEN U, 1985, HEREDITAS, V102, P47, DOI 10.1111/j.1601-5223.1985.tb00464.x; Horvath G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-396; Hurt A, 2016, CANINE OLFACTION SCIENCE AND LAW: ADVANCES IN FORENSIC SCIENCE, MEDICINE, CONSERVATION, AND ENVIRONMENTAL REMEDIATION, P139; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jezierski T, 2008, POL PSYCHOL B, V39, P71, DOI [10.2478/v10059-008-0010-y., DOI 10.2478/V10059-008-0010-Y]; Jezierski TA, 2016, CANINE OLFACTION SCE; Jezierski T, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027001; Johansson A, 2018, BIORXIV; Johnen D, 2017, APPL ANIM BEHAV SCI, V189, P1, DOI 10.1016/j.applanim.2017.01.001; Johnen D, 2013, APPL ANIM BEHAV SCI, V148, P201, DOI 10.1016/j.applanim.2013.09.002; Kardish M. R., 2015, FRONTIERS ECOLOGY EV, V3, P1, DOI DOI 10.3389/FEV0.2015.00051; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Lehikoinen A, 2014, J AVIAN BIOL, V45, P3, DOI 10.1111/j.1600-048X.2013.00177.x; Long RA, 2007, J WILDLIFE MANAGE, V71, P2018, DOI 10.2193/2006-292; Orkin J.D., 2016, SCI REP-UK, V6, P1; Papet LE, 2016, CANINE OLFACTION SCI; Pfungst O., 1911, CLEVER HANS THE HORS, DOI 10.5962/bhl.title.56164; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Quintela M, 2010, CONSERV GENET, V11, P557, DOI 10.1007/s10592-009-0040-9; Rosell R, 2018, SECRETS SNOUT DOGS I; Schoon G. A. A., 2002, PROBLEMY KRYMINALIST, V226, P43; Schoon GAA, 1996, APPL ANIM BEHAV SCI, V49, P257, DOI 10.1016/0168-1591(95)00656-7; Smith DA, 2003, ANIM CONSERV, V6, P339, DOI 10.1017/S136794300300341X; Smith DA, 2013, FREE RANGING DOGS WI; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Storch I, 2000, WILDLIFE BIOL, V6, P195, DOI 10.2981/wlb.2000.016; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; Sveinsdottir M, 2017, MITOCHONDRIAL DNA B, V2, P400, DOI 10.1080/23802359.2017.1347834; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Topal J, 1997, ANTHROZOOS, V10, P214, DOI 10.2752/089279397787000987; Traniello JFA, 2015, BEHAV ECOL SOCIOBIOL, V69, P1573, DOI 10.1007/s00265-015-2001-2; Vinuela J., 2002, GAMEBIRD HUNTING BIO; Wasser SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042892; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Watson A, 2004, BIOL CONSERV, V116, P267, DOI 10.1016/S0006-3207(03)00197-6; Watson A, 2008, GROUSE; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712	72	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228143	10.1371/journal.pone.0228143	http://dx.doi.org/10.1371/journal.pone.0228143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990940	Green Published, gold			2022-12-26	WOS:000534605400044
J	Iyadorai, T; Mariappan, V; Vellasamy, KM; Wanyiri, JW; Roslani, AC; Lee, GK; Sears, C; Vadivelu, J				Iyadorai, Thevambiga; Mariappan, Vanitha; Vellasamy, Kumutha Malar; Wanyiri, Jane Wangui; Roslani, April Camilla; Lee, Goh Khean; Sears, Cynthia; Vadivelu, Jamuna			Prevalence and association of pks(+) Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia	PLOS ONE			English	Article							BACTERIA ADHERENT; INFLAMMATION; MICROBIOTA; MUCOSA; GUT	Escherichia coli (E. coli) from the B2 phylogenetic group is implicated in colorectal cancer (CRC) as it possesses a genomic island, termed polyketide synthetase (pks), which codes for the synthesis of colibactin, a genotoxin that induces DNA damage, cell cycle arrest, mutations and chromosomal instability in eukaryotic cells. The aim of this study was to detect and compare the prevalence of E. coli expressing pks (pks(+) E. coli) in CRC patients and healthy controls followed by investigating the virulence triggered by pks(+) E. coli using an in-vitro model. Mucosal colon tissues were collected and processed to determine the presence of pks(+) E. coli. Thereafter, primary colon epithelial (PCE) and colorectal carcinoma (HCT116) cell lines were used to detect cytopathic response to the isolated pks(+) E. coli strains. Our results showed 16.7% and 4.3% of CRC and healthy controls, respectively were pks(+) E. coli. Further, PCE displayed syncytia and cell swelling and HCT116 cells, megalocytosis, in response to treatment with the isolated pks(+) E. coli strains. In conclusion, pks(+) E. coli was more often isolated from tissue of CRC patients compared to healthy individuals, and our in-vitro assays suggest these isolated strains may be involved in the initiation and development of CRC.	[Iyadorai, Thevambiga; Mariappan, Vanitha; Vellasamy, Kumutha Malar; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Mariappan, Vanitha] Univ Malaya, Univ Malaya Ctr Prote Res UMCPR, Kuala Lumpur, Malaysia; [Wanyiri, Jane Wangui; Sears, Cynthia] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Roslani, April Camilla] Univ Malaya, Dept Surg, Kuala Lumpur, Malaysia; [Roslani, April Camilla] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia; [Lee, Goh Khean] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Sears, Cynthia] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Universiti Malaya; Universiti Malaya; Johns Hopkins University; Universiti Malaya; Universiti Malaya; Universiti Malaya; Johns Hopkins University; Johns Hopkins Medicine	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@um.edu.my	Mariappan, Vanitha/I-4769-2013; Mariappan, Vanitha/ABD-4066-2020; Roslani, April Camilla/B-8245-2010; Vellasamy, Kumutha Malar/CAF-0007-2022; Iyadorai, Thevambiga/GSN-4683-2022; VADIVELU, JAMUNARANI S/B-8696-2010	Mariappan, Vanitha/0000-0002-2351-1597; Mariappan, Vanitha/0000-0002-2351-1597; Roslani, April Camilla/0000-0003-2458-965X; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Iyadorai, Thevambiga/0000-0002-9258-620X; VADIVELU, JAMUNARANI S/0000-0001-7322-3676	University of Malaya Research Grant [RP016B-13HTM]; Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE Grant [UM.C/625/1/HIR/MoE/CHAN/02 (H-50001-A000013)]; Swami Institute for International Medical Education (SIIME) from the Johns Hopkins University School of Medicine	University of Malaya Research Grant; Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE Grant; Swami Institute for International Medical Education (SIIME) from the Johns Hopkins University School of Medicine	This work was funded by: 1) University of Malaya Research Grant (RP016B-13HTM) and Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE Grant UM.C/625/1/HIR/MoE/CHAN/02 (H-50001-A000013) - Received by JV; and 2) Swami Institute for International Medical Education (SIIME) from the Johns Hopkins University School of Medicine-Received by CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hassan MR, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016007; Albrecht T., 1996, MED MICROBIOLOGY; ARIES V, 1969, GUT, V10, P334, DOI 10.1136/gut.10.5.334; Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Arthur JC, 2013, GUT MICROBES, V4, P253, DOI 10.4161/gmic.24220; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343; Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Dalmasso G, 2014, GUT MICROBES, V5, P675, DOI 10.4161/19490976.2014.969989; Douaiher J, 2017, J SURG ONCOL, V115, P619, DOI 10.1002/jso.24578; FIROR WM, 1945, ANN SURG, V121, P700, DOI 10.1097/00000658-194505000-00013; Green GL, 2006, J APPL MICROBIOL, V100, P460, DOI 10.1111/j.1365-2672.2005.02783.x; Greene FL, 2002, AJCC CANC STAGING MA, pxiv; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; Jeon J, 2018, GASTROENTEROLOGY, V154, P2152, DOI 10.1053/j.gastro.2018.02.021; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nowrouzian FL, 2012, MICROB PATHOGENESIS, V53, P180, DOI 10.1016/j.micpath.2012.05.011; Raisch J, 2014, WORLD J GASTROENTERO, V20, P6560, DOI 10.3748/wjg.v20.i21.6560; Schosserer M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00278; Secher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077157; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Witold K, 2018, REP PRACT ONCOL RADI, V23, P75, DOI 10.1016/j.rpor.2017.12.003; Xie L L, 2016, Zhonghua Yi Xue Za Zhi, V96, P954, DOI 10.3760/cma.j.issn.0376-2491.2016.12.010; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100	27	37	39	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228217	10.1371/journal.pone.0228217	http://dx.doi.org/10.1371/journal.pone.0228217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990962	Green Published, Green Submitted, gold			2022-12-26	WOS:000534605400050
J	Moreno, V; Areces, F; Ruiz-Vicente, D; Ordovas, JM; Del Coso, J				Moreno, Victor; Areces, Francisco; Ruiz-Vicente, Diana; Ordovas, Jose M.; Del Coso, Juan			Influence of the ACTN3 R577X genotype on the injury epidemiology of marathon runners	PLOS ONE			English	Article							MUSCLE DAMAGE; POLYMORPHISM; ALPHA-ACTININ-3; ASSOCIATION; PERFORMANCE; DEFICIENCY; RISK	A common single nucleotide polymorphism in the ACTN3 gene might result in the complete deficiency of alpha-actinin-3 (i.e., XX genotype). It has been found that ACTN3 XX individuals have several traits related to lessened muscle performance. This study aimed to determine the influence, if any, of ACTN3 genotypes on injury incidence of marathoners during the year preceding to participating in a competitive marathon race. Using a cross-sectional experimental design, the type and conditions of sports injuries were documented for one year in a group of 139 marathoners. Injuries were recorded following a consensus statement on injuries in Athletics. Afterward, ACTN3 genotyping was performed, and injury epidemiology was compared among RR, RX, and XX genotypes. The distribution of the RR/RX/XX genotypes was 28.8/42.8/23.5%, respectively. A total of 67 injuries were recorded. The frequency of marathoners that reported any injury during the previous year was not different across the genotypes (55.0/38.8/40.6%, P = 0.241). Although the overall injury incidence was not different among genotypes (2.78/1.65/1.94 injuries/1000 h of running, P = 0.084), the likelihood of suffering an injury was higher in RR than in RX (OR = 1.93: 95%CI = 0.87-4.30), and higher than in XX (OR = 1.79: 0.70-4.58). There was no difference in the conditions, severity, body location, time of year, or leading cause of injury among genotypes. However, XX presented a higher frequency of sudden-onset injuries (P = 0.024), and the OR for muscle-type injuries was 2.0 (0.51-7.79) times higher compared to RR runners. Although XX marathoners did not have a higher overall incidence of injury, the OR in these runners for muscle-type injuries was superior to RR and RX runners. The likelihood of suffering a muscle injury, especially with a sudden-onset, was twice in XX than in RR endurance runners.	[Moreno, Victor] Miguel Hernandez Univ Elche, Sports Res Ctr, Alicante, Spain; [Areces, Francisco; Ruiz-Vicente, Diana] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain; [Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, USDA ARS, Boston, MA 02111 USA; [Ordovas, Jose M.] CEI UAM CSIC, IMDEA Food Inst, Madrid, Spain; [Del Coso, Juan] Rey Juan Carlos Univ, Ctr Sport Studies, Madrid, Spain	Universidad Miguel Hernandez de Elche; Camilo Jose Cela University; Tufts University; United States Department of Agriculture (USDA); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Rey Juan Carlos	Del Coso, J (corresponding author), Rey Juan Carlos Univ, Ctr Sport Studies, Madrid, Spain.	juan.delcoso@urjc.es	Areces, Francisco/ABH-3023-2020	Areces, Francisco/0000-0003-2996-4156; Del Coso, Juan/0000-0002-5785-984X	ViceRectorate of Research and Science, at the Camilo Jose Cela University	ViceRectorate of Research and Science, at the Camilo Jose Cela University	The study was part of the ACTN3 project supported by a Grant-in-aid from the ViceRectorate of Research and Science, at the Camilo Jose Cela University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred T, 2011, HUM MUTAT, V32, P1008, DOI 10.1002/humu.21526; Baxter C, 2017, RES SPORTS MED, V25, P78, DOI 10.1080/15438627.2016.1258640; Belli T, 2017, BIOL SPORT, V34, P105, DOI 10.5114/biolsport.2017.64583; Bramah C, 2018, AM J SPORT MED, V46, P3023, DOI 10.1177/0363546518793657; Broos S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150594; Chung KM, 2000, EUR J NEUROSCI, V12, P205; Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Clos E, 2019, KNEE SURG SPORT TR A, V27, P4055, DOI 10.1007/s00167-019-05381-x; Del Coso J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060413; Del Coso J, 2019, EUR J APPL PHYSIOL, V119, P49, DOI 10.1007/s00421-018-4010-0; Del Coso J, 2017, EUR J APPL PHYSIOL, V117, P409, DOI 10.1007/s00421-017-3542-z; Del Coso J, 2017, EUR J APPL PHYSIOL, V117, P151, DOI 10.1007/s00421-016-3507-7; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Hogarth MW, 2016, HUM MOL GENET, V25, P866, DOI 10.1093/hmg/ddv613; Houweling PJ, 2018, HUM MUTAT, V39, P1774, DOI 10.1002/humu.23663; Koizumi K.I., 2015, J MOL BIOMARK DIAGN, Vs6, P1, DOI [10.4172/2155-9929.S6-002, DOI 10.4172/2155-9929.S6-002]; Massidda M, 2019, CLIN J SPORT MED, V29, P57, DOI 10.1097/JSM.0000000000000487; Messier SP, 2018, AM J SPORT MED, V46, P2211, DOI 10.1177/0363546518773755; Miyamoto N, 2018, SCAND J MED SCI SPOR, V28, P1209, DOI 10.1111/sms.12994; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Pickering C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01080; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saragiotto BT, 2014, SPORTS MED, V44, P1153, DOI 10.1007/s40279-014-0194-6; Seto JT, 2011, HUM MOL GENET, V20, P2914, DOI 10.1093/hmg/ddr196; Shang XY, 2015, J SPORT SCI, V33, P1775, DOI 10.1080/02640414.2015.1012098; Tillander B, 2018, J SPORT MED PHYS FIT, V58, P1839, DOI 10.23736/S0022-4707.18.07747-2; Timpka T, 2014, BRIT J SPORT MED, V48, P483, DOI 10.1136/bjsports-2013-093241; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P140, DOI 10.1111/j.1600-0838.2007.00683.x; Vitti A, 2020, RES SPORTS MED, V28, P121, DOI 10.1080/15438627.2019.1586705; Vlahovich N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4185-5; Walsh S, 2008, J APPL PHYSIOL, V105, P1486, DOI 10.1152/japplphysiol.90856.2008; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	35	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227548	10.1371/journal.pone.0227548	http://dx.doi.org/10.1371/journal.pone.0227548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990958	Green Published, gold			2022-12-26	WOS:000534605400018
J	Singh, H; Yadav, M; Kumar, N; Kumar, A; Kumar, M				Singh, Hukum; Yadav, Mukta; Kumar, Narendra; Kumar, Amit; Kumar, Manoj			Assessing adaptation and mitigation potential of roadside trees under the influence of vehicular emissions: A case study of Grevillea robusta and Mangifera indica planted in an urban city of India	PLOS ONE			English	Article							AIR-POLLUTION TOLERANCE; PROLINE; PHOTOSYNTHESIS; ACCUMULATION; CHLOROPHYLL; PARAMETERS; LEAVES; INDEX	The ever-increasing vehicle counts have resulted in a significant increase in air pollution impacting human and natural ecosystems including trees, and physical properties. Roadside plantations often act as a first defense line against the vehicular emissions to mitigate the impacts of pollutants. However, they are themselves vulnerable to these pollutants with varying levels of tolerance capacity. This demands a scientific investigation to assess the role of roadside plantation for better management and planning for urban sprawl where selected trees could be grown to mitigate the impacts of harmful pollutants. The present study assesses the impacts of vehicular emissions on the adaptation and mitigation potential of two important roadside tree species i.e. Grevillea robusta and Mangifera indica planted along roadsides in the capital city of Uttarakhand. Uttarakhand is one of the Indian Western Himalayan State and its capital city is situated on the foothills of Himalaya. The adaptation and mitigation potential were evaluated by studying the response of pollutants on the functional traits which drive the physiology of the trees. The CO2 assimilation rate, transpiration rate, stomatal conductance, water use efficiency (WUE), air pollution tolerance index (APTI), copper and proline accumulation, dust removal efficiency (DRE), leaf thickness and cooling created by plantation were studied to evaluate the response of trees exposed to roadside traffics. To compare the influence of pollutants, traits of trees grown in a control site with few or absence of vehicular movement were compared with the roadside trees. The control site represented part of a reserve forest where human interference is controlled and human-induced activities are prohibited. The vehicular frequency was found to modulate tree characteristics. The tree characteristics representing WUE, APTI, proline and copper accumulation, leaf thickness, cooling impact, and DRE were enhanced significantly, while the decreased CO2 assimilation rate was observed near roadside trees compared to the control site. We found both of the species to perform well to be used as one of the potential species for roadside and urban greening. However, there is a need to assess the potential of other species in reference to the present study.	[Singh, Hukum; Yadav, Mukta; Kumar, Narendra; Kumar, Amit; Kumar, Manoj] Forest Res Inst, Dehra Dun, Uttarakhand, India	Indian Council of Forestry Research & Education (ICFRE); Forest Research Institute (FRI)	Singh, H (corresponding author), Forest Res Inst, Dehra Dun, Uttarakhand, India.	hukumsingh97@yahoo.com	Kumar, Manoj/X-8489-2018; Singh, Hukum/AAE-5338-2020	Kumar, Manoj/0000-0003-2360-5451; Singh, Hukum/0000-0003-2112-6182; KUMAR, NARENDRA/0000-0001-7601-4490; Kumar, Amit/0000-0001-7001-3243				Abdel-Aziz D., 2014, Journal of Environment and Earth Science, V4, P37; Agbaire PO, 2016, CHEM MAT RES, V8, P72; Allen LH, 1987, GLOBAL BIOGEOCHEM CY, V1, P1, DOI 10.1029/GB001i001p00001; Amulya L., 2015, BRAZ J BIOL SCI, V2, P287; Anicic M, 2011, ECOL INDIC, V11, P824, DOI 10.1016/j.ecolind.2010.10.009; [Anonymous], 2015, INT J ADV ENG TECHNO; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bitopan Sarma, 2017, Tropical Plant Research, V4, P161, DOI 10.22271/tpr.2017.v4.i1.023; Celik U, EUROPEAN FOOD RES TE, V220, P37; Chaturvedi AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07464-6; Chauhan A, 2010, LIFE SCI LEAFLETS, V3, P45; Cheng FY, 2007, ENVIRON POLLUT, V150, P355, DOI 10.1016/j.envpol.2007.01.022; Davison A.W., 1976, EFFECTS AIR POLLUTIO; DEDIO W, 1975, CAN J PLANT SCI, V55, P369, DOI 10.4141/cjps75-059; Dhankar R., 2015, INT J RECENT SCI RES, V6, P2890; Doganlar ZB, 2012, CHEM SPEC BIOAVAILAB, V24, P65, DOI 10.3184/095422912X13338055043100; Doganlar ZB, 2011, WATER AIR SOIL POLL, V214, P509, DOI 10.1007/s11270-010-0442-9; FLUCKIGER W, 1979, Z PFLANZENPHYSIOL, V91, P173; Giri S., 2013, CURR AGR RES J, V1, P93, DOI [10.12944/CARJ.1.2.04, DOI 10.12944/CARJ.1.2.04, 10.12944/carj.1.2.04]; Gratani L, 2008, ATMOS ENVIRON, V42, P8273, DOI 10.1016/j.atmosenv.2008.07.032; Gupta S.K., 2018, J GEOSCI ENV PROTEC, V6, P151, DOI DOI 10.4236/GEP.2018.68011; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hukum Singh, 2018, Indian Forester, V144, P6; Jaleel CA, 2007, COLLOID SURFACE B, V60, P110, DOI 10.1016/j.colsurfb.2007.06.006; Joshi N., 2011, REPORT OPINION, V3, P42; Jyothi SJ, 2010, J ENVIRON BIOL, V31, P379; Kumar N, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1700-1; Lin BS, 2010, HORTSCIENCE, V45, P83, DOI 10.21273/HORTSCI.45.1.83; Liu YJ., 2008, WSEAS T ENV DEV, V4, P24; Lohe RN, 2015, GLOB J ENVIRON SCI M, V1, P315, DOI 10.7508/gjesm.2015.04.006; McCormick DB, 1999, TIETZ TXB CLIN CHEM, V3rd, P999; Mohammad MA, 2015, J APPL RES, V1, P378; Monaci F, 2000, ENVIRON POLLUT, V107, P321, DOI 10.1016/S0269-7491(99)00175-X; Nayak A. K., 2018, International Research Journal of Agricultural Economics and Statistics, V9, P1, DOI 10.15740/HAS/IRJAES/9.1/1-8; Patidar S., 2016, INT J CURR MICROBIOL, V5, P107; Paulsamy S., 2000, J ECOL RES BIOCON, V1, P20; Pawar K., 2010, INT J BIOL MED RES, V1, P291; Prajapati SK, 2006, J ENVIRON QUAL, V2, P865; QADIR SU, 2014, INT J RES APPL NAT S, V2, P7; Radhapriya P, 2012, J ENVIRON BIOL, V33, P635; Rai P.K., 2015, INT J ADV RES TECHNO, V4, P14; Ravichandran M., 2012, WORLD J ENVIRON BIOS, V1, P51; SANDELIUS A, 1995, NEW PHYTOL, V131, P231, DOI 10.1111/j.1469-8137.1995.tb05724.x; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; SCHOLZ F, 1977, WATER AIR SOIL POLL, V8, P41; SELLERS PJ, 1987, REMOTE SENS ENVIRON, V21, P143, DOI 10.1016/0034-4257(87)90051-4; Sharma R, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1292-1; Singh H, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0690-0; Singh H., 2017, AUSTIN BIOCH, V2, P1012; Singh SK., 1983, P S AIR POLL CONTR H, V1, P218; Stephen R.H., 2015, AGR METEOROL, V201, P187; Taib N., 2016, RENEWABLE SUSTAINABL, P151; Tripathi AK, 2007, J ENVIRON BIOL, V28, P127; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Zia-Khan S, 2015, WATER-SUI, V7, P116, DOI 10.3390/w7010116	55	18	18	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227380	10.1371/journal.pone.0227380	http://dx.doi.org/10.1371/journal.pone.0227380			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990922	Green Published, gold			2022-12-26	WOS:000534605400016
J	Ward-Flanagan, R; Scavuzzo, C; Mandhane, PJ; Bolduc, FV; Dickson, CT				Ward-Flanagan, Rachel; Scavuzzo, Claire; Mandhane, Piush J.; Bolduc, Francois, V; Dickson, Clayton T.			Prenatal fruit juice exposure enhances memory consolidation in male post-weanling Sprague-Dawley rats	PLOS ONE			English	Article							MATERNAL-CARE; WATER-MAZE; PREGNANCY; DIET; NEUROGENESIS; HIPPOCAMPUS; DISEASE	Objectives Nutritional intake during gestation is known to impact health outcomes for progeny. Correlational evidence in humans suggests that increased fruit consumption of pregnant mothers enhances infant cognitive development. Moreover, wild-type Drosophila supplemented with a combination of orange and tomato juice showed robust enhancements in performance on an associative olfactory memory task. The current study aimed to experimentally test the effects of prenatal fruit juice exposure in a non-human, mammalian model of learning and memory. Methods Across three separate birth cohorts, pregnant rats were given access to diluted tomato and orange juice (N = 2 per cohort), with control rats (N = 2 per cohort) receiving only water, in addition to standard rodent chow, throughout the duration of gestation, ending at parturition. Following weaning, male offspring were tested for learning and memory in a spatial version of the circular water maze and an auditory-cued fear-conditioning task. Results All pregnant rats increased fluid and food intake over the gestational period. Fruit juice-fed pregnant rats had increased fluid intake compared to control pregnant rats. When testing progeny, there were no effects of prenatal fruit juice on spatial learning, while it appeared to impair learning in fear conditioning relative to controls. However, we measured significant enhancements in both spatial memory and conditioned fear memory in the prenatal fruit-juice group compared to controls. Measures of vigilance, in response to the conditioned cue, were increased in prenatal fruit rats compared to controls, suggesting less generalized, and more adaptive, anxiety behaviours. Discussion Our results corroborate the human and Drosophila findings of prenatal fruit effects on behaviour, specifically that prenatal fruit juice exposure may be beneficial for early-life memory consolidation in rats.	[Ward-Flanagan, Rachel; Bolduc, Francois, V; Dickson, Clayton T.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Scavuzzo, Claire; Dickson, Clayton T.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Mandhane, Piush J.; Bolduc, Francois, V] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Bolduc, Francois, V] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Dickson, Clayton T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Dickson, CT (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.; Dickson, CT (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Dickson, CT (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	cdickson@ualberta.ca		Dickson, Clayton/0000-0002-3849-8110	CTD - Natural Sciences and Engineering Research Council of Canada [2016-06576]	CTD - Natural Sciences and Engineering Research Council of Canada	CTD - Natural Sciences and Engineering Research Council of Canada. Grant number (2016-06576) www.nserc-crsng.gc.ca NO	Androschuk A, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00085; [Anonymous], 2018, USDA NAT NUTR DAT ST; Bolduc FV, 2016, EBIOMEDICINE, V8, P331, DOI 10.1016/j.ebiom.2016.04.025; Borge TC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016777; Bruce-Keller AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175577; Cohen JFW, 2018, AM J PREV MED, V54, P727, DOI 10.1016/j.amepre.2018.02.020; Dickson CT, 2010, BEHAV BRAIN RES, V214, P35, DOI 10.1016/j.bbr.2010.04.002; Fagan JF, 2007, INTELLIGENCE, V35, P225, DOI 10.1016/j.intell.2006.07.007; Fonseca BM, 2012, REPROD BIOL, V12, P97, DOI 10.1016/S1642-431X(12)60080-1; Garcia-Alonso FJ, 2017, FOOD FUNCT, V8, P3542, DOI [10.1039/c7fo00393e, 10.1039/C7FO00393E]; Gibson RS, 2007, FOOD NUTR BULL, V28, pS77, DOI 10.1177/15648265070281S108; Gomes S, 2016, PUBLIC HEALTH NUTR, V19, P176, DOI 10.1017/S1368980015000555; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz PO, 1998, GASTROENTEROL CLIN N, V27, P153, DOI 10.1016/S0889-8553(05)70351-4; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037/0735-7044.107.5.799; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martinez-Frias ML, 1998, AM J MED GENET, V78, P140, DOI 10.1002/(SICI)1096-8628(19980630)78:2<140::AID-AJMG8>3.0.CO;2-S; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mottaghi T, 2017, EUROPEAN J CLIN NUTR, P1; Nyaradi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00097; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Palombo DJ, 2010, DEV PSYCHOBIOL, V52, P142, DOI 10.1002/dev.20422; Parada J, 2007, J FOOD SCI, V72, pR21, DOI 10.1111/j.1750-3841.2007.00274.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Ross MG, 2005, AM J PHYSIOL-REG I, V288, pR25, DOI 10.1152/ajpregu.00418.2004; Smithson L, 2018, SLEEP MED; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wu L, 2017, J NUTR HEALTH AGING, P21	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227938	10.1371/journal.pone.0227938	http://dx.doi.org/10.1371/journal.pone.0227938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990931	gold, Green Published			2022-12-26	WOS:000534605400028
J	Da Re, D; Gilbert, M; Chaiban, C; Bourguignon, P; Thanapongtharm, W; Robinson, TP; Vanwambeke, SO				Da Re, Daniele; Gilbert, Marius; Chaiban, Celia; Bourguignon, Pierre; Thanapongtharm, Weerapong; Robinson, Timothy P.; Vanwambeke, Sophie O.			Downscaling livestock census data using multivariate predictive models: Sensitivity to modifiable areal unit problem	PLOS ONE			English	Article							REGRESSION-MODEL; PLANT DIVERSITY; DUCKS; MAUP; VEGETATION; CITIES; BIAS	The analysis of census data aggregated by administrative units introduces a statistical bias known as the modifiable areal unit problem (MAUP). Previous researches have mostly assessed the effect of MAUP on upscaling models. The present study contributes to clarify the effects of MAUP on the downscaling methodologies, highlighting how a priori choices of scales and shapes could influence the results. We aggregated chicken and duck fine-resolution census in Thailand, using three administrative census levels in regular and irregular shapes. We then disaggregated the data within the Gridded Livestock of the World analytical framework, sampling predictors in two different ways. A sensitivity analysis on Pearson's r correlation statistics and RMSE was carried out to understand how size and shapes of the response variables affect the goodness-of-fit and downscaling performances. We showed that scale, rather than shapes and sampling methods, affected downscaling precision, suggesting that training the model using the finest administrative level available is preferable. Moreover, datasets showing non-homogeneous distribution but instead spatial clustering seemed less affected by MAUP, yielding higher Pearson's r values and lower RMSE compared to a more spatially homogenous dataset. Implementing aggregation sensitivity analysis in spatial studies could help to interpret complex results and disseminate robust products.	[Da Re, Daniele; Chaiban, Celia; Bourguignon, Pierre; Vanwambeke, Sophie O.] UCLouvain, Earth & Life Inst, George Lemaitre Ctr Earth & Climate Res, Louvain La Neuve, Belgium; [Gilbert, Marius; Chaiban, Celia] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium; [Thanapongtharm, Weerapong] Dept Livestock Dev DLD, Bangkok, Thailand; [Robinson, Timothy P.] Int Livestock Res Inst ILRI, Policies Inst & Livelihoods PIL, Nairobi, Kenya; [Robinson, Timothy P.] Food & Agr Org United Nat FAO, Sect Anal & Policy Branch AGAL, Livestock Informat, Rome, Italy	Universite Catholique Louvain; Universite Libre de Bruxelles; CGIAR; International Livestock Research Institute (ILRI); Food & Agriculture Organization of the United Nations (FAO)	Da Re, D (corresponding author), UCLouvain, Earth & Life Inst, George Lemaitre Ctr Earth & Climate Res, Louvain La Neuve, Belgium.	daniele.dare@uclouvain.be	Da Re, Daniele/U-3629-2019	Da Re, Daniele/0000-0002-3398-9295; Vanwambeke, Sophie/0000-0001-6620-6173; Thanapongtharm, Weerapong/0000-0002-9957-2011	FRFS-WISD Walloon Institute for Sustainable Development PDR "Mapping livestock's transition" [PDR-WISD X302317F]	FRFS-WISD Walloon Institute for Sustainable Development PDR "Mapping livestock's transition"	D.D.R. is supported by the FRFS-WISD Walloon Institute for Sustainable Development PDR "Mapping livestock's transition" (PDR-WISD X302317F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici V, 2015, ECOL COMPLEX, V21, P44, DOI 10.1016/j.ecocom.2014.12.004; Bacaro G, 2015, ECOL COMPLEX, V24, P37, DOI 10.1016/j.ecocom.2015.09.003; Briant A, 2010, J URBAN ECON, V67, P287, DOI 10.1016/j.jue.2009.09.014; Cebrecos A, 2018, APPL GEOGR, V95, P9, DOI 10.1016/j.apgeog.2018.04.001; Center for International Earth Science Information Network (CIESIN) & NASA Socioeconomic Data and Applications Center (SEDAC), 2016, GRIDD POP WORLD VERS; Dark SJ, 2007, PROG PHYS GEOG, V31, P471, DOI 10.1177/0309133307083294; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fox J., 2003, PEOPLE ENV APPROACHE, V1; Garcia-Llamas P, 2018, ECOL INDIC, V85, P285, DOI 10.1016/j.ecolind.2017.10.026; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.227; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Goodchild M.F., 1997, GEOGRAPHICAL ENV MOD, V1, P5, DOI DOI 10.1007/S10708-007-9111-Y; GOODMAN AC, 1977, LAND ECON, V53, P483, DOI 10.2307/3145991; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Salas-Olmedo MH, 2018, TOURISM MANAGE, V66, P13, DOI 10.1016/j.tourman.2017.11.001; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jara M, 2019, TRANSBOUND EMERG DIS, V66, P2482, DOI 10.1111/tbed.13306; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Jones P, CROPPERS LIVESTOCK K; Land Process Distributed Active Archive Center (LDAAC), 2004, GLOB 30 AR 2 EL DAT; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; Lee G, 2016, URBAN GEOGR, V37, P223, DOI 10.1080/02723638.2015.1057397; Linard C, 2011, GEOJOURNAL, V76, P525, DOI 10.1007/s10708-010-9364-8; Manley D., 2014, HDB REGIONAL SCI, P1157, DOI [DOI 10.1007/978-3-642-23430-9_69, 10.1007/978-3-642-23430-9_69.]; Manley D, 2006, COMPUT ENVIRON URBAN, V30, P143, DOI 10.1016/j.compenvurbsys.2005.08.005; Marceau DJ., 1999, CAN J REMOTE SENS, V25, P18, DOI DOI 10.1080/07038992.1999.10874734; Mitra R, 2012, J TRANSP GEOGR, V20, P51, DOI 10.1016/j.jtrangeo.2011.07.009; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nicolas G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150424; Nouri H, 2017, SCI TOTAL ENVIRON, V584, P11, DOI 10.1016/j.scitotenv.2017.01.130; OPENSHAW S, 1984, ENVIRON PLANN A, V16, P17, DOI 10.1068/a160017; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Parenteau MP, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-58; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; R Development Core Team, 2011, R LANG ENV STAT COMP; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rohde D, 2010, COMPUT ENVIRON URBAN, V34, P58, DOI 10.1016/j.compenvurbsys.2009.09.001; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Sere C, 1996, WORLD LIVESTOCK PROD; Sleeter R., 2007, GEOGRAPHIC INFORM SY; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Swift A, 2008, COMPUT ENVIRON URBAN, V32, P134, DOI 10.1016/j.compenvurbsys.2008.01.002; Swift A, 2014, GEOJOURNAL, V79, P137, DOI 10.1007/s10708-013-9504-z; Tagashira N, 2002, GEOGR ANAL, V34, P1; Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4; Truong PN, 2018, SPAT STAT-NETH, V23, P36, DOI 10.1016/j.spasta.2017.11.002; Tuson M, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0170-3; Utazi CE, 2019, STAT METHODS MED RES, V28, P3226, DOI 10.1177/0962280218797362; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Van Bogaert E., 2012, GLOBAL LAND COVER MA; Vigiak O, 2019, SCI TOTAL ENVIRON, V666, P1089, DOI 10.1016/j.scitotenv.2019.02.252; Wakefield J, 2003, BIOMETRICS, V59, P9, DOI 10.1111/1541-0420.00002; Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO; Xu PP, 2014, ACCIDENT ANAL PREV, V70, P110, DOI 10.1016/j.aap.2014.02.012; Yetman G., 2004, GLOBAL DISTRIBUTION; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	61	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0221070	10.1371/journal.pone.0221070	http://dx.doi.org/10.1371/journal.pone.0221070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986146	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400005
J	Ayyagari, VN; Wang, XJ; Diaz-Sylvester, PL; Groesch, K; Brard, L				Ayyagari, Vijayalakshmi N.; Wang, Xinjia; Diaz-Sylvester, Paula L.; Groesch, Kathleen; Brard, Laurent			Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; PANCREATIC-CANCER; MUTANT P53; RESISTANCE; GROWTH; METABOLISM; ACTIVATION; EXPRESSION; INHIBITOR; BCL-2	Abnormal accumulation of acyl-CoA cholesterol acyltransferase-1 (ACAT-1) mediated cholesterol ester has been shown to contribute to cancer progression in various cancers including leukemia, glioma, breast, pancreatic and prostate cancers. However, the significance of ACAT-1 and cholesterol esters (CE) is relatively understudied in ovarian cancer. In this in vitro study, we assessed the expression and contribution of ACAT-1 in ovarian cancer progression. We observed a significant increase in the expression of ACAT-1 and CE levels in a panel of ovarian cancer cell lines (OC-314, SKOV-3 and IGROV-1) compared to primary ovarian epithelial cells (normal controls). To confirm the tumor promoting capacity of ACAT1, we inhibited ACAT-1 expression and activity by treating our cell lines with an ACAT inhibitor, avasimibe, or by stable transfection with ACAT-1 specific short hairpin RNA (shRNA). We observed significant suppression of cell proliferation, migration and invasion in ACAT-1 knockdown ovarian cancer cell lines compared to their respective controls (cell lines transfected with scrambled shRNA). ACAT-1 inhibition enhanced apoptosis with a concurrent increase in caspases 3/7 activity and decreased mitochondrial membrane potential. Increased generation of reactive oxygen species (ROS) coupled with increased expression of p53 may be the mechanism(s) underlying pro-apoptotic action of ACAT-1 inhibition. Additionally, ACAT-1 inhibited ovarian cancer cell lines displayed enhanced chemosensitivity to cisplatin treatment. These results suggest ACAT-1 may be a potential new target for the treatment of ovarian cancer.	[Ayyagari, Vijayalakshmi N.; Wang, Xinjia; Diaz-Sylvester, Paula L.; Groesch, Kathleen; Brard, Laurent] Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA; [Diaz-Sylvester, Paula L.; Groesch, Kathleen] Southern Illinois Univ, Sch Med, Ctr Clin Res, Springfield, IL USA; [Brard, Laurent] Southern Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Brard, L (corresponding author), Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA.; Brard, L (corresponding author), Southern Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62702 USA.	lbrard@siumed.edu		Diaz-Sylvester, Paula/0000-0002-1531-1958; Ayyagari, Vijayalakshmi/0000-0003-1001-7044				Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; American Cancer Society, 2013, CANC FACTS FIG 2013, P18; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61; Bandyopadhyay S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179558; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; BRADLEY EC, 1985, CANCER RES, V45, P1464; Chan TA, 2000, GENE DEV, V14, P1584; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Crowe DL, 2006, HEAD NECK-J SCI SPEC, V28, P15, DOI 10.1002/hed.20319; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Danilo C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3483; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gaida MM, 2016, ONCOTARGET, V7, P12623, DOI 10.18632/oncotarget.7206; Geng Feng, 2017, Intern Med Rev (Wash D C), V3, DOI 10.18103/imr.v3i5.443; Geng F, 2016, CLIN CANCER RES, V22, P5337, DOI 10.1158/1078-0432.CCR-15-2973; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Harn HJ, 1996, HISTOPATHOLOGY, V28, P317, DOI 10.1046/j.1365-2559.1996.d01-431.x; He M, 2002, FEBS LETT, V517, P151, DOI 10.1016/S0014-5793(02)02609-1; Herzog Thomas J, 2006, Curr Oncol Rep, V8, P448, DOI 10.1007/s11912-006-0074-9; Hultsch S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4757-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin SK, 2001, J CELL SCI, V114, P4139; Kasibhatla Shailaja, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4493; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Koizume S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091430; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; LaPensee CR, 2016, ENDOCRINOLOGY, V157, P1775, DOI 10.1210/en.2015-2052; Lee SSY, 2015, ACS NANO, V9, P2420, DOI 10.1021/nn504025a; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 2016, ONCOGENE, V35, P6378, DOI 10.1038/onc.2016.168; Li JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193318; Liscovitch M, 2000, TRENDS BIOCHEM SCI, V25, P530, DOI 10.1016/S0968-0004(00)01668-6; Luo XJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0646-3; McDonnel AC, 2003, EXP BIOL MED, V228, P308, DOI 10.1177/153537020322800310; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MIYASHITA T, 1994, CANCER RES, V54, P3131; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Murai Toshiyuki, 2012, Int J Cell Biol, V2012, P763283, DOI 10.1155/2012/763283; Ohmoto T, 2015, MOL MED REP, V12, P6037, DOI 10.3892/mmr.2015.4200; Paillasse MR, 2009, J LIPID RES, V50, P2203, DOI 10.1194/jlr.M800668-JLR200; Pampalakis Georgios, 2015, Genes Cancer, V6, P472; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Saraon P, 2014, PROSTATE, V74, P372, DOI 10.1002/pros.22758; Stopsack KH, 2017, CARCINOGENESIS, V38, P806, DOI 10.1093/carcin/bgx058; Tosi MR, 2005, CLIN CHIM ACTA, V359, P27, DOI 10.1016/j.cccn.2005.04.003; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	61	22	22	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228024	10.1371/journal.pone.0228024	http://dx.doi.org/10.1371/journal.pone.0228024			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978092	gold, Green Published			2022-12-26	WOS:000534599100096
J	Xu, Y; Cantwell, L; Molosh, AI; Plant, LD; Gazgalis, D; Fitz, SD; Dustrude, ET; Yang, YH; Kawano, T; Garai, S; Noujaim, SF; Shekhar, A; Logothetis, DE; Thakur, GA				Xu, Yu; Cantwell, Lucas; Molosh, Andrei I.; Plant, Leigh D.; Gazgalis, Dimitris; Fitz, Stephanie D.; Dustrude, Erik T.; Yang, Yuchen; Kawano, Takeharu; Garai, Sumanta; Noujaim, Sami F.; Shekhar, Anantha; Logothetis, Diomedes E.; Thakur, Ganesh A.			The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoinositide; medicinal chemistry; potassium channel; small molecule; neurophysiology; basolateral amygdala; GIRK channels; PIP2; specific activator	RECTIFYING POTASSIUM CHANNELS; SODIUM-DEPENDENT ACTIVATION; MUSCARINIC K+ CHANNEL; BETA-GAMMA; G-PROTEINS; STRUCTURAL ELEMENTS; SUBUNIT; MECHANISMS; INSIGHTS; AMYGDALA	G-protein?gated inwardly-rectifying K+ (GIRK) channels are targets of G(i/o)-protein?signaling systems that inhibit cell excitability. GIRK channels exist as homotetramers (GIRK2 and GIRK4) or heterotetramers with nonfunctional homomeric subunits (GIRK1 and GIRK3). Although they have been implicated in multiple conditions, the lack of selective GIRK drugs that discriminate among the different GIRK channel subtypes has hampered investigations into their precise physiological relevance and therapeutic potential. Here, we report on a highly-specific, potent, and efficacious activator of brain GIRK1/2 channels. Using a chemical screen and electrophysiological assays, we found that this activator, the bromothiophene-substituted small molecule GAT1508, is specific for brain-expressed GIRK1/2 channels rather than for cardiac GIRK1/4 channels. Computational models predicted a GAT1508-binding site validated by experimental mutagenesis experiments, providing insights into how urea-based compounds engage distant GIRK1 residues required for channel activation. Furthermore, we provide computational and experimental evidence that GAT1508 is an allosteric modulator of channel?phosphatidylinositol 4,5-bisphosphate interactions. Through brain-slice electrophysiology, we show that subthreshold GAT1508 concentrations directly stimulate GIRK currents in the basolateral amygdala (BLA) and potentiate baclofen-induced currents. Of note, GAT1508 effectively extinguished conditioned fear in rodents and lacked cardiac and behavioral side effects, suggesting its potential for use in pharmacotherapy for post-traumatic stress disorder. In summary, our findings indicate that the small molecule GAT1508 has high specificity for brain GIRK1/2 channel subunits, directly or allosterically activates GIRK1/2 channels in the BLA, and facilitates fear extinction in a rodent model.	[Xu, Yu; Cantwell, Lucas; Plant, Leigh D.; Gazgalis, Dimitris; Yang, Yuchen; Kawano, Takeharu; Garai, Sumanta; Logothetis, Diomedes E.; Thakur, Ganesh A.] Northeastern Univ, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Sch Pharm, Boston, MA 02115 USA; [Xu, Yu; Cantwell, Lucas; Plant, Leigh D.; Gazgalis, Dimitris; Yang, Yuchen; Kawano, Takeharu; Garai, Sumanta; Logothetis, Diomedes E.; Thakur, Ganesh A.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Molosh, Andrei I.; Fitz, Stephanie D.; Dustrude, Erik T.; Shekhar, Anantha] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indiana Clin & Translat Sci Inst, Dept Psychiat, Indianapolis, IN 46202 USA; [Noujaim, Sami F.] Univ S Florida, Mol Pharmacol & Physiol, Tampa, FL 33612 USA	Northeastern University; Northeastern University; Indiana University System; Indiana University Bloomington; State University System of Florida; University of South Florida	Logothetis, DE; Thakur, GA (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Sch Pharm, Boston, MA 02115 USA.; Logothetis, DE; Thakur, GA (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.; Shekhar, A (corresponding author), Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indiana Clin & Translat Sci Inst, Dept Psychiat, Indianapolis, IN 46202 USA.	ashekhar@iu.edu; d.logothetis@northeastern.edu; g.thakur@northeastern.edu	Yang, Yuchen/GZK-6062-2022; Xu, Yu/AAM-8492-2021	Garai, Sumanta/0000-0003-4071-8490; Molosh, Andrei/0000-0001-6451-7912; Plant, Leigh/0000-0002-1622-1655	National Institutes of Health [R01-EY024717, R01-HL059949-21, R01-HL059949-22, R01-MH052619, R01-MH065702, UL1-TR001108, R21-HL138064, R01-HL129136]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01-EY024717 (to G. A. T.), R01-HL059949-21 and R01-HL059949-22 (to D. E. L.), and R01-MH052619, R01-MH065702, UL1-TR001108 (to A. S), R21-HL138064, and R01-HL129136 (to S.F.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 2015, INT REV NEUROBIOL, V123, P27, DOI 10.1016/bs.irn.2015.06.001; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Days E, 2010, PROBE REPORTS NIH MO; de Velasco EMF, 2015, INT REV NEUROBIOL, V123, P201, DOI 10.1016/bs.irn.2015.05.011; Doupnik CA, 2015, INT REV NEUROBIOL, V123, P87, DOI 10.1016/bs.irn.2015.05.010; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Glaaser IW, 2015, INT REV NEUROBIOL, V123, P117, DOI 10.1016/bs.irn.2015.05.014; Ha J, 2018, J BIOL CHEM, V293, P3546, DOI 10.1074/jbc.RA117.001679; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hickey AL, 2014, J PHYS CHEM A, V118, P3678, DOI 10.1021/jp502475e; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Johnson PL, 2015, PHARMACOL BIOCHEM BE, V138, P174, DOI 10.1016/j.pbb.2015.09.021; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaufmann K, 2013, ACS CHEM NEUROSCI, V4, P1278, DOI 10.1021/cn400062a; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee Y, 2008, NEUROPSYCHOPHARMACOL, V33, P2586, DOI 10.1038/sj.npp.1301674; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Li LP, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0208-5; Liao YJ, 1996, J NEUROSCI, V16, P7137; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin FY, 2017, J PHYS CHEM B, V121, P6813, DOI 10.1021/acs.jpcb.7b04198; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2015, INT REV NEUROBIOL, V123, P1, DOI 10.1016/bs.irn.2015.05.013; Logothetis DE, 2015, ANNU REV PHYSIOL, V77, P81, DOI 10.1146/annurev-physiol-021113-170358; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 2015, INT REV NEUROBIOL, V123, P161, DOI 10.1016/bs.irn.2015.05.009; Lujan R, 2014, TRENDS NEUROSCI, V37, P20, DOI 10.1016/j.tins.2013.10.006; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Manteghi AA, 2014, J CLIN PSYCHOPHARM, V34, P240, DOI 10.1097/JCP.0000000000000089; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mase Y, 2012, J BIOL CHEM, V287, P19537, DOI 10.1074/jbc.M112.353888; Mayfield J, 2015, INT REV NEUROBIOL, V123, P279, DOI 10.1016/bs.irn.2015.05.016; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Mirshahi Tooraj, 2002, Mol Interv, V2, P289, DOI 10.1124/mi.2.5.289; Molosh AI, 2014, NAT NEUROSCI, V17, P1583, DOI 10.1038/nn.3822; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Scholfield MR, 2017, BIOCHEMISTRY-US, V56, P2794, DOI 10.1021/acs.biochem.7b00022; Schr?dinger LLC, 2019, SCHROD REL IND FIT D; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sosulina L, 2008, MOL CELL NEUROSCI, V39, P491, DOI 10.1016/j.mcn.2008.08.002; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o; Takemoto Y, 2018, FASEB J, V32, P1778, DOI 10.1096/fj.201700349R; Tipps ME, 2015, INT REV NEUROBIOL, V123, P239, DOI 10.1016/bs.irn.2015.05.012; Weigl LG, 2001, MOL PHARMACOL, V60, P282, DOI 10.1124/mol.60.2.282; Wen WD, 2014, BIOORG MED CHEM LETT, V24, P5102, DOI 10.1016/j.bmcl.2014.08.061; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wieting JM, 2017, ACS CHEM NEUROSCI, V8, P1873, DOI 10.1021/acschemneuro.7b00217; Wydeven N, 2014, P NATL ACAD SCI USA, V111, P10755, DOI 10.1073/pnas.1405190111; Wydeven N, 2012, P NATL ACAD SCI USA, V109, P21492, DOI 10.1073/pnas.1212019110; Xu Y, 2015, BIOPHYS J, V108, P62, DOI 10.1016/j.bpj.2014.10.059; Yamakura T, 2001, ANESTHESIOLOGY, V95, P144, DOI 10.1097/00000542-200107000-00025; Yow TT, 2011, BRIT J PHARMACOL, V163, P1017, DOI 10.1111/j.1476-5381.2011.01315.x; Zarzoso M, 2013, CARDIOVASC RES, V99, P566, DOI 10.1093/cvr/cvt081; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	80	12	12	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3614	3634		10.1074/jbc.RA119.011527	http://dx.doi.org/10.1074/jbc.RA119.011527			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31953327	Green Published, hybrid			2022-12-26	WOS:000527725300020
J	Diaz-Jimenez, D; Petrillo, MG; Busada, J; Hermoso, MA; Cidlowski, JA				Diaz-Jimenez, David; Grazia Petrillo, Maria; Busada, Jonathan; Hermoso, Marcela A.; Cidlowski, John A.			Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid receptor; glucocorticoid; migration; macrophage; gene expression; immunology; inflammation; chromatin remodeling; nuclear receptor; dipeptidyl peptidase-4 (DPP4); DPP4 inhibitors; linagliptin; sitagliptin	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; TUMOR-ASSOCIATED MACROPHAGES; GENE-EXPRESSION; IN-VITRO; MIGRATION; INSULIN; DIFFERENTIATION; ACTIVATION; MONOCYTES; METFORMIN	Glucocorticoids are potent endogenous anti-inflammatory molecules, and their cognate receptor, glucocorticoid receptor (GR), is expressed in nearly all immune cells. Macrophages are heterogeneous immune cells having a central role in both tissue homeostasis and inflammation and also play a role in the pathogenesis of some inflammatory diseases. Paradoxically, glucocorticoids have only a limited efficacy in controlling the resolution of these macrophage-related diseases. Here, we report that the transcriptomes of monocyte-like THP-1 cells and macrophage-like THP-1 cells (THP1-M?) have largely conserved gene expression patterns. In contrast, the differentiation to THP1-M? significantly altered the sensitivity of gene transcription to glucocorticoids. Among glucocorticoid-regulated genes, we identified the exopeptidase dipeptidyl peptidase-4 (DPP4) as a critical glucocorticoid-responsive gene in THP1-M?. We found that GR directly induces DPP4 gene expression by binding to two glucocorticoid-responsive elements (GREs) within the DPP4 promoter. Additionally, we show that glucocorticoid-induced DPP4 expression is blocked by the GR antagonist RU-486 and by GR siRNA transfection and that DPP4 enzyme activity is reduced by DPP4 inhibitors. Of note, glucocorticoids highly stimulated macrophage mobility; unexpectedly, DPP4 mediated the glucocorticoid-induced macrophage migration, and siRNA-mediated knockdowns of GR and DPP4 blocked dexamethasone-induced THP1-M? migration. Moreover, glucocorticoid-induced DPP4 activation was also observed in proinflammatory M1-polarized murine macrophages, as well as peritoneal macrophages, and was associated with increased macrophage migration. Our results indicate that glucocorticoids directly up-regulate DPP4 expression and thereby induce migration in macrophages, potentially explaining why glucocorticoid therapy is less effective in controlling macrophage-dominated inflammatory disorders.	[Diaz-Jimenez, David; Grazia Petrillo, Maria; Busada, Jonathan; Cidlowski, John A.] NIEHS, Mol Endocrinol Grp, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Diaz-Jimenez, David; Hermoso, Marcela A.] Univ Chile, Fac Med, Inst Biomed Sci, Lab Innate Immun,Disciplinary Program Immunol, Santiago 8380000, Chile	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Universidad de Chile	Cidlowski, JA (corresponding author), NIEHS, NIH, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Hermoso, Marcela A./AAF-6893-2021; Cidlowski, John/G-2548-2019	Hermoso, Marcela A./0000-0002-7936-7571; Petrillo, Maria Grazia/0000-0001-5999-9355; Cidlowski, John/0000-0003-1420-0516	Intramural Research Program of the NIEHS, National Institutes of Health [1ZIAES090057]; NIH Research Program [37432]; NIGMS, NIH [1Fi2GM123974]; FONDECYT [1170648];  [CONICYT-PFCHA/Doctorado Nacional/2015/21150264]	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); 	This work was supported by Intramural Research Program of the NIEHS, National Institutes of Health, Grant 1ZIAES090057. This work was also supported by CONICYT-PFCHA/Doctorado Nacional/2015/21150264 and a supplemental predoctoral fellowship of the NIH Research Program (Grant 37432) (to D. D. J.), a postdoctoral research associate (PRAT) fellowship from NIGMS, NIH (Grant 1Fi2GM123974) (to J. T. B.), and FONDECYT Grant 1170648 (to M. A. H.).	Angsana J, 2016, EUR J IMMUNOL, V46, P1592, DOI 10.1002/eji.201546262; Apostolopoulos D, 2017, RHEUMATOLOGY, V56, P114, DOI 10.1093/rheumatology/kew406; Ayoub S, 2008, NAT CLIN PRACT RHEUM, V4, P98, DOI 10.1038/ncprheum0701; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Blauenfeldt T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01456; Broxmeyer HE, 2016, STEM CELLS DEV, V25, P575, DOI 10.1089/scd.2016.0026; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Crowley MJ, 2017, DIABETES CARE, V40, P1787, DOI 10.2337/dc17-1528; Cucak H, 2014, J LEUKOCYTE BIOL, V95, P149, DOI 10.1189/jlb.0213075; de Lange P, 2001, CANCER RES, V61, P3937; Desmet SJ, 2017, J CLIN INVEST, V127, P1136, DOI 10.1172/JCI88886; Diaz J, 2014, J CELL SCI, V127, P2401, DOI 10.1242/jcs.141689; Fen ZG, 2016, DIABETES, V65, P2966, DOI 10.2337/db16-0317; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Guo B, 2017, NAT MED, V23, P424, DOI 10.1038/nm.4298; Heideveld E, 2018, HAEMATOLOGICA, V103, P395, DOI 10.3324/haematol.2017.179341; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Herrera C, 2001, J BIOL CHEM, V276, P19532, DOI 10.1074/jbc.M004586200; Hiromura M, 2018, BIOCHEM BIOPH RES CO, V495, P223, DOI 10.1016/j.bbrc.2017.11.016; Ishiguro Y, 2006, CLIN IMMUNOL, V120, P335, DOI 10.1016/j.clim.2006.05.010; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jewell CM, 2016, AM J PHYSIOL-ENDOC M, V311, pE741, DOI 10.1152/ajpendo.00105.2016; Koenen M, 2018, ANN RHEUM DIS, V77, P1610, DOI 10.1136/annrheumdis-2017-212762; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Liao XD, 2018, P NATL ACAD SCI USA, V115, pE4661, DOI 10.1073/pnas.1720065115; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Necela BM, 2004, J BIOL CHEM, V279, P39279, DOI 10.1074/jbc.M405489200; Ou SM, 2017, HEART, V103, P414, DOI 10.1136/heartjnl-2016-309687; Rohrborn D, 2016, BIOCHEM BIOPH RES CO, V471, P348, DOI 10.1016/j.bbrc.2016.02.019; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Simon Jeremy M, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2126s102; Takahashi H, 2019, J DIABETES INVEST, V10, P714, DOI 10.1111/jdi.12922; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; van Genugten RE, 2014, EUR J ENDOCRINOL, V170, P429, DOI 10.1530/EJE-13-0610; Vilsboll T, 2019, DIABETES CARE, V42, P1464, DOI 10.2337/dc18-1988; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; Yata Y, 2017, INTERNAL MED, V56, P2555, DOI 10.2169/internalmedicine.8296-16; Yen FS, 2018, DIABETES RES CLIN PR, V140, P279, DOI 10.1016/j.diabres.2018.04.012; Zhong JX, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00477; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230	51	18	19	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3213	3227		10.1074/jbc.RA119.010894	http://dx.doi.org/10.1074/jbc.RA119.010894			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988243	hybrid, Green Published			2022-12-26	WOS:000519597300026
J	Wang, RZ; Xu, C; Zhong, HJ; Hu, B; Wei, LX; Liu, N; Zhang, YZ; Shi, QH; Wang, C; Qi, M; Gu, YF; Shen, XL; Tian, Y; Liu, Y; Cao, P; Chen, HJ; Yuan, W				Wang, Ruizhe; Xu, Chen; Zhong, Huajian; Hu, Bo; Wei, Leixin; Liu, Ning; Zhang, Yizhi; Shi, Qianghui; Wang, Chen; Qi, Min; Gu, Yifei; Shen, Xiaolong; Tian, Ye; Liu, Yang; Cao, Peng; Chen, Huajiang; Yuan, Wen			Inflammatory-sensitive CHI3L1 protects nucleus pulposus via AKT3 signaling during intervertebral disc degeneration	FASEB JOURNAL			English	Article						AKT3; intervertebral disc degeneration; nucleus pulposus	HUMAN CARTILAGE GP-39; SYNOVIAL-CELLS; YKL-40; EXPRESSION; PROLIFERATION; INHIBITION; IL-1-BETA; APOPTOSIS; RESPONSES; THERAPY	Intervertebral disc degeneration (IDD) is the main cause of low back pain and the mechanism of which is far from fully revealed. Although inflammation directed nucleus pulposus (NP) extracellular matrix metabolism dysregulation is known to be the main cause of the degeneration process, few is known about the protective factors. Using high-throughput label-free proteomics, we found that inflammation-related autocrine factor Chitinase-3-like protein 1 (CHI3L1, or YKL-40) is highly expressed in the NP cells during degeneration. Immunohistochemical analysis show that the expression of CHI3L1 is NP tissue specific, and increase significantly during degeneration. Overexpression of CHI3L1 significantly decrease the catabolism, and increase the anabolism of extracellular matrix. Knockdown of CHI3L1 using siRNAs show the opposite results, which imply that the protective role of CHI3L1 in IDD. Using high-throughput RNA sequencing and functional analyses, we find that AKT3 expression and its phosphorylation is mainly regulated by CHI3L1. And lastly, the mechanism of which is also validated using human and mouse degenerated NP tissues. In summary, our findings show that the inflammation-related autocrine factor CHI3L1 is NP specific, and it protects IDD by promoting the AKT3 signaling, which may serve as a potential therapeutic target in intervertebral disc degeneration.	[Wang, Ruizhe; Xu, Chen; Zhong, Huajian; Hu, Bo; Wei, Leixin; Liu, Ning; Zhang, Yizhi; Shi, Qianghui; Wang, Chen; Qi, Min; Gu, Yifei; Shen, Xiaolong; Tian, Ye; Liu, Yang; Cao, Peng; Chen, Huajiang; Yuan, Wen] Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthoped, 415th Feng Yang Rd, Shanghai 200003, Peoples R China	Naval Medical University	Cao, P; Chen, HJ; Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthoped, 415th Feng Yang Rd, Shanghai 200003, Peoples R China.	pinocao@163.com; chen.huajiang@163.com; yuanwenspine@smmu.edu.cn	Xu, Chen/AAQ-5514-2020	Xu, Chen/0000-0001-8068-2109				Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Blanquer SBG, 2015, ADV DRUG DELIVER REV, V84, P172, DOI 10.1016/j.addr.2014.10.024; Choi H, 2018, MATRIX BIOL, V70, P102, DOI 10.1016/j.matbio.2018.03.019; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Deutschmann C, 2019, CLIN IMMUNOL, V199, P12, DOI 10.1016/j.clim.2018.12.005; Ebner F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01868; Gullbrand SE, 2017, OSTEOARTHR CARTILAGE, V25, P146, DOI 10.1016/j.joca.2016.08.006; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Hu B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21190; Hu B, 2015, CELL PHYSIOL BIOCHEM, V37, P793, DOI 10.1159/000430396; Huang K, 2009, J INT MED RES, V37, P18, DOI 10.1177/147323000903700102; Ji ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07360-1; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; Kao TH, 2014, J NEUROSURG-SPINE, V21, P653, DOI 10.3171/2014.6.SPINE13756; Kognole AA, 2017, J BIOL CHEM, V292, P2624, DOI 10.1074/jbc.M116.764985; Lee CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12752; Lee DH, 2019, MOL THER-NUCL ACIDS, V16, P63, DOI 10.1016/j.omtn.2019.02.007; Li Y, 2016, BIOCHEM BIOPH RES CO, V469, P507, DOI 10.1016/j.bbrc.2015.12.020; Lin HP, 2015, ONCOTARGET, V6, P27097, DOI 10.18632/oncotarget.4553; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; MELCHERS LS, 1994, PLANT J, V5, P469, DOI 10.1046/j.1365-313X.1994.5040469.x; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mo XM, 2016, MOL MED REP, V13, P1961, DOI 10.3892/mmr.2016.4760; Molinos M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1191; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; Mouser VHM, 2019, J ORTHOP RES, V37, P1110, DOI 10.1002/jor.24268; Nakazawa KR, 2018, SPINE J, V18, P343, DOI 10.1016/j.spinee.2017.09.018; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Pasku D, 2011, EUR SPINE J, V20, P1676, DOI 10.1007/s00586-011-1841-3; Pozzuoli A, 2007, CLIN EXP RHEUMATOL, V25, P453; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Rutges JPHJ, 2008, J PATHOL, V214, P523, DOI 10.1002/path.2317; Sakai D, 2015, ADV DRUG DELIVER REV, V84, P159, DOI 10.1016/j.addr.2014.06.009; Shen JL, 2016, PAIN PHYSICIAN, V19, pE215; Studer RK, 2008, J ORTHOP RES, V26, P991, DOI 10.1002/jor.20604; Sun DD, 2015, J CELL MOL MED, V19, P1296, DOI 10.1111/jcmm.12501; Tang P, 2018, FREE RADICAL BIO MED, V120, P368, DOI 10.1016/j.freeradbiomed.2018.04.008; Tian Y, 2016, MATRIX BIOL, V50, P39, DOI 10.1016/j.matbio.2015.11.008; Wang F, 2016, OSTEOARTHR CARTILAGE, V24, P398, DOI 10.1016/j.joca.2015.09.019; Wu XH, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.107; Zhang MM, 2015, APOPTOSIS, V20, P1150, DOI 10.1007/s10495-015-1148-7; Zhang Y, 2018, MATRIX BIOL, V70, P123, DOI 10.1016/j.matbio.2018.03.024; Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096	47	8	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3554	3569		10.1096/fj.201902096R	http://dx.doi.org/10.1096/fj.201902096R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31997395	hybrid			2022-12-26	WOS:000519218400009
J	Crown, A; McAlary, L; Fagerli, E; Brown, H; Yerbury, JJ; Galaleldeen, A; Cashman, NR; Borchelt, DR; Ayers, JI				Crown, Anthony; McAlary, Luke; Fagerli, Eric; Brown, Hilda; Yerbury, Justin J.; Galaleldeen, Ahmad; Cashman, Neil R.; Borchelt, David R.; Ayers, Jacob I.			Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT CU,ZN-SUPEROXIDE DISMUTASE; MOLECULAR-WEIGHT COMPLEXES; WILD-TYPE; AGGREGATION PROPENSITIES; DECREASED STABILITY; HYALINE INCLUSIONS; CLINICAL-FEATURES; DISULFIDE BOND; MISFOLDED SOD1	Mutations in Cu/Zn superoxide dismutase 1 (SOD1) associated with familial amyotrophic lateral sclerosis cause the protein to aggregate via a prion-like process in which soluble molecules are recruited to aggregates by conformational templating. These misfolded SOD1 proteins can propagate aggregation-inducing conformations across cellular membranes. Prior studies demonstrated that mutation of a Trp (W) residue at position 32 to Ser (S) suppresses the propagation of misfolded conformations between cells, whereas other studies have shown that mutation of Trp 32 to Phe (F), or Cys 111 to Ser, can act in cis to attenuate aggregation of mutant SOD1. By expressing mutant SOD1 fused with yellow fluorescent protein (YFP), we compared the relative ability of these mutations to modulate the formation of inclusions by ALS-mutant SOD1 (G93A and G85R). Only mutation of Trp 32 to Ser persistently reduced the formation of the amorphous inclusions that form in these cells, consistent with the idea that a Ser at position 32 inhibits templated propagation of aggregation prone conformations. To further test this idea, we produced aggregated fibrils of recombinant SOD1-W32S in vitro and injected them into the spinal cords of newborn mice expressing G85R-SOD1: YFP. The injected mice developed an earlier onset paralysis with a frequency similar to mice injected with WT SOD1 fibrils, generating a strain of misfolded SOD1 that produced highly fibrillar inclusion pathology. These findings suggest that the effect of Trp 32 in modulating the propagation of misfolded SOD1 conformations may be dependent upon the "strain" of the conformer that is propagating.	[Crown, Anthony; Fagerli, Eric; Brown, Hilda; Borchelt, David R.; Ayers, Jacob I.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, SantaFe HealthCare Alzheimers Dis Res Ctr, Dept Neurosci,McKnight Brain Inst, Gainesville, FL 32609 USA; [McAlary, Luke; Yerbury, Justin J.] Univ Wollongong, Mol Horizons & Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [McAlary, Luke; Yerbury, Justin J.] Univ Wollongong, Sch Chem & Mol Biosci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Galaleldeen, Ahmad] St Marys Univ, Dept Biol Sci, San Antonio, TX USA; [Cashman, Neil R.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Ayers, Jacob I.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	State University System of Florida; University of Florida; University of Wollongong; University of Wollongong; University of British Columbia; University of California System; University of California San Francisco	Ayers, JI (corresponding author), Univ Florida, Ctr Translat Res Neurodegenerat Dis, SantaFe HealthCare Alzheimers Dis Res Ctr, Dept Neurosci,McKnight Brain Inst, Gainesville, FL 32609 USA.; Ayers, JI (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	Jacob.Ayers@ucsf.edu	Yerbury, Justin/AAC-7054-2022; Ayers, Jacob/AAQ-7158-2021	Yerbury, Justin/0000-0003-2528-7039; McAlary, Luke/0000-0002-1764-3809; Galaleldeen, Ahmad/0000-0003-1160-6908	National Institutes of Neurological Disease and Stroke [1R21NS088839, 1R01NS092788]; Packard Center for ALS Research at Johns Hopkins University; St. Mary's University Research Grant; Biaggini Research Program National Institutes of Health [S10OD020026]	National Institutes of Neurological Disease and Stroke; Packard Center for ALS Research at Johns Hopkins University(Johns Hopkins University); St. Mary's University Research Grant; Biaggini Research Program National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DB - National Institutes of Neurological Disease and Stroke (1R21NS088839) DB National Institutes of Neurological Disease and Stroke (1R01NS092788) DB -Packard Center for ALS Research at Johns Hopkins University AG St. Mary's University Research Grant AG - Biaggini Research Program National Institutes of Health S10OD020026 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Ayers JI, 2017, J NEUROCHEM, V140, P140, DOI 10.1111/jnc.13864; Ayers JI, 2016, ACTA NEUROPATHOL, V132, P827, DOI 10.1007/s00401-016-1623-4; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Ayers JI, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-55; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bergh J, 2015, P NATL ACAD SCI USA, V112, P4489, DOI 10.1073/pnas.1419228112; Bidhendi EE, 2016, J CLIN INVEST, V126, P2249, DOI 10.1172/JCI84360; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Chattopadhyay M, 2015, J BIOL CHEM, V290, P30624, DOI 10.1074/jbc.M115.666503; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Ciryam P, 2017, P NATL ACAD SCI USA, V114, pE3935, DOI 10.1073/pnas.1613854114; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; Coelho FR, 2014, J BIOL CHEM, V289, P30690, DOI 10.1074/jbc.M114.586370; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Crown AM, 2019, G3-GENES GENOM GENET, V9, P719, DOI 10.1534/g3.118.200787; Da Cruz S, 2017, ACTA NEUROPATHOL, V134, P97, DOI 10.1007/s00401-017-1688-8; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Duval MG, 2019, NEUROBIOL DIS, V124, P297, DOI 10.1016/j.nbd.2018.11.025; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; FRIDOVICH I, 1974, ADV ENZYMOL RAMB, V41, P35; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2016, J BIOL CHEM, V291, P4144, DOI 10.1074/jbc.M115.683763; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hineno A, 2012, J NEUROL SCI, V319, P63, DOI 10.1016/j.jns.2012.05.014; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2008, ANN NEUROL, V63, P671, DOI 10.1002/ana.21356; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Karch CM, 2008, J BIOL CHEM, P283; Kato S, 2001, ACTA NEUROPATHOL, V102, P233; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Knibb JA, 2016, J NEUROL NEUROSUR PS, V87, P1361, DOI 10.1136/jnnp-2015-312908; Kokubo Y, 1999, ARCH NEUROL-CHICAGO, V56, P1506, DOI 10.1001/archneur.56.12.1506; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Maniecka Z, 2015, VIRUS RES, V207, P94, DOI 10.1016/j.virusres.2014.12.032; McAlary L, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00499; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nagano S, 2015, HUM MOL GENET, V24, P3427, DOI 10.1093/hmg/ddv093; Nakamura S, 2014, NEUROPATHOLOGY, V34, P58, DOI 10.1111/neup.12049; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; Pokrishevsky E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32835-y; Pokrishevsky E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184384; Pratt AJ, 2014, P NATL ACAD SCI USA, V111, pE4568, DOI 10.1073/pnas.1308531111; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Qualls DA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-46; Qualls DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083981; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Ray SS, 2004, P NATL ACAD SCI USA, V101, P5701, DOI 10.1073/pnas.0401934101; Roberts BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042532; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rotunno MS, 2014, J BIOL CHEM, V289, P28527, DOI 10.1074/jbc.M114.581801; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sabado J, 2013, J NEUROPATH EXP NEUR, V72, P646, DOI 10.1097/NEN.0b013e318297fd10; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sasaki S, 1998, NEUROLOGY, V51, P871, DOI 10.1212/WNL.51.3.871; Sea K, 2015, J BIOL CHEM, V290, P2405, DOI 10.1074/jbc.M114.588798; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Steinacker P, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0130-x; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Takehisa Y, 2001, ARCH NEUROL-CHICAGO, V58, P736, DOI 10.1001/archneur.58.5.736; Tan CF, 2004, ACTA NEUROPATHOL, V108, P332, DOI 10.1007/s00401-004-0893-4; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106	91	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227655	10.1371/journal.pone.0227655	http://dx.doi.org/10.1371/journal.pone.0227655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999698	Green Published, gold			2022-12-26	WOS:000534612400026
J	Farahani, S; Bandani, AR; Alizadeh, H; Goldansaz, SH; Whyard, S				Farahani, Saeed; Bandani, Ali R.; Alizadeh, Houshang; Goldansaz, Seyed Hossein; Whyard, Steven			Differential expression of heat shock proteins and antioxidant enzymes in response to temperature, starvation, and parasitism in the Carob moth larvae, Ectomyelois ceratoniae (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							UP-REGULATION; SARCOPHAGA-CRASSIPALPIS; OXIDATIVE STRESS; FLESH FLY; GENES; COLD; EVOLUTIONARY; ACCLIMATION; ADAPTATION; CLONING	Insects face diverse biotic and abiotic stresses that can affect their survival. Many of these stressors impact cellular metabolism, often resulting in increased accumulation of reactive oxygen species (ROS). Consequently, insects will respond to these stressors by increasing antioxidant activity and increased production of heat shock proteins (HSPs). In this study, the effect of heat, cold, starvation, and parasitism by Habroacon hebetor wasps was examined in the carob moth, Ectomyelois ceratoniae, to determine which responses were common to different stresses. For all stressors, malondialdehyde levels increased, indicative of oxidative stress in the insects. The activity of two antioxidant enzymes, superoxide dismutase (SOD) and catalase (CAT), increased with each stress, suggesting that these enzymes were serving a protective role for the insects. Heat (46 degrees C for 100 min) and cold (-15 degrees C for 30 min) treatments caused significant mortalities to all developmental stages, but pretreatments of moderate heat (37 degrees C for 10 min) or cold (10 degrees C for 10 min) induced thermotolerance and reduced the mortality rates when insects were subsequently exposed to lethal temperatures. Quantitative RT-PCR confirmed that heat and cold tolerance were associated with up-regulation of two HSPs, HSP70 and HSP90. Interestingly, HSP70 transcripts increased to a greater extent with cold treatment, while HSP90 transcripts increased more in response to high temperatures. RNA interference (RNAi)-mediated knockdown of either HSP70 or HSP90 transcripts was achieved by injecting larvae with dsRNA targeting each gene's transcripts, and resulted in a loss of acquired thermotolerance in insects subjected to the heat or cold pretreatments. These observations provide convincing evidence that both HSP70 and HSP90 are important mediators of the acquired thermotolerance. Starvation and parasitism by wasps caused differential expression of the HSP genes. In response to starvation, HSP90 transcripts increased to a greater extent than HSP70, while in contrast, HSP70 transcripts increased to a greater extent than those of HSP90 during the first 48 h of wasp parasitism. These results showed the differential induction of the two HSPs' transcripts with variable stresses. As well as, heat, cold, starvation, and parasitism induce oxidative stress, and antioxidant enzymes likely play an important role in reducing oxidative damage in E. ceratoniae.	[Farahani, Saeed; Bandani, Ali R.; Goldansaz, Seyed Hossein] Univ Tehran, Coll Agr & Nat Resources, Plant Protect Dept, Karaj, Iran; [Alizadeh, Houshang] Univ Tehran, Coll Agr & Nat Resources, Dept Agron & Plant Breeding, Karaj, Iran; [Whyard, Steven] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Tehran; University of Tehran; University of Manitoba	Bandani, AR (corresponding author), Univ Tehran, Coll Agr & Nat Resources, Plant Protect Dept, Karaj, Iran.	abandani@ut.ac.ir	Goldansaz, Seyed Hossein/AFO-8311-2022; Bandani, Ali R./AAH-9460-2020	Bandani, Ali R./0000-0002-1766-9355; Whyard, Steve/0000-0002-9874-7780	University of Tehran; Natural Sciences and Engineering Research Council; Iran's Minister of Science Research and Technology	University of Tehran(University of Tehran); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Iran's Minister of Science Research and Technology	This research was supported by funds to Ali R. Bandani from the University of Tehran, funds to Steven Whyard from Natural Sciences and Engineering Research Council, and a scholarship from Iran's Minister of Science Research and Technology to Saeed Farahani. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi M, 2004, MED SCI MONITOR, V10, pRA141; Addo-Bediako A, 2002, FUNCT ECOL, V16, P332, DOI 10.1046/j.1365-2435.2002.00634.x; Ali A, 2017, B ENTOMOL RES, V107, P382, DOI 10.1017/S0007485316001000; Amiri A, 2016, ARCH INSECT BIOCHEM, V91, P189, DOI 10.1002/arch.21311; Andreadis SS, 2017, CROP PROT, V91, P93, DOI 10.1016/j.cropro.2016.08.013; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bennett AF, 1997, EVOLUTION, V51, P36, DOI 10.1111/j.1558-5646.1997.tb02386.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burks CS, 1999, J STORED PROD RES, V35, P65, DOI 10.1016/S0022-474X(98)00031-9; Dmochowska-Slezak K, 2015, APIDOLOGIE, V46, P432, DOI 10.1007/s13592-014-0333-y; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Guo XJ, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey059; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Huey Raymond B., 2010, P223, DOI 10.1017/CBO9780511675997.010; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jia FX, 2011, FLA ENTOMOL, V94, P956, DOI 10.1653/024.094.0432; Kang ZW, 2017, FRONT PHYSIOL, V8, P1, DOI [10.3389/fphys.2017.00001, DOI 10.3389/FPHYS.2017.00001]; Kim M, 2017, ENVIRON ENTOMOL, V46, P1005, DOI 10.1093/ee/nvx112; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Kolawole AO, 2014, INT J INSECT SCI, V6; Lee R.E. Jr, 1991, P17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsh P.M., 1979, CATALOG HYMENOPTERA, VVolume 1, P144; Mediouni J., 2007, P265, DOI 10.1007/978-1-4020-6059-5_25; Moreira DC, 2016, COMP BIOCHEM PHYS A, V200, P64, DOI 10.1016/j.cbpa.2016.01.023; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Rahimi V, 2018, J ECON ENTOMOL, V111, P662, DOI 10.1093/jee/toy006; Rinehart JP, 2002, J INVERTEBR PATHOL, V79, P62, DOI 10.1016/S0022-2011(02)00002-2; SALT RW, 1966, CAN J ZOOLOG, V44, P655, DOI 10.1139/z66-064; Sambrook J., 2001, MOL CLONING LAB MANU; Shim JK, 2008, J INVERTEBR PATHOL, V97, P306, DOI 10.1016/j.jip.2007.10.001; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stejskal V., 2015, IOBC/WPRS Bulletin, V111, P171; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian L, 2018, GENE, V642, P268, DOI 10.1016/j.gene.2017.11.041; Tungjitwitayakul J, 2016, EUR J ENTOMOL, V113, P135, DOI 10.14411/eje.2016.017; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Wang H, 2012, ARCH INSECT BIOCHEM, V79, P247, DOI 10.1002/arch.21013; Wang L, 2015, FLA ENTOMOL, V98, P506, DOI 10.1653/024.098.0218; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; Wu HD, 2012, BIOCONTROL SCI TECHN, V22, P601, DOI 10.1080/09583157.2012.670803; Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286; YOCUM GD, 1992, J INSECT PHYSIOL, V38, P603, DOI 10.1016/0022-1910(92)90112-Q; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93	48	16	16	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228104	10.1371/journal.pone.0228104	http://dx.doi.org/10.1371/journal.pone.0228104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995629	gold, Green Submitted, Green Published			2022-12-26	WOS:000534609400045
J	Friend, N; Noll, JE; Opperman, KS; Clark, KC; Mrozik, KM; Vandyke, K; Hewett, DR; Zannettino, ACW				Friend, Natasha; Noll, Jacqueline E.; Opperman, Khatora S.; Clark, Kimberley C.; Mrozik, Krzysztof M.; Vandyke, Kate; Hewett, Duncan R.; Zannettino, Andrew C. W.			GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice	PLOS ONE			English	Article							P53 TARGET GENE; MONOCLONAL GAMMOPATHY; MURINE MODEL; PLASMA-CELLS; IDIOPATHIC PARAPROTEINEMIA; INTRACLONAL HETEROGENEITY; FLOW-CYTOMETRY; BONE; CANCER; METHYLATION	Multiple myeloma, a plasma cell malignancy, is a genetically heterogeneous disease and the genetic factors that contribute to its development and progression remain to be fully elucidated. The tumour suppressor gene GLIPR1 has previously been shown to be deleted in approximately 10% of myeloma patients, to inhibit the development of plasma cell tumours in ageing mice and to have reduced expression levels in the plasma cells of patients with light-chain amyloidosis, a myeloma-related malignancy. Therefore, we hypothesised that GLIPR1 may have tumour suppressor activity in multiple myeloma. In this study, we demonstrate that plasma cell expression of GLIPR1 is reduced in the majority of myeloma patients and Glipr1 expression is lost in the 5TGM1 murine myeloma cell line. However, overexpression of GLIPR1 in a human myeloma cell line did not affect cell proliferation in vitro. Similarly, re-expression of Glipr1 in 5TGM1 cells did not significantly reduce their in vitro proliferation or in vivo growth in C57BL/KaLwRij mice. In addition, using CRISPR-Cas9 genome editing, we generated C57BL/Glipr1(-/-) mice and showed that loss of Glipr1 in vivo did not affect normal haematopoiesis or the development of monoclonal plasma cell expansions in these mice up to one year of age. Taken together, our results suggest that GLIPR1 is unlikely to be a potent tumour suppressor in multiple myeloma. However, it remains possible that the down-regulation of GLIPR1 may cooperate with other genetic lesions to promote the development of myeloma.	[Friend, Natasha; Noll, Jacqueline E.; Opperman, Khatora S.; Clark, Kimberley C.; Mrozik, Krzysztof M.; Vandyke, Kate; Hewett, Duncan R.; Zannettino, Andrew C. W.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia; [Friend, Natasha; Noll, Jacqueline E.; Opperman, Khatora S.; Clark, Kimberley C.; Mrozik, Krzysztof M.; Vandyke, Kate; Hewett, Duncan R.; Zannettino, Andrew C. W.] South Australian Hlth & Med Res Inst, Canc Program, Precis Med, Adelaide, SA, Australia	University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Zannettino, ACW (corresponding author), Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia.; Zannettino, ACW (corresponding author), South Australian Hlth & Med Res Inst, Canc Program, Precis Med, Adelaide, SA, Australia.	andrew.zannettino@adelaide.edu.au	Vandyke, Kate/G-6280-2010	Vandyke, Kate/0000-0002-1033-849X; Mrozik, Krzysztof/0000-0002-4890-8208; Noll, Jacqueline/0000-0001-7375-635X; Clark, Kimberley/0000-0001-6277-8297	Cancer Council SA [APP1087011]; Veronika Sacco Clinical Cancer Research Fellowship from the Florey Medical Research Foundation; University of Adelaide; Early Career Cancer Research Fellowship from the Cancer Council SA Beat Cancer Project; State Government of South Australia through the Department of Health	Cancer Council SA(Cancer Council South Australia); Veronika Sacco Clinical Cancer Research Fellowship from the Florey Medical Research Foundation; University of Adelaide; Early Career Cancer Research Fellowship from the Cancer Council SA Beat Cancer Project; State Government of South Australia through the Department of Health	This research was supported by a Cancer Council SA (https://www.cancersa.org.au) Grant (no. APP1087011) awarded to ACWZ. JEN was supported by a Veronika Sacco Clinical Cancer Research Fellowship from the Florey Medical Research Foundation, University of Adelaide (https://health.adelaide.edu.au/engage/philanthropy/florey-medical-research-foundation). KV was supported by an Early Career Cancer Research Fellowship from the Cancer Council SA Beat Cancer Project on behalf of its donors and the State Government of South Australia through the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Agnelli L, 2009, GENE CHROMOSOME CANC, V48, P603, DOI 10.1002/gcc.20668; Bolli N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05058-y; Bolli N, 2018, LEUKEMIA, V32, P2604, DOI 10.1038/s41375-018-0037-9; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Cohen AD, 2020, CLIN CANCER RES, V26, P1541, DOI 10.1158/1078-0432.CCR-19-2111; CROESE JW, 1987, BRIT J CANCER, V56, P555, DOI 10.1038/bjc.1987.241; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Das R, 2016, NAT MED, V22, P1351, DOI 10.1038/nm.4202; Diamond P, 2009, J BONE MINER RES, V24, P1150, DOI [10.1359/jbmr.090210, 10.1359/JBMR.090210]; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dong J, 2016, ONCOL REP, V36, P1585, DOI 10.3892/or.2016.4949; Durie BGM, 2017, LANCET, V389, P519, DOI 10.1016/S0140-6736(16)31594-X; Dutta AK, 2019, LEUKEMIA, V33, P457, DOI 10.1038/s41375-018-0206-x; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Heuck CJ, 2013, J IMMUNOL, V190, P2966, DOI 10.4049/jimmunol.1202493; Hill QA, 2014, BLOOD, V124, P1296, DOI 10.1182/blood-2014-04-566521; Kaiser MF, 2013, BLOOD, V122, P219, DOI 10.1182/blood-2013-03-487884; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kumar SK, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.46; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Li LK, 2013, MOL ONCOL, V7, P484, DOI 10.1016/j.molonc.2012.12.005; Li LK, 2011, CANCER RES, V71, P7694, DOI 10.1158/0008-5472.CAN-11-1714; Li LP, 2008, CANCER RES, V68, P9141, DOI 10.1158/0008-5472.CAN-08-1127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lopez-Corral L, 2012, LEUKEMIA, V26, P2521, DOI 10.1038/leu.2012.128; Lwin ST, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2015.142; Maes K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33396-w; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Mussetti A, 2019, ANN HEMATOL, V98, P1713, DOI 10.1007/s00277-019-03648-4; Noll JE, 2014, NEOPLASIA, V16, P572, DOI 10.1016/j.neo.2014.07.002; Noll JE, 2014, HAEMATOLOGICA, V99, P163, DOI 10.3324/haematol.2013.090977; Paiva B, 2016, BLOOD, V127, P3035, DOI 10.1182/blood-2015-10-673095; Paiva B, 2014, BLOOD, V124, P1300, DOI 10.1182/blood-2014-04-567909; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Puccini J, 2013, CELL DEATH DIFFER, V20, P964, DOI 10.1038/cdd.2013.35; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1985, CANCER-AM CANCER SOC, V55, P1030, DOI 10.1002/1097-0142(19850301)55:5<1030::AID-CNCR2820550518>3.0.CO;2-Y; RADL J, 1988, AM J PATHOL, V132, P593; RADL J, 1978, CLIN EXP IMMUNOL, V33, P395; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Ramadas M, 2016, 2016 6TH INTERNATIONAL CONFERENCE - CLOUD SYSTEM AND BIG DATA ENGINEERING (CONFLUENCE), P59, DOI 10.1109/CONFLUENCE.2016.7508048; Ren CH, 2002, MOL CELL BIOL, V22, P3345, DOI 10.1128/MCB.22.10.3345-3357.2002; Ren CZ, 2006, GENOMICS, V88, P163, DOI 10.1016/j.ygeno.2006.03.021; Ren CZ, 2004, CANCER RES, V64, P969, DOI 10.1158/0008-5472.CAN-03-2592; Ria R, 2011, AM J BLOOD RES, V1, P76; Satoh T, 2003, HUM GENE THER, V14, P91, DOI 10.1089/104303403321070793; Shaughnessy JD, 2011, BLOOD, V118, P3512, DOI 10.1182/blood-2010-12-328252; Sheng XM, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0508-4; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Tam Michael, 2010, J Assoc Genet Technol, V36, P111; Tenreiro MM, 2017, ANGIOGENESIS, V20, P443, DOI 10.1007/s10456-017-9571-8; Walker BA, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.13; Walker BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/leu.2013.199; Walker BA, 2018, BLOOD, V132, P587, DOI 10.1182/blood-2018-03-840132; Walker BA, 2015, J CLIN ONCOL, V33, P3911, DOI 10.1200/JCO.2014.59.1503; Walker BA, 2012, BLOOD, V120, P1077, DOI 10.1182/blood-2012-03-412981; Walker BA, 2011, BLOOD, V117, P553, DOI 10.1182/blood-2010-04-279539; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Weinhold N, 2016, BLOOD, V128, P1735, DOI 10.1182/blood-2016-06-723007; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Yan L, 2018, J CELL BIOCHEM, V119, P1791, DOI 10.1002/jcb.26340; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	73	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228408	10.1371/journal.pone.0228408	http://dx.doi.org/10.1371/journal.pone.0228408			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995627	gold, Green Published			2022-12-26	WOS:000534609400067
J	Giroux, SA; McCord, P; Lopus, S; Gower, D; Dell'Angelo, J; Dickinson, S; Chen, X; Caylor, KK; Evans, TP				Giroux, Stacey A.; McCord, Paul; Lopus, Sara; Gower, Drew; Dell'Angelo, Jampel; Dickinson, Stephanie; Chen, Xiwei; Caylor, Kelly K.; Evans, Tom P.			Environmental heterogeneity and commodity sharing in smallholder agroecosystems	PLOS ONE			English	Article							HIGHLAND-LOWLAND SYSTEM; CLIMATE-CHANGE; MOUNT KENYA; WATER-RESOURCES; COMMUNITY RESILIENCE; BEHAVIORAL ECOLOGY; FOOD SECURITY; ADAPTATION; STRATEGIES; NETWORKS	Smallholder farmers undertake a number of strategies to cope with climate shocks in a community. The sharing of resources across households constitutes one coping mechanism when environmental shocks differentially impact households. This paper investigates commodity sharing dynamics among households in eight communities in an environmentally heterogeneous highland-lowland area in central Kenya. We use survey data and meteorological data to test whether commodity sharing, measured at the household level by net inflow of commodities, varies across a regional precipitation gradient, and we reveal how sharing fluctuates with rainfall over the course of a year. We find both precipitation and income to be significant predictors of households' net value of shared commodities. Specifically, farmers who live in drier areas with less income are more likely to receive more commodities than they give. We also find that the length of time a household has been established in the area is significantly related to commodity sharing. Further, commodity sharing follows the pattern of harvest and food storage over the course of the year, with households giving the most commodities at times when food storage levels are higher, that is, post-harvest. The study sheds light on the relationship between commodity sharing as a coping mechanism and environmental heterogeneity in a region prone to seasonal food insecurity.	[Giroux, Stacey A.] Indiana Univ, Ostrom Workshop, Bloomington, IN 47405 USA; [Giroux, Stacey A.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [McCord, Paul] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Lopus, Sara] Calif Polytech State Univ San Luis Obispo, Dept Social Sci, San Luis Obispo, CA 93407 USA; [Gower, Drew] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Dell'Angelo, Jampel] Vrije Univ Amsterdam, Inst Environm Studies, Dept Environm Policy Anal, Amsterdam, Netherlands; [Dickinson, Stephanie; Chen, Xiwei] Indiana Univ, Sch Publ Hlth Epidemiol & Biostat, Bloomington, IN USA; [Caylor, Kelly K.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Caylor, Kelly K.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Evans, Tom P.] Univ Arizona, Sch Geog & Dev, Tucson, AZ USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Michigan State University; California State University System; California Polytechnic State University San Luis Obispo; Princeton University; Vrije Universiteit Amsterdam; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Arizona	Giroux, SA (corresponding author), Indiana Univ, Ostrom Workshop, Bloomington, IN 47405 USA.; Giroux, SA (corresponding author), Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA.	sagiroux@indiana.edu	Caylor, Kelly/ABF-2818-2020; Dell'Angelo, Jampel/AFQ-5722-2022	Caylor, Kelly/0000-0002-6466-6448; Gower, Drew/0000-0002-2944-871X; Dickinson, Stephanie/0000-0002-2998-4467; Dell'Angelo, Jampel/0000-0003-1431-5364	U.S. National Science Foundation [BCS-1115009]	U.S. National Science Foundation(National Science Foundation (NSF))	U.S. National Science Foundation award number SES-1360463; T.P.E.; nsf.gov. U.S. National Science Foundation award number BCS-1115009; T.P.E.; nsf.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2003, ECON GEOGR, V79, P387; Aeschbacher J, 2005, MT RES DEV, V25, P155, DOI 10.1659/0276-4741(2005)025[0155:RWSIAH]2.0.CO;2; Agrawal A, 2010, NEW FRONT SOC POLICY, P173; Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; [Anonymous], 2008, SAS STAT 9 2 US GUID; ARHEM K, 1989, ANTHROPOS, V84, P1; Baggio JA, 2016, P NATL ACAD SCI USA, V113, P13708, DOI 10.1073/pnas.1604401113; Baldwin E, 2016, GOVERNANCE, V29, P207, DOI 10.1111/gove.12160; Banejee AV, 2007, J ECON PERSPECT, V21, P141, DOI 10.1257/jep.21.1.141; Below T.B., 2010, IFPRI DISCUSSION PAP; Bird RLB, 1997, CURR ANTHROPOL, V38, P49, DOI 10.1086/204581; Bollig M., 2006, RISK MANAGEMENT HAZA; Bryan E, 2013, J ENVIRON MANAGE, V114, P26, DOI 10.1016/j.jenvman.2012.10.036; Burnham M, 2016, CLIM DEV, V8, P289, DOI 10.1080/17565529.2015.1067180; CASHDAN EA, 1985, MAN, V20, P454, DOI 10.2307/2802441; Cashdan Elizabeth A., 1990, RISK UNCERTAINTY TRI; Chuku CA, 2009, AFR J AGR RES, V4, P1524; Cobb C., 1995, GENUINE PROGR INDICA; Dell'Angelo J, 2016, MT RES DEV, V36, P102, DOI 10.1659/MRD-JOURNAL-D-15-00040.1; Dercon S., 2004, INSURANCE POVERTY; Deressa TT, 2009, GLOBAL ENVIRON CHANG, V19, P248, DOI 10.1016/j.gloenvcha.2009.01.002; Di Falco S, 2013, WORLD DEV, V43, P100, DOI 10.1016/j.worlddev.2012.10.011; di Falco S, 2011, J DEV STUD, V47, P1128, DOI 10.1080/00220388.2010.514328; Ember CR, 2018, EVOL HUM BEHAV, V39, P380, DOI 10.1016/j.evolhumbehav.2018.03.001; Fafchamps M, 2003, J DEV ECON, V71, P261, DOI 10.1016/S0304-3878(03)00029-4; Folke C, 2010, ECOL SOC, V15; Gower DB, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/115005; Grimard F, 1997, J DEV ECON, V53, P391, DOI 10.1016/S0304-3878(97)00016-3; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Harmer N, 2014, GEOGR COMPASS, V8, P808, DOI 10.1111/gec3.12180; Hogg R., 1989, CONSERVATION AFRICA, P293; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Kasper C, 2015, CURR ANTHROPOL, V56, P701, DOI 10.1086/683024; Kemerink J, 2016, INT J COMMONS, V10; King CA, 2008, SYST RES BEHAV SCI, V25, P111, DOI 10.1002/sres.854; Knowler D, 2007, FOOD POLICY, V32, P25, DOI 10.1016/j.foodpol.2006.01.003; Kofinas G., 2016, 2015023 BOEM U AL FA; Komter A, 2007, INT SOCIOL, V22, P93, DOI 10.1177/0268580907070127; Lebot V, 2015, HUM ECOL, V43, P827, DOI 10.1007/s10745-015-9796-3; Liniger H, 2005, MT RES DEV, V25, P163, DOI 10.1659/0276-4741(2005)025[0163:AAMSTM]2.0.CO;2; Magis K, 2010, SOC NATUR RESOUR, V23, P401, DOI 10.1080/08941920903305674; Masten AS, 2008, ECOL SOC, V13; Mauss M., 2007, ESSAI DON FORME RAIS; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McCabe JT., 1997, NOMADIC PEOPLES, V1, P54, DOI DOI 10.3167/082279497782384730; McCord P, 2018, WORLD DEV, V108, P296, DOI 10.1016/j.worlddev.2018.02.009; McCord P, 2017, ECOL SOC, V22, DOI 10.5751/ES-09156-220148; McCord PF, 2015, LAND USE POLICY, V42, P738, DOI 10.1016/j.landusepol.2014.10.012; Miller F, 2010, ECOL SOC, V15; Ngigi SN, 2007, LAND USE POLICY, V24, P129, DOI 10.1016/j.landusepol.2005.10.002; Nolin DA, 2012, EVOL HUM BEHAV, V33, P334, DOI 10.1016/j.evolhumbehav.2011.11.003; NORDHAUS WD, 1973, MEASUREMENT EC SOCIA, P509; Ongoma V, 2017, METEOROL ATMOS PHYS, V129, P131, DOI 10.1007/s00703-016-0462-0; Osbahr H., 2007, BUILDING RESILIENCE; Perez I, 2016, GLOBAL ENVIRON CHANG, V40, P82, DOI 10.1016/j.gloenvcha.2016.07.005; Ready E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193759; Reyes-Garcia V, 2014, GLOBAL ENVIRON CHANG, V24, P223, DOI 10.1016/j.gloenvcha.2013.11.022; Ricciardi V, 2018, GLOB FOOD SECUR-AGR, V17, P64, DOI 10.1016/j.gfs.2018.05.002; Rural Focus Ltd, 2004, RIV ABSTR SURV; Sahlins M., 1965, RELEVANCE MODELS SOC, P139; Saint Ville AS, 2016, FOOD SECUR, V8, P535, DOI 10.1007/s12571-016-0581-y; Samuelson PA, 1980, ECONOMICS, V11; Schmocker J, 2016, INT J CLIMATOL, V36, P1500, DOI 10.1002/joc.4438; Schnegg M, 2015, HUM NATURE-INT BIOS, V26, P313, DOI 10.1007/s12110-015-9236-5; Sheffield J, 2014, B AM METEOROL SOC, V95, P861, DOI 10.1175/BAMS-D-12-00124.1; Talk A., 1987, ETHNOS, V52, P50, DOI 10.1080/00141844.1987.9981335; Walker B., 2004, Ecology and Society, V9, P5; Wiesmann U, 2000, MT RES DEV, V20, P10, DOI 10.1659/0276-4741(2000)020[0010:MCOSWR]2.0.CO;2; Winterhalder Bruce, 1996, Evolutionary Anthropology, V5, P46; Yang D, 2007, WORLD BANK ECON REV, V21, P219, DOI 10.1093/wber/lhm003	70	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228021	10.1371/journal.pone.0228021	http://dx.doi.org/10.1371/journal.pone.0228021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995584	Green Published, gold, Green Submitted			2022-12-26	WOS:000534609400038
J	Averett, JP; Morris, LR; Naylor, BJ; Taylor, RV; Endress, BA				Averett, Joshua P.; Morris, Lesley R.; Naylor, Bridgett J.; Taylor, Robert V.; Endress, Bryan A.			Vegetation change over seven years in the largest protected Pacific Northwest Bunchgrass Prairie remnant	PLOS ONE			English	Article							GREAT-BASIN; CULTIVATION LEGACIES; PLANT COMMUNITY; ANNUAL GRASSES; DIVERSITY; IMPACTS; INVASIONS; CONSERVATION; MOUNTAINS; DOMINANCE	Temperate grasslands are one of the most altered ecosystems on Earth. Consequently, conservation of important characteristics of such ecosystems (e.g., biodiversity) is uncertain even within grasslands that have been protected. Invasion by non-native plants is considered a primary threat to intact grasslands. Here, we evaluated native and non-native vegetation composition change over seven years in the largest Pacific Northwest Bunchgrass remnant. We sampled 124 permanent plots across the Zumwalt Prairie Preserve (northeastern Oregon, USA) twice, seven years apart. With data collected from three grassland community types (xeric prairie, mesic prairie, old fields), we asked: (1) how has species composition changed over time; (2) which species showed the greatest changes in abundance; and (3) how did abundance of Ventenata dubia (the most abundant non-native species) relate to patterns of native and non-native plant abundance? Vegetation composition changed in all three plant communities. Ventenata dubia, an annual non-native grass: (1) became the third most dominant species across the study area; (2) was the only nonnative that increased in abundance substantially in all three communities; and (3) was negatively related to native perennial forb cover. Relative cover of non-native species decreased in old fields concomitant with increases in native bunchgrass (Festuca idahoensis) and V. dubia cover. Increased cover of native perennial grasses and non-native annual grasses in old fields were associated with loss of bare ground, but not with reductions in non-native perennial grass cover. Native species dominated in the mesic prairie; however, non-native cover (particularly V. dubia) increased (mean cover increased from 3 to 10%) while mean native perennial forb cover decreased (from 30 to 25%) over time. Continued shifts towards non-native annual grass dominance coupled with potentially declining native perennial forbs, may challenge conservation efforts in one of the last large tracts of Pacific Northwest Bunchgrass Prairie.	[Averett, Joshua P.; Morris, Lesley R.; Endress, Bryan A.] Oregon State Univ, Eastern Oregon Agr Res Ctr, Union, OR USA; [Naylor, Bridgett J.] US Forest Serv, USDA, Pacific Northwest Res Stn, La Grande, OR USA; [Taylor, Robert V.] Natl Wildlife Refuge Assoc, Enterprise, OR USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Averett, JP (corresponding author), Oregon State Univ, Eastern Oregon Agr Res Ctr, Union, OR USA.	averettj@oregonstate.edu			USDA NRI Competitive Grant [2006-35320-17244]; USDA Forest Service Pacific Northwest Research Station [05-JV-11261967-069]; Oregon State University Agricultural Research Foundation; Oregon State University Agriculture Experiment Station; The Nature Conservancy	USDA NRI Competitive Grant; USDA Forest Service Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Oregon State University Agricultural Research Foundation; Oregon State University Agriculture Experiment Station; The Nature Conservancy	Funding was provided by USDA NRI Competitive Grant Agreement No. 2006-3532017244 (BE), USDA Forest Service Pacific Northwest Research Station #05-JV-11261967069 (BE), the Oregon State University Agricultural Research Foundation (LM, BE), and the Oregon State University Agriculture Experiment Station (LM, BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kent Coe, Andie Lueders, Tyler Dungannon, Kolby Haliewicz, Walker Powell, JoAnna Perren, Luke Ridder, Brogan Watson, Ashtin Olsen, Ngeyaol Polycarp, and Shanda Zettles for assistance collecting field data; The Nature Conservancy for their collaboration and support for this project; and anonymous reviewers for suggestions on the manuscript. Funding was provided by USDA NRI Competitive Grant Agreement No. 2006-35320-17244 (BE), USDA Forest Service Pacific Northwest Research Station #05-JV-11261967-069 (BE), the Oregon State University Agricultural Research Foundation (LM, BE), and the Oregon State University Agriculture Experiment Station (LM, BE).	Andersen EM, 2019, BIOL INVASIONS, V21, P405, DOI 10.1007/s10530-018-1831-z; Averett J.P., DATA IN BRIEF; Averett JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147826; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Bansal S, 2014, J ARID ENVIRON, V104, P38, DOI 10.1016/j.jaridenv.2014.01.010; Bartuszevige AM, 2012, NAT AREA J, V32, P166, DOI 10.3375/043.032.0205; Bernards SJ, 2017, APPL VEG SCI, V20, P236, DOI 10.1111/avsc.12272; Bernards SJ, 2017, NORTHWEST SCI, V91, P27, DOI 10.3955/046.091.0105; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brooks ML, 2016, SPRINGER SER ENV MAN, P11, DOI 10.1007/978-3-319-24930-8_2; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Canty A, 2016, BOOT BOOTSTRAP R S P; Cellini J., 2016, THESIS; Coleman HM, 2007, BIOL INVASIONS, V9, P65, DOI 10.1007/s10530-006-9008-6; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DARAMBAZAR E, 2007, P W SECT AM SOC ANIM, V58, P233; DAUBENMIRE R. F., 1942, ECOL MONOGR, V12, P53, DOI 10.2307/1948422; Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2; Davison A.C., 1997, BOOTSTRAP METHODS TH, P5; Dion N, 2000, CONDOR, V102, P629, DOI 10.1650/0010-5422(2000)102[0629:IEOVAP]2.0.CO;2; Dixon AP, 2014, J BIOGEOGR, V41, P2003, DOI 10.1111/jbi.12381; Dufrene M, 1989, ECOL MONOGR, V67, P345; Endress BA, APPL VEGETATION SCI; Endress BA, 2007, RANGELAND ECOL MANAG, V60, P218, DOI 10.2111/1551-5028(2007)60[218:LFITAA]2.0.CO;2; Foxcroft LC, 2013, INVAD NAT SPRING SER, V7, P621, DOI 10.1007/978-94-007-7750-7_28; Freeman ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108843; Gilbert B, 2013, P NATL ACAD SCI USA, V110, P1744, DOI 10.1073/pnas.1212375110; Gould IJ, 2016, ECOL LETT, V19, P1140, DOI 10.1111/ele.12652; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Henwood William D., 2010, Great Plains Research, V20, P121; Herrick J. E., 2005, MONITORING MANUAL GR, VI; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hunn Eugene S., 2015, CAW PAWA LAAKNI THEY; Johnson C.G., 1987, PLANT ASS WALLOWA SN; Johnson CG, 2013, RANGELANDS, V35, P11, DOI DOI 10.2111/RANGELANDS-D-12-00081.1; Johnson CG, 2005, PNWGTR641 USDA FOR S, P119; Johnson TN, 2011, AGR ECOSYST ENVIRON, V144, P338, DOI 10.1016/j.agee.2011.10.003; Jones LC, 2018, INVAS PLANT SCI MANA, V11, P1, DOI 10.1017/inp.2018.7; Keeley JE, 2006, CONSERV BIOL, V20, P375, DOI 10.1111/J.1523-1739.2006.00339.X; Kennedy PL, 2009, RESTOR ECOL, V17, P515, DOI 10.1111/j.1526-100X.2008.00402.x; Kimoto C, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00118.1; Kulmatiski A, 2006, PLANT ECOL, V187, P261, DOI 10.1007/s11258-006-9140-5; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Mack RN, 1989, BIOL INVASIONS GLOBA; McCune B., 2015, MULTIVARIATE ANAL EC; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McDougall KL, 2011, MT RES DEV, V31, P380, DOI 10.1659/MRD-JOURNAL-D-11-00082.1; McKay S, 2015, SOC RANG MAN C SACR; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; MOREMAN D, 1998, NATIVE AM ETHNOBOTAN; Morris LR, 2016, ARID LAND RES MANAG, V30, P362, DOI 10.1080/15324982.2015.1129651; Morris LR, 2014, RANGELAND ECOL MANAG, V67, P285, DOI 10.2111/REM-D-12-00147.1; Morris LR, 2011, RANGELAND ECOL MANAG, V64, P488, DOI 10.2111/REM-D-10-00147.1; Morris LR, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00130.1; Noss R. E, 1995, 28 NAT BIOL SERV BIO; Pickering C, 2007, MT RES DEV, V27, P359, DOI 10.1659/mrd.0805; Pokorny ML, 2004, WEST N AM NATURALIST, V64, P219; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R_Core_Team, 2015, R LANG ENV STAT COMP; Rejmanek M., 2005, VEGETATION ECOLOGY, DOI DOI 10.1002/9781118452592.CH13; Ridder LW, 2019, THESIS; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Taylor R. V., 2013, Ecological Restoration, V31, P141, DOI 10.3368/er.31.2.141; Taylor R.V., 2012, MONITORING UPLAND PR; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tisdale E.W., 1982, PROCEDDINGS 1982 GRA, P232; Tubbesing C, 2014, NAT AREA J, V34, P200, DOI 10.3375/043.034.0209; Wallace JM, 2015, INVAS PLANT SCI MANA, V8, P57, DOI 10.1614/IPSM-D-14-00034.1	71	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227337	10.1371/journal.pone.0227337	http://dx.doi.org/10.1371/journal.pone.0227337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978057	Green Published, gold			2022-12-26	WOS:000534599100032
J	Dufour, C; Fournier, V; Giovenazzo, P				Dufour, Claude; Fournier, Valerie; Giovenazzo, Pierre			The impact of lowbush blueberry (Vaccinium angustifolium Ait.) and cranberry (Vaccinium macrocarpon Ait.) pollination on honey bee (Apis mellifera L.) colony health status	PLOS ONE			English	Article							NUTRITION; PSEUDOREPLICATION; DIVERSITY; NECTAR; DIET	Commercial lowbush blueberry (Vaccinium angustifolium Ait.) and cranberry (Vaccinium macrocarpon Ait.) crops benefit from the presence of honey bee (Apis mellifera L.) for pollination. Unfortunately, beekeepers are observing negative impacts of pollination services on honey bee colonies. In this study, we investigated three beekeeping management strategies (MS) and measured their impact on honey bee colony health and development. Experimental groups (five colonies/MS) were: A) Control farmland honey producing MS (control MS); B) Blueberry pollination MS (blueberry MS); C) Cranberry pollination MS (cranberry MS) and D) Double pollination MS, blueberry followed by cranberry (double MS). Our goals were to 1) compare floral abundance and attractiveness of foraging areas to honey bees between apiaries using a Geographic Information System, and 2) compare honey bee colony health status and population development between MS during a complete beekeeping season. Our results show significantly lower floral abundance and honey bee attractiveness of foraging areas during cranberry pollination compared to the other environments. The blueberry pollination site seemed to significantly reduce brood population in the colonies who provided those services (blueberry MS and double MS). The cranberry pollination site seemed to significantly reduce colony weight gain (cranberry MS and double MS) and induce a significantly higher winter mortality rate (cranberry MS). We also measured significantly higher levels of Black queen cell virus and Sacbrood virus in the MS providing cranberry pollination (cranberry MS and double MS).	[Dufour, Claude; Giovenazzo, Pierre] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Fournier, Valerie] Univ Laval, Ctr Rech & Innovat Vegetaux, Quebec City, PQ, Canada	Laval University; Laval University	Giovenazzo, P (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ, Canada.	pierre.giovenazzo@bio.ulaval.ca		giovenazzo, pierre/0000-0002-8080-4935	Bayer Crop Science	Bayer Crop Science(Bayer AG)	PG received a research grant from Bayer Crop Science. Bayer Crop Science participated in the initial study design but was not involved in the final study design nor the data collection, data analysis, decision to publish and preparation of manuscript. PG did not receive any other support from Bayer Crop Science. No additional external funding was received for this study.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; APCQ Association des producteurs de canneberges du Quebec, 2019, PROF IND CANN; Arien Y, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01001; Asare E, 2017, J ECON ENTOMOL, V110, P1980, DOI 10.1093/jee/tox191; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Bizotto LD, 2018, PESQUI AGROPECU BRAS, V53, P399, DOI [10.1590/S0100-204X2018000400001, 10.1590/s0100-204x2018000400001]; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Cane JH, 2003, AM J BOT, V90, P1425, DOI 10.3732/ajb.90.10.1425; Cane JH, 1997, J AM SOC HORTIC SCI, V122, P665, DOI 10.21273/JASHS.122.5.665; Chagnon M., 2007, 2216 CONS DEV AGR QU; Chagnon M., 2008, CAUSES EFFETS DECLIN, P1; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Colwell MJ, 2017, ECOL EVOL, V7, P7243, DOI 10.1002/ece3.3178; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Darrach M, 2016, AGR AGROALIMENTAIRE, P22; Davies GM, 2015, ECOL EVOL, V5, P5295, DOI 10.1002/ece3.1782; DeGrandi-Hoffman G, 2015, J APICULT RES, V47, P265; DeGrandi-Hoffman G, 2015, CURR OPIN INSECT SCI, V10, P170, DOI 10.1016/j.cois.2015.05.007; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Di Pasquale G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162818; Donkersley P, 2014, ECOL EVOL, V4, P4195, DOI 10.1002/ece3.1293; Erler S, 2014, ECOL EVOL, V4, P3960, DOI 10.1002/ece3.1252; ESRI, 2011, ARCGIS DESKT REL 10; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; Giovenazzo P, 2011, EXP APPL ACAROL, V55, P65, DOI 10.1007/s10493-011-9447-3; Girard M, 2012, BOTANY, V90, P545, DOI [10.1139/B2012-049, 10.1139/b2012-049]; Gisder S, 2017, J INVERTEBR PATHOL, V147, P51, DOI 10.1016/j.jip.2016.07.010; Gisder S, 2013, J INVERTEBR PATHOL, V113, P1, DOI 10.1016/j.jip.2013.01.004; Glenny W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182814; Groff SC, 2016, ENVIRON MODELL SOFTW, V79, P1, DOI 10.1016/j.envsoft.2016.01.003; Herbert EWJ, 2015, HIVE HONEY BEE, P237; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Institut de la statistique du Quebec, 2018, FAITS SAILL ENQ AP Q; Institut de la statistique du Quebec, 2019, PROF SECT IND BIOAL; KEVAN PG, 1983, P ENTOMOL SOC ONT, V114, P45; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kleinschmidt G. J., 1974, Australasian Beekeeper, V75, P261; Lee KV, 2010, J ECON ENTOMOL, V103, P1039, DOI 10.1603/EC10037; Li JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188291; MAPAQ Ministere de l'Agriculture des Pecheries et de l'Alimentation du Quebec, 2017, CULT BLEUET; Martin G, 2009, INFLUENCE SUPPLEMENT; Moisan-DeSerres J, 2014, GUIDE IDENTIFICATION; Mondet F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004323; Morimoto T, 2011, ECOL EVOL, V1, P201, DOI 10.1002/ece3.21; Morrant DS, 2009, ANN BOT-LONDON, V103, P533, DOI 10.1093/aob/mcn241; Myra M., 2004, Small Fruits Review, V3, P313, DOI 10.1300/J301v03n03_08; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Omar E, 2017, APIDOLOGIE, V48, P425, DOI 10.1007/s13592-016-0487-x; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Requier F, 2017, J APPL ECOL, V54, P1161, DOI 10.1111/1365-2664.12836; Requier F, 2015, ECOL APPL, V25, P881, DOI 10.1890/14-1011.1; Rioux M-C, 2018, SOUS MINISTERIAT TRA, P1; SAS Institute Inc, 2018, SAS U ED QUICK START; Scofield HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121731; Simone-Finstrom M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32023; Singh RP, 1996, APIDOLOGIE, V27, P21, DOI 10.1051/apido:19960103; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Starast M, 2014, EFFECT CULTIVATION A; Tritschler M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15358-w; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Venturini EM, 2017, J ECON ENTOMOL, V110, P333, DOI 10.1093/jee/tow285; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K, 2011, VIE MOEURS ABEILLES; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Winston M., 1987, The biology of the honey bee.; Winston M.L., 1992, HIVE HONEY BEE, P73; Zhu X, 2015, J APICULT RES, V53, P469	71	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227970	10.1371/journal.pone.0227970	http://dx.doi.org/10.1371/journal.pone.0227970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978125	Green Published, gold			2022-12-26	WOS:000534599100087
J	Graham, CF; Boreham, DR; Manzon, RG; Stott, W; Wilson, JY; Somers, CM				Graham, Carly F.; Boreham, Douglas R.; Manzon, Richard G.; Stott, Wendylee; Wilson, Joanna Y.; Somers, Christopher M.			How "simple" methodological decisions affect interpretation of population structure based on reduced representation library DNA sequencing: A case study using the lake whitefish	PLOS ONE			English	Article							COREGONUS-CLUPEAFORMIS; ECOLOGICAL SPECIATION; GENETIC DIVERSITY; SPECIES PAIRS; MISSING DATA; RAD MARKERS; TOOL SET; DE-NOVO; COVERAGE; CONSERVATION	Reduced representation (RRL) sequencing approaches (e.g., RADSeq, genotyping by sequencing) require decisions about how much to invest in genome coverage and sequencing depth, as well as choices of values for adjustable bioinformatics parameters. To empirically explore the importance of these "simple" methodological decisions, we generated two independent sequencing libraries for the same 142 individual lake whitefish (Coregonus clupeaformis) using a nextRAD RRL approach: (1) a larger number of loci at low sequencing depth based on a 9mer (library A); and (2) fewer loci at higher sequencing depth based on a 10mer (library B). The fish were selected from populations with different levels of expected genetic subdivision. Each library was analyzed using the STACKS pipeline followed by three types of population structure assessment (FST, DAPC and ADMIXTURE) with iterative increases in the stringency of sequencing depth and missing data requirements, as well as more specific a priori population maps. Library B was always able to resolve strong population differentiation in all three types of assessment regardless of the selected parameters, largely due to retention of more loci in analyses. In contrast, library A produced more variable results; increasing the minimum sequencing depth threshold (-m) resulted in a reduced number of retained loci, and therefore lost resolution at high -m values for FST and ADMIXTURE, but not DAPC. When detecting fine population differentiation, the population map influenced the number of loci and missing data, which generated artefacts in all downstream analyses tested. Similarly, when examining fine scale population subdivision, library B was robust to changing parameters but library A lost resolution depending on the parameter set. We used library B to examine actual subdivision in our study populations. All three types of analysis found complete subdivision among populations in Lake Huron, ON and Dore Lake, SK, Canada using 10,640 SNP loci. Weak population subdivision was detected in Lake Huron with fish from sites in the north-west, Search Bay, North Point and Hammond Bay, showing slight differentiation. Overall, we show that apparently simple decisions about library construction and bioinformatics parameters can have important impacts on the interpretation of population subdivision. Although potentially more costly on a per-locus basis, early investment in striking a balance between the number of loci and sequencing effort is well worth the reduced genomic coverage for population genetics studies. More conservative stringency settings on STACKS parameters lead to a final dataset that was more consistent and robust when examining both weak and strong population differentiation. Overall, we recommend that researchers approach "simple" methodological decisions with caution, especially when working on non-model species for the first time.	[Graham, Carly F.; Manzon, Richard G.; Somers, Christopher M.] Univ Regina, Dept Biol, Regina, SK, Canada; [Boreham, Douglas R.] Northern Ontario Sch Med, Med Sci, Greater Sudbury, ON, Canada; [Stott, Wendylee] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Wilson, Joanna Y.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	University of Regina; Northern Ontario School of Medicine; Michigan State University; McMaster University	Somers, CM (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.	chris.somers@uregina.ca		Graham, Carly/0000-0002-6455-4438	Natural Sciences and Engineering Research Council of Canada; Bruce Power, Collaborative Research and Development Grants; Canada Foundation for Innovation; McMaster University; Northern Ontario School of Medicine; University of Regina	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bruce Power, Collaborative Research and Development Grants; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); McMaster University; Northern Ontario School of Medicine; University of Regina	This work was supported by Natural Sciences and Engineering Research Council of Canada and Bruce Power, Collaborative Research and Development Grants, awarded to JYW, CMS and RGM; the Canada Foundation for Innovation, McMaster University, the Northern Ontario School of Medicine, and the University of Regina.	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ali OA, 2016, GENETICS, V202, P389, DOI 10.1534/genetics.115.183665; Allendorf FW, 1997, GENETICS, V145, P1083; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Andrews KR, 2014, MOL ECOL, V23, P1661, DOI 10.1111/mec.12686; Andrews S., 2010, FASTQC QUALITY CONTR; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Benestan L, 2016, MOL ECOL, V25, P5073, DOI 10.1111/mec.13811; Benestan L, 2015, MOL ECOL, V24, P3299, DOI 10.1111/mec.13245; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; Cammen KM, 2015, MOL ECOL, V24, P4697, DOI 10.1111/mec.13350; Cariou M, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0791-0; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chattopadhyay Balaji, 2014, BMC Research Notes, V7, P841, DOI 10.1186/1756-0500-7-841; Cooke TF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005631; CRAWFORD JE, 2012, FRONT GENET, V3, P1, DOI DOI 10.3389/FGENE.2012.00001; Cristofari R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11842; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dawson A. G., 1992, ICE AGE EARTH; Diaz-Arce N, 2016, MOL PHYLOGENET EVOL, V102, P202, DOI 10.1016/j.ympev.2016.06.002; Dion-Cote AM, 2017, MOL ECOL, V26, P178, DOI 10.1111/mec.13816; Eaton DAR, 2017, SYST BIOL, V66, P399, DOI 10.1093/sysbio/syw092; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Ebener M.P., 2008, INT GOVERNANCE FISHE, P99; Ebener MP, 2010, J GREAT LAKES RES, V36, P38, DOI 10.1016/j.jglr.2010.02.002; Eberts RL, 2017, N AM J FISH MANAGE, V37, P133, DOI 10.1080/02755947.2016.1245225; Evans ML, 2012, MOL ECOL, V21, P4038, DOI 10.1111/j.1365-294X.2012.05682.x; Flanagan SP, 2018, MOL ECOL RESOUR, V18, P264, DOI 10.1111/1755-0998.12734; Flanagan SP, 2016, MOL ECOL, V25, P5043, DOI 10.1111/mec.13794; Fountain ED, 2016, MOL ECOL RESOUR, V16, P966, DOI 10.1111/1755-0998.12519; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Fumagalli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079667; Funk WC, 2016, MOL ECOL, V25, P2176, DOI 10.1111/mec.13605; Gagnaire PA, 2013, MOL ECOL, V22, P3036, DOI 10.1111/mec.12127; Gaughran S, 2017, EVOL APPL, V11, P1; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Gleason LU, 2016, MOL ECOL, V25, P3557, DOI 10.1111/mec.13703; Gosselin T, 2018, GRUR R PACKAGE TAILO, DOI 10.5281/zenodo.496176; Graham CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146656; Graham CF, 2015, MOL ECOL RESOUR, V15, P1304, DOI 10.1111/1755-0998.12404; Harford W., 2007, BAYESIAN STOCK ASSES; Henning F, 2014, MOL ECOL, V23, P5224, DOI 10.1111/mec.12860; Hodel RGJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16810-7; Hoffberg SL, 2016, MOL ECOL RESOUR, V16, P1264, DOI 10.1111/1755-0998.12566; Hohenlohe PA, 2013, MOL ECOL, V22, P3002, DOI 10.1111/mec.12239; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Lah L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162792; Larson WA, 2014, EVOL APPL, V7, P355, DOI 10.1111/eva.12128; LOFTUS DH, 1986, CAN J FISH AQUAT SCI, V43, P812, DOI 10.1139/f86-100; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Maroso F, 2016, MAR GENOM, V28, P57, DOI 10.1016/j.margen.2016.07.003; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McPhail J. D., 1970, BULLETIN, V173; Mee JA, 2015, EVOL APPL, V8, P423, DOI 10.1111/eva.12247; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Morgan TD, 2018, CAN J FISH AQUAT SCI, V75, P836, DOI 10.1139/cjfas-2016-0528; Nalepa TF, 2005, P WORK DYNLAK WHIT C; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; O'Leary SJ, 2018, MOL ECOL, V27, P3193, DOI 10.1111/mec.14792; Paris JR, 2017, METHODS ECOL EVOL, V8, P1360, DOI 10.1111/2041-210X.12775; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pielou EC, 1991, ICE AGE RETURN LIFE; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Puebla O, 2014, MOL ECOL, V23, P5291, DOI 10.1111/mec.12926; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renaut S, 2011, MOL ECOL, V20, P545, DOI 10.1111/j.1365-294X.2010.04952.x; Rochette NC, 2017, NAT PROTOC, V12, P2640, DOI 10.1038/nprot.2017.123; Rodriguez-Ezpeleta N, 2016, MOL ECOL RESOUR, V16, P991, DOI 10.1111/1755-0998.12518; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; Russello MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1106; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Shafer A., 2016, METHODS ECOLOGY EVOL, V8, P1; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Song K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35736; Stott W, 2008, ADV LIMNOLOGY, V63, P241; Stott W, 2013, ADV LIMNOL, V64, P205, DOI 10.1127/1612-166X/2013/0064-0015; Stott W, 2010, J GREAT LAKES RES, V36, P59, DOI 10.1016/j.jglr.2010.01.004; Thome C, 2017, ENVIRON TOXICOL CHEM, V36, P1955, DOI 10.1002/etc.3727; Tripp EA, 2017, ECOL EVOL, V7, P7920, DOI 10.1002/ece3.3274; Vandehey JA, 2009, CAN J FISH AQUAT SCI, V66, P382, DOI 10.1139/F08-213; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wessinger CA, 2016, AM J BOT, V103, P912, DOI 10.3732/ajb.1500519; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Xuereb A, 2018, MOL ECOL, V27, P2347, DOI 10.1111/mec.14589; Zhou H, 2011, STAT COMPUT, V21, P261, DOI 10.1007/s11222-009-9166-3	99	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226608	10.1371/journal.pone.0226608	http://dx.doi.org/10.1371/journal.pone.0226608			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978053	Green Published, gold			2022-12-26	WOS:000534599100018
J	Halvachizadeh, S; Baradaran, L; Cinelli, P; Pfeifer, R; Sprengel, K; Pape, HC				Halvachizadeh, Sascha; Baradaran, Larissa; Cinelli, Paolo; Pfeifer, Roman; Sprengel, Kai; Pape, Hans-Christoph			How to detect a polytrauma patient at risk of complications: A validation and database analysis of four published scales	PLOS ONE			English	Article							INJURY SEVERITY SCORE; RESPIRATORY-DISTRESS-SYNDROME; REMOTE ORGAN DYSFUNCTION; GLOBAL STATUS-REPORT; TRAUMA PATIENTS; SYSTEMIC INFLAMMATION; AMERICAN ASSOCIATION; CYTOKINE RELEASE; MULTIPLE TRAUMA; FRACTURE	Introduction Early accurate assessment of the clinical status of severely injured patients is crucial for guiding the surgical treatment strategy. Several scales are available to differentiate between risk categories. They vary between expert recommendations and scores developed on the basis of patient data (level II). We compared four established scoring systems in regard to their predictive abilities for early (e.g., hemorrhage-induced mortality) versus late (Multiple Organ Failure (MOF), sepsis, late death) in-hospital complications. Methods A database from a level I trauma center was used. The inclusion criteria implied an injury severity score (ISS) of.16 points, primary admission, and a complete data set from admission to hospital-day 21. The following four scales were tested: the clinical grading scale (CGS; covers acidosis, shock, coagulation, and soft tissue injuries), the modified clinical grading scale (mCGS; covers CGS with modifications), the polytrauma grading score (PTGS; covers shock, coagulation, and ISS), and the early appropriate care protocol (EAC; covers acid-base changes). Admission values were selected from each scale and the following endpoints were compared: mortality, pneumonia, sepsis, death from hemorrhagic shock, and multiple organ failure. Statistics Shapiro-Wilk test for normal distribution, Pearson Chi square, odds ratios (OR) for all endpoints, 95% confidence intervals. Fitted, generalized linear models were used for prediction analysis. Krippendorff was used for comparison of CGS and mCGS. Alpha set at 0.05. Results In total, 3668 severely injured patients were included (mean age, 45.8 +/- 20 years; mean ISS, 28.2 +/- 15.1 points; incidence of pneumonia, 19.0%; incidence of sepsis, 14.9%; death from hem. shock, 4.1%; death from multiple organ failure (MOF), 1.9%; mortality rate, 26.8%). Our data show distinct differences in the prediction of complications, including mortality, for these scores (OR ranging from 0.5 to 9.1). The PTGS demonstrated the highest predictive value for any late complication (OR = 2.0), sepsis (OR = 2.6, p = 0.05), or pneumonia (OR = 2.0, p = 0.2). The EAC demonstrated good prediction for hemorrhage-induced early mortality (OR = 7.1, p<0.0001), but did not predict late complications (sepsis, OR = 0.8 and p = 0.52; pneumonia, OR = 1.1 and p = 0.7) CGS and mCGS are not comparable and should not be used interchangeably (Krippendorff alpha = 0.045). Conclusion Our data show that prediction of complications is more precise after using values that covers different physiological systems (coagulation, hemorrhage, acid-base changes, and soft tissue damage) when compared with using values of only one physiological system (e.g., acidosis). When acid-base changes alone were tested in terms of complications, they were predictive of complications within 72 hours but failed to predict late complications. These findings should be considered when performing early assessment of trauma patients or for the development of new scores.	[Halvachizadeh, Sascha; Baradaran, Larissa; Cinelli, Paolo; Pfeifer, Roman; Sprengel, Kai; Pape, Hans-Christoph] Univ Spital Zurich, Dept Trauma, Zurich, Switzerland; [Halvachizadeh, Sascha; Cinelli, Paolo; Pfeifer, Roman; Sprengel, Kai; Pape, Hans-Christoph] Univ Zurich, Univ Hosp Zurich, Dept Trauma, Harald Tscherne Lab, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Halvachizadeh, S (corresponding author), Univ Spital Zurich, Dept Trauma, Zurich, Switzerland.; Halvachizadeh, S (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Trauma, Harald Tscherne Lab, Zurich, Switzerland.	sascha.halvachizadeh@usz.ch		Cinelli, Paolo/0000-0002-0163-9055; Pape, Hans-Christoph/0000-0002-2059-4980				BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benns M, 2013, J TRAUMA ACUTE CARE, V75, P426, DOI 10.1097/TA.0b013e31829cfa19; Billeter A, 2009, WORLD J SURG, V33, P558, DOI 10.1007/s00268-008-9896-y; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Dezman ZDW, 2018, AM J EMERG MED, V36, P2005, DOI 10.1016/j.ajem.2018.03.012; Dezman ZDW, 2015, J TRAUMA ACUTE CARE, V79, P580, DOI 10.1097/TA.0000000000000810; Dienstknecht T, 2013, CLIN ORTHOP RELAT R, V471, P2878, DOI 10.1007/s11999-013-2924-8; Domingues CD, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0171-8; EICHELBERGER MR, 1989, ANN EMERG MED, V18, P939, DOI 10.1016/S0196-0644(89)80457-3; Flohe S, 2018, GRUNDLAGEN SCHWERVER, P3; Hildebrand F, 2015, INJURY, V46, pS93, DOI 10.1016/S0020-1383(15)30025-5; Hildebrand F, 2014, J TRAUMA ACUTE CARE, V76, P1495, DOI 10.1097/TA.0000000000000236; Joseph B, 2018, WORLD J SURG, V42, P3560, DOI 10.1007/s00268-018-4674-y; Kaserer A, 2019, ANAESTHESIA, V74, P1534, DOI 10.1111/anae.14816; Kobbe P, 2008, J ORTHOP TRAUMA, V22, P385, DOI 10.1097/BOT.0b013e318175dd88; Kobbe P, 2008, SHOCK, V30, P43, DOI [10.1097/SHK.0b013e318d190b, 10.1097/SHK.0b013e31815d190b]; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Menzel CL, 2011, J SURG RES, V166, pE149, DOI 10.1016/j.jss.2010.11.914; Mica L, 2012, EUR J TRAUMA EMERG S, V38, P665, DOI 10.1007/s00068-012-0227-5; Mica Ladislav, 2013, J Trauma Manag Outcomes, V7, P6, DOI 10.1186/1752-2897-7-6; MOORE EE, 1989, J TRAUMA, V29, P1664, DOI 10.1097/00005373-198912000-00013; Moore EE, 2018, J TRAUMA ACUTE CARE, V84, pS35, DOI 10.1097/TA.0000000000001797; Moore EE, 2010, J TRAUMA, V69, P1600, DOI 10.1097/TA.0b013e318201124e; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Moore HB, 2017, AM J SURG, V214, P1041, DOI 10.1016/j.amjsurg.2017.08.036; Nahm NJ, 2014, J TRAUMA ACUTE CARE, V77, P268, DOI 10.1097/TA.0000000000000283; Napolitano LM, 2010, J TRAUMA, V69, P1619, DOI 10.1097/TA.0b013e3182011089; O'Toole RV, 2009, J TRAUMA, V67, P1013, DOI 10.1097/TA.0b013e3181b890be; Ogura T, 2014, J TRAUMA ACUTE CARE, V76, P1243, DOI 10.1097/TA.0000000000000200; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pape HC, 2016, INJURY, V47, P787, DOI 10.1016/j.injury.2016.03.020; Pape Hans-Christoph, 2005, J Orthop Trauma, V19, P551, DOI 10.1097/01.bot.0000161712.87129.80; Pape HC, 2016, J TRAUMA ACUTE CARE, V80, P838, DOI 10.1097/TA.0000000000000990; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Pape HC, 1999, J TRAUMA, V46, P907, DOI 10.1097/00005373-199905000-00022; Pape HC, 2002, AM J SURG, V183, P622, DOI 10.1016/S0002-9610(02)00865-6; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; Pfeifer R, 2015, J SURG RES, V196, P388, DOI 10.1016/j.jss.2015.03.038; Pfeifer R, 2011, J ORTHOP RES, V29, P270, DOI 10.1002/jor.21214; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Spahn DR, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0637-3; Stein P, 2017, ANAESTHESIA, V72, P1317, DOI 10.1111/anae.13920; TEASDALE G, 1974, LANCET, V2, P81; Theusinger OM, 2015, ANESTH ANALG, V120, P627, DOI 10.1213/ANE.0000000000000561; Theusinger OM, 2013, ANESTH ANALG, V117, P314, DOI 10.1213/ANE.0b013e31829569ac; Toroyan T, 2013, INJURY PREV, V19, P150, DOI 10.1136/injuryprev-2013-040775; Toroyan T, 2009, INJURY PREV, V15, P286, DOI 10.1136/ip.2009.023697; Vallier HA, 2013, J ORTHOP TRAUMA, V27, P543, DOI 10.1097/BOT.0b013e31829efda1	53	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228082	10.1371/journal.pone.0228082	http://dx.doi.org/10.1371/journal.pone.0228082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978109	Green Published, gold, Green Accepted			2022-12-26	WOS:000534599100109
J	Darby, B; Bryant, R; Keller, A; Jochim, M; Moe, J; Schreiner, Z; Pratt, C; Euliss, NH; Park, M; Simmons, R; Otto, C				Darby, Brian; Bryant, Russ; Keller, Abby; Jochim, Madison; Moe, Josephine; Schreiner, Zoe; Pratt, Carrie; Euliss, Ned H., Jr.; Park, Mia; Simmons, Rebecca; Otto, Clint			Molecular sequencing and morphological identification reveal similar patterns in native bee communities across public and private grasslands of eastern North Dakota	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; PHYLOGENETIC-RELATIONSHIPS; COPY NUMBER; HYMENOPTERA; DIVERSITY; CONSERVATION; ABUNDANCE; WILD; EXTRAPOLATION; VULNERABILITY	Bees play a key role in the functioning of human-modified and natural ecosystems by pollinating agricultural crops and wild plant communities. Global pollinator conservation efforts need large-scale and long-term monitoring to detect changes in species' demographic patterns and shifts in bee community structure. The objective of this project was to test a molecular sequencing pipeline that would utilize a commonly used locus, produce accurate and precise identifications consistent with morphological identifications, and generate data that are both qualitative and quantitative. We applied this amplicon sequencing pipeline to native bee communities sampled across Conservation Reserve Program (CRP) lands and native grasslands in eastern North Dakota. We found the 28S LSU locus to be more capable of discriminating between species than the 18S SSU rRNA locus, and in some cases even resolved instances of cryptic species or morphologically ambiguous species complexes. Overall, we found the amplicon sequencing method to be a qualitatively accurate representation of the sampled bee community richness and species identity, especially when a wellcurated database of known 28S LSU sequences is available. Both morphological identification and molecular sequencing revealed similar patterns in native bee community structure across CRP lands and native prairie. Additionally, a genetic algorithm approach to compute taxon-specific correction factors using a small subset of the most concordant samples demonstrated that a high level of quantitative accuracy could be possible if the specimens are fresh and processed soon after collection. Here we provide a first step to a molecular pipeline for identifying insect pollinator communities. This tool should prove useful for future national monitoring efforts as use of molecular tools becomes more affordable and as numbers of 28S LSU sequences for pollinator species increase in publicly-available databases.	[Darby, Brian; Keller, Abby; Jochim, Madison; Moe, Josephine; Schreiner, Zoe; Pratt, Carrie; Park, Mia; Simmons, Rebecca] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Bryant, Russ; Euliss, Ned H., Jr.; Otto, Clint] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA; [Bryant, Russ] Humboldt State Univ, Coll Nat Resources & Sci, Arcata, ND USA; [Park, Mia] North Dakota State Univ, Dept Biol Sci, Fargo, ND USA	University of North Dakota Grand Forks; United States Department of the Interior; United States Geological Survey; North Dakota State University Fargo	Darby, B (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.	brian.darby@und.edu		Otto, Clint/0000-0002-7582-3525	United States Geological Survey [CESU-USGS G16AC00430]; NSF EPSCoR Track-1 Cooperative Agreement [1355466]	United States Geological Survey(United States Geological Survey); NSF EPSCoR Track-1 Cooperative Agreement	RS, BD, and MP received funding from United States Geological Survey (https://www.usgs.gov/), grant number CESU-USGS G16AC00430. RS received funding from NSF EPSCoR Track-1 Cooperative Agreement (https://www.ndepscor.ndus.edu/) (Women in Science and Engineering), grant number OIA #1355466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sarah Clark, Emily Sypolt, and Sam O'Dell for assistance with bee identification and fieldwork. Nadia Noori developed the study site map. We appreciate the support of the private landowners and USFWS for permitting us access to the study sites. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bendel CR, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2569; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Danforth BN, 1999, SYST ENTOMOL, V24, P377, DOI 10.1046/j.1365-3113.1999.00087.x; Darby BJ, 2013, MOL ECOL, V22, P5456, DOI 10.1111/mec.12480; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; Droege S, 2010, INSECT CONSERV DIVER, V3, P15, DOI 10.1111/j.1752-4598.2009.00074.x; Durant JL, 2019, LAND USE POLICY, V87, DOI 10.1016/j.landusepol.2019.05.024; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans E, 2018, AGR ECOSYST ENVIRON, V268, P162, DOI 10.1016/j.agee.2018.09.014; Farm Service Agency, 2019, 2019 CONS RES PROGR; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grant EHC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25625; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113; KUMAR A, 1990, HEREDITAS, V113, P277, DOI 10.1111/j.1601-5223.1990.tb00094.x; Lozier JD, 2017, CONSERV GENET, V18, P713, DOI 10.1007/s10592-016-0893-7; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; Mardulyn P, 1999, MOL PHYLOGENET EVOL, V12, P282, DOI 10.1006/mpev.1999.0618; McArt SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.2181; Michener C. D., 2007, BEES WORLD; National Research Council, 2007, STAT POLL N AM; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Otto CRV, 2017, ENVIRON ENTOMOL, V46, P565, DOI 10.1093/ee/nvx070; Otto CRV, 2018, P NATL ACAD SCI USA, V115, P7629, DOI 10.1073/pnas.1800057115; Otto CRV, 2016, P NATL ACAD SCI USA, V113, P10430, DOI 10.1073/pnas.1603481113; Patiny S, 2008, CLADISTICS, V24, P255, DOI 10.1111/j.1096-0031.2007.00182.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; SAMWAYS MJ, 1993, BIODIVERS CONSERV, V2, P258, DOI 10.1007/BF00056672; Smart MD, 2017, ENVIRON ENTOMOL, V46, P38, DOI 10.1093/ee/nvw159; Stephen WP, 2005, J KANSAS ENTOMOL SOC, V78, P373, DOI 10.2317/0410.03.1; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Vaudo AD, 2018, INSECT SYST DIVER, V2, DOI 10.1093/isd/ixy014; Wheeler Q, 2010, SYST BIODIVERS, V8, P11, DOI 10.1080/14772001003628075; Williams NM, 2015, ECOL APPL, V25, P2119, DOI [10.1890/14-1748.1, 10.1890/14-1748.1.sm]; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	51	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227918	10.1371/journal.pone.0227918	http://dx.doi.org/10.1371/journal.pone.0227918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971987	Green Published, gold			2022-12-26	WOS:000534374400027
J	Liljeqvist, ML; Eriksson, L; Villard, C; Lengquist, M; Kronqvist, M; Hultgren, R; Roy, J				Liljeqvist, Moritz Lindquist; Eriksson, Linnea; Villard, Christina; Lengquist, Mariette; Kronqvist, Malin; Hultgren, Rebecka; Roy, Joy			Dipeptidyl peptidase-4 is increased in the abdominal aortic aneurysm vessel wall and is associated with aneurysm disease processes	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GENE; IV; EXPRESSION; INHIBITOR; PROTEASE; HYPOXIA; RUPTURE; BIOLOGY; CELLS	Background Abdominal aortic aneurysm (AAA) is a potentially life-threatening disease, and until today there is no other treatment available than surgical intervention. Dipeptidyl peptidase-4 (DPP4)-inhibitors, used clinically to treat type 2 diabetes, have in murine models been shown to attenuate aneurysm formation and decrease aortic wall matrix degradation, inflammation and apoptosis. Our aim was to investigate if DPP4 is present, active and differentially expressed in human AAA. Methods and results DPP4 gene expression was elevated in both media and adventitia of AAA tissue compared with control tissue, as measured by microarrays and qPCR, with consistent findings in external data. The plasma activity of DPP4 was however lower in male patients with AAA compared with age-and gender-matched controls, independently of comorbidity or medication. Immunohistochemical double staining revealed co-localization of DPP4 with cells positive for CD68, CD4 and-8, CD20, and SMA. Gene set enrichment analysis demonstrated that expression of DPP4 in AAA tissue correlated with expression of biological processes related to B-and T-cells, extracellular matrix turnover, peptidase activity, oxidative stress and angiogenesis whereas it correlated negatively with muscle-/actin-related processes. Conclusion DPP4 is upregulated in both media and adventitia of human AAA and correlates with aneurysm pathophysiological processes. These results support previous murine mechanistic studies and implicate DPP4 as a target in AAA disease.	[Liljeqvist, Moritz Lindquist; Eriksson, Linnea; Villard, Christina; Lengquist, Mariette; Kronqvist, Malin; Hultgren, Rebecka; Roy, Joy] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Hultgren, Rebecka; Roy, Joy] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Roy, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Roy, J (corresponding author), Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden.	joy.roy@ki.se	Hultgren, Rebecka/K-8738-2012	Hultgren, Rebecka/0000-0002-8869-0493; Roy, Joy/0000-0002-5645-1260	Swedish Heart-Lung Foundation [20140722, 20130657, 20160266, 20180596]; Swedish Society of Medicine [SLS-174151]; regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council [20150537, 20180072, 20150916, 20180867]; The Health, Medicine and Technology (Stockholm County Council) [20150916, 20180867]; Senior Clinical Research Appointment (Stockholm County Council) [20150906]; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council; The Health, Medicine and Technology (Stockholm County Council)(Stockholm County Council); Senior Clinical Research Appointment (Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This research was supported by the Swedish Heart-Lung Foundation (20140722, 20130657, 20160266, 20180596), the Swedish Society of Medicine (SLS-174151), and through the regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council (20150537, 20180072, 20150916, 20180867), The Health, Medicine and Technology (Stockholm County Council 20150916, 20180867), Senior Clinical Research Appointment (Stockholm County Council: 20150906), and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001469; [Anonymous], 2019, R LANG ENV STAT COMP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao W, 2014, J VASC SURG, V59, P1098, DOI 10.1016/j.jvs.2013.04.048; BENGTSSON H, 1993, J VASC SURG, V18, P74, DOI 10.1067/mva.1993.42107; Biros E, 2015, ONCOTARGET, V6, P12984, DOI 10.18632/oncotarget.3848; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Choke E, 2006, ANN NY ACAD SCI, V1085, P306, DOI 10.1196/annals.1383.005; Choke E, 2006, ARTERIOSCL THROM VAS, V26, P2077, DOI 10.1161/01.ATV.0000234944.22509.f9; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eagleton MJ, 2012, VASCULAR, V20, P278, DOI 10.1258/vasc.2011.201207; Eriksson L, 2017, J CARDIOVASC PHARM, V69, P101, DOI 10.1097/FJC.0000000000000447; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Ghersi G, 2006, CANCER RES, V66, P4652, DOI 10.1158/0008-5472.CAN-05-1245; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Hans SS, 2005, J VASC SURG, V41, P584, DOI 10.1016/j.jvs.2005.01.004; Hultgren R, 2016, WORLD J SURG, V40, P3080, DOI 10.1007/s00268-016-3705-9; Kohashi K, 2016, J ATHEROSCLER THROMB, V23, P441, DOI 10.5551/jat.31997; Krizhanovskii C, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0279-0; Kuivaniemi H, 2015, EXPERT REV CARDIOVAS, V13, P975, DOI 10.1586/14779072.2015.1074861; Lareyre F, 2017, ARTERIOSCL THROM VAS, V37, P2171, DOI 10.1161/ATVBAHA.117.309999; Lenk GM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-237; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Lu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121077; Lu HY, 2017, J VASC SURG, V66, P1217, DOI 10.1016/j.jvs.2016.05.093; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Nystrom T, 2008, HORM METAB RES, V40, P593, DOI 10.1055/s-0028-1082326; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Raffort J, 2018, BIOCHIMIE, V152, P149, DOI 10.1016/j.biochi.2018.06.026; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Rohrborn D, 2014, FEBS LETT, V588, P3870, DOI 10.1016/j.febslet.2014.08.029; RStudio Team, RSTUDIO INT DEV R; Sakalihasani N, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0030-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siika A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216558; Sjoholm A, 2009, DIABETES OBES METAB, V11, P19, DOI 10.1111/j.1463-1326.2009.01074.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahara Y, 2018, J ATHEROSCLER THROMB, V25, P698, DOI 10.5551/jat.42481; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wronkowitz N, 2014, BBA-MOL BASIS DIS, V1842, P1613, DOI 10.1016/j.bbadis.2014.06.004; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227889	10.1371/journal.pone.0227889	http://dx.doi.org/10.1371/journal.pone.0227889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971988	gold, Green Published			2022-12-26	WOS:000534374400026
J	van Klink, R; Van Laar-Wiersma, J; Vorst, O; Smit, C				van Klink, Roel; Van Laar-Wiersma, Jitske; Vorst, Oscar; Smit, Christian			Rewilding with large herbivores: Positive direct and delayed effects of carrion on plant and arthropod communities	PLOS ONE			English	Article							DECOMPOSITION; VEGETATION; CARCASSES; SUCCESSION; FOREST; SOIL; YELLOWSTONE; VERTEBRATES; COLEOPTERA; SCAVENGERS	Carrion of large animals is an extremely nutrient rich, ephemeral resource that is essential for many species, but is scarce in the anthropogenic Western-European landscape due to legislative restrictions. Rewilding, a novel conservation strategy that aims at restoring natural processes with minimal human intervention, is increasing in popularity and could lead to increased carrion availability in the landscape. It is therefore important to understand the effects of carrion on biodiversity. We investigated the direct and delayed (five months) effects of red deer (Cervus elaphus) carcasses on plants and arthropods in the Oostvaardersplassen, the Netherlands, one of the oldest rewilding sites in Europe. Specifically, we tested whether carrion has a positive direct effect on the abundances and diversity of various arthropod functional groups, as well as a delayed effect on the vegetation and arthropods through the increased nutrient availability. During the active decomposition stage in spring, we, not surprisingly, observed higher abundances of carrion associated species (scavengers and their specialized predators) at the carrion sites than at control sites without carrion, but no higher abundances of predators or detritivores. In late summer, after nearcomplete decomposition, plant biomass was five times higher, and nutritional plant quality (C:N ratio) was higher at the carrion sites than at the control sites. Arthropod abundance and diversity were also manifold higher, owing to higher numbers of herbivorous and predatory species. Regression analysis showed that abundances of herbivores and detritivores were positively related to plant biomass, and predator abundances were positively related to abundances of herbivores and detritivores, suggesting bottom-up effects propagating through the food chain. Our results show that even in a naturally nutrient-rich ecosystem like the Oostvaardersplassen, carrion can have strong positive effects on local plant biomass and nutritional quality and arthropod abundances, lasting the whole growing season. We found evidence that these effects were first directly caused by the presence of carrion, and later by the enhanced nutrient availability in the soil. This highlights the importance of the indirect pathways by which carrion can structure arthropod communities.	[van Klink, Roel; Van Laar-Wiersma, Jitske; Smit, Christian] Univ Groningen, Conservat Ecol Grp, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands; [van Klink, Roel] German Inst Integrat Biodivers Res iDiv, Halle, Germany	University of Groningen	van Klink, R (corresponding author), Univ Groningen, Conservat Ecol Grp, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands.; van Klink, R (corresponding author), German Inst Integrat Biodivers Res iDiv, Halle, Germany.	Roel.klink@idiv.de	smit, christian/B-9817-2008	smit, christian/0000-0002-4044-9473; van Klink, Roel/0000-0002-8125-1463	Staatsbosbeheer	Staatsbosbeheer	RvK and CS were financially supported by Staatsbosbeheer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Arnaldos MI, 2004, INT J LEGAL MED, V118, P197, DOI 10.1007/s00414-004-0446-3; Barry JM, 2019, OECOLOGIA, V189, P577, DOI 10.1007/s00442-018-4315-z; Barton PS, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1537; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Barton PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053961; Benecke M, 2001, FORENSIC SCI INT, V120, P2, DOI 10.1016/S0379-0738(01)00409-1; BRAACK LEO, 1987, OECOLOGIA, V72, P402, DOI 10.1007/BF00377571; Bump JK, 2009, ECOSYSTEMS, V12, P996, DOI 10.1007/s10021-009-9274-0; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Cobaugh KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130201; Colijn Ed O., 2014, Entomologische Berichten (Amsterdam), V74, P60; Cornelissen P, 2013, VEGETATIE GROTE HERB; Cornelissen P, 2014, BASIC APPL ECOL, V15, P396, DOI 10.1016/j.baae.2014.06.006; Cornelissen P, 2014, J NAT CONSERV, V22, P84, DOI 10.1016/j.jnc.2013.09.004; Cortes-Avizanda A, 2009, ANIM CONSERV, V12, P85, DOI 10.1111/j.1469-1795.2008.00231.x; Cortes-Avizanda A, 2012, ECOLOGY, V93, P2570, DOI 10.1890/12-0221.1; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; Danell K, 2002, ARCTIC, V55, P389; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Fielding D, 2014, AMBIO, V43, P810, DOI 10.1007/s13280-013-0469-4; Gu Xiaoying, 2014, Entomologische Berichten (Amsterdam), V74, P68; ICMO, 2010, REP 2 INT COMM MAN O; Kocarek P, 2003, EUR J SOIL BIOL, V39, P31, DOI 10.1016/S1164-5563(02)00007-9; Komar D., 1998, CAN SOC FORENSIC SCI, V31, P35, DOI [10.1080/00085030.1998.10757107, DOI 10.1080/00085030.1998.10757107]; Macdonald BCT, 2014, SOIL BIOL BIOCHEM, V69, P132, DOI 10.1016/j.soilbio.2013.10.042; Matuszewski S, 2016, INT J LEGAL MED, V130, P221, DOI 10.1007/s00414-015-1145-y; Matuszewski S, 2010, FORENSIC SCI INT, V194, P85, DOI 10.1016/j.forsciint.2009.10.016; Melis C, 2004, EUR J WILDLIFE RES, V50, P146, DOI 10.1007/s10344-004-0051-2; Melis C, 2007, ECOL RES, V22, P807, DOI 10.1007/s11284-006-0321-4; Michaud JP, 2015, Q REV BIOL, V90, P45, DOI 10.1086/679763; Moleon M, 2015, OIKOS, V124, P1391, DOI 10.1111/oik.02222; Moleon M, 2014, BIOL REV, V89, P1042, DOI 10.1111/brv.12097; Moreno-Opo R, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00108.1; Olson Z., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0147798; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal JL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00022.1; REED H. B., 1958, AMER MIDLAND NAT, V59, P213, DOI 10.2307/2422385; Sandom C., 2013, KEY TOPICS CONSERVAT, V2, P430, DOI DOI 10.1002/9781118520178.ch23; Simmons T, 2010, J FORENSIC SCI, V55, P889, DOI 10.1111/j.1556-4029.2010.01402.x; Sugiura S, 2013, BIOL CONSERV, V159, P206, DOI 10.1016/j.biocon.2012.11.003; Svenning JC, 2016, P NATL ACAD SCI USA, V113, P898, DOI 10.1073/pnas.1502556112; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; Turner KL, 2017, ECOLOGY, V98, P2413, DOI 10.1002/ecy.1930; Turner WC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1785; Van Geel P., 2018, ADVIES BEHEER OOSTVA; van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113; van Klink R, 2016, AGR ECOSYST ENVIRON, V234, P81, DOI 10.1016/j.agee.2016.01.050; Venables WN., 2002, MODERN APPL STAT S 4; Vulink JT, 2000, APPL VEG SCI, V3, P73, DOI 10.2307/1478920; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x	55	10	13	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0226946	10.1371/journal.pone.0226946	http://dx.doi.org/10.1371/journal.pone.0226946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31967995	gold, Green Submitted, Green Published			2022-12-26	WOS:000534373000009
J	Herold, F; Hamacher, D; Torpel, A; Goldschmidt, L; Muller, NG; Schega, L				Herold, Fabian; Hamacher, Dennis; Toerpel, Alexander; Goldschmidt, Leonard; Mueller, Notger G.; Schega, Lutz			Does squatting need attention?-A dual-task study on cognitive resources in resistance exercise	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MOTOR INTERFERENCE; OLDER; TRAIL; WALKING; PERFORMANCE; ADULTS; SPEED; PARTS; COST	Introduction Accumulating evidence shows that acute resistance exercises and long-term resistance training positively influence cognitive functions, but the underlying mechanisms have been rarely investigated. One explanatory approach assumes that the execution of resistance exercises requires higher cognitive processes which, in turn, lead to an `indirect' training of higher cognitive functions. However, current knowledge on the engagement of higher cognitive functions during the execution of resistance exercises is relatively sparse. Hence, the purpose of this study was to examine to what extent cognitive resources are needed to perform a resistance exercise in the form of barbell back squatting. Methods Twenty-four young adults performed a cognitive task (serial subtraction of 7's) during standing and during barbell back squatting on a Smith machine. The total number and the number of correct responses were analyzed and taken as indicators of the cognitive load imposed by the experimental condition (squatting) and the control condition (standing). Additionally, participants' perceived exertion, mean heart rate, and the number of squats they were able to perform were assessed. Results While accuracy scores were found not to be significantly different between conditions, the numbers of total and of correct responses were significantly lower during squatting than during standing. Additionally, during squatting a higher number of total answers was given in the fifth set compared to the first set. We attribute this phenomenon to a learning effect. Furthermore, there was no statistically significant correlation between cognitive measures and perceived exertion. Conclusion Results suggest that perceived exertion cannot explain the higher dual-task costs observed during squatting. They rather reflect that more cognitive resources are needed to perform low-load barbell back squats than during standing. However, further research is necessary to confirm and generalize these findings.	[Herold, Fabian; Mueller, Notger G.] German Ctr Neurodegenerat Dis DZNE, Res Grp Neuroprotect, Magdeburg, Germany; [Hamacher, Dennis; Toerpel, Alexander; Goldschmidt, Leonard; Schega, Lutz] Otto von Guericke Univ, Inst 3, Dept Sport Sci, Magdeburg, Germany; [Mueller, Notger G.] Ctr Behav Brain Sci CBBS, Magdeburg, Germany; [Mueller, Notger G.] Otto von Guericke Univ, Med Fac, Dept Neurol, Magdeburg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University; Otto von Guericke University	Hamacher, D (corresponding author), Otto von Guericke Univ, Inst 3, Dept Sport Sci, Magdeburg, Germany.	dennis.hamacher@ovgu.de	Herold, Fabian/J-6226-2019; Törpel, Alexander/AAN-4255-2020	Herold, Fabian/0000-0003-3453-090X; Törpel, Alexander/0000-0002-3142-6819; Mueller, Notger/0000-0002-5483-6423				Adams R, 1999, CAN FAM PHYSICIAN, V45, P992; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; [Anonymous], STAT DATA ANAL LC S; Atkinson G, 2002, PHYS THER SPORT, V3, P191, DOI 10.1054/ptsp.2002.0123; Baechle TR, 2008, ESSENTIALS STRENGTH; Balady GJ, 1998, CIRCULATION, V97, P2283, DOI 10.1161/01.CIR.97.22.2283; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Boisgontier MP, 2013, NEUROSCI BIOBEHAV R, V37, P1824, DOI 10.1016/j.neubiorev.2013.07.014; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Chang YK, 2012, J AGING PHYS ACTIV, V20, P497, DOI 10.1123/japa.20.4.497; Clark DJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00246; Coolican H., 2009, RES METHODS STAT PSY; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Finger JD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0109-5; Fissler P, 2013, PROG BRAIN RES, V207, P403, DOI 10.1016/B978-0-444-63327-9.00017-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fuchs R, 2015, Z GESUNDHEITSPSYCHOL, V23, P60, DOI 10.1026/0943-8149/a000137; Gail S, 2015, ISOKINET EXERC SCI, V23, P291, DOI 10.3233/IES-150590; Hamacher D, 2017, EXP BRAIN RES, V235, P2997, DOI 10.1007/s00221-017-5036-y; Herold F, 2019, EUR REV AGING PHYS A, V16, DOI 10.1186/s11556-019-0217-2; HOLM S, 1979, SCAND J STAT, V6, P65; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Landrigan JF, 2020, PSYCHOL RES-PSYCH FO, V84, P1167, DOI 10.1007/s00426-019-01145-x; Li ZH, 2018, AGING CLIN EXP RES, V30, P1259, DOI 10.1007/s40520-018-0998-6; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Mayer RE, 2003, WEB-BASED LEARNING: WHAT DO WE KNOW? WHERE DO WE GO?, P23; McLaughlin MJ, 2014, PM&R, V6, P544, DOI 10.1016/j.pmrj.2014.04.006; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Pendleton DM, 2016, INT J PSYCHOPHYSIOL, V109, P124, DOI 10.1016/j.ijpsycho.2016.08.012; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Remy F, 2010, NEUROPSYCHOLOGIA, V48, P2517, DOI 10.1016/j.neuropsychologia.2010.04.026; Schaefer S, 2020, J MOTOR BEHAV, V52, P204, DOI 10.1080/00222895.2019.1602506; Schaefer S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00316; Soga K, 2018, J COGN ENHANCE, V2, P200, DOI 10.1007/s41465-018-0079-y; Srygley JM, 2009, BRAIN RES, V1253, P92, DOI 10.1016/j.brainres.2008.11.067; Stillman CM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00626; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Torpel A, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100337; Tsukamoto H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184075; de Sousa TLW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210216; Whitley E, 2002, CRIT CARE, V6, P509, DOI 10.1186/cc1820; Wickens C.D., 1980, ATTENTION PERFORM, VVIII, P239; Wollesen B, 2016, NEUROSCIENCE, V318, P166, DOI 10.1016/j.neuroscience.2016.01.031; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zhu WM, 2012, J SPORT HEALTH SCI, V1, P9, DOI 10.1016/j.jshs.2012.02.002; Zourdos MC, 2016, J STRENGTH COND RES, V30, P267, DOI 10.1519/JSC.0000000000001049	51	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0226431	10.1371/journal.pone.0226431	http://dx.doi.org/10.1371/journal.pone.0226431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5QJ	31961904	gold, Green Published			2022-12-26	WOS:000534372000007
J	Xing, BX; Zhang, KJ; Zhang, LK; Wu, XD; Si, HH; Zhang, H; Zhu, KL; Sun, SQ				Xing, Baixi; Zhang, Kejun; Zhang, Lekai; Wu, Xinda; Si, Huahao; Zhang, Hui; Zhu, Kaili; Sun, Shouqian			And the nominees are: Using design-awards datasets to build computational aesthetic evaluation model	PLOS ONE			English	Article							IMAGE	Aesthetic perception is a human instinct that is responsive to multimedia stimuli. Giving computers the ability to assess human sensory and perceptual experience of aesthetics is a well-recognized need for the intelligent design industry and multimedia intelligence study. In this work, we constructed a novel database for the aesthetic evaluation of design, using 2,918 images collected from the archives of two major design awards, and we also present a method of aesthetic evaluation that uses machine learning algorithms. Reviewers' ratings of the design works are set as the ground-truth annotations for the dataset. Furthermore, multiple image features are extracted and fused. The experimental results demonstrate the validity of the proposed approach. Primary screening using aesthetic computing can be an intelligent assistant for various design evaluations and can reduce misjudgment in art and design review due to visual aesthetic fatigue after a long period of viewing. The study of computational aesthetic evaluation can provide positive effect on the efficiency of design review, and it is of great significance to aesthetic recognition exploration and applications development.	[Xing, Baixi; Zhang, Lekai] Zhejiang Univ Technol, Inst Ind Design, Hangzhou, Peoples R China; [Xing, Baixi; Zhang, Kejun; Zhang, Lekai; Wu, Xinda; Zhang, Hui; Zhu, Kaili; Sun, Shouqian] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Peoples R China; [Si, Huahao] Hangzhou Dianzi Univ, Sch Media & Design, Hangzhou, Peoples R China	Zhejiang University of Technology; Zhejiang University; Hangzhou Dianzi University	Zhang, KJ (corresponding author), Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Peoples R China.	zhangkejun@zju.edu.cn		Xing, Baixi/0000-0001-6778-3650	Natural Science Foundation of Zhejiang Province of China [LY19F020047, LZ19F020002]; National Natural Science Foundation of China [61402141]; Philosophy and Social Science Planning Fund Project of Zhejiang Province [20NDQN260YB]; Fundamental Research Funds for the Provincial Universities of Zhejiang [GB201901006]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Philosophy and Social Science Planning Fund Project of Zhejiang Province; Fundamental Research Funds for the Provincial Universities of Zhejiang	This study is partly supported by the Natural Science Foundation of Zhejiang Province of China (LY19F020047, LZ19F020002), National Natural Science Foundation of China (61402141), the Philosophy and Social Science Planning Fund Project of Zhejiang Province (20NDQN260YB) and the Fundamental Research Funds for the Provincial Universities of Zhejiang (GB201901006). Thefunders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch PH, 2003, J CONSUM RES, V29, P551, DOI 10.1086/346250; Browne C, 2012, IEEE T COMP INTEL AI, V4, P229, DOI 10.1109/TCIAIG.2012.2197621; Brunner R, 2008, DO YOU MATTER GREAT; Chen R, 2016, Proceedings NICOGRAPH International 2016, P142, DOI 10.1109/NicoInt.2016.35; Chen W, 2018, GEOCARTO INT, V33, P1398, DOI 10.1080/10106049.2018.1425738; Chien CF, 2016, COMPUT IND ENG, V99, P162, DOI 10.1016/j.cie.2016.07.006; Erdem AN, 2016, IEEE COMPUT GRAPH, V36, P23, DOI 10.1109/MCG.2016.43; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fu X, 2018, IEEE IMAGE PROC, P3528, DOI 10.1109/ICIP.2018.8451133; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hou GH, 2019, INT J TECHNOL DES ED, V29, P543, DOI 10.1007/s10798-018-9450-7; Hsiao KL, 2018, TELEMAT INFORM, V35, P103, DOI 10.1016/j.tele.2017.10.002; Iqbal A, 2012, IEEE T COMP INTEL AI, V4, P178, DOI 10.1109/TCIAIG.2012.2192933; Jin B, 2016, IEEE IMAGE PROC, P2291, DOI 10.1109/ICIP.2016.7532767; Kucer M, 2018, IEEE T IMAGE PROCESS, V27, P5100, DOI 10.1109/TIP.2018.2845100; Law D, 2017, ERGONOMICS, V60, P876, DOI 10.1080/00140139.2016.1227093; Lee HJ, 2017, IEEE T MULTIMEDIA, V19, P1921, DOI 10.1109/TMM.2017.2687759; Liu Zhenguang, 2018, IEEE Trans Image Process, DOI 10.1109/TIP.2018.2828326; Lovato P, 2014, IEEE T INF FOREN SEC, V9, P364, DOI 10.1109/TIFS.2014.2298370; Lu X, 2015, IEEE T MULTIMEDIA, V17, P2021, DOI 10.1109/TMM.2015.2477040; Maity R, 2019, IEEE T COMPUT SOC SY, V6, P149, DOI 10.1109/TCSS.2019.2891126; Meng X., 2018, P INT C IM PROC THEO, DOI [10.1109/IPTA.2018.8608132, DOI 10.1109/IPTA.2018.8608132]; Miao H, 2019, PROCEEDINGS OF 3RD INTERNATIONAL CONFERENCE ON INFORMATION SYSTEM AND DATA MINING (ICISDM 2019), P47, DOI 10.1145/3325917.3325956; Murray N, 2012, PROC CVPR IEEE, P2408, DOI 10.1109/CVPR.2012.6247954; Nanda Parul, 2008, TQM Journal, V20, P348, DOI 10.1108/17542730810881339; Norman D. A., 2004, EMOTIONAL DESIGN WHY; Persada AG, 2017, 2017 INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING AND COMPUTER SCIENCE (ICECOS), P137; Qian XM, 2018, IEEE T IMAGE PROCESS, V27, P1178, DOI 10.1109/TIP.2017.2769454; Ren J, 2017, IEEE I CONF COMP VIS, P638, DOI 10.1109/ICCV.2017.76; Ross BJ, 2006, IEEE C EVOL COMPUTAT, P1072; Schindler I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178899; Sheng KK, 2018, PROCEEDINGS OF THE 2018 ACM MULTIMEDIA CONFERENCE (MM'18), P879, DOI 10.1145/3240508.3240554; Sidhu DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200431; Simmonds G, 2017, FOOD QUAL PREFER, V62, P340, DOI 10.1016/j.foodqual.2016.11.010; Simonyan K., 2015, INT C LEARN REPR; Su HH, 2012, IEEE T MULTIMEDIA, V14, P833, DOI 10.1109/TMM.2012.2186123; Tarvainen J, 2014, IEEE T MULTIMEDIA, V16, P2085, DOI 10.1109/TMM.2014.2357688; Temel D, 2014, IEEE IMAGE PROC, P590, DOI 10.1109/ICIP.2014.7025118; Tian XM, 2018, IEEE SYS MAN CYBERN, P2509, DOI 10.1109/SMC.2018.00430; Tong S, 2017, 2017 INTERNATIONAL CONFERENCE ON CULTURE AND COMPUTING (CULTURE AND COMPUTING), P97, DOI 10.1109/Culture.and.Computing.2017.53; Toufani S, 2017, MARK INTELL PLAN, V35, P316, DOI 10.1108/MIP-12-2015-0230; Wang WG, 2017, IEEE I CONF COMP VIS, P2205, DOI 10.1109/ICCV.2017.240; Wen-Hung Liao, 2014, Smart Graphics. 12th International Symposium (SG 2014). Proceedings: LNCS 8698, P73, DOI 10.1007/978-3-319-11650-1_7; Wong LK, 2009, IEEE IMAGE PROC, P997, DOI 10.1109/ICIP.2009.5413825; Wu O, 2016, IEEE T MULTIMEDIA, V18, P1062, DOI 10.1109/TMM.2016.2538722; Wu T, 2016, 2016 12TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (ICNC-FSKD), P1077, DOI 10.1109/FSKD.2016.7603328; Zhang CJ, 2018, PROCEEDINGS OF THE 2018 ACM MULTIMEDIA CONFERENCE (MM'18), P1231, DOI 10.1145/3240508.3241386; Zhang SQ, 2014, LECT N MANAG SCI, V23, P3	48	0	0	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227754	10.1371/journal.pone.0227754	http://dx.doi.org/10.1371/journal.pone.0227754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KW5DK	31961909	gold, Green Published			2022-12-26	WOS:000521185100001
J	Deuschl, C; Ruber, T; Ernst, L; Fendler, WP; Kirchner, J; Monninghoff, C; Herrmann, K; Quesada, CM; Forsting, M; Elger, CE; Umutlu, L				Deuschl, Cornelius; Rueber, Theodor; Ernst, Leon; Fendler, Wolfgang P.; Kirchner, Julian; Moenninghoff, Christoph; Herrmann, Ken; Quesada, Carlos M.; Forsting, Michael; Elger, Christian E.; Umutlu, Lale			F-18-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis	PLOS ONE			English	Article							RAPIDLY PROGRESSIVE DEMENTIAS; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET/MRI; PET; MRI; MALIGNANCIES; ANTIBODIES; SYMPTOMS; PATTERNS	Introduction Limbic encephalitis (LE) is an immune-related, sometimes paraneoplastic process of the central nervous system. Initial diagnosis and treatment are based on the clinical presentation as well as antibody profiles and MRI. This study investigated the diagnostic value of integrated F-18-FDG-PET/MRI in the diagnostic work-up of patients with LE for a cerebral and whole-body imaging concept. Material and methods Twenty patients with suspected LE were enrolled in this prospective study. All patients underwent a dedicated PET/MRI protocol of the brain as well as the whole-body. Two neuroradiologists, one body radiologist and one nuclear medicine physician performed blinded consensus readings of each corresponding MRI and PET/MRI dataset of the brain and whole-body. Diagnostic confidence was evaluated on a Likert scale. Results Based on integrated PET/MRI 19 / 20 patients were found to show morphologic and / or metabolic changes indicative of LE, whereas sole MRI enabled correct identification in 16 / 20 patients. Three patients with negative MRI showed metabolic changes of the limbic system or extra-limbic regions, shifting the diagnosis from (negative) MRI to positive for LE in PET/ MRI. Whole-body staging revealed suspected lesions in 2/20 patients, identified by MRI and PET, one confirmed as malignant and one false positive. Diagnostic confidence for cerebral and whole-body imaging reached higher scores for PET/MRI (cerebral: 2.7 and whole body: 4.8) compared to MRI alone (cerebral: 2.4 and whole body: 4.5). Conclusion LE diagnosis remains challenging for imaging as it shows only subtle imaging findings in most patients. Nevertheless, based on the simultaneous and combined analysis of morphologic and metabolic data, integrated PET/MRI may enable a dual platform for improved diagnostic confidence and overall detection of LE as well as whole-body imaging for exclusion of paraneoplastic LE.	[Deuschl, Cornelius; Moenninghoff, Christoph; Forsting, Michael; Umutlu, Lale] Univ Duisburg Essen, Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Rueber, Theodor; Ernst, Leon; Elger, Christian E.] Univ Bonn, Dept Epileptol, Bonn, Germany; [Fendler, Wolfgang P.; Herrmann, Ken] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Kirchner, Julian] Univ Duesseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Moenninghoff, Christoph] Clemenshosp Muenster, Neuroradiol, Munster, Germany; [Quesada, Carlos M.] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany	University of Duisburg Essen; University of Bonn; University of Duisburg Essen; University of Duisburg Essen	Deuschl, C (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	cornelius.deuschl@uk-essen.de	Herrmann, Ken/GOH-1465-2022; Fendler, Wolfgang/AAH-1611-2021	Fendler, Wolfgang/0000-0002-5106-3584				Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; [Anonymous], IMM ERKR GRAUEN ZNS; Baumgartner A, 2013, J NEUROL, V260, P2744, DOI 10.1007/s00415-013-7048-2; Beiderwellen K, 2015, EUR J NUCL MED MOL I, V42, P56, DOI 10.1007/s00259-014-2902-8; Chassoux F, 2010, NEUROLOGY, V75, P2168, DOI 10.1212/WNL.0b013e31820203a9; Cistaro A, 2015, CLIN IMAG, V39, P329, DOI 10.1016/j.clinimag.2014.09.004; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Degnan AJ, 2014, AM J NEURORADIOL, V35, P424, DOI 10.3174/ajnr.A3455; Degnan AJ, 2014, AM J NEURORADIOL, V35, P418, DOI 10.3174/ajnr.A3454; Erhamamci S, 2015, ANN NUCL MED, V29, P420, DOI 10.1007/s12149-015-0959-5; Fisher RE, 2012, CLIN NUCL MED, V37, pE213, DOI 10.1097/RLU.0b013e31824852c7; Florance NR, 2009, ANN NEUROL, V66, P11, DOI 10.1002/ana.21756; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Greiner H, 2011, SEIZURE-EUR J EPILEP, V20, P266, DOI 10.1016/j.seizure.2010.11.013; Grueneisen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157880; Grueneisen J, 2014, INVEST RADIOL, V49, P808, DOI 10.1097/RLI.0000000000000086; Gultekin SH, 2000, BRAIN, V123, P1481, DOI 10.1093/brain/123.7.1481; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kassubek J, 2001, J NEUROIMAGING, V11, P55, DOI 10.1111/j.1552-6569.2001.tb00011.x; Kirchner J, 2018, EUR J NUCL MED MOL I, V45, P2328, DOI 10.1007/s00259-018-4102-4; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Leypoldt F, 2012, J NEUROL NEUROSUR PS, V83, P681, DOI 10.1136/jnnp-2011-301969; Mohr BC, 2010, CLIN NUCL MED, V35, P461, DOI 10.1097/RLU.0b013e3181db4d4a; Morbelli S, 2016, LANCET NEUROL, V15, P1009, DOI 10.1016/S1474-4422(16)30140-5; Morbelli S, 2016, EUR J NUCL MED MOL I, V43, P1337, DOI 10.1007/s00259-016-3335-3; Oyanguren B, 2013, EUR J NEUROL, V20, P1566, DOI 10.1111/ene.12249; Pillai SC, 2010, PEDIATR NEUROL, V43, P217, DOI 10.1016/j.pediatrneurol.2010.04.019; Probasco JC, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000352; Pruss H, 2010, NEUROLOGY, V75, P1735, DOI 10.1212/WNL.0b013e3181fc2a06; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Rey C, 2012, J NEUROL, V259, P1106, DOI 10.1007/s00415-011-6308-2; Rubi S, 2011, EPILEPSIA, V52, P2216, DOI 10.1111/j.1528-1167.2011.03295.x; Scheid R, 2004, ARCH NEUROL-CHICAGO, V61, P1785, DOI 10.1001/archneur.61.11.1785; Schievelkamp AH, 2019, CLIN NEURORADIOL, V29, P623, DOI 10.1007/s00062-018-0705-1; Takano A, 2009, EUR J NUCL MED MOL I, V36, P1885, DOI 10.1007/s00259-009-1194-x; Taneja S, 2018, INDIAN J NUCL MED, V33, P174, DOI 10.4103/ijnm.IJNM_147_17; Urbach H, 2015, NEURORADIOLOGY, V57, P1203, DOI 10.1007/s00234-015-1581-x; Urbach H, 2006, NEURORADIOLOGY, V48, P380, DOI 10.1007/s00234-006-0069-0; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vitaliani R, 2005, ANN NEUROL, V58, P594, DOI 10.1002/ana.20614; Wagner J, 2016, EPILEPSIA, V57, P475, DOI 10.1111/epi.13297; Wagner J, 2015, J NEUROL NEUROSUR PS, V86, P735, DOI 10.1136/jnnp-2014-307875; Wagner J, 2013, EPILEPSIA, V54, P1679, DOI 10.1111/epi.12320	43	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227906	10.1371/journal.pone.0227906	http://dx.doi.org/10.1371/journal.pone.0227906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951636	Green Published, gold			2022-12-26	WOS:000534370500034
J	Valenzuela-Vazquez, L; Nunez-Enriquez, JC; Sanchez-Herrera, J; Jimenez-Hernandez, E; Martin-Trejo, JA; Espinoza-Hernandez, LE; Medina-Sanson, A; Flores-Villegas, LV; Penaloza-Gonzalez, JG; Torres-Nave, JR; Espinosa-Elizondo, RM; Amador-Sanchez, R; Santillan-Juarez, JD; Flores-Lujano, J; Perez-Saldivar, ML; Garcia-Lopez, LR; Castaneda-Echevarria, A; Rodriguez-Leyva, F; Rosas-Vargas, H; Mato-Rocha, M; Duarte-Rodriguez, DA; Sepulveda-Robles, OA; Mancilla-Herrera, I; Mejia-Arangure, JM; Cruz-Munoz, ME				Valenzuela-Vazquez, Lucero; Carlos Nunez-Enriquez, Juan; Sanchez-Herrera, Jacqueline; Jimenez-Hernandez, Elva; Alfonso Martin-Trejo, Jorge; Eugenia Espinoza-Hernandez, Laura; Medina-Sanson, Aurora; Victoria Flores-Villegas, Luz; Gabriel Penaloza-Gonzalez, Jose; Refugio Torres-Nave, Jose; Martha Espinosa-Elizondo, Rosa; Amador-Sanchez, Raquel; Denisse Santillan-Juarez, Jessica; Flores-Lujano, Janet; Luisa Perez-Saldivar, Maria; Ramiro Garcia-Lopez, Luis; Castaneda-Echevarria, Alejandro; Rodriguez-Leyva, Francisco; Rosas-Vargas, Haydee; Mato-Rocha, Minerva; Aldebaran Duarte-Rodriguez, David; Alejandro Sepulveda-Robles, Omar; Mancilla-Herrera, Ismael; Manuel Mejia-Arangure, Juan; Ernesto Cruz-Munoz, Mario			Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; CANCER INCIDENCE; SAP FAMILY; EXPRESSION; CHILDREN; ADAPTERS; KIR; DEFICIENCY; MECHANISM; INFECTION	Acute lymphoblastic leukemia (ALL) is the most common cancer in children around the globe. Mexico City has one of the highest incidence rates of childhood leukemia worldwide with 49.5 cases per million children under the age of 15 which is similar to that reported for Hispanic populations living in the United States. In addition, it has been noted a dismal prognosis in Mexican and Hispanic ALL pediatric population. Although ALL, like cancer in general, has its origins in endogenous, exogenous, and genetic factors, several studies have shown that the immune system also plays a deterministic role in cancer development. Among various elements of the immune system, T lymphocytes and NK cells seem to dominate the immune response against leukemia. The aim of the present study was to perform a phenotypic and functional characterization of NK cells in ALL Mexican children at the moment of diagnosis and before treatment initiation. A case-control study was conducted by the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia (MIGICCL). 41 cases were incident ALL children younger than 17 years old and residents of Mexico City. 14 controls were children without leukemia, matched by age and sex with cases. NK cell function was evaluated by degranulation assays towards K562 cells and SLAM-associated protein (SAP) expression was measured by intracellular staining. All assays were performed using peripheral blood mononuclear cells from controls and patients. The results indicate that NK mediated cytotoxicity, measured by CD107a degranulation assays in response to K562 cells, was reduced in ALL patients compared to controls. Interestingly, an impaired NK cell killing of target cells was not equally distributed among ALL patients. In contrast to patients classified as high-risk, standard-risk patients did not display a significant reduction in NK cell-mediated cytotoxicity. Moreover, patients presenting a leukocyte count >= 50,000xmm(3) displayed a reduction in NK-cell mediated cytotoxicity and a reduction in SAP expression, indicating a positive correlation between a reduced SAP expression and an impaired NK cell-mediated citotoxicity. In the present study it was observed that unlike patients with standard-risk, NK cells from children presenting high-risk ALL, harbor an impaired cytotoxicity towards K562 at diagnosis. In addition, NK cell function was observed to be compromised in patients with a leukocyte count >= 50,000xmm(3), where also it was noticed a decreased expression of SAP compared to patients with a leukocyte count <50,000xmm(3). These data indicate NK cell-mediated cytotoxicity is not equally affected in ALL patients, nevertheless a positive correlation between low SAP expression and decreased NK cell-mediated cytotoxicity was observed in ALL patients with a leukocyte count >= 50,000xmm(3). Finally, an abnormal NK cell-mediated cytotoxicity may represent a prognostic factor for high-risk acute lymphoblastic leukemia.	[Valenzuela-Vazquez, Lucero; Sanchez-Herrera, Jacqueline; Ernesto Cruz-Munoz, Mario] Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico; [Carlos Nunez-Enriquez, Juan; Flores-Lujano, Janet; Luisa Perez-Saldivar, Maria; Aldebaran Duarte-Rodriguez, David] UMAE Hosp Pediat, IMSS, Ctr Med Nacl CMN Siglo XXI, Unidad Invest Med Epidemiol Clin, Mexico City, DF, Mexico; [Jimenez-Hernandez, Elva; Eugenia Espinoza-Hernandez, Laura] Hosp Gen Gaudencio Gonzalez Garza, Serv Hematol Pediat, IMSS, Ctr Med Nacl CMN La Raza, Mexico City, DF, Mexico; [Alfonso Martin-Trejo, Jorge] UMAE Hosp Pediat, IMSS, Ctr Med Nacl CMN Siglo XXI, Serv Hematol Pediat, Mexico City, DF, Mexico; [Medina-Sanson, Aurora] Hosp Infantil Mexico Dr Federico Gomez, SS, Serv Oncopediat, Mexico City, DF, Mexico; [Victoria Flores-Villegas, Luz] ISSSTE, Ctr Med Nacl CMN 20 Noviembre, Serv Hematol Pediat, Mexico City, DF, Mexico; [Gabriel Penaloza-Gonzalez, Jose] Hosp Juarez Mexico, SS, Serv Oncopediat, Mexico City, DF, Mexico; [Refugio Torres-Nave, Jose] Hosp Pediat Moctezuma, Serv Oncol, Secretaria Salud DF, Mexico City, DF, Mexico; [Martha Espinosa-Elizondo, Rosa] Hosp Gen Mexico City, Serv Hematol Pediat, SS, Mexico City, DF, Mexico; [Amador-Sanchez, Raquel] Hosp Gen Reg 1 Carlos McGregor Sanchez Navarro, IMSS, Mexico City, DF, Mexico; [Denisse Santillan-Juarez, Jessica] Hosp Reg 1 Octubre, ISSSTE, Serv Hematooncol Pediat, Mexico City, DF, Mexico; [Ramiro Garcia-Lopez, Luis] Hosp Pediat Tacubaya, Serv Pediat, SS, Mexico City, DF, Mexico; [Castaneda-Echevarria, Alejandro] HGR 25, IMSS, Serv Pediat, Mexico City, DF, Mexico; [Rodriguez-Leyva, Francisco] HGZ 30 IMSS, Serv Cirugia Pediat, Mexico City, DF, Mexico; [Rosas-Vargas, Haydee; Mato-Rocha, Minerva; Alejandro Sepulveda-Robles, Omar] UMAE Hosp Pediat, Ctr Med Nacl CMN Siglo XXI, IMSS, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico; [Mancilla-Herrera, Ismael] Inst Nacl Perinatol, Dept Infectol & Inmunol, Mexico City, DF, Mexico; [Manuel Mejia-Arangure, Juan] IMSS, Coordinac Invest Salud, Mexico City, DF, Mexico	Universidad Autonoma del Estado de Morelos; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico Gomez; Hospital General de Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Cruz-Munoz, ME (corresponding author), Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico.; Mejia-Arangure, JM (corresponding author), IMSS, Coordinac Invest Salud, Mexico City, DF, Mexico.	juan.mejiaa@imss.gob.mx; mario.cruz@uaem.mx	Mejia-Arangure, Juan Manuel/T-6743-2019; Núñez-Enríquez, Juan Carlos/A-8651-2018; Duarte Rodriguez, David Aldebaran/F-1848-2018; Sepulveda-Robles, Omar/N-9483-2017	Mejia-Arangure, Juan Manuel/0000-0001-8027-6231; Núñez-Enríquez, Juan Carlos/0000-0002-8070-9727; PEREZ, MARIA LUISA/0000-0002-9987-2479; Duarte Rodriguez, David Aldebaran/0000-0002-0560-2540; MATA, MINERVA/0000-0003-0949-461X; Flores Lujano, Janet/0000-0003-0727-2837; Sepulveda-Robles, Omar/0000-0003-2152-3954; Rosas-Vargas, Haydee/0000-0003-0635-8284	Consejo Nacional de Ciencia y Tecnologia [SALUD-2010-1-141026, FIS/IMSS/PROT/895, PDCPN2013-01-215726, FIS/IMSS/PROT/1364, SALUD 2015-1-262190, FIS/IMSS/PROT/1533, CB-2015-1-258042, FIS/IMSS/PROT/1548, FONCICYT/37/2018, FIS/IMSS/PROT/1782]; Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/PRIO/11/017, FIS/IMSS/PROT/G12/1134, FIS/IMSS/PROT/G11/951, FIS/IMSS/PROT/PRIO/14/031, FIS/IMSS/PROT/MD13/1254, FIS/IMSS/PROT/PRIO/15/048, FIS/IMSS/PROT/MD15/1504, FIS/IMSS/PROT/G15/1477]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Mexicano del Seguro Social	This work was supported by the Consejo Nacional de Ciencia y Tecnologia [grant numbers SALUD-2010-1-141026, FIS/IMSS/PROT/895, PDCPN2013-01-215726, FIS/IMSS/PROT/1364, SALUD 2015-1-262190, FIS/IMSS/PROT/1533, CB-2015-1-258042, FIS/IMSS/PROT/1548, and FONCICYT/37/2018, FIS/IMSS/PROT/1782]; and by the Instituto Mexicano del Seguro Social [grant numbers FIS/IMSS/PROT/PRIO/11/017, FIS/IMSS/PROT/G12/1134, FIS/IMSS/PROT/G11/951, FIS/IMSS/PROT/PRIO/14/031, FIS/IMSS/PROT/MD13/1254, FIS/IMSS/PROT/PRIO/15/048, FIS/IMSS/PROT/MD15/1504, FIS/IMSS/PROT/G15/1477]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao R, 2015, PEDIATR BLOOD CANCER, V62, P1819, DOI 10.1002/pbc.25544; Aggarwal N, 2016, CYTOM PART B-CLIN CY, V90, P349, DOI 10.1002/cyto.b.21349; Baier C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00459; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Nunez-Enriquez JC, 2016, ARCH MED RES, V47, P644, DOI 10.1016/j.arcmed.2016.12.005; Bekker-Mendez VC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/210560; CARROLL M, 2003, HEMATOL-AM SOC HEMAT, P102, DOI DOI 10.1182/ASHEDUCATION-2003.1.102; Chang MC, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03152; Chiossone L, 2018, NAT REV IMMUNOL, V18, P726, DOI 10.1038/s41577-018-0077-4; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; de Smith AJ, 2014, BLOOD, V123, P2497, DOI 10.1182/blood-2013-11-540625; Diermayr S, 2008, BLOOD, V111, P1428, DOI 10.1182/blood-2007-07-101311; Dong ZJ, 2010, TRENDS IMMUNOL, V31, P295, DOI 10.1016/j.it.2010.05.008; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Cruz-Munoz ME, 2019, J LEUKOCYTE BIOL, V105, P955, DOI 10.1002/JLB.MR0618-224RR; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Francis SS, 2017, BLOOD, V129, P1680, DOI 10.1182/blood-2016-07-723148; Friedmann A M, 2000, Oncologist, V5, P321, DOI 10.1634/theoncologist.5-4-321; Greaves M, 2018, NAT REV CANCER, V18, P471, DOI 10.1038/s41568-018-0015-6; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latour S, 2004, SEMIN IMMUNOL, V16, P409, DOI 10.1016/j.smim.2004.08.020; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Locatelli F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00015; Locatelli F, 2009, CLIN IMMUNOL, V133, P171, DOI 10.1016/j.clim.2009.04.009; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Perez-Saldivar ML, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-355; Maki G, 2008, LEUKEMIA, V22, P998, DOI 10.1038/leu.2008.15; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Mizia-Malarz A, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/3596983; Moretta L, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00087; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; PARRADO A, 1994, LEUKEMIA RES, V18, P191, DOI 10.1016/0145-2126(94)90114-7; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Ramirez-Ramirez D, 2019, J LEUKOCYTE BIOL, V105, P999, DOI 10.1002/JLB.MA0618-231R; Rouce RH, 2016, LEUKEMIA, V30, P800, DOI 10.1038/leu.2015.327; Sanchez-Correa B, 2011, CANCER IMMUNOL IMMUN, V60, P1195, DOI 10.1007/s00262-011-1050-2; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Schuster V, 2000, IMMUNOL REV, V178, P21, DOI 10.1034/j.1600-065X.2000.17819.x; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Stary J, 2014, J CLIN ONCOL, V32, P174, DOI 10.1200/JCO.2013.48.6522; Tsirogianni M, 2019, LEUKEMIA LYMPHOMA, V60, P2457, DOI 10.1080/10428194.2019.1581935; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Wilkinson JD, 2005, REV PANAM SALUD PUBL, V18, P5, DOI 10.1590/S1020-49892005000600002; Wu N, 2016, NAT IMMUNOL, V17, P387, DOI 10.1038/ni.3369	48	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227314	10.1371/journal.pone.0227314	http://dx.doi.org/10.1371/journal.pone.0227314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951638	Green Published, gold			2022-12-26	WOS:000534370500015
J	Dumbrepatil, AB; Zegalia, KA; Sajja, K; Kennedy, RT; Marsh, ENG				Dumbrepatil, Arti B.; Zegalia, Kelcie A.; Sajja, Keerthi; Kennedy, Robert T.; Marsh, E. Neil G.			Targeting viperin to the mitochondrion inhibits the thiolase activity of the trifunctional enzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inhibitor; enzyme degradation; metabolic regulation; metalloenzyme; mitochondria; innate immunity; fatty acid oxidation; cytomegalovirus; HADHB thiolase; mitochondrial trifunctional protein; radical SAM enzyme; viperin	ANTIVIRAL PROTEIN VIPERIN; RADICAL SAM ENZYME; IMMUNE-RESPONSES; INNATE IMMUNITY; QUALITY-CONTROL; VIRAL EVASION	Understanding the mechanisms by which viruses evade host cell immune defenses is important for developing improved antiviral therapies. In an unusual twist, human cytomegalovirus co-opts the antiviral radical SAM enzyme viperin (virus-inhibitory protein, endoplasmic reticulum?associated, interferon-inducible) to enhance viral infectivity. This process involves translocation of viperin to the mitochondrion, where it binds the ?-subunit (HADHB) of the mitochondrial trifunctional enzyme complex that catalyzes thiolysis of ?-ketoacyl?CoA esters as part of fatty acid ?-oxidation. Here we investigated how the interaction between these two enzymes alters their activities and affects cellular ATP levels. Experiments with purified enzymes indicated that viperin inhibits the thiolase activity of HADHB, but, unexpectedly, HADHB activates viperin, leading to synthesis of the antiviral nucleotide 3?-deoxy-3?,4?-didehydro-CTP. Measurements of enzyme activities in lysates prepared from transfected HEK293T cells expressing these enzymes mirrored the findings obtained with purified enzymes. Thus, localizing viperin to mitochondria decreased thiolase activity, and coexpression of HADHB significantly increased viperin activity. Furthermore, targeting viperin to mitochondria also increased the rate at which HADHB is retrotranslocated out of mitochondria and degraded, providing an additional mechanism by which viperin reduces HADHB activity. Targeting viperin to mitochondria decreased cellular ATP levels by more than 50%, consistent with the enzyme disrupting fatty acid catabolism. These results provide biochemical insight into the mechanism by which human cytomegalovirus subverts viperin; they also provide a biochemical rationale for viperin's recently discovered role in regulating thermogenesis in adipose tissues.	[Dumbrepatil, Arti B.; Zegalia, Kelcie A.; Sajja, Keerthi; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu	; Marsh, Neil/G-7553-2016	Zegalia, Kelcie/0000-0003-0389-134X; Dumbrepatil, Arti/0000-0002-0105-9667; Marsh, Neil/0000-0003-1713-1683	National Institutes of Health [GM 093088, DK 046960]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants GM 093088 (to A. B. D., K. S., and E. N. G. M.) and DK 046960 (to K. A. Z. and R. T. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Broderick WE, 2019, J BIOL INORG CHEM, V24, P769, DOI 10.1007/s00775-019-01706-w; Chakravarti A, 2018, J BIOL CHEM, V293, P14122, DOI 10.1074/jbc.RA118.003998; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Dumbrepatil AB, 2019, J BIOL CHEM, V294, P6888, DOI 10.1074/jbc.RA119.007719; Duschene Kaitlin S, 2012, Biomol Concepts, V3, P255; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Ebrahimi KH, 2017, FEBS LETT, V591, P2394, DOI 10.1002/1873-3468.12769; Eom J, 2019, P NATL ACAD SCI USA, V116, P17419, DOI 10.1073/pnas.1904480116; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Hee JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172236; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Iannello A, 2006, J LEUKOCYTE BIOL, V79, P16, DOI 10.1189/jlb.0705397; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Marsh ENG, 2004, BIOORG CHEM, V32, P326, DOI 10.1016/j.bioorg.2004.06.001; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/jvi.02054-17, 10.1128/JVI.02054-17]; Pang HR, 2018, METHOD ENZYMOL, V606, P485, DOI 10.1016/bs.mie.2018.04.014; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rettberg L, 2018, METHOD ENZYMOL, V606, P341, DOI 10.1016/bs.mie.2018.04.009; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang SC, 2018, NAT PROD REP, V35, P707, DOI 10.1039/c7np00059f; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wang YY, 2018, METHOD ENZYMOL, V606, P199, DOI 10.1016/bs.mie.2018.05.018; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Yokoyama K, 2018, NAT PROD REP, V35, P660, DOI 10.1039/c8np00006a; Zhou ZQ, 2012, BIOCHEM BIOPH RES CO, V427, P305, DOI 10.1016/j.bbrc.2012.09.047	49	12	12	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2839	2849		10.1074/jbc.RA119.011526	http://dx.doi.org/10.1074/jbc.RA119.011526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31980458	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000519969100025
J	Ebert, SM; Bullard, SA; Basisty, N; Marcotte, GR; Skopec, ZP; Dierdorff, JM; Al-Zougbi, A; Tomcheck, KC; DeLau, AD; Rathmacher, JA; Bodine, SC; Schilling, B; Adams, CM				Ebert, Scott M.; Bullard, Steven A.; Basisty, Nathan; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Bodine, Sue C.; Schilling, Birgit; Adams, Christopher M.			Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBP?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle atrophy; skeletal muscle; muscle; protein?protein interaction; protein?DNA interaction; gene regulation; activating transcription factor 4 (ATF4); basic leucine zipper transcription factor (bZIP); CCAAT enhancer-binding protein ? (C; EBP?); growth arrest and DNA damage-inducible ? (Gadd45?)	LEUCINE-ZIPPER; DNA-BINDING; GENE-EXPRESSION; GADD45A EXPRESSION; PROTEIN; PATHWAY; FAMILY; PHOSPHORYLATION; IDENTIFICATION; MASS	Skeletal muscle atrophy is a highly-prevalent and debilitating condition that remains poorly understood at the molecular level. Previous work found that aging, fasting, and immobilization promote skeletal muscle atrophy via expression of activating transcription factor 4 (ATF4) in skeletal muscle fibers. However, the direct biochemical mechanism by which ATF4 promotes muscle atrophy is unknown. ATF4 is a member of the basic leucine zipper transcription factor (bZIP) superfamily. Because bZIP transcription factors are obligate dimers, and because ATF4 is unable to form highly-stable homodimers, we hypothesized that ATF4 may promote muscle atrophy by forming a heterodimer with another bZIP family member. To test this hypothesis, we biochemically isolated skeletal muscle proteins that associate with the dimerization- and DNA-binding domain of ATF4 (the bZIP domain) in mouse skeletal muscle fibers in vivo. Interestingly, we found that ATF4 forms at least five distinct heterodimeric bZIP transcription factors in skeletal muscle fibers. Furthermore, one of these heterodimers, composed of ATF4 and CCAAT enhancer-binding protein ? (C/EBP?), mediates muscle atrophy. Within skeletal muscle fibers, the ATF4?C/EBP? heterodimer interacts with a previously unrecognized and evolutionarily conserved ATF?C/EBP composite site in exon 4 of the Gadd45a gene. This three-way interaction between ATF4, C/EBP?, and the ATF?C/EBP composite site activates the Gadd45a gene, which encodes a critical mediator of muscle atrophy. Together, these results identify a biochemical mechanism by which ATF4 induces skeletal muscle atrophy, providing molecular-level insights into the etiology of skeletal muscle atrophy.	[Ebert, Scott M.; Bullard, Steven A.; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Bodine, Sue C.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Internal Med, Iowa City, IA 52242 USA; [Ebert, Scott M.; Bullard, Steven A.; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Bodine, Sue C.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Ebert, Scott M.; Bullard, Steven A.; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Ebert, Scott M.; Bodine, Sue C.; Adams, Christopher M.] Emmyon Inc, Coralville, IA 52241 USA; [Basisty, Nathan; Schilling, Birgit] Buck Inst Res Aging, Novato, CA 94945 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Buck Institute for Research on Aging	Adams, CM (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu	Basisty, Nathan B/J-9294-2014	Basisty, Nathan B/0000-0001-6173-1139; Marcotte, George/0000-0002-9162-135X; Adams, Christopher/0000-0002-5795-7212	NIH [1S10 OD016281]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Peter Snyder and Daryl Granner for critical review of the manuscript. We also acknowledge support from the NIH shared instrumentation grant for the TripleTOF system at the Buck Institute (1S10 OD016281 to the Buck Institute).	Ampofo E, 2013, BBA-MOL CELL RES, V1833, P439, DOI 10.1016/j.bbamcr.2012.10.025; Bagheri-Yarmand R, 2015, J BIOL CHEM, V290, P11749, DOI 10.1074/jbc.M114.619833; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; Basisty N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800123; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bullard SA, 2016, J BIOL CHEM, V291, P17496, DOI 10.1074/jbc.M116.740308; Cohen DM, 2015, ELIFE, V4, DOI 10.7554/eLife.06821; Collins BC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00249-5; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; DUBOWITZ V, 2007, MUSCLE BIOPSY PRACTI, P83; Ebert SM, 2019, PHYSIOLOGY, V34, P232, DOI 10.1152/physiol.00003.2019; Ebert SM, 2015, J BIOL CHEM, V290, P25497, DOI 10.1074/jbc.M115.681445; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gombart AF, 2007, J LEUKOCYTE BIOL, V81, P1535, DOI 10.1189/jlb.0806516; Hirsch N, 2015, PERSPECT BIOL MED, V58, P182, DOI 10.1353/pbm.2015.0026; Huggins CJ, 2016, MOL CELL BIOL, V36, P693, DOI 10.1128/MCB.00911-15; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Inoue Y, 2017, FEBS LETT, V591, P3682, DOI 10.1002/1873-3468.12869; Jiang HY, 2007, J BIOL CHEM, V282, P3755, DOI 10.1074/jbc.M606461200; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Pons J, 2007, PEPTIDES, V28, P2253, DOI 10.1016/j.peptides.2007.09.016; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reinke AW, 2013, SCIENCE, V340, P730, DOI 10.1126/science.1233465; Rodriguez-Martinez JA, 2017, ELIFE, V6, DOI 10.7554/elife.19272.001; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; Segatto M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01645-7; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sun DS, 1996, GENOMICS, V36, P54, DOI 10.1006/geno.1996.0425; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wang GX, 2019, MOL CELL, V74, P844, DOI 10.1016/j.molcel.2019.03.021; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	65	22	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2787	2803		10.1074/jbc.RA119.012095	http://dx.doi.org/10.1074/jbc.RA119.012095			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31953319	Green Published, hybrid			2022-12-26	WOS:000519969100022
J	Loreti, M; Shi, DL; Carron, C				Loreti, Mafalda; Shi, De-Li; Carron, Cmence			The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during Xenopus development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						STAT3; polycomb; embryo; Xenopus; post-translational modification (PTM); DSCR6; embryonic axis patterning; Ezh2; mesoderm	CELL-ADHESION MOLECULE; GENE-EXPRESSION; COMPLEX PRC2; TARGET GENES; POLYCOMB; METHYLATION; ZEBRAFISH; SPECIFICATION; ACTIVATION; INDUCTION	Embryonic cell fate specification and axis patterning requires integration of several signaling pathways that orchestrate region-specific gene expression. The transcription factor signal transducer and activator of transcription 3 (Stat3) plays important roles during early development, but it is unclear how Stat3 is activated. Here, using Xenopus as a model, we analyzed the post-translational regulation and functional consequences of Stat3 activation in dorsoventral axis patterning. We show that Stat3 phosphorylation, lysine methylation, and transcriptional activity increase before gastrulation and induce ventral mesoderm formation. Down syndrome critical region gene 6 (DSCR6), a RIPPLY family member that induces dorsal mesoderm by releasing repressive polycomb group proteins from chromatin, bound to the Stat3 C-terminal region and antagonized its transcriptional and ventralizing activities by interfering with its lysine methylation. Enhancer of zeste 2 polycomb-repressive complex 2 subunit (Ezh2) also bound to this region; however, its methyltransferase activity was required for Stat3 methylation and activation. Loss of Ezh2 resulted in dorsalization of ventral mesoderm and formation of a secondary axis. Furthermore, interference with Ezh2 phosphorylation also prevented Stat3 lysine methylation and transcriptional activity. Thus, inhibition of either Ezh2 phosphorylation or Stat3 lysine methylation compensated for the absence of DSCR6 function. These results reveal that DSCR6 and Ezh2 critically and post-translationally regulate Stat3 transcriptional activity. Ezh2 promotes Stat3 activation in ventral mesoderm formation independently of epigenetic regulation, whereas DSCR6 specifies dorsal fate by counteracting this ventralizing activity. This antagonism helps pattern the mesoderm along the dorsoventral axis, representing a critical facet of cell identity regulation during development.	[Loreti, Mafalda; Shi, De-Li; Carron, Cmence] Sorbonne Univ, CNRS, Dev Biol Lab, UMR7622,IBPS, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Shi, DL; Carron, C (corresponding author), Sorbonne Univ, CNRS, Dev Biol Lab, UMR7622,IBPS, F-75005 Paris, France.	de-li.shi@upmc.fr; clemence.carron_homo@upmc.fr	Shi, De-Li/AAG-1807-2021; Carron, Clémence/AAG-6304-2021	Carron, Clemence/0000-0002-8776-7380; Shi, Deli/0000-0002-6104-9137	Centre National de la Recherche Scientifique (CNRS); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (Gefluc); Ministere de l'Enseignement Superieur et de la Recherche; the Sorbonne Universite	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (Gefluc); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); the Sorbonne Universite	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Sorbonne Universite, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (Gefluc), and a Doctoral Fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aldiri I, 2013, DEVELOPMENT, V140, P2867, DOI 10.1242/dev.088096; Barnett MW, 2001, MECH DEVELOP, V102, P157, DOI 10.1016/S0925-4773(01)00304-5; Besser D, 1999, MOL CELL BIOL, V19, P1401; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao JM, 2012, MECH DEVELOP, V129, P263, DOI 10.1016/j.mod.2012.07.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Carron C, 2016, WIRES DEV BIOL, V5, P150, DOI 10.1002/wdev.217; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cheng XN, 2019, EXP CELL RES, V381, P112, DOI 10.1016/j.yexcr.2019.04.033; Cheng XN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01552-x; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; Dasgupta M, 2014, J BIOL CHEM, V289, P30763, DOI 10.1074/jbc.M114.603894; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Deevy O, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.181354; Diaz HDM, 2014, GENESIS, V52, P849, DOI 10.1002/dvg.22804; Faust C, 1998, DEVELOPMENT, V125, P4495; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Guanizo AC, 2018, GROWTH FACTORS, V36, P1, DOI 10.1080/08977194.2018.1473393; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hong JY, 2012, J CELL SCI, V125, P561, DOI 10.1242/jcs.086173; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Isaacs HV, 1999, EVOL DEV, V1, P143, DOI 10.1046/j.1525-142x.1999.99020.x; Jalvy S, 2019, DEV BIOL, V447, P200, DOI 10.1016/j.ydbio.2018.12.020; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Li HY, 2013, DEVELOPMENT, V140, P4903, DOI 10.1242/dev.098319; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Li HY, 2006, DEV BIOL, V290, P470, DOI 10.1016/j.ydbio.2005.11.020; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishinakamura R, 1999, DEV BIOL, V216, P481, DOI 10.1006/dbio.1999.9518; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Pan YM, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0561-z; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Shan YL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00668-4; Shao M, 2009, DEVELOPMENT, V136, P2121, DOI 10.1242/dev.032649; Stark GR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028555; Stark GR, 2011, CELL RES, V21, P375, DOI 10.1038/cr.2010.174; Tien CL, 2015, DEVELOPMENT, V142, P722, DOI 10.1242/dev.111997; Volkel P, 2015, AM J TRANSL RES, V7, P175; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Yu YX, 2017, STEM CELL REP, V9, P752, DOI 10.1016/j.stemcr.2017.07.016; Zhang T, 2014, DEVELOPMENT, V141, P4332, DOI 10.1242/dev.104885; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	58	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2724	2735		10.1074/jbc.RA119.010719	http://dx.doi.org/10.1074/jbc.RA119.010719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31996376	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000519969100017
J	Howard-Azzeh, M; Pearl, DL; O'Sullivan, TL; Berke, O				Howard-Azzeh, Mohammad; Pearl, David L.; O'Sullivan, Terri L.; Berke, Olaf			The identification of risk factors contributing to accidental opioid poisonings in companion dogs using data from a North American poison control center (2006-2014)	PLOS ONE			English	Article							UNITED-STATES; EXPOSURES; TRENDS; DRUG	In the last decade, there has been a marked increase in opioid-related human deaths in the U.S. However, the effects of the growth in opioid use on vulnerable populations, such as pet dogs, are largely unknown. The objective of this study was to investigate potential risk factors at the dog, county, and state-levels that contributed to accidental dog opioid poisonings. Dog demographic information was collected during calls to the Animal Poison Control Center (APCC), operated by the American Society for the Prevention of Cruelty to Animals, about pet dog exposures to poisons from 2006-2014. Data concerning state-level opioid-related human death rates and county-level human opioid prescription rates were collected from databases accessed from the Centers for Disease Control and Prevention. A multilevel logistic regression model with random intercepts for county and state was fitted to explore associations between the odds of a call to the APCC being related to dog opioid poisonings with the following independent variables: sex, weight, age, reproductive status, breed class, year, source of calls, county-level human opioid prescription rate, and state-level opioid human death rate. There was a significant non-linear positive association between accidental opioid dog poisoning calls and county-level human opioid prescription rates. Similarly, the odds of a call being related to an opioid poisoning significantly declined over the study period. Depending on the breed class, the odds of a call being related to an opioid poisoning event were generally lower for older and heavier dogs. The odds of a call being related to an opioid poisoning were significantly higher for intact compared to neutered dogs, and if the call was made by a veterinarian compared to a member of the public. Veterinarians responding to poisonings may benefit from knowledge of trends in the use and abuse of both legal and illegal drugs in human populations.	[Howard-Azzeh, Mohammad; Pearl, David L.; O'Sullivan, Terri L.; Berke, Olaf] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada	University of Guelph	Howard-Azzeh, M (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.	mhowardia@uoguelph.ca	Berke, Olaf/F-7798-2010	Berke, Olaf/0000-0003-3537-0629	Natural Sciences and Engineering Research Council (Discovery NSERC grant)	Natural Sciences and Engineering Research Council (Discovery NSERC grant)	The work was supported by a grant to DL Pearl from the Natural Sciences and Engineering Research Council (Discovery NSERC grant) -http://www.nserc-crsng.gc.ca/index_eng.asp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JE, 2009, ANN EMERG MED, V53, P419, DOI 10.1016/j.annemergmed.2008.07.015; Berny P, 2010, VET J, V183, P255, DOI 10.1016/j.tvjl.2009.03.034; Burghardt LC, 2013, PEDIATRICS, V132, P18, DOI 10.1542/peds.2012-2978; Center for Behavioral Health Statistics and Quality, 2017, NSDUH SER H, V51; Centers of Disease Control and Prevention, 2018, US OP PRECR RAT MAPS; Centers of Disease Control and Prevention, 2019, WID RANG DAT EP RES; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Gaither JR, 2016, JAMA PEDIATR, V170, P1195, DOI 10.1001/jamapediatrics.2016.2154; Gfeller R.W., 2004, HDB SMALL ANIMAL TOX; Lovegrove MC, 2014, PEDIATRICS, V134, pE1009, DOI 10.1542/peds.2014-0840; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; Martin TC, 2011, CURR DRUG SAF, V6, P12, DOI 10.2174/157488611794480034; Meola SD, 2012, J VET EMERG CRIT CAR, V22, P690, DOI 10.1111/j.1476-4431.2012.00818.x; National Institute of Health, 2019, OV DEATH RAT; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227701	10.1371/journal.pone.0227701	http://dx.doi.org/10.1371/journal.pone.0227701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995582	Green Published, gold			2022-12-26	WOS:000534609400026
J	Kim, SH; Kim, SW; Lim, GH; Lyu, JI; Choi, HI; Jo, YD; Kang, SY; Kang, BC; Kim, JB				Kim, Sang Hoon; Kim, Se Won; Lim, Gah-Hyun; Lyu, Jae Il; Choi, Hong-Il; Jo, Yeong Deuk; Kang, Si-Yong; Kang, Byoung-Cheorl; Kim, Jin-Baek			Transcriptome analysis to identify candidate genes associated with the yellow-leaf phenotype of a Cymbidium mutant generated by Upsilon-irradiation	PLOS ONE			English	Article							CHLOROPHYLLASE ACTIVITY; ARABIDOPSIS-THALIANA; PHOTOSYNTHESIS; IDENTIFICATION; DEGRADATION; HOMEOSTASIS; SENESCENCE; SEQUENCE; GENOME; COPPER	Leaf color is an important agronomic trait in flowering plants, including orchids. However, factors underlying leaf phenotypes in plants remain largely unclear. A mutant displaying yellow leaves was obtained by the Upsilon-ray-based mutagenesis of a Cymbidium orchid and characterized using RNA sequencing. A total of 144,918 unigenes obtained from over 25 million reads were assigned to 22 metabolic pathways in the Kyoto Encyclopedia of Genes and Genomes database. In addition, gene ontology was used to classify the predicted functions of transcripts into 73 functional groups. The RNA sequencing analysis identified 2,267 differentially expressed genes between wild-type and mutant Cymbidium sp. Genes involved in the chlorophyll biosynthesis and degradation, as well as ion transport, were identified and assayed for their expression levels in wild-type and mutant plants using quantitative real-time profiling. No critical expression changes were detected in genes involved in chlorophyll biosynthesis. In contrast, seven genes involved in ion transport, including two metal ion transporters, were down-regulated, and chlorophyllase 2, associated with chlorophyll degradation, was up-regulated. Together, these results suggest that alterations in chlorophyll metabolism and/or ion transport might contribute to leaf color in Cymbidium orchids.	[Kim, Sang Hoon; Kim, Se Won; Lim, Gah-Hyun; Lyu, Jae Il; Choi, Hong-Il; Jo, Yeong Deuk; Kang, Si-Yong; Kim, Jin-Baek] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup, South Korea; [Kim, Se Won] Rural Dev Adm, Natl Inst Agr Sci, Jeonju, South Korea; [Kang, Byoung-Cheorl] Seoul Natl Univ, Coll Agr & Life Sci, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Kang, Byoung-Cheorl] Seoul Natl Univ, Coll Agr & Life Sci, Vegetable Breeding Res Ctr, Seoul, South Korea	Korea Atomic Energy Research Institute (KAERI); National Institute of Agricultural Sciences; Rural Development Administration (RDA); Seoul National University (SNU); Seoul National University (SNU)	Kim, JB (corresponding author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup, South Korea.	jbkim74@kaeri.re.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2017M2A2A6A05018543]; Korea Atomic Energy Research Institute (KAERI)	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Atomic Energy Research Institute (KAERI)	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (2017M2A2A6A05018543) and a grant from the Korea Atomic Energy Research Institute (KAERI).	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Aiamla-or S, 2010, FOOD CHEM, V120, P645, DOI 10.1016/j.foodchem.2009.10.056; Almela L, 1996, J SCI FOOD AGR, V70, P173, DOI [10.1002/(SICI)1097-0010(199602)70:2<173::AID-JSFA479>3.3.CO;2-A, 10.1002/(SICI)1097-0010(199602)70:2&lt;173::AID-JSFA479&gt;3.0.CO;2-J]; [Anonymous], 2015, INT C ADV AGR BIOL E; BARTSEVICH VV, 1995, EMBO J, V14, P1845, DOI 10.1002/j.1460-2075.1995.tb07176.x; Ben-Yaakov E, 2006, ISR J PLANT SCI, V54, P129, DOI 10.1560/IJPS_54_2_129; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Blanco E, 2018, CURR PROTOC BIOINF, V64, DOI [DOI 10.1002/CPBI.56, 10.1002/cpbi.56]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cheamuangphan A, 2013, BUSINESS INFORM  JUL, P7; Chen WR, 2012, RUSS J PLANT PHYSL+, V59, P732, DOI 10.1134/S1021443712060040; Choi SH, 2006, SCI HORTIC-AMSTERDAM, V108, P79, DOI 10.1016/j.scienta.2006.01.010; Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; [邓晓娟 Deng Xiaojuan], 2012, [杂交水稻, Hybrid Rice], V27, P9; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hendry G.A.F., 1993, METHODS COMP PLANT E, P148, DOI DOI 10.1007/978-94-011-1494-3; Himelblau E, 1998, PLANT PHYSIOL, V117, P1227, DOI 10.1104/pp.117.4.1227; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang JL, 2013, PLANT SCI, V210, P241, DOI 10.1016/j.plantsci.2013.06.003; Huang WH, 2013, MOL PLANT, V6, P1673, DOI 10.1093/mp/sst069; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Kraj W, 2015, DENDROBIOLOGY, V74, P43, DOI 10.12657/denbio.074.005; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Leitch IJ., 2007, FLOW CYTOMETRY PLANT, P153, DOI [DOI 10.1002/9783527610921.CH7, 10.1002/9783527610921.ch7]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YH, 2004, J JPN SOC HORTIC SCI, V73, P386, DOI 10.2503/jjshs.73.386; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lopez-Millan AF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00178; Ma XZ, 2017, PLANT PHYSIOL BIOCH, V111, P1, DOI 10.1016/j.plaphy.2016.11.007; MINGUEZMOSQUERA MI, 1994, J AGR FOOD CHEM, V42, P38, DOI 10.1021/jf00037a005; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nouet C, 2011, TRENDS PLANT SCI, V16, P395, DOI 10.1016/j.tplants.2011.03.005; Pilon M, 2009, CURR OPIN PLANT BIOL, V12, P347, DOI 10.1016/j.pbi.2009.04.011; Qin R, 2017, GENE, V627, P351, DOI 10.1016/j.gene.2017.05.059; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RODRIGUEZ MT, 1987, J PLANT PHYSIOL, V129, P369, DOI 10.1016/S0176-1617(87)80094-9; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Sarmah D, 2017, INT J CUR MICROBIOL, V6, P1909, DOI DOI 10.20546/IJCMAS.2017.609.235; Senoura T, 2017, PLANT MOL BIOL, V95, P375, DOI 10.1007/s11103-017-0656-y; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tian XQ, 2013, GENES GENOM, V35, P87, DOI 10.1007/s13258-013-0069-5; Todorov DT, 2003, BIOL PLANTARUM, V46, P633, DOI 10.1023/A:1024896418839; Tsai WC, 2017, BOT STUD, V58, DOI 10.1186/s40529-017-0213-7; Varotto C, 2002, PLANT J, V31, P589, DOI 10.1046/j.1365-313X.2002.01381.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yan L, 2015, MOL PLANT, V8, P922, DOI 10.1016/j.molp.2014.12.011; Yruela I, 2013, METALLOMICS, V5, P1090, DOI 10.1039/c3mt00086a; Yruela I, 2009, FUNCT PLANT BIOL, V36, P409, DOI 10.1071/FP08288; Yukawa T, 2002, BOT J LINN SOC, V138, P383, DOI 10.1046/j.1095-8339.2002.00038.x; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhu GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128592	65	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228078	10.1371/journal.pone.0228078	http://dx.doi.org/10.1371/journal.pone.0228078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995594	Green Published, gold			2022-12-26	WOS:000534609400041
J	Pellegrino, M; Traversi, G; Arena, A; Cappa, M; Rosado, MM; Andreani, M; Delfino, DV; Moretti, F; Fierabracci, A				Pellegrino, Marsha; Traversi, Gianandrea; Arena, Andrea; Cappa, Marco; Rosado, M. Manuela; Andreani, Marco; Delfino, Domenico, V; Moretti, Fabiola; Fierabracci, Alessandra			Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-SUPPRESSOR GENE; AUTOIMMUNE-DISEASES; ARTHRITIS; POLYMORPHISM; EXPRESSION; ANTIBODIES; MUTATIONS; TP53; MDM2	Various immunotherapies for the treatment of type 1 diabetes are currently under investigation. Some of these aim to rescue the remaining beta cells from autoimmune attack caused by the disease. Among the strategies employed, p53 has been envisaged as a possible target for immunomodulation. We studied the possible effect of p53 activation on Treg subsets and Treg/Teff balance in type 1 diabetes patients' PBMC. Upon p53 activation, we observed an increase in CD8+ Treg and activated CD8+ Teff whilst CD8+ Teff cells significantly decreased in healthy PBMC when stimulated with anti-CD3/CD28. No effect was detected on percentages of CD4+ Treg, while a reduction was seen in CD4+ Teff cells and an increase in activated CD4+ Teff cells. In patients' PBMC, upon p53 activation followed by 6 days of anti-CD3/CD28 stimulation, CD8+ Treg and activated CD8+ Teff were increased while CD8+ Teff were decreased. No differences were detected in the CD4+ counterparts. CD8+ Teff PD1+, CD8+ Teff PD1low were increased upon p53 activation in type 1 diabetics compared to controls while CD8+ Teff PD1high were increased in both groups. The same increased percentages were detected for CD4+ counterparts. CD4+ Treg PD1high cells were decreased in diabetics upon p53 activation at day 6 of anti-CD3/CD28 stimulation. In conclusion, a Teff dysregulation is observed upon p53 activation suggesting that molecules promoting p53 cannot be used for therapy in type 1 diabetics.	[Pellegrino, Marsha; Traversi, Gianandrea; Arena, Andrea; Fierabracci, Alessandra] Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Dept, IRCCS, Rome, Italy; [Cappa, Marco] Bambino Gesu Pediat Hosp, Endocrinol Dept, IRCCS, Rome, Italy; [Rosado, M. Manuela] Bambino Gesu Pediat Hosp, IRCCS, Res Labs, Rome, Italy; [Andreani, Marco] Bambino Gesu Pediat Hosp, IRCCS, Transplantat Immunogenet Lab, Rome, Italy; [Delfino, Domenico, V] Univ Perugia, Dept Med, Sect Pharmacol, Perugia, Italy; [Moretti, Fabiola] Natl Res Council Italy CNR, Inst Cell Biol & Neurobiol, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR)	Fierabracci, A (corresponding author), Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Dept, IRCCS, Rome, Italy.	alessandra.fierabracci@opbg.net	Pellegrino, Marsha/K-4500-2016; Moretti, Fabiola/I-5647-2013; Fierabracci, Alessandra/K-5930-2016; Rosado, Maria Manuela/AAX-6495-2020	Pellegrino, Marsha/0000-0002-9002-3622; Moretti, Fabiola/0000-0002-2691-1254; Fierabracci, Alessandra/0000-0003-3078-9754; Andreani, Marco/0000-0003-3451-3624	Italian Ministry of Health Ricerca Corrente [201802P004265]; AIRC (Associazione Italiana Ricerca sul Cancro) [IG 21814]	Italian Ministry of Health Ricerca Corrente(Ministry of Health, Italy); AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	AF 201802P004265 Italian Ministry of Health Ricerca Corrente FM IG 21814 AIRC (Associazione Italiana Ricerca sul Cancro) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046871; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bitti MLM, 2011, J PEDIATR ENDOCR MET, V24, P437, DOI 10.1515/JPEM.2011.058; Buscemi S, 2018, ENDOCRINE, V60, P339, DOI 10.1007/s12020-017-1394-2; Chauhan R, 2004, CLIN EXP IMMUNOL, V136, P574, DOI 10.1111/j.1365-2249.2004.02463.x; Chen RH, 2008, J CLIN LAB ANAL, V22, P321, DOI 10.1002/jcla.20249; Churlaud G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00171; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Del Fattore A, 2015, CELL TRANSPLANT, V24, P2615, DOI 10.3727/096368915X687543; Dong ZY, 2017, CLIN CANCER RES, V23, P3012, DOI 10.1158/1078-0432.CCR-16-2554; Fierabracci A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121975; Firestein GS, 1997, P NATL ACAD SCI USA, V94, P10895, DOI 10.1073/pnas.94.20.10895; Gianchecchi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110755; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Han ZN, 1999, ARTHRITIS RHEUM, V42, P1088, DOI 10.1002/1529-0131(199906)42:6<1088::AID-ANR4>3.0.CO;2-E; Hara T, 2008, J RHEUMATOL, V35, P451; Harron KL, 2011, DIABETIC MED, V28, P1508, DOI 10.1111/j.1464-5491.2011.03413.x; Herkel J, 2004, EUR J IMMUNOL, V34, P3623, DOI 10.1002/eji.200425371; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Iancu-Rubin C, 2014, EXP HEMATOL, V42, P137, DOI 10.1016/j.exphem.2013.11.012; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kovacs B, 1997, ARTHRITIS RHEUM, V40, P980, DOI 10.1002/art.1780400531; Kuhn HM, 1999, AUTOIMMUNITY, V31, P229, DOI 10.3109/08916939908994068; Leech M, 2008, CLIN EXP IMMUNOL, V152, P345, DOI 10.1111/j.1365-2249.2008.03629.x; Levrero M, 2000, J CELL SCI, V113, P1661; Li XY, 2019, AM J CHINESE MED, V47, P1755, DOI 10.1142/S0192415X19500897; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Mancini F, 2016, ONCOGENE, V35, P228, DOI 10.1038/onc.2015.76; Mellati M, 2015, DIABETES CARE, V38, pE137, DOI 10.2337/dc15-0889; Mimura Y, 2007, CLIN RHEUMATOL, V26, P1328, DOI 10.1007/s10067-006-0473-1; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Park JS, 2013, ARTHRITIS RHEUM-US, V65, P949, DOI 10.1002/art.37841; Pellegrino M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210839; Pellegrino M, 2019, NANOMED-NANOTECHNOL, V18, P371, DOI 10.1016/j.nano.2018.11.001; Pellegrino M, 2015, CANCER RES, V75, P4560, DOI 10.1158/0008-5472.CAN-15-0439; Perri V, 2015, INT J MOL SCI, V16, P22584, DOI 10.3390/ijms160922584; Raja KRM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049446; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Ruggeri RM, 2015, J ENDOCRINOL INVEST, V38, P1175, DOI 10.1007/s40618-015-0292-9; Simelyte E, 2005, ARTHRITIS RHEUM-US, V52, P1876, DOI 10.1002/ART.21099; Takatori H, 2014, CRIT REV IMMUNOL, V34, P509, DOI 10.1615/CritRevImmunol.2014012193; Thomasova D, 2012, NEOPLASIA, V14, P1097, DOI 10.1593/neo.121534; Volodko N, 2015, WORLD J GASTROENTERO, V21, P10358, DOI 10.3748/wjg.v21.i36.10358; Woittiez NJC, 2015, IMMUNOTHERAPY-UK, V7, P163, DOI 10.2217/imt.14.104; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Yokoyama M, 2019, J MOL CELL CARDIOL, V129, P105, DOI 10.1016/j.yjmcc.2019.02.010; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669; Zhang SZ, 2011, FASEB J, V25, P2387, DOI 10.1096/fj.10-175299; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228296	10.1371/journal.pone.0228296	http://dx.doi.org/10.1371/journal.pone.0228296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995625	Green Published, gold			2022-12-26	WOS:000534609400062
J	Semakula, JR; Mouton, JP; Jorgensen, A; Hutchinson, C; Allie, S; Semakula, L; French, N; Lamorde, M; Toh, CH; Blockman, M; Sekaggya-Wiltshire, C; Waitt, C; Pirmohamed, M; Cohen, K				Semakula, Jerome Roy; Mouton, Johannes P.; Jorgensen, Andrea; Hutchinson, Claire; Allie, Shaazia; Semakula, Lynn; French, Neil; Lamorde, Mohammed; Toh, Cheng-Hock; Blockman, Marc; Sekaggya-Wiltshire, Christine; Waitt, Catriona; Pirmohamed, Munir; Cohen, Karen			A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa	PLOS ONE			English	Article							PATIENT CHARACTERISTICS; ATRIAL-FIBRILLATION; LEVEL	Introduction Warfarin is the most commonly prescribed oral anticoagulant in sub-Saharan Africa and requires ongoing monitoring. The burden of both infectious diseases and non-communicable diseases is high and medicines used to treat comorbidities may interact with warfarin. We describe service provision, patient characteristics, and anticoagulation control at selected anticoagulation clinics in Uganda and South Africa. Methods We evaluated two outpatient anticoagulation services in Kampala, Uganda and three in Cape Town, South Africa between 1 January and 31 July 2018. We collected information from key staff members about the clinics' service provision and extracted demographic and clinical data from a sample of patients' clinic records. We calculated time in therapeutic range (TTR) over the most recent 3-month period using the Rosendaal interpolation method. Results We included three tertiary level, one secondary level and one primary level anticoagulation service, seeing between 30 and 800 patients per month. Care was rendered by nurses, medical officers, and specialists. All healthcare facilities had on-site pharmacies; laboratory INR testing was off-site at two. Three clinics used warfarin dose-adjustment protocols; these were not validated for local use. We reviewed 229 patient clinical records. Most common indications for warfarin were venous thrombo-embolism in 112/229 (49%), atrial fibrillation in 74/229 (32%) and valvular heart disease in 30/229 (13%). Patients were generally followed up monthly. HIV prevalence was 20% and 5% at Ugandan and South African clinics respectively. Cardiovascular comorbidity predominated. Furosemide, paracetamol, enalapril, simvastatin, and tramadol were the most common concomitant drugs. Anticoagulation control was poor at all included clinics with median TTR of 41% (interquartile range 14% to 69%). Conclusions TTR was suboptimal at all included sites, despite frequent patient follow-up. Strategies to improve INR control in sub-Saharan patients taking warfarin are needed. Locally validated warfarin dosing algorithms in Uganda and South Africa may improve INR control.	[Semakula, Jerome Roy; Semakula, Lynn; Lamorde, Mohammed; Sekaggya-Wiltshire, Christine; Waitt, Catriona] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Mouton, Johannes P.; Allie, Shaazia; Blockman, Marc; Cohen, Karen] Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa; [Jorgensen, Andrea] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England; [Hutchinson, Claire; French, Neil; Waitt, Catriona] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Toh, Cheng-Hock] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Pirmohamed, Munir] Univ Liverpool, Wolfson Ctr Personalised Med, Inst Translat Med, Liverpool, Merseyside, England	Makerere University; University of Cape Town; University of Liverpool; University of Liverpool; University of Liverpool; University of Liverpool	Cohen, K (corresponding author), Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa.	karen.cohen@uct.ac.za	Mouton, Hannes/U-5827-2019; Cohen, Karen/D-4036-2017	Mouton, Hannes/0000-0002-3511-1259; Cohen, Karen/0000-0002-1892-4207; semakula, jerome roy/0000-0003-3333-8502; French, Neil/0000-0003-4814-8293	UK aid from the UK Government [16/137/101]	UK aid from the UK Government(CGIAR)	This research was commissioned by the National Institute for Health Research (NIHR) Global Health Research Group on Warfarin anticoagulation in patients with cardiovascular disease in sub-Saharan Africa [ref: 16/137/101] using UK aid from the UK Government. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ebrahim I, 2018, SAMJ S AFR MED J, V108, P490, DOI [10.7196/SAMJ.2018.v108i6.13062, 10.7196/samj.2018.v108i6.13062]; Esterly JS, 2013, J ANTIMICROB CHEMOTH, V68, P1360, DOI 10.1093/jac/dkt043; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Jonkman LJ, 2019, DRUGS THERAPY PERSPE, P1; Kim YK, 2010, J THROMB HAEMOST, V8, P101, DOI [10.14801/JAITC.2018.8.2.101, 10.1111/j.1538-7836.2009.03652.x]; Liedtke MD, 2009, ANN PHARMACOTHER, V43, P322, DOI 10.1345/aph.1L497; Martins MAP, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-27; Mouton JP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003437; Mouton JP, 2015, BRIT J CLIN PHARMACO, V80, P818, DOI 10.1111/bcp.12567; Mwita JC, 2018, CLIN APPL THROMB-HEM, V24, P596, DOI 10.1177/1076029617747413; Nelson WW, 2013, AM J CARDIOL, V112, P509, DOI 10.1016/j.amjcard.2013.04.013; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Preston CL., 2019, STOCKLEYS DRUG INTER; Reynolds MW, 2004, CHEST, V126, P1938, DOI 10.1378/chest.126.6.1938; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sekaggya C, 2016, BMC Hematol, V16, P16, DOI 10.1186/s12878-016-0056-6; Sonuga B., 2016, PROFILE ANTICOAGULAT; Suarez-Kurtz G, 2013, BRIT J CLIN PHARMACO, V75, P334, DOI 10.1111/j.1365-2125.2012.04354.x; UBOS, 2018, UG NAT HOUS SURV 201; WHO, 2019, GLOB TUB REP; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	24	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227458	10.1371/journal.pone.0227458	http://dx.doi.org/10.1371/journal.pone.0227458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995565	gold, Green Published, Green Submitted			2022-12-26	WOS:000534609400022
J	Bai, BX; Ren, JH; Bai, FL; Hao, L				Bai, Bianxia; Ren, Jiahong; Bai, Fenling; Hao, Lin			Selection and validation of reference genes for gene expression studies in Pseudomonas brassicacearum GS20 using real-time quantitative reverse transcription PCR	PLOS ONE			English	Article							HOUSEKEEPING GENES; IDENTIFICATION; SIDEROPHORES; ANTAGONISM; AERUGINOSA; STABILITY; IDENTIFY	Pseudomonas brassicacearum GS20 is an antagonistic strain of bacteria recently isolated from the rhizosphere of Codonopsis pilosula. No validated reference gene has been indentified from P. brassicacearum to use in the normalization of real-time quantitative reverse transcription-PCR data. Therefore, in this study, nine candidate reference genes (recA, gyrA, rpoD, proC, gmk, rho, 16S, ftsz, and secA) were assessed at different growth phases and under various growth conditions. The expression stability of these candidate genes was evaluated using BestKeeper, NormFinder and GeNorm. In general, the results showed rho, rpoD and gyrA were the most suitable reference genes for P. brassicacearum GS20. The relative expression of iron-regulated gene (fhu) was normalized to verify the reliability of the proposed reference genes under iron-replete and iron-limited conditions. The trend in relative expression was consistent with the change in siderophore production under different iron conditions. This study presents reliable reference genes for transcriptional studies in P. brassicacearum GS20 under the chosen experimental conditions.	[Bai, Bianxia; Hao, Lin] Shanxi Agr Univ, Coll Agr, Jinzhong, Shanxi, Peoples R China; [Bai, Bianxia; Ren, Jiahong; Bai, Fenling] Changzhi Univ, Dept Biol Sci & Technol, Changzhi, Shanxi, Peoples R China; [Bai, Bianxia; Ren, Jiahong; Bai, Fenling] Ecol & Environm Res Inst Taihang Mt, Changzhi, Shanxi, Peoples R China	Shanxi Agricultural University; Changzhi University	Hao, L (corresponding author), Shanxi Agr Univ, Coll Agr, Jinzhong, Shanxi, Peoples R China.; Ren, JH (corresponding author), Changzhi Univ, Dept Biol Sci & Technol, Changzhi, Shanxi, Peoples R China.; Ren, JH (corresponding author), Ecol & Environm Res Inst Taihang Mt, Changzhi, Shanxi, Peoples R China.	renjiahong76@hotmail.com; haolinsxndspxy@163.com	Ren, Jiahong/GPT-3292-2022		National Natural Science Foundation of China [31100471]; Fund for Shanxi "1331 Project" Key Subjects Construction [1331KSC]; Fund for Shanxi Key Subjects Construction (FSKSC); Fund for Key Research and Development (R&D) Projects of Shanxi Province [201803D31056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Shanxi "1331 Project" Key Subjects Construction; Fund for Shanxi Key Subjects Construction (FSKSC); Fund for Key Research and Development (R&D) Projects of Shanxi Province	This work was supported by the National Natural Science Foundation of China (31100471), the Fund for Shanxi "1331 Project" Key Subjects Construction (1331KSC), the Fund for Shanxi Key Subjects Construction (FSKSC), and the Fund for Key Research and Development (R&D) Projects of Shanxi Province (No. 201803D31056). Jiahong Ren and Bianxia Bai awarded these fundings.	Alqarni B, 2016, J MICROBIOL METH, V127, P182, DOI 10.1016/j.mimet.2016.06.008; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUYER JS, 1986, J BIOL CHEM, V261, P791; Chang Q, 2009, J BIOSCI BIOENG, V107, P210, DOI 10.1016/j.jbiosc.2008.09.017; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Conte E, 2006, APPL MICROBIOL BIOT, V72, P1054, DOI 10.1007/s00253-006-0373-y; CROWLEY DE, 1991, PLANT SOIL, V130, P179, DOI 10.1007/BF00011873; Desroche N, 2005, J MICROBIOL METH, V60, P325, DOI 10.1016/j.mimet.2004.10.010; Fischer SE, 2010, ANTON LEEUW INT J G, V97, P241, DOI 10.1007/s10482-009-9405-9; Hernandez-Leon R, 2015, BIOL CONTROL, V81, P83, DOI 10.1016/j.biocontrol.2014.11.011; Gomes AEI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27420-2; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Li MY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00313; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martins PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28348; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; Nielsen MN, 1998, APPL ENVIRON MICROB, V64, P3563; Panina Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26707-8; Petriccione M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16961; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44905; Radjacommare R., 2010, Archives of Phytopathology and Plant Protection, V43, P1, DOI 10.1080/03235400701650494; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Schwartz T, 2007, ANAL BIOANAL CHEM, V387, P513, DOI 10.1007/s00216-006-0909-0; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sullivan-Gunn M, 2011, BRIT J CANCER, V104, P1055, DOI 10.1038/bjc.2011.35; Theis T, 2007, J MICROBIOL METH, V70, P355, DOI 10.1016/j.mimet.2007.05.011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	37	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227927	10.1371/journal.pone.0227927	http://dx.doi.org/10.1371/journal.pone.0227927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN9XL	31986172	Green Published, gold			2022-12-26	WOS:000533283800001
J	Koschollek, C; Kuehne, A; Mullerschon, J; Amoah, S; Batemona-Abeke, H; Dela Bursi, T; Mayamba, P; Thorlie, A; Tshibadi, CM; Greiner, VW; Bremer, V; Santos-Hovener, C				Koschollek, Carmen; Kuehne, Anna; Mullerschon, Johanna; Amoah, Stephen; Batemona-Abeke, Helene; Dela Bursi, Taty; Mayamba, Pierre; Thorlie, Adama; Tshibadi, Christina Mputu; Greiner, Virginia Wangare; Bremer, Viviane; Santos-Hovener, Claudia			Knowledge, information needs and behavior regarding HIV and sexually transmitted infections among migrants from sub-Saharan Africa living in Germany: Results of a participatory health research survey	PLOS ONE			English	Article							CONDOM USE; VIOLENCE; EPIDEMIC; CARE; DETERMINANTS; SURVEILLANCE; ATTITUDES; WOMEN; MEN	Background A total of 3,419 new HIV diagnoses were reported in Germany in 2016, with migrants from sub-Saharan Africa (misSA) accounting for 14.1%. To understand the driving factors behind the epidemiological situation, we conducted a quantitative cross-sectional survey on knowledge, attitudes, behavior, and practices regarding HIV and sexually transmitted infections (STIs) among misSA living in six German cities utilizing participatory health research. Methods Participants were recruited by peer researchers. Levels of knowledge, information needs, and preferred methods of information dissemination were analyzed to inform future prevention planning. Additionally, we analyzed sexual behavior and other risk factors for contracting HIV and STIs. The results may facilitate the formulation of targeted prevention messages in the future. Results We included 2,432 participants in the analysis. General knowledge about HIV was adequate, as 86.9% were aware of the presented information. Statements about HIV co-infections were prior knowledge for 53.4% of the participants and about German HIV policies and HIV testing for 54.7%. Knowledge about other STIs differed, ranging from 69.6% who have ever heard of gonorrhea to 23.8% who have ever heard of genital warts. Groups with particular knowledge gaps were i) younger misSA, ii) recent migrants, iii) misSA without regular access to the German health care system, iv) misSA of lower socioeconomic status, and v) misSA with Muslim religious affiliation. The majority of participants reported information needs (72.8%), and 71.3% wanted to obtain this information from health professionals. Male misSA were more likely to report five or more sexual partners compared to females. Less than half of participants reported always using condoms with non-steady sexual partners (46.8%). Reasons for not using condoms differed between males and females. A considerable proportion of females (16.3%) and males (6.8%) experienced sexualized violence. More than one fourth of women (26.9%) were affected by female genital mutilation/cutting. Discussion Future prevention planning should focus on sub-groups with particular knowledge gaps, recognizing their preferred methods of information dissemination. Prevention messages for male misSA should focus on their own risk perception and for female misSA on empowerment, e.g. to negotiate condom use.	[Koschollek, Carmen; Kuehne, Anna; Mullerschon, Johanna; Thorlie, Adama; Bremer, Viviane; Santos-Hovener, Claudia] Robert Koch Inst, Dept Infect Dis Epidemiol, Unit HIV AIDS STI & Bloodborne Infect, Berlin, Germany; [Koschollek, Carmen; Amoah, Stephen] Charite, Berlin, Germany; [Amoah, Stephen] Reg Verband Berlin Brandenburg eV, Afrikaherz Berlin, Verband Interkulturelle Arbeit, Berlin, Germany; [Batemona-Abeke, Helene] Pamoja Afrika eV, Cologne, Germany; [Dela Bursi, Taty] Hannoversche Aids Hilfe eV, Hannover, Germany; [Mayamba, Pierre] Aidshilfe Essen eV, Essen, Germany; [Tshibadi, Christina Mputu] Munchner Aids Hilfe eV, Munich, Germany; [Greiner, Virginia Wangare] Maisha eV, Frankfurt, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Koschollek, C (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Unit HIV AIDS STI & Bloodborne Infect, Berlin, Germany.; Koschollek, C (corresponding author), Charite, Berlin, Germany.	KoschollekC@rki.de	Kuehne, Anna/AAD-7816-2022	Kuehne, Anna/0000-0002-8578-0362	German Ministry of Health;  [ZMVI5-2514-AUK-001]	German Ministry of Health; 	The study was funded by the German Ministry of Health. The funding was granted to the Robert Koch Institute, Berlin, dated August 13, 2014 for the study "KABP (knowledge, attitudes, behaviour and practices)-study with optional HIV/STI-testing among migrants from sub-Saharan Africa living in Germany (MisSA-study)". The funds are budgeted in the federal budget 2014, chapter 1502, title 68618 - Research and projects for identification and elimination of AIDS and other sexual transmitted infections, project lead: Claudia Santos-Hovener, Grant number: ZMVI5-2514-AUK-001. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abu-Moghli F, 2010, SCAND J CARING SCI, V24, P655, DOI 10.1111/j.1471-6712.2009.00757.x; Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571; an der Heiden M, 2017, EPID B, V47, P531, DOI [10.17886/EpiBull-2017-066, DOI 10.17886/EPIBULL-2017-066]; Bastick M, 2001, SEXUAL VIOLANCE ARME; Bourne A, 2014, AFRICAN HLTH SEX SUR; Bundeszentrale fur Gesundheitliche Aufklarung, 2008, AIDS OFF BEW BUND DE; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Castelli F, 2017, CLIN MICROBIOL INFEC, V23, P283, DOI 10.1016/j.cmi.2017.03.012; Ciccio L., 2010, Giornale Italiano di Medicina Tropicale, V15, P29; Deutsche AIDS-Hilfe e.V, 2013, MUMM MIGR MIGR ALS M; Deutsche AIDS-Hilfe e.V, 2007, AUFS PRAV AFR COMM K; Deutsche AIDS-Hilfe e.V, 2019, YOUR HLTH YOUR FAITH; Dimbuene ZT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-348; Dodds C, 2008, BASS LINE 2007 SURVE; European Centre for Disease Prevention and Control, 2013, SEX TRANSM HIV MIGR; European Centre for Disease Prevention and Control, 2009, TECHN REP MAPP HIV S; European Centre for Disease Prevention and Control/ WHO Regional Office for Europe, 2017, HIV AIDS SURV EUR 20; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; Garnett GP, 2006, SEX TRANSM INFECT, V82, pI57, DOI 10.1136/sti.2005.016543; Glick P, 2009, AFR DEV REV, V21, P147, DOI 10.1111/j.1467-8268.2009.00206.x; Gold J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-792; Graser S, 2009, HIV AIDS PRAVENTION; Hasnain Memoona, 2005, Harm Reduct J, V2, P23, DOI 10.1186/1477-7517-2-23; Haversath J, 2017, DTSCH ARZTEBL INT, V114, P545, DOI 10.3238/arztebl.2017.0545; Hernando V, 2015, JAIDS-J ACQ IMM DEF, V70, P204, DOI 10.1097/QAI.0000000000000717; Hickson F, 2009, BASS LINE 2008 09 AS; International Collaboration for Participatory Health Research (ICPHR), 2013, 1 ICPHR; Jewkes R, 2015, LANCET, V385, P1580, DOI 10.1016/S0140-6736(14)61683-4; Juzang I, 2011, J TELEMED TELECARE, V17, P150, DOI 10.1258/jtt.2010.091107; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; Kamarulzaman A, 2013, LANCET, V381, P2058, DOI 10.1016/S0140-6736(13)61033-8; Koch-Goppert G, 2015, GESUNDHEITSWESEN, V77, pS33, DOI 10.1055/s-0032-1329997; Koschollek C., 2019, SURV METHODS INSIGHT, DOI [10.13094/SMIF-2019-00011, DOI 10.13094/SMIF-2019-00011]; Kuehne A, 2015, MIGRATION INFECT DIS, P1, DOI [10.1007/s00103-014-2102-5, DOI 10.1007/S00103-014-2102-5]; Kuehne A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194244; Kuehne A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2268-2; Leung MW, 2004, INT J EPIDEMIOL, V33, P499, DOI 10.1093/ije/dyh010; Levine D, 2008, AM J PUBLIC HEALTH, V98, P393, DOI 10.2105/AJPH.2007.110767; Loos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174677; Loos J, 2014, AIDS EDUC PREV, V26, P81, DOI 10.1521/aeap.2014.26.1.81; Maticka-Tyndale E, 2012, SEX HEALTH, V9, P59, DOI 10.1071/SH11033; Minkler M., 2003, COMMUNITY BASED PART; Mullerschon J, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0189-3; Oginni AB, 2017, AFR J REPROD HEALTH, V21, P26, DOI 10.29063/ajrh2017/v21i2.4; Oljira L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17349; Rehle T, 2004, B WORLD HEALTH ORGAN, V82, P121; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Robert Koch-Institut, 2017, EPIDEMIOLOGISCHES B, V39, P431; Robert Koch-Institut, 2012, EPIDEMIOL B, V3, P19, DOI DOI 10.17886/EPIBULL-2015-011.3; Sadler KE, 2007, SEX TRANSM INFECT, V83, P523, DOI 10.1136/sti.2007.027128; Santos-Hovener C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2098-2; Santos-Hovener C, 2015, PRAVENT GESUNDHEIT, V10, P68, DOI 10.1007/s11553-014-0466-x; Santos-Hovener C, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.6833; Sarkar NN, 2008, EUR J CONTRACEP REPR, V13, P114, DOI 10.1080/13625180802011302; Simonson T, 2015, ENQUETE ANSWER 2013; Sivakumaran S, 2007, EUR J INT LAW, V18, P253, DOI 10.1093/ejil/chm013; Statistisches Bundesamt (Destatis), 2016, AUSL KREIS STICHT GE; Statistisches Bundesamt (Destatis), 2013, AUSL KREIS STICHT GE; Statistisches Bundesamt (Destatis), 2016, BEV DEUTSCHL STICHT; Suess A, 2014, EUR J PUBLIC HEALTH, V24, P712, DOI 10.1093/eurpub/cku036; Swan H, 2012, J INTERPERS VIOLENCE, V27, P775, DOI 10.1177/0886260511423240; UNAIDS Joint United Nations Programme on HIV/AIDS, 2017, UNAIDS DAT 2017; United Nations Children's Fund, 2011, OPP CRIS PREV HIV EA; von Unger H, 2012, PAKOMI HDB HIV PREVE; von UngerH., 2012, INT J ACTION RES, V8, P266, DOI [10.1688/1861-9916_ijar_2012_03_unger, DOI 10.1688/1861-9916_IJAR_2012_03_UNGER, 10.1688/1861-9916_IJAR_2012_03_Unger]; Wagner AD, 2017, AIDS, V31, pS243, DOI 10.1097/QAD.0000000000001531; World Health Organization and UNAIDS Joint United Nations Programme on HIV/AIDS, 2000, GUID 2 GEN HIV SURV; Wright MT, 2007, INFOD GESUNDHEITSFOR, V3, P4; Zaba B, 2005, AIDS, V19, pS39, DOI 10.1097/01.aids.0000172876.74886.86; Zeitlmann N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2070-5; Zuma K, 2016, AJAR-AFR J AIDS RES, V15, P67, DOI 10.2989/16085906.2016.1153491	72	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227178	10.1371/journal.pone.0227178	http://dx.doi.org/10.1371/journal.pone.0227178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986162	Green Published, gold			2022-12-26	WOS:000534603400018
J	Barnett, BK; Chanton, JP; Ahrens, R; Thornton, L; Patterson, WF				Barnett, Beverly K.; Chanton, Jeffrey P.; Ahrens, Robert; Thornton, Laura; Patterson, William F., III			Life history of northern Gulf of Mexico Warsaw grouper Hyporthodus nigritus inferred from otolith radiocarbon analysis	PLOS ONE			English	Article							DEEP-WATER SNAPPERS; AGE VALIDATION; BOMB RADIOCARBON; RED SNAPPER; LUTJANUS-CAMPECHANUS; NATURAL MORTALITY; INTERNATIONAL WORKSHOP; FISHING MORTALITY; QUALITY-CONTROL; GROWTH	Warsaw grouper, Hyporthodus nigritus, is a western Atlantic Ocean species typically found at depths between 55 and 525 m. It is listed as a species of concern by the U.S. National Marine Fisheries Service and as near threatened by the International Union for the Conservation of Nature. However, little information exists on the species' life history in the northern Gulf of Mexico (nGOM) and its stock status in that region is currently unknown. Age of nGOM Warsaw grouper was investigated via opaque zone counts in otolith thin sections (max age = 61 y), and then the bomb C-14 chronometer was employed to validate the accuracy of age estimates. Otolith cores (n = 14) were analyzed with accelerator mass spectrometry and resulting Delta C-14 values overlain on a loess regression computed for a regional coral and known-age red snapper Delta C-14 time series. Residual analysis between predicted Delta C-14 values from the loess regression versus Warsaw grouper otolith core Delta C-14 values indicated no significant difference in the two data series. Therefore, the accuracy of otolith-based aging was validated, which enabled growth and longevity estimates to be made for nGOM Warsaw grouper. Dissolved inorganic carbon (DIC) Delta C-14 values collected from the nGOM support the inference that juvenile Warsaw grouper occur in shelf waters (< 200 m) since DIC Delta C-14 values in this depth range are enriched in C-14 and similar to the Delta C-14 values from otolith cores. A Bayesian model was fit to fishery-dependent age composition data and produced von Bertalanffy growth function parameters of L-infinity = 1,533 mm, k = 0.14 y(-1), and t(0) = 1.82 y. Fishing mortality also was estimated in the model, which resulted in a ratio of fishing to natural mortality of 5.1:1. Overall, study results indicate Warsaw grouper is a long-lived species that is estimated to have experienced significant overfishing in the nGOM, with the age of most landed fish being <10 y.	[Barnett, Beverly K.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Panama City Lab, Panama City, FL 32408 USA; [Barnett, Beverly K.; Ahrens, Robert; Patterson, William F., III] Univ Florida, Fisheries & Aquat Sci, Gainesville, FL 32611 USA; [Chanton, Jeffrey P.] Florida State Univ, Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Thornton, Laura] Riverside Technol Inc, Ft Collins, CO USA	National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of Florida; State University System of Florida; Florida State University	Barnett, BK (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Panama City Lab, Panama City, FL 32408 USA.; Barnett, BK (corresponding author), Univ Florida, Fisheries & Aquat Sci, Gainesville, FL 32611 USA.	beverly.barnett@noaa.gov		Ahrens, Robert/0000-0002-6791-9156				AguilarPerera A, 2018, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-2.RLTS, DOI 10.2305/IUCN.UK.2018-2.RLTS.T7860A46909320.EN]; Allman RJ, 2007, FISH RES, V88, P88, DOI 10.1016/j.fishres.2007.07.017; [Anonymous], 2021, LANG ENV STAT COMP; Bahnick Cook M, 2007, THESIS; Barnett BK, 2018, ICES J MAR SCI, V75, P1664, DOI 10.1093/icesjms/fsy043; Barnett BK, 2010, ENVIRON BIOL FISH, V89, P463, DOI 10.1007/s10641-010-9697-7; BEAMISH RJ, 1983, T AM FISH SOC, V112, P735, DOI 10.1577/1548-8659(1983)112<735:TFRFAV>2.0.CO;2; Beamish RJ, 1995, BEL BAR LIB, P545; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Broecker W. S., 1983, TRACERS SEA; BULLOCK LH, 1994, B MAR SCI, V55, P30; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Cook M, 2009, ENVIRON BIOL FISH, V86, P461, DOI 10.1007/s10641-009-9536-x; Cowan JH, 2011, REV FISH BIOL FISHER, V21, P187, DOI 10.1007/s11160-010-9165-7; Crabtree RE, 1998, FISH B-NOAA, V96, P735; Data Southeast Assessment and Review (SEDAR), 2011, STOCK ASSESSMENT REP; DRUFFEL EM, 1978, GEOPHYS RES LETT, V5, P913, DOI 10.1029/GL005i011p00913; Druffel EM, 1980, THESIS; DRUFFEL ERM, 1989, J GEOPHYS RES-OCEANS, V94, P3271, DOI 10.1029/JC094iC03p03271; Farmer NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078682; FRANCIS RC, 1974, J FISH RES BOARD CAN, V31, P1539, DOI 10.1139/f74-189; Heemstra PC., 1993, FAMILY SERRANIDAE SU, V16, P125; Hewitt DA, 2005, FISH B-NOAA, V103, P433; HOOD PB, 1992, B MAR SCI, V51, P337; Horn PL, 2010, J FISH BIOL, V77, P1552, DOI 10.1111/j.1095-8649.2010.02787.x; KALISH JM, 1993, EARTH PLANET SC LETT, V114, P549, DOI 10.1016/0012-821X(93)90082-K; Kalish JM, 1997, MAR BIOL, V128, P557, DOI 10.1007/s002270050121; Kalish JM, 1995, BEL BAR LIB, P723; Kalish JM, 1995, BEL BAR LIB, P637; Kandula S, 2015, MAR BIOL RES, V11, P18, DOI 10.1080/17451000.2014.949271; Kastelle CR, 2008, CAN J FISH AQUAT SCI, V65, P1101, DOI 10.1139/F08-038; Kimura DK, 2005, MAR FRESHWATER RES, V56, P783, DOI 10.1071/MF04141; Manooch C.S. III, 1987, P329; Manooch C.S. III, 1987, Northeast Gulf Science, V9, P65; Martin AD, 2011, J STAT SOFTW, V42, P1; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Moyer RP, 2011, CORAL REEFS, V30, P791, DOI 10.1007/s00338-011-0758-y; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:POMFSA>2.0.CO;2; National Marine Fisheries Service (NMFS), 2009, SPEC WARS GROUP; Newman SJ, 2003, FISH B-NOAA, V101, P116; Newman SJ, 2017, MAR POLICY, V79, P78, DOI 10.1016/j.marpol.2017.02.009; Newman SJ, 2016, REV FISH BIOL FISHER, V26, P537, DOI 10.1007/s11160-016-9442-1; Newman SJ, 2015, MAR POLICY, V60, P182, DOI 10.1016/j.marpol.2015.06.020; Patterson WF, 2001, FISH B-NOAA, V99, P617; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; RICKER WE, 1969, J FISH RES BOARD CAN, V26, P479, DOI 10.1139/f69-051; Shepard KE, 2010, B MAR SCI, V86, P515; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Taylor NG, 2005, CAN J FISH AQUAT SCI, V62, P215, DOI 10.1139/F04-189; Tracey DM, 2017, MAR FRESHWATER RES, V68, P352, DOI 10.1071/MF15267; Treble MA, 2008, CAN J FISH AQUAT SCI, V65, P1047, DOI 10.1139/F08-030; Wagner AR, 2009, THESIS; Wakefield CB, 2017, ICES J MAR SCI, V74, P193, DOI 10.1093/icesjms/fsw162; Wakefield CB, 2015, FISH RES, V172, P26, DOI 10.1016/j.fishres.2015.06.021; Wakefield CB, 2013, AQUAT BIOL, V18, P161, DOI 10.3354/ab00501; Williams AJ, 2012, REV FISH BIOL FISHER, V22, P527, DOI [10.1007/s11160-011-9234-6, DOI 10.1007/S11160-011-9234-6]; Williams AJ, 2015, ICES J MAR SCI, V72, P2098, DOI 10.1093/icesjms/fsv042; Zhou SJ, 2012, CAN J FISH AQUAT SCI, V69, P1292, DOI 10.1139/F2012-060	60	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228254	10.1371/journal.pone.0228254	http://dx.doi.org/10.1371/journal.pone.0228254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978207	Green Published, gold			2022-12-26	WOS:000534599100132
J	Tran, DT; Bhaskara, A; Kuberan, B; Might, M				Diem-Trang Tran; Bhaskara, Aditya; Kuberan, Balagurunathan; Might, Matthew			A graph-based algorithm for RNA-seq data normalization	PLOS ONE			English	Article							PACKAGE; NEED	The use of RNA-sequencing has garnered much attention in recent years for characterizing and understanding various biological systems. However, it remains a major challenge to gain insights from a large number of RNA-seq experiments collectively, due to the normalization problem. Normalization has been challenging due to an inherent circularity, requiring that RNA-seq data be normalized before any pattern of differential (or non-differential) expression can be ascertained; meanwhile, the prior knowledge of non-differential transcripts is crucial to the normalization process. Some methods have successfully overcome this problem by the assumption that most transcripts are not differentially expressed. However, when RNA-seq profiles become more abundant and heterogeneous, this assumption fails to hold, leading to erroneous normalization. We present a normalization procedure that does not rely on this assumption, nor prior knowledge about the reference transcripts. This algorithm is based on a graph constructed from intrinsic correlations among RNA-seq transcripts and seeks to identify a set of densely connected vertices as references. Application of this algorithm on our synthesized validation data showed that it could recover the reference transcripts with high precision, thus resulting in high-quality normalization. On a realistic data set from the ENCODE project, this algorithm gave good results and could finish in a reasonable time. These preliminary results imply that we may be able to break the long persisting circularity problem in RNA-seq normalization.	[Diem-Trang Tran; Bhaskara, Aditya] Univ Utah, Sch Comp, Salt Lake City, UT 84112 USA; [Kuberan, Balagurunathan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Kuberan, Balagurunathan] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Might, Matthew] Univ Alabama Birmingham, Hugh Kaul Precis Med Inst, Birmingham, AL USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham	Tran, DT (corresponding author), Univ Utah, Sch Comp, Salt Lake City, UT 84112 USA.	dtrang.tran@utah.edu		Tran, Diem-Trang/0000-0002-4219-2990	National Heart, Lung, and Blood Institute (NHLBI)-NIH [HL107152]; National Science Foundation [CAREER grant] [1350344]	National Heart, Lung, and Blood Institute (NHLBI)-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation [CAREER grant](National Science Foundation (NSF))	This material was based on research supported by the National Heart, Lung, and Blood Institute (NHLBI)-NIH sponsored Programs of Excellence in Glycosciences [grant number HL107152 to B.K.], and by the National Science Foundation [CAREER grant 1350344 to M.M.]. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Aoto Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188285; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chen CM, 2014, METHODS, V67, P354, DOI 10.1016/j.ymeth.2014.01.019; Chen CM, 2013, IET SYST BIOL, V7, P135, DOI 10.1049/iet-syb.2012.0060; Chen KF, 2016, MOL CELL BIOL, V36, P662, DOI 10.1128/MCB.00970-14; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eppstein D, 2010, ARXIV10065440CS; Evans C, 2018, BRIEF BIOINFORM, V19, P776, DOI 10.1093/bib/bbx008; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gilad Yoav, 2015, F1000Res, V4, P121, DOI 10.12688/f1000research.6536.1; Goh WWB, 2017, TRENDS BIOTECHNOL, V35, P498, DOI 10.1016/j.tibtech.2017.02.012; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hicks SC, 2018, BIOSTATISTICS, V19, P185, DOI 10.1093/biostatistics/kxx028; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kadota K, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-5; Kang GL, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1111-9; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lin YZ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2353-z; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mizrahi-Man O, 2015, DATA FILES CODES USE; Risso D, 2014, FRONT PROBAB STAT SC, P169, DOI 10.1007/978-3-319-07212-8_9; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou XB, 2013, RNA, V19, P733, DOI 10.1261/rna.037895.112; Zhu B, 2016, PEERJ, V4, DOI 10.7717/peerj.2791	42	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227760	10.1371/journal.pone.0227760	http://dx.doi.org/10.1371/journal.pone.0227760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978105	gold, Green Submitted, Green Published			2022-12-26	WOS:000534599100057
J	Engle, E; Gabrielian, A; Long, A; Hurt, DE; Rosenthal, A				Engle, Eric; Gabrielian, Andrei; Long, Alyssa; Hurt, Darrell E.; Rosenthal, Alex			Performance of Qure.ai automatic classifiers against a large annotated database of patients with diverse forms of tuberculosis	PLOS ONE			English	Article								Availability of trained radiologists for fast processing of CXRs in regions burdened with tuberculosis always has been a challenge, affecting both timely diagnosis and patient monitoring. The paucity of annotated images of lungs of TB patients hampers attempts to apply data-oriented algorithms for research and clinical practices. The TB Portals Program database (TBPP, https://TBPortals.niaid.nih.gov) is a global collaboration curating a large collection of the most dangerous, hard-to-cure drug-resistant tuberculosis (DR-TB) patient cases. TBPP, with 1,179 (83%) DR-TB patient cases, is a unique collection that is well positioned as a testing ground for deep learning classifiers. As of January 2019, the TBPP database contains 1,538 CXRs, of which 346 (22.5%) are annotated by a radiologist and 104 (6.7%) by a pulmonologist-leaving 1,088 (70.7%) CXRs without annotations. The Qure.ai qXR artificial intelligence automated CXR interpretation tool, was blind-tested on the 346 radiologist-annotated CXRs from the TBPP database. Qure.ai qXR CXR predictions for cavity, nodule, pleural effusion, hilar lymphadenopathy was successfully matching human expert annotations. In addition, we tested the 12 Qure.ai classifiers to find whether they correlate with treatment success (information provided by treating physicians). Ten descriptors were found as significant: abnormal CXR (p = 0.0005), pleural effusion (p = 0.048), nodule (p = 0.0004), hilar lymphadenopathy (p = 0.0038), cavity (p = 0.0002), opacity (p = 0.0006), atelectasis (p = 0.0074), consolidation (p = 0.0004), indicator of TB disease (p = <.0001), and fibrosis (p = <.0001). We conclude that applying fully automated Qure.ai CXR analysis tool is useful for fast, accurate, uniform, large-scale CXR annotation assistance, as it performed well even for DR-TB cases that were not used for initial training. Testing artificial intelligence algorithms (encapsulating both machine learning and deep learning classifiers) on diverse data collections, such as TBPP, is critically important toward progressing to clinically adopted automatic assistants for medical data analysis.	[Engle, Eric; Gabrielian, Andrei; Long, Alyssa; Hurt, Darrell E.; Rosenthal, Alex] NIAID, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Engle, E (corresponding author), NIAID, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Eric.Engle@niaid.nih.gov		Hurt, Darrell/0000-0002-9829-8567	Office of Information and Resource Management (US) [HHSN316201300006W/HHSN27200002]; Civilian Research and Development Foundation [BOB1-31120-MK-13]	Office of Information and Resource Management (US); Civilian Research and Development Foundation	This work was supported by the Office of Information and Resource Management (US) HHSN316201300006W/HHSN27200002 and Civilian Research and Development Foundation and BOB1-31120-MK-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ECONOMIST; [Anonymous], 2003, RADIOLOGIST SIGHTING; DeVries G, 2018, 49 UN WORLD C OCT HA; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Dunnmon JA, 2019, RADIOLOGY, V290, P537, DOI 10.1148/radiol.2018181422; ESR, 2016, INSIGHTS IMAGING, V7, P481, DOI 10.1007/s13244-016-0493-6; Folio Les R, 2012, CHEST IMAGING ALGORI; Henostroza G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1460-z; Heo SJ, 2019, INT J ENV RES PUBLIC; Hwang EJ, 2018, CLIN INFECT DIS; Irvin J., 2019, ARXIV190107031; Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099; Lakhani P, 2017, RADIOLOGY; Liauchuk V, 2017, P INT C COMP ASS RAD; Lovelace Jr. B., GES HLTH UNIT WINS F; Nielsen M., NEURAL NETWORKS DEEP; Pasa F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42557-4; Pedrazzoli D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01877-2016; Putha P., 2018, INSIGHTS IMAGING S1, V9, P1, DOI [10.1007/s13244-018-0603-8, DOI 10.1007/S13244-018-0603-8]; Putha Preetham, 2018, ARXIV180707455; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rajpurkar P., 2018, PLOS MED; Ravimohan S., 2018, EUROPEAN RESP REV; Ridley E, IS SEEING BELIEVING; Roman V, DEV MACHINE LEARNING; Rosenthal A, 2017, J CLIN MICROBIOL; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; Sivaramakrishnan R, 2018, INT SOC OPTICS PHOTO; Topalovic M, 2019, EUR RESP J; Wang X, 2017, IEEE CVPR; WHO, 2017, WHO TUBERCULOSIS COU; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; World Health Organization, 2016, CHEST RAD TUB DET SU; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, WHO GLOBAL TUBERCULO; Zaidi S., 2018, 49 UN WORLD C	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0224445	10.1371/journal.pone.0224445	http://dx.doi.org/10.1371/journal.pone.0224445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978149	Green Published, gold			2022-12-26	WOS:000534599100008
J	Hannaford, PC; Thornton, AJ; Murchie, P; Whitaker, KL; Adam, R; Elliott, AM				Hannaford, Philip C.; Thornton, Alison J.; Murchie, Peter; Whitaker, Katriina L.; Adam, Rosalind; Elliott, Alison M.			Patterns of symptoms possibly indicative of cancer and associated help-seeking behaviour in a large sample of United Kingdom residents-The USEFUL study	PLOS ONE			English	Article							PUBLIC AWARENESS; LUNG-CANCER; DIAGNOSIS; DELAY; KNOWLEDGE; PARTICIPATION; EXPERIENCE; BELIEFS; CARE	Background Cancer awareness campaigns aim to increase awareness of the potential seriousness of signs and symptoms of cancer, and encourage their timely presentation to healthcare services. Enhanced understanding of the prevalence of symptoms possibly indicative of cancer in different population subgroups, and associated general practitioner (GP) help-seeking behaviour, will help to target cancer awareness campaigns more effectively. Aim To determine: i) the prevalence of 21 symptoms possibly indicative of breast, colorectal, lung or upper gastrointestinal cancer in the United Kingdom (UK), including six 'red flag' symptoms; ii) whether the prevalence varies among population subgroups; iii) the proportion of symptoms self-reported as presented to GPs; iv) whether GP help-seeking behaviour varies within population subgroups. Methods Self-completed questionnaire about experience of, and response to, 25 symptoms (including 21 possibly indicative of the four cancers of interest) in the previous month and year; sent to 50,000 adults aged 50 years or more and registered with 21 general practices in Staffordshire, England or across Scotland. Results Completed questionnaires were received from 16,778 respondents (corrected response rate 34.2%). Almost half (45.8%) of respondents had experienced at least one symptom possibly indicative of cancer in the last month, and 58.5% in the last year. The prevalence of individual symptoms varied widely (e.g. in the last year between near zero% (vomiting up blood) and 15.0% (tired all the time). Red flag symptoms were uncommon. Female gender, inability to work because of illness, smoking, a history of a specified medical diagnosis, low social support and lower household income were consistently associated with experiencing at least one symptom possibly indicative of cancer in both the last month and year. The proportion of people who had contacted their GP about a symptom experienced in the last month varied between 8.1% (persistent cough) and 39.9% (unexplained weight loss); in the last year between 32.8% (hoarseness) and 85.4% (lump in breast). Nearly half of respondents experiencing at least one red flag symptom in the last year did not contact their GP about it. Females, those aged 80+ years, those unable to work because of illness, ex-smokers and those previously diagnosed with a specified condition were more likely to report a symptom possibly indicative of cancer to their GP; and those on high household income less likely. Conclusion Symptoms possibly indicative of cancer are common among adults aged 50+ years in the UK, although they are not evenly distributed. Help-seeking responses to different symptoms also vary. Our results suggest important opportunities to provide more nuanced messaging and targeting of symptom-based cancer awareness campaigns.	[Hannaford, Philip C.; Thornton, Alison J.; Murchie, Peter; Adam, Rosalind] Univ Aberdeen, Inst Appl Hlth Sci, Ctr Acad Primary Care, Aberdeen, Scotland; [Whitaker, Katriina L.] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England; [Elliott, Alison M.] Abertay Univ, Grad Sch, Dundee, Scotland	University of Aberdeen; University of Surrey; University of Abertay Dundee	Hannaford, PC (corresponding author), Univ Aberdeen, Inst Appl Hlth Sci, Ctr Acad Primary Care, Aberdeen, Scotland.	p.hannaford@abdn.ac.uk		Hannaford, Philip/0000-0002-2588-1006; Murchie, Peter/0000-0001-9968-5991; Adam, Rosalind/0000-0003-3082-6578	Cancer Research UK [C45810/A17927]	Cancer Research UK(Cancer Research UK)	The study was funded by a project grant to Dr Alison M Elliott, Professor Philip C Hannaford, Professor Peter Murchie and Dr Katriina L Whitaker (C45810/A17927) from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by a project grant (C45810/A17927) from Cancer Research UK. We thank the primary care research networks, practices and members of the public who enabled the study to happen.	Andersen RS, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-189; [Anonymous], IBM SPSS STAT WINDW; [Anonymous], 2015, ACHIEVING WORLD CLAS; [Anonymous], 2016, BEAT CANC ABM ACT; Arnold M, 2019, LANCET ONCOL, V20, P1493, DOI 10.1016/S1470-2045(19)30456-5; Baughan P, 2009, BRIT J CANCER, V101, pS87, DOI 10.1038/sj.bjc.6605397; Birring SS, 2005, THORAX, V60, P268, DOI 10.1136/thx.2004.032698; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Corner J, 2006, SOC SCI MED, V62, P1381, DOI 10.1016/j.socscimed.2005.08.012; Corner J, 2005, THORAX, V60, P314, DOI 10.1136/thx.2004.029264; Dingwall R., 2001, ASPECTS OF ILLNESS; Elliott AM, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-16; Elnegaard S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2034-5; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Grunfeld EA, 2002, BRIT J CANCER, V86, P1373, DOI 10.1038/sj.bjc.6600260; Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573; Jensen AR, 2002, ACTA ONCOL, V41, P147, DOI 10.1080/028418602753669517; Leventhal H., 1980, MED PSYCHOL, VII; Linsell L, 2008, BRIT J CANCER, V99, P1221, DOI 10.1038/sj.bjc.6604668; McAteer A, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548910; McCaffery K, 2003, PREV MED, V36, P525, DOI 10.1016/S0091-7435(03)00016-1; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; National Institute for Health and Clinical Excellence, 2005, REF SUSP CANC CLIN P; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; PESCOSOLIDO BA, 1992, AM J SOCIOL, V97, P1096, DOI 10.1086/229863; Power E, 2015, BRIT J CANCER, V112, pS22, DOI 10.1038/bjc.2015.32; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Scottish Executive, 2007, SCOTT REF GUID SUSP; Sheikh I, 1998, PATIENT EDUC COUNS, V35, P35, DOI 10.1016/S0738-3991(98)00081-0; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Smith SM, 2020, FAM PRACT, V37, P91, DOI 10.1093/fampra/cmz047; Stubbings S, 2009, BRIT J CANCER, V101, pS13, DOI 10.1038/sj.bjc.6605385; Svendsen RP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-686; Svendsen RP, 2010, SCAND J PRIM HEALTH, V28, P132, DOI 10.3109/02813432.2010.505412; Tentzeris V, 2011, INTERACT CARDIOV TH, V12, P32, DOI 10.1510/icvts.2010.247213; Tromp DM, 2004, EUR J CANCER, V40, P1509, DOI 10.1016/j.ejca.2004.03.009; Weinstein ND, 2005, TOB CONTROL, V14, P55, DOI 10.1136/tc.2004.008375; Whitaker KL, 2016, BRIT J CANCER, V114, P334, DOI 10.1038/bjc.2015.445; Whitaker KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114028	41	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228033	10.1371/journal.pone.0228033	http://dx.doi.org/10.1371/journal.pone.0228033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978177	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000534599100099
J	Lee, C; McCrory, R; Tully, MP; Carrington, A; Donnelly, R; Dornan, T				Lee, Ciara; McCrory, Richard; Tully, Mary P.; Carrington, Angela; Donnelly, Rosie; Dornan, Tim			Readiness to prescribe: Using educational design to untie the Gordian Knot	PLOS ONE			English	Article							REGISTRATION HOUSE OFFICER; MEDICAL-STUDENTS; JUNIOR DOCTORS; ACUTE-CARE; PREPAREDNESS; PERCEPTIONS; VIEWS	Introduction Junior residents routinely prescribe medications for hospitalised patients with only arms-length supervision, which compromises patient safety. A cardinal example is insulin prescribing, which is commonplace, routinely delegated to very junior doctors, difficult, potentially very dangerous, and getting no better. Our aim was to operationalise the concept of 'readiness to prescribe' by validating an instrument to quality-improve residents' workplace prescribing education. Methods Guided by theories of behaviour change, implementation, and error, and by empirical evidence, we developed and refined a mixed-methods 24-item evaluation instrument, and analysed numerical responses from Foundation Trainees (junior residents) in Northern Ireland, UK using principal axis factoring, and conducted a framework analysis of participants' free-text responses. Results 255 trainees participated, 54% women and 46% men, 80% of whom were in the second foundation year. The analysis converged on a 4-factor solution explaining 57% of the variance. Participants rated their capability to prescribe higher (79%) than their capability to learn to prescribe (69%; p<0.001) and rated the support to their prescribing education lower still (43%; p<0.001). The findings were similar in men and women, first and second year trainees, and in different hospitals. Free text responses described an unreflective type of learning from experience in which participants tended to 'get by' when faced with complex problems. Discussion Operationalising readiness to prescribe as a duality, comprising residents' capability and the fitness of their educational environments, demonstrated room for improvement in both. We offer the instrument to help clinical educators improve the two in tandem.	[Lee, Ciara; McCrory, Richard; Dornan, Tim] Queens Univ Belfast, Ctr Med Educ, Belfast, Antrim, North Ireland; [Tully, Mary P.] Univ Manchester, Div Pharm & Optometry, Manchester, Lancs, England; [Carrington, Angela] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Donnelly, Rosie] South Eastern Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Lee, Ciara] Univ Otago, Dept Gen Practice & Rural Hlth, Dunedin, New Zealand	Queens University Belfast; University of Manchester; University of Otago	Dornan, T (corresponding author), Queens Univ Belfast, Ctr Med Educ, Belfast, Antrim, North Ireland.	T.Dornan@qub.ac.uk	McCrory, Richard/AAY-8046-2021	McCrory, Richard/0000-0002-9451-1324; Lee, Ciara/0000-0002-2296-7867	Research and Development Division of the Public Health Agency of Health and Social Northern Ireland [RES/5199/15]	Research and Development Division of the Public Health Agency of Health and Social Northern Ireland	The Research and Development Division of the Public Health Agency of Health and Social Northern Ireland awarded TLD Grant no RES/5199/15 - URL: https://www.publichealth.hscni.net.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge EJ, 2007, MED TEACH, V29, P119, DOI 10.1080/01421590701310897; Billett, 2014, MIMETIC LEARNING WOR; Billett S., 2006, MIND CULT ACT, V13, P53, DOI [DOI 10.1207/S15327884MCA1301_5, 10.1207/s15327884mca1301_5]; Bleakley A, 2011, MED TEACH, V33, P459, DOI 10.3109/0142159X.2010.540267; Burford B, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-223; CLACK GB, 1994, MED EDUC, V28, P418, DOI 10.1111/j.1365-2923.1994.tb02553.x; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dolmans DHJM, 2012, MED TEACH, V34, P1, DOI 10.3109/0142159X.2011.595437; Downing SM, 2003, MED EDUC, V37, P830, DOI 10.1046/j.1365-2923.2003.01594.x; Eppich WJ, 2019, ACAD MED, V94, P1033, DOI 10.1097/ACM.0000000000002713; Eraut M., 2004, STUD CONTIN EDUC, V26, P247, DOI [10.1080/158037042000225245, DOI 10.1080/158037042000225245]; Han WH, 2006, SCOT MED J, V51, P27; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; Illing J, 2008, PREPARED ARE MED GRA; Illing JC, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-34; Jones A, 2002, MED EDUC, V36, P16, DOI 10.1046/j.1365-2923.2002.01105.x; Jones A, 2001, MED EDUC, V35, P578, DOI 10.1046/j.1365-2923.2001.00955.x; Kellett J, 2015, MED TEACH, V37, P949, DOI 10.3109/0142159X.2014.970619; Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1; Lave J., 1991, SITUATED LEARNING LE; Lewis PJ, 2014, BRIT J CLIN PHARMACO, V78, P310, DOI 10.1111/bcp.12332; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Monrouxe LV, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013656; NaDIA advisory group, 2018, NAT DIAB INP AUD ENG; Noble C, 2017, MED EDUC, V51, P442, DOI 10.1111/medu.13227; O'Donnell M., 1997, SCEPTICS MED DICT; Prince CJAH, 2006, PROBLEM BASED LEARNI; Prince KJAH, 2005, MED EDUC, V39, P704, DOI 10.1111/j.1365-2929.2005.02207.x; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; T Dornan, 2009, DEPTH INVESTIGATION; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tallentire VR, 2012, POSTGRAD MED J, V88, P365, DOI 10.1136/postgradmedj-2011-130232; Tallentire VR, 2011, MED EDUC, V45, P995, DOI 10.1111/j.1365-2923.2011.04024.x; Tobaiqy M, 2007, BRIT J CLIN PHARMACO, V64, P363, DOI 10.1111/j.1365-2125.2007.02925.x; Tully MP, 2009, DRUG SAFETY, V32, P819, DOI 10.2165/11316560-000000000-00000; Van Hamel C, 2015, MED TEACH, V37, P181, DOI 10.3109/0142159X.2014.947929	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227865	10.1371/journal.pone.0227865	http://dx.doi.org/10.1371/journal.pone.0227865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978199	Green Published, Green Submitted, gold			2022-12-26	WOS:000534599100069
J	Lee, JM; Park, YM; Yun, JS; Ahn, YB; Lee, KM; Kim, DB; Lee, JM; Han, K; Ko, SH				Lee, Jung-Min; Park, Yong-Moon; Yun, Jae-Seung; Ahn, Yu-Bae; Lee, Kang-Moon; Kim, Dae Bum; Lee, Ji Min; Han, Kyungdo; Ko, Seung-Hyun			The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; BODY-MASS INDEX; RISK-FACTOR; ATRIAL-FIBRILLATION; EPIDEMIOLOGY; OBESITY; PREVALENCE; MANAGEMENT; ADENOMA; NAFLD	We investigated the association between nonalcoholic fatty liver disease (NAFLD) and gastrointestinal tract cancer in the general population. Retrospective data on individuals aged.20 years who received healthcare checkups from January 1, 2009 to December 31, 2009 were analyzed using the National Health Insurance Database in Korea. NAFLD was defined based on the fatty liver index (FLI.60). The primary outcome was newly diagnosed esophageal, stomach, or colorectal cancer using ICD-10 codes during follow-up until 31 December 2017. Cox regression analysis was used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs). Among 8,120,674 subjects, 936,159 adults (11.5%) were identified as having NAFLD. Their mean age was 46.7 +/- 14.1 years, and 52.1% were male. During the follow-up period (7.2 years), 3,792 esophageal, 57,292 stomach and 68,769 colorectal cancer cases were identified. FLI.60 was significantly associated with the development of esophageal (HR 2.10, 95% CI 1.88-2.35), stomach (HR 1.18, 95% CI 1.14-1.22), and colon cancer (HR, 1.23, 95% CI 1.19-1.26) after multivariable adjustment. Compared to subjects without NAFLD, all-cause mortality in patients with esophageal (HR 1.46, 95% CI 1.28-1.67), stomach (HR 1.26, 95% CI 1.18-1.34), and colorectal cancer (HR 1.16, 95% CI 1.10-1.22) was significantly increased in subjects with NAFLD (FLI.60). NAFLD defined using FLI was a good predictive indicator for GI tract malignancy and all-cause mortality in the general population. Subjects with NAFLD are needed for active surveillance of esophageal, stomach, and colorectal cancers.	[Lee, Jung-Min; Yun, Jae-Seung; Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Park, Yong-Moon] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Lee, Kang-Moon; Kim, Dae Bum; Lee, Ji Min] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Catholic University of Korea; Catholic University of Korea	Ko, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.; Han, K (corresponding author), Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea.	hkd917@naver.com; kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Ko, Seung-Hyun/0000-0003-3703-1479	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C0275]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea, grant number HI18C0275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2017, ALIMENT PHARM THER, V45, P345, DOI 10.1111/apt.13866; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Cha JM, 2015, GASTROINTEST ENDOSC, V82, P1080, DOI 10.1016/j.gie.2015.04.018; Chen ZF, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1461-z; Choi YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201308; Choi YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177053; Corey KE, 2014, CLIN LIVER DIS, V18, P1, DOI 10.1016/j.cld.2013.09.019; Cornejo A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081303; Edens MA, 2009, OBES REV, V10, P412, DOI 10.1111/j.1467-789X.2009.00594.x; Goh LY, 2014, J DIGEST DIS, V15, P463, DOI 10.1111/1751-2980.12164; Ha TH, 2017, DIGEST DIS SCI, V62, P273, DOI 10.1007/s10620-016-4352-6; Huang H, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3523-y; Huang KW, 2013, COLORECTAL DIS, V15, P830, DOI 10.1111/codi.12172; Huang XL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001682; Hwang ST, 2010, J GASTROEN HEPATOL, V25, P562, DOI 10.1111/j.1440-1746.2009.06117.x; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Jung CH, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-016-0482-6; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Ko SH, 2018, DIABETES METAB J, V42, P93, DOI 10.4093/dmj.2018.42.2.93; Ko SH, 2018, J DIABETES COMPLICAT, V32, P157, DOI 10.1016/j.jdiacomp.2017.09.009; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Lahmann PH, 2012, CANCER-AM CANCER SOC, V118, P1901, DOI 10.1002/cncr.26455; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lee YH, 2019, DIABETES METAB J, V43, P31, DOI 10.4093/dmj.2019.0011; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Lee YH, 2016, HEPATOLOGY, V63, P776, DOI 10.1002/hep.28376; Lee YI, 2012, J GASTROEN HEPATOL, V27, P91, DOI 10.1111/j.1440-1746.2011.06816.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin XF, 2014, MOL BIOL REP, V41, P2989, DOI 10.1007/s11033-014-3157-y; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mikolasevic I, 2017, POSTGRAD MED J, V93, P153, DOI 10.1136/postgradmedj-2016-134383; Min YW, 2012, CLIN RES HEPATOL GAS, V36, P78, DOI 10.1016/j.clinre.2011.10.006; Mok Y, 2016, INT J CANCER, V138, P311, DOI 10.1002/ijc.29659; Muhidin SO, 2012, J OBES, V2012, DOI 10.1155/2012/637538; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Pandur S, 2007, FREE RADICAL RES, V41, P1376, DOI 10.1080/10715760701739488; Paschos P, 2009, HIPPOKRATIA, V13, P9; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sanna C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050717; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Seto WK, 2017, J GASTROENTEROL, V52, P164, DOI 10.1007/s00535-016-1264-3; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Stadlmayr A, 2011, J INTERN MED, V270, P41, DOI 10.1111/j.1365-2796.2011.02377.x; Sun LM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002080; Tilg H, 2011, GUT, V60, P745, DOI 10.1136/gut.2011.239392; Touzin Nadege T, 2011, Therap Adv Gastroenterol, V4, P169, DOI 10.1177/1756283X11402118; Uzel M, 2015, J BUON, V20, P662; Volkova E, 2011, BRIT J CANCER, V104, P51, DOI 10.1038/sj.bjc.6606005; Wong VWS, 2006, CLIN GASTROENTEROL H, V4, P1154, DOI 10.1016/j.cgh.2006.06.011; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Wongjarupong N, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0696-4; Yang YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182014; Ze EY, 2018, DIS COLON RECTUM, V61, P36, DOI 10.1097/DCR.0000000000000973	55	22	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226351	10.1371/journal.pone.0226351	http://dx.doi.org/10.1371/journal.pone.0226351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978054	Green Published, gold			2022-12-26	WOS:000534599100014
J	Shamsi, U; Khan, S; Azam, I; Khan, AH; Maqbool, A; Hanif, M; Gill, T; Iqbal, R; Callen, D				Shamsi, Uzma; Khan, Shaista; Azam, Iqbal; Khan, Aysha Habib; Maqbool, Amir; Hanif, Mohammad; Gill, Tiffany; Iqbal, Romaina; Callen, David			A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D DEFICIENCY; 25(OH)D LEVELS; CARDIOVASCULAR-DISEASE; D SUPPLEMENTATION; RISK; HEALTH; MORTALITY; CALCIUM; 1,25-DIHYDROXYVITAMIN-D	Background The prevalence of vitamin D inadequacy and breast cancer are both high among women living in Karachi, Pakistan. Methods A matched case control study was conducted in two hospitals of Karachi, Pakistan to evaluate the association of vitamin D (serum 25-hydroxyvitamin D) concentrations, vitamin D supplementation and sun exposure with breast cancer among Pakistani women. A total of 411 newly diagnosed histologically confirmed primary breast cancer cases were enrolled and 784 controls, free of breast and any other cancers, were matched by age (year of birth +/- 5 years), residence in the same geographic area and study site. Information was collected on sociodemographic history, history of vitamin D supplementation, past medical and obstetrical history, family history of breast cancer, sun exposure history, histopathology reports and anthropometric measurement and venous blood was collected to measure serum 25-hydroxyvitamin D (25(OH)D) concentration. Results Compared to patients with sufficient serum vitamin D (>30 ng/ml), women with serum vitamin D deficiency (<20ng/ml), had a higher risk of breast cancer (OR = 1.65, 95%CI: 1.10, 2.50). Women with history of vitamin D supplementation one year prior to enrollment, had significant protective effect against breast cancer (OR = 0.32, 95% CI: 0.24, 0.43). Conclusions and recommendation Serum vitamin D deficiency was associated with increased risk of breast cancer, while vitamin D supplementation was associated with decreased risk of breast cancer. In Pakistani women, where vitamin D deficiency is common, raising and maintaining serum vitamin D at population level is a safe and affordable strategy. It may play a role in reducing the incidence of both vitamin D deficiency and breast cancer, particularly among poor women where the breast cancer mortality is highest due to limited resources for early detection, diagnosis, and treatment. The effects of vitamin D with regard to breast cancer risk in Karachi Pakistan should be further evaluated.	[Shamsi, Uzma; Gill, Tiffany; Callen, David] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Khan, Shaista] Aga Khan Univ, Dept Surg, Karachi, Pakistan; [Azam, Iqbal; Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Khan, Aysha Habib] Aga Khan Univ, Dept Pathol & Lab Med, Karachi, Pakistan; [Maqbool, Amir; Hanif, Mohammad] Karachi Inst Radiat & Nucl Med Hosp KIRAN, Dept Oncol, Karachi, Pakistan	University of Adelaide; Aga Khan University; Aga Khan University; Aga Khan University	Shamsi, U (corresponding author), Univ Adelaide, Sch Med, Adelaide, SA, Australia.	uzma.shamsi@adelaide.edu.au	Gill, Tiffany/F-9042-2010	Gill, Tiffany/0000-0002-2822-2436; shamsi, uzma/0000-0002-5068-3773	Deans fund Aga Khan University Hospital [201 710550 20251 500 81001 0000]	Deans fund Aga Khan University Hospital	This work was supported by the Deans fund Aga Khan University Hospital grant (201 710550 20251 500 81001 0000). The funding bodies were not involved in the design of this study or in the collection of data, analysis, and interpretation of results.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Abbas S, 2013, NUTR CANCER, V65, P178, DOI 10.1080/01635581.2013.752018; Alzaheb RA, 2018, CLIN MED INSIGHTS-WO, V11, DOI 10.1177/1179562X18767884; Amir E, 2012, BREAST CANCER RES TR, V133, P1077, DOI 10.1007/s10549-012-2012-x; Anderson LN, 2010, AM J CLIN NUTR, V91, P1699, DOI 10.3945/ajcn.2009.28869; [Anonymous], WHY DOES VIT D MATT; Atoum MF, 2017, CHINESE MED J-PEKING, V130, P1074, DOI 10.4103/0366-6999.204933; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bauer SR, 2013, MEDICINE, V92, P123, DOI 10.1097/MD.0b013e3182943bc2; Begum N, 2018, JCPSP-J COLL PHYSICI, V28, P87, DOI 10.29271/jcpsp.2018.02.87; Belorusova AY, 2016, VITAM HORM, V100, P83, DOI 10.1016/bs.vh.2015.10.003; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Bhurgri Y, 2000, INT J CANCER, V85, P325, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;325::AID-IJC5&gt;3.0.CO;2-J; Bidgoli SA, 2014, ASIAN PAC J CANCER P, V15, P3391, DOI 10.7314/APJCP.2014.15.8.3391; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Budhathoki S, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k671; Buono G, 2017, CLIN BREAST CANCER, V17, P559, DOI 10.1016/j.clbc.2017.05.007; Cadeau C, 2015, AM J CLIN NUTR, V102, P966, DOI 10.3945/ajcn.114.104323; Chen PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049312; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Choi HS, 2011, J NUTR, V141, P1524, DOI 10.3945/jn.111.139121; Colston KW, 2006, ANTICANCER RES, V26, P2573; Crew KD, 2009, J CLIN ONCOL, V27, P2151, DOI 10.1200/JCO.2008.19.6162; Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138; de Souza JA, 2016, J CLIN ONCOL, V34, P6, DOI 10.1200/JCO.2015.62.2860; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Edvardsen K, 2011, INT J CANCER, V128, P1425, DOI 10.1002/ijc.25463; Eliassen AH, 2016, CANCER RES, V76, P5423, DOI 10.1158/0008-5472.CAN-16-0353; Eliassen AH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2880; Engel P, 2010, CANCER EPIDEM BIOMAR, V19, P2341, DOI 10.1158/1055-9965.EPI-10-0264; Feizabad E, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0323-6; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Freedman DM, 2008, CANCER EPIDEM BIOMAR, V17, P889, DOI 10.1158/1055-9965.EPI-07-2594; Fuhrman BJ, 2013, ANTICANCER RES, V33, P543; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gissel T, 2008, J STEROID BIOCHEM, V111, P195, DOI 10.1016/j.jsbmb.2008.06.002; GORHAM ED, 1990, INT J EPIDEMIOL, V19, P820, DOI 10.1093/ije/19.4.820; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P272, DOI 10.1002/cncr.10196; Grant WB, 2016, ANTICANCER RES, V36, P1357; Grant WB, 2015, ANTICANCER RES, V35, P1154; Hassan S, 2015, J PAK MED ASSOC, V65, P1247; Hatse S, 2012, CARCINOGENESIS, V33, P1319, DOI 10.1093/carcin/bgs187; Hiatt RA, 1998, J NATL CANCER I, V90, P461, DOI 10.1093/jnci/90.6.461; Ho A, 2014, MED SCI MONITOR, V20, P818, DOI 10.12659/MSM.890062; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2017, REV ENDOCR METAB DIS, V18, P153, DOI 10.1007/s11154-017-9424-1; Holick MF, 2008, MOL ASPECTS MED, V29, P361, DOI 10.1016/j.mam.2008.08.008; Hong ZQ, 2012, BREAST CANCER RES TR, V136, P309, DOI 10.1007/s10549-012-2172-8; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Hu KJ, 2018, INTEGR CANCER THER, V17, P217, DOI 10.1177/1534735417712007; Humayun Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-421; Imtiaz Saba, 2014, J Ayub Med Coll Abbottabad, V26, P186; Imtiaz Saba, 2012, Indian J Endocrinol Metab, V16, P409, DOI 10.4103/2230-8210.95684; Jamshidinaeini Y, 2016, J AM COLL NUTR, V35, P639, DOI 10.1080/07315724.2015.1127786; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karthikayan A, 2018, ARCH ENDOCRIN METAB, V62, P452, DOI 10.20945/2359-3997000000062; Khaw KT, 2014, AM J CLIN NUTR, V100, P1361, DOI 10.3945/ajcn.114.086413; Kim Y, 2014, BRIT J CANCER, V110, P2772, DOI 10.1038/bjc.2014.175; Kuhn T, 2013, INT J CANCER, V133, P1689, DOI 10.1002/ijc.28172; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lope V, 2018, J STEROID BIOCHEM, V182, P4, DOI 10.1016/j.jsbmb.2018.04.005; Lynch T, 2013, J PAIN SYMPTOM MANAG, V45, P1094, DOI 10.1016/j.jpainsymman.2012.05.011; McCullough ML, 2019, JNCI-J NATL CANCER I, V111, P158, DOI 10.1093/jnci/djy087; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; McDonnell SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199265; McKibben RA, 2016, J CLIN ENDOCR METAB, V101, P32, DOI 10.1210/jc.2015-1711; Misotti AM, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.365; Mousavi SE, 2019, ENVIRON INT, V122, P67, DOI 10.1016/j.envint.2018.11.052; Mullin GE, 2007, NUTR CLIN PRACT, V22, P305, DOI 10.1177/0115426507022003305; Neuhouser ML, 2012, AM J EPIDEMIOL, V175, P673, DOI 10.1093/aje/kwr350; O'Brien KM, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP943; Oh EY, 2010, BREAST CANCER RES TR, V123, P233, DOI 10.1007/s10549-009-0676-7; Ordonez-Mena JM, 2016, EUR J EPIDEMIOL, V31, P311, DOI 10.1007/s10654-015-0040-7; Paap E, 2008, EUR J CANCER, V44, P1485, DOI 10.1016/j.ejca.2008.04.008; Park S, 2015, BREAST CANCER RES TR, V152, P147, DOI 10.1007/s10549-015-3433-0; Peppone LJ, 2012, ANN SURG ONCOL, V19, P2590, DOI 10.1245/s10434-012-2297-3; Pilz S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00373; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Robien K, 2007, CANCER CAUSE CONTROL, V18, P775, DOI 10.1007/s10552-007-9020-x; Robsahm Trude E, 2013, Cancers (Basel), V5, P1439, DOI 10.3390/cancers5041439; Rollison DE, 2012, BREAST CANCER RES TR, V132, P683, DOI 10.1007/s10549-011-1885-4; Rossi M, 2009, ANN ONCOL, V20, P374, DOI 10.1093/annonc/mdn550; Salarabadi Asadollah, 2015, Asian Pac J Cancer Prev, V16, P7473; Scarmo S, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3390; Shaukat N, 2017, PAK J MED SCI, V33, P645, DOI 10.12669/pjms.333.11753; Sheikh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033452; Sheng L, 2018, J STEROID BIOCHEM, V178, P348, DOI 10.1016/j.jsbmb.2018.02.006; Shi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086467; Sofi NY, 2018, J STEROID BIOCHEM, V175, P55, DOI 10.1016/j.jsbmb.2016.09.020; Sofi NY, 2018, J STEROID BIOCHEM, V175, P200, DOI 10.1016/j.jsbmb.2017.11.003; Stearns V, 2013, MEDICINE, V92, P132, DOI 10.1097/MD.0b013e3182946335; Stoll F, 2013, GYNECOL OBSTET FERTI, V41, P242, DOI 10.1016/j.gyobfe.2013.02.002; Tavera-Mendoza LE, 2017, P NATL ACAD SCI USA, V114, pE2186, DOI 10.1073/pnas.1615015114; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Valrance ME, 2007, ENDOCRINOLOGY, V148, P4887, DOI 10.1210/en.2007-0267; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang D, 2013, TUMOR BIOL, V34, P3509, DOI 10.1007/s13277-013-0929-2; Wang J, 2014, CANCER CAUSE CONTROL, V25, P819, DOI 10.1007/s10552-014-0383-5; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; Yao S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017251; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	105	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0225402	10.1371/journal.pone.0225402	http://dx.doi.org/10.1371/journal.pone.0225402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KH6MU	31967989	gold, Green Published			2022-12-26	WOS:000510766400001
J	Jana, A; Das, A; Krett, NL; Guzman, G; Thomas, A; Mancinelli, G; Bauer, J; Ushio-Fukai, M; Fukai, T; Jung, B				Jana, Arundhati; Das, Archita; Krett, Nancy L.; Guzman, Grace; Thomas, Alexandra; Mancinelli, Georgina; Bauer, Jessica; Ushio-Fukai, Masuko; Fukai, Tohru; Jung, Barbara			Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NADPH OXIDASE; COPPER; PROLIFERATION; ANTIOXIDANT-1; CARCINOMA	Background Colorectal cancer remains a deadly cancer due to metastatic disease. To understand the molecular mechanisms of metastasis in colon cancer, we investigated whether the copper chaperone antioxidant-1 (Atox1) protein plays a role in this process. Recent findings indicate that Atox1 protein has transcription factor activities and plays a vital role in cell proliferation in cancer cells. However, the role of Atox1 in metastasis has not been examined. Methods Atox1 expression was determined by immunofluorescence in a tissue microarray generated from a spectrum of CRC patients. Subcellular fractionation of colon cancer cell lines SW480 and SW620 cells was used to examine the cellular location of Atox1 in the face of activin A, a cytokine that stimulates colon cancer metastasis. Atox1 expression was genetically manipulated and cellular migration measured through trans-well assay and proliferation measured by colony formation assays. Results Here we demonstrate that in patients with metastatic colon cancer, there is a significant increase in the expression of nuclear Atox1. Interestingly, the metastatic CRC cell line SW620 has increased nuclear localization of Atox1 compared to its related non-metastatic cell line SW480. Further, inhibition of endogenous Atox1 by siRNA in SW620 decreased colony formation and reactive oxygen species generation via decreased expression of Atox1 targets cyclin D1 and NADPH oxidase subunit p47 phox, respectively. Additionally, overexpression of nuclear-targeted but not copper binding domain-mutated Atox1 in SW480 cells increased colony formation and cell migration that was further augmented by activin A stimulation, a known enhancer of colon cancer metastasis. Conclusions Our findings suggest that nuclear Atox1 might be a new therapeutic target as well as a new biomarker for metastatic colorectal cancer.	[Jana, Arundhati; Krett, Nancy L.; Thomas, Alexandra; Mancinelli, Georgina; Bauer, Jessica; Jung, Barbara] Univ Illinois, Coll Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA; [Das, Archita; Fukai, Tohru] Augusta Univ, Vasc Biol Ctr, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA USA; [Guzman, Grace] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Ushio-Fukai, Masuko] Augusta Univ, Vasc Biol Ctr, Dept Med Cardiol, Med Coll Georgia, Augusta, GA USA; [Fukai, Tohru] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Bauer, Jessica; Jung, Barbara] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle	Jung, B (corresponding author), Univ Illinois, Coll Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA.; Jung, B (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	bhjung@uw.edu	Bauer, Jessica/AAT-7399-2020; Fukai, Tohru/AAA-4562-2022; DAS, ARCHITA/ABD-5437-2020	Bauer, Jessica/0000-0001-9022-9877; Fukai, Tohru/0000-0001-9864-571X; Mancinelli, Georgina/0000-0002-5216-7086	National Institutes of Health [RO1 CA141057]; U.S. Department of Veterans Affairs [2I01BX001232]; National Heart, Lung, and Blood Institute [R01HL116976, RO1HL133613]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported in this manuscript was supported by National Institutes of Health RO1 CA141057, U.S. Department of Veterans Affairs 2I01BX001232, National Heart, Lung, and Blood Institute RO1HL133613, National Heart, Lung, and Blood Institute R01HL133613, and National Heart, Lung, and Blood Institute R01HL116976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arsene D, 2006, EXPERT OPIN BIOL TH, V6, P1175, DOI 10.1517/14712598.6.11.1175; Bauer J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0456-4; Bauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039381; Blockhuys S, 2017, METALLOMICS, V9, P112, DOI 10.1039/c6mt00202a; Blockhuys S, 2017, BIOCHEM BIOPH RES CO, V483, P301, DOI 10.1016/j.bbrc.2016.12.148; Cai HW, 2013, ONCOL REP, V30, P269, DOI 10.3892/or.2013.2436; Chen GH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09510; Das A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33783; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Fukai T, 2018, AM J PHYSIOL-CELL PH, V315, pC186, DOI 10.1152/ajpcell.00132.2018; Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280; Guzman G, 2006, APPL IMMUNOHISTO M M, V14, P411, DOI 10.1097/01.pai.0000208906.66618.61; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Hatori Y, 2017, IUBMB LIFE, V69, P246, DOI 10.1002/iub.1620; Hatori Y, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5030025; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Jana A, 2017, ONCOTARGET, V8, P37377, DOI 10.18632/oncotarget.16343; Juhasz A, 2017, J BIOL CHEM, V292, P7866, DOI 10.1074/jbc.M116.768283; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Muller PAJ, 2009, INT J BIOCHEM CELL B, V41, P1233, DOI 10.1016/j.biocel.2008.08.001; Nikitovic D, 2013, FOOD CHEM TOXICOL, V61, P178, DOI 10.1016/j.fct.2013.06.013; Prat A, 2007, WORLD J GASTROENTERO, V13, P5857, DOI 10.3748/wjg.v13.i44.5857; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Rodriguez J, 2007, WORLD J GASTROENTERO, V13, P5867, DOI 10.3748/wjg.v13.i44.5867; Staudacher JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05907-8; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Wang J, 2015, NAT CHEM, V7, P968, DOI [10.1038/NCHEM.2381, 10.1038/nchem.2381]; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409	32	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2020	15	1							e0227916	10.1371/journal.pone.0227916	http://dx.doi.org/10.1371/journal.pone.0227916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QJ	31961892	gold, Green Published			2022-12-26	WOS:000534372000017
J	Stopschinski, BE; Thomas, TL; Nadji, S; Darvish, E; Fan, LF; Holmes, BB; Modi, AR; Finnell, JG; Kashmer, O; Estill-Terpack, S; Mirbaha, H; Luu, HS; Diamond, MI				Stopschinski, Barbara E.; Thomas, Talitha L.; Nadji, Sourena; Darvish, Eric; Fan, Linfeng; Holmes, Brandon B.; Modi, Anuja R.; Finnell, Jordan G.; Kashmer, Omar; Estill-Terpack, Sandi; Mirbaha, Hilda; Luu, Hung S.; Diamond, Marc, I			A synthetic heparinoid blocks Tau aggregate cell uptake and amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; heparan sulfate; Tau protein (Tau); tauopathy; heparin-binding protein; neurodegeneration; neurodegenerative disease; heparin; glycosaminoglycan	MOLECULAR-WEIGHT HEPARIN; PENTOSAN POLYSULFATE; SULFATE; PROTEIN; ANTITHROMBIN; BINDING; SCRAPIE; GLYCOSAMINOGLYCAN; PROPAGATION; ACTIVATION	Tau aggregation underlies neurodegeneration in Alzheimer's disease and related tauopathies. We and others have proposed that transcellular propagation of pathology is mediated by Tau prions, which are ordered protein assemblies that faithfully replicate in vivo and cause specific biological effects. The prion model predicts the release of aggregates from a first-order cell and subsequent uptake into a second-order cell. The assemblies then serve as templates for their own replication, a process termed ?seeding.? We have previously observed that heparan sulfate proteoglycans on the cell surface mediate the cellular uptake of Tau aggregates. This interaction is blocked by heparin, a sulfated glycosaminoglycan. Indeed, heparin-like molecules, or heparinoids, have previously been proposed as a treatment for PrP prion disorders. However, heparin is not ideal for managing chronic neurodegeneration, because it is difficult to synthesize in defined sizes, may have poor brain penetration because of its negative charge, and is a powerful anticoagulant. Therefore, we sought to generate an oligosaccharide that would bind Tau and block its cellular uptake and seeding, without exhibiting anticoagulation activity. We created a compound, SN7?13, from pentasaccharide units and tested it in a range of assays that measured direct binding of Tau to glycosaminoglycans and inhibition of Tau uptake and seeding in cells. SN7?13 does not inhibit coagulation, binds Tau with low nanomolar affinity, and inhibits cellular Tau aggregate propagation similarly to standard porcine heparin. This synthetic heparinoid could facilitate the development of agents to treat tauopathy.	[Stopschinski, Barbara E.; Thomas, Talitha L.; Holmes, Brandon B.; Modi, Anuja R.; Finnell, Jordan G.; Kashmer, Omar; Estill-Terpack, Sandi; Mirbaha, Hilda; Diamond, Marc, I] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Luu, Hung S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Childrens Hlth, Dallas, TX 75390 USA; [Stopschinski, Barbara E.] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany; [Nadji, Sourena; Darvish, Eric] PharmaRen Discovery LLC, Berkeley, MO 63134 USA; [Fan, Linfeng] Shanghai Acana Pharmtech Co Ltd, Berkeley, MO 63134 USA; [Holmes, Brandon B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; RWTH Aachen University; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, NL10 120,6000 Harry Hines Blvd, Dallas, TX 75390 USA.	marc.diamond@utsouthwestern.edu		Luu, Hung S/0000-0003-2001-4031; Holmes, Brandon/0000-0002-1153-840X	Texas Institute for Brain Injury and Repair; Peter O'Donnell Jr. Brain Institute; Haggerty Center for Research on Brain Injury and Repair in Stroke	Texas Institute for Brain Injury and Repair; Peter O'Donnell Jr. Brain Institute; Haggerty Center for Research on Brain Injury and Repair in Stroke	We thank Baovy Pham (Departments of Pathology, Children's Medical Center Dallas) for performing the coagulation assays for the spiking study; Denise Ramirez (Whole Brain Microscopy Facility at University of Texas Southwestern Medical Center) for assistance with slide scanning (the Whole Brain Microscopy Facility is supported by the Texas Institute for Brain Injury and Repair and the Peter O'Donnell Jr. Brain Institute); and Eric Plautz (Neuro-Models Facility Core at University of Texas Southwestern Medical Center) for help with animal surgery (the Neuro-Models Facility Core is supported by the Texas Institute for Brain Injury and Repair and the Haggerty Center for Research on Brain Injury and Repair in Stroke).	Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; DIRINGER H, 1991, J GEN VIROL, V72, P457, DOI 10.1099/0022-1317-72-2-457; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Dudas B, 2008, NEURODEGENER DIS, V5, P200, DOI 10.1159/000113702; Dudas B, 2002, NEUROBIOL AGING, V23, P97, DOI 10.1016/S0197-4580(01)00255-X; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fareed J, 2000, SEMIN THROMB HEMOST, V26, P5, DOI 10.1055/s-2000-9498; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; GlaxoSmithKline, 2009, AR PRESCR INF 2009; Hemker HC, 2016, J THROMB HAEMOST, V14, P2329, DOI 10.1111/jth.13555; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kaufman SK, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0442-8; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; Lapierre F, 1996, GLYCOBIOLOGY, V6, P355, DOI 10.1093/glycob/6.3.355; Leveugle B, 1998, J NEUROCHEM, V70, P736; LEVEUGLE B, 1994, NEUROREPORT, V5, P1389, DOI 10.1097/00001756-199406000-00025; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Ma Q, 2002, THROMB RES, V105, P447, DOI 10.1016/S0049-3848(02)00050-6; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Naini SMA, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00163; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Payal Parth Patel C. M., 2013, EFFICIENT SCALABLE P; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; PETITOU M, 1991, SEMIN THROMB HEMOST, V17, P143; Rainov NG, 2007, EXPERT OPIN BIOL TH, V7, P713, DOI 10.1517/14712598.7.5.713; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Schonberger O, 2003, BIOCHEM BIOPH RES CO, V312, P473, DOI 10.1016/j.bbrc.2003.10.150; Shafiei SS, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00083; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Sourena Nadji J. T. S., 2015, PROCESS PREPARING FO; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Stopschinski BE, 2017, LANCET NEUROL, V16, P323, DOI 10.1016/S1474-4422(17)30037-6; Teruya K, 2015, BIOCHEM BIOPH RES CO, V460, P989, DOI 10.1016/j.bbrc.2015.03.139; Timmer NM, 2010, NEUROBIOL DIS, V40, P340, DOI 10.1016/j.nbd.2010.06.008; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Walzer M, 2002, EUR J PHARMACOL, V445, P211, DOI 10.1016/S0014-2999(02)01759-4; Wang P, 2018, CHEM COMMUN, V54, P10120, DOI 10.1039/c8cc05072d; Weiss RJ, 2017, ORG BIOMOL CHEM, V15, P5656, DOI 10.1039/c7ob01058c; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024	54	14	14	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2974	2983		10.1074/jbc.RA119.010353	http://dx.doi.org/10.1074/jbc.RA119.010353			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974166	hybrid, Green Published			2022-12-26	WOS:000519597300009
J	Vanbeselaere, J; Jin, CS; Eckmair, B; Wilson, IBH; Paschinger, K				Vanbeselaere, Jorick; Jin, Chunsheng; Eckmair, Barbara; Wilson, Iain B. H.; Paschinger, Katharina			Sulfated and sialylated N-glycans in the echinoderm Holothuria atra reflect its marine habitat and phylogeny	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycomics; glycosylation; N-linked glycosylation; glycobiology; MS; evolution; echinoderm; lollyfish; N-glycans; N-glycome	STRUCTURAL-ANALYSIS; ACETYLNEURAMINIC ACID; LINKED GLYCANS; OLIGOSACCHARIDES; CONSTITUENTS; GANGLIOSIDE; DERIVATIVES; ANTICANCER; CANCER; CHAINS	Among the earliest deuterostomes, the echinoderms are an evolutionary important group of ancient marine animals. Within this phylum, the holothuroids (sea cucumbers) are known to produce a wide range of glycoconjugate biopolymers with apparent benefits to health; therefore, they are of economic and culinary interest throughout the world. Other than their highly modified glycosaminoglycans (e.g. fucosylated chondroitin sulfate and fucoidan), nothing is known about their protein-linked glycosylation. Here we used multistep N-glycan fractionation to efficiently separate anionic and neutral N-glycans before analyzing the N-glycans of the black sea cucumber (Holothuria atra) by MS in combination with enzymatic and chemical treatments. These analyses showed the presence of various fucosylated, phosphorylated, sialylated, and multiply sulfated moieties as modifications of oligomannosidic, hybrid, and complex-type N-glycans. The high degree of sulfation and fucosylation parallels the modifications observed previously on holothuroid glycosaminoglycans. Compatible with its phylogenetic position, H. atra not only expresses vertebrate motifs such as sulfo? and sialyl?Lewis A epitopes but displays a high degree of anionic substitution of its glycans, as observed in other marine invertebrates. Thus, as for other echinoderms, the phylum- and order-specific aspects of this species' N-glycosylation reveal both invertebrate- and vertebrate-like features.	[Vanbeselaere, Jorick; Eckmair, Barbara; Wilson, Iain B. H.; Paschinger, Katharina] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Jin, Chunsheng] Gothenburg Univ, Sahlgrenska Acad, Inst Biomed, S-40530 Gothenburg, Sweden	University of Natural Resources & Life Sciences, Vienna; University of Gothenburg	Wilson, IBH (corresponding author), Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Wilson, Iain/B-3326-2009	Wilson, Iain/0000-0001-8996-1518; Eckmair, Barbara/0000-0003-0818-867X; Paschinger, Katharina/0000-0002-3594-7136; Vanbeselaere, Jorick/0000-0002-1949-4835	Austrian Science Fund [P25058, P29466]; European Commission [PITN-GA-2013-608295]	Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Austrian Science Fund Grants P25058 (to K. P.) and P29466 (to I. B. H. W.) and European Commission Grant PITN-GA-2013-608295 (to J. V.).	Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Cabrera G, 2016, GLYCOBIOLOGY, V26, P230, DOI 10.1093/glycob/cwv096; Correia-Da-Silva M, 2017, SEMIN CANCER BIOL, V46, P55, DOI 10.1016/j.semcancer.2017.03.011; Dolmatov Igor Yu, 2014, ScientificWorldJournal, V2014, P527234, DOI 10.1155/2014/527234; Dragosits M, 2014, APPL MICROBIOL BIOT, V98, P3553, DOI 10.1007/s00253-013-5192-3; Eckmair B, 2020, J BIOL CHEM, V295, P3173, DOI 10.1074/jbc.RA119.011703; Eckmair B, 2016, MOL CELL PROTEOMICS, V15, P573, DOI 10.1074/mcp.M115.051573; Engle DD, 2019, SCIENCE, V364, P1156, DOI 10.1126/science.aaw3145; Gonzalez-Wanguemert M, 2014, OCEAN COAST MANAGE, V92, P87, DOI 10.1016/j.ocecoaman.2014.02.014; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Guerardel Y, 2012, GLYCOBIOLOGY, V22, P479, DOI 10.1093/glycob/cwr155; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harvey DJ, 2010, J MASS SPECTROM, V45, P528, DOI 10.1002/jms.1736; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Hykollari A, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.08.002; Hykollari A, 2017, METHODS MOL BIOL, V1503, P167, DOI 10.1007/978-1-4939-6493-2_13; Hykollari A, 2016, MOL CELL PROTEOMICS, V15, P73, DOI 10.1074/mcp.M115.055061; Hykollari A, 2013, J PROTEOME RES, V12, P1173, DOI 10.1021/pr300806b; Ishimizu T, 1999, EUR J BIOCHEM, V263, P624, DOI 10.1046/j.1432-1327.1999.00499.x; Janakiram NB, 2015, MAR DRUGS, V13, P2909, DOI 10.3390/md13052909; Jimenez-Castells C, 2016, GLYCOBIOLOGY, V26, P1297, DOI 10.1093/glycob/cww051; Karamanos NK, 1996, BIOCHIMIE, V78, P171, DOI 10.1016/0300-9084(96)89502-2; Kisa F, 2006, CHEM PHARM BULL, V54, P1293, DOI 10.1248/cpb.54.1293; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Mertsalov IB, 2016, BIOCHEM J, V473, P1905, DOI 10.1042/BCJ20160347; Miyagawa S, 2014, GLYCOBIOLOGY, V24, P125, DOI 10.1093/glycob/cwt088; Mou JJ, 2017, INT J BIOL MACROMOL, V98, P208, DOI 10.1016/j.ijbiomac.2017.01.123; MUCHMORE EA, 1989, J BIOL CHEM, V264, P20216; Murakami T, 2007, GLYCOCONJUGATE J, V24, P195, DOI 10.1007/s10719-006-9026-8; OKU H, 1991, J BIOCHEM-TOKYO, V110, P982, DOI 10.1093/oxfordjournals.jbchem.a123700; Paschinger K, 2020, GLYCOCONJUGATE J, V37, P27, DOI 10.1007/s10719-019-09874-2; Paschinger K, 2019, PARASITOLOGY, V146, P1733, DOI 10.1017/S0031182019000398; Paschinger K, 2016, GLYCOCONJUGATE J, V33, P273, DOI 10.1007/s10719-016-9650-x; SCHLENZKA W, 1993, BIOCHIM BIOPHYS ACTA, V1161, P131, DOI 10.1016/0167-4838(93)90206-7; Silchenko AS, 2016, NAT PROD COMMUN, V11, P741; Stanton R, 2017, BBA-GEN SUBJECTS, V1861, P699, DOI 10.1016/j.bbagen.2017.01.009; Taguchi T, 1996, EUR J BIOCHEM, V238, P357, DOI 10.1111/j.1432-1033.1996.0357z.x; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yamada K, 2002, CHEM PHARM BULL, V50, P1467, DOI 10.1248/cpb.50.1467; Yamada K, 2001, CHEM PHARM BULL, V49, P447, DOI 10.1248/cpb.49.447; Yamakawa N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06950-3; YAMASHITA K, 1977, J BIOL CHEM, V252, P5408; Yan S, 2015, ELECTROPHORESIS, V36, P1314, DOI 10.1002/elps.201400528; Yu SY, 2009, GLYCOBIOLOGY, V19, P1136, DOI 10.1093/glycob/cwp113	53	8	8	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3159	3172		10.1074/jbc.RA119.011701	http://dx.doi.org/10.1074/jbc.RA119.011701			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31969392	hybrid, Green Published			2022-12-26	WOS:000519597300022
J	Robinson, PJ; Kanemura, S; Cao, XF; Bulleid, NJ				Robinson, Philip J.; Kanemura, Shingo; Cao, Xiaofei; Bulleid, Neil J.			Protein secondary structure determines the temporal relationship between folding and disulfide formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; endoplasmic reticulum (ER); protein disulfide isomerase; protein secretion; protein folding; protein structure; folded precursor model; nascent chain; protein homeostasis; protein translocation; quasi-stochastic model	REDUCTASE; RIBOSOME; BONDS; ISOMERIZATION; GLYCOPROTEIN; CLEAVAGE; SYSTEM; FORM	How and when disulfide bonds form in proteins relative to the stage of their folding is a fundamental question in cell biology. Two models describe this relationship: the folded precursor model, in which a nascent structure forms before disulfides do, and the quasi-stochastic model, where disulfides form prior to folding. Here we investigated oxidative folding of three structurally diverse substrates, ?2-microglobulin, prolactin, and the disintegrin domain of ADAM metallopeptidase domain 10 (ADAM10), to understand how these mechanisms apply in a cellular context. We used a eukaryotic cell-free translation system in which we could identify disulfide isomers in stalled translation intermediates to characterize the timing of disulfide formation relative to translocation into the endoplasmic reticulum and the presence of non-native disulfides. Our results indicate that in a domain lacking secondary structure, disulfides form before conformational folding through a process prone to nonnative disulfide formation, whereas in proteins with defined secondary structure, native disulfide formation occurs after partial folding. These findings reveal that the nascent protein structure promotes correct disulfide formation during cotranslational folding.	[Robinson, Philip J.; Cao, Xiaofei; Bulleid, Neil J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Kanemura, Shingo] Kwansei Gakuin Univ, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan	University of Glasgow; Kwansei Gakuin University	Bulleid, NJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Kanemura, Shingo/0000-0002-7012-8179; Robinson, Philip/0000-0003-2576-5010; Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [103720]; Royal Society [IE140492]; Chinese Scholarship Council; BBSRC [BB/D00764X/1, BB/P017665/1, BB/M017656/1, BB/L00593X/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Chinese Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Wellcome Trust Grant 103720 and Royal Society Grant IE140492. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Chinese Scholarship Council award.	BAILEY CA, 1989, P NATL ACAD SCI USA, V86, P22, DOI 10.1073/pnas.86.1.22; BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Fass D, 2018, CHEM REV, V118, P293, DOI 10.1021/acs.chemrev.7b00123; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; KADERBHAI MA, 1985, EUR J BIOCHEM, V153, P167, DOI 10.1111/j.1432-1033.1985.tb09283.x; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lv JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20014-y; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Robinson PJ, 2017, J BIOL CHEM, V292, P6978, DOI 10.1074/jbc.M117.780742; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Singh RR, 2002, BBA-PROTEIN STRUCT M, V1597, P280, DOI 10.1016/S0167-4838(02)00301-1; Spurway TD, 2001, J BIOL CHEM, V276, P15975, DOI 10.1074/jbc.M010128200; Thommen M, 2017, CURR OPIN STRUC BIOL, V42, P83, DOI 10.1016/j.sbi.2016.11.020; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]	34	7	7	5	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2438	2448		10.1074/jbc.RA119.011983	http://dx.doi.org/10.1074/jbc.RA119.011983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953323	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000517330200024
J	O'Hara, CC; Scarborough, C; Hunter, KL; Afflerbach, JC; Bodtker, K; Frazier, M; Lowndes, JSS; Perry, RI; Halpern, BS				O'Hara, Casey C.; Scarborough, Courtney; Hunter, Karen L.; Afflerbach, Jamie C.; Bodtker, Karin; Frazier, Melanie; Lowndes, Julia S. Stewart; Perry, R. Ian; Halpern, Benjamin S.			Changes in ocean health in British Columbia from 2001 to 2016	PLOS ONE			English	Article							MARINE; CANADA; AQUACULTURE; COASTAL; INDEX	Effective management of marine systems requires quantitative tools that can assess the state of the marine social-ecological system and are responsive to management actions and pressures. We applied the Ocean Health Index (OHI) framework to retrospectively assess ocean health in British Columbia annually from 2001 to 2016 for eight goals that represent the values of British Columbia's coastal communities. We found overall ocean health improved over the study period, from 75 (out of 100) in 2001 to 83 in 2016, with scores for inhabited regions ranging from 68 (North Coast, 2002) to 87 (West Vancouver Island, 2011). Highest-scoring goals were Tourism & Recreation (average 94 over the period) and Habitat Services (100); lowest-scoring goals were Sense of Place (61) and Food Provision (64). Significant increases in scores over the time period occurred for Food Provision (+1.7 per year), Sense of Place (+1.4 per year), and Coastal Livelihoods (+0.6 per year), while Habitat Services (-0.01 per year) and Biodiversity (-0.09 per year) showed modest but statistically significant declines. From the results of our time-series analysis, we used the OHI framework to evaluate impacts of a range of management actions. Despite challenges in data availability, we found evidence for the ability of management to reduce pressures on several goals, suggesting the potential of OHI as a tool for assessing the effectiveness of marine resource management to improve ocean health. Our OHI assessment provides an important comprehensive evaluation of ocean health in British Columbia, and our open and transparent process highlights opportunities for improving accessibility of social and ecological data to inform future assessment and management of ocean health.	[O'Hara, Casey C.; Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Scarborough, Courtney; Afflerbach, Jamie C.; Frazier, Melanie; Lowndes, Julia S. Stewart; Halpern, Benjamin S.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Hunter, Karen L.; Perry, R. Ian] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Bodtker, Karin] MapSea Consulting, Vancouver, BC, Canada	University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Fisheries & Oceans Canada	O'Hara, CC (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	cohara@bren.ucsb.edu	Frazier, Melanie R/A-2367-2012; O'Hara, Casey/AGF-2964-2022	O'Hara, Casey/0000-0003-2968-7005; Hunter, Karen Louise/0000-0001-8323-4635; Scarborough, Courtney/0000-0001-7270-9228	Gordon and Betty Moore Foundation [3538.01]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The authors were supported in this project with funding from the Gordon and Betty Moore Foundation, grant #3538.01 awarded to BSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboriginal Affairs and Northern Development Canada, 2015, COMM WELL BEING IND; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.EN; B.C. Conservation Data Centre, 2016, SPEC COMM SUMM MAR S; Ban N, 2008, AQUAT CONSERV, V18, P55, DOI 10.1002/aqc.816; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Baum J.K., 2016, CANADAS MARINE FISHE; Bennett NJ, 2018, MAR POLICY, V87, P186, DOI 10.1016/j.marpol.2017.10.023; Bodtker K., 2017, OCEAN WATCH HOWE SOU; Bonzon K, 2010, CATCH SHARE DESIGN M; Bundy A, 2017, FISH FISH, V18, P412, DOI 10.1111/faf.12184; Burgass MJ, 2019, REG ENVIRON CHANGE, V19, P293, DOI 10.1007/s10113-018-1395-6; Burgess J, 2007, PUBLIC UNDERST SCI, V16, P299, DOI 10.1177/0963662507077510; Canadian Science Advisory Secretariat, 2009, DEV FRAM PRINC BIOG; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Costello MJ, 2014, BIOL CONSERV, V176, P289, DOI 10.1016/j.biocon.2014.04.023; Daigle RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178044; Elfes CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092589; Fisheries and Oceans Canada, 2017, CAN REACH IMP 5 MAR; Fisheries and Oceans Canada, 2006, 2006023 DFO CAN FISH; Folke C, 2010, ECOL SOC, V15; Gentry RR, 2017, ECOL EVOL, V7, P733, DOI 10.1002/ece3.2637; Groesbeck AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091235; Halpern B. S., 2019, SCI REP, V9, P1, DOI DOI 10.1038/S41598-018-37186-2; Halpern BS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178267; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2003, ECOLOGICAL APPL, V13; IUCN & UNEP-WCMC, 2018, WORLD DAT PROT AR WD; Klain SC, 2014, ECOL SOC, V19, DOI 10.5751/ES-07123-190452; Konecny C, 2018, MAR POLLUT BULL, V135, P411, DOI 10.1016/j.marpolbul.2018.07.036; Levings CD, 1994, HABITAT CHANGES GEOR; Lowndes JSS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0160; Lowndes JSS, 2015, PEERJ, V3, DOI 10.7717/peerj.1503; Marchak P., 1983, GREEN GOLD FOREST IN; Marine Planning Partnership Initiative, 2015, CENTR COAST MAR PLAN; Marine Planning Partnership Initiative, 2015, N VANC ISL MAR PLAN; Marine Planning Partnership Initiative, 2015, N COAST MAR PLAN; Marine Planning Partnership Initiative (M a PP), 2015, HAID GWAII MAR PLAN; McIntyre L, 2013, MAR DRUGS, V11, P4144, DOI 10.3390/md11114144; Murray CC, 2015, MAR POLICY, V58, P71, DOI 10.1016/j.marpol.2015.04.003; O'Hara C., 2019, OHIBC OCEAN HLTH IND; ODonnell K., 2013, UNDERSTANDING VALUES; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rust MB, 2014, FISHERIES, V39, P508, DOI 10.1080/03632415.2014.966818; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Selig ER, 2015, ECOSYST SERV, V16, P403, DOI 10.1016/j.ecoser.2014.11.007; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Treasury Board Secretariat of Canada, CAN 2018 2020 NAT AC; Turner KL, 2011, INT INDIG POLICY J, V2, DOI 10.18584/iipj.2011.2.2.3; Turner NJ, 2000, ECOL APPL, V10, P1275, DOI 10.1890/1051-0761(2000)010[1275:TEKAWO]2.0.CO;2; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; Wallace S, 2015, MAR POLICY, V60, P240, DOI 10.1016/j.marpol.2015.06.028; Weatherdon LV, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00096	55	4	4	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227502	10.1371/journal.pone.0227502	http://dx.doi.org/10.1371/journal.pone.0227502			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999705	Green Published, Green Submitted, gold			2022-12-26	WOS:000534612400019
J	Addepalli, A; Kalyani, S; Singh, M; Bandyopadhyay, D; Mohan, KN				Addepalli, Aditya; Kalyani, Sakhare; Singh, Minali; Bandyopadhyay, Debashree; Mohan, K. Naga			CalPen (Calculator of Penetrance), a web-based tool to estimate penetrance in complex genetic disorders	PLOS ONE			English	Article							COPY-NUMBER VARIATION; ASSOCIATION ANALYSIS; SCHIZOPHRENIA; POLYMORPHISMS; VARIANTS; RISK	Mutations conferring susceptibility to complex disorders also occur in healthy individuals but at significantly lower frequencies than in patients, indicating that these mutations are not completely penetrant. Therefore, it is important to estimate the penetrance or the likelihood of developing a disease in presence of a mutation. Recently, a method to calculate penetrance and its credible intervals was developed on the basis of the Bayesian method and since been used in literature. However, in the present form, this approach demands programming skills for its utility. Here, we developed 'CalPen', a web-based tool for straightforward calculation of penetrance and its credible intervals by entering the number of mutations identified in controls and patients, and the number of patients and controls studied. For validation purposes, we show that CalPen-derived penetrance values are in good agreement with the published values. As further demonstration of its utility, we used schizophrenia as an example of complex disorder and estimated penetrance values for 15 different copy number variants (CNVs) reported in 39,059 patients and 55,084 controls, and 145 SNPs reported in 45,405 patients and 122,761 controls. CNVs showed an average penetrance of 7% with 22q11.21 CNVs having highest value (similar to 20%) and 15q11.2 deletions with lowest value (similar to 1.4%). Most SNPs, on the other hand showed a penetrance of 0.7% with rs1801028 having the highest penetrance (1.6%). In summary, CalPen is an accurate and user-friendly web-based tool useful in human genetic research to ascertain the ability of the mutation/variant to cause a complex genetic disorder.	[Addepalli, Aditya; Kalyani, Sakhare; Singh, Minali; Bandyopadhyay, Debashree; Mohan, K. Naga] Dept Biol Sci, Hyderabad, India		Bandyopadhyay, D; Mohan, KN (corresponding author), Dept Biol Sci, Hyderabad, India.	banerjee.debi@hyderabad.bits-pilani.ac.in; kommumohan@gmail.com	Bandyopadhyay, Debashree/AAL-9043-2021; Mohan, Kommu Naga/HIK-1746-2022	Kommu, Naga Mohan/0000-0001-7408-5041	OPERA award from BITS Pilani; Centre for Human Diseases	OPERA award from BITS Pilani; Centre for Human Diseases	KNM lab is supported by OPERA award from BITS Pilani and by the Centre for Human Diseases.	Buttenschon HN, 2013, J AFFECT DISORDERS, V148, P291, DOI 10.1016/j.jad.2012.12.011; Chen J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.96; Chowdari KV, 2007, GENES BRAIN BEHAV, V6, P229, DOI 10.1111/j.1601-183X.2006.00251.X; Fan H, 2010, NEUROSCI LETT, V477, P53, DOI 10.1016/j.neulet.2009.11.017; Faul T, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-35; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Hodge SE, 2016, HUM HERED, V81, P173, DOI 10.1159/000454804; Hori H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00634; Khan RAW, 2016, AM J MED GENET B, V171, P237, DOI 10.1002/ajmg.b.32397; Kim HJ, 2008, NEUROSCI LETT, V430, P60, DOI 10.1016/j.neulet.2007.10.010; Kushima I, 2018, CELL REP, V24, P2838, DOI 10.1016/j.celrep.2018.08.022; Li ZQ, 2016, BIOL PSYCHIAT, V80, P331, DOI 10.1016/j.biopsych.2015.11.012; Lobo I, 2008, NATURE ED, V1, P64; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Nunokawa A, 2007, NEUROSCI RES, V58, P291, DOI 10.1016/j.neures.2007.03.015; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Richards Misty, 2006, Behav Brain Funct, V2, P39, DOI 10.1186/1744-9081-2-39; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Schmuller J., 2016, STAT ANAL EXCEL DUMM; Shin HD, 2007, SCHIZOPHR RES, V96, P119, DOI 10.1016/j.schres.2007.05.004; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P1; Sun SL, 2008, NEUROSCI LETT, V440, P35, DOI 10.1016/j.neulet.2008.05.029; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Vassos E, 2010, HUM MOL GENET, V19, P3477, DOI 10.1093/hmg/ddq259; Wang T, 2012, WORLD J BIOL PSYCHIA, V13, P599, DOI 10.3109/15622975.2011.650203; Warland A, 2020, MOL PSYCHIATR, V25, P854, DOI 10.1038/s41380-019-0355-y; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang FQ, 2011, AM J MED GENET B, V156B, P613, DOI 10.1002/ajmg.b.31203; Zhang J, 2010, J PSYCHIATR RES, V44, P409, DOI 10.1016/j.jpsychires.2009.10.009	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228156	10.1371/journal.pone.0228156	http://dx.doi.org/10.1371/journal.pone.0228156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995602	Green Submitted, gold, Green Published			2022-12-26	WOS:000534609400049
J	Albus, KH; Thompson, R; Mitchell, F; Kennedy, J; Ponette-Gonzalez, AG				Albus, Kelly Hibbeler; Thompson, Ruthanne; Mitchell, Forrest; Kennedy, James; Ponette-Gonzalez, Alexandra G.			Accuracy of long-term volunteer water monitoring data: A multiscale analysis from a statewide citizen science program	PLOS ONE			English	Article							ECOLOGICAL RESEARCH; DATA QUALITY; TOOL; FLORIDA	An increasing number of citizen science water monitoring programs is continuously collecting water quality data on streams throughout the United States. Operating under quality assurance protocols, this type of monitoring data can be extremely valuable for scientists and professional agencies, but in some cases has been of limited use due to concerns about the accuracy of data collected by volunteers. Although a growing body of studies attempts to address accuracy concerns by comparing volunteer data to professional data, rarely has this been conducted with large-scale datasets generated by citizen scientists. This study assesses the relative accuracy of volunteer water quality data collected by the Texas Stream Team (TST) citizen science program from 1992-2016 across the State of Texas by comparing it to professional data from corresponding stations during the same time period. Use of existing data meant that sampling times and protocols were not controlled for, thus professional and volunteer comparisons were refined to samples collected at stations within 60 meters of one another and during the same year. Results from the statewide TST dataset include 82 separate station/year ANOVAs and demonstrate that large-scale, existing volunteer and professional data with unpaired samples can show agreement of similar to 80% for all analyzed parameters (DO = 77%, pH = 79%, conductivity = 85%). In addition, to assess whether limiting variation within the source datasets increased the level of agreement between volunteers and professionals, data were analyzed at a local scale. Data from a single partner city, with increased controls on sampling times and locations and correction of a systematic bias in DO, confirmed this by showing an even greater agreement of 91% overall from 2009-2017 (DO = 91%, pH = 83%, conductivity = 100%). An experimental sampling dataset was analyzed and yielded similar results, indicating that existing datasets can be as accurate as experimental datasets designed with researcher supervision. Our findings underscore the reliability of large-scale citizen science monitoring datasets already in existence, and their potential value to scientific research and water management programs.	[Albus, Kelly Hibbeler; Thompson, Ruthanne; Kennedy, James] Univ North Texas, Dept Biol, Denton, TX 76203 USA; [Mitchell, Forrest] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Ponette-Gonzalez, Alexandra G.] Univ North Texas, Dept Geog & Environm, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton; Texas A&M University System; Texas A&M University College Station; University of North Texas System; University of North Texas Denton	Thompson, R (corresponding author), Univ North Texas, Dept Biol, Denton, TX 76203 USA.	ruthanne.thompson@unt.edu		Thompson, Ruthanne/0000-0002-3314-3273				Aceves-Bueno E., 2017, B ECOL SOC AM, V98, P278, DOI DOI 10.1002/BES2.1336; Albus Thompson, CITIZEN SCI THEORY P; [Anonymous], 2019, TEXAS STREAM TEAM MA; [Anonymous], 2014, P 7 AUSTR STREM MAN; [Anonymous], 2019, TEXAS STREAM TEAM CI; Bonney R, 2009, PUBLIC PARTICIPATION; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Canfield DE, 2002, LAKE RESERV MANAGE, V18, P1; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Cox TE, 2012, ECOL APPL, V22, P1201, DOI 10.1890/11-1614.1; Deutsch WG, 2015, ECOL SOC, V20, DOI 10.5751/ES-07578-200314; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hoyer MV, 2012, LAKE RESERV MANAGE, V28, P277, DOI 10.1080/07438141.2012.736016; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Lewandowski E, 2015, CONSERV BIOL, V29, P713, DOI 10.1111/cobi.12481; Loperfido JV, 2010, ENVIRON SCI TECHNOL, V44, P7193, DOI 10.1021/es100164c; Nerbonne JF, 2003, J N AM BENTHOL SOC, V22, P152, DOI 10.2307/1467984; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nicholson E, 2002, WATER SCI TECHNOL, V45, P193, DOI 10.2166/wst.2002.0395; PENROSE D, 1995, J N AM BENTHOL SOC, V14, P203, DOI 10.2307/1467735; Pocock MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172579; Safford H, 2018, ENVIRON ENG SCI, V35, P362, DOI 10.1089/ees.2017.0218; Shirk J.L., 2012, PUBLIC PARTICIPATION; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Specht H., 2018, BIASED ASSUMPTIONS O, V99, P251, DOI [DOI 10.1002/BES2.1388, 10.1002/bes2.1388]; Stepenuck KF, 2013, THESIS; Stepenuck KF, 2018, ENVIRON MANAGE, V61, P46, DOI 10.1007/s00267-017-0956-7; Stepenuck KF, 2011, ENVIRON MONIT ASSESS, V174, P625, DOI 10.1007/s10661-010-1483-7; Storey RG, 2016, ECOL SOC, V21, DOI 10.5751/ES-08934-210432; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Tredick CA, 2017, BIOSCIENCE, V67, P834, DOI 10.1093/biosci/bix090	34	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227540	10.1371/journal.pone.0227540	http://dx.doi.org/10.1371/journal.pone.0227540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995580	Green Published, gold			2022-12-26	WOS:000534609400023
J	Bordy, EM; Rampersadh, A; Abrahams, M; Lockley, MG; Head, HV				Bordy, Emese M.; Rampersadh, Akhil; Abrahams, Miengah; Lockley, Martin G.; Head, Howard, V			Tracking the Pliensbachian-Toarcian Karoo firewalkers: Trackways of quadruped and biped dinosaurs and mammaliaforms	PLOS ONE			English	Article							TRIASSIC MASS EXTINCTION; FLOOD-BASALT ERUPTIONS; ELLIOT FORMATION; MORPHOLOGICAL VARIATION; GEOCHRONOLOGY LINKS; BOTUCATU FORMATION; SOUTH-AFRICA; SUPERGROUP; FOOTPRINTS; BASIN	The Karoo igneous rocks represent one of the largest continental flood basalt events (by volume) on Earth, and are not normally associated with fossils remains. However, these Pliensbachian-Toarcian lava flows contain sandstone interbeds that are particularly common in the lower part of the volcanic succession and are occasionally fossiliferous. On a sandstone interbed in the northern main Karoo Basin, we discovered twenty-five tridactyl and tetradactyl vertebrate tracks comprising five trackways. The tracks are preserved among desiccation cracks and low-amplitude, asymmetrical ripple marks, implying deposition in low energy, shallow, ephemeral water currents. Based on footprint lengths of 2-14 cm and trackway patterns, the trackmakers were both bipedal and quadrupedal animals of assorted sizes with walking and running gaits. We describe the larger tridactyl tracks as "grallatorid" and attribute them to bipedal theropod dinosaurs, like Coelophysis, a genus common in the Early Jurassic of southern Africa. The smallest tracks are tentatively interpreted as Brasilichnium-like tracks, which are linked to synapsid trackmakers, a common attribution of similar tracks from the Lower to Middle Jurassic record of southern and southwestern Gondwana. The trackway of an intermediate-sized quadruped reveals strong similarities in morphometric parameters to a post-Karoo Zimbabwean trackway from Chewore. These trackways are classified here as a new ichnogenus attributable to small ornithischian dinosaurs as yet without a body fossil record in southern Africa. These tracks not only suggest that dinosaurs and therapsids survived the onset of the Drakensberg volcanism, but also that theropods, ornithischians and synapsids were among the last vertebrates that inhabited the main Karoo Basin some 183 Ma ago. Although these vertebrates survived the first Karoo volcanic eruptions, their rapidly dwindling habitat was turned into a land of fire as it was covered by the outpouring lavas during one of the most dramatic geological episodes in southern Africa.	[Bordy, Emese M.; Rampersadh, Akhil; Abrahams, Miengah; Head, Howard, V] Univ Cape Town, Dept Geol Sci, Cape Town, South Africa; [Lockley, Martin G.] Univ Colorado, Dinosaur Tracks Museum, Denver, CO 80202 USA	University of Cape Town; University of Colorado System; University of Colorado Denver	Bordy, EM (corresponding author), Univ Cape Town, Dept Geol Sci, Cape Town, South Africa.	emese.bordy@uct.ac.za	Bordy, Emese Maria M/J-1361-2016	Bordy, Emese Maria M/0000-0003-4699-0823; Head, Howard/0000-0002-4808-7104	National Research Foundation-DST Centre of Excellence in Palaeosciences [COE PAL grant] [COE2019-OP04]; National Research Foundation of South Africa [NRF CPRR grant] [113394]; National Research Foundation of South Africa [NRF AOP grant] [98825]; COE PAL bursary	National Research Foundation-DST Centre of Excellence in Palaeosciences [COE PAL grant]; National Research Foundation of South Africa [NRF CPRR grant]; National Research Foundation of South Africa [NRF AOP grant]; COE PAL bursary	This work was supported by grants to EMB from the National Research Foundation-DST Centre of Excellence in Palaeosciences [COE PAL grant number COE2019-OP04], National Research Foundation of South Africa [NRF CPRR grant number 113394; NRF AOP grant number 98825], as well as COE PAL bursaries to AR and MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams M, 2017, HIST BIOL, V29, P958, DOI 10.1080/08912963.2016.1267164; Ait-Kaci Ahmed A, 2001, ANN ZIMBABWE GEOL SU; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; [Anonymous], NEW MEXICO MUSEUM NA; [Anonymous], 2009, MODERN ANCIENT FLUVI, DOI DOI 10.1002/9781444303773.CH7; Avanzini Marco, 1998, Ichnos, V6, P129; Baird D., 1980, P219; Banham SG, 2014, SEDIMENTOLOGY, V61, P570, DOI 10.1111/sed.12064; Beukes N, 1970, 2 GONDW S GONDW STRA; Blackburn TJ, 2013, SCIENCE, V340, P941, DOI 10.1126/science.1234204; Bordy EM, 2018, S AFR J GEOL, V121, P119, DOI 10.25131/sajg.121.0009; Bordy EM, 2015, S AFR J GEOL, V118, P311, DOI 10.2113/gssajg.118.3.311; Bordy EM, 2004, S AFR J GEOL, V107, P397, DOI 10.2113/107.3.397; Bordy EM, 2004, J AFR EARTH SCI, V38, P383, DOI 10.1016/j.jafrearsci.2004.02.004; Bordy EM, 2001, J AFR EARTH SCI, V33, P605, DOI 10.1016/S0899-5362(01)00090-2; Bordy EM, 2010, J AFR EARTH SCI, V58, P127, DOI 10.1016/j.jafrearsci.2010.02.006; Bordy EM, 2008, PALAEONTOL ELECTRON, V11; Buck PV, 2017, PALAEOGEOGR PALAEOCL, V466, P21, DOI 10.1016/j.palaeo.2016.11.009; Burgess SD, 2015, EARTH PLANET SC LETT, V415, P90, DOI 10.1016/j.epsl.2015.01.037; Casamiquela RM., 1964, ESTUDIOS ICHNOLOGICO; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054177; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; Dalman SG, 2013, B PEABODY MUS NAT HI, V54, P67, DOI 10.3374/014.054.0104; de Valais S, 2011, AMEGHINIANA, V48, P28, DOI 10.5710/AMGH.v48i1(244); Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; Dera G, 2011, GLOBAL PLANET CHANGE, V78, P92, DOI 10.1016/j.gloplacha.2011.05.009; Dera G, 2010, J GEOL SOC LONDON, V167, P21, DOI 10.1144/0016-76492009-068; Duncan RA, 1997, J GEOPHYS RES-SOL EA, V102, P18127, DOI 10.1029/97JB00972; Ellenberger, 1972, PALAEOVERTEBRATA MEM; Ellenberger F, 1964, 22 INT GEOL C; Ellenberger P., 1970, P PAPERS 2 GONDWANAL, P343; Ellenberger P, 1974, CONTRIBUTION CLASSIF; Ellenberger P., 1975, LEXPLOSION DEMOGRAPH; Engelmann G., 2017, EUR C COMP EL APPL E, P1; Eriksson P.G., 1986, T GEOL SOC S AFR, V89, P389; Falkingham P. L., 2011, PALAEONTOL ELECTRON, V15, P1; Falkingham PL, 2018, PALAEONTOLOGY, V61, P469, DOI 10.1111/pala.12373; Francischini H, 2018, PEERJ, V6, DOI 10.7717/peerj.4764; Getty Patrick Ryan, 2005, Ichnos, V12, P163, DOI 10.1080/10420940591008999; Gierlinski G, 2002, ACTA PALAEONTOLOGICA, V47; Gierlinski G, 2005, TRIASS JUR TERR TRAN; Gierlinski Gerard, 2004, Ichnos, V11, P195, DOI 10.1080/10420940490444861; Guex J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23168; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hanson EK, 2009, S AFR J GEOL, V112, P125, DOI 10.2113/gssajg.112.2.125; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hitchcock E., 1848, MEMOIRS AM ACAD ARTS, V3, P129, DOI DOI 10.2307/25058147; HUNT A. P., 2006, NEW MEXICO MUSEUM NA, V37, P164; Jay AE, 2018, B VOLCANOL, V80, DOI 10.1007/s00445-017-1189-6; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Jenkyns H., 1988, AM J SCI, V288; Jerram DA, 2002, J VOLCANOL GEOTH RES, V114, P231, DOI 10.1016/S0377-0273(01)00279-7; Johnson M.R., 2008, SIMPLIFIED GEOLOGICA; Kim JY, 2016, CRETACEOUS RES, V61, P5, DOI 10.1016/j.cretres.2015.12.023; Kingsley CS, 1964, GEOLOGIE SERIE STORM; Knoll F, 2005, B SOC GEOL FR, V176, P81, DOI 10.2113/176.1.81; Kubo T, 2009, PALAEONTOLOGY, V52, P1029, DOI 10.1111/j.1475-4983.2009.00897.x; Kummell SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113911; Lallensack JN, 2016, PEERJ, V4, DOI 10.7717/peerj.2059; Leonardi G., 1987, GLOSSARY MANUAL TETR; Li DQ, 2019, J PALAEOGEOG-ENGLISH, V8, DOI 10.1186/s42501-019-0028-4; Lingham-Soliar Theagarten, 2000, Ichnos, V7, P135; Lock B.E., 1974, S AFR J GEOL, V77, P117; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley Martin G., 2004, Ichnos, V11, P89, DOI 10.1080/10420940490442331; Lockley MG, 2015, PALAEOGEOGR PALAEOCL, V426, P85, DOI 10.1016/j.palaeo.2015.03.008; Lockley MG, 2009, GEOL Q, V53, P415; Lockley MG., 2006, TRIASSIC JURASSIC TE, V37, P176; Lockley MG, 1996, CONT JUR S VOL MUS N; Lucas Spencer G., 2007, Ichnos, V14, P5, DOI 10.1080/10420940601006792; Lull R. S., 1904, Memoirs of the Boston Society, Vv, P461; MacEachern J, 2010, FACIES MODELS; MacEachern JA, 2007, ICHNOFACIES PARADIGM, P52; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Marsh J., 1998, COMMUNICATION; Marsh J., 1997, GEOPH MONOG SERIES, V100, P247; Marsh J.S., 1984, GEOL C GEOL SOC S AF; Marzoli A, 2004, GEOLOGY, V32, P973, DOI 10.1130/G20652.1; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McCrea RT, 2001, LIFE O PAST, P413; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McPhee BW, 2018, CURR BIOL, V28, P3143, DOI 10.1016/j.cub.2018.07.063; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Miall A.D., 1978, FLUV SEDIMENTOL, VVolume 5, P597; MIALL AD, 1988, AAPG BULL, V72, P682; Miall AD, 2010, GEOLOGY OF STRATIGRAPHIC SEQUENCES, SECOND EDITION, P1, DOI 10.1007/978-3-642-05027-5; Moulin M, 2017, J GEOPHYS RES-SOL EA, V122, P738, DOI 10.1002/2016JB013354; Moulin M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008210; OLSEN P E, 1984, Palaeontologia Africana, V25, P87; Olsen P.E., 1986, P61; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Olsen PE, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P314; Palfy J, 2000, GEOLOGY, V28, P747, DOI 10.1130/0091-7613(2000)28<747:SBEJEO>2.0.CO;2; Palfy J, 2000, GEOLOGY, V28, P39, DOI 10.1130/0091-7613(2000)28<39:TTEMEF>2.0.CO;2; Paul G.S., 1991, Modern Geology, V16, P69; Percival LME, 2015, EARTH PLANET SC LETT, V428, P267, DOI 10.1016/j.epsl.2015.06.064; Petersen HI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047236; PICARD MD, 1970, J SEDIMENT PETROL, V40, P708, DOI 10.1306/74D7201D-2B21-11D7-8648000102C1865D; Porchetti Simone D'Orazi, 2007, Ichnos, V14, P219, DOI 10.1080/10420940601049990; Porchetti SD, 2018, ICHNOS, V25, P192, DOI 10.1080/10420940.2017.1308929; Porchetti SD, 2017, PALAEOGEOGR PALAEOCL, V465, P14, DOI 10.1016/j.palaeo.2016.10.009; Porchetti SD, 2015, PALAEONTOL Z, V89, P807, DOI 10.1007/s12542-015-0264-6; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Richoz S, 2012, NAT GEOSCI, V5, P662, DOI [10.1038/ngeo1539, 10.1038/NGEO1539]; Romano M., 2007, Ichnos, V14, P257, DOI 10.1080/10420940601050014; Rowland SM, 2014, PALAIOS, V29, P539, DOI 10.2110/palo.2013.067; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Sciscio L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185941; Sciscio L, 2016, PEERJ, V4, DOI 10.7717/peerj.2285; Self S, 2014, GEOL SOC AM SPEC PAP, V505, P319, DOI 10.1130/2014.2505(16); Sell B, 2014, EARTH PLANET SC LETT, V408, P48, DOI 10.1016/j.epsl.2014.10.008; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Smith RMH, 2009, PALAIOS, V24, P672, DOI 10.2110/palo.2008.p08-115r; Stanford Ray, 2004, Ichnos, V11, P251, DOI 10.1080/10420940490428797; STEAR WM, 1985, SEDIMENT GEOL, V45, P209, DOI 10.1016/0037-0738(85)90003-X; Suan G, 2011, EARTH PLANET SC LETT, V312, P102, DOI 10.1016/j.epsl.2011.09.050; Suan G, 2010, EARTH PLANET SC LETT, V290, P448, DOI 10.1016/j.epsl.2009.12.047; Svensen H, 2007, EARTH PLANET SC LETT, V256, P554, DOI 10.1016/j.epsl.2007.02.013; Svensen H, 2012, EARTH PLANET SC LETT, V325, P1, DOI 10.1016/j.epsl.2012.01.015; Tanner LH, 2004, EARTH-SCI REV, V65, P103, DOI 10.1016/S0012-8252(03)00082-5; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Thulborn T., 1990, DINOSAUR TRACKS; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Xing Li-da, 2009, Dizhi Tongbao, V28, P705	124	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0226847	10.1371/journal.pone.0226847	http://dx.doi.org/10.1371/journal.pone.0226847			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995575	Green Published, gold			2022-12-26	WOS:000534609400017
J	Lu, CH; Kuo, YY; Lin, GB; Chen, WT; Chao, CY				Lu, Chueh-Hsuan; Kuo, Yu-Yi; Lin, Guan-Bo; Chen, Wei-Ting; Chao, Chih-Yu			Application of non-invasive low-intensity pulsed electric field with thermal cycling-hyperthermia for synergistically enhanced anticancer effect of chlorogenic acid on PANC-1 cells	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; P53; COMBINATION; ABLATION; STIMULI; FAMILY; BCL-2; ROS	Most existing cancer treatments involve high-cost chemotherapy and radiotherapy, with major side effects, prompting effort to develop alternative treatment modalities. It was reported that the combination of thermal-cycling hyperthermia (TC-HT) and phenolic compound exhibited a moderate cytotoxic effect against human pancreatic cancer PANC-1 cells. In this study, we investigate the efficacy of triple combination in PANC-1 cancer cells by adopting low-intensity pulsed electric field (LIPEF) to couple with TC-HT and CGA (chlorogenic acid). The study finds that this triple combination can significantly impede the proliferation of PANC-1 cells, with only about 20% viable cells left after 24h, whereas being nontoxic to normal cells. The synergistic activity against the PANC-1 cells was achieved by inducing G2/M phase arrest and apoptosis, which were associated with up-regulation of p53 and coupled with increased expression of downstream proteins p21 and Bax. Further mechanism investigations revealed that the cytotoxic activity could be related to mitochondrial apoptosis, characterized by the reduced level of Bcl-2, mitochondrial dysfunction, and sequential activation of caspase-9 and PARP. Also, we found that the triple treatment led to the increase of intracellular reactive oxygen species (ROS) production. Notably, the triple treatment-induced cytotoxic effects and the elevated expression of p53 and p21 proteins as well as the increased Bax/Bcl-2 ratio, all could be alleviated by the ROS scavenger, N-acetyl-cysteine (NAC). These findings indicate that the combination of CGA, TC-HT, and LIPEF may be a promising modality for cancer treatment, as it can induce p53-dependent cell cycle arrest and apoptosis through accumulation of ROS in PANC-1 cells.	[Lu, Chueh-Hsuan; Kuo, Yu-Yi; Lin, Guan-Bo; Chen, Wei-Ting; Chao, Chih-Yu] Natl Taiwan Univ, Lab Med Phys & Biomed Engn, Dept Phys, Taipei, Taiwan; [Lu, Chueh-Hsuan; Kuo, Yu-Yi; Lin, Guan-Bo; Chen, Wei-Ting; Chao, Chih-Yu] Natl Taiwan Univ, Coll Med, Biomed & Mol Imaging Ctr, Taipei, Taiwan; [Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Lab Med Phys & Biomed Engn, Dept Phys, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Coll Med, Biomed & Mol Imaging Ctr, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw			Ministry of Science and Technology of the Republic of China [MOST 108-2112-M-002-016]; Ministry of Education of the Republic of China [MOE 106R880708]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan)	This work was supported by grants from Ministry of Science and Technology (MOST 108-2112-M-002-016 to CYC) and Ministry of Education (MOE 106R880708 to CYC) of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antov Y, 2005, BIOPHYS J, V88, P2206, DOI 10.1529/biophysj.104.051268; Baig S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.275; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Chaplin V, 2017, J THER ULTRASOUND, V5, DOI 10.1186/s40349-017-0089-8; Chen B, 2013, CLIN PHARMACOL THER, V94, P627, DOI 10.1038/clpt.2013.181; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Deodhar A, 2011, AM J ROENTGENOL, V196, pW330, DOI 10.2214/AJR.10.4490; Fumoto S, 2014, BIOL PHARM BULL, V37, P212, DOI 10.1248/bpb.b13-00703; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guionet A, 2018, DRUG DELIV TRANSL RE, V8, P1152, DOI 10.1007/s13346-018-0533-5; Gulick RM, 2019, ANNU REV MED, V70, P137, DOI 10.1146/annurev-med-041217-013717; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Hottinger AF, 2016, NEURO-ONCOLOGY, V18, P1338, DOI 10.1093/neuonc/now182; Hou N, 2017, ANTI-CANCER DRUG, V28, P59, DOI 10.1097/CAD.0000000000000430; Hsieh CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214100; Hsieh CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201920; Hsieh CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188885; Huang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07160; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; KORCHAK HM, 1982, BIOCHEM BIOPH RES CO, V108, P1495, DOI 10.1016/S0006-291X(82)80076-4; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Lee JJ, 2007, J BIOPHARM STAT, V17, P461, DOI 10.1080/10543400701199593; Lee JC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017249; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lopes JR, 2013, CURR PHARM DESIGN, V19, P7169, DOI 10.2174/13816128113199990698; Lu CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217676; Lu CH, 2018, ONCOTARGETS THER, V11, P4723, DOI 10.2147/OTT.S166264; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Mi Y, 2007, P ANN INT IEEE EMBS, P5815; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Partanen A, 2013, MED PHYS, V40, DOI 10.1118/1.4769116; Partanen A, 2012, INT J HYPERTHER, V28, P320, DOI 10.3109/02656736.2012.680173; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Probst U, 2018, TECHNOL CANCER RES T, V17, P1, DOI 10.1177/1533033818785329; Rakshit S, 2010, BIOCHEM PHARMACOL, V80, P1662, DOI 10.1016/j.bcp.2010.08.013; Robinson VS, 2017, BIOMED PHYS ENG EXPR, V3, DOI 10.1088/2057-1976/aa630a; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Terrault NA, 2009, HEPATOLOGY, V49, pS122, DOI 10.1002/hep.22921; Urgesi R, 2012, CLIN EXP GASTROENTER, V5, P152, DOI 10.2147/CEG.S25416; Vaity C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0804-1; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Yue XT, 2017, J MOL BIOL, V429, P1595, DOI 10.1016/j.jmb.2017.03.030	47	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0222126	10.1371/journal.pone.0222126	http://dx.doi.org/10.1371/journal.pone.0222126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995555	gold, Green Published, Green Submitted			2022-12-26	WOS:000534609400004
J	Henriquez, T; Salazar, JC; Marvasi, M; Shah, A; Corsini, G; Toro, CS				Henriquez, Tania; Carlos Salazar, Juan; Marvasi, Massimiliano; Shah, Ajit; Corsini, Gino; Toro, Cecilia S.			SRL pathogenicity island contributes to the metabolism of D-aspartate via an aspartate racemase in Shigella flexneri YSH6000	PLOS ONE			English	Article							RESISTANCE; TRANSPORT; BURDEN	In recent years, multidrug resistance of Shigella strains associated with genetic elements like pathogenicity islands, have become a public health problem. The Shigella resistance locus pathogenicity island (SRL PAI) of S. flexneri 2a harbors a 16Kbp region that contributes to the multidrug resistance phenotype. However, there is not much information about other functions such as metabolic, physiologic or ecological ones. For that, wild type S. flexneri YSH6000 strain, and its spontaneous SRL PAI mutant, 1363, were used to study the contribution of the island in different growth conditions. Interestingly, when both strains were compared by the Phenotype Microarrays, the ability to metabolize D-aspartic acid as a carbon source was detected in the wild type strain but not in the mutant. When D-aspartate was added to minimal medium with other carbon sources such as mannose or mannitol, the SRL PAI-positive strain was able to metabolize it, while the SRL PAI-negative strain did not. In order to identify the genetic elements responsible for this phenotype, a bioinformatic analysis was performed and two genes belonging to SRL PAI were found: orf8, coding for a putative aspartate racemase, and orf9, coding for a transporter. Thus, it was possible to measure, by an indirect analysis of racemization activity in minimal medium supplemented only with D-aspartate, that YSH6000 strain was able to transform the D-form into L-, while the mutant was impaired to do it. When the orf8-orf9 region from SRL island was transformed into S. flexneri and S. sonnei SRL PAI-negative strains, the phenotype was restored. Although, when single genes were cloned into plasmids, no complementation was observed. Our results strongly suggest that the aspartate racemase and the transporter encoded in the SRL pathogenicity island are important for bacterial survival in environments rich in D-aspartate.	[Henriquez, Tania; Carlos Salazar, Juan; Toro, Cecilia S.] Univ Chile, Fac Med, ICBM, Programa Microbiol & Micol, Santiago, Chile; [Henriquez, Tania] Ludwig Maximilians Univ Munchen, Biozentrum, Martinsried, Germany; [Marvasi, Massimiliano] Univ Firenze, Florence, Italy; [Shah, Ajit] Middlesex Univ London, London, England; [Corsini, Gino] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile	Universidad de Chile; University of Munich; University of Florence; Middlesex University; Universidad Autonoma de Chile	Toro, CS (corresponding author), Univ Chile, Fac Med, ICBM, Programa Microbiol & Micol, Santiago, Chile.	cetoro@med.uchile.cl	Henriquez, Tania/AAS-3183-2020; Henriquez, Tania/GZL-4286-2022	Henriquez, Tania/0000-0003-0543-9250; Henriquez, Tania/0000-0003-0543-9250; Corsini, Gino/0000-0002-0418-8616	FONDECYT [1130394]; CONICYT [8994, Uch1304]; Middlesex University London; BioMentoring Program, Faculty of Biology, Ludwig-Maximilians Universitat Munchen, Germany 2018-2019	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Middlesex University London; BioMentoring Program, Faculty of Biology, Ludwig-Maximilians Universitat Munchen, Germany 2018-2019	This work was supported by FONDECYT grant 1130394 to CT and CONICYT Doctoral Scholarship 2012-2016, Uch1304 MECESUP Fellowship for doctoral internship 2015 and Operational expenses for Doctoral thesis, CONICYT (Res. 8994), 2014 to TH. HPLC and MS-LS were funded through Research Funds from MMand AS, Middlesex University London. Publication fees are funded by BioMentoring Program, Faculty of Biology, Ludwig-Maximilians Universitat Munchen, Germany 2018-2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliashkevich A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00683; Ashkenazi S, 2003, J ANTIMICROB CHEMOTH, V51, P427, DOI 10.1093/jac/dkg080; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; DAVIS H, 1988, AM J EPIDEMIOL, V128, P1312, DOI 10.1093/oxfordjournals.aje.a115084; EISENSTADT JM, 1964, J BACTERIOL, V87, P1355, DOI 10.1128/JB.87.6.1355-1363.1964; EISENSTADT JM, 1959, BIOCHIM BIOPHYS ACTA, V36, P292, DOI 10.1016/0006-3002(59)90113-1; GABRIDGE MG, 1976, INFECT IMMUN, V13, P84, DOI 10.1128/IAI.13.1.84-91.1976; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; GRULA MM, 1968, CAN J MICROBIOL, V14, P1217, DOI 10.1139/m68-204; Gupta Soham, 2010, Indian J Med Sci, V64, P553; Hatanaka T, 2002, BIOCHEM BIOPH RES CO, V291, P291, DOI 10.1006/bbrc.2002.6441; Hernandez SB, 2016, ENVIRON MICROBIOL, V18, P1673, DOI 10.1111/1462-2920.13072; Janausch IG, 2001, ARCH MICROBIOL, V176, P224, DOI 10.1007/s002030100317; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Luck SN, 2001, INFECT IMMUN, V69, P6012, DOI 10.1128/IAI.69.10.6012-6021.2001; MARKOVETZ AJ, 1966, CAN J MICROBIOL, V12, P745, DOI 10.1139/m66-101; Matsumoto M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36244-z; Niyogi SK, 2005, J MICROBIOL, V43, P133; Poteete AR, 2006, BIOTECHNIQUES, V41, P261, DOI 10.2144/000112242; Ray S, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0257-6; ROSA N, 1968, CAN J BIOCHEM CELL B, V46, P797, DOI 10.1139/o68-121; Turner SA, 2003, ANTIMICROB AGENTS CH, V47, P727, DOI 10.1128/AAC.47.2.727-734.2003; Turner SA, 2001, J BACTERIOL, V183, P5535, DOI 10.1128/JB.183.19.5535-5543.2001; Uyanik MH, 2008, TURK J MED SCI, V38, P307; Warnes SL, 2012, MBIO, V3, DOI 10.1128/mBio.00489-12; Zhang GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092101; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	30	5	5	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228178	10.1371/journal.pone.0228178	http://dx.doi.org/10.1371/journal.pone.0228178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978153	Green Published, Green Accepted, gold			2022-12-26	WOS:000534599100124
J	Park, C; Park, HM; Kang, U				Park, Chiwan; Park, Ha-Myung; Kang, U.			FlexGraph: Flexible partitioning and storage for scalable graph mining	PLOS ONE			English	Article							LINEAR ALGEBRA; ANALYTICS; VERTEX	How can we analyze large graphs such as the Web, and social networks with hundreds of billions of vertices and edges? Although many graph mining systems have been proposed to perform various graph mining algorithms on such large graphs, they have difficulties in processing Web-scale graphs due to massive communication and I/O costs caused by communication between workers, and reading subgraphs repeatedly. In this paper, we propose FlexGraph, a scalable distributed graph mining method reducing the costs by exploiting properties of real-world graphs. FlexGraph significantly decreases the communication cost, which is the main bottleneck of distributed systems, by exploiting different edge placement policies based on types of vertices. Furthermore, we propose a flexible storage format to reduce I/O costs when reading input graph repeatedly. Experiments show that FlexGraph succeeds in processing up to 64x larger graphs than existing distributed memory-based graph mining methods, and consistently outperforms previous disk-based graph mining methods.	[Park, Chiwan; Park, Ha-Myung; Kang, U.] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Park, Chiwan] Kakao Corp, Adv Recommendat Technol Team, Seongnam, Gyeonggi, South Korea	Seoul National University (SNU)	Kang, U (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	ukang@snu.ac.kr		Park, Chiwan/0000-0001-6680-2434	Institute for Information AMP; Communications Technology Planning AMP; Evaluation (IITP) - Korea government (MSIP)	Institute for Information AMP; Communications Technology Planning AMP; Evaluation (IITP) - Korea government (MSIP)	This work was supported by Institute for Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIP) (No. R0190-15-2012, High Performance Big Data Analytics Platform Performance Acceleration Technologies Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2018, PROC VLDB ENDOW, V11, P920, DOI 10.14778/3204028.3204035; Akoglu L., 2012, SIGMOD, P717, DOI DOI 10.1145/2213836.2213941; Anderson MJ, 2016, INT PARALL DISTRIB P, P313, DOI 10.1109/IPDPS.2016.86; [Anonymous], 2016, ECML PKDD PROCEEDING; [Anonymous], 2004, SPAA 04, DOI DOI 10.1145/1007912.1007931; Borkar V, 2011, PROC INT CONF DATA, P1151, DOI 10.1109/ICDE.2011.5767921; Bourse F, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1456, DOI 10.1145/2623330.2623660; Bu YY, 2014, PROC VLDB ENDOW, V8, P161, DOI 10.14778/2735471.2735477; Chakrabarti D, 2004, SIAM PROC S, P442; Chen R, 2014, APSYS; Chen R., 2015, ACM T PARALLEL COMPU, V5, P1, DOI DOI 10.1145/2741948.2741970; Ching A, 2015, PROC VLDB ENDOW, V8, P1804, DOI 10.14778/2824032.2824077; Yan D, 2014, PROC VLDB ENDOW, V7, P1981, DOI 10.14778/2733085.2733103; Dave A., 2016, P 4 INT WORKSH GRAPH, P2; Elgohary A, 2016, PROC VLDB ENDOW, V9, P960; Fan WF, 2017, PROC VLDB ENDOW, V10, P1889, DOI 10.14778/3137765.3137801; Fan WF, 2017, SIGMOD'17: PROCEEDINGS OF THE 2017 ACM INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P495, DOI 10.1145/3035918.3035942; Gao J, 2014, PROC INT CONF DATA, P556, DOI 10.1109/ICDE.2014.6816681; Gonzalez J. E., 2012, 10 USENIX S OPERATIN, P17; Han WS, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P77; Hoque I, 2013, TRIOS SOSP; Jeon B, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P1620, DOI 10.1109/ICDMW.2015.96; Jose RS, 2014, SPRINGER PR COMPLEX, P599, DOI 10.1007/978-3-319-04379-1__99; Kalavri V, 2018, IEEE T KNOWL DATA EN, V30, P305, DOI 10.1109/TKDE.2017.2762294; Kang U., 2014, Advances in Knowledge Discovery and Data Mining. 18th Pacific-Asia Conference (PAKDD 2014). Proceedings: LNCS 8443, P348, DOI 10.1007/978-3-319-06608-0_29; Kang U, 2014, IEEE T KNOWL DATA EN, V26, P350, DOI 10.1109/TKDE.2012.244; Kang U, 2012, VLDB J, V21, P637, DOI 10.1007/s00778-012-0283-9; Kang U, 2011, LECT NOTES ARTIF INT, V6635, P13, DOI 10.1007/978-3-642-20847-8_2; Kang U, 2011, ACM T KNOWL DISCOV D, V5, DOI 10.1145/1921632.1921634; Kang U., 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P875, DOI 10.1109/ICDM.2010.121; Kang U, 2009, IEEE DATA MINING, P229, DOI 10.1109/ICDM.2009.14; Kang U, 2011, KNOWL INF SYST, V27, P303, DOI 10.1007/s10115-010-0305-0; Kang U., 2010, SDM, P548; Kang YS, 2011, 2011 INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND NEURAL COMPUTING (FSNC 2011), VOL II, P300; Khayyat Z., 2013, P 8 EUROSYS C EUROSY, P169, DOI DOI 10.1145/2465351.2465369; Kwak HG, 2010, INT CONF ADV COMMUN, P591; Kyrola A., 2012, PROC 10 USENIX S OPE, P31; Lee H, 2015, INFORM SCIENCES, V315, P56, DOI 10.1016/j.ins.2015.04.016; Liakos P, 2018, IEEE T KNOWL DATA EN, V30, P743, DOI 10.1109/TKDE.2017.2779797; Liakos P, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P2317, DOI 10.1145/2983323.2983687; Lim Y, 2014, IEEE T KNOWL DATA EN, V26, P3077, DOI 10.1109/TKDE.2014.2320716; Lin JCH, 2011, PROC IEEE MICR ELECT, P1091, DOI 10.1109/MEMSYS.2011.5734619; Lin ZY, 2014, IEEE INT CONF BIG DA, P159, DOI 10.1109/BigData.2014.7004226; Ma LX, 2017, 2017 USENIX ANNUAL TECHNICAL CONFERENCE (USENIX ATC '17), P195; Maass S, 2017, PROCEEDINGS OF THE TWELFTH EUROPEAN CONFERENCE ON COMPUTER SYSTEMS (EUROSYS 2017), P527, DOI 10.1145/3064176.3064191; Malewicz G., 2010, P 2010 ACM SIGMOD IN, P135, DOI [DOI 10.1145/1807167.1807184, 10.1145/1807167.1807184]; Mukkara A, 2018, 2018 51ST ANNUAL IEEE/ACM INTERNATIONAL SYMPOSIUM ON MICROARCHITECTURE (MICRO), P1, DOI 10.1109/MICRO.2018.00010; Park H., 2018, P 32 AAAI C ART INT; Qin L, 2014, SIGMOD'14: PROCEEDINGS OF THE 2014 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P827, DOI 10.1145/2588555.2593661; Quick L, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P457, DOI 10.1109/ASONAM.2012.254; Sahu S, 2017, PROC VLDB ENDOW, V11, P420, DOI 10.1145/3164135.3164139; Sangwon Seo, 2010, Proceedings of the 2010 IEEE 2nd International Conference on Cloud Computing Technology and Science (CloudCom 2010), P721, DOI 10.1109/CloudCom.2010.17; Seo H, 2015, ACM SIGPLAN NOTICES, V50, P253, DOI [10.1145/2858788.2688526, 10.1145/2688500.2688526]; Shvachko K., 2010, SYMPOSIUM, P1, DOI DOI 10.1109/MSST.2010.5496972; Stutz P, 2010, LECT NOTES COMPUT SC, V6496, P764, DOI 10.1007/978-3-642-17746-0_48; Sundaram N, 2015, PROC VLDB ENDOW, V8, P1214, DOI 10.14778/2809974.2809983; Suri S., 2011, P WWW, P607, DOI DOI 10.1145/1963405.1963491; Tian Y, 2013, PROC VLDB ENDOW, V7, P193, DOI 10.14778/2732232.2732238; Venkataraman S., 2013, EUROSYS 13, P197, DOI [DOI 10.1145/2465351.2465371, 10.1145/2465351.2465371]; Wang Z, 2016, SIGMOD'16: PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P479, DOI 10.1145/2882903.2882938; Yan D, 2018, IEEE T PARALL DISTR, V29, P99, DOI 10.1109/TPDS.2017.2743708; Yan D, 2014, PROC VLDB ENDOW, V7, P1821, DOI 10.14778/2733085.2733089; Zhang YM, 2017, IEEE INT CONF BIG DA, P293	64	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227032	10.1371/journal.pone.0227032	http://dx.doi.org/10.1371/journal.pone.0227032			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978075	Green Published, gold			2022-12-26	WOS:000534599100025
J	Puschel, TA; Friess, M; Manriquez, G				Puschel, Thomas A.; Friess, Martin; Manriquez, German			Morphological consequences of artificial cranial deformation: Modularity and integration	PLOS ONE			English	Article							VAULT MODIFICATION; GEOMETRIC MORPHOMETRICS; PHENOTYPIC VARIATION; BASE; ONTOGENY; SKULL; HOMO; EVOLUTION; SHAPE; COVARIATION	The cranium is an anatomically complex structure. One source of its complexity is due to its modular organization. Cranial modules are distinct and partially independent units that interact substantially during ontogeny thus generating morphological integration. Artificial Cranial Deformation (ACD) occurs when the human skull is intentionally deformed, through the use of different deforming devices applied to the head while it is developing. Hence, ACD provides an interesting example to assess the degree to which biomechanical perturbations of the developing neurocranium impact on the degree of morphological integration in the skull as a whole. The main objective of this study was to assess how ACD affects the morphological integration of the skull. This was accomplished by comparing a sample of non-deformed crania and two sets of deformed crania (i.e. antero-posterior and oblique). Both developmental and static modularity and integration were assessed through Generalized Procrustes Analysis by considering the symmetric and asymmetric components of variation in adults, using 3D landmark coordinates as raw data. The presence of two developmental modules (i.e. viscero and neurocranium) in the skull was tested. Then, in order to understand how ACD affects morphological integration, the covariation pattern between the neuro and viscerocranium was examined in antero-posterior, oblique and non-deformed cranial categories using Partial Least-Squares. The main objective of this study was to assess how ACD affects the morphological integration of the skull. This was accomplished by comparing a sample of deformed (i.e. antero-posterior and oblique) and non-deformed crania. Hence, differences in integration patterns were compared between groups. The obtained results support the modular organization of the human skull in the two analyzed modules. The integration analyses show that the oblique ACD style differentially affects the static morphological integration of the skull by increasing the covariance between neuro and viscerocranium in a more constrained way than in antero-posterior and non-deformed skulls. In addition, the antero-posterior ACD style seems to affect the developmental integration of the skull by directing the covariation pattern in a more defined manner as compared to the other cranial categories.	[Puschel, Thomas A.] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Primate Models Behav Evolut, Oxford, England; [Friess, Martin] Museum Natl Hist Nat, Dept Homme & Environm, Paris, France; [Manriquez, German] Univ Chile, Fac Odontol, Ctr Anal Cuantitat Antropol Dent, Inst Invest Ciencias Odontol, Santiago, Chile; [Manriquez, German] Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile	University of Oxford; Museum National d'Histoire Naturelle (MNHN); Universidad de Chile; Universidad de Chile	Puschel, TA (corresponding author), Univ Oxford, Inst Cognit & Evolutionary Anthropol, Primate Models Behav Evolut, Oxford, England.; Manriquez, G (corresponding author), Univ Chile, Fac Odontol, Ctr Anal Cuantitat Antropol Dent, Inst Invest Ciencias Odontol, Santiago, Chile.; Manriquez, G (corresponding author), Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile.	thomas.puschelrouliez@anthro.ox.ac.uk; gmanriquezs@odontologia.uchile.cl	Püschel, Thomas A/AAS-4535-2020	Püschel, Thomas A/0000-0002-2231-2297; Manriquez, German/0000-0002-3376-8804	CONICYT, Programa de Investigacion Asociativa Anillos en Ciencia y Tecnologia [096]; CNRS-Ecos-Conicyt [C10H03]; Leverhulme Trust Early Career Fellowship [ECF-2018-264]	CONICYT, Programa de Investigacion Asociativa Anillos en Ciencia y Tecnologia; CNRS-Ecos-Conicyt; Leverhulme Trust Early Career Fellowship(Leverhulme Trust)	This work was partially supported by CONICYT, Programa de Investigacion Asociativa Anillos en Ciencia y Tecnologia ACT N degrees 096 grant (GM) and by CNRS-Ecos-Conicyt N degrees C10H03 grant (GM, MF). TP was partially supported by the Leverhulme Trust Early Career Fellowship, ECF-2018-264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Adams D.C., 2020, GEOMORPH SOFTWARE GE; Adams DC, 2016, METHODS ECOL EVOL, V7, P565, DOI 10.1111/2041-210X.12511; Adams DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094335; Aichel O, 1932, KUNSTLICHE SCHADELDE; Cocilovo JA, 2010, RELACIONES, V35, P41; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANTON SC, 1992, J MORPHOL, V214, P321, DOI 10.1002/jmor.1052140307; ANTON SC, 1989, AM J PHYS ANTHROPOL, V79, P253, DOI 10.1002/ajpa.1330790213; Arensburg B., 1988, B MEM SOC ANTHRO PAR, V5, P139; Arnold W, 2008, J BIOL CLIN ANTHR ST, V2, P1; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Baylac M, 2005, DEV PRIMATOL-PROG PR, P145, DOI 10.1007/0-387-27614-9_6; BJORK A, 1964, J DENT RES, V43, P353, DOI 10.1177/00220345640430030601; Blom DE, 2005, J ANTHROPOL ARCHAEOL, V24, P1, DOI 10.1016/j.jaa.2004.10.001; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Broca P, 1871, B MEM SOC ANTHRO PAR, V6, P100, DOI [10.3406/bmsap.1871.4449, DOI 10.3406/BMSAP.1871.4449]; Broca P, 1875, B SOC ANTHROPOL PAR, V10, P199; Bruner E, 2008, AM J PHYS ANTHROPOL, V137, P30, DOI 10.1002/ajpa.20837; Bruner Emiliano, 2008, Paleoanthropology, V2008, P93; Bucchi A, 2016, REV CHIL ANTROPOL, V34, P19; Carlson B. M., 2013, HUMAN EMBRYOLOGY DEV; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V88, P323, DOI 10.1002/ajpa.1330880307; Cheverud JM, 1995, AM NAT AMER NAT, V145; Cottin M, 2017, CR PALEVOL, V16, P545, DOI 10.1016/j.crpv.2017.03.001; Delisle F, 1902, B MEM SOC ANTHRO PAR, V5, P111; Dembo A., 1938, DEFORMACIONES INTENC; Depew M.J., 2002, MOUSE DEV PATTERNING, P421; DiGirolamo DJ, 2013, J BONE MINER RES, V28, P1509, DOI 10.1002/jbmr.1969; Dingwall EJ, 1931, ARTIFICIAL CRANIAL D; Enchev Y, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10193; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Esteve-Altava B, 2013, J EXP ZOOL PART B, V320, P489, DOI 10.1002/jez.b.22524; Ferros I, 2014, EUR J ORTHODONT, V8, P1; FitzSimmons E, 1998, ARCH FAM MED, V7, P88, DOI 10.1001/archfami.7.1.88; Fletcher A, 2008, CAMB ARCHAEOL J, V18, P309, DOI 10.1017/S0959774308000383; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; GERSZTEN PC, 1995, NEUROSURGERY, V37, P374, DOI 10.1227/00006123-199509000-00002; Gosse LA, 1855, ESSAI DEFORMATIONS A; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Goswami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009517; Gump W, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10203; Gunz P, 2007, J HUM EVOL, V52, P262, DOI 10.1016/j.jhevol.2006.08.010; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2004, J EXP ZOOL PART B, V302B, P207, DOI 10.1002/jez.b.21002; Heuze Y, 2014, BIRTH DEFECTS RES A, V100, P250, DOI 10.1002/bdra.23228; Hrdlicka A, 1910, ACT 17 C INT AM BUEN, P147; Ketoff S, 2016, J ANAT; Khonsari RH, 2013, AM J PHYS ANTHROPOL, V151, P110, DOI 10.1002/ajpa.22263; Klingenberg CP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0249; Klingenberg CP, 2013, HYSTRIX, V24, P43, DOI 10.4404/hystrix-24.1-6367; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Kohler G., 1901, THESIS; KOHN LAP, 1993, AM J PHYS ANTHROPOL, V90, P147, DOI 10.1002/ajpa.1330900203; Kondo H, 2014, 2014 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P52, DOI 10.1109/SII.2014.7028010; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Manriquez G, 2017, INTERAKTION OHNE GRE, P958; Manriquez G, 2006, CHUNGARA, V38, P13, DOI 10.4067/S0717-73562006000100004; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Marroig G, 2001, EVOLUTION, V55, P2576; Martin R., 1959, LEHRBUCH ANTHR SYSTE, V3rd; Martinez-Abadias N, 2009, EVOL BIOL, V36, P37, DOI 10.1007/s11692-008-9045-4; Mayall P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171064; Mednikova M, 2006, OPUS INTERDISCIP MAY, P206; Mendonca de Souza SMF, 2009, CHUNGARA, V40, P41; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Molnar M, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13466; Morton SG, 1839, AM J DOBSON; Morton SG., 1839, CRANIA AM COMP VIEW; Moss ML, 1962, VISTAS ORTHODONTICS, P85; MUNIZAGA JR, 1976, AM J PHYS ANTHROPOL, V45, P687, DOI 10.1002/ajpa.1330450335; Neaux D, 2019, AM J PHYS ANTHROPOL, V170, P37, DOI 10.1002/ajpa.23899; Neaux D, 2018, J HUM EVOL, V118, P43, DOI 10.1016/j.jhevol.2018.02.007; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Noback ML, 2011, AM J PHYS ANTHROPOL, V145, P599, DOI 10.1002/ajpa.21523; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; O'Loughlin VD, 2004, AM J PHYS ANTHROPOL, V123, P146, DOI 10.1002/ajpa.10304; Ozbek M, 2001, AM J PHYS ANTHROPOL, V115, P238, DOI 10.1002/ajpa.1078; Pap I, 1985, ANN HIST NAT MUSEI N, V77, P281; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Perez SI, 2007, J ARCHAEOL SCI, V34, P1649, DOI 10.1016/j.jas.2006.12.003; Polanski JM, 2006, AM J PHYS ANTHROPOL, V131, P38, DOI 10.1002/ajpa.20421; Prestigiacomo CJ, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.12.FOCUS.Intro; Profico A, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22721; Puschel T, 2014, INT J MORPHOL, V32, P299, DOI 10.4067/s0717-95022014000100048; Richtsmeier JT, 2009, ORTHOD CRANIOFAC RES, V12, P149, DOI 10.1111/j.1601-6343.2009.01448.x; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Roth VL, 1996, AM ZOOL, V36, P14; ROUSE I, 1960, AM ANTIQUITY, V25, P313, DOI 10.2307/277514; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Sandy R, 2018, J ANAT, V233, P302, DOI 10.1111/joa.12844; Schijman E, 2005, CHILD NERV SYST, V21, P945, DOI 10.1007/s00381-004-1127-8; SCOTT JH, 1957, AM J PHYS ANTHROPOL, V15, P197, DOI 10.1002/ajpa.1330150210; [Шведчикова Т.Ю. Shvedchikova T.Yu.], 2009, [Вестник Московского университета. Серия 23: Антропология, Vestnik Moskovskogo universiteta. Seriya 23: Antropologiya], P78; Singh N, 2012, J HUM EVOL, V62, P155, DOI 10.1016/j.jhevol.2011.11.006; SMITH V, 2011, INT J EVOL BIOL, DOI DOI 10.1155/2011/380371; Soto-Heim P., 1987, CHUNGARA, V19, P129; Soto-Heim P, 2005, BIOMETRIE HUM ANTHR, V23, P203; Sperber GH., 2001, CRANIOFACIAL DEV BOO; Topinard P, 1879, REV ANTHR, V2, P496; Torres-Rouff C, 2002, CURR ANTHROPOL, V43, P163, DOI 10.1086/338290; Torres-Rouff C, 2005, HOMO, V56, P1, DOI 10.1016/j.jchb.2004.09.001; Torres-Rouff Christina, 2007, Estud. atacam., P25, DOI 10.4067/S0718-10432007000100003; Tritsaroli P, 2011, INT J OSTEOARCHAEOL, V21, P464, DOI 10.1002/oa.1153; Van der KLAAUW C. J., 1948, ARCH NORLAND ZOOL, V9, P1; Vioarsdottir US, 2002, J ANAT, V201, P211; von Cramon-Taubadel N, 2018, EVOL ANTHROPOL, V28, P21; von Cramon-Taubadel N, 2011, AM J PHYS ANTHROPOL, V146, P83, DOI 10.1002/ajpa.21550; Vora SR, 2017, ORTHOD CRANIOFAC RES, V20, P18, DOI 10.1111/ocr.12180; Weber J, 2008, ACTA NEUROCHIR, V150, P1107, DOI 10.1007/s00701-008-0025-3; Weiss P., 1961, OSTEOLOGIA CULTURAL; Wiley DF, 2005, EEE VISUALIZATION 20; Zelditch M.L., 2012, GEOMETRIC MORPHOMETR, V2nd, P209	125	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227362	10.1371/journal.pone.0227362	http://dx.doi.org/10.1371/journal.pone.0227362			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978063	Green Published, gold			2022-12-26	WOS:000534599100034
J	Schroder, C; Diaz, LAP; Rohde, AM; Piening, B; Aghdassi, SJS; Pilarski, G; Thoma, N; Gastmeier, P; Leistner, R; Behnke, M				Schroeder, Christin; Diaz, Luis Alberto Pena; Rohde, Anna Maria; Piening, Brar; Aghdassi, Seven Johannes Sam; Pilarski, Georg; Thoma, Norbert; Gastmeier, Petra; Leistner, Rasmus; Behnke, Michael			Lean back and wait for the alarm? Testing an automated alarm system for nosocomial outbreaks to provide support for infection control professionals	PLOS ONE			English	Article							TIME-SERIES; SURVEILLANCE	Introduction Outbreaks of communicable diseases in hospitals need to be quickly detected in order to enable immediate control. The increasing digitalization of hospital data processing offers potential solutions for automated outbreak detection systems (AODS). Our goal was to assess a newly developed AODS. Methods Our AODS was based on the diagnostic results of routine clinical microbiological examinations. The system prospectively counted detections per bacterial pathogen over time for the years 2016 and 2017. The baseline data covers data from 2013-2015. The comparative analysis was based on six different mathematical algorithms (normal/Poisson and score prediction intervals, the early aberration reporting system, negative binomial CUSUMs, and the Farrington algorithm). The clusters automatically detected were then compared with the results of our manual outbreak detection system. Results During the analysis period, 14 different hospital outbreaks were detected as a result of conventional manual outbreak detection. Based on the pathogens' overall incidence, outbreaks were divided into two categories: outbreaks with rarely detected pathogens (sporadic) and outbreaks with often detected pathogens (endemic). For outbreaks with sporadic pathogens, the detection rate of our AODS ranged from 83% to 100%. Every algorithm detected 6 of 7 outbreaks with a sporadic pathogen. The AODS identified outbreaks with an endemic pathogen were at a detection rate of 33% to 100%. For endemic pathogens, the results varied based on the epidemiological characteristics of each outbreak and pathogen. Conclusion AODS for hospitals based on routine microbiological data is feasible and can provide relevant benefits for infection control teams. It offers in-time automated notification of suspected pathogen clusters especially for sporadically occurring pathogens. However, outbreaks of endemically detected pathogens need further individual pathogen-specific and setting-specific adjustments.	[Schroeder, Christin; Diaz, Luis Alberto Pena; Rohde, Anna Maria; Piening, Brar; Aghdassi, Seven Johannes Sam; Pilarski, Georg; Thoma, Norbert; Gastmeier, Petra; Leistner, Rasmus; Behnke, Michael] Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schroder, C (corresponding author), Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany.	christin.schroeder@charite.de	Piening, Brar/E-2622-2014	Piening, Brar/0000-0002-4478-5597; Pena Diaz, Luis Alberto/0000-0001-6798-7872; Leistner, Rasmus/0000-0002-1225-9023; Behnke, Michael/0000-0002-3993-9651; Aghdassi, Seven Johannes Sam/0000-0002-8263-3455; Schroder, Christin/0000-0003-3527-5226	German Society of Hospital Hygiene (DGKH); Stiftung Charite	German Society of Hospital Hygiene (DGKH); Stiftung Charite	This work was partly funded by grants from the German Society of Hospital Hygiene (DGKH). The concept of the project won a scientific price from Stiftung Charite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2016, INFECT CONT HOSP EP, V37, P466, DOI 10.1017/ice.2015.325; Bedubourg G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181227; Bergin J, 2018, ARTECH HSE RADAR LIB, P1; Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; DESSAU RB, 1993, J CLIN MICROBIOL, V31, P857, DOI 10.1128/JCM.31.4.857-860.1993; Eyre DW, 2012, LANCET, V380, pS12; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fricker RD, 2008, STAT MED, V27, P3407, DOI 10.1002/sim.3197; Gastmeier P, 2006, AM J INFECT CONTROL, V34, P603, DOI 10.1016/j.ajic.2006.01.014; Grundmann H, 2005, CRIT CARE MED, V33, P946, DOI 10.1097/01.CCM.0000163223.26234.56; Guillou A, 2014, STAT MED, V33, P5015, DOI 10.1002/sim.6275; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Leclere B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176438; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Miller JK, 2019, J BIOMED INFORM, V91, DOI 10.1016/j.jbi.2019.103126; <monospace>R</monospace>Development Core Team, 2019, R LANG ENV STAT COMP; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Nishiura Hiroshi, 2012, Osong Public Health Res Perspect, V3, P121, DOI 10.1016/j.phrp.2012.07.010; Pelecanos AM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-74; Raven KE, 2017, CLIN INFECT DIS, V64, P886, DOI 10.1093/cid/ciw872; Remschmidt C, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0353-x; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Salmon M, 2016, J STAT SOFTW, V70, P1, DOI 10.18637/jss.v070.i10; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stoesser N, 2015, J CLIN MICROBIOL; Ulrich N, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00473; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227955	10.1371/journal.pone.0227955	http://dx.doi.org/10.1371/journal.pone.0227955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978086	Green Published, gold			2022-12-26	WOS:000534599100084
J	Sung, YK; Jung, SY; Kim, H; Choi, S; Im, SG; Lee, YS; Jang, EJ; Cho, SK				Sung, Yoon-Kyoung; Jung, Sun-Young; Kim, Hyoungyoung; Choi, Seongmi; Im, Seul Gi; Lee, Yu Sang; Jang, Eun Jin; Cho, Soo-Kyung			Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world	PLOS ONE			English	Article							INNOVATOR INFLIXIMAB; PARALLEL-GROUP; DOUBLE-BLIND; ARTHRITIS; CT-P13; EFFICACY; SAFETY; SWITCH	Background To identify factors for starting biosimilar TNF inhibitors (TNFI) in patients with rheumatic diseases. Methods and finding Using a national claims database, we identified patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) who had used TNFIs since they were approved in Korea in 2004. We assessed changes in the proportion of each form of TNFI used between 2004 and 2017. We then selected patients starting on TNFIs between 2013 and 2017 to identify factors for starting biosimilars. In RA (n = 4,216), biosimilars were more likely to be initiated in clinics [odds ratio (OR) 2.54] and in the metropolitan area (OR, 2.02), but were less likely to be initiated in general hospitals (OR 0.40) or orthopedics (OR 0.44). In AS (n = 2,338), biosimilars were common at the hospital level (OR 2.20) and tended to increase over the years (OR 1.16), but were initiated less in orthopedics (OR 0.07). In addition, RA patients were more likely to initiate biosimilars in combination with methotrexate (OR 1.37), but biosimilars were not initiated frequently by patients with higher comorbidity scores (OR 0.97) or receiving glucocorticoids (OR 0.67). The patient factors favoring biosimilar in AS use were not clear. Conclusions In Korea, the proportion of biosimilar TNFIs has increased. Type of institution and physician specialty are more important than patient factors in affecting biosimilar use. In RA, biosimilar TNFIs tend to be initiated in combination with MTX, and are less likely to be initiated in patients taking glucocorticoids or in those with high comorbidities.	[Sung, Yoon-Kyoung; Kim, Hyoungyoung; Cho, Soo-Kyung] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul, South Korea; [Jung, Sun-Young] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Choi, Seongmi; Im, Seul Gi; Lee, Yu Sang] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Jang, Eun Jin] Andong Natl Univ, Dept Informat Stat, Andong, South Korea	Hanyang University; Chung Ang University; Kyungpook National University; Andong National University	Cho, SK (corresponding author), Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul, South Korea.	skchomd@hanyang.ac.kr		Cho, Soo-Kyung/0000-0003-4493-8837	Hanyang University [201600000002778]	Hanyang University	This work was supported by the research fund of Hanyang University 201600000002778). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho SK, 2013, RHEUMATOL INT, V33, P2985, DOI 10.1007/s00296-013-2833-x; Codreanu C, 2018, CURR MED RES OPIN, V34, P1763, DOI 10.1080/03007995.2018.1441144; Cohen H, 2017, ADV THER, V33, P2160, DOI 10.1007/s12325-016-0431-5; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Emery P, 2017, ANN RHEUM DIS, V76, P51, DOI 10.1136/annrheumdis-2015-207588; Frantzen L, 2019, PATIENTS INFORM PERS; Germain V, 2018, ANN RHEUMATIC DIS; Glintborg B, 2019, ANN RHEUM DIS, V78, P192, DOI 10.1136/annrheumdis-2018-213474; Ingrasciotta Y, 2015, BIODRUGS, V29, P275, DOI 10.1007/s40259-015-0132-7; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kravvariti E, 2018, NAT REV RHEUMATOL, V14, P727, DOI 10.1038/s41584-018-0110-9; Nikiphorou E, 2015, EXPERT OPIN BIOL TH, V15, P1677, DOI 10.1517/14712598.2015.1103733; Park W, 2013, ANN RHEUM DIS, V72, P1605, DOI 10.1136/annrheumdis-2012-203091; Scavone C, 2018, BIODRUGS, V32, P607, DOI 10.1007/s40259-018-0313-2; Scheinberg MA, 2012, NAT REV RHEUMATOL, V8, P430, DOI 10.1038/nrrheum.2012.84; Scherlinger M, 2019, ANN RHEUMATIC DIS; Schmitz EMH, 2017, CLIN RHEUMATOL, V36, P2129, DOI 10.1007/s10067-017-3686-6; Schulze-Koops H, 2017, RHEUMATOLOGY, V56, P30, DOI 10.1093/rheumatology/kex277; Smolen JS, 2015, ANN RHEUM DIS, V74, P785, DOI 10.1136/annrheumdis-2015-eular.1435; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Sung YK, 2017, RHEUMATOL INT, V37, P1007, DOI 10.1007/s00296-017-3663-z; Teeple A, 2019, CURR MED RES OPIN, V35, P603, DOI 10.1080/03007995.2018.1560221; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; Vashisht P, 2016, ARTHRIT CARE RES, V68, P1478, DOI 10.1002/acr.22860; Yoo DH, 2013, ANN RHEUM DIS, V72, P1613, DOI 10.1136/annrheumdis-2012-203090	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227960	10.1371/journal.pone.0227960	http://dx.doi.org/10.1371/journal.pone.0227960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978121	gold, Green Published			2022-12-26	WOS:000534599100086
J	Wray, R; Wang, JM; Iscla, I; Blount, P				Wray, Robin; Wang, Junmei; Iscla, Irene; Blount, Paul			Novel MscL agonists that allow multiple antibiotics cytoplasmic access activate the channel through a common binding site	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; MECHANOSENSITIVE CHANNEL; ESCHERICHIA-COLI; OSMOTIC DOWNSHOCK; ATOMIC CHARGES; ION CHANNELS; ACCURACY; RELEASE; STREPTOMYCIN; EXPRESSION	The antibiotic resistance crisis is becoming dire, yet in the past several years few potential antibiotics or adjuvants with novel modes of action have been identified. The bacterial mechanosensitive channel of large conductance, MscL, found in the majority of bacterial species, including pathogens, normally functions as an emergency release valve, sensing membrane tension upon low-osmotic stress and discharging cytoplasmic solutes before cell lysis. Opening the huge similar to 30A diameter pore of MscL inappropriately is detrimental to the cell, allowing solutes from and even passage of drugs into to cytoplasm. Thus, MscL is a potential novel drug target. However, there are no known natural agonists, and small compounds that modulate MscL activity are just now being identified. Here we describe a small compound, K05, that specifically modulates MscL activity and we compare results with those obtained for the recently characterized MscL agonist 011A. While the structure of K05 only vaguely resembles 011A, many of the findings, including the binding pocket, are similar. On the other hand, both in vivo and molecular dynamic simulations indicate that the two compounds modulate MscL activity in significantly different ways.	[Wray, Robin; Iscla, Irene; Blount, Paul] UT Southwestern Med Ctr, Dept Physiol, Dallas, TX 75390 USA; [Wang, Junmei] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA; [Wang, Junmei] Univ Pittsburgh, Sch Pharm, Computat Chem Genom Screening Ctr, Pittsburgh, PA 15260 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Iscla, I; Blount, P (corresponding author), UT Southwestern Med Ctr, Dept Physiol, Dallas, TX 75390 USA.; Wang, JM (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA.; Wang, JM (corresponding author), Univ Pittsburgh, Sch Pharm, Computat Chem Genom Screening Ctr, Pittsburgh, PA 15260 USA.	junmei.wang@pitt.edu; irene.iscla@utsouthwestern.edu; paul.blount@utsouthwestern.edu	Wang, Junmei/ACQ-2446-2022	Wang, Junmei/0000-0002-9607-8229; Iscla, Irene/0000-0001-8936-430X; Blount, Paul/0000-0001-5259-4881	National Institutes of Health [GM121780, GM 079383]; Welch Foundation [I-1420]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	This work was supported by Grants GM121780 (PB) and GM 079383 (JW) from the National Institutes of Health, and Grant I-1420 of the Welch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding organizations.	Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; [Anonymous], 2015, GLID VERS 6 8; BAITINGER WF, 1964, TETRAHEDRON, V20, P1635, DOI 10.1016/S0040-4020(01)99161-6; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Batiza AF, 2002, P NATL ACAD SCI USA, V99, P5643, DOI 10.1073/pnas.082092599; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; Blount P, 1999, Methods Enzymol, V294, P458; Blount Paul, 2008, V1, P71; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44; Case D. A., 2015, AMBER 14; Cox CD, 2018, ANNU REV PHYSIOL, V80, P71, DOI 10.1146/annurev-physiol-021317-121351; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; DIAMOND JM, 1969, PROC R SOC SER B-BIO, V172, P273, DOI 10.1098/rspb.1969.0022; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; DUBIN DT, 1963, BIOCHIM BIOPHYS ACTA, V74, P476, DOI 10.1016/0006-3002(63)91390-8; Dukes MNG, 1980, SIDE EFFECTS DRUGS A; Ewis HE, 2005, FEMS MICROBIOL LETT, V253, P295, DOI 10.1016/j.femsle.2005.09.046; Frisch M. J., 2016, GAUSSIAN 16 REV B 01; Ge XX, 2010, J PHYS CHEM B, V114, P9525, DOI 10.1021/jp100579y; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Iscla I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137994; Iscla I, 2015, J ANTIBIOT, V68, P453, DOI 10.1038/ja.2015.4; Iscla I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5891; Iscla I, 2012, CHANNELS, V6, P255, DOI 10.4161/chan.20756; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kouwen TRHM, 2009, ANTIMICROB AGENTS CH, V53, P4702, DOI 10.1128/AAC.00439-09; Lee TS, 2017, J CHEM THEORY COMPUT, V13, P3077, DOI 10.1021/acs.jctc.7b00102; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malcolm HR, 2014, BIOCHEMISTRY-US, V53, P8005, DOI 10.1021/bi501118c; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Maurer JA, 2001, BBA-BIOMEMBRANES, V1514, P165, DOI 10.1016/S0005-2736(01)00390-X; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; NAGAKURA S, 1957, J CHEM PHYS, V26, P881, DOI 10.1063/1.1743428; Nepali K, 2019, J MED CHEM, V62, P2851, DOI 10.1021/acs.jmedchem.8b00147; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Piddock L, 2013, NEW SCI, V217, P29, DOI 10.1016/S0262-4079(13)60811-8; RAMPERSAUD A, 1991, J BACTERIOL, V173, P6882, DOI 10.1128/jb.173.21.6882-6888.1991; Rao SS, 2016, J ANTIBIOT, V69, P879, DOI 10.1038/ja.2016.45; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sybyl-X, 2013, SYBYL 10 MOL MOD SOF; TAYLOR RK, 1983, J MOL BIOL, V166, P273, DOI 10.1016/S0022-2836(83)80085-0; Ventola C Lee, 2015, P T, V40, P344; Ventola C Lee, 2015, P T, V40, P277; Wang EC, 2019, CHEM REV, V119, P9478, DOI 10.1021/acs.chemrev.9b00055; Wang J, 2001, ANAL CHEM, V73, P1804, DOI 10.1021/ac001424e; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, CURR COMPUT-AID DRUG, V2, P287, DOI 10.2174/157340906778226454; Wang JM, 2012, J CHEM INF MODEL, V52, P1199, DOI 10.1021/ci300064d; Wang L, 2015, J AM CHEM SOC, V137, P2695, DOI 10.1021/ja512751q; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Wray R, 2019, MOL MICROBIOL, V112, P896, DOI 10.1111/mmi.14325; Wray R, 2019, FASEB J, V33, P3180, DOI 10.1096/fj.201801628R; Wray R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002473	70	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228153	10.1371/journal.pone.0228153	http://dx.doi.org/10.1371/journal.pone.0228153			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978161	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100116
J	Gentile, E; Brunetti, A; Ricci, K; Delussi, M; Bevilacqua, V; de Tommaso, M				Gentile, Eleonora; Brunetti, Antonio; Ricci, Katia; Delussi, Marianna; Bevilacqua, Vitoantonio; de Tommaso, Marina			Mutual interaction between motor cortex activation and pain in fibromyalgia: EEG-fNIRS study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; NEAR-INFRARED SPECTROSCOPY; LASER-EVOKED POTENTIALS; DIAGNOSTIC-CRITERIA; FUNCTIONAL MRI; VALIDATION; MOVEMENT; EXERCISE; SYSTEM; BLOOD	Background Experimental and clinical studies suggested an analgesic effect on chronic pain by motor cortex activation. The present study explored the complex mechanisms of interaction between motor and pain during performing the slow and fast finger tapping task alone and in concomitant with nociceptive laser stimulation. Method The participants were 38 patients with fibromyalgia (FM) and 21 healthy subjects. We used a simultaneous multimodal method of laser-evoked potentials and functional near-infrared spectroscopy to investigate metabolic and electrical changes during the finger tapping task and concomitant noxious laser stimulation. Functional near-infrared spectroscopy is a portable and optical method to detect cortical metabolic changes. Laser-evoked potentials are a suitable tool to study the nociceptive pathways function. Results We found a reduced tone of cortical motor areas in patients with FM compared to controls, especially during the fast finger tapping task. FM patients presented a slow motor performance in all the experimental conditions, requesting rapid movements. The amplitude of laser evoked potentials was different between patients and controls, in each experimental condition, as patients showed smaller evoked responses compared to controls. Concurrent phasic pain stimulation had a low effect on motor cortex metabolism in both groups nor motor activity changed laser evoked responses in a relevant way. There were no correlations between Functional Near-Infrared Spectroscopy (FNIRS) and clinical features in FM patients. Conclusion Our findings indicated that a low tone of motor cortex activation could be an intrinsic feature in FM and generate a scarce modulation on pain condition. A simple and repetitive movement such as that of the finger tapping task seems inefficacious in modulating cortical responses to pain both in patients and controls. The complex mechanisms of interaction between networks involved in pain control and motor function require further studies for the important role they play in structuring rehabilitation strategies.	[Gentile, Eleonora; Ricci, Katia; Delussi, Marianna; de Tommaso, Marina] Bari Aldo Moro Univ, Polyclin Gen Hosp, SMBNOS Dept, Appl Neurophysiol & Pain Unit, Bari, Italy; [Brunetti, Antonio; Bevilacqua, Vitoantonio] Polytecn Univ Bari, Dept Elect & Informat Engn, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Politecnico di Bari	Gentile, E (corresponding author), Bari Aldo Moro Univ, Polyclin Gen Hosp, SMBNOS Dept, Appl Neurophysiol & Pain Unit, Bari, Italy.	eleonora.gentile@uniba.it	Brunetti, Antonio/X-7544-2019; delussi, marianna/J-9983-2018; Gentile, Eleonora/AAM-5563-2020; de Tommaso, Marina/K-9790-2018; Bevilacqua, Vitoantonio/AAH-6468-2019; Bevilacqua, Vitoantonio/AAF-5588-2020	Brunetti, Antonio/0000-0002-1934-0983; Gentile, Eleonora/0000-0002-1556-8518; Bevilacqua, Vitoantonio/0000-0002-3088-0788; delussi, marianna/0000-0002-5888-3024	Bari Aldo Moro University Research funds	Bari Aldo Moro University Research funds	The study was supported by Bari Aldo Moro University Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 2017, FRONT HUM NEUROSCI, V11, DOI DOI 10.3389/FNHUM.2017; Arun KM, 2018, NEURORADIOL J, V31, P133, DOI 10.1177/1971400917739083; Atzeni Fabiola, 2019, Clin Exp Rheumatol, V37 Suppl 116, P3; Bair MJ, 2009, PAIN MED, V10, P1280, DOI 10.1111/j.1526-4637.2009.00707.x; Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Belza B, 2018, J NURS MEAS, V26, P36, DOI 10.1891/1061-3749.26.1.36; Brighina F, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00040; Busch AJ, 2011, CURR PAIN HEADACHE R, V15, P358, DOI 10.1007/s11916-011-0214-2; Canny ML, 2009, AM J OCCUP THER, V63, P506, DOI 10.5014/ajot.63.4.506; Cha M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08208-2; Chang WJ, 2018, J PAIN, V19, P341, DOI 10.1016/j.jpain.2017.10.007; Chang WJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008540; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Costa ID, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00014; de Tommaso M, 2017, PAIN RES TREAT, V2017, DOI 10.1155/2017/9747148; de Tommaso M, 2014, J NEUROL, V261, P461, DOI 10.1007/s00415-013-7211-9; de Tommaso M, 2010, J HEADACHE PAIN, V11, P505, DOI 10.1007/s10194-010-0247-7; Devrimsel G, 2019, Z RHEUMATOL, V78, P889, DOI 10.1007/s00393-018-0558-7; Fagerlund AJ, 2015, PAIN, V156, P62, DOI 10.1016/j.pain.0000000000000006; Farina S, 2003, NEUROL RES, V25, P130, DOI 10.1179/016164103101201283; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Gentile E, 2019, FUNCT NEUROL, V34, P107; Gentile E, 2019, PAIN RES TREAT, V2019, DOI 10.1155/2019/2623161; Knijnik LM, 2016, PAIN PRACT, V16, P294, DOI 10.1111/papr.12276; Koklu K, 2016, ARCH RHEUMATOL, V31, P158, DOI 10.5606/ArchRheumatol.2016.5736; Kuboyama Naomi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P105, DOI 10.2114/jpa.23.105; La Bianca G., 2017, NEUROLOGY, V88, P219; Le Pera D, 2007, EUR J NEUROSCI, V25, P1900, DOI 10.1111/j.1460-9568.2007.05389.x; Leavitt F, 2014, PSYCHOL REP, V115, P828, DOI 10.2466/04.15.PR0.115c32z1; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Martinez-Lavin M, 2018, CLIN RHEUMATOL, V37, P3167, DOI 10.1007/s10067-018-4300-2; Mease PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P952, DOI 10.1002/art.23826; Mercier C, 2011, PHYSIOTHER CAN, V63, P305, DOI 10.3138/ptc.2010-08p; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Moyano S, 2015, REUMATOL CLIN, V11, P210, DOI [10.1016/j.reumae.2014.07.005, 10.1016/j.reuma.2014.07.008]; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; O'Connell NE, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008208.pub4, 10.1002/14651858.CD008208.pub5]; O'Connell NE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parker RS, 2016, BRAIN STIMUL, V9, P488, DOI 10.1016/j.brs.2016.03.020; Passard A, 2007, BRAIN, V130, P2661, DOI 10.1093/brain/awm189; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Rasouli O, 2017, J PAIN RES, V10, P303, DOI 10.2147/JPR.S127038; Sarzi-Puttini P, 2003, CLIN EXP RHEUMATOL, V21, P459; Schachter CL, 2003, PHYS THER, V83, P340, DOI 10.1093/ptj/83.4.340; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Shin J, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.3; Togo F, 2015, J NEUROPSYCHOL, V9, P1, DOI 10.1111/jnp.12030; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Valeriani M, 1996, EVOKED POTENTIAL, V100, P343, DOI 10.1016/0168-5597(96)95625-7; Valle Angela, 2009, J Pain Manag, V2, P353; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wolfe F, 2003, J RHEUMATOL, V30, P369; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Xu Y, NIRLAB USER MANUAL; Zama T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16438; Zhao XJ, 2017, NEUROIMAGE-CLIN, V13, P33, DOI 10.1016/j.nicl.2016.11.006; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	64	16	17	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228158	10.1371/journal.pone.0228158	http://dx.doi.org/10.1371/journal.pone.0228158			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971993	Green Published, gold			2022-12-26	WOS:000534374400043
J	Ouahoud, S; Voorneveld, PW; van der Burg, LRA; de Jonge-Muller, ESM; Schoonderwoerd, MJA; Paauwe, M; de Vos, T; de Wit, S; van Pelt, GW; Mesker, WE; Hawinkels, LJAC; Hardwick, JCH				Ouahoud, Sarah; Voorneveld, Philip W.; van der Burg, Lennart R. A.; de Jonge-Muller, Eveline S. M.; Schoonderwoerd, Mark J. A.; Paauwe, Madelon; de Vos, Thijs; de Wit, Sophie; van Pelt, Gabi W.; Mesker, Wilma E.; Hawinkels, Lukas J. A. C.; Hardwick, James C. H.			Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN; APOPTOSIS-INDUCING LIGAND; TUMOR-STROMA RATIO; CONSENSUS MOLECULAR SUBTYPES; INDEPENDENT PREDICTOR; PANCREATIC-CANCER; POOR-PROGNOSIS; CELLS; SMAD4; SURVIVAL	Patients with the mesenchymal subtype colorectal cancer (CRC) have a poor prognosis, in particular patients with stroma-rich tumors and aberrant SMAD4 expression. We hypothesized that interactions between SMAD4-deficient CRC cells and cancer-associated fibroblasts provide a biological explanation. In transwell invasion assays, fibroblasts increased the invasive capacity of SMAD4-deficient HT29 CRC cells, but not isogenic SMAD4-proficient HT29 cells. A TGF-beta/BMP-specific array showed BMP2 upregulation by fibroblasts upon stimulation with conditioned medium from SMAD4-deficient CRC cells, while also stimulating their invasion. In a mouse model for experimental liver metastasis, the co-injection of fibroblasts increased metastasis formation of SMAD4-deficient CRC cells (p = 0.02) but not that of SMAD4-proficient CRC cells. Significantly less metastases were seen in mice co-injected with BMP2 knocked-down fibroblasts. Fibroblast BMP2 expression seemed to be regulated by TRAIL, a factor overexpressed in SMAD4-deficient CRC cells. In a cohort of 146 stage III CRC patients, we showed that patients with a combination of high stromal BMP2 expression and the loss of tumor SMAD4 expression had a significantly poorer overall survival (HR 2.88, p = 0.04). Our results suggest the existence of a reciprocal loop in which TRAIL from SMAD4-deficient CRC cells induces BMP2 in fibroblasts, which enhances CRC invasiveness and metastasis.	[Ouahoud, Sarah; Voorneveld, Philip W.; van der Burg, Lennart R. A.; de Jonge-Muller, Eveline S. M.; Schoonderwoerd, Mark J. A.; Paauwe, Madelon; de Vos, Thijs; de Wit, Sophie; Hawinkels, Lukas J. A. C.; Hardwick, James C. H.] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands; [van Pelt, Gabi W.; Mesker, Wilma E.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hardwick, JCH (corresponding author), Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands.	J.C.H.Hardwick@LUMC.nl	Hawinkels, Lukas/Q-5098-2019; Hardwick, James/J-4862-2013	Hawinkels, Lukas/0000-0002-2274-9325; Hardwick, James/0000-0002-9575-5099; Voorneveld, Philip/0000-0002-3881-4435				Alazzouzi H, 2005, CLIN CANCER RES, V11, P2606, DOI 10.1158/1078-0432.CCR-04-1458; Alhopuro P, 2005, CLIN CANCER RES, V11, P6311, DOI 10.1158/1078-0432.CCR-05-0244; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chen SX, 2014, J PROTEOMICS, V110, P155, DOI 10.1016/j.jprot.2014.07.031; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Dekker TJA, 2013, BREAST CANCER RES TR, V139, P371, DOI 10.1007/s10549-013-2571-5; Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Herzer K, 2008, MOL CANCER RES, V6, P1169, DOI 10.1158/1541-7786.MCR-08-0073; Huijbers A, 2013, ANN ONCOL, V24, P179, DOI 10.1093/annonc/mds246; Irshad S, 2017, J PATHOL, V242, P178, DOI 10.1002/path.4891; Jin H, 2012, APPL MICROBIOL BIOT, V93, P1715, DOI 10.1007/s00253-011-3865-3; Jiramongkolchai P, 2016, BIOCHEM SOC T, V44, P1117, DOI 10.1042/BST20160069; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Karagiannis GS, 2013, MOL ONCOL, V7, P826, DOI 10.1016/j.molonc.2013.04.002; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Kodach LL, 2008, CANCER, V112, P300, DOI 10.1002/cncr.23160; Koornstra JJ, 2003, J PATHOL, V200, P327, DOI 10.1002/path.1364; Lane D, 2004, GYNECOL ONCOL, V93, P594, DOI 10.1016/j.ygyno.2004.03.029; Lee TJ, 2006, BIOCHEM BIOPH RES CO, V351, P1024, DOI 10.1016/j.bbrc.2006.10.163; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Liu J, 2014, GYNECOL ONCOL, V132, P81, DOI 10.1016/j.ygyno.2013.11.003; Lv Z, 2015, SURGERY, V158, P142, DOI 10.1016/j.surg.2015.02.013; Mesker WE, 2007, CELL ONCOL, V29, P387; Mesker WE, 2009, CELL ONCOL, V31, P169, DOI 10.3233/CLO-2009-0478; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Paauwe M, 2018, CLIN CANCER RES, V24, P6331, DOI 10.1158/1078-0432.CCR-18-0329; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Voorneveld PW, 2015, BRIT J CANCER, V112, P122, DOI 10.1038/bjc.2014.560; Voorneveld PW, 2013, BRIT J CANCER, V109, P1805, DOI 10.1038/bjc.2013.486; Voorneveld PW, 2014, GASTROENTEROLOGY, V147, P196, DOI 10.1053/j.gastro.2014.03.052; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang K, 2012, J THORAC ONCOL, V7, P1457, DOI 10.1097/JTO.0b013e318260dfe8; Wenger T, 2006, CELL DEATH DIFFER, V13, P1740, DOI 10.1038/sj.cdd.4401867; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	45	15	15	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2453	2466		10.1038/s41388-020-1157-z	http://dx.doi.org/10.1038/s41388-020-1157-z		JAN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31974473	Green Published			2022-12-26	WOS:000509037000001
J	Nott, MA; Driscoll, HE; Takeda, M; Vangala, M; Corsi, SR; Tighe, SW				Nott, Michelle A.; Driscoll, Heather E.; Takeda, Minoru; Vangala, Mahesh; Corsi, Steven R.; Tighe, Scott W.			Advanced biofilm analysis in streams receiving organic deicer runoff	PLOS ONE			English	Article							SPHAEROTILUS-NATANS; AQUATIC TOXICITY; WATER-QUALITY; OXYGEN-DEMAND; BACTERIA; AIRPORT; GROWTH; SHEATH; POLYSACCHARIDE; IDENTIFICATION	Prolific heterotrophic biofilm growth is a common occurrence in airport receiving streams containing deicers and anti-icers, which are composed of low-molecular weight organic compounds. This study investigated biofilm spatiotemporal patterns and responses to concurrent and antecedent (i.e., preceding biofilm sampling) environmental conditions at stream sites upstream and downstream from Milwaukee Mitchell International Airport in Milwaukee, Wisconsin, during two deicing seasons (2009-2010; 2010-2011). Biofilm abundance and community composition were investigated along spatial and temporal gradients using field surveys and microarray analyses, respectively. Given the recognized role of Sphaerotilus in organically enriched environments, additional analyses were pursued to specifically characterize its abundance: a consensus sthA sequence was determined via comparison of whole metagenome sequences with a previously identified sthA sequence, the primers developed for this gene were used to characterize relative Sphaerotilus abundance using quantitative real-time PCR, and a Sphaerotilus strain was isolated to validate the determined sthA sequence. Results indicated that biofilm abundance was stimulated by elevated antecedent chemical oxygen demand concentrations, a surrogate for deicer concentrations, with minimal biofilm volumes observed when antecedent chemical oxygen demand concentrations remained below 48 mg/L. Biofilms were composed of diverse communities (including sheathed bacterium Thiothrix) whose composition appeared to shift in relation to antecedent temperature and chemical oxygen demand. The relative abundance of sthA correlated most strongly with heterotrophic biofilm volume (positive) and dissolved oxygen (negative), indicating that Sphaerotilus was likely a consistent biofilm member and thrived under low oxygen conditions. Additional investigations identified the isolate as a new strain of Sphaerotilus montanus (strain KMKE) able to use deicer components as carbon sources and found that stream dissolved oxygen concentrations related inversely to biofilm volume as well as to antecedent temperature and chemical oxygen demand. The airport setting provides insight into potential consequences of widescale adoption of organic deicers for roadway deicing.	[Nott, Michelle A.; Corsi, Steven R.] US Geol Survey, Upper Midwest Water Sci Ctr, Middleton, WI 53562 USA; [Driscoll, Heather E.] Norwich Univ, Dept Biol, Vermont Genet Network, Northfield, VT USA; [Takeda, Minoru] Yokohama Natl Univ, Grad Sch Engn, Yokohama, Kanagawa, Japan; [Vangala, Mahesh] Univ Vermont, Vermont Genet Network, Burlington, VT USA; [Tighe, Scott W.] Univ Vermont, Adv Genome Technol Core, Burlington, VT USA; [Vangala, Mahesh] Univ Massachusetts, Med Sch, Data Sci & Technol, Worcester, MA 01605 USA	United States Department of the Interior; United States Geological Survey; Yokohama National University; University of Vermont; University of Vermont; University of Massachusetts System; University of Massachusetts Worcester	Nott, MA (corresponding author), US Geol Survey, Upper Midwest Water Sci Ctr, Middleton, WI 53562 USA.	mnott@usgs.gov		Driscoll, Heather/0000-0002-3772-9933; Nott, Michelle/0000-0003-3968-7586	Milwaukee Mitchell International Airport; US Geological Survey; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [P20GM103449]; Rex Forehand at The University of Vermont	Milwaukee Mitchell International Airport; US Geological Survey(United States Geological Survey); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH); Rex Forehand at The University of Vermont	Financial support for this research was provided by Milwaukee Mitchell International Airport (https://www.mitchellairport.com/) and the US Geological Survey (https://www.usgs.gov/) and was received by SRC. Funding for Vermont Genetics Network (VGN) Bioinformatics and Microarray Core services performed by HED was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS; https://www.nigms.nih.gov/) of the National Institutes of Health (NIH) under grant number P20GM103449; the grant was received by Rex Forehand at The University of Vermont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRP, 2014, 115 ACRP TRANSP RES, P63; American Society for Testing and Materials, 1995, ANN BOOK ASTM STAND; [Anonymous], 1998, US GEOLOGICAL SURVEY; ARMBRUSTER EH, 1969, APPL MICROBIOL, V17, P320, DOI 10.1128/AEM.17.2.320-321.1969; Barr Engineering Company, 2013, CR1102 BARR ENG CO, P64; Battin TJ, 2016, NAT REV MICROBIOL, V14, P251, DOI 10.1038/nrmicro.2016.15; Becking J.H., 2006, PROKARYOTES PROTEOBA, VVolume 5, P151; Berendsen RL, 2018, ISME J, V12, P1496, DOI 10.1038/s41396-018-0093-1; Bernhardt ES, 2002, ECOLOGY, V83, P1689, DOI 10.1890/0012-9658(2002)083[1689:DOCEAN]2.0.CO;2; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Corsi SR, 2001, ENVIRON TOXICOL CHEM, V20, P1474, DOI 10.1002/etc.5620200709; Corsi SR, 2015, SCI TOTAL ENVIRON, V508, P488, DOI 10.1016/j.scitotenv.2014.12.012; Corsi SR, 2012, WATER AIR SOIL POLL, V223, P2447, DOI 10.1007/s11270-011-1036-x; Corsi SR, 2010, ENVIRON SCI TECHNOL, V44, P7376, DOI 10.1021/es101333u; Corsi SR, 2009, ENVIRON SCI TECHNOL, V43, P40, DOI 10.1021/es8017732; CURTIS EJC, 1969, WATER RES, V3, P289, DOI 10.1016/0043-1354(69)90084-0; DeMartini FE, 1934, SEWAGE WORKS J, V6, P950; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DONDERO NC, 1975, ANNU REV MICROBIOL, V29, P407, DOI 10.1146/annurev.mi.29.100175.002203; Dworkin M, 2006, PROKARYOTES, V3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferguson L, 2008, AIRCRAFT DEICING AIR, P1; Findlay SEG, 2011, ANN NY ACAD SCI, V1223, P58, DOI 10.1111/j.1749-6632.2010.05942.x; GRAY NF, 1985, BIOL REV, V60, P499, DOI 10.1111/j.1469-185X.1985.tb00621.x; Gridneva E, 2011, INT J SYST EVOL MICR, V61, P916, DOI 10.1099/ijs.0.023887-0; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1; HIRSCH ALLAN, 1958, NEW ZEALAND JOUR SCI, V1, P500; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Hynes H.B.N., 1960, BIOL POLLUTED WATERS; Kaushal SS, 2016, ENVIRON SCI TECHNOL, V50, P2765, DOI 10.1021/acs.est.6b00679; Kellogg CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108767; Kondo K, 2013, INT J BIOL MACROMOL, V59, P59, DOI 10.1016/j.ijbiomac.2013.04.013; Koryak M, 1998, J FRESHWATER ECOL, V13, P287, DOI 10.1080/02705060.1998.9663621; Lampert W., 2007, LIMNOECOLOGY ECOLOGY, V2; LAU AO, 1984, J WATER POLLUT CON F, V56, P41; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Mapelli F, 2018, ISME J, V12, P1188, DOI 10.1038/s41396-017-0026-4; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mendenhall W, 1999, INTRO PROBABILITY ST; Minot S. S., 2015, ONE CODEX SENSITIVE, DOI [10.1101/027607, DOI 10.1101/027607]; Mohamed MN, 1998, MICROBIAL ECOL, V36, P121; MULDER EG, 1964, J APPL BACTERIOL, V27, P151, DOI 10.1111/j.1365-2672.1964.tb04824.x; Muthumani A, 2015, CR1302 MINN DEP TRAN, P160; Nott MA, 2017, NCBI BIOPROJECT; ODUM HT, 1956, LIMNOL OCEANOGR, V1, P102, DOI 10.4319/lo.1956.1.2.0102; Pellegrin V, 1999, APPL ENVIRON MICROB, V65, P156; Piceno YM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177626; Pillard DA, 1996, J FRESHWATER ECOL, V11, P51, DOI 10.1080/02705060.1996.9663493; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Quinn JM, 1988, T I PROF ENG NZ, V16, P22; R Core Team, 2013, R LANG ENV STAT COMP; Ramakrishna DM, 2005, WATER AIR SOIL POLL, V166, P49, DOI 10.1007/s11270-005-8265-9; Ramothokang TR, 2003, WATER SA, V29, P405; Rantz S.E., 1982, 2175 US GEOL SURV, V2, P631; Schuler MS, 2017, J APPL ECOL, V54, P1353, DOI 10.1111/1365-2664.12877; Seder-Colomina M, 2015, ANTON LEEUW INT J G, V107, P1135, DOI 10.1007/s10482-015-0405-7; Smith L. L., 1963, Transactions of the American Fisheries Society, V92, P220, DOI 10.1577/1548-8659(1963)92[220:SOWEIR]2.0.CO;2; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Stevenson R. J., 1999, RAPID BIOASSESSMENT, P1; Stevenson R. Jan, 2007, P785, DOI 10.1016/B978-012332908-0.50047-4; STOKES JL, 1954, J BACTERIOL, V67, P278, DOI 10.1128/JB.67.3.278-291.1954; Suzuki T, 2002, APPL ENVIRON MICROB, V68, P365, DOI 10.1128/AEM.68.1.365-371.2002; Takeda M, 1998, BIOSCI BIOTECH BIOCH, V62, P1138, DOI 10.1271/bbb.62.1138; Takeda M, 2003, INT J BIOL MACROMOL, V33, P245, DOI 10.1016/j.ijbiomac.2003.08.008; U.S. Environmental Protection Agency, 2007, 8015C US EPA, P36; U.S. Environmental Protection Agency O, 2012, EPA821R12003, P98; U.S. Environmental Protection Agency O, 2012, EPA821R12005, P193; *US EPA, 1993, EPA600R93100 OFF RES; Yang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155472	71	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0227567	10.1371/journal.pone.0227567	http://dx.doi.org/10.1371/journal.pone.0227567			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968006	Green Published, gold			2022-12-26	WOS:000534373000018
J	Han, F; Bonnett, T; Brenowitz, WD; Teylan, MA; Besser, LM; Chen, YC; Chan, G; Cao, KG; Gao, Y; Zhou, XH				Han, Fang; Bonnett, Tyler; Brenowitz, Willa D.; Teylan, Merilee A.; Besser, Lilah M.; Chen, Yen-Chi; Chan, Gary; Cao, Ke-Gang; Gao, Ying; Zhou, Xiao-Hua			Estimating associations between antidepressant use and incident mild cognitive impairment in older adults with depression	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; ALZHEIMERS-DISEASE; DEMENTIA; RISK; POPULATION; VALIDATION; SYMPTOMS; DATABASE; HAZARDS; HEALTH	Introduction Previous studies have provided equivocal evidence of antidepressant use on subsequent cognitive impairment; this could be due to inconsistent modeling approaches. Our goals are methodological and clinical. We evaluate the impact of statistical modeling approaches on the associations between antidepressant use and risk of Mild Cognitive Impairment (MCI) in older adults with depression. Methods 716 participants were enrolled. Our primary analysis employed a time-dependent Cox proportional hazards model. We also implemented two fixed-covariate proportional hazards models-one based on having ever used antidepressants during follow-up, and the other restricted to baseline use only. Results Treating antidepressant use as a time-varying covariate, we found no significant association with incident MCI (HR = 0.92, 95% CI: 0.70, 1.20). In contrast, when antidepressant use was treated as a fixed covariate, we observed a significant association between having ever used antidepressants and lower risk of MCI (HR = 0.40, 95% CI: 0.28, 0.56). However, in the baseline-use only model, the association was non-significant (HR = 0.84, 95% CI: 0.60, 1.17). Discussion Our results were dependent upon statistical models and suggest that antidepressant use should be modeled as a time-varying covariate. Using a robust time-dependent analysis, antidepressant use was not significantly associated with incident MCI among cognitively normal persons with depression.	[Han, Fang] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Acupuncture & Moxibust, Beijing, Peoples R China; [Han, Fang; Teylan, Merilee A.; Besser, Lilah M.; Chen, Yen-Chi; Chan, Gary] Univ Washington, Dept Epidemiol, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Han, Fang; Cao, Ke-Gang; Gao, Ying] Beijing Univ Chinese Med, Dept Neurol, Dongzhimen Hosp, Beijing, Peoples R China; [Bonnett, Tyler] NCI, Clin Monitoring Res Program Directorate, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Brenowitz, Willa D.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Zhou, Xiao-Hua] Peking Univ, Beijing Int Ctr Math Res, Dept Biostat, Beijing, Peoples R China	Capital Medical University; University of Washington; University of Washington Seattle; Beijing University of Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; Peking University	Han, F (corresponding author), Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Acupuncture & Moxibust, Beijing, Peoples R China.; Han, F (corresponding author), Univ Washington, Dept Epidemiol, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA.; Zhou, XH (corresponding author), Peking Univ, Beijing Int Ctr Math Res, Dept Biostat, Beijing, Peoples R China.	1989hanfang@sina.com; azhou@math.pku.edu.cn		Bonnett, Tyler/0000-0001-5545-6433; Zhou, Xiaohua/0000-0001-7935-1222	NIH/NIA [U01 AG016976]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NACC funding (U01 AG016976) from NIH/NIA supported overall data collection. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali V, 2016, AM J ALZHEIMERS DIS, V31, P678, DOI 10.1177/1533317516673463; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Besser L, 2018, ALZ DIS ASSOC DIS, V32, P351, DOI 10.1097/WAD.0000000000000279; Boyle PA, 2010, NEUROEPIDEMIOLOGY, V34, P43, DOI 10.1159/000256662; Brainerd CJ, 2013, NEUROPSYCHOLOGY, V27, P86, DOI 10.1037/a0030855; Burke SL, 2018, INT J GERIATR PSYCH, V33, P200, DOI 10.1002/gps.4709; Carriere I, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0847-z; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Evans DA, 1997, JAMA-J AM MED ASSOC, V277, P822, DOI 10.1001/jama.277.10.822; Fountoulakis KN, 1999, AGING-CLIN EXP RES, V11, P367, DOI 10.1007/BF03339814; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Goveas JS, 2012, INT PSYCHOGERIATR, V24, P1252, DOI 10.1017/S1041610211002778; Han L, 2011, J CLIN PSYCHOPHARM, V31, P429, DOI 10.1097/JCP.0b013e318221b2f8; Jia JP, 2018, ALZHEIMERS DEMENT, V14, P483, DOI 10.1016/j.jalz.2017.12.006; Jones M, 2016, J CRIT CARE, V36, P195, DOI 10.1016/j.jcrc.2016.07.017; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kessing LV, 2011, INT CLIN PSYCHOPHARM, V26, P316, DOI 10.1097/YIC.0b013e32834ace0f; Kessing LV, 2009, J AFFECT DISORDERS, V117, P24, DOI 10.1016/j.jad.2008.11.020; Kodesh A, 2019, AM J GERIATR PSYCHIA; Kostev K, 2019, J ALZHEIMERS DIS, V69, P577, DOI 10.3233/JAD-190239; Lee CWS, 2016, J CLIN PSYCHIAT, V77, P117, DOI 10.4088/JCP.14m09580; Leng Y, 2018, J GERONTOL A-BIOL, V73, P1390, DOI 10.1093/gerona/glx226; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Liu Q, 2019, J PSYCHIAT RES; Mirza SS, 2016, LANCET PSYCHIAT, V3, P628, DOI 10.1016/S2215-0366(16)00097-3; Moraros J, 2017, DEPRESS ANXIETY, V34, P217, DOI 10.1002/da.22584; Patterson C, ANAL PREVALENCE INCI; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Richard E, 2013, JAMA NEUROL, V70, P383, DOI 10.1001/jamaneurol.2013.603; Saczynski JS, 2015, AM J MED, V128, P739, DOI 10.1016/j.amjmed.2015.01.007; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Then CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175187; Tian YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28028; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Wang CK, 2016, ALZ DIS ASSOC DIS, V30, P99, DOI 10.1097/WAD.0000000000000103	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227924	10.1371/journal.pone.0227924	http://dx.doi.org/10.1371/journal.pone.0227924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951629	Green Published, gold			2022-12-26	WOS:000534370500035
J	Tetley, GJN; Murphy, NP; Bonetto, S; Ivanova-Berndt, G; Revell, J; Mott, HR; Cooley, RN; Owen, D				Tetley, George J. N.; Murphy, Natasha P.; Bonetto, Stephane; Ivanova-Berndt, Gabriela; Revell, Jefferson; Mott, Helen R.; Cooley, R. Neil; Owen, Darerca			The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; CDC42; peptide conformation; nuclear magnetic resonance (NMR); GTPase Kras (KRAS); drug discovery; cyclic peptide; cell proliferation; cell signaling; cell migration; biologics; cancer therapeutics; drug discovery	RHO; BINDING; ACTIVATION; MODEL; PHOSPHORYLATION; INHIBITORS; COMPLEXES; GTPASES; KRAS; BACK	Aberrant Ras signaling drives 30% of cancers, and inhibition of the Rho family small GTPase signaling has been shown to combat Ras-driven cancers. Here, we present the discovery of a 16-mer cyclic peptide that binds to Cdc42 with nanomolar affinity. Affinity maturation of this sequence has produced a panel of derived candidates with increased affinity and modulated specificity for other closely-related small GTPases. The structure of the tightest binding peptide was solved by NMR, and its binding site on Cdc42 was determined. Addition of a cell-penetrating sequence allowed the peptides to access the cell interior and engage with their target(s), modulating signaling pathways. In Ras-driven cancer cell models, the peptides have an inhibitory effect on proliferation and show suppression of both invasion and motility. As such, they represent promising candidates for Rho-family small GTPase inhibitors and therapeutics targeting Ras-driven cancers. Our data add to the growing literature demonstrating that peptides are establishing their place in the biologics arm of drug discovery.	[Tetley, George J. N.; Murphy, Natasha P.; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Bonetto, Stephane; Ivanova-Berndt, Gabriela; Cooley, R. Neil] Isogenica Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England; [Revell, Jefferson] MedImmune, Sir Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England; [Tetley, George J. N.] ImmTune Therapies Ltd, 51 Eastcheap, London EC3M 1JP, England; [Bonetto, Stephane] Agenus UK Ltd, 315 Sci Pk, Cambridge CB4 0WG, England; [Ivanova-Berndt, Gabriela] Bicycle Therapeut Ltd, B900 Babraham Res Campus, Cambridge CB22 3AT, England; [Cooley, R. Neil] Abzena, Babraham Res Campus, Cambridge CB22 3AT, England	University of Cambridge; Isogenica Limited; AstraZeneca; Medimmune; Agenus Inc; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Mott, HR; Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	hrm28@cam.ac.uk; do202@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Tetley, George/0000-0002-7134-7066	MRC CASE Studentship [MR/K017101/1]; BBSRC DTP iCASE Studentship [BB/M011194/1]; short-term Glover Research Fund Fellowship	MRC CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC DTP iCASE Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); short-term Glover Research Fund Fellowship	This work was supported by MRC CASE Studentship MR/K017101/1 (to D. O. and R. N. C.), BBSRC DTP iCASE Studentship Grant BB/M011194/1 (to D. O. and J. R.), and a short-term Glover Research Fund Fellowship (to G. J. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2018, LANG ENV STAT COMP; Arias-Romero LE, 2013, EXPERT OPIN THER TAR, V17, P1263, DOI 10.1517/14728222.2013.828037; Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Campbell LJ, 2015, BIOCHEMISTRY-US, V54, P1380, DOI 10.1021/bi501530u; Chakraborty A, 2018, BIOCHEM SOC T, V46, P1303, DOI 10.1042/BST20170529; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Elliot-Smith AE, 2007, BIOCHEMISTRY-US, V46, P14087, DOI 10.1021/bi701539x; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Galande AK, 2001, LETT PEPT SCI, V8, P247, DOI 10.1023/A:1016285331403; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Heard KR, 2013, J MED CHEM, V56, P8339, DOI 10.1021/jm400423p; Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hubbard S. J., 1993, NACCESS; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; LeCher Julia C., 2017, BioMolecular Concepts, V8, P131, DOI 10.1515/bmc-2017-0023; Li SQ, 2018, NAT REV CANCER, V18, P767, DOI 10.1038/s41568-018-0076-6; Lim YT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208273; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mahendrarajah N, 2017, CELL SIGNAL, V39, P9, DOI 10.1016/j.cellsig.2017.07.014; Mahendrarajah N, 2016, J CANCER RES CLIN, V142, P2263, DOI 10.1007/s00432-016-2229-x; Martinek TA, 2012, CHEM SOC REV, V41, P687, DOI 10.1039/c1cs15097a; McCormick F, 2018, ANNU REV CANC BIOL, V2, P81, DOI 10.1146/annurev-cancerbio-050216-122010; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Mott HR, 2019, SEMIN CANCER BIOL, V54, P149, DOI 10.1016/j.semcancer.2018.01.001; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Owen D, 2018, BIOCHEM SOC T, V46, P1289, DOI 10.1042/BST20170570; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Qian ZQ, 2016, BIOCHEMISTRY-US, V55, P2601, DOI 10.1021/acs.biochem.6b00226; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Santra S, 2011, J AM CHEM SOC, V133, P16680, DOI 10.1021/ja207463b; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spencer-Smith R, 2019, SEMIN CANCER BIOL, V54, P138, DOI 10.1016/j.semcancer.2017.12.005; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Tetley GJN, 2018, J BIOL CHEM, V293, P15136, DOI 10.1074/jbc.RA118.003290; Tetley GJN, 2017, J BIOL CHEM, V292, P11361, DOI 10.1074/jbc.M117.789883; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang K, 2014, INT J NANOMED, V9, P4991, DOI 10.2147/IJN.S72560; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200	65	8	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2866	2884		10.1074/jbc.RA119.010077	http://dx.doi.org/10.1074/jbc.RA119.010077			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31959628	Green Published, hybrid			2022-12-26	WOS:000519969100027
J	Weldon, KB; Woolgar, A; Rich, AN; Williams, MA				Weldon, Kimberly B.; Woolgar, Alexandra; Rich, Anina N.; Williams, Mark A.			Late disruption of central visual field disrupts peripheral perception of form and color	PLOS ONE			English	Article							DISTINCT MODES; FEEDBACK; CORTEX; BINDING; SIGNALS; VISION	Evidence from neuroimaging and brain stimulation studies suggest that visual information about objects in the periphery is fed back to foveal retinotopic cortex in a separate representation that is essential for peripheral perception. The characteristics of this phenomenon have important theoretical implications for the role fovea-specific feedback might play in perception. In this work, we employed a recently developed behavioral paradigm to explore whether late disruption to central visual space impaired perception of color. In the first experiment, participants performed a shape discrimination task on colored novel objects in the periphery while fixating centrally. Consistent with the results from previous work, a visual distractor presented at fixation similar to 100ms after presentation of the peripheral stimuli impaired sensitivity to differences in peripheral shapes more than a visual distractor presented at other stimulus onset asynchronies. In a second experiment, participants performed a color discrimination task on the same colored objects. In a third experiment, we further tested for this foveal distractor effect with stimuli restricted to a low-level feature by using homogenous color patches. These two latter experiments resulted in a similar pattern of behavior: a central distractor presented at the critical stimulus onset asynchrony impaired sensitivity to peripheral color differences, but, importantly, the magnitude of the effect was stronger when peripheral objects contained complex shape information. These results show a behavioral effect consistent with disrupting feedback to the fovea, in line with the foveal feedback suggested by previous neuroimaging studies.	[Weldon, Kimberly B.] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55455 USA; [Weldon, Kimberly B.; Woolgar, Alexandra; Rich, Anina N.; Williams, Mark A.] Macquarie Univ, Fac Human Sci, Dept Cognit Sci, Percept Act Res Ctr PARC, Sydney, NSW, Australia; [Weldon, Kimberly B.; Woolgar, Alexandra; Rich, Anina N.; Williams, Mark A.] Macquarie Univ, ARC Ctr Excellence Cognit & its Disorders, Sydney, NSW, Australia; [Woolgar, Alexandra] Univ Cambridge, Cognit & Brain Sci Unit, Med Res Council UK, Cambridge, England	University of Minnesota System; University of Minnesota Twin Cities; Macquarie University; Macquarie University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Weldon, KB (corresponding author), Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55455 USA.; Weldon, KB (corresponding author), Macquarie Univ, Fac Human Sci, Dept Cognit Sci, Percept Act Res Ctr PARC, Sydney, NSW, Australia.; Weldon, KB (corresponding author), Macquarie Univ, ARC Ctr Excellence Cognit & its Disorders, Sydney, NSW, Australia.	kweldon@umn.edu		Woolgar, Alexandra/0000-0002-8453-7424; Rich, Anina/0000-0002-5702-6450	NHMRC [APP1028578]; ARC [DP170101840]; MRC (U.K) [SUAG/052/G101400]; International Macquarie University Research Excellence Scholarship [2013234]; MRC [MC_UU_00005/17] Funding Source: UKRI	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); MRC (U.K)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); International Macquarie University Research Excellence Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an NHMRC project grant (APP1028578) awarded to MAW and ANR, and an ARC grant (DP170101840) awarded to ANR and AW. AW is supported by MRC (U.K) intramural funding SUAG/052/G101400. KBW was supported by an International Macquarie University Research Excellence Scholarship (No. 2013234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck DM, 2005, J EXP PSYCHOL HUMAN, V31, P592, DOI 10.1037/0096-1523.31.3.592; Chambers CD, 2013, CORTEX, V49, P327, DOI 10.1016/j.cortex.2012.03.007; Clifford CWG, 2003, J VISION, V3, P106, DOI 10.1167/3.2.1; Fan XX, 2016, P NATL ACAD SCI USA, V113, P11627, DOI 10.1073/pnas.1606137113; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Forte JD, 2005, VISION RES, V45, P2715, DOI 10.1016/j.visres.2005.05.001; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hurme M, 2017, NEUROIMAGE, V150, P230, DOI 10.1016/j.neuroimage.2017.02.060; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Zhaoping L, 2019, CURR OPIN NEUROBIOL, V58, P1, DOI 10.1016/j.conb.2019.06.001; Macknik Stephen L, 2008, Adv Cogn Psychol, V3, P125, DOI 10.2478/v10053-008-0020-5; Merriam EP, 2007, J NEUROPHYSIOL, V97, P1738, DOI 10.1152/jn.00189.2006; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Seymour KJ, 2016, CEREB CORTEX, V26, P1997, DOI 10.1093/cercor/bhv021; Seymour K, 2010, CEREB CORTEX, V20, P1946, DOI 10.1093/cercor/bhp265; Shapley R, 2011, VISION RES, V51, P701, DOI 10.1016/j.visres.2011.02.012; Shipp S, 2009, CEREB CORTEX, V19, P2230, DOI 10.1093/cercor/bhn243; Stockman A, 2010, OSA HDB OPTICS; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Weldon KB, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2015.00699, 10.3389/fpsyg.2016.00699]; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Wyatte D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00674; Yu Q, 2016, J VISION, V16, DOI 10.1167/16.3.15; Zhaoping L, 2017, VISION RES, V136, P32, DOI 10.1016/j.visres.2017.05.002	30	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0219725	10.1371/journal.pone.0219725	http://dx.doi.org/10.1371/journal.pone.0219725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999697	gold, Green Published, Green Submitted			2022-12-26	WOS:000534612400002
J	Ching, KH; Berg, K; Morales, J; Pedersen, D; Harriman, WD; Abdiche, YN; Leighton, PA				Ching, Kathryn H.; Berg, Kimberley; Morales, Jacqueline; Pedersen, Darlene; Harriman, William D.; Abdiche, Yasmina N.; Leighton, Philip A.			Expression of human lambda expands the repertoire of OmniChickens	PLOS ONE			English	Article							RECOMBINANT ANTIBODIES; DOMAIN INTERACTIONS; FAB FRAGMENT; GENERATION; CHICKENS; MOUSE	Most of the approved monoclonal antibodies used in the clinic were initially discovered in mice. However, many targets of therapeutic interest are highly conserved proteins that do not elicit a robust immune response in mice. There is a need for non-mammalian antibody discovery platforms which would allow researchers to access epitopes that are not recognized in mammalian hosts. Recently, we introduced the OmniChicken (R), a transgenic animal carrying human VH3-23 and VK3-15 at its immunoglobulin loci. Here, we describe a new version of the OmniChicken which carries VH3-23 and either VL1-44 or VL3-19 at its heavy and light chain loci, respectively. The V lambda-expressing birds showed normal B and T populations in the periphery. A panel of monoclonal antibodies demonstrated comparable epitope coverage of a model antigen compared to both wild-type and V kappa-expressing OmniChickens. Kinetic analysis identified binders in the picomolar range. The V lambda-expressing bird increases the antibody diversity available in the OmniChicken platform, further enabling discovery of therapeutic leads.	[Ching, Kathryn H.; Berg, Kimberley; Morales, Jacqueline; Pedersen, Darlene; Harriman, William D.; Leighton, Philip A.] Ligand Pharmaceut Inc, Emeryville, CA 94608 USA; [Abdiche, Yasmina N.] Carterra Inc, Salt Lake City, UT USA	Ligand Pharmaceuticals	Ching, KH (corresponding author), Ligand Pharmaceut Inc, Emeryville, CA 94608 USA.	kching@ligand.com		Ching, Kathryn/0000-0002-1932-1504; Berg, Kimberley/0000-0003-2639-2981	Neither Carterra, Inc; Ligand Pharmaceuticals Incorporated	Neither Carterra, Inc; Ligand Pharmaceuticals Incorporated	Neither Carterra, Inc or Ligand Pharmaceuticals Incorporated played a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Both organizations provided only financial support in the form of salary and research materials.	Abdiche YN, 2016, MABS-AUSTIN, V8, P264, DOI 10.1080/19420862.2015.1118596; Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Andris-Widhopf J, 2000, METHODS GENERATION C, P1; Bowes T, 2011, J BIOMOL SCREEN, V16, P744, DOI 10.1177/1087057111407067; Ching KH, 2018, MABS-AUSTIN, V10, P71, DOI 10.1080/19420862.2017.1386825; Clarke J, 2004, REGUL TOXICOL PHARM, V40, P219, DOI 10.1016/j.yrtph.2004.06.007; Collarini E, 2015, POULTRY SCI, V94, P799, DOI [10.3382/ps.2014-04372, 10.3382/ps.2014-4372]; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Finlay WJJ, 2005, CLIN EXP ALLERGY, V35, P1040, DOI 10.1111/j.1365-2222.2005.02307.x; Gassmann M, 2004, EFFICIENT PRODUCTION, P1; Gjetting T, 2019, MABS-AUSTIN, V11, P666, DOI 10.1080/19420862.2019.1596514; Green LL, 2014, TRANSGENIC MOUSE STR, P1; Green LL, 2004, AIAA ATM FLIGHT MECH, P1; Grilo AL, 2019, TRENDS BIOTECHNOL, V37, P9, DOI 10.1016/j.tibtech.2018.05.014; Grzeschik J, 2018, METHODS MOL BIOL, V1701, P147, DOI 10.1007/978-1-4939-7447-4_8; Hof D, 2008, CLIN EXP IMMUNOL, V151, P367, DOI 10.1111/j.1365-2249.2007.03569.x; Huynh K, 2001, ANAL PROTEIN STABILI, DOI [10.1002/0471140864.ps2809s79, DOI 10.1002/0471140864.PS2809S79]; Ibrahim RA, 2015, SPRINGER PROC PHYS, V168, P1, DOI 10.1007/978-3-319-19851-4_1; Izquierdo SM, 2016, MICROSCOPY-JPN, V65, P341, DOI 10.1093/jmicro/dfw014; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lee CH, 2017, TOXINS, V9, DOI 10.3390/toxins9110347; Leighton PA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01317; Lonberg N, 2002, ANTIGEN SPECIFIC HUM, P1; Lonberg N, 2008, CURR OPIN IMMUNOL, V20, P450, DOI 10.1016/j.coi.2008.06.004; Muyldermans S, 2016, CURR OPIN IMMUNOL, V40, P7, DOI 10.1016/j.coi.2016.02.003; Palfree RGE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133749; Reynaud C-A, 2003, SOMATIC HYPERCONVERS, P1; Reynaud C-A, 1995, SINGLE REARRANGEMENT, P1; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Schusser B, 2016, EUR J IMMUNOL, V46, P2137, DOI 10.1002/eji.201546171; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Schusser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080108; Song YH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113381; Stewart R, 2015, CANCER IMMUNOL RES, V3, P1052, DOI 10.1158/2326-6066.CIR-14-0191; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Teerinen T, 2006, J MOL BIOL, V361, P687, DOI 10.1016/j.jmb.2006.06.073; Tiller T, 2013, MABS-AUSTIN, V5, P445, DOI 10.4161/mabs.24218; Toughiri R, 2016, MABS-AUSTIN, V8, P1276, DOI 10.1080/19420862.2016.1214785; Treacy G., 2006, HUMAN EXPT TOXICOLOG, P226; van de Lavoir MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035664; Vedadi M, 2006, CHEM SCREENING METHO, P1; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228164	10.1371/journal.pone.0228164	http://dx.doi.org/10.1371/journal.pone.0228164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995598	Green Published, gold			2022-12-26	WOS:000534609400051
J	Criss, SD; Palazzo, L; Watson, TR; Paquette, AM; Sigel, K; Wisnivesky, J; Kong, CY				Criss, Steven D.; Palazzo, Lauren; Watson, Tina R.; Paquette, Adelle M.; Sigel, Keith; Wisnivesky, Juan; Kong, Chung Yin			Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden	PLOS ONE			English	Article							HEALTH; CHEMOTHERAPY; CISPLATIN; OUTCOMES	Objectives While previous cost-effectiveness studies on pembrolizumab in stage IV non-small cell lung cancer (NSCLC) have found these regimens to be cost-effective, their reliance on randomized controlled trial (RCT) data with strict inclusion criteria limits generalizability to patients with comorbidities. We estimated the cost-effectiveness of first-line pembrolizumab for patients with various comorbidities. Materials and methods In our base case analysis, we studied pembrolizumab plus chemotherapy (pembrolizumab combination therapy) versus chemotherapy alone. In a secondary analysis, we considered only patients with PD-L1 expression of at least 50% (PD-L1-high) and evaluated pembrolizumab monotherapy, pembrolizumab combination therapy, and chemotherapy alone. Microsimulation models were developed for the base case and the PD-L1-high analyses. To estimate outcomes of patients with differing comorbidities, we combined survival data from patients with few or no comorbidities from the RCTs with estimates from the general population obtained from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. Comorbidity burden level was divided into three groups based on the Charlson score (equal to 0, 1, or 2+); patients with various other specific comorbidities were also analyzed. Incremental cost-effectiveness ratios (ICER) were compared to a willingness-to-pay (WTP) threshold of $100,000/quality-adjusted life-year (QALY). Results In the Charlson 0, Charlson 1, and Charlson 2+ patient populations, estimated ICERs for pembrolizumab combination therapy in the base case model were $173,919/QALY, $175,165/QALY, and $181,777/QALY, respectively, compared to chemotherapy. In the PD-L1-high model, the Charlson 0, Charlson 1, and Charlson 2+ patients had ICERs of $147,406/QALY, $149,026/QALY, and $154,521/QALY with pembrolizumab combination therapy versus chemotherapy. Pembrolizumab monotherapy was weakly dominated for each comorbidity group in the PD-L1-high model. Conclusion For patients with stage IV NSCLC and varying comorbidity burden, first-line treatment with pembrolizumab does not represent a cost-effective strategy compared to chemotherapy. Resources should be focused on collecting immunotherapy survival data for more representative NSCLC patient populations.	[Criss, Steven D.; Palazzo, Lauren; Watson, Tina R.; Paquette, Adelle M.; Kong, Chung Yin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Sigel, Keith; Wisnivesky, Juan] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA; [Wisnivesky, Juan] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, New York, NY 10029 USA; [Kong, Chung Yin] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School	Kong, CY (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Kong, CY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	joey@mgh-ita.org	Sigel, Keith Magnus/AAZ-7898-2021	Sigel, Keith Magnus/0000-0002-4051-4861; Kong, Chung Yin/0000-0001-6431-7830; Criss, Steven/0000-0002-9394-1381	National Institutes of Health [U01CA199284, R01CA202956]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [grant numbers U01CA199284, R01CA202956; CYK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HEALTHC COST UT PROJ; [Anonymous], 2018, SEER MED LINK DAT; [Anonymous], 2019, PHYS FEE SCHED SEARC; [Anonymous], 2018, SEER CANC STAT FACTS; Centers for Medicare & Medicaid Services, 2019, ASP DRUG PRIC FIL; Criss SD, 2019, JAMA ONCOL, V5, P358, DOI 10.1001/jamaoncol.2018.5449; Dunn A, 2018, HEALTH SERV RES, V53, P175, DOI 10.1111/1475-6773.12612; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Georgieva M, 2018, LUNG CANCER, V124, P248, DOI 10.1016/j.lungcan.2018.08.018; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Hellmann Matthew D, 2018, N Engl J Med, V378, P2093, DOI 10.1056/NEJMoa1801946; Ho GY, 2016, CRIT REV ONCOL HEMAT, V102, P37, DOI 10.1016/j.critrevonc.2016.03.014; Howlader N, SEER CANC STAT REV; Huang M, 2017, PHARMACOECONOMICS, V35, P831, DOI 10.1007/s40273-017-0527-z; Insinga RP, 2019, CURR MED RES OPIN, V35, P1241, DOI 10.1080/03007995.2019.1571297; Insinga RP, 2018, J MED ECON, V21, P1191, DOI 10.1080/13696998.2018.1521416; Institute NC, SURV EP END RES MED; Khozin S, 2019, ONCOLOGIST, V24, P648, DOI 10.1634/theoncologist.2018-0307; Kumar V, 2018, ANN INTERN MED, V168, P161, DOI 10.7326/M17-1401; Leduc C, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01721-2016; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Reck M, 2019, J CLIN ONCOL, V37, P537, DOI 10.1200/JCO.18.00149; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Santana-Davila R, 2014, J THORAC ONCOL, V9, P702, DOI 10.1097/JTO.0000000000000146; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sigel K, 2017, ANN AM THORAC SOC, V14, P1512, DOI 10.1513/AnnalsATS.201706-442ED; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Tramontano AC, 2015, MED DECIS MAKING, V35, P371, DOI 10.1177/0272989X15570364; Unger JM, 2019, JAMA ONCOL, V5, P326, DOI 10.1001/jamaoncol.2018.5953; Unger JM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju002	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228288	10.1371/journal.pone.0228288	http://dx.doi.org/10.1371/journal.pone.0228288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995619	Green Published, gold			2022-12-26	WOS:000534609400061
J	Liu, L; Basso, B				Liu, Lin; Basso, Bruno			Impacts of climate variability and adaptation strategies on crop yields and soil organic carbon in the US Midwest	PLOS ONE			English	Article							NO-TILL; CORN; MODEL; MANAGEMENT; TERM; PRODUCTIVITY; TEMPERATURE; SENSITIVITY; RESPONSES; ROTATION	Climate change is likely to increase the frequency of drought and more extreme precipitation events. The objectives of this study were i) to assess the impact of extended drought followed by heavy precipitation events on yield and soil organic carbon (SOC) under historical and future climate, and ii) to evaluate the effectiveness of climate adaptation strategies (no-tillage and new cultivars) in mitigating impacts of increased frequencies of extreme events and warming. We used the validated SALUS crop model to simulate long-term maize and wheat yield and SOC changes of maize-soybean-wheat rotation cropping systems in the northern Midwest USA under conventional tillage and no-till for three climate change scenarios (one historical and two projected climates under the Representative Concentration Path (RCP) 4.5 and RCP6) and two precipitation changes (extreme precipitation occurring early or late season). Extended drought events caused additional yield reduction when they occurred later in the season (10-22% for maize and 5-13% for wheat) rather than in early season (5-17% for maize and 2-18% for wheat). We found maize grain yield declined under the projected climates, whereas wheat grain yield increased. No-tillage is able to reduce yield loss compared to conventional tillage and increased SOC levels (1.4-2.0 t/ha under the three climates), but could not reverse the adverse impact of climate change, unless early and new improved maize cultivars are introduced to increase yield and SOC under climate change. This study demonstrated the need to consider extreme weather events, particularly drought and extreme precipitation events, in climate impact assessment on crop yield and adaptation through no-tillage and new genetics reduces yield losses.	[Liu, Lin; Basso, Bruno] Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA; [Basso, Bruno] Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Basso, B (corresponding author), Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA.; Basso, B (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA.	basso@msu.edu	Liu, Lin/ABC-6165-2020; Basso, Bruno/A-3128-2012	Basso, Bruno/0000-0003-2090-4616	US Department of Agriculture National Institute of Food and Agriculture [2015-6800723133]; U.S. National Science Foundation's Dynamics of Coupled Natural and Human Systems Program [1313677]; NSF's Kellogg Biological Station Long Term Ecological Research Site (NSF) [DEB 1027253]; Environmental Science and Policy Program at Michigan State University; Michigan State University AgBioResearch; USDA/NIFA HATCH [MCL02368]	US Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); U.S. National Science Foundation's Dynamics of Coupled Natural and Human Systems Program; NSF's Kellogg Biological Station Long Term Ecological Research Site (NSF); Environmental Science and Policy Program at Michigan State University; Michigan State University AgBioResearch; USDA/NIFA HATCH	This work was partially funded by US Department of Agriculture National Institute of Food and Agriculture (award no. 2015-6800723133) to BB, U.S. National Science Foundation's Dynamics of Coupled Natural and Human Systems Program (award 1313677) to BB, with additional support from NSF's Kellogg Biological Station Long Term Ecological Research Site (NSF grant no. DEB 1027253); the Environmental Science and Policy Program at Michigan State University, and Michigan State University AgBioResearch and USDA/NIFA HATCH grant N. MCL02368 to BB.	Asseng S, 2017, GLOBAL CHANGE BIOL, V23, P2464, DOI 10.1111/gcb.13530; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Basso B, 2018, AGR ENV LETT, V3, DOI 10.2134/ael2018.05.0026; Basso B., 2006, Italian Journal of Agronomy, V1, P677; Basso B., 2015, ECOLOGY AGR LANDSCAP, P252; Basso B, 2018, AGR ENV LETT, V3, DOI 10.2134/ael2017.11.0039; Basso B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127333; Basso B, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0173; Basso B, 2011, SOIL SCI SOC AM J, V75, P69, DOI 10.2136/sssaj2010.0115; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Brouder SM, 2014, AGR ECOSYST ENVIRON, V187, P11, DOI 10.1016/j.agee.2013.08.010; Busari MA, 2015, INT SOIL WATER CONSE, V3, P119, DOI 10.1016/j.iswcr.2015.05.002; Crawley H, 2018, POL PRESS SHORT, P29; Crum JR, 1995, KELLOGG BIOL STATION; Dai SW, 2016, INT J CLIMATOL, V36, P517, DOI 10.1002/joc.4354; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Derpsch R, 2008, NO TILL FARMING SYST, V3, P7; Doll JE, 2017, WEATHER CLIM SOC, V9, P739, DOI 10.1175/WCAS-D-16-0110.1; Dzotsi KA, 2013, ECOL MODEL, V260, P62, DOI 10.1016/j.ecolmodel.2013.03.017; Fischer EM, 2013, NAT CLIM CHANGE, V3, P1033, DOI [10.1038/NCLIMATE2051, 10.1038/nclimate2051]; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Giller KE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00870; Halvorson AD, 2002, AGRON J, V94, P1429, DOI 10.2134/agronj2002.1429; Hatfield JL, 2018, CLIMATIC CHANGE, V146, P263, DOI 10.1007/s10584-017-1997-x; Huggins DR, 2008, SCI AM, V299, P70, DOI 10.1038/scientificamerican0708-70; ISMAIL I, 1994, SOIL SCI SOC AM J, V58, P193, DOI 10.2136/sssaj1994.03615995005800010028x; Jones JW, 2017, AGR SYST, V155, P240, DOI 10.1016/j.agsy.2016.05.014; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2015, J SOIL WATER CONSERV, V70, p55A, DOI 10.2489/jswc.70.3.55A; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Liu L, 2017, GCB BIOENERGY, V9, P1320, DOI 10.1111/gcbb.12417; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; NESMITH DS, 1992, AGRON J, V84, P107, DOI 10.2134/agronj1992.00021962008400010021x; Nordstrom R, 2014, NATL CLIMATE ASSESSM, P418; Ogle SM, 2012, AGR ECOSYST ENVIRON, V149, P37, DOI 10.1016/j.agee.2011.12.010; Pathak P, 2017, INT J WATER RESOUR D, V33, P1003, DOI 10.1080/07900627.2016.1238343; Paustian K, 1995, SOIL MANAGEMENT GREE, P69; Pittelkow CM, 2015, FIELD CROP RES, V183, P156, DOI 10.1016/j.fcr.2015.07.020; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen DJ, 2016, J APPL METEOROL CLIM, V55, P2301, DOI 10.1175/JAMC-D-15-0302.1; Riha SJ, 1996, CLIMATIC CHANGE, V32, P293, DOI 10.1007/BF00142466; Ritchie JT, 1998, SYST APPR S, V7, P41; Ritchie JT, 1998, SOIL WATER BALANCE P, P79; Robertson G.P., 2015, ECOLOGY AGR LANDSCAP, P1; Robertson GP, 2014, FARMING ECOSYSTEM SE; Rotter RP, 2018, FIELD CROP RES, V221, P142, DOI 10.1016/j.fcr.2018.02.023; Sacks WJ, 2011, AGR FOREST METEOROL, V151, P882, DOI 10.1016/j.agrformet.2011.02.010; Semenov MA, 1997, CLIMATIC CHANGE, V35, P397, DOI 10.1023/A:1005342632279; Senthilkumar S, 2009, SOIL SCI SOC AM J, V73, P2078, DOI 10.2136/sssaj2009.0044; Sindelar AJ, 2015, AGRON J, V107, P2241, DOI 10.2134/agronj15.0085; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Skaalsveen K, 2019, SOIL TILL RES, V189, P98, DOI 10.1016/j.still.2019.01.004; Southworth J, 2000, AGR ECOSYST ENVIRON, V82, P139, DOI 10.1016/S0167-8809(00)00223-1; Suleiman AA, 2003, SOIL SCI SOC AM J, V67, P377, DOI 10.2136/sssaj2003.0377; Turmel MS, 2015, AGR SYST, V134, P6, DOI 10.1016/j.agsy.2014.05.009; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [DOI 10.7930/J0KW5CXT, 10.7930/J0KW5CXT]; Westgate ME, 2011, CROP ADAPTATION TO CLIMATE CHANGE, P314; Wiesmeier M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32525; Wuebbles Donald J., 2014, Eos, Transactions American Geophysical Union, V95, P149, DOI 10.1002/2014EO180001	64	21	21	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0225433	10.1371/journal.pone.0225433	http://dx.doi.org/10.1371/journal.pone.0225433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990907	Green Published, gold, Green Submitted			2022-12-26	WOS:000534605400007
J	Michalak-Majewska, M; Teterycz, D; Muszynski, S; Radzki, W; Sykut-Domanska, E				Michalak-Majewska, Monika; Teterycz, Dorota; Muszynski, Siemowit; Radzki, Wojciech; Sykut-Domanska, Emilia			Influence of onion skin powder on nutritional and quality attributes of wheat pasta	PLOS ONE			English	Article							CELL-WALL POLYMERS; DIETARY FIBER; BY-PRODUCTS; ANTIOXIDANT PROPERTIES; WASTE; SPAGHETTI; SEMOLINA; COOKING; FLOUR	Onion skin is a waste produced during onion bulb processing. Recent studies have reported that it contains large amounts of bioaccessible and bioavailable compounds thus it can be used to design of novel food products. The objective of the study was an attempt to substitute semolina with onion skin (OS) powder in pasta at 2.5, 5 and 7.5 g/100 g levels. The effects on the chemical composition, antioxidant potential, technological and sensory properties of the fortified pasta samples were evaluated compared with a control sample. Fortification with OS resulted in a significant (P < 0.05) improvement in nutritional properties, which was demonstrated by an increase in the content of dietary fibre, ash, total phenolic compounds, flavonoids content and antioxidant activity (FRAP and DPPH). Cooking loss increased with increasing levels of OS, however, all pasta samples were in the acceptable range (8 g/100 g). Onion skin incorporation decreased optimal cooking time, water solubility index and increase redness (a*), compared to the control sample. Results of sensory evaluation suggest that pasta, in which 2.5% of the flour was replaced by this plant component, showed the highest value of the "overall quality". Our study indicates that onion skin powder can be a potential alternative for the food industry to provide nutritional enriched pasta.	[Michalak-Majewska, Monika; Radzki, Wojciech] Univ Life Sci Lublin, Dept Fruits Vegetables & Mushrooms Technol, Dept Plant Food Technol & Gastron, Lublin, Poland; [Teterycz, Dorota; Sykut-Domanska, Emilia] Univ Life Sci Lublin, Dept Plant Food Technol & Gastron, Div Engn & Cereals Technol, Lublin, Poland; [Muszynski, Siemowit] Univ Life Sci Lublin, Dept Biophys, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin; University of Life Sciences in Lublin	Michalak-Majewska, M (corresponding author), Univ Life Sci Lublin, Dept Fruits Vegetables & Mushrooms Technol, Dept Plant Food Technol & Gastron, Lublin, Poland.	monika.michalak@up.lublin.pl	Muszyński, Siemowit/U-4945-2018; Michalak-Majewska, Monika/Y-4222-2018	Muszyński, Siemowit/0000-0002-4118-6302; Sykut-Domanska, Emilia/0000-0002-2741-2772; Radzki, Wojciech/0000-0001-9094-3026; Michalak-Majewska, Monika/0000-0002-3575-1838; Teterycz, Dorota/0000-0002-8714-9814				AACC, 2000, APPR METH AM ASS CER; Aranibar C, 2018, LWT-FOOD SCI TECHNOL, V89, P381, DOI 10.1016/j.lwt.2017.11.003; Aravind N, 2012, FOOD CHEM, V130, P299, DOI 10.1016/j.foodchem.2011.07.042; Awaja F, 2005, EUR POLYM J, V41, P1453, DOI 10.1016/j.eurpolymj.2005.02.005; Benitez V, 2011, PLANT FOOD HUM NUTR, V66, P48, DOI 10.1007/s11130-011-0212-x; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Desai A, 2018, LWT-FOOD SCI TECHNOL, V89, P52, DOI 10.1016/j.lwt.2017.10.023; Dick JW., 1988, DURUM WHEAT CHEM TEC, P237; Fares C, 2010, FOOD CHEM, V119, P1023, DOI 10.1016/j.foodchem.2009.08.006; Fu BX, 2013, J CEREAL SCI, V57, P560, DOI 10.1016/j.jcs.2013.03.007; Fuad T, 2010, CRIT REV FOOD SCI, V50, P787, DOI 10.1080/10408390903001693; Gallegos-Infante JA, 2010, FOOD CHEM, V119, P1544, DOI 10.1016/j.foodchem.2009.09.040; Gawlik-Dziki U, 2013, FOOD CHEM, V138, P1621, DOI 10.1016/j.foodchem.2012.09.151; Grigelmo-Miguel N, 1999, FOOD SCI TECHNOL-LEB, V32, P503, DOI 10.1006/fstl.1999.0587; Helrick K., 1990, OFF METH AN, V15 th ed.; Horiuchi JI, 2000, BIORESOURCE TECHNOL, V75, P153, DOI 10.1016/S0960-8524(00)00044-4; Hunt R. G. W., 1987, MEASURING COLOUR; International Pasta Organisation-Survey, WORLD PAST IND 2013; ISO, 2012, 85862012 ISO; Jaime L, 2001, J SCI FOOD AGR, V81, P177, DOI 10.1002/1097-0010(20010115)81:2&lt;177::AID-JSFA796&gt;3.0.CO;2-9; Jalgaonkar K, 2018, J FOOD PROCESS PRES, V42, DOI 10.1111/jfpp.13575; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kee H.J., 2000, KOREAN SOC FOOD SCI, V32, P578; Kee H.J., 2001, J KOREAN SOC FOOD SC, V30, P64; Laleg K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160721; Lecain S, 1999, CARBOHYD POLYM, V38, P59, DOI 10.1016/S0144-8617(98)00080-0; Lu XK, 2018, FOOD CHEM, V264, P199, DOI 10.1016/j.foodchem.2018.04.130; Manthey FA, 2002, CEREAL CHEM, V79, P504, DOI 10.1094/CCHEM.2002.79.4.504; Michalak-Majewska M, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.12914; Minarovicova L, 2018, CZECH J FOOD SCI, V36, P66, DOI 10.17221/242/2017-CJFS; Monteiro MLG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168270; Mourtzinos I, 2018, ELECTROPHORESIS, V39, P1975, DOI 10.1002/elps.201800073; Ng A, 1999, CARBOHYD POLYM, V39, P341, DOI 10.1016/S0144-8617(99)00025-9; Ng A, 1999, CARBOHYD POLYM, V38, P69, DOI 10.1016/S0144-8617(98)00081-2; Oliviero T, 2016, TRENDS FOOD SCI TECH, V51, P58, DOI 10.1016/j.tifs.2016.03.008; Pasqualone A, 2017, INT J FOOD SCI TECH, V52, P2078, DOI 10.1111/ijfs.13486; Radzki W, 2014, INT J MED MUSHROOMS, V16, P65, DOI 10.1615/IntJMedMushr.v16.i1.60; Rajeswari G., 2013, Food Bioscience, V4, P13; Roldan-Marin E, 2009, BRIT J NUTR, V102, P1574, DOI 10.1017/S0007114509990870; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Sayed H.S., 2014, CURRENT SCI J, V3, P468; Schieber A, 2001, TRENDS FOOD SCI TECH, V12, P401, DOI 10.1016/S0924-2244(02)00012-2; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sobota A, 2015, INT J FOOD SCI TECH, V50, P111, DOI 10.1111/ijfs.12641; Stone H, 2007, SENSORY EVALUATION P; Tonyali B, 2017, ACTA HORTIC, V1152, P393, DOI [10.17660/ActaHortic.2017.1152.53, 10.17660/actahortic.2017.1152.53]; WHO/FAO, 2003, FAO FOOD NUTR PAPER, V77, P93; Wiczkowski Wieslaw, 2003, Polish Journal of Food and Nutrition Sciences, V12, P95	50	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227942	10.1371/journal.pone.0227942	http://dx.doi.org/10.1371/journal.pone.0227942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986166	Green Published, gold			2022-12-26	WOS:000534603400034
J	Nelson, WC; Graham, EB; Crump, AR; Fansler, SJ; Arntzen, EV; Kennedy, DW; Stegen, JC				Nelson, William C.; Graham, Emily B.; Crump, Alex R.; Fansler, Sarah J.; Arntzen, Evan, V; Kennedy, David W.; Stegen, James C.			Distinct temporal diversity profiles for nitrogen cycling genes in a hyporheic microbiome	PLOS ONE			English	Article							BIODIVERSITY; COMMUNITIES; RESILIENCE; REDUNDANCY; MAFFT; SOIL	Biodiversity is thought to prevent decline in community function in response to changing environmental conditions through replacement of organisms with similar functional capacity but different optimal growth characteristics. We examined how this concept translates to the within-gene level by exploring seasonal dynamics of within-gene diversity for genes involved in nitrogen cycling in hyporheic zone communities. Nitrification genes displayed low richness-defined as the number of unique within-gene phylotypes-across seasons. Conversely, denitrification genes varied in both richness and the degree to which phylotypes were recruited or lost. These results demonstrate that there is not a universal mechanism for maintaining community functional potential for nitrogen cycling activities, even across seasonal environmental shifts to which communities would be expected to be well adapted. As such, extreme environmental changes could have very different effects on the stability of the different nitrogen cycle activities. These outcomes suggest a need to modify existing conceptual models that link biodiversity to microbiome function to incorporate within-gene diversity. Specifically, we suggest an expanded conceptualization that 1) recognizes component steps (genes) with low diversity as potential bottlenecks influencing pathway-level function, and 2) includes variation in both the number of entities (e.g. species, phylotypes) that can contribute to a given process and the turnover of those entities in response to shifting conditions. Building these concepts into process-based ecosystem models represents an exciting opportunity to connect within-gene-scale ecological dynamics to ecosystem-scale services.	[Nelson, William C.; Graham, Emily B.; Fansler, Sarah J.; Arntzen, Evan, V; Kennedy, David W.; Stegen, James C.] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Crump, Alex R.] Univ Idaho, Dept Soil & Water Syst, Moscow, ID 83843 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Idaho; University of Idaho	Nelson, WC (corresponding author), Pacific Northwest Natl Lab, Richland, WA 99352 USA.	william.nelson@pnnl.gov	Graham, Emily/AAD-6705-2021; Stegen, James/Q-3078-2016; Nelson, William C/E-9263-2016	Graham, Emily/0000-0002-4623-7076; Stegen, James/0000-0001-9135-7424; Nelson, William C/0000-0002-1873-3929; Crump, Alex/0000-0002-2443-6146	US Department of Energy, Office of Biological and environmental Research, Subsurface Biogeochemical Research Program's Scientific Focus Area (SFA) at the Pacific Northwest National Laboratory (PNNL); DOE [DE-AC06-76RLO 1830]; DOE Joint Genome Institute under Community Science Project [1781]	US Department of Energy, Office of Biological and environmental Research, Subsurface Biogeochemical Research Program's Scientific Focus Area (SFA) at the Pacific Northwest National Laboratory (PNNL)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); DOE Joint Genome Institute under Community Science Project(United States Department of Energy (DOE))	This research and all authors were supported by the US Department of Energy, Office of Biological and environmental Research (https://www.energy.gov/science/ber/biological-andenvironmental-research), as part of Subsurface Biogeochemical Research Program's (https://www.doesbr.org) Scientific Focus Area (SFA) at the Pacific Northwest National Laboratory (PNNL). PNNL is operated for DOE by Battelle under contract DE-AC06-76RLO 1830. Sequencing was done at the DOE Joint Genome Institute under Community Science Project 1781 awarded to J.C. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Coskun OK, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01083-18; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gibbons SM, 2015, CURR OPIN GENET DEV, V35, P66, DOI 10.1016/j.gde.2015.10.003; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Graham EB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00214; Graham EB, 2017, ENVIRON MICROBIOL, V19, P1552, DOI 10.1111/1462-2920.13720; Graham EB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01949; Graham EB, 2014, SOIL BIOL BIOCHEM, V68, P279, DOI 10.1016/j.soilbio.2013.08.023; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jones CM, 2014, NAT CLIM CHANGE, V4, P801, DOI [10.1038/NCLIMATE2301, 10.1038/nclimate2301]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keil D, 2011, FEMS MICROBIOL ECOL, V77, P95, DOI 10.1111/j.1574-6941.2011.01091.x; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lansdown K, 2014, ENVIRON SCI TECHNOL, V48, P4425, DOI 10.1021/es4056005; Mobberley JM, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix028; Nelson MB, 2016, P NATL ACAD SCI USA, V113, P8033, DOI 10.1073/pnas.1601070113; Nelson MB, 2015, APPL ENVIRON MICROB, V81, P7012, DOI 10.1128/AEM.02222-15; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rosenfeld JS, 2002, OIKOS, V98, P156, DOI 10.1034/j.1600-0706.2002.980116.x; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; SCHIMEL J, 1995, ECOL STU AN, V113, P239; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Shapleigh J.P., 2013, PROKARYOTES, VFourth, P405, DOI [10.1007/978-3-642-30141-4_71, DOI 10.1007/978-3-642-30141-4_71]; Song HS, 2017, BIOINFORMATICS, V33, P2345, DOI 10.1093/bioinformatics/btx171; Stegen JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02922-9; Stoliker DL, 2016, ENVIRON SCI TECHNOL, V50, P3649, DOI 10.1021/acs.est.5b06155; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wang Q, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0093-6; Wang ZY, 2012, WORLD J MICROB BIOT, V28, P2741, DOI 10.1007/s11274-012-1085-3; West SA, 2016, NAT REV MICROBIOL, V14, P716, DOI 10.1038/nrmicro.2016.111; Winogradsky S., 1890, ANN I PASTEUR, V4, P213; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	44	5	5	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228165	10.1371/journal.pone.0228165	http://dx.doi.org/10.1371/journal.pone.0228165			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986180	Green Published, Green Submitted, gold			2022-12-26	WOS:000534603400040
J	Baier, C; Linke, L; Eder, M; Schwab, F; Chaberny, IF; Vonberg, RP; Ebadi, E				Baier, Claas; Linke, Lena; Eder, Matthias; Schwab, Frank; Chaberny, Iris Freya; Vonberg, Ralf-Peter; Ebadi, Ella			Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients	PLOS ONE			English	Article							CENTRAL VENOUS CATHETER; LENGTH-OF-STAY; DISEASES WORKING PARTY; STEM-CELL TRANSPLANT; NEUTROPENIC PATIENTS; ATTRIBUTABLE COST; INSERTION SITE; COMPLICATIONS; SURVEILLANCE; PREVENTION	Non-implanted central vascular catheters (CVC) are frequently required for therapy in hospitalized patients with hematological malignancies or solid tumors. However, CVCs may represent a source for bloodstream infections (central line-associated bloodstream infections, CLABSI) and, thus, may increase morbidity and mortality of these patients. A retrospective cohort study over 3 years was performed. Risk factors were determined and evaluated by a multivariable logistic regression analysis. Healthcare costs of CLABSI were analyzed in a matched case-control study. In total 610 patients got included with a CLABSI incidence of 10.6 cases per 1,000 CVC days. The use of more than one CVC per case, CVC insertion for conditioning for stem cell transplantation, acute myeloid leukemia, leukocytopenia (<= 1000/mu L), carbapenem therapy and pulmonary diseases were independent risk factors for CLABSI. Hospital costs directly attributed to the onset of CLABSI were 8,810 (sic) per case. CLABSI had a significant impact on the overall healthcare costs. Knowledge about risk factors and infection control measures for CLABSI prevention is crucial for best clinical practice.	[Baier, Claas; Linke, Lena; Vonberg, Ralf-Peter; Ebadi, Ella] Hannover Med Sch, Inst Med Microbiol, Hannover, Germany; [Baier, Claas; Linke, Lena; Vonberg, Ralf-Peter; Ebadi, Ella] Hannover Med Sch, Hosp Epidemiol, Hannover, Germany; [Eder, Matthias] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Schwab, Frank] Charite, Inst Hyg & Environm Med, Berlin, Germany; [Chaberny, Iris Freya] Leipzig Univ Hosp, Hosp Epidemiol & Environm Med, Inst Hyg, Leipzig, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Ebadi, E (corresponding author), Hannover Med Sch, Inst Med Microbiol, Hannover, Germany.; Ebadi, E (corresponding author), Hannover Med Sch, Hosp Epidemiol, Hannover, Germany.	ebadi.ella@mh-hannover.de	Chaberny, Iris F./P-5579-2019	Chaberny, Iris F./0000-0001-5859-3660	Hannover Medical School	Hannover Medical School	We would like to thank the financial and controlling department of the Hannover Medical School for providing financial data.	Apostolopolou E, 2010, J CLIN NURS, V19, P1560, DOI 10.1111/j.1365-2702.2009.03011.x; Arvaniti K, 2017, CRIT CARE MED, V45, pE437, DOI 10.1097/CCM.0000000000002092; Blennow O, 2014, TRANSPL INFECT DIS, V16, P106, DOI 10.1111/tid.12175; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; Dettenkofer M, 2005, CLIN INFECT DIS, V40, P926, DOI 10.1086/428046; Goudie A, 2014, PEDIATRICS, V133, pE1525, DOI 10.1542/peds.2013-3795; Hanna HA, 2001, INFECT CONT HOSP EP, V22, P165, DOI 10.1086/501885; Heinz WJ, 2017, ANN HEMATOL, V96, P1775, DOI 10.1007/s00277-017-3098-3; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; HOWELL PB, 1995, CANCER, V75, P1367, DOI 10.1002/1097-0142(19950315)75:6<1367::AID-CNCR2820750620>3.0.CO;2-Z; Huang CT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2155-1; Ielapi N, 2020, REV RECENT CLIN TRIA, V15, P22, DOI 10.2174/1574887114666191018144739; Kato Y, 2018, J INFECT CHEMOTHER, V24, P31, DOI 10.1016/j.jiac.2017.08.013; Kelly M, 2011, INFECT CONT HOSP EP, V32, P1079, DOI 10.1086/662376; Leistner R, 2014, INFECTION, V42, P31, DOI 10.1007/s15010-013-0494-z; Lu Y, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0386-1; Luft D, 2010, ANN HEMATOL, V89, P1265, DOI 10.1007/s00277-010-1005-2; Marik PE, 2012, CRIT CARE MED, V40, P2479, DOI 10.1097/CCM.0b013e318255d9bc; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Metzger KE, 2015, INFECT CONT HOSP EP, V36, P119, DOI 10.1017/ice.2014.38; Meyer E, 2007, BONE MARROW TRANSPL, V39, P173, DOI 10.1038/sj.bmt.1705561; Miliaraki M, 2017, PEDIATR INT, V59, P769, DOI 10.1111/ped.13289; Mollee P, 2011, J HOSP INFECT, V78, P26, DOI 10.1016/j.jhin.2011.01.018; National Healthcare Safety Network, 2020, BLOODSTR INF EV CENT; Nosari AM, 2008, LEUKEMIA LYMPHOMA, V49, P2148, DOI 10.1080/10428190802409930; Parienti JJ, 2015, NEW ENGL J MED, V373, P1220, DOI 10.1056/NEJMoa1500964; Puchter L, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0291-z; Rhee Y, 2015, INFECT CONT HOSP EP, V36, P424, DOI 10.1017/ice.2014.86; Safdar N, 2004, INTENS CARE MED, V30, P62, DOI 10.1007/s00134-003-2045-z; Shaul DB, 1998, J AM COLL SURGEONS, V186, P654, DOI 10.1016/S1072-7515(98)00096-9; Snarski E, 2015, TRANSPL INFECT DIS, V17, P558, DOI 10.1111/tid.12399; Tarpatzi A, 2012, NEW MICROBIOL, V35, P429; Wilson MZ, 2014, AM J INFECT CONTROL, V42, P1157, DOI 10.1016/j.ajic.2014.07.025; Wisplinghoff H, 2003, INFECT CONT HOSP EP, V24, P905, DOI 10.1086/502158; Wolf HH, 2008, ANN HEMATOL, V87, P863, DOI 10.1007/s00277-008-0509-5; Wylie MC, 2010, INFECT CONT HOSP EP, V31, P1049, DOI 10.1086/656246; Ziegler MJ, 2015, INFECTION, V43, P29, DOI 10.1007/s15010-014-0689-y; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	39	23	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227772	10.1371/journal.pone.0227772	http://dx.doi.org/10.1371/journal.pone.0227772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978169	Green Published, gold			2022-12-26	WOS:000534599100058
J	Bonaretti, S; Gold, GE; Beaupre, GS				Bonaretti, Serena; Gold, Garry E.; Beaupre, Gary S.			pyKNEEr: An image analysis workflow for open and reproducible research on femoral knee cartilage	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; ARTICULAR-CARTILAGE; OSTEOARTHRITIC KNEES; MR-IMAGES; SEGMENTATION; CLASSIFICATION; JOINT; EFFICIENT; T-2	Transparent research in musculoskeletal imaging is fundamental to reliably investigate diseases such as knee osteoarthritis (OA), a chronic disease impairing femoral knee cartilage. To study cartilage degeneration, researchers have developed algorithms to segment femoral knee cartilage from magnetic resonance (MR) images and to measure cartilage morphology and relaxometry. The majority of these algorithms are not publicly available or require advanced programming skills to be compiled and run. However, to accelerate discoveries and findings, it is crucial to have open and reproducible workflows. We present pyKNEEr, a framework for open and reproducible research on femoral knee cartilage from MR images. pyKNEEr is written in python, uses Jupyter notebook as a user interface, and is available on GitHub with a GNU GPLv3 license. It is composed of three modules: 1) image preprocessing to standardize spatial and intensity characteristics; 2) femoral knee cartilage segmentation for intersubject, multimodal, and longitudinal acquisitions; and 3) analysis of cartilage morphology and relaxometry. Each module contains one or more Jupyter notebooks with narrative, code, visualizations, and dependencies to reproduce computational environments. pyKNEEr facilitates transparent image-based research of femoral knee cartilage because of its ease of installation and use, and its versatility for publication and sharing among researchers. Finally, due to its modular structure, pyKNEEr favors code extension and algorithm comparison. We tested our reproducible workflows with experiments that also constitute an example of transparent research with pyKNEEr, and we compared pyKNEEr performances to existing algorithms in literature review visualizations. We provide links to executed notebooks and executable environments for immediate reproducibility of our findings.	[Bonaretti, Serena; Gold, Garry E.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Bonaretti, Serena; Beaupre, Gary S.] VA Palo Alto Hlth Care Syst, Musculoskeletal Res Lab, Palo Alto, CA 94304 USA; [Beaupre, Gary S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Bonaretti, Serena] Transparent MSK Res, Maastricht, Netherlands	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Bonaretti, S (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.; Bonaretti, S (corresponding author), VA Palo Alto Hlth Care Syst, Musculoskeletal Res Lab, Palo Alto, CA 94304 USA.; Bonaretti, S (corresponding author), Transparent MSK Res, Maastricht, Netherlands.	serena.bonaretti.research@gmail.com	Beaupre, Gary/B-9880-2013	Beaupre, Gary/0000-0002-6211-7621; Gold, Garry/0000-0002-3207-822X	Merit Review award from the United States (U.S.) Department of Veterans Affairs, Rehabilitation Research & Development Service [I01 RX001811]; U.S. National Institutes of Health (NIH) [R01 EB002524, K24 AR062068]	Merit Review award from the United States (U.S.) Department of Veterans Affairs, Rehabilitation Research & Development Service(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.B. and G.S.B. were supported by Merit Review award I01 RX001811 from the United States (U.S.) Department of Veterans Affairs, Rehabilitation Research & Development Service (https://www.rehab.research.va.gov).G.E.G.was supported by awards R01 EB002524 and K24 AR062068 from the U.S. National Institutes of Health (NIH) (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambellan F, 2018, MED IMAGE ANAL; Amberg M, 2010, MICCAI 2010 WORKSH M, P251; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bae KT, 2009, OSTEOARTHR CARTILAGE, V17, P1589, DOI 10.1016/j.joca.2009.06.003; Bollen K., 2015, REPORT SUBCOMMITTEE; Carballido-Gamio J, 2008, MED IMAGE ANAL, V12, P120, DOI 10.1016/j.media.2007.08.002; Chen W, 2015, QUANT IMAGING MED SU, V5, P583, DOI 10.3978/j.issn.2223-4292.2015.08.05; Claerbout Jon F., 2005, 62 ANN INT M, P601, DOI [10.1190/1.1822162, DOI 10.1190/1.1822162]; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Commission TE, 2012, COMM REC 17 JUL 2012; Dam EB, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.2.024001; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doehrmann O, 2013, JAMA PSYCHIAT, V70, P87, DOI 10.1001/2013.jamapsychiatry.5; Donoho DL, 2009, COMPUT SCI ENG, V11, P8, DOI 10.1109/MCSE.2009.15; Eckstein F, 2016, EUR RADIOL, V26, P1942, DOI 10.1007/s00330-015-3977-8; Esteban O, 2019, NATURE METHODS, V16, P1; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Folkesson J, 2007, IEEE T MED IMAGING, V26, P106, DOI 10.1109/TMI.2006.886808; Gil Y, 2016, EARTH SPACE SCI, V3, P388, DOI 10.1002/2015EA000136; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Gundersen OE, 2018, AI MAG, V39, P56, DOI 10.1609/aimag.v39i3.2816; Hafezi-Nejad N, 2018, OSTEOARTHR CARTILAGE, V26, P341, DOI 10.1016/j.joca.2018.01.007; Halilaj E, 2018, OSTEOARTHR CARTILAGE, V26, P770, DOI 10.1016/j.joca.2018.03.009; Heimann T., 2010, P MICCAI WORKSH MED, P207; Hunter DJ, 2014, NAT REV RHEUMATOL, V10, P437, DOI 10.1038/nrrheum.2014.44; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jimenez Rafael C, 2017, F1000Res, V6, DOI 10.12688/f1000research.11407.1; Jupyter Project, 2018, P 17 PYTHON SCI C, P113, DOI [10.25080/Majora-4af1f417-011, DOI 10.25080/MAJORA-4AF1F417-011]; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Lawson GM, 2013, DEVELOPMENTAL SCI, V16, P641, DOI 10.1111/desc.12096; Lee JG, 2014, MED PHYS, V41, DOI 10.1118/1.4893533; Lee S, 2011, COMPUT VIS IMAGE UND, V115, P1710, DOI 10.1016/j.cviu.2011.05.014; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Liu F, 2018, MAGN RESON MED, V79, P2379, DOI 10.1002/mrm.26841; Liu Q, 2016, INT WORKSH MACH LEAR, P186; Liukkonen MK, 2017, COMPUT METHOD BIOMEC, V20, P1453, DOI 10.1080/10255842.2017.1375477; Lowekamp BC, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00045; Luger R, 2018, ARXIV181006559V1ASTR; Maier J, 2017, J INTEGR BIOINFORMAT, V14, DOI 10.1515/jib-2017-0015; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16073, DOI [10.1038/nrdp.2016.72, 10.1038/nrdp.2016.73]; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Miller K, 2015, INT J EARLY YEARS ED, V23, P153, DOI 10.1080/09669760.2014.992869; Monu UD, 2017, OSTEOARTHR CARTILAGE, V25, P513, DOI 10.1016/j.joca.2016.09.015; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Norman B, 2018, RADIOLOGY, V288, P177, DOI 10.1148/radiol.2018172322; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Ozturk CN, 2016, COMPUT BIOL MED, V72, P90, DOI 10.1016/j.compbiomed.2016.03.011; Palazzo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090633; Pang JF, 2015, J DIGIT IMAGING, V28, P695, DOI 10.1007/s10278-015-9780-x; Pedoia V, 2016, MAGN RESON MATER PHY, V29, P207, DOI 10.1007/s10334-016-0532-9; Pedoia V, 2016, J MAGN RESON IMAGING, V43, P970, DOI 10.1002/jmri.25065; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Peterfy CG, 2008, OSTEOARTHR CARTILAGE, V16, P1433, DOI 10.1016/j.joca.2008.06.016; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Prasoon A, 2013, LECT NOTES COMPUT SC, V8150, P246, DOI 10.1007/978-3-642-40763-5_31; Prasoon A, 2013, IEEE ENG MED BIO, P5469, DOI 10.1109/EMBC.2013.6610787; Prlic A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002802; R Core Team, 2021, R LANGUAGE ENV STAT; Rule A, 2018, ARXIV181008055; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schaefer LF, 2017, OSTEOARTHR CARTILAGE, V25, P1107, DOI 10.1016/j.joca.2017.01.010; Seim H., 2010, PROC MEDICAL IMAGE A, P215; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Shan L, 2014, MED IMAGE ANAL, V18, P1233, DOI 10.1016/j.media.2014.05.008; Shim H, 2009, RADIOLOGY, V251, P548, DOI 10.1148/radiol.2512081332; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Solloway S, 1997, MAGNET RESON MED, V37, P943, DOI 10.1002/mrm.1910370620; Sveinsson B, 2017, MAGN RESON IMAGING, V38, P63, DOI 10.1016/j.mri.2016.12.018; Tamez-Pena JG, 2012, IEEE T BIO-MED ENG, V59, P1177, DOI 10.1109/TBME.2012.2186612; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; van Tiel J, 2016, RADIOLOGY, V279, P523, DOI 10.1148/radiol.2015150693; Vincent G, 2011, MICCAI 2010 WORKSH M; Wang P, 2016, J MED IMAG HEALTH IN, V6, P948, DOI 10.1166/jmihi.2016.1748; Wang Q, 2013, REMIE-MULTIDISCIP J, V3, P101, DOI 10.4471/remie.2013.08; Wang ZH, 2013, LECT NOTES COMPUT SC, V8184, P98, DOI 10.1007/978-3-319-02267-3_13; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkinson L., 2005, GRAMMAR GRAPHICS STA, V2nd; Williams TG, 2010, IEEE T MED IMAGING, V29, P1541, DOI 10.1109/TMI.2010.2047653; Woelfle M, 2011, NAT CHEM, V3, P745, DOI 10.1038/nchem.1149; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; YANIV Z, 2018, J DIGIT IMAGING, V31, P290, DOI DOI 10.1007/S10278-017-0037-8; Yin Y, 2010, IEEE T MED IMAGING, V29, P2023, DOI 10.1109/TMI.2010.2058861; Zhang B, 2018, COMPUTER AIDED KNEE; Zhang KL, 2013, MAGN RESON IMAGING, V31, P1731, DOI 10.1016/j.mri.2013.06.005; Zhou ZY, 2018, MAGN RESON MED, V80, P2759, DOI 10.1002/mrm.27229	87	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0226501	10.1371/journal.pone.0226501	http://dx.doi.org/10.1371/journal.pone.0226501			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978052	Green Published, Green Submitted, gold			2022-12-26	WOS:000534599100016
J	Morales-Ramos, JA; Rojas, MG; Dossey, AT; Berhow, M				Morales-Ramos, Juan A.; Rojas, M. Guadalupe; Dossey, Aaron T.; Berhow, Mark			Self-selection of food ingredients and agricultural by-products by the house cricket, Acheta domesticus (Orthoptera: Gryllidae): A holistic approach to develop optimized diets	PLOS ONE			English	Article							DISTILLERS DRIED GRAINS; CONVERSION EFFICIENCY; CORN-EARWORM; VITAMINS; SOLUBLES; PROTEIN; GROWTH; LARVAE; FEED	The house cricket, Acheta domesticus L. (Orthoptera: Gryllidae) is one of the most important species of industrialized insects in the United States. Within the past five years the market of cricket powder as a food ingredient has been growing with increasing consumer interest on more sustainable sources of food. However, high labor costs of cricket production and high prices of cricket feed formulations result in cricket powder market prices much higher than other protein-rich food ingredients, making cricket powder only competitive within the novelty food market. In this study new diets formulated using by-products were developed using dietary self-selection followed by regression analysis. Crickets selected among seven different combinations of ingredients. Consumption ratios of food ingredients and by-products were used to determine macro and micro-nutrient intake. Regression analysis was used to determine the individual nutrient intake effect on cricket biomass production. Intake of vitamin C, sterol, manganese, and vitamins B1 and B5 had the most significant impact on live biomass production. Four diets were formulated based on this information and compared with a reference (Patton's 13) and a commercial diet. Although, crickets reared on Patton's diet 13 produced the most dry-weight biomass and developed the fastest, diet 4 (consisting of 92% by-products) generated the most profit (with a cost of $0.39 USD per kg) after an economic analysis that did not include the commercial formulation. Dry-weight biomass production was not significantly different among the four new diets and the commercial diet. This study demonstrated the value of dietary self-selection studies in developing oligidic insect diets and in studies of insect nutrition. This is the first such study involving farmed edible crickets and agricultural by-products. Four new cricket diet formulations contain between 62 and 92% agricultural by-products are included.	[Morales-Ramos, Juan A.; Rojas, M. Guadalupe] ARS, USDA, Natl Biol Control Lab, Stoneville, MS USA; [Dossey, Aaron T.] All Things Bugs LLC, Oklahoma City, OK USA; [Berhow, Mark] ARS, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Morales-Ramos, JA (corresponding author), ARS, USDA, Natl Biol Control Lab, Stoneville, MS USA.	juan.moralesramos@ars.usda.gov		Dossey, Aaron T/0000-0002-6652-964X; Morales-Ramos, Juan/0000-0002-3506-3859	company All Things Bugs, LLC	company All Things Bugs, LLC	One of the authors was affiliated to the company All Things Bugs, LLC, and this company was awarded the SBIR grant specified in the funding statement. This author's "Aaron T. Dossey" salary was paid by the SBIR grant. The company itself "All Things Bugs" did not provide any funding to the project. This project was executed under a USDA-ARS Cooperative Research and Development Agreement with All Things Bugs, LLC, which stated that all the results and any intellectual property obtained through this study belong to the United States Government. No company or funding organization participated in the planning of this study. Since in principle they are public property according to the policies of USDA-ARS on scientific research results obtained by government scientist as part of their duties. All the other three authors are US Government employees, who participated in this study as part of their duties.	AgEBB (Agricultural Electronic Bulletin Board), 2019, BY PROD FEED PRIC LI; Alibaba.com, 2019, AGR FOOD; Amorim M, 2016, J FOOD ENG, V185, P42, DOI 10.1016/j.jfoodeng.2016.03.032; Barragan-Fonseca K, 2018, J ECON ENTOMOL, V111, P2676, DOI 10.1093/jee/toy270; Batajoo KK, 1998, ANIM FEED SCI TECH, V71, P165, DOI 10.1016/S0377-8401(97)00132-6; Bills CE, 1930, J BIOL CHEM, V87, P258; Blasi DA, 2000, SOYBEAN HULLS KANSAS; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chapman R. F., 1998, THE INSECTS; Cohen A. C., 2015, INSECT DIETS SCI TEC; Conway G, 2012, ONE BILLION HUNGRY C; Ortiz JAC, 2016, INSECTS AS SUSTAINABLE FOOD INGREDIENTS: PRODUCTION, PROCESSING AND FOOD APPLICATIONS, P153, DOI 10.1016/B978-0-12-802856-8.00006-5; Dossey AT, 2016, INSECTS AS SUSTAINABLE FOOD INGREDIENTS: PRODUCTION, PROCESSING AND FOOD APPLICATIONS, P113, DOI 10.1016/B978-0-12-802856-8.00005-3; Downer R.G.H., 1978, P57; Finke MD, 2015, ZOO BIOL, V34, P554, DOI 10.1002/zoo.21246; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; Freund R. J., 2003, REGRESSION USING JMP; Gahukar RT, 2016, INSECTS AS SUSTAINABLE FOOD INGREDIENTS: PRODUCTION, PROCESSING AND FOOD APPLICATIONS, P85, DOI 10.1016/B978-0-12-802856-8.00004-1; HOUSE HL, 1961, ANNU REV ENTOMOL, V6, P13, DOI 10.1146/annurev.en.06.010161.000305; Huszar S., 2003, Allattenyesztes es Takarmanyozas, V52, P277; Huynh MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39709-x; Jung B, 2013, J APPL POULTRY RES, V22, P71, DOI 10.3382/japr.2012-00595; Kahlon, 2009, FIBER INGREDIENTS FO, P305, DOI DOI 10.1201/9781420043853-C14; KAUFMAN MG, 1989, J INSECT PHYSIOL, V35, P957, DOI 10.1016/0022-1910(89)90019-X; KEUTH S, 1993, J APPL BACTERIOL, V75, P427, DOI 10.1111/j.1365-2672.1993.tb02798.x; Kim Y, 2008, BIORESOURCE TECHNOL, V99, P5165, DOI 10.1016/j.biortech.2007.09.028; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lundy ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118785; McFarlane J.E., 1985, P59; Morales-Ramos JA, 2018, J INSECTS FOOD FEED, V4, P51, DOI [10.3920/JIFF2017.0062, 10.3920/jiff2017.0062]; Morales-Ramos JA., 2014, MASS PRODUCTION BENE, P203; Morales-Ramos JA, 2013, J ENTOMOL SCI, V48, P206; Myers R.H., 1986, CLASSICAL MODERN REG; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; National Research Council United States, 1982, CAN TABL FEED COMP N, V3; Nelson P.R., 2005, ANAL MEANS GRAPHICAL; NEVILLE PF, 1961, J NUTR, V74, P265, DOI 10.1093/jn/74.3.265; Newkirk R, 2009, CANOLA MEAL FEED IND; Nguyen TTX, 2015, ENVIRON ENTOMOL, V44, P406, DOI 10.1093/ee/nvv002; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pascacio-Villafan C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173205; PATTON RL, 1967, ANN ENTOMOL SOC AM, V60, P1238, DOI 10.1093/aesa/60.6.1238; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; SAS Institute, 2015, JMP STAT DISC SOFTW; SCHIFF NM, 1988, ENTOMOL EXP APPL, V46, P249, DOI 10.1007/BF00364196; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Smetana S, 2016, J CLEAN PROD, V137, P741, DOI 10.1016/j.jclepro.2016.07.148; Spiehs MJ, 2002, J ANIM SCI, V80, P2639; Steinfeld H., 2006, LIV LONG SHAD; Tosch W, 2005, J I BREWING, V111, P197, DOI 10.1002/j.2050-0416.2005.tb00666.x; TRUMPER S, 1993, J INSECT PHYSIOL, V39, P857, DOI 10.1016/0022-1910(93)90118-B; U. S. Grains Council, 2012, GUID DIST DRIED GAIN; ULRICH RG, 1981, APPL ENVIRON MICROB, V41, P246, DOI 10.1128/AEM.41.1.246-254.1981; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; USDA, 2019, FOOD MARK PRIC; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; Vogel G, 2010, SCIENCE, V327, P811, DOI 10.1126/science.327.5967.811; WALDBAUE.GP, 1973, J INSECT PHYSIOL, V19, P407, DOI 10.1016/0022-1910(73)90115-7; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; WALDBAUER GP, 1984, PHYSIOL ZOOL, V57, P590, DOI 10.1086/physzool.57.6.30155985; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; WU YV, 1982, J FOOD SCI, V47, P1155, DOI 10.1111/j.1365-2621.1982.tb07639.x; Zar JH, 1999, BIOSTATISTICAL ANAL	65	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227400	10.1371/journal.pone.0227400	http://dx.doi.org/10.1371/journal.pone.0227400			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978186	Green Published, gold			2022-12-26	WOS:000534599100037
J	Shahkouhi, AM; Motamedian, E				Shahkouhi, Ali Malek; Motamedian, Ehsan			Reconstruction of a regulated two-cell metabolic model to study biohydrogen production in a diazotrophic cyanobacterium Anabaena variabilis ATCC 29413	PLOS ONE			English	Article							PHOTOBIOLOGICAL HYDROGEN-PRODUCTION; NITROGEN-FIXING CYANOBACTERIUM; BLUE-GREEN-ALGAE; BIDIRECTIONAL HYDROGENASE; CELLULAR-DIFFERENTIATION; CARBON-DIOXIDE; HETEROCYST; FIXATION; GROWTH; EXPRESSION	Anabaena variabilis is a diazotrophic filamentous cyanobacterium that differentiates to heterocysts and produces hydrogen as a byproduct. Study on metabolic interactions of the two differentiated cells provides a better understanding of its metabolism especially for improving hydrogen production. To this end, a genome-scale metabolic model for Anabaena variabilis ATCC 29413, iAM957, was reconstructed and evaluated in this research. Then, the model and transcriptomic data of the vegetative and heterocyst cells were applied to construct a regulated two-cell metabolic model. The regulated model improved prediction for biomass in high radiation levels. The regulated model predicts that heterocysts provide an oxygen-free environment and then, this model was used to find strategies for improving hydrogen production in heterocysts. The predictions indicate that the removal of uptake hydrogenase improves hydrogen production which is consistent with previous empirical research. Furthermore, the regulated model proposed activation of some reactions to provide redox cofactors which are required for improving hydrogen production up to 60% by bidirectional hydrogenase.	[Shahkouhi, Ali Malek; Motamedian, Ehsan] Tarbiat Modares Univ, Dept Biotechnol, Fac Chem Engn, Tehran, Iran	Tarbiat Modares University	Motamedian, E (corresponding author), Tarbiat Modares Univ, Dept Biotechnol, Fac Chem Engn, Tehran, Iran.	motamedian@modares.ac.ir	Motamedian, Ehsan/GPK-8344-2022	, Ehsan/0000-0001-8750-2879				Adams DG, 2000, CURR OPIN MICROBIOL, V3, P618, DOI 10.1016/S1369-5274(00)00150-8; AGEL G, 1987, ARCH MICROBIOL, V147, P370, DOI 10.1007/BF00406135; Beck C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-56; Berberoglu H, 2008, INT J HYDROGEN ENERG, V33, P1172, DOI 10.1016/j.ijhydene.2007.12.036; Berla BM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00246; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; Bryant, 1994, MOL BIOL CYANOBACTER; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; Burnap RL, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00001; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chang A, 2014, NUCLEIC ACIDS RES; Consortium U, 2014, NUCLEIC ACIDS RES; Curatti L, 2002, FEBS LETT, V513, P175, DOI 10.1016/S0014-5793(02)02283-4; DONZE M, 1972, BIOCHIM BIOPHYS ACTA, V256, P157, DOI 10.1016/0005-2728(72)90170-3; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Erdrich P, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0128-x; ERNST A, 1984, ARCH MICROBIOL, V140, P120, DOI 10.1007/BF00454913; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Gerdtzen ZP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S16; Hallenbeck PC, 2002, INT J HYDROGEN ENERG, V27, P1185, DOI 10.1016/S0360-3199(02)00131-3; HEALEY FP, 1968, J PHYCOL, V4, P126, DOI 10.1111/j.1529-8817.1968.tb04685.x; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrero A, 2013, ADV BOT RES, V65, P281, DOI 10.1016/B978-0-12-394313-2.00008-1; JENSEN BB, 1983, ARCH MICROBIOL, V135, P287, DOI 10.1007/BF00413483; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khetkorn W, 2012, BIORESOURCE TECHNOL, V118, P265, DOI 10.1016/j.biortech.2012.05.052; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Klanchui A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-71; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Kolman Maria A., 2015, Life-Basel, V5, P102, DOI 10.3390/life5010102; Kumar K, 2009, COLD SPRING HARB PER, V2; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Malatinszky D, 2017, PLANT PHYSIOL, V173, P509, DOI 10.1104/pp.16.01487; Mariscal V, 2007, MOL MICROBIOL, V65, P1139, DOI 10.1111/j.1365-2958.2007.05856.x; Markou G, 2011, APPL ENERG, V88, P3389, DOI 10.1016/j.apenergy.2010.12.042; Martin-Figueroa E, 2000, FEBS LETT, V476, P282, DOI 10.1016/S0014-5793(00)01722-1; Masukawa H, 2002, APPL MICROBIOL BIOT, V58, P618, DOI 10.1007/s00253-002-0934-7; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Motamedian E, 2017, BIOINFORMATICS, V33, P1057, DOI 10.1093/bioinformatics/btw772; Nakao M, 2009, NUCLEIC ACIDS RES; Nogales J, 2013, BIOENGINEERED, V4, P158, DOI 10.4161/bioe.22792; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Nurnberg DJ, 2015, MBIO, V6, DOI 10.1128/mBio.02109-14; Oh YK, 2011, BIORESOURCE TECHNOL, V102, P8357, DOI 10.1016/j.biortech.2011.04.054; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Park JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-759; Perez R, 2016, MICROBIOL-SGM, V162, P214, DOI 10.1099/mic.0.000230; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; RAI AN, 1982, J GEN MICROBIOL, V128, P2203; RODRIGUEZ H, 1989, APPL ENVIRON MICROB, V55, P758, DOI 10.1128/AEM.55.3.758-760.1989; Rosgaard L, 2012, J BIOTECHNOL, V162, P134, DOI 10.1016/j.jbiotec.2012.05.006; Saha R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048285; Salleh SF, 2016, ARCH MICROBIOL, V198, P101, DOI 10.1007/s00203-015-1164-6; Salleh SF, 2014, ENERG CONVERS MANAGE, V87, P599, DOI 10.1016/j.enconman.2014.06.069; SATO N, 1979, BIOCHIM BIOPHYS ACTA, V572, P19; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; SCHILLING N, 1985, Z NATURFORSCH C, V40, P776; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Shevela D., 2013, OXYGENIC PHOTOSYNTHE; Srirangan K, 2011, BIORESOURCE TECHNOL, V102, P8589, DOI 10.1016/j.biortech.2011.03.087; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Steuer R, 2012, J EXP BOT, V63, P2259, DOI 10.1093/jxb/ers018; STOCKER A, 1993, HELV CHIM ACTA, V76, P1729, DOI 10.1002/hlca.19930760429; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Sveshnikov DA, 1997, FEMS MICROBIOL LETT, V147, P297, DOI 10.1016/S0378-1097(97)00005-0; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; THOMAS J, 1977, J BACTERIOL, V129, P1545, DOI 10.1128/JB.129.3.1545-1555.1977; Tiwari A, 2012, INT J HYDROGEN ENERG, V37, P139, DOI 10.1016/j.ijhydene.2011.09.100; Torres-Sanchez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004129; Triana J, 2014, METABOLITES, V4, P680, DOI 10.3390/metabo4030680; Tsygankov AS, 1997, INT J HYDROGEN ENERG, V22, P859, DOI 10.1016/S0360-3199(96)00242-X; Vargas MA, 1998, J PHYCOL, V34, P812, DOI 10.1046/j.1529-8817.1998.340812.x; Vincent WF, 2012, ECOLOGY CYANOBACTERI, P371, DOI [10.1007/978-94-007-3855-3_13, DOI 10.1007/978-94-007-3855-3_14]; WALSBY A E, 1985, Proceedings of the Royal Society of London Series B Biological Sciences, V226, P345, DOI 10.1098/rspb.1985.0099; Weyman PD, 2010, FEMS MICROBIOL LETT, V304, P55, DOI 10.1111/j.1574-6968.2009.01883.x; WINKENBACH F, 1973, PLANT PHYSIOL, V52, P480, DOI 10.1104/pp.52.5.480; Wolk CP, 1996, ANNU REV GENET, V30, P59, DOI 10.1146/annurev.genet.30.1.59; Yoon JH, 2002, INT J HYDROGEN ENERG, V27, P1265, DOI 10.1016/S0360-3199(02)00109-X; Yoon JH, 2008, BIORESOURCE TECHNOL, V99, P1204, DOI 10.1016/j.biortech.2007.02.012	85	8	8	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227977	10.1371/journal.pone.0227977	http://dx.doi.org/10.1371/journal.pone.0227977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978122	Green Published, gold			2022-12-26	WOS:000534599100088
J	Okoboi, S; Lazarus, O; Castelnuovo, B; Nanfuka, M; Kambugu, A; Mujugira, A; King, R				Okoboi, Stephen; Lazarus, Oucul; Castelnuovo, Barbara; Nanfuka, Mastula; Kambugu, Andrew; Mujugira, Andrew; King, Rachel			Peer distribution of HIV self-test kits to men who have sex with men to identify undiagnosed HIV infection in Uganda: A pilot study	PLOS ONE			English	Article							ACCEPTABILITY; FEASIBILITY; CARE	Introduction One-in-three men who have sex with men (MSM) in Uganda have never tested for HIV. Peer-driven HIV testing strategies could increase testing coverage among non-testers. We evaluated the yield of peer distributed HIV self-test kits compared with standard-of-care testing approaches in identifying undiagnosed HIV infection. Methods From June to August 2018, we conducted a pilot study of secondary distribution of HIV self-testing (HIVST) through MSM peer networks at The AIDS Support Organization (TASO) centres in Entebbe and Masaka. Peers were trained in HIVST use and basic HIV counselling. Each peer distributed 10 HIVST kits in one wave to MSM who had not tested in the previous six months. Participants who tested positive were linked by peers to HIV care. The primary outcome was the proportion of undiagnosed HIV infections. Data were analysed descriptively. Results A total of 297 participants were included in the analysis, of whom 150 received HIVST (intervention). The median age of HIVST recipients was 25 years (interquartile range [IQR], 2228) compared to 28 years IQR (25-35) for 147 MSM tested using standard-of-care (SOC) strategies. One hundred forty-three MSM (95%) completed HIVST, of which 32% had never tested for HIV. A total of 12 participants were newly diagnosed with HIV infection: 8 in the peer HIVST group and 4 in the SOC group [5.6% vs 2.7%, respectively; P = 0.02]. All participants newly diagnosed with HIV infection received confirmatory HIV testing and were initiated on antiretroviral therapy. Conclusion Peer distribution of HIVST through MSM networks is feasible and effective and could diagnose more new HIV infections than SOC approaches. Public health programs should consider scaling up peer-delivered HIVST for MSM.	[Okoboi, Stephen; Castelnuovo, Barbara; Kambugu, Andrew; Mujugira, Andrew] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Okoboi, Stephen] Clarke Int Univ, Kampala, Uganda; [Lazarus, Oucul; Nanfuka, Mastula] AIDS Support Org TASO, Kampala, Uganda; [Mujugira, Andrew; King, Rachel] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [King, Rachel] Univ Calif San Francisco, Dept Global Hlth, San Francisco, CA 94143 USA	Makerere University; Makerere University; University of California System; University of California San Francisco	Okoboi, S (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.; Okoboi, S (corresponding author), Clarke Int Univ, Kampala, Uganda.	okoboi25@gmail.com		Nanfuka, Mastula/0000-0002-7888-530X; Okoboi, Stephen/0000-0002-8738-0397; Mujugira, Andrew/0000-0001-6646-6733	University of California San Francisco Centre for AIDS Research (UCSF CFAR International Mentored Scientist Award) [P30-283 AI027763]; National Institutes of Health [K43 TW010695]	University of California San Francisco Centre for AIDS Research (UCSF CFAR International Mentored Scientist Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The University of California San Francisco Centre for AIDS Research (UCSF CFAR International Mentored Scientist Award, grant P30-283 AI027763 to SO) and the National Institutes of Health (grant K43 TW010695 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to The AIDS Support Organization (TASO) leadership of Masaka and Entebbe for allowing us to conduct this pilot study within their MSM dedicated care program. We are indebted to the TASO Program Director, Dr. Kenneth Mugisha and the Executive Director of TASO, Dr. Bernard Michael Etukoit for administratively supporting this study and to the participants for taking part in the study.	Choko AT, 2018, PLOS ONE, V13; Choko AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158107; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Flowers P, 2017, HIV MED, V18, P245, DOI 10.1111/hiv.12420; Hladik W, 2017, AIDS BEHAV, V21, P1478, DOI 10.1007/s10461-016-1535-2; Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lightfoot MA, 2018, JAIDS-J ACQ IMM DEF, V79, P38, DOI [10.1097/qai.0000000000001726, 10.1097/QAI.0000000000001726]; Lippman SA, 2018, JAIDS-J ACQ IMM DEF, V77, P279, DOI [10.1097/QAI.0000000000001601, 10.1097/qai.0000000000001601]; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Matovu JKB, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3713-0; Mavedzenge S, 2011, HIV SELF TESTING HLT; Musoba N, 2016, UGANDA HIV AIDS COUN; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Okoboi S, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25269; Sharma A, 2017, AIDS CARE, V29, P1499, DOI 10.1080/09540121.2017.1313386; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; Uganda AIDS Commission, 2015, NAT HIV AIDS IND HDB; Uganda National Council for Science and Technology, 2014, NAT GUID RES INV HUM; UN Joint Programme on HIV/AIDS (UNAIDS), 2018, GLOB AIDS UPD MIL GO, P268; UNAIDS, 2014, GAP REP, P1; UNAIDS. Uganda, 2017, UG 2017 COUNTR FACTS; Volk JE, 2016, INT J STD AIDS, V27, P531, DOI 10.1177/0956462415586676; Wong V, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25256; Wong V, 2014, AIDS BEHAV, V18, pS415, DOI 10.1007/s10461-014-0825-9; Wood BR, 2014, HIV AIDS-RES PALLIAT, V6, P117, DOI 10.2147/HIV.S49083; Young SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103790; Zhang C., 2017, PLOS ONE, V12; Zhong F, 2017, HIV MED, V18, P376, DOI 10.1111/hiv.12437	30	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0227741	10.1371/journal.pone.0227741	http://dx.doi.org/10.1371/journal.pone.0227741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971991	Green Published, gold			2022-12-26	WOS:000534374400016
J	Li, Y; Liu, Y; Huang, YH; Yang, K; Xiao, TL; Xiong, JC; Wang, KL; Liu, C; He, T; Yu, YL; Han, WH; Wang, Y; Bi, XJ; Zhang, JB; Huang, YJ; Zhang, B; Zhao, JH				Li, Yan; Liu, Yong; Huang, Yinghui; Yang, Ke; Xiao, Tangli; Xiong, Jiachuan; Wang, Kailong; Liu, Chi; He, Ting; Yu, Yanlin; Han, Wenhao; Wang, Yue; Bi, Xianjin; Zhang, Jingbo; Huang, Yunjian; Zhang, Bo; Zhao, Jinghong			IRF-1 promotes renal fibrosis by downregulation of Klotho	FASEB JOURNAL			English	Article						chronic kidney disease; IRF; Klotho; renal fibrosis; TNF-alpha	NF-KAPPA-B; SIGNALING PATHWAY; EPITHELIAL-CELLS; KIDNEY INJURY; EXPRESSION; INFLAMMATION; CONTRIBUTES; FACTOR-1; MECHANISMS; TRANSITION	Although the key role of renal fibrosis in the progression of chronic kidney disease (CKD) is well known, the causes of renal fibrosis are not fully clarified. In this study, interferon regulatory factor 1 (IRF-1), a mammalian transcription factor, was highly expressed in fibrotic kidney of CKD patients. Concordantly, the expression level of IRF-1 was significantly elevated in the kidney of unilateral ureteral obstruction (UUO) and Adriamycin nephropathy (ADR) mice. In tubular epithelial cells, overexpression of IRF-1 could induce profibrotic markers expression, which accompanied by dramatic downregulation of Klotho, an important inhibitor of renal fibrosis. Luciferase reporter analysis and ChIP assay revealed that IRF-1 repressed Klotho expression by downregulation of C/EBP-beta, which regulates Klotho gene transcription via directly binding to its promoter. Further investigation showed that tumor necrosis factor-alpha may be an important inducement for the increase of IRF-1 in tubular epithelial cells after UUO and genetic deletion of IRF-1 attenuated renal fibrosis in UUO mice. Hence, these findings demonstrate that IRF-1 contributes to the pathogenesis of renal fibrosis by downregulation of Klotho, and suppresses IRF-1 may be a potential therapeutic target for CKD.	[Li, Yan; Liu, Yong; Huang, Yinghui; Yang, Ke; Xiao, Tangli; Xiong, Jiachuan; Wang, Kailong; Liu, Chi; He, Ting; Yu, Yanlin; Han, Wenhao; Wang, Yue; Bi, Xianjin; Zhang, Jingbo; Huang, Yunjian; Zhang, Bo; Zhao, Jinghong] Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Kidney Ctr PLA,Dept Nephrol,Key Lab Prevent & Tre, Chongqing 400037, Peoples R China	Army Medical University	Zhao, JH (corresponding author), Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Kidney Ctr PLA,Dept Nephrol,Key Lab Prevent & Tre, Chongqing 400037, Peoples R China.	zhaojh@tmmu.edu.cn			Nature Science Foundation of China [81873605, 81500544, 81700379, 81800621, 81500561, 81800640]; Personal training Program for Clinical Medicine Research of Army Medical University [2018XLC1007]; Frontier specific projects of Xinqiao Hospital [2018YQYLY004]; Program for Clinical Medicine Research of Army Medical University [2018XLC1007]; Xinqiao Hospital [2018YQYLY004]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Personal training Program for Clinical Medicine Research of Army Medical University; Frontier specific projects of Xinqiao Hospital; Program for Clinical Medicine Research of Army Medical University; Xinqiao Hospital	the Nature Science Foundation of China, Grant/Award Number: 81873605, 81500544, 81700379, 81800621, 81500561 and 81800640; Personal training Program for Clinical Medicine Research of Army Medical University, Grant/Award Number: 2018XLC1007; Frontier specific projects of Xinqiao Hospital, Grant/Award Number: 2018YQYLY004; Program for Clinical Medicine Research of Army Medical University, Grant/Award Number: 2018XLC1007; Xinqiao Hospital, Grant/Award Number: 2018YQYLY004	Adachi T, 2015, BIOCHEM BIOPH RES CO, V467, P63, DOI 10.1016/j.bbrc.2015.09.121; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen FF, 2012, TUMOR BIOL, V33, P2217, DOI 10.1007/s13277-012-0483-3; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Ding H, 2018, ANTIOXID REDOX SIGN, V29, P637, DOI 10.1089/ars.2017.7041; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Dong YJ, 2016, J IMMUNOL, V196, P1874, DOI 10.4049/jimmunol.1501232; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Guan X, 2014, J PATHOL, V234, P560, DOI 10.1002/path.4420; Gun SY, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12819; Hara H, 2014, BIOL PHARM BULL, V37, P1042, DOI 10.1248/bpb.b14-00116; He LY, 2017, KIDNEY INT, V92, P1071, DOI 10.1016/j.kint.2017.06.030; Huang JS, 2014, MOL CELL ENDOCRINOL, V390, P45, DOI 10.1016/j.mce.2014.04.001; Ide N, 2016, KIDNEY INT, V90, P348, DOI 10.1016/j.kint.2016.04.009; Irifuku T, 2016, KIDNEY INT, V89, P147, DOI 10.1038/ki.2015.291; Jiang DS, 2014, HYPERTENSION, V64, P77, DOI 10.1161/HYPERTENSIONAHA.114.03229; Jiang L, 2013, EXP CELL RES, V319, P2254, DOI 10.1016/j.yexcr.2013.06.007; Jin MH, 2017, BIOCHEM BIOPH RES CO, V486, P451, DOI 10.1016/j.bbrc.2017.03.061; Kang SJ, 2011, ARCH PHARM RES, V34, P829, DOI 10.1007/s12272-011-0517-1; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Klahr S, 2003, KIDNEY INT, V64, pS105, DOI 10.1046/j.1523-1755.64.s87.16.x; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Li BH, 2017, TRANSL RES, V180, P103, DOI 10.1016/j.trsl.2016.08.006; Ling L, 2019, AM J TRANSL RES, V11, P131; Liu QF, 2017, INT UROL NEPHROL, V49, P345, DOI 10.1007/s11255-016-1439-0; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Remoli AL, 2016, MBIO, V7, DOI 10.1128/mBio.01528-16; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Sanchez-Nino MD, 2013, J AM SOC NEPHROL, V24, P687, DOI 10.1681/ASN.2013030294; Satoh M, 2012, AM J PHYSIOL-RENAL, V303, pF1641, DOI 10.1152/ajprenal.00460.2012; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Sun QZ, 2019, J IMMUNOL, V202, P37, DOI 10.4049/jimmunol.1800782; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Tie YY, 2018, J CELL MOL MED, V22, P1475, DOI 10.1111/jcmm.13406; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; Wang HD, 2019, MOL THER, V27, P571, DOI 10.1016/j.ymthe.2019.01.008; Wang YX, 2009, J AM SOC NEPHROL, V20, P1544, DOI 10.1681/ASN.2008080843; Wen Y, 2019, J AM SOC NEPHROL, V30, P1925, DOI 10.1681/ASN.2019020111; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412; Xie P, 2009, J AM SOC NEPHROL, V20, P807, DOI 10.1681/ASN.2008091007; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yan R, 2017, J INNATE IMMUN, V9, P546, DOI 10.1159/000477211; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Zeng Y, 2016, AGING CLIN EXP RES, V28, P69, DOI 10.1007/s40520-015-0371-y; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhao J, 2015, J MOL NEUROSCI, V57, P595, DOI 10.1007/s12031-015-0642-2; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhou XJ, 2014, J PHARMACOL SCI, V126, P344, DOI 10.1254/jphs.14173FP	62	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4415	4429		10.1096/fj.201902446R	http://dx.doi.org/10.1096/fj.201902446R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31965641	Bronze			2022-12-26	WOS:000508585400001
J	Guan, YF; Huang, QL; Ai, YL; Chen, QT; Zhao, WX; Wang, XM; Wu, Q; Chen, HZ				Guan, Yun-feng; Huang, Qiao-ling; Ai, Yuan-li; Chen, Qi-tao; Zhao, Wen-xiu; Wang, Xiao-min; Wu, Qiao; Chen, Hang-zi			Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis	ONCOGENE			English	Article							LONG NONCODING RNAS; NUCLEAR RECEPTOR TR3; PYRUVATE-KINASE M2; HEPATOCELLULAR-CARCINOMA; GLUCOSE-METABOLISM; CANCER; PHOSPHOFRUCTOKINASE; EXPRESSION; ISOFORM	Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Orphan nuclear receptor Nur77, which is low expressed in HCC, functions as a tumor suppressor to suppress HCC. However, the detailed mechanism is still not well understood. Here, we demonstrate that Nur77 could inhibit HCC development via transcriptional activation of the lncRNA WAP four-disulfide core domain 21 pseudogene (WFDC21P). Nur77 binds to its response elements on the WFDC21P promoter to directly induce WFDC21P transcription, which inhibits HCC cell proliferation, tumor growth, and tumor metastasis both in vitro and in vivo. In clinical HCC samples, WFDC21P expression positively correlated with that of Nur77, and the loss of WFDC21P is associated with worse prognosis. Mechanistically, WFDC21P could inhibit glycolysis by simultaneously interacting with PFKP and PKM2, two key enzymes in glycolysis. These interactions not only abrogate the tetramer formation of PFKP to impede its catalytic activity but also prevent the nuclear translocation of PKM2 to suppress its function as a transcriptional coactivator. Cytosporone-B (Csn-B), an agonist for Nur77, could stimulate WFDC21P expression and suppress HCC in a WFDC21P-dependent manner. Therefore, our study reveals a new HCC suppressor and connects the glycolytic remodeling of HCC with the Nur77-WFDC21P-PFKP/PKM2 axis.	[Guan, Yun-feng; Huang, Qiao-ling; Ai, Yuan-li; Chen, Qi-tao; Wu, Qiao; Chen, Hang-zi] Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Zhao, Wen-xiu; Wang, Xiao-min] Xiamen Univ, Zhong Shan Hosp, Fujian Prov Key Lab Chron Liver Dis & Hepatocellu, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University	Chen, HZ (corresponding author), Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.	Chenhz@xmu.edu.cn		Chen, Hang-zi/0000-0002-4827-2182	National Natural Science Fund of China; Ministry of Science and Technology of China [31822013, 31871434, U1405224, 81672695, 2017YFA0504502]; Fundamental Research Funds for the Central Universities of China [20720190083]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	We thank Dr Hui-ying Huang for her assistance with the metabolites detection using NMR magnet system. This work was supported by grants from the National Natural Science Fund of China and the Ministry of Science and Technology of China (31822013, 31871434, U1405224, 81672695, and 2017YFA0504502), the Fundamental Research Funds for the Central Universities of China (20720190083).	Allen AE, 2018, CANCER CELL, V33, P337, DOI 10.1016/j.ccell.2018.02.008; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459; Beard JA, 2015, CELL SIGNAL, V27, P257, DOI 10.1016/j.cellsig.2014.11.009; Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030; Bian XL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14420; Chen HZ, 2012, ONCOGENE, V31, P2876, DOI 10.1038/onc.2011.463; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu WM, 2015, J HEPATOL, V63, P886, DOI 10.1016/j.jhep.2015.05.016; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Hung CL, 2014, P NATL ACAD SCI USA, V111, P18697, DOI 10.1073/pnas.1415669112; Jiang SH, 2017, NATURE, V544, P460, DOI 10.1038/nature22032; Klingenberg M, 2017, J HEPATOL, V67, P603, DOI 10.1016/j.jhep.2017.04.009; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li XX, 2018, MOL CELL, V69, P480, DOI 10.1016/j.molcel.2018.01.001; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Morita M, 2018, CANCER CELL, V33, P355, DOI 10.1016/j.ccell.2018.02.004; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Park YY, 2013, HEPATOLOGY, V58, P182, DOI 10.1002/hep.26310; Pawlak A, 2015, STEROIDS, V95, P1, DOI 10.1016/j.steroids.2014.12.020; Safe S, 2016, J STEROID BIOCHEM, V157, P48, DOI 10.1016/j.jsbmb.2015.04.016; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Takahashi K, 2014, HEPATOLOGY, V60, P744, DOI 10.1002/hep.27043; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; VORA S, 1983, HUM GENET, V63, P374, DOI 10.1007/BF00274765; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; Webb BA, 2015, NATURE, V523, P111, DOI 10.1038/nature14405; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang H, 2011, HEPATOLOGY, V53, P865, DOI 10.1002/hep.24101; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yao LM, 2012, CARCINOGENESIS, V33, P301, DOI 10.1093/carcin/bgr287; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Yuan JH, 2017, NAT CELL BIOL, V19, P820, DOI 10.1038/ncb3538; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002	52	32	33	5	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	11					2408	2423		10.1038/s41388-020-1158-y	http://dx.doi.org/10.1038/s41388-020-1158-y		JAN 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KU0ZS	31959898	Green Published, hybrid			2022-12-26	WOS:000508322900001
J	Altekruse, SF; Cosgrove, CM; Altekruse, WC; Jenkins, RA; Blanco, C				Altekruse, Sean F.; Cosgrove, Candace M.; Altekruse, William C.; Jenkins, Richard A.; Blanco, Carlos			Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC)	PLOS ONE			English	Article							DRUG POISONING MORTALITY; ALCOHOL-USE DISORDER; LIFE EXPECTANCY; FAMILY COHESION; SUBSTANCE USE; HEALTH; US; DEATH; ADULTS; SEVERITY	Background Understanding relationships between individual-level demographic, socioeconomic status (SES) and U.S. opioid fatalities can inform interventions in response to this crisis. Methods The Mortality Disparities in American Community Study (MDAC) links nearly 4 million 2008 American Community Survey responses to the 2008-2015 National Death Index. Univariate and multivariable models were used to estimate opioid overdose fatality hazard ratios (HR) and 95% confidence intervals (CI). Results Opioid overdose was an overrepresented cause of death among people 10 to 59 years of age. In multivariable analysis, compared to Hispanics, Whites and American Indians/Alaska Natives had elevated risk (HR = 2.52, CI:2.21-2.88) and (HR = 1.88, CI:1.35-2.62), respectively. Compared to women, men were at-risk (HR = 1.61, CI:1.50-1.72). People who were disabled were at higher risk than those who were not (HR = 2.80, CI:2.59-3.03). Risk was higher among widowed than married (HR = 2.44, CI:2.03-2.95) and unemployed than employed individuals (HR = 2.46, CI:2.17-2.79). Compared to adults with graduate degrees, those with high school only were at-risk (HR = 2.48, CI:2.00-3.06). Citizens were more likely than noncitizens to die from this cause (HR = 4.62, CI:3.48-6.14). Compared to people who owned homes with mortgages, those who rented had higher HRs (HR = 1.36, CI:1.25-1.48). Non-rural residents had higher risk than rural residents (HR = 1.46, CI:1.34, 1.59). Compared to respective referent groups, people without health insurance (HR = 1.30, CI:1.20-1.41) and people who were incarcerated were more likely to die from opioid overdoses (HR = 2.70, CI:1.91-3.81). Compared to people living in households at least five-times above the poverty line, people who lived in poverty were more likely to die from this cause (HR = 1.36, CI:1.20-1.54). Compared to people living in West North Central states, HRs were highest among those in South Atlantic (HR = 1.29, CI:1.11, 1.50) and Mountain states (HR = 1.58, CI:1.33, 1.88). Discussion Opioid fatality was associated with indicators of low SES. The findings may help to target prevention, treatment and rehabilitation efforts to vulnerable groups.	[Altekruse, Sean F.] NHLBI, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Cosgrove, Candace M.] US Bur Census, Ctr Adm Records Res & Applicat, Suitland, MD USA; [Altekruse, William C.] NIMH, Div Translat Res, NIH, Bethesda, MD 20892 USA; [Jenkins, Richard A.; Blanco, Carlos] NIDA, Div Epidemiol Serv & Prevent Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Altekruse, SF (corresponding author), NHLBI, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA.	altekrusesf@mail.nih.gov			National Heart, Lung, and Blood Institute; National Institute on Aging; Census Bureau	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Census Bureau	The authors received no specific funding for this work. MDAC is funded by National Heart, Lung, and Blood Institute and National Institute on Aging agreements with the Census Bureau. The National Center for Health Statistics performed the National Death Index match and the Center for Medicare and Medicaid Services performed the CMS match.; MDAC is funded by National Heart, Lung, and Blood Institute and National Institute on Aging agreements with the Census Bureau.	Abrecht CR, 2017, ANESTH ANALG, V125, P1761, DOI 10.1213/ANE.0000000000002499; [Anonymous], INT CLASS DIS; [Anonymous], 2018, BMJ-BRIT MED J, V362, pk3210; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Binswanger IA, 2016, ADDICTION, V111, P499, DOI 10.1111/add.13200; Blanco C, 2019, LANCET, V393, P1760, DOI 10.1016/S0140-6736(18)33078-2; Bohnert ASB, 2019, NEW ENGL J MED, V380, P71, DOI 10.1056/NEJMra1802148; Bozinoff N, 2018, J ADDICT MED, V12, P19, DOI 10.1097/ADM.0000000000000355; Brinkley-Rubinstein L, 2018, DRUG ALCOHOL DEPEN, V185, P189, DOI 10.1016/j.drugalcdep.2017.12.014; Caetano R, 2017, AM J DRUG ALCOHOL AB, V43, P87, DOI 10.1080/00952990.2016.1225073; Caetano R, 2016, ALCOHOL CLIN EXP RES, V40, P806, DOI 10.1111/acer.13020; Cano MA, 2018, SUBST USE MISUSE, V53, P668, DOI 10.1080/10826084.2017.1356333; Census Bureau, CENS REG DIV US; Centers for Disease Control and Prevention, CDC ACT 2018 RESP OP; Centers for Disease Control and Prevention, NAT DEATH IND; COX DR, 1972, J R STAT SOC B, V34, P187; Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187; Day BF, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.06.020; Dowell D, 2019, NEW ENGL J MED, V380, P2285, DOI 10.1056/NEJMp1904190; Dowell D, 2017, JAMA-J AM MED ASSOC, V318, P1065, DOI 10.1001/jama.2017.9308; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Economic Innovation Group, ESC VEL EL COMM AR P; Ellaway A, 1998, HEALTH PLACE, V4, P141, DOI 10.1016/S1353-8292(98)00006-9; Hagan J, 2020, PREV MED, V130, DOI 10.1016/j.ypmed.2019.105897; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Hedegaard H., 2019, URBAN RURAL DIFFEREN; Hedegaard H, 2017, NCHS DATA BRIEF, V273, p1 ; Hedegaard Holly, 2018, NCHS Data Brief, P1; Hollingsworth A, 2017, J HEALTH ECON, V56, P222, DOI 10.1016/j.jhealeco.2017.07.009; Imtiaz S, 2018, DRUG ALCOHOL REV, V37, pS263, DOI 10.1111/dar.12616; Johnson EM, 2013, J GEN INTERN MED, V28, P522, DOI 10.1007/s11606-012-2225-z; Kiang MV, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0040; Kroelinger CD, 2019, MMWR-MORBID MORTAL W, V68, P777, DOI 10.15585/mmwr.mm6836a1; Kroenke K, 2019, PAIN MED, V20, P724, DOI 10.1093/pm/pny307; Lanier WA, 2012, PAIN MED, V13, P1580, DOI 10.1111/j.1526-4637.2012.01518.x; Linton SL, 2017, SOC SCI MED, V185, P81, DOI 10.1016/j.socscimed.2017.04.055; Lo CC, 2016, INT J PUBLIC HEALTH, V61, P91, DOI 10.1007/s00038-015-0695-6; Martins SS, 2015, AM J PUBLIC HEALTH, V105, P2373, DOI 10.2105/AJPH.2015.302843a; Martins SS, 2015, SOC PSYCH PSYCH EPID, V50, P713, DOI 10.1007/s00127-014-0980-3; Masters RK, 2018, INT J EPIDEMIOL, V47, P81, DOI 10.1093/ije/dyx127; McLean K, 2016, INT J DRUG POLICY, V29, P19, DOI 10.1016/j.drugpo.2016.01.009; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Miranda PY, 2017, PREV MED, V100, P3, DOI 10.1016/j.ypmed.2017.03.006; Monnat SM, 2018, AM J PREV MED, V54, P611, DOI 10.1016/j.amepre.2018.01.040; Muennig PA, 2018, AM J PUBLIC HEALTH, V108, P1626, DOI 10.2105/AJPH.2018.304585; National Academies of Science Engineering and Medicine, 2019, MED OP US DIS SAV LI; Orgera K., KEY FACTS UNINSURED; Paulozzi LJ, 2008, PHARMACOEPIDEM DR S, V17, P997, DOI 10.1002/pds.1626; Pear VA, 2019, DRUG ALCOHOL DEPEN, V195, P66, DOI 10.1016/j.drugalcdep.2018.11.024; Pitt AL, 2018, AM J PUBLIC HEALTH, V108, P1394, DOI 10.2105/AJPH.2018.304590; Preuss CV., 2019, STATPEARLS; Ratcliffe M, 2018, DEFINING RURAL US CE; Rigg KK, 2015, INT J DRUG POLICY, V26, P484, DOI 10.1016/j.drugpo.2014.10.001; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Ruhm CJ, 2017, AM J PREV MED, V53, P745, DOI 10.1016/j.amepre.2017.06.009; Sanchez-Salas A, 2017, INT CONF ENG DES, P21; Schepis TS, 2018, DRUG ALCOHOL DEPEN, V189, P172, DOI 10.1016/j.drugalcdep.2018.05.017; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Smith DE, 2017, J PSYCHOACTIVE DRUGS, V49, P95, DOI 10.1080/02791072.2017.1295334; Stoicea N, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015425; U.S. Census Bureau, MORT DISP AM COMM MD; United States Census Bureau, AM COMMUNITY SURVEY; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Willison C, 2017, HEALTH POLICY, V121, P1113, DOI 10.1016/j.healthpol.2017.08.002; Woolf SH, 2019, JAMA-J AM MED ASSOC, V322, P1996, DOI 10.1001/jama.2019.16932	66	74	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227966	10.1371/journal.pone.0227966	http://dx.doi.org/10.1371/journal.pone.0227966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KL0SC	31951640	gold, Green Published			2022-12-26	WOS:000513141900001
J	McClean, MCW; Bhattacharyya, T; Mertens, P; Murphy, N; Gilleman, Q; Gustin, Y; Zeippen, N; Xavier, SCC; Jansen, AM; Miles, MA				McClean, Mairi C. W.; Bhattacharyya, Tapan; Mertens, Pascal; Murphy, Niamh; Gilleman, Quentin; Gustin, Yves; Zeippen, Nicolas; Xavier, Samanta C. C.; Jansen, Ana M.; Miles, Michael A.			A lineage-specific rapid diagnostic test (Chagas Sero K-SeT) identifies Brazilian Trypanosoma cruzi II/V/VI reservoir hosts among diverse mammalian orders	PLOS ONE			English	Article							NATURALLY INFECTED-DOGS; SMALL SURFACE-ANTIGEN; DISEASE; WILD; TCI; AREAS; BATS; TRANSMISSION; ORIGINS; REGION	Trypanosoma cruzi, the protozoan agent of Chagas disease in the Americas, is comprised of six genetic lineages (TcI-TcVI) and a possible seventh (TcBat, related to TcI). Identification of T. cruzi lineages infecting reservoir mammalian species is fundamental to resolving transmission cycles. However, this is hindered by the limited sensitivity and technical complexity of parasite isolation and genotyping. An alternative approach is serology using T. cruzi lineage-specific epitopes, such as those of the trypomastigote small surface antigen (TSSA). For surveillance of T. cruzi lineage infections in mammal species from diverse Brazilian regions, we apply a novel rapid diagnostic test (RDT, Chagas Sero K-SeT), which incorporates the TSSA peptide epitope specific to TcII/V/VI (TSSApep-II/V/VI) and Protein G detection of antibodies. Chagas Sero K-SeT RDT results with sera from experimentally infected mice, from tamarin primates (Leontopithecus spp.) and from canines (Canis familiaris) were concordant with corresponding TSSApep-II/V/VI ELISAs. The Chagas Sero KSet detected TcII/V/VI infections in Leontopithecus spp. from the Atlantic forest (n = 46), in C. familiaris (n = 16) and Thrichomys laurentius (n = 2) from Caatinga biome and Chiroptera (n = 1) from Acre, Amazonia. The Chagas Sero K-SeT RDT is directly applicable to TcII/V/VI-specific serological surveillance of T. cruzi infection in several different mammalian Orders. It can replace ELISAs and provides efficient, point-of-sampling, low-cost detection of TcII/V/VI infections, with at least equivalent sensitivity, although some mammals may be difficult to trap, and, not unexpectedly, Chagas Sero K-SeT could not recognise feline IgG. Knowledge of sylvatic hosts of T. cruzi can be expanded, new reservoir species discovered, and the ecology of transmission cycles clarified, particularly with adaptation to further mammalian Orders.	[McClean, Mairi C. W.; Bhattacharyya, Tapan; Murphy, Niamh; Miles, Michael A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Mertens, Pascal; Gilleman, Quentin; Gustin, Yves; Zeippen, Nicolas] Coris BioConcept, Gembloux, Belgium; [Xavier, Samanta C. C.; Jansen, Ana M.] Fiocruz MS, Lab Trypanosomatid Biol, Oswaldo Cruz Inst, Rio De Janeiro, Brazil	University of London; London School of Hygiene & Tropical Medicine; Fundacao Oswaldo Cruz	Bhattacharyya, T (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	tapan.bhattacharyya@lshtm.ac.uk		Jansen, Ana Maria/0000-0001-5804-6210; Bhattacharyya, Tapan/0000-0003-3385-2536; Mertens, Pascal/0000-0002-1458-8306; Xavier, Samanta Cristina/0000-0002-3475-0075	National Institutes of Health, USA [5R01AI107028]; Bayer Research and Travel Grant; Johns Hopkins Bloomberg School of Public Health, USA; Sir Halley Stewart Trust	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Research and Travel Grant; Johns Hopkins Bloomberg School of Public Health, USA(Johns Hopkins University); Sir Halley Stewart Trust	This work was supported by the National Institutes of Health, USA (www.nih.gov; 5R01AI107028) to MAM, and by the Bayer Research and Travel Grant (www.bayer.com) to MCWM. We acknowledge Robert H. Gilman (Johns Hopkins Bloomberg School of Public Health, USA) for contributing to financial support. The commercial collaborator (Coris BioConcept) provided no external funding or salary support. The work undertaken by NM was funded by the Sir Halley Stewart Trust (www.sirhalleystewart.org.uk).The views expressed within this article are those of the authors and not necessarily those of the Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acosta N, 2016, REV BRAS PARASITOL V, V25, P327, DOI 10.1590/S1984-29612016052; Adamczyk B, 2014, CARBOHYD RES, V389, P174, DOI 10.1016/j.carres.2014.01.018; Alessio GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006140; Balouz V, 2015, CLIN VACCINE IMMUNOL, V22, P304, DOI 10.1128/CVI.00684-14; Barros JHS, 2017, ACTA TROP, V172, P173, DOI 10.1016/j.actatropica.2017.05.003; Bhattacharyya T, 2018, CLIN INFECT DIS, V67, P519, DOI 10.1093/cid/ciy121; Bhattacharyya T, 2015, ACTA TROP, V151, P182, DOI 10.1016/j.actatropica.2015.06.017; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002892; Bhattacharyya T, 2010, INT J PARASITOL, V40, P921, DOI 10.1016/j.ijpara.2010.01.002; Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Cimino RO, 2011, PARASITOLOGY, V138, P995, DOI 10.1017/S0031182011000540; Curtis-Robles R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005298; da Costa AP, 2016, ACTA TROP, V164, P185, DOI 10.1016/j.actatropica.2016.08.033; Da Silva FM, 2008, ACTA TROP, V107, P168, DOI 10.1016/j.actatropica.2008.05.015; Di Noia JM, 2002, J EXP MED, V195, P401, DOI 10.1084/jem.20011433; dos Santos FCB, 2018, PARASITOLOGY, V145, P828, DOI [10.1017/S0031182017001834, 10.1017/s0031182017001834]; Duthie MS, 2011, CLIN VACCINE IMMUNOL, V18, P254, DOI 10.1128/CVI.00420-10; Enriquez GF, 2013, ACTA TROP, V126, P211, DOI 10.1016/j.actatropica.2013.03.001; Martinez MF, 2016, INT J PARASITOL-PAR, V5, P198, DOI 10.1016/j.ijppaw.2016.05.001; Floridia-Yapur N, 2014, PARASITE IMMUNOL, V36, P694, DOI 10.1111/pim.12144; Lidani KCF, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00166; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; Jansen AM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3067-2; Jansen AM, 2015, ACTA TROP, V151, P1, DOI 10.1016/j.actatropica.2015.07.018; Kerr CL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1873-y; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lima L, 2015, ACTA TROP, V151, P166, DOI 10.1016/j.actatropica.2015.07.015; Lima MM, 2012, T ROY SOC TROP MED H, V106, P143, DOI 10.1016/j.trstmh.2011.10.013; Lima VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116137; Lisboa CV, 2015, MEM I OSWALDO CRUZ, V110, P394, DOI 10.1590/0074-02760140400; Llewellyn MS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000510; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Martin DL, 2014, AM J TROP MED HYG, V90, P1074, DOI 10.4269/ajtmh.13-0391; MOTT KE, 1978, AM J TROP MED HYG, V27, P1123, DOI 10.4269/ajtmh.1978.27.1123; Murphy N, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3681-7; Nunes MCP, 2018, CIRCULATION, V138, pE169, DOI 10.1161/CIR.0000000000000599; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Sosa-Estani S, 2008, AM J TROP MED HYG, V79, P755, DOI 10.4269/ajtmh.2008.79.755; Verani JR, 2009, AM J TROP MED HYG, V80, P410; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2018, ACTA TROP, V184, P38, DOI 10.1016/j.actatropica.2017.09.017	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227828	10.1371/journal.pone.0227828	http://dx.doi.org/10.1371/journal.pone.0227828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951634	gold, Green Published			2022-12-26	WOS:000534370500030
J	Meng, YX; Sheen, C; Magon, NJ; Hampton, MB; Dobson, RCJ				Meng, Yanxiang; Sheen, Campbell; Magon, Nicholas J.; Hampton, Mark B.; Dobson, Renwick C. J.			Structure-function analyses of alkylhydroperoxidase D from Streptococcus pneumoniae reveal an unusual three-cysteine active site architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; oxidative stress; X-ray crystallography; analytical ultracentrifugation; small-angle X-ray scattering (SAXS); electron transfer; alkylhydroperoxidase D; liquid chromatography-mass spectrometry (LC-MS; MS); redox switch; Streptococcus pneumoniae	ALKYL HYDROPEROXIDE REDUCTASE; ANTIOXIDANT DEFENSE SYSTEM; PYRUVATE OXIDASE; NADH OXIDASE; AHPD; MACROMOLECULES; THIOREDOXIN; SCATTERING; APOPTOSIS; VIRULENCE	During aerobic growth, the Gram-positive facultative anaerobe and opportunistic human pathogen Streptococcus pneumoniae generates large amounts of hydrogen peroxide that can accumulate to millimolar concentrations. The mechanism by which this catalase-negative bacterium can withstand endogenous hydrogen peroxide is incompletely understood. The enzyme alkylhydroperoxidase D (AhpD) has been shown to contribute to pneumococcal virulence and oxidative stress responses in vivo. We demonstrate here that SpAhpD exhibits weak thiol-dependent peroxidase activity and, unlike the previously reported Mycobacterium tuberculosis AhpC/D system, SpAhpD does not mediate electron transfer to SpAhpC. A 2.3-? resolution crystal structure revealed several unusual structural features, including a three-cysteine active site architecture that is buried in a deep pocket, in contrast to the two-cysteine active site found in other AhpD enzymes. All single-cysteine SpAhpD variants remained partially active, and LC-MS/MS analyses revealed that the third cysteine, Cys-163, formed disulfide bonds with either of two cysteines in the canonical Cys-78-X?X-Cys-81 motif. We observed that SpAhpD formed a dimeric quaternary structure both in the crystal and in solution, and that the highly conserved Asn-76 of the AhpD core motif is important for SpAhpD folding. In summary, SpAhpD is a weak peroxidase and does not transfer electrons to AhpC, and therefore does not fit existing models of bacterial AhpD antioxidant defense mechanisms. We propose that it is unlikely that SpAhpD removes peroxides either directly or via AhpC, and that SpAhpD cysteine oxidation may act as a redox switch or mediate electron transfer with other thiol proteins.	[Meng, Yanxiang; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8041, New Zealand; [Meng, Yanxiang; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 8041, New Zealand; [Sheen, Campbell] Univ Canterbury, Callaghan Innovat, Christchurch 8041, New Zealand; [Magon, Nicholas J.; Hampton, Mark B.] Univ Otago, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch 8011, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	University of Canterbury; University of Canterbury; University of Canterbury; University of Otago; University of Melbourne	Dobson, RCJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 8041, New Zealand.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 8041, New Zealand.; Hampton, MB (corresponding author), Univ Otago, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch 8011, New Zealand.; Dobson, RCJ (corresponding author), Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	mark.hampton@otago.ac.nz; renwick.dobson@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021; Hampton, Mark/A-8490-2008	Dobson, Renwick/0000-0002-5506-4939; Hampton, Mark/0000-0002-7349-3729; Meng, Yanxiang/0000-0001-7447-9788	New Zealand Royal Society Marsden Fund [UOC1506]; Health Research Council of New Zealand; AINSE Honours Scholarship 2018; University of Otago; University of Canterbury	New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); AINSE Honours Scholarship 2018; University of Otago; University of Canterbury	This work was supported by New Zealand Royal Society Marsden Fund contract UOC1506 (to R. C. J. D.), the Health Research Council of New Zealand (to M. B. H.), and AINSE Honours Scholarship 2018, University of Canterbury Summer Scholarship 2017/2018, and University of Otago Summer Scholarship 2018/2019 (to Y. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Clarke TE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-27; Clontech Laboratories Inc.-Takara Bio USA, 2015, HD CLON PLUS CLON CO; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Hajaj B, 2012, INFECT IMMUN, V80, P4333, DOI 10.1128/IAI.00126-12; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Hong EJ, 2019, J BIOCHEM, V165, P197, DOI 10.1093/jb/mvy097; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kamariah N, 2015, BBA-BIOENERGETICS, V1847, P1139, DOI 10.1016/j.bbabio.2015.06.011; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishiyama Y, 2001, J BACTERIOL, V183, P2431, DOI 10.1128/JB.183.8.2431-2438.2001; Nunn CM, 2002, J BIOL CHEM, V277, P20033, DOI 10.1074/jbc.M200864200; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Paterson GK, 2006, MICROB PATHOGENESIS, V40, P152, DOI 10.1016/j.micpath.2005.12.003; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; PERRY FE, 1993, THORAX, V48, P364, DOI 10.1136/thx.48.4.364; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shrivastava AK, 2015, FUNCT INTEGR GENOMIC, V15, P77, DOI 10.1007/s10142-014-0407-y; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winther JR, 2014, BBA-GEN SUBJECTS, V1840, P838, DOI 10.1016/j.bbagen.2013.03.031; Wong CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05354-5; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Yesilkaya H, 2013, TRENDS MICROBIOL, V21, P187, DOI 10.1016/j.tim.2013.01.004	49	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2984	2999		10.1074/jbc.RA119.012226	http://dx.doi.org/10.1074/jbc.RA119.012226			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974167	hybrid, Green Published			2022-12-26	WOS:000519597300010
J	Li, FKK; Rosell, FI; Gale, RT; Simorre, JP; Brown, ED; Strynadka, NCJ				Li, Franco K. K.; Rosell, Federico I.; Gale, Robert T.; Simorre, Jean-Pierre; Brown, Eric D.; Strynadka, Natalie C. J.			Crystallographic analysis of Staphylococcus aureus LcpA, the primary wall teichoic acid ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; teichoic acid; peptidoglycan; gram-positive bacteria; Staphylococcus aureus (S; aureus); Bacillus; X-ray crystallography; oligomerization; LytR?CpsA?Psr; size-exclusion chromatography with multiangle light scattering	CPSA-PSR PROTEINS; CELL-WALL; PEPTIDOGLYCAN; BIOSYNTHESIS; POLYSACCHARIDE; FEATURES; REVEALS; FAMILY; GENE	Gram-positive bacteria, including major clinical pathogens such as Staphylococcus aureus, are becoming increasingly drug-resistant. Their cell walls are composed of a thick layer of peptidoglycan (PG) modified by the attachment of wall teichoic acid (WTA), an anionic glycopolymer that is linked to pathogenicity and regulation of cell division and PG synthesis. The transfer of WTA from lipid carriers to PG, catalyzed by the LytR?CpsA?Psr (LCP) enzyme family, offers a unique extracellular target for the development of new anti-infective agents. Inhibitors of LCP enzymes have the potential to manage a wide range of bacterial infections because the target enzymes are implicated in the assembly of many other bacterial cell wall polymers, including capsular polysaccharide of streptococcal species and arabinogalactan of mycobacterial species. In this study, we present the first crystal structure of S. aureus LcpA with bound substrate at 1.9 ? resolution and those of Bacillus subtilis LCP enzymes, TagT, TagU, and TagV, in the apo form at 1.6?2.8 ? resolution. The structures of these WTA transferases provide new insight into the binding of lipid-linked WTA and enable assignment of the catalytic roles of conserved active-site residues. Furthermore, we identified potential subsites for binding the saccharide core of PG using computational docking experiments, and multiangle light-scattering experiments disclosed novel oligomeric states of the LCP enzymes. The crystal structures and modeled substrate-bound complexes of the LCP enzymes reported here provide insights into key features linked to substrate binding and catalysis and may aid the structure-guided design of specific LCP inhibitors.	[Li, Franco K. K.; Rosell, Federico I.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Li, Franco K. K.; Rosell, Federico I.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z4, Canada; [Simorre, Jean-Pierre] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Simorre, Jean-Pierre] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38000 Grenoble, France	University of British Columbia; University of British Columbia; McMaster University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Strynadka, NCJ (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		Li, Franco/0000-0001-7318-9754; simorre, jean-pierre/0000-0002-7943-1342	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Howard Hughes Medical Institute International Senior Scholar program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Canada Research Chairs program; Joint Programming Initiative on Antimicrobial Resistance	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Senior Scholar program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Canada Research Chairs program(Canada Research Chairs); Joint Programming Initiative on Antimicrobial Resistance	This work was supported by the Natural Sciences and Engineering Research Council (to F. K. K. L.), the Canadian Institutes of Health Research (to R. T. G., N. C. J. S., and E. D. B.), the Howard Hughes Medical Institute International Senior Scholar program (to N. C. J. S.), the Canada Foundation for Innovation (to N. C. J. S. and E. D. B.), the British Columbia Knowledge Development Fund (to N. C. J. S.), the Canada Research Chairs program (tier 1; to N. C. J. S. and E. D. B.), and the Joint Programming Initiative on Antimicrobial Resistance (to J.-P. S). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Baumgart M, 2016, J BACTERIOL, V198, P3045, DOI 10.1128/JB.00406-16; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Caveney NA, 2018, CURR OPIN STRUC BIOL, V53, P45, DOI 10.1016/j.sbi.2018.05.002; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Gale RT, 2017, CELL CHEM BIOL, V24, P1537, DOI 10.1016/j.chembiol.2017.09.006; Grzegorzewicz AE, 2016, J BIOL CHEM, V291, P18867, DOI 10.1074/jbc.M116.739227; Harrison J, 2016, MBIO, V7, DOI 10.1128/mBio.00972-16; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kim H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204375; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Malm S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22012-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misawa Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005061; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Over B, 2011, FEMS MICROBIOL LETT, V320, P142, DOI 10.1111/j.1574-6968.2011.02303.x; Rausch M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09356-x; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Riley JG, 2005, GLYCOBIOLOGY, V15, P605, DOI 10.1093/glycob/cwi038; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Schaefer K, 2018, J AM CHEM SOC, V140, P2442, DOI 10.1021/jacs.7b13551; Schaefer K, 2017, NAT CHEM BIOL, V13, P396, DOI 10.1038/nchembio.2302; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Siegel SD, 2019, MBIO, V10, DOI 10.1128/mBio.01580-18; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weissgerber TL, 2017, J BIOL CHEM, V292, P20592, DOI 10.1074/jbc.RA117.000147	43	13	13	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2629	2639		10.1074/jbc.RA119.011469	http://dx.doi.org/10.1074/jbc.RA119.011469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31969390	hybrid, Green Published			2022-12-26	WOS:000519969100009
J	Uno, S; Masuya, T; Shinzawa-Itoh, K; Lasham, J; Haapanen, O; Shiba, T; Inaoka, DK; Sharma, V; Murai, M; Miyoshi, H				Uno, Shinpei; Masuya, Takahiro; Shinzawa-Itoh, Kyoko; Lasham, Jonathan; Haapanen, Outi; Shiba, Tomoo; Inaoka, Daniel Ken; Sharma, Vivek; Murai, Masatoshi; Miyoshi, Hideto			Oversized ubiquinones as molecular probes for structural dynamics of the ubiquinone reaction site in mitochondrial respiratory complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; mitochondria; complex I; ubiquinone; chemical biology; respiratory chain; proton pump	PINPOINT CHEMICAL-MODIFICATION; 49 KDA; CRYSTAL-STRUCTURE; INNER MEMBRANE; PROTON PUMP; NADH; REDUCTION; OXIDOREDUCTASE; MECHANISM; BINDING	NADH-quinone oxidoreductase (complex I) couples electron transfer from NADH to quinone with proton translocation across the membrane. Quinone reduction is a key step for energy transmission from the site of quinone reduction to the remotely located proton-pumping machinery of the enzyme. Although structural biology studies have proposed the existence of a long and narrow quinone-access channel, the physiological relevance of this channel remains debatable. We investigated here whether complex I in bovine heart submitochondrial particles (SMPs) can catalytically reduce a series of oversized ubiquinones (OS-UQs), which are highly unlikely to transit the narrow channel because their side chain includes a bulky ?block? that is ?13 ? across. We found that some OS-UQs function as efficient electron acceptors from complex I, accepting electrons with an efficiency comparable with ubiquinone-2. The catalytic reduction and proton translocation coupled with this reduction were completely inhibited by different quinone-site inhibitors, indicating that the reduction of OS-UQs takes place at the physiological reaction site for ubiquinone. Notably, the proton-translocating efficiencies of OS-UQs significantly varied depending on their side-chain structures, suggesting that the reaction characteristics of OS-UQs affect the predicted structural changes of the quinone reaction site required for triggering proton translocation. These results are difficult to reconcile with the current channel model; rather, the access path for ubiquinone may be open to allow OS-UQs to access the reaction site. Nevertheless, contrary to the observations in SMPs, OS-UQs were not catalytically reduced by isolated complex I reconstituted into liposomes. We discuss possible reasons for these contradictory results.	[Uno, Shinpei; Masuya, Takahiro; Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Shinzawa-Itoh, Kyoko] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Lasham, Jonathan; Haapanen, Outi; Sharma, Vivek] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Sharma, Vivek] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Shiba, Tomoo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Kyoto 6068585, Japan; [Inaoka, Daniel Ken] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Mol Infect Dynam, Nagasaki 8528523, Japan; [Inaoka, Daniel Ken] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan	Kyoto University; University of Hyogo; University of Helsinki; University of Helsinki; Kyoto Institute of Technology; Nagasaki University; Nagasaki University	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp	Inaoka, Daniel Ken/GMX-4344-2022; Sharma, Vivek/CAG-0014-2022; Lasham, Jonathan/AAX-8331-2021	Inaoka, Daniel Ken/0000-0002-9791-927X; Lasham, Jonathan/0000-0001-6393-9654; Murai, Masatoshi/0000-0001-6601-2854; Haapanen, Outi/0000-0002-1958-8997; Sharma, Vivek/0000-0002-8838-3151; Miyoshi, Hideto/0000-0002-1792-554X; Masuya, Takahiro/0000-0003-4950-0527	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP18H02147, JP19K22278, JP18K05458]; Academy of Finland [294652]; University of Helsinki; Sigrid Juselius Foundation; doctoral program in chemistry and molecular sciences (CHEMS) of the University of Helsinki funding	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Academy of Finland(Academy of Finland); University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); doctoral program in chemistry and molecular sciences (CHEMS) of the University of Helsinki funding	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP18H02147 and JP19K22278 (to H. M.) and JP18K05458 (to M. M.), by the Academy of Finland (294652), the University of Helsinki and the Sigrid Juselius Foundation grants (to V. S.), and by the doctoral program in chemistry and molecular sciences (CHEMS) of the University of Helsinki funding (to O. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2016, J BIOL CHEM, V291, P15491, DOI 10.1074/jbc.M116.718510; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Banba A, 2019, J BIOL CHEM, V294, P6550, DOI 10.1074/jbc.RA119.007687; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brookes PS, 1997, J MEMBRANE BIOL, V155, P167, DOI 10.1007/s002329900168; Cabrera-Orefice A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06955-y; Cermakova P, 2019, PARASITE, V26, DOI 10.1051/parasite/2019017; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Galassi VV, 2015, BBA-BIOENERGETICS, V1847, P1560, DOI 10.1016/j.bbabio.2015.08.001; Gamiz-Hernandez AP, 2017, J AM CHEM SOC, V139, P16282, DOI 10.1021/jacs.7b08486; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Haapanen O, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00221; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jones AJY, 2017, J BIOL CHEM, V292, P4987, DOI 10.1074/jbc.M116.771899; Jones AJY, 2016, ANGEW CHEM INT EDIT, V55, P728, DOI 10.1002/anie.201507332; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kido Y, 2010, BBA-BIOENERGETICS, V1797, P443, DOI 10.1016/j.bbabio.2009.12.021; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Masuya T, 2017, BIOCHEMISTRY-US, V56, P4279, DOI 10.1021/acs.biochem.7b00612; Masuya T, 2016, BIOSCI BIOTECH BIOCH, V80, P1464, DOI 10.1080/09168451.2016.1179095; Masuya T, 2014, BIOCHEMISTRY-US, V53, P7816, DOI 10.1021/bi501342w; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; Murai M, 2015, BIOCHEMISTRY-US, V54, P2739, DOI 10.1021/acs.biochem.5b00187; Murai M, 2011, BIOCHEMISTRY-US, V50, P6901, DOI 10.1021/bi200883c; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakanishi S, 2011, BBA-BIOENERGETICS, V1807, P1170, DOI 10.1016/j.bbabio.2011.05.012; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Okuda K, 2016, BIOCHEMISTRY-US, V55, P470, DOI 10.1021/acs.biochem.5b01090; Parey K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9484; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rieske J. S., 1967, METHOD ENZYMOL, V10, P239; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Shiba T, 2019, BBA-BIOENERGETICS, V1860, P375, DOI 10.1016/j.bbabio.2019.03.008; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Shimada S, 2018, PROTEIN EXPRES PURIF, V150, P33, DOI 10.1016/j.pep.2018.04.015; Shintou K, 2007, BIOPHYS J, V93, P3900, DOI 10.1529/biophysj.107.108399; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Uno SP, 2019, J BIOL CHEM, V294, P679, DOI 10.1074/jbc.RA118.006056; Warnau J, 2018, P NATL ACAD SCI USA, V115, pE8413, DOI 10.1073/pnas.1805468115; Wikstrom M, 2015, CHEM REV, V115, P2196, DOI 10.1021/cr500448t; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zhu X, 2012, WIRES COMPUT MOL SCI, V2, P167, DOI 10.1002/wcms.74; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	65	14	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2449	2463		10.1074/jbc.RA119.012347	http://dx.doi.org/10.1074/jbc.RA119.012347			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953326	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000517330200025
J	Besada, D; Eagar, D; Rensburg, R; Shabangu, G; Hlahane, S; Daviaud, E				Besada, Donela; Eagar, Daygan; Rensburg, Russel; Shabangu, Gugu; Hlahane, Salamina; Daviaud, Emmanuelle			Resource requirements for community-based care in rural, deep-rural and peri-urban communities in South Africa: A comparative analysis in 2 South African provinces	PLOS ONE			English	Article							HEALTH; WORKERS	Introduction As South Africa embarks on the implementation of the community health care worker (CHW) 2018 policy, quantifying the resource requirements to effectively manage the programme across different geographical communities is essential. This study was conducted to quantify and compare costs associated with travel and service delivery demands on CHWs between area types in two districts. Methods This economic analysis adopted a provider perspective to cost CHW services between January and November 2016. A total of 221 CHWs completed diaries for 10 days to document their activities. Quintile regression and the Kruskall Wallis test were used to test for differences in time and activities across urban and rural sites. Results While travel time across rural and urban settings within each district did differ it was not the most significant predictor of differences in time utilization. Time on activities showed more significant differences with overall median time by unit of activity being 15% longer in rural than urban areas in Sedibeng and 10% longer in uMzinyathi respectively. Most CHW time was spent conducting home visits (57% in rural,66% in peri-urban/urban). Median time per home visit in uMzinyathi was 50% longer in deep-rural areas than urban areas and 20% longer in rural than urban areas in Sedibeng. Referrals and number of home visits per capita (0.4 visits in rural and 0.7 in urban/peri-urban areas) were low in both districts. Expenditure on the programme translated to under 4% of PHC expenditure per capita and remains under 5% if despite the new national minimum wage (R3,500/$245). Conclusion Because home visits take longer and CHWs spend a lower share of time on visits, a higher number is required in rural and deep rural areas (33% and 66% respectively) than in urban areas. Effective budget planning will therefore need to recognize the different geographical needs.	[Besada, Donela; Daviaud, Emmanuelle] South African Med Res Council, Hlth Syst Unit, Cape Town, South Africa; [Eagar, Daygan; Rensburg, Russel] Rural Hlth Advocacy Project, Johannesburg, South Africa; [Shabangu, Gugu] Umzinyathi Hlth Dist, Kwa Zulu, South Africa; [Hlahane, Salamina] Sedibeng Hlth Dist, Gauteng, South Korea	South African Medical Research Council	Besada, D (corresponding author), South African Med Res Council, Hlth Syst Unit, Cape Town, South Africa.	Donnela.Besada@mrc.ac.za		Besada, Donela/0000-0002-2020-5244	South African Medical Research Council (SAMRC); Rural Health Advocacy Project(RHAP)	South African Medical Research Council (SAMRC); Rural Health Advocacy Project(RHAP)	The authors would like to acknowledge the funding support from the South African Medical Research Council (SAMRC) and the Rural Health Advocacy Project(RHAP) provided to carry out this study. The SAMRC provided salary support for Emmanuelle Daviaud and Donela Besada, and funding support from RHAP went towards the salary support for Daygan Eagar, Russel Rensburg. All travel related expenses were also supported through funds from RHAP. The funders had no direct role in the study design, data collection and analysis and the preparation of the manuscript.	Austin-Evelyn K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173863; Bryant M, 1995, HEALTH POLICY PLANN, V10, P415, DOI 10.1093/heapol/10.4.415; Daviaud E, 2012, STAFFING NORMS CONTE; Doherty T, 2016, SAMJ S AFR MED J, V106, P41, DOI [10.7196/SAMJ.2016.v106i7.10790, 10.7196/samj.2016.v106i7.10790]; Health Policy Project, 2016, HLTH FIN PROF S AFR; Khuzwayo LS, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1388; Languza N., 2011, COMMUNITY HLTH WORKE; Mangham-Jefferies L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-61; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Naidoo S, 2012, J PUBLIC HEALTH-UK, V34, P149, DOI 10.1093/pubmed/fds008; Naomi M, 2016, DISTRICT HLTH BAROME; Pallas SW, 2013, AM J PUBLIC HEALTH, V103, pE74, DOI 10.2105/AJPH.2012.301102; Schneider H, 2018, WARD BASED PRIMARY H; South African National Department of Health, 2015, INV CAS WARD BAS PRI; South African National Department of Health, 2011, PROVINCIAL GUIDELINE; STATS SA, 2016, MID POP EST 2016; Tani K, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1718-6; Tseng YH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022186; van Pletzen E, 2014, HEALTH POLICY PLANN, V29, P742, DOI 10.1093/heapol/czt058; van Rensburg HCJ, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-26; Vaughan K, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0070-y; White Mary Jo, 2017, COMMUNITY HLTH WORKE	22	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0218682	10.1371/journal.pone.0218682	http://dx.doi.org/10.1371/journal.pone.0218682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999700	Green Published, gold			2022-12-26	WOS:000534612400001
J	Kovacs, I; Demeter, I; Janka, Z; Demetrovics, Z; Maraz, A; Ando, B				Kovacs, Ildiko; Demeter, Ildiko; Janka, Zoltan; Demetrovics, Zsolt; Maraz, Aniko; Ando, Balint			Different aspects of impulsivity in chronic alcohol use disorder with and without comorbid problem gambling	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; DECISION-MAKING; PROBLEM GAMBLERS; INDUCED IMPAIRMENT; DELAYED REWARDS; SUBSTANCE-USE; DRUG; INDIVIDUALS; AGGRESSION; SEVERITY	Background and aims Alcohol use disorder (AUD) and problem gambling are highly comorbid disorders. This study aims to explore the role of four aspects of impulsivity (trait concept of impulsivity, choice impulsivity, impulsive aggression and response inhibition/decision-making) in longterm chronic AUD patients with and without problem or pathological gambling symptoms. Methods Cognitively intact chronic AUD patients were enrolled with (n = 32) and without (n = 71) problem gambling symptoms in an inpatient clinic for chronic alcohol users. Multiple facets of impulsivity, cognitive ability, psychopathological symptoms, alcohol and gambling severity were measured. Results Chronic AUD patients with gambling disorder symptoms showed longer lifetime alcohol consumption, more severe alcohol use and higher psychopathological symptom severity than AUD patients without gambling symptoms. Gambling severity correlated with overall trait impulsivity, but not with choice impulsivity, impulsive aggression or cognitive impulsivity with controlling for lifetime alcohol consumption, lifetime alcohol use and psychopathological symptom severity. High trait impulsivity and non-planning was associated with comorbid gambling symptoms in AUD patients, which was independent of the level of intelligence, age and psychopathological symptoms. Conclusion Comorbid gambling disorder symptoms in chronic AUD was connected to more severe alcohol-related variables. Higher trait impulsivity was also linked with gambling disorder symptoms in patients with chronic AUD. This accents the need of special focus on comorbid GD symptoms in AUD, since prognosis and treatment for them may vary.	[Kovacs, Ildiko; Demeter, Ildiko; Janka, Zoltan; Ando, Balint] Univ Szeged, Dept Psychiat, Fac Med, Szeged, Hungary; [Demetrovics, Zsolt] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Maraz, Aniko] Humboldt Univ, Inst Psychol, Berlin, Germany	Szeged University; Eotvos Lorand University; Humboldt University of Berlin	Kovacs, I (corresponding author), Univ Szeged, Dept Psychiat, Fac Med, Szeged, Hungary.	kovacs.ildiko.1@med.u-szeged.hu	Demetrovics, Zsolt/F-8613-2010	Demetrovics, Zsolt/0000-0001-5604-7551; Kovacs, Ildiko/0000-0003-4215-8351	Hungarian National Research, Development and Innovation Office [NKFIH-1157-8/2019-DT, KKP126835, SZTE-A OK-KKA2019-HG]	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	Zsolt Demetrovics was supported by the Hungarian National Research, Development and Innovation Office (NKFIH-1157-8/2019-DT, KKP126835).; Balint Ando was supported by the Geza Hetenyi Grant (Grant Number: SZTE-A OK-KKA2019-HG).	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Aragay N, 2018, COMPR PSYCHIAT, V83, P79, DOI 10.1016/j.comppsych.2018.03.008; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Berlin H. A., 2008, PSYCHIAT TIMES, V25, P58; Blair RJR, 2016, J CHILD ADOL PSYCHOP, V26, P4, DOI 10.1089/cap.2015.0088; Bottesi G., 2014, PSYCHOPATHOLOGY REV, DOI [DOI 10.5127/PR.032713, 10.5127/pr.032713]; Bottesi G, 2015, J GAMBL STUD, V31, P825, DOI 10.1007/s10899-014-9470-5; Buja A, 2017, J BEHAV ADDICT, V6, P425, DOI 10.1556/2006.6.2017.043; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Butler SF, 2001, PSYCHOL ADDICT BEHAV, V15, P4; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Charney DA, 2010, J SUBST ABUSE TREAT, V38, P42, DOI 10.1016/j.jsat.2009.06.002; Cho SS, 2013, BRAIN TOPOGR, V26, P479, DOI 10.1007/s10548-012-0270-x; Choi SW, 2014, J BEHAV ADDICT, V3, P246, DOI 10.1556/JBA.3.2014.4.6; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corp I., 2016, IBM SPSS STAT WINDOW; Cunningham-Williams RM, 1998, AM J PUBLIC HEALTH, V88, P1093, DOI 10.2105/AJPH.88.7.1093; Daghestani AN, 1996, J CLIN PSYCHIAT, V57, P360; Derogatis LR, 1986, SCL 90 R ADM SCORING; Dussault F, 2011, J CHILD PSYCHOL PSYC, V52, P130, DOI 10.1111/j.1469-7610.2010.02313.x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Evren C, 2014, EUR PSYCHIAT, V29, P1, DOI [10.1016/j.eurpsy.2013.08.001, DOI 10.1016/J.EURPSY.2013.08.001]; Evren C, 2012, DRUG ALCOHOL REV, V31, P81, DOI 10.1111/j.1465-3362.2011.00303.x; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P613, DOI 10.1016/0191-8869(85)90011-X; Feigelman W, 1998, AM J PUBLIC HEALTH, V88, P467, DOI 10.2105/AJPH.88.3.467; FEIN G, 1990, WESTERN J MED, V152, P531; Fillmore MT, 2005, J STUD ALCOHOL, V66, P663, DOI 10.15288/jsa.2005.66.663; Fillmore MT, 2002, J STUD ALCOHOL, V63, P237, DOI 10.15288/jsa.2002.63.237; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Gerevich J, 2007, INT J METH PSYCH RES, V16, P124, DOI 10.1002/mpr.221; Gerevich Jozsef, 2006, Psychiatr Hung, V21, P45; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Guillot CR, 2010, EXP CLIN PSYCHOPHARM, V18, P409, DOI 10.1037/a0021053; Gyollai Agoston, 2011, Psychiatr Hung, V26, P230; Harding AJ, 1997, HIPPOCAMPUS, V7, P78, DOI 10.1002/(SICI)1098-1063(1997)7:1<78::AID-HIPO8>3.3.CO;2-B; Hasin DS, 2015, SOC PSYCH PSYCH EPID, V50, P1609, DOI 10.1007/s00127-015-1088-0; Hentges RF, 2018, DEV PSYCHOPATHOL, V30, P1305, DOI 10.1017/S0954579417001596; Hildebrandt H, 2004, NEUROPSYCHOLOGY, V18, P203, DOI 10.1037/0894-4105.18.2.203; Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z; Houston RJ, 2014, ADDICT BEHAV, V39, P345, DOI 10.1016/j.addbeh.2013.09.032; Ioannidis K, 2019, AM J DRUG ALCOHOL AB, V43, P24; Jacob L, 2018, J BEHAV ADDICT, V7, P781, DOI 10.1556/2006.7.2018.72; Johnson SL, 2003, J PSYCHOPATHOL BEHAV, V25, P25, DOI 10.1023/A:1022247919288; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Keough MT, 2015, SUBST ABUS-RES TREAT, V9, P33, DOI 10.4137/SART.S31434; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Korman L, 2008, PSYCHOTHER RES, V18, P454, DOI 10.1080/10503300701858362; Kovacs I, 2019, DATASET MANUSCRIPT E, DOI [10.6084/m9.figshare.11473296, DOI 10.6084/M9.FIGSHARE.11473296]; Kovacs I, 2017, DRUG ALCOHOL DEPEN, V181, P152, DOI 10.1016/j.drugalcdep.2017.09.023; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lawrence AJ, 2009, PSYCHOPHARMACOLOGY, V207, P163, DOI 10.1007/s00213-009-1645-x; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; Lee JY, 2017, J BEHAV ADDICT, V6, P387, DOI 10.1556/2006.6.2017.055; Lesieur H R, 1991, J Gambl Stud, V7, P5, DOI 10.1007/BF01019763; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Logan Gordon D., 1994, P189; Lorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.x; Mackey S, 2018, AM J PSYCHIAT; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Manning V, 2017, J BEHAV ADDICT, V6, P678, DOI 10.1556/2006.6.2017.077; Marczinski CA, 2005, PSYCHOPHARMACOLOGY, V181, P337, DOI 10.1007/s00213-005-2269-4; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McCarthy DM, 2012, ADDICTION, V107, P2109, DOI 10.1111/j.1360-0443.2012.03974.x; McPherson A, 2010, J AGGRESS CONFL PEAC, V2, P45, DOI 10.5042/jacpr.2010.0004; Metzger CD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00138; Mitchell JM, 2005, ALCOHOL CLIN EXP RES, V29, P2158, DOI 10.1097/01.alc.0000191755.63639.4a; Mitchell Marci R, 2014, Curr Behav Neurosci Rep, V1, P1; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Murray DE, 2015, DRUG ALCOHOL DEPEN, V150, P120, DOI 10.1016/j.drugalcdep.2015.02.022; Paksi Borbala, 2017, Neuropsychopharmacol Hung, V19, P55; Parke A., 2005, INT J MENT HEALTH AD, V2, P50; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Petry NM, 2005, J CLIN PSYCHIAT, V66, P564, DOI 10.4088/JCP.v66n0504; Petry NM, 1999, DRUG ALCOHOL DEPEN, V56, P25, DOI 10.1016/S0376-8716(99)00010-1; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Piper BJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1460; Potenza MN, 2001, JAMA-J AM MED ASSOC, V286, P141, DOI 10.1001/jama.286.2.141; Racz J, 2002, MAGYAR PSZICHOLOGIAI, V57, P587, DOI DOI 10.1556/MPSZLE.57.2002.4.4; Rochat L, 2018, J CLIN EXP NEUROPSYC, V40, P45, DOI 10.1080/13803395.2017.1313393; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Rozsa S, 2008, WISC 4 GYERM INT MAG, P9; Rubio G, 2008, ALCOHOL CLIN EXP RES, V32, P1681, DOI 10.1111/j.1530-0277.2008.00746.x; Salvatore Jessica E, 2015, Curr Addict Rep, V2, P76; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Slutske WS, 2000, ARCH GEN PSYCHIAT, V57, P666, DOI 10.1001/archpsyc.57.7.666; Stephan RA, 2017, AM J DRUG ALCOHOL AB, V43, P24, DOI 10.1080/00952990.2016.1206113; Stevens AK, 2017, ADDICT BEHAV, V65, P147, DOI 10.1016/j.addbeh.2016.10.026; Stinchfield R, 2005, J GAMBL STUD, V21, P273, DOI 10.1007/s10899-005-3100-1; Sullivan EV, 2010, ALCOHOL RES HEALTH, V33, P127; Urban R, 2016, PSYCHIAT RES, V239, P265, DOI 10.1016/j.psychres.2016.03.039; Urban R, 2014, PSYCHIAT RES, V216, P146, DOI 10.1016/j.psychres.2014.01.027; Uva MCD, 2010, ALCOHOL ALCOHOLISM, V45, P241, DOI 10.1093/alcalc/agq012; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Vitaro F, 1999, ADDICTION, V94, P565, DOI 10.1046/j.1360-0443.1999.94456511.x; Wechsler D., 2008, WECHSLER ADULT INTEL; WHITE HR, 1993, J STUD ALCOHOL, P62, DOI 10.15288/jsas.1993.s11.62; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Yakovenko I, 2018, J BEHAV ADDICT, V7, P375, DOI 10.1556/2006.7.2018.31; Yan WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39233	106	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227645	10.1371/journal.pone.0227645	http://dx.doi.org/10.1371/journal.pone.0227645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9CB	31999707	Green Published, Green Accepted, gold			2022-12-26	WOS:000534612400025
J	Smeets, RGM; Elissen, AMJ; Kroese, MEAL; Hameleers, N; Ruwaard, D				Smeets, Rowan G. M.; Elissen, Arianne M. J.; Kroese, Marielle E. A. L.; Hameleers, Niels; Ruwaard, Dirk			Identifying subgroups of high-need, high-cost, chronically ill patients in primary care: A latent class analysis	PLOS ONE			English	Article							ACCOUNTABLE CARE; HEALTH-CARE; MANAGEMENT; SEGMENTATION	Introduction Segmentation of the high-need, high-cost (HNHC) population is required for reorganizing care to accommodate person-centered, integrated care delivery. Therefore, we aimed to identify and characterize relevant subgroups of the HNHC population in primary care by using demographic, biomedical, and socioeconomic patient characteristics. Methods This was a retrospective cohort study within a Dutch primary care group, with a follow-up period from September 1, 2014 to August 31, 2017. Chronically ill patients were included in the HNHC population if they belonged to the top 10% of care utilizers and/or suffered from multimorbidity and had an above-average care utilization. In a latent class analysis, forty-one patient characteristics were initially used as potential indicators of heterogeneity in HNHC patients' needs. Results Patient data from 12 602 HNHC patients was used. A 4-class model was considered statistically and clinically superior. The classes were named according to the characteristics that were most dominantly present and distinctive between the classes (i.e. mainly age, household position, and source of income). Class 1 ('older adults living with partner') included 39.3% of patients, class 2 ('older adults living alone') included 25.5% of patients, class 3 ('middle-aged, employed adults with family') included 23.3% of patients, and class 4 ('middle-aged adults with social welfare dependency') included 11.9% of patients. Diabetes was the most common condition in all classes; the second most prevalent condition differed between osteoarthritis in class 1 (21.7%) and 2 (23.8%), asthma in class 3 (25.3%), and mood disorders in class 4 (23.1%). Furthermore, while general practitioner (GP) care utilization increased during the follow-up period in the classes of older adults, it remained relatively stable in the middle-aged classes. Conclusions Although the HNHC population is heterogeneous, distinct subgroups with relatively homogeneous patterns of mainly demographic and socioeconomic characteristics can be identified. This calls for tailoring care and increased attention for social determinants of health.	[Smeets, Rowan G. M.; Elissen, Arianne M. J.; Kroese, Marielle E. A. L.; Hameleers, Niels; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands	Maastricht University	Smeets, RGM (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands.	rowan.smeets@maastrichtuniversity.nl		, Rowan/0000-0001-8840-3485; Hameleers, Niels/0000-0002-3107-4702; Ruwaard, Dirk/0000-0003-4887-8413	primary care group 'HZD', the Netherlands	primary care group 'HZD', the Netherlands(Netherlands Government)	The current study was funded by primary care group 'HZD', the Netherlands (https://www.hzd.nu).The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2016, VITAL DIRECTIONS HLT; AKAIKE H, 1970, ANN I STAT MATH, V22, P203, DOI 10.1007/BF02506337; Beeber AS, 2008, NURS RES, V57, P312, DOI 10.1097/01.NNR.0000313500.07475.eb; Benjamin CY, 2018, MILBANK Q, V96, P369, DOI 10.1111/1468-0009.12328; Blumenthal D, 2016, NEW ENGL J MED, V375, P909, DOI 10.1056/NEJMp1608511; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Buja A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208875; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Cooil B., 2008, J RELATIONSHIP MARKE, V6, P9, DOI [10.1300/J366v06n03_02, DOI 10.1300/J366V06N03_02]; de Bakker DH, 2012, HEALTH AFFAIR, V31, P426, DOI 10.1377/hlthaff.2011.0912; Dreyer K, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0939-4; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Flinterman LE, 2015, DEEL 1 EVALUATIE HUI; Ganguli I, 2018, JAMA-J AM MED ASSOC, V319, P655, DOI 10.1001/jama.2017.18995; Hayes Susan L, 2016, Issue Brief (Commonw Fund), V26, P1; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P2572, DOI 10.1001/jama.2013.7103; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031; Kindig DA, 2007, MILBANK Q, V85, P139, DOI 10.1111/j.1468-0009.2007.00479.x; Krewski D, 2007, HUM ECOL RISK ASSESS, V13, P1288, DOI 10.1080/10807030701655798; Lafortune L, 2009, MED CARE, V47, P286, DOI 10.1097/MLR.0b013e3181894293; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; Low LL, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2736-8; Lynn J, 2007, MILBANK Q, V85, P185, DOI 10.1111/j.1468-0009.2007.00483.x; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; Muthen B., 2012, MPLUS WEB NOTES, V14; Nabalamba Alice, 2007, Health Rep, V18, P23; National Academy of Medicine, 2017, EFFECTIVE CARE HIGH; Nederlands Zorgautoriteit (NZa), 2018, PREST TAR HUIS MULT; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; REYNOLDS R, 2018, BMC FAM PRACT, V19, DOI DOI 10.1186/S12875-017-0677-2; Rinehart DJ, 2018, MED CARE, V56, pE1, DOI 10.1097/MLR.0000000000000628; Ryan CJ, 2007, NURS RES, V56, P72, DOI 10.1097/01.NNR.0000263968.01254.d6; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shadmi Efrat, 2013, J Comorb, V3, P45; Smits FT, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-138; Sondergaard E, 2015, SCAND J PRIM HEALTH, V33, P121, DOI 10.3109/02813432.2015.1041828; Soto-Gordoa M, 2019, HEALTH SERV RES, V54, P466, DOI 10.1111/1475-6773.13094; Spoorenberg SLW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190751; Struijs JN, 2015, HEALTH POLICY, V119, P522, DOI 10.1016/j.healthpol.2014.12.003; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Vedsted P, 2004, SOC SCI MED, V59, P813, DOI 10.1016/j.socscimed.2003.11.027; Vektis, VEKT; Vuik SI, 2016, HEALTH AFFAIR, V35, P769, DOI 10.1377/hlthaff.2015.1311; Wammes JJG, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023113; Wammes JJG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017775; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Wodchis WP, 2016, CAN MED ASSOC J, V188, P182, DOI 10.1503/cmaj.150064; Xu JJ, 2018, J HEALTH CARE POOR U, V29, P202, DOI 10.1353/hpu.2018.0014; Yan S, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0584-9; Zhou Yi Yvonne, 2014, Perm J, V18, P18, DOI 10.7812/TPP/14-005; Zulman DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007771	59	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228103	10.1371/journal.pone.0228103	http://dx.doi.org/10.1371/journal.pone.0228103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995630	gold, Green Published			2022-12-26	WOS:000534609400044
J	Matsumoto, M; Yashiro, H; Ogino, H; Aoyama, K; Nambu, T; Nakamura, S; Nishida, M; Wang, XL; Erion, DM; Kaneko, M				Matsumoto, Mitsuharu; Yashiro, Hiroaki; Ogino, Hitomi; Aoyama, Kazunobu; Nambu, Tadahiro; Nakamura, Sayuri; Nishida, Mayumi; Wang, Xiaolun; Erion, Derek M.; Kaneko, Manami			Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DE-NOVO LIPOGENESIS; SELECTIVE INSULIN-RESISTANCE; MUTANT MICE; MOUSE MODEL; GENE; BETA; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION	Acetyl-CoA carboxylase (ACC) catalyzes the rate-limiting step in de novo lipogenesis, which is increased in the livers of patients with nonalcoholic steatohepatitis. GS-0976 (firsocostat), an inhibitor of isoforms ACC1 and ACC2, reduced hepatic steatosis and serum fibrosis biomarkers such as tissue inhibitor of metalloproteinase 1 in patients with nonalcoholic steatohepatitis in a randomized controlled trial, although the impact of this improvement on fibrosis has not fully been evaluated in preclinical models. Here, we used Western diet-fed melanocortin 4 receptor-deficient mice that have similar phenotypes to nonalcoholic steatohepatitis patients including progressively developed hepatic steatosis as well as fibrosis. We evaluated the effects of ACC1/2 inhibition on hepatic fibrosis. After the confirmation of significant hepatic fibrosis with a 13-week pre-feeding, GS-0976 (4 and 16 mg/kg/day) treatment for 9 weeks lowered malonyl-CoA and triglyceride content in the liver and improved steatosis, histologically. Furthermore, GS-0976 reduced the histological area of hepatic fibrosis, hydroxyproline content, mRNA expression level of type I collagen in the liver, and plasma tissue metalloproteinase inhibitor 1, suggesting an improvement of hepatic fibrosis. The treatment with GS-0976 was also accompanied by reductions of plasma ALT and AST levels. These data demonstrate that improvement of hepatic lipid metabolism by ACC1/2 inhibition could be a new option to suppress fibrosis progression as well as to improve hepatic steatosis in nonalcoholic steatohepatitis.	[Matsumoto, Mitsuharu; Ogino, Hitomi; Nishida, Mayumi; Kaneko, Manami] Axcelead Drug Discovery Partners Inc, Dept Integrated Biol, Fujisawa, Kanagawa, Japan; [Yashiro, Hiroaki; Wang, Xiaolun; Erion, Derek M.] Takeda Pharmaceut Co Ltd, Gastroenterol Drug Discovery Unit, Cambridge, MA USA; [Aoyama, Kazunobu] Axcelead Drug Discovery Partners Inc, Dept Drug Disposit & Anal, Fujisawa, Kanagawa, Japan; [Nambu, Tadahiro; Nakamura, Sayuri] Axcelead Drug Discovery Partners Inc, Dept Nonclin Safety Res, Fujisawa, Kanagawa, Japan		Matsumoto, M (corresponding author), Axcelead Drug Discovery Partners Inc, Dept Integrated Biol, Fujisawa, Kanagawa, Japan.	mitsuharu.matsumoto@axcelead.com		Wang, Xiaolun/0000-0001-9576-7746	Takeda Pharmaceutical Company limited	Takeda Pharmaceutical Company limited(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company limited. During the time this study was conducted, Takeda provided support in the form of salaries for authors [HY, XW, DE]. Axcelead Drug Discovery Partners, Inc., also provided salaries for authors [MM, HO, KA, TN, SN, MN, MK], but did not fund this study. These companies did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bedossa P, 2017, LIVER INT, V37, P85, DOI 10.1111/liv.13301; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Del Ben M, 2017, BRIT J CLIN PHARMACO, V83, P88, DOI 10.1111/bcp.12899; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Goedeke L, 2018, HEPATOLOGY, V68, P2197, DOI 10.1002/hep.30097; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113; Honma M, 2018, INT J OBESITY, V42, P1544, DOI 10.1038/s41366-018-0062-9; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082163; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kim CW, 2017, CELL METAB, V26, P394, DOI 10.1016/j.cmet.2017.07.009; Kim YO, 2017, METHODS MOL BIOL, V1559, P279, DOI 10.1007/978-1-4939-6786-5_19; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Konuma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121528; Kubota N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12977; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lawitz EJ, 2018, CLIN GASTROENTEROL H, V16, P1983, DOI 10.1016/j.cgh.2018.04.042; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Loomba R, 2018, GASTROENTEROLOGY, V155, P1463, DOI 10.1053/j.gastro.2018.07.027; Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Richter K, 2015, REDOX BIOL, V6, P344, DOI 10.1016/j.redox.2015.08.015; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Weber E, 2018, HEPATOLOGY, V68, p988A; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; WHITTON PD, 1979, FEBS LETT, V98, P85, DOI 10.1016/0014-5793(79)80157-X; Widmer J, 1996, BIOCHEM J, V316, P915, DOI 10.1042/bj3160915; Yamamoto S, 2013, TRANSGENIC RES, V22, P537, DOI 10.1007/s11248-012-9651-x; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228212	10.1371/journal.pone.0228212	http://dx.doi.org/10.1371/journal.pone.0228212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990961	Green Published, gold			2022-12-26	WOS:000534605400049
J	Wu, HJ; Hao, MG; Yeo, SK; Guan, JL				Wu, Hsin-Jung; Hao, Mingang; Yeo, Syn Kok; Guan, Jun-Lin			FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication	ONCOGENE			English	Article							FOCAL-ADHESION KINASE; EPITHELIAL-SPECIFIC DISRUPTION; STEM-CELLS; HETEROGENEITY; SURVIVAL; BIOLOGY; GENES	Cancer-associated fibroblasts (CAFs) are activated fibroblasts that constitute the major components of tumor microenvironment (TME) and play crucial roles in tumor development and metastasis. Here, we generated fibroblast-specific inducible focal adhesion kinase (FAK) knockout (cKO) mice in a breast cancer model to study potential role and mechanisms of FAK signaling in CAF to promote breast cancer metastasis in vivo. While not affecting primary tumor development and growth, FAK deletion significantly suppressed breast cancer metastasis in vivo. Analyses of CAFs derived from cKO mice as well as human CAFs showed that FAK is required for their activity to promote mammary tumor cell migration. We further showed that FAK ablation in CAFs decreased exosome functions to promote tumor cell migration and other activities, which could contribute to the reduced metastasis observed in cKO mice. Lastly, profiling of miRs from CAF exosomes showed alterations of several exosomal miRs in FAK-null CAFs, and further analysis suggested that miR-16 and miR-148a enriched in exosomes from FAK-null CAFs contribute to the reduced tumor cell activities and metastasis. Together, these results identify a new role for FAK signaling in CAFs that regulate their intercellular communication with tumor cells to promote breast cancer metastasis.	[Wu, Hsin-Jung; Hao, Mingang; Yeo, Syn Kok; Guan, Jun-Lin] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Guan, JL (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA.	guanjl@uc.edu	Hao, Mingang/AAL-7254-2020; Hao, Mingang/X-2317-2018; Yeo, Syn/I-1617-2019	Hao, Mingang/0000-0001-6456-1710; Yeo, Syn/0000-0002-4333-2510	NIH [R01CA163493, R01NS094144, R01HL073394]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Glenn Doerman for his help in the preparation of figures. We are grateful to members of our laboratory for their critical comments and suggestions for the manuscript. The work in this study is funded by NIH grants R01CA163493, R01NS094144, and R01HL073394 to J-LG.	Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Donnarumma E, 2017, ONCOTARGET, V8, P19592, DOI 10.18632/oncotarget.14752; Duran A, 2016, CANCER CELL, V30, P595, DOI 10.1016/j.ccell.2016.09.004; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li Y, 2016, J CANCER, V7, P1233, DOI 10.7150/jca.14616; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Luo M, 2013, CANCER RES, V73, P5591, DOI 10.1158/0008-5472.CAN-13-1351; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Serrels B, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan8355; Shiga K, 2015, CANCERS, V7, P2443, DOI 10.3390/cancers7040902; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Sun SG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20930-z; Symeonides SN, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0217-6; Tavora B, 2014, NATURE, V514, P112, DOI 10.1038/nature13541; Tavora B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/emmm.201000106; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	50	67	71	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	12					2539	2549		10.1038/s41388-020-1162-2	http://dx.doi.org/10.1038/s41388-020-1162-2		JAN 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KW4HU	31988451	Green Accepted			2022-12-26	WOS:000509655100003
J	He, JZ; Hommen, F; Lauer, N; Balmert, S; Scholz, H				He, Jianzheng; Hommen, Franziska; Lauer, Nina; Balmert, Sophia; Scholz, Henrike			Serotonin transporter dependent modulation of food-seeking behavior	PLOS ONE			English	Article							ANTENNAL LOBE; OLFACTORY INFORMATION; DROSOPHILA; NEURONS; EXPRESSION; CONNECTIVITY; ARCHITECTURE; GLOMERULI; DOPAMINE; ETHANOL	The olfactory pathway integrates the odor information required to generate correct behavioral responses. To address how changes of serotonin signaling in two contralaterally projecting, serotonin-immunoreactive deutocerebral neurons impacts key odorant attraction in Drosophila melanogaster, we selectively alter serotonin signaling using the serotonin transporter with mutated serotonin binding sites in these neurons and analyzed the consequence on odorant-guided food seeking. The expression of the mutated serotonin transporter selectively changed the odorant attraction in an odorant-specific manner. The shift in attraction was not influenced by more up-stream serotonergic mechanisms mediating behavioral inhibition. The expression of the mutated serotonin transporter in CSD neurons did not influence other behaviors associated with food seeking such as olfactory learning and memory or food consumption. We provide evidence that the change in the attraction by serotonin transporter function might be achieved by increased serotonin signaling and by different serotonin receptors. The 5-HT1B receptor positively regulated the attraction to low and negatively regulated the attraction to high concentrations of acetic acid. In contrast, 5-HT1A and 5-HT2A receptors negatively regulated the attraction in projection neurons to high acetic acid concentrations. These results provide insights into how serotonin signaling in two serotonergic neurons selectively regulates the behavioral response to key odorants during food seeking.	[He, Jianzheng; Hommen, Franziska; Lauer, Nina; Balmert, Sophia; Scholz, Henrike] Albertus Magnus Univ Cologne, Dept Biol, Inst Zool, Cologne, Germany	University of Cologne	Scholz, H (corresponding author), Albertus Magnus Univ Cologne, Dept Biol, Inst Zool, Cologne, Germany.	henrike.scholz@uni-koeln.de	Scholz, Henrike/ABE-1063-2020	Hommen, Franziska/0000-0002-1612-6973	German Science Foundation (DFG); Chinese Scholarship Council (CSC); CSC; DFG [Scho 656/8-1, SFB1340]; Heisenberg Professorship [Scho 656/7-2]	German Science Foundation (DFG)(German Research Foundation (DFG)); Chinese Scholarship Council (CSC)(China Scholarship Council); CSC; DFG(German Research Foundation (DFG)); Heisenberg Professorship(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) and the Chinese Scholarship Council (CSC). Scho 656/7-2 Heisenberg Professorship, DFG Scho 656/8-1 and SFB1340 to HS; CSC fellowship to JH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Albin SD, 2015, CURR BIOL, V25, P2435, DOI 10.1016/j.cub.2015.08.005; Alves Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143641; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Blenau W, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00028; Bracker LB, 2013, CURR BIOL, V23, P1228, DOI 10.1016/j.cub.2013.05.029; Coates KE, 2017, J NEUROSCI, V37, P7318, DOI 10.1523/JNEUROSCI.0192-17.2017; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Davis RL, 2015, CELL, V163, DOI 10.1016/j.cell.2015.09.043; Diegelmann S, 2008, FLY, V2, P236, DOI 10.4161/fly.6817; Diegelmann S, 2017, JOVE-J VIS EXP, DOI 10.3791/55024; Ellen CW, 2012, J MOL HISTOL, V43, P401, DOI 10.1007/s10735-012-9401-7; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gaudry Q, 2018, YALE J BIOL MED, V91, P23; Giang T, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00160; Giang T, 2011, J NEUROGENET, V25, P17, DOI 10.3109/01677063.2011.553002; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Grabe V, 2016, CELL REP, V16, P3401, DOI 10.1016/j.celrep.2016.08.063; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lizbinski KM, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00424; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Mehinagic E, 2006, J AGR FOOD CHEM, V54, P2678, DOI 10.1021/jf052288n; Munch D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21841; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Pech U, 2013, J COMP NEUROL, V521, P3992, DOI 10.1002/cne.23388; RAO MRR, 1953, J BACTERIOL, V66, P634, DOI 10.1128/JB.66.6.634-638.1953; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Singh AP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003452; Sizemore TR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37119; Sudhakaran IP, 2012, J NEUROSCI, V32, P7225, DOI 10.1523/JNEUROSCI.1099-12.2012; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang KY, 2014, P NATL ACAD SCI USA, V111, P3164, DOI 10.1073/pnas.1317911111; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wu YY, 2012, LEARN MEMORY, V19, P478, DOI 10.1101/lm.025726.112; Xu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167518; Zhang XN, 2016, ELIFE, V5, DOI 10.7554/eLife.16836; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	56	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227554	10.1371/journal.pone.0227554	http://dx.doi.org/10.1371/journal.pone.0227554			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978073	Green Published, gold			2022-12-26	WOS:000534599100043
J	Song, XH; Yu, Y; Shen, CJ; Wang, YB; Wang, N				Song, Xiaohan; Yu, Yi; Shen, Cangjie; Wang, Yubo; Wang, Nan			Dimerization/oligomerization of the extracellular domain of the GLP-1 receptor and the negative cooperativity in its ligand binding revealed by the improved NanoBiT	FASEB JOURNAL			English	Article						binding kinetics; exenatide; fragment complementation; GPCR; luminescence	GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED SECRETIN; IN-VITRO; MEDIATED DIMERIZATION; HOMODIMERIZATION; EXPRESSION; STABILITY; MECHANISM; REPORTER; AFFINITY	The glucagon-like peptide-1 receptor (GLP-1R), a family B G-protein coupled receptor (GPCR), regulates the insulin secretion following stimulation by ligands. The transmembrane domain (TM) mediates GLP-1R homodimerization, which modulates its ligand binding and signaling. We investigated the possible involvement of the N-terminal extracellular domain (NTD) in dimerization/oligomerization and dimer-associated ligand binding by NanoLuc Binary Technology (NanoBiT). With improved NanoBiT detection using a decreasing substrate concentration, the negative cooperativity of ligand binding to the NTD was confirmed by accelerated dissociation and Scatchard analysis. The dimerization/oligomerization of the isolated NTD was observed by NanoBiT and validated by analytical ultracentrifugation, deriving the comparable dimerization affinity (10(5) M-1). The NTD was also involved in the dimerization/oligomerization of the full-length GLP-1R with mutated TM4 at the cellular level. In an analysis of the parameters of the NTD binding, the K-d for the probe GLP-1 (7-36, A8G) was similar (6-8 mu M) in both the 1:1 binding model and the receptor dimerization model. Compared with GLP-1 and dulaglutide, exenatide showed two-site binding with K-i values of 1.4 pM and 8.7 nM. Our study indicates the involvement of NTD in the GLP-1R dimerization/oligomerization and suggests that further investigations on the role in other family B GPCRs are needed.	[Song, Xiaohan; Yu, Yi; Shen, Cangjie; Wang, Yubo; Wang, Nan] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, N (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, 1st Xiannongtan St, Beijing, Peoples R China.	wangnan@imm.ac.cn		Wang, Nan/0000-0003-0330-8636	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) [7162134]; Ministry of Science and Technology of the People's Republic of China (MOST) [2018ZX09711001-003-001]	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Grant/Award Number: No. 7162134; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2018ZX09711001-003-001	Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Burcelin R, 1999, METABOLISM, V48, P252, DOI 10.1016/S0026-0495(99)90043-4; Casado-Anguera V, 2019, PHARMACOL RES, V139, P337, DOI 10.1016/j.phrs.2018.11.032; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Deacon CF, 1998, DIABETOLOGIA, V41, P271, DOI 10.1007/s001250050903; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Deng LG, 2017, PROTEIN EXPRES PURIF, V138, P46, DOI 10.1016/j.pep.2017.06.019; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Durroux T, 2005, TRENDS PHARMACOL SCI, V26, P376, DOI 10.1016/j.tips.2005.05.006; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Haglin ER, 2017, BIOCHEMISTRY-US, V56, P5874, DOI 10.1021/acs.biochem.7b00698; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2017, ENDOCRINOLOGY, V158, P1685, DOI 10.1210/en.2017-00023; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu MJ, 2018, AMINO ACIDS, V50, P1111, DOI 10.1007/s00726-018-2588-5; Jimenez-Solem E, 2010, CURR OPIN MOL THER, V12, P790; Karageorgos V, 2018, HORM-INT J ENDOCRINO, V17, P45, DOI 10.1007/s42000-018-0009-5; Koole C, 2017, J BIOL CHEM, V292, P7131, DOI 10.1074/jbc.M117.779496; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laschet C, 2019, J BIOL CHEM, V294, P4079, DOI 10.1074/jbc.RA118.006231; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Maniatis T., 1983, ANAL BIOCHEM, V186, P182; Miller L J, 2014, Int J Obes Suppl, V4, pS9, DOI 10.1038/ijosup.2014.4; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Norisada J, 2018, MOL BIOTECHNOL, V60, P539, DOI 10.1007/s12033-018-0092-5; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Oh-hashi K, 2016, CELL BIOCHEM FUNCT, V34, P497, DOI 10.1002/cbf.3222; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Roed Sarah Norklit, 2012, Front Endocrinol (Lausanne), V3, P62, DOI 10.3389/fendo.2012.00062; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schroder-Tittmann K, 2010, BIOCHEMISTRY-US, V49, P7956, DOI 10.1021/bi101159s; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Taylor ES, 2017, PROTEINS, V85, P561, DOI 10.1002/prot.25220; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; van Zoelen EJJ, 1998, TRENDS PHARMACOL SCI, V19, P487, DOI 10.1016/S0165-6147(98)01250-4; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; Ward RJ, 2017, BIOCHEM J, V474, P1879, DOI 10.1042/BCJ20170184; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051811; Yuan SJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-5	58	6	6	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4348	4368		10.1096/fj.201902007R	http://dx.doi.org/10.1096/fj.201902007R		JAN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31970836				2022-12-26	WOS:000508879400001
J	Lu, CF; Song, GJ; Beale, K; Yan, JB; Garst, E; Feng, J; Lund, E; Catteruccia, F; Springer, TA				Lu, Chafen; Song, Gaojie; Beale, Kristin; Yan, Jiabin; Garst, Emma; Feng, Juan; Lund, Emily; Catteruccia, Flaminia; Springer, Timothy A.			Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines	PLOS ONE			English	Article							FALCIPARUM CIRCUMSPOROZOITE-PROTEIN; B SURFACE-ANTIGEN; PLASMODIUM-FALCIPARUM; GLIDING MOTILITY; PFSPZ VACCINE; DUAL BINDING; HIGH-LEVEL; IMMUNOGENICITY; EFFICACY; PROTECTION	The circumsporozoite protein (CSP) and thrombospondin-related adhesion protein (TRAP) are major targets for pre-erythrocytic malaria vaccine development. However, the CSPbased vaccine RTS,S provides only marginal protection, highlighting the need for innovative vaccine design and development. Here we design and characterize expression and folding of P. berghei (Pb) and P. falciparum (Pf) TRAP-CSP fusion proteins, and evaluate immunogenicity and sterilizing immunity in mice. TRAP N-terminal domains were fused to the CSP C-terminal aTSR domain with or without the CSP repeat region, expressed in mammalian cells, and evaluated with or without N-glycan shaving. Pb and Pf fusions were each expressed substantially better than the TRAP or CSP components alone; furthermore, the fusions but not the CSP component could be purified to homogeneity and were well folded and monomeric. As yields of TRAP and CSP fragments were insufficient, we immunized BALB/c mice with Pb TRAP-CSP fusions in AddaVax adjuvant and tested the effects of absence or presence of the CSP repeats and absence or presence of high mannose N-glycans on total antibody titer and protection from infection by mosquito bite both 2.5 months and 6 months after the last immunization. Fusions containing the repeats were completely protective against challenge and re-challenge, while those lacking repeats were significantly less effective. These results correlated with higher total antibody titers when repeats were present. Our results show that TRAP-CSP fusions increase protein antigen production, have the potential to yield effective vaccines, and also guide design of effective proteins that can be encoded by nucleic acid-based and virally vectored vaccines.	[Lu, Chafen; Song, Gaojie; Beale, Kristin; Yan, Jiabin; Garst, Emma; Feng, Juan; Springer, Timothy A.] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lund, Emily; Catteruccia, Flaminia] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Song, Gaojie] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China; [Song, Gaojie] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; East China Normal University; East China Normal University	Lu, CF; Springer, TA (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	lu@crystal.harvard.edu; Springer@crystal.harvard.edu		Springer, Timothy/0000-0001-6627-2904	National Institute of Health [5R01AI95686]; Kidder Fund from Boston Children's Hospital; NIH [5R01AI95686]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidder Fund from Boston Children's Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant 5R01AI95686 from the National Institute of Health, issued to T.A.S. and C.L. (https://www.nih.gov/), and the Kidder Fund from Boston Children's Hospital, issued to T.A.S. (http://www.childrenshospital.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Shahid Khan and Dr. Chris J. Janse (Leiden Malaria Research Group) for providing transgenic Plasmodium berghei lines. Supported by NIH grant 5R01AI95686.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Bauza K, 2016, INFECT IMMUN, V84, P622, DOI 10.1128/IAI.01063-15; Bauza K, 2014, INFECT IMMUN, V82, P1277, DOI 10.1128/IAI.01187-13; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Datta D, 2015, CLIN VACCINE IMMUNOL, V22, P1013, DOI 10.1128/CVI.00185-15; Doll KL, 2016, J IMMUNOL, V196, P4253, DOI 10.4049/jimmunol.1600155; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Dups JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00625; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gilbert SC, 1997, NAT BIOTECHNOL, V15, P1280, DOI 10.1038/nbt1197-1280; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Hickey BW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1435-y; Kester KE, 2014, VACCINE, V32, P6683, DOI 10.1016/j.vaccine.2014.06.033; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Mensah V. A., 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0167951, DOI 10.1371/J0URNAL.P0NE.0167951]; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; NUSSENZWEIG V, 1985, CELL, V42, P401, DOI 10.1016/0092-8674(85)90093-5; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rampling T, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0084-2; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Richie TL, 2015, VACCINE, V33, P7452, DOI 10.1016/j.vaccine.2015.09.096; RUTGERS T, 1988, BIO-TECHNOL, V6, P1065, DOI 10.1038/nbt0988-1065; Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]; Song GJ, 2014, P NATL ACAD SCI USA, V111, P4862, DOI 10.1073/pnas.1403059111; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Swearingen KE, 2019, J PROTEOME RES, V18, P652, DOI 10.1021/acs.jproteome.8b00638; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tiono AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208328; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0216260	10.1371/journal.pone.0216260	http://dx.doi.org/10.1371/journal.pone.0216260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31967991	Green Published, Green Submitted, gold			2022-12-26	WOS:000534373000001
J	Nagarajan, RP; Goodbla, A; Graves, E; Baerwald, M; Holyoak, M; Schreier, A				Nagarajan, Raman P.; Goodbla, Alisha; Graves, Emily; Baerwald, Melinda; Holyoak, Marcel; Schreier, Andrea			Non-invasive genetic monitoring for the threatened valley elderberry longhorn beetle	PLOS ONE			English	Article							DNA; PCR; DESMOCERUS; LARVAE	The valley elderberry longhorn beetle (VELB), Desmocerus californicus dimorphus (Coleoptera: Cerambycidae), is a federally threatened subspecies endemic to the Central Valley of California. The VELB range partially overlaps with that of its morphologically similar sister taxon, the California elderberry longhorn beetle (CELB), Desmocerus californicus californicus (Coleoptera: Cerambycidae). Current surveying methods are limited to visual identification of larval exit holes in the VELB/CELB host plant, elderberry (Sambucus spp.), into which larvae bore and excavate feeding galleries. Unbiased genetic approaches could provide a much-needed complementary approach that has more precision than relying on visual inspection of exit holes. In this study we developed a DNA sequencing-based method for indirect detection of VELB/CELB from frass (insect fecal matter), which can be easily and non-invasively collected from exit holes. Frass samples were collected from 37 locations and the 12S and 16S mitochondrial genes were partially sequenced using nested PCR amplification. Three frass-derived sequences showed 100% sequence identity to VELB/ CELB barcode references from museum specimens sequenced for this study. Database queries of frass-derived sequences also revealed high similarity to common occupants of old VELB feeding galleries, including earwigs, flies, and other beetles. Overall, this non-invasive approach is a first step towards a genetic assay that could augment existing VELB monitoring and accurately discriminate between VELB, CELB, and other insects. Furthermore, a phylogenetic analysis of 12S and 16S data from museum specimens revealed evidence for the existence of a previously unrecognized, genetically distinct CELB subpopulation in southern California.	[Nagarajan, Raman P.; Goodbla, Alisha; Baerwald, Melinda; Schreier, Andrea] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Graves, Emily; Holyoak, Marcel] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Baerwald, Melinda] Calif Dept Water Resources, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Nagarajan, RP (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	rpnagarajan@ucdavis.edu	Schreier, Andrea/J-7023-2013	Schreier, Andrea/0000-0002-2241-3119; Baerwald, Melinda/0000-0001-7462-5212; Nagarajan, Raman/0000-0003-4422-9934; Goodbla, Alisha/0000-0003-0416-2069	United States Fish and Wildlife Service (USFWS) [F15AC00060]	United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service)	This work was supported by United States Fish and Wildlife Service (USFWS) Award #F15AC00060 (Dr. Andrea Schreier, principal investigator) to A.S., M.B., M.H. The URL for the funder's website is: https://www.fws.gov.The funders had no role in study design, data collection and analysis,	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Ali B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216998; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barr CB, 1991, DISTRIBUTION HABITAT; Brandl S, 2015, MOL ECOL RESOUR, V15, P278, DOI 10.1111/1755-0998.12305; Briski E, 2011, BIOL INVASIONS, V13, P1325, DOI 10.1007/s10530-010-9892-7; Burke HE, 1921, J ECON ENTOMOL, V14, P450, DOI 10.1093/jee/14.5.450; CHEMSAK JA, 2005, ILLUSTRATED REVISION, V2; Collinge SK, 2001, BIOL CONSERV, V100, P103, DOI 10.1016/S0006-3207(00)00211-1; Feinstein J, 2004, CONSERV GENET, V5, P103, DOI 10.1023/B:COGE.0000014058.34840.94; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fish US and Service Wildlife, 2014, FED REG, V79; Fish US and Service Wildlife, 2017, FRAM ASS IMP VALL EL; Fish US and Service Wildlife, 2006, VALL ELD LONGH BETTL; Fish US and Service Wildlife, 2012, FED REG, V77; Fish US and Service Wildlife, 1980, FED REG, V45; Fisher W. S., 1921, Proceedings of the Entomological Society of Washington, V23, P206; Halstead JA, 1990, REVISION NEARCTIC DE; Holyoak M, 2010, J INSECT CONSERV, V14, P43, DOI 10.1007/s10841-009-9223-4; Ide T, 2016, J ECON ENTOMOL, V109, P1410, DOI 10.1093/jee/tow030; Jackson JK, 2014, FRESHW SCI, DOI [10.1086/674430, DOI 10.1086/674430]; Kamenova S, 2018, MOL ECOL RESOUR, V18, P966, DOI 10.1111/1755-0998.12775; Katibah E., 1984, CALIFORNIA RIPARIAN; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lang FJ, HABITAT POPULATIONS; Lee AB, 1995, BIOTECHNIQUES; Lefort MC, 2012, MOL ECOL RESOUR, V12, P389, DOI 10.1111/j.1755-0998.2011.03103.x; Lin-sley E.G., 1972, University of California Publications in Entomology, V69, P1; Nagarajan R, 2018, USING FECAL DNA SURV; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Ray AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115498; Ray AM, 2012, J CHEM ECOL, V38, P157, DOI 10.1007/s10886-012-0070-5; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Roy K, 2019, FOREST PATHOL, DOI [10.1111/efp.12484, DOI 10.1111/EFP.12484]; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schapker PA., 2014, REV LEPTURINAE COLEO; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Scriven JJ, 2013, MOL ECOL RESOUR, V13, P225, DOI 10.1111/1755-0998.12036; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Talley TS, 2007, BIOL CONSERV, V135, P21, DOI 10.1016/j.biocon.2006.09.022; Talley TS, 2006, ASSISTANCE 5 YEAR RE; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; US Fish and Wildlife Service, 1984, REC PLAN VALL ELD LO; USFWS, 2017, FRAM ASS IMP VALL EL; USFWS, 2014, WITHDR PROP DEL VALL; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	47	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227333	10.1371/journal.pone.0227333	http://dx.doi.org/10.1371/journal.pone.0227333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31952076	Green Published, gold			2022-12-26	WOS:000534370500016
J	Carr, RM; Duran, PAR; Tolosa, EJ; Ma, CC; Oseini, AM; Moser, CD; Banini, BA; Huang, JB; Asumda, F; Dhanasekaran, R; Graham, RP; Toruner, MD; Safgren, SL; Almada, LL; Wang, SQ; Patnaik, MM; Roberts, LR; Fernandez-Zapico, ME				Carr, Ryan M.; Duran, Paola A. Romecin; Tolosa, Ezequiel J.; Ma, Chenchao; Oseini, Abdul M.; Moser, Catherine D.; Banini, Bubu A.; Huang, Jianbo; Asumda, Faizal; Dhanasekaran, Renumathy; Graham, Rondell P.; Toruner, Merih D.; Safgren, Stephanie L.; Almada, Luciana L.; Wang, Shaoqing; Patnaik, Mrinal M.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.			The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocellular carcinoma; carcinogenesis; STAT transcription factor; gene transcription; gene regulation; GLI1; promoter conformation; STAT3; SULF2; tumorigenesis	HEPATOCELLULAR-CARCINOMA; FACTOR GLI1; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; DOUBLE-BLIND; SORAFENIB; ACTIVATION; INHIBITION; THERAPY	The expression of the extracellular sulfatase SULF2 has been associated with increased hepatocellular carcinoma (HCC) growth and poor patient survival. However, the molecular mechanisms underlying SULF2-associated tumor growth remain unclear. To address this gap, here we developed a transgenic mouse overexpressing Sulf2 in hepatocytes under the control of the transthyretin promoter. In this model, Sulf2 overexpression potentiated diethylnitrosamine-induced HCC. Further analysis indicated that the transcription factor GLI family zinc finger 1 (GLI1) mediates Sulf2 expression during HCC development. A cross of the Sulf2-overexpressing with Gli1-knockout mice revealed that Gli1 inactivation impairs SULF2-induced HCC. Transcriptomic analysis revealed that Sulf2 overexpression is associated with signal transducer and activator of transcription 3 (STAT3)-specific gene signatures. Interestingly, the Gli1 knockout abrogated SULF2-mediated induction of several STAT3 target genes, including suppressor of cytokine signaling 2/3 (Socs2/3); Pim-1 proto-oncogene, Ser/Thr kinase (Pim1); and Fms-related tyrosine kinase 4 (Flt4). Human orthologs were similarly regulated by SULF2, dependent on intact GLI1 and STAT3 functions in HCC cells. SULF2 overexpression promoted a GLI1-STAT3 interaction and increased GLI1 and STAT3 enrichment at the promoters of their target genes. Interestingly, the SULF2 overexpression resulted in GLI1 enrichment at select STAT3 consensus sites, and vice versa. siRNA-mediated STAT3 or GLI1 knockdown reduced promoter binding of GLI1 and STAT3, respectively. Finally, chromatin-capture PCR confirmed long-range co-regulation of SOCS2 and FLT3 through changes in promoter conformation. These findings define a mechanism whereby SULF2 drives HCC by stimulating formation of a GLI1-STAT3 transcriptional complex.	[Carr, Ryan M.; Duran, Paola A. Romecin; Tolosa, Ezequiel J.; Toruner, Merih D.; Safgren, Stephanie L.; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55902 USA; [Graham, Rondell P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55902 USA; [Patnaik, Mrinal M.] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA; [Ma, Chenchao; Oseini, Abdul M.; Moser, Catherine D.; Banini, Bubu A.; Huang, Jianbo; Asumda, Faizal; Dhanasekaran, Renumathy; Wang, Shaoqing; Roberts, Lewis R.] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Roberts, LR (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA.; Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Dept Oncol, Schulze Ctr Novel Therapeut, Rochester, MN 55902 USA.	roberts.lewis@mayo.edu; fernandez-zapico.martin@mayo.edu	Tolosa, Ezequiel J/AAD-9799-2019	Tolosa, Ezequiel J/0000-0001-5167-0782; Roberts, Lewis/0000-0001-7885-8574; Romecin Duran, Paola Alejandra/0000-0001-6890-5883; Graham, Rondell/0000-0002-8686-4867; Carr, Ryan/0000-0001-5762-367X; Huang, Jianbo/0000-0002-1662-2969	NCI, National Institutes of Health [CA165076, CA136526]; Mayo Clinic Pancreatic SPORE [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; Mayo Clinic Hepatobiliary SPORE [P50 CA210964]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Pancreatic SPORE; Mayo Clinic Center for Cell Signaling in Gastroenterology; Mayo Clinic Hepatobiliary SPORE	This work was supported by NCI, National Institutes of Health, Grant CA136526, Mayo Clinic Pancreatic SPORE P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology P30 DK84567 (to M. E. F.-Z.); NCI, National Institutes of Health, Grant CA165076 (to M. E. F.-Z. and L. R. R.), and Mayo Clinic Hepatobiliary SPORE P50 CA210964 (to L.R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Brault L, 2012, BRIT J CANCER, V107, P491, DOI 10.1038/bjc.2012.272; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Chen G, 2017, CANCER RES, V77, P632, DOI 10.1158/0008-5472.CAN-15-2556; Davey HW, 1999, J BIOL CHEM, V274, P35331, DOI 10.1074/jbc.274.50.35331; Dhanasekaran R, 2015, HEPATOLOGY, V61, P1269, DOI 10.1002/hep.27658; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; Geng LY, 2017, ONCOTARGET, V8, P48701, DOI 10.18632/oncotarget.9792; Parra RG, 2016, BIOINFORMATICS, V32, P1229, DOI 10.1093/bioinformatics/btv726; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Han Hui, 2013, Frontiers in Genetics, V4, P224, DOI 10.3389/fgene.2013.00224; Hsu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103629; Ke JQ, 2018, ONCOL LETT, V16, P4577, DOI 10.3892/ol.2018.9165; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lai JP, 2008, FUTURE ONCOL, V4, P803, DOI 10.2217/14796694.4.6.803; Lau AHY, 2012, PROSTAG LEUKOTR ESS, V86, P119, DOI 10.1016/j.plefa.2011.12.002; Li SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25754; Lin YW, 2016, J INNATE IMMUN, V8, P97, DOI 10.1159/000433539; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440; Nault JC, 2017, GASTROENTEROLOGY, V152, P880, DOI 10.1053/j.gastro.2016.11.042; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Qin HW, 2016, J NEUROSCI, V36, P5144, DOI 10.1523/JNEUROSCI.4658-15.2016; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Scuto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.159; Sirkisoon SR, 2018, ONCOGENE, V37, P2502, DOI 10.1038/s41388-018-0132-4; Tang AC, 2017, J INFECT DIS, V215, P293, DOI 10.1093/infdis/jiw516; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Wu KJ, 2015, CELL SIGNAL, V27, P2515, DOI 10.1016/j.cellsig.2015.09.014; Yang JD, 2011, GENE CHROMOSOME CANC, V50, P122, DOI 10.1002/gcc.20838; Yun M, 2015, CELL PHYSIOL BIOCHEM, V35, P1821, DOI 10.1159/000373993; Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628; Zhang Y, 2013, CELL BIOCHEM BIOPHYS, V67, P575, DOI 10.1007/s12013-013-9544-5; Zheng X, 2013, GENE CHROMOSOME CANC, V52, P225, DOI 10.1002/gcc.22022; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zhu AX, 2015, LANCET ONCOL, V16, P859, DOI 10.1016/S1470-2045(15)00050-9	46	6	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2698	2712		10.1074/jbc.RA119.011146	http://dx.doi.org/10.1074/jbc.RA119.011146			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31988246	hybrid, Green Published			2022-12-26	WOS:000519969100015
J	Naidu, K; Ali, MS; Abu Bakar, A; Tan, CK; Arof, H; Mokhlis, H				Naidu, Kanendra; Ali, Mohd Syukri; Abu Bakar, Ab Halim; Tan, Chia Kwang; Arof, Hamzah; Mokhlis, Hazlie			Optimized artificial neural network to improve the accuracy of estimated fault impedances and distances for underground distribution system	PLOS ONE			English	Article							RADIAL-DISTRIBUTION SYSTEMS; CONTINUOUS-WAVELET TRANSFORM; SUPPORT VECTOR MACHINE; LOCATION ALGORITHM; SINGLE LINE; DISCRETE	This paper proposes an approach to accurately estimate the impedance value of a high impedance fault (HIF) and the distance from its fault location for a distribution system. Based on the three-phase voltage and current waveforms which are monitored through a single measurement in the network, several features are extracted using discrete wavelet transform (DWT). The extracted features are then fed into the optimized artificial neural network (ANN) to estimate the HIF impedance and its distance. The particle swarm optimization (PSO) technique is employed to optimize the parameters of the ANN to enhance the performance of fault impedance and distance estimations. Based on the simulation results, the proposed method records encouraging results compared to other methods of similar complexity for both HIF impedance values and estimated distances.	[Naidu, Kanendra] Univ Kuala Lumpur, Elect Technol Sect, British Malaysian Inst, Gombak, Selongor Darul, Malaysia; [Ali, Mohd Syukri; Abu Bakar, Ab Halim; Tan, Chia Kwang] Univ Malaya, Higher Inst Ctr Excellence HICoE, UM Power Energy Dedicated Adv Ctr UMPEDAC, Wisma R&D, Level 4,Jalan Pantai Baharu, Kuala Lumpur, Malaysia; [Arof, Hamzah; Mokhlis, Hazlie] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia	University of Kuala Lumpur; Universiti Malaya; Universiti Malaya	Naidu, K (corresponding author), Univ Kuala Lumpur, Elect Technol Sect, British Malaysian Inst, Gombak, Selongor Darul, Malaysia.	kanendra@unikl.edu.my	Ali, Mohd Syukri/E-2921-2018; Naidu, Kanendra/J-3663-2019; Ali, Mohd Syukri/AAF-9322-2020; AROF, HAMZAH/ABI-1052-2020; Abu Bakar, Ab Halim/B-8085-2010; MOKHLIS, HAZLIE/B-8616-2010	Ali, Mohd Syukri/0000-0002-4758-3966; Ali, Mohd Syukri/0000-0002-4758-3966; Abu Bakar, Ab Halim/0000-0001-8390-0204; MOKHLIS, HAZLIE/0000-0002-1166-1934	University of Malaya, Kuala Lumpur under Fundamental Research Grant Scheme (FRGS) [FP093-2018A]	University of Malaya, Kuala Lumpur under Fundamental Research Grant Scheme (FRGS)	This work was supported by the University of Malaya, Kuala Lumpur under Fundamental Research Grant Scheme (FRGS Grant No: FP093-2018A) to AHAB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2014, IEEJ T ELECTR ELECTR, V9, P176, DOI 10.1002/tee.21953; Aziz MSA, 2012, INT J SYST DYN APPL, V1, P44, DOI 10.4018/ijsda.2012040104; Bakar AHA, 2014, INT J ELEC POWER, V55, P723, DOI 10.1016/j.ijepes.2013.10.003; Baqui I, 2011, ELECTR POW SYST RES, V81, P1325, DOI 10.1016/j.epsr.2011.01.022; Barakat S., 2014, J ELECTR SYST INF TE, V1, P198, DOI [10.1016/j.jesit.2014.12.003, DOI 10.1016/J.JESIT.2014.12.003]; Borghetti A, 2006, INT J ELEC POWER, V28, P608, DOI 10.1016/j.ijepes.2006.03.001; Borghetti A, 2008, IEEE T POWER SYST, V23, P380, DOI 10.1109/TPWRS.2008.919249; Dehghani F, 2013, 22 INT C EXH EL DIST, P213; Fan CJ, 2007, INT J ELEC POWER, V29, P497, DOI 10.1016/j.ijepes.2006.11.009; Filomena AD, 2009, INT J ELEC POWER, V31, P489, DOI 10.1016/j.ijepes.2009.03.026; Gazzana DS, 2014, ELECTR POW SYST RES, V115, P65, DOI 10.1016/j.epsr.2014.02.002; Ghaderi A, 2017, ELECTR POW SYST RES, V143, P376, DOI 10.1016/j.epsr.2016.10.021; Ghaderi A, 2015, IEEE T POWER DELIVER, V30, P1260, DOI 10.1109/TPWRD.2014.2361207; Goudarzi M, 2015, INT J ELEC POWER, V67, P423, DOI 10.1016/j.ijepes.2014.12.014; Huang JX, 2018, IEEE ACM T COMPUT BI, V15, P705, DOI 10.1109/TCBB.2016.2618380; Iurinic L., 2015, IEEE T POWER DELIVER, P1, DOI [DOI 10.1109/TCBB.2016.2618380, 10.1109/TCBB.2016.2618380]; Jung CK, 2007, ELECTR POW SYST RES, V77, P1349, DOI 10.1016/j.epsr.2006.10.005; Khorramdel B, 2014, INT J ELEC POWER, V58, P215, DOI 10.1016/j.ijepes.2014.01.028; Li LJ, 2018, IEEE PHOTONICS J, V10, DOI 10.1109/JPHOT.2017.2784541; Liang R, 2015, INT J ELEC POWER, V66, P160, DOI 10.1016/j.ijepes.2014.10.026; Lim PK, 2000, POW ENG SOC WINT M 2; Macedo JR, 2015, IET GENER TRANSM DIS, V9, P2593, DOI 10.1049/iet-gtd.2015.0407; Mathworks, 2016, NEURAL NETWORK TOOLB; Moloi K, 2017, AFRICON, P9, DOI 10.1109/AFRCON.2017.8095447; Mora-Florez J, 2008, ELECTR POW SYST RES, V78, P657, DOI 10.1016/j.epsr.2007.05.010; Moshtagh J, 2006, EL COMP ENG 2006 CCE; Naidu K, 2014, INT J ELEC POWER, V63, P401, DOI 10.1016/j.ijepes.2014.05.055; Nam SR, 2012, ELECTR POW SYST RES, V86, P151, DOI 10.1016/j.epsr.2011.12.010; Pourahmadi-Nakhli M, 2011, IEEE T POWER DELIVER, V26, P772, DOI 10.1109/TPWRD.2010.2050218; Rafinia A, 2014, INT J ELEC POWER, V55, P261, DOI 10.1016/j.ijepes.2013.09.011; Ray P, 2014, 2014 INT C INF TECHN; Raza S, IET RENEWABLE POWER; Sadeh J, 2013, INT J ELEC POWER, V45, P271, DOI 10.1016/j.ijepes.2012.08.053; Shafiullah M, 2017, 2017 11 IEEE INT C C; Thukaram D, 2005, IEEE T POWER DELIVER, V20, P710, DOI 10.1109/TPWRD.2005.844307; Xiu WJ, 2014, ELECTR POW SYST RES, V106, P95, DOI 10.1016/j.epsr.2013.08.012; Ye L, 2014, INT J ELEC POWER, V55, P467, DOI 10.1016/j.ijepes.2013.09.027	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2020	15	1							e0227494	10.1371/journal.pone.0227494	http://dx.doi.org/10.1371/journal.pone.0227494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9CB	31999711	Green Published, gold			2022-12-26	WOS:000534612400018
J	Burt, JR; Agha, AM; Yacoub, B; Zahergivar, A; Pepe, J				Burt, Jeremy R.; Agha, Ali M.; Yacoub, Basel; Zahergivar, Aryan; Pepe, Julie			Marijuana use and coronary artery disease in young adults	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CANNABIS; RISK; COLLEGE	Background Marijuana is the most popular drug of abuse in the United States. The association between its use and coronary artery disease has not yet been fully elucidated. This study aims to determine the frequency of coronary artery disease among young to middle aged adults presenting with chest pain who currently use marijuana as compared to nonusers. Methods In this retrospective study, 1,420 patients with chest pain or angina equivalent were studied. Only men between 18 and 40 years and women between 18 and 50 years of age without history of cardiac disease were included. All patients were queried about current or prior cannabis use and underwent coronary CT angiography. Each coronary artery on coronary CT angiography was assessed based on the CAD-RADS reporting system. Results A total of 146 (10.3%) out of 1,420 patients with chest pain were identified as marijuana users. Only 6.8% of the 146 marijuana users had evidence of coronary artery disease on coronary CT angiography. In comparison, the rate was 15.0% among the 1,274 marijuana nonusers (p = 0.008). After accounting for other cardiac risk factors in a multivariate analysis, the negative association between marijuana use and coronary artery disease on coronary CT angiography diminished (p = 0.12, 95% CI 0.299-1.15). A majority of marijuana users were younger than nonusers and had a lower frequency of hypertension and diabetes than nonusers. There was no statistical difference in lipid panel values between the two groups. Only 2 out of 10 marijuana users with coronary artery disease on coronary CT angiography had hemodynamically significant stenosis. Conclusion Among younger patients being evaluated for chest pain, self-reported cannabis use conferred no additional risk of coronary artery disease as detected on coronary CT angiography.	[Burt, Jeremy R.; Yacoub, Basel; Zahergivar, Aryan] Med Univ South Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Agha, Ali M.] Univ Texas Houston, Dept Internal Med, McGovern Med Sch, Houston, TX USA; [Pepe, Julie] AdventHlth Orlando, Translat Res Inst, Orlando, FL USA	Medical University of South Carolina; University of Texas System; University of Texas Health Science Center Houston; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando	Burt, JR (corresponding author), Med Univ South Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA.	burtje@musc.edu	Zahergivar, Aryan/GNH-6167-2022	Yacoub, Basel/0000-0001-9294-7100; Zahergivar, Aryan/0000-0002-1428-4054				Agha AM, 2019, JACC-CARDIOVASC IMAG, V12, P372, DOI 10.1016/j.jcmg.2018.08.011; Basnet S, 2009, PEDIATR CARDIOL, V30, P543, DOI 10.1007/s00246-009-9384-7; BEACONSFIELD P, 1972, NEW ENGL J MED, V287, P209, DOI 10.1056/NEJM197208032870501; Budney Alan J, 2007, Addict Sci Clin Pract, V4, P4; Caldeira KM, 2008, ADDICT BEHAV, V33, P397, DOI 10.1016/j.addbeh.2007.10.001; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chami T, 2019, MAYO CLIN PROC, V94, P1647, DOI 10.1016/j.mayocp.2019.05.008; Cury RC, 2016, J CARDIOVASC COMPUT, V10, P269, DOI 10.1016/j.jcct.2016.04.005; Franz CA, 2016, CARDIOL REV, V24, P158, DOI 10.1097/CRD.0000000000000103; Goyal H, 2017, J THORAC DIS, V9, P2079, DOI 10.21037/jtd.2017.06.104; Gunawardena MD, 2014, BMJ CASE REPORTS, V2014; Kang KM, 2012, KOREAN J RADIOL, V13, P27, DOI 10.3348/kjr.2012.13.1.27; Mittleman MA, 2001, CIRCULATION, V103, P2805; Pierard Sophie, 2017, J Cardiol Cases, V15, P115, DOI 10.1016/j.jccase.2016.12.001; Ravi D, 2018, ANN INTERN MED, V168, P187, DOI 10.7326/M17-1548; Reis JP, 2017, AM J PUBLIC HEALTH, V107, P601, DOI 10.2105/AJPH.2017.303654; Singla S, 2012, CLIN CARDIOL, V35, P329, DOI 10.1002/clc.21962; Yin XX, 2016, J THORAC DIS, V8, P1688, DOI 10.21037/jtd.2016.06.06	18	6	6	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228326	10.1371/journal.pone.0228326	http://dx.doi.org/10.1371/journal.pone.0228326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995626	Green Published, gold			2022-12-26	WOS:000534609400064
J	De Ley, IT; Schurkman, J; Wilen, C; Dillman, AR				De Ley, Irma Tandingan; Schurkman, Jacob; Wilen, Cheryl; Dillman, Adler R.			Mortality of the invasive white garden snail Theba pisana exposed to three US isolates of Phasmarhabditis spp (P. hermaphrodita, P. californica, and P. papillosa)	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; RHABDITID NEMATODE; BIOCONTROL AGENT; SUSCEPTIBILITY; MOLLUSCA; SLUGS; PESTICIDES	Theba pisana is a serious snail pest in many parts of the world and affects diverse crops including grain, vegetables, grapevines, and ornamental plants and shrubs. Due to its gregarious nature, ability to reproduce rapidly, and the difficulty of controlling it by conventional methods, it has the potential to become a significant pest where introduced. Mitigating this pest is an important challenge that must be addressed. Phasmarhabditis hermaphrodita, is a gastropod-killing nematode that is commercially available only in Europe (Nemaslug (R)) and Sub-Saharan Africa (Slugtech (R) SP). The use of effective gastropod-killing nematodes in the genus Phasmarhabditis (P. hermaphrodita, P. californica and P. papillosa) in California may provide one strategy for alleviating the potential damage and further spread of these snails, which are currently limited to San Diego and Los Angeles counties. Laboratory assays demonstrated for the first time that US isolates of P. hermaphrodita, P. californica and P. papillosa at 150 DJs/cm(2) caused significant mortality and are equally lethal to T. pisana. Molluscicidal efficacy of these nematodes are comparable with those of iron phosphate, at the recommended high dose of 4.88 kg/m(2). Additional trials are needed to determine their effects at lower dose and whether they are dependent on the size or age of the snails.	[De Ley, Irma Tandingan; Schurkman, Jacob; Dillman, Adler R.] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Wilen, Cheryl] Univ Calif Cooperat Extens, San Diego, CA USA	University of California System; University of California Riverside; University of California System	Dillman, AR (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.	adlerd@ucr.edu	Dillman, Adler/H-6737-2019	Dillman, Adler/0000-0001-7171-4332; Tandingan De Ley, Irma/0000-0002-9399-0693	California Department of Food and Agriculture Specialty Crop Multi-State Program (CDFA SCMP) grant [12509488]	California Department of Food and Agriculture Specialty Crop Multi-State Program (CDFA SCMP) grant	This research was funded by the California Department of Food and Agriculture Specialty Crop Multi-State Program (CDFA SCMP) grant #12509488; a generous gift from CANERS Foundation through the California Association of Nurseries and Garden Centers (CANGC); and logistical contribution from and partnership with Altman Plants in Perris, California, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgaleil SAM, 2010, APPL ENTOMOL ZOOL, V45, P425, DOI 10.1303/aez.2010.425; Avidov Z, 1969, PLANT PESTS ISRAEL, V91; Bailey Stuart E. R., 2002, P33, DOI 10.1079/9780851993201.0033; BAKER GH, 1988, J APPL ECOL, V25, P889, DOI 10.2307/2403753; BAKER GH, 1988, J APPL ECOL, V25, P867, DOI 10.2307/2403752; Basinger AJ, 1927, B CALIF DEP AGR, V16, P51; Brown A. P., 2011, IOBC/WPRS Bulletin, V64, P99; Byers Robert A., 2002, P325, DOI 10.1079/9780851993201.0325; Castaneda AR, 1996, J ENVIRON SCI HEAL A, V31, P83, DOI 10.1080/10934529609376345; Chace E. P., 1915, Nautilus Boston Mass, V29; COUPLAND JB, 1995, J INVERTEBR PATHOL, V66, P207, DOI 10.1006/jipa.1995.1088; Cowie RH, 2001, INT J PEST MANAGE, V47, P23, DOI 10.1080/09670870150215577; Cowie RH, 1998, BIODIVERS CONSERV, V7, P349, DOI 10.1023/A:1008881712635; COWIE RH, 1985, J ZOOL, V207, P201; Daumer C, 2012, BIOL INVASIONS, V14, P1665, DOI 10.1007/s10530-012-0179-z; De Ley IT, 2014, NEMATOLOGY, V16, P1129, DOI 10.1163/15685411-00002838; De Nardo EAB, 2004, BIOCONTROL SCI TECHN, V14, P93, DOI 10.1080/0958315031000151693; Deisler JE, 2001, WHITE GARDEN SNAIL T; Deisler JE, 2015, WHITE GARDEN SNAIL T; Durr HJR, 1946, STELLENBOSCH ELSENBU, V47, P1; Flint ML, 2011, UC IPM ONLINE   0714; GODAN D, 1983, PEST SLUGS SNAILS BI; Grewal SK, 2003, J INVERTEBR PATHOL, V82, P72, DOI 10.1016/S0022-2011(02)00200-8; Hammond Ronald B., 2002, P301, DOI 10.1079/9780851993201.0301; Hodel R., 2018, PALMARBOR, V3, P1; Hollingsworth RG, 2007, PAC SCI, V61, P457, DOI 10.2984/1534-6188(2007)61[457:DOPCMP]2.0.CO;2; Joubert C. J., 1951, FARMING S AFRICA, V26, P379; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Kozlowski J, 2012, PROG PLANT PROT, V3, P52; Matkin O., 1957, UC SYSTEM PRODUCING, P68; Mc Donnell R, 2018, BIOCONTROL SCI TECHN, V28, P1091, DOI 10.1080/09583157.2018.1514586; Mc Donnell RJ, 2018, J NEMATOL, V50, P77, DOI 10.21307/jofnem-2018-014; MEAD A R, 1971, Biologist (Charleston), V53, P104; MILLER E, 1988, Journal of Agricultural Entomology, V5, P189; Pilsbry H., 1939, ACAD NAT SCI PHILA M, V3, P1; RADWAN MA, 1992, J ENVIRON SCI HEAL B, V27, P759, DOI 10.1080/03601239209372811; Rae R, 2007, PEST MANAG SCI, V63, P1153, DOI 10.1002/ps.1424; Sakovich Nicholas J., 2002, P353, DOI 10.1079/9780851993201.0353; Salmijah S., 2000, Plant Protection Quarterly, V15, P2; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Swart P. L., 1976, Deciduous Fruit Grower, V26, P169; Tandingan De Ley I, 2016, NEMATOLOGY, V18, P175, DOI 10.1163/15685411-00002952; Wilen CA, 2018, SNAILS SLUGS, V7427; Williams AJ, 2015, J INVERTEBR PATHOL, V127, P122, DOI 10.1016/j.jip.2015.03.012; WILSON MJ, 1993, BIOCONTROL SCI TECHN, V3, P503, DOI 10.1080/09583159309355306; Wilson MJ, 1996, ANN APPL BIOL, V128, P117, DOI 10.1111/j.1744-7348.1996.tb07095.x; Wilson MJ, 2000, PEST MANAG SCI, V56, P711, DOI 10.1002/1526-4998(200008)56:8<711::AID-PS185>3.0.CO;2-O	47	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228244	10.1371/journal.pone.0228244	http://dx.doi.org/10.1371/journal.pone.0228244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995592	gold, Green Published			2022-12-26	WOS:000534609400055
J	Genise, JF; Bellosi, ES; Sarzetti, LC; Krause, JM; Dinghi, PA; Sanchez, MV; Umazano, AM; Puerta, P; Cantil, LF; Jicha, BR				Fernando Genise, Jorge; Bellosi, Eduardo S.; Sarzetti, Laura C.; Marcelo Krause, J.; Dinghi, Pablo A.; Victoria Sanchez, M.; Martin Umazano, A.; Puerta, Pablo; Cantil, Liliana F.; Jicha, Brian R.			100 Ma sweat bee nests: Early and rapid co-diversification of crown bees and flowering plants	PLOS ONE			English	Article							SAN-JORGE-BASIN; CENTRAL PATAGONIA; POLLEN GRAINS; FOSSIL BEE; EVOLUTION; ARCHITECTURE; AGE; CLASSIFICATION; ANGIOSPERMS; ARGENTINA	100 Ma sweat bee nests reported herein are the oldest evidence of crown bees. A new phylogeny for short-tongued bees, calibrated with these nests dated with 40Ar/39Ar, attests for the first time for a late Albian rapid diversification of bees along with angiosperms. Such hypothesis lacked paleontological support until this study. The new ichnospecies Cellicalichnus krausei, which was found along with wasp trace fossils and new beetle trace fossils in the Castillo Formation of Patagonia, represents typical Halictini nests composed of sessile cells that are attached to main tunnels. According to geological, paleosol, paleobotanical, and ichnological data, bees, and angiosperms cohabited in an inland and dry environment comparable to an open dry woodland or savanna, under warm-temperate and semiarid-subhumid climate, in the Southern Hemisphere by the Albian.	[Fernando Genise, Jorge; Bellosi, Eduardo S.; Sarzetti, Laura C.; Victoria Sanchez, M.; Cantil, Liliana F.] Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Div Icnol, Buenos Aires, DF, Argentina; [Marcelo Krause, J.; Puerta, Pablo] Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Dinghi, Pablo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Grp Invest Filogenias Mol & Filogeog, Buenos Aires, DF, Argentina; [Martin Umazano, A.] Univ Nacl La Pampa, CONICET, INCITAP, Santa Rosa, La Pampa, Argentina; [Martin Umazano, A.] Univ Nacl La Pampa, CONICET, Fac Ciencias Exactas & Nat, Santa Rosa, La Pampa, Argentina; [Jicha, Brian R.] Univ Wisconsin, Dept Geosci, Madison, WI USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Wisconsin System; University of Wisconsin Madison	Genise, JF (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Div Icnol, Buenos Aires, DF, Argentina.	jgenise@macn.gov.ar			Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina FONCYT-PICT [12/0022, 17/0779]; FONCYT-PICT [12/0326, 17/1265]; Consejo Nacional de Investigaciones Cientificas y Tcnicas of Argentina CONICET-PIP [13/0058]	Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina FONCYT-PICT; FONCYT-PICT(ANPCyTFONCyT); Consejo Nacional de Investigaciones Cientificas y Tcnicas of Argentina CONICET-PIP	This project was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina FONCYT-PICT (https://www.argentina.gob.ar > ciencia > agencia) 12/0022 and 17/0779 to JFG, and FONCYT-PICT 12/0326 and 17/1265 to ESB, and Consejo Nacional de Investigaciones Cientificas y Tcnicas of Argentina CONICET-PIP (www.conicet.gov.ar)13/0058 to ESB and JFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHANGELSKY S, 1994, CRETACEOUS RES, V15, P127, DOI 10.1006/cres.1994.1006; Archangelsky S, 2009, CRETACEOUS RES, V30, P1073, DOI 10.1016/j.cretres.2009.03.001; Bao T, 2019, P NATL ACAD SCI USA, V116, P24707, DOI 10.1073/pnas.1916186116; Barcat C., 1989, SER CORREL GEOL, V6, P319; Barreda V, 2006, CRETACEOUS RES, V27, P778, DOI 10.1016/j.cretres.2006.02.002; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bridge JS, 2000, J SEDIMENT RES, V70, P341, DOI 10.1306/2DC40915-0E47-11D7-8643000102C1865D; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Coiffard C, 2007, ANN BOT-LONDON, V100, P545, DOI 10.1093/aob/mcm160; Crepet WL, 2008, ANN MO BOT GARD, V95, P3, DOI 10.3417/2007065; Crepet WL, 1998, AM J BOT, V85, P1122, DOI 10.2307/2446345; Cuneo N, 2010, PLANTS MESOZOIC TIME, P187; Danforth BN, 2004, SYST BIOL, V53, P309, DOI 10.1080/10635150490423737; Danforth BN, 2011, J PALEONTOL, V85, P882, DOI 10.1666/10-130.1; de Gibert J.M., 2003, ICNOLOG A HACIA CONV, V9, P9; Doyle JA, 2012, ANNU REV EARTH PL SC, V40, P301, DOI 10.1146/annurev-earth-042711-105313; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EICKWORT GC, 1979, BIOTROPICA, V11, P28, DOI 10.2307/2388168; Elliott David K., 1998, Ichnos, V5, P243; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Engel MS, 2004, REV TECNOLOGIA AMBIE, V10, P9; FITZGERALD MG, 1990, AAPG BULL, V74, P879; Frenguelli J., 1930, ANALES SOC CIENTIFIC, V2, P29; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Genise JF, 2002, PALAEOGEOGR PALAEOCL, V177, P215, DOI 10.1016/S0031-0182(01)00333-9; Genise JF, 2016, ICHNOENTOMOLOGY INSE; Genise JF, 2000, 1 INT M PAL RIB PRET, P116; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; Grimaldi David A., 2019, Communications Biology, V2, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Jicha BR, 2016, CHEM GEOL, V431, P54, DOI 10.1016/j.chemgeo.2016.03.024; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Labandeira CC, 1998, SCIENCE, V280, P57, DOI 10.1126/science.280.5360.57; Lesta P, 1980, 2 S GEOL REG ARG, P1306; Llorens M, 2016, CRETACEOUS RES, V57, P66, DOI 10.1016/j.cretres.2015.07.019; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Martinez LCA, 2016, CRETACEOUS RES, V59, P129, DOI 10.1016/j.cretres.2015.10.023; Menendez CA, 1959, REV ASOC GEOL ARGENT, V14, P219; Michener C. D., 2007, BEES WORLD; Michez Denis, 2012, Systematics Association Special Volume Series, V81, P103; Miller M, 2010, MATH COMPUT SCI, V3, P1, DOI 10.1007/s11786-009-0002-0; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Ohl M., 2007, Denisia, P687; Paredes José M, 2015, Rev. Asoc. Geol. Argent., V72, P38; Passalia MG, 2000, 11 S ARG PAL PAL RES, P87; Peris D, 2017, CURR BIOL, V27, P897, DOI 10.1016/j.cub.2017.02.009; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Ramos Victor A, 2015, Rev. Asoc. Geol. Argent., V72, P12; RETALLACK G, 1981, Palaeontographica Abteilung B Palaeophytologie, V179, P103; RETALLACK G.J., 2001, SOILPAST, Vsecond; Retallack G J, 1981, PALEOBOTANY PALEOECO, P22; Retallack G.J., 2000, GEOL SOC AM SPEC PAP, V344, P1, DOI DOI 10.1130/0-8137-2344-2.1; Retallack GJ, 2007, J GEOL, V115, P271, DOI 10.1086/512753; Roberts EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156847; Romero E, 2016, P 2 JORN GEOL CUENC, P82; Romero EJ, 2019, J S AM EARTH SCI, V95, DOI 10.1016/j.jsames.2019.102310; Rozen J. G., 1971, American Mus Novit, VNo. 2457, P1; Sakagami SF, 1962, NEXT ARCHITECTURE SW; Sarzetti LC, 2014, PALAEONTOLOGY, V57, P447, DOI 10.1111/pala.12074; Sauquet H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16047; Sciutto JC, 1981, ACT 8 C GEOL ARG SAN, P203; Scotese CR, 2001, PALEOGEOGRAPHY PALEO; Sewall JO, 2007, CLIM PAST, V3, P647, DOI 10.5194/cp-3-647-2007; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; Suarez M., 2009, 12 CONGRESO GEOLOGIC, P1; Suarez M, 2014, J S AM EARTH SCI, V50, P67, DOI 10.1016/j.jsames.2013.10.008; Uliana M.A, 1999, GEOLOGIA ARGENTINA, V29, P496; Umazano AM, 2012, J S AM EARTH SCI, V40, P94, DOI 10.1016/j.jsames.2012.09.005; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379; Zalba P, 2003, 3 C MEX ZEOL NAT, P91	78	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227789	10.1371/journal.pone.0227789	http://dx.doi.org/10.1371/journal.pone.0227789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995815	Green Published, gold			2022-12-26	WOS:000534609400028
J	Kadam, R; White, W; Banks, N; Katz, Z; Dittrich, S; Kelly-Cirino, C				Kadam, Rigveda; White, Wallace; Banks, Nicholas; Katz, Zachary; Dittrich, Sabine; Kelly-Cirino, Cassandra			Target Product Profile for a mobile app to read rapid diagnostic tests to strengthen infectious disease surveillance	PLOS ONE			English	Article							CALPROTECTIN	The essential role of rapid diagnostic tests (RDTs) in disease control is compromised every time a test is not performed correctly or its result is not reported accurately and promptly. A mobile app that utilizes the camera and connectivity of a common smartphone can fill this role of supporting the test's proper execution and the automatic transmission of results. In a consensus process with 51 expert participants representing the needs of clinical users, healthcare programs, health information systems, surveillance systems, and global public health stakeholders, we developed a Target Product Profile describing the minimal and optimal characteristics of such an app. We collected feedback over two rounds and refined the characteristics to arrive at a preferred agreement level of greater than 75%, with an average of 92% agreement (range: 79-100%). As per this feedback, such an app should be compatible with many RDTs and mobile devices without needing accessories. The app should assist the user with RDT-specific instructions, include checks to facilitate quality control of the testing process and suggest results with. 95% accuracy across common lighting conditions while allowing the user to determine the final result. Data from the app must be under the control of the health program that operates it, and the app should support at least one of the common data exchange formats HL7, FHIR, ASTM or JSON. The Target Product Profile also lays out the minimum data security and privacy requirements for the app.	[Kadam, Rigveda; White, Wallace; Banks, Nicholas; Katz, Zachary; Dittrich, Sabine; Kelly-Cirino, Cassandra] Fdn Innovat Diagnost FIND, Geneva, Switzerland; [Dittrich, Sabine] Univ Oxford, Nuffield Dept Med, Oxford, England	Foundation For Innovative New Diagnostics; University of Oxford	Kadam, R (corresponding author), Fdn Innovat Diagnost FIND, Geneva, Switzerland.	rigveda.kadam@finddx.org		Banks, Nicholas/0000-0002-5268-9634; Kelly-Cirino, Cassandra/0000-0002-4526-8487; Kadam, Rigveda/0000-0002-2299-5630	Global Antimicrobial Resistance Innovation Fund (GAMRIF), a UK aid programme	Global Antimicrobial Resistance Innovation Fund (GAMRIF), a UK aid programme	This project is supported by the Global Antimicrobial Resistance Innovation Fund (GAMRIF), a UK aid programme. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, 510K PREM NOT K17332; [Anonymous], 2017, 510K PREM NOT K17011; Cori A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0371; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Denkinger CM, 2015, J INFECT DIS, V211, pS39, DOI 10.1093/infdis/jiu682; Dittrich S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161721; Faulstich K, 2009, LATERAL FLOW IMMUNOASSAY, P157, DOI 10.1007/978-1-59745-240-3_9; Francis F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1956-z; Haisma SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214751; Heida A, 2017, CLIN GASTROENTEROL H, V15, P1742, DOI 10.1016/j.cgh.2017.06.007; Hopkins H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1054; IACG, 2019, NO TIM WAIT SEC FUT; Kanal Koum, 2005, AIDS Res Ther, V2, P5, DOI 10.1186/1742-6405-2-5; Meyers DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152738; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Odaga J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008998.pub2; Olson D, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8041; Population Services International (PSI), MAL CAS SURV APPL; Vinding KK, 2016, INFLAMM BOWEL DIS, V22, P336, DOI 10.1097/MIB.0000000000000619; WHO, MAL THREATS MAP; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; WHO MSF FIND, 2018, MULT MULT DIAGN PLAT	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0228311	10.1371/journal.pone.0228311	http://dx.doi.org/10.1371/journal.pone.0228311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995628	Green Submitted, Green Published, gold			2022-12-26	WOS:000534609400063
J	Sungpud, C; Panpipat, W; Chaijan, M; Yoon, AS				Sungpud, Chatchai; Panpipat, Worawan; Chaijan, Manat; Yoon, Attawadee Sae			Techno-biofunctionality of mangostin extract-loaded virgin coconut oil nanoemulsion and nanoemulgel	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEM; HYDROPHILIC-LIPOPHILIC BALANCE; PHYSICOCHEMICAL PROPERTIES; ANTIMICROBIAL PROPERTIES; ANTIOXIDANT PROPERTIES; OXIDATIVE STABILITY; LIPID OXIDATION; IN-VITRO; FORMULATION; EMULSION	Techno-biofunctional characteristics of nanoemulsion and (nano)emulgel loaded with mangostin extracts were elucidated. Crude mangostins from mangosteen peels recovered by virgin coconut oil (VCO), mixed VCO and propylene glycol (PG), and pure PG were used. The extracts were loaded in the dispersed phase in the presence of mixed surfactants (Tween20/Span20) with a varying hydrophilic-lipophilic balance (HLB) from 10.2 to 15.1. Results showed that globular and uniformly distributed droplets of the nanoemulsion were observed. The small particle sizes (typically 18-62 nm) with the zeta potential of -39 to -54.5 mV were obtained when mixed emulsifiers with HLB values of 12.6 and 15.1 were employed. With HLB values of 12.6 and 15.1, nanoemulsions loaded with mangostin extracts prepared with mixed VCO-PG and pure PG-based extracts showed approximately a 2 to 3-fold lower droplet size diameter when compared with the VCO-based extract. For the stability test, all nanoemulsions were stable over three freeze-thaw cycles with some changes in pH, zeta potential, and droplet size. The DPPH. scavenging activity, H2O2 scavenging activity, reducing power and antibacterial activities (E. coli and S. aureus) of the nanoemulsions were greater than their corresponding bulk extracts. Nanoemulgels produced by embedding the nanoemulsions in a hydrogel matrix was homogeneous and creamy yellow-white in appearance. The nanoemulgels had a higher mangostin release (87-92%) than their normal emulgels (74-78%). Therefore, this study presented the feasibility of nanoemulsions and nanoemulgels loaded with mangostin extracts as a promising delivery system for bioactive polyphenol in food supplements, pharmaceuticals and cosmetics.	[Sungpud, Chatchai; Panpipat, Worawan; Chaijan, Manat] Walailak Univ, Food Technol & Innovat Res Ctr Excellence, Sch Agr Technol, Dept Agroind, Nakhon Si Thammarat, Thailand; [Yoon, Attawadee Sae] Walailak Univ, Drug & Cosmet Excellence Ctr, Sch Pharm, Nakhon Si Thammarat, Thailand	Walailak University; Walailak University	Panpipat, W (corresponding author), Walailak Univ, Food Technol & Innovat Res Ctr Excellence, Sch Agr Technol, Dept Agroind, Nakhon Si Thammarat, Thailand.	pworawan@wu.ac.th			Walailak University [22/2562]; Nakhon Si Thammarat Rajabhat University; New Strategic Research (P2P) project, Walailak University, Thailand	Walailak University; Nakhon Si Thammarat Rajabhat University; New Strategic Research (P2P) project, Walailak University, Thailand	The authors gratefully acknowledge the financial supports from Walailak University (Grant No. 22/2562) and Nakhon Si Thammarat Rajabhat University to CS. This research was partially supported by the New Strategic Research (P2P) project, Walailak University, Thailand to WP.	Aboalnaja KO, 2016, EXPERT OPIN DRUG DEL, V13, P1327, DOI 10.1517/17425247.2016.1162154; Ali SM, 2013, ACTA DERM-VENEREOL, V93, P261, DOI 10.2340/00015555-1531; Ambala R., 2015, J APPL PHARM SCI, V5, P112, DOI DOI 10.7324/JAPS.2015.50717; [Anonymous], [No title captured]; Ariyaprakai S, 2015, J FOOD ENG, V152, P57, DOI 10.1016/j.jfoodeng.2014.11.023; AUNGST BJ, 1993, J PHARM SCI-US, V82, P979, DOI 10.1002/jps.2600821002; Beikert FC, 2013, DERMATOLOGY, V226, P47, DOI 10.1159/000346641; Berton-Carabin CC, 2014, COMPR REV FOOD SCI F, V13, P945, DOI 10.1111/1541-4337.12097; Biruss B, 2007, INT J PHARMACEUT, V328, P142, DOI 10.1016/j.ijpharm.2006.08.003; Brunstein John, 2015, MLO Med Lab Obs, V47, P44; Canabady-Rochelle LLS, 2015, FOOD CHEM, V183, P129, DOI 10.1016/j.foodchem.2015.02.147; Carson J, 1999, COSMET SCI TECHNOL S, V21, P111; Chang WC, 2020, LWT-FOOD SCI TECHNOL, V117, DOI 10.1016/j.lwt.2019.108619; Chen GQ, 2018, EXPERT OPIN THER PAT, V28, P415, DOI 10.1080/13543776.2018.1455829; Donsi F, 2014, INNOV FOOD SCI EMERG, V22, P212, DOI 10.1016/j.ifset.2014.01.008; Donsi F, 2012, J BIOTECHNOL, V159, P342, DOI 10.1016/j.jbiotec.2011.07.001; Ereifej Evon S, 2017, Vet Med Int, V2017, P1757059, DOI 10.1155/2017/1757059; Fofaria NM, 2016, INT J PHARMACEUT, V498, P12, DOI 10.1016/j.ijpharm.2015.11.045; Gershanik T, 2000, INT J PHARM, V211, P29, DOI 10.1016/S0378-5173(00)00591-3; Gibis Monika, 2013, Pharmaceutics, V5, P421, DOI 10.3390/pharmaceutics5030421; Gomes C, 2011, J FOOD SCI, V76, pS16, DOI 10.1111/j.1750-3841.2010.01985.x; Gupta A, 2016, SOFT MATTER, V12, P2826, DOI 10.1039/c5sm02958a; Gupta P., 2015, WORLD J PHARM PHARM, V4, P1871; Nguyen HH, 2013, J FOOD PROCESS PRES, V37, P139, DOI 10.1111/j.1745-4549.2011.00633.x; Ibrahim N., 2015, MALAYSIAN J ANAL SCI, V19, P261; Jadhav C, 2015, J NANOSTRUCTURE CHEM, V5, P107, DOI 10.1007/s40097-014-0141-y; Kamarza M., 2018, MATEC WEB C EDP SCI, V156, P1; Kaur L.P., 2013, ASIAN J BIOMED PHARM, V3, P1, DOI DOI 10.15272/AJBPS.V3I17.183; Khanum R, 2017, ASIAN J PHARM SCI, V12, P401, DOI 10.1016/j.ajps.2017.05.003; Khor YP, 2014, MOLECULES, V19, P9187, DOI 10.3390/molecules19079187; Kong M, 2011, CARBOHYD POLYM, V83, P462, DOI 10.1016/j.carbpol.2010.08.001; Kotyla T, 2008, INT J PHARMACEUT, V347, P144, DOI 10.1016/j.ijpharm.2007.06.045; Krongrawa W, 2018, ASIAN J PHARM SCI, V13, P415, DOI 10.1016/j.ajps.2018.01.005; Lethuaut L, 2002, J AM OIL CHEM SOC, V79, P425, DOI 10.1007/s11746-002-0500-z; Liang R, 2012, J AGR FOOD CHEM, V60, P7548, DOI 10.1021/jf301129k; Lim Terri Y, 2014, J Pediatr Pharmacol Ther, V19, P277, DOI 10.5863/1551-6776-19.4.277; Loung F. S., 2014, International Journal of PharmTech Research, V6, P628; McClements DJ, 2011, CRIT REV FOOD SCI, V51, P285, DOI 10.1080/10408398.2011.559558; Mirhosseini H, 2008, COLLOID SURFACE A, V315, P47, DOI 10.1016/j.colsurfa.2007.07.007; Mohamed MI, 2004, AAPS J, V6; Mohammed A., 2016, INT J SCI BASIC APPL, V25, P256; Mukhopadhyay D., 2016, FREE RADIC ANTIOX, V6, P123; Nejadmansouri M, 2016, COLLOID SURFACE A, V506, P821, DOI 10.1016/j.colsurfa.2016.07.075; Nikumbh KV, 2015, DRUG DELIV, V22, P509, DOI 10.3109/10717544.2013.859186; Patel J, 2011, J ADV PHARM TECHNOL, V2, P9, DOI 10.4103/2231-4040.79799; Pengon S, 2018, ASIAN J PHARM SCI, V13, P409, DOI 10.1016/j.ajps.2018.02.005; Peshkovsky AS, 2013, CHEM ENG PROCESS, V69, P77, DOI 10.1016/j.cep.2013.02.010; Reeves Anna, 2015, Mol Cell Pharmacol, V7, P25; Safdar MN, 2017, J FOOD DRUG ANAL, V25, P488, DOI 10.1016/j.jfda.2016.07.010; Sarkar R, 2017, INT J DERMATOL, V56, P1080, DOI 10.1111/ijd.13623; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Sivakumar M, 2014, ULTRASON SONOCHEM, V21, P2069, DOI 10.1016/j.ultsonch.2014.03.025; Suksamrarn S, 2003, CHEM PHARM BULL, V51, P857, DOI 10.1248/cpb.51.857; Sungpud C, 2019, PROCESS BIOCHEM, V87, P179, DOI 10.1016/j.procbio.2019.08.023; Suttirak W, 2014, J FOOD SCI TECH MYS, V51, P3546, DOI 10.1007/s13197-012-0887-5; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Ha TVA, 2015, FOOD CHEM, V178, P115, DOI 10.1016/j.foodchem.2015.01.048; Topuz OK, 2016, FOOD CHEM, V203, P117, DOI 10.1016/j.foodchem.2016.02.051; Tubtimsri S, 2018, ASIAN J PHARM SCI, V13, P425, DOI 10.1016/j.ajps.2018.02.003; Uslinawaty Z., 2015, INT J PHARM PHARM SC, V7, P419; VAUGHAN CD, 1990, J DISPER SCI TECHNOL, V11, P83, DOI 10.1080/01932699008943238; Wang LJ, 2009, J COLLOID INTERF SCI, V330, P443, DOI 10.1016/j.jcis.2008.10.077; Wani R.R., 2015, INT J PHARM RES, V4, P398; WARSHAW TG, 1952, J INVEST DERMATOL, V19, P423, DOI 10.1038/jid.1952.118; Weerapol Y, 2014, AAPS PHARMSCITECH, V15, P456, DOI 10.1208/s12249-014-0078-y; Weiss J., 2009, GLOBAL ISSUES FOOD S, V1, P425, DOI DOI 10.1016/B978-0-12-374124-0.00024-7; Yadav S.K., 2016, INT J CURR PHARM RES, V9, P15, DOI 10.22159/ijcpr.2017v9i1.16628; Zarena A. S., 2009, Journal of Natural Products (India), V2, P23; Zarena AS, 2009, ACTA SCI POLON-TECHN, V8, P23	69	16	16	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227979	10.1371/journal.pone.0227979	http://dx.doi.org/10.1371/journal.pone.0227979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9AX	31995599	Green Published, gold			2022-12-26	WOS:000534609400035
J	Boyko, KM; Kryukova, MV; Petrovskaya, LE; Nikolaeva, AY; Korzhenevsky, DA; Novototskaya-Vlasova, KA; Rivkina, EM; Dolgikh, DA; Kirpichnikov, MP; Popov, VO				Boyko, Konstantin M.; Kryukova, Marya, V; Petrovskaya, Lada E.; Nikolaeva, Alena Y.; Korzhenevsky, Dmitry A.; Novototskaya-Vlasova, Ksenia A.; Rivkina, Elizaveta M.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.; Popov, Vladimir O.			Crystal structure of PMGL2 esterase from the hormone-sensitive lipase family with GCSAG motif around the catalytic serine	PLOS ONE			English	Article							MICROBIAL ECOLOGY; ENZYMES; CARBOXYLESTERASE; THERMOSTABILITY; BIODIVERSITY; SUBFAMILY; ALIGNMENT; TOOLS; LIFE	Lipases comprise a large class of hydrolytic enzymes which catalyze the cleavage of the ester bonds in triacylglycerols and find numerous biotechnological applications. Previously, we have cloned the gene coding for a novel esterase PMGL2 from a Siberian permafrost metagenomic DNA library. We have determined the 3D structure of PMGL2 which belongs to the hormone-sensitive lipase (HSL) family and contains a new variant of the active site motif, GCSAG. Similar to many other HSLs, PMGL2 forms dimers in solution and in the crystal. Our results demonstrated that PMGL2 and structurally characterized members of the GTSAG motif subfamily possess a common dimerization interface that significantly differs from that of members of the GDSAG subfamily of known structure. Moreover, PMGL2 had a unique organization of the active site cavity with significantly different topology compared to the other lipolytic enzymes from the HSL family with known structure including the distinct orientation of the active site entrances within the dimer and about four times larger size of the active site cavity. To study the role of the cysteine residue in GCSAG motif of PMGL2, the catalytic properties and structure of its double C173T/C202S mutant were examined and found to be very similar to the wild type protein. The presence of the bound PEG molecule in the active site of the mutant form allowed for precise mapping of the amino acid residues forming the substrate cavity.	[Boyko, Konstantin M.; Popov, Vladimir O.] Russian Acad Sci, Bach Inst Biochem, Dept Enzyme Engn, Res Ctr Biotechnol, Moscow, Russia; [Kryukova, Marya, V; Nikolaeva, Alena Y.; Korzhenevsky, Dmitry A.; Popov, Vladimir O.] Natl Res Ctr Kurchatov Inst, Kurchatov Complex NBICS Technol, Moscow, Russia; [Petrovskaya, Lada E.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia; [Novototskaya-Vlasova, Ksenia A.; Rivkina, Elizaveta M.] Russian Acad Sci, Inst Physicochem & Biol Problems Soil Sci, Lab Soil Cryol, Pushchino, Moscow Region, Russia; [Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Physicohemical & Biological Problems of Soil Science; Lomonosov Moscow State University	Boyko, KM (corresponding author), Russian Acad Sci, Bach Inst Biochem, Dept Enzyme Engn, Res Ctr Biotechnol, Moscow, Russia.	kmb@inbi.ras.ru	Boyko, Konstantin/AAQ-9580-2021; Boyko, Konstantin/ABG-2095-2020; Petrovskaya, Lada/S-1118-2016; Rivkina, Elizaveta/O-5344-2014	Boyko, Konstantin/0000-0001-8229-189X; Krukova, Maria/0000-0002-6410-0807; Rivkina, Elizaveta/0000-0001-7949-8056; Popov, Vladimir/0000-0002-0133-7962; Petrovskaya, Lada/0000-0002-0217-9708; Kirpichnikov, Mikhail/0000-0001-8170-1607	Russian Foundation for Basic Research project [18-04-00491]; Russian Science Foundation [19-14-00164]; Ministry of Science and Higher Education of the Russian Federation; Russian Federal Space Agency	Russian Foundation for Basic Research project(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Science and Higher Education of the Russian Federation; Russian Federal Space Agency	The work was supported in part by the Russian Foundation for Basic Research project. 18-04-00491 to KMB (protein purification, structure solution and analysis), Russian Science Foundation project. 19-14-00164 to KMB (data collection and processing), Ministry of Science and Higher Education of the Russian Federation to VOP (biochemical experiments and MALDI analysis) and by the Russian Federal Space Agency to KMB (protein crystallization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2015, ENVIRON MICROBIOL, V17, P332, DOI 10.1111/1462-2920.12660; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakermans C, 2006, INT J SYST EVOL MICR, V56, P1285, DOI 10.1099/ijs.0.64043-0; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Casas-Godoy L, 2018, METHODS MOL BIOL, V1835, P3, DOI 10.1007/978-1-4939-8672-9_1; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; Chow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047665; Elleuche S, 2014, CURR OPIN BIOTECH, V29, P116, DOI 10.1016/j.copbio.2014.04.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferrer M, 2015, BIOCATAL BIOTRANSFOR, V33, P235, DOI 10.3109/10242422.2016.1151416; Gaur R, 2017, CURRENT DEVELOPMENTS IN BIOTECHNOLOGY AND BIOENGINEERING: PRODUCTION, ISOLATION AND PURIFICATION OF INDUSTRIAL PRODUCTS, P175, DOI 10.1016/B978-0-444-63662-1.00008-7; Hinsa-Leasure S, 2013, COLD-ADAPTED MICROORGANISMS, P1; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Kim HJ, 2015, MOL BIOTECHNOL, V57, P781, DOI 10.1007/s12033-015-9871-4; Kim TD, 2017, J MICROBIOL BIOTECHN, V27, P1907, DOI 10.4014/jmb.1708.08004; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee Myung Hwan, 2013, Genomics & Informatics, V11, P114, DOI 10.5808/GI.2013.11.3.114; Lewin A, 2013, CURR OPIN BIOTECH, V24, P516, DOI 10.1016/j.copbio.2012.10.012; Li PY, 2015, J BIOL CHEM, V290, P11188, DOI 10.1074/jbc.M115.646182; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Lokendra Kumar, 2011, Biotechnology, V10, P121; Margesin R, 2007, NATURWISSENSCHAFTEN, V94, P77, DOI 10.1007/s00114-006-0162-6; McKary MG, 2016, BIOCHEMISTRY-US, V55, P7099, DOI 10.1021/acs.biochem.6b01057; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; Novototskaya-Vlasova KA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P385, DOI 10.1134/S000629791304007X; Novototskaya-Vlasova K, 2013, PROTEIN EXPRES PURIF, V91, P96, DOI 10.1016/j.pep.2013.07.011; Novototskaya-Vlasova K, 2012, FEMS MICROBIOL ECOL, V82, P367, DOI 10.1111/j.1574-6941.2012.01385.x; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Pereira MR, 2017, APPL MICROBIOL BIOT, V101, P4935, DOI 10.1007/s00253-017-8226-4; Petrovskaya L E, 2012, Dokl Biol Sci, V445, P279, DOI 10.1134/S0012496612040035; Petrovskaya LE, 2017, BIOENGINEERED, V8, P420, DOI 10.1080/21655979.2016.1230571; Petrovskaya LE, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw046; Rhee JK, 2006, APPL ENVIRON MICROB, V72, P3021, DOI 10.1128/AEM.72.4.3021-3025.2006; Rivkina E, 2004, ADV SPACE RES-SERIES, V33, P1215, DOI 10.1016/j.asr.2003.06.024; Romano MF, 2015, J CLIN ONCOL, V33; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Suzuki K, 2014, PROTEINS, V82, P2857, DOI 10.1002/prot.24649; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Xing MN, 2012, BIOTECHNOL ADV, V30, P920, DOI 10.1016/j.biotechadv.2012.01.021; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	55	9	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0226838	10.1371/journal.pone.0226838	http://dx.doi.org/10.1371/journal.pone.0226838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990908	Green Published, Green Submitted, gold			2022-12-26	WOS:000534605400009
J	Ito, T; Tsubahara, A; Shiraga, Y; Yoshimura, Y; Kimura, D; Suzuki, K; Hanayama, K				Ito, Tomotaka; Tsubahara, Akio; Shiraga, Yoshiki; Yoshimura, Yosuke; Kimura, Daisuke; Suzuki, Keita; Hanayama, Kozo			Motor activation is modulated by visual experience during cyclic gait observation: A transcranial magnetic stimulation study	PLOS ONE			English	Article							CORTICOSPINAL EXCITABILITY; CORTEX EXCITABILITY; HAND ACTIONS; IMAGERY; RESONANCE; WALKING; FACILITATION; RECOGNITION; OUTPUT; IMITATION	Transcranial magnetic stimulation (TMS) has been widely utilized to noninvasively explore the motor system during the observation of human movement. However, few studies have characterized motor cortex activity during periodic gait observation. Thus, this study examined the effects of an observer's visual experience and/or intention to imitate on corticospinal excitability during the observation of another's gait. Twenty-six healthy volunteers were included in this study and allocated to two different groups. Participants in the visual experience group had formal experience with gait observation (physical therapist training), while those in the control group did not. Motor-evoked potentials induced by TMS in the tibialis anterior and soleus muscles were measured as surrogates of corticospinal excitability. Participants were seated and, while resting, they observed a demonstrator's gait or observed it with the intention to subsequently reproduce it. Compared with the resting state, cyclic gait observation led to significant corticospinal facilitation in the tibialis anterior and soleus muscles. However, this pattern of corticospinal facilitation in the measured muscles was not coupled to the pattern of crural muscle activity during actual gait and was independent of the step cycle. This motor cortex facilitation effect during gait observation was enhanced by the observer's visual experience in a manner that was not step cycle-dependent, while the observer's intent to imitate did not affect corticospinal excitatory input to either muscle. In addition, visual experience did not modulate corticospinal excitability in gait-related crural muscles. Our findings indicate that motor cortex activity during gait observation is not in line with the timing of muscle activity during gait execution and is modulated by an individual's gait observation experience. These results suggest that visual experience acquired from repetitive gait observation may facilitate the motor system's control on bipedal walking, but may not promote the learning of muscle activity patterns.	[Ito, Tomotaka; Tsubahara, Akio; Yoshimura, Yosuke; Kimura, Daisuke] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Kurashiki, Okayama, Japan; [Shiraga, Yoshiki] Kawasaki Med Sch Hosp, Rehabil Ctr, Kurashiki, Okayama, Japan; [Suzuki, Keita] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan; [Hanayama, Kozo] Kawasaki Med Sch, Dept Rehabil Med, Kurashiki, Okayama, Japan	Kawasaki Medical School; Kanazawa University; Kawasaki Medical School	Ito, T (corresponding author), Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Kurashiki, Okayama, Japan.	s-ito@mw.kawasaki-m.ac.jp		Ito, Tomotaka/0000-0002-2833-3945; Kimura, Daisuke/0000-0001-5620-8263	JSPS KAKENHI [JP15K16384]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K16384 to TI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Bakker M, 2008, CLIN NEUROPHYSIOL, V119, P2519, DOI 10.1016/j.clinph.2008.07.282; Bang DH, 2013, CLIN REHABIL, V27, P1118, DOI 10.1177/0269215513501528; Bellelli G, 2010, ARCH PHYS MED REHAB, V91, P1489, DOI 10.1016/j.apmr.2010.07.013; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Borroni P, 2008, SOC NEUROSCI-UK, V3, P276, DOI 10.1080/17470910701515269; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buccino G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0185; Buccino G, 2012, DEV MED CHILD NEUROL, V54, P822, DOI 10.1111/j.1469-8749.2012.04334.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Capaday C, 1999, J NEUROPHYSIOL, V81, P129, DOI 10.1152/jn.1999.81.1.129; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; D'Innocenzo G, 2017, NEUROPSYCHOLOGIA, V103, P77, DOI 10.1016/j.neuropsychologia.2017.07.017; Dalla Volta R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01502; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Fusco A, 2016, RESTOR NEUROL NEUROS, V34, P247, DOI 10.3233/RNN-150573; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hardwick RM, 2018, NEUROSCI BIOBEHAV R, V94, P31, DOI 10.1016/j.neubiorev.2018.08.003; Hardwick RM, 2012, EUR J NEUROSCI, V35, P1475, DOI 10.1111/j.1460-9568.2012.08046.x; Hogeveen J, 2014, J EXP PSYCHOL GEN, V143, P755, DOI 10.1037/a0033477; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Iseki K, 2008, NEUROIMAGE, V41, P1021, DOI 10.1016/j.neuroimage.2008.03.010; Ito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117931; Janssen L, 2015, CEREB CORTEX, V25, P192, DOI 10.1093/cercor/bht220; Jola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033343; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Knikou M, 2013, CLIN NEUROPHYSIOL, V124, P2431, DOI 10.1016/j.clinph.2013.06.004; Leonetti A, 2015, EXP BRAIN RES, V233, P3013, DOI 10.1007/s00221-015-4371-0; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2002, BEHAV BRAIN RES, V134, P209, DOI 10.1016/S0166-4328(02)00030-X; Park SD, 2014, J EXERC REHABIL, V10, P168, DOI 10.12965/jer.140112; Pelosin E, 2010, NEUROREHAB NEURAL RE, V24, P746, DOI 10.1177/1545968310368685; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P51; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Puglisi G, 2018, BRAIN COGNITION, V128, P7, DOI 10.1016/j.bandc.2018.10.006; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Roosink M, 2010, BEHAV BRAIN RES, V213, P35, DOI 10.1016/j.bbr.2010.04.027; Sartori L, 2012, NEUROPSYCHOLOGIA, V50, P2341, DOI 10.1016/j.neuropsychologia.2012.06.002; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Takahashi M, 2008, NEUROREPORT, V19, P727, DOI 10.1097/WNR.0b013e3282fd0dc3; Takakusaki K, 2013, MOVEMENT DISORD, V28, P1483, DOI 10.1002/mds.25669; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; van der Meulen M, 2014, HUM BRAIN MAPP, V35, P455, DOI 10.1002/hbm.22192; van Elk M, 2008, NEUROIMAGE, V43, P808, DOI 10.1016/j.neuroimage.2008.07.057; Williams J, 2012, BEHAV BRAIN RES, V226, P369, DOI 10.1016/j.bbr.2011.09.014; Wright DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190165; Wright DJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00017	65	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0228389	10.1371/journal.pone.0228389	http://dx.doi.org/10.1371/journal.pone.0228389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990939	Green Published, gold			2022-12-26	WOS:000534605400055
J	Kostrzewa-Nowak, D; Nowak, R				Kostrzewa-Nowak, Dorota; Nowak, Robert			T helper cell-related changes in peripheral blood induced by progressive effort among soccer players	PLOS ONE			English	Article							ENDURANCE EXERCISE; IMMUNE-RESPONSE; TNF-ALPHA; CYTOKINE; EXPRESSION; MODERATE; PLASMA; IMPACT; INTERLEUKIN-8; INFLAMMATION	Objectives The regulatory mechanisms affecting the modulation of the immune system accompanying the progressive effort to exhaustion, particularly associated with T cells, are not fully understood. We analysed the impact of two progressive effort protocols on T helper (Th) cell distribution and selected cytokines. Methods Sixty-two male soccer players with a median age of 17 (16-29) years performed different protocols for progressive exercise until exhaustion: YO-YO (YYRL1) and Beep. Blood samples for all analyses were taken three times: at baseline, post-effort, and in recovery. Results The percentage of Th1 cells increased post-effort and in recovery. The post-effort percentage of Th1 cells was higher in the Beep group compared to the YYRL1 group. Significant post-effort increase in Th17 cells was observed in both groups. The post-effort percentage of regulatory T cells (Treg) increased in the Beep group. An increased post-effort concentration of IL-2, IL-6, IL-8 and IFN-gamma in both groups was observed. Post-effort TNF-alpha and IL-10 levels were higher than baseline in the YYRL1 group, while the post-effort IL-17A concentration was lower than baseline only in the Beep group. The recovery IL-2, IL-4, TNF-alpha and IFN-gamma levels were higher than baseline in the YYRL1 group. The recovery IL-4, IL-6, IL-8, TNF-alpha and IFN-gamma values were higher than baseline in the Beep group. Conclusion The molecular patterns related to cytokine secretion are not the same between different protocols for progressive effort. It seems that Treg cells are probably the key cells responsible for silencing the inflammation and enhancing anti-inflammatory pathways.	[Kostrzewa-Nowak, Dorota; Nowak, Robert] Univ Szczecin, Ctr Human Struct & Funct Res, Szczecin, Poland	University of Szczecin	Kostrzewa-Nowak, D (corresponding author), Univ Szczecin, Ctr Human Struct & Funct Res, Szczecin, Poland.	dorota.kostrzewa-nowak@usz.edu.pl		Nowak, Robert/0000-0003-3037-644X; Kostrzewa-Nowak, Dorota/0000-0001-7025-3087				Abedelmalek Salma, 2011, Asian J Sports Med, V2, P154; Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546; Akimoto T, 2000, EUR J APPL PHYSIOL, V81, P510, DOI 10.1007/s004210050076; Akseki D, 2008, ACTA ORTHOP TRAUMATO, V42, P316, DOI 10.3944/AOTT.2009.316; Arguis MJ, 2008, REGION ANESTH PAIN M, V33, P211, DOI 10.1016/j.rapm.2007.12.003; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; Banfi G, 2012, ADV CLIN CHEM, V56, P1, DOI 10.1016/B978-0-12-394317-0.00015-7; Bangsbo J., 2003, FITNESS TRAINING SOC; Baumann S, 2005, BLOOD, V106, P617, DOI 10.1182/blood-2004-11-4390; Benczik M, 2004, IMMUNOL INVEST, V33, P109, DOI 10.1081/IMM-120030732; Brown FF, 2014, BRAIN BEHAV IMMUN, V39, P152, DOI 10.1016/j.bbi.2013.10.031; CADEFAU J, 1990, ACTA PHYSIOL SCAND, V140, P341, DOI 10.1111/j.1748-1716.1990.tb09008.x; Crowley Lisa C, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087163; de Abreu MS, 2018, PSYCHONEUROENDOCRINO, V92, P1, DOI 10.1016/j.psyneuen.2018.03.014; Bote ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074524; Ernberg M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1041-y; Fallon KE, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.041137; Fatouros IG, 2016, J INFLAMM RES, V9, P175, DOI 10.2147/JIR.S114635; Gabriel H, 1997, INT J SPORTS MED, V18, pS28, DOI 10.1055/s-2007-972698; Ghafourian M, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.21498; Gravina L, 2011, J SPORT SCI, V29, P1345, DOI 10.1080/02640414.2011.597420; Higdon LE, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000613; Hirose L, 2004, EXERC IMMUNOL REV, V10, P75; Hyldahl RD, 2014, MUSCLE NERVE, V49, P155, DOI 10.1002/mus.24077; Kakanis MW, 2014, J INTERF CYTOK RES, V34, P699, DOI 10.1089/jir.2013.0031; Keaney LC, 2018, J SCI MED SPORT, V21, P1192, DOI 10.1016/j.jsams.2018.05.014; Kostrzewa-Nowak D, 2019, J MED BIOCHEM, V38, P256, DOI 10.2478/jomb-2018-0029; Kostrzewa-Nowak D, 2018, BIOCHEM MEDICA, V28, DOI 10.11613/BM.2018.030707; Lancaster GI, 2005, J APPL PHYSIOL, V98, P565, DOI 10.1152/japplphysiol.00754.2004; Lauruschkat CD, 2018, MYCOSES, V61, P549, DOI 10.1111/myc.12780; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Malm C, 2002, EXERC IMMUNOL REV, V8, P116; Metsios GS, 2008, J SCI MED SPORT, V11, P214, DOI 10.1016/j.jsams.2006.12.120; Meyer T, 2011, INT J SPORTS MED, V32, P875, DOI 10.1055/s-0031-1280776; Moldoveanu AI, 2000, J APPL PHYSIOL, V89, P1499, DOI 10.1152/jappl.2000.89.4.1499; Naseem S, 2018, VIRAL IMMUNOL, V31, P624, DOI 10.1089/vim.2018.0045; Naufel AO, 2017, BRAZ ORAL RES, V31, DOI 10.1590/1807-3107bor-2017.vol31.0103; Navalta JW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/694801; Neubauer O, 2013, J APPL PHYSIOL, V114, P1677, DOI 10.1152/japplphysiol.00143.2013; Nielsen Hilde G, 2016, J Sports Med (Hindawi Publ Corp), V2016, P7186137, DOI 10.1155/2016/7186137; Nieman DC, 1997, INT J SPORTS MED, V18, pS91, DOI 10.1055/s-2007-972705; Nowak R, 2017, J HUM KINET, V60, P255, DOI 10.1515/hukin-2017-0141; Ogawa K, 2003, MECH AGEING DEV, V124, P951, DOI 10.1016/S0047-6374(03)00167-2; Peake J, 2004, J APPL PHYSIOL, V97, P612, DOI 10.1152/japplphysiol.01331.2003; Peake JM, 2017, J APPL PHYSIOL, V122, P1077, DOI 10.1152/japplphysiol.00622.2016; Peake JM, 2017, J APPL PHYSIOL, V122, P559, DOI 10.1152/japplphysiol.00971.2016; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Pedersen BK, 2000, BRIT J SPORT MED, V34, P246, DOI 10.1136/bjsm.34.4.246; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Phadnis-Moghe Ashwini S., 2017, Current Opinion in Toxicology, V3, P25, DOI 10.1016/j.cotox.2017.04.005; Raeber ME, 2018, IMMUNOL REV, V283, P176, DOI 10.1111/imr.12644; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Simpson RJ, 2011, EXERC SPORT SCI REV, V39, P23, DOI 10.1097/JES.0b013e318201f39d; SMITH JA, 1992, J APPL PHYSIOL, V73, P1396, DOI 10.1152/jappl.1992.73.4.1396; Spielmann G, 2011, BRAIN BEHAV IMMUN, V25, P1521, DOI 10.1016/j.bbi.2011.07.226; Suzuki K, 2000, EUR J APPL PHYSIOL, V81, P281, DOI 10.1007/s004210050044; Suzuki K, 2003, MED SCI SPORT EXER, V35, P348, DOI 10.1249/01.MSS.0000048861.57899.04; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Suzuki K, 1999, J APPL PHYSIOL, V87, P1360, DOI 10.1152/jappl.1999.87.4.1360; Tanghetti Emil A, 2013, J Clin Aesthet Dermatol, V6, P27; ULLUM H, 1994, J APPL PHYSIOL, V77, P93, DOI 10.1152/jappl.1994.77.1.93; Walsh NP, 2018, EUR J SPORT SCI, V18, P820, DOI 10.1080/17461391.2018.1449895; Walsh NP, 2016, IMMUNOL CELL BIOL, V94, P132, DOI 10.1038/icb.2015.99; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Wasinski F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/326803; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wiacek M, 2011, J STRENGTH COND RES, V25, P1514, DOI 10.1519/JSC.0b013e3181ddf860; Windsor MT, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00203; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang J, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0144-1; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zhang CQ, 2017, CELL PHYSIOL BIOCHEM, V43, P2155, DOI 10.1159/000484295; Zhao GG, 2012, EXERC IMMUNOL REV, V18, P98	74	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227993	10.1371/journal.pone.0227993	http://dx.doi.org/10.1371/journal.pone.0227993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990927	Green Published, gold			2022-12-26	WOS:000534605400033
J	Roos, PE; Vasavada, A; Zheng, LY; Zhou, XL				Roos, Paulien E.; Vasavada, Anita; Zheng, Liying; Zhou, Xianlian			Neck musculoskeletal model generation through anthropometric scaling	PLOS ONE			English	Article							MOMENT ARMS; STRENGTH; MORPHOMETRY; HEAD; MASS; PAIN	A new methodology was developed to quickly generate whole body models with detailed neck musculoskeletal architecture that are properly scaled in terms of anthropometry and muscle strength. This method was implemented in an anthropometric model generation software that allows users to interactively generate any new male or female musculoskeletal models with adjustment of anthropometric parameters (such as height, weight, neck circumference, and neck length) without the need of subject-specific motion capture or medical images. 50th percentile male and female models were developed based on the 2012 US Army Anthropometric Survey (ANSUR II) database and optimized with a novel bilevel optimization method to have strengths comparable to experimentally measured values in the literature. Other percentile models (ranging from the 1st to 99th percentile) were generated based on anthropometric scaling of the 50th percentile models and compared. The resultant models are reasonably accurate in terms of both musculoskeletal geometry and neck strength, demonstrating the effectiveness of the developed methodology for interactive neck model generation with anthropometric scaling.	[Roos, Paulien E.] CFD Res Corp, Biomed & Life Sci Div, Huntsville, AL USA; [Vasavada, Anita] Washington State Univ, Dept Integrat Physiol & Neurosci, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Zheng, Liying] Natl Inst Occupat Safety & Hlth, Hlth Effects Lab Div, Morgantown, WV USA; [Zhou, Xianlian] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	CFD Research Corporation; Washington State University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); New Jersey Institute of Technology	Zhou, XL (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	alexzhou@njit.edu		Zhou, Xianlian/0000-0001-9282-5410	US Army [W81XWH-14-C-003]; NJIT's new faculty startup fund	US Army(United States Department of DefenseUnited States Army); NJIT's new faculty startup fund	XZ and PR received funding provided by the US Army under grant W81XWH-14-C-003 for this study. XZ is also supported by NJIT's new faculty startup fund.	Albery CB, 2003, P 31 INT WORKSH INJ, p[157, 157]; Anderson JS, 2005, SPINE, V30, pE86, DOI 10.1097/01.brs.0000153700.97830.02; Becker EB, 1973, SAE T, P2818; Beier G, 1979, TECHNICAL REPORT; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; BUCHANAN TS, 1995, MED ENG PHYS, V17, P529, DOI 10.1016/1350-4533(95)00005-8; Cazzola D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169329; Chancey Valeta Carol, 2003, Stapp Car Crash J, V47, P135; Correa TA, 2011, J BIOMECH, V44, P2782, DOI 10.1016/j.jbiomech.2011.08.024; Cote P, 2000, SPINE, V25, P1109; Desantis Klinich Kathleen, 2004, Stapp Car Crash J, V48, P301; Foust DR, 1973, CERVICAL RANGE MOTIO; Garner BA, 2003, ANN BIOMED ENG, V31, P207, DOI 10.1114/1.1540105; Gordon C.C., 2014, TECHNICAL REPORT NAT; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hedenstierna S, 2006, 6 EUR LS DYNA US C, P89; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hotzman J, 2011, MEASURERS HDB US ARM; Jager M De, 1994, SAE T, P1660; Kamibayashi LK, 1998, SPINE, V23, P1314, DOI 10.1097/00007632-199806150-00005; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; McConville JT, 1980, AFAMRLTR80119 ANTHR; Mortensen JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199912; Myers CA, 2015, ANN BIOMED ENG, V43, P1098, DOI 10.1007/s10439-014-1181-7; Oi Nelson, 2004, Stapp Car Crash J, V48, P397; Pavol MJ, 2002, J BIOMECH, V35, P707, DOI 10.1016/S0021-9290(01)00250-0; Reed EB, 2015, COMPUT METHOD BIOMEC, V18, P607, DOI 10.1080/10255842.2013.822489; Suderman BL, 2017, ANN BIOMED ENG, V45, P2009, DOI 10.1007/s10439-017-1830-8; Suderman BL, 2012, COMPUT METHOD BIOMEC, V15, P735, DOI 10.1080/10255842.2011.558085; Suderman BL, 2012, EFFECT CURVATURE NEC; van der MJ Horst, 2002, THESIS, P217; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Vasavada AN, 2018, ANN BIOMED ENG, V46, P1844, DOI 10.1007/s10439-018-2084-9; Walker LB, 1973, 762581 DEP NAV OFF N; Whitley PE, 2018, ADV INTELL SYST, V591, P469, DOI 10.1007/978-3-319-60591-3_42; Yang HO, 2015, SPINE, V40, P184, DOI 10.1097/BRS.0000000000000700; YEADON MR, 1990, J BIOMECH, V23, P67, DOI 10.1016/0021-9290(90)90370-I; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zheng L., 2011, THESIS; Zheng LY, 2013, J BIOMECH, V46, P899, DOI 10.1016/j.jbiomech.2012.12.018; Zhou X., 2016, INT J DIGITAL HUMAN, V1, P321, DOI DOI 10.1504/IJDH.2016.084584	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0219954	10.1371/journal.pone.0219954	http://dx.doi.org/10.1371/journal.pone.0219954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990914	Green Submitted, Green Published, gold			2022-12-26	WOS:000534605400002
J	Smidt, ED; Paez, MZ; Vieira, LN; Viruel, J; de Baura, VA; Balsanelli, E; de Souza, EM; Chase, MW				Smidt, Eric de Camargo; Paez, Michelle Zavala; Vieira, Leila Nascimento; Viruel, Juan; de Baura, Valter Antonio; Balsanelli, Eduardo; de Souza, Emanuel Maltempi; Chase, Mark W.			Characterization of sequence variability hotspots in Cranichideae plastomes (Orchidaceae, Orchidoideae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SPIRANTHINAE ORCHIDACEAE; DNA-SEQUENCES; NUCLEAR; EVOLUTION; PRESCOTTIINAE; CHLOROPLAST; SUBTRIBE; GENOMES; UTILITY	This study reports complete plastome sequences for six species of Neotropical Cranichideae and focuses on identification of the most variable regions (hotspots) in this group of orchids. These structure of these six plastomes is relatively conserved, exhibiting lengths ranging between 142,599 to 154,562 bp with 36.7% GC on average and exhibiting typical quadripartite arrangement (LSC, SSC and two IRs). Variation detected in the LSC/IR and SSC/IR junctions is explained by the loss of ndhF and ycf1 length variation. For the two genera of epiphytic clade in Spiranthinae, almost whole sets of the ndh-gene family were missing. Eight mutation hotspots were identified based on nucleotide diversity, sequence variability and parsimony-informative sites. Three of them (rps16-trnQ, trnT-trnL, rpl32-trnL) seem to be universal hotspots in the family, and the other five (trnG-trnR, trnR-atpA, trnP-psaJ, rpl32-infA, and rps15-ycf1) are described for the first time as orchid molecular hotspots. These regions have much more variation than all those used previously in phylogenetics of the group and offer useful plastid markers for phylogenetic, barcoding and population genetic studies. The use of whole plastomes or exclusive no-gap matrices also positioned with high support the holomycotrophic Rhizanthella among Orchidoideae plastomes in model-based analyses, showing the utility of plastomes for phylogenetic placement of this unusual genus.	[Smidt, Eric de Camargo; Paez, Michelle Zavala; Vieira, Leila Nascimento] Univ Fed Parana, Dept Bot, Curitiba, Parana, Brazil; [Smidt, Eric de Camargo; Viruel, Juan; Chase, Mark W.] Royal Bot Gardens, Richmond, Surrey, England; [de Baura, Valter Antonio; Balsanelli, Eduardo; de Souza, Emanuel Maltempi] Univ Fed Parana, Dept Bioquim, Nucleo Fixacao Biol Nitrogenio, Curitiba, Parana, Brazil; [Chase, Mark W.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia	Universidade Federal do Parana; Royal Botanic Gardens, Kew; Universidade Federal do Parana; Curtin University	Smidt, ED (corresponding author), Univ Fed Parana, Dept Bot, Curitiba, Parana, Brazil.; Smidt, ED (corresponding author), Royal Bot Gardens, Richmond, Surrey, England.	ecsmidt@yahoo.com.br	Smidt, Eric C/F-7632-2011; Vieira, Leila N/F-9934-2012; Viruel Sanchez, Juan/H-4227-2015	Smidt, Eric C/0000-0002-1177-1682; do Nascimento Vieira, Leila/0000-0001-8413-2155; Viruel Sanchez, Juan/0000-0001-5658-8411	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [311001/2014-9, 203304/2018-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ECS would like to thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for grant Bolsa de Produtividade em Pesquisa CNPq-Nivel 2 (proc. 311001/2014-9) and Pos-doc grant (proc. 203304/2018-7) and Brazilian Program of National Institutes of Science and Technology-INCT/Brazilian Research Council-CNPq/MCT.	Alvarez-Molina A, 2009, AM J BOT, V96, P1020, DOI 10.3732/ajb.0800219; Amiryousefi A, 2018, BIOINFORMATICS, V34, P3030, DOI 10.1093/bioinformatics/bty220; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; Batista JAN, 2011, BOT J LINN SOC, V165, P348, DOI 10.1111/j.1095-8339.2011.01113.x; Borba EL, 2014, BOT J LINN SOC, V175, P29, DOI 10.1111/boj.12136; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Chen SP, 2019, MOL PHYLOGENET EVOL, V139, DOI 10.1016/j.ympev.2019.106542; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Cisternas MA, 2012, BOT J LINN SOC, V168, P258, DOI 10.1111/j.1095-8339.2011.01200.x; Clements MA, 2011, AUST J BOT, V59, P99, DOI 10.1071/BT10190; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Doyle J. J., 1987, PHYTOCHEM B, P11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueroa C, 2008, ANN BOT-LONDON, V101, P509, DOI 10.1093/aob/mcm328; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Givnish TJ, 2015, P ROY SOC B-BIOL SCI, V282, P171, DOI 10.1098/rspb.2015.1553; Graham SW, 2017, NEW PHYTOL, V214, P48, DOI 10.1111/nph.14398; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150366; Janes JK, 2010, AUST SYST BOT, V23, P248, DOI 10.1071/SB10006; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187318; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lin CS, 2017, PLANT J, V90, P994, DOI 10.1111/tpj.13525; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Merckx V, 2010, NEW PHYTOL, V185, P605, DOI 10.1111/j.1469-8137.2009.03155.x; Merckx V, 2009, CLADISTICS, V25, P64, DOI 10.1111/j.1096-0031.2008.00241.x; Niu ZT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02252-8; Niu ZT, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00715; Olson PD, 2016, SYSTEMATICS ASS SPEC, V85; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; POWO, 2019, PKANTS WORLD ONL; Pridgeon AM, 2003, GEN ORCHIDACEAR 2, V3; Rambaut A., 2014, FIGTREE V14 TREE FIG; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross TG, 2016, CLADISTICS, V32, P160, DOI 10.1111/cla.12133; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Ruhlman TA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0484-7; Sakaguchi S, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1700002; Salazar GA, 2003, AM J BOT, V90, P777, DOI 10.3732/ajb.90.5.777; Salazar GA, 2018, BOT J LINN SOC, V186, P273, DOI 10.1093/botlinnean/box096; Salazar GA, 2014, PHYTOTAXA, V173, P127, DOI 10.11646/phytotaxa.173.2.3; Salazar GA, 2009, ANN BOT-LONDON, V104, P403, DOI 10.1093/aob/mcn257; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Mauad AVSR, 2019, BRAZ J BOT, V42, P345, DOI 10.1007/s40415-019-00524-3; Vieira LD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084792, 10.1371/journal.pone.0090618]; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	65	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2020	15	1							e0227991	10.1371/journal.pone.0227991	http://dx.doi.org/10.1371/journal.pone.0227991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8ZJ	31990943	gold, Green Published			2022-12-26	WOS:000534605400031
J	Valt, C; Huber, D; Sturmer, B				Valt, Christian; Huber, Dorothea; Stuermer, Birgit			Treatment-related changes towards normalization of the abnormal external signal processing in panic disorder	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE-BEHAVIORAL THERAPY; BRAIN ACTIVITY; FACIAL EXPRESSIONS; NEURAL SYSTEM; FACE; POTENTIALS; TASK; MODULATION; DEPRESSION	Despite the scientific consensus on the efficacy of psychotherapy for the treatment of psychological disorders, the evidence of treatment-related changes towards normalization of abnormal brain functions in patients is mixed. In the present experiment, we investigated whether treatment can affect early information processing, by testing abnormal eventrelated potentials (ERPs) evoked by internal and external signals in panic disorder. Sixteen patients with panic disorder and comorbid personality disorder and sixteen control participants performed a response-choice task and a passive viewing task in two testing sessions, separated by around 14 months. During this period, patients received psychological treatment. In agreement with previous studies of performance monitoring, the abnormal amplitude of the Ne/ERN-an index of error processing based on internal signals-did not change between the first and second testing session. However, treatment-related changes were evident for the abnormal vertex positive potential (VPP) evoked by external signals in the response-choice task and the passive viewing task. In patients, the VPP was smaller in the second session compared to the first session, whereas no significant changes occurred in controls. This result supplies evidence of treatment-related changes towards normalization in the early information processing of external visual stimuli in panic disorder.	[Valt, Christian; Huber, Dorothea; Stuermer, Birgit] Int Psychoanalyt Univ Berlin, Berlin, Germany		Valt, C (corresponding author), Int Psychoanalyt Univ Berlin, Berlin, Germany.	christian.valt@ipu-berlin.de			Deutsche Forschungsgemeinschaft [STU 248/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by funding of the Deutsche Forschungsgemeinschaft granted to Prof. Sturmer (STU 248/4-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsaglini A, 2014, PROG NEUROBIOL, V114, P1, DOI 10.1016/j.pneurobio.2013.10.006; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benecke C, 2016, Z PSYCHOSOM MED PSYC, V62, P252, DOI 10.13109/zptm.2016.62.3.252; Buchheim A, 2018, PSYCHOTHER PSYCHOSOM, V87, P252, DOI 10.1159/000488090; Buchheim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033745; Burkhouse KL, 2017, J AFFECT DISORDERS, V217, P73, DOI 10.1016/j.jad.2017.03.061; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Endrass T, 2013, J ABNORM PSYCHOL, V122, P387, DOI 10.1037/a0031496; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fu CHY, 2008, BIOL PSYCHIAT, V64, P505, DOI 10.1016/j.biopsych.2008.04.033; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gorka SM, 2018, NEUROPSYCHOPHARMACOL, V43, P1355, DOI 10.1038/npp.2017.289; Hajcak G, 2008, AM J PSYCHIAT, V165, P116, DOI 10.1176/appi.ajp.2007.07010143; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Hildebrandt A, 2013, PSYCHOL AGING, V28, P243, DOI 10.1037/a0031490; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Huffmeijer R, 2014, PHYSIOL BEHAV, V130, P13, DOI 10.1016/j.physbeh.2014.03.008; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Koban L, 2014, NEUROSCI BIOBEHAV R, V46, P71, DOI 10.1016/j.neubiorev.2014.02.014; Kujawa A, 2016, PROG NEURO-PSYCHOPH, V71, P162, DOI 10.1016/j.pnpbp.2016.07.010; Ladouceur CD, 2018, J CHILD PSYCHOL PSYC, V59, P1152, DOI 10.1111/jcpp.12900; Laux L., 1981, STATE TRAIT ANGSTINV; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Meyer A, 2018, J CHILD PSYCHOL PSYC, V59, P1162, DOI 10.1111/jcpp.12922; Meyer A, 2015, J ABNORM PSYCHOL, V124, P266, DOI 10.1037/abn0000044; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moran TP, 2017, INT J PSYCHOPHYSIOL, V111, P17, DOI 10.1016/j.ijpsycho.2016.07.001; Moser JS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00466; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Riesel A, 2015, AM J PSYCHIAT, V172, P665, DOI 10.1176/appi.ajp.2014.14070886; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Siegle GJ, 2010, INT J PSYCHOPHYSIOL, V75, P107, DOI 10.1016/j.ijpsycho.2008.04.008; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Spielberger C. D., 1983, MIND GARDEN; Stober J., 1995, Z DIFF DIAGN PSYCHOL, V16, P50; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; Valt C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208257; Valt C, 2017, ADV COGN PSYCHOL, V13, P190, DOI 10.5709/acp-0219-5; Wittchen HU, 1997, SKID	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227673	10.1371/journal.pone.0227673	http://dx.doi.org/10.1371/journal.pone.0227673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986163	Green Published, gold			2022-12-26	WOS:000534603400025
J	Bello, P; Gallardo, P; Pradenas, L; Ferland, JA; Parada, V				Bello, Paul; Gallardo, Pedro; Pradenas, Lorena; Ferland, Jacques A.; Parada, Victor			Best compromise nutritional menus for childhood obesity	PLOS ONE			English	Article								Childhood obesity is an undeniable reality that has rapidly increased in many countries. Obesity at an early age not only increases the risks of chronic diseases but also produces a problem for the whole healthcare system. One way to alleviate this problem is to provide each patient with an appropriate menu that is defined by a mathematical model. Existing mathematical models only partially address the objective and constraints of childhood obesity; therefore, the solutions provided are insufficient for health specialists to prepare nutritional menus for individual patients. This manuscript proposes a multiobjective mathematical programming model to aid in healthy nutritional menu planning that may prevent childhood obesity. This model provides a plan for combinations and amounts of food across different schedules and daily meals. This approach minimizes the major risk factors of childhood obesity (i.e., glycemic load and cholesterol intake). In addition, this approach considers the minimization of nutritional mismatch and total cost. The model is solved using a deterministic method and two metaheuristic methods. Test instances associated with children aged 4-18 years were created with the support of health professionals to complete this numerical study. The quality of the solutions generated using the three methods was similar, but the metaheuristic methods provided solutions in a shorter computational time. These results are submitted to statistical hypothesis tests to be validated. The numerical results indicate proper guidelines for personalized plans for individual children.	[Bello, Paul; Gallardo, Pedro; Pradenas, Lorena] Univ Concepcion, Dept Ingn Ind, Concepcion, Chile; [Ferland, Jacques A.] Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ, Canada; [Parada, Victor] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile	Universidad de Concepcion; Universite de Montreal; Universidad de Santiago de Chile	Pradenas, L (corresponding author), Univ Concepcion, Dept Ingn Ind, Concepcion, Chile.	lpradena@udec.cl	Pradenas, Lorena/ACZ-4624-2022; Parada, Victor/M-5840-2014; Parada, Victor/AHD-6455-2022	Parada, Victor/0000-0002-8649-5694	CONICYT: Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile [FB0816]; CONICYT PIA/BASAL [AFB180003]	CONICYT: Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT PIA/BASAL(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	Funded by LP: grant number FB0816. VP: grant number FB0816. CONICYT: Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile. https://www.conicyt.cl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the financial support of this study from CONICYT PIA/BASAL AFB180003.; The authors gratefully acknowledge the financial supported of this study from CONICYT PIA/BASAL AFB180003. We also acknowledge the comments from the referees that were useful to prepare this revised version of the paper.	Bas E, 2014, APPL MATH MODEL, V38, P4926, DOI 10.1016/j.apm.2014.03.049; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Cohon J.L., 2004, MULTIOBJECTIVE PROGR; Daniels SR, 2006, FUTURE CHILD, V16, P47, DOI 10.1353/foc.2006.0004; DANTZIG GB, 1990, INTERFACES, V20, P43, DOI 10.1287/inte.20.4.43; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Donati M, 2016, APPETITE, V106, P48, DOI 10.1016/j.appet.2016.02.151; Dunteman George H, 1984, INTRO MULTIVARIATE A; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Lake A, 2006, J R SOC PROMO HEALTH, V126, P262, DOI 10.1177/1466424006070487; Lehmann Erich Leo, 1986, TESTING STAT HYPOTHE, V150; Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; Montgomery D.C., 2012, DESIGN ANAL EXPT; Nojima Y, 2005, LECT NOTES COMPUT SC, V3410, P341; Okubo H, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0047-7; Oreskovic P, 2015, J FOOD COMPOS ANAL, V37, P112, DOI 10.1016/j.jfca.2014.07.002; Reeves CR, 2010, INT SER OPER RES MAN, V146, P109, DOI 10.1007/978-1-4419-1665-5_5; Seljak B. K., 2006, P INT C INT ENG SYST, P108, DOI [DOI 10.1109/INES.2006.1689351, 10.1109/INES.2006.1689351]; Seljak BK, 2009, J FOOD COMPOS ANAL, V22, P414, DOI 10.1016/j.jfca.2009.02.006; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Stigler GJ, 1945, J FARM ECON, V27, P303, DOI 10.2307/1231810; Sufahani S, 2014, APPL MATH SCI, V8, P7511, DOI 10.12988/ams.2014.49725; Talbi E.G., 2009, METAHEURISTICS DESIG, V74, DOI 10.1002/9780470496916; Van Mierlo K, 2017, J CLEAN PROD, V165, P930, DOI 10.1016/j.jclepro.2017.07.098; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; World Health Organization, FACTS FIG CHILDH OB; Zitzler E., 2002, EVOL METHODS OPTIM C, P95	28	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0216516	10.1371/journal.pone.0216516	http://dx.doi.org/10.1371/journal.pone.0216516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KH6NG	31978089	Green Published, Green Submitted, gold			2022-12-26	WOS:000510767600001
J	Radcliff, AB; Heidari, M; Field, AS; Duncan, ID				Radcliff, Abigail B.; Heidari, Moones; Field, Aaron S.; Duncan, Ian D.			Feline irradiated diet-induced demyelination; a model of the neuropathology of sub-acute combined degeneration?	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; SPINAL-CORD; VITAMIN-B12 DEFICIENCY; COBALAMIN DEFICIENCY; B-12 DEFICIENCY; SERUM COBALAMIN; INBORN ERROR; MYELOPATHY; MYELIN	Irradiation of food at 50-55 kGy results in a profound, chronic demyelinating-remyelinating disease of the entire central nervous system (CNS) in cats, named Feline Irradiated DietInduced Demyelination (FIDID). This study examines the early stages of demyelination and long-term consequences of demyelination and remyelination on axon survival or loss. Myelin vacuolation is the primary defect leading to myelin breakdown, demyelination then prompt remyelination in the spinal cord and brain. There is no evidence of oligodendrocyte death. The spinal cord dorsal column is initially spared yet eventually becomes severely demyelinated with subsequent loss of axons in the core and then surface of the fasciculus gracilis. However remyelination of the sub-pial axons in the dorsal column results in their protection. While there was a lack of biochemical evidence of Vitamin B12 deficiency, the pathological similarities of FIDID with sub-acute combined degeneration (SCD) led us to explore treatment with Vitamin B12. Treatment led to recovery or improvement in some cats and neurologic relapse on cessation of B12 therapy. While the reason that irradiated food is myelinotoxic in the cat remains unresolved, nonetheless the neuropathological changes match exactly what is seen in SCD and its models and provide an ideal model to study the cellular and molecular basis of remyelination.	[Radcliff, Abigail B.; Heidari, Moones; Duncan, Ian D.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Field, Aaron S.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Duncan, ID (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	ian.duncan@wisc.edu			National Multiple Sclerosis Society [RG-1501-02876]; MS Hope for a Cure	National Multiple Sclerosis Society(National Multiple Sclerosis Society); MS Hope for a Cure	This work was supported by the National Multiple Sclerosis Society grant no. RG-1501-02876 (IDD) and MS Hope for a Cure (IDD) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1976, NEUROLOGY, V26, P905, DOI 10.1212/WNL.26.10.905; AGAMANOLIS DP, 1978, J NEUROPATH EXP NEUR, V37, P273, DOI 10.1097/00005072-197805000-00006; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; ALLEN RH, 1993, FASEB J, V7, P1344, DOI 10.1096/fasebj.7.14.7901104; Cassidy JP, 2007, VET PATHOL, V44, P912, DOI 10.1354/vp.44-6-912; Caulfield CD, 2009, VET PATHOL, V46, P1258, DOI 10.1354/vp.08-VP-0336-C-FL; Caulfield CD, 2008, J AM ASSOC LAB ANIM, V47, P61; Child G, 2009, AUST VET J, V87, P349, DOI 10.1111/j.1751-0813.2009.00475.x; CLAYTON PT, 1986, J NEUROL NEUROSUR PS, V49, P920, DOI 10.1136/jnnp.49.8.920; DAYAN AD, 1974, J NEUROL SCI, V23, P117, DOI 10.1016/0022-510X(74)90147-6; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Duncan ID, 2018, P NATL ACAD SCI USA, V115, pE11807, DOI 10.1073/pnas.1808064115; Duncan ID, 2016, EXP NEUROL, V283, P452, DOI 10.1016/j.expneurol.2016.04.002; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; Duncan ID, 2015, PROMOTION REMYELINAT; Dutta DJ, 2018, P NATL ACAD SCI USA, V115, P11832, DOI 10.1073/pnas.1811013115; FINE EJ, 1980, J NEUROL SCI, V45, P331, DOI 10.1016/0022-510X(80)90176-8; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Goodman BP, 2006, AM J NEURORADIOL, V27, P2112; GREEN R, 1975, NATURE, V254, P148, DOI 10.1038/254148a0; Hagen G., 1991, Progress in Veterinary Neurology, V2, P15; HAGEN G, 1990, VET PATHOL, V27, P187, DOI 10.1177/030098589002700306; Harper C, 1996, GREENFIELDS NEUROPAT, V1, P601; Hathout L, 2011, J NEUROL SCI, V301, P1, DOI 10.1016/j.jns.2010.10.033; Heidari M, 2019, P NATL ACAD SCI; Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Jain KK, 2014, J NEUROL SCI, V342, P162, DOI 10.1016/j.jns.2014.05.020; Koike H, 2018, NEUROLOGY, V91, P1051, DOI 10.1212/WNL.0000000000006625; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 2014, GLIA, V62, P1816, DOI 10.1002/glia.22597; LINDENBAUM J, 1990, AM J HEMATOL, V34, P99, DOI 10.1002/ajh.2830340205; Lindenbaum J., 1995, NUTRITION, V11, P181; McCaddon A, 2013, BIOCHIMIE, V95, P1066, DOI 10.1016/j.biochi.2012.11.017; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Olabarria M, 2015, ACTA NEUROPATHOL, V130, P469, DOI 10.1007/s00401-015-1469-1; PALMER AC, 1984, J SMALL ANIM PRACT, V25, P139, DOI 10.1111/j.1748-5827.1984.tb00461.x; PALMER AC, 1995, J SMALL ANIM PRACT, V36, P57, DOI 10.1111/j.1748-5827.1995.tb02822.x; PANT SS, 1968, ACTA NEUROL SCAND, VS 44, P7; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Pittock SJ, 2002, MAYO CLIN PROC, V77, P291, DOI 10.4065/77.3.291; Puri V, 2005, Electromyogr Clin Neurophysiol, V45, P273; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Ruaux CG, 2001, AM J VET RES, V62, P1852, DOI 10.2460/ajvr.2001.62.1852; Rusher DR, 2013, J HUMAN NUTR FOOD SC, V1, P1; Russell JSR, 1900, BRAIN, V23, P39, DOI 10.1093/brain/23.1.39; Salvadori C, 2003, J VET MED A, V50, P292, DOI 10.1046/j.1439-0442.2003.00545.x; SCALABRINO G, 1990, LAB INVEST, V62, P297; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Schultz V, 2017, GLIA, V65, P1350, DOI 10.1002/glia.23167; SHEAHAN BJ, 1991, VET PATHOL, V28, P117, DOI 10.1177/030098589102800203; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Simpson KW, 2001, J VET INTERN MED, V15, P26, DOI 10.1892/0891-6640(2001)015&lt;0026:SCOSCV&gt;2.3.CO;2; Smith SE, 2006, MOL GENET METAB, V88, P138, DOI 10.1016/j.ymgme.2006.02.007; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Susuki K., 2016, CLIN EXP NEUROIMMUNO, V7, P324, DOI DOI 10.1111/CEN3.12338; TOMODA H, 1988, ARCH NEUROL-CHICAGO, V45, P526, DOI 10.1001/archneur.1988.00520290058014; TRONCOSO J, 1979, ARCH NEUROL-CHICAGO, V36, P168, DOI 10.1001/archneur.1979.00500390086010; van den Ingh T, 2019, J ANIM PHYSL ANIM NU; Vasconcelos OM, 2006, J GEN INTERN MED, V21, P1063, DOI 10.1111/j.1525-1497.2006.00525.x; Weil MT, 2016, CELL REP, V16, P314, DOI 10.1016/j.celrep.2016.06.008; Winston GP, 2008, MED HYPOTHESES, V71, P229, DOI 10.1016/j.mehy.2008.03.027	66	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228109	10.1371/journal.pone.0228109	http://dx.doi.org/10.1371/journal.pone.0228109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978144	Green Published, gold			2022-12-26	WOS:000534599100112
J	Stivala, A; Robins, G; Lomi, A				Stivala, Alex; Robins, Garry; Lomi, Alessandro			Exponential random graph model parameter estimation for very large directed networks	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SNOWBALL; INFERENCE; LAW	Exponential random graph models (ERGMs) are widely used for modeling social networks observed at one point in time. However the computational difficulty of ERGM parameter estimation has limited the practical application of this class of models to relatively small networks, up to a few thousand nodes at most, with usually only a few hundred nodes or fewer. In the case of undirected networks, snowball sampling can be used to find ERGM parameter estimates of larger networks via network samples, and recently published improvements in ERGM network distribution sampling and ERGM estimation algorithms have allowed ERGM parameter estimates of undirected networks with over one hundred thousand nodes to be made. However the implementations of these algorithms to date have been limited in their scalability, and also restricted to undirected networks. Here we describe an implementation of the recently published Equilibrium Expectation (EE) algorithm for ERGM parameter estimation of large directed networks. We test it on some simulated networks, and demonstrate its application to an online social network with over 1.6 million nodes.	[Stivala, Alex; Lomi, Alessandro] Univ Svizzera italiana, Inst Computat Sci, Lugano, Ticino, Switzerland; [Stivala, Alex] Swinburne Univ Technol, Ctr Transformat Innovat, Melbourne, Vic, Australia; [Robins, Garry] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Lomi, Alessandro] Univ Exeter, Univ Exeter Business Sch, Exeter, Devon, England	Universita della Svizzera Italiana; Swinburne University of Technology; University of Melbourne; University of Exeter	Stivala, A (corresponding author), Univ Svizzera italiana, Inst Computat Sci, Lugano, Ticino, Switzerland.; Stivala, A (corresponding author), Swinburne Univ Technol, Ctr Transformat Innovat, Melbourne, Vic, Australia.	alexander.stivala@usi.ch	Lomi, Alessandro/AFR-0469-2022; Stivala, Alex/F-7770-2015	Stivala, Alex/0000-0002-2442-4743; lomi, alessandro/0000-0002-2858-0022	Swiss National Science Foundation [167326]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	A.L. and G.R. were awarded a grant, from which the salary of A.S. is paid, from the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx) National Research Programme 75 "Big Data" (NRP 75, http://www.nfp75.ch/en/Pages/Home.aspx) under project number 167326 "The Global Structure of Knowledge Networks: Data, Models and Empirical Results." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati V, 2018, ANNU REV STAT APPL, V5, P343, DOI 10.1146/annurev-statistics-031017-100746; An CK, 2018, STAT MED, V37, P847, DOI 10.1002/sim.7565; Asuncion Arthur, 2010, P 13 INT C ART INT S, P33; Babkin S., 2017, PREPRINT; Barndorff-Nielsen O., 2014, INFORM EXPONENTIAL F; Benaglia T, 2009, J STAT SOFTW, V32, P1; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Borisenko A, 2019, PREPRINT; Broido AD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08746-5; Byshkin M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29725-8; Byshkin M, 2016, J STAT PHYS, V165, P740, DOI 10.1007/s10955-016-1650-5; Caimo A, 2011, SOC NETWORKS, V33, P41, DOI 10.1016/j.socnet.2010.09.004; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLEMAN JS, 1958, HUM ORGAN, V17, P28, DOI 10.17730/humo.17.4.q5604m676260q8n7; Corander J, 1998, MAXIMUM LIKELIHOOD E; Corander J, 2002, CONTRIBUTIONS SOCIAL, P1; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Fellows IE, 2014, PREPRINT; GEYER CJ, 1992, J R STAT SOC B, V54, P657; Gillespie CS, 2015, J STAT SOFTW, V64; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Goodman LA, 2011, SOCIOL METHODOL, V41, P347, DOI 10.1111/j.1467-9531.2011.01242.x; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Handcock M.S., 2016, STATNET SOFTWARE TOO; Handcock MS, 2011, SOCIOL METHODOL, V41, P367, DOI 10.1111/j.1467-9531.2011.01243.x; Handcock MS, 2010, ANN APPL STAT, V4, P5, DOI 10.1214/08-AOAS221; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Hanson TD, 2018, UTHASH; Hartung J., 2008, STAT METAANALYSIS AP; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hummel RM, 2012, J COMPUT GRAPH STAT, V21, P920, DOI 10.1080/10618600.2012.679224; Hunter DR, 2008, J AM STAT ASSOC, V103, P248, DOI 10.1198/016214507000000446; Hunter DR, 2006, J COMPUT GRAPH STAT, V15, P565, DOI 10.1198/106186006X133069; Hunter DR, 2012, J COMPUT GRAPH STAT, V21, P856, DOI 10.1080/10618600.2012.732921; Jones GL, 2006, J AM STAT ASSOC, V101, P1537, DOI 10.1198/016214506000000492; Kleineberg KK, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031046; Krivitsky PN, 2017, COMPUT STAT DATA AN, V107, P149, DOI 10.1016/j.csda.2016.10.015; Leskovec J., 2014, SNAP DATASETS STANFO; Leskovec J, 2016, ACM T INTEL SYST TEC, V8, DOI 10.1145/2898361; Lusher D., 2013, EXPONENTIAL RANDOM G, DOI [10.1017/CBO9780511894701, DOI 10.1017/CBO9780511894701]; Morris Martina, 2008, J Stat Softw, V24, P1548; Pattison PE, 2013, J MATH PSYCHOL, V57, P284, DOI 10.1016/j.jmp.2013.05.004; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Salmon J. K., 2011, SC 11 P 2011 INT C H, P1, DOI [DOI 10.1145/2063384.2063405, 10.1145/2063384.2063405]; Schweinberger M, 2019, PREPRINT; Snijders TAB, 2003, J MATH SOCIOL, V27, P123, DOI 10.1080/00222500305892; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stivala AD, 2016, SOC NETWORKS, V47, P167, DOI 10.1016/j.socnet.2015.11.003; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Takac L, 2012, P INT SCI C INT WORK; Thiemichen S, 2017, SOC NETWORKS, V49, P67, DOI 10.1016/j.socnet.2016.12.002; Tieleman T., 2008, P 25 INT C MACHINE L, P1064, DOI DOI 10.1145/1390156.1390290; van Duijn MAJ, 2009, SOC NETWORKS, V31, P52, DOI 10.1016/j.socnet.2008.10.003; Vats D, 2017, PREPRINT; Wang P., 2009, PNET PROGRAM SIMULAT; Wang P.C., 2012, THESIS; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; YOUNES L, 1988, ANN I H POINCARE-PR, V24, P269	64	14	14	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227804	10.1371/journal.pone.0227804	http://dx.doi.org/10.1371/journal.pone.0227804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	31978150	Green Submitted, Green Published, gold			2022-12-26	WOS:000534599100062
J	Wang, YK; Ge, L; Chen, S; Wang, HY; Han, JC; Guo, Z; Lu, YJ				Wang, Yike; Ge, Lei; Chen, Shi; Wang, Huanyuan; Han, Jichang; Guo, Zhen; Lu, Yangjie			Analysis on hydraulic characteristics of improved sandy soil with soft rock	PLOS ONE			English	Article							CDSE/ZNS QUANTUM DOTS; WATER-RETENTION; LAND; CONDUCTIVITY; MODEL	Hydraulic properties of sandy soil from the Mu Us sandy land of Shaanxi Province were analyzed by using SEM technology. Soil porosity, the water characteristic curve, and unsaturated hydraulic conductivity of aeolian sandy soil with added soft rock were analyzed, and fractal characteristics were established. Soil hydraulic properties revealed the effect of soft rock application on soil structure and hydraulic properties. Mass ratios of soft rock to aeolian sand were 1:5, 1:2, and 1:1. Results showed that the addition of soft rock can significantly increase the bulk density of sandy soil and reduce the total porosity and macroporosity. The mass fraction of water-stable aggregates greater than 0.25mm increases significantly, increasing the fractal dimension of soil pores; reducing the soil saturated water content and saturated hydraulic conductivity. SEM technology and pore fractal theory were used to predict the soil salinity curve and unsaturated hydraulic conductivity of the improved saline soil.	[Wang, Yike; Ge, Lei; Chen, Shi; Wang, Huanyuan; Han, Jichang; Guo, Zhen; Lu, Yangjie] Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Shaanxi, Peoples R China; [Wang, Yike; Ge, Lei; Chen, Shi; Wang, Huanyuan; Han, Jichang; Guo, Zhen; Lu, Yangjie] Minist Nat Resources China, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Shaanxi, Peoples R China; [Wang, Yike; Ge, Lei; Chen, Shi; Wang, Huanyuan; Han, Jichang; Guo, Zhen; Lu, Yangjie] Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Shaanxi, Peoples R China; [Wang, Yike; Ge, Lei; Chen, Shi; Wang, Huanyuan; Han, Jichang; Guo, Zhen; Lu, Yangjie] Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Peoples R China	Ministry of Natural Resources of the People's Republic of China	Han, JC (corresponding author), Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Shaanxi, Peoples R China.; Han, JC (corresponding author), Minist Nat Resources China, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Shaanxi, Peoples R China.; Han, JC (corresponding author), Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Shaanxi, Peoples R China.; Han, JC (corresponding author), Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Peoples R China.	2392574359@qq.com		Guo, Zhen/0000-0003-3383-6341	Shaanxi Provincial Land Engineering Construction Group Ltd. [DJNY2019-12, DJNY2018-12]; Fund Project of Shaanxi Key Laboratory of Land Consolidation [2018-JC18, 2019-JC08]	Shaanxi Provincial Land Engineering Construction Group Ltd.; Fund Project of Shaanxi Key Laboratory of Land Consolidation	This research was supported by the Shaanxi Provincial Land Engineering Construction Group Ltd., internal research project (DJNY2019-12, DJNY2018-12); The Fund Project of Shaanxi Key Laboratory of Land Consolidation (2018-JC18, 2019-JC08). The funding organizations had no role in the design, management, analysis, or interpretation of the data, nor in the preparation, review or approval of the manuscript. The funder, Jichang Han, provided support in the formal analysis and funding acquisition of this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company, Shaanxi Provincial Land Engineering Construction Group Co., Ltd., provided support in the form of salaries for authors Yike Wang and Jichang Han, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVNIR D, 1983, J CHEM PHYS, V79, P3566, DOI 10.1063/1.446211; Bird NRA, 2000, EUR J SOIL SCI, V51, P55, DOI 10.1046/j.1365-2389.2000.00278.x; Guarracino L, 2006, J HYDROL, V324, P154, DOI 10.1016/j.jhydrol.2005.10.004; Guo Fei, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P6; Han JC, 2015, J GEOGR SCI, V25, P428, DOI 10.1007/s11442-015-1178-7; Hu L, 2019, ECOTOX ENVIRON SAFE, V181, P336, DOI 10.1016/j.ecoenv.2019.06.027; Hu L, 2017, ENVIRON SCI-NANO, V4, P2018, DOI 10.1039/c7en00517b; Jia J, 2018, CAN J SOIL SCI, V98, P2017; Jia JC, CANADIAN J SOIL SCI; Kravchenko A, 1998, SOIL SCI, V163, P171, DOI 10.1097/00010694-199803000-00001; Kribaa M, 2001, SOIL TILL RES, V60, P43, DOI 10.1016/S0167-1987(01)00171-4; Li YR, 2017, J CLEAN PROD, V142, P697, DOI 10.1016/j.jclepro.2016.09.011; Niu QF, 2015, J HYDROL, V522, P475, DOI 10.1016/j.jhydrol.2014.12.055; Omoro LMA, 2013, SILVA FENNICA, V47, P250; Periard Y, 2016, GEODERMA, V279, P22, DOI 10.1016/j.geoderma.2016.05.020; Rajika SA, ENV EARTH SCI, V64, P1795; Song ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138057; Sun ZH, 2018, FIELD CROP RES, V222, P85, DOI 10.1016/j.fcr.2018.03.016; Touma J, 2009, EUR J SOIL SCI, V60, P671, DOI 10.1111/j.1365-2389.2009.01145.x; TYLER SW, 1989, SOIL SCI SOC AM J, V53, P987, DOI 10.2136/sssaj1989.03615995005300040001x; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wang HY, 2017, J SCI FOOD AGR, V97, P2553, DOI 10.1002/jsfa.8075; Wang N, 2014, LAND USE POLICY, V40, P69, DOI 10.1016/j.landusepol.2013.09.022	23	8	8	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227957	10.1371/journal.pone.0227957	http://dx.doi.org/10.1371/journal.pone.0227957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978135	gold, Green Published			2022-12-26	WOS:000534599100085
J	Elhadidy, M; Ali, MM; El-Shibiny, A; Miller, WG; Elkhatib, WF; Botteldoorn, N; Dierick, K				Elhadidy, Mohamed; Ali, Mohamed Medhat; El-Shibiny, Ayman; Miller, William G.; Elkhatib, Walid F.; Botteldoorn, Nadine; Dierick, Katelijne			Antimicrobial resistance patterns and molecular resistance markers of Campylobacter jejuni isolates from human diarrheal cases	PLOS ONE			English	Article							LEVEL ERYTHROMYCIN RESISTANCE; MULTIDRUG EFFLUX PUMP; MACROLIDE RESISTANCE; ANTIBIOTIC-RESISTANCE; QUINOLONE RESISTANCE; GENETIC DIVERSITY; FOOD ANIMALS; MECHANISMS; COLI; MUTATIONS	The aim of this study is to characterize the antimicrobial resistance of Campylobacterjejuni recovered from diarrheal patients in Belgium, focusing on the genetic diversity of resistant strains and underlying molecular mechanisms of resistance among Campylobacterjejuni resistant strains isolated from diarrheal patients in Belgium. Susceptibility profile of 199 clinical C. jejuni isolates was determined by minimum inhibitory concentrations against six commonly-used antibiotics (ciprofloxacin, nalidixic acid, tetracycline, streptomycin, gentamicin, and erythromycin). High rates of resistance were observed against nalidixic acid (56.3%), ciprofloxacin (55.8%) and tetracycline (49.7%); these rates were similar to those obtained from different national reports in broilers intended for human consumption. Alternatively, lower resistance rates to streptomycin (4.5%) and erythromycin (2%), and absolute sensitivity to gentamicin were observed. C. jejuni isolates resistant to tetracycline or quinolones (ciprofloxacin and/or nalidixic acid) were screened for the presence of the tet0 gene and the C257T mutation in the quinolone resistance determining region (QRDR) of the gyrase gene gyrA, respectively. Interestingly, some of the isolates that displayed phenotypic resistance to these antimicrobials lacked the corresponding genetic determinants. Among erythromycin-resistant isolates, a diverse array of potential molecular resistance mechanisms was investigated, including the presence of ermB and mutations in the 23S rRNA gene, the rpID and rpIV ribosomal genes, and the regulatory region of the cmeABC operon. Two of the four erythromycin-resistant isolates harboured the A2075G transition mutation in the 23S rRNA gene; one of these isolates exhibited further mutations in rpID, rpIVand in the cmeABC regulatory region. This study expands the current understanding of how different genetic determinants and particular clones shape the epidemiology of antimicrobial resistance in C. jejuni in Belgium. It also reveals many questions in need of further investigation, such as the role of other undetermined molecular mechanisms that may potentially contribute to the antimicrobial resistance of Campylobacter.	[Elhadidy, Mohamed; Ali, Mohamed Medhat; El-Shibiny, Ayman] Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt; [Elhadidy, Mohamed] Mansoura Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Mansoura, Egypt; [Ali, Mohamed Medhat] Mansoura Univ, Fac Med, Dept Med Microbiol & Immunol, Mansoura, Egypt; [El-Shibiny, Ayman] Arish Univ, Fac Environm Agr Sci, Arish, Egypt; [Miller, William G.] ARS, Prodce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Elkhatib, Walid F.] Badr Univ Cairo BUC, Sch Pharm & Pharmaceut Ind, Dept Microbiol & Immunol, Entertainment Area, Cairo, Egypt; [Elkhatib, Walid F.] Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, African Union Org St Abbassia, Cairo, Egypt; [Botteldoorn, Nadine] Diergezondheidszorg Vlaanderen DGZ, Torhout, Belgium; [Dierick, Katelijne] Natl Reference Lab Campylobacter Sciensano Sci Se, Brussels, Belgium	Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; United States Department of Agriculture (USDA); Badr University in Cairo; Egyptian Knowledge Bank (EKB); Ain Shams University; Sciensano	Elhadidy, M (corresponding author), Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt.; Elhadidy, M (corresponding author), Mansoura Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Mansoura, Egypt.	melhadidy@zewailcity.edu.eg	Elkhatib, Walid/AAT-2062-2021; El-Shibiny, Ayman/AAM-5706-2021	Elkhatib, Walid/0000-0001-5815-3200; El-Shibiny, Ayman/0000-0002-7667-9457	BELSPO (Belgian Federal Science Policy Office)	BELSPO (Belgian Federal Science Policy Office)(Belgian Federal Science Policy Office)	BELSPO (Belgian Federal Science Policy Office) supported the research fellowship of Dr. Mohamed Elhadidy at Sciensano, Brussels.; The authors are thankful to the BELSPO (Belgian Federal Science Policy Office) for supporting the research fellowship of Dr. Mohamed Elhadidy at Sciensano, Brussels. The authors are grateful to Delphine Martiny, Marie Hallin, and Olivier Vandenberg at National Reference Center for Campylobacter, Saint Pierre University Hospital, Brussels, Belgium for providing our group with the tested strains.	Agunos A, 2013, EMERG INFECT DIS; Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Akinkunmi EO, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.5; Alfredson DA, 2007, FEMS MICROBIOLOGY LE; Alonso R, 2005, J MICROBIOL METH, V63, P99, DOI 10.1016/j.mimet.2005.03.013; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blaser MJ, 2014, CAMPYLOBACTER, P99; Caldwell DB, 2008, ANTIMICROB AGENTS CH, V52, P3947, DOI 10.1128/AAC.00450-08; Castanon JIR, 2007, POULTRY SCI; Cha W, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00589; Cody AJ, 2019, EURO SURVEILL; Cody AJ, 2012, J CLIN MICROBIOL, V50, P3193, DOI 10.1128/JCM.01086-12; Connell SR, 2003, EMBO J, V22, P945, DOI 10.1093/emboj/cdg093; Corcoran D, 2006, INT J ANTIMICROB AG, V27, P40, DOI 10.1016/j.ijantimicag.2005.08.019; Domingues AR, 2012, EPIDEMIOLOGY INFECT; Elhadidy M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01014; Elhadidy M, 2018, INT J FOOD MICROBIOL, V275, P66, DOI 10.1016/j.ijfoodmicro.2018.04.004; Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; Friesema IHM, 2012, EMERG INFECT DIS; Gibreel A, 2004, ANTIMICROB AGENTS CH, V48, P3442, DOI 10.1128/AAC.48.9.3442-3450.2004; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Habib I, 2009, APPL ENVIRON MICROB, V75, P4264, DOI 10.1128/AEM.00168-09; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Iovine NM, 2013, VIRULENCE, V4, P230, DOI 10.4161/viru.23753; JACOBSREITSMA WF, 1994, LETT APPL MICROBIOL, V19, P228, DOI 10.1111/j.1472-765X.1994.tb00950.x; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kittl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081796; Klein-Jostl D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00072; KONKEL ME, 1989, INFECT IMMUN, V57, P2984, DOI 10.1128/IAI.57.10.2984-2990.1989; Kovac J, 2014, EPIDEMIOL INFECT, V142, P2595, DOI 10.1017/S0950268813003245; Kovac J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01169; Kurincic M, 2007, INT J FOOD MICROBIOL, V120, P186, DOI 10.1016/j.ijfoodmicro.2007.03.012; Levy SB, 2004, NATURE MED; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Lin J, 2007, ANTIMICROB AGENTS CH, V51, P1678, DOI 10.1128/AAC.01411-06; Magiorakos AP, 2012, CLIN MICROBIOL INFEC; Maron DF, 2013, GLOBAL HLTH; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Nelson JM, 2004, J INFECT DIS, V190, P1150, DOI 10.1086/423282; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Niwa H, 2001, INT J ANTIMICROB AG, V18, P359, DOI 10.1016/S0924-8579(01)00425-3; Payot S, 2006, MICROBES INFECT, V8, P1967, DOI 10.1016/j.micinf.2005.12.032; Peres-Boto D, 2010, J ANTIMICROB CHEMOTH, V65, P2083, DOI 10.1093/jac/dkq268; Petersen L, 2001, VET MICROBIOL, V82, P141, DOI 10.1016/S0378-1135(01)00382-0; Qin SS, 2014, J ANTIMICROB CHEMOTH, V69, P964, DOI 10.1093/jac/dkt492; Rukambile E, 2019, ZOONOSES PUBLIC HLTH; Sam WIC, 1999, J CLIN PATHOL, V52, P709, DOI 10.1136/jcp.52.9.709; Sheppard SK, 2014, MOL ECOL, V23, P2442, DOI 10.1111/mec.12742; Shin E, 2015, ANTIMICROB AGENTS CH, V59, P6670, DOI 10.1128/AAC.01395-15; Skirrow M.B., 2000, CAMPYLOBACTER, V2nd ed., P69; SKIRROW MB, 1994, J COMP PATHOL, V111, P113, DOI 10.1016/S0021-9975(05)80046-5; Stone D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/794643; Tam CC, 2003, J INFECTION, V47, P28, DOI 10.1016/S0163-4453(03)00042-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YZ, 2017, ANIM HEALTH RES REV, V18, P87, DOI 10.1017/S1466252317000135; Vacher S, 2005, MICROB DRUG RESIST, V11, P40, DOI 10.1089/mdr.2005.11.40; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; Van Looveren M, 2001, J ANTIMICROB CHEMOTH, V48, P235, DOI 10.1093/jac/48.2.235; Vandenberg O, 2006, J ANTIMICROB CHEMOTH, V57, P908, DOI 10.1093/jac/dkl080; Walton JR, 2012, BRIT VET J, V145; Wimalarathna HML, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-160; Wu ZW, 2014, J CLIN MICROBIOL, V52, P1853, DOI 10.1128/JCM.00355-14; Zahin M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/340605, 10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/510736]; Zhou JY, 2016, INT J INFECT DIS, V42, P28, DOI 10.1016/j.ijid.2015.11.005; Zirnstein G, 1999, J CLIN MICROBIOL, V37, P3276, DOI 10.1128/JCM.37.10.3276-3280.1999; 2019, EFSA J, V17	72	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227833	10.1371/journal.pone.0227833	http://dx.doi.org/10.1371/journal.pone.0227833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951631	Green Published, gold			2022-12-26	WOS:000534370500031
J	Rasmussen, SL; Nielsen, JL; Jones, OR; Berg, TB; Pertoldi, C				Rasmussen, Sophie Lund; Nielsen, Jeppe Lund; Jones, Owen R.; Berg, Thomas B.; Pertoldi, Cino			Genetic structure of the European hedgehog (Erinaceus europaeus) in Denmark	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; EXTINCTION RISK; DIVERSITY; ABUNDANCE; POPULATIONS; ENVIRONMENT; MOVEMENT; SOFTWARE; GENOTYPE; CONCOLOR	Objectives Low genetic diversity can lead to reduced average fitness in a population or even extinction. Preserving genetic connectivity across fragmented landscapes is therefore vital to counteract the negative consequences of genetic drift and inbreeding. This study aimed to assess the genetic composition and consequently the conservation status of a nationwide sample of European hedgehogs (Erinaceus europaeus) in Denmark. Methods We applied an adaptation of the genotyping by sequencing (GBS) technique to 178 individuals from six geographically distinct populations. We used a Bayesian clustering method to subdivide individuals into genetically distinct populations. We estimated individual observed (iHO), observed (HO), and unbiased expected (uHE) heterozygosity, inbreeding coefficient (FIS), percentage of polymorphic loci (P%) and tested for deviations from Hardy-Weinberg equilibrium (HWE). We used linear models to test for potential anthropogenic effects on the genetic variability of hedgehogs with iHO, uHE, P% and FIS as response variables, and assessed the demographic history of the population. Results The Danish hedgehog population is composed of three genetic clusters. We found a mean P% of 54.44-94.71, a mean uHE of 0.126-0.318 and a mean HO of 0.124-0.293 in the six populations. The FIS was found to be significantly positive for three of the six populations. We detected a large heterogeneity of iHO values within populations, which can be due to inbreeding and/or fragmentation. FIS values decreased with increasing farmland density, but there was no significant association with human population or road density. Conclusions We found a low level of genetic variability and evidence for genetic substructure and low effective population size, which are all consequences of habitat fragmentation. We failed to detect signs of a recent population bottleneck or population increase or decline. However, because the test only identifies recent changes in population size, we cannot reject the possibility of a longer-term decline in the Danish hedgehog population.	[Rasmussen, Sophie Lund; Jones, Owen R.; Berg, Thomas B.] Univ Southern Denmark, Dept Biol, Odense, Denmark; [Nielsen, Jeppe Lund; Pertoldi, Cino] Aalborg Univ, Dept Chem & Biosci, Sect Biotechnol, Aalborg, Denmark; [Jones, Owen R.] Univ Southern Denmark, Interdisciplinary Ctr Populat Dynam CPop, Dept Biol, Odense, Denmark; [Berg, Thomas B.] Naturama, Svendborg, Denmark; [Pertoldi, Cino] Aalborg Zoo, Aalborg, Denmark	University of Southern Denmark; Aalborg University; University of Southern Denmark	Rasmussen, SL (corresponding author), Univ Southern Denmark, Dept Biol, Odense, Denmark.	sophielundrasmussen@gmail.com	Pertoldi, Cino/I-1746-2012; Dietz, Rune/F-9154-2015; Rasmussen, Sophie Lund/AAS-6739-2020; Jones, Owen/B-8439-2008; Nielsen, Jeppe Lund/V-1762-2018	Pertoldi, Cino/0000-0002-4644-8981; Dietz, Rune/0000-0001-9652-317X; Rasmussen, Sophie Lund/0000-0002-2975-678X; Jones, Owen/0000-0001-5720-4686; Nielsen, Jeppe Lund/0000-0002-8747-6938; Berg, Thomas Bjorneboe/0000-0003-0737-1229	Beckett Fonden [44200]; Svalens Fond; Fonden til Vaern for Vaergelose Dyr; Iwan Kliem Larsens Mindelegat [108060]; Ingenior K. A. Rohde og hustrus legat; Bodil Pedersen Fonden [16-2015]; Aalborg Zoo Conservation Foundation (AZCF) [5-2017]; 15. Juni Fonden [2015-B-134]; Naturama	Beckett Fonden; Svalens Fond; Fonden til Vaern for Vaergelose Dyr; Iwan Kliem Larsens Mindelegat; Ingenior K. A. Rohde og hustrus legat; Bodil Pedersen Fonden; Aalborg Zoo Conservation Foundation (AZCF); 15. Juni Fonden; Naturama	SLR received grants from Beckett Fonden (grant number: 44200), (http://www.beckett-fonden.dk); Svalens Fond; Fonden til Vaern for Vaergelose Dyr; Iwan Kliem Larsens Mindelegat (grant number: 108060); Ingenior K. A. Rohde og hustrus legat; Bodil Pedersen Fonden (grant number: 16-2015), (http://bodilpedersenfonden.dk); and Aalborg Zoo Conservation Foundation (AZCF; grant number: 5-2017), (https://aalborgzoo.dk/aalborg-zoos-naturbevaringsfond.aspx). SLR and TBB both received grants 15. Juni Fonden (grant number: 2015-B-134) (http://www.15junifonden.dk) and Naturama (naturama.dk).	Aaris-Sorensen K., 1998, DANMARKS FORHISTORIS; Aaris-Sorensen K, 2009, FOSS STRATA, P1; [Anonymous], 2019, R LANG ENV STAT COMP; Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Barthel L.M.F., 2019, THESIS; Becher SA, 1997, MOL ECOL, V6, P89, DOI 10.1046/j.1365-294X.1997.00159.x; Becher SA, 1998, MOL ECOL, V7, P1599, DOI 10.1046/j.1365-294x.1998.00457.x; Bennike O, 2019, B GEOLOGICAL SOC DEN; Bennike O, 2011, GEOL SURV DEN GREENL, P37; Berggren KT, 2005, HEREDITY, V95, P84, DOI 10.1038/sj.hdy.6800694; Bolfikova B, 2012, HEREDITY, V108, P248, DOI 10.1038/hdy.2011.67; Bolfikova B, 2013, MOL ECOL, V22, P3709, DOI 10.1111/mec.12331; Bolfikova BC, 2017, PEERJ, V5, DOI 10.7717/peerj.3163; Braaker S, 2017, LANDSCAPE URBAN PLAN, V160, P107, DOI 10.1016/j.landurbplan.2016.12.011; Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Crooks KR, 2017, P NATL ACAD SCI USA, V114, P7635, DOI 10.1073/pnas.1705769114; Danish Nature Agency, VEJL VILDTPL 2013; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doncaster CP, 2001, J ANIM ECOL, V70, P33; Dowding CV, 2010, ANIM BEHAV, V80, P13, DOI 10.1016/j.anbehav.2010.04.007; Dowding CV, 2010, ENVIRON POLLUT, V158, P161, DOI 10.1016/j.envpol.2009.07.017; Elmeros M, 2014, PAKORTE STORRE VILDE; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fraser M, 2012, J ARCHAEOL SCI, V39, P229, DOI 10.1016/j.jas.2011.08.006; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haigh A, 2012, MAMMALIA, V76, P261, DOI 10.1515/mammalia-2011-0110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henderson M, 2000, MOL ECOL, V9, P1949, DOI 10.1046/j.1365-294x.2000.01098-18.x; Hof AR, 2010, ANIM CONSERV, V13, P467, DOI 10.1111/j.1469-1795.2010.00359.x; Hof AR, 2016, EUR J WILDLIFE RES, V62, P407, DOI 10.1007/s10344-016-1013-1; Hof Anouschka R., 2009, Lutra, V52, P69; Holsbeek L., 1999, Lutra, V42, P111; Hubert P, 2011, LANDSCAPE URBAN PLAN, V103, P34, DOI 10.1016/j.landurbplan.2011.05.010; Huijser MP, 2000, BIOL CONSERV, V95, P111, DOI 10.1016/S0006-3207(00)00006-9; Jakobsen EM, 1987, VARV, V4, P104; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Krange M., 2015, THESIS; KRISTIANSSON H, 1981, ANN ZOOL FENN, V18, P115; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Michel N, 2006, ACTA OECOL, V30, P11, DOI 10.1016/j.actao.2005.12.006; MICOL T, 1994, J ANIM ECOL, V63, P851, DOI 10.2307/5262; Moran S, 2009, J ZOOL, V278, P349, DOI 10.1111/j.1469-7998.2009.00583.x; Morris P, 2018, NEW NATURALIST, V137, pi; Morris P., 2014, HEDGEHOGS; MORRIS PA, 1985, MAMMAL REV, V15, P23, DOI 10.1111/j.1365-2907.1985.tb00383.x; Muller F., 2018, BEITR GE NATURKD OST, V54, P21; O'Reilly C, 2016, UNPUB; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pettett CE, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1113-6; Pritchard JK, 2000, GENETICS, V155, P945; Provine WB, 2004, GENETICS, V167, P1041; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Ralls K, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12412; Rasmussen S. L., 2019, Genetics and Biodiversity Journal, V3, P78; Rasmussen S.L, 2013, THESIS; Rautio A, 2016, MAMMAL RES, V61, P161, DOI 10.1007/s13364-015-0256-7; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Reeve N., 1994, HEDGEHOGS T AD POYSE; Riber AB, 2006, ACTA THERIOL, V51, P363, DOI 10.1007/BF03195183; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Saether HM, 1997, THESIS; Santucci F, 1998, MOL ECOL, V7, P1163, DOI 10.1046/j.1365-294x.1998.00436.x; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; SoBH, 2011, BRIT TRUST ORN BTO C; SoBH, 2018, BRIT HEDG PRES SOC P; SoBH, 2015, BRIT HEDG PRES SOC P; Statistics Denmark, 2019, POP DENM 2019; Statistics Denmark, BY2 POP 1 JAN MUN SI; Statistics Denmark, 2019, AR 2019; Statistics Denmark, 2019, AFG07 CULT AR REG UN; Statistics Denmark, 2018, VEJN 2018; Statistics Denmark, AFGR DANSK LANDBR 2; Statistics Denmark, 2019, ARE207 AR 1; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; The Danish Road Directorate, 2019, LAENGD OFF VEJ KOMM; van de Poel JL, 2015, WILDLIFE BIOL, V21, P51, DOI 10.2981/wlb.00072; Williams B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30130-4; Young RP, 2006, J ZOOL, V269, P349, DOI 10.1111/j.1469-7998.2006.00078.x	85	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227205	10.1371/journal.pone.0227205	http://dx.doi.org/10.1371/journal.pone.0227205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951621	gold, Green Submitted, Green Published			2022-12-26	WOS:000534370500011
J	Irie, K; Nagai, T; Mizuno, K				Irie, Kazuki; Nagai, Tomoaki; Mizuno, Kensaku			Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; yes-associated protein (YAP); NDR (nuclear Dbf2-related) kinase; protein kinase; phosphorylation; cancer; cell signaling; Furry (FRY); gene knockout; large tumor suppressor kinase (LATS)	CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; SIGNALING PATHWAY; DROSOPHILA; GROWTH; YAP/TAZ; PHOSPHORYLATION; MORPHOGENESIS; INACTIVATION	The Hippo signaling pathway suppresses cell proliferation and tumorigenesis. In the canonical Hippo pathway, large tumor suppressor kinases 1/2 (LATS1/2) phosphorylate the transcriptional coactivator yes-associated protein (YAP) and thereby suppress its nuclear localization and co-transcriptional activity. Nuclear Dbf2-related kinases 1/2 (NDR1/2), which are closely related to LATS1/2, also phosphorylate and inactivate YAP by suppressing its nuclear localization. Furry (FRY) is a cytoplasmic protein that associates with NDR1/2 and activates them, but its role in the nuclear/cytoplasmic localization of YAP remains unknown. Here, we constructed FRY-knockout cell lines to examine the role of FRY in YAP's cytoplasmic localization. FRY depletion markedly increased YAP nuclear localization and decreased NDR1/2 kinase activity and YAP phosphorylation levels, but did not affect LATS1/2 kinase activity. This indicated that FRY suppresses YAP's nuclear localization by promoting its phosphorylation via NDR1/2 activation. NDR1/2 depletion also promoted YAP nuclear localization, but depletion of both FRY and NDR1/2 increased the number of cells with YAP nuclear localization more strongly than did depletion of NDR1/2 alone, suggesting that FRY suppresses YAP nuclear localization by a mechanism in addition to NDR1/2 activation. Co-precipitation assays revealed that Fry uses its N-terminal 1?2400-amino-acid-long region to bind to YAP. Expression of full-length FRY or its 1?2400 N-terminal fragment restored YAP cytoplasmic localization in FRY-knockout cells. Taken together, these results suggest that FRY plays a crucial role in YAP cytoplasmic retention by promoting YAP phosphorylation via NDR1/2 kinase activation and by binding to YAP, leading to its cytoplasmic sequestration.	[Irie, Kazuki; Nagai, Tomoaki; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Mol & Chem Life Sci, Sendai, Miyagi 9808578, Japan; [Mizuno, Kensaku] Tohoku Univ, Inst Liberal Arts & Sci, Sendai, Miyagi 9808576, Japan	Tohoku University; Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Mol & Chem Life Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp		Irie, Kazuki/0000-0002-7553-6948	MEXT/Japan Society for the Promotion of Science (JSPS) Grants for Scientific Research [15H04347, 18H02398]	MEXT/Japan Society for the Promotion of Science (JSPS) Grants for Scientific Research	This work was supported by MEXT/Japan Society for the Promotion of Science (JSPS) Grants for Scientific Research 15H04347 and 18H02398 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cong JL, 2001, DEVELOPMENT, V128, P2793; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; Das A, 2016, J BIOL CHEM, V291, P6096, DOI 10.1074/jbc.M115.708313; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hirata D, 2002, EMBO J, V21, P4863, DOI 10.1093/emboj/cdf495; Ikeda M, 2012, J BIOL CHEM, V287, P27670, DOI 10.1074/jbc.M112.378968; Kim J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7781; Liu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01279; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Nagai T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183030; Nagai T, 2014, J BIOCHEM, V155, P137, DOI 10.1093/jb/mvu001; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070930; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharif AAD, 2018, SEMIN CANCER BIOL, V48, P104, DOI 10.1016/j.semcancer.2017.04.010; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Xiong S, 2018, STRUCTURE, V26, P1101, DOI 10.1016/j.str.2018.05.014; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	41	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3017	3028		10.1074/jbc.RA119.010783	http://dx.doi.org/10.1074/jbc.RA119.010783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996378	Green Published, hybrid			2022-12-26	WOS:000519597300012
J	Kawaguchi, M; Dashzeveg, N; Cao, Y; Jia, YZ; Liu, X; Shen, Y; Liu, HP				Kawaguchi, Madoka; Dashzeveg, Nurmaa; Cao, Yue; Jia, Yuzhi; Liu, Xia; Shen, Yang; Liu, Huiping			Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; metastasis; protein domain; protein-protein interaction; mutagenesis; homophilic interactions; circulating tumor cell; P21-activated kinase 2 (PAK2); machine learning; protein docking; cancer; cell-cell aggregation; tumor cell cluster	CANCER STEM-CELLS; GLYCOSYLATION; METASTASES; ADHESION; BINDING	CD44 molecule (CD44) is a well-known surface glycoprotein on tumor-initiating cells or cancer stem cells. However, its utility as a therapeutic target for managing metastases remains to be fully evaluated. We previously demonstrated that CD44 mediates homophilic interactions for circulating tumor cell (CTC) cluster formation, which enhances cancer stemness and metastatic potential in association with an unfavorable prognosis. Furthermore, CD44 self-interactions activate the P21-activated kinase 2 (PAK2) signaling pathway. Here, we further examined the biochemical properties of CD44 in homotypic tumor cell aggregation. The standard CD44 form (CD44s) mainly assembled as intercellular homodimers (trans-dimers) in tumor clusters rather than intracellular dimers (cis-dimers) present in single cells. Machine learning?based computational modeling combined with experimental mutagenesis tests revealed that the extracellular Domains I and II of CD44 are essential for its trans-dimerization and predicted high-score residues to be required for dimerization. Substitutions of 10 these residues in Domain I (Ser-45, Glu-48, Phe-74, Cys-77, Arg-78, Tyr-79, Ile-88, Arg-90, Asn-94, and Cys-97) or 5 residues in Domain II (Ile-106, Tyr-155, Val-156, Gln-157, and Lys-158) abolished CD44 dimerization and reduced tumor cell aggregation in vitro. Importantly, the substitutions in Domain II dramatically inhibited lung colonization in mice. The CD44 dimer-disrupting substitutions decreased downstream PAK2 activation without affecting the interaction between CD44 and PAK2, suggesting that PAK2 activation in tumor cell clusters is CD44 trans-dimer?dependent. These results shed critical light on the biochemical mechanisms of CD44-mediated tumor cell cluster formation and may help inform the development of therapeutic strategies to prevent tumor cluster formation and block cluster-mediated metastases.	[Kawaguchi, Madoka; Dashzeveg, Nurmaa; Jia, Yuzhi; Liu, Xia; Liu, Huiping] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA; [Kawaguchi, Madoka] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto 6068501, Japan; [Cao, Yue; Shen, Yang] Texas A&M Univ, Dept Elect & Comp Engn, TEES AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77843 USA; [Liu, Xia] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Liu, Huiping] Northwestern Univ, Feinberg Sch Med, Dept Med, Hematol Oncol Div, Chicago, IL 60611 USA; [Liu, Huiping] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Kyoto University; Texas A&M University System; Texas A&M University College Station; University of Kentucky; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Liu, X; Liu, HP (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA.; Shen, Y (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, TEES AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77843 USA.; Liu, X (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.; Liu, HP (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Hematol Oncol Div, Chicago, IL 60611 USA.; Liu, HP (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	xli369@uky.edu; YShen@tamu.edu; huiping.liu@northwestern.edu	Shen, Yang/A-7939-2012	Shen, Yang/0000-0002-1703-7796; Liu, Huiping/0000-0003-4822-7995	Susan G. Komen Foundation Grant [CCR18548501, CCR15332826]; American Cancer Society [ACS127951-RSG-15-025-01-CSM]; National Institutes of Health [1R01CA245699, R00CA160638, R35GM124952]; DHA, Department of Defense [W81XWH-16-1-0021]; Northwestern University Start-Up Grant	Susan G. Komen Foundation Grant(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHA, Department of Defense; Northwestern University Start-Up Grant	This work was supported by Susan G. KomenFoundation Grant CCR18548501 (to X. L.) and CCR15332826 (to H. L.); American Cancer Society Grant ACS127951-RSG-15-025-01-CSM (to H. L.); National Institutes of Health Grants 1R01CA245699 and R00CA160638 (to H. L.) and R35GM124952 (to Y. S.); DHA, Department of Defense Grant W81XWH-16-1-0021 (to H. L.); and Northwestern University Start-Up Grant (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the United States Government.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Azevedo R, 2018, CLIN PROTEOM, V15, DOI 10.1186/s12014-018-9198-9; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Cao Y., 2019, ARXIV190200067, DOI [10.1101/537035, DOI 10.1101/537035]; Chen HR, 2017, PROTEINS, V85, P544, DOI 10.1002/prot.25212; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gkountela S, 2019, CELL, V176, P98, DOI 10.1016/j.cell.2018.11.046; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Inoue K, 2015, GENET EPIGENETICS, V7, P19, DOI 10.4137/GEG.S35500; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu X, 2019, CANCER DISCOV, V9, P96, DOI 10.1158/2159-8290.CD-18-0065; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliwa T, 2015, BIOINFORMATICS, V31, P151, DOI 10.1093/bioinformatics/btv252; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prochazka L, 2014, CELL SIGNAL, V26, P2234, DOI 10.1016/j.cellsig.2014.07.011; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang HH, 2019, GENE DEV, V33, P166, DOI 10.1101/gad.319889.118; ZHOU DFH, 1989, J IMMUNOL, V143, P3390; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	37	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2640	2649		10.1074/jbc.RA119.010252	http://dx.doi.org/10.1074/jbc.RA119.010252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31969394	Green Published, hybrid			2022-12-26	WOS:000519969100010
J	Li, J; Zhang, Y; Soubias, O; Khago, D; Chao, FA; Li, YF; Shaw, K; Byrd, RA				Li, Jess; Zhang, Yue; Soubias, Olivier; Khago, Domarin; Chao, Fa-an; Li, Yifei; Shaw, Katherine; Byrd, R. Andrew			Optimization of sortase A ligation for flexible engineering of complex protein systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sortase A; GTPase-activating protein (GAP); post-translational modification (PTM); cyclic peptide; protein engineering; cyclic proteins; lipidated proteins; nanodisc; segmental labeling; segmental labeling; sortase; protein tagging; protein ligation; SrtA; intrinsically disordered region; structural biology	STAPHYLOCOCCUS-AUREUS SORTASE; MOTILITY FACTOR-RECEPTOR; MEDIATED LIGATIONS; ARF FAMILY; GP78; ACTIVATION; INHIBITORS; DOMAIN; GENE	Engineering and bioconjugation of proteins is a critically valuable tool that can facilitate a wide range of biophysical and structural studies. The ability to orthogonally tag or label a domain within a multidomain protein may be complicated by undesirable side reactions to noninvolved domains. Furthermore, the advantages of segmental (or domain-specific) isotopic labeling for NMR, or deuteration for neutron scattering or diffraction, can be realized by an efficient ligation procedure. Common methods?expressed protein ligation, protein trans-splicing, and native chemical ligation?each have specific limitations. Here, we evaluated the use of different variants of Staphylococcus aureus sortase A for a range of ligation reactions and demonstrate that conditions can readily be optimized to yield high efficiency (i.e. completeness of ligation), ease of purification, and functionality in detergents. These properties may enable joining of single domains into multidomain proteins, lipidation to mimic posttranslational modifications, and formation of cyclic proteins to aid in the development of nanodisc membrane mimetics. We anticipate that the method for ligating separate domains into a single functional multidomain protein reported here may enable many applications in structural biology.	[Li, Jess; Zhang, Yue; Soubias, Olivier; Khago, Domarin; Chao, Fa-an; Li, Yifei; Shaw, Katherine; Byrd, R. Andrew] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, POB B,Bldg 538,Rm 110, Frederick, MD 21702 USA; [Li, Yifei] Fosun Pharmaceut Co Ltd, 1289 Yishan Rd, Shanghai, Peoples R China; [Shaw, Katherine] Apic Bio Inc, 700 Main St North, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Byrd, RA (corresponding author), NCI, Struct Biophys Lab, Ctr Canc Res, NIH, POB B,Bldg 538,Rm 110, Frederick, MD 21702 USA.	byrdra@mail.nih.gov	Li, Yifei/GYA-2567-2022; Byrd, R. Andrew/F-8042-2015	Byrd, R. Andrew/0000-0003-3625-4232; Chao, Fa-An/0000-0001-5215-8545; Soubias, Olivier/0000-0003-4819-2753; Khago, Domarin/0000-0001-5676-6804; Zhang, Yue/0000-0003-4367-4470; Li, Jess/0000-0001-7708-8555; Shaw, Katherine/0000-0001-7906-5672	Intramural Research Program of NCI, National Institutes of Health [ZIA BC 011419, ZIA BC 011131, ZIA BC 011132]	Intramural Research Program of NCI, National Institutes of Health	The research was supported by the Intramural Research Program of NCI, National Institutes of Health, Projects ZIA BC 011419, ZIA BC 011131, and ZIA BC 011132. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antos John M, 2017, Curr Protoc Protein Sci, V89, DOI 10.1002/cpps.38; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Chakrabarti KS, 2017, STRUCTURE, V25, P794, DOI 10.1016/j.str.2017.03.016; Chan AH, 2013, CHEM BIOL DRUG DES, V82, P418, DOI 10.1111/cbdd.12167; Chao FA, 2019, J AM CHEM SOC, V141, P11881, DOI 10.1021/jacs.9b02602; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Chen JH, 2018, J MOL BIOL, V430, P2275, DOI 10.1016/j.jmb.2018.06.012; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31899; Chin JW, 2017, NATURE, V550, P53, DOI 10.1038/nature24031; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Freiburger L, 2015, J BIOMOL NMR, V63, P1, DOI 10.1007/s10858-015-9981-0; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hirakawa H, 2015, BIOTECHNOL J, V10, P1487, DOI 10.1002/biot.201500012; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Josts I, 2018, STRUCTURE, V26, P1072, DOI 10.1016/j.str.2018.05.007; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; Li YF, 2019, BIOCHEMISTRY-US, V58, P1423, DOI 10.1021/acs.biochem.8b01323; Liu S, 2012, STRUCTURE, V20, P2138, DOI 10.1016/j.str.2012.09.020; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Mejuch T, 2016, BIOCONJUGATE CHEM, V27, P1771, DOI 10.1021/acs.bioconjchem.6b00261; Michel E, 2015, METHOD ENZYMOL, V565, P389, DOI 10.1016/bs.mie.2015.05.028; Miehling J, 2018, CHEMBIOCHEM, V19, P1927, DOI 10.1002/cbic.201800345; Mikula KM, 2018, J BIOMOL NMR, V71, P225, DOI 10.1007/s10858-018-0175-4; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nasr ML, 2017, NAT METHODS, V14, P49, DOI [10.1038/NMETH.4079, 10.1038/nmeth.4079]; Nikghalb KD, 2018, CHEMBIOCHEM, V19, P185, DOI 10.1002/cbic.201700517; Nikic I, 2015, NAT PROTOC, V10, P780, DOI 10.1038/nprot.2015.045; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Raltchev K, 2018, CHEM-EUR J, V24, P5493, DOI 10.1002/chem.201800812; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Refaei MA, 2011, J BIOMOL NMR, V49, P3, DOI 10.1007/s10858-010-9464-2; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Row RD, 2015, CHEM COMMUN, V51, P12548, DOI 10.1039/c5cc04657b; Sakamoto S, 2019, ANAL SCI, V35, P5, DOI 10.2116/analsci.18R003; Schmohl L, 2014, CURR OPIN CHEM BIOL, V22, P122, DOI 10.1016/j.cbpa.2014.09.020; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Spicer CD, 2013, CHEM COMMUN, V49, P2747, DOI 10.1039/c3cc38824g; Spicer CD, 2012, J AM CHEM SOC, V134, P800, DOI 10.1021/ja209352s; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Williams FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154607; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o	58	18	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2664	2675		10.1074/jbc.RA119.012039	http://dx.doi.org/10.1074/jbc.RA119.012039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31974162	hybrid, Green Published			2022-12-26	WOS:000519969100012
J	Kretchy, IA; Boima, V; Agyabeng, K; Koduah, A; Appiah, B				Kretchy, Irene A.; Boima, Vincent; Agyabeng, Kofi; Koduah, Augustina; Appiah, Bernard			Psycho-behavioural factors associated with medication adherence among male out-patients with hypertension in a Ghanaian hospital	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; PSYCHOLOGICAL DISTRESS; ANTIHYPERTENSIVE DRUGS; SCALE; POPULATION; INSOMNIA	Medication adherence is a key health outcome that reflects the health and general wellbeing of patients with hypertension. Challenges with adherence are common and associated with clinical, behavioural and psychosocial factors. This study sought to provide data on the extent of medication adherence among male patients with hypertension and their biopsychosocial predictors. Patient and clinical characteristics, psychological distress, insomnia and sexual dysfunction were hypothesized to predict outcomes of medication adherence. Utilizing quantitative data from a hospital-based cross-sectional study from 358 male out-patients with hypertension attending a tertiary hospital in Ghana, medication adherence was associated with age, marital status, educational level, income, duration of diagnosis, number of medications taken and sexual dysfunction. These findings support the need for biopsychosocial interventions aiming at promoting adherence while taking these factors into consideration for the benefit of improving the health and general well-being of male patients with hypertension.	[Kretchy, Irene A.; Koduah, Augustina] Univ Ghana, Coll Hlth Sci, Sch Pharm, Dept Pharm Practice & Clin Pharm, Legon, Ghana; [Boima, Vincent] Univ Ghana, Med Sch, Coll Hlth Sci, Dept Med & Therapeut, Korle Bu, Ghana; [Agyabeng, Kofi] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Legon, Ghana; [Appiah, Bernard] TAMU, Dept Environm & Occupat Hlth, Sch Publ Hlth, Texas A&M Hlth Sci Ctr, College Stn, TX USA	University of Ghana; University of Ghana; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Boima, V (corresponding author), Univ Ghana, Med Sch, Coll Hlth Sci, Dept Med & Therapeut, Korle Bu, Ghana.	vincentboima@yahoo.com	Koduah, Augustina/AAE-4626-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Boima, Vincent/0000-0002-0562-6307; Kretchy, Irene/0000-0001-6811-5937; Agyabeng, Kofi/0000-0001-8417-8161				ABEGAZ TM, 2017, MEDICINE, V96, DOI DOI 10.1093/SLEEP/33.9.1139; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Al Khaja KAJ, 2016, J CARDIOVASC PHARM T, V21, P233, DOI 10.1177/1074248415598321; Ambaw AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-282; Amidu N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-118; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Awobusuyi JO, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/564050; Bhagavathula AS, 2016, VALUE HEALTH, V19, pA657, DOI 10.1016/j.jval.2016.09.1787; Bocchio M, 2009, INT J ANDROL, V32, P74, DOI 10.1111/j.1365-2605.2007.00820.x; Bochkareva EV, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0366-9; Bohdana B, 2014, CENTRAL EUROPEAN J N, V6, P237; Boima V, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/205716; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Braverman J, 2009, ETHNIC DIS, V19, P396; de Terline DM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219266; Doumas M, 2016, J CARDIOL PRACT, V14, P1; Doumas Michael, 2006, J Clin Hypertens (Greenwich), V8, P269, DOI 10.1111/j.1524-6175.2006.04708.x; Ferrini MG, 2017, TRANSL ANDROL UROL, V6, P20, DOI 10.21037/tau.2016.11.18; Gellad WF, 2011, AM J GERIATR PHARMAC, V9, P11, DOI 10.1016/j.amjopharm.2011.02.004; Gerbild H, 2018, SEXUAL MED; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Holt EW, 2010, AGE AGEING, V39, P481, DOI 10.1093/ageing/afq040; Huffman MD, 2017, JAMA-J AM MED ASSOC, V317, P142, DOI 10.1001/jama.2016.19685; Ker JA, 2012, S AFRICAN FAMILY PRA, V54; Kretchy Irene A, 2015, Clin Hypertens, V21, P19, DOI 10.1186/s40885-015-0028-3; Kretchy Irene Akwo, 2014, Pan Afr Med J, V17 Suppl 1, P13, DOI 10.11694/pamj.supp.2014.17.1.3433; Lavsa SM, 2011, J AM PHARM ASSOC, V51, P90, DOI 10.1331/JAPhA.2011.09154; Morris AB, 2006, PHARMACOTHERAPY, V26, P483, DOI 10.1592/phco.26.4.483; Oghagbon E, 2008, NIGERIAN J CLIN PRAC, V11; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Seedat YK, 2015, CARDIOVASC J AFR, V26, P193, DOI 10.5830/CVJA-2015-065; Sivertsen B, 2014, EUR CHILD ADOLES PSY, V23, P681, DOI 10.1007/s00787-013-0502-y; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Spencer J, 2005, ETHNIC DIS, V15, P748; Sutton EL, 2014, MED CLIN N AM, V98, P1123, DOI 10.1016/j.mcna.2014.06.009; Nguyen TMU, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013375; Uchmanowicz I, 2019, CLIN INTERV AGING, V14, P155, DOI 10.2147/CIA.S188499; Ulasi II, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/869675; Viigimaa M, 2014, WORLD J CARDIOL, V6, P908, DOI 10.4330/wjc.v6.i9.908; Vlachopoulos C, 2013, EUR HEART J, V34, P2034, DOI 10.1093/eurheartj/eht112; Voils Corrine I, 2008, Patient Prefer Adherence, V2, P201; Wilhelmsen NC, 2019, EUR J HOSP PHARM, V26, P187, DOI 10.1136/ejhpharm-2018-001725; Zhan YQ, 2014, HEART ASIA, V6, P88, DOI 10.1136/heartasia-2013-010440	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2020	15	1							e0227874	10.1371/journal.pone.0227874	http://dx.doi.org/10.1371/journal.pone.0227874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9AX	31995606	gold, Green Published			2022-12-26	WOS:000534609400031
J	Reyes, M; Pena-Oyarzun, D; Silva, P; Venegas, S; Criollo, A; Torres, VA				Reyes, Montserrat; Pena-Oyarzun, Daniel; Silva, Patricio; Venegas, Sebastian; Criollo, Alfredo; Torres, Vicente A.			Nuclear accumulation of beta-catenin is associated with endosomal sequestration of the destruction complex and increased activation of Rab5 in oral dysplasia	FASEB JOURNAL			English	Article						cell signaling; destruction complex; endosome; keratinocyte; oral cancer; oral dysplasia; Rab5; beta-catenin	POTENTIALLY MALIGNANT DISORDERS; EPITHELIAL DYSPLASIA; EXPRESSION; LOCALIZATION; PROGRESSION; CLASSIFICATION; TRANSFORMATION; ENDOCYTOSIS; CARCINOMA; MIGRATION	Potentially malignant lesions, commonly referred to as dysplasia, are associated with malignant transformation by mechanisms that remain unclear. We recently reported that increased Wnt secretion promotes the nuclear accumulation of beta-catenin and expression of target genes in oral dysplasia. However, the mechanisms accounting for nuclear re-localization of beta-catenin in oral dysplasia remain unclear. In this study, we show that endosomal sequestration of the beta-catenin destruction complex allows nuclear accumulation of beta-catenin in oral dysplasia, and that these events depended on the endocytic protein Rab5. Tissue immunofluorescence analysis showed aberrant accumulation of enlarged early endosomes in oral dysplasia biopsies, when compared with healthy oral mucosa. These observations were confirmed in cell culture models, by comparing dysplastic oral keratinocytes (DOK) and non-dysplastic oral keratinocytes (OKF6). Intriguingly, DOK depicted higher levels of active Rab5, a critical regulator of early endosomes, when compared with OKF6. Increased Rab5 activity in DOK was necessary for nuclear localization of beta-catenin and Tcf/Lef-dependent transcription, as shown by expression of dominant negative and constitutively active mutants of Rab5, along with immunofluorescence, subcellular fractionation, transcription, and protease protection assays. Mechanistically, elevated Rab5 activity in DOK accounted for endosomal sequestration of components of the destruction complex, including GSK3 beta, Axin, and adenomatous polyposis coli (APC), as observed in Rab5 dominant negative experiments. In agreement with these in vitro observations, tissue immunofluorescence analysis showed increased co-localization of GSK3 beta, APC, and Axin, with early endosome antigen 1- and Rab5-positive early endosomes in clinical samples of oral dysplasia. Collectively, these data indicate that increased Rab5 activity and endosomal sequestration of the beta-catenin destruction complex leads to stabilization and nuclear accumulation of beta-catenin in oral dysplasia.	[Reyes, Montserrat; Pena-Oyarzun, Daniel; Silva, Patricio; Venegas, Sebastian; Criollo, Alfredo; Torres, Vicente A.] Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago, Chile; [Reyes, Montserrat; Pena-Oyarzun, Daniel; Silva, Patricio; Venegas, Sebastian; Criollo, Alfredo; Torres, Vicente A.] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Reyes, Montserrat] Univ Chile, Fac Dent, Dept Pathol & Oral Med, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Torres, VA (corresponding author), Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago, Chile.	vatorres@odontologia.uchile.cl	Reyes, Montserrat/O-6843-2019	Reyes, Montserrat/0000-0002-4116-4074; Torres, Vicente A/0000-0002-5973-7248	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1180495, 1171075, 3170660]; MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [15130011]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Grant/Award Number: 1180495, 1171075 and 3170660; MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Grant/Award Number: 15130011	Angiero F, 2008, ANTICANCER RES, V28, P2535; Arriagada C, 2019, J BIOL CHEM, V294, P12836, DOI 10.1074/jbc.RA119.008667; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; da Silva SD, 2015, ONCOTARGET, V6, P21950, DOI 10.18632/oncotarget.4277; Diaz J, 2014, J CELL SCI, V127, P2401, DOI 10.1242/jcs.141689; Dost F, 2014, OR SURG OR MED OR PA, V117, P343, DOI 10.1016/j.oooo.2013.09.017; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Fukui K, 2007, HEPATOL RES, V37, P957, DOI 10.1111/j.1872-034X.2007.00143.x; Gonzalez-Moles MA, 2010, ORAL ONCOL, V46, P525, DOI 10.1016/j.oraloncology.2010.03.020; He S, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0052-4; Igarashi T, 2017, ONCOTARGET, V8, P12290, DOI 10.18632/oncotarget.14703; Ishida K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-62; Johnson IRD, 2015, ONCOTARGET, V6, P37919, DOI 10.18632/oncotarget.6114; Jung YS, 2018, NAT CELL BIOL, V20, P1421, DOI 10.1038/s41556-018-0219-8; Li Y, 1999, CLIN EXP METASTAS, V17, P213, DOI 10.1023/A:1006617016451; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Palamidessi A, 2013, CURR BIOL, V23, P2355, DOI 10.1016/j.cub.2013.09.060; Polanska H, 2014, ORAL ONCOL, V50, P168, DOI 10.1016/j.oraloncology.2013.12.008; Prasad CP, 2018, CANCER METAST REV, V37, P767, DOI 10.1007/s10555-018-9760-y; Qin XY, 2017, DRUG DISCOV TODAY, V22, P1139, DOI 10.1016/j.drudis.2017.03.012; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reyes M, 2019, ORAL ONCOL, V94, P58, DOI 10.1016/j.oraloncology.2019.05.010; Reyes M, 2015, MED ORAL PATOL ORAL, V20, pE540, DOI 10.4317/medoral.20341; Saito-Diaz K, 2018, DEV CELL, V44, P566, DOI 10.1016/j.devcel.2018.02.013; Sato K, 2002, ORAL ONCOL, V38, P772, DOI 10.1016/S1368-8375(02)00044-1; Silva P, 2016, ONCOTARGET, V7, P29548, DOI 10.18632/oncotarget.8794; Silva P, 2015, BIOCHEM BIOPH RES CO, V464, P642, DOI 10.1016/j.bbrc.2015.06.176; Speight PM, 2007, HEAD NECK PATHOL, V1, P61, DOI 10.1007/s12105-007-0014-5; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; van der Waal I, 2014, MED ORAL PATOL ORAL, V19, pE386, DOI 10.4317/medoral.20205; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P127, DOI 10.1111/j.1600-0714.2007.00584.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x	43	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4009	4025		10.1096/fj.201902345RR	http://dx.doi.org/10.1096/fj.201902345RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31990106				2022-12-26	WOS:000510650600001
J	Heitmann, J; Jonker, NC; Ostafin, BD; de Jong, PJ				Heitmann, Janika; Jonker, Nienke C.; Ostafin, Brian D.; de Jong, Peter J.			Attentional bias for alcohol cues in visual search-Increased engagement, difficulty to disengage or both?	PLOS ONE			English	Article							INTERNAL RELIABILITY; PROBLEMATIC DRINKERS; ADDICTIVE BEHAVIORS; SPEEDED DETECTION; COGNITIVE BIASES; ADOLESCENTS; IMPLICIT; STIMULI; ANXIETY; GENDER	Cognitive models emphasise the importance of attentional bias in addiction. However, many attentional bias tasks have been criticised for questionable psychometric properties and inability to differentiate between engagement and disengagement processes. This study therefore examined the suitability of two alternative tasks for assessing attentional bias within the context of alcohol use. Participants were undergraduate students (N = 169) who completed the Visual Search Task and Odd-One-Out Task, the latter of which is designed to differentiate between engagement and disengagement processes of attention, at baseline and one week later. Participants also completed baseline measures of alcohol consumption, craving, and alcohol use problems. Internal consistency was adequate for the Visual Search Task index, and weak for the Odd-One-Out Task indices. Test-retest reliability was weak for both tasks. The Visual Search Task index and the disengagement (but not the engagement) index of the Odd-One-Out Task showed a positive association with alcohol consumption. This study was restricted to a non-clinical student sample. The relatively high error rate of the Odd-One-Out Task might have reduced its sensitivity as an index of attentional bias. Both tasks showed some merit as attentional bias measures, and results suggested that attentional disengagement might be particularly related to alcohol use. However, the reliability of the current measures was inadequate. One potential explanation for the low reliability is that non-clinical samples may have weak and unstable attentional biases to alcohol. Future efforts should be made to improve the psychometric qualities of both tasks and to administer them in a clinical sample.	[Heitmann, Janika] Verslavingszorg Noord Nederland, Groningen, Netherlands; [Heitmann, Janika; Jonker, Nienke C.; Ostafin, Brian D.; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands	University of Groningen	Heitmann, J (corresponding author), Verslavingszorg Noord Nederland, Groningen, Netherlands.; Heitmann, J (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	j.heitmann@vnn.nl	Jonker, Nienke/AAE-7512-2020; de Jong, Peter/ABB-1750-2020; de Jong, Peter/E-9095-2014	Jonker, Nienke/0000-0002-2567-3776; de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663	ZonMw (The Netherlands Organisation for Health Research and Development) [80-84,300-98-61,035]; Verslavingszorg Noord Nederland; NWO research talent grand (Dutch Research Council) [406-14-091]	ZonMw (The Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development); Verslavingszorg Noord Nederland; NWO research talent grand (Dutch Research Council)	This work was supported by ZonMw (The Netherlands Organisation for Health Research and Development; 80-84,300-98-61,035; https://www.zonmw.nl/nl/), and Verslavingszorg Noord Nederland; institution for addiction care (https://www.vnn.nl/) to JH. NCJ was supported by NWO research talent grand (Dutch Research Council; 406-14-091; https://www.nwo.nl/en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arria AM, 2017, AM J DRUG ALCOHOL AB, V43, P711, DOI 10.1080/00952990.2017.1310219; Ataya AF, 2012, DRUG ALCOHOL DEPEN, V121, P148, DOI 10.1016/j.drugalcdep.2011.08.023; Bongers P, 2015, HEALTH PSYCHOL, V34, P677, DOI 10.1037/hea0000167; Christiansen P, 2015, DRUG ALCOHOL DEPEN, V155, P170, DOI 10.1016/j.drugalcdep.2015.07.672; Cisler JM, 2009, COGNITIVE THER RES, V33, P221, DOI 10.1007/s10608-007-9161-y; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; De Voogd EL, 2017, BEHAV RES THER, V92, P57, DOI 10.1016/j.brat.2017.02.006; De Voogd EL, 2014, J BEHAV THER EXP PSY, V45, P252, DOI 10.1016/j.jbtep.2013.11.006; Eide P, 2002, J PSYCHOL, V136, P514, DOI 10.1080/00223980209605547; Emery NN, 2015, ADDICT BEHAV, V50, P1, DOI 10.1016/j.addbeh.2015.06.007; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Field M, 2016, HEALTH PSYCHOL, V35, P767, DOI 10.1037/hea0000405; Field M, 2012, DRUG ALCOHOL DEPEN, V124, P189, DOI 10.1016/j.drugalcdep.2012.02.009; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Gladwin TE, 2019, ALKOHOL NARKOM, V32, P63, DOI 10.5114/ain.2019.85769; Grafton B, 2014, COGNITION EMOTION, V28, P1287, DOI 10.1080/02699931.2014.881326; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Heitmann J, 2017, BMC PSYCHIATRY, V5, P17; Hertel PT, 2011, PERSPECT PSYCHOL SCI, V6, P521, DOI 10.1177/1745691611421205; Hollitt S, 2010, APPETITE, V54, P309, DOI 10.1016/j.appet.2009.12.005; Jones BT, 2006, PSYCHOL ADDICT BEHAV, V20, P171, DOI 10.1037/0893-164X.20.2.171; Jones BT, 2003, ADDICTION, V98, P235, DOI 10.1046/j.1360-0443.2003.00270.x; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Melles RJ, 2016, J SEX MED, V13, P1255, DOI 10.1016/j.jsxm.2016.05.008; Oliver JA, 2012, EXP CLIN PSYCHOPHARM, V20, P489, DOI 10.1037/a0029519; Pronk T, 2015, ALCOHOL CLIN EXP RES, V39, P2047, DOI 10.1111/acer.12853; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rinck M, 2005, J ABNORM PSYCHOL, V114, P235, DOI 10.1037/0021-843X.114.2.235; Roy-Charland A, 2017, AM J DRUG ALCOHOL AB, V43, P332, DOI 10.1080/00952990.2016.1209511; Schippers G. M., 2011, MATE 2 1 HANDLEIDING; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Stacy AW, 2010, ANNU REV CLIN PSYCHO, V6, P551, DOI 10.1146/annurev.clinpsy.121208.131444; van Duijvenbode N, 2017, J INTELL DISABIL RES, V61, P255, DOI 10.1111/jir.12335; Van Duijvenbode N, 2016, J INTELL DISABIL RES, V60, P242, DOI 10.1111/jir.12244; van Hemel-Ruiter ME, 2016, DRUG ALCOHOL DEPEN, V159, P133, DOI 10.1016/j.drugalcdep.2015.12.005; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2002, J ABNORM PSYCHOL, V111, P648, DOI 10.1037/0021-843X.111.4.648; Willem L, 2013, PERS INDIV DIFFER, V54, P925, DOI 10.1016/j.paid.2013.01.015	40	4	5	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0228272	10.1371/journal.pone.0228272	http://dx.doi.org/10.1371/journal.pone.0228272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8YP	31986192	gold, Green Published			2022-12-26	WOS:000534603400043
J	Sanchez, E; Price, DR; Chung, KP; Oromendia, C; Choi, AMK; Schenck, EJ; Siempos, II				Sanchez, Elizabeth; Price, David R.; Chung, Kuei-Pin; Oromendia, Clara; Choi, Augustine M. K.; Schenck, Edward J.; Siempos, Ilias I.			Persistent severe acute respiratory distress syndrome for the prognostic enrichment of trials	PLOS ONE			English	Article							LUNG INJURY; EPIDEMIOLOGY; ARDS; DEFINITION; PATTERNS; CARE	Background Acute respiratory distress syndrome (ARDS) is heterogeneous. As an indication of the heterogeneity of ARDS, there are patients whose syndrome improves rapidly (i.e., within 24 hours), others whose hypoxemia improves gradually and still others whose severe hypoxemia persists for several days. The latter group of patients with persistent severe ARDS poses challenges to clinicians. We attempted to assess the baseline characteristics and outcomes of persistent severe ARDS and to identify which variables are useful to predict it. Methods A secondary analysis of patient-level data from the ALTA, EDEN and SAILS ARDSNet clinical trials was conducted. We defined persistent severe ARDS as a partial pressure of arterial oxygen to fraction of inspired oxygen ratio (PaO2:FiO(2)) of equal to or less than 100 mmHg on the second study day following enrollment. Regularized logistic regression with an L1 penalty [Least Absolute Shrinkage and Selection Operator (LASSO)] techniques were used to identify predictive variables of persistent severe ARDS. Results Of the 1531 individuals with ARDS alive on the second study day after enrollment, 232 (15%) had persistent severe ARDS. Of the latter, 100 (43%) individuals had mild or moderate hypoxemia at baseline. Usage of vasopressors was greater [144/232 (62%) versus 623/1299 (48%); p< 0.001] and baseline severity of illness was higher in patients with versus without persistent severe ARDS. Mortality at 60 days [95/232 (41%) versus 233/1299 (18%); p< 0.001] was higher, and ventilator-free (p< 0.001), intensive care unit-free [0 (0-14) versus 19 (7-23); p< 0.001] and non-pulmonary organ failure-free [3 (0-21) versus 20 (1-26); p<0.001] days were fewer in patients with versus without persistent severe ARDS. PaO2:FiO(2), FiO(2), hepatic failure and positive end-expiratory pressure at enrollment were useful predictive variables. Conclusions Patients with persistent severe ARDS have distinct baseline characteristics and poor prognosis. Identifying such patients at enrollment may be useful for the prognostic enrichment of trials.	[Sanchez, Elizabeth; Price, David R.; Choi, Augustine M. K.; Schenck, Edward J.; Siempos, Ilias I.] Weill Cornell Med, Weill Cornell Med Ctr, New York Presbyterian Hosp, Dept Med,Div Pulm & Crit Care Med, New York, NY 10065 USA; [Chung, Kuei-Pin] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Oromendia, Clara] Weill Cornell Med, Dept Healthcare Policy & Res, Div Biostat & Epidemiol, New York, NY USA; [Siempos, Ilias I.] Univ Athens, Med Sch, Evangelismos Hosp, Dept Crit Care Med & Pulm Serv 1, Athens, Greece	Cornell University; NewYork-Presbyterian Hospital; National Taiwan University; National Taiwan University Hospital; Cornell University; Evangelismos Hospital; National & Kapodistrian University of Athens	Siempos, II (corresponding author), Weill Cornell Med, Weill Cornell Med Ctr, New York Presbyterian Hosp, Dept Med,Div Pulm & Crit Care Med, New York, NY 10065 USA.; Siempos, II (corresponding author), Univ Athens, Med Sch, Evangelismos Hosp, Dept Crit Care Med & Pulm Serv 1, Athens, Greece.	isiempos@yahoo.com	Schenck, Edward/AAX-8836-2020; Siempos, Ilias/GQZ-7330-2022	Schenck, Edward/0000-0002-7950-5989; CHUNG, KUEI-PIN/0000-0003-1916-8068; Siempos, Ilias/0000-0003-0036-3322	National Institutes of Health [UL1 TR000457-06, KL2 TR000458-10, R01 HL055330, P01 HL108801]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants UL1 TR000457-06 (to DRP), KL2 TR000458-10 (to EJS), R01 HL055330 (to AMKC) and P01 HL108801 (to AMKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Cardinal-Fernandez P, 2017, ANN AM THORAC SOC, V14, P844, DOI 10.1513/AnnalsATS.201609-728PS; Coady SA, 2017, NEW ENGL J MED, V376, P1849, DOI 10.1056/NEJMsa1603542; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Harrington JS, 2018, J CRIT CARE, V47, P49, DOI 10.1016/j.jcrc.2018.06.002; Laffey JG, 2017, LANCET RESP MED, V5, P627, DOI [10.1016/s2213-2600(17)30213-8, 10.1016/S2213-2600(17)30213-8]; Lorente JA, 2015, INTENS CARE MED, V41, P1921, DOI 10.1007/s00134-015-4046-0; Madotto F, 2018, INTENS CARE MED, V44, P564, DOI 10.1007/s00134-018-5152-6; Matthay MA, 2017, LANCET RESP MED, V5, P524, DOI 10.1016/S2213-2600(17)30188-1; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Meyer NJ, 2017, LANCET RESP MED, V5, P512, DOI 10.1016/S2213-2600(17)30187-X; Oromendia C, 2018, ANN AM THORAC SOC, V15, P998, DOI 10.1513/AnnalsATS.201803-192RL; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Schenck EJ, 2019, CHEST, V155, P474, DOI 10.1016/j.chest.2018.09.031; Pham T, 2017, AM J RESP CRIT CARE, V195, P860, DOI 10.1164/rccm.201609-1773CP; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC; Villar J, 2016, CRIT CARE MED, V44, P1361, DOI 10.1097/CCM.0000000000001653; Villar J, 2013, INTENS CARE MED, V39, P583, DOI 10.1007/s00134-012-2803-x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2020	15	1							e0227346	10.1371/journal.pone.0227346	http://dx.doi.org/10.1371/journal.pone.0227346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8YP	31986174	Green Published, gold			2022-12-26	WOS:000534603400019
J	Emmer, BT; Lascuna, PJ; Tang, VT; Kotnik, EN; Saunders, TL; Khoriaty, R; Ginsburg, D				Emmer, Brian T.; Lascuna, Paul J.; Tang, Vi T.; Kotnik, Emilee N.; Saunders, Thomas L.; Khoriaty, Rami; Ginsburg, David			Murine Surf4 is essential for early embryonic development	PLOS ONE			English	Article							LOCUS CONTAINS; MICE; ER; DEFICIENCY; TRANSPORT; SEC23B; LETHALITY; KNOCKOUT; DISPLAY; CLUSTER	Newly synthesized proteins co-translationally inserted into the endoplasmic reticulum (ER) lumen may be recruited into anterograde transport vesicles by their association with specific cargo receptors. We recently identified a role for the cargo receptor SURF4 in facilitating the secretion of PCSK9 in cultured cells. To examine the function of SURF4 in vivo, we used CRISPR/Cas9-mediated gene editing to generate mice with germline loss-of-function mutations in Surf4. Heterozygous Surf4(+/-) mice exhibit grossly normal appearance, behavior, body weight, fecundity, and organ development, with no significant alterations in circulating plasma levels of PCSK9, apolipoprotein B, or total cholesterol, and a detectable accumulation of intrahepatic apoliprotein B. Homozygous Surf4(-/-) mice exhibit embryonic lethality, with complete loss of all Surf4(-/-) offspring between embryonic days 3.5 and 9.5. In contrast to the milder murine phenotypes associated with deficiency of known SURF4 cargoes, the embryonic lethality of Surf4(-/-) mice implies the existence of additional SURF4 cargoes or functions that are essential for murine early embryonic development.	[Emmer, Brian T.; Saunders, Thomas L.; Khoriaty, Rami; Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Emmer, Brian T.; Lascuna, Paul J.; Tang, Vi T.; Kotnik, Emilee N.; Ginsburg, David] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Tang, Vi T.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Transgen Anim Model Core Lab, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.; Khoriaty, Rami; Ginsburg, David] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Khoriaty, Rami; Ginsburg, David] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Khoriaty, Rami] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Kotnik, Emilee N.] Washington Univ, Mol Genet & Genom Program, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Washington University (WUSTL)	Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu		Kotnik, Emilee/0000-0002-9229-3378; Emmer, Brian T./0000-0001-7365-1021; Saunders, Thom/0000-0003-2015-101X	NIH [R35-HL135793T, T32-HL007853, KL2-TR002241, K08-HL148552]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH grants R35-HL135793T (DG), T32-HL007853, KL2-TR002241 and K08-HL148552 (BTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2014, J BIOL CHEM, V289, P20858, DOI 10.1074/jbc.M114.566687; Baines AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061114; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Becker K., 2011, ADV PROTOCOLS ANIMAL, P99, DOI 10.1007/978-3-642-20792-1_6; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Emmer BT, 2018, ELIFE, V7, DOI 10.7554/eLife.38839; FARESE RV, 1995, P NATL ACAD SCI USA, V92, P1774, DOI 10.1073/pnas.92.5.1774; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hughes ED, ADV PROTOCOLS ANIMAL, P291; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; HUXLEY C, 1990, MOL CELL BIOL, V10, P605, DOI 10.1128/MCB.10.2.605; Khoriaty R, 2018, P NATL ACAD SCI USA, V115, pE7748, DOI 10.1073/pnas.1805784115; Khoriaty R, 2017, MOL BIOL CELL, V28, P2146, DOI 10.1091/mbc.E17-01-0001; Khoriaty R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27802; Khoriaty R, 2014, MOL CELL BIOL, V34, P3721, DOI 10.1128/MCB.00287-14; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; MCBURNEY MW, 1994, SOMAT CELL MOLEC GEN, V20, P515, DOI 10.1007/BF02255842; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Saegusa K, 2018, J CELL BIOL, V217, P2073, DOI 10.1083/jcb.201708115; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Takeo T, 2016, THERIOGENOLOGY, V86, P1341, DOI 10.1016/j.theriogenology.2016.04.076; Tao JY, 2012, P NATL ACAD SCI USA, V109, pE2001, DOI 10.1073/pnas.1209207109; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS T, 1988, P NATL ACAD SCI USA, V85, P3527, DOI 10.1073/pnas.85.10.3527; Yin Y, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005140; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Zhang B, 2011, BLOOD, V118, P3384, DOI 10.1182/blood-2011-05-352815; Zhu M, 2018, BLOOD ADV, V2, P1014, DOI 10.1182/bloodadvances.2018018317; Zhu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15471	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227450	10.1371/journal.pone.0227450	http://dx.doi.org/10.1371/journal.pone.0227450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978056	gold, Green Submitted, Green Published			2022-12-26	WOS:000534599100039
J	Hin, N; Newman, M; Kaslin, J; Douek, AM; Lumsden, A; Nik, SHM; Dong, Y; Zhou, XF; Manucat-Tan, NB; Ludington, A; Adelson, DL; Pederson, S; Lardelli, M				Hin, Nhi; Newman, Morgan; Kaslin, Jan; Douek, Alon M.; Lumsden, Amanda; Nik, Seyed Hani Moussavi; Dong, Yang; Zhou, Xin-Fu; Manucat-Tan, Noralyn B.; Ludington, Alastair; Adelson, David L.; Pederson, Stephen; Lardelli, Michael			Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; GENETIC RISK; MITOCHONDRIAL DYSFUNCTION; COGNITIVE IMPAIRMENT; EXPRESSION PATTERNS; YOUNG-ADULTS; A-BETA; PROTEIN; NEURODEGENERATION	Background The molecular changes involved in Alzheimer's disease (AD) progression remain unclear since we cannot easily access antemortem human brains. Some non-mammalian vertebrates such as the zebrafish preserve AD-relevant transcript isoforms of the PRESENILIN genes lost from mice and rats. One example is PS2V, the alternative transcript isoform of the PSEN2 gene. PS2V is induced by hypoxia/oxidative stress and shows increased expression in late onset, sporadic AD brains. A unique, early onset familial AD mutation of PSEN2, K115fs, mimics the PS2V coding sequence suggesting that forced, early expression of PS2V-like isoforms may contribute to AD pathogenesis. Here we use zebrafish to model the K115fs mutation to investigate the effects of forced PS2V-like expression on the transcriptomes of young adult and aged adult brains. Methods We edited the zebrafish genome to model the K115fs mutation. To explore its effects at the molecular level, we analysed the brain transcriptome and proteome of young (6-month-old) and aged (24-month-old) wild type and heterozygous mutant female sibling zebrafish. Finally, we used gene co-expression network analysis (WGCNA) to compare molecular changes in the brains of these fish to human AD. Results Young heterozygous mutant fish show transcriptional changes suggesting accelerated brain aging and increased glucocorticoid signalling. These early changes precede a transcriptional `inversion' that leads to glucocorticoid resistance and other likely pathological changes in aged heterozygous mutant fish. Notably, microglia-associated immune responses regulated by the ETS transcription factor family are altered in both our zebrafish mutant model and in human AD. The molecular changes we observe in aged heterozygous mutant fish occur without obvious histopathology and possibly in the absence of A beta. Conclusions Our results suggest that forced expression of a PS2V-like isoform contributes to immune and stress responses favouring AD pathogenesis. This highlights the value of our zebrafish genetic model for exploring molecular mechanisms involved in AD pathogenesis.	[Hin, Nhi; Nik, Seyed Hani Moussavi; Dong, Yang; Ludington, Alastair; Pederson, Stephen] Univ Adelaide, Sch Biol Sci, Bioinformat Hub, Adelaide, SA, Australia; [Hin, Nhi; Newman, Morgan; Lardelli, Michael] Univ Adelaide, Sch Biol Sci, Alzheimers Dis Genet Lab, Adelaide, SA, Australia; [Kaslin, Jan; Douek, Alon M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Lumsden, Amanda] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Lumsden, Amanda] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA, Australia; [Zhou, Xin-Fu; Manucat-Tan, Noralyn B.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Adelson, David L.] Sch Bio Sci, Ctr Bioinformat & Computat Genet, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; Australian Regenerative Medicine Institute; Monash University; Flinders University South Australia; Flinders University South Australia; University of South Australia	Lardelli, M (corresponding author), Univ Adelaide, Sch Biol Sci, Alzheimers Dis Genet Lab, Adelaide, SA, Australia.	michael.lardelli@adelaide.edu.au	Douek, Alon/AGF-1295-2022	Douek, Alon/0000-0001-5739-3835; Moussavi Nik, Seyyed Hani/0000-0002-5727-6863; Pederson, Stephen/0000-0001-8197-3303; Hin, Nhi/0000-0003-3063-4058; Dong, Yang/0000-0002-4810-2730; Lumsden, Amanda/0000-0002-0214-6498; Manucat-Tan, Noralyn/0000-0002-9618-753X; Newman, Morgan/0000-0002-4930-4529	Australia's National Health and Medical Research Council [GNT1061006, GNT1126422]; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Alzheimer's Australia Research; family of Lindsay Carthew; NHMRC [APP1126422]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Alzheimer's Australia Research; family of Lindsay Carthew; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from Australia's National Health and Medical Research Council, GNT1061006 and GNT1126422. Development of the psen1K97fs/+ mutation was funded by a grant to ML by the Judith Jane Mason and Harold Stannett Williams Memorial Foundation and to MN by Alzheimer's Australia Research. MN was also generously supported by a grant from the family of Lindsay Carthew. MN and other research costs are supported by NHMRC project grant APP1126422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2013, DEV BIOL, V381, P377, DOI 10.1016/j.ydbio.2013.06.026; Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Allaire J. J., 2017, NETWORKD3 D3 JAVASCR; Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Andrews S, FASTQC 0 11; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Antonell A, 2013, NEUROBIOL AGING, V34, P1772, DOI 10.1016/j.neurobiolaging.2012.12.026; Arimon M, 2015, NEUROBIOL DIS, V84, P109, DOI 10.1016/j.nbd.2015.06.013; Arlt S, 2013, CURR ALZHEIMER RES, V10, P72; Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118; Barron AM, 2006, ANTIOXID REDOX SIGN, V8, P2047, DOI 10.1089/ars.2006.8.2047; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benner C., HOMER HYPERGEOMETRIC; Berchtold NC, 2014, NEUROBIOL AGING, V35, P1961, DOI 10.1016/j.neurobiolaging.2014.03.031; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BRAAK H, 1997, NEUROBIOL AGING S1, V18, pS8, DOI DOI 10.1016/S0197-4580(97)00062-6; Braggin JE, 2019, ANN CLIN TRANSL NEUR, V6, P762, DOI 10.1002/acn3.755; Broad Institute, PICARD 2 14; Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Daulatzai MA, 2017, J NEUROSCI RES, V95, P943, DOI 10.1002/jnr.23777; Daulatzai MA, 2013, NEUROTOX RES, V24, P216, DOI 10.1007/s12640-013-9379-2; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; DESTGROTH SF, 1982, J IMMUNOL METHODS, V49, pR11, DOI 10.1016/0022-1759(82)90269-1; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Du X, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00032; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; Gamberger Dragan, 2016, Brain Inform, V3, P169, DOI 10.1007/s40708-016-0035-5; Giner G, 2016, F1000RESEARCH, V5, DOI [10.7490/11000F1000Research.1113351.1, DOI 10.7490/11000F1000RESEARCH.1113351.1]; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hargis KE, 2017, BEHAV BRAIN RES, V322, P311, DOI 10.1016/j.bbr.2016.05.007; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Head E, 2007, J ALZHEIMERS DIS, V11, P61; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Huggett JF, 2013, CLIN CHEM, V59, P1691, DOI 10.1373/clinchem.2013.214742; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Kaslin J, 2017, DEVELOPMENT, V144, P1462, DOI 10.1242/dev.144907; Kawasumi M, 2004, EUR J NEUROSCI, V19, P2826, DOI 10.1111/j.0953-816X.2004.03397.x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kolde R., PHEATMAP PRETTY HEAT; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kumar D, 2016, PROTEOMICS, V16, P2533, DOI 10.1002/pmic.201600140; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2012, J STAT SOFTW, V46, P1; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Magis Andrew T, 2015, IEEE Life Sci Lett, V1, P22, DOI 10.1109/LLS.2015.2465870; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Martin S, 2011, IS T SPIE ELECT IMAG; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; Moir RD, 1999, EUR J CLIN INVEST, V29, P569; Monsell SE, 2015, JAMA NEUROL, V72, P1124, DOI 10.1001/jamaneurol.2015.1721; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moore DB, 2014, MOL BIOL EVOL, V31, P696, DOI 10.1093/molbev/mst262; Morgan SC, 2004, J NEUROCHEM, V90, P89, DOI 10.1111/j.1471-4159.2004.02461.x; Morris GP, 2018, ACTA NEUROPATHOL, V136, P663, DOI 10.1007/s00401-018-1918-8; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; Newman M, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0467-y; Newman M, 2014, HUM MOL GENET, V23, P602, DOI 10.1093/hmg/ddt448; Nik SHM, 2015, HUM MOL GENET, V24, P3662, DOI 10.1093/hmg/ddv110; Nornes S, 2008, HUM MOL GENET, V17, P402, DOI 10.1093/hmg/ddm317; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Oosterhof N, 2017, GLIA, V65, P138, DOI 10.1002/glia.23083; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X; Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Poirier J, 2014, NEUROBIOL AGING, V35, pS3, DOI 10.1016/j.neurobiolaging.2014.03.037; Quiroz YT, 2015, JAMA NEUROL, V72, P912, DOI 10.1001/jamaneurol.2015.1099; Rapoport SI, 1996, NEURODEGENERATION, V5, P473, DOI 10.1006/neur.1996.0065; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Schapira AHV, 1996, CURR OPIN NEUROL, V9, P260, DOI 10.1097/00019052-199608000-00003; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Sharman MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066235; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Siman R, 2000, J NEUROSCI, V20, P8717; Solchenberger B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118956; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Whitehouse PJ, 2016, J ALZHEIMERS DIS, V49, P21, DOI 10.3233/JAD-150663; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; YAMADA T, 1987, BIOCHEM BIOPH RES CO, V149, P665, DOI 10.1016/0006-291X(87)90419-0; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520; Zotova E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt24	117	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227258	10.1371/journal.pone.0227258	http://dx.doi.org/10.1371/journal.pone.0227258			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978074	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000534599100029
J	Kokelj, S; Kim, JL; Andersson, M; Eden, GR; Bake, B; Olin, AC				Kokelj, Spela; Kim, Jeong-Lim; Andersson, Marianne; Eden, Gunilla Runstrom; Bake, Bjorn; Olin, Anna-Carin			Intra-individual variation of particles in exhaled air and of the contents of Surfactant protein A and albumin	PLOS ONE			English	Article							NORMAL VOLUNTEER SUBJECT; BRONCHOALVEOLAR LAVAGE; NITRIC-OXIDE; PULMONARY-FUNCTION; DIURNAL-VARIATION; LUNG-FUNCTION; HEALTHY; BIOMARKER; REPRODUCIBILITY; INFLAMMATION	Introduction Particles in exhaled air (PEx) provide samples of respiratory tract lining fluid from small airways containing, for example, Surfactant protein A (SP-A) and albumin, potential biomarkers of small airway disease. We hypothesized that there are differences between morning, noon, and afternoon measurements and that the variability of repeated measurements is larger between days than within days. Methods PEx was obtained in sixteen healthy non-smoking adults on 11 occasions, within one day and between days. SP-A and albumin were quantified by ELISA. The coefficient of repeatability (CR), intraclass correlation coefficient (ICC), and coefficient of variation (CV) were used to assess the variation of repeated measurements. Results SP-A and albumin increased significantly from morning towards the noon and afternoon by 13% and 25% on average, respectively, whereas PEx number concentration and particle mean mass did not differ significantly between the morning, noon and afternoon. Between-day CRs were not larger than within-day CRs. Conclusions Time of the day influences the contents of SP-A and albumin in exhaled particles. The variation of repeated measurements was rather high but was not influenced by the time intervals between measurements.	[Kokelj, Spela; Kim, Jeong-Lim; Andersson, Marianne; Eden, Gunilla Runstrom; Olin, Anna-Carin] Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Sch Publ Hlth & Community Med,Inst Med, Gothenburg, Sweden; [Bake, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Unit Resp Med & Allergy, Dept Internal Med,Inst Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Kokelj, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Sch Publ Hlth & Community Med,Inst Med, Gothenburg, Sweden.	spela.kokelj@amm.gu.se	Olin, Anna-Carin/ABH-2627-2021	Runstrom, Gunilla/0000-0003-0911-3493	Swedish Heart-Lung Foundation [20180209]	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This research was supported by the Swedish Heart-Lung Foundation (ACO, grant number 20180209). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Bake B, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0970-9; Bake B, 2017, J AEROSOL MED PULM D, V30, P267, DOI 10.1089/jamp.2016.1330; Balbi B, 2007, EUR RESPIR J, V30, P769, DOI 10.1183/09031936.00112306; Borsboom GJJM, 1999, AM J RESP CRIT CARE, V159, P1163, DOI 10.1164/ajrccm.159.4.9703106; Bredberg A, 2012, CLIN CHEM, V58, P431, DOI 10.1373/clinchem.2011.169235; Brisman J, 2017, CLIN PHYSIOL FUNCT I, V37, P640, DOI 10.1111/cpf.12349; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Ekroos H, 2000, CLIN PHYSIOL, V20, P434, DOI 10.1046/j.1365-2281.2000.00277.x; Ekroos H, 2002, RESP MED, V96, P895, DOI 10.1053/rmed.2002.1378; ETTENSOHN DB, 1988, CHEST, V94, P275, DOI 10.1378/chest.94.2.275; ETTENSOHN DB, 1988, CHEST, V94, P281, DOI 10.1378/chest.94.2.281; Faul JL, 1999, AM J RESP CRIT CARE, V160, P1457, DOI 10.1164/ajrccm.160.5.9812027; FREY TM, 1987, AM REV RESPIR DIS, V136, P1381, DOI 10.1164/ajrccm/136.6.1381; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Helleday R, 2006, CHEST, V130, P672, DOI 10.1378/chest.130.3.672; Hoegh SV, 2010, IMMUNOBIOLOGY, V215, P314, DOI 10.1016/j.imbio.2009.05.001; Holmgren H, 2013, RESP PHYSIOL NEUROBI, V185, P228, DOI 10.1016/j.resp.2012.10.010; Honma S, 2020, EUR J NEUROSCI, V51, P182, DOI 10.1111/ejn.14318; HUGHES JMB, 1970, J APPL PHYSIOL, V29, P340, DOI 10.1152/jappl.1970.29.3.340; Johansson SL, 2014, AM J PHYSIOL-LUNG C, V306, pL887, DOI 10.1152/ajplung.00340.2013; Kharitonov SA, 2003, EUR RESPIR J, V21, P433, DOI 10.1183/09031936.03.00066903a; Khor YH, 2009, CLIN EXP ALLERGY, V39, P1659, DOI 10.1111/j.1365-2222.2009.03349.x; Kuroki Y, 1998, BBA-MOL BASIS DIS, V1408, P334, DOI 10.1016/S0925-4439(98)00079-9; Larsson P, 2015, CLIN PHYSIOL FUNCT I, V37, P489, DOI DOI 10.HTTPS://D0I.0RG/10.1111/CPF.12323; Larstad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144463; Lock-Johansson S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0147-5; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Fernandez-Real JM, 2008, DIABETES CARE, V31, P958, DOI 10.2337/dc07-2173; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ropcke S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046207; Schwarz K, 2015, J AEROSOL MED PULM D, V28, P52, DOI 10.1089/jamp.2013.1104; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Winkler C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-29	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227980	10.1371/journal.pone.0227980	http://dx.doi.org/10.1371/journal.pone.0227980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	31978133	Green Published, gold			2022-12-26	WOS:000534599100089
J	Ahsan, T; Urmi, NJ; Sajib, A				Ahsan, Tamim; Urmi, Nusrat Jahan; Sajib, Abu Ashfaqur			Heterogeneity in the distribution of 159 drug-response related SNPs in world populations and their genetic relatedness	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM PATTERNS; NICOTINE REPLACEMENT THERAPY; AFRICAN-AMERICAN MEN; ALLELE FREQUENCY; ROSUVASTATIN PHARMACOKINETICS; NEANDERTHAL ANCESTRY; SMOKING-CESSATION; ASIAN POPULATIONS; NATURAL-SELECTION; PROSTATE-CANCER	Interethnic variability in drug response arises from genetic differences associated with drug metabolism, action and transport. These genetic variations can affect drug efficacy as well as cause adverse drug reactions (ADRs). We retrieved drug-response related single nucleotide polymorphism (SNP) associated data from databases and analyzed to elucidate population specific distribution of 159 drug-response related SNPs in twenty six populations belonging to five super-populations (African, Admixed Americans, East Asian, European and South Asian). Significant interpopulation differences exist in the minor (variant) allele frequencies (MAFs), linkage disequilibrium (LD) and haplotype distributions among these populations. 65 of the drug-response related alleles, which are considered as minor (variant) in global population, are present as the major alleles (frequency >= 0.5) in at least one or more populations. Populations that belong to the same super-population have similar distribution pattern for majority of the variant alleles. These drug response related variant allele frequencies and their pairwise LD measure (r(2)) can clearly distinguish the populations in a way that correspond to the known evolutionary history of human and current geographic distributions, while D' cannot. The data presented here may aid in identifying drugs that are more appropriate and/or require pharmacogenetic testing in these populations. Our findings emphasize on the importance of distinct, ethnicity-specific clinical guidelines, especially for the African populations, to avoid ADRs and ensure effective drug treatment.	[Ahsan, Tamim] Bangabandhu Sheikh Mujibur Rahman Maritime Univ, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh; [Urmi, Nusrat Jahan] BIRDEM Gen Hosp, Dept Med, Dhaka, Bangladesh; [Sajib, Abu Ashfaqur] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh	University of Dhaka	Sajib, A (corresponding author), Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh.	abu.sajib@du.ac.bd			Ministry of Science and Technology, Bangladesh	Ministry of Science and Technology, Bangladesh	This work was supported by the Ministry of Science and Technology, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeloye D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153496; Ahsan T, 2019, META GENE, V21, DOI 10.1016/j.mgene.2019.100585; Aka I, 2017, J PERS MED, V7, DOI 10.3390/jpm7040014; Alhusain L, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0156-4; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ampadu HH, 2016, DRUG SAFETY, V39, P335, DOI 10.1007/s40264-015-0387-4; Anderson KO, 2009, J PAIN, V10, P1187, DOI 10.1016/j.jpain.2009.10.002; Antunez de Mayolo G, 2002, ELECTROPHORESIS, V23, P3346, DOI 10.1002/1522-2683(200210)23:19<3346::AID-ELPS3346>3.0.CO;2-J; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Asamoah FA, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00234; Bachtiar M., 2013, CURR GENET MED REP, V1, P162, DOI DOI 10.1007/S40142-013-0017-3; Bahar MA, 2017, PHARMACOGENOMICS, V18, P701, DOI 10.2217/pgs-2017-0194; Brown AMK, 2014, PHARMACOGENOMICS, V15, P1185, DOI [10.2217/PGS.14.81, 10.2217/pgs.14.81]; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Campbell MC, 2014, CURR OPIN GENET DEV, V29, P120, DOI 10.1016/j.gde.2014.09.003; Cepeda-Benito A, 2004, J CONSULT CLIN PSYCH, V72, P712, DOI 10.1037/0022-006X.72.4.712; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Claudio-Campos Karla, 2015, Drug Metabolism and Personalized Therapy, V30, P87, DOI 10.1515/dmdi-2014-0023; Cokugras A.N., 2003, TURK J BIOCHEM, V28, P54, DOI DOI 10.1016/J.CBI.2005.10.013; David SM, 2013, CHEM-BIOL INTERACT, V203, P30, DOI 10.1016/j.cbi.2012.10.010; Nagar SD, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00241; Dou YL, 2018, DRUG METAB PHARMACOK, V33, P228, DOI 10.1016/j.dmpk.2018.08.001; Duncan G, 1996, GENETICA, V98, P277, DOI 10.1007/BF00057592; Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; EXCOFFIER L, 1994, GENETICS, V136, P343; Fan SH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1679-2; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Gammal RS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3479; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Gonzalez-Neira Anna, 2004, Human Genomics, V1, P399; Goulding R, 2015, BRIT J CLIN PHARMACO, V80, P868, DOI 10.1111/bcp.12475; Gross Tonya, 2018, Ment Health Clin, V8, P235, DOI 10.9740/mhc.2018.09.235; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Grossman I, 2009, EXPERT OPIN DRUG MET, V5, P449, DOI [10.1517/17425250902902322 , 10.1517/17425250902902322]; Hariprakash JM, 2018, PHARMACOGENOMICS, V19, P227, DOI 10.2217/pgs-2017-0101; Hayes VM, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2016.008862; He P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12104-0; Hellwege Jacklyn N, 2017, Curr Protoc Hum Genet, V95, DOI 10.1002/cphg.48; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Homburger JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005602; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Ivanov M, 2012, CLIN PHARMACOL THER, V92, P727, DOI 10.1038/clpt.2012.152; Katoh T, 2002, AM J HUM GENET, V71, P395, DOI 10.1086/341608; Kawaguchi DM, 2014, PHARMACOGENOMICS, V15, P1451, DOI [10.2217/pgs.14.96, 10.2217/PGS.14.96]; Khan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18755; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Kim IW, 2012, PHARMACOGENET GENOM, V22, P829, DOI 10.1097/FPC.0b013e328358dd70; Kirchheiner J, 2007, PHARMACOGENOMICS J, V7, P257, DOI 10.1038/sj.tpj.6500406; Knisely MR, 2017, APPL NURS RES, V38, P107, DOI 10.1016/j.apnr.2017.10.001; Lam MPS, 2012, BRIT J CLIN PHARMACO, V73, P340, DOI 10.1111/j.1365-2125.2011.04097.x; Lambert CA, 2009, COLD SH Q B, V74, P395, DOI 10.1101/sqb.2009.74.053; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Laval G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010284; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013; Lee YF, 2017, PHARMACOGENOMIC ERA, V8; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Losi L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061559; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MACHIELA MJ, 2015, BIOINFORMATICS, V31, P3555, DOI DOI 10.1093/BI0INF0RMATICS/BTV402; Maekawa K, 2012, DRUG METAB PHARMACOK, V27, P447, DOI 10.2133/dmpk.DMPK-11-NT-120; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Manoharan I, 2006, PHARMACOGENET GENOM, V16, P461; Marigorta UM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003566; McGraw J, 2012, EXPERT OPIN DRUG MET, V8, P371, DOI 10.1517/17425255.2012.657626; Meisner J, 2018, GENETICS, V210, P719, DOI 10.1534/genetics.118.301336; Moaddeb J, 2013, THER ADV DRUG SAF, V4, P155, DOI 10.1177/2042098613485595; Montinaro F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7596; Mouton JP, 2015, BRIT J CLIN PHARMACO, V80, P818, DOI 10.1111/bcp.12567; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Mukerjee G, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0065-4; Mustafina O E, 2015, Genetika, V51, P109; Nebert D. W., 2001, Pharmacogenomics Journal, V1, P19; Norris ET, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5195-7; Odedina Folakemi T, 2009, Infect Agent Cancer, V4 Suppl 1, pS2, DOI 10.1186/1750-9378-4-S1-S2; Oetting WS, 2016, AM J TRANSPLANT, V16, P574, DOI 10.1111/ajt.13495; Ortega VE, 2014, J ALLERGY CLIN IMMUN, V133, P16, DOI 10.1016/j.jaci.2013.10.040; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Patillon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053049; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Qin PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09500; Rahal AJ, 2016, SAUDI MED J, V37, P1051, DOI 10.15537/smj.2016.10.16078; Rahman Siddiqur, 2018, Current Pharmacogenomics & Personalized Medicine, V16, P199, DOI 10.2174/1875692117666181207121639; Rajman I, 2017, EBIOMEDICINE, V17, P67, DOI 10.1016/j.ebiom.2017.02.017; Ray B, 2019, PHARMACOGENET GENOM, V29, P39, DOI 10.1097/FPC.0000000000000363; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Ross KA, 2010, J HUM GENET, V55, P582, DOI 10.1038/jhg.2010.73; Rotimi CN, 2017, HUM MOL GENET, V26, pR225, DOI 10.1093/hmg/ddx253; Rotimi CN, 2016, CURR OPIN GENET DEV, V41, P77, DOI 10.1016/j.gde.2016.08.005; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Salzano FM, 2014, GENET MOL BIOL, V37, P151, DOI 10.1590/S1415-47572014000200003; Sanghavi K, 2017, PHARMACOGENOMICS J, V17, P61, DOI 10.1038/tpj.2015.87; Sanghera DK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33981-z; Sattar NA, 2014, ATHEROSCLEROSIS SUPP, V15, P1, DOI 10.1016/j.atherosclerosissup.2014.04.001; Shenoy D, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0137-7; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Solovieff N, 2011, BLOOD CELL MOL DIS, V47, P41, DOI 10.1016/j.bcmd.2011.04.002; Spratt DE, 2018, INT J RADIAT ONCOL, V102, pS3, DOI 10.1016/j.ijrobp.2018.06.104; Srivastava MR, 2017, ENDOCRINOL METAB INT, V5, P241; Sticchi L, 2013, J Prev Med Hyg, V54, P83; Suarez-Kurtz G, 2018, ADV PHARMACOL, V83, P133, DOI 10.1016/bs.apha.2018.02.001; Szpiech ZA, 2011, THEOR POPUL BIOL, V80, P100, DOI 10.1016/j.tpb.2011.03.006; Taranto F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3297-7; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Thummel KE, 2014, METHODS MOL BIOL, V1113, P363, DOI 10.1007/978-1-62703-758-7_17; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; VanLiere JM, 2008, THEOR POPUL BIOL, V74, P130, DOI 10.1016/j.tpb.2008.05.006; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Villanea FA, 2019, NAT ECOL EVOL, V3, P39, DOI 10.1038/s41559-018-0735-8; Visscher H, 2009, PHARMACOGENOMICS J, V9, P362, DOI 10.1038/tpj.2009.36; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wang DX, 2014, HUM MOL GENET, V23, P268, DOI 10.1093/hmg/ddt417; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Wu HF, 2017, J PHARM SCI-US, V106, P2751, DOI 10.1016/j.xphs.2017.03.027; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xu Shuhua, 2012, Genomics & Informatics, V10, P133, DOI 10.5808/GI.2012.10.3.133; Yang Yao, 2014, Drug Metabolism and Drug Interactions, V29, P221, DOI 10.1515/dmdi-2013-0069; Zagars GK, 1998, INT J RADIAT ONCOL, V42, P517, DOI 10.1016/S0360-3016(98)00260-0; Zencirci Beyazit, 2009, Cases J, V2, P9148, DOI 10.1186/1757-1626-2-9148	128	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0228000	10.1371/journal.pone.0228000	http://dx.doi.org/10.1371/journal.pone.0228000			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971968	Green Published, gold			2022-12-26	WOS:000534374400031
J	Auclair, M; Guenantin, AC; Fellahi, S; Garcia, M; Capeau, J				Auclair, Martine; Guenantin, Anne-Claire; Fellahi, Soraya; Garcia, Marie; Capeau, Jacqueline			HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells	PLOS ONE			English	Article							NF-KAPPA-B; PROTEASE INHIBITORS; RESISTANCE; RECEPTOR; IMPACT; GROWTH; SIRT1; RISK; ACTIVATOR; DISEASE	Objectives Aging HIV-infected antiretroviral-treatment (ART)-controlled patients often present cardiovascular and metabolic comorbidities. Thus, it is mandatory that life-long used ART has no cardiometabolic toxicity. Protease inhibitors have been associated with cardiometabolic risk, integrase-strand-transfer-inhibitors (INSTI) with weight gain and the CCR5 inhibitor maraviroc with improved vascular function. We have previously reported that the INSTI dolutegravir and maraviroc improved, and ritonavir-boosted atazanavir(atazanavir/r) worsened, inflammation and senescence in human coronary artery endothelial cells (HCAEC)s from adult controls. Here, we analyzed the pathways involved in the drugs' effects on inflammation, senescence and also insulin resistance. Methods We analyzed the involvement of the anti-inflammatory SIRT-1 pathway in HCAECs. Then, we performed a transcriptomic analysis of the effect of dolutegravir, maraviroc and atazanavir/r and used siRNA-silencing to address ubiquitin-specific-peptidase-18 (USP18) involvement into ART effects. Results Dolutegravir reduced inflammation by decreasing NF kappa B activation and IL-6/IL-8/sICAM-1/sVCAM-1 secretion, as did maraviroc with a milder effect. However, when SIRT-1 was inhibited by splitomicin, the drugs anti-inflammatory effects were maintained, indicating that they were SIRT-1-independant. From the transcriptomic analysis we selected USP18, previously shown to decrease inflammation and insulin-resistance. USP18-silencing enhanced basal inflammation and senescence. Maraviroc still inhibited NF kappa B activation, cytokine/adhesion molecules secretion and senescence but the effects of dolutegravir and atazanavir/r were lost, suggesting that they involved USP18. Otherwise, in HCAECs, dolutegravir improved and atazanavir/r worsened insulin resistance while maraviroc had no effect. In USP18-silenced cells, basal insulin resistance was increased, but dolutegravir and atazanavir/r kept their effect on insulin sensitivity, indicating that USP18 was dispensable. Conclusion USP18 reduced basal inflammation, senescence and insulin resistance in coronary endothelial cells. Dolutegravir and atazanavir/r, but not maraviroc, exerted opposite effects on inflammation and senescence that involved USP18. Otherwise, dolutegravir improved and atazanavir/r worsened insulin resistance independently of USP18. Thus, in endothelial cells, dolutegravir and atazanavir/r oppositely affected pathways leading to inflammation, senescence and insulin resistance.	[Auclair, Martine; Guenantin, Anne-Claire; Fellahi, Soraya; Garcia, Marie; Capeau, Jacqueline] Sorbonne Univ, Paris, France; [Auclair, Martine; Guenantin, Anne-Claire; Fellahi, Soraya; Garcia, Marie; Capeau, Jacqueline] Rech St Antoine, Inserm UMR 5938, Paris, France; [Auclair, Martine; Guenantin, Anne-Claire; Fellahi, Soraya; Garcia, Marie; Capeau, Jacqueline] Inst Cardiometab & Nutr, ICAN, Paris, France; [Fellahi, Soraya] Tenon Hosp, AP HP, Dept Biochem, Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Capeau, J (corresponding author), Sorbonne Univ, Paris, France.; Capeau, J (corresponding author), Rech St Antoine, Inserm UMR 5938, Paris, France.; Capeau, J (corresponding author), Inst Cardiometab & Nutr, ICAN, Paris, France.	jacqueline.capeau@inserm.fr		Capeau, Jacqueline/0000-0002-1710-4186; Auclair, Martine/0000-0003-3600-1999	ViiV Healthcare	ViiV Healthcare	This work was supported in part by a research grant from ViiV Healthcare paid to Sorbonne University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, there was no additional external funding received for this study.	Afonso P, 2017, ANTIVIR THER, V22, P645, DOI 10.3851/IMP3160; An SM, 2017, HEPATOLOGY, V66, P1866, DOI 10.1002/hep.29375; Artunc F, 2016, NAT REV NEPHROL, V12, P721, DOI 10.1038/nrneph.2016.145; Auclair M, 1999, J CLIN ENDOCR METAB, V84, P3197, DOI 10.1210/jc.84.9.3197; Auclair M, 2014, ANTIVIR THER, V19, P773, DOI 10.3851/IMP2752; Bastard JP, 2019, DIABETES METAB, V45, P573, DOI [10.1016/j.diabet.2019.02.008, 10.1016/j.diabet.2019.02,008]; Basters A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180250; Berger O, 1999, MOL MED, V5, P795, DOI 10.1007/BF03401992; Bernardino JI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209911; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Bourgi K, 2019, GREATER WEIGHT GAIN, DOI [10.1093/cid/ciz407, DOI 10.1093/CID/CIZ407]; Bourgi K, 2019, GREATER WEIGHT GAIN; Brenner BG, 2017, AIDS, V31, P2551, DOI 10.1097/QAD.0000000000001676; Calza L, 2019, J ANTIMICROB CHEMOTH, V74, P731, DOI 10.1093/jac/dky507; Cencioni C, 2015, J MOL CELL CARDIOL, V83, P55, DOI 10.1016/j.yjmcc.2014.12.023; de Kerdanet M, 2015, DIABETES METAB, V41, P331, DOI 10.1016/j.diabet.2014.11.001; Dirajlal-Fargo S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw174; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Duffau P, 2015, AIDS, V29, P2099, DOI 10.1097/QAD.0000000000000807; Eckard AR, 2016, J INFECT DIS, V214, pS83, DOI 10.1093/infdis/jiw288; Francisci D, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz112; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gano LB, 2014, AM J PHYSIOL-HEART C, V307, pH1754, DOI 10.1152/ajpheart.00377.2014; Gatell JM, 2019, CLIN INFECT DIS, V68, P597, DOI 10.1093/cid/ciy505; Gupta Nancy, 2016, World J Gastrointest Pharmacol Ther, V7, P469; Hill A, 2019, J VIRUS ERAD, V5, P41; Hill AM, 2018, CURR OPIN HIV AIDS, V13, P102, DOI [10.1097/COH.0000000000000445, 10.1097/coh.0000000000000445]; Katlama C, 2019, J ANTIMICROB CHEMOTH, V74, P2742, DOI 10.1093/jac/dkz224; Lagathu C, 2019, EXPERT OPIN DRUG SAF, V18, P829, DOI 10.1080/14740338.2019.1644317; Lake J., 2019, RISK FACTORS EXCESS; Lake JE, 2017, CURR HIV-AIDS REP, V14, P211, DOI 10.1007/s11904-017-0368-6; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Li RL, 2016, AM J TRANSL RES, V8, P2876; Liu FC, 2012, EUR J PHARMACOL, V688, P68, DOI 10.1016/j.ejphar.2012.05.006; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Lo J, 2019, DOLUTEGRAVIR INSULIN; Maguire JJ, 2014, CARDIOVASC RES, V101, P513, DOI 10.1093/cvr/cvt333; Martinez E, 2018, J INT AIDS SOC, V21; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; McComsey GA, 2016, CLIN INFECT DIS, V62, P853, DOI 10.1093/cid/ciw017; Mukohda Masashi, 2016, Am J Physiol Heart Circ Physiol, V310, pH39, DOI 10.1152/ajpheart.00490.2015; Noor MA, 2006, AIDS, V20, P1813, DOI 10.1097/01.aids.0000244200.11006.55; O'Halloran JA, 2019, LOWER CARDIOVASCU LA; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Offor O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196395; Piconi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28853; Ryom L, 2018, LANCET HIV, V5, pE291, DOI 10.1016/S2352-3018(18)30043-2; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Stavrou EX, 2015, BLOOD, V125, P710, DOI 10.1182/blood-2014-01-550285; Stellbrink HJ, 2019, LANCET HIV, V6, pE364, DOI 10.1016/S2352-3018(19)30080-3; Venter WDF, 2019, NEW ENGL J MED, V381, P803, DOI 10.1056/NEJMoa1902824; Waters L, 2018, HIV DRUG THERAPY; Yang ZF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12738; Zhang Y, 2019, J CELL PHYSIOL, V234, P7467, DOI 10.1002/jcp.27508	54	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2020	15	1							e0226924	10.1371/journal.pone.0226924	http://dx.doi.org/10.1371/journal.pone.0226924			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5RH	31971958	Green Published, gold			2022-12-26	WOS:000534374400008
J	Axpe, E; Chan, D; Abegaz, MF; Schreurs, AS; Alwood, JS; Globus, RK; Appel, EA				Axpe, Eneko; Chan, Doreen; Abegaz, Metadel F.; Schreurs, Ann-Sofie; Alwood, Joshua S.; Globus, Ruth K.; Appel, Eric A.			A human mission to Mars: Predicting the bone mineral density loss of astronauts	PLOS ONE			English	Article							SKELETAL SYSTEM; PROXIMAL FEMUR; SPINE; ADAPTATION; MANAGEMENT; REDUCTION; HIP	A round-trip human mission to Mars is anticipated to last roughly three years. Spaceflight conditions are known to cause loss of bone mineral density (BMD) in astronauts, increasing bone fracture risk. There is an urgent need to understand BMD progression as a function of spaceflight time to minimize associated health implications and ensure mission success. Here we introduce a nonlinear mathematical model of BMD loss for candidate human missions to Mars: (i) Opposition class trajectory (400-600 days), and (ii) Conjunction class trajectory (1000-1200 days). Using femoral neck BMD data (N = 69) from astronauts after 132-day and 228-day spaceflight and the World Health Organization's fracture risk recommendation, we predicted post-mission risk and associated osteopathology. Our model predicts 62% opposition class astronauts and 100% conjunction class astronauts will develop osteopenia, with 33% being at risk for osteoporosis. This model can help in implementing countermeasure strategies and inform space agencies' choice of crew candidates.	[Axpe, Eneko; Abegaz, Metadel F.; Schreurs, Ann-Sofie; Alwood, Joshua S.; Globus, Ruth K.] NASA, Ames Res Ctr, Space Biosci Div, Mountain View, CA 94035 USA; [Axpe, Eneko; Chan, Doreen; Appel, Eric A.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Chan, Doreen] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Appel, Eric A.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Stanford University; Stanford University; Stanford University	Globus, RK (corresponding author), NASA, Ames Res Ctr, Space Biosci Div, Mountain View, CA 94035 USA.; Appel, EA (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.; Appel, EA (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	ruth.k.globus@nasa.gov; eappel@stanford.edu		Appel, Eric/0000-0002-2301-7126	Center for Human Systems Immunology; Bill and Melinda Gates Foundation [OPP1113682]; Stanford BioX Interdisciplinary Initiatives Program Round 8 (2016) Seed Grant; Basque Government [IT-1005-16]; Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (ND-SEG) Fellowship [32 CFR168a, FA9550-11-C-0028]	Center for Human Systems Immunology; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Stanford BioX Interdisciplinary Initiatives Program Round 8 (2016) Seed Grant; Basque Government(Basque Government); Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (ND-SEG) Fellowship	EAA is thankful for funding from the Center for Human Systems Immunology with Bill and Melinda Gates Foundation OPP1113682. E.A. is thankful for funding support from a Stanford BioX Interdisciplinary Initiatives Program Round 8 (2016) Seed Grant, a postdoctoral fellowship of the Basque Government and the Basque Government Grant No. IT-1005-16. D.C. is grateful for an award by the Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (ND-SEG) Fellowship, 32 CFR168a with government support under FA9550-11-C-0028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappellesso R, 2015, Endocr Regul, V49, P231; Carpenter RD, 2010, ACTA ASTRONAUT, V67, P71, DOI 10.1016/j.actaastro.2010.01.022; Cavanagh Peter R, 2005, Gravit Space Biol Bull, V18, P39; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Goodliff KE, 2017, AIAA SPACE ASTR FOR, DOI [10.2514/6.2017-5122, DOI 10.2514/6.2017-5122]; Keyak JH, 2009, BONE, V44, P449, DOI 10.1016/j.bone.2008.11.014; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lang T, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0013-0; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LeBlanc AD, J MUSCULOSKELET NEUR, V7, P33; Li WJ, 2007, BONE, V41, P888, DOI 10.1016/j.bone.2007.07.006; Mahoney E., 2018, 2018 GLOBAL EXPLORAT; Maimoun L, 2006, SPINAL CORD, V44, P203, DOI 10.1038/sj.sc.3101832; Mattfeld B, 2014, AM I AERONAUT ASTRON, P1; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; Nelson ES, 2009, ANN BIOMED ENG, V37, P2337, DOI 10.1007/s10439-009-9779-x; Nicogossian AE., 1993, SPACE BIOL MED; Oganov V. S., 2011, Human Physiology, V37, P768, DOI 10.1134/S0362119711070243; Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948; Osterhoff G, 2016, INJURY, V47, pS11, DOI 10.1016/S0020-1383(16)47003-8; Scott JM, 2011, SPINAL CORD, V49, P4, DOI 10.1038/sc.2010.53; Shanbhogue VV, 2015, J BONE MINER RES, V30, P2188, DOI 10.1002/jbmr.2573; Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022; Sibonga JD, 2018, EVIDENCE REPORT RISK, P1; Sibonga JD, 2013, CURR OSTEOPOROS REP, V11, P92, DOI 10.1007/s11914-013-0136-5; Sibonga JD, 2007, CLIN REV BONE MINER, V5, P249, DOI 10.1007/s12018-008-9012-8; Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647; Sozen T, 2017, EUR J RHEUMATOL, V4, P46, DOI 10.5152/eurjrheum.2016.048; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Zhao QA, 2010, AUSTRALAS PHYS ENG S, V33, P163, DOI 10.1007/s13246-010-0024-6	32	15	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0226434	10.1371/journal.pone.0226434	http://dx.doi.org/10.1371/journal.pone.0226434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31967993	Green Published, gold, Green Submitted			2022-12-26	WOS:000534373000006
J	Jansen, MP; Mastbergen, SC; van Heerwaarden, RJ; Spruijt, S; van Empelen, MD; Kester, EC; Lafeber, FPJG; Custers, RJH				Jansen, Mylene P.; Mastbergen, Simon C.; van Heerwaarden, Ronald J.; Spruijt, Sander; van Empelen, Michelle D.; Kester, Esmee C.; Lafeber, Floris P. J. G.; Custers, Roel J. H.			Knee joint distraction in regular care for treatment of knee osteoarthritis: A comparison with clinical trial data	PLOS ONE			English	Article							CARTILAGINOUS TISSUE-REPAIR; HIGH TIBIAL OSTEOTOMY; ARTHROPLASTY; REVISION; BENEFIT; REPLACEMENT; HIP	Objectives Knee joint distraction (KJD) has been evaluated as a joint-preserving treatment to postpone total knee arthroplasty in knee osteoarthritis patients in three clinical trials. Since 2014 the treatment is used in regular care in some hospitals, which might lead to a deviation from the original indication and decreased treatment outcome. In this study, baseline characteristics, complications and clinical benefit are compared between patients treated in regular care and in clinical trials. Methods In our hospital, 84 patients were treated in regular care for 6 weeks with KJD. Surgical details, complications, and range of motion were assessed from patient hospital charts. Patient-reported outcome measures were evaluated in regular care before and one year after treatment. Trial patients (n = 62) were treated and followed as described in literature. Results Patient characteristics were not significantly different between groups, except for distraction duration (regular care 45.3 +/- 4.3; clinical trials 48.1 +/- 8.1 days; p = 0.019). Pin tract infections were the most occurring complication (70% regular care; 66% clinical trials), but there was no significant difference in treatment complications between groups (p> 0.1). The range of motion was recovered within a year after treatment for both groups. WOMAC questionnaires showed statistically and clinically significant improvement for both groups (both p< 0.001 and > 15 points in all subscales) and no significant differences between groups (all differences p> 0.05). After one year, 70% of patients were responders (regular care 61%, trial 75%; p = 0.120). Neither regular care compared to clinical trial, nor any other characteristic could predict clinical response. Conclusions KJD as joint-preserving treatment in clinical practice, to postpone arthroplasty for end-stage knee osteoarthritis patient below the age of 65, results in an outcome similar to that thus far demonstrated in clinical trials. Longer follow-up in regular care is needed to test whether also long-term results remain beneficial and comparable to trial data.	[Jansen, Mylene P.; Mastbergen, Simon C.; Lafeber, Floris P. J. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [van Heerwaarden, Ronald J.] Klin ViaSana, Ctr Deform Correct & Joint Preserving Surg, Mill, Netherlands; [Spruijt, Sander] HagaZiekenhuis, Dept Orthoped, The Hague, Netherlands; [van Empelen, Michelle D.; Kester, Esmee C.; Custers, Roel J. H.] Univ Med Ctr Utrecht, Dept Orthoped Surg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Haga Hospital; Utrecht University; Utrecht University Medical Center	Jansen, MP (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	m.p.jansen-36@umcutrecht.nl	Jansen, Mylène/AAE-1410-2022; ViaSana, Kliniek/GZH-0074-2022	Jansen, Mylène/0000-0003-1929-6350; 	Dutch Arthris Society (ReumaNederland) [LLP-9]; ZonMW (The Netherlands Organization for Health Research and Development) [95110008]	Dutch Arthris Society (ReumaNederland); ZonMW (The Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	The institution of MP Jansen, SC Mastbergen and FPJG Lafeber has, during the study period, received funding from: -Dutch Arthris Society (ReumaNederland), project number LLP-9, https://reumanederland.nl/.-ZonMW (The Netherlands Organization for Health Research and Development), project number 95110008, https://www.zonmw.nl/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss LE, 2017, LANCET, V389, P1424, DOI 10.1016/S0140-6736(17)30059-4; Escobar A, 2007, OSTEOARTHR CARTILAGE, V15, P273, DOI 10.1016/j.joca.2006.09.001; Escobar A, 2012, OSTEOARTHR CARTILAGE, V20, P87, DOI 10.1016/j.joca.2011.11.007; Hancock Graeme Ethan, 2018, J Exp Orthop, V5, P46, DOI 10.1186/s40634-018-0161-5; Hernandez-Diaz C., 2017, COMORBIDITY RHEUM DI, P197, DOI [10.1007/978-3-319-59963-2_9, DOI 10.1007/978-3-319-59963-2_9]; Hoell S, 2005, ARCH ORTHOP TRAUM SU, V125, P638, DOI 10.1007/s00402-005-0004-6; Intema F, 2011, ANN RHEUM DIS, V70, P1441, DOI 10.1136/ard.2010.142364; Jansen MP, 2018, OSTEOARTHR CARTILAGE, V26, P1604, DOI 10.1016/j.joca.2018.08.004; Jennison T, 2014, ACTA BIOMATER, V10, P595, DOI 10.1016/j.actbio.2013.09.019; LAFEBER F, 1992, BRIT J RHEUMATOL, V31, P437; Liabaud B, 2013, J ARTHROPLASTY, V28, P563, DOI 10.1016/j.arth.2012.07.037; Mandryk R., 2015, P 2015 ANN S COMP HU, P799, DOI [10.1145/2793107.2810258, DOI 10.1145/2793107.2810258]; Noble JW, 2012, J ARTHROPLASTY, V27, P153, DOI 10.1016/j.arth.2011.07.006; Patel A, 2015, BONE JOINT J, V97B, P1076, DOI 10.1302/0301-620X.97B8.35170; Siman H, 2017, J ARTHROPLASTY, V32, P1792, DOI 10.1016/j.arth.2017.01.020; Tonge DP, 2014, OSTEOARTHR CARTILAGE, V22, P609, DOI 10.1016/j.joca.2014.03.004; van der Woude JAD, 2017, KNEE SURG SPORT TR A, V25, P876, DOI 10.1007/s00167-016-4131-0; van der Woude JAD, 2017, BONE JOINT J, V99B, P51, DOI [10.1302/0301-620X.99B1.BJJ-2016-0099, 10.1302/0301-620X.99B1.BJJ-2016-0099.R3]; van der Woude JAD, 2016, KNEE, V23, P785, DOI 10.1016/j.knee.2016.05.001; van der Woude JAD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155524; van der Woude JTAD, 2017, CARTILAGE, V8, P263, DOI 10.1177/1947603516665442; van Heerwaarden RJ, 2019, CARTILAGE; Van Roermund PM, 2015, J SURG SURG RES, V1, P66, DOI DOI 10.17352/2455-2968.000016; van Valburg AA, 1998, J RHEUMATOL, V25, P515; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; Wiegant K, 2013, OSTEOARTHR CARTILAGE, V21, P1660, DOI 10.1016/j.joca.2013.08.006; Wiegant K, 2015, INT J ORTHOP, V2, P353, DOI DOI 10.17554/J.ISSN.2311-5106.2015.02.91	27	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0227975	10.1371/journal.pone.0227975	http://dx.doi.org/10.1371/journal.pone.0227975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31968005	Green Published, gold			2022-12-26	WOS:000534373000023
J	Juarez-Rodriguez, M; Heckel, G; Herguera-Garcia, JC; Elorriaga-Verplancken, FR; Herzka, SZ; Schramm, Y				Juarez-Rodriguez, Maricela; Heckel, Gisela; Carlos Herguera-Garcia, Juan; Elorriaga-Verplancken, Fernando R.; Herzka, Sharon Z.; Schramm, Yolanda			Trophic ecology of Mexican Pacific harbor seal colonies using carbon and nitrogen stable isotopes	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDII; LIONS ZALOPHUS-CALIFORNIANUS; GULF-OF-CALIFORNIA; GEOGRAPHICAL VARIATIONS; FORAGING ECOLOGY; FOOD-HABITS; DIET; RATIOS; NICHE; DELTA-N-15	There is limited information that provides a comprehensive understanding of the trophic ecology of Mexican Pacific harbor seal (Phoca vitulina richardii) colonies. While scat analysis has been used to determine the diet of some colonies, the integrative characterization of its feeding habits on broader temporal and spatial scales remains limited. We examined potential feeding grounds, trophic niche width, and overlap, and inferred the degree of dietary specialization using stable carbon and nitrogen isotope ratios (delta C-13 and delta N-15) in this subspecies. We analyzed delta C-13 and delta N-15 on fur samples from pups collected at five sites along the western coast of the Baja California Peninsula, Mexico. Fur of natal coat of Pacific harbor seal pups begins to grow during the seventh month in utero until the last stage of gestation. Therefore pup fur is a good proxy for the mother's feeding habits in winter (similar to December to March), based on the timing of gestation for the subspecies in this region. Our results indicated that the delta C-13 and delta N-15 values differed significantly among sampling sites, with the highest mean delta N-15 value occurring at the southernmost site, reflecting a well-characterized north to south latitudinal N-15-enrichment in the food web. The tendency identified in delta C-13 values, in which the northern colonies showed the most enriched values, suggests nearshore and benthic-demersal feeding habits. A low variance in delta C-13 and delta N-15 values for each colony (<1%) and relatively small standard ellipse areas suggest a specialized foraging behavior in adult female Pacific harbor seals in Mexican waters.	[Juarez-Rodriguez, Maricela; Heckel, Gisela] Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservac, Ensenada, Baja California, Mexico; [Carlos Herguera-Garcia, Juan] Ctr Invest Cient & Educ Super Ensenada, Dept Ecol Marina, Ensenada, Baja California, Mexico; [Elorriaga-Verplancken, Fernando R.] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Dept Pesquerias & Biol Marina, La Paz, Baja California, Mexico; [Herzka, Sharon Z.] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Schramm, Yolanda] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Instituto Politecnico Nacional - Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California	Heckel, G (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservac, Ensenada, Baja California, Mexico.	gheckel@cicese.mx	Herzka, Sharon Z./E-1507-2015; Heckel, Gisela/K-9170-2016; Herguera, Juan Carlos/B-7812-2016	Herzka, Sharon Z./0000-0001-7091-7656; Schramm, Yolanda/0000-0001-6951-4884; Heckel, Gisela/0000-0002-6003-7898; Herguera, Juan Carlos/0000-0001-8335-2607	Consejo Nacional de Ciencia y Tecnologia, Mexico [2012-179451]; Consejo Nacional de Ciencia y Tecnologia [26244]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	YS received grant no. 2012-179451 from Consejo Nacional de Ciencia y Tecnologia, Mexico, https://www.conacyt.gob.mx/.MJR received a scholarship no. 26244 from Consejo Nacional de Ciencia y Tecnologia.; The Pacific harbor seal pup fur samples were taken thanks to permits granted by the following: Direccion General de Vida Silvestre (General Wildlife Directorate), Secretaria de Medio Ambiente y Recursos Naturales (Ministry for Environment and Natural Resources), Nos. SGPA/DGVS/12269/13 and SGPA/DGVS/08370/14; Secretaria de Gobernacion (Ministry of the Interior), Nos. UG/211/0087/2014 and UG/211/01022/2014; and Reserva de la Biosfera ElVizcaino (El Vizcaino Biosphere Reserve) No. F00.DRPBCPN.-000027. We thank the following individuals for their assistance with field work: A. Arias, E. Brassea, P. Durazo, E. Fernandez, D. Lubinsky, G. Ruiz, and C. Tapia. We especially thank Natalia Castillo, and Anely Fernandez for helping with the Geographic Information System and Axel Rosas for sample analyses. The comments by L.W. Cooper, Academic Editor, and three anonymous reviewers helped to improve the manuscript significantly.	Alaman deRegules R, 2014, THESIS; Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Aurioles-Gamboa D, 2009, J MAMMAL, V90, P1410, DOI 10.1644/08-MAMM-A-209R2.1; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Beltran-Felix J.L, 1986, CIENC MAR, V12, P79; Bjorge A, 1995, DEV MAR BIO, V4, P211; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bossart Gregory D., 2006, Oceanography, V19, P134; Bowen WD, 2000, CAN J FISH AQUAT SCI, V57, P898, DOI 10.1139/cjfas-57-5-898; Boyd IL, 1998, AM NAT, V152, P717, DOI 10.1086/286202; Brassea-Perez E, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3555-8; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Cavole LM, 2016, OCEANOGRAPHY, V29, P273, DOI 10.5670/oceanog.2016.32; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Committee on Taxonomy, LIST MAR MAMM SPEC S; Cottrell PE, 2002, MAR MAMMAL SCI, V18, P721, DOI 10.1111/j.1748-7692.2002.tb01069.x; Das K, 2003, MAR ENVIRON RES, V56, P349, DOI 10.1016/S0141-1136(02)00308-2; del Rio CM, 2009, OECOLOGIA, V161, P149, DOI 10.1007/s00442-009-1357-2; Durazo-Rodriguez P., 2015, THESIS; Elorriaga-Verplancken F, 2013, MAR BIOL, V160, P641, DOI 10.1007/s00227-012-2119-y; Elorriaga-Verplancken FR, 2013, AQUAT MAMM, V39, P415, DOI 10.1578/AM.39.4.2013.415; Elorriaga-Verplancken FR, 2016, J MAR BIOL ASSOC UK, V96, P903, DOI 10.1017/S0025315415002143; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; FRY B, 1991, MAR ECOL PROG SER, V76, P149, DOI 10.3354/meps076149; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Garvey J. E., 2016, TROPHIC ECOLOGY; Gibble CM, 2015, MAR MAMMAL SCI, V31, P1014, DOI 10.1111/mms.12214; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; HARKONEN TJ, 1987, NETH J SEA RES, V21, P331, DOI 10.1016/0077-7579(87)90007-X; Harvey J, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-1.RLTS.T17022A66991556.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T17022A66991556.EN]; Hattori A., 1990, NITROGEN SEA FORMS A; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Herreman JK, 2009, MAR ECOL PROG SER, V374, P287, DOI 10.3354/meps07719; Hirons AC, 2001, OECOLOGIA, V129, P591, DOI 10.1007/s004420100756; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hutchinson G.E., 1978, INTRO POPULATION BIO; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Amador-Capitanachi MJ, 2017, AQUAT MAMM, V43, P14, DOI 10.1578/AM.43.1.2017.14; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lesage V, 2002, MAR MAMMAL SCI, V18, P182, DOI 10.1111/j.1748-7692.2002.tb01027.x; LING J. K., 1967, AUST J ZOOL, V15, P349, DOI 10.1071/ZO9670349; Lubinsky-Jinich D, 2017, AQUAT MAMM, V43, P73, DOI 10.1578/AM.43.1.2017.73; Luxa K, 2013, AQUAT MAMM, V39, P10, DOI 10.1578/AM.39.1.2013.10; Fernandez-Martin EM, 2016, CIENC MAR, V42, P195, DOI 10.7773/cm.v42i3.2615; McMahon KW, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1511; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; McPeek MA, 1996, AM NAT, V148, pS124, DOI 10.1086/285906; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; NAKAMURA K, 1982, BIOMED MASS SPECTROM, V9, P390, DOI 10.1002/bms.1200090906; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Odell DK, 1972, STUDIES BIOL CALIFOR; OFTEDAL OT, 1991, CAN J ZOOL, V69, P2489, DOI 10.1139/z91-351; Pablo-Rodriguez N, 2016, MAR MAMMAL SCI, V32, P466, DOI 10.1111/mms.12274; Paez-Rosas D, 2014, RAPID COMMUN MASS SP, V28, P2550, DOI 10.1002/rcm.7047; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; PAYNE PM, 1989, MAR MAMMAL SCI, V5, P173, DOI 10.1111/j.1748-7692.1989.tb00331.x; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; PITCHER KW, 1980, FISH B-NOAA, V78, P797; Porras-Peters H, 2008, MAR MAMMAL SCI, V24, P554, DOI 10.1111/j.1748-7692.2008.00197.x; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Ruiz-Mar G, 2016, THESIS; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Smith RJ, 1996, CAN J FISH AQUAT SCI, V53, P272, DOI 10.1139/cjfas-53-2-272; STUTZ SS, 1966, J FISH RES BOARD CAN, V23, P607, DOI 10.1139/f66-051; Takai N, 2000, J MAR BIOL ASSOC UK, V80, P675, DOI 10.1017/S0025315400002502; TEMTE JL, 1991, J ZOOL, V224, P617, DOI 10.1111/j.1469-7998.1991.tb03790.x; Thomson JA, 2012, MAR ECOL PROG SER, V453, P213, DOI 10.3354/meps09637; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Tollit DJ, 1997, CAN J FISH AQUAT SCI, V54, P105, DOI 10.1139/cjfas-54-1-105; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Yang DY, 2008, ENVIRON REV, V16, P71, DOI 10.1139/A08-001	91	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2020	15	1							e0225889	10.1371/journal.pone.0225889	http://dx.doi.org/10.1371/journal.pone.0225889			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5QT	31967988	gold, Green Published, Green Submitted			2022-12-26	WOS:000534373000002
J	Wen, SH; Li, X; Ling, YH; Chen, SQ; Deng, QW; Yang, L; Li, Y; Shen, JT; Qiu, YX; Zhan, YQ; Lai, HJ; Zhang, XY; Ke, ZF; Huang, WQ				Wen, Shihong; Li, Xiang; Ling, Yihong; Chen, Shaoqian; Deng, Qiwen; Yang, Lu; Li, Ying; Shen, Jiantong; Qiu, Yuxin; Zhan, Yaqing; Lai, Hanjin; Zhang, Xuyu; Ke, Zunfu; Huang, Wenqi			HMGB1-associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats	FASEB JOURNAL			English	Article						cell death; gut-liver axis; high-mobility group box-1; inflammation	MOBILITY GROUP BOX-1; ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSE; REACTIVE OXYGEN; PROTECTS; GUT; ACTIVATION; DEPLETION; RECEPTOR; STRESS	Reperfusion of the ischemic intestine often leads to drive distant organ injury, especially injuries associated with hepatocellular dysfunction. The precise molecular mechanisms and effective multiple organ protection strategies remain to be developed. In the current study, significant remote liver dysfunction was found after 6 hours of reperfusion according to increased histopathological scores, serum lactate dehydrogenase (LDH), alanine aminotransferase (ALT)/aspartate aminotransferase (AST) levels, as well as enhanced bacterial translocation in a rat intestinal ischemia/reperfusion (I/R) injury model. Moreover, receptor-interacting protein kinase 1/3 (RIP1/3) and phosphorylated-MLKL expressions in tissue were greatly elevated, indicating that necroptosis occurred and resulted in acute remote liver function impairment. Inhibiting the necroptotic pathway attenuated HMGB1 cytoplasm translocation and tissue damage. Meanwhile, macrophage-depletion study demonstrated that Kupffer cells (KCs) are responsible for liver damage. Blocking HMGB1 partially restored the liver function via suppressed hepatocyte necroptosis, tissue inflammation, hepatic KCs, and circulating macrophages M1 polarization. What's more, HMGB1 neutralization further protects against intestinal I/R-associated liver damage in microbiota-depleted rats. Therefore, intestinal I/R is likely associated with acute liver damage due to hepatocyte necroptosis, and which could be ameliorated by Nec-1 administration and HMGB1 inhibition with the neutralizing antibody and inhibitor. Necroptosis inhibition and HMGB1 neutralization/inhibition, may emerge as effective pharmacological therapies to minimize intestinal I/R-induced acute remote organ dysfunction.	[Wen, Shihong; Deng, Qiwen; Yang, Lu; Shen, Jiantong; Qiu, Yuxin; Zhan, Yaqing; Zhang, Xuyu; Huang, Wenqi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Peoples R China; [Li, Xiang] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Anesthesiol, Shanghai, Peoples R China; [Ling, Yihong] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Ling, Yihong] Sun Yat Sen Univ, Canc Ctr, Dept Pathol, Guangzhou, Peoples R China; [Chen, Shaoqian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Lab, Guangzhou, Peoples R China; [Li, Ying] State Key Lab Appl Microbiol Southern China, Guangzhou, Peoples R China; [Li, Ying] Guangdong Acad Sci, Guangdong Inst Microbiol, Guangzhou, Peoples R China; [Lai, Hanjin] Sun Yat Sen Univ, Affiliated Hosp 1, Surg Intens Care Unit, Guangzhou, Peoples R China; [Ke, Zunfu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Sun Yat Sen University; Sun Yat Sen University	Huang, WQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Peoples R China.; Ke, ZF (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China.	kezunfu@mail.sysu.edu.cn; scorpiosslove@aliyun.com	Wen, Shihong/T-5246-2019; Wen, shihong/GWC-7753-2022; huang, wen/GXW-0661-2022	Wen, Shihong/0000-0003-3433-2938; Li, Ying/0000-0003-4012-6954	National Natural Science Foundation of China [81772116, 81801895, 81770619]; Natural Science Foundation of Guangdong Province, China [2017A030313572]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from National Natural Science Foundation of China (No. 81772116, No. 81801895 and No. 81770619), and grant from Natural Science Foundation of Guangdong Province, China (No. 2017A030313572).	Acosta S, 2010, SEMIN VASC SURG, V23, P4, DOI 10.1053/j.semvascsurg.2009.12.001; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Beaumont M, 2018, FASEB J, V32, P6681, DOI 10.1096/fj.201800544; Boulter L, 2015, J CLIN INVEST, V125, P1269, DOI 10.1172/JCI76452; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Degos V, 2013, ANESTHESIOLOGY, V118, P527, DOI 10.1097/ALN.0b013e3182834d94; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718; Emal D, 2017, J AM SOC NEPHROL, V28, P1450, DOI 10.1681/ASN.2016030255; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Feng D, 2017, 5TH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER SCIENCE APPLICATIONS AND TECHNOLOGIES (ACSAT 2017), P1, DOI 10.23977/acsat.2017.1001; Ferenbach DA, 2012, KIDNEY INT, V82, P928, DOI 10.1038/ki.2012.207; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Horie Y, 1997, J CLIN INVEST, V99, P781, DOI 10.1172/JCI119224; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kalimeris K, 2016, J SURG RES, V206, P263, DOI 10.1016/j.jss.2016.08.049; Kanou T, 2018, J HEART LUNG TRANSPL, V37, P1261, DOI 10.1016/j.healun.2018.04.005; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Li L, 2018, CELL PHYSIOL BIOCHEM, V51, P557, DOI 10.1159/000495276; Li X, 2018, J SURG RES, V225, P108, DOI 10.1016/j.jss.2018.01.007; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Liu JP, 2014, INT J MED SCI, V11, P626, DOI 10.7150/ijms.8228; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Matsuo S, 2018, AM J PHYSIOL-GASTR L, V315, pG283, DOI 10.1152/ajpgi.00024.2018; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Mihm S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103104; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Oami T, 2018, SHOCK, V50, P427, DOI 10.1097/SHK.0000000000001040; Pavlosky A, 2014, AM J TRANSPLANT, V14, P1778, DOI 10.1111/ajt.12779; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711; Rao ZQ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01299; Shafik AN, 2013, DIGEST DIS SCI, V58, P650, DOI 10.1007/s10620-012-2391-1; Shukla PK, 2018, FASEB J, V32, P6274, DOI 10.1096/fj.201800351R; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sturm E, 2005, J HEPATOL, V42, P102, DOI 10.1016/j.jhep.2004.09.019; Sureshbabu A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98411; Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007; Van Hauwermeiren F, 2015, MUCOSAL IMMUNOL, V8, P828, DOI 10.1038/mi.2014.112; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang Q, 2009, ANESTHESIOLOGY, V110, P1279, DOI 10.1097/ALN.0b013e3181a160d6; Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982; Wen SH, 2013, SURGERY, V153, P555, DOI 10.1016/j.surg.2012.09.017; Wen SH, 2017, J CELL MOL MED, V21, P432, DOI 10.1111/jcmm.12987; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Yamagishi Y, 2002, AM J PHYSIOL-GASTR L, V282, pG640, DOI 10.1152/ajpgi.00171.2001; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b; Yokoi T, 2018, SURGERY, V163, P270, DOI 10.1016/j.surg.2017.08.025; Zelic M, 2018, J CLIN INVEST, V128, P2064, DOI 10.1172/JCI96147; Zhao HL, 2018, AM J TRANSPLANT, V18, P1890, DOI 10.1111/ajt.14699; Zhao HL, 2015, KIDNEY INT, V87, P738, DOI 10.1038/ki.2014.388; Zhou S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00948	66	39	42	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4384	4402		10.1096/fj.201900817R	http://dx.doi.org/10.1096/fj.201900817R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961020	hybrid			2022-12-26	WOS:000508840200001
J	de Laffolie, J; Sheridan, D; Reinshagen, K; Wessel, L; Zimmermann, C; Stricker, S; Lerch, MM; Weigel, M; Hain, T; Domann, E; Rudloff, S; Nichols, BL; Naim, HY; Zimmer, KP				de Laffolie, Jan; Sheridan, Diana; Reinshagen, Konrad; Wessel, Lucas; Zimmermann, Christian; Stricker, Sebastian; Lerch, Markus M.; Weigel, Markus; Hain, Torsten; Domann, Eugen; Rudloff, Silvia; Nichols, Buford L.; Naim, Hassan Y.; Zimmer, Klaus-Peter			Digestive enzyme expression in the large intestine of children with short bowel syndrome in a late stage of adaptation	FASEB JOURNAL			English	Article						enteral nutrition; microbiota; parenteral nutrition; pediatric intestinal failure; pediatric short bowel syndrome; prognostic factors	MICROBIOTA SIGNATURES; ADULT PATIENTS; RAT MODEL; RESECTION; COLON; GROWTH; FEATURES; STARCH	Background and aims: Intestinal adaptation in short bowel syndrome (SBS) includes morphologic processes and functional mechanisms. This study investigated whether digestive enzyme expression in the duodenum and colon is upregulated in SBS patients. Method: Sucrase-isomaltase (SI), lactase-phlorizin hydrolase (LPH), and neutral Aminopeptidase N (ApN) were analyzed in duodenal and colonic biopsies from nine SBS patients in a late stage of adaptation as well as healthy and disease controls by immunoelectron microscopy (IEM), Western blots, and enzyme activities. Furthermore, proliferation rates and intestinal microbiota were analyzed in the mucosal specimen. Results: We found significantly increased amounts of SI, LPH, and ApN in colonocytes in most SBS patients with large variation and strongest effect for SI and ApN. Digestive enzyme expression was only partially elevated in duodenal enterocytes due to a low proliferation level measured by Ki-67 staining. Microbiome analysis revealed high amounts of Lactobacillus resp. low amounts of Proteobacteria in SBS patients with preservation of colon and ileocecal valve. Colonic expression was associated with a better clinical course in single cases. Conclusion: In SBS patients disaccharidases and peptidases can be upregulated in the colon. Stimulation of this colonic intestinalization process by drugs, nutrients, and pre- or probiotics might offer better therapeutic approaches.	[de Laffolie, Jan; Zimmermann, Christian; Stricker, Sebastian; Rudloff, Silvia; Zimmer, Klaus-Peter] Justus Liebig Univ Giessen, Dept Paediat, Giessen, Germany; [Sheridan, Diana] Justus Liebig Univ Giessen, Dept Pathol, Giessen, Germany; [Reinshagen, Konrad] UKE Univ Hosp Eppendorf, Altona Childrens Hosp, Dept Pediat Surg, Hamburg, Germany; [Wessel, Lucas] Heidelberg Univ, Med Fac Mannheim, Dept Pediat Surg, Mannheim, Germany; [Lerch, Markus M.] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med A, Greifswald, Germany; [Weigel, Markus; Hain, Torsten; Domann, Eugen] Justus Liebig Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Weigel, Markus; Hain, Torsten; Domann, Eugen] Justus Liebig Univ Giessen, German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Giessen, Germany; [Nichols, Buford L.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Ernst Moritz Arndt Universitat Greifswald; Justus Liebig University Giessen; German Center for Infection Research; Justus Liebig University Giessen; Baylor College of Medicine; University of Veterinary Medicine Hannover, Foundation	de Laffolie, J (corresponding author), Univ Giessen, Dept Gen Pediat & Neonatol, Feulgenstr 12, D-35392 Giessen, Germany.	jan.delaffolie@paediat.med.uni-giessen.de	Zimmer, Klaus-Peter/AAY-9261-2020; Lerch, Markus M./E-2206-2016; Zimmer, Klaus-Peter/AAY-9351-2020; de Laffolie, Jan/K-2215-2019	Lerch, Markus M./0000-0002-9643-8263; de Laffolie, Jan/0000-0003-1023-7442; Weigel, Markus/0000-0002-3140-3174	German Research Foundation (DFG) [SFB621]; Justus Liebig University Giessen	German Research Foundation (DFG)(German Research Foundation (DFG)); Justus Liebig University Giessen	German Research Foundation (DFG) (SFB621, to HYN); intramural funding from Justus Liebig University Giessen	Buccigrossi V, 2013, J PEDIATR GASTR NUTR, V56, P40, DOI 10.1097/MPG.0b013e318268a9a4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Davidovics ZH, 2016, JPEN-PARENTER ENTER, V40, P1106, DOI 10.1177/0148607115591216; Domann E, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00747-16; Dou Y, 2002, NEUROGASTROENT MOTIL, V14, P43, DOI 10.1046/j.1365-2982.2002.00301.x; Dunn JCY, 1997, J SURG RES, V67, P90, DOI 10.1006/jsre.1996.4959; Engelstad HJ, 2018, J AM COLL SURGEONS, V227, P439, DOI 10.1016/j.jamcollsurg.2018.07.657; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; Fouhse JM, 2015, J NUTR, V145, P2464, DOI 10.3945/jn.115.214353; Gao S, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0105-4; Gillard L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00224; GRIFFITHS G, 1986, J HISTOCHEM CYTOCHEM, V34, P1389, DOI 10.1177/34.11.3534077; Huang YH, 2017, J GASTROEN HEPATOL, V32, P1949, DOI 10.1111/jgh.13806; Jiang HP, 2011, WORLD J GASTROENTERO, V17, P2572, DOI 10.3748/wjg.v17.i20.2572; Joly F, 2009, AM J PHYSIOL-GASTR L, V297, pG116, DOI 10.1152/ajpgi.90657.2008; King DR, 1996, AUST NZ J SURG, V66, P543, DOI 10.1111/j.1445-2197.1996.tb00806.x; Korpela K, 2017, JPEN-PARENTER ENTER, V41, P238, DOI 10.1177/0148607115584388; Kouti V, 2011, FUND CLIN PHARMACOL, V25, P734, DOI 10.1111/j.1472-8206.2010.00901.x; Li GP, 2015, J MICROBIOL BIOTECHN, V25, P1136, DOI 10.4014/jmb.1412.12047; Lilja HE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0084-7; Liu XW, 2006, AM J CLIN NUTR, V84, P1142, DOI 10.1093/ajcn/84.5.1142; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Mayeur C, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4010016; MENARD D, 1987, J PEDIATR GASTR NUTR, V6, P509, DOI 10.1097/00005176-198707000-00003; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; Musch MW, 2002, AM J PHYSIOL-GASTR L, V283, pG975, DOI 10.1152/ajpgi.00528.2001; Neelis E, 2019, JPEN-PARENTER ENTER, V43, P194, DOI 10.1002/jpen.1423; NIGHTINGALE JMD, 1992, GUT, V33, P1493, DOI 10.1136/gut.33.11.1493; Norsa L, 2019, AM J CLIN NUTR, V109, P1112, DOI 10.1093/ajcn/nqy367; Pereira-Fantini PM, 2011, HISTOCHEM CELL BIOL, V135, P195, DOI 10.1007/s00418-011-0778-2; Piper HG, 2017, JPEN-PARENTER ENTER, V41, P1202, DOI 10.1177/0148607116658762; Rossi L, 2007, J PEDIATR GASTR NUTR, V45, P213, DOI 10.1097/MPG.0b013e31803c75e8; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Sigalet DL, 2006, DIGEST DIS SCI, V51, P1557, DOI 10.1007/s10620-006-9077-5; Sukhotnik I, 2004, PEDIATR SURG INT, V20, P185, DOI 10.1007/s00383-004-1143-5; Sukhotnik I, 2012, AM J PHYSIOL-GASTR L, V302, pG1274, DOI 10.1152/ajpgi.00532.2011; Thiesen A, 2003, BEST PRACT RES CL GA, V17, P981, DOI 10.1016/S1521-6918(03)00097-0; Topping DL, 1997, J NUTR, V127, P615, DOI 10.1093/jn/127.4.615; Tremblay E, 2011, J PEDIATR GASTR NUTR, V52, P670, DOI 10.1097/MPG.0b013e3182078370; Turner JM, 2011, J PEDIATR GASTR NUTR, V52, P9, DOI 10.1097/MPG.0b013e3181f18ca0; VANDERHOOF JA, 1992, GASTROENTEROLOGY, V102, P1949, DOI 10.1016/0016-5085(92)90318-S; Vegge A, 2013, AM J PHYSIOL-GASTR L, V305, pG277, DOI 10.1152/ajpgi.00064.2013; Wang WS, 2012, PEDIATR SURG INT, V28, P533, DOI 10.1007/s00383-012-3075-9; Wetzel G, 2009, BIOL CHEM, V390, P545, DOI 10.1515/BC.2009.077; Yang Q, 2010, J PEDIATR GASTR NUTR, V50, P16, DOI 10.1097/MPG.0b013e3181c2c2af; Zeichner SL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215351; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656; ZWEIBAUM A, 1984, INT J CANCER, V34, P591, DOI 10.1002/ijc.2910340502	51	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3983	3995		10.1096/fj.201901758RR	http://dx.doi.org/10.1096/fj.201901758RR		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957074	hybrid			2022-12-26	WOS:000508135700001
J	Alabi, EB; Simpson, TL				Alabi, Emmanuel B.; Simpson, Trefford L.			Pupil response to noxious corneal stimulation	PLOS ONE			English	Article							SEX-DIFFERENCES; DILATION RESPONSE; CLINICAL PAIN; SENSITIVITY; GENDER; CONJUNCTIVA; ATTENTION; PATHOPHYSIOLOGY; INNERVATION; VOLUNTEERS	Purpose Ocular somatosensory-autonomic reflexes play critical roles in maintaining homeostasis of the eye. The purpose of this study was to investigate the pupil response to nociceptive corneal stimuli. Methods A Waterloo-Belmonte pneumatic esthesiometer was used to determine detection thresholds and randomly deliver mechanical and chemical stimuli from levels of detection threshold to twice the threshold in 50% steps to the central cornea of 15 healthy subjects. For each stimulus, imaging of the stimulated/unstimulated eye was performed using two modified/calibrated Logitech c920 digital cameras for 4 seconds each, pre/post stimulus capture. The data were processed with a custom segmentation algorithm to help identify the pupils and pupil diameter was measured using ImageJ software. Pupil dilation response differences between the ipsi- and contralateral eye was analyzed using dependent t-tests. The effect of stimulus intensity, modality and sex of subjects were analyzed using repeated measures. Results In mechanical and chemical stimulation experiments, there was no difference in pupil responses between the stimulated eye and the unstimulated eye, (all dependent T-test p > 0.05). On average, pupil diameter increased from baseline as the corneal stimulus intensity increased. This happened regardless of whether mechanical or chemical stimulation occurred (ANOVA p < 0.05). At 200% threshold, pupil diameter was greater than at all stimulus intensities (Tukey HSD, all p < 0.05). Based on stimulus intensity, females had greater pupil diameters than males at levels of 150% threshold and 200% threshold (ANOVA p < 0.05, all Tukey HSD p < 0.05). Conclusion This study serves as a basis for the characterization of the local stimulus-response neural circuitry relating nociceptive stimuli to autonomic responses and in combination with our work on completely separate autonomic circuits of bulbar conjunctival vessel dilation and reflex tearing suggests that the monotonic measurements of redness, tearing and pupils provide accurate, separable responses that reflect painful stimulus intensity.	[Alabi, Emmanuel B.; Simpson, Trefford L.] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada	University of Waterloo	Alabi, EB (corresponding author), Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada.	ebalabi@uwaterloo.ca		Alabi, Emmanuel/0000-0001-8841-2306	Natural Sciences and Engineering Research Council of Canada (NSERC) [53274, 101]; Canadian Foundation for Innovation (CFI) [51]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant101 (http://www.nserc-crsng.gc.ca/index_eng.asp) and the Canadian Foundation for Innovation (CFI) Infrastructure Grant 51 (https://www.innovation.ca/) to TLS. This work was also supported by Natural Sciences and Engineering Research Council of Canada (NSERC) 53274 (http://www.nserc-crsng.gc.ca/index_eng.asp) to EBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2006, EXP EYE RES, V83, P932, DOI 10.1016/j.exer.2006.04.018; Acosta MC, 2001, INVEST OPHTH VIS SCI, V42, P2063; Alabi EB, 2019, OPTOMETRY VISION SCI, V96, P507, DOI 10.1097/OPX.0000000000001398; BEATTY J, 1982, PSYCHOPHYSIOLOGY, V19, P167, DOI 10.1111/j.1469-8986.1982.tb02540.x; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Belmonte C, 1999, INVEST OPHTH VIS SCI, V40, P513; Belmonte Carlos, 2004, Ocul Surf, V2, P248; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Chapman CR, 1999, PSYCHOPHYSIOLOGY, V36, P44, DOI 10.1017/S0048577299970373; CHEN ACN, 1993, PAIN, V54, P115, DOI 10.1016/0304-3959(93)90200-9; Chen JT, 2010, INVEST OPHTH VIS SCI, V51, P876, DOI 10.1167/iovs.08-3072; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Colloca L, 2006, EUR J PAIN, V10, P659, DOI 10.1016/j.ejpain.2005.10.009; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Donaldson GW, 2003, PAIN, V102, P97, DOI 10.1016/S0304-3959(02)00351-2; Eisenach JC, 2017, J NEUROSCI METH, V279, P52, DOI 10.1016/j.jneumeth.2017.01.005; ELLERMEIER W, 1995, PAIN, V61, P435, DOI 10.1016/0304-3959(94)00203-Q; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FEINE JS, 1991, PAIN, V44, P255, DOI 10.1016/0304-3959(91)90094-E; Feng YW, 2003, INVEST OPHTH VIS SCI, V44, P529, DOI 10.1167/iovs.02-0003; Fillingim RB, 1995, GENDER DIFFERENCES R, P209; Gescheider, 1997, PSYCHOPHYSICS FUNDAM, P1; Hofle M, 2012, PAIN, V153, P1074, DOI 10.1016/j.pain.2012.02.010; Hofle M, 2008, INT J PSYCHOPHYSIOL, V70, P171, DOI 10.1016/j.ijpsycho.2008.06.008; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Iriki A, 1996, NEUROSCI RES, V25, P173; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; JENSEN MP, 1991, J PSYCHOSOM RES, V35, P149, DOI 10.1016/0022-3999(91)90069-Z; Kardon R, 1995, Curr Opin Ophthalmol, V6, P20, DOI 10.1097/00055735-199512000-00004; LARSON MD, 1993, ANESTH ANALG, V76, P1072; LAUTENBACHER S, 1991, PERCEPT PSYCHOPHYS, V50, P179, DOI 10.3758/BF03212218; LAWRENSON JG, 1993, BRIT J OPHTHALMOL, V77, P339, DOI 10.1136/bjo.77.6.339; LEVINE FM, 1991, PAIN, V44, P69, DOI 10.1016/0304-3959(91)90149-R; LOEWENFELD I. E., 1958, DOCUMENTA OPHTHALMOL, V12, P185, DOI 10.1007/BF00913471; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; MILLODOT M, 1974, BRIT J OPHTHALMOL, V58, P752, DOI 10.1136/bjo.58.8.752; MILLODOT M, 1975, NATURE, V255, P151, DOI 10.1038/255151a0; MILLODOT M, 1984, ACTA OPHTHALMOL, V62, P819; MILLODOT M, 1972, BRIT J OPHTHALMOL, V56, P844, DOI 10.1136/bjo.56.11.844; Oka S, 2000, J PSYCHOPHYSIOL, V14, P97, DOI 10.1027//0269-8803.14.2.97; Oka S, 2007, CLIN NEUROPHYSIOL, V118, P2016, DOI 10.1016/j.clinph.2007.04.023; OTTO MW, 1985, PERCEPT MOTOR SKILL, V61, P383, DOI 10.2466/pms.1985.61.2.383; Pedersen EJ, 2019, PEERJ, V7, DOI 10.7717/peerj.6876; Rao SBS, 2014, INVEST OPHTH VIS SCI, V55, P1095, DOI 10.1167/iovs.13-12874; RCore Team, 2020, R LANG ENV STAT COMP; REEVES AG, 1969, NEUROLOGY, V19, P1145, DOI 10.1212/WNL.19.12.1145; RISS B, 1982, BRIT J OPHTHALMOL, V66, P123, DOI 10.1136/bjo.66.2.123; Rosenthal P, 2012, OCUL SURF, V10, P2, DOI 10.1016/j.jtos.2012.01.002; Situ P, 2007, EXP EYE RES, V85, P400, DOI 10.1016/j.exer.2007.06.006; Situ P, 2010, INVEST OPHTH VIS SCI, V51, P5640, DOI 10.1167/iovs.10-5502; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Treister R, 2012, PAIN, V153, P1807, DOI 10.1016/j.pain.2012.04.008; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; VanderWerf F, 1996, J ANAT, V189, P285; Vega JA, 1999, CORNEA, V18, P675, DOI 10.1097/00003226-199911000-00009; VELLE W, 1987, PERSPECT BIOL MED, V30, P490; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Yang LL, 2003, ANESTHESIOLOGY, V99, P1281, DOI 10.1097/00000542-200312000-00008	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227771	10.1371/journal.pone.0227771	http://dx.doi.org/10.1371/journal.pone.0227771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951635	Green Published, gold			2022-12-26	WOS:000534370500027
J	Devall, M; Jennelle, LT; Bryant, J; Bien, S; Peters, U; Powell, S; Casey, G				Devall, Matthew; Jennelle, Lucas T.; Bryant, Jennifer; Bien, Stephanie; Peters, Ulrike; Powell, Steven; Casey, Graham			Modeling the effect of prolonged ethanol exposure on global gene expression and chromatin accessibility in normal 3D colon organoids	PLOS ONE			English	Article							ATAC-SEQ; CANCER; OPPORTUNITIES; TRANSITION; PATHWAYS; GROWTH; CELL	In this study we aimed to explore the potential biological effect of ethanol exposure on healthy colon epithelial cells using normal human colon 3D organoid "mini-gut" cultures. In numerous published studies ethanol use has been shown to be an environmental risk factor for colorectal cancer (CRC) development; however, the influence of ethanol exposure on normal colon epithelial cell biology remains poorly understood. We investigated the potential molecular effects of ethanol exposure in normal colon 3D organoids in a small pilot study (n = 3) using RNA-seq and ATAC-seq. We identify 1965 differentially expressed genes and 2217 differentially accessible regions of chromatin in response to ethanol treatment. Further, by cross-referencing our results with previously published analysis in colorectal cancer cell lines, we have not only validated a number of reported differentially expressed genes, but also identified several novel candidates for future investigation. In summary, our data highlights the potential importance for the use of normal colon 3D organoid models as a novel tool for the investigation of the relationship between the effects of environmental risk factors associated with colorectal cancer and the molecular mechanisms through which they confer this risk.	[Devall, Matthew; Jennelle, Lucas T.; Bryant, Jennifer; Casey, Graham] Univ Virginia, Ctr Publ Hlth Genom, Dept Publ Hlth Sci, Charlottesville, VA 22904 USA; [Bien, Stephanie; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Powell, Steven] Univ Virginia, Gastroenterol & Heaptol, Digest Hlth Ctr, Charlottesville, VA USA	University of Virginia; Fred Hutchinson Cancer Center; University of Virginia	Casey, G (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Dept Publ Hlth Sci, Charlottesville, VA 22904 USA.	gc8r@virginia.edu	Devall, Matthew/GPG-1785-2022	Devall, Matthew/0000-0001-5943-4397; Jennelle, Lucas/0000-0001-5696-1749	NCI [NIH/NCI CA201407, NIH/NCI CA143237]; NIH [NIH/NCI CA201407, NIH/NCI CA143237]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this research was provided by NIH and NCI grants: NIH/NCI CA201407 to UP, and NIH/NCI CA143237 to GC (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2016, MOL METAB, V5, P233, DOI 10.1016/j.molmet.2016.01.002; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 2008, GENOME BIOL; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Cao J, 2018, SCIENCE; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen W, 2019, MOD PATHOL; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dame MK, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.153049; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forsyth CB, 2017, ALCOHOL CLIN EXP RES, V41, P2100, DOI 10.1111/acer.13519; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Fujii M, 2018, CELL STEM CELL, V23, P787, DOI 10.1016/j.stem.2018.11.016; Huyghe JR, 2019, NAT GENET, V51, P76, DOI 10.1038/s41588-018-0286-6; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindeboom RGH, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188227; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Moon JW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-377; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Saeed O, 2019, J CLIN PATHOL, V72, P135, DOI 10.1136/jclinpath-2018-205471; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Stark R., 2011, R PACKAGE VERSION, V100, P1; Wang J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03856-y; Wang SY, 2012, BREAST CANCER RES TR, V133, P1037, DOI 10.1007/s10549-011-1902-7	32	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227116	10.1371/journal.pone.0227116	http://dx.doi.org/10.1371/journal.pone.0227116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951625	gold, Green Published			2022-12-26	WOS:000534370500010
